PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Miloyan, B; Bulley, A; Brilot, B; Suddendorf, T				Miloyan, Beyon; Bulley, Adam; Brilot, Ben; Suddendorf, Thomas			The association of Social Anxiety Disorder, Alcohol Use Disorder and reproduction: Results from four nationally representative samples of adults in the USA	PLOS ONE			English	Article							COMORBIDITY SURVEY REPLICATION; EMOTIONAL FACIAL EXPRESSIONS; SUBSTANCE USE; EVOLUTIONARY PERSPECTIVE; EPIDEMIOLOGIC SURVEY; NCS-R; PHOBIA; INDIVIDUALS; IMPULSIVITY; BEHAVIOR	Social Anxiety Disorder (SAD) and Alcohol Use Disorder (AUD) are highly prevalent and frequently co-occur. The results of population studies suggest that SAD tends to precede AUD, and the results of laboratory studies suggest that alcohol use facilitates social behaviors in socially anxious individuals. Therefore, we posited that, in a modern context, a tendency to consume alcohol may be positively selected for among socially anxious individuals by its effect on the likelihood of finding a partner and reproducing. We tested the hypothesis that a higher proportion of individuals with a lifetime diagnosis of SAD and AUD reproduce (i.e., have at least one child) relative to individuals with SAD absent AUD in an individual participant meta-analysis based on over 65,000 adults derived from four nationally representative cross-sectional samples. We then cross-validated these findings against the results of a 10-year follow up of one of these surveys. Lifetime history of SAD was not associated with reproduction whereas lifetime history of AUD was positively associated with reproduction. There was no statistically detectable difference in the proportion of individuals with a lifetime history of SAD with or without AUD who reproduced. There was considerable heterogeneity in all of the analyses involving SAD, suggesting that there are likely to be other pertinent variables relating to SAD and reproduction that should be delineated.	[Miloyan, Beyon] Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Miloyan, Beyon] Federat Univ, Fac Hlth, Dept Psychol, Ballarat, Vic, Australia; [Bulley, Adam; Suddendorf, Thomas] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Brilot, Ben] Plymouth Univ, Sch Biol Sci, Plymouth, Devon, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Federation University Australia; University of Queensland; University of Plymouth	Miloyan, B (corresponding author), Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA.; Miloyan, B (corresponding author), Federat Univ, Fac Hlth, Dept Psychol, Ballarat, Vic, Australia.	b.miloyan@federation.edu.au	Bulley, Adam/V-2897-2017; Brilot, Ben/C-6435-2008; Brilot, Ben/M-9074-2019; Suddendorf, Thomas/A-1631-2017	Bulley, Adam/0000-0001-8014-0078; Brilot, Ben/0000-0002-2124-080X; Brilot, Ben/0000-0002-2124-080X; Suddendorf, Thomas/0000-0003-3328-7442	National Institute on Aging (US) [T32AG000247]; Australian Research Council (ARC) [DP140101341]	National Institute on Aging (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Australian Research Council (ARC)(Australian Research Council)	This work was supported by National Institute on Aging (US) grant #T32AG000247 and Australian Research Council (ARC) Discovery Grant DP140101341.	Abrams K, 2001, DRUG ALCOHOL DEPEN, V64, P219, DOI 10.1016/S0376-8716(01)00125-9; Alegria M, 2009, INT J METH PSYCH RES, V13, P208; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bacon AK, 2010, ADDICT BEHAV, V35, P925, DOI 10.1016/j.addbeh.2010.06.002; Bateson P, 2013, TRENDS ECOL EVOL, V28, P712, DOI 10.1016/j.tree.2013.09.013; Battista SR, 2012, J SOC CLIN PSYCHOL, V31, P1074, DOI 10.1521/jscp.2012.31.10.1074; Buckner JD, 2008, J PSYCHIATR RES, V42, P230, DOI 10.1016/j.jpsychires.2007.01.002; Buckner JD, 2013, DEPRESS ANXIETY, V30, P276, DOI 10.1002/da.22032; Bulley A, 2016, J AFFECT DISORDERS, V196, P62, DOI 10.1016/j.jad.2016.02.028; Burstein M, 2011, J AM ACAD CHILD PSY, V50, P870, DOI 10.1016/j.jaac.2011.06.005; CRAWFORD CB, 1993, TRENDS ECOL EVOL, V8, P183, DOI 10.1016/0169-5347(93)90145-F; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eaton W., 2012, JOHNS HOPKINS BLOOMB; Eaton WW, 2013, AM J EPIDEMIOL, V178, P1366, DOI 10.1093/aje/kwt219; Emanuele MA, 1998, ALCOHOL HEALTH RES W, V22, P195; Fernie G, 2013, ADDICTION, V108, P1916, DOI 10.1111/add.12283; Gerlach AL, 2006, BRIT J CLIN PSYCHOL, V45, P279, DOI 10.1348/014466505X49862; Gilbert P, 2001, PSYCHIAT CLIN N AM, V24, P723, DOI 10.1016/S0193-953X(05)70260-4; Gilbert P, 2003, SOC RES, V70, P1205; Gilles DM, 2006, ADDICT BEHAV, V31, P388, DOI 10.1016/j.addbeh.2005.05.020; Grant B. F., 2003, SOURCE AND ACCURACY; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1351, DOI 10.4088/JCP.v66n1102; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Gullo MJ, 2008, NEUROSCI BIOBEHAV R, V32, P1507, DOI 10.1016/j.neubiorev.2008.06.003; Heeringa SG, 2004, INT J METH PSYCH RES, V13, P221, DOI 10.1002/mpr.179; Keough MT, 2016, PERS INDIV DIFFER, V88, P45, DOI 10.1016/j.paid.2015.08.036; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; Kessler RC, 2004, INT J METH PSYCH RES, V13, P69, DOI 10.1002/mpr.167; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC., 1994, INT REV PSYCHIAT, V6; Kessler RC, 2011, TXB PSYCHIAT EPIDEMI; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; MARKS IM, 1994, ETHOL SOCIOBIOL, V15, P247, DOI 10.1016/0162-3095(94)90002-7; Meisel MK, 2015, ADDICT BEHAV, V51, P72, DOI 10.1016/j.addbeh.2015.07.009; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; Nesse RM, 1997, SCIENCE, V278, P63, DOI 10.1126/science.278.5335.63; Nettle D, 2011, PHILOS T R SOC B, V366, P357, DOI 10.1098/rstb.2010.0073; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; OHMAN A, 1986, PSYCHOPHYSIOLOGY, V23, P123, DOI 10.1111/j.1469-8986.1986.tb00608.x; Ornoy A, 2010, INT J ENV RES PUB HE, V7, P364, DOI 10.3390/ijerph7020364; Schneier FR, 2010, PSYCHOL MED, V40, P977, DOI 10.1017/S0033291709991231; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stevens S, 2008, J ANXIETY DISORD, V22, P940, DOI 10.1016/j.janxdis.2007.09.007; Stevens S, 2009, BRIT J CLIN PSYCHOL, V48, P125, DOI 10.1348/014466508X368856; Stieglitz J, 2015, BRAIN BEHAV IMMUN, V49, P130, DOI 10.1016/j.bbi.2015.05.008; Stieglitz J, 2015, J GERONTOL B-PSYCHOL, V70, P948, DOI 10.1093/geronb/gbu080; Stulp G, 2016, HUM NATURE-INT BIOS, V27, P422, DOI 10.1007/s12110-016-9269-4; TROWER P, 1989, CLIN PSYCHOL REV, V9, P19, DOI 10.1016/0272-7358(89)90044-5; Trower P., 1990, HDB SOCIAL EVALUATIO, P11, DOI [DOI 10.1007/978-1-4899-2504-6_2, 10.1007/978-1-4899-2504-6_2]; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119965; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WITTCHEN HU, 1994, J PSYCHIAT RES, V28, P57, DOI 10.1016/0022-3956(94)90036-1	55	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188436	10.1371/journal.pone.0188436	http://dx.doi.org/10.1371/journal.pone.0188436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161319	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000055
J	Ritov, I; Kogut, T				Ritov, Ilana; Kogut, Tehila			Altruistic behavior in cohesive social groups: The role of target identifiability	PLOS ONE			English	Article							MEASUREMENT ISSUES; IDENTITY; DILEMMAS; SELF; CATEGORIZATION; IDENTIFICATION; INTERVENTION; ENTITATIVITY; VICTIM; TRANSFORMATION	People's tendency to be more generous toward identifiable victims than toward unidentifiable or statistical victims is known as the Identifiable Victim Effect. Recent research has called the generality of this effect into question, showing that in cross-national contexts, identifiability mostly affects willingness to help victims of one's own "in-group." Furthermore, in inter-group conflict situations, identifiability increased generosity toward a member of the adversary group, but decreased generosity toward a member of one's own group. In the present research we examine the role of group-cohesiveness as an underlying factor accounting for these divergent findings. In particular, we examined novel groups generated in the lab, using the minimal group paradigm, as well as natural groups of students in regular exercise sections. Allocation decisions in dictator games revealed that a group's cohesiveness affects generosity toward in-group and out-group recipients differently, depending on their identifiability. In particular, in cohesive groups the identification of an in-group recipient decreased, rather than increased generosity.	[Ritov, Ilana] Hebrew Univ Jerusalem, Sch Educ, Jerusalem, Israel; [Ritov, Ilana] Hebrew Univ Jerusalem, Ctr Study Rat, Jerusalem, Israel; [Kogut, Tehila] Ben Gurion Univ Negev, Dept Educ, Beer Sheva, Israel; [Kogut, Tehila] Ben Gurion Univ Negev, Decis Making & Econ Psychol Ctr, Beer Sheva, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Ben Gurion University; Ben Gurion University	Ritov, I (corresponding author), Hebrew Univ Jerusalem, Sch Educ, Jerusalem, Israel.; Ritov, I (corresponding author), Hebrew Univ Jerusalem, Ctr Study Rat, Jerusalem, Israel.	ilana.ritov@huji.ac.il		Kogut, Tehila/0000-0001-8652-5112	Israel Science Foundation [1068/15]	Israel Science Foundation(Israel Science Foundation)	Research supported by the Israel Science Foundation, grants 1068/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1990, ECON J, V100, P464, DOI 10.2307/2234133; Badea C, 2012, J EXP SOC PSYCHOL, V48, P1094, DOI 10.1016/j.jesp.2012.03.006; Batson CD, 2002, PERS SOC PSYCHOL B, V28, P1656, DOI 10.1177/014616702237647; Begue L, 2008, AM J PSYCHOL, V121, P47, DOI 10.2307/20445443; BOLLEN KA, 1990, SOC FORCES, V69, P479, DOI 10.2307/2579670; Brewer M.B., 1984, GROUPS CONTACT PSYCH, P281, DOI DOI 10.1016/B978-0-12-497780-8.50019-X; Brewer MB, 1997, J SOC ISSUES, V53, P197, DOI 10.1111/0022-4537.14199714; BREWER MB, 1986, J PERS SOC PSYCHOL, V50, P543, DOI 10.1037/0022-3514.50.3.543; Brewer MB, 1996, J PERS SOC PSYCHOL, V71, P83, DOI 10.1037/0022-3514.71.1.83; Brewer MB., 1988, ELIMINATING RACISM P, P315, DOI [10.1007/978-1-4899-0818-6_16, DOI 10.1007/978-1-4899-0818-6_16]; Carless SA, 2000, SMALL GR RES, V31, P107, DOI 10.1177/104649640003100106; Carron AV, 2000, SMALL GR RES, V31, P89, DOI 10.1177/104649640003100105; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; Converse BA, 2012, PSYCHOL SCI, V23, P923, DOI 10.1177/0956797612437248; Crump SA, 2010, EUR J SOC PSYCHOL, V40, P1212, DOI 10.1002/ejsp.716; Cryder Cynthia, 2010, SCI GIVING EXPT APPR, P237; Cryder CE, 2013, ORGAN BEHAV HUM DEC, V120, P15, DOI 10.1016/j.obhdp.2012.08.002; De Cremer D, 1999, EUR J SOC PSYCHOL, V29, P871, DOI 10.1002/(SICI)1099-0992(199911)29:7<871::AID-EJSP962>3.0.CO;2-I; De Cremer D, 2008, J APPL SOC PSYCHOL, V38, P1562, DOI 10.1111/j.1559-1816.2008.00359.x; Dovidio J.F., 1991, REV PERSONALITY SOCI, P86; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P401, DOI 10.1006/jesp.1997.1327; DOVIDIO JF, 1984, ADV EXP SOC PSYCHOL, V17, P361, DOI 10.1016/S0065-2601(08)60123-9; Espin AM, 2015, PATIENCE PREDICTS WI; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Gaertner L, 1998, EUR J SOC PSYCHOL, V28, P963, DOI 10.1002/(SICI)1099-0992(1998110)28:6<963::AID-EJSP905>3.0.CO;2-S; Hogg M. A., 1993, EUROPEAN REV SOCIAL, V4, P85, DOI [10.1080/14792779343000031, DOI 10.1080/14792779343000031]; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; Kaiser CR, 2010, J SOC ISSUES, V66, P461, DOI 10.1111/j.1540-4560.2010.01656.x; Kaiser CR, 2009, J EXP SOC PSYCHOL, V45, P770, DOI 10.1016/j.jesp.2009.04.027; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Kogut T, 2005, ORGAN BEHAV HUM DEC, V97, P106, DOI 10.1016/j.obhdp.2005.02.003; Kogut T, 2007, ORGAN BEHAV HUM DEC, V104, P150, DOI 10.1016/j.obhdp.2007.04.006; Kogut T, 2011, J EXP SOC PSYCHOL, V47, P748, DOI 10.1016/j.jesp.2011.02.011; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Levine M, 2004, J SOC PSYCHOL, V144, P229, DOI 10.3200/SOCP.144.3.229-245; Levine M, 2002, J APPL SOC PSYCHOL, V32, P1452, DOI 10.1111/j.1559-1816.2002.tb01446.x; Lishner DA, 2011, PERS SOC PSYCHOL B, V37, P614, DOI 10.1177/0146167211403157; MASELLI MD, 1969, PSYCHOL BULL, V71, P445, DOI 10.1037/h0027348; OWEN WF, 1985, SMALL GROUP BEHAV, V16, P415, DOI 10.1177/0090552685163011; Risen JL, 2008, J PERS SOC PSYCHOL, V95, P293, DOI 10.1037/0022-3514.95.2.293; Ritov I, 2011, ORGAN BEHAV HUM DEC, V116, P96, DOI 10.1016/j.obhdp.2011.05.005; Schelling TC, 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015; Sherif M., 1966, GROUP CONFLICT COOPE; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Small DA, 2003, J RISK UNCERTAINTY, V26, P5, DOI 10.1023/A:1022299422219; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Smith RW, 2013, J CONSUM RES, V39, P961, DOI 10.1086/666470; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Turner J.C., 1987, REDISCOVERING SOCIAL; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; White K, 2012, EMOTION, V12, P737, DOI 10.1037/a0026533; WIT AP, 1992, J ECON PSYCHOL, V13, P135, DOI 10.1016/0167-4870(92)90056-D	53	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187903	10.1371/journal.pone.0187903	http://dx.doi.org/10.1371/journal.pone.0187903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161282	Green Submitted, gold, Green Published			2022-12-27	WOS:000415987000025
J	Kalan, L; Zhou, M; Labbie, M; Willing, B				Kalan, Lindsay; Zhou, Mi; Labbie, Michele; Willing, Benjamin			Measuring the microbiome of chronic wounds with use of a topical antimicrobial dressing - A feasibility study	PLOS ONE			English	Article							HUMAN SKIN MICROBIOME; STAPHYLOCOCCUS-AUREUS; SILVER OXYNITRATE; DIABETIC FOOT; EFFICACY; INFECTION; BACTERIA; DIVERSITY	Background Polymicrobial communities colonize all wounds, and biofilms are hypothesized to be a key link to the chronic state and stalled healing. Molecular methods offer greater insight when studying microbial ecology in chronic wounds, as only a small fraction of wound bacteria are cultured by currently available methods and studies have shown little agreement between culture and molecular based approaches. Some interventions, like dressings with oxidized silver, are reported to help the stalled wounds move to a normal healing trajectory but the underlying mechanisms are difficult to measure. One hypothesis is that the use of topical antimicrobial dressings targets the wound microbiome and reduces bioburden. Objectives Our objective was to determine if culture-independent molecular methods could be used to identify the microbial composition in chronic wounds, and measure the microbiome over time when a topical antimicrobial dressing is used to reduce bioburden. Methods Patients with chronic wounds defined as >6 weeks in duration and not taking systemic antibiotics were recruited to participate. A wound contact layer containing silver oxynitrate was applied immediately after routine sharp debridement material was collected and swabs of the wound bed taken. Next-generation sequencing of the bacterial 16S rRNA gene in each specimen was used to measure the microbiome. Results Distinct bacterial communities were observed between swab and debridement samples, highlighting spatial differences and the importance of sampling consistency. The microbial communities appeared to be similar between different diabetes statuses, but different among the three wound categories included. Conclusions Culture-independent methods can be applied to measure the microbiome of chronic wounds even when a topical antimicrobial dressing is applied to the wound.	[Kalan, Lindsay] Exciton Technol Inc, Edmonton, AB, Canada; [Zhou, Mi; Willing, Benjamin] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Labbie, Michele] Westview Hlth Ctr, Stony Plain, AB, Canada; [Kalan, Lindsay] Univ Penn, Dept Dermatol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Alberta; University of Pennsylvania; Pennsylvania Medicine	Willing, B (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	willing@ualberta.ca	Willing, Benjamin/AAA-9650-2019	Kalan, Lindsay/0000-0003-4980-5128	Alberta Innovates Technology Futures R&D Associate Fellowship; NSERC ENGAGE; Exciton Technologies Inc (ETI); Canada Research Chairs Program	Alberta Innovates Technology Futures R&D Associate Fellowship; NSERC ENGAGE(Natural Sciences and Engineering Research Council of Canada (NSERC)); Exciton Technologies Inc (ETI); Canada Research Chairs Program(Canada Research Chairs)	L.K was supported by Alberta Innovates Technology Futures R&D Associate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The current study was funded by an NSERC ENGAGE grant to B.W, which was supported by in-kind contributions from Exciton Technologies Inc (ETI) in the form of dressing materials. L.K was employed as a research scientist at ETI during the time this study was completed. The funder provided support in the form of salaries for authors [LK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. B.P.W recognizes the Canada Research Chairs Program for funding and support.; The authors would like to thank staff at Westview Health Centre Wound Clinic (Stony Plain, AB, CAN) for patient care and sample collection. L.K was supported by Alberta Innovates Technology Futures R&D Associate Fellowship. The current study was funded by an NSERC ENGAGE grant to B.W, which was supported by in-kind contributions from Exciton Technologies Inc (ETI) in the form of dressing materials. L.K was employed as a research scientist at ETI during the time this study was completed. The funder provided support in the form of salaries for authors [LK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. B.P.W recognizes the Canada Research Chairs Program for funding and support.	Ammons MCB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126735; Angel DE, 2011, INT WOUND J, V8, P176, DOI 10.1111/j.1742-481X.2010.00765.x; [Anonymous], 1983, Can Med Assoc J, V129, P554; [Anonymous], 2012, AM FAM PHYSICIAN, V85, P195; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cavanagh MH, 2010, INT WOUND J, V7, P394, DOI 10.1111/j.1742-481X.2010.00705.x; Coletti D, 2013, REGEN MED RES, V1, DOI 10.1186/2050-490X-1-4; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Frieden T., 2013, ANT RES THREATS US; Ganesh K, 2015, ADV WOUND CARE, V4, P382, DOI 10.1089/wound.2014.0587; Gardner SE, 2006, WOUND REPAIR REGEN, V14, P548, DOI 10.1111/j.1743-6109.2006.00162.x; Gardner SE, 2013, DIABETES, V62, P923, DOI 10.2337/db12-0771; GOLDENHEIM PD, 1993, POSTGRAD MED J, V69, pS62; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P8, DOI 10.2174/1874285801004010008; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Grice EA, 2010, P NATL ACAD SCI USA, V107, P14799, DOI 10.1073/pnas.1004204107; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; HALSTED WS, 1895, AM J MED SCI, V110, P13; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Harris C, 2010, J WOUND OSTOMY CONT, V37, P253, DOI 10.1097/WON.0b013e3181d73aab; Higginbottom J, 1866, AM J MED SCI, V51, P502; Higginbottom J, 1826, ESSAY APPL LUNAR CAU; Iacopi E, 2015, INT J LOW EXTR WOUND, V14, P316, DOI 10.1177/1534734615606534; Kalan L, 2016, MBIO, V7, DOI [10.1128/mBio.01058-16, 10.1128/mbio.01058-16]; Kalan LR, 2017, INT J ANTIMICROB AG, V49, P719, DOI 10.1016/j.ijantimicag.2017.01.019; Kugelberg E, 2005, ANTIMICROB AGENTS CH, V49, P3435, DOI 10.1128/AAC.49.8.3435-3441.2005; Lansdown ABG, 2010, ISSUES TOXICOL, V6, P1; Lemire JA, 2017, BIOFOULING, P1; Lemire JA, 2015, ANTIMICROB AGENTS CH, V59, P4031, DOI 10.1128/AAC.05177-14; Loesche M, 2016, J INVEST DERMATOL; Loesche M, 2016, AM SOC MICROBIOLOGY, V7; Loesche M, J INVESTIGATIVE DERM; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Nguyen CT, 2015, J MICROBIOL, V53, P741, DOI 10.1007/s12275-015-5432-6; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Percival SL, 2011, INT WOUND J, V8, P237, DOI 10.1111/j.1742-481X.2011.00774.x; Perez GIP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151990; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Rantala S, 2014, EUR J CLIN MICROBIOL, V33, P1303, DOI 10.1007/s10096-014-2092-0; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rhoads DD, 2012, INT J MOL SCI, V13, P2535, DOI 10.3390/ijms13032535; Swanson T., 2016, WOUND INFECT CLIN PR; Takeo M, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023267; Thomas JG, 2011, J WOUND CARE, V20, P580, DOI 10.12968/jowc.2011.20.12.580; U. S. Preventive Services Task Force, 2012, AM FAM PHYSICIAN, P197; White R.J., 2001, BR J COMMUNITY NURS, V6, P3, DOI DOI 10.12968/BJCN.2001.6.SUP1.12619; Wolcott R D, 2009, J Wound Care, V18, P317; Wolcott R D, 2009, J Wound Care, V18, P54; World Health Organization, 2016, ANTIMICROBIAL RESIST; ZANONI D, 1992, CLIN PEDIATR, V31, P295, DOI 10.1177/000992289203100506	54	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187728	10.1371/journal.pone.0187728	http://dx.doi.org/10.1371/journal.pone.0187728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155834	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700014
J	Malinova, I; Fettke, J				Malinova, Irina; Fettke, Joerg			Reduced starch granule number per chloroplast in the dpe2/phs1 mutant is dependent on initiation of starch degradation	PLOS ONE			English	Article							MALTOSE METABOLISM; ARABIDOPSIS LEAVES; HETEROGLYCANS SHG; WATER DIKINASE; ALPHA-GLUCAN; PHOSPHORYLATION; CYTOSOL; NIGHT	An Arabidopsis double knock-out mutant lacking cytosolic disproportionating enzyme 2 (DPE2) and the plastidial phosphorylase (PHS1) revealed a dwarf-growth phenotype, reduced starch content, an uneven distribution of starch within the plant rosette, and a reduced number of starch granules per chloroplast under standard growth conditions. In contrast, the wild type contained 5-7 starch granules per chloroplast. Mature and old leaves of the double mutant were essentially starch free and showed plastidial disintegration. Several analyses revealed that the number of starch granules per chloroplast was affected by the dark phase. So far, it was unclear if it was the dark phase per se or starch degradation in the dark that was connected to the observed decrease in the number of starch granules per chloroplast. Therefore, in the background of the double mutant dpe2/phs1, a triple mutant was generated lacking the initial starch degrading enzyme glucan, water dikinase (GWD). The triple mutant showed improved plant growth, a starch-excess phenotype, and a homogeneous starch distribution. Furthermore, the number of starch granules per chloroplast was increased and was similar to wild type. However, starch granule morphology was only slightly affected by the lack of GWD as in the triple mutant and, like in dpe2/phs1, more spherical starch granules were observed. The characterized triple mutant was discussed in the context of the generation of starch granules and the formation of starch granule morphology.	[Malinova, Irina; Fettke, Joerg] Univ Potsdam, Biopolymer Analyt, Potsdam, Germany	University of Potsdam	Fettke, J (corresponding author), Univ Potsdam, Biopolymer Analyt, Potsdam, Germany.	fettke@uni-potsdam.de		Fettke, Joerg/0000-0003-0137-7611				Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Crumpton-Taylor M, 2013, NEW PHYTOL, V200, P1064, DOI 10.1111/nph.12455; Crumpton-Taylor M, 2012, PLANT PHYSIOL, V158, P905, DOI 10.1104/pp.111.186957; Fettke J, 2006, PLANT J, V46, P668, DOI 10.1111/j.1365-313X.2006.02732.x; Fettke J, 2005, PLANT J, V43, P568, DOI 10.1111/j.1365-313X.2005.02475.x; Fettke J, 2012, ESSENTIAL REV EXPT B, V5, P309; Fettke J, 2011, PLANT PHYSIOL, V155, P1723, DOI 10.1104/pp.110.168716; Fettke J, 2009, J EXP BOT, V60, P2907, DOI 10.1093/jxb/erp054; Hejazi M, 2012, ESSENTIAL REV EXPT B, V5, P279; Hejazi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28892; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Mahlow S, 2014, NEW PHYTOL, V203, P495, DOI 10.1111/nph.12801; Malinova I, 2017, PLANT PHYSIOL, V174, P73, DOI 10.1104/pp.16.01859; Malinova I, 2014, PLANT PHYSIOL, V164, P907, DOI 10.1104/pp.113.227843; Niittyla T, 2004, SCIENCE, V303, P87, DOI 10.1126/science.1091811; Ritte G, 2002, P NATL ACAD SCI USA, V99, P7166, DOI 10.1073/pnas.062053099; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	19	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187985	10.1371/journal.pone.0187985	http://dx.doi.org/10.1371/journal.pone.0187985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155859	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700024
J	Ma, LJ; Liu, Y; Landry, NK; El-Achkar, TM; Lieske, JC; Wu, XR				Ma, Lijie; Liu, Yan; Landry, Nichole K.; El-Achkar, Tarek M.; Lieske, John C.; Wu, Xue-Ru			Point mutation in D8C domain of Tamm-Horsfall protein/uromodulin in transgenic mice causes progressive renal damage and hyperuricemia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COTRANSPORTER NKCC2; URINARY SECRETION; MUTANT UROMODULIN; URATE TRANSPORT; UMOD GENE; URIC-ACID; NEPHROPATHY; PROTEIN; GLYCOPROTEIN	Hereditary mutations in Tamm-Horsfall protein (THP/uromodulin) gene cause autosomal dominant kidney diseases characterized by juvenile-onset hyperuricemia, gout and progressive kidney failure, although the disease pathogenesis remains unclear. Here we show that targeted expression in transgenic mice of a mutation within the domain of 8 cysteines of THP in kidneys' thick ascending limb (TAL) caused unfolded protein response in younger (1-month old) mice and apoptosis in older (12-month old) mice. While the young mice had urine concentration defects and polyuria, such defects progressively reversed in the older mice to marked oliguria, highly concentrated urine, fibrotic kidneys and reduced creatinine clearance. Both the young and the old transgenic mice had significantly higher serum uric acid and its catabolic product, allantoin, than age-matched wild-type mice. This THP mutation apparently caused primary defects in TAL by compromising the luminal translocation and reabsorptive functions of NKCC2 and ROMK and secondary responses in proximal tubules by upregulating NHE3 and URAT1. Our results strongly suggest that the progressive worsening of kidney functions reflects the accumulation of the deleterious effects of the misfolded mutant THP and the compensatory responses. Transgenic mice recapitulating human THP/uromodulin-associated kidney diseases could be used to elucidate their pathogenesis and test novel therapeutic strategies.	[Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Ma, Lijie; Liu, Yan; Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Landry, Nichole K.; El-Achkar, Tarek M.] Indiana Univ Sch Med, Div Nephrol, Indianapolis, IN 46202 USA; [Landry, Nichole K.; El-Achkar, Tarek M.] Indianapolis VA, Indianapolis, IN USA; [Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst, Manhattan Campus, New York, NY 10010 USA	New York University; New York University; Indiana University System; Indiana University Bloomington; Mayo Clinic	Wu, XR (corresponding author), NYU, Sch Med, Dept Urol, New York, NY 10016 USA.; Wu, XR (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Wu, XR (corresponding author), Vet Affairs New York Harbor Healthcare Syst, Manhattan Campus, New York, NY 10010 USA.	xue-ru.wu@med.nyu.edu	Lieske, John/ABA-4829-2020	Wu, Xue-Ru/0000-0001-6058-6291	United States National Institutes of Health [R01DK056903]; Mayo Clinic O'Brien Urology Research Center [U54DK100227]; Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service) [1I01BX002049]; New York University School of Medicine; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056903, R01DK111651] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX004479] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic O'Brien Urology Research Center; Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service); New York University School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from the United States National Institutes of Health (R01DK056903), the Mayo Clinic O'Brien Urology Research Center (U54DK100227), and the Veterans Affairs Office of Research and Development (Biomedical Laboratory Research and Development Service; 1I01BX002049) and a grant-in-aid from the Goldstein Fund for Urological Research of the New York University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2012, CLIN EXP NEPHROL, V16, P89, DOI 10.1007/s10157-011-0532-z; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bernascone I, 2010, HUM MOL GENET, V19, P2998, DOI 10.1093/hmg/ddq205; Bleyer AJ, 2016, CLIN J AM SOC NEPHRO, V11, P6, DOI 10.2215/CJN.12201115; Cameron JS, 2005, SEMIN NEPHROL, V25, P9, DOI 10.1016/j.semnephrol.2004.09.003; Capasso G, 2005, CURR PHARM DESIGN, V11, P4153, DOI 10.2174/138161205774913219; Castrop H, 2014, AM J PHYSIOL-RENAL, V307, pF991, DOI 10.1152/ajprenal.00432.2014; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; El-Achkar TM, 2012, AM J KIDNEY DIS, V59, P452, DOI 10.1053/j.ajkd.2011.10.054; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Gudbjartsson DF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001039; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; Iorember FM, 2014, PEDIATR NEPHROL, V29, P1151, DOI 10.1007/s00467-013-2563-z; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Kottgen A, 2010, J AM SOC NEPHROL, V21, P337, DOI 10.1681/ASN.2009070725; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; KUMAR S, 1990, KIDNEY INT, V37, P1395, DOI 10.1038/ki.1990.128; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lhotta K, 2010, KIDNEY BLOOD PRESS R, V33, P393, DOI 10.1159/000320681; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Moskowitz JL, 2013, CLIN J AM SOC NEPHRO, V8, P1349, DOI 10.2215/CJN.11151012; Muratsubaki H, 2006, ANAL BIOCHEM, V359, P161, DOI 10.1016/j.ab.2006.09.024; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Palmer BF, 2011, SEMIN NEPHROL, V31, P542, DOI 10.1016/j.semnephrol.2011.09.009; Rafey MA, 2003, CURR OPIN NEPHROL HY, V12, P511, DOI 10.1097/00041552-200309000-00005; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Renigunta A, 2011, J BIOL CHEM, V286, P2224, DOI 10.1074/jbc.M110.149880; Schaeffer C, 2012, KIDNEY INT, V81, P769, DOI 10.1038/ki.2011.456; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Scolari Francesco, 2003, Saudi J Kidney Dis Transpl, V14, P316; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Shlipak MG, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-2; SIKRI KL, 1979, BIOCHEM J, V181, P525, DOI 10.1042/bj1810525; Takiue Y, 2008, NUCLEOS NUCLEOT NUCL, V27, P596, DOI 10.1080/15257770802136065; Turner JJO, 2003, J CLIN ENDOCR METAB, V88, P1398, DOI 10.1210/jc.2002-021973; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; WU XW, 1994, P NATL ACAD SCI USA, V91, P742, DOI 10.1073/pnas.91.2.742; Yang HR, 2004, FEBS LETT, V578, P236, DOI 10.1016/j.febslet.2004.10.092; Zhu XH, 2003, TRANSGENIC RES, V12, P155, DOI 10.1023/A:1022967505222; Zhu XH, 2002, AM J PHYSIOL-RENAL, V282, pF608, DOI 10.1152/ajprenal.00297.2001	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186769	10.1371/journal.pone.0186769	http://dx.doi.org/10.1371/journal.pone.0186769			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145399	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800005
J	Maydych, V; Claus, M; Dychus, N; Ebel, M; Damaschke, J; Diestel, S; Wolf, OT; Kleinsorge, T; Watzl, C				Maydych, Viktoriya; Claus, Maren; Dychus, Nicole; Ebel, Melanie; Damaschke, Juergen; Diestel, Stefan; Wolf, Oliver T.; Kleinsorge, Thomas; Watzl, Carsten			Impact of chronic and acute academic stress on lymphocyte subsets and monocyte function	PLOS ONE			English	Article							BECK-DEPRESSION-INVENTORY; SELF-CONTROL DEMANDS; SALIVARY CORTISOL; CYTOKINE PRODUCTION; CELLULAR-IMMUNITY; STRENGTH MODEL; EGO DEPLETION; LIFE STRESS; CELLS; VALIDATION	This study investigated the effects of a temporally confined naturalistic stressor (academic stress) on immune functions. Furthermore, moderating influences of a number of psychological variables were assessed. Five blood samples were obtained from 20 students during an observation period of 8 weeks, starting 4.5 weeks before an exam period up to 1 week following the last exam. The analysis of 45 immune parameters revealed several time-dependent changes attributable to examination stress. We observed a reduction in the absolute numbers of natural killer (NK) cells and monocytes in peripheral blood and a shift towards more immature and naive cells within NK and T cell populations. In addition, IL-6 and TNF-alpha production by LPS-stimulated monocytes was increased. Psychological variables were grouped by means of factor analyses into two factors. One factor, which was interpreted as an indication of chronic stress, moderated the relationships between academic stress and percentages of mature CD57(+) NK cells. This chronic stress factor was also associated with an increase in memory and a decrease in naive CD8 T cells and increased serum levels of IL-17. The present study identifies important potential psychological mediators of stress-induced changes in specific immunological parameters.	[Maydych, Viktoriya; Diestel, Stefan; Kleinsorge, Thomas] TU Dortmund, IfADo, Dept Psychol & Neurosci, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Claus, Maren; Dychus, Nicole; Ebel, Melanie; Damaschke, Juergen; Watzl, Carsten] TU Dortmund, IfADo, Dept Immunol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany; [Wolf, Oliver T.] Ruhr Univ Bochum, Inst Cognit Neurosci, Bochum, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Ruhr University Bochum	Kleinsorge, T (corresponding author), TU Dortmund, IfADo, Dept Psychol & Neurosci, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.; Watzl, C (corresponding author), TU Dortmund, IfADo, Dept Immunol, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	kleinsorge@ifado.de; watzl@ifado.de	Watzl, Carsten/B-4911-2013; Kleinsorge, Thomas/A-2801-2008; Claus, Maren/AAO-5187-2021	Watzl, Carsten/0000-0001-5195-0995; Kleinsorge, Thomas/0000-0002-4913-1728; Claus, Maren/0000-0001-8732-0645; Wolf, Oliver T./0000-0002-9320-2124	Leibniz Association	Leibniz Association	The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all volunteer participants of this study and Manfred Schedlowski for his discussions and the critical reading of the manuscript. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Baumeister RF, 2007, SOC PERSONAL PSYCHOL, V1, P115, DOI 10.1111/j.1751-9004.2007.00001.x; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Borella P, 1999, PSYCHONEUROENDOCRINO, V24, P613, DOI 10.1016/S0306-4530(99)00016-5; BROSSCHOT JF, 1994, PSYCHOSOM MED, V56, P216, DOI 10.1097/00006842-199405000-00007; Bussing A., 1992, DIAGNOSTICA; Cardinal J, 2010, J CLIN ENDOCR METAB, V95, P3657, DOI 10.1210/jc.2009-2720; Claus M, 2016, ARCH TOXICOL, V90, P2481, DOI 10.1007/s00204-016-1809-5; Cohen S, 2012, OXFORD HDB PSYCHONEU; De Gucht V, 1999, PSYCHIAT RES, V85, P105, DOI 10.1016/S0165-1781(98)00131-0; Demas GE, 2004, HORM BEHAV, V45, P173, DOI 10.1016/j.yhbeh.2003.11.002; DOBBIN JP, 1991, BRAIN BEHAV IMMUN, V5, P339, DOI 10.1016/0889-1591(91)90029-A; Geiger TL, 2016, CURR OPIN IMMUNOL, V39, P82, DOI 10.1016/j.coi.2016.01.007; GLASER R, 1985, PSYCHIAT RES, V16, P233; GLASER R, 1994, PSYCHONEUROENDOCRINO, V19, P765, DOI 10.1016/0306-4530(94)90023-X; Goldstein DS, 2001, AUTONOMIC NERVOUS SY, Vxii; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; HALVORSEN R, 1987, J PSYCHOSOM RES, V31, P693, DOI 10.1016/0022-3999(87)90018-3; Hamaker EL, 2007, J RES PERS, V41, P295, DOI 10.1016/j.jrp.2006.04.003; HERBERT TB, 1993, PSYCHOSOM MED, V55, P364, DOI 10.1097/00006842-199307000-00004; Hoglund CO, 2006, CLIN EXP ALLERGY, V36, P982, DOI 10.1111/j.1365-2222.2006.02529.x; IRWIN M, 1990, BIOL PSYCHIAT, V27, P22, DOI 10.1016/0006-3223(90)90016-U; KANNER A D, 1981, Journal of Behavioral Medicine, V4, P1, DOI 10.1007/BF00844845; Katsuura S, 2010, INT J PSYCHOPHYSIOL, V77, P135, DOI 10.1016/j.ijpsycho.2010.05.004; KIECOLTGLASER JK, 1986, J BEHAV MED, V9, P5, DOI 10.1007/BF00844640; KIECOLTGLASER JK, 1987, PSYCHOSOM MED, V49, P523, DOI 10.1097/00006842-198709000-00008; KIECOLTGLASER JK, 1984, PSYCHOSOM MED, V46, P7, DOI 10.1097/00006842-198401000-00003; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; LATACK JC, 1992, J ORGAN BEHAV, V13, P479, DOI 10.1002/job.4030130505; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Marshall GD, 1998, BRAIN BEHAV IMMUN, V12, P297, DOI 10.1006/brbi.1998.0537; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Murphy L, 2010, STRESS, V13, P366, DOI 10.3109/10253891003615473; Nakamura H, 1999, J PSYCHOSOM RES, V46, P569, DOI 10.1016/S0022-3999(99)00009-4; Neubach B, 2006, Z ARB ORGAN, V50, P103, DOI 10.1026/0932-4089.50.2.103; Olff M, 1999, PSYCHIAT RES, V85, P7, DOI 10.1016/S0165-1781(98)00139-5; Pehlivanoglu B, 2001, Arch Physiol Biochem, V109, P383, DOI 10.1076/apab.109.3.383.9338; Preuss D, 2010, STRESS, V13, P221, DOI 10.3109/10253890903277579; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; PRUMPER J, 1995, Z ARB ORGAN, V39, P125; Schmidt KH, 2015, J PERS PSYCHOL, V14, P49, DOI 10.1027/1866-5888/a000123; Schmidt KH, 2012, WORK STRESS, V26, P21, DOI 10.1080/02678373.2012.660367; Schmitt M, 2000, DIAGNOSTICA, V46, P38, DOI 10.1026//0012-1924.46.1.38; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 1998, J PERS SOC PSYCHOL, V74, P1646, DOI 10.1037/0022-3514.74.6.1646; Segerstrom SC, 2010, ANN BEHAV MED, V40, P114, DOI 10.1007/s12160-010-9195-3; Slattery M, 2012, BRAIN BEHAVIOR AND I, V26, pS44; Steckler T., TECHNIQUES BEHAV NEU, V152005, P25; Stowell JR, 2003, PSYCHOSOM MED, V65, P1055, DOI 10.1097/01.PSY.0000097349.84109.1F; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Urlaub D, 2017, J IMMUNOL, V198, P1944, DOI 10.4049/jimmunol.1601004; Van Heck GL, 2007, PSIHOLOGIJSKE TEME, V16, P178; Waite JC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/819467; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Weekes N, 2006, STRESS, V9, P199, DOI 10.1080/10253890601029751; Weekes NY, 2008, PSYCHONEUROENDOCRINO, V33, P766, DOI 10.1016/j.psyneuen.2008.03.003; Wirtz PH, 2007, BRAIN BEHAV IMMUN, V21, P851, DOI 10.1016/j.bbi.2007.02.003; Xu WL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081742; Yang JF, 2014, TRENDS PHARMACOL SCI, V35, P493, DOI 10.1016/j.tips.2014.07.006	64	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188108	10.1371/journal.pone.0188108	http://dx.doi.org/10.1371/journal.pone.0188108			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145439	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800066
J	Lindquist, KJ; Sanford, T; Friedlander, TW; Paris, PL; Porten, SP				Lindquist, Karla J.; Sanford, Thomas; Friedlander, Terence W.; Paris, Pamela L.; Porten, Sima P.			Copy number gains at chr3p25 and chr11p11 are associated with lymph node involvement and survival in muscle-invasive bladder tumors	PLOS ONE			English	Article							GENE-EXPRESSION; RADICAL CYSTECTOMY; CANCER; CHEMOTHERAPY; PREDICTION; SIGNATURES; CARCINOMA; OUTCOMES; DISEASE	Patients with muscle-invasive bladder cancer (MIBC) have poorer prognoses if cancer has metastasized to the lymph nodes. Genomic markers of lymph node involvement (LNI) would be useful for treatment planning, especially if measured at the biopsy stage, but large-scale studies of tumor tissue at any stage are needed to discover robust markers of LNI. We performed a genome-wide query of copy number alterations (CNA) in 237 MIBC surgical tumor specimens from patients in The Cancer Genome Atlas who had radical cystectomy and lymphadenectomy without neoadjuvant treatment. Pathology reports were independently reviewed to confirm LNI, and copy number data was analyzed to confirm gene-level gains and losses while adjusting for tumor purity and ploidy. Using logistic regression and elastic net models, we identified the CNA most significantly associated with LNI. Multivariable logistic regression was used to describe these CNA associations while adjusting for clinical variables. Kaplan-Meier and Cox regression were used to describe their association with overall survival. Gains in 26 genes were identified as having strong associations with LNI. After adjusting for age, gender, race, pathological tumor stage, histology, and number of nodes examined, gains in 22 genes on chr3p25 or chr11p11 remained significantly associated with LNI (p<0.01) and improved model discrimination over clinical variables alone (p = 0.04). They were also associated with shorter overall survival (adjusted p = 0.02). These results suggest that a simple genomic test for gains in chr3p25 and chr11p11 could inform adjuvant treatment or clinical trial decisions if validated in external cohorts. Additional studies will also be needed to determine if these CNA are detectible in biopsy tissue and can inform clinical decisions at the preoperative stage.	[Lindquist, Karla J.; Sanford, Thomas; Paris, Pamela L.; Porten, Sima P.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Friedlander, Terence W.; Paris, Pamela L.] Univ Calif San Francisco, Dept Med, Div Hematol & Med Oncol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lindquist, KJ (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.	karla.lindquist@ucsf.edu		Sanford, Thomas/0000-0002-7123-9807; Lindquist, Karla/0000-0002-1971-2273	Marie Lundin Cancer Research Trust	Marie Lundin Cancer Research Trust	Funded by the Marie Lundin Cancer Research Trust to KJL, TS, TWF, PLP, SPP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2016, CANC FACTS FIGURES 2; Bruins HM, 2012, EUR UROL, V62, P671, DOI 10.1016/j.eururo.2012.04.050; Bruins HM, 2009, J UROLOGY, V182, P2182, DOI 10.1016/j.juro.2009.07.017; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cox dr, 1984, ANAL SURVIVAL DATA, DOI DOI 10.1201/9781315137438; Dancik Garrett, 2011, PLoS Curr, V3, pRRN1248, DOI 10.1371/currents.RRN1248; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Herr HW, 2001, J UROLOGY, V165, P62, DOI 10.1097/00005392-200101000-00015; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Hurle R, 2010, SURG ONCOL, V19, P208, DOI 10.1016/j.suronc.2009.05.004; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kassouf W, 2009, UROLOGY, V73, P147, DOI 10.1016/j.urology.2008.07.035; Laurberg JR, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-638; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lindgren D, 2010, CANCER RES, V70, P3463, DOI 10.1158/0008-5472.CAN-09-4213; Maurer T, 2012, EUR UROL, V61, P1031, DOI 10.1016/j.eururo.2011.12.009; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mitra AP, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju290; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Park A, 2007, UROLOGY, V70, P257, DOI 10.1016/j.urology.2007.03.054; Perez CA, 2007, ONCOGENE, V26, P7363, DOI 10.1038/sj.onc.1210561; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; R Development Core Team, 2009, R LANG ENV STAT COMP; Riester M, 2012, CLIN CANCER RES, V18, P1323, DOI 10.1158/1078-0432.CCR-11-2271; Seiler R, 2016, J UROLOGY, V196, P1036, DOI 10.1016/j.juro.2016.04.061; Smith SC, 2011, LANCET ONCOL, V12, P137, DOI 10.1016/S1470-2045(10)70296-5; StataCorp, 2009, STAT STAT SOFTW REL; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vieweg J, 1999, J UROLOGY, V161, P72, DOI 10.1016/S0022-5347(01)62067-6; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Zehnder P, 2014, BJU INT, V113, P554, DOI 10.1111/bju.12520; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187975	10.1371/journal.pone.0187975	http://dx.doi.org/10.1371/journal.pone.0187975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140994	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400039
J	Wang, NN; Guo, J; Liu, FD; Wang, MX; Li, CT; Jia, LH; Zhai, LL; Wei, W; Bai, YL				Wang, Nannan; Guo, Jie; Liu, Fuding; Wang, Mingxia; Li, Chuntao; Jia, Lihong; Zhai, Lingling; Wei, Wei; Bai, Yinglong			Depot-specific inflammation with decreased expression of ATM2 in white adipose tissues induced by high-margarine/lard intake	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; DIET-INDUCED OBESE; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; CHEMOKINE RECEPTORS; MOLECULAR-CLONING; GENE-EXPRESSION; KIDNEY-DISEASE	A high-fat diet has been recognized as an important risk factor of obesity, with variable impacts of different fatty acid compositions on the physiological process. To understand the effects of a high-margarine/lard diet, which is a major source of trans fatty acids (TFAs)/saturated fatty acids (SFAs), elaidic acid as a biomarker of margarine intake was used to screen affected adipokines on mature human adipocytes in vitro. Weaned male Wistar rats were fed a high-fat diet enriched with margarine/lard to generate obesity-prone (OP) and obesity-resistant (OR) models, which were then used to explore the inflammatory responses of depot-specific white adipose tissue. Adiposity, glucose and lipid metabolism parameters and macrophage cell markers were also compared in vivo. In the subcutaneous depot, a high-margarine diet induced elevated IL-6, MCP-1 and XCL1 expression levels in both MOP and M-OR groups. High-lard diet-fed rats displayed higher protein expression levels of MCP-1 and XCL1 compared with the control group. In the epididymal depot, significantly elevated IL-6 production was observed in M-OP rats, and high-lard diet-fed rats displayed elevated IL-6 and decreased XCL1 expression. In the retroperitoneal depot, a high-margarine diet caused higher IL-6 and MCP-1 expression levels, a high-lard diet caused elevated IL-6 expression in L-OP/L-OR rats, and elevated XCL1 expression was observed only in LOP rats. In general, CD206 mRNA levels were notably down-regulated by high-fat diet feeding in the above-mentioned depots. CD11c mRNA levels were slightly upregulated in the subcutaneous depot of OP rats fed a high-margarine/lard diet. In the epidydimal depot, higher expression levels of F4/80 and CD206 mRNA were observed only in high-margarine diet-fed OP rats. These results suggest that depot-specific inflammation with decreased expression of adipose tissue anti-inflammatory M2-type (ATM2) macrophages could be induced by high-margarine/lard intake.	[Wang, Nannan; Guo, Jie; Liu, Fuding; Wang, Mingxia; Jia, Lihong; Zhai, Lingling; Wei, Wei; Bai, Yinglong] China Med Univ, Sch Publ Hlth, Dept Child & Adolescent Hlth, Shenyang, Liaoning, Peoples R China; [Guo, Jie] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Fuding] Huangshi Cent Hosp, Dept Publ Hlth, Edong Healthcare Grp, Huangshi, Hubei, Peoples R China; [Li, Chuntao] China Med Univ, Informat Ctr, Hosp 1, Shenyang, Liaoning, Peoples R China	China Medical University; Sun Yat Sen University; China Medical University	Bai, YL (corresponding author), China Med Univ, Sch Publ Hlth, Dept Child & Adolescent Hlth, Shenyang, Liaoning, Peoples R China.	ylbai@cmu.edu.cn	白, 英龙/AAF-6124-2020		National Natural Science Foundation Committee of China [81373018, 81172691]	National Natural Science Foundation Committee of China(National Natural Science Foundation of China (NSFC))	The present study was supported by grants from the National Natural Science Foundation Committee of China (No 81373018 and 81172691).	Albersen M, 2013, SEX MED-UK, V1, P3, DOI 10.1002/sm2.1; Austin GL, 2011, AM J CLIN NUTR, V93, P836, DOI 10.3945/ajcn.110.000141; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; BELZUNG F, 1993, AM J PHYSIOL, V264, pR1111, DOI 10.1152/ajpregu.1993.264.6.R1111; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; Benoit B, 2013, NUTR RES, V33, P952, DOI 10.1016/j.nutres.2013.07.017; Blogowski W, 2012, J BIOL REG HOMEOS AG, V26, P607; Booth A, 2016, HORM MOL BIOL CLIN I, V26, P25, DOI 10.1515/hmbci-2015-0073; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Bueno AA, 2010, EUR J NUTR, V49, P235, DOI 10.1007/s00394-009-0069-z; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Casas-Agustench P, 2009, CLIN NUTR, V28, P39, DOI 10.1016/j.clnu.2008.10.008; Chacon MR, 2007, OBESITY, V15, P664, DOI 10.1038/oby.2007.578; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chu Y, 2010, ENDOCRINOLOGY, V151, P5669, DOI 10.1210/en.2010-0772; Comstock IA, 2017, FERTIL STERIL, V107, P740, DOI [10.1016/.fertnstert.2016.11.009, 10.1016/j.fertnstert.2016.11.009]; Dawczynski C, 2016, EXPERT REV CARDIOVAS, V14, P1001, DOI 10.1080/14779072.2016.1199956; Ellander A, 2015, EUR J LIPID SCI TECH, V117, P1370, DOI 10.1002/ejlt.201400513; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Fenton JI, 2009, DIABETES OBES METAB, V11, P343, DOI 10.1111/j.1463-1326.2008.00974.x; Fox JC, 2015, ACS CHEM BIOL, V10, P2580, DOI 10.1021/acschembio.5b00542; Fu CP, 2012, CLIN CHIM ACTA, V413, P1647, DOI 10.1016/j.cca.2012.05.008; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Gayet-Boyer C, 2014, BRIT J NUTR, V112, P1914, DOI 10.1017/S0007114514002578; Ghosh Sagar, 2013, Front Biosci (Elite Ed), V5, P461; Giancarlo B, 1996, EUR J IMMUNOL, V26, P3238, DOI 10.1002/eji.1830261260; Ginter E, 2016, BRATISL MED J, V117, P251, DOI 10.4149/BLL_2016_048; Gomez-Hernandez A, 2013, CLIN INVEST ARTERIOS, V25, P27, DOI 10.1016/j.arteri.2012.11.003; Harris HR, 2017, CANCER RES, V77, P1179, DOI 10.1158/0008-5472.CAN-16-2273; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hodge AM, 2004, CANCER CAUSE CONTROL, V15, P11, DOI 10.1023/B:CACO.0000016568.25127.10; Hooper Lee, 2015, Cochrane Database Syst Rev, pCD011737, DOI 10.1002/14651858.CD011737; Huang H, 2001, BIOCHEM BIOPH RES CO, V281, P378, DOI 10.1006/bbrc.2001.4363; Hutcheson J, 2015, CYTOKINE, V75, P272, DOI 10.1016/j.cyto.2015.04.004; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Jen KLC, 2003, EXP BIOL MED, V228, P843, DOI 10.1177/15353702-0322807-10; Jung C, 2009, PEDIATR DIABETES, V10, P329, DOI 10.1111/j.1399-5448.2008.00486.x; Kalaitzidis RG, 2011, INT UROL NEPHROL, V43, P771, DOI 10.1007/s11255-011-9974-1; Kang YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154003; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; KENNEDY J, 1995, J IMMUNOL, V155, P203; Khorramdelazad H, 2016, J NEUROIMMUNOL, V290, P70, DOI 10.1016/j.jneuroim.2015.11.021; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2014, DIABETOLOGIA, V57, P1456, DOI 10.1007/s00125-014-3237-5; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Lamacchia O, 2011, NEPHROL DIAL TRANSPL, V26, P892, DOI 10.1093/ndt/gfq522; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR382, DOI 10.1152/ajpregu.1999.276.2.R382; Li SY, 2008, OBESITY, V16, P811, DOI 10.1038/oby.2007.116; Lichtenstein A H, 2000, J Cardiopulm Rehabil, V20, P143, DOI 10.1097/00008483-200005000-00001; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Liu AD, 2015, BIOMED ENVIRON SCI, V28, P477, DOI 10.3967/bes2015.069; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo MY, 2016, OBESITY, V24, P1244, DOI 10.1002/oby.21463; Lytle LA, 2002, PUBLIC HEALTH NUTR, V5, P319, DOI 10.1079/PHN2002255; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; Mansour SG, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0490-0; Mayneris-Perxachs J, 2010, FOOD CHEM, V123, P296, DOI 10.1016/j.foodchem.2010.04.035; Mertens E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010075; Micha R, 2010, AM J CLIN NUTR, V91, P883, DOI 10.3945/ajcn.2009.28877; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Odegaard JI, 2013, IMMUNITY, V38, P644, DOI 10.1016/j.immuni.2013.04.001; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ordway D, 2007, J LEUKOCYTE BIOL, V82, P1221, DOI 10.1189/jlb.0607426; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pande G, 2012, J FOOD SCI, V77, pC1203, DOI 10.1111/j.1750-3841.2012.02935.x; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; de Heredia FP, 2012, P NUTR SOC, V71, P332, DOI 10.1017/S0029665112000092; Perusse L, 2000, AM J CLIN NUTR, V72, p1285S, DOI 10.1093/ajcn/72.5.1285s; Proenca ARG, 2014, BRAZ J MED BIOL RES, V47, P192, DOI 10.1590/1414-431X20132911; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; Rokling-Andersen MH, 2009, BRIT J NUTR, V102, P995, DOI 10.1017/S0007114509353210; Rumsaeng V, 1997, J IMMUNOL, V158, P1353; Saadatian-Elahi M, 2009, AM J CLIN NUTR, V89, P331, DOI 10.3945/ajcn.2008.26834; Sackmann-Sala L, 2012, OBESITY, V20, P101, DOI 10.1038/oby.2011.235; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Sheng XL, 2007, WORLD J GASTROENTERO, V13, P5944, DOI 10.3748/wjg.v13.i44.5944; Sindhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133494; Skeaff CM, 2006, BRIT J NUTR, V96, P377, DOI 10.1079/BJN20061737; Skopkova M, 2007, OBESITY, V15, P2396, DOI 10.1038/oby.2007.285; Stender S, 2006, NEW ENGL J MED, V354, P1650, DOI 10.1056/NEJMc052959; Suburu Janel, 2013, Food Biosci, V4, P1; Tang Wenjing, 2013, Wei Sheng Yan Jiu, V42, P571; Tardy AL, 2011, NUTR RES REV, V24, P111, DOI 10.1017/S0954422411000011; Tschop M, 2001, EXP CLIN ENDOCR DIAB, V109, P307, DOI 10.1055/s-2001-17297; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Vaughan RA, 2015, LIPIDS, V50, P1115, DOI 10.1007/s11745-015-4072-2; Wang QY, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000914; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Xu L, 2015, BIOMOLECULES, V5, P1563, DOI 10.3390/biom5031563; Xu ZG, 2005, CIRCULATION, V111, P1962, DOI 10.1161/01.CIR.0000161831.07637.63; Yamada M, 2010, J EPIDEMIOL, V20, P119, DOI 10.2188/jea.JE20090080; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zong G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5796	104	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188007	10.1371/journal.pone.0188007	http://dx.doi.org/10.1371/journal.pone.0188007			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141038	Green Submitted, gold, Green Published			2022-12-27	WOS:000415260400043
J	Montoya-Tangarife, C; de la Barrera, F; Salazar, A; Inostroza, L				Montoya-Tangarife, Claudia; de la Barrera, Francisco; Salazar, Alejandro; Inostroza, Luis			Monitoring the effects of land cover change on the supply of ecosystem services in an urban region: A study of Santiago-Valparaiso Chile	PLOS ONE			English	Article							LANDSCAPE CHANGE; DRIVING FORCES; LATIN-AMERICA; PROVISION; DEMAND; QUANTIFICATION; CHALLENGES; STRATEGIES; FRAMEWORK; HERITAGE	Mankind's quest for well-being results in continuous pressure to transform landscapes, with said transformation driven by land use changes, urbanization, production activity, and protective measures in addition to climate variability and other environmental drivers. The relationship between anthropogenic landscape changes and the provision of ecosystem services (ES) is a topic of increasing interest in Latin America. In Chile, land cover changes due to increased urbanization and forestry, and expansion of agricultural land, in addition to conservation initiatives as a part of land planning, have been intensive in the last few decades. In this study, the effects of anthropogenic landscape changes on the supply of ES were analyzed for the urban region of Santiago-Valparaiso (Chile) using a method based on expert consultation and land cover change assessment. A pool of experts scored the potential of specific land covers to provide certain ES. The results enabled calculation and mapping of changes in the potential of the landscape to supply ES. The aforementioned changes over a period of 15 years were evaluated. The results indicate a tenuous balance between positive and negative changes to the supply of ES derived from land cover changes. Understanding and reporting how these processes occur in urban regions contributes to the conservation of valuable landscapes through spatial planning tools, especially in areas close to housing developments and sensitive ecosystems.	[Montoya-Tangarife, Claudia; Salazar, Alejandro] Pontificia Univ Catolica Chile, Inst Geog, Santiago, Chile; [de la Barrera, Francisco; Salazar, Alejandro] Pontificia Univ Catolica Chile, Ctr Desarrollo Urbano Sustentable, Santiago, Chile; [de la Barrera, Francisco] Univ Concepcion, Fac Arquitectura Urbanismo & Geog, Concepcion, Chile; [Inostroza, Luis] Ruhr Univ Bochum, Inst Geog, Bochum, Germany; [Inostroza, Luis] Univ Autonoma Chile, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Ruhr University Bochum; Universidad Autonoma de Chile	Montoya-Tangarife, C (corresponding author), Pontificia Univ Catolica Chile, Inst Geog, Santiago, Chile.	cmmontoya@uc.cl	Inostroza, Luis/N-1524-2014	Inostroza, Luis/0000-0002-6303-4529; de la Barrera, Francisco/0000-0002-6854-3197; Montoya Tangarife, Claudia/0000-0001-7085-2805; Salazar Burrows, Alejandro/0000-0003-1558-7898	CONICYT-FONDECYT project [1150422]; CONICYT-FONDAP [15110020]	CONICYT-FONDECYT project(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP)	This work has been funded by CONICYT-FONDECYT project 1150422 (to FD and AS), and CONICYT-FONDAP 15110020 (to FD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Hulkko T, 2016, ECOL INDIC, V66, P416, DOI 10.1016/j.ecolind.2016.02.013; Altamirano A, 2010, BOSQUE, V31, P53, DOI 10.4067/S0717-92002010000100007; [Anonymous], HYDROLOGICAL SCI J; Antrop M, 2006, LANDSCAPE URBAN PLAN, V75, P187, DOI 10.1016/j.landurbplan.2005.02.014; Armesto J, 2007, MEDITERRANEAN ENV CE, P184; Balvanera P, 2012, ECOSYST SERV, V2, P56, DOI 10.1016/j.ecoser.2012.09.006; Burgi M, 2004, LANDSCAPE ECOL, V19, P857, DOI 10.1007/s10980-004-0245-8; Burkhard B., 2009, Landscape Online; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; CONAF, 2013, MON CAMB CORR CART A; CONAF, 2001, MON ACT CAT US SUEL; Crespin SJ, 2016, ECOSYST SERV, V17, P5, DOI 10.1016/j.ecoser.2015.10.020; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; De La Barrera F, 2015, INVESTIGACION SERVIC, V50, P3; Delgado LE, 2015, ECOSYST SERV, V14, P24, DOI 10.1016/j.ecoser.2015.03.002; Eitelberg DA, 2016, GLOBAL ENVIRON CHANG, V40, P101, DOI 10.1016/j.gloenvcha.2016.06.014; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Forman R.T.T, 2008, URBAN REGIONS ECOLOG; Frank S, 2014, LANDSCAPE ECOL, V29, P1377, DOI 10.1007/s10980-014-9992-3; Furst C, 2014, LANDSCAPE ECOL, V29, P1435, DOI 10.1007/s10980-014-0052-9; Furst C, 2013, J ENVIRON MANAGE, V127, pS96, DOI 10.1016/j.jenvman.2012.09.020; Han J, 2017, J CLEAN PROD, V141, P1040, DOI 10.1016/j.jclepro.2016.09.177; Heilmayr R, 2016, APPL GEOGR, V75, P71, DOI 10.1016/j.apgeog.2016.07.014; Hendrychova M, 2016, APPL GEOGR, V74, P151, DOI 10.1016/j.apgeog.2016.07.009; Hermann A., 2011, Living Reviews in Landscape Research, V5, P1; Hermanns T, 2015, LAND-BASEL, V4, P778, DOI 10.3390/land4030778; Hidalgo R., 2005, REV INVI, V20, P104, DOI DOI 10.4067/1NVI.V20I54.330; INE, 2014, PROD EST DEM VIT; Inostroza L, 2008, CUAD INVEST URBANIST, V56, P122; Inostroza L, 2017, ECOSYST SERV, V26, P303, DOI 10.1016/j.ecoser.2017.07.004; Inostroza L, 2016, REG ENVIRON CHANGE, V16, P2071, DOI 10.1007/s10113-016-0935-1; Inostroza L, 2013, J ENVIRON MANAGE, V115, P87, DOI 10.1016/j.jenvman.2012.11.007; Konig H. J., 2010, Sustainability, V2, P1991, DOI 10.3390/su2071991; Kopperoinen L, 2014, LANDSCAPE ECOL, V29, P1361, DOI 10.1007/s10980-014-0014-2; Koschke L, 2012, ECOL INDIC, V21, P54, DOI 10.1016/j.ecolind.2011.12.010; Kroll F, 2012, LAND USE POLICY, V29, P521, DOI 10.1016/j.landusepol.2011.07.008; Paula BM, 2012, AGR ECOSYST ENVIRON, V154, P34, DOI 10.1016/j.agee.2011.07.010; Millennium Ecosystem Assessment (MEA), 2005, EC SERV HUM WELL BEI; Miranda A, 2017, REG ENVIRON CHANGE, V17, P285, DOI 10.1007/s10113-016-1010-7; Moran D, 2017, NAT ECOL EVOL, V1, DOI [10.1038/41559-016-0023, 10.1038/s41559-016-0023]; Moreira-Munoz A., 2014, SERIES PLANT VEGETAT, V9, P221; Mukul SA, 2017, ECOSSYTEM S IN PRESS; Nahuelhual L, 2014, ECOL INDIC, V40, P90, DOI 10.1016/j.ecolind.2014.01.005; Nahuelhual L, 2016, ECOL SOC, V21, DOI 10.5751/ES-08676-210324; Nunez D, 2006, ECOL ECON, V58, P606, DOI 10.1016/j.ecolecon.2005.08.010; Plieninger T, 2016, LAND USE POLICY, V57, P204, DOI 10.1016/j.landusepol.2016.04.040; Portman ME, 2013, APPL GEOGR, V45, P185, DOI 10.1016/j.apgeog.2013.09.011; Potschin M, 2013, LANDSCAPE ECOL, V28, P1053, DOI 10.1007/s10980-012-9756-x; Quense A., 2006, THESIS; Ramirez-Gomez SOI, 2015, ECOSYST SERV, V13, P93, DOI 10.1016/j.ecoser.2014.12.009; Ravetz J., 2000, ENVIRON IMPACT ASSES, V20, P31; Reyers B, 2013, FRONT ECOL ENVIRON, V11, P268, DOI 10.1890/120144; Rozas-Vasquez D, 2017, ENVIRON IMPACT ASSES, V62, P135, DOI 10.1016/j.eiar.2016.09.001; Salazar A., 2010, SCRIPTA NOVA, V14, P47; SCHULZ J, 2008, APPL GEOGR, V30, P436, DOI DOI 10.1016/J.APGE0G.2009.12.003; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Shoyama K, 2014, ECOSYST SERV, V8, P25, DOI 10.1016/j.ecoser.2014.02.004; Tengberg A, 2012, ECOSYST SERV, V2, P14, DOI 10.1016/j.ecoser.2012.07.006; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; van Berkel DB, 2014, ECOL INDIC, V37, P163, DOI 10.1016/j.ecolind.2012.06.025; van Zanten BT, 2016, ECOSYST SERV, V17, P87, DOI 10.1016/j.ecoser.2015.11.011; Vigl LE, 2017, SCI TOTAL ENVIRON, V574, P422, DOI [10.1016/jscitotenv.2016.08.209, 10.1016/j.scitotenv.2016.08.209]; Vihervaara P, 2010, ECOL COMPLEX, V7, P410, DOI 10.1016/j.ecocom.2009.12.002; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weng YC, 2007, LANDSCAPE URBAN PLAN, V81, P341, DOI 10.1016/j.landurbplan.2007.01.009; Wu JG, 2013, LANDSCAPE ECOL, V28, P999, DOI 10.1007/s10980-013-9894-9; Xu G., 2016, ECOL PROCESS, V5, P23, DOI [10.1186/s13717-016-0067-z, DOI 10.1186/s13717-016-0067-z]; Yeh CT, 2009, LANDSCAPE URBAN PLAN, V93, P151, DOI 10.1016/j.landurbplan.2009.07.002; Youlton C, 2010, CIENC INVESTIG AGRAR, V37, P113; Zamorano-Elgueta C, 2015, FOREST ECOL MANAG, V345, P10, DOI 10.1016/j.foreco.2015.02.025; Zewdie W, 2017, APPL GEOGR, V79, P167, DOI 10.1016/j.apgeog.2016.12.019	73	30	30	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188117	10.1371/journal.pone.0188117	http://dx.doi.org/10.1371/journal.pone.0188117			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136016	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200067
J	Baptista, AMG; Serra, PM; McAlinden, C; Barrett, BT				Goncalves Baptista, Antonio Manuel; Serra, Pedro M.; McAlinden, Colm; Barrett, Brendan T.			Vision in high-level football officials	PLOS ONE			English	Article							VISUAL-ACUITY; CONTRAST SENSITIVITY; CLINICAL-TESTS; PRECISION REPEATABILITY; SUBJECTIVE QUALITY; SPORTS VISION; LETTER-CHART; QUESTIONNAIRE; DESIGN; AGE	Officiating in football depends, at least to some extent, upon adequate visual function. However, there is no vision standard for football officiating and the nature of the relationship between officiating performance and level of vision is unknown. As a first step in characterising this relationship, we report on the clinically-measured vision and on the perceived level of vision in elite-level, Portuguese football officials. Seventy-one referees (R) and assistant referees (AR) participated in the study, representing 92% of the total population of elite level football officials in Portugal in the 2013/2014 season. Nine of the 22 Rs (40.9%) and ten of the 49 ARs (20.4%) were international-level. Information about visual history was also gathered. Perceived vision was assessed using the preference-values-assigned-to-globalvisual-status (PVVS) and the Quality-of-Vision (QoV) questionnaire. Standard clinical vision measures (including visual acuity, contrast sensitivity and stereopsis) were gathered in a subset (n = 44, 62%) of the participants. Data were analysed according to the type (R/AR) and level (international/national) of official, and Bonferroni corrections were applied to reduce the risk of type I errors. Adopting criterion for statistical significance of p<0.01, PVVS scores did not differ between R and AR (p = 0.88), or between national-and international-level officials (p = 0.66). Similarly, QoV scores did not differ between R and AR in frequency (p = 0.50), severity (p = 0.71) or bothersomeness (p = 0.81) of symptoms, or between international-level vs national-level officials for frequency (p = 0.03) or bothersomeness (p = 0.07) of symptoms. However, international-level officials reported less severe symptoms than their national-level counterparts (p<0.01). Overall, 18.3% of officials had either never had an eye examination or if they had, it was more than 3 years previously. Regarding refractive correction, 4.2% had undergone refractive surgery and 23.9% wear contact lenses when officiating. Clinical vision measures in the football officials were similar to published normative values for young, adult populations and similar between R and AR. Clinically-measured vision did not differ according to officiating level. Visual acuity measured with and without a pinhole disc indicated that around one quarter of participants may be capable of better vision when officiating, as evidenced by better acuity (>= 1 line of letters) using the pinhole. Amongst the clinical visual tests we used, we did not find evidence for above-average performance in elite-level football officials. Although the impact of uncorrected mild to moderate refractive error upon officiating performance is unknown, with a greater uptake of eye examinations, visual acuity may be improved in around a quarter of officials.	[Goncalves Baptista, Antonio Manuel] Univ Minho, Ctr Phys Optometry, Campus Gualtar, Braga, Portugal; [Serra, Pedro M.] Univ Plymouth, Fac Hlth & Human Sci, Sch Hlth Profess, Plymouth, Devon, England; [McAlinden, Colm] Hywel Dda Univ Hlth Board, Glangwili Hosp, Dept Ophthalmol, Carmarthen, Dyfed, Wales; [McAlinden, Colm] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Barrett, Brendan T.] Univ Bradford, Sch Optometry & Vis Sci, Richmond Rd, Bradford, W Yorkshire, England	Universidade do Minho; University of Plymouth; Wenzhou Medical University; University of Bradford	Baptista, AMG (corresponding author), Univ Minho, Ctr Phys Optometry, Campus Gualtar, Braga, Portugal.	abaptista@fisica.uminho.pt	Baptista, Antonio M. G./G-9176-2014; Serra, Pedro/AAG-3569-2021	Baptista, Antonio M. G./0000-0002-7304-8756; Serra, Pedro/0000-0003-0471-0213	Portuguese Foundation for Science and Technology (FCT) [UID/FIS/04650/2013]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UID/FIS/04650/2013. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDITI A, 1993, INVEST OPHTH VIS SCI, V34, P120; BAILEY IL, 1991, INVEST OPHTH VIS SCI, V32, P422; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Bailey IL, 2006, BORISHS CLIN REFRACT, V2nd, P217; Barrett BT., 2014, CLIN PROCEDURES PRIM; Bass EB, 2004, ARCH OPHTHALMOL-CHIC, V122, P1856; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BECK RW, 1993, CLIN VISION SCI, V8, P207; Branco MJ, 2006, ECOS SENTIDOS SAUDE; Bulson RC, 2015, CLIN EXP OPTOM; Cabot F, 2013, AM J OPHTHALMOL, V155, P629, DOI 10.1016/j.ajo.2012.11.005; CEGEA, 2011, COMP FOR 4 LINH REFL; Coffey B., 1990, PROBL OPTOM, V2, P32; Elliott D. B, 2006, BORISHS CLIN REFRACT; ELLIOTT DB, 1990, OPHTHAL PHYSL OPT, V10, P21, DOI 10.1111/j.1475-1313.1990.tb01100.x; ELLIOTT DB, 1990, EYE, V4, P712, DOI 10.1038/eye.1990.100; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Elliott DB., 2014, CLIN PROCEDURES PRIM, V3rd ed, P32; Elmurr P, 2011, EYE CONTACT LENS, V37, P164, DOI 10.1097/ICL.0b013e318217cc09; Erickson GB., 2007, VISUAL TASK ANAL SPO, P8; Gall R, 1998, OPTOMETRY VISION SCI, V75, P731, DOI 10.1097/00006324-199810000-00018; Gardner JJ, 1995, SPORTS VISION, P22; Garnham L, 2006, BRIT J OPHTHALMOL, V90, P91, DOI 10.1136/bjo.2005.077719; Ghasemi A, 2011, PERCEPT MOTOR SKILL, V112, P161, DOI 10.2466/05.22.24.27.PMS.112.1.161-171; Ghasemi A, 2009, J HUM KINET, V22, P15; GREENE HA, 1987, AM J OPTOM PHYS OPT, V64, P749; Haymes SA, 2006, INVEST OPHTH VIS SCI, V47, P2739, DOI 10.1167/iovs.05-1419; Helsen W, 2004, J SPORT SCI, V22, P179, DOI 10.1080/02640410310001641502; HERON G, 1985, AM J OPTOM PHYS OPT, V62, P505; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, INVEST OPHTH VIS SCI, V53, P4042, DOI 10.1167/iovs.12-9728; Kirschen D, 2014, INVEST OPHTH VIS SCI, V55; Kirschen DG, 2011, EYE CONTACT LENS, V37, P127, DOI 10.1097/ICL.0b013e3182126a08; Laby DM, 2011, EYE CONTACT LENS, V37, P116, DOI 10.1097/ICL.0b013e31820c5002; Mangine GT, 2014, J STRENGTH COND RES, V28, P2406, DOI 10.1519/JSC.0000000000000550; MarketProbe, 2015, VIS NEEDS MON; McAlinden C, 2015, J CATARACT REFR SURG, V41, P2598, DOI 10.1016/j.jcrs.2015.06.029; McAlinden C, 2013, OPTOMETRY VISION SCI, V90, P760, DOI 10.1097/OPX.0b013e3182993856; McAlinden C, 2012, OPHTHALMOLOGY, V119, P1715, DOI 10.1016/j.ophtha.2012.03.035; McAlinden C, 2012, J REFRACT SURG, V28, P313, DOI 10.3928/1081597X-20120501-06; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P5685, DOI 10.1167/iovs.10-67951; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; McAlinden C, 2011, J CATARACT REFR SURG, V37, P1097, DOI 10.1016/j.jcrs.2010.10.061; McAlinden C, 2010, INVEST OPHTH VIS SCI, V51, P5537, DOI 10.1167/iovs.10-5341; Ohlsson J, 2005, ACTA OPHTHALMOL SCAN, V83, P487, DOI 10.1111/j.1600-0420.2005.00516.x; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Piano MEF, 2016, STRABISMUS, V24, P169, DOI 10.1080/09273972.2016.1242636; PORTADA, 2016, PRAT DESP FED TOT AL; Rosa AM, 2017, OPHTHALMOLOGY, V124, P1280, DOI 10.1016/j.ophtha.2017.03.033; Scheiman M, 2008, CLIN MANAGEMENT BINO; Schwab S, 2012, J SPORT SCI MED, V11, P624; Simunovic MP, 2010, EYE, V24, P747, DOI 10.1038/eye.2009.251; Skiadaresi E, 2012, ARCH OPHTHALMOL-CHIC, V130, P1377, DOI 10.1001/archophthalmol.2012.1603; Spitz J, 2016, COGN RES, V1, DOI 10.1186/s41235-016-0013-8; Stifter E, 2006, INVEST OPHTH VIS SCI, V47, P5412, DOI 10.1167/iovs.05-1564; UEFA, 2014, FIN REP 2012 13 38 O; Wobbrock JO, 2011, P SIGCHI C HUM FACT, DOI DOI 10.1145/1978942; Wobbrock JO, 2017, ARTOOL 1 6; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x; Zellers J A, 1984, J Am Optom Assoc, V55, P31	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188463	10.1371/journal.pone.0188463	http://dx.doi.org/10.1371/journal.pone.0188463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161310	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000060
J	Munoz, RC; Buckel, CA; Whitfield, PE; Viehman, S; Clark, R; Taylor, JC; Degan, BP; Hickerson, EL				Munoz, Roldan C.; Buckel, Christine A.; Whitfield, Paula E.; Viehman, Shay; Clark, Randy; Taylor, J. Christopher; Degan, Brian P.; Hickerson, Emma L.			Conventional and technical diving surveys reveal elevated biomass and differing fish community composition from shallow and upper mesophotic zones of a remote United States coral reef	PLOS ONE			English	Article							GULF-OF-MEXICO; MARINE PROTECTED AREAS; FLOWER GARDEN BANKS; CLIMATE-CHANGE; NORTHWESTERN GULF; ATLANTIC-OCEAN; PUERTO-RICO; BASE-LINES; ECOLOGY; ASSEMBLAGES	The world's coral reefs appear to be in a global decline, yet most previous research on coral reefs has taken place at depths shallower than 30 m. Mesophotic coral ecosystem (depths deeper than similar to 30 m) studies have revealed extensive, productive habitats and rich communities. Despite recent advances, mesophotic coral ecosystems remain understudied due to challenges with sampling at deeper depths. The few previous studies of mesophotic coral ecosystems have shown variation across locations in depth-specific species composition and assemblage shifts, potentially a response to differences in habitat or light availability/ water clarity. This study utilized scuba to examine fish and benthic communities from shallow and upper mesophotic (to 45 m) zones of Flower Garden Banks National Marine Sanctuary (FGBNMS, 28 degrees 0 'N; 93 degrees 50 'W) from 2010-2012. Dominant planktivores were ubiquitous in shallow and upper mesophotic habitats, and comparisons with previous shallow research suggest this community distribution has persisted for over 30 years. Planktivores were abundant in shallow low-relief habitats on the periphery of the coral reef, and some of these sites that contained habitat transitioning from high to low relief supported high biomass of benthic predators. These peripheral sites at FGBNMS may be important for the trophic transfer of oceanic energy to the benthic coral reef. Distinct differences between upper mesophotic and shallow communities were also observed. These included greater overall fish (as well as apex predator) biomass in the upper mesophotic, differences in apex predator community composition between depth zones, and greater percent cover of algae, rubble, sand, and sponges in the upper mesophotic. Greater fish biomass in the upper mesophotic and similar fish community composition between depth zones provide preliminary support that upper mesophotic habitats at FGBNMS have the capacity to serve as refugia for the shallow-water reefs. Diving surveys of the upper mesophotic and shallow-water coral reef have revealed valuable information concerning the reef fish community in the northern Gulf of Mexico, with implications for the conservation of apex predators, oceanic coral reefs, and the future management of FGBNMS.	[Munoz, Roldan C.] NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA; [Buckel, Christine A.; Whitfield, Paula E.; Viehman, Shay; Taylor, J. Christopher; Degan, Brian P.] NOAA, Natl Ocean Serv, Beaufort Lab, Beaufort, NC 28516 USA; [Clark, Randy] NOAA, Natl Ocean Serv, Ctr Coastal Monitoring & Assessment, Stennis Space Ctr, Mississippi State, MS USA; [Hickerson, Emma L.] NOAA, Natl Ocean Serv, Off Natl Marine Sanctuaries Flower Garden Banks N, Galveston, TX USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; Mississippi State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Munoz, RC (corresponding author), NOAA, Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA.	roldan.munoz@noaa.gov			National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Flower Garden Banks National Marine Sanctuary; National Centers for Coastal Ocean Science; NOAA's Coral Reef Conservation Program; FGBNMS; National Centers for Coastal Ocean Science (NCCOS); Southeast Fisheries Science Center	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Flower Garden Banks National Marine Sanctuary; National Centers for Coastal Ocean Science(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); FGBNMS; National Centers for Coastal Ocean Science (NCCOS); Southeast Fisheries Science Center	This study was funded by the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program, https://coralreef.noaa.gov, with in-kind support from Flower Garden Banks National Marine Sanctuary and the National Centers for Coastal Ocean Science. Recipients: RC, JCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by NOAA's Coral Reef Conservation Program with in-kind support from FGBNMS and the National Centers for Coastal Ocean Science (NCCOS). The Southeast Fisheries Science Center provided support to RCM during manuscript preparation. We thank M. Burton, A. Chester, A. Hohn, C. Kane, T. Kellison, W. Mitchell, R. Pyle, and G. Schmahl for comments that improved the manuscript. Dive support was provided from the crews of the NOAA ship Nancy Foster, RV Manta, and L. Arbuckle, L. Bauer, K. Buch, E. Ebert, R. Eckert, K. Edwards, J. Embesi, D. Field, S. Henry, Z. Hileman, M. Johnston, D. Kesling, R. Mays, G. McFall, M. Nuttall, M. Ruiz, W. Sautter, G. Schmahl, M. Tartt, T. Tysall, A. Uhrin, J. Vander Pluym, J. Voss, J. Waddell, and M. Winfield.	Afonso P, 2011, BIOL CONSERV, V144, P2739, DOI 10.1016/j.biocon.2011.07.028; Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Andradi-Brown DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156641; Appeldoorn R, 2016, CORAL REEFS, V35, P63, DOI 10.1007/s00338-015-1360-5; Asher J, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00098; Asher J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03568-1; Baker E, 2016, MESOPHOTIC CORAL ECO, P11; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bosscher H, 1992, P 7 INT COR REEF S, V1; Bridge TCL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2332; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Bruno JF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29778; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Buckel CA, 2014, FISH BENTHIC COMMUNI, V179, P20; Buckel CA, 2014, 179 NOAA NOS NCCOS, P74; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Caldow C, 2009, 81 NOAA NOS NCCOS, V81, P134; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Clark R.D., 2014, 179 NOS NCCOS NOAA, V179, P317; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Collins AB, 2015, B MAR SCI, V91, P399, DOI 10.5343/bms.2015.1001; Connell SD, 1998, CORAL REEFS, V17, P49, DOI 10.1007/s003380050094; DeMartini EE, 2007, B MAR SCI, V81, P139; DENNIS GD, 1988, B MAR SCI, V43, P280; Deslarzes K.J.P, 1998, 980010 MMS OCS US DE; Duffy JE, 2003, ECOL LETT, V6, P680, DOI 10.1046/j.1461-0248.2003.00494.x; Espinoza M, 2015, ECOL APPL, V25, P2101; Feitoza BM, 2005, B MAR SCI, V76, P725; Field IC, 2011, CORAL REEFS, V30, P61, DOI 10.1007/s00338-010-0699-x; Fitzpatrick BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039634; Floeter SR, 2007, ENVIRON BIOL FISH, V78, P147, DOI 10.1007/s10641-006-9084-6; Friedlander AM, 2007, ECOL APPL, V17, P715, DOI 10.1890/06-0536; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisch AJ, 2016, CORAL REEFS, V35, P375, DOI 10.1007/s00338-016-1401-8; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Hamner WM, 2012, FISH FISH SER, V35, P159, DOI 10.1007/978-94-007-1980-4_6; HAMNER WM, 1988, B MAR SCI, V42, P459; Harborne AR, 2012, CORAL REEFS, V31, P977, DOI 10.1007/s00338-012-0938-4; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Hedley JD, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020118; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hobson E.S., 1991, P69; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Johnston MA, 2015, LONG TERM MONITORING, V1; Johnston MA, 2016, CORAL REEFS, V35, P821, DOI 10.1007/s00338-016-1452-x; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Koeck B, 2014, MAR ENVIRON RES, V94, P38, DOI 10.1016/j.marenvres.2013.12.002; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Laverick JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183075; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; Lindeman KC, 2000, B MAR SCI, V66, P929; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McGovern JC, 2005, B MAR SCI, V76, P47; McMahon KW, 2012, P NATL ACAD SCI USA, V109, P15372, DOI 10.1073/pnas.1206378109; Momigliano P, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00016; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Nemeth RS, 2005, MAR ECOL PROG SER, V286, P81, DOI 10.3354/meps286081; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; O'Toole AC, 2011, MAR BIOL, V158, P2227, DOI 10.1007/s00227-011-1728-1; Osgood GJ, 2015, J FISH BIOL, V87, P1489, DOI 10.1111/jfb.12839; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Pickard AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151221; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Pinheiro HT, 2011, J FISH BIOL, V79, P1984, DOI 10.1111/j.1095-8649.2011.03138.x; Pyle RL, 2016, PEERJ, V4, DOI 10.7717/peerj.2475; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Rosa MR, 2016, CORAL REEFS, V35, P113, DOI 10.1007/s00338-015-1368-x; Russ GR, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12442; Sandin Stuart A., 2010, P71; Schmahl George R., 2008, V1, P221, DOI 10.1007/978-1-4020-6847-8_6; Semmler R. F., 2016, CORAL REEFS; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Sluka R, 1998, B MAR SCI, V62, P219; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; Valdivia A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601303; Warwick RM, 2001, OCEANOGR MAR BIOL, V39, P207; WARWICK RM, 1993, AUST J ECOL, V18, P63, DOI 10.1111/j.1442-9993.1993.tb00435.x; Weinstein DK, 2014, GEOMORPHOLOGY, V222, P14, DOI 10.1016/j.geomorph.2014.03.005; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; 2012, FISH FISH SER, V35, P1	100	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188598	10.1371/journal.pone.0188598	http://dx.doi.org/10.1371/journal.pone.0188598			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161314	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000066
J	Abdel-Naby, W; Cole, B; Liu, AH; Liu, JB; Wan, PX; Schreiner, R; Infanger, DW; Paulson, NB; Lawrence, BD; Rosenblatt, MI				Abdel-Naby, Waleed; Cole, Brigette; Liu, Aihong; Liu, Jingbo; Wan, Pengxia; Schreiner, Ryan; Infanger, David W.; Paulson, Nicholas B.; Lawrence, Brian D.; Rosenblatt, Mark I.			Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; FIBROIN; MATRIX; BIOMATERIALS; ARCHITECTURE; SUBSTRATE	There is a significant clinical need to improve current therapeutic approaches to treat ocular surface injuries and disease, which affect hundreds of millions of people annually worldwide. The work presented here demonstrates that the presence of Silk-Derived Protein (SDP) on the healing rabbit corneal surface, administered in an eye drop formulation, corresponds with an enhanced epithelial wound healing profile. Rabbit corneas were denuded of their epithelial surface, and then treated for 72-hours with either PBS or PBS containing 5 or 20 mg/mL SDP in solution four times per day. Post-injury treatment with SDP formulations was found to accelerate the acute healing phase of the injured rabbit corneal epithelium. In addition, the use of SDP corresponded with an enhanced tissue healing profile through the formation of a multi-layered epithelial surface with increased tight junction formation. Additional biological effects were also revealed that included increased epithelial proliferation, and increased focal adhesion formation with a corresponding reduction in the presence of MMP-9 enzyme. These in vivo findings demonstrate for the first time that the presence of SDP on the injured ocular surface may aid to improve various steps of rabbit corneal wound healing, and provides evidence that SDP may have applicability as an ingredient in therapeutic ophthalmic formulations.	[Abdel-Naby, Waleed] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA; [Abdel-Naby, Waleed; Cole, Brigette; Liu, Aihong; Liu, Jingbo; Wan, Pengxia; Schreiner, Ryan] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Infanger, David W.; Paulson, Nicholas B.; Lawrence, Brian D.] Silk Technol Ltd, Dept Res, Plymouth, MN 55447 USA; [Rosenblatt, Mark I.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	Cornell University; Cornell University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lawrence, BD (corresponding author), Silk Technol Ltd, Dept Res, Plymouth, MN 55447 USA.; Rosenblatt, MI (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	brianlawrence@silk-tech.com; mrosenbl@uic.edu	Lawrence, Brian David/AAI-9088-2020	Schreiner, Ryan/0000-0002-7457-6606	Silk Technologies, Ltd.; Research to Prevent Blindness; NSF [DGE-1144153]; NSF SBIR [IIP-1013484]; DOD-DHA SBIR [W81XWH-16-C-0063]; Army SBIR [A151-061-0107]	Silk Technologies, Ltd.; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NSF(National Science Foundation (NSF)); NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); DOD-DHA SBIR; Army SBIR	Three of the authors (BL, DI, NP) are employed by the commercial company Silk Technologies, Ltd. Silk Technologies, Ltd. provided support in the form of salaries for authors (BL, DI, NP), institutional overhead, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors are articulated in the 'author contributions' section. This work was supported by a Research to Prevent Blindness Career Development ward to MR, NSF Graduate Research Fellowship Award DGE-1144153 to WA, NSF SBIR Phase II award number IIP-1013484 to BL, DOD-DHA SBIR Phase II award number W81XWH-16-C-0063 to BL, Army SBIR Phase I award number A151-061-0107 to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this work was from Research to Prevent Blindness Career Development Award, NSF Graduate Research Fellowship Award DGE-1144153, NSF SBIR Phase II award number IIP-1013484, DOD-DHA SBIR Phase II award number W81XWH-16-C-0063, Army SBIR Phase I award number A151-061-0107. hCLE cell line provided courtesy of Dr. Ilene Gipson. Silk Technologies, Ltd. kindly provided the SDP solution.	Abdel-Naby W., 2017, INVESTIGATIVE OPHTHA, V58; Agrawal Vinay B, 2003, Indian J Ophthalmol, V51, P5; Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068; Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]; Chon JW, 2012, INT J MOL MED, V30, P1203, DOI 10.3892/ijmm.2012.1120; Cutler TJ, 2004, VET CLIN N AM-EQUINE, V20, P319, DOI 10.1016/j.cveq.2004.04.014; Dieckow J., 2011, OCUL SURF, V9, P3; Fraunfelder FW, 2006, CORNEA, V25, P1133, DOI 10.1097/01.ico.0000240084.27663.fd; Garrett Q, 2008, CURR EYE RES, V33, P567, DOI 10.1080/02713680802140213; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432; Gong Y., 2016, PLOS ONE, V11; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041; Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415; Hu CL, 2008, INT J FOOD ENG, V4, DOI 10.2202/1556-3758.1298; Irina S. Barequet, 2014, CORNEA, V33; Jia L, 2016, J BIOMED MATER RES B, V104, P431, DOI 10.1002/jbm.b.33408; Kim DW, 2012, J MICROBIOL BIOTECHN, V22, P494, DOI 10.4014/jmb.1111.11024; Kim JC, 2014, PFLUGERS ARCH, V7, P1; Lan WW, 2012, OCUL SURF, V10, P137, DOI 10.1016/j.jtos.2012.04.001; Lawrence B, 2016, US Patent Office, Patent No. [US9394355, 9394355]; Lawrence BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050190; Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876; Market Scope, 2016, DRY EYE PROD REP GLO; Martinez-Mora C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042271; Pflugfelder SC, 2005, AM J PATHOL, V166, P61, DOI 10.1016/S0002-9440(10)62232-8; RHEE D, 1999, WILLS EYE MANUAL OFF; Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q; Stepp MA, 2006, EXP EYE RES, V83, P3, DOI 10.1016/j.exer.2006.01.010; Sugrue SP, 1997, EXP EYE RES, V64, P11, DOI 10.1006/exer.1996.0175; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tsukita S, 2008, ONCOGENE, V27, P6930, DOI 10.1038/onc.2008.344; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875; Zainuddin, 2008, BIOMATERIALS, V29	40	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188154	10.1371/journal.pone.0188154	http://dx.doi.org/10.1371/journal.pone.0188154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155856	gold, Green Published, Green Submitted			2022-12-27	WOS:000415756700032
J	Bispo, PD; Balzter, H; Malhi, Y; Slik, JWF; dos Santos, JR; Renno, CD; Espirito-Santo, FD; Aragao, LEOC; Ximenes, AC; Bispo, PD				Bispo, Polyanna da Conceicao; Balzter, Heiko; Malhi, Yadvinder; Slik, J. W. Ferry; dos Santos, Joao Roberto; Renno, Camilo Daleles; Espirito-Santo, Fernando D.; Aragao, Luiz E. O. C.; Ximenes, Arimatea C.; Bispo, Pitagoras da Conceicao			Drivers of metacommunity structure diverge for common and rare Amazonian tree species	PLOS ONE			English	Article							RADAR TOPOGRAPHY MISSION; LOCAL GEOMORPHOMETRIC VARIABLES; NEUTRAL THEORY; TROPICAL FORESTS; SPATIAL PROCESSES; BETA-DIVERSITY; PATTERNS; VEGETATION; ECOLOGY; TRAITS	We analysed the flora of 46 forest inventory plots (25 m x 100 m) in old growth forests from the Amazonian region to identify the role of environmental (topographic) and spatial variables (obtained using PCNM, Principal Coordinates of Neighbourhood Matrix analysis) for common and rare species. For the analyses, we used multiple partial regression to partition the specific effects of the topographic and spatial variables on the univariate data (standardised richness, total abundance and total biomass) and partial RDA (Redundancy Analysis) to partition these effects on composition (multivariate data) based on incidence, abundance and biomass. The different attributes (richness, abundance, biomass and composition based on incidence, abundance and biomass) used to study this metacommunity responded differently to environmental and spatial processes. Considering standardised richness, total abundance (univariate) and composition based on biomass, the results for common species differed from those obtained for all species. On the other hand, for total biomass (univariate) and for compositions based on incidence and abundance, there was a correspondence between the data obtained for the total community and for common species. Our data also show that in general, environmental and/ or spatial components are important to explain the variability in tree communities for total and common species. However, with the exception of the total abundance, the environmental and spatial variables measured were insufficient to explain the attributes of the communities of rare species. These results indicate that predicting the attributes of rare tree species communities based on environmental and spatial variables is a substantial challenge. As the spatial component was relevant for several community attributes, our results demonstrate the importance of using a metacommunities approach when attempting to understand the main ecological processes underlying the diversity of tropical forest communities.	[Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester Inst Space & Earth Observ, Leicester, Leics, England; [Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Natl Ctr Earth Observ, NERC, Leicester, Leics, England; [Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Slik, J. W. Ferry] Univ Brunei Darussalam, Fac Sci, Gadong, Brunei; [dos Santos, Joao Roberto; Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, Brazil; [Renno, Camilo Daleles] Natl Inst Space Res INPE, Image Proc Div, Sao Jose Dos Campos, Brazil; [Espirito-Santo, Fernando D.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Ximenes, Arimatea C.] Univ Libre Bruxelles, Dept Biol Organisms, Lab Syst Ecol & Resource Management, Brussels, Belgium; [Ximenes, Arimatea C.] Vrije Univ Brussel, Lab Plant Biol & Nat Management Ecol & Biodivers, Brussels, Belgium; [Bispo, Pitagoras da Conceicao] State Univ Sao Paulo UNESP, Fac Sci & Languages Assis, Dept Biol Sci, Assis, Brazil	University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; University of Leicester; University of Oxford; University Brunei Darussalam; Instituto Nacional de Pesquisas Espaciais (INPE); Instituto Nacional de Pesquisas Espaciais (INPE); Lancaster University; University of Exeter; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universidade Estadual Paulista	Bispo, PD (corresponding author), Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester Inst Space & Earth Observ, Leicester, Leics, England.; Bispo, PD (corresponding author), Univ Leicester, Natl Ctr Earth Observ, NERC, Leicester, Leics, England.	polybispo@gmail.com	aragao, luiz eoc/G-8387-2012; Espirito-Santo, Fernando/O-4371-2014; Balzter, Heiko/B-5976-2008; Rennó, Camilo Daleles/B-9070-2014	aragao, luiz eoc/0000-0002-4134-6708; Espirito-Santo, Fernando/0000-0001-7497-3639; Balzter, Heiko/0000-0002-9053-4684; Rennó, Camilo Daleles/0000-0001-9920-4473; da Conceicao Bispo, Polyanna/0000-0003-0247-8449; /0000-0002-7356-8882; Ximenes, Arimatea C./0000-0002-9111-5481	European Unions Horizon research and innovation programme under the Marie Sklodowska-Curie grant [660020]; Royal Society Wolfson Research Merit Award [2011/R3]; Natural Environment Research Councils National Centre for Earth Observation; CNPq National Council for Scientific and Technological Development [305275/2014-3, 303228/2013-0, 305054/2016-3]; Natural Environment Research Council (NERC) grants [BIO-RED NE/N012542/1, AFIRE NE/P004512/1]; Newton Fund (The UK Academies/FAPESP) [2015/50392-8]; NERC [NE/N012542/1, nceo020005] Funding Source: UKRI; Natural Environment Research Council [NE/N012542/1, nceo020005] Funding Source: researchfish	European Unions Horizon research and innovation programme under the Marie Sklodowska-Curie grant; Royal Society Wolfson Research Merit Award(Royal Society of London); Natural Environment Research Councils National Centre for Earth Observation; CNPq National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Natural Environment Research Council (NERC) grants(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Newton Fund (The UK Academies/FAPESP); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PCB was supported by European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 660020. HB was supported by Royal Society Wolfson Research Merit Award (2011/R3) and by the Natural Environment Research Councils National Centre for Earth Observation. PITCB, JRS and LEOCA were supported by CNPq National Council for Scientific and Technological Development) productivity fellowships (grants 305275/2014-3, 303228/2013-0 and 305054/2016-3, respectively). FES was supported by Natural Environment Research Council (NERC) grants (BIO-RED NE/N012542/1 and AFIRE NE/P004512/1) and Newton Fund (The UK Academies/FAPESP Proc. No: 2015/50392-8 Fellowship and Research Mobility).	Alahuhta J, 2014, ECOL COMPLEX, V20, P61, DOI 10.1016/j.ecocom.2014.08.003; Alexander HM, 2012, J ECOL, V100, P88, DOI 10.1111/j.1365-2745.2011.01917.x; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Balvanera P, 2011, BIOTROPICA, V43, P414, DOI 10.1111/j.1744-7429.2010.00712.x; Barlow J, 2016, NATURE, V535, P144, DOI 10.1038/nature18326; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bispo PC, 2014, CAN J REMOTE SENS, V40, P26, DOI 10.1080/07038992.2014.913477; Bispo PD, 2010, REV BRAS ENG AGR AMB, V14, P523, DOI 10.1590/S1415-43662010000500010; Bispo PD, 2012, AUSTRAL ECOL, V37, P491, DOI 10.1111/j.1442-9993.2011.02310.x; Bispo PD, 2010, ACTA BOT BRAS, V24, P96; Bispo Polyanna da Conceição, 2009, Acta Amaz., V39, P81, DOI 10.1590/S0044-59672009000100008; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Branco CCZ, 2014, HYDROBIOLOGIA, V732, P123, DOI 10.1007/s10750-014-1852-2; BROWN S, 1989, FOREST SCI, V35, P881; Chase JM, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P335; Clark JS, 2012, TRENDS ECOL EVOL, V27, P364, DOI 10.1016/j.tree.2012.04.009; Clark JS, 2012, TRENDS ECOL EVOL, V27, P198, DOI 10.1016/j.tree.2012.02.001; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; dos Santos AS, 2015, PERSPECT PLANT ECOL, V17, P96, DOI 10.1016/j.ppees.2015.01.002; Dray, 2011, PACKFOR FORWARD SELE, P46; Espeland EK, 2011, BIODIVERS CONSERV, V20, P963, DOI 10.1007/s10531-011-0007-2; Etienne RS, 2007, J STAT PHYS, V128, P485, DOI 10.1007/s10955-006-9163-2; Furniss TJ, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1847; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Guadagnin PMA, 2015, GEOGR DEP U SAO PAUL, V29, P246; Guitet S, 2015, BIODIVERS CONSERV, V24, P1215, DOI 10.1007/s10531-014-0854-8; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Heino J, 2010, LIMNOL OCEANOGR, V55, P2397, DOI 10.4319/lo.2010.55.6.2397; Hubbell S.P., 2001, MG POP BIOL, V32; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kellndorfer J, 2004, REMOTE SENS ENVIRON, V93, P339, DOI 10.1016/j.rse.2004.07.017; Kunin WE, 1997, CONSERV BIOL, V11, P183, DOI 10.1046/j.1523-1739.1997.95469.x; Laszlo Z, 2014, J INSECT CONSERV, V18, P1203, DOI 10.1007/s10841-014-9734-5; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Lennon JJ, 2011, ECOGRAPHY, V34, P529, DOI 10.1111/j.1600-0587.2010.06669.x; Lennon JJ, 2004, ECOL LETT, V7, P81, DOI 10.1046/j.1461-0248.2004.00548.x; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; Luizao RCC, 2004, GLOBAL CHANGE BIOL, V10, P592, DOI 10.1111/j.1529-8817.2003.00757.x; Markham J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06012; Mazaris A, 2008, BIODIVERS CONSERV, V17, P3567, DOI 10.1007/s10531-008-9480-7; MUNOZ V, 2013, GEOGRATIA, V38, P139; Murphy SJ, 2015, ECOLOGY, V96, P705, DOI 10.1890/14-0695.1; Myers JA, 2013, ECOL LETT, V16, P151, DOI 10.1111/ele.12021; Oksanen J, 2013, VEGAN COMMUNITY ECOL, DOI 10.4135/9781412971874.n145; Pandit SN, 2009, ECOLOGY, V90, P2253, DOI 10.1890/08-0851.1; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Development Core Team, 2011, R FDN STAT COMP; RADAMBRASIL Departamento Nacional de Produc Mineral, 1976, LEVANTAMENTO RECURSO, V10; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Saito VS, 2015, J BIOGEOGR, V42, P2101, DOI 10.1111/jbi.12577; Simard M, 2008, REMOTE SENS ENVIRON, V112, P2131, DOI 10.1016/j.rse.2007.10.012; Siqueira T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043626; Siqueira T, 2012, ECOGRAPHY, V35, P183, DOI 10.1111/j.1600-0587.2011.06875.x; Spasojevic MJ, 2014, ECOGRAPHY, V37, P939, DOI 10.1111/ecog.00711; Spitale D, 2012, ECOSCIENCE, V19, P80, DOI 10.2980/19-1-3435; TOKESHI M, 1990, J ANIM ECOL, V59, P1129, DOI 10.2307/5036; Tsang TPN, 2017, LANDSCAPE ECOL, V32, P47, DOI 10.1007/s10980-016-0427-1; Valeriano MD, 2012, APPL GEOGR, V32, P300, DOI 10.1016/j.apgeog.2011.05.004; Veloso HP, 1991, CLASSIFICAC TEMA UNI; Wang QG, 2017, J PLANT ECOL, V10, P440, DOI 10.1093/jpe/rtw047; Wennekes PL, 2012, ACTA BIOTHEOR, V60, P257, DOI 10.1007/s10441-012-9144-6	74	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188300	10.1371/journal.pone.0188300	http://dx.doi.org/10.1371/journal.pone.0188300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155865	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000415756700044
J	Tsuda, M; Cho, K; Ooka, M; Shimizu, N; Watanabe, R; Yasui, A; Nakazawa, Y; Ogi, T; Harada, H; Agama, K; Nakamura, J; Asada, R; Fujiike, H; Sakuma, T; Yamamoto, T; Murai, J; Hiraoka, M; Koike, K; Pommier, Y; Takeda, S; Hirota, K				Tsuda, Masataka; Cho, Kosai; Ooka, Masato; Shimizu, Naoto; Watanabe, Reiko; Yasui, Akira; Nakazawa, Yuka; Ogi, Tomoo; Harada, Hiroshi; Agama, Keli; Nakamura, Jun; Asada, Ryuta; Fujiike, Haruna; Sakuma, Tetsushi; Yamamoto, Takashi; Murai, Junko; Hiraoka, Masahiro; Koike, Kaoru; Pommier, Yves; Takeda, Shunichi; Hirota, Kouji			ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; ATAXIA-TELANGIECTASIA; TRANSLESION SYNTHESIS; CELLULAR-RESPONSES; SNF2 FAMILY; POLY(ADP-RIBOSE); RECRUITMENT; PARP1; ALC1	ALC1/CHD1L is a member of the SNF2 superfamily of ATPases carrying a macrodomain that binds poly(ADP-ribose). Poly(ADP-ribose) polymerase (PARP) 1 and 2 synthesize poly(ADP-ribose) at DNA-strand cleavage sites, promoting base excision repair (BER). Although depletion of ALC1 causes increased sensitivity to various DNA-damaging agents (H2O2, UV, and phleomycin), the role played by ALC1 in BER has not yet been established. To explore this role, as well as the role of ALC1's ATPase activity in BER, we disrupted the ALC1 gene and inserted the ATPase-dead (E165Q) mutation into the ALC1 gene in chicken DT40 cells, which do not express PARP2. The resulting ALC1(-/-) and ALC1(-/E165Q) cells displayed an indistinguishable hypersensitivity to methylmethane sulfonate (MMS), an alkylating agent, and to H2O2, indicating that ATPase plays an essential role in the DNA-damage response. PARP1(-/-) and ALC1(-/-)/PARP1(-/-) cells exhibited a very similar sensitivity to MMS, suggesting that ALC1 and PARP1 collaborate in BER. Following pulse-exposure to H2O2, PARP1(-/-) and ALC1(-/-)/PARP1(-/-) cells showed similarly delayed kinetics in the repair of single- strand breaks, which arise as BER intermediates. To ascertain ALC1's role in BER in mammalian cells, we disrupted the ALC1 gene in human TK6 cells. Following exposure to MMS and to H2O2, the ALC1(-/-) TK6 cell line showed a delay in single-strand-break repair. We therefore conclude that ALC1 plays a role in BER. Following exposure to H2O2, ALC1(-/-) cells showed compromised chromatin relaxation. We thus propose that ALC1 is a unique BER factor that functions in a chromatin context, most likely as a chromatin-remodeling enzyme.	[Tsuda, Masataka; Cho, Kosai; Shimizu, Naoto; Fujiike, Haruna; Murai, Junko; Takeda, Shunichi; Hirota, Kouji] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Cho, Kosai; Koike, Kaoru] Kyoto Univ, Grad Sch Med, Dept Primary Care & Emergency Med, Sakyo Ku, Kyoto, Japan; [Ooka, Masato; Asada, Ryuta; Hirota, Kouji] Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan; [Watanabe, Reiko; Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome, Aoba Ku, Seiryomachi 4-1, Sendai, Miyagi, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagasaki Univ Sakamoto, Atom Bomb Dis Inst, Dept Genome Repair, Nagasaki, Japan; [Nakazawa, Yuka; Ogi, Tomoo] Nagoya Univ, Res Inst Environm Med RIeM, Dept Genet, Chikusa Ku, Furo Cho, Nagoya, Aichi, Japan; [Harada, Hiroshi] Kyoto Univ, Radiat Biol Ctr, Lab Canc Cell Biol, Sakyo Ku, Kyoto, Japan; [Agama, Keli; Murai, Junko; Pommier, Yves] NCI, Ctr Canc Res, NIH, Dev Therapeut Branch,Lab Mol Pharmacol, Bethesda, MD USA; [Nakamura, Jun] Univ North Carolina Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Sakuma, Tetsushi; Yamamoto, Takashi] Hiroshima Univ, Grad Sch Sci, Dept Math & Life Sci, Hiroshima, Japan; [Hiraoka, Masahiro] Japanese Red Cross Soc Wakayama Med Ctr, Dept Radiat Oncol, Wakayama, Japan; [Watanabe, Reiko] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan	Kyoto University; Kyoto University; Tokyo Metropolitan University; Tohoku University; Nagasaki University; Nagoya University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Hiroshima University	Takeda, S; Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan.; Hirota, K (corresponding author), Tokyo Metropolitan Univ, Dept Chem, Hachioji, Tokyo, Japan.	stakeda@rg.med.kyoto-u.ac.jp; khirota@tmu.ac.jp	Murai, Junko/AAU-9516-2021; Sakuma, Tetsushi/A-7615-2013; Yamamoto, Takashi/U-4790-2017; Tsuda, Masataka/G-2505-2019; Ooka, Masato/HHN-0222-2022	Sakuma, Tetsushi/0000-0003-0396-1563; Yamamoto, Takashi/0000-0002-6516-2903; Ooka, Masato/0000-0002-2729-2619; Asada, Ryuta/0000-0001-8360-6355; Tsuda, Masataka/0000-0002-1267-3777; Nakazawa, Yuka/0000-0002-3835-3093; Ogi, Tomoo/0000-0002-5492-9072; Takeda, Shunichi/0000-0002-7924-7991; Nakamura, Jun/0000-0002-1756-7199	JSPS KAKENHI [JP16K12598, JP16H02957, JP16H01314, JP16H06306, JP16J02252]; JSPS; Takeda Science Foundation; Yamada Science Foundation; Center for Cancer Research; US National Cancer Institute [Z01 BC 006150]; Grants-in-Aid for Scientific Research [15H05333, 16J02252] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [ZIABC006150] Funding Source: NIH RePORTER	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yamada Science Foundation; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the JSPS KAKENHI Grant Number (JP16K12598, JP16H02957 and JP16H01314 to KH, JP16H06306 to ST and JP16J02252 to RA), the JSPS Core-to-Core Program (A) Advanced Research Networks (to ST), the Takeda Science Foundation and Yamada Science Foundation (to KH), and the Center for Cancer Research, Intramural Program of the US National Cancer Institute (Z01 BC 006150 to KA and YP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbotts R, 2016, FREE RADIC BIOL MED; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Asada R, 2015, MOL CELL BIOL, V35, P847, DOI 10.1128/MCB.00924-14; Ball LG, 2005, ACTA PHARMACOL SIN, V26, P897, DOI 10.1111/j.1745-7254.2005.00165.x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Braafladt S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32162; BRADLEY MO, 1979, NUCLEIC ACIDS RES, V7, P793, DOI 10.1093/nar/7.3.793; Breslin C, 2006, METHOD ENZYMOL, V409, P410, DOI 10.1016/S0076-6879(05)09024-5; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Dantzer F, 1999, CARCINOGENESIS, V20, P177, DOI 10.1093/carcin/20.1.177; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fujita M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060043; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gottschalk AJ, 2012, J BIOL CHEM, V287, P43527, DOI 10.1074/jbc.M112.401141; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Hanzlikova H, 2016, NUCL ACIDS RES; Hirota K., 2010, PLOS GENET, V6, P10, DOI DOI 10.1371/J0URNAL.PGEN.1001151; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2016, NUCLEIC ACIDS RES, V44, P7242, DOI 10.1093/nar/gkw439; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Honma M, 2005, ENVIRON MOL MUTAGEN, V45, P162, DOI 10.1002/em.20113; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kohn KW, 1996, BIOESSAYS, V18, P505, DOI 10.1002/bies.950180613; KOHN KW, 1991, PHARMACOL THERAPEUT, V49, P55, DOI 10.1016/0163-7258(91)90022-E; Kulkarni A, 2013, J BIOL CHEM, V288, P32357, DOI 10.1074/jbc.M113.459164; Lan L, 2004, P NATL ACAD SCI USA, V101, P13738, DOI 10.1073/pnas.0406048101; LEVY JA, 1968, CANCER-AM CANCER SOC, V22, P517, DOI 10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nakamura J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng105; Okano S, 2000, J BIOL CHEM, V275, P32635, DOI 10.1074/jbc.M004085200; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Pachkowski BF, 2009, MUTAT RES-FUND MOL M, V671, P93, DOI 10.1016/j.mrfmmm.2009.09.006; Pines A, 2012, J CELL BIOL, V199, P235, DOI 10.1083/jcb.201112132; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Saberi A, 2007, MOL CELL BIOL, V27, P2562, DOI 10.1128/MCB.01243-06; Sakuma T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03379; Sellou H, 2016, MOL BIOL CELL, V27, P3791, DOI 10.1091/mbc.E16-05-0269; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yoshimura M, 2006, MOL CELL, V24, P115, DOI 10.1016/j.molcel.2006.07.032	46	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188320	10.1371/journal.pone.0188320	http://dx.doi.org/10.1371/journal.pone.0188320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149203	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100037
J	Icks, A; Claessen, H; Kvitkina, T; Narres, M; Weingartner, M; Schwab, S; Kolominsky-Rabas, PL				Icks, Andrea; Claessen, Heiner; Kvitkina, Tatjana; Narres, Maria; Weingaertner, Michael; Schwab, Stefan; Kolominsky-Rabas, Peter L.			Incidence and relative risk of stroke in the diabetic and the non-diabetic population between 1998 and 2014: A community-based stroke register	PLOS ONE			English	Article							LOWER-LIMB AMPUTATIONS; ISCHEMIC-STROKE; CASE-FATALITY; PROJECT; TRENDS; EPIDEMIOLOGY; PREVALENCE; MELLITUS; GERMANY; SPAIN	One major objective of the St. Vincent Declaration was to reduce excess risk of stroke in people with diabetes mellitus. The aim of this study is to estimate the trend of incidence and relative risk of stroke in the diabetic and the non-diabetic populations in Germany over a 17-year period. We estimated age-sex standardised incidence rates of all stroke and ischaemic stroke in people with and without diabetes based on an ongoing prospective community-based stroke register covering 105,000 inhabitants. Time trends were analysed using Poisson regression. In total, 3,111 individuals (diabetes: 28.4%, men 46.9%, mean age 73.1 years (SD 13.2)) had a first stroke, 84.9% of which were ischaemic stroke. Among people with diabetes we observed a significant reduction in all stroke incidence by 1.5% per year (relative risk: 0.985; 95% confidence interval 0.972-0.9995) Likewise, this incidence tended to decrease for ischaemic stroke by 1% per year (0.993; 0.979-1.008). In contrast, the incidence rate for all stroke remained nearly stable among people without diabetes (1.003; 0.993-1.013) and for ischaemic stroke (1.002; 0.991-1.013). The relative risk comparing diabetic and non-diabetic population decreased for all stroke (two percent annual reduction) but not for ischaemic stroke. Time trends were similar for both sexes regarding all and ischaemic strokes. We found a reduction in risk of stroke in the diabetic population while this rate did not materially change in the non-diabetic population.	[Icks, Andrea; Narres, Maria] Heinrich Heine Univ, Ctr Hlth & Soc, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Icks, Andrea; Claessen, Heiner; Kvitkina, Tatjana; Narres, Maria] Heinrich Heine Univ, German Diabet Ctr, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Icks, Andrea; Claessen, Heiner; Kvitkina, Tatjana; Narres, Maria] German Ctr Diabet Res, Neuherberg, Germany; [Weingaertner, Michael; Kolominsky-Rabas, Peter L.] Friedrich Alexander Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, Erlangen, Germany; [Weingaertner, Michael; Kolominsky-Rabas, Peter L.] Natl Informat Syst Fed Hlth Monitoring Gesundheits, Erlangen Stroke Project ESPro, Erlangen, Germany; [Schwab, Stefan] Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany	Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Claessen, H (corresponding author), Heinrich Heine Univ, German Diabet Ctr, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany.; Claessen, H (corresponding author), German Ctr Diabet Res, Neuherberg, Germany.	heiner.claessen@ddz.uni-duesseldorf.de; Michael.Weingaertner@uk-erlangen.de		Kolominsky-Rabas, Peter/0000-0002-7168-058X	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Education and Research (BMBF); German Federal Ministry of Health (BMG) as part of the National Information System of the Federal Health Monitoring (GBE) [ZMV I 1-2516DIA001]	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Health (BMG) as part of the National Information System of the Federal Health Monitoring (GBE)	This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW) and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD). The data collection in the Erlangen Stroke Registry (ESPro) is supported [grant number ZMV I 1-2516DIA001] by the German Federal Ministry of Health (BMG) as part of the National Information System of the Federal Health Monitoring (GBE).	Almdal T, 2004, ARCH INTERN MED, V164, P1422, DOI 10.1001/archinte.164.13.1422; [Anonymous], 1990, Diabet Med, V7, P360; Centers for Disease Control and Prevention (CDC), 2007, MMWR Morb Mortal Wkly Rep, V56, P1129; Almaraz MC, 2012, DIABETES RES CLIN PR, V95, P399, DOI 10.1016/j.diabres.2011.10.035; Du Y, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000135; Fang MC, 2014, AM J MED, V127, P608, DOI 10.1016/j.amjmed.2014.03.017; Feigin V, 2004, LANCET, V363, P1920, DOI 10.1016/S0140-6736(04)16436-2; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Gattellari M, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001161; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Heidemann C, 2016, DIABETIC MED, V33, P1406, DOI 10.1111/dme.13008; Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Icks A, 2009, DIABETOLOGIA, V52, P1836, DOI 10.1007/s00125-009-1434-4; Icks A, 2011, J DIABETES COMPLICAT, V25, P90, DOI 10.1016/j.jdiacomp.2010.05.002; Kissela BM, 2005, DIABETES CARE, V28, P355, DOI 10.2337/diacare.28.2.355; Kolominsky-Rabas PL, 2015, NEUROEPIDEMIOLOGY, V44, P24, DOI 10.1159/000371353; Kolominsky-Rabas PL, 2006, STROKE, V37, P1179, DOI 10.1161/01.STR.0000217450.21310.90; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; Le CT, 2003, INTRO BIOSTATISTICS, DOI 10.1002/0471308889; Mulnier HE, 2006, DIABETOLOGIA, V49, P2859, DOI 10.1007/s00125-006-0493-z; Munoz-Rivas N, 2016, J STROKE CEREBROVASC, V25, P1431, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.031; Ramirez L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003233; Rautio A, 2008, STROKE, V39, P3137, DOI 10.1161/STROKEAHA.107.504100; Robert Koch Institute, 2000, GERM NAT HLTH INT EX; Robert Koch Institute, 2015, GERM HLTH INT EX SUR; Statistisches Bundesamt, 2015, DER REG; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; World Health Organization, 1995, 07MT02 EURICPCIND	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188306	10.1371/journal.pone.0188306	http://dx.doi.org/10.1371/journal.pone.0188306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145522	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800108
J	Seo, SR; Lee, HM; Choi, HS; Kim, WT; Cho, EW; Ryu, CJ				Seo, Se-Ri; Lee, Hyun Min; Choi, Hong Seo; Kim, Won-Tae; Cho, Eun-Wie; Ryu, Chun Jeih			Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOPLASMIC-RETICULUM; BAP31; IDENTIFICATION; APOPTOSIS; MOLECULE; COMPLEX; SYSTEM; GRP78; A549	B-cell receptor-associated protein 31 (BAP31) is an endoplasmic reticulum (ER) membrane protein which plays a role as a molecular chaperone for the newly synthesized transmembrane proteins. BAP31 is also an important apoptosis regulator for extrinsic apoptosis induction in the ER membrane. Recent studies have shown that BAP31 is also expressed on the surface of embryonic stem cells. However, the function of cell surface BAP31 (csBAP31) still remains unclarified. In an attempt to search for surface markers on tumorspheres, here, we generated monoclonal antibodies (MAbs) against the sphere cells from the non-small cell lung carcinoma cell (NSCLC) line A549. SP1-B7, one of the MAbs, recognized csBAP31 whose expression was further increased on A549 sphere cells, as compared with A549 adherent cells. To investigate the role of csBAP31 in A549 cells, A549 adherent and sphere cells were stained with annexin V, propidium iodide, and SP1-B7. Interestingly, annexin V-high cells showed increased expression of csBAP31 as compared with annexin V-low cells. Caspase-3/7 activity was also increased in csBAP31-high cells as compared with csBAP31-low cells, suggesting that csBAP31-high cells are more sensitive to apoptosis. To further demonstrate the survival of csBAP31-positive A549 cells, csBAP31-positive and -negative A549 cells were sorted and subjected to the clonogenic survival assay. The colony number of csBAP31-positive A549 cells was decreased by approximately 1.7-fold, as compared that of csBAP31-negative A549 cells, suggesting that csBAP31-positve cells are sensitive to cell death indeed. The results suggest that enhanced expression of csBAP31 contributes to poor survival of NSCLC cells.	[Seo, Se-Ri; Lee, Hyun Min; Choi, Hong Seo; Kim, Won-Tae; Ryu, Chun Jeih] Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Antiancer Med Dev, Seoul, South Korea; [Cho, Eun-Wie] Korea Res Inst Biosci & Biotechnol, Epigenom Res Ctr, Daejeon, South Korea	Sejong University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Ryu, CJ (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, Inst Antiancer Med Dev, Seoul, South Korea.	cjryu@sejong.ac.kr			National Research Foundation of Korea [2016008610, 2016903249]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported in part by the National Research Foundation of Korea (2016008610 and 2016903249). There was no additional external funding received for this further study.; This study was supported in part by the National Research Foundation of Korea (2016008610 and 2016903249).	Adachi T, 1996, EMBO J, V15, P1534, DOI 10.1002/j.1460-2075.1996.tb00497.x; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Choi HS, 2008, CELL TISSUE RES, V333, P197, DOI 10.1007/s00441-008-0632-6; Choi HS, 2013, STEM CELLS, V31, P2647, DOI 10.1002/stem.1366; Choi HS, 2011, STEM CELLS DEV, V20, P609, DOI 10.1089/scd.2010.0265; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Iwasawa R, 2011, EMBO J, V30, P556, DOI 10.1038/emboj.2010.346; KIM KM, 1994, EMBO J, V13, P3793, DOI 10.1002/j.1460-2075.1994.tb06690.x; Kim WT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167527; Kim WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130670; Kim WT, 2014, STEM CELLS, V32, P2626, DOI 10.1002/stem.1765; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Meng XJ, 2009, ONCOL REP, V21, P995, DOI 10.3892/or_00000314; Moreb JS, 2007, CYTOM PART B-CLIN CY, V72B, P281, DOI 10.1002/cyto.b.20161; Ng FWH, 1997, J CELL BIOL, V139, P327, DOI 10.1083/jcb.139.2.327; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Raiter A, 2014, ONCOTARGET, V5, P11452, DOI 10.18632/oncotarget.2576; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh SK, 2003, CANCER RES, V63, P5821; Stojanovic M, 2005, J BIOL CHEM, V280, P30018, DOI 10.1074/jbc.M501306200; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Yerushalmi R, 2015, ONCOL LETT, V10, P2149, DOI 10.3892/ol.2015.3579; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188075	10.1371/journal.pone.0188075	http://dx.doi.org/10.1371/journal.pone.0188075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145450	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800060
J	Pawlowska, S; Nakielski, P; Pierini, F; Piechocka, IK; Zembrzycki, K; Kowalewski, TA				Pawlowska, Sylwia; Nakielski, Pawel; Pierini, Filippo; Piechocka, Izabela K.; Zembrzycki, Krzysztof; Kowalewski, Tomasz A.			Lateral migration of electrospun hydrogel nanofilaments in an oscillatory flow	PLOS ONE			English	Article							SHEAR-INDUCED MIGRATION; POISEUILLE FLOW; INERTIAL MIGRATION; POLYMER-SOLUTIONS; ACTIN-FILAMENTS; FLEXIBLE FIBERS; RIGID SPHERES; DYNAMICS; DNA; FLUID	The recent progress in bioengineering has created great interest in the dynamics and manipulation of long, deformable macromolecules interacting with fluid flow. We report experimental data on the cross-flow migration, bending, and buckling of extremely deformable hydrogel nanofilaments conveyed by an oscillatory flow into a microchannel. The changes in migration velocity and filament orientation are related to the flow velocity and the filament's initial position, deformation, and length. The observed migration dynamics of hydrogel filaments qualitatively confirms the validity of the previously developed worm-like bead-chain hydrodynamic model. The experimental data collected may help to verify the role of hydrodynamic interactions in molecular simulations of long molecular chains dynamics.	[Pawlowska, Sylwia; Nakielski, Pawel; Pierini, Filippo; Piechocka, Izabela K.; Zembrzycki, Krzysztof; Kowalewski, Tomasz A.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Warsaw, Poland	Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Pawlowska, S; Kowalewski, TA (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Warsaw, Poland.	spaw@ippt.pan.pl; tkowale@ippt.pan.pl	Kowalewski, Tomasz Aleksander/F-2055-2011; Pawłowska, Sylwia/HIK-1653-2022; Nakielski, Pawel/A-2077-2013; Pierini, Filippo/B-5328-2019; Piechocka, Izabela Katarzyna/L-3079-2014	Kowalewski, Tomasz Aleksander/0000-0002-3664-9659; Nakielski, Pawel/0000-0001-6194-701X; Pierini, Filippo/0000-0002-6526-4141; Piechocka, Izabela Katarzyna/0000-0002-2877-3924	Polish National Science Center (NCN) [2015/17/N/ST8/02012]; EC structural funds of the Center for Preclinical Research and Technology (CePT), POIG [02.02.00-17-024/08-00]; EC structural funds of the Biocentrum Ochota [POIG.02.03.00-00-003/09-00]	Polish National Science Center (NCN); EC structural funds of the Center for Preclinical Research and Technology (CePT), POIG; EC structural funds of the Biocentrum Ochota	This work was supported by Polish National Science Center (NCN), grant no. 2015/17/N/ST8/02012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the Polish National Science Center (NCN, grant no. 2015/17/N/5T8/02012). The experiments were performed using apparatus available thanks to the EC structural funds in framework of the Center for Preclinical Research and Technology (CePT), POIG Nr. 02.02.00-17-024/08-00. The computational resources were made available thanks to the EC structural funds in framework of the Biocentrum Ochota, POIG.02.03.00-00-003/09-00.	Bloom KS, 2008, CHROMOSOMA, V117, P103, DOI 10.1007/s00412-007-0138-0; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; CHAKRABORTY K, 2013, J CHEM PHYS, V139, DOI DOI 10.1063/1.4769980; CHAN PCH, 1979, J FLUID MECH, V92, P131, DOI 10.1017/S0022112079000562; CHAUDHURY K, 2016, PHYS REV E, V93, DOI DOI 10.1063/1.2176587; CHELAKKOT R, 2010, EPL-EUROPHYS LETT, V91, P17060, DOI DOI 10.1017/S0022112006000243; Chen YL, 2014, RSC ADV, V4, P17908, DOI 10.1039/c4ra00837e; Chen YJ, 2014, P NATL ACAD SCI USA, V111, P17396, DOI 10.1073/pnas.1415685111; Chen YL, 2005, MACROMOLECULES, V38, P6680, DOI 10.1021/ma050238d; Chun B, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2176587; Corbin EA, 2013, BIOMED MICRODEVICES, V15, P311, DOI 10.1007/s10544-012-9730-z; DEPABLO JJ, 1992, AICHE J, V38, P273, DOI 10.1002/aic.690380213; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Doyle PS, 2000, PHYS REV LETT, V84, P4769, DOI 10.1103/PhysRevLett.84.4769; Elbaum M, 1996, PHYS REV LETT, V76, P4078, DOI 10.1103/PhysRevLett.76.4078; Fahraeus R, 1929, PHYSIOL REV, V9, P241, DOI 10.1152/physrev.1929.9.2.241; Farutin A, 2016, SOFT MATTER, V12, P7307, DOI 10.1039/c6sm00819d; GAUTHIER F J, 1972, Biorheology, V9, P205; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Gerashchenko S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.038304; Gittes F, 1996, BIOPHYS J, V70, P418, DOI 10.1016/S0006-3495(96)79585-1; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Graham MD, 2011, ANNU REV FLUID MECH, V43, P273, DOI 10.1146/annurev-fluid-121108-145523; Guo ZJ, 2008, J PHYS CHEM B, V112, P16163, DOI 10.1021/jp806260h; Harasim M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.108302; Herczynski R, 2016, ARCH MECH, V68, P81; HILLER W, 1987, EXP FLUIDS, V5, P141, DOI 10.1007/BF00776185; HLADKY SB, 2014, FLUIDS BARRIERS CNS, V11, P17060, DOI DOI 10.1007/S10544-012-9730-Z; HO BP, 1974, J FLUID MECH, V65, P365, DOI 10.1017/S0022112074001431; Izmitli A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2831777; Jendrejack RM, 2004, J CHEM PHYS, V120, P2513, DOI 10.1063/1.1637331; Jo K, 2009, LAB CHIP, V9, P2348, DOI 10.1039/b902292a; Kantsler V, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.038103; Kirchenbuechler I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6060; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; KUEI S, 2015, NEW J PHYS, V17, DOI DOI 10.1088/0953-8984/19/28/285224; Lamour G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-16; Lang PS, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022606; LeDuc P, 1999, NATURE, V399, P564, DOI 10.1038/21148; Lei YM, 2017, PROG NEUROBIOL, V157, P230, DOI 10.1016/j.pneurobio.2015.12.007; Lopez HM, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4905920; Ma HB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.2011367; Murrell MP, 2012, P NATL ACAD SCI USA, V109, P20820, DOI 10.1073/pnas.1214753109; Nakielski P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129816; Noding B, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.088101; Pal K, 2009, DES MONOMERS POLYM, V12, P197, DOI 10.1163/156855509X436030; Perez A, 2012, ACCOUNTS CHEM RES, V45, P196, DOI 10.1021/ar2001217; Quennouz N, 2015, J FLUID MECH, V769, P387, DOI 10.1017/jfm.2015.115; Reddig S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3656070; Sadlej K, 2010, INT J HEAT FLUID FL, V31, P996, DOI 10.1016/j.ijheatfluidflow.2010.02.021; Saintillan D, 2006, J FLUID MECH, V557, P297, DOI 10.1017/S0022112006000243; Schroeder CM, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.018301; SEGRE G, 1962, J FLUID MECH, V14, P136, DOI 10.1017/S0022112062001111; SEGRE G, 1961, NATURE, V189, P209, DOI 10.1038/189209a0; Slowicka AM, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3678852; SLOWICKA AM, 2013, EUR PHYS J E, V36, P17060, DOI DOI 10.1063/1.1637331; Smith DE, 1999, SCIENCE, V283, P1724, DOI 10.1126/science.283.5408.1724; Steinhauser D, 2012, ACS MACRO LETT, V1, P541, DOI 10.1021/mz3000539; Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107; SZYMCZAK P, 2007, J PHYS-CONDENS MAT, V19, DOI DOI 10.1103/PHYSREVLETT.96.038304; Teixeira RE, 2005, MACROMOLECULES, V38, P581, DOI 10.1021/ma048077l; Tornberg AK, 2004, J COMPUT PHYS, V196, P8, DOI 10.1016/j.jcp.2003.10.017; Truong NP, 2015, EXPERT OPIN DRUG DEL, V12, P129, DOI 10.1517/17425247.2014.950564; Vezeridis PS, 2006, BIOCHEM BIOPH RES CO, V348, P1082, DOI 10.1016/j.bbrc.2006.07.146; Wandersman E, 2010, SOFT MATTER, V6, P5715, DOI 10.1039/c0sm00132e; Wang JH, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4769980; Wen Q, 2012, SOFT MATTER, V8, P8039, DOI 10.1039/c2sm25364j; Wiig H, 2012, PHYSIOL REV, V92, P1005, DOI 10.1152/physrev.00037.2011	68	10	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187815	10.1371/journal.pone.0187815	http://dx.doi.org/10.1371/journal.pone.0187815			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141043	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400031
J	Shimizu, JF; Pereira, CM; Bittar, C; Batista, MN; Campos, GRF; da Silva, S; Cintra, ACO; Zothner, C; Harris, M; Sampaio, SV; Aquino, VH; Rahal, P; Jardim, ACG				Shimizu, Jacqueline Farinha; Pereira, Carina Machado; Bittar, Cintia; Batista, Mariana Nogueira; Fernandes Campos, Guilherme Rodrigues; da Silva, Suely; Oliveira Cintra, Adelia Cristina; Zothner, Carsten; Harris, Mark; Sampaio, Suely Vilela; Aquino, Victor Hugo; Rahal, Paula; Gomes Jardim, Ana Carolina			Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; REPLICATION IN-VITRO; PHOSPHOLIPASES A(2); ANTIVIRAL STRATEGIES; ISOLATED SUBUNITS; CROTOXIN COMPLEX; CORE PROTEIN; SNAKE-VENOM; INHIBITORS; INFECTION	Hepatitis C virus (HCV) is one of the main causes of liver disease and transplantation worldwide. Current therapy is expensive, presents additional side effects and viral resistance has been described. Therefore, studies for developing more efficient antivirals against HCV are needed. Compounds isolated from animal venoms have shown antiviral activity against some viruses such as Dengue virus, Yellow fever virus and Measles virus. In this study, we evaluated the effect of the complex crotoxin (CX) and its subunits crotapotin (CP) and phospholipase A(2) (PLA(2)-CB) isolated from the venom of Crotalus durissus terrificus on HCV life cycle. Huh 7.5 cells were infected with HCVcc JFH-1 strain in the presence or absence of these toxins and virus was titrated by focus formation units assay or by qPCR. Toxins were added to the cells at different time points depending on the stage of virus life cycle to be evaluated. The results showed that treatment with PLA(2)-CB inhibited HCV entry and replication but no effect on HCV release was observed. CX reduced virus entry and release but not replication. By treating cells with CP, an antiviral effect was observed on HCV release, the only stage inhibited by this compound. Our data demonstrated the multiple antiviral effects of toxins from animal venoms on HCV life cycle.	[Shimizu, Jacqueline Farinha; Pereira, Carina Machado; Bittar, Cintia; Batista, Mariana Nogueira; Fernandes Campos, Guilherme Rodrigues; da Silva, Suely; Rahal, Paula; Gomes Jardim, Ana Carolina] Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Paulo, Brazil; [Shimizu, Jacqueline Farinha; da Silva, Suely; Aquino, Victor Hugo] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Lab Virol, Sao Paulo, Brazil; [Oliveira Cintra, Adelia Cristina; Sampaio, Suely Vilela] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Lab Toxinol, Sao Paulo, Brazil; [Zothner, Carsten; Harris, Mark] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Zothner, Carsten; Harris, Mark] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Gomes Jardim, Ana Carolina] Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; University of Leeds; University of Leeds; Universidade Federal de Uberlandia	Jardim, ACG (corresponding author), Sao Paulo State Univ, IBILCE, Genom Study Lab, Sao Paulo, Brazil.; Jardim, ACG (corresponding author), Univ Fed Uberlandia, ICBIM, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.	jardim@ufu.br	Aquino, Victor Hugo/C-1922-2012; Rahal, Paula/D-3871-2012; Jardim, Ana Carolina/H-3615-2012; Bittar, Cintia/A-5042-2015; Vilela, Suely/D-7429-2012	Aquino, Victor Hugo/0000-0003-1910-0776; Rahal, Paula/0000-0001-5693-6148; Jardim, Ana Carolina/0000-0002-6348-7923; Bittar, Cintia/0000-0002-2048-4589; Vilela, Suely/0000-0003-3274-180X; Rodrigues Fernandes Campos, Guilherme/0000-0003-1118-8486; Farinha Shimizu, Jacqueline/0000-0002-9844-7745	Royal Society [NA 150195]; FAPEMIG [APQ-00587-14, SICONV 793988/2013]; FAPESP (Sao Paulo Research Foundation) [2011/00313-3, 2012/01403-9, 2013/03897-1]; CAPES (Coordination for the Improvement of Higher Education Personnel); CNPQ (National Council for Scientific and Technological Development) [45021/2014-4]; Wellcome Trust Investigator Award [096670]	Royal Society(Royal Society of London); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust Investigator Award(Wellcome Trust)	This work was supported by the Royal Society (Newton Advanced Fellowship: NA 150195 to ACGJ), FAPEMIG (grants: APQ-00587-14 and SICONV 793988/2013 to ACGJ), FAPESP (Sao Paulo Research Foundation grants: 2011/00313-3 to ACGJ, 2012/01403-9 to CB, and 2013/03897-1 to JFS), CAPES (Coordination for the Improvement of Higher Education Personnel) to JFS, and CNPQ (National Council for Scientific and Technological Development grant 45021/2014-4) to ACGJ. Research in the MH laboratory is funded by a Wellcome Trust Investigator Award (grant reference 096670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD SD, 1985, BIOCHEMISTRY-US, V24, P7054, DOI 10.1021/bi00346a005; Ayoub WS, 2015, CLIN LIVER DIS, V19, P619, DOI 10.1016/j.cld.2015.06.003; Bailey P, 2001, Emerg Med (Fremantle), V13, P28, DOI 10.1046/j.1442-2026.2001.00174.x; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Blaising J, 2013, BIOCHIMIE, V95, P96, DOI 10.1016/j.biochi.2012.07.016; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; BON C, 1979, EUR J BIOCHEM, V99, P471, DOI 10.1111/j.1432-1033.1979.tb13278.x; BON C, 1982, TOXICON, V20, P105, DOI 10.1016/0041-0101(82)90173-8; BREITHAUPT H, 1976, TOXICON, V14, P221, DOI 10.1016/0041-0101(76)90010-6; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803; Cecilio AB, 2013, TOXINS, V5, P1780, DOI 10.3390/toxins5101780; Ciesek S, 2009, HEPATOLOGY, V50, P1638, DOI 10.1002/hep.23281; Dabbouseh NM, 2013, NAT REV GASTRO HEPAT, V10, P268, DOI 10.1038/nrgastro.2013.17; FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036; Faure G, 2012, TOXICON, V60, P531, DOI 10.1016/j.toxicon.2012.05.009; Faure G, 2011, J MOL BIOL, V412, P176, DOI 10.1016/j.jmb.2011.07.027; Fenard D, 1999, J CLIN INVEST, V104, P611, DOI 10.1172/JCI6915; FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Goldwasser J, 2011, J HEPATOL, V55, P963, DOI 10.1016/j.jhep.2011.02.011; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; HENDON RA, 1971, P NATL ACAD SCI USA, V68, P1560, DOI 10.1073/pnas.68.7.1560; Houghton M, 2011, IMMUNOL REV, V239, P99, DOI 10.1111/j.1600-065X.2010.00977.x; Jardim ACG, 2015, ANTIVIR RES, V115, P39, DOI 10.1016/j.antiviral.2014.12.018; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Krawczyk M, 2009, BIOL CHEM, V390, P351, DOI 10.1515/BC.2009.040; Macdonald A, 2003, J BIOL CHEM, V278, P17775, DOI 10.1074/jbc.M210900200; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Meenakshisundaram R., 2009, AIDS RES THER, V6, P25, DOI DOI 10.1186/1742-6405-6-25; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Menjon Muller VD., 2014, J VIROL ANTIVIR RES, V3; Meuleman P, 2008, HEPATOLOGY, V48, P1761, DOI 10.1002/hep.22547; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller VD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112351; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Park IW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075648; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Petricevich VL, 2003, TOXICON, V42, P143, DOI 10.1016/S0041-0101(03)00124-7; Popescu Costin-Ioan, 2014, Biology (Basel), V3, P892, DOI 10.3390/biology3040892; Rojas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31777; Sampaio SC, 2010, TOXICON, V55, P1045, DOI 10.1016/j.toxicon.2010.01.011; Santos KF, 2007, ACTA CRYSTALLOGR F, V63, P287, DOI 10.1107/S1744309107006719; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Stankiewicz-Drogon A, 2010, J MED CHEM, V53, P3117, DOI 10.1021/jm901741p; Sugawara E, 2014, ANTIMICROB AGENTS CH, V58, P7250, DOI 10.1128/AAC.03728-14; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Talwani R, 2012, DRUG TODAY, V48, P219, DOI 10.1358/dot.2012.48.3.1740457; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wandeler G, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14093; Wyles DL, 2007, J VIROL, V81, P3005, DOI 10.1128/JVI.02083-06; Wyles DL, 2009, ANTIMICROB AGENTS CH, V53, P2660, DOI 10.1128/AAC.01546-08; Xiao F, 2014, GUT, P1; Yan R, 2011, PEPTIDES, V32, P11, DOI 10.1016/j.peptides.2010.10.008; Zhang S, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0320-4; Zona L, 2014, VIRUSES-BASEL, V6, P875, DOI 10.3390/v6020875	62	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187857	10.1371/journal.pone.0187857	http://dx.doi.org/10.1371/journal.pone.0187857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141010	gold, Green Published			2022-12-27	WOS:000415260400034
J	Sanz, H; Aponte, JJ; Harezlak, J; Dong, Y; Ayestaran, A; Nhabomba, A; Mpina, M; Maurin, OR; Diez-Padrisa, N; Aguilar, R; Moncunill, G; Todagbe, AS; Daubenberger, C; Dobano, C; Valim, C				Sanz, Hector; Aponte, John J.; Harezlak, Jaroslaw; Dong, Yan; Ayestaran, Aintzane; Nhabomba, Augusto; Mpina, Maxmillian; Maurin, Obiang Regis; Diez-Padrisa, Nuria; Aguilar, Ruth; Moncunill, Gemma; Todagbe, Agnandij Selidji; Daubenberger, Claudia; Dobano, Carlota; Valim, Clarissa			drLumi: An open-source package to manage data, calibrate, and conduct quality control of multiplex bead-based immunoassays data analysis	PLOS ONE			English	Article							R PACKAGE; RESPONSES; ASSAYS; ARRAY	Multiplex bead-based immunoassays are used to measure concentrations of several analytes simultaneously. These assays include control standard curves (SC) to reduce between-plate variability and normalize quantitation of analytes of biological samples. Suboptimal calibration might result in large random error and decreased number of samples with analyte concentrations within the limits of quantification. Suboptimal calibration may be a consequence of poor fitness of the functions used for the SC, the treatment of the background noise and the method used to estimate the limits of quantification. Currently assessment of fitness of curves is largely dependent on operator and that may add additional error. Moreover, there is no software to automate data managing and quality control. In this article we present a R package, drLumi, with functions for managing data, calibrating assays and performing quality control. To optimize the assay the package implements: i) three dose-response functions, ii) four approaches for treating background noise and iii) three methods for estimating limits of quantifications. Other implemented functions are focused on the quality control of the fitted standard curve: detection of outliers, estimation of the confidence or prediction interval, and estimation of summary statistics. With demonstration purpose, we apply the software to 30 cytokines, chemokines and growth factors measured in a multiplex bead-based immunoassay in a study aiming to measure correlates of risk or protection from malaria of the RTS, S malaria vaccine nested in the Phase 3 randomized controlled trial of this vaccine.	[Sanz, Hector; Aponte, John J.; Ayestaran, Aintzane; Diez-Padrisa, Nuria; Aguilar, Ruth; Moncunill, Gemma; Dobano, Carlota] Univ Barcelona, Hosp Cln, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Harezlak, Jaroslaw; Dong, Yan] Indiana Univ, Fairbanks Sch Publ Hlth, Dept Biostat, Indianapolis, IN 46204 USA; [Nhabomba, Augusto] CISM, Maputo, Mozambique; [Mpina, Maxmillian] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Maurin, Obiang Regis; Todagbe, Agnandij Selidji] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Todagbe, Agnandij Selidji] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Daubenberger, Claudia] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Daubenberger, Claudia] Univ Basel, Basel, Switzerland; [Valim, Clarissa] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Valim, Clarissa] Michigan State Univ, Coll Osteopath Med East Lansing, Dept Osteopath Med Specialties, E Lansing, MI 48824 USA	ISGlobal; CRESIB; University of Barcelona; Indiana University System; Indiana University-Purdue University Indianapolis; Centro de Investigacao em Saude de Manhica; Ifakara Health Institute; Eberhard Karls University of Tubingen; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Harvard University; Harvard T.H. Chan School of Public Health; Michigan State University	Sanz, H (corresponding author), Univ Barcelona, Hosp Cln, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	hector.sanz@isglobal.org	Dobaño, Carlota/N-4119-2014; Diez-Padrisa, Nuria/AAE-1000-2020; Moncunill, Gemma/B-7989-2011; Aguilar, Ruth/D-2147-2018; Harezlak, Jaroslaw/P-8557-2014	Dobaño, Carlota/0000-0002-6751-4060; Moncunill, Gemma/0000-0001-5105-9836; Aguilar, Ruth/0000-0003-3277-3107; Harezlak, Jaroslaw/0000-0002-3070-7686; Daubenberger, Claudia/0000-0001-7136-0642	PATH-MVI [00408682-COL, GAT0888-08-00374112.1-COL]; National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID) [R01AI095789]; European Unions Seventh Framework Programme for research, technological development and demonstration [305869]; Ministerio de Economia y Competitividad (Instituto de Salud Carlos III) [PI11/00423]; Agencia de Gestio dAjuts Universitaris i de Recerca AGAUR [2014SGR991]	PATH-MVI(United States Agency for International Development (USAID)); National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Unions Seventh Framework Programme for research, technological development and demonstration; Ministerio de Economia y Competitividad (Instituto de Salud Carlos III); Agencia de Gestio dAjuts Universitaris i de Recerca AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	The work described in this publication was made possible by grants from the PATH-MVI (grant 00408682-COL, GAT0888-08-00374112.1-COL), National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID), Grant Number R01AI095789, the European Unions Seventh Framework Programme for research, technological development and demonstration under grant agreement number 305869, the Ministerio de Economia y Competitividad (Instituto de Salud Carlos III, PI11/00423), the Agencia de Gestio dAjuts Universitaris i de Recerca AGAUR, grant number 2014SGR991. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the funders.	[Anonymous], 2014, R LANG ENV STAT COMP; Bates DM, NONLINEAR REGRESSION; Berthoud TK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-115; Defawe OD, 2012, J IMMUNOL METHODS, V382, P117, DOI 10.1016/j.jim.2012.05.011; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Fong YY, 2013, BIOINFORMATICS, V29, P2653, DOI 10.1093/bioinformatics/btt456; Gamer M, 2012, IRR VARIOUS COEFFICI; Gottschalk PG, 2005, COMPUT METH PROG BIO, V80, P204, DOI 10.1016/j.cmpb.2005.08.003; Gottschalk PG, 2005, ANAL BIOCHEM, V343, P54, DOI 10.1016/j.ab.2005.04.035; Moncunill G, 2013, PLOS ONE, V8; Moncunill G, 2017, CLIN INFECT DIS, V65, P746, DOI 10.1093/cid/cix429; Moncunill G, 2014, METHODS MOL BIOL, V1172, P65, DOI 10.1007/978-1-4939-0928-5_6; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; NEILL JW, 1988, ANN STAT, V16, P733, DOI 10.1214/aos/1176350831; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Valim C, 2016, AM J RESP CRIT CARE, V193, P448, DOI 10.1164/rccm.201506-1100OC	20	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187901	10.1371/journal.pone.0187901	http://dx.doi.org/10.1371/journal.pone.0187901			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136653	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000415121200044
J	Wang, MM; Ong, LLS; Dauwels, J; Asada, HH				Wang, Mengmeng; Ong, Lee-Ling Sharon; Dauwels, Justin; Asada, H. Harry			Automated tracking and quantification of angiogenic vessel formation in 3D microfluidic devices	PLOS ONE			English	Article							CENTERLINE EXTRACTION; ENDOTHELIAL-CELLS; IDENTIFICATION; MICROSCOPY; BEHAVIORS; MIGRATION; GUIDANCE; IMAGES; MODEL; VEGF	Angiogenesis, the growth of new blood vessels from pre-existing vessels, is a critical step in cancer invasion. Better understanding of the angiogenic mechanisms is required to develop effective antiangiogenic therapies for cancer treatment. We culture angiogenic vessels in 3D microfluidic devices under different Sphingosin-1-phosphate (S1P) conditions and develop an automated vessel formation tracking system (AVFTS) to track the angiogenic vessel formation and extract quantitative vessel information from the experimental time-lapse phase contrast images. The proposed AVFTS first preprocesses the experimental images, then applies a distance transform and an augmented fast marching method in skeletonization, and finally implements the Hungarian method in branch tracking. When applying the AVFTS to our experimental data, we achieve 97.3% precision and 93.9% recall by comparing with the ground truth obtained from manual tracking by visual inspection. This system enables biologists to quantitatively compare the influence of different growth factors. Specifically, we conclude that the positive S1P gradient increases cell migration and vessel elongation, leading to a higher probability for branching to occur. The AVFTS is also applicable to distinguish tip and stalk cells by considering the relative cell locations in a branch. Moreover, we generate a novel type of cell lineage plot, which not only provides cell migration and proliferation histories but also demonstrates cell phenotypic changes and branch information.	[Wang, Mengmeng; Dauwels, Justin] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore; [Wang, Mengmeng; Ong, Lee-Ling Sharon; Asada, H. Harry] Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Asada, H. Harry] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Wang, MM (corresponding author), Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore, Singapore.; Wang, MM; Ong, LLS (corresponding author), Singapore MIT Alliance Res & Technol, Singapore, Singapore.	mwang009@e.ntu.edu.sg; sharon.ong@smart.mit.edu		Ong, Lee Ling/0000-0002-4120-163X	National Research Foundation Singapore through Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme	National Research Foundation Singapore through Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme(National Research Foundation, SingaporeSingapore-MIT Alliance for Research & Technology Centre (SMART))	This research was supported by the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's BioSystems and Micromechanics Inter-Disciplinary Research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2010, ADV PATTERN RECOGNIT, P331, DOI 10.1007/978-1-84996-098-4_7; Adanja I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022263; Amat F, 2014, NAT METHODS, V11, P951, DOI [10.1038/NMETH.3036, 10.1038/nmeth.3036]; Angulo J, 2007, CELL MOL BIOL, V53, P22, DOI 10.1170/T784; Angulo J, 2005, Proceedings of the Fifth IASTED International Conference on Visualization, Imaging, and Image Processing, P51; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bouix S, 2005, MED IMAGE ANAL, V9, P209, DOI 10.1016/j.media.2004.06.026; Burkard  R., 2009, ASSIGNMENT PROBLEMS; Carlier A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002724; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; Das SK, 2008, BIOMICROFLUIDICS, V2, DOI 10.1063/1.2988313; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Debeir O, 2005, IEEE T MED IMAGING, V24, P697, DOI 10.1109/TMI.2005.846851; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Ebert D., 2002, P S DATA VISUALISATI, P251; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Farahat WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037333; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Gerhardt Holger, 2008, P68, DOI 10.1007/978-0-387-78632-2_6; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Gonzalez R. C., 2009, DIGITAL IMAGE PROCES, DOI 10.1117/1.3115362; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Hassouna MS, 2005, PROC CVPR IEEE, P458; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kanade T., 2011, 2011 IEEE WORKSH APP, P374; KIMMEL R, 1995, P SOC PHOTO-OPT INS, V2356, P137, DOI 10.1117/12.198602; Kuhn H, 1955, NAV RES LOGIST Q, V2, P83, DOI [10.1002/nav.3800020109, DOI 10.1002/NAV.3800020109]; Lim SH, 2013, INTEGR BIOL-UK, V5, P1474, DOI 10.1039/c3ib40082d; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lumsdaine A, 2002, BOOST GRAPH LIB USER; Michaels JG, 1991, APPL DISCRETE MATH; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Murphy D.B., 2002, FUNDAMENTALS LIGHT M; Nguyen DHT, 2013, P NATL ACAD SCI USA, V110, P6712, DOI 10.1073/pnas.1221526110; Ong LLS, 2014, MED IMAGE ANAL, V18, P211, DOI 10.1016/j.media.2013.10.008; Otsu N, 1975, AUTOMATICA, V11, P23, DOI [10.1109/tsmc.1979.4310076, DOI 10.1109/TSMC.1979.4310076]; Palagyi K, 1998, PATTERN RECOGN LETT, V19, P613, DOI 10.1016/S0167-8655(98)00031-2; Parsa H, 2011, P NATL ACAD SCI USA, V108, P5133, DOI 10.1073/pnas.1007508108; PAWELETZ N, 1989, CRIT REV ONCOL HEMAT, V9, P197, DOI 10.1016/S1040-8428(89)80002-2; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Progatzky F, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0001; Schiegg M, 2014, BIOINFORMATICS; Schuermann A, 2014, SEMIN CELL DEV BIOL, V31, P106, DOI 10.1016/j.semcdb.2014.04.037; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; Song Y, 2010, LEUKEMIA, V24, P153, DOI 10.1038/leu.2009.191; Strzodka R, 2004, P EG IEEE TCVG S VIS, P221, DOI DOI 10.2312/VISSYM/VISSYM04/221-230; Suman R, 2016, SCI REP-UK, V6, DOI 10.1038/srep22032; Wan M, 2002, IEEE T MED IMAGING, V21, P1450, DOI 10.1109/TMI.2002.806409; Wang MM, 2015, INT CONF ACOUST SPEE, P942, DOI 10.1109/ICASSP.2015.7178108; Wood L, 2011, INT J ROBOT RES, V30, P659, DOI 10.1177/0278364910394690; Yan TQ, 2012, COMM COM INF SC, V304, P251; Yi-Chun Lin, 2012, 2012 4th International Conference on Computational Intelligence, Communication Systems and Networks (CICSyN 2012), P278, DOI 10.1109/CICSyN.2012.59; Zattara EE, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0104-2; Zhao FJ, 2016, MED BIOL ENG COMPUT, V54, P511, DOI 10.1007/s11517-015-1337-0; Zhou Y, 1999, IEEE T VIS COMPUT GR, V5, P196, DOI 10.1109/2945.795212	62	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186465	10.1371/journal.pone.0186465	http://dx.doi.org/10.1371/journal.pone.0186465			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136008	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200005
J	Adiya, T; Johnson, CL; Loewen, MA; Ritterbush, KA; Constenius, KN; Dinter, CM				Adiya, Tsolmon; Johnson, Cari L.; Loewen, Mark A.; Ritterbush, Kathleen A.; Constenius, Kurt N.; Dinter, Cory M.			Microbial-caddisfly bioherm association from the Lower Cretaceous Shinekhudag Formation, Mongolia: Earliest record of plant armoring in fossil caddisfly cases	PLOS ONE			English	Article							GREEN RIVER FORMATION; EAST GOBI BASIN; SOUTHERN MONGOLIA; STRUCTURAL RECORDS; LAKE ENVIRONMENTS; CALCIUM-CARBONATE; SOURCE ROCKS; CENTRAL-ASIA; ALGAL MATS; EVOLUTION	Caddisfly larvae construct underwater protective cases using surrounding materials, thus providing information on environmental conditions in both modern and ancient systems. Microbial bioherms associated with caddisfly cases are found in the Berriassian-Hauterivian (similar to 140-130 Ma) Shinekhudag Formation of Mongolia, and yield new insights into aspects of lacustrine paleoecosystems and paleoenvironments. This formation contains the earliest record of plant-armored caddisfly cases and a rare occurrence of microbial-caddisfly association from the Mesozoic. The bioherms are investigated within the context of stratigraphic correlations, depositional environment interpretations, and basin-evolution models of the sedimentary fill. The bioherms form 0.5-2.0 m diameter mound-shaped bodies and are concentrated within a single, oil shale-bound stratigraphic interval. Each bioherm is composed of up to 40% caddisfly cases along with stromatolites of millimeter-scale, micritic laminations. Petrographic analyses reveal these bioherms are composed of non-systematic associations of columnar and oncoidal microbialites, constructed around colonies of caddisfly cases. The cases are straight to curved, slightly tapered, and tube-shaped, with a progressively increasing length and width trend (7-21 mm by 1.5-2.5 mm). Despite these variations, the case architectures reveal similar construction materials; the particles used for cases are dominated by plant fragments, ostracod valves, carbonate rocks, and rare mica and feldspar grains. Allochems within the bioherms include ooids, ostracods, plant fragments, rare gastropods, feldspar grains bound in micritic matrices, and are consolidated by carbonate dominated cements. The combination of microbial-caddisfly association, plant fragment case particles, and ooids/oncoids are indicative of a shallow, littoral lake setting. Stratigraphic juxtaposition of nearshore bioherms and the bounding distal oil-shale facies suggests that the bioherms developed in an underfilled lake basin, resulting from an abrupt and short-lived lake desiccation event. Lake chemistry is believed to have been relatively alkaline, saline to hypersaline, and rich in Ca, Mg, and HCO3 ions. Through analyzing bioherm characteristics, caddisfly case architecture, carbonate microfacies, and stratigraphic variability, we infer larger-scale processes that controlled basin development during their formation.	[Adiya, Tsolmon; Johnson, Cari L.; Loewen, Mark A.; Ritterbush, Kathleen A.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Loewen, Mark A.] Nat Hist Museum Utah, Salt Lake City, UT USA; [Dinter, Cory M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Constenius, Kurt N.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Dinter, Cory M.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa	Utah System of Higher Education; University of Utah; University of Witwatersrand; University of Arizona; University of Witwatersrand	Adiya, T (corresponding author), Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA.	tsolmon.adiya@utah.edu			Fulbright Association	Fulbright Association	The Fulbright Association fully funded the education of the first author, Tsolmon Adiya, at the University of Utah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariunchimeg Y, 2012, GEOLOGY MINERAL RESO, P408; Awramik SM, 2015, GEOLOGY, V43, P691, DOI 10.1130/G36793.1; Badarch G, 2002, J ASIAN EARTH SCI, V21, P87, DOI 10.1016/S1367-9120(02)00017-2; Baskin R.L., 2014, THESIS; Bhattacharya JP., 2010, SOC SEDIMENTARY GEOL, V6, P233, DOI DOI 10.2110/PEC.06.84.0237; Bohacs K.M., 2007, MT GEOL, V44, P79; Bohacs K. M., 2000, LAKE BASINS SPACE TI, V46, P3; Botosaneanu L, 2004, ANN LIMNOL-INT J LIM, V40, P15, DOI 10.1051/limn/2004002; BRAITHWAITE C. J. R., 1991, EARTH SCI, V82, P99; BRIDGE JS, 1993, SEDIMENTOLOGY, V40, P801, DOI 10.1111/j.1365-3091.1993.tb01361.x; Buchheim H. P., 2012, AAPG HEDB C MICR CAR; Buchheim HP, 2009, 2009 PORTL GSA ANN M; Bull WB, 1972, RECOGNITION ANCIENT, V16, P63, DOI DOI 10.2110/PEC.72.02.0063; BURNE R V, 1987, Palaios, V2, P241, DOI 10.2307/3514674; Carroll AR, 1999, GEOLOGY, V27, P99, DOI 10.1130/0091-7613(1999)027<0099:SCOALB>2.3.CO;2; Carroll AR, 2001, AAPG BULL, V85, P1033; Chafetz HS, 2013, AAPG BULL, V97, P2103, DOI 10.1306/04231312173; CHOQUETTE PW, 1970, AM ASSOC PETR GEOL B, V54, P207; COHEN AS, 1989, PALAEOGEOGR PALAEOCL, V70, P65, DOI 10.1016/0031-0182(89)90080-1; Coleman JM., 1982, SANDSTONE DEPOSITION, P139; Cunningham D, 2005, EARTH PLANET SC LETT, V240, P436, DOI 10.1016/j.epsl.2005.09.013; Cunningham D, 2011, GEOL SOC SPEC PUBL, V338, P361, DOI 10.1144/SP338.17; DICKSON JAD, 1966, J SEDIMENT PETROL, V36, P491; Drysdale RN, 2003, SEDIMENT GEOL, V161, P207, DOI 10.1016/S0037-0738(03)00114-3; Dumitru TA, 2001, FISSION TRACK CONSTR, P215; Dunham R.J., 1962, CLASSIFICATION CARBO, V1, P108; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; ELIAS SA, 1991, BIOSCIENCE, V41, P552, DOI 10.2307/1311608; EMBRY A.F., 1971, THESIS U CALGARY CAL, V19, P730, DOI DOI 10.11575/PRISM/22817; Eugster H. P., 1983, LACUSTRINE CHEM SEDI, P321; Fleet AJ, 1988, LACUSTRINE PETROLEUM; Flugel E., 2004, MICROFACIES CARBONAT, P177, DOI 10.1007/978-3-662-08726-8; Flugel E., 2010, MICROFACIES CARBONAT, DOI DOI 10.1007/978-3-642-03796-2; Flugel E., 1982, MICROFACIES ANAL LIM, DOI DOI 10.1007/978-3-642-68423-4; FOLK RL, 1975, AAPG BULL, V59, P60; FOLK RL, 1974, J SEDIMENT PETROL, V44, P40; Frantz CM, 2015, GEOBIOLOGY, V13, P409, DOI 10.1111/gbi.12145; Frantz CM, 2013, STROMATOLITES BIOSIG; Friedman G, 1959, J SEDIMENT PETROL, V29, P87, DOI DOI 10.1306/74D70894-2B21-11D7-86480001020C1865D; Gierlowski-Kordesch E.H., 2010, FACIES ENV PROCESSES, V61, P1, DOI DOI 10.1016/S0070-4571(09)06101-9; Graham SA, 2012, REGIONAL GEOLOGY AND TECTONICS: PHANEROZOIC RIFT SYSTEMS AND SEDIMENTARY BASINS, VOL 1B, P443, DOI 10.1016/B978-0-444-56356-9.00016-X; Graham SA, 2001, GEOL SOC AM BULL, V113, P1560, DOI 10.1130/0016-7606(2001)113<1560:SRATIO>2.0.CO;2; Hinchliffe R, 2010, INTEGR COMP BIOL, V50, P606, DOI 10.1093/icb/icq069; Holzenthal RW, 2007, ZOOTAXA, P639; Horton BK, 2013, AAPG ANN CONV EXH DE; HUGUENEY M, 1990, PALAEONTOLOGY, V33, P495; Ivanov VD, 2002, TRICHOPTERA PHRYGANE, P199; JERZYKIEWICZ T, 1991, CRETACEOUS RES, V12, P345, DOI 10.1016/0195-6671(91)90015-5; Johnson CL, 2015, BASIN RES, V27, P272, DOI 10.1111/bre.12073; Johnson CL, 2015, GEOL SOC AM SPEC PAP, V513, P543, DOI 10.1130/2015.2513(17); Johnson CL, 2004, BASIN RES, V16, P79, DOI 10.1111/j.1365-2117.2004.00221.x; Johnson CL, 2003, AAPG BULL, V87, P817, DOI 10.1306/12170201073; Johnson CL, 2001, GEOL SOC AM MEM, V194, P413; KARLO KELTS K., 1978, LAKES, P295; KEDDY PA, 1986, J GREAT LAKES RES, V12, P25, DOI 10.1016/S0380-1330(86)71697-3; Keller AM, 1997, PALAIOS, V12, P282, DOI 10.2307/3515428; Kelty TK, 2008, TECTONOPHYSICS, V451, P290, DOI 10.1016/j.tecto.2007.11.052; Klement, 1967, AAPG BULL, V51, P167; Kuzmina S, 2008, PALAEOGEOGR PALAEOCL, V267, P245, DOI 10.1016/j.palaeo.2008.07.007; Leggitt VL, 2007, SEDIMENTOLOGY, V54, P661, DOI 10.1111/j.1365-3091.2007.00854.x; Leggitt VL, 2001, SEDIMENT GEOL, V145, P377, DOI 10.1016/S0037-0738(01)00155-5; Leggitt VL, 2002, SEDIMENT GEOL, V148, P139, DOI 10.1016/S0037-0738(01)00214-7; Lloyd JT, 1921, BIOL N AM CADDIS FLY; Loewen M. A., 1999, NATL PARK SERVICE PA, V4, P72; MACKAY RJ, 1979, ANNU REV ENTOMOL, V24, P185, DOI 10.1146/annurev.en.24.010179.001153; Mancini EA, 2013, AAPG BULL, V97, P1835, DOI 10.1306/intro070913; McCafferty WP, 1983, AQUATIC ENTOMOLOGY F; MCPHERSON JG, 1987, GEOL SOC AM BULL, V99, P331, DOI 10.1130/0016-7606(1987)99<331:FABDVO>2.0.CO;2; MEADOWS A, 1994, SEDIMENTOLOGY, V41, P423, DOI 10.1111/j.1365-3091.1994.tb02004.x; Meng QR, 2003, TECTONOPHYSICS, V369, P155, DOI 10.1016/S0040-1951(03)00195-1; MERRILL D, 1969, ANIM BEHAV, V17, P486, DOI 10.1016/0003-3472(69)90151-1; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; NEAL J., 1997, GEOLOGICAL SOC AM, V29, P239; Nemec W., 1988, FAN DELTAS SEDIMENTO, P3, DOI DOI 10.1111/J.1365-2117.1988.TB00021.X; Paik IS, 2005, PALAEOGEOGR PALAEOCL, V218, P301, DOI 10.1016/j.palaeo.2004.12.020; Philip H, 1999, GEOLOGY, V27, P211, DOI 10.1130/0091-7613(1999)027<0211:GPAWAF>2.3.CO;2; Platt, 1991, LACUSTRINE FACIES AN; Postma G., 1990, COARSE GRAINED DELTA, V10, P13; POWELL TG, 1986, MAR PETROL GEOL, V3, P200, DOI 10.1016/0264-8172(86)90045-0; Prost GL, 2004, AAPG BULL, V88, P483, DOI 10.1306/11150303042; Renault R.W., 2010, FACIES MODELS 4; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; Riding R., 1991, CALCAREOUS ALGAE STR, DOI DOI 10.1007/978-3-642-52335-9_2; Rosenberg MJ, 2015, SYNTH LIMNOGEOL, V1, P211, DOI 10.1007/978-94-017-9906-5_9; ROSS HH, 1967, ANNU REV ENTOMOL, V12, P169, DOI 10.1146/annurev.en.12.010167.001125; S A Ali, 2010, OILFIELD REV, V22, P14; Schieber J, 2013, J SEDIMENT RES, V83, P1026, DOI 10.2110/jsr.2013.77; Schnurrenberger D, 2003, J PALEOLIMNOL, V29, P141, DOI 10.1023/A:1023270324800; Scholle P., 2003, AM ASS PETROLEUM GEO, V77, P473, DOI [10.1306/M77973, DOI 10.1306/M77973]; Seard C, 2013, PALAEOGEOGR PALAEOCL, V381, P128, DOI 10.1016/j.palaeo.2013.04.023; SEMIKHATOV MA, 1979, CAN J EARTH SCI, V16, P992, DOI 10.1139/e79-088; Shapiro RS, 2000, PALAIOS, V15, P166, DOI 10.2307/3515503; Shapley MD, 2005, GEOCHIM COSMOCHIM AC, V69, P2517, DOI 10.1016/j.gca.2004.12.001; Shcherbakov Dmitry E., 2008, Alavesia, V2, P125; SIBLEY DF, 1991, GEOLOGY, V19, P151, DOI 10.1130/0091-7613(1991)019<0151:SCITAA>2.3.CO;2; SIBLEY DF, 1987, J SEDIMENT PETROL, V57, P967; Smith ME, 2008, GEOL SOC AM BULL, V120, P54, DOI 10.1130/B26073.1; Statzner B, 2011, LIMNOLOGICA, V41, P266, DOI 10.1016/j.limno.2011.04.002; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Sukatcheva I. D, 1968, PALEONTOLOGY J, V2, P59; Sukatsheva ID, 2016, PALEONTOL J+, V50, P396, DOI 10.1134/S0031030116040134; Tanavsuu-Milkeviciene K, 2012, SEDIMENTOLOGY, V59, P1735, DOI 10.1111/j.1365-3091.2012.01324.x; THOMPSON JB, 1990, GEOLOGY, V18, P995, DOI 10.1130/0091-7613(1990)018<0995:CPOGCA>2.3.CO;2; TRAYNOR JJ, 1995, MAR PETROL GEOL, V12, P35, DOI 10.1016/0264-8172(95)90386-X; Tully J, 2015, GEOEXPRO, V11, P48; Vincent SJ, 2001, MEMOIRS GEOLOGICAL S, P341; Warren J, 2000, EARTH-SCI REV, V52, P1, DOI 10.1016/S0012-8252(00)00022-2; WATSON MP, 1987, MAR PETROL GEOL, V4, P205, DOI 10.1016/0264-8172(87)90045-6; Webb LE, 1999, GEOLOGY, V27, P143, DOI 10.1130/0091-7613(1999)027<0143:OAAIOT>2.3.CO;2; Wells JT, 1999, J SEDIMENT RES, V69, P816, DOI 10.2110/jsr.69.816; Wiggins G, 2015, LARVAE N AM CADDISFL; Wiggins G.B., 2004, CADDISFLIES UNDERWAT; Wiggins GB, 1998, CADDISFLY FAMILY PHR; WILSON MVH, 1980, PALAEOGEOGR PALAEOCL, V32, P21, DOI 10.1016/0031-0182(80)90029-2; WILSON MVH, 1988, PALAEOGEOGR PALAEOCL, V62, P609, DOI 10.1016/0031-0182(88)90074-0; Wright VP, 2012, GEOL SOC SPEC PUBL, V370, P39, DOI 10.1144/SP370.2; Zheng Y, 1996, J STRUCT GEOL, V18, P1111, DOI 10.1016/0191-8141(96)00038-7	117	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188194	10.1371/journal.pone.0188194	http://dx.doi.org/10.1371/journal.pone.0188194			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161280	Green Published, Green Accepted, gold			2022-12-27	WOS:000415987000035
J	Al-Rifai, RH; Pearson, F; Critchley, JA; Abu-Raddad, LJ				Al-Rifai, Rami H.; Pearson, Fiona; Critchley, Julia A.; Abu-Raddad, Laith J.			Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis	PLOS ONE			English	Review							RISK-FACTORS; PULMONARY TUBERCULOSIS; INFECTION; DISEASE; PREVALENCE; EPIDEMIC; TRANSPLANTATION; TAIWAN; IMPACT; COHORT	The burgeoning epidemic of diabetes mellitus (DM) is one of the major global health challenges. We systematically reviewed the published literature to provide a summary estimate of the association between DM and active tuberculosis (TB). We searched Medline and EMBASE databases for studies reporting adjusted estimates on the TB-DM association published before December 22, 2015, with no restrictions on region and language. In the meta-analysis, adjusted estimates were pooled using a DerSimonian-Laird random-effects model, according to study design. Risk of bias assessment and sensitivity analyses were conducted. 44 eligible studies were included, which consisted of 58,468,404 subjects from 16 countries. Compared with non-DM patients, DM patients had 3.59-fold (95% confidence interval (CI) 2.25-5.73), 1.55-fold (95% CI 1.39-1.72), and 2.09-fold (95% CI 1.71-2.55) increased risk of active TB in four prospective, 16 retrospective, and 17 case-control studies, respectively. Country income level (3.16-fold in low/middle-vs. 1.73-fold in high-income countries), background TB incidence (2.05-fold in countries with > 50 vs. 1.89-fold in countries with-50 TB cases per 100,000 person-year), and geographical region (2.44-fold in Asia vs. 1.71-fold in Europe and 1.73-fold in USA/Canada) affected appreciably the estimated association, but potential risk of bias, type of population (general versus clinical), and potential for duplicate data, did not. Microbiological ascertainment for TB (3.03-fold) and/or blood testing for DM (3.10-fold), as well as uncontrolled DM (3.30-fold), resulted in stronger estimated association. DM is associated with a two-to four-fold increased risk of active TB. The association was stronger when ascertainment was based on biological testing rather than medical records or self-report. The burgeoning DM epidemic could impact upon the achievements of the WHO "End TB Strategy" for reducing TB incidence.	[Al-Rifai, Rami H.; Abu-Raddad, Laith J.] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar; [Al-Rifai, Rami H.; Abu-Raddad, Laith J.] Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Al-Rifai, Rami H.] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Pearson, Fiona; Critchley, Julia A.] St Georges Univ London, Populat Hlth Res Inst, London, England; [Abu-Raddad, Laith J.] Hamad Bin Khalifa Univ, Coll Publ Hlth, Qatar Fdn, Doha, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; United Arab Emirates University; St Georges University London; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Al-Rifai, RH (corresponding author), Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Coll Qatar, Infect Dis Epidemiol Grp, Doha, Qatar.; Al-Rifai, RH (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA.; Al-Rifai, RH (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates.	rrifai@uaeu.ac.ae	Rifai, Rami Al/AAD-9903-2020; Pearson, Fiona/AAS-4455-2021; Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506; Pearson, Fiona/0000-0003-1626-0862; Critchley, Julia/0000-0002-5248-4188; Al-Rifai, Rami H./0000-0001-6102-0353	Qatar National Research Fund (Qatar Foundation) [7-627-3-167]; Higher Education Funding Council for England	Qatar National Research Fund (Qatar Foundation); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE))	This publication was made possible by NPRP grant number 7-627-3-167 from the Qatar National Research Fund (a member of Qatar Foundation). The findings achieved herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful for infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar. This publication was made possible by NPRP grant number 7-627-3-167 from the Qatar National Research Fund (a member of Qatar Foundation). The findings achieved herein are solely the responsibility of the authors. The authors are also grateful for infrastructure support provided by the Biostatistics, Epidemiology, and Biomathematics Research Core at Weill Cornell Medicine-Qatar. JAC is also supported by the Higher Education Funding Council for England.	Alisjahbana B, 2006, INT J TUBERC LUNG D, V10, P696; Awad SF, 2017, CHARACTERIZING IMPAC; Baker MA, 2012, CLIN INFECT DIS, V54, P818, DOI 10.1093/cid/cir939; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Borenstein M., 2009, INTRO METAANALYSIS; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; BUSKIN SE, 1994, AM J PUBLIC HEALTH, V84, P1750, DOI 10.2105/AJPH.84.11.1750; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Chen CH, 2006, TRANSPL INFECT DIS, V8, P148, DOI 10.1111/j.1399-3062.2006.00147.x; Chen WK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056540, 10.1371/journal.pone.0053985, 10.1371/journal.pone.0073764]; Chung WS, 2014, INT J TUBERC LUNG D, V18, P79, DOI 10.5588/ijtld.13.0288; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Corris V, 2012, CHRONIC ILLN, V8, P121, DOI 10.1177/1742395312440294; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Demlow SE, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1600-1; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dyck RF, 2007, CAN J PUBLIC HEALTH, V98, P55, DOI 10.1007/BF03405386; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Faurholt-Jepsen D, 2013, TROP MED INT HEALTH, V18, P822, DOI 10.1111/tmi.12120; Faurholt-Jepsen D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-165; Faurholt-Jepsen D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024215; FEINSTEIN AR, 1986, J CHRON DIS, V39, P495, DOI 10.1016/0021-9681(86)90194-3; Gaziano TA, 2010, CURR PROB CARDIOLOGY, V35, P72, DOI 10.1016/j.cpcardiol.2009.10.002; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hu HY, 2014, EPIDEMIOL INFECT, V142, P191, DOI 10.1017/S0950268813000551; Jeon CY, 2008, PLOS MED, V5, P1298; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; John GT, 2001, KIDNEY INT, V60, P1148, DOI 10.1046/j.1523-1755.2001.0600031148.x; Joshi N, 1999, NEW ENGL J MED, V341, P1906, DOI 10.1056/NEJM199912163412507; Jurcev-Savicevic A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-991; Kamper-Jorgensen Z, 2015, INT J TUBERC LUNG D, V19, P1169, DOI 10.5588/ijtld.14.0932; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kim SJ, 1995, TUBERCLE LUNG DIS, V76, P529, DOI 10.1016/0962-8479(95)90529-4; Ku NS, 2013, INT J TUBERC LUNG D, V17, P777, DOI 10.5588/ijtld.12.0607; Kuo MC, 2013, PLOS ONE, V8; Lai SW, 2014, EUR J CLIN MICROBIOL, V33, P1573, DOI 10.1007/s10096-014-2112-0; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Lee M-R, 2016, CLIN INFECT DIS; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Lo HY, 2011, J FORMOS MED ASSOC, V110, P501, DOI 10.1016/S0929-6646(11)60076-4; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Marks SM, 2011, INT J TUBERC LUNG D, V15, P982, DOI 10.5588/ijtld.10.0637; Martens GW, 2007, AM J RESP CELL MOL, V37, P518, DOI 10.1165/rcmb.2006-0478OC; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; MORI MA, 1992, ARCH INTERN MED, V152, P547, DOI 10.1001/archinte.152.3.547; Ou SM, 2012, TRANSPL INFECT DIS, V14, P502, DOI 10.1111/j.1399-3062.2012.00737.x; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Pealing L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0381-9; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Perez A, 2006, AM J TROP MED HYG, V74, P604, DOI 10.4269/ajtmh.2006.74.604; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; RAYFIELD EJ, 1982, AM J MED, V72, P439, DOI 10.1016/0002-9343(82)90511-3; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Rosenman KD, 1996, AM J IND MED, V30, P148, DOI 10.1002/(SICI)1097-0274(199608)30:2<148::AID-AJIM5>3.0.CO;2-X; Rungruanghiranya S, 2008, TRANSPL P, V40, P2376, DOI 10.1016/j.transproceed.2008.07.034; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Shen TC, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000096; Stalenhoef JE, 2008, EUR J CLIN MICROBIOL, V27, P97, DOI 10.1007/s10096-007-0395-0; StataCorp, 2015, STAT STAT SOFTW REL; Suwanpimolkul G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114442; Tsukaguchi K, 1997, Kekkaku, V72, P617; U. S. Department of Health and Human Services Public Health Service Centers for Disease Control, 1990, MMWR-MORBID MORTAL W, V39, P39; Vardakas KZ, 2007, DIABETIC MED, V24, P1168, DOI 10.1111/j.1464-5491.2007.02234.x; Viardot A, 2007, ENDOCRINOLOGY, V148, P346, DOI 10.1210/en.2006-0686; Viney K, 2015, TROP MED INT HEALTH, V20, P650, DOI 10.1111/tmi.12462; Viswanathan M, 2013, AHRQ METHODS EFFECTI; Wang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059845; WHO, 2011, WORLD REPORT ON DISABILITY, P1; Wu CY, 2011, INT J TUBERC LUNG D, V15, P125; Wu HP, 2007, RESPIROLOGY, V12, P416, DOI 10.1111/j.1440-1843.2007.01033.x; Yamashiro S, 2005, CLIN EXP IMMUNOL, V139, P57, DOI 10.1111/j.1365-2249.2005.02677.x; Young F, 2012, J EPIDEMIOL COMMUN H, V66, P519, DOI 10.1136/jech.2010.114595	87	120	132	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187967	10.1371/journal.pone.0187967	http://dx.doi.org/10.1371/journal.pone.0187967			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161276	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000027
J	Hsieh, MS; Chen, MY; Hsieh, CH; Pan, CH; Yu, GY; Chen, HW				Hsieh, Ming-Shu; Chen, Mei-Yu; Hsieh, Chun-Hsiang; Pan, Chien-Hsiung; Yu, Guann-Yi; Chen, Hsin-Wei			Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity	PLOS ONE			English	Article							SIMIAN CELL SYSTEMS; MYCOPHENOLIC-ACID; SERINE-PROTEASE; NONSTRUCTURAL PROTEINS; PLAQUE DEVELOPMENT; RECOMBINANT NS3; RNA REPLICATION; REPLICON SYSTEM; OVERLAY MEDIUM; VIRAL-RNA	Background The traditional methods, plaque assays and immuno-focus assays, used to titrate infectious dengue virus (DENV) particles are time consuming and labor intensive. Here, we developed a DENV protease activity detection system (DENPADS) to visualize DENV infection in cells based on dengue protease activity. Methodology/Principal findings Dengue NS3 protease cleaves NS4B-NS5. BHK-21 cells stably expressing the sensor module comprising DENV-2 NS4 and the 10 amino-terminal amino acids of NS5 ((N10)NS5) fused with the SV40 nuclear localization signal (NLS) and Cre recombinase (Cre), were generated. Cre is constrained outside the nucleus in the absence of NS3 activity but translocates into the nucleus through NS4B-NS5 cleavage when cells are infected with DENV. Nuclear translocation of Cre can trigger the reporter system, which contains a cis-loxP-flanked mCherry with three continuous stop codons following an SV40 polyA tail cDNA upstream of EGFP or mHRP cDNA. Our results show that DENPADS is an efficient and accurate method to titrate 4 DENV serotypes in 24 hours. Compared with current virus titration methods, the entire process is easy to perform, and the data are easily acquired. Conclusions/Significance In this study, we demonstrate that DENPADS can be used to detect dengue viral infection through a fluorescence switch or HRP activity in the infected cells. This approach is sensitive with less incubation time and labor input. In addition, DENPADS can simultaneously evaluate the efficacy and cytotoxicity of potential anti-DENV candidates. Overall, DENPADS is a useful tool for dengue research.	[Hsieh, Ming-Shu; Chen, Hsin-Wei] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hsieh, Ming-Shu; Chen, Mei-Yu; Hsieh, Chun-Hsiang; Pan, Chien-Hsiung; Yu, Guann-Yi; Chen, Hsin-Wei] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Pan, Chien-Hsiung; Chen, Hsin-Wei] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	National Defense Medical Center; National Health Research Institutes - Taiwan; China Medical University Taiwan	Chen, HW (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chen, HW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.; Chen, HW (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.	chenhw@nhri.org.tw	Chen, Hsin-Wei/ABA-7436-2021; Yu, Guann-Yi/O-5139-2019	Chen, Hsin-Wei/0000-0002-3207-2397; Yu, Guann-Yi/0000-0002-0580-8282	National Health Research Institutes [IV-105-PP-03, IV-104-PP-16]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This study was supported by the National Health Research Institutes (IV-105-PP-03, IV-104-PP-16).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200; CASS CE, 1977, CANCER RES, V37, P3314; CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Che PL, 2009, INT J CLIN EXP MED, V2, P363; Chen HW, 2014, J GEN VIROL, V95, P1983, DOI 10.1099/vir.0.067280-0; Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Freire MS, 2007, MEM I OSWALDO CRUZ, V102, P203, DOI 10.1590/S0074-02762007005000011; Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4; Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084; KANTOCH M, 1980, ACTA VIROL, V24, P335; Kato F, 2014, JPN J INFECT DIS, V67, P209, DOI 10.7883/yoken.67.209; Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022553; Li XQ, 2013, APPL MICROBIOL BIOT, V97, P6503, DOI 10.1007/s00253-013-5021-8; Liao FH, 2016, CELL CYCLE, V15, P1073, DOI 10.1080/15384101.2016.1156267; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; MALEWICZ B, 1979, J CLIN MICROBIOL, V9, P609; Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010; Murthy HMK, 1999, J BIOL CHEM, V274, P5573, DOI 10.1074/jbc.274.9.5573; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; PLANTEROSE DN, 1969, J GEN VIROL, V4, P629, DOI 10.1099/0022-1317-4-4-629; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006; Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Smith KM, 2012, AM J TROP MED HYG, V87, P743, DOI 10.4269/ajtmh.2012.12-0004; STIM TB, 1969, J GEN VIROL, V5, P329, DOI 10.1099/0022-1317-5-3-329; STIM TB, 1970, APPL MICROBIOL, V19, P757, DOI 10.1128/AEM.19.5.757-762.1970; STIM TB, 1970, APPL MICROBIOL, V19, P751, DOI 10.1128/AEM.19.5.751-756.1970; Sudiro TM, 2001, J MED VIROL, V63, P29, DOI 10.1002/1096-9071(200101)63:1&lt;29::AID-JMV1004&gt;3.0.CO;2-S; Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI 10.1016/S0065-3527(10)77001-9; Wang QY, 2015, J VIROL, V89, P8233, DOI 10.1128/JVI.00855-15; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wu CF, 2003, J VIROL METHODS, V114, P45, DOI 10.1016/j.jviromet.2003.09.001; Yang CC, 2014, ANTIMICROB AGENTS CH, V58, P110, DOI 10.1128/AAC.01281-13; Yang CC, 2013, ANTIVIR RES, V98, P228, DOI 10.1016/j.antiviral.2013.03.001; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188170	10.1371/journal.pone.0188170	http://dx.doi.org/10.1371/journal.pone.0188170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161301	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000032
J	Hannibal, J; Georg, B; Fahrenkrug, J				Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan			PAC1-and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; RETINAL GANGLION-CELLS; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; 2-DEFICIENT MICE; DEFICIENT MICE; PACAP; LACKING; VIP; ENTRAINMENT	The two sister peptides, pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) and their receptors, the PAC1- and the VPAC2 receptors, are involved in regulation of the circadian timing system. PACAP as a neurotransmitter in the retinohypothalamic tract (RHT) and VIP as a neurotransmitter, involved in synchronization of SCN neurons. Behavior and physiology in VPAC2 deficient mice are strongly regulated by light most likely as a result of masking. Consequently, we used VPAC2 and PAC1/VPAC2 double mutant mice in comparison with PAC1 receptor deficient mice to further elucidate the role of PACAP in the light mediated regulation of behavior and physiology of the circadian system. We compared circadian rhythms in mice equipped with running wheels or implanted radio-transmitter measuring core body temperature kept in a full photoperiod ((FPP)(12: 12 h light dark-cycles (LD)) and skeleton photo periods (SPP) at high and low light intensity. Furthermore, we examined the expression of PAC1- and VPAC2 receptors in the SCN of the different genotypes in combination with visualization of PACAP and VIP and determined whether compensatory changes in peptide and/or receptor expression in the reciprocal knockouts (KO) (PAC1 and VPAC2) had occurred. Our data demonstrate that in although being closely related at both ligand and receptor structure/sequence, PACAP/PAC1 receptor signaling are independent of VIP/VPAC2 receptor signaling and vice versa. Furthermore, lack of either of the receptors does not result in compensatory changes at neither the physiological or anatomical level. PACAP/PAC1 signaling is important for light regulated behavior, VIP/VPAC2signaling for stable clock function and both signaling pathways may play a role in shaping diurnality versus nocturnality.	[Hannibal, Jens; Georg, Birgitte; Fahrenkrug, Jan] Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital	Hannibal, J (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Fac Hlth Sci, Dept Clin Biochem, Copenhagen, Denmark.	j.hannibal@dadlnet.dk	Hannibal, Jens/H-5482-2019	Hannibal, Jens/0000-0001-9416-0125	Danish Biotechnology Center for Cellular Communication	Danish Biotechnology Center for Cellular Communication	The Danish Biotechnology Center for Cellular Communication supported this work.; The Danish Biotechnology Center for Cellular Communication supported this work. We would also like to express our gratitude to Anita Hansen for excellent technical assistance.	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; An S, 2012, J COMP NEUROL, V520, P2730, DOI 10.1002/cne.23078; Aton SJ, 2005, NAT NEUROSCI, V8, P476, DOI 10.1038/nn1419; Beaule C, 2009, J BIOL RHYTHM, V24, P126, DOI 10.1177/0748730409332037; Bechtold DA, 2008, AM J PHYSIOL-REG I, V294, pR344, DOI 10.1152/ajpregu.00667.2007; Colwell CS, 2003, AM J PHYSIOL-REG I, V285, pR939, DOI 10.1152/ajpregu.00200.2003; Colwell CS, 2004, AM J PHYSIOL-REG I, V287, pR1194, DOI 10.1152/ajpregu.00268.2004; Dragich JM, 2010, EUR J NEUROSCI, V31, P864, DOI 10.1111/j.1460-9568.2010.07119.x; FAHRENKRUG J, 1995, REGUL PEPTIDES, V58, P89, DOI 10.1016/0167-0115(95)00052-D; Fahrenkrug J, 2012, J MOL NEUROSCI, V48, P584, DOI 10.1007/s12031-012-9804-7; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gompf HS, 2014, J BIOL RHYTHM; Hannibal J, 2014, J COMP NEUROL, V522, P2231, DOI [10.1002/cne.23588, 10.1002/cne.23555]; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; HANNIBAL J, 1995, REGUL PEPTIDES, V55, P133, DOI 10.1016/0167-0115(94)00099-J; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hannibal J, 2001, J NEUROSCI, V21, P4883, DOI 10.1523/JNEUROSCI.21-13-04883.2001; Hannibal J, 2006, INT REV CYTOL, V251, P1, DOI 10.1016/S0074-7696(06)51001-0; Hannibal J, 2011, AM J PHYSIOL-REG I, V300, pR519, DOI 10.1152/ajpregu.00599.2010; Hannibal J, 2008, AM J PHYSIOL-REG I, V295, pR2050, DOI 10.1152/ajpregu.90563.2008; Harmar AJ, 2002, CELL, V109, P497, DOI 10.1016/S0092-8674(02)00736-5; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Hughes ATL, 2008, J BIOL RHYTHM, V23, P211, DOI 10.1177/0748730408316290; Hughes ATL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14044; Hughes AT, 2004, J NEUROSCI, V24, P3522, DOI 10.1523/JNEUROSCI.5345-03.2004; Kawaguchi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009286; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Mohawk JA, 2011, TRENDS NEUROSCI, V34, P349, DOI 10.1016/j.tins.2011.05.003; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; Vosko AM, 2007, GEN COMP ENDOCR, V152, P165, DOI 10.1016/j.ygcen.2007.04.018	32	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188166	10.1371/journal.pone.0188166	http://dx.doi.org/10.1371/journal.pone.0188166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155851	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700033
J	Maden, M; Ertugrul, IF; Orhan, EO; Erik, CE; Yetis, CC; Tuncer, Y; Kahriman, M				Maden, Murat; Ertugrul, Ihsan Furkan; Orhan, Ekim Onur; Erik, Cevat Emre; Yetis, Ceylan Cagil; Tuncer, Yasin; Kahriman, Mesud			Enhancing antibacterial effect of sodium hypochlorite by low electric current-assisted sonic agitation (vol 12, e0183895, 2017)	PLOS ONE			English	Correction													ORHAN, Ekim Onur/Q-6015-2019; Ertugrul, İhsan Furkan/Y-7841-2018	ORHAN, Ekim Onur/0000-0002-8755-2558; Ertugrul, İhsan Furkan/0000-0001-7583-6679; kahriman, mesud/0000-0003-0731-0936				Maden M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183895	1	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188672	10.1371/journal.pone.0188672	http://dx.doi.org/10.1371/journal.pone.0188672			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155895	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700066
J	Alperson-Afil, N; Richter, D; Goren-Inbar, N				Alperson-Afil, Nira; Richter, Daniel; Goren-Inbar, Naama			Evaluating the intensity of fire at the Acheulian site of Gesher Benot Ya'aqov - Spatial and thermoluminescence analyses	PLOS ONE			English	Article							MIDDLE STONE-AGE; ARCHAEOLOGICAL IMPLICATIONS; HAYONIM CAVE; QESEM CAVE; AMUD CAVE; ISRAEL; LUMINESCENCE; ASSEMBLAGES; SEDIMENTS; FEATURES	This manuscript presents an attempt to evaluate the intensity of fire through spatial patterning and thermoluminescence methodology. Previous studies of Layer II-6 Level 2 at the Acheulian site of Gesher Benot Ya'aqov suggested that hominins differentiated their activities across space, including multiple activities around a hearth reconstructed on the basis of the distribution of burned flint artifacts. A transect of similar to 4 m was extended from the center of the reconstructed hearth of Level 2 to its periphery in order to examine the intensity of fire. Burned and unburned flint microartifacts were sampled along this transect. The results of earlier and current thermoluminescence (TL) analysis demonstrate a general agreement with the macroscopic determination of burning, indicating that the possibility of misinterpretation based on macroscopic observations is negligible. The TL signal from flint microartifacts close to the hearth's center shows unambiguous signs of strong heating, whereas with increasing distance from the hearth the TL signal can be interpreted as a result of decreasing temperatures and/or shorter durations of exposure to fire in addition to a decreasing number of flints showing fire damage. Our study shows that TL analysis can identify some variation in fire intensity, which allows a more precise classification of burned flint microartifacts with respect to their heating history.	[Alperson-Afil, Nira] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Richter, Daniel] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Richter, Daniel] Freiberg Instruments GmbH, Freiberg, Germany; [Goren-Inbar, Naama] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	Bar Ilan University; Max Planck Society; Hebrew University of Jerusalem	Alperson-Afil, N (corresponding author), Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel.	nira.alperson-afil@biu.ac.il	Richter, Daniel G/A-1367-2011	Richter, Daniel G/0000-0003-1681-727X	German Israeli Foundation for Scientific Research and Development (GIF) [I-896-208.4/2005]; Israel Science Foundation [27/12]; Max-Planck Society, the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology; Institute of Archaeology of the Hebrew University of Jerusalem	German Israeli Foundation for Scientific Research and Development (GIF)(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Max-Planck Society, the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology; Institute of Archaeology of the Hebrew University of Jerusalem	This work was supported by German Israeli Foundation for Scientific Research and Development (GIF) [grant no. I-896-208.4/2005]. www.gif.org.il; and Israel Science Foundation [grant no. 27/12]. www.isf.org.il. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the German-Israeli Foundation for Scientific Research and Development (GIF) [grant no. I-896-208.4/2005] and by a grant from the Israel Science Foundation to N. Goren-Inbar [grant no. 27/12]. The Max-Planck Society, the Department of Human Evolution of the Max Planck Institute for Evolutionary Anthropology, and the Institute of Archaeology of the Hebrew University of Jerusalem are thanked for their support. The authors thank Guy Hivroni for producing Fig 4, Sue Gorodetsky for her skillful editing of the manuscript, and Sara. E. Rhodes and an anonymous reviewer for commenting on and improving the manuscript.	Aitken MJ, 1985, THERMOLUMINESCENCE D; Albert RM, 1999, J ARCHAEOL SCI, V26, P1249, DOI 10.1006/jasc.1999.0355; Albert RM, 2012, QUATERN INT, V247, P278, DOI 10.1016/j.quaint.2010.10.016; Alperson-Afil N., 2007, PALEOANTHROPOLOGY, V2007, P1; Alperson-Afil N, 2017, CURRENT ANTHR, V58; Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; Alperson-Afil N, 2012, EARTH-SCI REV, V113, P111, DOI 10.1016/j.earscirev.2012.03.012; Alperson-Afil N, 2009, SCIENCE, V326, P1677, DOI 10.1126/science.1180695; AlpersonAfil N, 2010, VERTEBR PALEOBIOL PA, P1; ALPERSONAFIL N, 2006, ARCHAEOLOGY ANTHR ET, V4, P63; Ashkenazi S, 2010, LETHAIA, V43, P116, DOI 10.1111/j.1502-3931.2009.00178.x; Binford LR, 1998, P 13 C INT UN PREH P; Binford LR., 1983, PURSUIT DECODING ARC; Farrand, 2001, SEDIMENTS ARCHAEOLOG, P127; Feibel C. S., 2004, HUMAN PALEOECOLOGY L, P21; Friesem DE, 2014, QUATERN INT, V331, P128, DOI 10.1016/j.quaint.2013.03.023; Galanidou N, 2000, J ANTHROPOL ARCHAEOL, V19, P243, DOI 10.1006/jaar.1999.0362; Galanidou N., 1997, HOME IS HEARTH IS SP; Gilead I., 1984, P PREHIST SOC, V50, P71, DOI DOI 10.1017/S0079497X00007489; Gilead I., 1990, BIG PUZZL INT S REF, V1, P101; Gopher A, 2016, QUATEMARY INT; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Goren-Inbar N, ACHEULIAN SITE GESHE; Goring-Morris A. N., 1988, PALEORIENT, V14, P231, DOI DOI 10.3406/PALEO.1988.4470; Hovers E., 2011, LOWER MIDDLE PALAEOL, V126, P101, DOI DOI 10.13140/2.1.2004.4809; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Leesch D, 2005, MAGDALENIAN CENTRAL; Leroi-Gourhan A., 1972, FOUILLES PINCEVENT E; Melamed Y, 2016, PNAS; Melamed Y., 2003, RECONSTRUCTION HULA; Melamed Y, 2011, J HUM EVOL, V60, P320, DOI 10.1016/j.jhevol.2010.07.025; Mienis H, 2006, HAASIANA, V3, P70; Rabinovich R, 2004, INT J OSTEOARCHAEOL, V14, P287, DOI 10.1002/oa.762; Rabinovich R, 2012, MAMMAL TAPHONOMY ASS; Rabinovich R, 2008, J HUM EVOL, V54, P134, DOI 10.1016/j.jhevol.2007.07.007; Rabinovich R, 2011, J HUM EVOL, V60, P357, DOI 10.1016/j.jhevol.2010.12.002; Richter D, 2011, ARCHAEOMETRY, V53, P842, DOI 10.1111/j.1475-4754.2010.00581.x; Richter D, 2007, GEOARCHAEOLOGY, V22, P671, DOI 10.1002/gea.20180; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Schiegl S, 1996, J ARCHAEOL SCI, V23, P763, DOI 10.1006/jasc.1996.0071; Schiegl Solveig, 1994, Israel Journal of Earth Sciences, V43, P267; Schmidt C, 2015, J ARCHAEOL SCI, V63, P94, DOI 10.1016/j.jas.2015.08.016; Sergant J, 2006, J ARCHAEOL SCI, V33, P999, DOI 10.1016/j.jas.2005.11.011; Shahack-Gross R, 2014, J ARCHAEOL SCI, V44, P12, DOI 10.1016/j.jas.2013.11.015; Shahack-Gross R, 1997, J ARCHAEOL SCI, V24, P439, DOI 10.1006/jasc.1996.0128; Shahack-Gross R, 2008, GEOARCHAEOLOGY, V23, P43, DOI 10.1002/gea.20203; Shimelmitz R, 2014, J HUM EVOL, V77, P196, DOI 10.1016/j.jhevol.2014.07.005; Spurling B., 1984, INTRASITE SPATIAL AN, P224; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; VALLADAS H, 1981, ARCHAEOMETRY, V23, P221, DOI 10.1111/j.1475-4754.1981.tb00309.x; Valladas H, THERMOLUMINSCENCE GR; van Zeist W, 2009, VEG HIST ARCHAEOBOT, V18, P105, DOI 10.1007/s00334-008-0167-5; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Weiner S, 2002, J ARCHAEOL SCI, V29, P1289, DOI 10.1006/jasc.2001.0790; WEINER S, 1995, ISRAEL J CHEM, V35, P143; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Zohar I, 2011, J HUM EVOL, V60, P343, DOI 10.1016/j.jhevol.2010.10.007	59	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188091	10.1371/journal.pone.0188091	http://dx.doi.org/10.1371/journal.pone.0188091			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145432	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800065
J	Jung, HS; Hong, SM				Jung, Hyung-Sup; Hong, Soo-Min			Mapping three-dimensional surface deformation caused by the 2010 Haiti earthquake using advanced satellite radar interferometry	PLOS ONE			English	Article							MULTIPLE-APERTURE INTERFEROMETRY; SAR INTERFEROMETRY; IMPROVEMENT; RUPTURE; COMPLEX; NOISE; FAULT	Mapping three-dimensional (3D) surface deformation caused by an earthquake is very important for the environmental, cultural, economic and social sustainability of human beings. Synthetic aperture radar (SAR) systems made it possible to measure precise 3D deformations by combining SAR interferometry (InSAR) and multiple aperture interferometry (MAI). In this paper, we retrieve the 3D surface deformation field of the 2010 Haiti earthquake which occurred on January 12, 2010 by a magnitude 7.0 Mw by using the advanced interferometric technique that integrates InSAR and MAI data. The surface deformation has been observed by previous researchers using the InSAR and GPS method, but 3D deformation has not been measured yet due to low interferometric coherence. The combination of InSAR and MAI were applied to the ALOS PALSAR ascending and descending pairs, and were validated with the GPS in-situ measurements. The archived measurement accuracy was as little as 1.85, 5.49 and 3.08 cm in the east, north and up directions, respectively. This result indicates that the InSAR/MAI-derived 3D deformations are well matched with the GPS deformations. The 3D deformations are expected to allow us to improve estimation of the area affected by the 2010 Haiti earthquake.	[Jung, Hyung-Sup] Univ Seoul, Dept Geoinformat, Seoul, South Korea; [Hong, Soo-Min] Univ Seoul, Dept English Language & Literature, Seoul, South Korea	University of Seoul; University of Seoul	Hong, SM (corresponding author), Univ Seoul, Dept English Language & Literature, Seoul, South Korea.	soomhong@uos.ac.kr			Korea Meteorological Administration Research and Development Program [KMIPA2015-3071]	Korea Meteorological Administration Research and Development Program(Korea Meteorological Administration (KMA))	This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-3071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Korea Meteorological Administration Research and Development Program under Grant KMIPA2015-3071.	Agram PS, 2015, J GEOPHYS RES-SOL EA, V120, P2752, DOI 10.1002/2014JB011271; Bechor NBD, 2006, GEOPHYS RES LETT, P33, DOI DOI 10.1029/2006G1026883; Boncori JPM, 2014, SEISMOL RES LETT, V86, P1; Calais E, 2010, NAT GEOSCI, V3, P794, DOI [10.1038/ngeo992, 10.1038/NGEO992]; Cavallo EA, 2010, IDB WORKING PAPERS S; Chae SH, 2017, IEEE J-STARS, V10, P3591, DOI 10.1109/JSTARS.2017.2690799; DesRoches R, 2011, EARTHQUAKE SPEC, V27, P325; Douilly R, 2015, J GEOPHYS RES-SOL EA, V120, P1108, DOI 10.1002/2014JB011595; Goldstein RM, 1998, GEOPHYS RES LETT, V25, P4035, DOI 10.1029/1998GL900033; Grandin R, 2016, GEOPHYS RES LETT, V43, P2552, DOI 10.1002/2016GL067954; Hashimoto M, 2011, NAT GEOSCI, V4, P255, DOI [10.1038/ngeo1115, 10.1038/NGEO1115]; Hayes GP, 2010, NAT GEOSCI, V3, P800, DOI [10.1038/ngeo977, 10.1038/NGEO977]; He LM, 2015, REMOTE SENS-BASEL, V7, P12440, DOI 10.3390/rs70912440; Hu J, 2013, IEEE T GEOSCI REMOTE, V51, P4226, DOI 10.1109/TGRS.2012.2227759; Jo MJ, 2015, REMOTE SENS-BASEL, V7, P14386, DOI 10.3390/rs71114386; Jo MJ, 2015, REMOTE SENS ENVIRON, V169, P176, DOI 10.1016/j.rse.2015.08.003; Jo MJ, 2015, J GEODESY, V89, P411, DOI 10.1007/s00190-014-0786-9; Jung HS, 2011, IEEE GEOSCI REMOTE S, V8, P34, DOI 10.1109/LGRS.2010.2051793; Jung HS, 2015, IEEE T GEOSCI REMOTE, V53, P6196, DOI 10.1109/TGRS.2015.2435776; Jung HS, 2015, IEEE J-STARS, V8, P1743, DOI 10.1109/JSTARS.2015.2399249; Jung HS, 2015, IEEE T GEOSCI REMOTE, V53, P4952, DOI 10.1109/TGRS.2015.2413948; Jung HS, 2014, SENSORS-BASEL, V14, P17703, DOI 10.3390/s140917703; Jung HS, 2013, IEEE T GEOSCI REMOTE, V51, P3191, DOI 10.1109/TGRS.2012.2218660; Jung HS, 2013, IEEE T GEOSCI REMOTE, V51, P573, DOI 10.1109/TGRS.2012.2197861; Jung HS, 2009, IEEE T GEOSCI REMOTE, V47, P2859, DOI 10.1109/TGRS.2009.2016554; Kocel E, 2016, INTERPRETATION-J SUB, V4, pT49, DOI 10.1190/INT-2015-0038.1; Liu Z, 2014, IEEE T GEOSCI REMOTE, V52, P3421, DOI 10.1109/TGRS.2013.2272791; Morishita Y, 2016, GEOPHYS RES LETT, V43, P4197, DOI 10.1002/2016GL068293; Prentice CS, 2010, NAT GEOSCI, V3, P789, DOI [10.1038/ngeo991, 10.1038/NGEO991]; Wang XW, 2015, REMOTE SENS ENVIRON, V170, P388, DOI 10.1016/j.rse.2015.09.024; Wang XW, 2014, REMOTE SENS ENVIRON, V152, P174, DOI 10.1016/j.rse.2014.06.014; Wdowinski S, 2010, POSTSEISMIC DEFORMAT; Wright TJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018827; Zhou W, 2015, SUSTAINABILITY-BASEL, V7, P1712, DOI 10.3390/su7021712	34	25	25	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188286	10.1371/journal.pone.0188286	http://dx.doi.org/10.1371/journal.pone.0188286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145475	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800105
J	Mizuno, H; Ekuni, D; Maruyama, T; Kataoka, K; Yoneda, T; Fukuhara, D; Sugiura, Y; Tomofuji, T; Wada, J; Morita, M				Mizuno, Hirofumi; Ekuni, Daisuke; Maruyama, Takayuki; Kataoka, Kota; Yoneda, Toshiki; Fukuhara, Daiki; Sugiura, Yoshio; Tomofuji, Takaaki; Wada, Jun; Morita, Manabu			The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: A randomized clinical trial	PLOS ONE			English	Article							HYDROGEN-RICH WATER; REACTIVE OXYGEN; THERAPY; GLUCOSE; DNA; ANTIOXIDANTS; ASSOCIATION; METABOLISM; MELLITUS; OUTCOMES	Aim The purpose of this study was to investigate the effects of non-surgical periodontal treatment on hemoglobinA1c (HbA1c) levels, oxidative stress balance and quality of life (QOL) in patients with type 2 diabetes mellitus (T2DM) compared to no periodontal treatment (simple oral hygiene instructions only). Methods The design was a 6-month, single-masked, single center, randomized clinical trial. Patients had both T2DM and chronic periodontitis. Forty participants were enrolled between April 2014 and March 2016 at the Nephrology, Diabetology and Endocrinology Department of Okayama University Hospital. The periodontal treatment group (n = 20) received non-surgical periodontal therapy, including scaling and root planing plus oral hygiene instructions, and consecutive supportive periodontal therapy at 3 and 6 months. The control group (n = 17) received only oral hygiene instructions without treatment during the experimental period. The primary study outcome was the change in HbA1c levels from baseline to 3 months. Secondary outcomes included changes in oxidative stress balance (Oxidative-INDEX), the Diabetes Therapy-Related QOL and clinical periodontal parameters from baseline to 3 months and baseline to 6 months. Results Changes in HbA1c in the periodontal treatment group were not significantly different with those in the control group at 3 and 6 months. Systemic oxidative stress balance and QOL significantly improved in the periodontal treatment group compared to the control group at 3 months. In the subgroup analysis (moderately poor control of diabetes), the decrease in HbA1c levels in the periodontal treatment group was greater than that in the control group at 3 months but not significant. Conclusions In T2DM patients, non-surgical periodontal treatment improved systemic oxidative stress balance and QOL, but did not decrease HbA1c levels at 3 months follow-up.	[Mizuno, Hirofumi; Ekuni, Daisuke; Kataoka, Kota; Yoneda, Toshiki; Fukuhara, Daiki; Sugiura, Yoshio; Morita, Manabu] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama, Japan; [Ekuni, Daisuke] Okayama Univ, Dent Sch, Adv Res Ctr Oral & Craniofacial Sci, Okayama, Japan; [Maruyama, Takayuki] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Tomofuji, Takaaki] Asahi Univ, Sch Dent, Dept Community Oral Hlth, Mizuho, Japan; [Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan	Okayama University; Okayama University; Okayama University; Asahi University; Okayama University	Ekuni, D (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Prevent Dent, Okayama, Japan.; Ekuni, D (corresponding author), Okayama Univ, Dent Sch, Adv Res Ctr Oral & Craniofacial Sci, Okayama, Japan.	dekuni7@md.okayama-u.ac.jp; t-maru@md.okayama-u.ac.jp	WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170	Ministry of Health, Labour and Welfare [25110601]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labour and Welfare: 25110601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcubierre N, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0131-2; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS23, DOI 10.2337/dc16-S006; Azuma T, 2015, ANTIOXIDANTS, V4, P513, DOI 10.3390/antiox4030513; Borges I, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/45794; Borgnakke WS, 2014, J EVID-BASED DENT PR, V14, P127, DOI 10.1016/j.jebdp.2014.04.017; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Bullon P, 2014, PERIODONTOL, V2000, P64; Casanova L, 2014, BRIT DENT J, V217, P433, DOI 10.1038/sj.bdj.2014.907; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chapple ILC, 2007, PERIODONTOL 2000, V43, P160, DOI 10.1111/j.1600-0757.2006.00178.x; Chapple ILC, 2013, J CLIN PERIODONTOL, V40, pS106, DOI [10.1902/jop.2013.1340011, 10.1111/jcpe.12077]; (CHMP) CfMPfHU, 2010, GUID MISS DAT CONF C; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Darre L, 2008, DIABETES METAB, V34, P497, DOI 10.1016/j.diabet.2008.03.006; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Engebretson S, 2013, CONTEMP CLIN TRIALS, V36, P515, DOI 10.1016/j.cct.2013.09.010; Engebretson S, 2013, J CLIN PERIODONTOL, V40, pS153, DOI [10.1111/jcpe.12084, 10.1902/jop.2013.1340017]; Engebretson SP, 2013, JAMA-J AM MED ASSOC, V310, P2523, DOI 10.1001/jama.2013.282431; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Guideline Committee of the Japan Diabetes Society, 2016, JAP DIAB SOC EV BAS; HIRSCHFELD L, 1978, J PERIODONTOL, V49, P225, DOI 10.1902/jop.1978.49.5.225; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ishii Hitoshi, 2012, J Med Econ, V15, P556, DOI 10.3111/13696998.2012.665111; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kiran M, 2005, J CLIN PERIODONTOL, V32, P266, DOI 10.1111/j.1600-051X.2005.00658.x; Kisa K, 2011, INTERNAL MED, V50, P1403, DOI 10.2169/internalmedicine.50.5107; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Koya D, 2003, J AM SOC NEPHROL, V14, pS250, DOI 10.1097/01.ASN.0000077412.07578.44; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Le Lay S, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/908539; Liew AKC, 2013, AUST DENT J, V58, P350, DOI 10.1111/adj.12091; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Santos CMML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145262; Miranda TS, 2014, J CLIN PERIODONTOL, V41, P890, DOI 10.1111/jcpe.12282; Muniz FWMG, 2015, ARCH ORAL BIOL, V60, P1203, DOI 10.1016/j.archoralbio.2015.05.007; Nezu S, 2014, J EPIDEMIOL, V24, P259, DOI 10.2188/jea.JE20130131; Nowotny K, 2015, BIOMOLECULES, V5, P194, DOI 10.3390/biom5010194; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Panjamurthy K, 2005, CELL MOL BIOL LETT, V10, P255; Reddy PVN, 2015, J INT SOC PREV COMMU, V5, P25, DOI 10.4103/2231-0762.156520; Rombopoulos G, 2013, HORM-INT J ENDOCRINO, V12, P550, DOI 10.14310/horm.2002.1443; Santos VR, 2013, J CLIN PERIODONTOL, V40, P155, DOI 10.1111/jcpe.12040; Simpson TC, 2010, COCHRANE DB SYST REV, V12; Simpson TC, 2015, COCHRANE DB SYST REV, V6, DOI [DOI 10.1002/14651858, 10.1002/14651858]; Su HX, 2009, FREE RADICAL BIO MED, V46, P914, DOI 10.1016/j.freeradbiomed.2009.01.008; Takane M, 2002, J PERIODONTOL, V73, P551, DOI 10.1902/jop.2002.73.5.551; Tamaki N, 2011, CLIN ORAL INVEST, V15, P953, DOI 10.1007/s00784-010-0458-y; Tamaki N, 2009, J PERIODONTOL, V80, P901, DOI 10.1902/jop.2009.080640; Teeuw WJ, 2010, DIABETES CARE, V33, P421, DOI 10.2337/dc09-1378; Telgi RL, 2013, J PERIODONTAL IMPLAN, V43, P177, DOI 10.5051/jpis.2013.43.4.177; Terao M, 2015, INTERNAL MED, V54, P2815, DOI 10.2169/internalmedicine.54.4889; Teshome A, 2016, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-016-0249-1; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; van Dam PS, 1999, EUR J PHARMACOL, V376, P217, DOI 10.1016/S0014-2999(99)00376-3; Vassalle C, 2012, FERTIL STERIL, V97, P414, DOI 10.1016/j.fertnstert.2011.11.045; Casarin RCV, 2010, ARCH ORAL BIOL, V55, P902, DOI 10.1016/j.archoralbio.2010.07.009; Wang X., 2014, PLOS ONE, V9	57	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188171	10.1371/journal.pone.0188171	http://dx.doi.org/10.1371/journal.pone.0188171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145468	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800079
J	Prioreschi, A; Wrottesley, SV; Cohen, E; Reddy, A; Said-Mohamed, R; Twine, R; Tollman, SM; Kahn, K; Dunger, DB; Norris, SA				Prioreschi, Alessandra; Wrottesley, Stephanie V.; Cohen, Emmanuel; Reddy, Ankita; Said-Mohamed, Rihlat; Twine, Rhian; Tollman, Stephen M.; Kahn, Kathleen; Dunger, David B.; Norris, Shane A.			Examining the relationships between body image, eating attitudes, BMI, and physical activity in rural and urban South African young adult females using structural equation modeling	PLOS ONE			English	Article							OBESITY; DISSATISFACTION; ADOLESCENTS; TRANSITION; OVERWEIGHT; DISORDERS; DYNAMICS; PROFILE; HEALTH; WOMEN	The persistence of food insecurity, malnutrition, increasing adiposity, and decreasing physical activity, heightens the need to understand relationships between body image satisfaction, eating attitudes, BMI and physical activity levels in South Africa. Females aged 18-23 years were recruited from rural (n = 509) and urban (n = 510) settings. Body image satisfaction was measured using Stunkard's silhouettes, and the 26-item Eating Attitudes questionnaire (EAT-26) was used to evaluate participants' risk of disordered eating. Minutes per week of moderate to vigorous physical activity (MVPA) was assessed using the Global Physical Activity Questionnaire (GPAQ). Significant linear correlates were included in a series of regressions run separately for urban and rural participants. Structural equation modeling (SEM) was used to test the relationships between variables. Urban females were more likely to be overweight and obese than rural females (p = 0.02), and had a greater desire to be thinner (p = 0.02). In both groups, being overweight or obese was positively associated with a desire to be thinner (p<0.01), and negatively associated with a desire to be fatter (p<0.01). Having a disordered eating attitude was associated with body image dissatisfaction in the urban group (beta = 1.27, p<0.01, CI: 0.38; 2.16), but only with a desire to be fatter in the rural group (beta = 0.63, p = 0.04, CI: 0.03; 1.23). In the SEM model, body image dissatisfaction was associated with disordered eating (beta = 0.63), as well as higher MVPA participation (p<0.01). These factors were directly associated with a decreased risk of disordered eating attitude, and with a decreased desire to be thinner. Findings indicate a shift in both settings towards more Westernised ideals. Physical activity may provide a means to promote a healthy body image, while reducing the risk of disordered eating. Given the high prevalence of overweight and obesity in both rural and urban women, this study provides insights for future interventions aimed at decreasing adiposity in a healthy way.	[Prioreschi, Alessandra; Wrottesley, Stephanie V.; Cohen, Emmanuel; Reddy, Ankita; Said-Mohamed, Rihlat; Dunger, David B.; Norris, Shane A.] Univ Witwatersrand, Fac Hlth Sci, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa; [Twine, Rhian; Tollman, Stephen M.; Kahn, Kathleen] Univ Witwatersrand, Fac Hlth Sci, MRC WITS Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Johannesburg, South Africa; [Tollman, Stephen M.; Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Tollman, Stephen M.; Kahn, Kathleen] Umea Univ, Umea Ctr Global Hlth Res, Umea, Sweden; [Dunger, David B.] Univ Cambridge, MRL Wellcome Trust, MRC Inst Metab Sci, NIHR Cambridge Comprehens Biomed Res Ctr,Dept Paed, Cambridge, England	University of Witwatersrand; University of Witwatersrand; INDEPTH Network; Umea University; University of Cambridge	Prioreschi, A (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat,Sch Clin Med, Johannesburg, South Africa.	Alessandra.Prioreschi@wits.ac.za	Wrottesley, Stephanie/L-5462-2019; Cohen, Emmanuel/ABE-1916-2021; Norris, Shane/C-4664-2014	Cohen, Emmanuel/0000-0001-5643-1473; Norris, Shane/0000-0001-7124-3788; Tollman, Stephen/0000-0003-0744-7588; Reddy, Ankita/0000-0003-4986-8719; Dunger, Professor David/0000-0002-2566-9304; Prioreschi, Alessandra/0000-0002-6913-0706; SAID MOHAMED, Rihlat/0000-0003-1592-5412; Wrottesley, Stephanie/0000-0002-5419-2920; Twine, Rhian/0000-0002-0766-6556; Kahn, Kathleen/0000-0003-3339-3931	UK DfID/MRC African Research Leader Scheme; Wellcome Trust (UK); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Medical Research, South Africa; Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z, 085477/B/08/Z]; Claude Leon Foundation; Medical Research Council [G1001333, MC_UU_12012/5/B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10012, NF-SI-0508-10274] Funding Source: researchfish; MRC [G1001333] Funding Source: UKRI	UK DfID/MRC African Research Leader Scheme; Wellcome Trust (UK)(Wellcome Trust); DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Medical Research, South Africa; Wellcome Trust, UK(Wellcome Trust); Claude Leon Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the following funders: The UK DfID/MRC African Research Leader Scheme (Norris and Dunger) and the Wellcome Trust (UK) to SAN funded the research. The MRC/Wits Rural Public Health and Health Transitions Research Unit and Agincourt health and socio-demographic surveillance system have been supported by the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa to AP, and Medical Research, South Africa, and the Wellcome Trust, UK (grants 058893/Z/99/A to SMT; 069683/Z/02/Z; 085477/Z/08/Z; 085477/B/08/Z to SMT). Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the CoE in Human Development. Claude Leon Foundation also supported the work of AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, J PSYCHIAT, DOI DOI 10.4172/1994-8220.1000101; Benkeser R M, 2012, Ghana Med J, V46, P66; Bhatnagar R., 2014, AM J ED RES, V2, P683, DOI [10.12691/education-2-8-18, DOI 10.12691/EDUCATION-2-8-18, 10.12691/ education- 2-8-18]; Blachno M, 2016, PSYCHIATR POL, V50, P55, DOI 10.12740/PP/34810; Bove CF, 2006, WOMEN HEALTH, V44, P57, DOI 10.1300/J013v44n01_04; Bucchianeri MM, 2013, BODY IMAGE, V10, P1, DOI 10.1016/j.bodyim.2012.09.001; Chisuwa N, 2010, APPETITE, V54, P5, DOI 10.1016/j.appet.2009.11.008; Cohen E, 2013, SOC SCI MED, V96, P24, DOI 10.1016/j.socscimed.2013.07.004; DAVIS C, 1994, PSYCHOL MED, V24, P957, DOI 10.1017/S0033291700029044; Draper CE, 2015, CHILD CARE HLTH DEV, V41, P654, DOI 10.1111/cch.12241; Filmer D, 2012, DEMOGRAPHY, V49, P359, DOI 10.1007/s13524-011-0077-5; Gitau TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109709; Hausenblas HA, 2006, PSYCHOL HEALTH, V21, P33, DOI 10.1080/14768320500105270; Hidaka BH, 2012, J AFFECT DISORDERS, V140, P205, DOI 10.1016/j.jad.2011.12.036; Holmqvist K, 2010, EUR EAT DISORD REV, V18, P133, DOI 10.1002/erv.965; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Knoll LJ, 2015, PSYCHOL SCI, V26, P583, DOI 10.1177/0956797615569578; Labadarios D, 2011, B WORLD HEALTH ORGAN, V89, P891, DOI 10.2471/BLT.11.089243; le Grange D, 1998, AM J PSYCHIAT, V155, P250; Mchiza ZJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2324-y; Mchiza ZJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-433; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mvo Z, 1999, Curationis, V22, P27; Organisation WH, GLOBAL RECOMMENDATIO; Pedro TM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154784; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; Pradeilles R, 2015, PUBLIC HEALTH NUTR, V18, P2998, DOI 10.1017/S1368980015000415; Puoane T, 2005, S AFR J CLIN NUTR, V18, P6; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES, V8, P23, DOI [10.13287/j.1001-9332.202201.010, DOI 10.1002/0470010940]; Senekal M, 2001, S AFR J PSYCHOL, V31, P45, DOI 10.1177/008124630103100108; Sharan P, 2015, INDIAN J PSYCHIAT, V57, pS286, DOI 10.4103/0019-5545.161493; Shisana O, 2014, S AFRICAN NATL HLTH; Sorsdahl K, 2011, J EPIDEMIOL COMMUN H, V65, P426, DOI 10.1136/jech.2009.091462; Steyn NP, 2000, ASIA PAC J CLIN NUTR, V9, P53, DOI 10.1046/j.1440-6047.2000.00137.x; Szabo Christopher Paul, 2006, Afr Health Sci, V6, P201; Szabo Christopher Paul, 2004, World Psychiatry, V3, P41; Townsend MS, 2001, J NUTR, V131, P1738, DOI 10.1093/jn/131.6.1738; van de Mortel TF, 2008, AUST J ADV NURS, V25, P40; Van Laar, 2007, SCI AGR RURAL DEV LO; Van Son GE, 2006, BRIT J PSYCHIAT, V189, P562, DOI 10.1192/bjp.bp.106.021378; Van Vonderen K. E., 2012, AM COMMUNICATION J, V14, P41; Vandenberg RJ, 2006, ORGAN RES METHODS, V9, P194, DOI 10.1177/1094428105285506; Vorster HH, 2010, HEALTH SA GESONDHEID, V15, DOI 10.4102/hsag.v15i1.435; Weinstein A, 2015, J BEHAV ADDICT, V4, P22, DOI 10.1556/JBA.4.2015.1.6; Wurwarg J., 2014, J INT AFF, V67, P75	48	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187508	10.1371/journal.pone.0187508	http://dx.doi.org/10.1371/journal.pone.0187508			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145423	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800017
J	Savic, M; Dembinski, JL; Laake, I; Hungnes, O; Cox, R; Oftung, F; Trogstad, L; Mjaaland, S				Savic, Miloje; Dembinski, Jennifer L.; Laake, Ida; Hungnes, Olav; Cox, Rebecca; Oftung, Fredrik; Trogstad, Lill; Mjaaland, Siri			Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy	PLOS ONE			English	Article							NATURAL-KILLER-CELL; A VIRUS; RESPONSES; SUBSET	' Maternal influenza infection during pregnancy is associated with increased risk of morbidity and mortality. However, the link between the anti-influenza immune responses and health-related risks during infection is not well understood. We have analyzed memory T and NK cell mediated immunity (CMI) responses in pandemic influenza A(H1N1) pdm09 (pdm09) virus infected non-vaccinated pregnant women participating in the Norwegian Influenza Pregnancy Cohort (NorFlu). The cohort includes information on immunization, self-reported health and disease status, and biological samples (plasma and PBMC). Infected cases (N = 75) were defined by having a serum hemagglutination inhibition (HI) titer > = 20 to influenza pdm09 virus at the time of delivery, while controls (N = 75) were randomly selected among non-infected pregnant women (HI titer < 10). In ELISpot assays cases had higher frequencies of IFN gamma(+) CD8(+) T cells responding to pdm09 virus or conserved CD8 T cell-restricted influenza A virus epitopes, compared to controls. Within this T cell population, frequencies of CD95(+) late effector (CD45RA(+)CCR7(-)) and naive (CD45RA(+)CCR7(+)) CD8(+) memory T cells correlated inversely with self-reported influenza illness (ILI) symptoms. ILI symptoms in infected women were also associated with lower numbers of poly-functional (IFN gamma(+) TNF alpha(+), IL2+IFN gamma(+), IL2(+)IFN gamma+TNF alpha(+)) CD4(+) T cells and increased frequencies of IFN gamma(+)CD3(-)CD7(+) NK cells compared to asymptomatic cases, or controls, after stimulation with the pdm09 virus. Taken together, virus specific and functionally distinct T and NK cell populations may serve as cellular immune correlates of clinical outcomes of pandemic influenza disease in pregnant women. Our results may provide information important for future universal influenza vaccine design.	[Savic, Miloje; Dembinski, Jennifer L.; Laake, Ida; Hungnes, Olav; Oftung, Fredrik; Trogstad, Lill; Mjaaland, Siri] Norwegian Inst Publ Hlth, Infect Control & Environm Hlth, Oslo, Norway; [Savic, Miloje; Dembinski, Jennifer L.; Cox, Rebecca; Oftung, Fredrik; Mjaaland, Siri] KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway; [Cox, Rebecca] Univ Bergen, Influenza Ctr, Dept Clin Sci, Bergen, Norway; [Cox, Rebecca] Haukeland Hosp, Dept Res & Dev, Bergen, Norway	Norwegian Institute of Public Health (NIPH); University of Bergen; University of Bergen; Haukeland University Hospital	Savic, M; Mjaaland, S (corresponding author), Norwegian Inst Publ Hlth, Infect Control & Environm Hlth, Oslo, Norway.; Savic, M; Mjaaland, S (corresponding author), KG Jebsen Ctr Influenza Vaccine Res, Oslo, Norway.	miloje.savic@fhi.no; siri.mjaaland@fhi.no		Mjaaland, Siri/0000-0002-3870-5861; Dembinski, Jennifer/0000-0001-9259-9572	Research Council of Norway [221122/H10]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway Award Grant No. 221122/H10.	Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; BENNETT S, 1992, J IMMUNOL METHODS, V146, P229, DOI 10.1016/0022-1759(92)90232-I; Budimir N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030898; Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dembinski JL, 2014, J VIROL METHODS, V207, P232, DOI 10.1016/j.jviromet.2014.07.003; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gras S, 2010, P NATL ACAD SCI USA, V107, P12599, DOI 10.1073/pnas.1007270107; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Hillaire MLB, 2011, J GEN VIROL, V92, P2339, DOI 10.1099/vir.0.033076-0; Horton H, 2007, J IMMUNOL METHODS, V323, P39, DOI 10.1016/j.jim.2007.03.002; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; Kay AW, 2014, P NATL ACAD SCI USA, V111, P14506, DOI 10.1073/pnas.1416569111; Kim JC, 2014, VIROLOGY, V448, P74, DOI 10.1016/j.virol.2013.10.001; Kraus TA, 2012, J CLIN IMMUNOL, V32, P300, DOI 10.1007/s10875-011-9627-2; Kraus TA, 2010, AM J REPROD IMMUNOL, V64, P411, DOI 10.1111/j.1600-0897.2010.00889.x; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; Marcelin G, 2011, J VIROL, V85, P11208, DOI 10.1128/JVI.00654-11; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Sargent IL, 2006, TRENDS IMMUNOL, V27, P399, DOI 10.1016/j.it.2006.06.009; Savic M, 2016, IMMUNOLOGY, V147, P165, DOI 10.1111/imm.12548; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Tilburgs T, 2013, AM J REPROD IMMUNOL, V69, P395, DOI 10.1111/aji.12094; Tilburgs T, 2010, J IMMUNOL, V185, P4470, DOI 10.4049/jimmunol.0903597; Trifonov V, 2009, EURO SURVEILL, V14; Tu WW, 2010, J VIROL, V84, P6527, DOI 10.1128/JVI.00519-10; Waldrop SL, 1997, J CLIN INVEST, V99, P1739, DOI 10.1172/JCI119338; Weinfurter JT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002381; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Yao Y, 2015, IMMUNOL CELL BIOL; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121; [No title captured]	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188055	10.1371/journal.pone.0188055	http://dx.doi.org/10.1371/journal.pone.0188055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145441	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800058
J	Butler, WE				Butler, William E.			Wavelet brain angiography suggests arteriovenous pulse wave phase locking	PLOS ONE			English	Article							CROSS-CORRELATION ANALYSIS; INTRACRANIAL-PRESSURE; SIGNAL ANALYSIS; IN-VIVO; FLOW; ULTRASOUND; MICROSCOPE; AMPLITUDE; INJURY; CT	When a stroke volume of arterial blood arrives to the brain, the total blood volume in the bony cranium must remain constant as the proportions of arterial and venous blood vary, and by the end of the cardiac cycle an equivalent volume of venous blood must have been ejected. I hypothesize the brain to support this process by an extraluminally mediated exchange of information between its arterial and venous circulations. To test this I introduce wavelet angiography methods to resolve single moving vascular pulse waves (PWs) in the brain while simultaneously measuring brain pulse motion. The wavelet methods require angiographic data acquired at significantly faster rate than cardiac frequency. I obtained these data in humans from brain surface optical angiograms at craniotomy and in piglets from ultrasound angiograms via cranial window. I exploit angiographic time of flight to resolve arterial from venous circulation. Initial wavelet reconstruction proved unsatisfactory because of angiographic motion alias from brain pulse motion. Testing with numerically simulated cerebral angiograms enabled the development of a vascular PW cine imaging method based on cross-correlated wavelets of mixed high frequency and high temporal resolution respectively to attenuate frequency and motion alias. Applied to the human and piglet data, the method resolves individual arterial and venous PWs and finds them to be phase locked each with separate phase relations to brain pulse motion. This is consistent with arterial and venous PW coordination mediated by pulse motion and points to a testable hypothesis of a function of cerebrospinal fluid in the ventricles of the brain.	[Butler, William E.] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Butler, WE (corresponding author), Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA.	wbutler@mgh.harvard.edu		Butler, William/0000-0002-4249-565X	Center for Integration of Medicine and Innovative Technology [a0K300000022wE4000840]; Center for Integration of Medicine and Innovative Technology (CIMIT) [a0K300000022wE4000840]	Center for Integration of Medicine and Innovative Technology; Center for Integration of Medicine and Innovative Technology (CIMIT)	Center for Integration of Medicine and Innovative Technology http://www.cimit.org/ grant #a0K300000022wE4000840 funded about 2% of the work, the remainder had no funding.; Benjamin I. Rapoport contributed an early Fourier-based version of the pulsation image phase reconstruction algorithm that inspired the development of the wavelet-based one. In addition, he contributed the brightness-hue model for rendering complex-valued data. Saad Khan helped create and implement the piglet cranial window ultrasound model. Kenneth Kwong performed the piglet MRI imaging. Pankaj K. Agarwalla, Paul H. Chapman, Patricia K. Donahoe, Ann Christine Duhaime, Bernard Kinane, Elizabeth G. Shannon, Victor Solo, Ralph Weissleder and Ziv Williams commented on versions of the manuscript. There was an earlier version of the manuscript that contained only the piglet data. James Baish and Lance Munn provided criticisms of it that prompted me to gather the human data and redirect the argument. The piglet cranial window studies were funded by Center for Integration of Medicine and Innovative Technology (CIMIT) grant a0K300000022wE4000840.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Ashmead J., 2012, QUANTA, V1, P1, DOI [10.12743/quanta.v1i1.5, DOI 10.12743/QUANTA.V1I1.5]; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bernstein MA, 2004, HDB MRI PULSE SEQUEN, P443; Bhadelia RA, 1997, NEURORADIOLOGY, V39, P258, DOI 10.1007/s002340050404; Butler WE, PLOS ONE; Carrera E, 2010, J NEUROTRAUM, V27, P317, DOI 10.1089/neu.2009.0951; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Daubechies I, 1992, 10 LECT WAVELETS; Daubechies I., 1992, 10 LECT WAVELETS; Gabor D., 1946, J I ENG ELECT 3, V93, P442, DOI [10.1049/ji-3-2.1946.0075, DOI 10.1049/JI-3-2.1946.0075]; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Hamberg LM, 1996, AM J NEURORADIOL, V17, P639; Hardesty DA, 2014, J CLIN NEUROSCIENCE; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; HYVARINEN L, 1980, ACTA OPHTHALMOL, V58, P528; Kachelriess M, 2000, MED PHYS, V27, P1881, DOI 10.1118/1.1286552; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Kim DJ, 2015, ACTA NEUROCHIR, V157, P633, DOI 10.1007/s00701-015-2353-4; Kim MH, 1998, ACT NEUR S, V71, P343; Klimenko S, 2002, GEN RELATIVITY QUANT; Kotelnikov V., 1933, P 1 ALL UN C TECHN R, P736; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Kuroiwa T, 2001, MINIM INVAS NEUROSUR, V44, P240, DOI 10.1055/s-2001-19929; Lassen N., 1979, TRACER KINETIC METHO; Lawton MT, 2011, 7 ANEURYSMS TENETS T; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Mizuno-Matsumoto Y, 2005, BRAIN TOPOGR, V17, P237, DOI 10.1007/s10548-005-6032-2; MORLET J, 1982, GEOPHYSICS, V47, P203, DOI 10.1190/1.1441328; Nyquist H., 1928, T AM I ELECT ING, V47, P617, DOI [10.1109/T-AIEE.1928.5055024, DOI 10.1109/T-AIEE.1928.5055024]; Provost J, 2014, PHYS MED BIOL, V59, pL1, DOI 10.1088/0031-9155/59/19/L1; Raabe A, 2005, J NEUROSURG, V103, P982, DOI 10.3171/jns.2005.103.6.0982; Serroukh A, 2012, ELECTRON J APPL STAT, V5, P289, DOI 10.1285/i20705948v5n2p289; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Tomita M, 2008, MICROCIRCULATION, V15, P163, DOI 10.1080/10739680701567089; Unser M, 2000, P IEEE, V88, P569, DOI 10.1109/5.843002; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zaidi HA, 2014, OPER NEUROSURG, V10, P246, DOI 10.1227/NEU.0000000000000318; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187014	10.1371/journal.pone.0187014	http://dx.doi.org/10.1371/journal.pone.0187014			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140981	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400014
J	Harris, DJ; Vine, SJ; Wilson, MR; McGrath, JS; LeBel, ME; Buckingham, G				Harris, David J.; Vine, Samuel J.; Wilson, Mark R.; McGrath, John S.; LeBel, Marie-Eve; Buckingham, Gavin			The effect of observing novice and expert performance on acquisition of surgical skills on a robotic platform	PLOS ONE			English	Article							TRAINING IMPROVES; TECHNICAL SKILLS; MOTION ANALYSIS; MOTOR; FEEDBACK; SURGERY; MECHANISMS; PRINCIPLES; EXPERIENCE; ENTROPY	Background Observational learning plays an important role in surgical skills training, following the traditional model of learning from expertise. Recent findings have, however, highlighted the benefit of observing not only expert performance but also error-strewn performance. The aim of this study was to determine which model (novice vs. expert) would lead to the greatest benefits when learning robotically assisted surgical skills. Methods 120 medical students with no prior experience of robotically-assisted surgery completed a ring-carrying training task on three occasions; baseline, post-intervention and at one-week follow-up. The observation intervention consisted of a video model performing the ring-carrying task, with participants randomly assigned to view an expert model, a novice model, a mixed expert/novice model or no observation (control group). Participants were assessed for task performance and surgical instrument control. Results There were significant group differences post-intervention, with expert and novice observation groups outperforming the control group, but there were no clear group differences at a retention test one week later. There was no difference in performance between the expertobserving and error-observing groups. Conclusions Similar benefits were found when observing the traditional expert model or the error-strewn model, suggesting that viewing poor performance may be as beneficial as viewing expertise in the early acquisition of robotic surgical skills. Further work is required to understand, then inform, the optimal curriculum design when utilising observational learning in surgical training.	[Harris, David J.; Vine, Samuel J.; Wilson, Mark R.; Buckingham, Gavin] Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England; [McGrath, John S.] RD&E Hosp, Exeter Surg Hlth Serv Res Unit, Exeter, Devon, England; [McGrath, John S.] Univ Exeter, Med Sch, Exeter, Devon, England; [LeBel, Marie-Eve] Univ Western Ontario, Div Orthopaed Surg, London, ON, Canada	University of Exeter; University of Exeter; Western University (University of Western Ontario)	Buckingham, G (corresponding author), Univ Exeter, Dept Sport & Hlth Sci, Exeter, Devon, England.	G.Buckingham@exeter.ac.uk	Harris, David/H-9114-2019; Vine, Samuel J/AAD-5226-2019	Harris, David/0000-0003-3880-3856; Vine, Samuel J/0000-0001-9329-1262; Buckingham, Gavin/0000-0002-6950-5504	Intuitive Surgical grant	Intuitive Surgical grant	This research was supported by an Intuitive Surgical grant awarded to DrG. Buckingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieux M, 2014, EXP BRAIN RES, V232, P3121, DOI 10.1007/s00221-014-4000-3; Andrieux M, 2013, EXP BRAIN RES, V229, P125, DOI 10.1007/s00221-013-3598-x; Bandura A, 1969, PRINCIPLES BEHAV MOD, VIX; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Blandin Y, 2000, Q J EXP PSYCHOL-A, V53, P846, DOI 10.1080/027249800410571; Broholm M, 2015, COLORECTAL DIS, V17, P375, DOI 10.1111/codi.12872; Brown LE, 2010, J NEUROPHYSIOL, V104, P1409, DOI 10.1152/jn.01047.2009; Buckingham G, 2014, CORTEX, V50, P115, DOI 10.1016/j.cortex.2013.07.004; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Causer J, 2014, AM J SURG, V208, P171, DOI 10.1016/j.amjsurg.2013.12.042; Chmarra MK, 2010, SURG ENDOSC, V24, P1031, DOI 10.1007/s00464-009-0721-y; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; CORDIER P, 1994, HUM MOVEMENT SCI, V13, P745, DOI 10.1016/0167-9457(94)90016-7; Cordovani L, 2016, ADV HEALTH SCI EDUC, V21, P1113, DOI 10.1007/s10459-015-9646-5; Custers EJFM, 1999, ADV HEALTH SCI EDUC, V4, P123, DOI 10.1023/A:1009763210212; Domuracki K, 2015, MED EDUC, V49, P186, DOI 10.1111/medu.12631; Duchowski A. T., 2017, EYE TRACKING METHODO; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Ghasemloonia A, 2017, J SURG EDUC, V74, P295, DOI 10.1016/j.jsurg.2016.10.006; Gorman PJ, 2000, AM J SURG, V180, P353, DOI 10.1016/S0002-9610(00)00514-6; Hardwick R. M., 2017, BIOMED J SCI TECH RE, DOI 10.1101/ 198432; Herron DM, 2008, SURG ENDOSC, V22, P313, DOI 10.1007/s00464-007-9727-5; Hodges NJ, 2007, J SPORT SCI, V25, P531, DOI 10.1080/02640410600946860; Hwang H, 2006, SURG ENDOSC, V20, P651, DOI 10.1007/s00464-005-0370-8; Janelle CM, 2003, J SPORT SCI, V21, P825, DOI 10.1080/0264041031000140310; Jarc AM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00315; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; LeBel M-E, 2017, J SURG ED; LeBlanc J, EYE GAZE STRATEGIES; Love J., 2015, JASP VERSION 07; Mason JD, 2013, SURG ENDOSC, V27, P1468, DOI 10.1007/s00464-012-2631-7; Mattar AAG, 2005, NEURON, V46, P153, DOI 10.1016/j.neuron.2005.02.009; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Moore LJ, 2015, J ROBOT SURG, V9, P67, DOI 10.1007/s11701-014-0493-9; Moorthy K, 2003, BMJ-BRIT MED J, V327, P1032, DOI 10.1136/bmj.327.7422.1032; Morris D, 2007, WORLD HAPTICS 2007: SECOND JOINT EUROHAPTICS CONFERENCE AND SYMPOSIUM ON HAPTIC INTERFACES FOR VIRTUAL ENVIRONMENT AND TELEOPERATOR SYSTEMS, PROCEEDINGS, P21; POLLOCK BJ, 1992, RES Q EXERCISE SPORT, V63, P25, DOI 10.1080/02701367.1992.10607553; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ritter EM, 2007, SURG INNOV, V14, P107, DOI 10.1177/1553350607302329; Robles-De-La-Torre G, 2006, IEEE MULTIMEDIA, V13, P24, DOI 10.1109/MMUL.2006.69; Rodrigues SP, 2012, SURG ENDOSC, V26, P1005, DOI 10.1007/s00464-011-1986-5; Rohbanfard H, 2011, EXP BRAIN RES, V215, P183, DOI 10.1007/s00221-011-2882-x; Sheffield FD, 1961, AA LUMSDAINE ED STUD; Smith R, 2014, INT J MED ROBOT COMP, V10, P379, DOI 10.1002/rcs.1559; Snyder CW, 2011, WORLD J SURG, V35, P245, DOI 10.1007/s00268-010-0861-1; Sutton DN, 1998, BRIT J SURG, V85, P1399; Trejos AL, 2013, IEEE INT CONF ROBOT, P4370, DOI 10.1109/ICRA.2013.6631196; Tytherleigh MG, 2001, ANN ROY COLL SURG, V83, P69; van der Meijden OAJ, 2009, SURG ENDOSC, V23, P1180, DOI 10.1007/s00464-008-0298-x; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Van Sickle KR, 2005, SURG ENDOSC, V19, P1227, DOI 10.1007/s00464-004-8274-6; Vine SJ, 2013, SURG ENDOSC, V27, P3205, DOI 10.1007/s00464-013-2893-8; Vine SJ, 2012, SURGERY, V152, P32, DOI 10.1016/j.surg.2012.02.002; Wagner CR, 2007, IEEE T ROBOT, V23, P1235, DOI 10.1109/TRO.2007.904891; Watson RA, 2012, J SURG EDUC, V69, P306, DOI 10.1016/j.jsurg.2011.12.001; Williams RL, 2004, IMPLEMENTATION EVALU; Wilson M, 2010, SURG ENDOSC, V24, P2458, DOI 10.1007/s00464-010-0986-1; Wilson MR, 2011, SURG ENDOSC, V25, P3731, DOI 10.1007/s00464-011-1802-2; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wulf G, 2010, MED EDUC, V44, P75, DOI 10.1111/j.1365-2923.2009.03421.x	61	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188233	10.1371/journal.pone.0188233	http://dx.doi.org/10.1371/journal.pone.0188233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141046	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400072
J	Proll, MJ; Neuhoff, C; Schellander, K; Uddin, MJ; Cinar, MU; Sahadevan, S; Qu, XQ; Islam, MA; Poirier, M; Muller, MA; Drosten, C; Tesfaye, D; Tholen, E; Grosse-Brinkhaus, C				Proell, Maren Julia; Neuhoff, Christiane; Schellander, Karl; Uddin, Muhammad Jasim; Cinar, Mehmet Ulas; Sahadevan, Sudeep; Qu, Xueqi; Islam, Md. Aminul; Poirier, Mikhael; Mueller, Marcel A.; Drosten, Christian; Tesfaye, Dawit; Tholen, Ernst; Grosse-Brinkhaus, Christine			Transcriptome profile of lung dendritic cells after in vitro porcine reproductive and respiratory syndrome virus (PRRSV) infection	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; ALVEOLAR MACROPHAGES; MOLECULAR CHARACTERIZATION; VIRAL-INFECTION; LELYSTAD VIRUS; RNA-SEQ; ACTIVATION; ARTERIVIRUS; POPULATIONS; DISEASE	The porcine reproductive and respiratory syndrome (PRRS) is an infectious disease that leads to high financial and production losses in the global swine industry. The pathogenesis of this disease is dependent on a multitude of factors, and its control remains problematic. The immune system generally defends against infectious diseases, especially dendritic cells (DCs), which play a crucial role in the activation of the immune response after viral infections. However, the understanding of the immune response and the genetic impact on the immune response to PRRS virus (PRRSV) remains incomplete. In light of this, we investigated the regulation of the host immune response to PRRSV in porcine lung DCs using RNA-sequencing (RNA-Seq). Lung DCs from two different pig breeds (Pietrain and Duroc) were collected before (0 hours) and during various periods of infection (3, 6, 9, 12, and 24 hours post infection (hpi)). RNA-Seq analysis revealed a total of 20,396 predicted porcine genes, which included breed-specific differentially expressed immune genes. Pietrain and Duroc infected lung DCs showed opposite gene expression courses during the first time points post infection. Duroc lung DCs reacted more strongly and distinctly than Pietrain lung DCs during these periods (3, 6, 9, 12 hpi). Additionally, cluster analysis revealed time-dependent co-expressed groups of genes that were involved in immune-relevant pathways. Key clusters and pathways were identified, which help to explain the biological and functional background of lung DCs post PRRSV infection and suggest IL-1 beta 1 as an important candidate gene. RNA-Seq was also used to characterize the viral replication of PRRSV for each breed. PRRSV was able to infect and to replicate differently in lung DCs between the two mentioned breeds. These results could be useful in investigations on immunity traits in pig breeding and enhancing the health of pigs.	[Proell, Maren Julia; Neuhoff, Christiane; Schellander, Karl; Islam, Md. Aminul; Poirier, Mikhael; Tesfaye, Dawit; Tholen, Ernst; Grosse-Brinkhaus, Christine] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Bonn, Germany; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton Campus, Gatton, Australia; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, Kayseri, Turkey; [Sahadevan, Sudeep] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Qu, Xueqi] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Lab Gene & Cell Engn, Shenzhen, Peoples R China; [Mueller, Marcel A.; Drosten, Christian] Charite, Inst Virol, Helmut Ruska Haus, Berlin, Germany	University of Bonn; University of Queensland; Erciyes University; University of Copenhagen; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Neuhoff, C (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Bonn, Germany.	cneu@itz.uni-bonn.de	Müller, Marcel A./O-2425-2019; Uddin, Muhammad Jasim/N-3866-2013; Große-Brinkhaus, Christine/AAF-6712-2020; Ertan, Asli/AAE-6201-2021; Islam, Aminul/AAE-9484-2019; Uddin, Muhammad Jasim/P-8497-2019	Müller, Marcel A./0000-0003-2242-5117; Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	State of North Rhine Westphalia of Germany; program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" [17-02.04.01-6/13]	State of North Rhine Westphalia of Germany; program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)"	This work was financially supported by the State of North Rhine Westphalia of Germany with the program "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" with the grant no. 17-02.04.01-6/13.	Abada PB, 2012, MOL PHARMACOL, V82, P510, DOI 10.1124/mol.112.079822; ABBAS AK, 2012, CELLULAR MOL IMMUNOL, DOI DOI 10.1016/J.VETMIC.2013.07.022; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Alberts B, 2008, MOL BIOL CELL, p[921, 1417]; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Badaoui B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091918; Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10; Balasuriya U. B. R., 2013, VET MICROBIOL, P456; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; BI J, 2014, MEDIAT INFLAMM, P22717, DOI DOI 10.1155/2014/403515; Brockmeier SL, 2002, POLYMICROBIAL DIS; Chen XX, 2014, VET MICROBIOL, V170, P48, DOI 10.1016/j.vetmic.2014.01.031; Chen Z, 2010, VIROLOGY, V398, P87, DOI 10.1016/j.virol.2009.11.033; CONZELMANN KK, 1993, VIROLOGY, V193, P329, DOI 10.1006/viro.1993.1129; De Baere MI, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-47; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dwivedi V, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-45; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Grayson MH, 2007, J IMMUNOL, V179, P1438, DOI 10.4049/jimmunol.179.3.1438; Halbur PG, 1998, J ANIM BREED GENET, V115, P181, DOI 10.1111/j.1439-0388.1998.tb00341.x; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Hu Rui, 2011, BMC Proc, V5 Suppl 4, pS10, DOI 10.1186/1753-6561-5-S4-S10; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; JANEWAY CA, 2001, IMMUNOBIOLOGY IMMUNE, DOI DOI 10.1126/SCISIGNAL.3105CM1; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kindt TJ, 2007, KUBY IMMUNOLOGY, p[1, 302, 447]; Li HX, 2010, J GEN VIROL, V91, P2947, DOI 10.1099/vir.0.025205-0; Lopez A., 2001, THOMSONS SPECIAL VET, P178; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; MacPherson G, 2012, EXPLORING IMMUNOLOGY, p[1, 99]; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Murphy K, 2017, JANEWAY'S IMMUNOBIOLOGY, 9TH EDITION, P1; Nauwynck HJ, 1999, J GEN VIROL, V80, P297, DOI 10.1099/0022-1317-80-2-297; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Park JY, 2008, J MICROBIOL BIOTECHN, V18, P1709; Pejsak Z, 1997, COMP IMMUNOL MICROB, V20, P345, DOI 10.1016/S0147-9571(97)00010-6; Petry DB, 2005, J ANIM SCI, V83, P1494; Rodriguez-Gomez Irene M, 2013, World J Virol, V2, P146, DOI 10.5501/wjv.v2.i4.146; Ross JW, 2003, BIOL REPROD, V69, P1251, DOI 10.1095/biolreprod.103.015842; Schmid MA, 2011, BLOOD, V118, P4829, DOI 10.1182/blood-2011-03-344960; SEO H, 2012, BIOL REPROD, V87, DOI DOI 10.1095/BIOLREPROD.103.015842; Sorensen V, 2006, DIS SWINE, V9th, P149; Stumbles PA, 2003, APMIS, V111, P741, DOI 10.1034/j.1600-0463.2003.11107806.x; Tizard I, 2013, VET IMMUNOLOGY, P1; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uddin MJ, 2011, INT J IMMUNOGENET, V38, P121, DOI 10.1111/j.1744-313X.2010.00985.x; Vanhee M, 2009, VET RES, V40, DOI 10.1051/vetres/2009046; Wang R, 2013, VET MICROBIOL, V166, P493, DOI 10.1016/j.vetmic.2013.07.022; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; WEBER A, 2010, SCI SIGNAL, V3, DOI DOI 10.1038/NRI3024; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296; Wolf JBW, 2013, MOL ECOL RESOUR, V13, P559, DOI 10.1111/1755-0998.12109; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Zentralverband der Deutschen Schweineproduktion ZDS, 2003, RICHTL STAT MASTL SC; Zhang K, 2013, VIROLOGY, V442, P156, DOI 10.1016/j.virol.2013.04.007; Zhao W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000726; Zhou A, 2012, CELL SIGNAL, V24, P973, DOI 10.1016/j.cellsig.2012.01.004; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947; Zimmerman J., 2012, DIS SWINE, V10, P461	68	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187735	10.1371/journal.pone.0187735	http://dx.doi.org/10.1371/journal.pone.0187735			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140992	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400027
J	Giordano, C; Li, XG; Kleiven, S				Giordano, Chiara; Li, Xiaogai; Kleiven, Svein			Performances of the PIPER scalable child human body model in accident reconstruction	PLOS ONE			English	Article							FINITE-ELEMENT MODEL	Human body models (HBMs) have the potential to provide significant insights into the pediatric response to impact. This study describes a scalable/posable approach to perform child accident reconstructions using the Position and Personalize Advanced Human Body Models for Injury Prediction (PIPER) scalable child HBM of different ages and in different positions obtained by the PIPER tool. Overall, the PIPER scalable child HBM managed reasonably well to predict the injury severity and location of the children involved in real-life crash scenarios documented in the medical records. The developed methodology and workflow is essential for future work to determine child injury tolerances based on the full Child Advanced Safety Project for European Roads (CASPER) accident reconstruction database. With the workflow presented in this study, the open-source PIPER scalable HBM combined with the PIPER tool is also foreseen to have implications for improved safety designs for a better protection of children in traffic accidents.	[Giordano, Chiara; Li, Xiaogai; Kleiven, Svein] KTH Royal Inst Technol, Sch Technol & Hlth, Div Neuron Engn, Stockholm, Sweden	Royal Institute of Technology	Li, XG (corresponding author), KTH Royal Inst Technol, Sch Technol & Hlth, Div Neuron Engn, Stockholm, Sweden.	xiaogai@kth.se		Li, Xiaogai/0000-0001-8522-4705	European Union Seventh Framework Program ([FP7]) [605544]	European Union Seventh Framework Program ([FP7])	This research has received funding from the European Union Seventh Framework Program ([FP7/2007-2013]) under grant agreement nr. 605544 [PIPER project]. More information about the project, partners and model release can be found at www.piper-project.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beillas P, 2014, P IRCOBI C BERL GERM; Beillas P, 2016, P POCC C MUN GERM; Branche C., 2008, WORLD REPORT CHILD I; Cavanaugh J., 1993, P 37 STAPP CAR CRASH, V37, P199; Cheng H., 1994, ALCFTR19940051 CREW; Croatto S, 2013, P 23 ESV C 2013 SEOU; Dong LQ, 2013, ANN BIOMED ENG, V41, P2538, DOI 10.1007/s10439-013-0858-7; Giordano C, 2016, P IRCOBI C MAL SPAIN; Iwamoto M, 2016, STAPP CAR CRASH J, V59, P53; Johannsen H, 2012, P IRCOBI C DUBL IR; Jolivet E, 2005, STAPP CAR CRASH J, V59, P337; Kirscht K, D1 3 FINAL VERSION V; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Li ZG, 2015, INT J LEGAL MED, V129, P1055, DOI 10.1007/s00414-015-1190-6; Lubbe N., 2010, P 8 INT C PROT CHILD; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Mizuno Koji, 2005, Traffic Inj Prev, V6, P361, DOI 10.1080/15389580500255922; Ouyang J, 2005, SPINE, V30, P716, DOI DOI 10.1097/01.BRS.0000192280.53831.70; Peden M, 2009, GLOB STAT REP ROAD S; Petitjean A., 2015, ACCIDENTAL INJURY, P769, DOI [10.1007/978-1-4939-1732-7_26, DOI 10.1007/978-1-4939-1732-7_26]; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Trosseille X, D4 4 REPORT FEASIBIL; Untaroiu CD, ASME INT DES ENG TEC, V3; Viano D.C., 1989, BIOMECHANICAL RESPON, P113, DOI DOI 10.4271/892432; Vicini A., 2014, THESIS; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	27	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187916	10.1371/journal.pone.0187916	http://dx.doi.org/10.1371/journal.pone.0187916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135997	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200046
J	Gibbons, SJ; Grover, M; Choi, KM; Wadhwa, A; Zubair, A; Wilson, LA; Wu, YH; Abell, TL; Hasler, WL; Koch, KL; McCallum, RW; Nguyen, LAB; Parkman, HP; Sarosiek, I; Snape, WJ; Tonascia, J; Hamilton, FA; Pasricha, PJ; Farrugia, G				Gibbons, Simon J.; Grover, Madhusudan; Choi, Kyoung Moo; Wadhwa, Akhilesh; Zubair, Adeel; Wilson, Laura A.; Wu, Yanhong; Abell, Thomas L.; Hasler, William L.; Koch, Kenneth L.; McCallum, Richard W.; Nguyen, Linda A. B.; Parkman, Henry P.; Sarosiek, Irene; Snape, William J.; Tonascia, James; Hamilton, Frank A.; Pasricha, Pankaj J.; Farrugia, Gianrico			Repeat polymorphisms in the Homo sapiens heme oxygenase-1 gene in diabetic and idiopathic gastroparesis	PLOS ONE			English	Article							CHRONIC UNEXPLAINED NAUSEA; MICROSATELLITE POLYMORPHISM; INTERSTITIAL-CELLS; PROMOTER POLYMORPHISMS; ATHEROSCLEROSIS RISK; SYMPTOM SEVERITY; CARBON-MONOXIDE; ASSOCIATION; SUSCEPTIBILITY; SEQUENCES	Background Idiopathic and diabetic gastroparesis in Homo sapiens cause significant morbidity. Etiology or risk factors have not been clearly identified. Failure to sustain elevated heme oxygenase-1 (HO1) expression is associated with delayed gastric emptying in diabetic mice and polymorphisms in the HO1 gene (HMOX1, NCBI Gene ID: 3162) are associated with worse outcomes in other diseases. Aim Our hypothesis was that longer polyGT alleles are more common in the HMOX1 genes of individuals with gastroparesis than in controls without upper gastrointestinal motility disorders. Methods Repeat length was determined in genomic DNA. Controls with diabetes (84 type 1, 84 type 2) and without diabetes (n = 170) were compared to diabetic gastroparetics (99 type 1, 72 type 2) and idiopathic gastroparetics (n = 234). Correlations of repeat lengths with clinical symptom sub-scores on the gastroparesis cardinal symptom index (GCSI) were done. Statistical analyses of short (<29), medium and long (>32) repeat alleles and differences in allele length were used to test for associations with gastroparesis. Results The distribution of allele lengths was different between groups (P = 0.016). Allele lengths were longest in type 2 diabetics with gastroparesis (29.18 +/- 0.35, mean +/- SEM) and longer in gastroparetics compared to non-diabetic controls (28.50 +/- 0.14 vs 27.64 +/- 0.20 GT repeats/allele, P = 0.0008). Type 2 diabetic controls had longer alleles than non-diabetic controls. In all gastroparetic groups, allele lengths were longer in African Americans compared to other racial groups, differences in the proportion of African Americans in the groups accounted for the differences between gastroparetics and controls. Diabetic gastroparetics with 1 or 2 long alleles had worse GCSI nausea sub-scores (3.30 +/- 0.23) as compared to those with 0 long alleles (2.66 +/- 0.12), P = 0.022. Conclusions Longer poly-GT repeats in the HMOX1 gene are more common in African Americans with gastroparesis. Nausea symptoms are worse in subjects with longer alleles.	[Gibbons, Simon J.; Grover, Madhusudan; Choi, Kyoung Moo; Wadhwa, Akhilesh; Zubair, Adeel; Farrugia, Gianrico] Mayo Clin, Enter NeuroSci Program, Rochester, MN 55902 USA; [Wilson, Laura A.; Tonascia, James] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Wu, Yanhong] Mayo Clin, Med Genom Program, Rochester, MN USA; [Abell, Thomas L.] Univ Louisville, Louisville, KY 40292 USA; [Hasler, William L.] Univ Michigan, Ann Arbor, MI 48109 USA; [Koch, Kenneth L.] Wake Forest Univ, Winston Salem, NC 27109 USA; [McCallum, Richard W.; Sarosiek, Irene] Texas Tech Univ, El Paso, TX USA; [Nguyen, Linda A. B.] Stanford Univ, Palo Alto, CA 94304 USA; [Parkman, Henry P.] Temple Univ, Philadelphia, PA 19122 USA; [Snape, William J.] Calif Pacific Med Ctr, San Francisco, CA USA; [Hamilton, Frank A.] NIDDK, Bethesda, MD 20892 USA; [Pasricha, Pankaj J.] Johns Hopkins Sch Med, Baltimore, MD USA	Mayo Clinic; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Mayo Clinic; University of Louisville; University of Michigan System; University of Michigan; Wake Forest University; Texas Tech University System; Texas Tech University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; California Pacific Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Farrugia, G (corresponding author), Mayo Clin, Enter NeuroSci Program, Rochester, MN 55902 USA.	Farrugia.gianrico@mayo.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK073974, P01DK068055, U01DK074035, R01DK057061, K23DK103911, P30DK084567, U01DK112193, U24DK074008, U24DK076169, U01DK074008, U01DK074007] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK073974, R01 DK057061, P30 DK084567, U24 DK074008, U01 DK074007, U01 DK112193, U01 DK074008, U01 DK074035, K23 DK103911, P01 DK068055, U24 DK076169] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Angeli TR, 2015, GASTROENTEROLOGY, V149, P56, DOI 10.1053/j.gastro.2015.04.003; Arredondo M, 2007, AM J CLIN NUTR, V86, P1347, DOI 10.1093/ajcn/86.5.1347; Ayuso P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00298; Bao W, 2010, AM J EPIDEMIOL, V172, P631, DOI 10.1093/aje/kwq162; Bernard CE, 2014, NEUROGASTROENT MOTIL, V26, P1275, DOI 10.1111/nmo.12389; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Chen YH, 2002, HUM GENET, V111, P1, DOI 10.1007/s00439-002-0769-4; Cheng S, 2014, CIRCULATION, V130, P820, DOI 10.1161/CIRCULATIONAHA.113.008506; Cherian D, 2012, NEUROGASTROENT MOTIL, V24, P217, DOI 10.1111/j.1365-2982.2011.01828.x; Cherian D, 2010, CLIN GASTROENTEROL H, V8, P676, DOI 10.1016/j.cgh.2010.04.027; Choi KM, 2016, CELL MOL GASTROENTER, V2, P454, DOI 10.1016/j.jcmgh.2016.04.006; Choi KM, 2010, GASTROENTEROLOGY, V138, P2399, DOI 10.1053/j.gastro.2010.02.014; Choi KM, 2008, GASTROENTEROLOGY, V135, P2055, DOI 10.1053/j.gastro.2008.09.003; Choung RS, 2012, AM J GASTROENTEROL, V107, P82, DOI 10.1038/ajg.2011.310; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Exner M, 2004, FREE RADICAL BIO MED, V37, P1097, DOI 10.1016/j.freeradbiomed.2004.07.008; Friedenberg FK, 2013, J CLIN GASTROENTEROL, V47, P757, DOI 10.1097/MCG.0b013e3182819aae; Gibbons SJ, 2013, ALIMENT PHARM THER, V38, P689, DOI 10.1111/apt.12467; Grover M, 2012, NEUROGASTROENT MOTIL, V24, P531, DOI 10.1111/j.1365-2982.2012.01894.x; Guenegou A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039743; Hansson HH, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0668-5; Hasler WL, 2007, GASTROENTEROL CLIN N, V36, P619, DOI 10.1016/j.gtc.2007.07.004; Jung HK, 2009, GASTROENTEROLOGY, V136, P1225, DOI 10.1053/j.gastro.2008.12.047; Kashyap PC, 2010, AM J PHYSIOL-GASTR L, V298, pG1013, DOI 10.1152/ajpgi.00069.2010; Kikuchi A, 2005, HUM GENET, V116, P354, DOI 10.1007/s00439-004-1162-2; Kramer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077224; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; Olson JE, 2013, MAYO CLIN PROC, V88, P952, DOI 10.1016/j.mayocp.2013.06.006; Ono K, 2004, ATHEROSCLEROSIS, V173, P315, DOI 10.1016/j.atherosclerosis.2003.11.021; Ordog T, 2009, Minerva Gastroenterol Dietol, V55, P315; Parkman HP, 2015, GASTROENTEROL CLIN N, V44, P59, DOI 10.1016/j.gtc.2014.11.015; Parkman HP, 2013, JAMA-J AM MED ASSOC, V310, P2640, DOI 10.1001/jama.2013.282833; Parkman HP, 2011, CLIN GASTROENTEROL H, V9, P1056, DOI 10.1016/j.cgh.2011.08.013; Parkman HP, 2004, GASTROENTEROLOGY, V127, P1592, DOI 10.1053/j.gastro.2004.09.055; Pasricha PJ, 2011, CLIN GASTROENTEROL H, V9, P567, DOI 10.1016/j.cgh.2011.03.003; Quinn M, 1996, DIABETOLOGIA, V39, P940; Revicki DA, 2003, ALIMENT PHARM THER, V18, P141, DOI 10.1046/j.1365-2036.2003.01612.x; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sambo MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011141; Seu L, 2012, GENES IMMUN, V13, P258, DOI 10.1038/gene.2011.76; STALLINGS RL, 1991, GENOMICS, V10, P807, DOI 10.1016/0888-7543(91)90467-S; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Tiroch K, 2007, EUR HEART J, V28, P968, DOI 10.1093/eurheartj/ehm036; Villeneuve LM, 2010, AM J PHYSIOL-RENAL, V299, pF14, DOI 10.1152/ajprenal.00200.2010; Wagenknecht LE, 2001, DIABETES, V50, P861, DOI 10.2337/diabetes.50.4.861; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; WINTERO AK, 1992, GENOMICS, V12, P281, DOI 10.1016/0888-7543(92)90375-3; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729	52	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187772	10.1371/journal.pone.0187772	http://dx.doi.org/10.1371/journal.pone.0187772			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161307	gold, Green Submitted, Green Published			2022-12-27	WOS:000415987000019
J	Grier, MD; West, KL; Kelm, ND; Fu, C; Does, MD; Parker, B; McBrier, E; Lagrange, AH; Ess, KC; Carson, RP				Grier, Mark D.; West, Kathryn L.; Kelm, Nathaniel D.; Fu, Cary; Does, Mark D.; Parker, Brittany; McBrier, Eleanor; Lagrange, Andre H.; Ess, Kevin C.; Carson, Robert P.			Loss of mTORC2 signaling in oligodendrocyte precursor cells delays myelination	PLOS ONE			English	Article							TUBEROUS SCLEROSIS COMPLEX; CNS MYELINATION; WHITE-MATTER; MAMMALIAN TARGET; RAPAMYCIN; AKT; RICTOR; DIFFERENTIATION; REMYELINATION; INTEGRITY	Myelin abnormalities are increasingly being recognized as an important component of a number of neurologic developmental disorders. The integration of many signaling pathways and cell types are critical for correct myelinogenesis. The PI3-K and mechanistic target of rapamycin (mTOR) pathways have been found to play key roles. mTOR is found within two distinct complexes, mTORC1 and mTORC2. mTORC1 activity has been shown to play a major role during myelination, while the role of mTORC2 is not yet well understood. To determine the role of mTORC2 signaling in myelinogenesis, we generated a mouse lacking the critical mTORC2 component Rictor in oligodendrocyte precursors (OPCs). Targeted deletion of Rictor in these cells decreases and delays the expression of myelin related proteins and reduces the size of cerebral white matter tracts. This is developmentally manifest as a transient reduction in myelinated axon density and g-ratio. OPC cell number is reduced at birth without detectable change in proliferation with proportional reductions in mature oligodendrocyte number at P15. The total number of oligodendrocytes as well as extent of myelination, does improve over time. Adult conditional knock-out (CKO) animals do not demonstrate a behavioral phenotype likely due in part to preserved axonal conduction velocities. These data support and extend prior studies demonstrating an important but transient contribution of mTORC2 signaling to myelin development.	[Grier, Mark D.; Fu, Cary; Parker, Brittany; McBrier, Eleanor; Ess, Kevin C.; Carson, Robert P.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [West, Kathryn L.; Kelm, Nathaniel D.; Does, Mark D.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Lagrange, Andre H.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Carson, RP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.	robert.carson@vanderbilt.edu		Fu, Cary/0000-0001-7720-9249; carson, robert/0000-0002-0430-0831	NIH [K08NS083710, R01 NS078289, R01 EB001744]; VA [1101BX001189]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB019980, T32EB014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS083710, R01NS078289] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH K08NS083710 to RPC, NIH R01 NS078289 to KCE, NIH R01 EB001744 to MDD, VA 1101BX001189 to AHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azim K, 2011, GLIA, V59, P540, DOI 10.1002/glia.21122; Bercury KK, 2014, J NEUROSCI, V34, P4466, DOI 10.1523/JNEUROSCI.4314-13.2014; Carson RP, 2015, ANN CLIN TRANSL NEUR, V2, P1041, DOI 10.1002/acn3.254; Carson RP, 2013, HUM MOL GENET, V22, P140, DOI 10.1093/hmg/dds414; Carson RP, 2012, NEUROBIOL DIS, V45, P369, DOI 10.1016/j.nbd.2011.08.024; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; D'Ercole AJ, 2002, NEUROPEPTIDES, V36, P209, DOI 10.1054/npep.2002.0893; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Ess KC, 2005, NEUROLOGY, V64, P1446, DOI 10.1212/01.WNL.0000158653.81008.49; Fu C, 2012, CEREB CORTEX, V22, P2111, DOI 10.1093/cercor/bhr300; GILLESPIE MJ, 1983, BRAIN RES, V259, P41, DOI 10.1016/0006-8993(83)91065-X; Harrington EP, 2010, ANN NEUROL, V68, P703, DOI 10.1002/ana.22090; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; Lebrun-Julien F, 2014, J NEUROSCI, V34, P8432, DOI 10.1523/JNEUROSCI.1105-14.2014; Lundgaard I, 2011, GLIA, V59, pS62; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; Peters JM, 2012, ACAD RADIOL, V19, P17, DOI 10.1016/j.acra.2011.08.016; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Simao G, 2010, AM J NEURORADIOL, V31, P1273, DOI 10.3174/ajnr.A2033; Siuta MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000393; Wahl SE, 2014, J NEUROSCI, V34, P4453, DOI 10.1523/JNEUROSCI.4311-13.2014; West K. L., 2016, NEUROIMAGE; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529	30	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188417	10.1371/journal.pone.0188417	http://dx.doi.org/10.1371/journal.pone.0188417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161318	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000052
J	Haase, H; Jordan, L; Keitel, L; Keil, C; Mahltig, B				Haase, Hajo; Jordan, Lisa; Keitel, Laura; Keil, Claudia; Mahltig, Boris			Comparison of methods for determining the effectiveness of antibacterial functionalized textiles	PLOS ONE			English	Article							EFFECT PIGMENTS; COTTON FABRICS; SILVER IONS; COATINGS; BACTERIA; GROWTH; COPPER; CELLS; ZINC	Antimicrobial functionalization of textiles is important for various applications, such as protection of textile materials from decomposition, generation of more effective wound dressings, and the prevention of infections or malodors resulting from bacterial growth. In order to test the efficacy of new products, their antibacterial activity needs to be evaluated. At present, several different procedures are being used for this purpose, hindering comparisons among different studies. The present paper compares five of these assays using a sample panel of different textiles functionalized with copper (Cu) and silver (Ag) as antibacterial agents, and discusses the suitability of these methods for different analytical requirements. Bacterial viability was determined by measuring the optical density at 600 nm, a colorimetric assay based on MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide) conversion, an agar diffusion assay, and colony formation, either after culturing in media containing textile samples, or after recovery from textiles soaked with bacterial suspension. All experiments were performed with a Gram-negative (Escherichia coli) and a Gram-positive (Staphylococcus warneri) model organism. In general, the results yielded by the different methods were of good comparability. To identify the most suitable test system for the particular type of antibacterial coating, several factors need to be taken into account, such as choosing appropriate endpoints for analyzing passive or active antibacterial effects, selection of relevant microorganisms, correcting for potential interference by leaching of colored textile coatings, required hands on time, and the necessary sensitivity.	[Haase, Hajo; Jordan, Lisa; Keitel, Laura; Keil, Claudia] Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Chem & Toxicol, Berlin, Germany; [Mahltig, Boris] Univ Appl Sci, Hsch Niederrhein, Fac Text & Clothing Technol, Monchengladbach, Germany	Technical University of Berlin	Haase, H (corresponding author), Tech Univ Berlin, Inst Food Technol & Food Chem, Dept Food Chem & Toxicol, Berlin, Germany.	Haase@TU-Berlin.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718; Keil, Claudia/0000-0003-0317-0905	German Research Foundation; Technische Universitat Berlin	German Research Foundation(German Research Foundation (DFG)); Technische Universitat Berlin	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of Technische Universitat Berlin.	Aggarwal P, 2010, J BIOMED MATER RES B, V95B, P118, DOI 10.1002/jbm.b.31690; American Association of Textile Chemists and Colorists, 2010, AATCC TECHN MAN, V76, P142; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; BOMAN A, 1983, CONTACT DERMATITIS, V9, P159, DOI 10.1111/j.1600-0536.1983.tb04337.x; Du WL, 2009, CARBOHYD POLYM, V75, P385, DOI 10.1016/j.carbpol.2008.07.039; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fernandes JC, 2010, J MICROBIOL BIOTECHN, V20, P311, DOI 10.4014/jmb.0904.04038; Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10; Grethe T, 2015, J COAT TECHNOL RES, V12, P1133, DOI 10.1007/s11998-015-9709-9; Hofer Dirk, 2006, Curr Probl Dermatol, V33, P42; KOCH AL, 1970, ANAL BIOCHEM, V38, P252, DOI 10.1016/0003-2697(70)90174-0; Lansdown Alan B G, 2006, Curr Probl Dermatol, V33, P17; Li Z, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/14/145702; Mahltig B, 2013, MAT SCI ENG C-MATER, V33, P979, DOI 10.1016/j.msec.2012.11.033; Mahltig B, 2015, J FASHION TEXTILE EN, P1; Mahltig B, 2016, HDB SOL GEL SCI TECH, P1; Mahltig B, 2017, J COAT TECHNOL RES, V14, P35, DOI 10.1007/s11998-016-9854-9; Mahltig B, 2012, J TEXT I, V103, P1262, DOI 10.1080/00405000.2012.665245; Mahltig B, 2011, Z NATURFORSCH B, V66, P905, DOI 10.5560/ZNB.2011.66b0905; Martin A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065006; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Hanlon SJ, 2009, INT J ANTIMICROB AG, V33, P427, DOI 10.1016/j.ijantimicag.2008.10.020; Ringot C, 2011, BIOMACROMOLECULES, V12, P1716, DOI 10.1021/bm200082d; Rutala WA, 2004, INFECT CONT HOSP EP, V25, P333, DOI 10.1086/502401; Shrestha R, 2010, NEPAL J SCI TECHNOL, V10, P189; Topp K, 2014, J COAT TECHNOL RES, V11, P943, DOI 10.1007/s11998-014-9605-8; Vilcnik A, 2009, LANGMUIR, V25, P5869, DOI 10.1021/la803742c; Wahab R, 2016, RSC ADV, V6, P32328, DOI 10.1039/c6ra05297e; Wahab R, 2014, COLLOID SURFACE B, V117, P267, DOI 10.1016/j.colsurfb.2014.02.038; Wahab R, 2013, COLLOID SURFACE B, V111, P211, DOI 10.1016/j.colsurfb.2013.06.003; Windler L, 2013, ENVIRON INT, V53, P62, DOI 10.1016/j.envint.2012.12.010	31	32	32	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188304	10.1371/journal.pone.0188304	http://dx.doi.org/10.1371/journal.pone.0188304			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161306	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000042
J	Feito, Y; Hornbuckle, LM; Reid, LA; Crouter, SE				Feito, Yuri; Hornbuckle, Lyndsey M.; Reid, Lauren A.; Crouter, Scott E.			Effect of ActiGraph's low frequency extension for estimating steps and physical activity intensity	PLOS ONE			English	Article							FREE-LIVING ENVIRONMENTS; AFRICAN-AMERICAN WOMEN; ACTIVITY MONITORS; UNITED-STATES; PEDOMETER; ACCELEROMETER; ACCURACY; VALIDITY; WALKING; FILTER	This study examined the effects of the ActiGraph's (AG) low-frequency extension (LFE) filter on steps and physical activity classification in the free-living environment. Thirty-four African-American women (age, 24.5 +/- 5.2 years; BMI, 24.9 +/- 4.5 kg/m(2)) had daily activity measured simultaneously with an AG-GT3X(+) accelerometer and a New Lifestyles NL-800 pedometer for seven days. Steps per day (steps/day) and time (minutes/day) spent in sedentary, light, and moderate-to-vigorous physical activity (MVPA) were examined with and without the LFE filter (AG-LFE and AG-N, respectively). The AG-LFE recorded more total steps (13,723 +/- 4,983 steps/day) compared to AG-N and NL-800 (6,172 +/- 2,838 and 5,817 +/- 3,037 steps/day, respectively; p<0.001). Compared to the AG-N, the AG-LFE estimated less time in sedentary behaviors (518.7 +/- 92.1 vs. 504.2 +/- 105.4 min/day, respectively; p<0.001), and more time in light (247.7 +/- 70.4 vs. 279.1 +/- 74.7 min/day, respectively; p<0.001) and MVPA (18.9 +/- 16.9 vs. 21.5 +/- 18.2 min/day, respectively; p<0.001), respectively. These data suggest that steps and physical activity classifications will be affected when using the ActiGraph with and without the LFE filter. Future research should investigate the accuracy of these measures using the LFE filter.	[Feito, Yuri] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Hornbuckle, Lyndsey M.; Crouter, Scott E.] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Reid, Lauren A.] Univ South Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	University System of Georgia; Kennesaw State University; University of Tennessee System; University of Tennessee Knoxville; University of South Carolina System; University of South Carolina Columbia	Feito, Y (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	yfeito@kennesaw.edu	Crouter, Scott/H-4852-2011; Feito, Yuri/D-8255-2013	Crouter, Scott/0000-0003-1297-9538; Feito, Yuri/0000-0001-6790-6294; Reid, Lauren/0000-0003-1021-8364	Kennesaw State University Office of the Vice President for Research	Kennesaw State University Office of the Vice President for Research	The Kennesaw State University Office of the Vice President for Research funded this project; however, neither the Vice President of research, nor his staff had any role in the data collection or the preparation of this manuscript.	ActiGraph, LOW FREQ EXT EXPL 20; Barreira TV, 2013, J AGING PHYS ACTIV, V21, P402, DOI 10.1123/japa.21.4.402; Bassett DR, 2010, PHYS THER REV, V15, P135, DOI 10.1179/1743288X10Y.0000000004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cain KL, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-51; Crouter SE, 2005, MED SCI SPORT EXER, V37, P1673, DOI 10.1249/01.mss.0000181677.36658.a8; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Feito Y, 2015, MED SCI SPORT EXER, V47, P211, DOI 10.1249/MSS.0000000000000395; Feito Y, 2012, MED SCI SPORT EXER, V44, P733, DOI 10.1249/MSS.0b013e3182351913; Hornbuckle LM, 2005, MED SCI SPORT EXER, V37, P1069, DOI 10.1249/01.mss.0000166575.35311.07; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Newton RL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-44; Ried-Larsen M, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-113; Rothney MP, 2008, J APPL PHYSIOL, V105, P1091, DOI 10.1152/japplphysiol.90641.2008; Santos-Lozano A, 2012, MED ENG PHYS, V34, P787, DOI 10.1016/j.medengphy.2012.02.005; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Swartz AM, 2003, INT J SPORTS MED, V24, P588, DOI 10.1055/s-2003-43272; Toth LP, 2017, GAIT POSTURE, V52, P165, DOI 10.1016/j.gaitpost.2016.11.035; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Wallen MB, 2014, PHYSIOL MEAS, V35, P2287, DOI 10.1088/0967-3334/35/11/2287; Webber SC, 2016, J AGING PHYS ACTIV, V24, P451, DOI 10.1123/japa.2015-0234; Whitt M, 2003, MED SCI SPORT EXER, V35, P1887, DOI 10.1249/01.MSS.0000093618.60631.C3; Whitt-Glover MC, 2017, ETHNIC DIS, V27, P257, DOI 10.18865/ed.27.3.257	27	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188242	10.1371/journal.pone.0188242	http://dx.doi.org/10.1371/journal.pone.0188242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155845	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700037
J	Morenga, LT; Montez, JM				Morenga, Lisa Te; Montez, Jason M.			Health effects of saturated and trans-fatty acid intake in children and adolescents: Systematic review and meta-analysis	PLOS ONE			English	Review							FACTOR INTERVENTION PROJECT; CORONARY-HEART-DISEASE; LIPOPROTEIN CHOLESTEROL LEVELS; IMPROVES INSULIN SENSITIVITY; PROSPECTIVE RANDOMIZED-TRIAL; CARDIOVASCULAR RISK-FACTORS; ELEVATED LDL-CHOLESTEROL; DIETARY INTERVENTION; BLOOD-PRESSURE; SERUM-CHOLESTEROL	Background Elevated cholesterol has been linked to cardiovascular disease in adults and preclinical markers of atherosclerosis in children, thus reducing saturated (SFA) and trans-fatty acids (TFA) intake from an early age may help to reduce cholesterol and the risk of cardiovascular disease later in life. The aim of this review is to examine the evidence for health effects associated with reducing SFA and TFA intake in free-living children, adolescents and young adults between 2 to 19 years of age. Design Systematic review and meta-analysis of randomised controlled trials (RCTs) and prospective cohort studies. Study selection, assessment, validity, data extraction, and analysis were undertaken as specified by the Cochrane Collaboration and the GRADE working group. Data were pooled using inverse variance models with random effects. Data sources EMBASE; PubMed; Cochrane Central Register of Controlled Trials; LILACS; and WHO Clinical Trial Registry (up to July 2016). Eligibility criteria for selecting trials RCTs involving dietary interventions aiming to reduce SFA or TFA intakes and a control group, and cohort studies reporting the effects of SFA or TFA exposures, on outcomes including blood lipids; measures of growth; blood pressure; insulin resistance; and potential adverse effects. Minimum duration was 13 days for RCTs and one year for cohort studies. Trials of weight loss or confounded by additional medical or lifestyle interventions were excluded. Results Compared with control diets, there was a highly statistically significant effect of reduced SFA intake on total cholesterol (mean difference (MD) -0.16 mmol/l, [95% confidence interval (CI): -0.25 to -0.07]), LDL cholesterol (MD -0.13 mmol/l [95% CI:-0.22 to -0.03]) and diastolic blood pressure (MD -1.45 mmol/l [95% CI:-2.34 to -0.56]). There were no significant effects on any other risk factors and no evidence of adverse effects. Conclusions Advice to reduce saturated fatty acids intake of children results in a significant reduction in total and LDL-cholesterol levels as well as diastolic blood pressure without evidence of adverse effects on growth and development. Dietary guidelines for children and adolescents should continue to recommend diets low in saturated fat.	[Morenga, Lisa Te] Univ Otago, Dept Human Nutr, Edgar Diabet & Res Ctr, Dunedin, New Zealand; [Morenga, Lisa Te] Univ Otago, Riddet Inst, Dunedin, New Zealand; [Montez, Jason M.] WHO, Dept Nutr Hlth & Dev, Geneva, Switzerland	University of Otago; University of Otago; World Health Organization	Morenga, LT (corresponding author), Univ Otago, Dept Human Nutr, Edgar Diabet & Res Ctr, Dunedin, New Zealand.; Morenga, LT (corresponding author), Univ Otago, Riddet Inst, Dunedin, New Zealand.	lisa.temorenga@otago.ac.nz	Te Morenga, Lisa/C-4459-2011	Te Morenga, Lisa/0000-0003-3526-0091	University of Otago	University of Otago	The University of Otago provided support in the form of salary for author LTM, and the World Health Organization provided support in the form of salary for author JM. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, JAMA, V273, P1429; [Anonymous], 2003, DIET NUTR PREV CHRON; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Beinortas T, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2108; Bendsen NT, 2011, EUR J CLIN NUTR, V65, P773, DOI 10.1038/ejcn.2011.34; BERENSON GS, 1992, AM J CARDIOL, V70, P851, DOI 10.1016/0002-9149(92)90726-F; Bloom DE., 2012, GLOBAL EC BURDEN NON; Bonet Serra B., 2008, REV ESP PEDIAT, V64, P94; Brouwer I., 2016, EFFECT TRANSFATTY AC; Brouwer IA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009434; Cowin IS, 2001, EUR J CLIN NUTR, V55, P39, DOI 10.1038/sj.ejcn.1601120; Denke MA, 2000, JAMA-J AM MED ASSOC, V284, P2740, DOI 10.1001/jama.284.21.2740; Dorgan JF, 2003, J NATL CANCER I, V95, P132, DOI 10.1093/jnci/95.2.132; Dorgan JF, 2006, J CLIN ENDOCR METAB, V91, P3992, DOI 10.1210/jc.2006-0109; Estevez-Gonzalez MD, 1998, J PEDIATR-US, V132, P85, DOI 10.1016/S0022-3476(98)70490-1; Farvid MS, 2014, CIRCULATION, V130, P1568, DOI 10.1161/CIRCULATIONAHA.114.010236; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hendrie GA, 2011, AM J CLIN NUTR, V93, P1117, DOI 10.3945/ajcn.110.010694; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hooper L, 2015, REDUCTION SATURATED; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Kaitosaari T, 2006, DIABETES CARE, V29, P781, DOI 10.2337/diacare.29.04.06.dc05-1523; KAPLAN RM, 1992, PREV MED, V21, P33, DOI 10.1016/0091-7435(92)90004-2; LAPINLEIMU H, 1995, LANCET, V345, P471, DOI 10.1016/S0140-6736(95)90580-4; Lauer RM, 2000, AM J CLIN NUTR, V72, p1332S, DOI 10.1093/ajcn/72.5.1332s; Lavigne JV, 1999, HEALTH PSYCHOL, V18, P604, DOI 10.1037/0278-6133.18.6.604; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; LIFSHITZ F, 1989, AM J DIS CHILD, V143, P537, DOI 10.1001/archpedi.1989.02150170035015; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Magarey AM, 2001, EUR J CLIN NUTR, V55, P471, DOI 10.1038/sj.ejcn.1601207; MAUER AM, 1991, ANNU REV NUTR, V11, P375, DOI 10.1146/annurev.nu.11.070191.002111; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mensink RP, 2016, EFFECTS SATURATED FA, P1; MORRISON JA, 1980, METABOLISM, V29, P133, DOI 10.1016/0026-0495(80)90137-7; Moya M., 2008, REV ESPANOLA PEDIAT, V64, P89; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NICKLAS TA, 1988, ARTERIOSCLEROSIS, V8, P193, DOI 10.1161/01.ATV.8.2.193; Niinikoski H, 1997, AM J CLIN NUTR, V66, P569, DOI 10.1093/ajcn/66.3.569; Niinikoski H, 2012, PEDIATRICS, V129, pE704, DOI 10.1542/peds.2011-1503; Niinikoski H, 2009, HYPERTENSION, V53, P918, DOI 10.1161/HYPERTENSIONAHA.109.130146; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nupponen M, 2015, CIRCULATION, V131, P605, DOI 10.1161/CIRCULATIONAHA.114.010532; Oranta O, 2013, DIABETES CARE, V36, P2952, DOI 10.2337/dc13-0361; Racine NM, 2010, AM J CLIN NUTR, V91, P1157, DOI 10.3945/ajcn.2009.28404; RAMSDEN CE, 2013, BMJ-BRIT MED J, V346, pe8707, DOI DOI 10.1136/BMJ.E8707; Ramsden CE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1246; Rask-Nissila L, 2000, JAMA-J AM MED ASSOC, V284, P993, DOI 10.1001/jama.284.8.993; SHANNON BM, 1994, PEDIATRICS, V94, P923; Simell O, 2000, AM J CLIN NUTR, V72, p1316S, DOI 10.1093/ajcn/72.5.1316s; SimonsMorton DG, 1997, HYPERTENSION, V29, P930, DOI 10.1161/01.HYP.29.4.930; Srinivasan SR, 2006, PEDIATRICS, V118, P201, DOI 10.1542/peds.2005-1856; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; Tarmi-Mattsson M, 1997, INT J BEHAV MED, V4, P310, DOI 10.1207/s15327558ijbm0404_4; Tershakovec AM, 1998, J PEDIATR-US, V133, P28, DOI 10.1016/S0022-3476(98)70173-8; Tershakovec AM, 1998, AM J PUBLIC HEALTH, V88, P258, DOI 10.2105/AJPH.88.2.258; The Cochrane Collaboration, 2011, REV MAN REVMAN VERS; Wang DD, 2017, ANNU REV NUTR, V37, P423, DOI [10.1146/annurev-nutr-071816- 064614, 10.1146/annurev-nutr-071816-064614]; Williams CL, 2004, J AM COLL NUTR, V23, P117, DOI 10.1080/07315724.2004.10719351; Williams CL, 2002, J AM COLL NUTR, V21, P62, DOI 10.1080/07315724.2002.10719195; WILSON DKW, 1992, J AM DIET ASSOC, V92, P192; World Health Organization, 2014, WHO HDB GUID DEV, V2nd; Zhu Wen-li, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P794; ZWIAUER K, 1987, KLIN PADIATR, V199, P392, DOI 10.1055/s-2008-1026829; Zwiauer K, 1988, Prog Clin Biol Res, V255, P231	64	58	59	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0186672	10.1371/journal.pone.0186672	http://dx.doi.org/10.1371/journal.pone.0186672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149184	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100004
J	Calvez, ML; Benz, N; Huguet, F; Saint-Pierre, A; Rouille, E; Coraux, C; Ferec, C; Kerbiriou, M; Trouve, P				Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Coraux, Christelle; Ferec, Claude; Kerbiriou, Mathieu; Trouve, Pascal			Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GONADOTROPIN-RELEASING-HORMONE; IN-VITRO; MITOCHONDRIAL-FUNCTION; RECEPTOR EXPRESSION; DELTA-F508 MUTATION; CFTR; CHANNEL; RESCUE; CHAPERONES	Cystic fibrosis (CF) is the most common autosomal recessive disease in Caucasians caused by mutations in the gene encoding the Cystic Fibrosis Transmembrane conductance Regulator (CFTR) chloride (Cl-) channel regulated by protein kinases, phosphatases, divalent cations and by protein-protein interactions. Among protein-protein interactions, we previously showed that Annexin A5 (AnxA5) binds to CFTR and is involved in the channel localization within membranes and in its Cl-channel function. The deletion of phenylalanine at position 508 (F508del) is the most common mutation in CF which leads to an altered protein (F508del-CFTR) folding with a nascent protein retained within the ER and is quickly degraded. We previously showed that AnxA5 binds to F508del-CFTR and that its increased expression due to a Gonadoliberin (GnRH) augments Cl-efflux in cells expressing F508del/CFTR. The aim of the present work was to use the GnRH analog buserelin which is already used in medicine. Human nasal epithelial cells from controls and CF patients (F508del/F508del) were treated with buserelin and we show here that the treatment alleviates Clchannel defects in CF cells. Using proteomics we highlighted some proteins explaining this result. Finally, we propose that buserelin is a potential new pharmaceutical compound that can be used in CF and that bronchus can be targeted since we show here that they express GnRH-R.	[Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Ferec, Claude; Kerbiriou, Mathieu; Trouve, Pascal] Univ Brest, INSERM, IBSAM, EFS,Genet Genom Fonct & Biotechnol UMR1078, Brest, France; [Calvez, Marie-Laure; Huguet, Florentin; Saint-Pierre, Aude; Rouille, Elise; Ferec, Claude; Kerbiriou, Mathieu] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Calvez, Marie-Laure; Benz, Nathalie; Huguet, Florentin] Assoc G Saleun, Brest, France; [Coraux, Christelle] CHU Maison Blanche, Inserm UMRS903, Reims, France; [Ferec, Claude] CHRU Brest, Hop Morvan, Lab Genet Mol, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU de Reims; CHU Brest; Universite de Bretagne Occidentale	Trouve, P (corresponding author), Univ Brest, INSERM, IBSAM, EFS,Genet Genom Fonct & Biotechnol UMR1078, Brest, France.	pascal.trouve@univ-brest.fr	Ferec, Claude/ABG-9699-2020; CORAUX, Christelle/P-5668-2016	Ferec, Claude/0000-0002-2325-0710; CORAUX, Christelle/0000-0001-5345-5074; Huguet, Florentin/0000-0001-5377-8973	association Gaetan Salaun	association Gaetan Salaun	We thank the association Gaetan Salaun for its financial support.	Adam D, 2015, J PATHOL, V235, P408, DOI 10.1002/path.4471; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Atlante A, 2016, J BIOENERG BIOMEMBR, V48, P197, DOI 10.1007/s10863-016-9663-y; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Becq F, 1999, J BIOL CHEM, V274, P27415, DOI 10.1074/jbc.274.39.27415; Benz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088964; Bernacki SH, 1999, AM J RESP CELL MOL, V20, P595, DOI 10.1165/ajrcmb.20.4.3442; Bozoky Z, 2017, P NATL ACAD SCI USA, V114, pE2086, DOI 10.1073/pnas.1613546114; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Carlile GW, 2012, CHEM BIOL, V19, P1288, DOI 10.1016/j.chembiol.2012.08.014; Cholon DM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008680; Ciscato F, 2014, ONCOTARGET, V5, P2418, DOI 10.18632/oncotarget.1411; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Farre C, 2007, EXPERT OPIN THER TAR, V11, P557, DOI 10.1517/14728222.11.4.557; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; Valdivieso AG, 2013, REDOX BIOL, V1, P190, DOI 10.1016/j.redox.2012.11.007; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huguet F, 2016, CELL MOL LIFE SCI, V73, P3351, DOI 10.1007/s00018-016-2149-6; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Illek B, 2008, CELL PHYSIOL BIOCHEM, V22, P57, DOI 10.1159/000149783; Jeanson L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108671; Kakar SS, 1995, CANCER LETT, V98, P57, DOI 10.1016/0304-3835(95)90203-1; KERTSCHER U, 1995, J PHARMACOL EXP THER, V273, P709; Khadivi B, 2017, ACTA CIR BRAS, V32, P140, DOI 10.1590/s0102-865020170206; Koushik K, 2004, PHARM RES-DORDR, V21, P1034, DOI 10.1023/B:PHAM.0000029294.70707.74; Le Drevo MA, 2008, BBA-MOL BASIS DIS, V1782, P605, DOI 10.1016/j.bbadis.2008.08.002; LEMAY A, 1982, FERTIL STERIL, V37, P193; LEMAY A, 1988, AM J OBSTET GYNECOL, V158, P233, DOI 10.1016/0002-9378(88)90128-7; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; Miki H, 2010, J BIOL CHEM, V285, P19967, DOI 10.1074/jbc.M109.092684; Naghdi S, 2016, BBA-MOL CELL RES, V1863, P2503, DOI 10.1016/j.bbamcr.2016.04.020; Nederpelt I, 2016, BIOSENS BIOELECTRON, V79, P721, DOI 10.1016/j.bios.2015.12.066; Nederpelt I., 2015, BRIT J PHARMACOL, V173, P128; Nederpelt I, 2016, BRIT J PHARMACOL, V173, P128, DOI 10.1111/bph.13342; Norez C, 2006, FEBS LETT, V580, P2081, DOI 10.1016/j.febslet.2006.03.010; Ohlsson B., 2016, EUR SURG RES, V57, P1; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Perrett Rebecca M, 2013, Front Endocrinol (Lausanne), V4, P180, DOI 10.3389/fendo.2013.00180; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Sun Y, 2017, SEMIN CELL DEV BIOL, V62, P170, DOI 10.1016/j.semcdb.2016.09.005; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; Tieva A, 2001, PROSTATE, V47, P276; Trouve P, 2007, BBA-MOL BASIS DIS, V1772, P1121, DOI 10.1016/j.bbadis.2007.06.006; Valdivieso AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048059; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Y, 2007, J BIOL CHEM, V282, P33247, DOI 10.1074/jbc.C700175200; Wang Y, 2006, MOL PHARMACOL, V70, P297, DOI 10.1124/mol.106.023994; Wei QQ, 2013, GEN COMP ENDOCR, V189, P15, DOI 10.1016/j.ygcen.2013.04.019; WELSH MJ, 1993, J CELL SCI, P235; Zegarra-Moran O, 2016, CELL MOL LIFE SCI; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	66	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187774	10.1371/journal.pone.0187774	http://dx.doi.org/10.1371/journal.pone.0187774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145426	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800029
J	Chang, CK; Chen, CJ; Wu, CC; Chen, SW; Shih, SR; Kuo, RL				Chang, Cheng-Kai; Chen, Chi-Jene; Wu, Chih-Ching; Chen, Shiau-Wen; Shih, Shin-Ru; Kuo, Rei-Lin			Cellular hnRNP A2/B1 interacts with the NP of influenza A virus and impacts viral replication	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; NUCLEOPROTEIN; TRAFFICKING; LOCALIZATION; CARCINOMA; SEQUENCE; MODEL; NS1	The viral ribonucleoprotein (vRNP) of influenza A virus is formed by virion RNA (vRNA), viral polymerase complex, and nucleoprotein (NP). The NP plays an important role in facilitating the replication and stabilization of viral RNA. To explore host factors that may be involved in the regulation of viral replication through interactions with NP, we conducted an immunoprecipitation experiment followed by mass spectrometry to identify NP-associated cellular proteins. Here, we demonstrate that NP can interact and colocalize with heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 in mammalian cells and that the interaction may occur via direct binding to the glycine-rich domain (GRD) of hnRNP A2/B1. In addition, two residues in the tail loop of NP, F412 and R422, are required for the interaction of hnRNP A2/B1. Because the knockdown of hnRNP A2/B1 expression reduces viral RNP activity, hnRNP A2/B1 may act as a positive regulator in viral RNA synthesis of influenza A virus. More importantly, the findings in this research demonstrate that host proteins can regulate the replication of influenza A virus by interacting with NP.	[Chang, Cheng-Kai; Wu, Chih-Ching; Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Chen, Chi-Jene; Chen, Shiau-Wen] China Med Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan; [Chen, Chi-Jene] China Med Univ Hosp, Res Ctr Emerging Viruses, Taichung, Taiwan; [Wu, Chih-Ching; Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Wu, Chih-Ching] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan; [Shih, Shin-Ru; Kuo, Rei-Lin] Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan; [Shih, Shin-Ru] Chang Gung Mem Hosp, Clin Virol Lab, Taoyuan, Taiwan; [Kuo, Rei-Lin] Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan	Chang Gung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan.; Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan.; Shih, SR; Kuo, RL (corresponding author), Chang Gung Univ, Coll Med, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan.; Shih, SR (corresponding author), Chang Gung Mem Hosp, Clin Virol Lab, Taoyuan, Taiwan.; Kuo, RL (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Taoyuan, Taiwan.	srshih@mail.cgu.edu.tw; rlkuo@mail.cgu.edu.tw	Shih, Shin-Ru/M-9711-2016	Shih, Shin-Ru/0000-0003-4874-401X; Wu, Chih-Ching/0000-0002-7264-9672	Chang Gung Memorial Hospital [CMRPD1D0041similar to43, BMRP367, CMRPD1E0441similar to43, BMRPC09]; Chang Gung Memorial Hospital (CGMH) [CMRPD1D0041similar to43, BMRP367]; CGMH [CMRPD1E0441similar to43, BMRPC09]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Chang Gung Memorial Hospital (CGMH)(Chang Gung Memorial Hospital); CGMH(Chang Gung Memorial Hospital)	This research was supported by grants from Chang Gung Memorial Hospital (https://www.cgmh.org.tw): to SRS (grant numbers: CMRPD1D0041 similar to 43 and BMRP367), and to RLK (grant numbers: CMRPD1E0441 similar to 43 and BMRPC09). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Yizhi Jane Tao and Dr. Ching-Ho Wang for reagents. This research was supported by grants to S.-R. Shih from Chang Gung Memorial Hospital (CGMH) (CMRPD1D0041 similar to 43 and BMRP367), and grants to R.-L. Kuo from the CGMH (CMRPD1E0441 similar to 43 and BMRPC09).	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BURD CG, 1989, P NATL ACAD SCI USA, V86, P9788, DOI 10.1073/pnas.86.24.9788; Chan WH, 2010, J VIROL, V84, P7337, DOI 10.1128/JVI.02474-09; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Han QL, 2014, J VIROL, V88, P9379, DOI 10.1128/JVI.00509-14; He YW, 2009, CELL MOL LIFE SCI, V66, P1239, DOI 10.1007/s00018-008-8532-1; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kuo RL, 2016, J VIROL, V90, P4696, DOI 10.1128/JVI.02843-15; Lei KF, 2015, ANAL CHIM ACTA, V883, P37, DOI 10.1016/j.aca.2015.02.071; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Marklund JK, 2012, J VIROL, V86, P7292, DOI 10.1128/JVI.00014-12; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Minakuchi M, 2017, J VIROL, V91, DOI 10.1128/JVI.01398-16; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Newcomb LL, 2009, J VIROL, V83, P29, DOI 10.1128/JVI.02293-07; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wang YM, 2014, VIROLOGY, V449, P53, DOI 10.1016/j.virol.2013.11.009; Wu CC, 2005, PROTEOMICS, V5, P3173, DOI 10.1002/pmic.200401133; Wu CC, 2008, PROTEOM CLIN APPL, V2, P1586, DOI 10.1002/prca.200800080; Ye QZ, 2013, MBIO, V4, DOI 10.1128/mBio.00467-12; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhang JS, 2016, J VIROL, V90, P3966, DOI 10.1128/JVI.03137-15	31	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188214	10.1371/journal.pone.0188214	http://dx.doi.org/10.1371/journal.pone.0188214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145464	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800090
J	Shuping, LL; Kuonza, L; Musekiwa, A; Iyaloo, S; Perovic, O				Shuping, Liliwe L.; Kuonza, Lazarus; Musekiwa, Alfred; Iyaloo, Samantha; Perovic, Olga			Hospital-associated methicillin-resistant Staphylococcus aureus: A cross-sectional analysis of risk factors in South African tertiary public hospitals	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; ACTIVE SURVEILLANCE; CLINICAL-OUTCOMES; MRSA INFECTION; BURNS UNIT; BACTEREMIA; COLONIZATION; EPIDEMIOLOGY; PREVALENCE	Introduction Hospital-associated methicillin-resistant S. aureus (HA-MRSA) remains a significant cause of morbidity and mortality worldwide. We conducted a study to determine risk factors for HA-MRSA in order to inform control strategies in South Africa. Methods We used surveillance data collected from five tertiary hospitals in Gauteng and Western Cape provinces during 2014 for analysis. A case of HA-MRSA was defined as isolation of MRSA from a blood culture 48 hours after admission and/or if the patient was hospitalised in the six months prior to the current culture. Multivariable logistic regression modelling was used to determine risk factors for HA-MRSA. Results Of the 9971 patients with positive blood cultures, 7.7% (772) had S. aureus bacteraemia (SAB). The overall prevalence of MRSA among those with SAB was 30.9% (231/747; 95% confidence interval [CI] 27.6%-34.3%). HA-MRSA infections accounted for 28.3% of patients with SAB (207/731; 95% CI 25.1%-31.7%). Burns (adjusted odds ratio [aOR] 12.7; 95% CI 4.7-34.4), age <= 1 month (aOR 8.7; 95% CI 3.0-24.6), residency at a long-term care facility (aOR 5.2; 95% CI, 1.5-17.4), antibiotic use within two months of the current SAB episode (aOR 5.1; 95% CI 2.8-9.1), hospital stay of 13 days or more (aOR 2.8; 95% CI 1.3-5.6) and mechanical ventilation (aOR 2.2; 95% CI 1.07-4.6), were independent risk factors for HA-MRSA infection. Conclusion The prevalence of MRSA remains high in South African tertiary public hospitals. Several identified risk factors of HA-MRSA infections should be considered when instituting infection and prevention strategies in public-sector hospitals, including intensifying the implementation of antimicrobial stewardship programmes. There is an urgent need to strengthen infection prevention and control in burn wards, neonatal wards, and intensive care units which house mechanically ventilated patients.	[Shuping, Liliwe L.; Kuonza, Lazarus] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Shuping, Liliwe L.; Kuonza, Lazarus] Natl Inst Communicable Dis, Natl Hlth Lab Serv, South African Field Epidemiol Training Programme, Johannesburg, South Africa; [Shuping, Liliwe L.; Perovic, Olga] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Res, Johannesburg, South Africa; [Musekiwa, Alfred] Ctr Dis Control & Prevent, Pretoria, South Africa; [Iyaloo, Samantha] Natl Hlth Lab Serv, Natl Inst Occupat Hlth, Johannesburg, South Africa; [Perovic, Olga] Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; University of Witwatersrand	Perovic, O (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Healthcare Associated Infect Antimicrobial Res, Johannesburg, South Africa.; Perovic, O (corresponding author), Univ Witwatersrand, Dept Clin Microbiol & Infect Dis, Johannesburg, South Africa.	olgap@nicd.ac.za	Perovic, Olga/AAN-8276-2021	Musekiwa, Alfred/0000-0001-5880-3680; Iyaloo, Samantha/0000-0003-3332-9235; Shuping, Liliwe/0000-0002-1428-779X; Kuonza, Lazarus/0000-0001-5338-320X				Abbasi-Montazeri E, 2013, BURNS, V39, P650, DOI 10.1016/j.burns.2013.02.005; Antonanzas F, 2015, PHARMACOECONOMICS, V33, P285, DOI 10.1007/s40273-014-0242-y; Bahemia IA, 2015, BURNS, V41, P1536, DOI 10.1016/j.burns.2015.05.007; Barbut F, 2013, BURNS, V39, P395, DOI 10.1016/j.burns.2012.07.007; Bhat V. G., 2010, Southern African Journal of Epidemiology & Infection, V25, P16; Boyles TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079747; Brink AJ, 2016, LANCET INFECT DIS, P30012; Campbell RS, 2015, SURG INFECT, V16, P543, DOI 10.1089/sur.2013.250; Carnicer-Pont D, 2006, EPIDEMIOL INFECT, V134, P1167, DOI 10.1017/S0950268806006327; Catry B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089579; Cheng VCC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-205; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Falagas ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068024; Fortuin-de Smidt MC, 2015, INT J INFECT DIS, V30, P41, DOI 10.1016/j.ijid.2014.10.011; Graffunder EM, 2002, J ANTIMICROB CHEMOTH, V49, P999, DOI 10.1093/jac/dkf009; Hu BJ, 2013, AM J INFECT CONTROL, V41, P301, DOI 10.1016/j.ajic.2012.03.037; Issler-Fisher AC, 2015, BURNS, V41, P1212, DOI 10.1016/j.burns.2015.03.003; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaiser ML, 2011, J BURN CARE RES, V32, P429, DOI 10.1097/BCR.0b013e318217f92d; Kallen AJ, 2010, JAMA-J AM MED ASSOC, V304, P641, DOI 10.1001/jama.2010.1115; Lawes T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000797; Luzzaro F, 2011, DIAGN MICR INFEC DIS, V69, P363, DOI 10.1016/j.diagmicrobio.2010.10.016; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Mendelson M, 2015, MONITORING SURVEILLA, P54; Morrill HJ, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2015.11.013; Naidoo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078396; Nelson MU, 2012, SEMIN PERINATOL, V36, P424, DOI 10.1053/j.semperi.2012.06.004; Oztoprak N, 2006, AM J INFECT CONTROL, V34, P1, DOI 10.1016/j.ajic.2005.07.005; Perovic O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145429; Popoola VO, 2014, INFECT CONT HOSP EP, V35, P412, DOI 10.1086/675594; Safdar N, 2006, AM J INFECT CONTROL, V34, P476, DOI 10.1016/j.ajic.2006.01.011; Stefani S, 2012, INT J ANTIMICROB AG, V39, P273, DOI 10.1016/j.ijantimicag.2011.09.030; Swe Swe-Han K, 2010, INT J INFECT CONTROL, V6, P2; Tekin R, 2013, PEDIATR NEONATOL, V54, P303, DOI 10.1016/j.pedneo.2013.03.011; Thampi N, 2015, AM J INFECT CONTROL, V43, P739, DOI 10.1016/j.ajic.2015.01.031; Traa MX, 2014, CRIT CARE MED, V42, P2151, DOI 10.1097/CCM.0000000000000501; Wayne P.A., 2014, M100S24 CLSI; Whitby M, 2001, MED J AUSTRALIA, V175, P264, DOI 10.5694/j.1326-5377.2001.tb143562.x; WHO, 2011, WHO LIB CAT PUBL DAT; Zigmond J, 2014, INT J INFECT DIS, V21, P391, DOI 10.1016/j.ijid.2014.03.1227	41	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188216	10.1371/journal.pone.0188216	http://dx.doi.org/10.1371/journal.pone.0188216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145465	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800091
J	Bozler, J; Kacsoh, BZ; Bosco, G				Bozler, Julianna; Kacsoh, Balint Z.; Bosco, Giovanni			Nematocytes: Discovery and characterization of a novel anculeate hemocyte in Drosophila falleni and Drosophila phalerata	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; INNATE IMMUNITY; HEMATOPOIESIS; EVOLUTION; SYSTEM; CELLS	Immune challenges, such as parasitism, can be so pervasive and deleterious that they constitute an existential threat to a species' survival. In response to these ecological pressures, organisms have developed a wide array of novel behavioral, cellular, and molecular adaptations. Research into these immune defenses in model systems has resulted in a revolutionary understanding of evolution and functional biology. As the field has expanded beyond the limited number of model organisms our appreciation of evolutionary innovation and unique biology has widened as well. With this in mind, we have surveyed the hemolymph of several nonmodel species of Drosophila. Here we identify and describe a novel hemocyte, type-II nematocytes, found in larval stages of numerous Drosophila species. Examined in detail in Drosophila falleni and Drosophila phalerata, we find that these remarkable cells are distinct from previously described hemocytes due to their anucleate state (lacking a nucleus) and unusual morphology. Type-II nematocytes are long, narrow cells with spindle-like projections extending from a cell body with high densities of mitochondria and microtubules, and exhibit the ability to synthesize proteins. These properties are unexpected for enucleated cells, and together with our additional characterization, we demonstrate that these type-II nematocytes represent a biological novelty. Surprisingly, despite the absence of a nucleus, we observe through live cell imaging that these cells remain motile with a highly dynamic cellular shape. Furthermore, these cells demonstrate the ability to form multicellular structures, which we suggest may be a component of the innate immune response to macro-parasites. In addition, live cell imaging points to a large nucleated hemocyte, type-I nematocyte, as the progenitor cell, leading to enucleation through a budding or asymmetrical division process rather than nuclear ejection: This study is the first to report such a process of enucleation. Here we describe these cells in detail for the first time and examine their evolutionary history in Drosophila.	[Bozler, Julianna; Kacsoh, Balint Z.; Bosco, Giovanni] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA	Dartmouth College	Bozler, J (corresponding author), Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA.	Julianna.E.Bozler.GR@Dartmouth.edu	Kacsoh, Balint/AAF-2165-2019	Kacsoh, Balint/0000-0001-9171-0611; Bozler, Julianna/0000-0002-6275-3409	National Institutes of Health [1DP1MH110234]; Dartmouth College; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH110234] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dartmouth College; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the National Institutes of Health, Pioneer grant: 1DP1MH110234, (GB) and the Dartmouth College Alumni Research Award (JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; BERNSTEIN C, 1987, OIKOS, V49, P236, DOI 10.2307/3566033; COHEN WD, 1982, PROTOPLASMA, V113, P23, DOI 10.1007/BF01283036; de Back DZ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00009; Dzierzak E, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011601; EDMONDSON PW, 1963, BRIT J EXP PATHOL, V44, P72; Hebiguchi M, 2008, INT J HEMATOL, V88, P498, DOI 10.1007/s12185-008-0200-6; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Janssen A, 1987, J NETH ZOOL, V38, P61; Kacsoh BZ, 2014, PARASITOLOGY, V141, P697, DOI 10.1017/S0031182013001431; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lu J, 2010, PEPTIDES, V31, P44, DOI 10.1016/j.peptides.2009.09.028; Markus R, 2015, J INNATE IMMUN, V7, P340, DOI 10.1159/000369618; Migliaccio AR, 2010, HAEMATOL-HEMATOL J, V95, P1985, DOI 10.3324/haematol.2010.033225; Mueller RL, 2008, ZOOLOGY, V111, P218, DOI 10.1016/j.zool.2007.07.010; Nappi AJ, 2000, NITRIC OXIDE-BIOL CH, V4, P423, DOI 10.1006/niox.2000.0294; Polilov AA, 2012, ARTHROPOD STRUCT DEV, V41, P29, DOI 10.1016/j.asd.2011.09.001; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI MTM, 1953, J EXP ZOOL, V123, P397, DOI 10.1002/jez.1401230302; Russo J, 1996, PARASITOLOGY, V112, P135, DOI 10.1017/S0031182000065173; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Sloboda RD, 2007, CELL MOTIL CYTOSKEL, V64, P446, DOI 10.1002/cm.20195; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; WIGGLESWORTH VB, 1959, ANNU REV ENTOMOL, V4, P1, DOI 10.1146/annurev.en.04.010159.000245; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188133	10.1371/journal.pone.0188133	http://dx.doi.org/10.1371/journal.pone.0188133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141015	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400062
J	Ottoboni, G; Milani, M; Setti, A; Ceciliani, A; Chattat, R; Tessari, A				Ottoboni, Giovanni; Milani, Melissa; Setti, Annalisa; Ceciliani, Andrea; Chattat, Rabih; Tessari, Alessia			An observational study on sport-induced modulation of negative attitude towards disability	PLOS ONE			English	Article							IMPLICIT ASSOCIATION TEST; SELF-CONCEPT; CHILDREN; PARTICIPATION; PERCEPTIONS; COMPETENCE; PEOPLE; ADOLESCENTS; INVOLVEMENT; DEPRESSION	The present study investigates whether sport activities involving children with a disability can reduce negative attitudes towards disability in children without disability. We compared the effect of being schoolmate or member of the same football team whereby a child with disability was member of the class/team or not. This lead to four groups that were assessed both at the beginning and at the end of the school year. Two measures were collected: an ad-hoc questionnaire and an Implicit Association Test. The two assessments were designed to measure explicit and implicit attitudes towards children with disabilities. Results suggested that sport activities over one school year reduced more (p < .001) the implicit negative attitude towards disability (Mean = -.17, sd = .10) than the contact with the classmate in the school context (Mean = -.03, sd = .14), possibly due to their team building characteristic.	[Ottoboni, Giovanni; Chattat, Rabih; Tessari, Alessia] Univ Bologna, Dept Psychol, Bologna, Italy; [Milani, Melissa; Ceciliani, Andrea] Univ Bologna, Dept Life Qual Studies, Bologna, Italy; [Setti, Annalisa] Univ Cork, Sch Appl Psychol, Cork, Ireland	University of Bologna; University of Bologna; University College Cork	Ottoboni, G (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	giovanni.ottoboni@gmail.com	Tessari, Alessia/K-3457-2013; ottoboni, giovanni/E-3476-2010	Tessari, Alessia/0000-0002-6616-2454; ottoboni, giovanni/0000-0002-7649-6642; Chattat, Rabih/0000-0002-3889-2839	Department of Psychology, University of Bologna; Italian Paralympic Committee	Department of Psychology, University of Bologna; Italian Paralympic Committee	Department of Psychology, University of Bologna (recipients: Giovanni Ottoboni, Alessia Tessari, Rabih Chattat) grants the investigation. Italian Paralympic Committee (recipient: Melissa Milani) grants PLUS publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberson CL, 2007, GROUP PROCESS INTERG, V10, P179, DOI 10.1177/1368430207074726; Allport GW., 1954, NATURE PREJUDICE, Vxviii; Andrews JA, 2010, J APPL SOC PSYCHOL, V40, P2387, DOI 10.1111/j.1559-1816.2010.00663.x; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2011, WORLD REP DIS; Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Bandura A., 1969, HDB SOC THEORY RES, V213, P262; Beckett AE, 2014, BRIT J SOCIOL EDUC, V35, P856, DOI 10.1080/01425692.2013.800444; Beckett AE, 2009, BRIT J SOCIOL EDUC, V30, P317, DOI 10.1080/01425690902812596; Brittain I, 2004, J SPORT SOC ISSUES, V28, P429, DOI 10.1177/0193723504268729; Clark C., 1999, BRIT EDUC RES J, V25, P157, DOI DOI 10.1080/0141192990250203; COLLINS R, 1971, AM SOCIOL REV, V36, P1002, DOI 10.2307/2093761; DINH KT, 1995, HEALTH PSYCHOL, V14, P32, DOI 10.1037/0278-6133.14.1.32; Dishman RK, 2006, HEALTH PSYCHOL, V25, P396, DOI 10.1037/0278-6133.25.3.396; Federici S, 2016, DISABIL REHABIL, P1; Findlay LC, 2009, J YOUTH ADOLESCENCE, V38, P29, DOI 10.1007/s10964-007-9244-9; Gabel S, 2004, DISABIL SOC, V19, P585, DOI 10.1080/0968759042000252515; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Grenier M, 2014, ADAPT PHYS ACT Q, V31, P49, DOI [10.1123/apaq.2013-0006, 10.1123/apaq:2013-0006]; Gresham FM, 1997, REV EDUC RES, V67, P377, DOI 10.2307/1170514; HARTER S, 1982, CHILD DEV, V53, P87, DOI 10.2307/1129640; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Hodkinson A, 2007, RES EDUC, V77, P56, DOI 10.7227/RIE.77.5; Huckstadt LK, 2014, J SOC ISSUES, V70, P99, DOI 10.1111/josi.12049; Karpinski A, 2001, J PERS SOC PSYCHOL, V81, P774, DOI 10.1037/0022-3514.81.5.774; Krahe B, 2006, J COMMUNITY APPL SOC, V16, P59, DOI 10.1002/casp.849; Lai CK, 2014, J EXP PSYCHOL GEN, V143, P1765, DOI 10.1037/a0036260; Leonardi M, 2006, LANCET, V368, P1219, DOI 10.1016/S0140-6736(06)69498-1; Meloni F., 2012, P 17 INT ASS PSYCH P, P11; Mulvey KL, 2014, J SOC ISSUES, V70, P29, DOI 10.1111/josi.12045; Nosek B. A., 2007, AUTOMATIC PROCESSES, P265, DOI DOI 10.1080/10463280701489053; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504; Riall, 2005, INT J DISABIL DEV ED, V52, P101, DOI [10.1080/10349120500086348, DOI 10.1080/10349120500086348]; Roseth CJ, 2008, PSYCHOL BULL, V134, P223, DOI 10.1037/0033-2909.134.2.223; Sandieson, 2002, INT J DISABIL DEV ED, V49, P243, DOI [10.1080/1034912022000007270, DOI 10.1080/1034912022000007270]; Schneider W, 2012, E PRIME REFERENCE GU; Slee R., 2011, IRREGULAR SCHOOL; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; Weiss J, 2003, RES DEV DISABIL, V24, P281, DOI 10.1016/S0891-4222(03)00043-X; Wilson MC, 2014, RES DEV DISABIL, V35, P294, DOI 10.1016/j.ridd.2013.11.003	42	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187043	10.1371/journal.pone.0187043	http://dx.doi.org/10.1371/journal.pone.0187043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29140984	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400015
J	Padula, MC; Schaer, M; Scariati, E; Mutlu, AK; Zoller, D; Schneider, M; Eliez, S				Padula, Maria Carmela; Schaer, Marie; Scariati, Elisa; Mutlu, A. Kadir; Zoller, Daniela; Schneider, Maude; Eliez, Stephan			Quantifying indices of short-and long-range white matter connectivity at each cortical vertex	PLOS ONE			English	Article							22Q11.2 DELETION SYNDROME; CARDIO-FACIAL SYNDROME; SURFACE-BASED ANALYSIS; VELOCARDIOFACIAL SYNDROME; PSYCHIATRIC-DISORDERS; CINGULATE CORTEX; HUMAN CONNECTOME; FIBER TRACKING; GREY-MATTER; BRAIN	Several neurodevelopmental diseases are characterized by impairments in cortical morphology along with altered white matter connectivity. However, the relationship between these two measures is not yet clear. In this study, we propose a novel methodology to compute and display metrics of white matter connectivity at each cortical point. After co-registering the extremities of the tractography streamlines with the cortical surface, we computed two measures of connectivity at each cortical vertex: the mean tracts' length, and the proportion of short-and long-range connections. The proposed measures were tested in a clinical sample of 62 patients with 22q11.2 deletion syndrome (22q11DS) and 57 typically developing individuals. Using these novel measures, we achieved a fine-grained visualization of the white matter connectivity patterns at each vertex of the cortical surface. We observed an intriguing pattern of both increased and decreased short-and long-range connectivity in 22q11DS, that provides novel information about the nature and topology of white matter alterations in the syndrome. We argue that the method presented in this study opens avenues for additional analyses of the relationship between cortical properties and patterns of underlying structural connectivity, which will help clarifying the intrinsic mechanisms that lead to altered brain structure in neurodevelopmental disorders.	[Padula, Maria Carmela; Schaer, Marie; Scariati, Elisa; Zoller, Daniela; Schneider, Maude; Eliez, Stephan] Univ Geneva, Dev Imaging & Psychopathol Lab, Sch Med, Geneva, Switzerland; [Mutlu, A. Kadir] Neuroelect Res Flanders, Leuven, Netherlands; [Zoller, Daniela] Ecole Polytech Fed Lausanne, Inst Bioengn, Med Image Proc Lab, Lausanne, Switzerland; [Eliez, Stephan] Univ Geneva, Dept Genet Med & Dev, Sch Med, Geneva, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva	Padula, MC (corresponding author), Univ Geneva, Dev Imaging & Psychopathol Lab, Sch Med, Geneva, Switzerland.	Maria.Padula@unige.ch	Zöller, Daniela/D-7452-2019	Zöller, Daniela/0000-0002-7049-0696; Schaer, Marie/0000-0001-8479-6365; Schneider, Maude/0000-0001-7147-8915	Swiss National Science Foundation [324730 121996, 324730 144260, 324730_121996, 324730_144260]; National Center of Competence in Research (NCCR) synapsy [51NF40 158776, 51NF40_158776]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR) synapsy(Swiss National Science Foundation (SNSF))	This work have been funded by grants from the Swiss National Science Foundation to prof. Stephan Eliez [grant number: 324730 121996 and 324730 144260], and by the National Center of Competence in Research (NCCR) synapsy [grant number 51NF40 158776]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work have been funded by grants from the Swiss National Science Foundation to prof. Stephan Eliez [grant number: 324730_121996 and 324730_144260], and by the National Center of Competence in Research (NCCR) synapsy [grant number 51NF40_158776].	ARIKUNI T, 1994, NEUROSCI RES, V21, P19, DOI 10.1016/0168-0102(94)90065-5; Avants BB, 2010, NEUROIMAGE, V50, P1004, DOI 10.1016/j.neuroimage.2010.01.041; Bammer R, 2003, EUR J RADIOL, V45, P223, DOI 10.1016/S0720-048X(02)00311-X; Bearden CE, 2009, CEREB CORTEX, V19, P115, DOI 10.1093/cercor/bhn064; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Bozzali M, 2011, NEUROIMAGE, V54, P2045, DOI 10.1016/j.neuroimage.2010.08.069; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Caspers S, 2013, NEUROIMAGE, V80, P18, DOI 10.1016/j.neuroimage.2013.04.003; Catani M, 2011, BIOL PSYCHIAT, V70, P1143, DOI 10.1016/j.biopsych.2011.06.013; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; De Smedt B, 2009, DEV DISABIL RES REV, V15, P4, DOI 10.1002/ddrr.44; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Eliez S, 2000, AM J PSYCHIAT, V157, P409, DOI 10.1176/appi.ajp.157.3.409; Englander ZA, 2013, NEUROIMAGE-CLIN, V2, P440, DOI 10.1016/j.nicl.2013.03.006; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gao JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085005; Glaser B, 2002, J PEDIATR-US, V140, P753, DOI 10.1067/mpd.2002.124774; Gothelf D, 2008, DEV DISABIL RES REV, V14, P59, DOI 10.1002/ddrr.9; Gothelf D, 2007, SCHIZOPHR RES, V96, P72, DOI 10.1016/j.schres.2007.07.021; Gothelf D, 2011, J PSYCHIATR RES, V45, P322, DOI 10.1016/j.jpsychires.2010.07.008; Green T, 2009, J AM ACAD CHILD PSY, V48, P1060, DOI 10.1097/CHI.0b013e3181b76683; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hagler DJ, 2006, NEUROIMAGE, V33, P1093, DOI 10.1016/j.neuroimage.2006.07.036; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Huang H, 2015, CEREB CORTEX, V25, P1389, DOI 10.1093/cercor/bht335; Huang H, 2011, J NEUROSCI METH, V197, P324, DOI 10.1016/j.jneumeth.2011.02.017; Im K, 2014, NEUROIMAGE, V86, P182, DOI 10.1016/j.neuroimage.2013.08.011; Kates WR, 2001, BIOL PSYCHIAT, V49, P677, DOI 10.1016/S0006-3223(00)01002-7; Kunwar A, 2012, SCHIZOPHR RES, V137, P20, DOI 10.1016/j.schres.2012.01.032; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Nie JX, 2012, CEREB CORTEX, V22, P2831, DOI 10.1093/cercor/bhr361; O'Donnell LJ, 2013, NEUROIMAGE, V80, P283, DOI 10.1016/j.neuroimage.2013.04.066; Oguz I, 2009, LECT NOTES COMPUT SC, V5636, P651, DOI 10.1007/978-3-642-02498-6_54; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ottet MC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00402; Ottet MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058429; Ouyang Minhui, 2016, Proc SPIE Int Soc Opt Eng, V9788; Ouyang MH, 2017, NEUROSCI BIOBEHAV R, V83, P109, DOI 10.1016/j.neubiorev.2017.10.007; Padula MC, 2017, NEUROIMAGE-CLIN, V16, P142, DOI 10.1016/j.nicl.2017.07.023; Padula MC, 2017, HUM BRAIN MAPP, V38, P2177, DOI 10.1002/hbm.23512; Phillips OR, 2013, BRAIN CONNECT, V3, P146, DOI 10.1089/brain.2012.0111; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Pugliese L, 2009, NEUROIMAGE, V47, P427, DOI 10.1016/j.neuroimage.2009.05.014; Radoeva PD, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-38; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rushworth MFS, 2006, CEREB CORTEX, V16, P1418, DOI 10.1093/cercor/bhj079; Sandini C, BIOL PSYCHI IN PRESS; Savadjiev P, 2014, MED IMAGE ANAL, V18, P1349, DOI 10.1016/j.media.2014.06.013; Scariati E, 2016, J NEURAL TRANSM, V123, P823, DOI 10.1007/s00702-016-1548-z; Scariati E, 2014, BRAIN TOPOGR, V27, P808, DOI 10.1007/s10548-014-0356-8; Schaer M, 2006, PSYCHIAT RES-NEUROIM, V146, P1, DOI 10.1016/j.pscychresns.2005.10.002; Schaer M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00750; Schaer M, 2009, SCHIZOPHR RES, V115, P182, DOI 10.1016/j.schres.2009.09.016; Schaer M, 2009, DEV MED CHILD NEUROL, V51, P746, DOI 10.1111/j.1469-8749.2009.03281.x; Schmitt JE, 2015, BIOL PSYCHIAT, V78, P135, DOI 10.1016/j.biopsych.2014.10.025; Schneider M, 2014, AM J PSYCHIAT, V171, P627, DOI 10.1176/appi.ajp.2013.13070864; Schonberg T, 2006, NEUROIMAGE, V30, P1100, DOI 10.1016/j.neuroimage.2005.11.015; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Sepulcre J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000808; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Shukla DK, 2011, NEUROPSYCHOLOGIA, V49, P1378, DOI 10.1016/j.neuropsychologia.2011.02.022; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Srivastava S, 2012, HUM BRAIN MAPP, V33, P213, DOI 10.1002/hbm.21206; Swillen A, 1999, CHILD NEUROPSYCHOL, V5, P230, DOI 10.1076/0929-7049(199912)05:04;1-R;FT230; Thomas C, 2011, CORTEX, V47, P863, DOI 10.1016/j.cortex.2010.07.006; Thomason ME, 2011, ANNU REV CLIN PSYCHO, V7, P63, DOI 10.1146/annurev-clinpsy-032210-104507; Tozer DJ, 2012, NEUROIMAGE, V59, P3094, DOI 10.1016/j.neuroimage.2011.10.088; Tucholka A, 2012, NEUROIMAGE, V63, P1443, DOI 10.1016/j.neuroimage.2012.06.019; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zoller D, 2017, SCHIZOPHR RES	84	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187493	10.1371/journal.pone.0187493	http://dx.doi.org/10.1371/journal.pone.0187493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141024	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400025
J	Gorodeski, EZ; Joyce, E; Gandesbery, BT; Blackstone, EH; Taylor, DO; Tang, WHW; Starling, RC; Hachamovitch, R				Gorodeski, Eiran Z.; Joyce, Emer; Gandesbery, Benjamin T.; Blackstone, Eugene H.; Taylor, David O.; Tang, W. H. Wilson; Starling, Randall C.; Hachamovitch, Rory			Discordance between 'actual' and 'scheduled' check-in times at a heart failure clinic	PLOS ONE			English	Article							PATIENT SATISFACTION	Introduction A 2015 Institute Of Medicine statement "Transforming Health Care Scheduling and Access: Getting to Now", has increased concerns regarding patient wait times. Although waiting times have been widely studied, little attention has been paid to the role of patient arrival times as a component of this phenomenon. To this end, we investigated patterns of patient arrival at scheduled ambulatory heart failure (HF) clinic appointments and studied its predictors. We hypothesized that patients are more likely to arrive later than scheduled, with progressively later arrivals later in the day. Methods and results Using a business intelligence database we identified 6,194 unique patients that visited the Cleveland Clinic Main Campus HF clinic between January, 2015 and January, 2017. This clinic served both as a tertiary referral center and a community HF clinic. Transplant and left ventricular assist device (LVAD) visits were excluded. Punctuality was defined as the difference between 'actual' and 'scheduled' check-in times, whereby negative values (i.e., early punctuality) were patients who checked-in early. Contrary to our hypothesis, we found that patients checked-in late only a minority of the time (38% of visits). Additionally, examining punctuality by appointment hour slot we found that patients scheduled after 8AM had progressively earlier check-in times as the day progressed (P <.001 for trend). In both a Random Forest-Regression framework and linear regression models the most important risk-adjusted predictors of early punctuality were: later in the day appointment hour slot, patient having previously been to the hospital, age in the early 70s, and white race. Conclusions Patients attending a mixed population ambulatory HF clinic check-in earlier than scheduled times, with progressive discrepant intervals throughout the day. This finding may have significant implications for provider utilization and resource planning in order to maximize clinic efficiency. The impact of elective early arrival on patient's perceived wait times requires further study.	[Gorodeski, Eiran Z.; Joyce, Emer; Taylor, David O.; Tang, W. H. Wilson; Starling, Randall C.] Cleveland Clin, Sect Heart Failure & Cardiac Transplantat, Tomsich Family Dept Cardiovasc Med, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Gorodeski, Eiran Z.] Cleveland Clin, Ctr Connected Care, Med Operat, Cleveland, OH 44106 USA; [Gandesbery, Benjamin T.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Blackstone, Eugene H.] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Hachamovitch, Rory] Cleveland Clin, Sect Cardiovasc Imaging, Tomsich Family Dept Cardiovasc Med, Heart & Vasc Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Gorodeski, EZ (corresponding author), Cleveland Clin, Sect Heart Failure & Cardiac Transplantat, Tomsich Family Dept Cardiovasc Med, Heart & Vasc Inst, Cleveland, OH 44106 USA.; Gorodeski, EZ (corresponding author), Cleveland Clin, Ctr Connected Care, Med Operat, Cleveland, OH 44106 USA.	gorodee@ccf.org	Tang, Wai Hong Wilson/I-1238-2013	Gorodeski, Eiran/0000-0003-3756-8831; Tang, W. H. Wilson/0000-0002-8335-735X				Bleustein C, 2014, AM J MANAG CARE, V20, P393; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Cafri G., 2016, J DATA SCI, V14, P67, DOI DOI 10.6339/JDS.201601_14(1).0005; Cayirli Tugba, 2006, Health Care Manag Sci, V9, P47, DOI 10.1007/s10729-006-6279-5; Gorodeski EZ, 2011, CIRC-CARDIOVASC QUAL, V4, P521, DOI 10.1161/CIRCOUTCOMES.110.959023; Grolemond G, 2011, J STAT SOFTW, V40, P1; Hang SC, 2016, CLIN PEDIAT PHILA; Hsich E, 2011, CIRC-CARDIOVASC QUAL, V4, P39, DOI 10.1161/CIRCOUTCOMES.110.939371; Inglehart Marita Rohr, 2016, J Dent Hyg, V90, P203; Ishwaran H., 2016, RANDOM FORESTS SURVI; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Kaplan G., 2015, TRANSFORMING HLTH CA; Medway AM, 2016, HEALTHCARE-J DEL SCI, V4, P188, DOI 10.1016/j.hjdsi.2015.09.002; Meyer C, 2016, CHIRURG, V87, P964, DOI 10.1007/s00104-016-0243-9; Newcomb P, 2017, J EMERG NURS; Samorani M, 2016, PROD OPER MANAG, V25, P330, DOI 10.1111/poms.12426; Shirley Eric D, 2013, J Bone Joint Surg Am, V95, pe69, DOI 10.2106/JBJS.L.01048; Swartzman G, 1970, Health Serv Res, V5, P320; Taylor C, 2004, EMERG MED J, V21, P528, DOI 10.1136/emj.2002.003723; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Waters S, 2016, MANUAL THER, V25, P48, DOI 10.1016/j.math.2016.05.334; WHITE MJB, 1964, MED CARE, V2, P133, DOI 10.1097/00005650-196407000-00002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams KA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004679	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187849	10.1371/journal.pone.0187849	http://dx.doi.org/10.1371/journal.pone.0187849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136649	Green Submitted, gold, Green Published			2022-12-27	WOS:000415121200036
J	Javarone, MA; Marinazzo, D				Javarone, Marco Alberto; Marinazzo, Daniele			Evolutionary dynamics of group formation	PLOS ONE			English	Article							GROUP-SIZE; TRADE-OFFS; CONSEQUENCES; EMERGENCE; SELECTION; FISSION; CHOICE; GAMES	Group formation is a quite ubiquitous phenomenon across different animal species, whose individuals cluster together forming communities of diverse size. Previous investigations suggest that, in general, this phenomenon might have similar underlying reasons across the interested species, despite genetic and behavioral differences. For instance improving the individual safety (e.g. from predators), and increasing the probability to get food resources. Remarkably, the group size might strongly vary from species to species, e.g. shoals of fishes and herds of lions, and sometimes even within the same species, e.g. tribes and families in human societies. Here we build on previous theories stating that the dynamics of group formation may have evolutionary roots, and we explore this fascinating hypothesis from a purely theoretical perspective, with a model using the framework of Evolutionary Game Theory. In our model we hypothesize that homogeneity constitutes a fundamental ingredient in these dynamics. Accordingly, we study a population that tries to form homogeneous groups, i.e. composed of similar agents. The formation of a group can be interpreted as a strategy. Notably, agents can form a group (receiving a 'group payoff'), or can act individually (receiving an 'individual payoff'). The phase diagram of the modeled population shows a sharp transition between the 'group phase' and the 'individual phase', characterized by a critical 'individual payoff'. Our results then support the hypothesis that the phenomenon of group formation has evolutionary roots.	[Javarone, Marco Alberto] Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England; [Javarone, Marco Alberto] Univ Cagliari, Dept Math & Comp Sci, I-09123 Cagliari, Italy; [Marinazzo, Daniele] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, Ghent, Belgium; [Marinazzo, Daniele] Univ Elect Sci & Technol China, Chengdu Brain Sci Inst, Clin Hosp, MOE Key Lab Neuroinformat, Chengdu, Sichuan, Peoples R China	University of Hertfordshire; University of Cagliari; Ghent University; University of Electronic Science & Technology of China	Javarone, MA (corresponding author), Univ Hertfordshire, Sch Comp Sci, Hatfield AL10 9AB, Herts, England.; Javarone, MA (corresponding author), Univ Cagliari, Dept Math & Comp Sci, I-09123 Cagliari, Italy.	marcojavarone@gmail.com	Marinazzo, Daniele/H-4793-2019; Javarone, Marco/AFU-9191-2022	Marinazzo, Daniele/0000-0002-9803-0122; Javarone, Marco/0000-0003-0514-9544	H WiMUST project [645141]; National Group of Mathematical Physics (GNFM-INdAM); Faculty of Psychology and Educational Sciences of Ghent University	H WiMUST project; National Group of Mathematical Physics (GNFM-INdAM); Faculty of Psychology and Educational Sciences of Ghent University	MAJ would like to acknowledge support by the H2020-645141 WiMUST project, the National Group of Mathematical Physics (GNFM-INdAM), and the mobility funds of the Faculty of Psychology and Educational Sciences of Ghent University.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alcock J., 2013, ANIMAL BEHAV EVOLUTI; Antonioni A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025555; Couzin I, 2007, NATURE, V445, P715, DOI 10.1038/445715a; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Curry O, 2013, HUM NATURE-INT BIOS, V24, P336, DOI 10.1007/s12110-013-9174-z; David-Barrett T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1151; Dizard J. E., 1990, THE MINIMAL FAMILY; Du WB, 2009, PHYSICA A, V388, P4509, DOI 10.1016/j.physa.2009.07.012; Dunbar R, 2016, PSYCHOLOGY, P1; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frewen T.A., 2011, COPING COMPLEXITY MO, P299; Frey E, 2010, PHYSICA A, V389, P4265, DOI 10.1016/j.physa.2010.02.047; Galam S, 2000, PHYSICA A, V287, P644, DOI 10.1016/S0378-4371(00)00399-X; GALAM S, 1991, EUR J SOC PSYCHOL, V21, P49, DOI 10.1002/ejsp.2420210105; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; Gracia-Lazaro C, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042808; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guillen MF, 2000, ACAD MANAGE J, V43, P362, DOI 10.2307/1556400; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Hofmann HA, 2014, TRENDS ECOL EVOL, V29, P581, DOI 10.1016/j.tree.2014.07.008; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Javarone M. A., 2016, EPJ; Javarone M. A., 2017, SOURCE CODE; Javarone MA, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/07/073404; Javarone MA, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/38001; Johnson KVA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25267; Johnson S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.108702; Julia P. C., 2009, NEW J PHYS, V11; Kao AB, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003762; Kao AB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3305; Korstjens AH, 2006, BEHAV ECOL SOCIOBIOL, V60, P683, DOI 10.1007/s00265-006-0212-2; Lee J, 2002, STRATEGIC MANAGE J, V23, P727, DOI 10.1002/smj.250; Lehmann J., 2009, P ROY SOC LOND B BIO; Meenakshi JV, 2002, J POLICY MODEL, V24, P539, DOI 10.1016/S0161-8938(02)00129-1; Michod RE, 2006, P NATL ACAD SCI USA, V103, P9113, DOI 10.1073/pnas.0601080103; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Moreira JA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01521; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Perc M., 2013, J R SOC INTERFACE, V80, P10; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Perc M, 2013, CHAOS SOLITON FRACT, V56, P1, DOI 10.1016/j.chaos.2013.06.002; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Stewart AJ, 2016, P NATL ACAD SCI USA, V113, pE7003, DOI 10.1073/pnas.1608990113; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Szabo G, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.022820; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/58004; Szolnoki A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1299; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; Traulsen A, 2009, UNDERST COMPLEX SYST, P253, DOI 10.1007/978-3-642-01284-6_12; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006	57	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187960	10.1371/journal.pone.0187960	http://dx.doi.org/10.1371/journal.pone.0187960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136020	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200051
J	Scherz, V; Durussel, C; Greub, G				Scherz, Valentin; Durussel, Christian; Greub, Gilbert			Internal quality assurance in diagnostic microbiology: A simple approach for insightful data	PLOS ONE			English	Article							COMPETENCE ASSESSMENT; GRAM STAIN; CLINICAL MICROBIOLOGY; ERRORS; LABORATORIES; PROFICIENCY; SPUTUM; REPRODUCIBILITY; TECHNOLOGISTS; AGREEMENT	Given the importance of microbiology results on patient care, high quality standards are expected. Internal quality assurance (IQA) could mitigate the limitations of internal quality control, competency assessment and external quality assurance, adding a longitudinal insight, including pre-and post-analytical steps. Here, we implemented an IQA program in our clinical microbiology facilities with blind resubmission of routine samples during 22 months. One-hundred-and-twenty-one out of 123 (98.4%) serological analyses and 112 out of 122 (91.8%) molecular analyses were concordant. Among the discordances in molecular biology analyses, 6 results were low positive samples that turned out negative, likely due to stochastic repartition of nucleic acids. Moreover, one identified retranscription error led us to implement automated results transmission from the Applied Biosystems instruments to the laboratory information system (LIS). Regarding Gram stain microscopy, 560 out of 745 (75.2%) of compared parameters were concordant. As many as 67 out of 84 (79.8%) pairs of culture results were similar, including 16 sterile pairs, 27 having identical identification or description and semi-quantification and 24 only showing variations in semi-quantification with identical description or identification of colonies. Seventeen pairs had diverging identification or description of colonies. Culture was twice only done for one member of the pairs. Regarding antibiotic susceptibility testing, a major discrepancy was observed in 5 out of 48 results (10.4%). In conclusion, serological tests were highly reproducible. Molecular diagnosis also revealed to be robust except when the amounts of nucleic acids present in the sample were close to the limits of detection. Conventional microbiology was less robust with major discrepancies reaching 39.5% of the samples for microscopy. Similarly, culture and antibiotic susceptibility testing were prone to discrepancies. This work was ground for reconsidering multiples aspects of our practices and demonstrates the importance of IQA to complete the other quality management procedures.	[Greub, Gilbert] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; Univ Hosp Ctr, Lausanne, Switzerland	University of Lausanne	Greub, G (corresponding author), Univ Lausanne, Inst Microbiol, Lausanne, Switzerland.	gilbert.greub@chuv.ch	Greub, Gilbert GG/K-5804-2017	Greub, Gilbert GG/0000-0001-9529-3317; Scherz, Valentin/0000-0002-9746-5423				[Anonymous], 2012, 151892012 ISO; [Anonymous], 2014, SOUM PREM PAS; Arora D R, 2004, Indian J Med Microbiol, V22, P81; BARTLETT RC, 1994, CLIN MICROBIOL REV, V7, P55, DOI 10.1128/CMR.7.1.55-88.1994; BOONE J, 1982, AM J PUBLIC HEALTH, V72, P1364, DOI 10.2105/AJPH.72.12.1364; Brezmes M, 2014, EUR J CLIN MICROBIOL, V21, P582; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cicchetti DV., 1971, AM J EEG TECHNOL, V11, P101, DOI [10.1080/00029238.1971.11080840, DOI 10.1080/00029238.1971.11080840]; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CONSTANTINE CE, 1993, J CLIN PATHOL, V46, P1046, DOI 10.1136/jcp.46.11.1046; Desjardins M, 2014, J CLIN MICROBIOL, V52, P2940, DOI 10.1128/JCM.01035-14; Eleftheriadou M, 2013, EURACHEM GUIDE ACCRE; Ellinger PJ, 2006, LABMEDICINE, V37, P176, DOI 10.1309/YUVGRCGHP7P3RMQH; FARRINGTON M, 1995, J HOSP INFECT, V30, P364, DOI 10.1016/0195-6701(95)90040-3; Fournier PE, 2013, NAT REV MICROBIOL, V11, P574, DOI 10.1038/nrmicro3068; Fukuyama H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-534; GraphPad Software, 2016, GRAPHPAD QUICKCALCS; GRAY JJ, 1995, J CLIN PATHOL, V48, P168, DOI 10.1136/jcp.48.2.168; Greub G, 2016, FUTURE MICROBIOL, V11, P403, DOI 10.2217/fmb.15.152; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kalra J, 2004, CLIN BIOCHEM, V37, P1052, DOI 10.1016/j.clinbiochem.2004.08.009; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kumasaka K, 2001, J Infect Chemother, V7, P102, DOI 10.1007/s101560100016; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; McCarter Yvette S., 1997, Clinical Microbiology Newsletter, V19, P97, DOI 10.1016/S0196-4399(97)89811-X; MCCASKEY L, 1995, LAB MED, V26, P343, DOI 10.1093/labmed/26.5.343; Miller J. M., 2013, Clinical Microbiology Newsletter, V35, P195, DOI 10.1016/j.clinmicnews.2013.11.003; Munson E, 2007, J CLIN MICROBIOL, V45, P3754, DOI 10.1128/JCM.01632-07; Musher DM, 2004, CLIN INFECT DIS, V39, P165, DOI 10.1086/421497; Nagendra S, 2001, J CLIN MICROBIOL, V39, P2344, DOI 10.1128/JCM.39.6.2344-2347.2001; Parry CM, 2000, J INFECTION, V41, P55, DOI 10.1053/jinf.2000.0680; Plebani M, 2006, CLIN CHEM LAB MED, V44, P750, DOI 10.1515/CCLM.2006.123; Public Health England, 2015, UK STAND MICROBIOL Q, VQ2; Rand KH, 2006, AM J CLIN PATHOL, V126, P686, DOI 10.1309/V4KE2FPM5T8V4552; Reilly AA, 1999, J CLIN MICROBIOL, V37, P2297, DOI 10.1128/JCM.37.7.2297-2305.1999; ROBINSON A, 1994, CLIN MICROBIOL REV, V7, P185, DOI 10.1128/CMR.7.2.185-199.1994; Samuel LP, 2016, J CLIN MICROBIOL, V54, P1442, DOI 10.1128/JCM.03066-15; Schiffgens J, 2001, LAB MED, V32, P431; Shahangian S, 1998, ARCH PATHOL LAB MED, V122, P15; Sharp SE, 2004, CLIN MICROBIOL REV, V17, P681, DOI 10.1128/CMR.17.3.681-694.2004; TAYLOR RN, 1983, ANN NY ACAD SCI, V420, P13, DOI 10.1111/j.1749-6632.1983.tb22184.x; Virk A, 2000, MAYO CLIN PROC, V75, P200; Warrens MJ, 2013, COMPUT STAT DATA AN, V59, P180, DOI 10.1016/j.csda.2012.09.019; West J, 2017, ANN CLIN BIOCHEM, V54, P14, DOI 10.1177/0004563216669384; WOOD RJ, 1980, J CLIN MICROBIOL, V11, P541, DOI 10.1128/JCM.11.6.541-545.1980; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187263	10.1371/journal.pone.0187263	http://dx.doi.org/10.1371/journal.pone.0187263			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135992	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200015
J	Cheng, Y; Lin, CH; Chen, JY; Li, CH; Liu, YT; Chen, BC				Cheng, Yi; Lin, Chien-huang; Chen, Jing-Yun; Li, Chien-Hua; Liu, Yu-Tin; Chen, Bing-Chang			Induction of Connective Tissue Growth Factor Expression by Hypoxia in Human Lung Fibroblasts via the MEKK1/MEK1/ERK1/GLI-1/GLI-2 and AP-1 Pathways (vol 11, e0160593, 2016)	PLOS ONE			English	Correction																		Cheng Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160593	1	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188608	10.1371/journal.pone.0188608	http://dx.doi.org/10.1371/journal.pone.0188608			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161312	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000067
J	Kim, GE; Lee, JS; Park, MH; Yoon, JH				Kim, Ga-Eon; Lee, Ji Shin; Park, Min Ho; Yoon, Jung Han			Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma	PLOS ONE			English	Article							CANCER METASTASIS; LUNG-CANCER; TUMOR; PROTEIN; PROGRESSION; STROMA; DISEASE; COLON	Invasion and metastasis are direct causes of mortality in patients with breast cancer and require reciprocal interactions between cancer cells and the extracellular matrix (ECM). Periostin, a fasciclin-containing adhesive ECM glycoprotein, is frequently overexpressed in various types of human cancer, and its overexpression in cancer-associated stroma and/or cancer cells is usually associated with poor clinical outcomes. However, the expression of periostin in the successive steps of breast tumorigenesis and its association with outcome variables have not been well established in breast carcinoma. The present study aimed to assess the role of periostin alteration in breast tumorigenesis and evaluate the putative prognostic value of periostin as a function of its compartmentalization. Immunohistochemical staining with anti-periostin antibody was performed in a total of 300 patients (26 patients with normal breast tissues, 76 patients with ductal carcinoma in situ [DCIS], and 198 patients with invasive breast carcinoma [IBC]) using tissue microarray. Periostin immunoreactivity was assessed in both epithelial tissue and the surrounding stromal compartment. The mRNA and protein expression of periostin were analyzed in 10 paired normal/invasive cancer frozen specimens by quantitative real time-polymerase chain reaction and western blot analysis, respectively. In cancer tissues, periostin mRNA and protein expression were increased compared with adjacent normal tissues. Both epithelial and stromal periostin staining scores significantly increased in a stepwise manner with disease progression from normal breast tissue to DCIS and IBC (P = 0.000 and 0.000, respectively). High epithelial and stromal periostin expression was observed in 109/ 189 (57.7%) and 158/189 (83.6%) cases of IBC, respectively. High epithelial periostin expression was more frequently observed in the distant metastatic relapse-positive group than in the distant metastatic relapse-negative group (41/51 [80.4%] vs. 68/138 [49.3%] cases [P = 0.000]). Furthermore, high epithelial periostin expression was associated with reduced disease-free survival and overall survival in univariate and multivariate analysis. Periostin may play an important role in the progression of breast tumor, and epithelial periostin expression may serve as a new parameter for prediction of prognosis in patients with IBC. Further studies examining periostin expression and its potential as a target of IBC therapy are warranted.	[Kim, Ga-Eon; Lee, Ji Shin] Chonnam Natl Univ, Med Sch, Dept Pathol, Gwangju, South Korea; [Park, Min Ho; Yoon, Jung Han] Chonnam Natl Univ, Med Sch, Dept Surg, Gwangju, South Korea	Chonnam National University; Chonnam National University	Lee, JS (corresponding author), Chonnam Natl Univ, Med Sch, Dept Pathol, Gwangju, South Korea.	jshinlee@hanmail.net		, ji shin/0000-0003-4634-2228; Kim, Ga-Eon/0000-0001-8539-6654				Choi KU, 2011, INT J CANCER, V128, P332, DOI 10.1002/ijc.25341; FIDLER IJ, 1990, CANCER RES, V50, P6130; Fukushima N, 2008, MODERN PATHOL, V21, P1044, DOI 10.1038/modpathol.2008.77; Gunia S, 2013, J CLIN PATHOL, V66, P297, DOI 10.1136/jclinpath-2012-201262; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Hong LZ, 2013, ONCOL LETT, V6, P1595, DOI 10.3892/ol.2013.1590; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; Kharaishvili G, 2011, J CLIN PATHOL, V64, P977, DOI 10.1136/jclinpath-2011-200106; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Lakhani SR, 2012, WHO CLASSIFICATION T; Li MX, 2012, CLIN EXP METASTAS, V29, P865, DOI 10.1007/s10585-012-9465-5; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Lv Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0385-7; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Morra L, 2011, VIRCHOWS ARCH, V459, P465, DOI 10.1007/s00428-011-1151-5; Nuzzo PV, 2014, CLIN GENITOURIN CANC, V12, P301, DOI 10.1016/j.clgc.2014.02.005; Nuzzo PV, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-625; Oda G, 2012, ONCOL REP, V28, P2003, DOI 10.3892/or.2012.2040; Puglisi F, 2008, J CLIN PATHOL, V61, P494, DOI 10.1136/jcp.2007.052506; Riener MO, 2010, HISTOPATHOLOGY, V56, P600, DOI 10.1111/j.1365-2559.2010.03527.x; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sung SY, 2007, CURR PROB CANCER, V31, P36, DOI 10.1016/j.currproblcancer.2006.12.002; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wu GQ, 2013, CANCER BIOTHER RADIO, V28, P298, DOI 10.1089/cbr.2012.1374; Xu DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046670; Zhang Y, 2010, J SURG RES, V160, P102, DOI 10.1016/j.jss.2008.12.042	31	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187635	10.1371/journal.pone.0187635	http://dx.doi.org/10.1371/journal.pone.0187635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161296	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000014
J	Koeppel, F; Blanchard, S; Jovelet, C; Genin, B; Marcaillou, C; Martin, E; Rouleau, E; Solary, E; Soria, JC; Andre, F; Lacroix, L				Koeppel, Florence; Blanchard, Steven; Jovelet, Cecile; Genin, Berengsre; Marcaillou, Charles; Martin, Emmanuel; Rouleau, Etienne; Solary, Eric; Soria, Jean-Charles; Andre, Fabrice; Lacroix, Ludovic			Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients	PLOS ONE			English	Article							PD-1 BLOCKADE; LUNG-CANCER; DNA; SENSITIVITY; PROGNOSIS; BLOOD; LANDSCAPE; EVOLUTION; MELANOMA; TRIAL	Tumor mutation load (TML) has been proposed as a biomarker of patient response to immunotherapy in several studies. TML is usually determined by tumor biopsy DNA (tDNA) whole exome sequencing (WES), therefore TML evaluation is limited by informative biopsy availability. Circulating cell free DNA (cfDNA) provided by liquid biopsy is a surrogate specimen to biopsy for molecular profiling. Nevertheless performing WES on DNA from plasma is technically challenging and the ability to determine tumor mutation load from liquid biopsies remains to be demonstrated. In the current study, WES was performed on cfDNA from 32 metastatic patients of various cancer types included into MOSCATO 01 (NCT01566019) and/or MATCHR (NCT02517892) molecular triage trials. Results from targeted gene sequencing (TGS) and WES performed on cfDNA were compared to results from tumor tissue biopsy. In cfDNA samples, WES mutation detection sensitivity was 92% compared to targeted sequencing (TGS). When comparing cfDNA-WES to tDNA-WES, mutation detection sensitivity was 53%, consistent with previously published prospective study comparing cfDNA-TGS to tDNA-TGS. For samples in which presence of tumor DNA was confirmed in cfDNA, tumor mutation load from liquid biopsy was correlated with tumor biopsy. Taken together, this study demonstrated that liquid biopsy may be applied to determine tumor mutation load. Qualification of liquid biopsy for interpretation is a crucial point to use cfDNA for mutational load estimation.	[Koeppel, Florence; Jovelet, Cecile; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Genom Platform, Mol Biopathol Unit, AMMICA,INSERM,US23,CNRS,UMS3655, Villejuif, France; [Koeppel, Florence; Jovelet, Cecile; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Biol Resource Ctr, UMS3655, AMMICA,INSERM,US23,CNRS, Villejuif, France; [Blanchard, Steven; Genin, Berengsre; Marcaillou, Charles; Martin, Emmanuel] IntegraGen SA, Genopole CAMPUS 1 Bat,G8, Paris, France; [Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France; [Solary, Eric] Univ Paris Saclay, Fac Med Paris Sud, Gustave Roussy, INSERM,U1170, Villejuif, France; [Solary, Eric] Gustave Roussy, Dept Hematol, Villejuif, France; [Soria, Jean-Charles] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France; [Soria, Jean-Charles] Univ Paris Sud, Villejuif, France; [Soria, Jean-Charles; Andre, Fabrice] Gustave Roussy, Dept Med Oncol, Villejuif, France; [Soria, Jean-Charles; Andre, Fabrice] Univ Paris XI, Gustave Roussy, INSERM, U981, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Lacroix, L (corresponding author), Gustave Roussy, Genom Platform, Mol Biopathol Unit, AMMICA,INSERM,US23,CNRS,UMS3655, Villejuif, France.; Lacroix, L (corresponding author), Gustave Roussy, Biol Resource Ctr, UMS3655, AMMICA,INSERM,US23,CNRS, Villejuif, France.; Lacroix, L (corresponding author), Gustave Roussy, Dept Med Biol & Pathol, Villejuif, France.	Ludovic.LACROIX@gustaveroussy.fr	Soria, Jean-Charles/F-3619-2014; ANDRE, Fabrice/AAL-2683-2020	ANDRE, Fabrice/0000-0001-5795-8357; koeppel, florence/0000-0003-2421-2537; Solary, Eric/0000-0002-8629-1341	INCaD-GOS-INSERM [6043]; FUI [17-ICE]	INCaD-GOS-INSERM; FUI	This work was supported by grants INCaD-GOS-INSERM 6043 and FUI 17-ICE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; Chabanon RM, 2016, CLIN CANCER RES, V22, P4309, DOI 10.1158/1078-0432.CCR-16-0903; Chan KCA, 2013, CLIN CHEM, V59, P211, DOI 10.1373/clinchem.2012.196014; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Danilova L, 2016, P NATL ACAD SCI USA, V113, pE7769, DOI 10.1073/pnas.1607836113; Dietz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161012; Facchinetti F, 2016, CLIN CANCER RES, V22, P5983, DOI 10.1158/1078-0432.CCR-16-0917; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomez-Roca CA, 2012, ANN ONCOL, V23, P1301, DOI 10.1093/annonc/mdr383; Johnson DB, 2016, CANCER IMMUNOL RES, V4, P959, DOI 10.1158/2326-6066.CIR-16-0143; Jovelet C, 2016, CLIN CANCER RES, V22, P2960, DOI 10.1158/1078-0432.CCR-15-2470; Klevebring D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104417; Massard C, 2017, CANCER DISCOV, V7, P586, DOI 10.1158/2159-8290.CD-16-1396; Murtaza M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9760; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Schrock A, 2017, CLIN CHEM, V63, P1288, DOI 10.1373/clinchem.2016.270207; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Tacher V, 2016, EUR J CANCER, V59, P79, DOI 10.1016/j.ejca.2016.02.006; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Warton K, 2016, ENDOCR-RELAT CANCER, V23, pR157, DOI 10.1530/ERC-15-0369	23	65	67	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188174	10.1371/journal.pone.0188174	http://dx.doi.org/10.1371/journal.pone.0188174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161279	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000033
J	Oh, J; Kim, Y; Che, L; Kim, JB; Chang, GE; Cheong, E; Kang, SG; Ha, Y				Oh, Jinsoo; Kim, Yongbo; Che, Lihua; Kim, Jeong Beom; Chang, Gyeong Eon; Cheong, Eunji; Kang, Seok-Gu; Ha, Yoon			Regulation of cAMP and GSK3 signaling pathways contributes to the neuronal conversion of glioma	PLOS ONE			English	Article							NEURAL STEM-CELLS; FUNCTIONAL-NEURONS; HUMAN FIBROBLASTS; MOUSE; BRAIN; GENERATION	Glioma is the most malignant type of primary central nervous system tumors, and has an extremely poor prognosis. One potential therapeutic approach is to induce the terminal differentiation of glioma through the forced expression of pro-neural factors. Our goal is to show the proof of concept of the neuronal conversion of C6 glioma through the combined action of small molecules. We investigated the various changes in gene expression, cell-specific marker expression, signaling pathways, physiological characteristics, and morphology in glioma after combination treatment with two small molecules (CHIR99021, a glycogen synthase kinase 3 [GSK3] inhibitor and forskolin, a cyclic adenosine monophosphate [cAMP] activator). Here, we show that the combined action of CHIR99021 and forskolin converted malignant glioma into fully differentiated neurons with no malignant characteristics; inhibited the proliferation of malignant glioma; and significantly down-regulated gene ontology and gene expression profiles related to cell division, gliogenesis, and angiogenesis in small molecule-induced neurons. In vivo, the combined action of CHIR99021 and forskolin markedly delayed neurological deficits and significantly reduced the tumor volume. We suggest that reprogramming technology may be a potential treatment strategy replacing the therapeutic paradigm of traditional treatment of malignant glioma, and a combination molecule comprising a GSK3 inhibitor and a cAMP inducer could be the next generation of anticancer drugs.	[Oh, Jinsoo; Kim, Yongbo; Che, Lihua; Kang, Seok-Gu; Ha, Yoon] Yonsei Univ, Dept Neurosurg, Spine & Spinal Cord Inst, Coll Med, Seoul, South Korea; [Kim, Yongbo; Che, Lihua; Ha, Yoon] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Kim, Jeong Beom] Ulsan Natl Inst Sci & Technol, HSSCRC, Sch Life Sci, Ulsan, South Korea; [Kim, Jeong Beom] UNIST, MPPG, MBL, Ulsan, South Korea; [Chang, Gyeong Eon; Cheong, Eunji] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST); Yonsei University	Ha, Y (corresponding author), Yonsei Univ, Dept Neurosurg, Spine & Spinal Cord Inst, Coll Med, Seoul, South Korea.; Ha, Y (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	hayoon@yuhs.ac		Kim, Jeong Beom/0000-0001-6230-8826; Kang, Seok-Gu/0000-0001-5676-2037	National Research Foundation of Korea - Korean Government [NRF-2015R1A6A3A01018883]; National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A02059821, 2016R1D1A1A02937027]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2015R1A6A3A01018883). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02059821 and 2016R1D1A1A02937027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a National Research Foundation of Korea Grant, funded by the Korean Government (NRF-2015R1A6A3A01018883). This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A02059821 and 2016R1D1A1A02937027)	Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carrasco-Garcia E, 2014, CELLS-BASEL, V3, P199, DOI 10.3390/cells3020199; Chen J, 2012, CELL, V149, P36, DOI 10.1016/j.cell.2012.03.009; Erkan EP, 2014, ONCOGENE, V33, P4778, DOI 10.1038/onc.2013.423; Guichet PO, 2013, GLIA, V61, P225, DOI 10.1002/glia.22429; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Gwak SJ, 2014, SPINE, V39, pE65, DOI 10.1097/BRS.0000000000000070; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Kim E, 2017, NEUROPSYCHOPHARMACOL, V42, P941, DOI 10.1038/npp.2016.258; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lee C, 2012, STEM CELLS, V30, P1064, DOI 10.1002/stem.1081; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Liu YG, 2015, J NEUROSCI, V35, P9336, DOI 10.1523/JNEUROSCI.3975-14.2015; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Najm FJ, 2013, NAT BIOTECHNOL, V31, P426, DOI 10.1038/nbt.2561; Nakada Mitsutoshi, 2011, Cancers (Basel), V3, P3242, DOI 10.3390/cancers3033242; Nowinska K, 2016, INT J ONCOL, V48, P635, DOI 10.3892/ijo.2015.3273; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Schroder LBW, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00259; Su Z, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.425; Sukhdeo K, 2011, CELL, V146, P187, DOI 10.1016/j.cell.2011.06.047; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323	27	15	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0178881	10.1371/journal.pone.0178881	http://dx.doi.org/10.1371/journal.pone.0178881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161257	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000001
J	Pauchard, LA; Blot, M; Bruyere, R; Barbar, SD; Croisier, D; Piroth, L; Charles, PE				Pauchard, Laure-Anne; Blot, Mathieu; Bruyere, Remi; Barbar, Saber-Davide; Croisier, Delphine; Piroth, Lionel; Charles, Pierre-Emmanuel			Linezolid and atorvastatin impact on pneumonia caused by Staphyloccocus aureus in rabbits with or without mechanical ventilation	PLOS ONE			English	Article							INDUCED LUNG INJURY; TIDAL-VOLUME; OUTCOMES; STATINS; MODEL; INFLAMMATION; MORTALITY; THERAPY; PATHWAY; SEPSIS	Pneumonia may involve methicillin-resistant Staphylococcus aureus (MRSA), with elevated rates of antibiotics failure. The present study aimed to assess the effect of statins given prior to pneumonia development. Spontaneously breathing (SB) or mechanically ventilated (MV) rabbits with pneumonia received atorvastatin alone, linezolid (LNZ) alone, or a combination of both (n = 5 in each group). Spontaneously breathing and MV untreated infected animals (n = 11 in each group), as well as uninfected animals (n = 5 in each group) were used as controls. Microbiological features and inflammation were evaluated. Data are presented as medians (interquartile range). Linezolid alone tended to reduce pulmonary MRSA load in both SB and MV rabbits, but failed to prevent bacteremia (59%) in the latter. Linezolid alone dampened TNF-alpha lung production in both SB and MV rabbits (e.g., 2226 [789] vs. 11478 [10251] pg/g; p = 0.022). Statins alone did the same in both SB and MV animals (e.g., 2040 [133]; p = 0.016), and dampened systemic inflammation in the latter, possibly through TLR2 down-regulation within the lung. However, the combination of LNZ and statin led to an increased rate of bacteremia in MV animals up to 75%. Statins provide an anti-inflammatory effect in rabbits with MRSA pneumonia, especially in MV ones. However, dampening the systemic inflammatory response with statins could impede blood defenses against MRSA.	[Pauchard, Laure-Anne; Blot, Mathieu; Bruyere, Remi; Barbar, Saber-Davide; Charles, Pierre-Emmanuel] Univ Bourgogne, Lab Lipides Nutr Canc, UMR 1231, INSERM,UFR Sci Sante, Dijon, France; [Blot, Mathieu; Piroth, Lionel] Hop F Mitterrand, Serv Malad Infect & Tropicales, Dijon, France; [Croisier, Delphine] Vivexia SARL, Gemeaux, France; [Charles, Pierre-Emmanuel] Hop F Mitterrand, Serv Reanimat Med, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne	Charles, PE (corresponding author), Univ Bourgogne, Lab Lipides Nutr Canc, UMR 1231, INSERM,UFR Sci Sante, Dijon, France.; Charles, PE (corresponding author), Hop F Mitterrand, Serv Reanimat Med, Dijon, France.	pierre-emmanuel.charles@chu-dijon.fr	Blot, Mathieu/D-4508-2019	Blot, Mathieu/0000-0001-6541-2434; Charles, Pierre-Emmanuel/0000-0002-0201-9544; Barbar, Saber Davide/0000-0002-5089-8088	Pfizer	Pfizer(Pfizer)	DC is an employee of the "Vivexia S.A.R. L." company and as such received a salary. This funder only provided a part of the research materials (i.e., catheter insertion in rabbits). This funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pfizer (i.e., Aspire grant) has provided support in the form of the remaining research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbar SD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158799; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Broccard A, 2000, CRIT CARE MED, V28, P295, DOI 10.1097/00003246-200002000-00001; Bruyere R, 2014, CRIT CARE, V18, DOI 10.1186/cc13845; Calisto KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014232; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Charles PE, 2005, CRIT CARE MED, V33, P1029, DOI 10.1097/01.CCM.0000163404.35338.72; Charles PE, 2004, INTENS CARE MED, V30, P2263, DOI 10.1007/s00134-004-2442-y; Charles PE, 2002, CRIT CARE MED, V30, P2278, DOI 10.1097/00003246-200210000-00016; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chow OA, 2010, CELL HOST MICROBE, V8, P445, DOI 10.1016/j.chom.2010.10.005; Christaki E, 2014, VIRULENCE, V5, P57, DOI 10.4161/viru.26514; Diep BA, 2013, J INFECT DIS, V208, P75, DOI 10.1093/infdis/jit129; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Jacqueline C, 2014, J INFECT DIS, V210, P814, DOI 10.1093/infdis/jiu145; Kajikawa O, 2005, GENE, V344, P193, DOI 10.1016/j.gene.2004.09.032; Kruger P, 2013, AM J RESP CRIT CARE, V187, P743, DOI 10.1164/rccm.201209-1718OC; Ladoire S, 2013, ANESTHESIOLOGY, V118, P1150, DOI 10.1097/ALN.0b013e31828a7016; Leung S, 2012, CRIT CARE MED, V40, P1064, DOI 10.1097/CCM.0b013e31823bc9e7; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Makris D, 2011, CRIT CARE MED, V39, P2440, DOI 10.1097/CCM.0b013e318225742c; McAuley D, 2016, INTENSIVE CARE MED; Moriyama K, 2004, AM J PHYSIOL-LUNG C, V286, pL1114, DOI 10.1152/ajplung.00296.2003; Muller HC, 2010, CRIT CARE, V14, DOI 10.1186/cc9209; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Oliveira-Nascimento L, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00079; Papazian L, 2013, JAMA-J AM MED ASSOC, V310, P1692, DOI 10.1001/jama.2013.280031; Shyamsundar M, 2009, AM J RESP CRIT CARE, V179, P1107, DOI 10.1164/rccm.200810-1584OC; Siempos II, 2010, CRIT CARE MED, V38, P1321, DOI 10.1097/CCM.0b013e3181d9dad6; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Taubert M, 2016, ANTIMICROB AGENTS CH; Terblanche M, 2007, LANCET INFECT DIS, V7, P358, DOI 10.1016/S1473-3099(07)70111-1; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wang Y, 2011, AM J PHYSIOL-HEART C, V300, pH1743, DOI 10.1152/ajpheart.01335.2008; Wu BQ, 2014, CLIN EXP MED, V14, P151, DOI 10.1007/s10238-013-0231-z; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Yoshizawa S, 2012, ANTIMICROB AGENTS CH, V56, P1744, DOI 10.1128/AAC.05430-11	39	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187187	10.1371/journal.pone.0187187	http://dx.doi.org/10.1371/journal.pone.0187187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149185	gold, Green Published, Green Submitted			2022-12-27	WOS:000415646100008
J	Halboth, F; Roces, F				Halboth, Florian; Roces, Flavio			The construction of ventilation turrets in Atta vollenweideri leaf-cutting ants: Carbon dioxide levels in the nest tunnels, but not airflow or air humidity, influence turret structure	PLOS ONE			English	Article							WIND-INDUCED VENTILATION; INTERNAL STRUCTURE; 1893 HYM; FOREL; GROWTH; ARCHITECTURE; HYMENOPTERA; TEMPERATURE; PARAMETERS; PREFERENCE	Nest ventilation in the leaf-cutting ant Atta vollenweideri is driven via a wind-induced mechanism. On their nests, workers construct small turrets that are expected to facilitate nest ventilation. We hypothesized that the construction and structural features of the turrets would depend on the colony's current demands for ventilation and thus might be influenced by the prevailing environmental conditions inside the nest. Therefore, we tested whether climate-related parameters, namely airflow, air humidity and CO2 levels in the outflowing nest air influenced turret construction in Atta vollenweideri. In the laboratory, we simulated a seminatural nest arrangement with fungus chambers, a central ventilation tunnel providing outflow of air and an aboveground building arena for turret construction. In independent series, different climatic conditions inside the ventilation tunnel were experimentally generated, and after 24 hours, several features of the built turret were quantified, i.e., mass, height, number and surface area (aperture) of turret openings. Turret mass and height were similar in all experiments even when no airflow was provided in the ventilation tunnel. However, elevated CO2 levels led to the construction of a turret with several minor openings and a larger total aperture. This effect was statistically significant at higher CO2 levels of 5% and 10% but not at 1% CO2. The construction of a turret with several minor openings did not depend on the strong differences in CO2 levels between the outflowing and the outside air, since workers also built permeated turrets even when the CO2 levels inside and outside were both similarly high. We propose that the construction of turrets with several openings and larger opening surface area might facilitate the removal of CO2 from the underground nest structure and could therefore be involved in the control of nest climate in leaf-cutting ants.	[Halboth, Florian; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany	University of Wurzburg	Halboth, F (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany.	florian.halboth@uni-wuerzburg.de		Roces, Flavio/0000-0001-9258-3079	German Excellence Initiative; German Research Foundation (DFG); University of Wurzburg	German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wurzburg	Florian Halboth was supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences (GSLS), University of Wurzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wurzburg in the funding program Open Access Publishing. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; Bollazzi M, 2012, INSECT SOC, V59, P487, DOI 10.1007/s00040-012-0243-9; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2007, ANIM BEHAV, V74, P1349, DOI 10.1016/j.anbehav.2007.02.021; Bollazzi M, 2010, J ETHOL, V28, P399, DOI 10.1007/s10164-010-0207-3; Cosarinsky MI, 2007, GEODERMA, V141, P224, DOI 10.1016/j.geoderma.2007.06.006; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; CURRIE JA, 1984, J SOIL SCI, V35, P1, DOI 10.1111/j.1365-2389.1984.tb00253.x; FORSTER RE, 1957, PHYSIOL REV, V37, P391, DOI 10.1152/physrev.1957.37.4.391; Franks NR, 2004, ANIM BEHAV, V67, P965, DOI 10.1016/j.anbehav.2004.01.003; Garrett R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150111; Halboth F, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1504-2; Hangartner W., 1969, Psyche, Camb., V76, P58, DOI 10.1155/1969/58428; Hansell M., 2005, OXF ANIMAL BIOL SER; Hasin S, 2014, ECOL EVOL, V4, P3929, DOI 10.1002/ece3.1255; HEBLING MJA, 1992, COMP BIOCHEM PHYS A, V101, P319, DOI 10.1016/0300-9629(92)90539-3; Holldobler B., 1990, pi; HOLSCHER KH, 1980, ANN ENTOMOL SOC AM, V73, P288, DOI 10.1093/aesa/73.3.288; HOWSE PE, 1966, NATURE, V210, P967, DOI 10.1038/210967b0; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P158; JONKMAN JCM, 1980, Z ANGEW ENTOMOL, V89, P217; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; MCCOOK HC, 1877, T AM ENTOMOL SOC, V6, P253; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moreira AA, 2004, J APPL ENTOMOL, V128, P204, DOI 10.1111/j.1439-0418.2004.00839.x; NICOLAS G, 1989, ANNU REV ENTOMOL, V34, P97, DOI 10.1146/annurev.en.34.010189.000525; Pielstrom S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095658; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; POWELL RJ, 1986, T BRIT MYCOL SOC, V87, P205, DOI 10.1016/S0007-1536(86)80022-5; QUINLAN RJ, 1978, ECOL ENTOMOL, V3, P221, DOI 10.1111/j.1365-2311.1978.tb00922.x; REARDON EJ, 1979, J HYDROL, V43, P355, DOI 10.1016/0022-1694(79)90181-1; Ribeiro PL, 2008, J INSECT BEHAV, V21, P549, DOI 10.1007/s10905-008-9150-3; ROCES F, 1989, OECOLOGIA, V81, P33, DOI 10.1007/BF00377006; Romer D, 2015, INSECT SOC, V62, P401, DOI 10.1007/s00040-015-0419-1; Romer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174597; Sousa-Souto L, 2012, SOIL BIOL BIOCHEM, V44, P21, DOI 10.1016/j.soilbio.2011.09.008; STANGE G, 1992, J COMP PHYSIOL A, V171, P317, DOI 10.1007/BF00223962; Sudd JH, 1982, SOCIAL INSECTS, P107; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; VOGEL S, 1973, J COMP PHYSIOL, V85, P1, DOI 10.1007/BF00694136; Weidenmuller A, 2002, ANIM BEHAV, V63, P1065, DOI 10.1006/anbe.2002.3020; WILSON EDWARD O., 1962, ANIMAL BEHAVIOUR, V10, P159, DOI 10.1016/0003-3472(62)90143-4	46	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188162	10.1371/journal.pone.0188162	http://dx.doi.org/10.1371/journal.pone.0188162			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145459	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800077
J	Ho, JC; Abdullah, LN; Pang, QY; Jha, S; Chow, EKH; Yang, H; Kato, H; Poellinger, L; Ueda, J; Lee, KL				Ho, Jolene Caifeng; Abdullah, Lissa Nurrul; Pang, Qing You; Jha, Sudhakar; Chow, Edward Kai-Hua; Yang, Henry; Kato, Hiroyuki; Poellinger, Lorenz; Ueda, Jun; Lee, Kian Leong			Inhibition of the H3K9 methyltransferase G9A attenuates oncogenicity and activates the hypoxia signaling pathway	PLOS ONE			English	Article							HISTONE-H3 LYSINE-9 METHYLATION; PROMOTES PROLIFERATION; EPIGENETIC THERAPY; SURVIVIN GENE; GROWTH-FACTOR; CANCER; REPRESSION; CELLS; ANGIOGENESIS; METASTASIS	Epigenetic mechanisms play important roles in the regulation of tumorigenesis, and hypoxia- induced epigenetic changes may be critical for the adaptation of cancer cells to the hypoxic microenvironment of solid tumors. Previously, we showed that loss-of-function of the hypoxia-regulated H3K9 methyltransferase G9A attenuates tumor growth. However, the mechanisms by which blockade of G9A leads to a tumor suppressive effect remain poorly understood. We show that G9A is highly expressed in breast cancer and is associated with poor patient prognosis, where it may function as a potent oncogenic driver. In agreement with this, G9A inhibition by the small molecule inhibitor, BIX-01294, leads to increased cell death and impaired cell migration, cell cycle and anchorage-independent growth. Interestingly, whole transcriptome analysis revealed that genes involved in diverse cancer cell functions become hypoxia-responsive upon G9A inhibition. This was accompanied by the upregulation of the hypoxia inducible factors HIF1 alpha and HIF2 alpha during BIX-01294 treatment even in normoxia that may facilitate the tumor suppressive effects of BIX-01294. HIF inhibition was able to reverse some of the transcriptional changes induced by BIX-01294 in hypoxia, indicating that the HIFs may be important drivers of these derepressed target genes. Therefore, we show that G9A is a key mediator of oncogenic processes in breast cancer cells and G9A inhibition by BIX-01294 can successfully attenuate oncogenicity even in hypoxia.	[Ho, Jolene Caifeng; Abdullah, Lissa Nurrul; Pang, Qing You; Jha, Sudhakar; Chow, Edward Kai-Hua; Yang, Henry; Kato, Hiroyuki; Poellinger, Lorenz; Lee, Kian Leong] Natl Univ Singapore, Canc Stem Cells & Biol Program, Canc Sci Inst Singapore, Singapore, Singapore; [Poellinger, Lorenz] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Ueda, Jun] Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan; [Ho, Jolene Caifeng] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Lee, Kian Leong] Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore	National University of Singapore; Karolinska Institutet; Asahikawa Medical College; University of Toronto; Structural Genomics Consortium; National University of Singapore	Ho, JC; Lee, KL (corresponding author), Natl Univ Singapore, Canc Stem Cells & Biol Program, Canc Sci Inst Singapore, Singapore, Singapore.; Ueda, J (corresponding author), Asahikawa Med Univ, Ctr Adv Res & Educ, Asahikawa, Hokkaido, Japan.; Ho, JC (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.; Lee, KL (corresponding author), Duke NUS Med Sch, Canc & Stem Cell Biol Program, Singapore, Singapore.	jolene.ho@utoronto.ca; junueda@asahikawa-med.ac.jp; kianleong.lee@duke-nus.edu.sg	Ueda, Jun/AAX-9704-2020; LEE, Kian Leong/E-3584-2013; Jha, Sudhakar/B-2308-2009; Jha, Sudhakar/S-3550-2019	Ueda, Jun/0000-0002-9766-203X; LEE, Kian Leong/0000-0002-0443-2746; Jha, Sudhakar/0000-0002-5093-4843; Ho, Jolene/0000-0001-5908-0007	National University Cancer Institute, Singapore (NCIS) [NR13NMR1340M]; National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG) [NMRC/CIRG/1389/2014]; National Research Foundation (NRF) Singapore; Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative [R-713-005-014-271, R-713-010-189-112]; Ministry of Education, Singapore AcRF [MOE2015-T2-2-126]; Cancer Science Institute of Singapore RCE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [JP16K07099, JP16H01319]; Swedish Research Council	National University Cancer Institute, Singapore (NCIS); National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG)(National Medical Research Council, Singapore); National Research Foundation (NRF) Singapore(National Research Foundation, Singapore); Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative(Ministry of Education, Singapore); Ministry of Education, Singapore AcRF(Ministry of Education, Singapore); Cancer Science Institute of Singapore RCE; Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by National University Cancer Institute, Singapore (NCIS) Pilot Grant (NR13NMR1340M, H.K., L.P. and K.L.L.); National Medical Research Council (NM RC) Clinician Scientist Individual Research Grant (CS-IRG) (NMRC/CIRG/1389/2014, S.J. and L.P.); the National Research Foundation (NRF) Singapore and the Singapore Ministry of Education (MOE) under the Research Centres of Excellence initiative (R-713-005-014-271, J.C.H., Q.Y.P., H.K., L.P. and K.L.L.; R-713-010-189-112, H.Y.); Ministry of Education, Singapore AcRF Tier 2 (MOE2015-T2-2-126, L.N.A., E.K.C); Cancer Science Institute of Singapore RCE Main Grant (E.K.C.); the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grants-in-Aid for Scientific Research (JP16K07099 and JP16H01319, J.U.); the Swedish Research Council (L.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre E, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0141-5; Ahuja N, 2014, J CLIN INVEST, V124, P56, DOI 10.1172/JCI69736; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Casciello F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00487; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheloni G, 2017, BLOOD, V130, P655, DOI 10.1182/blood-2016-10-745588; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dong CF, 2012, J CLIN INVEST, V122, P1469, DOI 10.1172/JCI57349; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Haddad JJ, 2001, FEBS LETT, V505, P269, DOI 10.1016/S0014-5793(01)02833-2; Hale AT, 2014, J BIOL CHEM, V289, P12016, DOI 10.1074/jbc.M113.530956; Hockel M, 1996, CANCER RES, V56, P4509; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; HUA KT, 2014, MOL CANCER, V13; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Ke XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106962; Kohno M, 1999, J AM SOC NEPHROL, V10, P2495; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lee SH, 2009, ONCOGENE, V28, P184, DOI 10.1038/onc.2008.377; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li YD, 2015, INT J CLIN EXP PATHO, V8, P1731; Ma AN, 2010, BIOCHEM BIOPH RES CO, V393, P592, DOI 10.1016/j.bbrc.2010.02.020; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Michaelson JS, 2003, J CELL SCI, V116, P345, DOI 10.1242/jcs.00234; Mirza A, 2002, ONCOGENE, V21, P2613, DOI 10.1038/sj.onc.1205353; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Oh SY, 2015, MOL CELLS, V38, P528, DOI 10.14348/molcells.2015.0026; Peng XH, 2006, J BIOL CHEM, V281, P25903, DOI 10.1074/jbc.M603414200; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rao VK, 2016, NUCLEIC ACIDS RES, V44, P8129, DOI 10.1093/nar/gkw483; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 1996, TRENDS CARDIOVAS MED, V6, P151, DOI 10.1016/1050-1738(96)00039-4; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Si WZ, 2015, CANCER CELL, V27, P822, DOI 10.1016/j.ccell.2015.04.011; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Ueda J, 2014, MOL CELL BIOL, V34, P3702, DOI 10.1128/MCB.00099-14; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yuan ZG, 2010, MOL CELL BIOL, V30, P3004, DOI 10.1128/MCB.01023-09; Zhou RZ, 2005, CANCER RES, V65, P1839, DOI 10.1158/0008-5472.CAN-03-3755; Zhou XM, 2016, ONCOTARGET, V7, P13634, DOI 10.18632/oncotarget.7215	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188051	10.1371/journal.pone.0188051	http://dx.doi.org/10.1371/journal.pone.0188051			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145444	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800056
J	Imhof, HK; Rusek, J; Thiel, M; Wolinska, J; Laforsch, C				Imhof, Hannes K.; Rusek, Jakub; Thiel, Michaela; Wolinska, Justyna; Laforsch, Christian			Do microplastic particles affect Daphnia magna at the morphological, life history and molecular level?	PLOS ONE			English	Article							COPEPOD TIGRIOPUS-JAPONICUS; MYTILUS-EDULIS L.; GENE-EXPRESSION; MARINE-ENVIRONMENT; OXIDATIVE STRESS; CARCINUS-MAENAS; DEMERSAL FISH; RESPONSES; POLLUTION; EXPOSURE	Microplastic particles are ubiquitous not only in marine but also in freshwater ecosystems. However, the impacts of microplastics, consisting of a large variety of synthetic polymers, on freshwater organisms remains poorly understood. We examined the effects of two polymer mixtures on the morphology, life history and on the molecular level of the waterflea Daphnia magna (three different clones). Microplastic particles of similar to 40 mu m were supplied at a low concentration (1% of the food particles) leading to an average of similar to 30 particles in the digestive tract which reflects a high microplastic contamination but still resembles a natural situation. Neither increased mortality nor changes on the morphological (body length, width and tail spine length) or reproductive parameters were observed for adult Daphnia. The analyses of juvenile Daphnia revealed a variety of small and rather subtle responses of morphological traits (body length, width and tail spine length). For adult Daphnia, alterations in expression of genes related to stress responses (i.e. HSP60, HSP70 & GST) as well as of other genes involved in body function and body composition (i.e. SERCA) were observed already 48h after exposure. We anticipate that the adverse effects of microplastic might be influenced by many additional factors like size, shape, type and even age of the particles and that the rather weak effects, as detected in a laboratory, may lead to reduced fitness in a natural multi-stressor environment.	[Imhof, Hannes K.; Laforsch, Christian] Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany; [Imhof, Hannes K.; Laforsch, Christian] Univ Bayreuth, BayCEER, Bayreuth, Germany; [Imhof, Hannes K.; Rusek, Jakub; Thiel, Michaela] Ludwig Maximilians Univ Munchen, Dept Biol 2, Planegg Martinsried, Germany; [Wolinska, Justyna] Leibniz Inst Freshwater Ecol & Inland Fisheries, Dept Ecosyst Res, Muggelseedamm 301, Berlin, Germany; [Wolinska, Justyna] Free Univ Berlin, Inst Biol, Dept Biol Chem Pharm, Berlin, Germany	University of Bayreuth; University of Bayreuth; University of Munich; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); Free University of Berlin	Laforsch, C (corresponding author), Univ Bayreuth, Dept Anim Ecol 1, Bayreuth, Germany.; Laforsch, C (corresponding author), Univ Bayreuth, BayCEER, Bayreuth, Germany.	Christian.laforsch@uni-bayreuth.de	Wolinska, Justyna/N-6455-2014; Imhof, Hannes/HDN-2781-2022	Imhof, Hannes/0000-0003-4992-5357	Deutsche Forschungsgemeinschaft (DFG) [LA 2159/7-1]; Studienstiftung des deutschen Volkes; German Research Foundation (DFG); University of Bayreuth in the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth in the funding programme Open Access Publishing	We wish to thank the Deutsche Forschungsgemeinschaft (DFG; LA 2159/7-1) for funding. Generous financial support of Hannes Imhof by the "Studienstiftung des deutschen Volkes" is gratefully acknowledged. This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler I, 2015, GENOME, V58, P99, DOI 10.1139/gen-2015-0045; Altshuler I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052617; Anderson M., 2005, PERMUTATIONAL MULTIV, V24; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Barboza LGA, 2015, MAR POLLUT BULL, V97, P5, DOI 10.1016/j.marpolbul.2015.06.008; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Bakir A, 2012, MAR POLLUT BULL, V64, P2782, DOI 10.1016/j.marpolbul.2012.09.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Besseling E, 2014, ENVIRON SCI TECHNOL, V48, P12336, DOI 10.1021/es503001d; Biginagwa FJ, 2016, J GREAT LAKES RES, V42, P146, DOI 10.1016/j.jglr.2015.10.012; BLACK AR, 1990, OECOLOGIA, V83, P117, DOI 10.1007/BF00324642; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Brennecke D, 2015, MAR POLLUT BULL, V96, P491, DOI 10.1016/j.marpolbul.2015.05.001; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2015, ENVIRON SCI TECHNOL, V49, P7082, DOI 10.1021/es5060572; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Castaneda RA, 2014, CAN J FISH AQUAT SCI, V71, P1767, DOI 10.1139/cjfas-2014-0281; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Dantas DV, 2012, ENVIRON SCI POLLUT R, V19, P600, DOI 10.1007/s11356-011-0579-0; Dietrich S, 2010, CHEMOSPHERE, V79, P60, DOI 10.1016/j.chemosphere.2009.12.069; Dris R, 2015, ENVIRON CHEM, V12, P539, DOI 10.1071/EN14172; Duis K, 2016, ENVIRON SCI EUR, V28, DOI 10.1186/s12302-015-0069-y; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Farrell P, 2013, ENVIRON POLLUT, V177, P1, DOI 10.1016/j.envpol.2013.01.046; Flaherty CM, 2005, CHEMOSPHERE, V61, P200, DOI 10.1016/j.chemosphere.2005.02.016; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Gall SC, 2015, MAR POLLUT BULL, V92, P170, DOI 10.1016/j.marpolbul.2014.12.041; Haap T, 2009, AQUAT TOXICOL, V94, P131, DOI 10.1016/j.aquatox.2009.06.006; Hamer J, 2014, ENVIRON SCI TECHNOL, V48, P13451, DOI 10.1021/es501385y; Heckmann LH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r40; Heckmann LH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-175; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellemans J, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P139; Imhof HK, 2016, WATER RES, V98, P64, DOI 10.1016/j.watres.2016.03.015; Imhof HK, 2013, CURR BIOL, V23, pR867, DOI 10.1016/j.cub.2013.09.001; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Ki JS, 2009, AQUAT TOXICOL, V93, P177, DOI 10.1016/j.aquatox.2009.04.004; Kim J, 2009, AQUAT TOXICOL, V91, P87, DOI 10.1016/j.aquatox.2008.10.006; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Klein S, 2015, ENVIRON SCI TECHNOL, V49, P6070, DOI 10.1021/acs.est.5b00492; Koelmans AA, 2016, ENVIRON SCI TECHNOL, V50, P3315, DOI 10.1021/acs.est.5b06069; Lampert W., 2011, DAPHNIA DEVELOPMENT; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Lee KW, 2013, ENVIRON SCI TECHNOL, V47, P11278, DOI 10.1021/es401932b; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Lonnstedt OM, 2016, SCIENCE, V352, P1213, DOI 10.1126/science.aad8828; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Mani T, 2015, SCI REP-UK, V5, DOI 10.1038/srep17988; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; Mintenig SM, 2017, WATER RES, V108, P365, DOI 10.1016/j.watres.2016.11.015; Motulsky H., 1995, INTUITIVE BIOSTATIST; Oliveira M, 2013, ECOL INDIC, V34, P641, DOI 10.1016/j.ecolind.2013.06.019; Otte KA, 2015, MOL ECOL, V24, P3901, DOI 10.1111/mec.13287; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Pauwels K, 2005, J EVOLUTION BIOL, V18, P867, DOI 10.1111/j.1420-9101.2005.00890.x; Peters R. H, 1987, DAPHNIA CONSIGLIO NA; Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6257, DOI 10.1021/es800262k; Poynton HC, 2008, ENVIRON SCI TECHNOL, V42, P6250, DOI 10.1021/es8010783; Poynton HC, 2012, ENVIRON SCI TECHNOL, V46, P6288, DOI 10.1021/es3001618; Rabus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067856; Rabus M, 2011, FUNCT ECOL, V25, P1137, DOI 10.1111/j.1365-2435.2011.01840.x; Rehse S, 2016, CHEMOSPHERE, V153, P91, DOI 10.1016/j.chemosphere.2016.02.133; Rhee JS, 2009, COMP BIOCHEM PHYS C, V149, P104, DOI 10.1016/j.cbpc.2008.07.009; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rosenkranz P, 2009, ENVIRON TOXICOL CHEM, V28, P2142, DOI 10.1897/08-559.1; Rummel CD, 2016, MAR POLLUT BULL, V102, P134, DOI 10.1016/j.marpolbul.2015.11.043; Sanchez W, 2014, ENVIRON RES, V128, P98, DOI 10.1016/j.envres.2013.11.004; Schwarzenberger A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-527; Schwenk Klaus, 1998, Aquatic Ecology, V32, P37, DOI 10.1023/A:1009939901198; Spanier KI, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-50; Steinberg CEW, 2010, HYDROBIOLOGIA, V652, P223, DOI 10.1007/s10750-010-0334-4; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Tollrian R, 1999, ECOLOGY EVOLUTION IN; Turner A, 2015, ENVIRON CHEM, V12, P600, DOI 10.1071/EN14143; UNEP Year Book, 2011, UNEP YB; Vandermeersch G, 2015, ENVIRON RES, V143, P46, DOI 10.1016/j.envres.2015.07.016; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vegter AC, 2014, ENDANGER SPECIES RES, V25, P225, DOI 10.3354/esr00623; Watts AJR, 2014, ENVIRON SCI TECHNOL, V48, P8823, DOI 10.1021/es501090e; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	92	101	104	9	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187590	10.1371/journal.pone.0187590	http://dx.doi.org/10.1371/journal.pone.0187590			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145427	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800021
J	Zong, SM; Zeng, X; Liu, TY; Wan, FM; Luo, P; Xiao, HJ				Zong, Shimin; Zeng, Xue; Liu, Tianyi; Wan, Fangmin; Luo, Pan; Xiao, Hongjun			Association of polymorphisms in heat shock protein 70 genes with the susceptibility to noise-induced hearing loss: A meta-analysis	PLOS ONE			English	Article							STRESS; POPULATIONS; CHAPERONES; WORKERS	Background Several case-control studies reported the relationship between single nucleotide polymorphisms (SNPs) in HSP70 genes and noise-induced hearing loss (NIHL). However, their conclusions are conflicting. This meta-analysis aims to identify the association of HSP70 variants and NIHL susceptibility. Method A systematical literature search was performed in PubMed, Web of Science, EMBASE, and Wanfang Chinese database. The pooled odds radio (OR), 95% confidence interval (CI) and p value were calculated in fixed-or random-effects model according to the I 2 value in the heterogeneity test. Results Four articles containing five studies, including 633 cases and 926 controls, were included. Under the allele, homozygote and dominant model, the pooled ORs (95% CI, p-value) of rs1061581 were 1.32 (1.06-1.67, p = 0.019), 1.93 (1.10-3.36, p = 0.021) and 1.455 (1.408-2.019, p = 0.025), respectively. In addition, a significant association was found between rs2227956 in Caucasians and the NIHL susceptibility under all five genetic models. We did not discover evidence sufficient to prove the associations between the other three SNPs (rs1043618, rs2763979 and rs2075800) and the NIHL susceptibility. Conclusion This meta-analysis indicated that the two HSP70 variants, rs1061581 and rs2227956, may serve as genetic susceptibility factors for NIHL. Larger scale studies are required to further update the results.	[Zong, Shimin; Liu, Tianyi; Wan, Fangmin; Luo, Pan; Xiao, Hongjun] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otorhinolaryngol, Wuhan, Hubei, Peoples R China; [Zeng, Xue] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Xiao, HJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Otorhinolaryngol, Wuhan, Hubei, Peoples R China.	xhjent@163.com			National Natural Science Foundation of China [81470697]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81470697, http://www.nsfc.gov.cn/, H Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlsson PI, 2005, HEARING RES, V202, P87, DOI 10.1016/j.heares.2004.09.005; Chang NC, 2011, AUDIOL NEURO-OTOL, V16, P168, DOI 10.1159/000317119; Dobie RA, 2008, EAR HEARING, V29, P565, DOI 10.1097/AUD.0b013e31817349ec; Gratton MA, 2011, HEARING RES, V277, P211, DOI 10.1016/j.heares.2010.12.014; Konings A, 2009, ANN HUM GENET, V73, P215, DOI 10.1111/j.1469-1809.2008.00499.x; Konings A, 2009, EUR J HUM GENET, V17, P329, DOI 10.1038/ejhg.2008.172; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Li YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171722; Lin CY, 2009, HEARING RES, V257, P8, DOI 10.1016/j.heares.2009.07.008; Liu YM, 2010, DIS MARKERS, V28, P137, DOI [10.1155/2010/753073, 10.3233/DMA-2010-0693]; Maeda Y, 2015, OTOL NEUROTOL, V36, P1255, DOI 10.1097/MAO.0000000000000748; Mardan-Nik M, 2016, ANN HUM BIOL, V43, P542, DOI 10.3109/03014460.2015.1119309; Mardan-Nik M, 2014, GENE, V550, P180, DOI 10.1016/j.gene.2014.08.012; Nelson DI, 2005, AM J IND MED, V48, P446, DOI 10.1002/ajim.20223; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Schmitz-Abe K, 2015, BLOOD, V126, P2734, DOI 10.1182/blood-2015-09-659854; Sha SH, 2017, EXPERT OPIN INV DRUG, V26, P85, DOI 10.1080/13543784.2017.1269171; Shen HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089662; Sulkowski Wieslaw J, 2004, Otolaryngol Pol, V58, P233; Wallenius MA, 2004, J ENVIRON PSYCHOL, V24, P167, DOI 10.1016/j.jenvp.2003.12.002; Xue QH, 2016, NOISE HEALTH, V18, P247, DOI 10.4103/1463-1741.192481; Yang M, 2006, CELL STRESS CHAPERON, V11, P233, DOI 10.1379/CSC-192R.1; Zhang Y, 2013, CELL STRESS CHAPERON, V18, P703, DOI 10.1007/s12192-013-0420-4; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y; Zuo HY, 2008, J OCCUP HEALTH, V50, P373, DOI 10.1539/joh.L8032	25	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188195	10.1371/journal.pone.0188195	http://dx.doi.org/10.1371/journal.pone.0188195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145455	Green Published, Green Submitted			2022-12-27	WOS:000415378800086
J	Richardsen, E; Andersen, S; Al-Saad, S; Rakaee, M; Nordby, Y; Pedersen, MI; Ness, N; Grindstad, T; Movik, I; Donnem, T; Bremnes, R; Busund, LT				Richardsen, Elin; Andersen, Sigve; Al-Saad, Samer; Rakaee, Mehrdad; Nordby, Yngve; Pedersen, Mona Irene; Ness, Nora; Grindstad, Thea; Movik, Ingeborg; Donnem, Tom; Bremnes, Roy; Busund, Lill-Tove			Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; TUMOR-GROWTH FRACTION; ANDROGEN-DEPRIVATION; MONOCLONAL-ANTIBODY; CANCER; EXPRESSION; TISSUE; RECURRENCE; MIB-1; KI67	The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted and biologically heterogeneous disease, and overtreatment of localized, low volume indolent tumors, is evident. Here, we aimed to assess Ki-67 expression and related outcomes of 535 patients treated with radical prostatectomy. The percentage of tumor epithelial cells expressing Ki-67 was determined by immunohistochemical assay, both digital image analysis and visual scoring by light microscope were used for quantification. The association of Ki-67 and prostate cancer was evaluated, as well as its prognostic value. There was a positive correlation between high expression of Ki-67 and Gleason score > 7 (p < 0.001) as well as tumor size (>= 20 mm, p = 0.03). In univariate analyses, a high expression of Ki-67 in tumor epithelium was significantly associated with biochemical failure (BF) (digital scoring, p = 0.014) and (visual scoring, p = 0.004). In the multivariate analyses, a high level of Ki-67 was an independent poor prognostic factor for biochemical failure-free survival (BFFS) (Visual scoring, Ki67, p = 0.012, HR:1.50, CI95% 1.10-2.06). In conclusion, high Ki-67 expression is an independent negative prognostic marker for biochemical failure. Our findings support the role of Ki-67 as a significant, poor prognostic factor for in prostate cancer outcome.	[Richardsen, Elin; Al-Saad, Samer; Rakaee, Mehrdad; Pedersen, Mona Irene; Ness, Nora; Grindstad, Thea; Movik, Ingeborg; Busund, Lill-Tove] UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Richardsen, Elin; Al-Saad, Samer; Busund, Lill-Tove] Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway; [Andersen, Sigve; Nordby, Yngve; Donnem, Tom; Bremnes, Roy] UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway; [Andersen, Sigve; Donnem, Tom; Bremnes, Roy] Univ Hosp North Norway, Dept Oncol, Tromso, Norway; [Nordby, Yngve] Univ Hosp North Norway, Dept Urol, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway	Richardsen, E (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Translat Canc Res Grp, Tromso, Norway.; Richardsen, E (corresponding author), Univ Hosp North Norway, Dept Clin Pathol, Tromso, Norway.	elin-ri@live.no	Rakaee, Mehrdad/GMX-0729-2022	Rakaee, Mehrdad/0000-0002-9080-0153	Norwegian Cancer Society; Northern Health Administration, UiT Arctic University of Norway	Norwegian Cancer Society(Norwegian Cancer Society); Northern Health Administration, UiT Arctic University of Norway	This study was supported by grants from Norwegian Cancer Society (www.kreftforeningen. no) and The Northern Health Administration (www.helse-nord.no), UiT Arctic University of Norway (www.uit.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN S, 2014, BMC UROL, V14, P14, DOI DOI 10.1002/IJC.24174; BARBARESCHI M, 1994, AM J CLIN PATHOL, V102, P171, DOI 10.1093/ajcp/102.2.171; Bettencourt MC, 1996, J UROLOGY, V156, P1064, DOI 10.1016/S0022-5347(01)65703-3; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Cooperberg MR, 2015, JAMA-J AM MED ASSOC, V314, P80, DOI 10.1001/jama.2015.6036; Cowen D, 2002, CLIN CANCER RES, V8, P1148; Desmeules P, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0294-0; Edge SB, 2010, AJCC CANC STAGING MA; Epstein JI, 2016, AM J SURG PATHOL, V40, P244, DOI 10.1097/PAS.0000000000000530; Epstein JI, 2016, EUR UROL, V69, P428, DOI 10.1016/j.eururo.2015.06.046; Fisher G, 2013, BRIT J CANCER, V108, P271, DOI 10.1038/bjc.2012.598; GERDES J, 1984, J IMMUNOL, V133, P1710; GRINDSTAD T, 2016, SCI REP, V9, P33114, DOI DOI 10.1038/SJ.BJC.6602678; Havelund BM, 2013, APPL IMMUNOHISTO M M, V21, P298, DOI 10.1097/PAI.0b013e31826f4475; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; Kankuri M, 2006, ANTICANCER RES, V26, P3825; Leonardo E, 2007, APPL IMMUNOHISTO M M, V15, P220, DOI 10.1097/01.pai.0000213122.66096.f0; Li SY, 2013, AM J SURG PATHOL, V37, P14, DOI 10.1097/PAS.0b013e31826731b5; Lowrance William T, 2009, Rev Urol, V11, P117; MAZEROLLES C, 1994, HISTOPATHOLOGY, V25, P563, DOI 10.1111/j.1365-2559.1994.tb01375.x; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Mesko S, 2013, PROSTATE CANCER, V2013, DOI 10.1155/2013/717080; Munstedt K, 2004, CANCER INVEST, V22, P185, DOI 10.1081/CNV-120030206; Ness N, 2014, PROSTATE, V74, P1452, DOI 10.1002/pros.22862; Nordby Y, 2015, PROSTATE, V75, P1682, DOI 10.1002/pros.23048; Pascale M, 2016, RADIOL ONCOL, V50, P313, DOI 10.1515/raon-2016-0033; Pollack A, 2004, J CLIN ONCOL, V22, P2133, DOI 10.1200/JCO.2004.09.150; Potosky AL, 2014, J CLIN ONCOL, V32, P1324, DOI 10.1200/JCO.2013.52.5782; Richardsen E, 2015, AM J PATHOL, V185, P2722, DOI 10.1016/j.ajpath.2015.06.013; Rubio J, 2005, EUR UROL, V48, P745, DOI 10.1016/j.eururo.2005.06.014; Scholzen T, 2002, J PATHOL, V196, P135, DOI 10.1002/path.1016; Shariat SF, 2008, CURR OPIN UROL, V18, P279, DOI 10.1097/MOU.0b013e3282f9b3e5; Tollefson MK, 2014, MAYO CLIN PROC, V89, P308, DOI 10.1016/j.mayocp.2013.12.001; Tolonen TT, 2011, BJU INT, V108, P1430, DOI 10.1111/j.1464-410X.2011.10253.x; Vis AN, 2002, J PATHOL, V197, P148, DOI 10.1002/path.1084; WOLTERS R, 2010, BJU INT, V106, P280, DOI DOI 10.1111/J.1464-410X.2011.10253.X; Zellweger T, 2009, INT J CANCER, V124, P2116, DOI 10.1002/ijc.24174	38	32	34	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186852	10.1371/journal.pone.0186852	http://dx.doi.org/10.1371/journal.pone.0186852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141018	Green Published, gold			2022-12-27	WOS:000415260400011
J	Singh, D; Kabiraj, D; Sharma, P; Chetia, H; Mosahari, PV; Neog, K; Bora, U				Singh, Deepika; Kabiraj, Debajyoti; Sharma, Pragya; Chetia, Hasnahana; Mosahari, Ponnala Vimal; Neog, Kartik; Bora, Utpal			The mitochondrial genome of Muga silkworm (Antheraea assamensis) and its comparative analysis with other lepidopteran insects	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; GENE REARRANGEMENT; PERNYI LEPIDOPTERA; MOTH; EVOLUTION; DNA; ORGANIZATION; PHYLOGENY; SATURNIIDAE; DROSOPHILA	Muga (Antheraea assamensis) is an economically important silkmoth endemic to the states of Assam and Meghalaya in India and is the producer of the strongest known commercial silk. However, there is a scarcity of genomic and proteomic data for understanding the organism at a molecular level. Our present study is on decoding the complete mitochondrial genome (mitogenome) of A. assamensis using next generation sequencing technology and comparing it with other available lepidopteran mitogenomes. Mitogenome of A. assamensis is an AT rich circular molecule of 15,272 bp (A + T content similar to 80.2%). It contains 37 genes comprising of 13 protein coding genes (PCGs), 22 tRNA and 2 rRNA genes along with a 328 bp long control region. Its typical tRNA(Met)-tRNA(Ile)-tRNA(Gln) arrangement differed from ancestral insects (tRNA(Ile)-tRNA(Gln)-tRNA(Met)). Two PCGs cox1 and cox2 were found to have CGA and GTG as start codons, respectively as reported in some lepidopterans. Interestingly, nad4l gene showed higher transversion mutations at intra-species than inter-species level. All PCGs evolved under strong purifying selection with highest evolutionary rates observed for atp8 gene while lowest for cox1 gene. We observed the typical clover-leaf shaped secondary structures of tRNAs with a few exceptions in case of tRNA(Ser1) and tRNA(Tyr) where stable DHU and T psi C loop were absent. A significant number of mismatches (35) were found to spread over 19 tRNA structures. The control region of mitogenome contained a six bp (CTTAGA/G) deletion atypical of other Antheraea species and lacked tandem repeats. Phylogenetic position of A. assamensis was consistent with the traditional taxonomic classification of Saturniidae. The complete annotated mitogenome is available in GenBank (Accession No. KU379695). To the best of our knowledge, this is the first report on complete mitogenome of A. assamensis.	[Singh, Deepika; Kabiraj, Debajyoti; Chetia, Hasnahana; Bora, Utpal] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Bioengn Res Lab, Gauhati, Assam, India; [Singh, Deepika; Mosahari, Ponnala Vimal; Bora, Utpal] Indian Inst Technol Guwahati, Ctr Environm, Gauhati, Assam, India; [Sharma, Pragya] Gauhati Univ, GUIST, Dept Bioengn & Technol, Gauhati, Assam, India; [Neog, Kartik] CMER&TI, Biotechnol Sect, Jorhat, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati University	Bora, U (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Bioengn Res Lab, Gauhati, Assam, India.; Bora, U (corresponding author), Indian Inst Technol Guwahati, Ctr Environm, Gauhati, Assam, India.	ubora@iitg.ernet.in	Chetia, Hasnahana/O-8281-2014	Chetia, Hasnahana/0000-0002-9167-3643; Singh, Dr. Deepika/0000-0003-3013-1389; Sharma, Pragya/0000-0001-6405-7872; Mosahari, Ponnala Vimal/0000-0001-9507-0033	Department of Biotechnology, Govt. of India, New Delhi through the UXCEL [BT/411/NE/U-Excel/2013]	Department of Biotechnology, Govt. of India, New Delhi through the UXCEL	The authors thank the Department of Biotechnology, Govt. of India, New Delhi for supporting the research through the UXCEL project (Sanction Order No: BT/411/NE/U-Excel/2013 dated 06.02.2014). The funding agency had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andrews S., 2010, FASTQC QUALITY CONTR; Arunkumar KP, 2006, MOL PHYLOGENET EVOL, V40, P419, DOI 10.1016/j.ympev.2006.02.023; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cao YQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-276; Chakravorty R, 2005, PACKAGE PRACTICES MU, P1; Chen MM, 2014, GENE, V545, P95, DOI 10.1016/j.gene.2014.05.002; Chetia H, 2017, GENE, V611, P54, DOI 10.1016/j.gene.2017.02.021; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Coates BS, 2005, INT J BIOL SCI, V1, P13; Dai LS, 2016, MITOCHONDRIAL DNA A, V27, P1512, DOI 10.3109/19401736.2014.953116; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEBRUIJN MHL, 1983, NATURE, V304, P234, DOI 10.1038/304234a0; DESALLE R, 1987, J MOL EVOL, V26, P157, DOI 10.1007/BF02111289; Dowton M, 1999, MOL BIOL EVOL, V16, P298, DOI 10.1093/oxfordjournals.molbev.a026111; Drummond A, TRACER V1 6 2014; Gong YJ, 2014, MITOCHONDR DNA, V25, P288, DOI 10.3109/19401736.2013.792071; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Hong MY, 2008, GENE, V413, P49, DOI 10.1016/j.gene.2008.01.019; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037; Kim JS, 2012, J ASIA-PAC ENTOMOL, V15, P162, DOI 10.1016/j.aspen.2011.10.002; Kim MI, 2009, MOL CELLS, V28, P347, DOI 10.1007/s10059-009-0129-5; Kim MJ, 2013, MITOCHONDR DNA, V24, P622, DOI 10.3109/19401736.2013.772155; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Kim MJ, 2010, AFR J BIOTECHNOL, V9; Kim SR, 2009, MOL BIOL REP, V36, P1871, DOI 10.1007/s11033-008-9393-2; Kong WQ, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev032; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Lee ES, 2006, GENE, V373, P52, DOI 10.1016/j.gene.2006.01.003; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu QN, 2017, BIOCHEM BIOPH RES CO, V489, P149, DOI 10.1016/j.bbrc.2017.05.115; Liu QN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35878; Liu QN, 2012, GENE, V505, P291, DOI 10.1016/j.gene.2012.06.003; Liu YQ, 2012, ANN ENTOMOL SOC AM, V105, P498, DOI 10.1603/AN11156; Liu YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P693, DOI [10.1111/j.1745-7270.2008.00449.x, 10.1093/abbs/40.8.693]; Mandal D. S. L., 2014, DNA BARCODES, V2, P1; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016444; Meiklejohn CD, 2007, TRENDS GENET, V23, P259, DOI 10.1016/j.tig.2007.03.008; Mitter C, 2017, ANNU REV ENTOMOL, V62, P265, DOI 10.1146/annurev-ento-031616-035125; Nassig Wolfgang A., 1996, Heterocera Sumatrana, V10, P3; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Park JS, 2016, CURR GENET, V62, P809, DOI 10.1007/s00294-016-0585-3; Park JS, 2016, MITOCHONDRIAL DNA A, V27, P149, DOI 10.3109/19401736.2013.878918; Salvioli S, 2001, FEBS LETT, V492, P9, DOI 10.1016/S0014-5793(01)02199-8; Sarmah MC, 2011, CURR SCI INDIA, V100, P279; Shi BC, 2013, MITOCHONDR DNA, V24, P37, DOI 10.3109/19401736.2012.716054; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Smith C, 2010, NUCLEIC ACIDS RES, V38, pW373, DOI 10.1093/nar/gkq316; Stewart JB, 2009, GENE, V445, P49, DOI 10.1016/j.gene.2009.06.006; Stolle E, 2013, GENOME BIOL EVOL, V5, P151, DOI 10.1093/gbe/evs133; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tikader A, 2013, EUR J ENTOMOL, V110, P293, DOI 10.14411/eje.2013.096; Timmermans MJTN, 2014, MOL PHYLOGENET EVOL, V79, P169, DOI 10.1016/j.ympev.2014.05.031; Wu LW, 2010, ENTOMOL NEWS, V121, P267; Yang L, 2009, MOL BIOL REP, V36, P1441, DOI 10.1007/s11033-008-9334-0; Yang XS, 2013, GENE, V515, P349, DOI 10.1016/j.gene.2012.11.031; Yuan ML, 2013, MITOCHONDR DNA, V24, P328, DOI 10.3109/19401736.2012.760077; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhao Fang, 2013, Zoological Research, V34	75	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188077	10.1371/journal.pone.0188077	http://dx.doi.org/10.1371/journal.pone.0188077			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141006	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400055
J	Wang, ZH				Wang, Zhenhong			Process strengths determine the forms of the relationship between plant species richness and primary productivity	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ECOSYSTEM FUNCTION; FIELD EXPERIMENTS; TREE DIVERSITY; BIODIVERSITY; COMPETITION; DISTURBANCE; COEXISTENCE; BIOMASS; EQUIVALENCE	The current rates of biodiversity loss have exceeded the rates observed during the earth's major extinction events, which spurs the studies of the ecological relationships between biodiversity and ecosystem functions, stability, and services to determine the consequences of biodiversity loss. Plant species richness-productivity relationship (SRPR) is crucial to the understanding of these relationships in plants. Most ecologists have reached a widespread consensus that the loss of plant diversity undoubtedly impairs ecosystem functions, and have proposed many processes to explain the SRPR. However, none of the available studies has satisfactorily described the forms and mechanisms clarifying the SRPR. Observed results of the SRPR forms are inconsistent, and studies have long debated the ecological processes explaining the SRPR. Here, I have developed a simple model that combines the positive and/or negative effects of sixteen ecological processes on the SRPR and models that describe the dynamics of complementary-selection effect, density effect, and the interspecific competitive stress influenced by other ecological processes. I can regulate the strengths of the effects of these ecological processes to derive the asymptotic, positive, humped, negative, and irregular forms of the SRPR, and verify these forms using the observed data. The results demonstrated that the different strengths of the ecological processes determine the forms of the SRPR. The forms of the SRPR can change with variations in the strengths of the ecological processes. The dynamic characteristics of the complementary-selection effect, density effect, and the interspecific competitive stress on the SRPR are diverse, and are dependent on the strengths and variation of the ecological processes. This report explains the diverse forms of the SRPR, clarifies the integrative effects of the different ecological processes on the SRPR, and deepens our understanding of the interactions that occur among these ecological processes.	[Wang, Zhenhong] Changan Univ, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China; [Wang, Zhenhong] Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian, Shaanxi, Peoples R China	Chang'an University; Chang'an University	Wang, ZH (corresponding author), Changan Univ, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China.; Wang, ZH (corresponding author), Changan Univ, Minist Educ, Key Lab Subsurface Hydrol & Ecol Effects Arid Reg, Xian, Shaanxi, Peoples R China.	w_zhenhong@126.com		wang, zhenhong/0000-0002-7829-8834	National Natural Science Foundation of China [40861015]; Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau [10501-161]; Fundamental Research Funds for the Central Universities [310829173601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (No. 40861015) to Zhenhong Wang, the Foundation of State Key Laboratory of Soil Erosion and Dryland Forming on Loess Plateau (No. 10501-161) to Zhenhong Wang, and the Fundamental Research Funds for the Central Universities (No. 310829173601) to Zhenhong Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by grants from the Fundamental Research Funds for the Central Universities (No. 310829173601) and the National Natural Science Foundation of China (No. 40861015). We thank Dr. John A. Gamon, anonymous reviewers, and Axios Review for their constructive comments.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BELSKY JA, 1992, J VEG SCI, V3, P187, DOI 10.2307/3235679; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chisholm RA, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12132; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; GARCIA LV, 1993, J VEG SCI, V4, P417, DOI 10.2307/3235601; GOLDBERG DE, 1983, AM J BOT, V70, P1098, DOI 10.2307/2442821; Goudard A, 2008, AM NAT, V171, P91, DOI 10.1086/523945; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Hodapp D, 2016, ECOLOGY, V97, P1463, DOI 10.1890/15-0730.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2007, ECOL LETT, V10, P849, DOI 10.1111/j.1461-0248.2007.01075.x; Huston M A, 2000, Science, V289, P1255; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Huston MA, 2014, ECOLOGY, V95, P2382, DOI 10.1890/13-1397.1; Jiang L, 2007, OIKOS, V116, P324, DOI 10.1111/j.2006.0030-1299.15371.x; Jiang XiaoLei, 2004, Acta Prataculturae Sinica, V13, P8; Jiang Y.X., 2002, BIODIVERSITY FORMATI; Jucker T, 2016, J ECOL, V104, P388, DOI 10.1111/1365-2745.12522; Kessler M, 2014, J ECOL, V102, P1623, DOI 10.1111/1365-2745.12299; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lasky JR, 2014, ECOL LETT, V17, P1158, DOI 10.1111/ele.12322; Liang JJ, 2015, P NATL ACAD SCI USA, V112, P5738, DOI 10.1073/pnas.1409853112; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Matsinos YG, 2002, ECOL MODEL, V149, P71, DOI 10.1016/S0304-3800(01)00515-4; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mishra BP, 2004, BIODIVERS CONSERV, V13, P421, DOI 10.1023/B:BIOC.0000006509.31571.a0; Nuttle T, 2013, ECOL MONOGR, V83, P3, DOI 10.1890/11-2263.1; Partel M, 1996, OIKOS, V75, P111, DOI 10.2307/3546327; Perrings C, 2011, FRONT ECOL ENVIRON, V9, P512, DOI 10.1890/100212; Rees M, 2013, ECOL LETT, V16, P291, DOI 10.1111/ele.12037; ROBBINS H, 1951, ANN MATH STAT, V22, P400, DOI 10.1214/aoms/1177729586; Rychtecka T, 2014, NATURWISSENSCHAFTEN, V101, P637, DOI 10.1007/s00114-014-1198-7; Salo T, 2009, MAR ECOL PROG SER, V396, P261, DOI 10.3354/meps08325; Sammul M, 2000, OECOLOGIA, V125, P18, DOI 10.1007/PL00008887; Sammul M, 2006, OIKOS, V112, P138, DOI 10.1111/j.0030-1299.2006.13378.x; Schulze E.D., 1993, BIODIVERSITY ECOSYST; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Song Y.C., 2001, VEGETATION ECOLOGY; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Stevens MHH, 1999, ECOLOGY, V80, P455, DOI 10.1890/0012-9658(1999)080[0455:PDDSRA]2.0.CO;2; Stevens MHH, 2002, ECOL LETT, V5, P420, DOI 10.1046/j.1461-0248.2002.00333.x; Szwagrzyk J, 2007, J VEG SCI, V18, P555, DOI 10.1111/j.1654-1103.2007.tb02569.x; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Turnbull LA, 2013, ECOL LETT, V16, P116, DOI 10.1111/ele.12056; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Wang ZH, 2010, PLANT ECOL, V209, P205, DOI 10.1007/s11258-009-9680-6; Wang Zhenhong, 2006, Yingyong Shengtai Xuebao, V17, P1583; Wardle DA, 2001, OECOLOGIA, V129, P620, DOI 10.1007/s004420100753; Weis JJ, 2007, ECOLOGY, V88, P929, DOI 10.1890/06-0943; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Willig MR, 2011, SCIENCE, V333, P1709, DOI 10.1126/science.1212453; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x; Zunzunegui M, 2012, PLANT SOIL, V354, P299, DOI 10.1007/s11104-011-1066-6	75	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0185884	10.1371/journal.pone.0185884	http://dx.doi.org/10.1371/journal.pone.0185884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140995	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400003
J	Wu, YC; Xu, R; Jia, KR; Shi, H				Wu, Yingcheng; Xu, Ran; Jia, Keren; Shi, Hui			The efficacy of chimeric antigen receptor (CAR) immunotherapy in animal models for solid tumors: A systematic review and meta-analysis	PLOS ONE			English	Review							T-CELLS	Background Most recently, an emerging theme in the field of tumor immunology predominates: chimeric antigen receptor (CAR) therapy in treating solid tumors. The number of related preclinical trials was surging. However, an evaluation of the effects of preclinical studies remained absent. Hence, a meta-analysis was conducted on the efficacy of CAR in animal models for solid tumors. Methods The authors searched PubMed/Medline, Embase, and Google scholar up to April 2017. HR for survival was extracted based on the survival curve. The authors used fixed effect models to combine the results of all the trials. Heterogeneity was assessed by I-square statistic. Quality assessment was conducted following the Stroke Therapy Academic Industry Roundtable standard. Publication bias was assessed using Egger's test. Results Eleven trials were included, including 54 experiments with a total of 362 animals involved. CAR immunotherapy significantly improved the survival of animals (HR: 0.25, 95% CI: 0.13-0.37, P < 0.001). The quality assessment revealed that no study reported whether allocation concealment and blinded outcome assessment were conducted, and only five studies implemented randomization. Conclusions This meta-analysis indicated that CAR therapy may be a potential clinical strategy in treating solid tumors.	[Wu, Yingcheng; Xu, Ran; Jia, Keren] Nantong Univ, Med Sch, Nantong, Jiangsu, Peoples R China; [Shi, Hui] Nantong Univ, Affiliated Hosp, Dept Thorac Surg, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University	Shi, H (corresponding author), Nantong Univ, Affiliated Hosp, Dept Thorac Surg, Nantong, Jiangsu, Peoples R China.	disney1982@163.com	Wu, Yingcheng/AGB-5422-2022	Jia, Keren/0000-0001-6577-0573				Ahmed N, 2009, MOL THER, V17, P1779, DOI 10.1038/mt.2009.133; Choi BD, 2014, J CLIN NEUROSCI, V21, P189, DOI 10.1016/j.jocn.2013.03.012; Chow KKH, 2013, MOL THER, V21, P629, DOI 10.1038/mt.2012.210; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Holzinger A, 2016, CANCER IMMUNOL IMMUN, V65, P1433, DOI 10.1007/s00262-016-1895-5; Hong H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146885; Johnson LA, 2017, CELL RES, V27, P38, DOI 10.1038/cr.2016.154; Kakarla S, 2013, MOL THER, V21, P1611, DOI 10.1038/mt.2013.110; Kong S, 2012, CLIN CANCER RES, V18, P5949, DOI 10.1158/1078-0432.CCR-12-0319; Krebs S, 2014, CYTOTHERAPY, V16, P1121, DOI 10.1016/j.jcyt.2014.02.012; Maliar A, 2012, GASTROENTEROLOGY, V143, P1375, DOI 10.1053/j.gastro.2012.07.017; Mohammed S, 2017, MOL THER, V25, P249, DOI 10.1016/j.ymthe.2016.10.016; Ohno M, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-21; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Shiina S, 2016, CANC IMMUNOL RES; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Slaney CY, 2016, CLIN CANC RES OFFICI; Vandenbroucke J.P., 1997, BMJ, V315, P629; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Wu MR, 2015, GENE THER, V22, P675, DOI 10.1038/gt.2015.29; Wu Y, 2017, BIOTARGET, V1, P7, DOI DOI 10.21037/BIOTARGET.2017.05.02; Zhang TF, 2015, ONCOTARGET, V6, P33961, DOI 10.18632/oncotarget.5582; Zhou XK, 2013, NEOPLASIA, V15, P544, DOI 10.1593/neo.13168; Zhu XK, 2015, ONCOTARGET, V6, P171, DOI 10.18632/oncotarget.2767	25	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187902	10.1371/journal.pone.0187902	http://dx.doi.org/10.1371/journal.pone.0187902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141027	Green Published, gold			2022-12-27	WOS:000415260400036
J	Dunham, J; van de Vis, R; Bauer, J; Wubben, J; van Driel, N; Laman, JD; 't Hart, BA; Kap, YS				Dunham, Jordon; van de Vis, Reinofke; Bauer, Jan; Wubben, Jacqueline; van Driel, Nikki; Laman, Jon D.; 't Hart, Bert A.; Kap, Yolanda S.			Severe oxidative stress in an acute inflammatory demyelinating model in the rhesus monkey	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; INCOMPLETE FREUNDS-ADJUVANT; MULTIPLE-SCLEROSIS LESIONS; NONHUMAN PRIMATE MODELS; INNATE IMMUNE-SYSTEM; MITOCHONDRIAL DYSFUNCTION; RESPIRATORY BURST; TISSUE-INJURY; NEURODEGENERATION	Oxidative stress is increasingly implicated as a co-factor of tissue injury in inflammatory/demyelinating disorders of the central nervous system (CNS), such as multiple sclerosis (MS). While rodent experimental autoimmune encephalomyelitis (EAE) models diverge from human demyelinating disorders with respect to limited oxidative injury, we observed that in a non-human primate (NHP) model for MS, namely EAE in the common marmoset, key pathological features of the disease were recapitulated, including oxidative tissue injury. Here, we investigated the presence of oxidative injury in another NHP EAE model, i.e. in rhesus macaques, which yields an acute demyelinating disease, which may more closely resemble acute disseminated encephalomyelitis (ADEM) than MS. Rhesus monkey EAE diverges from marmoset EAE by abundant neutrophil recruitment into the CNS and destructive injury to white matter. This difference prompted us to investigate to which extent the oxidative pathway features elicited in MS and marmoset EAE are reflected in the acute rhesus monkey EAE model. The rhesus EAE brain was characterized by widespread demyelination and active lesions containing numerous phagocytic cells and to a lesser extent T cells. We observed induction of the oxidative stress pathway, including injury, with a predilection of p22phox expression in neutrophils and macrophages/microglia. In addition, changes in iron were observed. These results indicate that pathogenic mechanisms in the rhesus EAE model may differ from the marmoset EAE and MS brain due to the neutrophil involvement, but may in the end lead to similar induction of oxidative stress and injury.	[Dunham, Jordon; van de Vis, Reinofke; Wubben, Jacqueline; van Driel, Nikki; 't Hart, Bert A.; Kap, Yolanda S.] Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands; [Dunham, Jordon; Laman, Jon D.; 't Hart, Bert A.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Bauer, Jan] Med Univ, Brain Res Inst, Dept Neuroimmunol, Vienna, Austria	University of Groningen	Kap, YS (corresponding author), Biomed Primate Res Ctr, Dept Immunobiol, Rijswijk, Netherlands.	kap@bprc.nl	Bauer, Jan/F-5429-2011	Bauer, Jan/0000-0001-5802-8047	Marie Curie Fellowship, ITN Neurokine [316722]	Marie Curie Fellowship, ITN Neurokine	The authors have no financial disclosures. The salary of Jordon Dunham was funded by A Marie Curie Fellowship, ITN Neurokine 316722.	BABIOR BM, 1994, ENVIRON HEALTH PERSP, V102, P53, DOI 10.2307/3432214; Barrett MJ, 2004, J NEUROSCI RES, V78, P420, DOI 10.1002/jnr.20249; Brok HPM, 2001, IMMUNOL REV, V183, P173, DOI 10.1034/j.1600-065x.2001.1830114.x; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Dunham J, 2017, J NEUROPATH EXP NEUR, V76, P467, DOI 10.1093/jnen/nlx034; FINKEL TH, 1987, J BIOL CHEM, V262, P12589; Flynn JM, 2013, FREE RADICAL BIO MED, V62, P4, DOI 10.1016/j.freeradbiomed.2013.05.027; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Ghezzi A, 2004, NEUROL SCI, V25, pS336, DOI 10.1007/s10072-004-0336-y; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Haanstra KG, 2015, J IMMUNOL, V194, P1454, DOI 10.4049/jimmunol.1402563; Haanstra KG, 2013, J NEUROIMMUNE PHARM, V8, P1251, DOI 10.1007/s11481-013-9487-z; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hametner S, 2013, ANN NEUROL, V74, P848, DOI 10.1002/ana.23974; Hartung HP, 2001, NEUROLOGY, V56, P1257, DOI 10.1212/WNL.56.10.1257; Jagessar SA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0378-5; Kap YS, 2016, DRUG DISCOV TODAY, V21, P1200, DOI 10.1016/j.drudis.2016.03.014; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Kuhlmann T, 2008, ACTA NEUROPATHOL, V115, P275, DOI 10.1007/s00401-007-0320-8; Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Meguro R, 2007, ARCH HISTOL CYTOL, V70, P1, DOI 10.1679/aohc.70.1; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Popescu BFG, 2012, ANNU REV PATHOL-MECH, V7, P185, DOI 10.1146/annurev-pathol-011811-132443; Schuh C, 2014, ACTA NEUROPATHOL, V128, P247, DOI 10.1007/s00401-014-1263-5; SEGAL AW, 1993, TRENDS BIOCHEM SCI, V18, P43, DOI 10.1016/0968-0004(93)90051-N; Stephenson E, 2014, NAT REV NEUROL, V10, P459, DOI 10.1038/nrneurol.2014.118; 't Hart BA, 2005, J NEUROIMMUNOL, V168, P1, DOI 10.1016/j.jneuroim.2005.05.017; 't Hart BA, 2011, TRENDS MOL MED, V17, P119, DOI 10.1016/j.molmed.2010.11.006; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van Beek J, 2005, J IMMUNOL, V174, P2353, DOI 10.4049/jimmunol.174.4.2353; van Horssen J, 2008, FREE RADICAL BIO MED, V45, P1729, DOI 10.1016/j.freeradbiomed.2008.09.023; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Vargas DL, 2017, J INVESTIG MED; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Witte ME, 2014, TRENDS MOL MED, V20, P179, DOI 10.1016/j.molmed.2013.11.007; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	39	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188013	10.1371/journal.pone.0188013	http://dx.doi.org/10.1371/journal.pone.0188013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136024	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200056
J	Ioannou, A; Varotsis, C				Ioannou, Aristos; Varotsis, Constantinos			Modifications of hemoglobin and myoglobin by Maillard reaction products (MRPs)	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MODEL SYSTEMS; NONENZYMATIC GLYCATION; LIGAND-BINDING; SERUM-ALBUMIN; ACRYLAMIDE; TRANSITION; PH; CONFORMATION; SPECTROSCOPY	High performance liquid chromatography (HPLC) coupled with a Fraction Collector was employed to isolate Maillard reaction products (MRPs) formed in model systems comprising of asparagine and monosaccharides in the 60-180 degrees C range. The primary MRP which is detected at 60 E C is important for Acrylamide content and color/aroma development in foods and also in the field of food biotechnology for controlling the extent of the Maillard reaction with temperature. The discrete fractions of the reaction products were reacted with Hemoglobin (Hb) and Myoglobin (Mb) at physiological conditions and the reaction adducts were monitored by UV-vis and Attenuated Total Reflection-Fourier transform infrared (FTIR) spectrophotometry. The UV-vis kinetic profiles revealed the formation of a Soret transition characteristic of a low-spin six-coordinated species and the ATR-FTIR spectrum of the HbMRP and Mb-MRP fractions showed modifications in the protein Amide I and II vibrations. The UV-vis and the FTIR spectra of the Hb-MRPs indicate that the six-coordinated species is a hemichrome in which the distal E7 Histidine is coordinated to the heme Fe and blocks irreversibly the ligand binding site. Although the Mb-MRPs complex is a six-coordinated species, the 1608 cm(-1) FTIR band characteristic of a hemichrome was not observed.	[Ioannou, Aristos; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, Limassol, Cyprus	Cyprus University of Technology	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, Limassol, Cyprus.	c.varotsis@cut.ac.cy		Ioannou, Aristos/0000-0003-1884-0529	European Regional Development Fund; Republic of Cyprus through Research Promotion Foundation [YGEIA/TROFH/0311(BIE)/04]	European Regional Development Fund(European Commission); Republic of Cyprus through Research Promotion Foundation	Financial support by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Grant YGEIA/TROFH/0311(BIE)/04) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ajandouz EH, 2001, J FOOD SCI, V66, P926, DOI 10.1111/j.1365-2621.2001.tb08213.x; Alizadeh-Rahrovi J, 2015, J BIOL PHYS, V41, P349, DOI 10.1007/s10867-015-9383-2; Amrein TM, 2006, J AGR FOOD CHEM, V54, P10253, DOI 10.1021/jf0625860; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Banerjee S, 2017, INT J BIOL MACROMOL, V95, P1159, DOI 10.1016/j.ijbiomac.2016.11.006; Banerjee S, 2016, SPECTROCHIM ACTA A, V155, P1, DOI 10.1016/j.saa.2015.10.022; Banerjee S, 2014, INT J BIOL MACROMOL, V66, P311, DOI 10.1016/j.ijbiomac.2014.02.034; Bath A, 2002, O REV BIOPHYS, V35, P369; Benjakul S, 2005, FOOD CHEM, V93, P189, DOI 10.1016/j.foodchem.2004.10.019; Chen QY, 2005, BIOPHYS J, V88, P2057, DOI 10.1529/biophysj.104.046136; Deli G, 2013, NEUROENDOCRINOLOGY, V98, P267, DOI 10.1159/000358728; DOU Y, 1995, J BIOL CHEM, V270, P15993, DOI 10.1074/jbc.270.27.15993; DOUSSEAU F, 1990, BIOCHEMISTRY-US, V29, P8771, DOI 10.1021/bi00489a038; Garidel P., 2006, BIOPROCESS INT, V1, P48; Gul A, 2009, J DIABETES COMPLICAT, V23, P343, DOI 10.1016/j.jdiacomp.2008.04.001; Hegde AH, 2013, INT J BIOL MACROMOL, V52, P133, DOI 10.1016/j.ijbiomac.2012.09.015; Hidalgo FJ, 2010, J AGR FOOD CHEM, V58, P10512, DOI 10.1021/jf102026c; Iannuzzi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080768; Ioannou A., 2016, J PHYS CHEM BIOPHYSI, V6, P210, DOI [10.4172/2161-0398.1000210, DOI 10.4172/2161-0398.1000210]; Ioannou A, 2017, J MOL STRUCT, V1141, P634, DOI 10.1016/j.molstruc.2017.04.011; JAYARAMAN V, 1995, SCIENCE, V269, P1843, DOI 10.1126/science.7569921; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Lertittikul W, 2007, FOOD CHEM, V100, P669, DOI 10.1016/j.foodchem.2005.09.085; Little RR, 2013, CLIN CHIM ACTA, V418, P63, DOI 10.1016/j.cca.2012.12.026; LITVINKO N M, 1989, Prikladnaya Biokhimiya i Mikrobiologiya, V25, P847; Litvinov RI, 2012, BIOPHYS J, V103, P1020, DOI 10.1016/j.bpj.2012.07.046; Lu Z, 2007, J FLUORESC, V17, P580, DOI 10.1007/s10895-007-0220-2; Nass N, 2007, Z GERONTOL GERIATR, V40, P349, DOI 10.1007/s00391-007-0484-9; Pan T, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813500600; Paneni F, 2013, EUR HEART J, V34, P2436, DOI 10.1093/eurheartj/eht149; Riccio A, 2002, P NATL ACAD SCI USA, V99, P9801, DOI 10.1073/pnas.132182099; Robinson VL, 2003, BIOCHEMISTRY-US, V42, P10113, DOI 10.1021/bi030059t; RODGERS KR, 1994, SCIENCE, V265, P1697, DOI 10.1126/science.8085153; Schalkwijk CG, 2004, DIABETES-METAB RES, V20, P369, DOI 10.1002/dmrr.488; Sen S, 2007, MOL CELL BIOCHEM, V301, P251, DOI 10.1007/s11010-007-9418-5; SHAPIRO R, 1980, J BIOL CHEM, V255, P3120; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stadler RH, 2002, NATURE, V419, P449, DOI 10.1038/419449a; Stadler RH, 2004, J AGR FOOD CHEM, V52, P5550, DOI 10.1021/jf0495486; Sugawara Y, 2003, ACTA PHYSIOL SCAND, V179, P49, DOI 10.1046/j.1365-201X.2003.01142.x; Sugiyama K, 2011, United States patent US, Patent No. [8,021,887, 8021887]; Vergara A, 2008, METHOD ENZYMOL, V436, P425, DOI 10.1016/S0076-6879(08)36024-8; Yaylayan VA, 2003, J AGR FOOD CHEM, V51, P1753, DOI 10.1021/jf0261506; You Y, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2358-6; Zyzak DV, 2003, J AGR FOOD CHEM, V51, P4782, DOI 10.1021/jf034180i	47	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188095	10.1371/journal.pone.0188095	http://dx.doi.org/10.1371/journal.pone.0188095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136023	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200063
J	Miller, JC; Slim, AC				Miller, Joel C.; Slim, Anja C.			Saturation effects and the concurrency hypothesis: Insights from an analytic model	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV EPIDEMIC; SIR DYNAMICS; TRANSMISSION; PARTNERSHIPS; INFECTION; NETWORK; COMPLEX; LURIE; CONTRIBUTE	Sexual partnerships that overlap in time (concurrent relationships) may play a significant role in the HIV epidemic, but the precise effect is unclear. We derive edge-based compartmental models of disease spread in idealized dynamic populations with and without concurrency to allow for an investigation of its effects. Our models assume that partnerships change in time and individuals enter and leave the at-risk population. Infected individuals transmit at a constant per-partnership rate to their susceptible partners. In our idealized populations we find regions of parameter space where the existence of concurrent partnerships leads to substantially faster growth and higher equilibrium levels, but also regions in which the existence of concurrent partnerships has very little impact on the growth or the equilibrium. Additionally we find mixed regimes in which concurrency significantly increases the early growth, but has little effect on the ultimate equilibrium level. Guided by model predictions, we discuss general conditions under which concurrent relationships would be expected to have large or small effects in real-world settings. Our observation that the impact of concurrency saturates suggests that concurrency-reducing interventions may be most effective in populations with low to moderate concurrency.	[Miller, Joel C.] Inst Dis Modeling, Bellevue, WA USA; [Slim, Anja C.] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Slim, Anja C.] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia	Monash University; Monash University	Miller, JC (corresponding author), Inst Dis Modeling, Bellevue, WA USA.	joel.c.miller.research@gmail.com	Miller, Joel C./C-4229-2015	Miller, Joel C./0000-0003-4426-0405	Global Good; Larkins Fellowship from Monash University	Global Good; Larkins Fellowship from Monash University	JCM was funded by Global Good. ACS was supported by the Larkins Fellowship from Monash University.	Adams J, 2013, AM J PUBLIC HEALTH, V103, P322, DOI 10.2105/AJPH.2012.300908; Althaus CL, 2015, PEERJ PREPRINTS, V3, pe1821; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Chibo D, 2012, AIDS RES HUM RETROV, V28, P460, DOI [10.1089/AID.2011.0137, 10.1089/aid.2011.0137]; Decreusefond L, 2012, ANN APPL PROBAB, V22, P541, DOI 10.1214/11-AAP773; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-13; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Goodreau SM, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-12; Janson S, 2014, RANDOM STRUCT ALGOR, V45, P724, DOI 10.1002/rsa.20575; Kalipeni Ezekiel, 2004, HIV AIDS AFRICA EPID; Kamp C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000984; Kiss IZ, 2017, MATH EPIDEMICS NETWO, V46, DOI 10.1007/978-3-319-50806-1; Kretzschmar M, 2010, AIDS, V24, P313, DOI 10.1097/QAD.0b013e328333eb9d; Leung KY, 2012, THEOR POPUL BIOL, V82, P229, DOI 10.1016/j.tpb.2012.07.001; Leung KY, 2015, AIDS, V29, P1097, DOI 10.1097/QAD.0000000000000676; Leung KY, 2015, J MATH BIOL, V71, P1, DOI 10.1007/s00285-014-0808-5; Leung KY, 2016, J MATH BIOL, P1; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Lloyd-Smith JO, 2004, P ROY SOC B-BIOL SCI, V271, P625, DOI 10.1098/rspb.2003.2632; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Miller JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069162; Miller JC, 2012, J R SOC INTERFACE, V9, P890, DOI 10.1098/rsif.2011.0403; Miller JC, 2011, J MATH BIOL, V62, P349, DOI 10.1007/s00285-010-0337-9; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Pinkerton SD, 2008, AIDS BEHAV, V12, P677, DOI 10.1007/s10461-007-9329-1; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; Volz E, 2008, J MATH BIOL, V56, P293, DOI 10.1007/s00285-007-0116-4; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang W, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa5398	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187938	10.1371/journal.pone.0187938	http://dx.doi.org/10.1371/journal.pone.0187938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136021	Green Submitted, gold, Green Published			2022-12-27	WOS:000415121200048
J	Umeda, K; Tanaka, S; Ihara, F; Yamagishi, J; Suzuki, Y; Nishikawa, Y				Umeda, Kousuke; Tanaka, Sachi; Ihara, Fumiaki; Yamagishi, Junya; Suzuki, Yutaka; Nishikawa, Yoshifumi			Transcriptional profiling of Toll-like receptor 2-deficient primary murine brain cells during Toxoplasma gondii infection	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR-XIII; CHRONIC NEURODEGENERATION; PROSTAGLANDIN E-2; MICROGLIAL CELLS; GENE-EXPRESSION; CUTTING EDGE; GTPASES; MOUSE; TLR2	Background Toxoplasma gondii is capable of persisting in the brain, although it is efficiently eliminated by cellular immune responses in most other sites. While Toll-like receptor 2 (TLR2) reportedly plays important roles in protective immunity against the parasite, the relationship between neurological disorders induced by T. gondii infection and TLR2 function in the brain remains controversial with many unknowns. In this study, primary cultured astrocytes, microglia, neurons, and peritoneal macrophages obtained from wild-type and TLR2-deficient mice were exposed to T. gondii tachyzoites. To characterize TLR2-dependent functional pathways activated in response to T. gondii infection, gene expression of different cell types was profiled by RNA sequencing. Results During T. gondii infection, a total of 611, 777, 385, and 1105 genes were upregulated in astrocytes, microglia, neurons, and macrophages, respectively, while 163, 1207, 158, and 1274 genes were downregulated, respectively, in a TLR2-dependent manner. Overrepresented Gene Ontology (GO) terms for TLR2-dependently upregulated genes were associated with immune and stress responses in astrocytes, immune responses and developmental processes in microglia, metabolic processes and immune responses in neurons, and metabolic processes and gene expression in macrophages. Overrepresented GO terms for downregulated genes included ion transport and behavior in astrocytes, cell cycle and cell division in microglia, metabolic processes in neurons, and response to stimulus, signaling and cell motility in macrophages. Conclusions To our knowledge, this is the first transcriptomic study of TLR2 function across different cell types during T. gondii infection. Results of RNA-sequencing demonstrated roles for TLR2 varied by cell type during T. gondii infection. Our findings facilitate understanding of the detailed relationship between TLR2 and T. gondii infection, and elucidate mechanisms underlying neurological changes during infection.	[Umeda, Kousuke; Ihara, Fumiaki; Nishikawa, Yoshifumi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan; [Tanaka, Sachi] Shinshu Univ, Fac Agr, Dept Agr & Life Sci, Div Anim Sci, Minamiminowa, Nagano, Japan; [Yamagishi, Junya] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Suzuki, Yutaka] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan	Obihiro University of Agriculture & Veterinary Medicine; Shinshu University; Hokkaido University; University of Tokyo	Nishikawa, Y (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido, Japan.	nisikawa@obihiro.ac.jp		nishikawa, yoshifumi/0000-0001-5005-6377	Japan Society for the Promotion of Science (JSPS) [2011/LS003]; JSPS KAKENHI [JP24880006, JP17K17570, JP15K15118, JP17K19538]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Society for the Promotion of Science (JSPS), http://www.jsps.go.jp/english/, through the Funding Program for Next Generation World Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (2011/LS003) (YN) and JSPS KAKENHI (Grant-in-Aid for Research Activity Start-up JP24880006 [ST], Grant-in-Aid for Young Scientists (B) JP17K17570 [KU], Grant-in-Aid for Exploratory Research JP15K15118 [YN] and Challenging Research (Exploratory) JP17K19538 [YN]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ANGULO JA, 1990, J NEUROCHEM, V54, P1889, DOI 10.1111/j.1471-4159.1990.tb04887.x; Aravalli RN, 2005, J IMMUNOL, V175, P4189, DOI 10.4049/jimmunol.175.7.4189; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bjornsen LP, 2014, J NEUROCHEM, V128, P641, DOI 10.1111/jnc.12509; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Cabral CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005447; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; Conseil V, 1999, ANTIMICROB AGENTS CH, V43, P1358, DOI 10.1128/AAC.43.6.1358; Contreras-Ochoa CO, 2012, PARASITOL RES, V110, P2089, DOI 10.1007/s00436-012-2836-7; Crack PJ, 2007, IMMUNOL CELL BIOL, V85, P476, DOI 10.1038/sj.icb.7100103; Debierre-Grockiego F, 2007, J IMMUNOL, V179, P1129, DOI 10.4049/jimmunol.179.2.1129; Degrandi D, 2013, P NATL ACAD SCI USA, V110, P294, DOI 10.1073/pnas.1205635110; Dellacasa-Lindberg I, 2011, INFECT IMMUN, V79, P3046, DOI 10.1128/IAI.01042-10; Drogemuller K, 2008, J IMMUNOL, V181, P2683, DOI 10.4049/jimmunol.181.4.2683; Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; FISCHER HG, 1993, J NEUROIMMUNOL, V42, P87, DOI 10.1016/0165-5728(93)90215-K; FRESHMAN MM, 1966, P SOC EXP BIOL MED, V123, P862, DOI 10.3181/00379727-123-31625; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; GHOSH SK, 1991, J BIOL CHEM, V266, P15293; Gomez-Nicola D, 2013, J NEUROSCI, V33, P2481, DOI 10.1523/JNEUROSCI.4440-12.2013; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hill RD, 2012, INFECT IMMUN, V80, P968, DOI 10.1128/IAI.05421-11; Holst FGE, 1999, AM J TROP MED HYG, V60, P99, DOI 10.4269/ajtmh.1999.60.99; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Jin S, 2016, SCI REP-UK, V6, DOI 10.1038/srep29424; Jones J, 2003, AM FAM PHYSICIAN, V67, P2131; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lagal V, 2010, CELL MICROBIOL, V12, P1792, DOI 10.1111/j.1462-5822.2010.01509.x; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; LUFT BJ, 1983, LANCET, V1, P781; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Melzer TC, 2010, J NEUROPARASITOLOGY, V1; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mun HS, 2003, INT IMMUNOL, V15, P1081, DOI 10.1093/intimm/dxg108; Neuner R, 2009, MECH DEVELOP, V126, P240, DOI 10.1016/j.mod.2008.10.010; Oosterhoff JK, 2003, ONCOGENE, V22, P2920, DOI 10.1038/sj.onc.1206397; Pasterkamp RJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-98; Peng BW, 2008, PARASITOL RES, V102, P1043, DOI 10.1007/s00436-007-0873-4; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; Sanecka A, 2012, VIRULENCE, V3, P678, DOI 10.4161/viru.22833; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sridharan J, 2012, MECH DEVELOP, V129, P136, DOI 10.1016/j.mod.2012.05.002; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Sugitani K, 2012, NEUROCHEM INT, V61, P423, DOI 10.1016/j.neuint.2012.06.004; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss; Wilhelmsen K, 2012, INNATE IMMUN-LONDON, V18, P602, DOI 10.1177/1753425911429336; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Yoshida E, 2004, MOL BRAIN RES, V131, P33, DOI 10.1016/j.molbrainres.2004.08.023; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao H, 2012, CELL HOST MICROBE, V12, P705, DOI 10.1016/j.chom.2012.10.010	62	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187703	10.1371/journal.pone.0187703	http://dx.doi.org/10.1371/journal.pone.0187703			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136637	Green Submitted, gold, Green Published			2022-12-27	WOS:000415121200028
J	Soscia, D; Belle, A; Fischer, N; Enright, H; Sales, A; Osburn, J; Benett, W; Mukerjee, E; Kulp, K; Pannu, S; Wheeler, E				Soscia, D.; Belle, A.; Fischer, N.; Enright, H.; Sales, A.; Osburn, J.; Benett, W.; Mukerjee, E.; Kulp, K.; Pannu, S.; Wheeler, E.			Controlled placement of multiple CNS cell populations to create complex neuronal cultures	PLOS ONE			English	Article							HIPPOCAMPAL; NETWORKS; PATTERNS; BIOLOGY; TISSUES; SYSTEMS; ORGANS; CHIP; DRUG	In vitro brain-on-a-chip platforms hold promise in many areas including: drug discovery, evaluating effects of toxicants and pathogens, and disease modelling. A more accurate recapitulation of the intricate organization of the brain in vivo may require a complex in vitro system including organization of multiple neuronal cell types in an anatomically-relevant manner. Most approaches for compartmentalizing or segregating multiple cell types on microfabricated substrates use either permanent physical surface features or chemical surface functionalization. This study describes a removable insert that successfully deposits neurons from different brain areas onto discrete regions of a microelectrode array (MEA) surface, achieving a separation distance of 100 mu m. The regional seeding area on the substrate is significantly smaller than current platforms using comparable placement methods. The non-permanent barrier between cell populations allows the cells to remain localized and attach to the substrate while the insert is in place and interact with neighboring regions after removal. The insert was used to simultaneously seed primary rodent hippocampal and cortical neurons onto MEAs. These cells retained their morphology, viability, and function after seeding through the cell insert through 28 days in vitro (DIV). Co-cultures of the two neuron types developed processes and formed integrated networks between the different MEA regions. Electrophysiological data demonstrated characteristic bursting features and waveform shapes that were consistent for each neuron type in both mono-and co-culture. Additionally, hippocampal cells co-cultured with cortical neurons showed an increase in within-burst firing rate (p = 0.013) and percent spikes in bursts (p = 0.002), changes that imply communication exists between the two cell types in co-culture. The cell seeding insert described in this work is a simple but effective method of separating distinct neuronal populations on microfabricated devices, and offers a unique approach to developing the types of complex in vitro cellular environments required for anatomically-relevant brain-on-a-chip devices.	[Soscia, D.; Belle, A.; Benett, W.; Mukerjee, E.; Pannu, S.; Wheeler, E.] Lawrence Livermore Natl Lab, Engn Directorate, Livermore, CA 94550 USA; [Fischer, N.; Enright, H.; Sales, A.; Osburn, J.; Kulp, K.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Wheeler, E (corresponding author), Lawrence Livermore Natl Lab, Engn Directorate, Livermore, CA 94550 USA.; Kulp, K (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	kulp2@llnl.gov; wheeler16@llnl.gov	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390; Enright, Heather/0000-0001-6422-0481	U.S. Department of Energy, LDRD [14-SI-001]; U.S. Department of Energy by Lawrence Livermore National Laboratory through LDRD [14-SI-001, DE-AC52-07NA27344]	U.S. Department of Energy, LDRD(United States Department of Energy (DOE)); U.S. Department of Energy by Lawrence Livermore National Laboratory through LDRD(United States Department of Energy (DOE))	This study was supported by the U.S. Department of Energy, LDRD award 14-SI-001, https://st.llnl.gov/foundations/strategies/investments, to authors SP and EW.; We would like to thank Monica Moya for providing and staining hCMEC/D3 cells for use in the four-cell type funnel seeding. We would also like to thank Mona Huang and Ed Kuhn for their help in cell maintenance and electrophysiological recordings, respectively. Lastly, we would like to thank Julie Hamilton, Kerry Bettencourt, Ronnie Alferos, and Jeff Robinson for their microfabrication efforts. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344 through LDRD award 14-SI-001. LLNL IM release # LLNL-JRNL-728613.	Bajaj P, 2016, ACS BIOMATER SCI ENG, V2, P473, DOI 10.1021/acsbiomaterials.5b00480; Bakkum DJ, 2013, NAT COMMUN, P4; Berdichevsky Y, 2010, LAB CHIP, V10, P999, DOI 10.1039/b922365g; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Boehler MD, 2012, J NEUROSCI METH, V203, P344, DOI 10.1016/j.jneumeth.2011.09.020; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Charlesworth P, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-014-0028-0; Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049; Das AM, 2015, NAT PROTOC, V10, P904, DOI 10.1038/nprot.2015.056; Dauth S, 2016, JOURNAL OF NEUROPHYS; Defranchi E, 2011, FRONTIERS IN NEUROEN, V4; Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h; Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Enright HA, 2016, ANALYST, V141, P5346, DOI 10.1039/c5an01728a; Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H; Folch A, 2000, ANNU REV BIOMED ENG, V2, P227, DOI 10.1146/annurev.bioeng.2.1.227; Garcia-Munoz M, 2015, FRONTIERS IN SYSTEMS, P9; Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Gullo F, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00087; Hammond MW, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-38; Hannachi IE, 2009, BIOMATERIALS, V30, P5427, DOI 10.1016/j.biomaterials.2009.06.033; Hjornevik Trine, 2007, Front Neuroinform, V1, P4, DOI 10.3389/neuro.11.004.2007; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hynd MR, 2007, J NEUROSCI METH, V162, P255, DOI 10.1016/j.jneumeth.2007.01.024; Johnson BN, 2016, LAB CHIP, V16, P1393, DOI 10.1039/c5lc01270h; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Mukai Y, 2003, ELECTR ENG JPN, V145, P28, DOI 10.1002/eej.10216; Obien MEJ, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00423; Pimashkin A, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00087; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Schomburg EW, 2012, J NEUROSCI, V32, P11798, DOI 10.1523/JNEUROSCI.0656-12.2012; Suzuki M, 2005, CEREB CORTEX, V15, P187, DOI 10.1093/cercor/bhh121; Suzuki M, 2008, BIOSENS BIOELECTRON, V24, P1043, DOI 10.1016/j.bios.2008.06.051; Swanson LW, 1995, TRENDS NEUROSCI, V23, P519; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; Van Pelt J, 2004, NEUROSCI LETT, V361, P86, DOI 10.1016/j.neulet.2003.12.062; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Whalley BJ, 2006, NEUROSCIENCE, P140; Wikswo JP, 2013, LAB CHIP, V13, P3496, DOI 10.1039/c3lc50243k; Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035; Yum K, 2014, BIOTECHNOL J, V9, P16, DOI 10.1002/biot.201300187; Zhu G, 2016, SCI REPORTS, P6	48	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188146	10.1371/journal.pone.0188146	http://dx.doi.org/10.1371/journal.pone.0188146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161298	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000031
J	Sadikovic, B; Wang, J; El-Hattab, AW; Landsverk, M; Douglas, G; Brundage, EK; Craigen, WJ; Schmitt, ES; Wong, LJC				Sadikovic, Bekim; Wang, Jing; El-Hattab, Ayman W.; Landsverk, Megan; Douglas, Ganka; Brundage, Ellen K.; Craigen, William J.; Schmitt, Eric S.; Wong, Lee-Jun C.			Sequence Homology at the Breakpoint and Clinical Phenotype of Mitochondrial DNA Deletion Syndromes (vol 5, e15687, 2010)	PLOS ONE			English	Correction																		Sadikovic B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015687	1	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188610	10.1371/journal.pone.0188610	http://dx.doi.org/10.1371/journal.pone.0188610			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155871	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700065
J	Wybrecht, D; Reuter, F; Pariollaud, F; Zaaraoui, W; Le Troter, A; Rico, A; Confort-Gouny, S; Soulier, E; Guye, M; Maarouf, A; Ranjeva, JP; Pelletier, J; Audoin, B				Wybrecht, D.; Reuter, F.; Pariollaud, F.; Zaaraoui, W.; Le Troter, A.; Rico, A.; Confort-Gouny, S.; Soulier, E.; Guye, M.; Maarouf, A.; Ranjeva, J-P.; Pelletier, J.; Audoin, B.			New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; NEUROPSYCHOLOGICAL ASSESSMENT; IMPAIRMENT; MRI; DYSFUNCTION; DISCONNECTION; PATHOLOGY; ATROPHY; BURDEN	Objective In early multiple sclerosis, although brain T2 lesions accrual are hallmark of the disease, only weak correlations were found between T2 lesions accrual and EDSS progression, the disability scale commonly used in multiple sclerosis studies. This may be related to the very poor sensitivity of EDSS to cognitive dysfunctions that may occur and progress from the first stage of the disease. In the present study, we aimed to demonstrate that cognitive deficits progress during the first ten years of MS and are significantly impacted by new T2 lesions. Methods EDSS and extensive neuropsychological battery (22 measures) exploring memory, attention/ speed of information processing and executive functions were assessed at baseline, Year 1 and Year 10 in 26 patients enrolled after their first clinical attack. To limit the bias of test-retest effect, only measures obtained at Year 1 and Year 10 were reported in the analysis. Raw scores of patients were transformed into z-scores using published normative data when available or scores of matched controls. Lesion probability mapping was used to assess the potential relationships between T2 lesions accumulation, cognitive decline and EDSS progression (P<0.05, FWE-corrected). Results At Year 1, 27% of patients showed attention/speed of information processing deficits, 11.5% executive dysfunction and 11.5% memory impairment. During the follow-up, frequency and severity of executive dysfunction increased (from 11.5% of patients at Year 1 to 42% at Year 10, p<0.01) while no significant changes were evidenced for the other cognitive domains. Median EDSS increased from 0.5 [range: 0-3] at Year 1 to 2.5 [range: 0-6.5] at Year 10 (p<0.001). During the ten-year follow-up, lesions accumulation in the left cerebellum and semi-ovale centers was associated with EDSS progression. In contrast, most lesions accumulation in the frontal, parietal and temporal lobes were associated with cognitive decline but had no effect on EDSS progression. Conclusion The present study provides strong evidence that clinically silent T2 lesions impact cognition in early MS. In daily practice, early prevention of T2 lesions accrual may be useful to limit cognitive decline.	[Wybrecht, D.; Reuter, F.; Pariollaud, F.; Zaaraoui, W.; Le Troter, A.; Rico, A.; Confort-Gouny, S.; Soulier, E.; Guye, M.; Maarouf, A.; Ranjeva, J-P.; Pelletier, J.; Audoin, B.] Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France; [Wybrecht, D.] Hop Instruct Armees St Anne, Toulon, France; [Reuter, F.; Pariollaud, F.; Rico, A.; Maarouf, A.; Pelletier, J.; Audoin, B.] Hop La Timone, AP HM, Pole Neurosci Clin, Serv Neurol, Marseille, France; [Guye, M.] Hop La Timone, AP HM, Pole Imagerie Med, CEMEREM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Hospital Instruction Of Armees Sainte-Anne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Wybrecht, D (corresponding author), Aix Marseille Univ, CNRS, CRMBM UMR 7339, Marseille, France.; Wybrecht, D (corresponding author), Hop Instruct Armees St Anne, Toulon, France.	delphinewybrecht@gmail.com		le troter, arnaud/0000-0002-7897-9672	Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP); CNRS; Merck Serono France	Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP); CNRS(Centre National de la Recherche Scientifique (CNRS)); Merck Serono France	Dr. Pelletier serves on scientific advisory boards for Biogen Idec, Genzyme, Novartis and Teva. This study was supported by grants from the Association pour Ia Recherche sur Ia Sclerose En Plaques (ARSEP) and CNRS, and was funded by an unconditional grant from Merck Serono France. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The data are ethically restricted because of medical confidentiality. Any request needs to be approved by our local Committee, named "Comite d'Ethique de la Timone." Requests for the data should be sent to the corresponding author. Dr Wybrecht, Dr Reuter, Dr Pariollaud, Dr Zaaraoui, Dr Le Troter, Dr Rico, Dr Maarouf, Dr Confort-Gouny, Dr Soulier, Dr Ranjeva, Dr Audoin, Dr Guye report no disclosures.	Achiron A, 2003, J NEUROL NEUROSUR PS, V74, P443, DOI 10.1136/jnnp.74.4.443; Adam S., 2004, EVALUATION TROUBLES; Amato MP, 2008, NEUROLOGY, V71, P632, DOI 10.1212/01.wnl.0000324621.58447.00; Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; Bellmann-Strobl J, 2009, NEUROLOGY, V73, P1624, DOI 10.1212/WNL.0b013e3181c1de4f; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; CALLANAN MM, 1989, BRAIN, V112, P361, DOI 10.1093/brain/112.2.361; Garcia MC, 2015, ACTA NEUROL SCAND, V131, P313, DOI 10.1111/ane.12345; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Deloire MSA, 2011, NEUROLOGY, V76, P1161, DOI 10.1212/WNL.0b013e318212a8be; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Drew M, 2008, ARCH CLIN NEUROPSYCH, V23, P1, DOI 10.1016/j.acn.2007.09.005; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; Feuillet L, 2007, MULT SCLER, V13, P124, DOI 10.1177/1352458506071196; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Fulton JC, 1999, AM J NEURORADIOL, V20, P1951; Hohol MJ, 1997, ARCH NEUROL-CHICAGO, V54, P1018, DOI 10.1001/archneur.1997.00550200074013; Hynicova E, 2017, J NEUROL, V264, P482, DOI 10.1007/s00415-016-8368-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li DKB, 2006, NEUROLOGY, V66, P1384, DOI 10.1212/01.wnl.0000210506.00078.5c; Lin X, 2008, J NEUROL NEUROSUR PS, V79, P437, DOI 10.1136/jnnp.2006.112177; Louapre C, 2014, HUM BRAIN MAPP, V35, P4706, DOI 10.1002/hbm.22505; LYONCAEN O, 1986, ARCH NEUROL-CHICAGO, V43, P1138, DOI 10.1001/archneur.1986.00520110034010; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Reuter F, 2011, J NEUROL NEUROSUR PS, V82, P1157, DOI 10.1136/jnnp.2010.213744; Reuter F, 2009, NEUROIMAGE, V44, P590, DOI 10.1016/j.neuroimage.2008.08.024; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Rovaris M, 2003, AM J NEURORADIOL, V24, P75; Rovaris M, 2002, J NEUROL SCI, V195, P103, DOI 10.1016/S0022-510X(01)00690-6; Sanchez MP, 2008, EUR J NEUROL, V15, P1091, DOI 10.1111/j.1468-1331.2008.02259.x; Sperling RA, 2001, ARCH NEUROL-CHICAGO, V58, P115, DOI 10.1001/archneur.58.1.115; Summers M, 2008, J NEUROL NEUROSUR PS, V79, P955, DOI 10.1136/jnnp.2007.138685; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Uher T, 2014, J NEUROL, V261, P1735, DOI 10.1007/s00415-014-7413-9; Wechsler DA, 1991, ECHELLE CLIN MEMOIRE; Zivadinov R, 2001, NEURORADIOLOGY, V43, P272, DOI 10.1007/s002340000500	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0184650	10.1371/journal.pone.0184650	http://dx.doi.org/10.1371/journal.pone.0184650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149177	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100001
J	Brunner, SN; Bogert, NV; Schnitzbauer, AA; Juengel, E; Moritz, A; Werner, I; Kornberger, A; Beiras-Fernandez, A				Brunner, Stefanie N.; Bogert, Nicolai V.; Schnitzbauer, Andreas A.; Juengel, Eva; Moritz, Anton; Werner, Isabella; Kornberger, Angela; Beiras-Fernandez, Andres			Levosimendan protects human hepatocytes from ischemia-reperfusion injury	PLOS ONE			English	Article							ISCHEMIA/REPERFUSION INJURY; HEART-TRANSPLANTATION; PRESERVATION INJURY; LIVER ISCHEMIA; APOPTOSIS; FAILURE; BCL-2; MITOCHONDRIA; PROTEINS; CHANNELS	Background Ischemia-reperfusion injury (IRI) is a major challenge in liver transplantation. The mitochondrial pathway plays a pivotal role in hepatic IRI. Levosimendan, a calcium channel sensitizer, was shown to attenuate apoptosis after IRI in animal livers. The aim of this study was to investigate the effect of levosimendan on apoptosis in human hepatocytes. Methods Primary human hepatocytes were either exposed to hypoxia or cultured under normoxic conditions. After the hypoxic phase, reoxygenation was implemented and cells were treated with different concentrations of levosimendan (10ng/ml, 100ng/ml, 1000ng/ml). The overall metabolic activity of the cells was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and aspartate aminotransferase (AST) levels were determined in order to quantify hepatic injury. Fluorescence-activated cell sorting (FACS) analysis was applied to measure necrosis and apoptosis. Finally, Western blotting was performed to analyze apoptotic pathway proteins. Results Administration of levosimendan during reperfusion increases the metabolic activity of human hepatocytes and decreases AST levels. Moreover, apoptosis after IRI is reduced in treated vs. untreated hepatocytes, and levosimendan prevents down-regulation of the anti-apoptotic protein Bcl-2 as well as up-regulation of the pro-apoptotic protein BAX. Conclusion The present study suggests a protective effect of levosimendan on human hepatocytes. Our findings suggest that treatment with levosimendan during reperfusion attenuates apoptosis of human hepatocytes by influencing BAX and Bcl-2 levels.	[Brunner, Stefanie N.; Moritz, Anton; Werner, Isabella] Goethe Univ, Univ Hosp Frankfurt, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany; [Bogert, Nicolai V.] Ruprecht Karls Univ Heidelberg, Dept Cardiol, Univ Hosp Heidelberg, Heidelberg, Germany; [Schnitzbauer, Andreas A.] Goethe Univ, Univ Hosp Frankfurt, Clin Gen & Visceral Surg, Frankfurt, Germany; [Juengel, Eva] Johannes Gutenberg Univ Mainz, Dept Urol, Univ Hosp Mainz, Mainz, Germany; [Kornberger, Angela; Beiras-Fernandez, Andres] Johannes Gutenberg Univ Mainz, Dept Thorac & Cardiovasc Surg, Univ Hosp Mainz, Mainz, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Ruprecht Karls University Heidelberg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Johannes Gutenberg University of Mainz; University Hospital Mainz; Johannes Gutenberg University of Mainz; University Hospital Mainz	Kornberger, A (corresponding author), Johannes Gutenberg Univ Mainz, Dept Thorac & Cardiovasc Surg, Univ Hosp Mainz, Mainz, Germany.	Angela.Kornberger@unimedizin-mainz.de	Beiras, Andres/AAE-4864-2020					Beiras-Fernandez A, 2008, TRANSPL P, V40, P951, DOI 10.1016/j.transproceed.2008.03.106; Beiras-Fernandez A, 2006, TRANSPLANTATION, V82, P1101, DOI 10.1097/01.tp.0000233845.15508.89; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Caimmi PP, 2011, EUR J CARDIO-THORAC, V39, pE59, DOI 10.1016/j.ejcts.2010.11.044; FONG Y, 1990, SURG GYNECOL OBSTET, V170, P363; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Grossini E, 2014, LIVER TRANSPLANT, V20, P361, DOI 10.1002/lt.23799; Grossini E, 2010, CARDIOVASC DRUG THER, V24, P5, DOI 10.1007/s10557-010-6217-0; HAIKALA H, 1995, J MOL CELL CARDIOL, V27, P1859, DOI 10.1016/0022-2828(95)90009-8; Heusch G, 2015, COMPR PHYSIOL, V5, P1123, DOI 10.1002/cphy.c140075; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Jaeschke H, 1996, J HEPATOL, V25, P774, DOI 10.1016/S0168-8278(96)80253-4; Kaheinen P, 2001, J CARDIOVASC PHARM, V37, P367, DOI 10.1097/00005344-200104000-00003; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; KAWAMURA E, 1995, HEPATOLOGY, V21, P1138, DOI 10.1002/hep.1840210437; Ke B, 2006, CURR PHARM DESIGN, V12, P2969, DOI 10.2174/138161206777947669; Malmberg M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00017; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Mykytenko J, 2008, BASIC RES CARDIOL, V103, P472, DOI 10.1007/s00395-008-0731-2; Ng CSH, 2005, EUR RESPIR J, V25, P356, DOI 10.1183/09031936.05.00030304; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073758; Ozturk T, 2010, J CARDIOTHOR VASC AN, V24, P624, DOI 10.1053/j.jvca.2009.08.003; Patterson SD, 2000, CELL DEATH DIFFER, V7, P137, DOI 10.1038/sj.cdd.4400640; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Scheiermann Patrick, 2011, Recent Pat Cardiovasc Drug Discov, V6, P20, DOI 10.2174/157489011794578482; Selzner M, 2002, J HEPATOL, V36, P218, DOI 10.1016/S0168-8278(01)00259-8; Torraco A, 2014, BIOCHIMIE, V102, P166, DOI 10.1016/j.biochi.2014.03.006; Uberti F, 2011, J CARDIOVASC PHARM, V57, P246, DOI 10.1097/FJC.0b013e318204bb55; VOLLMAR B, 1994, AM J PATHOL, V145, P1421	30	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187839	10.1371/journal.pone.0187839	http://dx.doi.org/10.1371/journal.pone.0187839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145424	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800032
J	Francischini, FJB; de Campos, JB; Alves-Pereira, A; Viana, JPG; Grinter, CC; Clough, SJ; Zucchi, MI				Francischini, Fabricio J. B.; de Campos, Jaqueline Bueno; Alves-Pereira, Alessandro; Gomes Viana, Joao Paulo; Grinter, Christopher C.; Clough, Steven J.; Zucchi, Maria I.			Morphological and molecular characterization of Brazilian populations of Diatraea saccharalis (Fabricius, 1794) (Lepidoptera: Crambidae) and the evolutionary relationship among species of Diatraea Guilding	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; MITOCHONDRIAL-DNA VARIATION; SUGARCANE BORER; MOTHS LEPIDOPTERA; R-PACKAGE; GENETICS; NOCTUIDAE; VARIABILITY; DIVERSITY; GENITALIA	The sugarcane borer or corn stalk borer, Diatraea Guilding is polyphagous insect pest of many important crops such as corn, sorghum and sugarcane. Losses arising from the attack of Diatraea species have been a serious problem, which may cause loss in sugarcane production around 0.25% in sugar, 0.20% in alcohol and 0.77% of body weight for every 1% infestation and up to 21% in corn production fields. In Brazil, the most commonly reported species are Diatraea saccharalis (Fabricius, 1794) and Diatraea impersonatella (Walker, 1863) (= D. flavipennella). However, multiple other species of Diatraea have been identified in Brazil according to the literature. Currently, little information exists on the presence of the other species causing injury to sugarcane and corn. The objectives of this study were to improve the accuracy of species assignment, evaluate the population genetic structure, and address many of the outstanding questions of systematics and evolution of Brazilian populations of D. saccharalis. To address these main questions, classical taxonomic methods were used, focused on morphological characterization of the reproductive organs, especially the male genitalia. In addition, genetic studies were performed using simple sequence repeats (SSR) and a fragment of cytochrome C oxidase subunit I (COI) gene. The data and findings from this research will contribute to the understanding of evolutionary aspects of insect pests in order to develop more effective and sustainable population management practices.	[Francischini, Fabricio J. B.; de Campos, Jaqueline Bueno; Alves-Pereira, Alessandro; Gomes Viana, Joao Paulo] Univ Estadual Campinas, Inst Biol, Dept Genet & Mol Biol, Campinas, SP, Brazil; [Grinter, Christopher C.] Calif Acad Sci, Dept Entomol, San Francisco, CA 94118 USA; [Clough, Steven J.] Univ Illinois, Dept Crop Sci, USDA ARS, Urbana, IL 61801 USA; [Zucchi, Maria I.] APTA, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; California Academy of Sciences; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign	Zucchi, MI (corresponding author), APTA, Piracicaba, SP, Brazil.	mizucchi@apta.sp.gov.br	Zucchi, Maria Imaculada/D-2637-2012; Francischini, Fabricio/AAZ-9542-2020; Alves-Pereira, Alessandro/I-6595-2012; Zucchi, Maria Imaculada/AAC-8157-2019; Viana, João Paulo JPGV Gomes/K-1178-2012	Zucchi, Maria Imaculada/0000-0002-4863-1843; Alves-Pereira, Alessandro/0000-0002-3012-6355; Zucchi, Maria Imaculada/0000-0002-4863-1843; Viana, João Paulo JPGV Gomes/0000-0002-9217-9604	Sao Paulo Research Foundation (FAPESP) [2012/50848-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional [23038.010032/2013-14, 33762013]; National Council for Scientific and Technological Development of Brazil (CNPq) [310446/2015-5]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development of Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank the Sao Paulo Research Foundation (FAPESP) for the financial support (#2012/50848-3). FJBF received funding from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) AUXPE-BioComputacional 33762013 grant number: 23038.010032/2013-14. MIZ thanks the National Council for Scientific and Technological Development of Brazil (CNPq) for a productivity grant (#310446/2015-5).	Almeida JR, 1936, REV AGR PIRACICABA, V11, P257; Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Avise JC, 2000, PHYLOGEOGRAPHY HIST; BARTON NH, 1984, ANNU REV ECOL SYST, V15, P133, DOI 10.1146/annurev.es.15.110184.001025; Bleszynski S., 1969, PESTS SUGAR CANE, P11; BOGDANOWICZ SM, 1993, ANN ENTOMOL SOC AM, V86, P710, DOI 10.1093/aesa/86.6.710; BOX H. E., 1950, Proceedings of the Hawaiian Entomological Society, V14, P41; BOX HAROLD E., 1931, BULL ENT RES [LONDON], V22, P1, DOI 10.1017/S0007485300029709; BOX HE, 1951, B ENTOMOL RES, V42, P379, DOI 10.1017/S0007485300025402; Box HE, 1960, P INT SOC SUG CANE T, V10, P870; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; BROWER AVZ, 1991, EVOLUTION, V45, P1281, DOI 10.1111/j.1558-5646.1991.tb04393.x; Brown B, 1999, MOL PHYLOGENET EVOL, V13, P463, DOI 10.1006/mpev.1999.0662; Caixeta DF, 2010, THESIS; CHAPCO W, 1992, HEREDITY, V69, P547, DOI 10.1038/hdy.1992.170; Cirelli Kátia Resende Netto, 2003, Rev. Bras. entomol., V47, P89, DOI 10.1590/S0085-56262003000100014; Cruz FZ, 1976, ESPECIES DIATRAEA GU; De Freitas MDRT, 2006, FLA ENTOMOL, V89, P539, DOI 10.1653/0015-4040(2006)89[539:TPODFL]2.0.CO;2; DEBACH P, 1974, P323; Dinardo-Miranda LL, 2008, CANA DE ACUCAR, P349; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Dyar Harrison G., 1911, Entomological News Philadelphia, V22; DYAR HARRISON G., 1927, PROC U S NATION MM, V71, P1; Elias-Gutierrez Manuel, 2008, Zootaxa, V1839, P1; Elton C., 1958; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira ME, 1998, INTRO USO MARCADORES; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gepts P, 2004, PLANT PHYSIOL, V134, P1295, DOI 10.1104/pp.103.038885; Goldstein D, 1999, MICROSATELLITES EVOL; Gomez LA, 1995, SERIE DIVULGATIVA CE; Goyes P. C., 2008, CARACTERIZACION MORF; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; Hartl Daniel L., 1997; Hayward KJ, 1943, BRASIL ACUCAREIRO, V11, P69; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Holloway TE, 1928, USDA TECHNICAL B, V41; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Joyce AL, 2016, ECOLOGY EVOLUTION, P1; Joyce AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110036; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Lange CL, 2004, B ENTOMOL RES, V94, P457, DOI 10.1079/BER2004320; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; LONG WH, 1972, ANNU REV ENTOMOL, V17, P149, DOI 10.1146/annurev.en.17.010172.001053; Lopes DA, 2014, ACTA SCI-AGRON, V36, P189, DOI 10.4025/actasciagron.v36i2.16211; MARTIN A, 1990, EVOLUTION, V44, P1066, DOI 10.2307/2409567; Martinelli S, 2007, B ENTOMOL RES, V97, P225, DOI 10.1017/S0007485307004944; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; Mendonca AF, 1996, PRAGAS CANA DE ACUCA; MIKKOLA K, 1992, SYST ENTOMOL, V17, P145, DOI 10.1111/j.1365-3113.1992.tb00327.x; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Myers JG, 1935, ECOLOGICAL DISTRIBUT; Myers JG, 1932, ORIGINAL HABITAT HOS; Nascimento JB, 2015, DIVERSIDADE GENETICA; NEI M, 1974, GENETICS, V76, P379; Nei M., 1975, MOL POPULATION GENET; Neto MSR, 2014, ANALISE ESTRUTURAL A; Cortes AMP, 2010, J INSECT PHYSIOL, V56, P1624, DOI 10.1016/j.jinsphys.2010.06.005; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1990, ANN ENTOMOL SOC AM, V83, P1048, DOI 10.1093/aesa/83.6.1048; Passoa S. C., 2014, LEPINTERCEPT IDENTIF; Patwardhan A., 2014, J PHYLOGENETICS EVOL, DOI [10.4172/2329-9002.1000131, DOI 10.4172/2329-9002.1000131]; Pavinato VAC, 2013, GENET MOL RES, V12, P1631, DOI 10.4238/2013.May.14.3; Pavinato VAC, 1794, THESIS; Peairs B, 1980, AGRONOMIA CONSTARRIC, V4, P123; Peterson Merrill A., 1998, P263; Powell JA, 2009, ENCY INSECTS, P1132; Riley DR, 2005, SOUTHWEST ENTOMOL, V30, P35; Risco SH, 1975, OBSERVACIONES RELACI; ROBINSON G S, 1976, Entomologist's Gazette, V27, P127; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; RODRIGUEZDELBOSQUE LA, 1988, FLA ENTOMOL, V71, P176, DOI 10.2307/3495365; Roe RM, 1981, 20 USDA ARS ARMS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schilthuizen M., 2003, NETHERLANDS ENTOMOLO, V14, P9; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCUDDER GGE, 1971, ANNU REV ENTOMOL, V16, P379, DOI 10.1146/annurev.en.16.010171.002115; Shere-Kharwar A, 2013, INDIAN J L SCI, V2, P35; Shere-Kharwar A, 2012, LIFE SCI B, P123; Silva-Brandao KL, 2015, J ECON ENTOMOL, V108, P307, DOI 10.1093/jee/tou040; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson GG, 1949, TEMPO MODE EVOLUTION; Sneath Pha R. R., 1973, NUMERICAL TAXONOMY; Solis MA, 2016, ZOOKEYS, P73, DOI 10.3897/zookeys.565.6797; Sosa-Gomez DR, 2004, GENET MOL BIOL, V27, P378, DOI 10.1590/S1415-47572004000300012; Stireman JO, 2005, EVOLUTION, V59, P2573, DOI 10.1554/05-222.1; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1980, GENETICS, V94, P1011; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Vialatte A, 2005, P ROY SOC B-BIOL SCI, V272, P1075, DOI 10.1098/rspb.2004.3033; Walker F., 1863, LIST SPECIMENS LE 27; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; ZEHNDER GW, 1992, ANN ENTOMOL SOC AM, V85, P234, DOI 10.1093/aesa/85.2.234	103	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186266	10.1371/journal.pone.0186266	http://dx.doi.org/10.1371/journal.pone.0186266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145390	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800003
J	Masomi-Bornwasser, J; Winter, P; Muller-Werkmeister, H; Strand, S; Knig, J; Kempski, O; Ringel, F; Kantelhardt, SR; Keric, N				Masomi-Bornwasser, Julia; Winter, Philipp; Mueller-Werkmeister, Hendrik; Strand, Susanne; Koenig, Jochem; Kempski, Oliver; Ringel, Florian; Kantelhardt, Sven R.; Keric, Naureen			Combination of ultrasound and rtPA enhances fibrinolysis in an In Vitro clot system	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; INITIAL CONSERVATIVE TREATMENT; MINIMALLY INVASIVE EVACUATION; INTRACEREBRAL HEMORRHAGE; DELAYED EDEMA; EARLY SURGERY; THROMBOLYSIS; LYSIS; ASPIRATION; REDUCTION	Background Catheter-based lysis with recombinant tissue plasminogen activator (rtPA) is a well-established therapy for spontaneous intracerebral hemorrhage (ICH). The effectiveness of this therapy can be increased with ultrasound, but the optimal conditions are not yet clearly established. Using a novel in vitro system of blood clots previously developed by our group, we investigated various parameters of intralesional sonothrombolysis using an endosonography catheter in combination with rtPA. Methods Standardized human blood clots were equipped with a drainage catheter and weighed before and after 4 treatments: control (drainage only), rtPA only, ultrasound only and the combination of rtPA+ ultrasound. The effectiveness of ultrasound was further analysed in terms of optimal frequency, duration and distance to the probe. Temperature and acoustic peak rarefaction pressure (APRP) were assessed to analyse potential adverse effects and quantify lysis. Histo-morphological analysis of the treated clots was performed by H&E staining and confocal laser scanning microscopy using fluorescent fibrinogen. Results The combined treatment rtPA+ ultrasound achieved the highest lysis rates with a relative weight of 30.3%+/- 5.5% (p <= 0.0001) compared to all other groups. Similar results were observed when treating aged clots. Confocal fluorescent microscopy of the treated clots revealed a rarefied fibrin mesh without cavitations. No relevant temperature increase occurred (0.53 +/- 0.75 degrees C). The optimal insonation treatment time was 1 hour. APRP measurements showed a lysis threshold of 515.5 +/- 113.4 kPa. Application of 10 MHz achieved optimal lysis and lysis radius, while simultaneously proving to be the best frequency for morphologic imaging of the clot and surrounding tissue. Conclusions These promising data provide the basis for an individualized minimal invasive ICH therapy by rtPA and sonothrombolysis independent of ICH age.	[Masomi-Bornwasser, Julia; Winter, Philipp; Mueller-Werkmeister, Hendrik; Ringel, Florian; Kantelhardt, Sven R.; Keric, Naureen] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Germany; [Strand, Susanne] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1 1, Mainz, Germany; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, Mainz, Germany; [Kempski, Oliver] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Neurosurg Pathophysiol, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Masomi-Bornwasser, J (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neurosurg, Mainz, Germany.	Julia.Masomi@unimedizin-mainz.de	Müller, W. E. G./AAR-8651-2020; Ringel, Florian/E-4933-2014	Müller, W. E. G./0000-0002-8223-3689; Masomi-Bornwasser, Julia/0000-0003-1955-9827				Abdu E, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.1.FOCUS11362; Alexandrov AV, 2000, STROKE, V31, P610, DOI 10.1161/01.STR.31.3.610; APFEL RE, 1991, ULTRASOUND MED BIOL, V17, P179, DOI 10.1016/0301-5629(91)90125-G; Barlinn K, 2013, J CLIN ULTRASOUND, V41, P354, DOI 10.1002/jcu.21978; Bor-Seng-Shu E, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11251; Braaten JV, 1997, THROMB HAEMOSTASIS, V78, P1063; Cintas P, 2002, STROKE, V33, P626, DOI 10.1161/hs0202.103073; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Datta S, 2006, ULTRASOUND MED BIOL, V32, P1257, DOI 10.1016/j.ultrasmedbio.2006.04.008; Eggers J, 2003, ANN NEUROL, V53, P797, DOI 10.1002/ana.10590; Fernandes HM, 2000, ACT NEUR S, V76, P463; Fiorella D, 2015, J NEUROINTERV SURG, V7, P752, DOI 10.1136/neurintsurg-2014-011358; FRANCIS CW, 1995, ULTRASOUND MED BIOL, V21, P419, DOI 10.1016/0301-5629(94)00119-X; Gregson BA, 2012, STROKE, V43, P1496, DOI 10.1161/STROKEAHA.111.640284; Keric N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5472936; Keric N, 2013, J NEUROSURG ANESTH, V25, P317, DOI 10.1097/ANA.0b013e31828cb27e; Keric N, 2012, TRANSL STROKE RES, V3, pS88, DOI 10.1007/s12975-012-0188-3; Kreitzer N, 2013, SEMIN NEUROL, V33, P462, DOI 10.1055/s-0033-1364210; Linninger A, 2009, MED ENG PHYS, V31, P838, DOI 10.1016/j.medengphy.2009.03.011; LIPPITZ BE, 1994, ACTA NEUROCHIR, V127, P157, DOI 10.1007/BF01808759; Lord AS, 2015, STROKE, V46, P647, DOI 10.1161/STROKEAHA.114.007704; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Miller DL, 2000, ULTRASOUND MED BIOL, V26, P307, DOI 10.1016/S0301-5629(99)00138-6; Mizushige K, 1999, ULTRASOUND MED BIOL, V25, P1431, DOI 10.1016/S0301-5629(99)00095-2; Morgan T, 2008, ACTA NEUROCHIR SUPPL, V105, P147; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Nedelmann M, 2008, NERVENARZT, V79, P1399, DOI 10.1007/s00115-008-2550-y; Nedelmann M, 2008, ULTRASOUND MED BIOL, V34, P2019, DOI 10.1016/j.ultrasmedbio.2008.06.003; Newell DW, 2011, J NEUROSURG, V115, P592, DOI 10.3171/2011.5.JNS10505; Pfaffenberger S, 2005, STROKE, V36, P124, DOI 10.1161/01.STR.0000150503.10480.a7; Pieters M, 2004, ULTRASOUND MED BIOL, V30, P1545, DOI 10.1016/j.ultrasmedbio.2004.08.028; Prokop AF, 2007, ULTRASOUND MED BIOL, V33, P924, DOI 10.1016/j.ultrasmedbio.2006.11.022; Rohde V, 2002, J NEUROSURG, V97, P954, DOI 10.3171/jns.2002.97.4.0954; Schaberle W., 2005, ULTRASONOGRAPHY VASC; SCHALLER C, 1995, NEUROSURGERY, V36, P328, DOI 10.1227/00006123-199502000-00012; Soltani A, 2011, J THROMB THROMBOLYS, V31, P71, DOI 10.1007/s11239-010-0483-3; Thiex R, 2004, J NEUROL, V251, P1443, DOI 10.1007/s00415-004-0554-5; Thiex Ruth, 2007, Neurosurg Focus, V22, pE6; Wagner KR, 1996, STROKE, V27, P490, DOI 10.1161/01.STR.27.3.490; Wagner KR, 1999, J NEUROSURG, V90, P491, DOI 10.3171/jns.1999.90.3.0491; Wilhelm-Schwenkmezger T, 2007, STROKE, V38, P1031, DOI 10.1161/01.STR.0000257966.32242.0b	42	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188131	10.1371/journal.pone.0188131	http://dx.doi.org/10.1371/journal.pone.0188131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145482	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800072
J	Rocco, CJ; Wetterhorn, KM; Garvey, GS; Rayment, I; Escalante-Semerena, JC				Rocco, Christopher J.; Wetterhorn, Karl M.; Garvey, Graeme S.; Rayment, Ivan; Escalante-Semerena, Jorge C.			The PrpF protein of Shewanella oneidensis MR1 catalyzes the isomerization of 2-methyl-cis-aconitate during the catabolism of propionate via the AcnD-dependent 2-methylcitric acid cycle	PLOS ONE			English	Article							2-METHYLISOCITRATE LYASE PRPB; SALMONELLA-ENTERICA; METHYLCITRATE CYCLE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; MYCOBACTERIUM-TUBERCULOSIS; DEHYDRATASE; METABOLISM; ACONITASE	The 2-methylcitric acid cycle (2-MCC) is a common route of propionate catabolism in microorganisms. In Salmonella enterica, the prpBCDE operon encodes most of the 2-MCC enzymes. In other organisms, e.g., Shewanella oneidensis MR-1, two genes, acnD and prpF replace prpD, which encodes 2-methylcitrate dehydratase. We showed that together, S. oneidensis AcnD and PrpF (SoAcnD, SoPrpF) compensated for the absence of PrpD in a S. enterica prpD strain. We also showed that SoAcnD had 2-methylcitrate dehydratase activity and that PrpF has aconitate isomerase activity. Here we report in vitro evidence that the product of the SoAcnD reaction is an isomer of 2-methyl-cis-aconitate (2-MCA], the product of the SePrpD reaction. We show that the SoPrpF protein isomerizes the product of the AcnD reaction into the PrpD product (2-MCA], a known substrate of the housekeeping aconitase (AcnB]. Given that SoPrpF is an isomerase, that SoAcnD is a dehydratase, and the results from in vivo and in vitro experiments reported here, it is likely that 4-methylaconitate is the product of the AcnD enzyme. Results from in vivo studies using a S. enterica prpD strain show that SoPrpF variants with substitutions of residues K73 or C107 failed to support growth with propionate as the sole source of carbon and energy. High-resolution (1.22 angstrom) three-dimensional crystal structures of PrpF(K73E) in complex with trans-aconitate or malonate provide insights into the mechanism of catalysis of the wild-type protein.	[Rocco, Christopher J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Wetterhorn, Karl M.; Garvey, Graeme S.; Rayment, Ivan] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Escalante-Semerena, Jorge C.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Rocco, Christopher J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [Garvey, Graeme S.] Monsanto Vegetable Seeds, Woodland, CA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Monsanto	Escalante-Semerena, JC (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	jcescala@uga.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835; Escalante-Semerena, Jorge C./0000-0001-7428-2811	National Institute of General Medical Sciences [R01 GM062203, R01 GM086351]; National Institute of Allergy and Infectious Diseases [R21 AI082916]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062203] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx), grant R01 GM062203 to JCES; National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov), grant R21 AI082916 to JCES; National Institute of General Medical Sciences (https://www.nigms.nih.gov/Pages/default.aspx), grant R01 GM086351 to IR.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AOKI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1825, DOI 10.1271/bbb.59.1825; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; BERKOWIT.D, 1968, J BACTERIOL, V96, P215, DOI 10.1128/JB.96.1.215-220.1968; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blankenfeldt W, 2004, P NATL ACAD SCI USA, V101, P16431, DOI 10.1073/pnas.0407371101; Bramer CO, 2002, APPL ENVIRON MICROB, V68, P271, DOI 10.1128/AEM.68.1.271-279.2002; Bramer CO, 2001, MICROBIOL-SGM, V147, P2203, DOI 10.1099/00221287-147-8-2203; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Cirilli M, 1998, BIOCHEMISTRY-US, V37, P16452, DOI 10.1021/bi982138o; Claes WA, 2002, J BACTERIOL, V184, P2728, DOI 10.1128/JB.184.10.2728-2739.2002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garvey GS, 2007, PROTEIN SCI, V16, P1274, DOI 10.1110/ps.072801907; GAWRON O, 1961, NATURE, V189, P1004, DOI 10.1038/1891004a0; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; Grimek TL, 2003, J BACTERIOL, V185, P4837, DOI 10.1128/JB.185.16.4837-4843.2003; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; GUNSALUS RP, 1980, ANAL BIOCHEM, V101, P327, DOI 10.1016/0003-2697(80)90195-5; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANSON KR, 1963, P NATL ACAD SCI USA, V50, P981, DOI 10.1073/pnas.50.5.981; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Horswill AR, 1999, MICROBIOL-UK, V145, P1381, DOI 10.1099/13500872-145-6-1381; Horswill AR, 1997, J BACTERIOL, V179, P928, DOI 10.1128/jb.179.3.928-940.1997; Horswill AR, 2001, BIOCHEMISTRY-US, V40, P4703, DOI 10.1021/bi015503b; Huser AT, 2003, J BIOTECHNOL, V106, P269, DOI 10.1016/j.jbiotec.2003.08.006; KENNEDY MC, 1988, J BIOL CHEM, V263, P8194; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; KENNEDY MC, 1988, J BIOL CHEM, V263, P8190; KLINMAN JP, 1971, BIOCHEMISTRY-US, V10, P2259, DOI 10.1021/bi00788a012; Koo HM, 2000, ARCH BIOCHEM BIOPHYS, V378, P167, DOI 10.1006/abbi.2000.1813; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAUBLE H, 1995, PROTEINS, V22, P1, DOI 10.1002/prot.340220102; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munoz-Elias EJ, 2006, MOL MICROBIOL, V60, P1109, DOI 10.1111/j.1365-2958.2006.05155.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Roth JR, 1980, ADV BACTERIAL GENET; Savvi S, 2008, J BACTERIOL, V190, P3886, DOI 10.1128/JB.01767-07; SCHLOSS JV, 1984, BIOCHEMISTRY-US, V23, P4572, DOI 10.1021/bi00315a010; TABUCHI T, 1974, AGR BIOL CHEM TOKYO, V38, P1105, DOI 10.1080/00021369.1974.10861293; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Upton AM, 2007, MICROBIOL-SGM, V153, P3973, DOI 10.1099/mic.0.2007/011726-0; Velarde M, 2009, J MOL BIOL, V391, P609, DOI 10.1016/j.jmb.2009.06.052	46	6	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188130	10.1371/journal.pone.0188130	http://dx.doi.org/10.1371/journal.pone.0188130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145506	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800071
J	Tsuang, FY; Hsieh, YY; Kuo, YJ; Chen, CH; Lin, FH; Chen, CS; Chiang, CJ				Tsuang, Fon-Yih; Hsieh, Yueh-Ying; Kuo, Yi-Jie; Chen, Chia-Hsien; Lin, Feng-Huei; Chen, Chen-Sheng; Chiang, Chang-Jung			Assessment of the suitability of biodegradable rods for use in posterior lumbar fusion: An in-vitro biomechanical evaluation and finite element analysis	PLOS ONE			English	Article							INTERBODY FUSION; SPINE SURGERY; FACET JOINTS; ADJACENT; THORACOLUMBAR; FIXATION; DEGENERATION; STRESS; CAGES	Interbody fusion with posterior instrumentation is a common method for treating lumbar degenerative disc diseases. However, the high rigidity of the fusion construct may produce abnormal stresses at the adjacent segment and lead to adjacent segment degeneration (ASD). As such, biodegradable implants are becoming more popular for use in orthopaedic surgery. These implants offer sufficient stability for fusion but at a reduced stiffness. Tailored to degrade over a specific timeframe, biodegradable implants could potentially mitigate the drawbacks of conventional stiff constructs and reduce the loading on adjacent segments. Six finite element models were developed in this study to simulate a spine with and without fixators. The spinal fixators used both titanium rods and biodegradable rods. The models were subjected to axial loading and pure moments. The range of motion (ROM), disc stresses, and contact forces of facet joints at adjacent segments were recorded. A 3-point bending test was performed on the biodegradable rods and a dynamic bending test was performed on the spinal fixators according to ASTM F1717-11a. The finite element simulation showed that lumbar spinal fusion using biodegradable implants had a similar ROM at the fusion level as at adjacent levels. As the rods degraded over time, this produced a decrease in the contact force at adjacent facet joints, less stress in the adjacent disc and greater loading on the anterior bone graft region. The mechanical tests showed the initial average fatigue strength of the biodegradable rods was 145 N, but this decreased to 115N and 55N after 6 months and 12 months of soaking in solution. Also, both the spinal fixator with biodegradable rods and with titanium rods was strong enough to withstand 5,000,000 dynamic compression cycles under a 145 N axial load. The results of this study demonstrated that biodegradable rods may present more favourable clinical outcomes for lumbar fusion. These polymer rods could not only provide sufficient initial stability, but the loss in rigidity of the fixation construct over time gradually transfers loading to adjacent segments.	[Tsuang, Fon-Yih; Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Tsuang, Fon-Yih] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Hsieh, Yueh-Ying; Chen, Chia-Hsien; Chiang, Chang-Jung] Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan; [Kuo, Yi-Jie] Taipei Med Univ Hosp, Dept Orthoped, Taipei, Taiwan; [Kuo, Yi-Jie; Chen, Chia-Hsien; Chiang, Chang-Jung] Taipei Med Univ, Sch Med, Dept Orthoped, Coll Med, Taipei, Taiwan; [Lin, Feng-Huei] Natl Hlth Res Inst, Div Med Engn, Zhunan Township, Miaoli County, Taiwan; [Chen, Chen-Sheng] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan; [Chiang, Chang-Jung] Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan; [Kuo, Yi-Jie] Taipei Med Univ, Wan Fang Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Chiang, Chang-Jung] Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; National Health Research Institutes - Taiwan; National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital	Chiang, CJ (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Orthoped, New Taipei, Taiwan.; Chiang, CJ (corresponding author), Taipei Med Univ, Sch Med, Dept Orthoped, Coll Med, Taipei, Taiwan.; Chiang, CJ (corresponding author), Taipei Med Univ, Coll Biomed Engn, Taipei, Taiwan.	chiang.spine@gmail.com		Chiang, Chang-Jung/0000-0002-2269-8337; Tsuang, Fon-Yih/0000-0001-5797-1885				Bastian L, 2001, EUR SPINE J, V10, P295, DOI 10.1007/s005860100278; Bezer M, 2005, EUR SPINE J, V14, P227, DOI 10.1007/s00586-004-0781-6; Chang UK, 2007, J NEUROSURG-SPINE, V7, P33, DOI 10.3171/SPI-07/07/033; Diwan AD, 2003, ORTHOP CLIN N AM, V34, P309, DOI 10.1016/S0030-5898(03)00028-2; Dreischarf M, 2014, J BIOMECH, V47, P1757, DOI 10.1016/j.jbiomech.2014.04.002; Etebar S, 1999, J NEUROSURG, V90, P163, DOI 10.3171/spi.1999.90.2.0163; Faizan A, 2012, CLIN BIOMECH, V27, P226, DOI 10.1016/j.clinbiomech.2011.09.014; Fischgrund JS, 1997, SPINE, V22, P2807, DOI 10.1097/00007632-199712150-00003; Fritzell P, 2002, SPINE, V27, P1131, DOI 10.1097/00007632-200206010-00002; Gercek E, 2003, EUR SPINE J, V12, P513, DOI 10.1007/s00586-003-0539-6; Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017; Hsieh YY, 2017, CLIN BIOMECH, V43, P115, DOI 10.1016/j.clinbiomech.2017.02.011; Jeon CH, 2015, SPINE, V40, pE627, DOI 10.1097/BRS.0000000000000870; Johnsson R, 1997, Eur Spine J, V6, P144, DOI 10.1007/BF01358748; Kim D, C NEUR SURG BOST OCT; Kok D, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-269; Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239; LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029; Li H, 2015, CHINESE MED J-PEKING, V128, P1042, DOI 10.4103/0366-6999.155080; Ma JX, 2014, P I MECH ENG H, V228, P665, DOI 10.1177/0954411914541435; Panjabi MM, 2007, CLIN BIOMECH, V22, P257, DOI 10.1016/j.clinbiomech.2006.08.006; PATEL A, 2000, OPER TECH ORTHOP, V10, P311; Radcliff KE, 2013, SPINE J, V13, P1339, DOI 10.1016/j.spinee.2013.03.020; Savage K, 2014, J SPINAL DISORD TECH, V27, pE66, DOI 10.1097/BSD.0b013e318299c6d8; Schlegel JD, 1996, SPINE, V21, P970, DOI 10.1097/00007632-199604150-00013; Shang XP, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-314; Shih SL, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-191; Shih SL, 2012, J SPINAL DISORD TECH, V25, pE140, DOI 10.1097/BSD.0b013e31824e5e10; van Dijk M, 2002, SPINE, V27, P682, DOI 10.1097/00007632-200204010-00003; Waguespack A, 2002, PAIN MED, V3, P18, DOI 10.1046/j.1526-4637.2002.02007.x; Zotti Mario G, 2015, J Spine Surg, V1, P50, DOI 10.3978/j.issn.2414-469X.2015.08.02	31	7	7	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188034	10.1371/journal.pone.0188034	http://dx.doi.org/10.1371/journal.pone.0188034			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145437	Green Submitted, gold, Green Published			2022-12-27	WOS:000415378800054
J	Aime, H; Broesch, T; Aknin, LB; Warneken, F				Aime, Hilary; Broesch, Tanya; Aknin, Lara B.; Warneken, Felix			Evidence for proactive and reactive helping in two- to five-year-olds from a small-scale society	PLOS ONE			English	Article							TODDLERS PROSOCIAL BEHAVIOR; MIND DEVELOPMENT; CHILDREN; METAANALYSIS; COOPERATION; SYNCHRONY; ONTOGENY; FAIRNESS; CULTURES; INFANTS	Humans are unique in their propensity for helping. Not only do we help others in need by reacting to their requests, we also help proactively by assisting in the absence of a request. Proactive helping requires the actor to detect the need for help, recognize the intention of the other, and remedy the situation. Very little is known about the development of this social phenomenon beyond an urban, industrialized setting. We examined helping in nineteen two- to five-year old children in small-scale rural villages of Vanuatu. In the experimental condition, the intentions of the experimenter were made salient, whereas in the control condition they were ambiguous. Children helped more often in the experimental compared to the control condition, suggesting that the propensity to monitor others' goals and act accordingly can be detected in different cultural contexts.	[Aime, Hilary; Broesch, Tanya; Aknin, Lara B.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Warneken, Felix] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	Simon Fraser University; University of Michigan System; University of Michigan	Broesch, T (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	tanya_broesch@sfu.ca		Broesch, Tanya/0000-0002-5937-5144				Aknin LB, 2015, J EXP PSYCHOL GEN, V144, P788, DOI 10.1037/xge0000082; Barragan RC, 2014, P NATL ACAD SCI USA, V111, P17071, DOI 10.1073/pnas.1419408111; Barrett HC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2654; Bischof-Kohler D., 1991, INFANT DEV PERSPECTI, P245; Blake PR, 2015, NATURE, V528, P258, DOI 10.1038/nature15703; Broesch T, 2016, CHILD DEV, V87, P700, DOI 10.1111/cdev.12501; Broesch T, 2011, J CROSS CULT PSYCHOL, V42, P1018, DOI 10.1177/0022022110381114; Brownell CA, 2016, CHILD DEV PERSPECT, V10, P222, DOI 10.1111/cdep.12189; Brownell CA, 2009, INFANCY, V14, P117, DOI 10.1080/15250000802569868; Callaghan T, 2005, PSYCHOL SCI, V16, P378, DOI 10.1111/j.0956-7976.2005.01544.x; Callaghan Tara, 2011, Monogr Soc Res Child Dev, V76, pvii, DOI 10.1111/j.1540-5834.2011.00603.x; Carpendale JIM, 2015, SOC DEV, V24, P357, DOI 10.1111/sode.12094; Carpendale JIM, 2013, ADV CHILD DEV BEHAV, V45, P125, DOI 10.1016/B978-0-12-397946-9.00006-3; Carpenter M, 2013, CHILD DEV, V84, P1511, DOI 10.1111/cdev.12083; CHISHOLM JS, 1983, NAVAJO INFANCY ETHOL; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Dahl A, 2017, CHILD DEV PERSPECT, V11, P79, DOI 10.1111/cdep.12217; Dahl A, 2017, DEV PSYCHOL, V53, P407, DOI 10.1037/dev0000244; Dahl A, 2015, CHILD DEV, V86, P1080, DOI 10.1111/cdev.12361; Dunfield K, 2011, INFANCY, V16, P227, DOI 10.1111/j.1532-7078.2010.00041.x; Dunfield KA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00958; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Hepach R, 2017, CHILD DEV PERSPECT, V11, P50, DOI 10.1111/cdep.12209; Hepach R, 2017, INFANCY, V22, P130, DOI 10.1111/infa.12143; Hewlett B. S., 2005, HUNTER GATHERER CHIL; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; Hughes C., 2015, CHILD DEV RES, V2014, P893492, DOI [10.1155/2014/893492, DOI 10.1155/2014/893492]; Jaeggi AV, 2010, PHILOS T R SOC B, V365, P2723, DOI 10.1098/rstb.2010.0118; Kartner J., 2015, HUMAN ETHOLOGY B, V30, P71; Keller H., 2007, CULTURES INFANCY; Koster M, 2016, CHILD DEV, V87, P1727, DOI 10.1111/cdev.12636; Lancy D. F., 2008, ANTHR CHILDHOOD CHER; Lancy David F., 1996, PLAYING MOTHER GROUN; Lecce S, 2010, BRIT J DEV PSYCHOL, V28, P747, DOI 10.1348/026151009X479006; LeVine R, 1994, CHILDCARE CULTURE LE; Liu D, 2008, DEV PSYCHOL, V44, P523, DOI 10.1037/0012-1649.44.2.523; Mayer A, 2013, INT J BEHAV DEV, V37, P21, DOI 10.1177/0165025412454030; Nielsen M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0071; Paulus M, 2014, CHILD DEV PERSPECT, V8, P77, DOI 10.1111/cdep.12066; RHEINGOLD HL, 1982, CHILD DEV, V53, P114, DOI 10.1111/j.1467-8624.1982.tb01298.x; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Rogoff B., 2003, CULTURAL NATURE HUMA; Shahaeian A, 2011, DEV PSYCHOL, V47, P1239, DOI 10.1037/a0023899; Svetlova M, 2010, CHILD DEV, V81, P1814, DOI 10.1111/j.1467-8624.2010.01512.x; Taumoepeau M, 2015, J CROSS CULT PSYCHOL, V46, P1169, DOI 10.1177/0022022115604393; Torrens MG, 2017, J CROSS CULT PSYCHOL, V48, P353, DOI 10.1177/0022022117690451; Triandis H.C, 1995, INDIVIDUALISM COLLEC; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2008, DEV PSYCHOL, V44, P1785, DOI 10.1037/a0013860; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Warneken F, 2016, CURR OPIN PSYCHOL, V7, P51, DOI 10.1016/j.copsyc.2015.07.013; Warneken F, 2015, CHILD DEV PERSPECT, V9, P1, DOI 10.1111/cdep.12101; Warneken F, 2013, COGNITION, V126, P101, DOI 10.1016/j.cognition.2012.09.011; Warneken F, 2009, BRIT J PSYCHOL, V100, P455, DOI 10.1348/000712608X379061; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Whiting B. B., 1975, CHILDREN 6 CULTURES	57	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187787	10.1371/journal.pone.0187787	http://dx.doi.org/10.1371/journal.pone.0187787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141009	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400029
J	Fiume, E; Coen, O; Xu, WJ; Lepiniec, L; Magnani, E				Fiume, Elisa; Coen, Olivier; Xu, Wenjia; Lepiniec, Loic; Magnani, Enrico			Developmental patterning of sub-epidermal cells in the outer integument of Arabidopsis seeds	PLOS ONE			English	Article							PROTEIN; FERTILIZATION; THALIANA; GORDITA; GENES	The seed, the reproductive unit of angiosperms, is generally protected by the seed coat. The seed coat is made of one or two integuments, each comprising two epidermal cells layers and, in some cases, extra sub-epidermal cell layers. The thickness of the seed-coat affects several aspects of seed biology such as dormancy, germination and mortality. In Arabidopsis, the inner integument displays one or two sub-epidermal cell layers that originate from periclinal cell divisions of the innermost epidermal cell layer. By contrast, the outer integument was considered to be two-cell layered. Here, we show that sub-epidermal chalazal cells grow in between the epidermal outer integument cell layers to create an incomplete three-cell layered outer integument. We found that the MADS box transcription factor TRANSPARENT TESTA 16 represses growth of the chalaza and formation of sub-epidermal outer integument cells. Finally, we demonstrate that sub-epidermal cells of the outer and inner integument respond differently to the repressive mechanism mediated by FERTILIZATION INDEPENDENT SEED Polycomb group proteins and to fertilization signals. Our data suggest that integument cell origin rather than sub-epidermal cell position underlies different responses to fertilization.	[Fiume, Elisa; Coen, Olivier; Xu, Wenjia; Lepiniec, Loic; Magnani, Enrico] Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France; [Coen, Olivier] Univ Paris Saclay, Univ Paris Sud, Ecole Doctorale Sci Vegetal 567, Bat 360, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Magnani, E (corresponding author), Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France.	enrico.magnani@inra.fr	Lepiniec, Loic/G-5808-2012	Lepiniec, Loic/0000-0002-5845-3323; Magnani, Enrico/0000-0002-2959-3714; XU, Wenjia/0000-0003-1945-4451	Marie Curie SEEDNET EU-CIG [E321710]; Labex Saclay Plant Sciences-SPS [ANR-10-LABX-0040-SPS]	Marie Curie SEEDNET EU-CIG; Labex Saclay Plant Sciences-SPS	The projec twas supported by the Marie Curie SEEDNET EU-CIG no E321710 and Labex Saclay Plant Sciences-SPS (ANR-10-LABX-0040-SPS) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coen O, 2017, DEVELOPMENT, V144, P1490, DOI 10.1242/dev.146274; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Debeaujon I, 2003, PLANT CELL, V15, P2514, DOI 10.1105/tpc.014043; Ehlers K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165075; Endress PK, 2011, ANN BOT-LONDON, V107, P1465, DOI 10.1093/aob/mcr120; Erdmann R, 2010, PLANT J, V63, P914, DOI 10.1111/j.1365-313X.2010.04290.x; Figueiredo DD, 2016, ELIFE, V5, DOI 10.7554/eLife.20542; Fiume E, 2017, PLANT SIGNAL BEHAV, V12, DOI 10.1080/15592324.2017.1339000; Gardarin A, 2010, SEED SCI RES, V20, P243, DOI 10.1017/S0960258510000255; Haughn G, 2005, TRENDS PLANT SCI, V10, P472, DOI 10.1016/j.tplants.2005.08.005; Kasahara RD, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600554; KELLY KM, 1992, PLANT GROWTH REGUL, V11, P201, DOI 10.1007/BF00024559; Kohler C, 2003, EMBO J, V22, P4804, DOI 10.1093/emboj/cdg444; Mizzotti C, 2012, PLANT J, V70, P409, DOI 10.1111/j.1365-313X.2011.04878.x; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; NOODEN LD, 1985, PLANT PHYSIOL, V79, P543, DOI 10.1104/pp.79.2.543; Oliva M, 2016, J EXP BOT, V67, P6111, DOI 10.1093/jxb/erw373; Prasad K, 2010, PLANT J, V62, P203, DOI 10.1111/j.1365-313X.2010.04139.x; Ron M, 2010, GENE DEV, V24, P1010, DOI 10.1101/gad.1882810; Roszak P, 2011, P NATL ACAD SCI USA, V108, P20826, DOI 10.1073/pnas.1117111108; SCHNEITZ K, 1995, PLANT J, V7, P731, DOI 10.1046/j.1365-313X.1995.07050731.x; Xu WJ, 2016, PLANT CELL, V28, P1343, DOI 10.1105/tpc.16.00041	23	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188148	10.1371/journal.pone.0188148	http://dx.doi.org/10.1371/journal.pone.0188148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141031	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400066
J	Morell, CM; Fiorotto, R; Meroni, M; Raizner, A; Torsello, B; Cadamuro, M; Spagnuolo, G; Kaffe, E; Sutti, S; Albano, E; Strazzabosco, M				Morell, Carola M.; Fiorotto, Romina; Meroni, Marica; Raizner, Aileen; Torsello, Barbara; Cadamuro, Massimiliano; Spagnuolo, Gaia; Kaffe, Eleanna; Sutti, Salvatore; Albano, Emanuele; Strazzabosco, Mario			Notch signaling and progenitor/ductular reaction in steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; DUCTULAR REACTION; MOUSE-LIVER; INSULIN-RESISTANCE; HEPATOCYTES; MICE; REGENERATION; CELLS; FIBROSIS; REPAIR	Background and objective Persistent hepatic progenitor cells (HPC) activation resulting in ductular reaction (DR) is responsible for pathologic liver repair in cholangiopathies. Also, HPC/DR expansion correlates with fibrosis in several chronic liver diseases, including steatohepatitis. Increasing evidence indicates Notch signaling as a key regulator of HPC/DR response in biliary and more in general liver injuries. Therefore, we aimed to investigate the role of Notch during HPC/DR activation in a mouse model of steatohepatitis. Methods Steatohepatitis was generated using methionine-choline deficient (MCD) diet. For hepatocyte lineage tracing, R26R-YFP mice were infected with AAV8-TBG-Cre. Results MCD diet promoted a strong HPC/DR response that progressively diffused in the lobule, and correlated with increased fibrosis and TGF-beta 1 expression. Notch signaling was unchanged in laser-capture microdissected HPC/DR, whereas Notch receptors were down regulated in hepatocytes. However, in-vivo lineage tracing experiments identified discrete hepatocytes showing Notch-1 activation and expressing (the Notch-dependent) Sox9. Stimulation of AML-12 hepatocyte-cell line with immobilized Jag1 induced Sox9 and down-regulated albumin and BSEP expression. TGF-beta 1 treatment in primary hepatic stellate cells (HSC) induced Jag1 expression. In MCD diet-fed mice, alpha SMA-positive HSC were localized around Sox9 expressing hepatocytes, suggesting that Notch activation in hepatocytes was promoted by TGF-beta 1 stimulated HSC. In-vivo Notch inhibition reduced HPC response and fibrosis progression. Conclusion Our data suggest that Notch signaling is an important regulator of DR and that in steatohepatitis, hepatocytes exposed to Jag1-positive HSC, contribute to pathologic DR by undergoing Notch-mediated differentiation towards an HPC-like phenotype. Given the roles of Notch in fibrosis and liver cancer, these data suggest mesenchymal expression of Jag1 as an alternative therapeutic target.	[Morell, Carola M.; Fiorotto, Romina; Meroni, Marica; Torsello, Barbara; Cadamuro, Massimiliano; Spagnuolo, Gaia; Strazzabosco, Mario] Univ Milano Bicocca, Dept Med & Surg, Int Ctr Digest Hlth, Monza, Italy; [Fiorotto, Romina; Raizner, Aileen; Kaffe, Eleanna; Strazzabosco, Mario] Yale Univ, Ctr Liver, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Sutti, Salvatore; Albano, Emanuele] Univ A Avogadro East Piedmont, Dept Hlth Sci, Novara, Italy; [Morell, Carola M.] Univ Cambridge, Wellcome Trust Med Res Council Stem Cell Inst, Anne McLaren Lab, Cambridge, England; [Meroni, Marica] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy; [Raizner, Aileen] Montefiore Med Ctr, Dept Pediat, Bronx, NY USA	University of Milano-Bicocca; Yale University; University of Eastern Piedmont Amedeo Avogadro; University of Cambridge; University of Milan; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Strazzabosco, M (corresponding author), Univ Milano Bicocca, Dept Med & Surg, Int Ctr Digest Hlth, Monza, Italy.; Strazzabosco, M (corresponding author), Yale Univ, Ctr Liver, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA.	mario.strazzabosco@yale.edu	Cadamuro, Massimiliano/AAC-6169-2022; meroni, marica/K-8621-2018; Sutti, Salvatore/X-5716-2019	Cadamuro, Massimiliano/0000-0002-0899-7613; meroni, marica/0000-0002-4161-4178; Sutti, Salvatore/0000-0002-0192-8199; Morell, Carola Maria/0000-0001-9140-8068; STRAZZABOSCO, MARIO/0000-0002-1995-6331	Italian Ministry of Education and University [PRIN 2009ARYX4T_005]; CARIPLO [2011-0470]; National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01DK079005, P30 DK034989]; Mario Strazzabosco; NICHD; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096096, P30DK034989, R01DK079005] Funding Source: NIH RePORTER	Italian Ministry of Education and University(Ministry of Education, Universities and Research (MIUR)); CARIPLO(Fondazione Cariplo); National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mario Strazzabosco; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Italian Ministry of Education and University (PRIN 2009ARYX4T_005), by CARIPLO 2011-0470, by the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK079005 and P30 DK034989-Silvio O. Conte Digestive Diseases Research Core. All funding received by Mario Strazzabosco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The rat anti-mouse K19 antibody (TROMA-III) developed by Kemler R. and the N2ICD (c651.6DbHN clone) developed by Artavanis-Tsakonas S. were obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242	Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Dill MT, 2012, HEPATOLOGY; Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073; Fabris L, 2017, AM J PHYSIOL-GASTR L, V313, pG102, DOI 10.1152/ajpgi.00452.2016; Fabris L, 2011, SEMIN LIVER DIS, V31, P11, DOI 10.1055/s-0031-1272832; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025; Flores AN, 2014, NAT REV UROL, V11, P499, DOI 10.1038/nrurol.2014.195; Geisler F, 2014, HEPATOLOGY; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; Huntzicker EG, 2014, HEPATOLOGY; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lazo M, 2008, SEMIN LIVER DIS, V28, P339, DOI 10.1055/s-0028-1091978; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600; Morell CM, 2014, J HEPATOL, V60, P885, DOI 10.1016/j.jhep.2013.11.028; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Pritchett J, 2012, HEPATOLOGY, V56, P1108, DOI 10.1002/hep.25758; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Roskams T, 1998, SEMIN DIAGN PATHOL, V15, P259; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Svegliati-Baroni G, 2011, GUT, V60, P108, DOI 10.1136/gut.2010.219741; Tanimizu N, 2014, J BIOL CHEM, V289, P7589, DOI 10.1074/jbc.M113.517243; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zender S, 2013, CANCER CELL, V23, P784, DOI 10.1016/j.ccr.2013.04.019; Zincarelli C, 2008, MOL THER, V16, P1073, DOI 10.1038/mt.2008.76; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	38	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187384	10.1371/journal.pone.0187384	http://dx.doi.org/10.1371/journal.pone.0187384			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140985	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400023
J	Rubio, AAV; Castro-Arellano, I; Mills, JN; List, R; Avila-Flores, R; Suzan, G				Rubio, Andre A. V.; Castro-Arellano, Ivan; Mills, James N.; List, Rurik; Avila-Flores, Rafael; Suzan, Gerardo			Is species richness driving intra- and interspecific interactions and temporal activity overlap of a hantavirus host? An experimental test	PLOS ONE			English	Article							SIN NOMBRE VIRUS; DEER MICE; SEASONAL-VARIATION; NICHE SEGREGATION; UNITED-STATES; BIODIVERSITY; TRANSMISSION; POPULATIONS; INFECTIONS; PREVALENCE	High species diversity of the potential animal host community for a zoonotic pathogen may reduce pathogen transmission among the most competent host, a phenomenon called the "dilution effect", but the mechanisms driving this effect have been little studied. One proposed mechanism is "encounter reduction" where host species of low-competency decrease contact rates between infected and susceptible competent hosts, especially in directly transmitted diseases. We conducted an experiment in outdoor enclosures in northwestern Mexico where we manipulated rodent assemblages to assess the effect of species richness on the frequency of intra-and interspecific interactions and activity patterns of a hantavirus reservoir host (North American deermouse; Peromyscus maniculatus). Trials consisted of three treatments of rodent assemblages that differed in species richness, but had equal abundance of deermice; treatment 1 consisted of only deermice, treatment 2 included deermice and one non-competent host species, and treatment 3 included two non-competent host species in addition to deermice. To measure interactions and temporal activity, we strategically deployed foraging stations and infrared cameras. We did not find differences in the frequency of intraspecific interactions of deermice among treatments, but there were significantly more interspecific interactions between deermouse and non-competent hosts in treatment 2 than treatment 3, which is explained by the identity of the non-competent host species. In addition, there were differences in activity patterns between rodent species, and also between deermice from treatment 1 and treatment 2. These results indicate that at least at a small-scale analysis, the co-occurrence with other species in the study area does not influence the frequency of intraspecific interactions of deermice, and that deermice may be changing their activity patterns to avoid a particular non-competent host species (Dipodomys merriami). In conclusion, in this deermouse-hantavirus system a potential dilution effect would not be through intraspecific encounter reduction in the most competent hantavirus host. To identify variables of host assemblages that can influence pathogen transmission, we highlight the need to address the identity of species and the composition of assemblages, not only host species richness or diversity.	[Rubio, Andre A. V.; Suzan, Gerardo] Univ Nacl Autonoma Mexico, Dept Etol Fauna Silvestre & Anim Lab, Fac Med Vet Zootecnia, Mexico City, DF, Mexico; [Castro-Arellano, Ivan] Texas State Univ, Biol Dept, San Marcos, TX USA; [Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [List, Rurik] Univ Autonoma Metropolitana, Area Invest Biol Conservac, Lerma, Estado De Mexic, Mexico; [Avila-Flores, Rafael] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Rubio, Andre A. V.] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile	Universidad Nacional Autonoma de Mexico; Texas State University System; Texas State University San Marcos; Emory University; Universidad Autonoma Metropolitana - Mexico; Universidad Juarez Autonoma de Tabasco; Universidad de Chile	Rubio, AAV (corresponding author), Univ Nacl Autonoma Mexico, Dept Etol Fauna Silvestre & Anim Lab, Fac Med Vet Zootecnia, Mexico City, DF, Mexico.; Rubio, AAV (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile.	andre.rubio@gmail.com	Rubio, André V./M-5307-2015	Rubio, André V./0000-0001-7297-9535; Suzan, Gerardo/0000-0003-2508-6376	Consejo Nacionalde Ciencia y Tecnologia (Mexico) [179482]; Becas-Chile PhD Scholarship	Consejo Nacionalde Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Becas-Chile PhD Scholarship	Funding for the study was provided by Consejo Nacionalde Ciencia y Tecnologia (Mexico) project no. 179482 (AVR, ICA, RAF, GS). AVR was supported by Becas-Chile PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Avila B, 2016, ACTA OECOL, V70, P67, DOI 10.1016/j.actao.2015.12.001; Bagamian KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047731; Bagamian KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037254; Calisher CH, 1999, EMERG INFECT DIS, V5, P126, DOI 10.3201/eid0501.990115; Cantoni G, 2001, TROP MED INT HEALTH, V6, P811, DOI 10.1046/j.1365-3156.2001.00788.x; Carver S, 2011, OECOLOGIA, V166, P713, DOI 10.1007/s00442-010-1882-z; Castro-Arellano I, 2010, METHODS ECOL EVOL, V1, P311, DOI 10.1111/j.2041-210X.2010.00031.x; Castro-Arellano I, 2009, J TROP ECOL, V25, P593, DOI 10.1017/S0266467409990186; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; Civitello DJ, 2015, P NATL ACAD SCI USA, V112, P8667, DOI 10.1073/pnas.1506279112; Clay CA, 2009, ECOHEALTH, V6, P250, DOI 10.1007/s10393-009-0240-2; Clay CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006467; Dearing MD, 2009, J WILDLIFE DIS, V45, P430, DOI 10.7589/0090-3558-45.2.430; Dizney L, 2016, ANIM BEHAV, V111, P341, DOI 10.1016/j.anbehav.2015.11.006; Dizney L, 2013, ANIM BEHAV, V86, P911, DOI 10.1016/j.anbehav.2013.08.003; Escutenaire S, 2000, VIRUS RES, V67, P91, DOI 10.1016/S0168-1702(00)00136-2; Falkenberg JC, 1998, J MAMMAL, V79, P558, DOI 10.2307/1382986; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; FLAKE LD, 1973, J MAMMAL, V54, P636, DOI 10.2307/1378963; Fuller CA, 1996, CAN J ZOOL, V74, P750, DOI 10.1139/z96-085; Hantsch L, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00103.1; HEALEY MC, 1967, ANNU REV ECOL SYST, V48, P377; Huang ZYX, 2016, PARASITOLOGY, V143, P1075, DOI 10.1017/S0031182016000536; Huang ZYX, 2014, PARASITOLOGY, V141, P981, DOI 10.1017/S0031182013002357; Johnson PTJ, 2015, ECOL LETT, V18, P1119, DOI 10.1111/ele.12479; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Khalil H, 2014, VECTOR-BORNE ZOONOT, V14, P537, DOI 10.1089/vbz.2013.1562; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0131; Knust B, 2013, EMERG INFECT DIS, V19, P1934, DOI 10.3201/eid1912.131217; Kovach WL, 2011, ORIANA CIRCULAR STAT; Kronfeld-Schor N, 2003, ANNU REV ECOL EVOL S, V34, P153, DOI 10.1146/annurev.ecolsys.34.011802.132435; LANDRY SO, 1970, Q REV BIOL, V45, P351, DOI 10.1086/406647; Luis AD, 2016, 101 ESA ANN M FLOR; McDonald PJ, 2015, BIOL CONSERVATION, V19; Milazzo ML, 2012, EMERG INFECT DIS, V18, P571, DOI 10.3201/eid1804.111028; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P563, DOI 10.1089/vbz.2009.0018; Mills JN, 2005, ARCH VIROL, P45; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Moreno-Torres K, 2014, SW NATURALIST, V59, P590; O'Regan SM, 2015, AM NAT, V186, P480, DOI 10.1086/682721; Ostfeld RS, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1676; Padula P, 2004, J VIROL, V78, P11972, DOI 10.1128/JVI.78.21.11972-11979.2004; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592; Rubio AV, 2015, MAMM BIOL, V80, P491, DOI 10.1016/j.mambio.2015.06.004; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Suzan G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005461; WATSON GS, 1962, BIOMETRIKA, V49, P57; YANAGIHARA R, 1990, REV INFECT DIS, V12, P449	53	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188060	10.1371/journal.pone.0188060	http://dx.doi.org/10.1371/journal.pone.0188060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141047	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400051
J	Jamaludin, FA; Ab-Kadir, MZA; Izadi, M; Azis, N; Jasni, J; Abd-Rahman, MS				Jamaludin, Farah Adilah; Ab-Kadir, Mohd Zainal Abidin; Izadi, Mahdi; Azis, Norhafiz; Jasni, Jasronita; Abd-Rahman, Muhammad Syahmi			Effects of RTV coating on the electrical performance of polymer insulator under lightning impulse voltage condition	PLOS ONE			English	Article								Located near the equator, Malaysia is a country with one of the highest lightning densities in the world. Lightning contributes to 70% of the power outages in Malaysia and affects power equipment, automated network systems, causes data losses and monetary losses in the nation. Therefore, consideration of insulator evaluation under lightning impulses can be crucial to evaluate and attempt to overcome this issue. This paper presents a new approach to increase the electrical performance of polymer insulators using a Room Temperature Vulcanisation (RTV) coating. The evaluation involves three different settings of polymer insulator, namely uncoated, RTV type 1, and RTV type 2 upper surface coatings. All the insulators were tested under three different conditions as dry, clean wet and salty under different impulse polarities using the even-rising test method. The voltage breakdown for each test was recorded. From the experiment, it was found that the effectiveness of the RTV coating application became apparent when tested under salty or polluted conditions. It increased the voltage withstand capabilities of the polymer insulator up to 50% from the basic uncoated insulator. Under dry and clean conditions, the RTV coating provided just a slight increase of the breakdown voltage. The increase in voltage breakdown capability decreased the probability of surface discharge and dry band arcing that could cause degradation of the polymeric material housing. The RTV type 1 coating was found to be more effective when performing under a lightning impulse. The findings might help the utility companies improve the performance of their insulators in order to increase power system reliability.	[Jamaludin, Farah Adilah; Ab-Kadir, Mohd Zainal Abidin; Izadi, Mahdi; Azis, Norhafiz; Jasni, Jasronita; Abd-Rahman, Muhammad Syahmi] Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Jamaludin, FA (corresponding author), Univ Putra Malaysia, Fac Engn, Ctr Electromagnet & Lightning Protect Res CELP, Serdang, Selangor, Malaysia.	farahad31@gmail.com	azis, norhafiz/AAD-8684-2020; Kadir, Zainal/B-6629-2009; Jasni, Jasronita/AAD-8703-2020; Izadi/AAN-5413-2021	azis, norhafiz/0000-0002-9669-569X; Kadir, Zainal/0000-0001-7263-2953; Jasni, Jasronita/0000-0002-9617-8609; Izadi, Mahdi/0000-0002-8348-4404				[Anonymous], 2010, 60507 IEC; Chandima G, 2012, IEEE C SUST UT DEV E; Charalampidis P, 2014, IEEE T DIELECT EL IN, V21, P740, DOI 10.1109/TDEI.2013.004015; Cherney EA, 1999, IEEE T DIELECT EL IN, V6, P605, DOI 10.1109/94.798117; Chinnusamy M., 2009, INT C POW SYST, P25; Fernando MARM, 2000, IEEE T POWER DELIVER, V15, P355, DOI 10.1109/61.847273; Gao HF, 2007, IEEE T POWER DELIVER, V22, P1117, DOI 10.1109/TPWRD.2007.893432; Homma H, 2000, IEEE T POWER DELIVER, V15, P1298, DOI 10.1109/61.891518; IEEE Standards, 2004, IEEE GUID IMPR LIGHT; Joseph V. V, 2012, TRACKING EROSION SIL, V19, P91; Krytian L. C, 2009, INT S HIGH VOLT; Maciej K, 2005, IEEE ELECTR INSUL M, V2, P14; Maciej K, 2005, IEEE ELECTR INSUL M, V21, P28; Marungsri B, 2006, IEEE T DIELECT EL IN, V13, P129, DOI 10.1109/TDEI.2006.1593411; Mohd Zainal Abidin A. K, 2012, INT C LIGHTN PROT IC; Ramirez I, 2012, C ELECT INSUL DIEL P, P794, DOI 10.1109/CEIDP.2012.6378900; RIZK FAM, 1975, P I ELECTR ENG, V122, P449, DOI 10.1049/piee.1975.0124; Rowland SM, 2010, IEEE T DIELECT EL IN, V17, P375, DOI 10.1109/TDEI.2010.5448091; Sendilkumar S, 2010, INT REV ELECTR ENG-I, V5, P2461; Shuji S, 2005, INT POW ENG C MAY 8; Siderakis K, 2008, ELECTR POW SYST RES, V78, P248, DOI 10.1016/j.epsr.2007.02.013; Stanislaw M. G., 2005, IEEE ELECTR INSUL M, V21, P5; Suwarno, 2012, PROCEEDINGS OF 2012 IEEE INTERNATIONAL CONFERENCE ON CONDITION MONITORING AND DIAGNOSIS (IEEE CMD 2012), P1143, DOI 10.1109/CMD.2012.6416361; Wei XX, 2014, IEEE ELECTR INSUL M, V30, P42, DOI 10.1109/MEI.2014.6749572	24	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187892	10.1371/journal.pone.0187892	http://dx.doi.org/10.1371/journal.pone.0187892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136025	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200041
J	Kim, SY; Sim, S; Choi, HG				Kim, So Young; Sim, Songyong; Choi, Hyo Geun			High stress, lack of sleep, low school performance, and suicide attempts are associated with high energy drink intake in adolescents	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; CAFFEINE INTAKE; RISK; BEVERAGES; INGESTION; PATTERNS; HEALTH; COFFEE; MOOD	Objective Although an association between energy drinks and suicide has been suggested, few prior studies have considered the role of emotional factors including stress, sleep, and school performance in adolescents. This study aimed to evaluate the association of energy drinks with suicide, independent of possible confounders including stress, sleep, and school performance. Methods In total, 121,106 adolescents with 13-18 years olds from the 2014 and 2015 Korea Youth Risk Behavior Web-based Survey were surveyed for age, sex, region of residence, economic level, paternal and maternal education level, sleep time, stress level, school performance, frequency of energy drink intake, and suicide attempts. Subjective stress levels were classified into severe, moderate, mild, a little, and no stress. Sleep time was divided into 6 groups: < 6 h; 6 <= h <= 7; 7 <= h <= 8; 8 <= h < 9; and >= 9 h. School performance was classified into 5 levels: A (highest), B (middle, high), C (middle), D (middle, low), and E (lowest). Frequency of energy drink consumption was divided into 3 groups: >= 3, 1-2, and 0 times a week. The associations of sleep time, stress level, and school performance with suicide attempts and the frequency of energy drink intake were analyzed using multiple and ordinal logistic regression analysis, respectively, with complex sampling. The relationship between frequency of energy drink intake and suicide attempts was analyzed using multiple logistic regression analysis with complex sampling. Results Higher stress levels, lack of sleep, and low school performance were significantly associated with suicide attempts (each P < 0.001). These variables of high stress level, abnormal sleep time, and low school performance were also proportionally related with higher energy drink intake (P < 0.001). Frequent energy drink intake was significantly associated with suicide attempts in multiple logistic regression analyses (AOR for frequency of energy intake >= 3 times a week = 3.03, 95% CI = 2.64-3.49, P < 0.001). Conclusion Severe stress, inadequate sleep, and low school performance were related with more energy drink intake and suicide attempts in Korean adolescents. Frequent energy drink intake was positively related with suicide attempts, even after adjusting for stress, sleep time, and school performance.	[Kim, So Young] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860, 2017R1C1B1007696]; Hallym University Sacred Heart Hospital [HURF-2016-38]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860 and 2017R1C1B1007696) from the National Research Foundation (NRF) of Korea and a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azagba S, 2014, PREV MED, V62, P54, DOI 10.1016/j.ypmed.2014.01.019; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Bonsignore A, 2014, FORENSIC SCI MED PAT, V10, P448, DOI 10.1007/s12024-014-9571-6; Chan CYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132457; Childs E, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12148; Jackson DAE, 2013, CLIN TOXICOL, V51, P557, DOI 10.3109/15563650.2013.820311; Jin MJ, 2016, KOREAN J FAM MED, V37, P111, DOI 10.4082/kjfm.2016.37.2.111; Johnson SJ, 2016, APPETITE, V96, P588, DOI 10.1016/j.appet.2015.10.007; Keaver L, 2017, PUBLIC HEALTH NUTR, V20, P1534, DOI 10.1017/S1368980017000362; Kelly Caitlin K., 2016, Journal of Caffeine Research, V6, P73, DOI 10.1089/jcr.2015.0027; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; Lee JW, 2015, EUR J PEDIATR, V174, P1671, DOI 10.1007/s00431-015-2581-x; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; Lucas M, 2014, WORLD J BIOL PSYCHIA, V15, P377, DOI 10.3109/15622975.2013.795243; McKetin R, 2015, DRUG ALCOHOL DEPEN, V151, P15, DOI 10.1016/j.drugalcdep.2015.01.047; Ogawa N, 2007, PSYCHIAT CLIN NEUROS, V61, P263, DOI 10.1111/j.1440-1819.2007.01652.x; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Owens JA, 2014, NUTR REV, V72, P65, DOI 10.1111/nure.12150; Park C, 2016, J AFFECT DISORDERS, V194, P16, DOI 10.1016/j.jad.2016.01.021; Park SM, 2016, INT C NUMER SIMUL, P87, DOI 10.1109/NUSOD.2016.7547042; Pelkonen Mirjami, 2003, Paediatr Drugs, V5, P243, DOI 10.2165/00148581-200305040-00004; Pettit ML, 2011, J AM COLL HEALTH, V59, P335, DOI 10.1080/07448481.2010.510163; Reid Jessica L, 2017, Prev Med Rep, V5, P65; Reid JL, 2015, CAN J PUBLIC HEALTH, V106, pE101, DOI 10.17269/cjph.106.4684; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Robins MT, 2016, ALCOHOL, V54, P1, DOI 10.1016/j.alcohol.2016.05.001; Roehrs T, 2008, SLEEP MED REV, V12, P153, DOI 10.1016/j.smrv.2007.07.004; Sanchez Sixto E, 2013, Health (Irvine Calif), V5, P26; Shilo Lotan, 2002, Sleep Med, V3, P271, DOI 10.1016/S1389-9457(02)00015-1; Silva AC, 2014, CNS NEUROL DISORD-DR, V13, P937, DOI 10.2174/1871527313666140612123656	31	26	27	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187759	10.1371/journal.pone.0187759	http://dx.doi.org/10.1371/journal.pone.0187759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135989	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200032
J	Jain, V; Das, B				Jain, Vinay; Das, Birajalaxmi			Global transcriptome profile reveals abundance of DNA damage response and repair genes in individuals from high level natural radiation areas of Kerala coast	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; IONIZING-RADIATION; EXPRESSION PROFILES; SOUTHWEST COAST; RADIOADAPTIVE RESPONSE; BACKGROUND-RADIATION; HUMAN-POPULATION; EXPOSURE	The high level natural radiation areas (HLNRA) of Kerala coast in south west India is unique for its wide variation in the background radiation dose (<1.0mGy to 45mGy/year) and vast population size. Several biological studies conducted in this area did not reveal any adverse effects of chronic low dose and low dose rate radiation on human population. In the present study, global transcriptome analysis was carried out in peripheral blood mono-nuclear cells of 36 individuals belonging to different background dose groups [NLNRA, (Group I, <= 1.50 mGy/year) and three groups of HLNRA; Group II, 1.51-5.0 mGy/year), Group III, 5.01-15mGy/year and Group IV, >15.0 mGy/year] to find out differentially expressed genes and their biological significance in response to chronic low dose radiation exposure. Our results revealed a dose dependent increase in the number of differentially expressed genes with respect to different background dose levels. Gene ontology analysis revealed majority of these differentially expressed genes are involved in DNA damage response (DDR) signaling, DNA repair, cell cycle arrest, apoptosis, histone/chromatin modification and immune response. In the present study, 64 background dose responsive genes have been identified as possible chronic low dose radiation signatures. Validation of 30 differentially expressed genes was carried out using fluorescent based universal probe library. Abundance of DDR and DNA repair genes along with pathways such as MAPK, p53 and JNK in higher background dose groups (>5.0mGy/year) indicated a possible threshold dose for DDR signaling and are plausible reason of observing in vivo radio-adaptive response and non-carcinogenesis in HLNRA population. To our knowledge, this is the first study on molecular effect of chronic low dose radiation exposure on human population from high background radiation areas at transcriptome level using high throughput approach. These findings have tremendous implications in understanding low dose radiation biology especially, the effect of low dose radiation exposure in humans.	[Jain, Vinay; Das, Birajalaxmi] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Low Level Radiat Res Sect, Biosci Grp, Bombay, Maharashtra, India; [Jain, Vinay; Das, Birajalaxmi] Homi Bhabha Natl Inst, Bombay, Maharashtra, India	Bhabha Atomic Research Center (BARC); Homi Bhabha National Institute	Das, B (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Low Level Radiat Res Sect, Biosci Grp, Bombay, Maharashtra, India.; Das, B (corresponding author), Homi Bhabha Natl Inst, Bombay, Maharashtra, India.	biraj@barc.gov.in		Jain, Vinay/0000-0002-9172-0067				Albanese J, 2007, EXP HEMATOL, V35, P47, DOI 10.1016/j.exphem.2007.01.012; Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Amundson SA, 2003, HEALTH PHYS, V85, P36, DOI 10.1097/00004032-200307000-00009; Amundson SA, 2003, MOL CANCER RES, V1, P445; Amundson SA, 2001, RADIAT PROT DOSIM, V97, P11, DOI 10.1093/oxfordjournals.rpd.a006632; Amundson Sally A, 2003, Methods Mol Biol, V223, P141; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Cheriyan VD, 1999, RADIAT RES, V152, pS154, DOI 10.2307/3580136; Das B, 2012, INT J RADIAT BIOL, V88, P642, DOI 10.3109/09553002.2012.699135; Das B, 2009, INT J RADIAT BIOL, V85, P272, DOI 10.1080/09553000902751462; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Fachin AL, 2007, RADIAT RES, V168, P650, DOI 10.1667/RR0487.1; Fachin AL, 2009, J RADIAT RES, V50, P61, DOI 10.1269/jrr.08034; Falk M, 2007, BBA-MOL CELL RES, V1773, P1534, DOI 10.1016/j.bbamcr.2007.07.002; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fornace Albert J Jr, 2002, Mil Med, V167, P13; Franco N, 2005, RADIAT RES, V163, P623, DOI 10.1667/RR3391; Fujimori A, 2005, CANCER RES, V65, P10159, DOI 10.1158/0008-5472.CAN-05-2015; Ghandhi SA, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0097-x; Gopal-Ayengar A.R., 1971, P 4 INT C PEAC US AT, V2, P31; GOPALAYEAR, 1970, INDIAN J EXP BIOL, V8, P313; Grudzenski S, 2010, P NATL ACAD SCI USA, V107, P14205, DOI 10.1073/pnas.1002213107; GRUNEBERG H, 1964, NATURE, V204, P222, DOI 10.1038/204222a0; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Jagirdar K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078075; Jaikrishan G, 1999, RADIAT RES, V152, pS149, DOI 10.2307/3580135; Jaikrishan G, 2013, J COMMUN GENET, V4, P21, DOI 10.1007/s12687-012-0113-1; Jain V, 2017, MUTAT RES-FUND MOL M, V806, P39, DOI 10.1016/j.mrfmmm.2017.09.003; Jain V, 2016, MUTAT RES-FUND MOL M, V788, P50, DOI 10.1016/j.mrfmmm.2016.03.002; Jain V, 2014, INT J RADIAT BIOL, V90, P1143, DOI 10.3109/09553002.2014.925605; Jain Vinay, 2011, International Journal of Low Radiation, V8, P55; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Karuppasamy CV, 2016, MUTAT RES-GEN TOX EN, V800, P40, DOI 10.1016/j.mrgentox.2016.03.005; Koya PKM, 2015, RADIAT ENVIRON BIOPH, V54, P453, DOI 10.1007/s00411-015-0615-4; Koya PKM, 2012, RADIAT RES, V177, P109, DOI 10.1667/RR2699.1; Kumar PRV, 2015, MUTAT RES-FUND MOL M, V775, P59, DOI 10.1016/j.mrfmmm.2015.03.011; Kumar PRV, 2012, RADIAT RES, V177, P643, DOI 10.1667/RR2681.1; Lanza V, 2005, J RADIAT RES, V46, P265, DOI 10.1269/jrr.46.265; Long XH, 2007, INT J MOL MED, V19, P607; Malewicz M, 2011, GENE DEV, V25, P2031, DOI 10.1101/gad.16872411; Morandi E, 2009, RADIAT RES, V172, P500, DOI 10.1667/RR1545.1; Morgan WF, 2013, RADIAT RES, V179, P501, DOI 10.1667/RR3306.1; Nair KRR, 2005, INT CONGR SER, V1276, P41, DOI 10.1016/j.ics.2004.10.030; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; NAYAR GG, 1970, RADIAT BOT, V10, P287, DOI 10.1016/S0033-7560(70)80023-0; Nenoi M, 2015, HUM EXP TOXICOL, V34, P272, DOI 10.1177/0960327114537537; Nylund R, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-52; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, RADIAT RES, V175, P257, DOI 10.1667/RR2420.1; Pernot E, 2012, MUTAT RES-REV MUTAT, V751, P258, DOI 10.1016/j.mrrev.2012.05.003; Ramachandran EN, 2017, MUTAGENESIS, V32, P267, DOI 10.1093/mutage/gew057; Ramachandran EN, 2013, INT J RADIAT BIOL, V89, P259, DOI 10.3109/09553002.2013.747014; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Saini D, 2012, MOL CELL BIOCHEM, V364, P271, DOI 10.1007/s11010-012-1227-9; Shelke S, 2015, MUTAGENESIS, V30, P365, DOI 10.1093/mutage/geu081; Shimizu T, 1999, EXP CELL RES, V251, P424, DOI 10.1006/excr.1999.4582; Sokolov M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010055; Sokolov M, 2014, INT J MOL SCI, V15, P588, DOI 10.3390/ijms15010588; Takahashi A, 2010, INT J RADIAT ONCOL, V78, P1171, DOI 10.1016/j.ijrobp.2010.04.062; Tang FR, 2015, INT J RADIAT BIOL, V91, P13, DOI 10.3109/09553002.2014.937510; Toprani S.M., 2015, MUTAGENESIS; Toprani SM, 2015, MUTAGENESIS, V30, P247, DOI 10.1093/mutage/geu065; Tubiana M, 2009, RADIOLOGY, V251, P13, DOI 10.1148/radiol.2511080671; Vaiserman AM, 2010, DOSE-RESPONSE, V8, P172, DOI 10.2203/dose-response.09-037.Vaiserman; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Warters RL, 2009, RADIAT RES, V172, P82, DOI 10.1667/RR1677.1; Wyrobek AJ, 2011, MUTAT RES-GEN TOX EN, V722, P119, DOI 10.1016/j.mrgentox.2011.03.002	71	12	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187274	10.1371/journal.pone.0187274	http://dx.doi.org/10.1371/journal.pone.0187274			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161272	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000006
J	Olinger, LK; Heidmann, SL; Durdall, AN; Howe, C; Ramseyer, T; Thomas, SG; Lasseigne, DN; Brown, EJ; Cassell, JS; Donihe, MM; Romero, MDD; Duke, MA; Green, D; Hillbrand, P; Grimes, KRW; Nemeth, RS; Smith, TB; Brandt, M				Olinger, Lauren K.; Heidmann, Sarah L.; Durdall, Allie N.; Howe, Colin; Ramseyer, Tanya; Thomas, Sara G.; Lasseigne, Danielle N.; Brown, Elizabeth J.; Cassell, John S.; Donihe, Michele M.; Romero, Mareike D. Duffing; Duke, Mara A.; Green, Damon; Hillbrand, Paul; Grimes, Kristin R. Wilson; Nemeth, Richard S.; Smith, Tyler B.; Brandt, Marilyn			Altered juvenile fish communities associated with invasive Halophila stipulacea seagrass habitats in the US Virgin Islands	PLOS ONE			English	Article							CORAL-REEF FISH; SYRINGODIUM-FILIFORME; CAULERPA-TAXIFOLIA; CARIBBEAN ISLAND; ASSEMBLAGES; BEDS; DIVERSITY; MANGROVES; PATTERNS; HAEMULIDAE	Caribbean seagrass habitats provide food and protection for reef-associated juvenile fish. The invasive seagrass Halophila stipulacea is rapidly altering these seascapes. Since its arrival in the Caribbean in 2002, H. stipulacea has colonized and displaced native sea-grasses, but the function of this invasive seagrass as a juvenile fish habitat remains unknown. To compare diversity, community structure, and abundance of juvenile fish between H. stipulacea and native seagrass beds, fish traps were deployed in four nearshore bays around St. Thomas, U.S. Virgin Islands. Traps were deployed in Frenchman, Lindbergh, and Sprat Bays for 24 h intervals in patches of bare sand, patches of H. stipulacea and patches of the native Caribbean seagrasses Thalassia testudinum and Syringodium filiforme. Traps were then deployed in Brewers Bay for 12 h intervals in stands of H. stipulacea and S. filiforme. Relative and total abundances of juvenile fish, identified at least to family, were compared across treatment habitats for each trap deployment period. The catch from H. stipulacea, compared to native seagrasses, comprised a greater abundance of nocturnal carnivores Lutjanus synagris (family Lutjanidae) and Haemulon flavolineatum (family Haemulidae). Additionally, the herbivore species Sparisoma aurofrenatum (family Labridae) and Acanthurus bahianus (family Acanthuridae) and the diurnal carnivore species Pseudopeneus maculatus (family Mullidae) were relatively scarce in H. stipulacea. The catch from sand was much smaller, compared to vegetated habitats, and comprised only L. synagris, H. flavolineatum, and H. aurolineatum. These results provide evidence of reduced family diversity and altered juvenile fish assemblages in H. stipulacea, driven by an abundance of some nocturnal carnivores and scarcity of herbivores and diurnal carnivores. The findings from the present work underpin the need for further investigation and mitigation of this invasion, particularly where H. stipulacea is driving seascape-alterations of key juvenile fish habitats.	[Olinger, Lauren K.; Heidmann, Sarah L.; Durdall, Allie N.; Howe, Colin; Ramseyer, Tanya; Thomas, Sara G.; Lasseigne, Danielle N.; Brown, Elizabeth J.; Cassell, John S.; Donihe, Michele M.; Romero, Mareike D. Duffing; Duke, Mara A.; Green, Damon; Hillbrand, Paul; Grimes, Kristin R. Wilson; Nemeth, Richard S.; Smith, Tyler B.; Brandt, Marilyn] Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI 00802 USA	University of the Virgin Islands	Olinger, LK (corresponding author), Univ Virgin Islands, Ctr Marine & Environm Studies, St Thomas, VI 00802 USA.	lauren.olinger@students.uvi.edu	Olinger, Lauren/AAW-2387-2020; Ramseyer, Tanya/GZG-4008-2022	Olinger, Lauren/0000-0003-1078-522X; Heidmann, Sarah/0000-0002-0729-0229; Howe, Colin/0000-0002-4124-7910	Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation) [1355437]; University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES)	Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation); University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES)	Funding was provided by the Virgin Islands Experimental Program to Stimulate Competitive Research (National Science Foundation #1355437). No funding agency participated in the design or interpretation of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Teresa Turner, Sennai Habtes, and Renata Platenberg for helpful comments on earlier drafts of this manuscript. We also thank the University of the Virgin Island's Masters of Marine and Environmental Science Program (MMES) for programmatic and research support. Finally, we thank the US National Science Foundation, through the VI Experimental Program to Stimulate Competitive Research (VI-EPSCoR), which contributed valuable infrastructure support and research equipment. This is contribution #170 from the Center for Marine and Environmental Studies, University of the Virgin Islands.	Able KW, 2000, ESTUARIES, V23, P633, DOI 10.2307/1352890; Allen G., 1985, FAO FISH SYNOP, V125, P1; [Anonymous], 2021, LANG ENV STAT COMP; BELL JD, 1989, BIOL SEAGRASSES; Bervoets T, 2013, RESULTS NATURE FDN R; Bohlke J.E., 1993, FISHES BAHAMAS ADJAC; Bohnsack JA, 1987, RESOURCE SURVEY FISH; Caldwell ZR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153066; Cappo MM, 1996, 6 CRC REEF; Castillo-Rivera M, 2002, REV FISH BIOL FISHER, V12, P167, DOI 10.1023/A:1025051027676; Cervigon F., 1993, PECES MARINOS VENEZU, V2; Courtenay WE, 1995, FAO SPECIES IDENTIFI; Crowder LB, 1991, HABITAT STRUCTURE; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; de la Moriniere EC, 2003, MAR ECOL PROG SER, V246, P279; de la Moriniere EC, 2003, ESTUAR COAST SHELF S, V57, P1079, DOI 10.1016/S0272-7714(03)00011-8; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Dorenbosch M, 2005, MAR ECOL PROG SER, V299, P277, DOI 10.3354/meps299277; Ellis S., 2016, POTENTIALLY INVASIVE; Fischer W, 1995, FAO GUIDE IDENTIFICA, VI; Franco A, 2006, ESTUAR COAST SHELF S, V66, P67, DOI 10.1016/j.ecss.2005.07.020; Franks James S., 2000, Gulf and Caribbean Research, V12, P11; FROESE R., 2022, US; GARDNER SM, 1995, J VEG SCI, V6, P349, DOI 10.2307/3236234; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; HIGH WL, 1970, COMMER FISH REV, V32, P31; Hitt S, 2011, MAR ECOL PROG SER, V427, P275, DOI 10.3354/meps09093; Hori M, 2009, MAR BIOL, V156, P1447, DOI 10.1007/s00227-009-1184-3; Huijbers CM, 2015, HYDROBIOLOGIA, V750, P89, DOI 10.1007/s10750-014-2162-4; Hylkema A, 2015, ESTUAR COAST, V38, P1448, DOI 10.1007/s12237-014-9907-1; Island Resources Foundation (US), 1977, MAR ENV VIRG ISL TEC; Kadison E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180063; Kimirei IA, 2013, ECOSYSTEMS, V16, P783, DOI 10.1007/s10021-013-9645-4; Kingsford M, 1996, STUDYING TEMPERATE M; Kopp D, 2007, AQUAT BOT, V87, P31, DOI 10.1016/j.aquabot.2007.01.008; Kopp D, 2010, J COASTAL RES, V26, P1133, DOI 10.2112/JCOASTRES-D-09-00063.1; Longepierre S, 2005, BIODIVERS CONSERV, V14, P365, DOI [10.1007/s10531-004-5356-7, 10.1007/s10531-004-5056-7]; Lugendo BR, 2007, HYDROBIOLOGIA, V586, P1, DOI 10.1007/s10750-006-0398-3; Macia S, 2005, MAR ECOL PROG SER, V303, P113, DOI 10.3354/meps303113; Mellin C, 2007, CORAL REEFS, V26, P895, DOI 10.1007/s00338-007-0281-3; Nagelkerken I, 2000, MAR ECOL PROG SER, V194, P55, DOI 10.3354/meps194055; Nagelkerken I, 2004, J SEA RES, V52, P127, DOI 10.1016/j.seares.2003.11.002; Nagelkerken I., 2001, Aquatic Ecology, V35, P73, DOI 10.1023/A:1011416902370; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nagelkerken I, 2001, MAR ECOL PROG SER, V214, P225, DOI 10.3354/meps214225; Overholtzer KL, 1999, MAR ECOL PROG SER, V177, P177, DOI 10.3354/meps177177; Pillans RD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105507; Pittman SJ, 2007, MAR ECOL PROG SER, V348, P273, DOI 10.3354/meps07052; Platenberg RJ, 2006, WETLANDS CONSERVATIO; Prado P, 2011, MAR ECOL PROG SER, V429, P45, DOI 10.3354/meps09076; Renchen FL, 2012, J FISH BIO, V81, P1; Rindi F, 1999, OCEANOL ACTA, V22, P421, DOI 10.1016/S0399-1784(00)88725-3; Robins C.R., 1986, PETERSON FIELD GUIDE; Rogers CS, 2014, FRONT ECOL ENVIRON, V12, P546, DOI 10.1890/14.WB.016; Rogers CS, 1982, MARINE ENV BREWERS B; Rojas PM, 2014, LAT AM J AQUAT RES, V42, P989, DOI 10.3856/vol42-issue5-fulltext-6; Ruiz H, 2004, B MAR SCI, V75, P131; Silvano RAM, 2001, ENVIRON BIOL FISH, V60, P465, DOI 10.1023/A:1011064923544; Smith T.B., 2015, US VIRGIN ISLANDS TE; Smith TM, 2008, MAR ECOL PROG SER, V359, P203, DOI 10.3354/meps07348; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Spotte S, 1996, OCEANOGR LIT REV, V12, P1263; Steiner S.C.C., 2015, REEF ENCOUNTER, V30, P43; Steiner SC, 2013, 32 I TROP MAR EC; Thompson M, 1969, ZOOL DEP U W INDIES, V3, P1; TRIBBLE GW, 1981, MAR BIOL, V65, P277, DOI 10.1007/BF00397122; Uiblein F, 2007, MAR BIOL RES, V3, P275, DOI 10.1080/17451000701687129; van der Loos LM, 2017, MAR BIODIVERS, V47, P123, DOI 10.1007/s12526-016-0608-9; van Tussenbroek BI, 2016, J SEA RES, V115, P1, DOI 10.1016/j.seares.2016.05.005; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Whitfield A. K, 2017, REV FISH BIOL FISHER, P1; Willette DA, 2014, AQUAT BOT, V112, P98, DOI 10.1016/j.aquabot.2013.10.001; Willette DA, 2012, AQUAT BOT, V103, P74, DOI 10.1016/j.aquabot.2012.06.007; York PH, 2006, MAR ECOL PROG SER, V312, P223, DOI 10.3354/meps312223	78	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188386	10.1371/journal.pone.0188386	http://dx.doi.org/10.1371/journal.pone.0188386			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161322	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000046
J	Bakker, JT; Kuperus, JS; Kuijf, HJ; Oner, FC; de Jong, PA; Verlaan, JJ				Bakker, Jessica T.; Kuperus, Jonneke S.; Kuijf, Hugo J.; Oner, F. Cumhur; de Jong, Pim A.; Verlaan, Jorrit-Jan			Morphological characteristics of diffuse idiopathic skeletal hyperostosis in the cervical spine	PLOS ONE			English	Article							FORESTIER-DISEASE; INTUBATION; DYSPHAGIA; OSSIFICATION; FEATURES	Objectives Diffuse idiopathic skeletal hyperostosis (DISH) is characterized by anterior ossification of the spine and can lead to dysphagia and airway obstruction. The morphology of the newly formed bone in the cervical spine is different compared to the thoracic spine, possibly due to dissimilarities in local vascular anatomy. In this study the spatial relationship of the new bone with the arterial system, trachea and esophagus was analyzed and compared between subjects with and without DISH. Methods Cervical computed tomography (CT) scans were obtained from five patients with dysphagia and DISH and ten control subjects. The location of the vertebral and carotid arteries, surface area of the hyperostosis and distance between the vertebral body and the trachea and esophagus was assessed in the axial view. Results The surface area of the newly formed bone was located symmetrically anterior to the vertebral body. The ossifications were non-flowing in the sagittal view and no segmental vessels were observed. Substantial displacement of the trachea/esophagus was present in the group with DISH compared to the controls. Conclusions The hyperostosis at the cervical level was symmetrically distributed anterior to the vertebral bodies without a flowing pattern, in contrast to the asymmetrical flowing pattern typically found in the thoracic spine. The hypothesis that the vascular system acts as a natural barrier against new bone formation in DISH could be further supported with these findings. The significant ventral displacement of the trachea and esophagus may explain the mechanism of dysphagia and airway obstruction in DISH.	[Bakker, Jessica T.; Kuperus, Jonneke S.; Oner, F. Cumhur; Verlaan, Jorrit-Jan] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Kuijf, Hugo J.] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Verlaan, JJ (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.j.verlaan@umcutrecht.nl	Kuijf, Hugo J/G-2711-2013	Kuijf, Hugo J/0000-0001-6997-9059				Bougaki M, 2004, ANAESTHESIA, V59, P303, DOI 10.1111/j.1365-2044.2004.03690.x; CARILE L, 1989, J RHEUMATOL, V16, P1120; CROSBY ET, 1993, CAN J ANAESTH, V40, P54, DOI 10.1007/BF03009319; Eskander MS, 2010, SPINE, V35, P2035, DOI 10.1097/BRS.0b013e3181c9f3d4; FORESTIER J, 1950, ANN RHEUM DIS, V9, P321, DOI 10.1136/ard.9.4.321; Kuijf HJ, 2013, IMAGE PROCESSING TEC; Le AQ, 2014, J NEUROSURG-SPINE, V21, P565, DOI 10.3171/2014.6.SPINE13908; Mader R, 2009, OSTEOARTHR CARTILAGE, V17, P825, DOI 10.1016/j.joca.2008.12.004; Mader R, 2013, NAT REV RHEUMATOL, V9, P741, DOI 10.1038/nrrheum.2013.165; MCCAFFERTY RR, 1995, J NEUROSURG, V83, P13, DOI 10.3171/jns.1995.83.1.0013; Naik B, 2004, ANESTHESIOLOGY, V100, P1311, DOI 10.1097/00000542-200405000-00039; Oppenlander ME, 2009, SURG NEUROL, V72, P266, DOI 10.1016/j.surneu.2008.08.081; Ozkalkanli Murat Y, 2006, J Anesth, V20, P304, DOI 10.1007/s00540-006-0418-5; Palmer JHM, 2000, ANAESTHESIA, V55, P70, DOI 10.1046/j.1365-2044.2000.01121.x; Presutti L, 2010, ANN OTO RHINOL LARYN, V119, P602, DOI 10.1177/000348941011900906; RESNICK D, 1976, RADIOLOGY, V119, P559, DOI 10.1148/119.3.559; Ritter F, 2011, IEEE PULSE, V2, P60, DOI 10.1109/MPUL.2011.942929; Thompson C, 2010, CAN J ANAESTH, V57, P679, DOI 10.1007/s12630-010-9313-5; van Seeters T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-37; Verlaan JJ, 2011, EUR SPINE J, V20, P1474, DOI 10.1007/s00586-011-1719-4; Verlaan JJ, 2011, SPINE J, V11, P1058, DOI 10.1016/j.spinee.2011.09.014; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Westerveld LA, 2008, J RHEUMATOL, V35, P1635	23	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188414	10.1371/journal.pone.0188414	http://dx.doi.org/10.1371/journal.pone.0188414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155874	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700057
J	Taylor, AW; Bewick, BM; Makanjuola, AB; Qian, L; Kirzhanova, VV; Alterwain, P				Taylor, Anne W.; Bewick, Bridgette M.; Makanjuola, Alfred B.; Qian, Ling; Kirzhanova, Valentina V.; Alterwain, Paulo			Context and culture associated with alcohol use amongst youth in major urban cities: A cross-country population based survey	PLOS ONE			English	Article							EARLY-ADULTHOOD; SUBSTANCE USE; GLOBAL HEALTH; DRINKING; ADOLESCENCE; GENDER; CONSEQUENCES; TRAJECTORIES; CONSUMPTION; CHINA	Background Alcohol consumption patterns are dependent upon culture and context. The aim of this study was to interview people aged 18 - 34 year old living in four cities in different regions of the world to explore differences in a range of alcohol measures to assist in determining culturally appropriate alcohol initiatives for this age group. Method Multistage random sampling was consistent across the four cities (Ilorin (Nigeria), Wuhan (China), Montevideo (Uruguay) and Moscow (Russia)). The questionnaire was forward and back translated into relevant languages and face-to-face interviewing undertaken. The data were weighted to the population of each city. Uni-variable analysis (ever consumed, first time consumed, age when drunk for first time, number of days consumed, type consumed) and logistic regression modeling were undertaken. The final model for each city was adjusted for age, sex, marital status, highest education and employment status. In total 6235 interviews were undertaken (1391 in Ilorin, 1600 in Montevideo, 1604 in Moscow and 1640 in Wuhan). Results Alcohol was consumed by 96.4% in Montevideo, 86.1% in Moscow, 53.4% in Wuhan and 33.3% in Ilorin. There was very little difference by gender except Ilorin males were more likely to consume alcohol than females. Alcohol was consumed on more days for Ilorin males; Wuhan females consumed alcohol on the least number of days; Ilorin had the most abstainers; Montevideo and Moscow the highest proportion of light drinkers; Ilorin and Montevideo the highest proportion of heavy drinkers. Differences by type of alcohol were also apparent. The final logistic regression model provided different models including higher alcohol consumption rates for males, 25 - 34 years of age, divorced/separated marital status and employed part time for Ilorin respondents; males and higher educated for Montevideo; males, 25 to 29 years of age and higher educated for Moscow; and 25 - 29 years of age, non-married and vocationally trained for those in Wuhan. Conclusion Alcohol consumption in these four cities does not increase with age as found in most high income countries. The alcohol consumption patterns during this stage of the life cycle are important to assess so that high level, as well as country-specific, planning and interventions can be implemented.	[Taylor, Anne W.] Univ Adelaide, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Bewick, Bridgette M.] Univ Leeds, Leeds Inst Hlth Sci, Sch Med, Leeds, W Yorkshire, England; [Makanjuola, Alfred B.] Univ Ilorin, Dept Behav Sci, Teaching Hosp, Ilorin, Nigeria; [Qian, Ling] PR Minist Hlth, Ctr Hlth Educ, Beijing, Peoples R China; [Kirzhanova, Valentina V.] Minist Hlth Russian Federat, Fed Med Res Ctr Psychiat & Narcol, Dept Epidemiol, Moscow, Russia; [Alterwain, Paulo] ProHumanitas Fdn, Montevideo, Uruguay	University of Adelaide; University of Leeds; University of Ilorin; Ministry of Health of the Russian Federation	Taylor, AW (corresponding author), Univ Adelaide, Populat Res & Outcome Studies, Adelaide, SA, Australia.	anne.taylor@adelaide.edu.au	Kirzhanova, Valentina/AAI-3529-2020; Taylor, Anne/F-5708-2010	Bewick, Bridgette/0000-0001-5752-5623; Kirzhanova, Valentina V./0000-0002-3243-1409; Taylor, Anne/0000-0002-4422-7974	International Alliance for Responsible Drinking	International Alliance for Responsible Drinking	Funding to support the work for this manuscript including travel and reasonable expenses was provided by International Alliance for Responsible Drinking. The funders had no role in the analysis, data interpretation and writing of this manuscript. The corresponding author was the only one to have full access to all the data and had final responsibility for the decision to submit for publication.	Adelekan M L, 2001, West Afr J Med, V20, P28; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; Colder CR, 2014, PSYCHOL ADDICT BEHAV, V28, P659, DOI 10.1037/a0035271; Costanzo PR, 2007, J STUD ALCOHOL DRUGS, V68, P727, DOI 10.15288/jsad.2007.68.727; Degenhardt L, 2016, LANCET PSYCHIAT, V3, P251, DOI 10.1016/S2215-0366(15)00508-8; Degenhardt L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003015; Dumbili EW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1499-6; Erol A, 2015, DRUG ALCOHOL DEPEN, V156, P1, DOI 10.1016/j.drugalcdep.2015.08.023; Esan O, 2013, ALCOHOL, V47, P249, DOI 10.1016/j.alcohol.2012.12.011; Graham K, 2011, ADDICTION, V106, P1391, DOI 10.1111/j.1360-0443.2011.03425.x; Guttmannova K, 2011, J STUD ALCOHOL DRUGS, V72, P221, DOI 10.15288/jsad.2011.72.221; Hall WD, 2016, LANCET PSYCHIAT, V3, P265, DOI 10.1016/S2215-0366(16)00013-4; Ibanga Akanidomo K J, 2009, Contemp Drug Probl, V36, P111; Keyes KM, 2011, ALCOHOL CLIN EXP RES, V35, P2101, DOI 10.1111/j.1530-0277.2011.01562.x; Kuendig H, 2008, EUR J PUBLIC HEALTH, V18, P386, DOI 10.1093/eurpub/ckn007; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; McCarty CA, 2004, PEDIATRICS, V114, P714, DOI 10.1542/peds.2003-0864-L; Mistry R, 2015, J YOUTH ADOLESCENCE, V44, P1871, DOI 10.1007/s10964-015-0309-x; Nelson DE, 2009, AM J PREV MED, V36, P218, DOI 10.1016/j.amepre.2008.10.018; Norstrom T, 2012, J STUD ALCOHOL DRUGS, V73, P542, DOI 10.15288/jsad.2012.73.542; Oesterle S, 2004, J STUD ALCOHOL, V65, P204, DOI 10.15288/jsa.2004.65.204; Van Gundy K, 2002, SUBST USE MISUSE, V37, P65, DOI 10.1081/JA-120001497; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5; Zhang JF, 2004, ADDICTION, V99, P1103, DOI 10.1111/j.1360-0443.2004.00799.x	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187812	10.1371/journal.pone.0187812	http://dx.doi.org/10.1371/journal.pone.0187812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155847	Green Published, gold			2022-12-27	WOS:000415756700018
J	Garbett, NC; Brock, GN; Chaires, JB; Mekmaysy, CS; DeLeeuw, L; Sivils, KL; Harley, JB; Rovin, BH; Kulasekera, KB; Jarjour, WN				Garbett, Nichola C.; Brock, Guy N.; Chaires, Jonathan B.; Mekmaysy, Chongkham S.; DeLeeuw, Lynn; Sivils, Kathy L.; Harley, John B.; Rovin, Brad H.; Kulasekera, K. B.; Jarjour, Wael N.			Characterization and classification of lupus patients based on plasma thermograms	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; DSC ANALYSIS; REVISED CRITERIA; DISEASE-ACTIVITY; CANCER PATIENTS; BLOOD-PLASMA; ERYTHEMATOSUS; PROTEOME; BIOMARKERS; DIAGNOSIS	Objective Plasma thermograms (thermal stability profiles of blood plasma) are being utilized as a new diagnostic approach for clinical assessment. In this study, we investigated the ability of plasma thermograms to classify systemic lupus erythematosus (SLE) patients versus non SLE controls using a sample of 300 SLE and 300 control subjects from the Lupus Family Registry and Repository. Additionally, we evaluated the heterogeneity of thermograms along age, sex, ethnicity, concurrent health conditions and SLE diagnostic criteria. Methods Thermograms were visualized graphically for important differences between covariates and summarized using various measures. A modified linear discriminant analysis was used to segregate SLE versus control subjects on the basis of the thermograms. Classification accuracy was measured based on multiple training/test splits of the data and compared to classification based on SLE serological markers. Results Median sensitivity, specificity, and overall accuracy based on classification using plasma thermograms was 86%, 83%, and 84% compared to 78%, 95%, and 86% based on a combination of five antibody tests. Combining thermogram and serology information together improved sensitivity from 78% to 86% and overall accuracy from 86% to 89% relative to serology alone. Predictive accuracy of thermograms for distinguishing SLE and osteoarthritis/rheumatoid arthritis patients was comparable. Both gender and anemia significantly interacted with disease status for plasma thermograms (p<0.001), with greater separation between SLE and control thermograms for females relative to males and for patients with anemia relative to patients without anemia. Conclusion Plasma thermograms constitute an additional biomarker which may help improve diagnosis of SLE patients, particularly when coupled with standard diagnostic testing. Differences in thermograms according to patient sex, ethnicity, clinical and environmental factors are important considerations for application of thermograms in a clinical setting.	[Garbett, Nichola C.; Chaires, Jonathan B.; Mekmaysy, Chongkham S.; DeLeeuw, Lynn] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Brock, Guy N.; Kulasekera, K. B.] Univ Louisville, Dept Bioinformat & Biostat, Sch Publ Hlth & Informat Sci, Louisville, KY 40292 USA; [Sivils, Kathy L.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, Oklahoma City, OK 73104 USA; [Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA; [Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Dept Pediat, Cincinnati, OH 45229 USA; [Harley, John B.] Univ Cincinnati, Cincinnati, OH USA; [Rovin, Brad H.] Ohio State Univ, Wexner Med Ctr, Nephrol Div, Columbus, OH 43210 USA; [Jarjour, Wael N.] Ohio State Univ, Wexner Med Ctr, Div Rheumatol & Immunol, Dept Internal Med, Columbus, OH 43210 USA; [Brock, Guy N.] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH 43210 USA	University of Louisville; University of Louisville; Oklahoma Medical Research Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Garbett, NC (corresponding author), Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	nichola.garbett@louisville.edu		brock, guy/0000-0001-5317-079X	National Institutes of Health [P20 RR018733, GM103482, UL1TR001070, N01AR62277, N01AR52221]; National Cancer Institute of the National Institutes of Health [R21CA187345]; Kentucky Science and Technology Corporation [COMMFUND-1517-RFP-017]; Office of the Executive Vice President for Research and Innovation at the University of Louisville; Elsa U. Pardee foundation; U.S. Department of Veterans Affairs [A124717, HG006828]; NATIONAL CANCER INSTITUTE [R21CA187345] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001070] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kentucky Science and Technology Corporation; Office of the Executive Vice President for Research and Innovation at the University of Louisville; Elsa U. Pardee foundation; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Collection of plasma thermogram data was supported by use of the Biophysical Core Facility at the James Graham Brown Cancer Center and by grants P20 RR018733 and P20 GM103482 from the National Institutes of Health (www.nih.gov). Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health (www.cancer.gov) under Award Number R21CA187345 (NCG), by the Kentucky Science and Technology Corporation (www.kstc.com) under Award Number COMMFUND-1517-RFP-017 (NCG), by a Competitive Enhancement Grant from the Office of the Executive Vice President for Research and Innovation at the University of Louisville (www. louisville.edu/research) (NCG) and by a grant from the Elsa U. Pardee foundation (www. pardeefoundation.org) (JBC). GNB was supported in part by the National Institutes of Health grant UL1TR001070. JBH was supported by the U.S. Department of Veterans Affairs (www.va.gov) and grants A124717 and HG006828. The Lupus Family Registry and Repository was supported by National Institutes of Health under Award Numbers N01AR62277 and N01AR52221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the immensely valuable resource of the Lupus Family Registry and Repository for lupus research and for generously providing access to patient samples and data for this study. We thank the James Graham Brown Cancer Center for support of the plasma thermogram research.	Ahearn JM, 2012, TRANSL RES, V159, P326, DOI 10.1016/j.trsl.2012.01.021; Anic F, 2014, CROAT MED J, V55, P514, DOI 10.3325/cmj.2014.55.514; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cerovec M, 2012, CROAT MED J, V53, P149, DOI 10.3325/cmj.2012.53.149; Chagovetz AA, 2013, NEUROSURGERY, V73, P289, DOI 10.1227/01.neu.0000430296.23799.cd; Chagovetz AA, 2011, J NEURO-ONCOL, V105, P499, DOI 10.1007/s11060-011-0630-5; Fekecs T, 2012, J THERM ANAL CALORIM, V108, P149, DOI 10.1007/s10973-011-1800-6; Fish DJ, 2010, BIOPHYS CHEM, V152, P184, DOI 10.1016/j.bpc.2010.09.007; Garbett NC, 2008, BIOPHYS J, V94, P1377, DOI 10.1529/biophysj.107.119453; Garbett NC, 2007, SEMIN NEPHROL, V27, P621, DOI 10.1016/j.semnephrol.2007.09.004; Garbett NC, 2016, BBA-GEN SUBJECTS, V1860, P981, DOI 10.1016/j.bbagen.2015.10.004; Garbett NC, 2015, METHODS, V76, P41, DOI 10.1016/j.ymeth.2014.10.030; Garbett NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084710; Garbett NC, 2013, BBA-GEN SUBJECTS, V1830, P4675, DOI 10.1016/j.bbagen.2013.05.007; Garbett NC, 2009, EXP MOL PATHOL, V86, P186, DOI 10.1016/j.yexmp.2008.12.001; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Illei GG, 2004, ARTHRITIS RHEUM, V50, P2048, DOI 10.1002/art.20345; Kalunian KC, 2012, ARTHRITIS RHEUM-US, V64, P4040, DOI 10.1002/art.34669; Krumova S, 2013, THERMOCHIM ACTA, V572, P59, DOI 10.1016/j.tca.2013.09.015; Liu CC, 2010, RHEUM DIS CLIN N AM, V36, P161, DOI 10.1016/j.rdc.2009.12.003; Mehdi M, 2013, J THERM ANAL CALORIM, V111, P1801, DOI 10.1007/s10973-012-2468-2; Michnik A, 2010, J THERM ANAL CALORIM, P102; Michnik A, 2011, THERMAL ANAL MED APP, P171; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Rasmussen A, 2011, RHEUMATOLOGY, V50, P47, DOI 10.1093/rheumatology/keq302; Romero-Diaz J, 2011, ARTHRIT CARE RES, V63, pS37, DOI 10.1002/acr.20572; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; The Autoimmune Diseases Coordinating Committee, 2005, NIH PUBL; Todinova S, 2012, BBA-GEN SUBJECTS, V1820, P1879, DOI 10.1016/j.bbagen.2012.08.001; Todinova S, 2011, ANAL CHEM, V83, P7992, DOI 10.1021/ac202055m; XI Y, 2011, SKIN CANC OVERVIEW; Xu P, 2009, COMPUT STAT DATA AN, V53, P1674, DOI 10.1016/j.csda.2008.02.005; Zapf I, 2011, THERMOCHIM ACTA, V524, P88, DOI 10.1016/j.tca.2011.06.019	33	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0186398	10.1371/journal.pone.0186398	http://dx.doi.org/10.1371/journal.pone.0186398			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149219	gold, Green Submitted, Green Published			2022-12-27	WOS:000415646100003
J	Gogna, N; Sharma, R; Gupta, V; Dorai, K; Prasad, NG				Gogna, Navdeep; Sharma, Rakesh; Gupta, Vanika; Dorai, Kavita; Prasad, N. G.			Evolution of the metabolome in response to selection for increased immunity in populations of Drosophila melanogaster	PLOS ONE			English	Article							STRESS; NMR; TEMPERATURE; MYOINOSITOL; HEMOLYMPH; NETWORKS; DIAPAUSE; MODELS; COST	We used NMR-based metabolomics to test two hypotheses-(i) there will be evolved differences in the metabolome of selected and control populations even under un-infected conditions and (ii) post infection, the metabolomes of the selected and control populations will respond differently. We selected replicate populations of Drosophila melanogaster for increased survivorship (I) against a gram-negative pathogen. We subjected the selected (I) and their control populations (S) to three different treatments: (1) infected with heat-killed bacteria (i), (2) sham infected (s), and (3) untreated (u). We performed 1D and 2D NMR experiments to identify the metabolic differences. Multivariate analysis of the metabolic profiles of the untreated (Iu and Su) flies yielded higher concentrations of lipids, organic acids, sugars, amino acids, NAD and AMP in the Iu treatment as compared to the Su treatment, showing that even in the absence of infection, the metabolome of the I and S regimes was different. In the S and I regimes, post infection/injury, concentration of metabolites directly or indirectly associated with energy related pathways (lipids, organic acids, sugars) declined while the concentration of metabolites that are probably associated with immune response (amino acids) increased. However, in most cases, the I regime flies had a higher concentration of such metabolites even under un-infected conditions. The change in the metabolite concentration upon infection/injury was not always comparable between I and S regimes (in case of lactate, alanine, leucine, lysine, threonine) indicating that the I and S regimes had evolved to respond differentially to infection and to injury.	[Gogna, Navdeep; Sharma, Rakesh; Dorai, Kavita] Indian Inst Sci Educ & Res, Dept Phys Sci, Mohali, Punjab, India; [Gupta, Vanika; Prasad, N. G.] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India; [Gupta, Vanika] Cornell Univ, Dept Entomol, Lazzaro Lab, Constock Hall, Ithaca, NY 14853 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Cornell University	Prasad, NG (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India.	prasad@iisermohali.ac.in	Gupta, Vanika/AAX-7429-2021	Gogna, Navdeep/0000-0003-4918-0850; Gupta, Vanika/0000-0002-5636-1337	Indian Institute of Science Education and Research Mohali	Indian Institute of Science Education and Research Mohali	The study was funded by Indian Institute of Science Education and Research Mohali through internal grants to KD and NGP. IISER Mohali had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bervoets L, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0246-9; Blomkalns A., 2006, EMERGENCY MED CARDIA, V2, P43; Brereton RG, 2007, APPL CHEMOMETRICS SC, DOI [10.1002/0470863242, DOI 10.1002/9780470057780.CH1, 10.1002/9780470057780.ch1]; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679; Chippindale AK, 1997, J EVOLUTION BIOL, V10, P269, DOI 10.1007/s000360050023; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dionne MS, 2014, FLY, V8, P75, DOI 10.4161/fly.28113; Dossey AT, 2006, ACS CHEM BIOL, V1, P511, DOI 10.1021/cb600318u; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; Feala JD, 2008, PROG BIOPHYS MOL BIO, V96, P209, DOI 10.1016/j.pbiomolbio.2007.07.014; Felix TM, 2012, GENETICS, V191, P989, DOI 10.1534/genetics.112.140640; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Gogna N, 2015, MOL BIOSYST, V11, P3305, DOI 10.1039/c5mb00386e; Gupta V, 2016, EVOLUTION, V70, P934, DOI 10.1111/evo.12896; Gupta V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-185; Hang SY, 2014, CELL HOST MICROBE, V16, P592, DOI 10.1016/j.chom.2014.10.006; Klepsatel P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33667; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kristensen TN, 2012, EVOL ECOL RES, V14, P821; Lenz EM, 2001, INSECT BIOCHEM MOLEC, V32, P51, DOI 10.1016/S0965-1748(01)00078-9; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; Malmendal A, 2013, NATURWISSENSCHAFTEN, V100, P417, DOI 10.1007/s00114-013-1040-7; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Park D, 2000, BBA-GENE STRUCT EXPR, V1494, P277, DOI 10.1016/S0167-4781(00)00085-3; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Phalaraksh C, 2008, SCIENCEASIA, V34, P279, DOI 10.2306/scienceasia1513-1874.2008.34.279; An PNT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099519; Sarup P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047461; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Snart CJP, 2015, ENTOMOL EXP APPL, V155, P1, DOI 10.1111/eea.12281; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948; Vigoder FM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165724; Wang YL, 2010, J PROTEOME RES, V9, P1257, DOI 10.1021/pr9007392; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Williams CM, 2014, EVOLUTION, V68, P3505, DOI 10.1111/evo.12541; Wu HF, 2008, ANAL BIOCHEM, V372, P204, DOI 10.1016/j.ab.2007.10.002; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	46	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188089	10.1371/journal.pone.0188089	http://dx.doi.org/10.1371/journal.pone.0188089			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149207	Green Submitted, Green Published, gold			2022-12-27	WOS:000415646100024
J	Balconi, M; Pezard, L; Nandrino, JL; Vanutelli, ME				Balconi, Michela; Pezard, Laurent; Nandrino, Jean-Louis; Vanutelli, Maria Elide			Two is better than one: The effects of strategic cooperation on intra- and inter-brain connectivity by fNIRS	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; SELF-EFFICACY; PREFRONTAL CORTEX; SOCIAL RANKING; FEEDBACK; PERFORMANCE; COMPETITION; SYNCHRONIZATION; MODULATION; FMRI	Inter-brain synchronization during joint actions is a core question in social neuroscience, and the differential contribution of intra-and inter-brain functional connectivity has yet to be clarified along with the role of psychological variables such as perceived self-efficacy. The cognitive performance and the neural activation underlying the execution of joint actions were recorded by functional Near-Infrared imaging during a synchronicity game. An 8-channel array of optodes was positioned over the frontal and prefrontal regions. During the task, the dyads received reinforcing feedback that was experimentally manipulated to induce adoption of common strategies. Intra-and inter-brain connectivity indices were computed along with an inter-brain/intra-brain connectivity index (ConIndex). Finally, correlation analyses were run to assess the relationship between behavioral and physiological levels. The results showed that the external feedback could modulate participant responses in both behavioral and neural components. After the reinforcing manipulation, there were faster response times and increased inter-brain connectivity, and ConIndex emerged primarily over the dorsolateral prefrontal cortex. Additionally, the presence of significant correlations between response times and inter-brain connectivity revealed that only the "two-players connection" may guarantee an efficient performance. The present study provides a significant contribution to the identification of intra-and inter-brain functional connectivity when social reinforcement is provided.	[Balconi, Michela; Vanutelli, Maria Elide] Catholic Univ Milan, Res Unit Affect & Social Neurosci, Milan, Italy; [Balconi, Michela; Vanutelli, Maria Elide] Catholic Univ Milan, Dept Psychol, Milan, Italy; [Pezard, Laurent] Aix Marseille Univ, CNRS UMR 7260, LNIA, Marseille, France; [Nandrino, Jean-Louis] Univ Lille, Lab SCALab, UMR CNRS 9193, Cognit & Affect Sci Lab,Equipe Dynam Emot & Patho, Lille, France	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille	Balconi, M (corresponding author), Catholic Univ Milan, Res Unit Affect & Social Neurosci, Milan, Italy.; Balconi, M (corresponding author), Catholic Univ Milan, Dept Psychol, Milan, Italy.	michela.balconi@unicatt.it	balconi, michela/AAB-5250-2022; Nandrino, Jean-Louis/O-8900-2017	Nandrino, Jean-Louis/0000-0003-2339-9432				Baeken C, 2010, PSYCHIAT DANUB, V22, pS163; Baker JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26492; Balconi M, NEUROSCIENCE; Balconi M, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00163; Balconi M, 2017, J CLIN EXP NEUROPSYC, V39, P607, DOI 10.1080/13803395.2016.1253666; Balconi M, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01587; Balconi M, 2015, SOC NEUROSCI-UK, V10, P166, DOI 10.1080/17470919.2014.977403; Balconi M, 2014, PHYSIOL BEHAV, V133, P207, DOI 10.1016/j.physbeh.2014.05.043; Balconi M, 2014, SOC NEUROSCI-UK, V9, P82, DOI 10.1080/17470919.2013.861361; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Chaudhary U, 2011, BRAIN RES BULL, V84, P197, DOI 10.1016/j.brainresbull.2011.01.002; Cherian J., 2013, INT J BUS MANAG, V8, P80, DOI [DOI 10.5539/IJBM.V8N14P80, 10.5539/ijbm.v8n14p80]; Cui F, 2016, SOC NEUROSCI-UK, V11, P289, DOI 10.1080/17470919.2015.1078258; Cui X, 2012, NEUROIMAGE, V59, P2430, DOI 10.1016/j.neuroimage.2011.09.003; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Dumas G, 2011, IRBM, V32, P48, DOI 10.1016/j.irbm.2011.01.002; Fallani FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014187; Giuliano RJ, 2015, BIOL PSYCHOL, V105, P29, DOI 10.1016/j.biopsycho.2014.12.009; Golland Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125804; Haruno M, 2009, J NEUROSCI, V29, P4542, DOI 10.1523/JNEUROSCI.2707-08.2009; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Holper L, 2012, NEUROIMAGE, V63, P212, DOI 10.1016/j.neuroimage.2012.06.028; Johnson DW, 2005, GENET SOC GEN PSYCH, V131, P285, DOI 10.3200/MONO.131.4.285-358; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Karafin MS, 2004, J COGNITIVE NEUROSCI, V16, P1796, DOI 10.1162/0898929042947856; KARL KA, 1993, J ORGAN BEHAV, V14, P379, DOI 10.1002/job.4030140409; Kawasaki M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01692; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Koessler L, 2009, NEUROIMAGE, V46, P64, DOI 10.1016/j.neuroimage.2009.02.006; Konvalinka I, 2011, P NATL ACAD SCI USA, V108, P8514, DOI 10.1073/pnas.1016955108; Konvalinka I, 2010, Q J EXP PSYCHOL, V63, P2220, DOI 10.1080/17470218.2010.497843; Lindenberger U, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-22; Liu T, 2015, BRAIN COGNITION, V99, P17, DOI 10.1016/j.bandc.2015.07.001; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Monterosso J, 2002, J ECON PSYCHOL, V23, P437, DOI 10.1016/S0167-4870(02)00095-8; Muller V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024893; Nozawa T, 2016, NEUROIMAGE, V133, P484, DOI 10.1016/j.neuroimage.2016.03.059; Petrican R, 2008, J RES PERS, V42, P1130, DOI 10.1016/j.jrp.2008.03.001; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Schilbach Leonhard, 2010, Nat Rev Neurosci, V11, P449, DOI 10.1038/nrn2805-c1; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; SCHUNK DH, 1995, J APPL SPORT PSYCHOL, V7, P112, DOI 10.1080/10413209508406961; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Smith TW, 2011, J PERS SOC PSYCHOL, V100, P103, DOI 10.1037/a0021136; Spielberger C. D., 1970, STAT MANUAL STATE TR; Suda M, 2010, NEUROPSYCHOLOGIA, V48, P441, DOI 10.1016/j.neuropsychologia.2009.09.036; Suzuki S, 2011, SOC COGN AFFECT NEUR, V6, P338, DOI 10.1093/scan/nsq042; Szymanski C, 2017, NEUROIMAGE, V152, P425, DOI 10.1016/j.neuroimage.2017.03.013; Toppi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154236; Vanutelli ME, 2016, NEUROPSYCHOL TRENDS, P83, DOI 10.7358/neur-2016-019-vanu; Wang SL, 2008, COMPUT EDUC, V51, P1589, DOI 10.1016/j.compedu.2008.03.004; Wheland D, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1551, DOI 10.1109/ISBI.2012.6235869; Yun K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00959	57	29	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187652	10.1371/journal.pone.0187652	http://dx.doi.org/10.1371/journal.pone.0187652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145416	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800026
J	Mao, BH; Qiu, J; Zhao, N; Shao, YW; Dai, W; He, XC; Cui, HM; Lin, XJ; Lv, L; Tang, ZF; Xu, SJ; Huang, H; Zhou, M; Xu, XY; Qiu, WT; Liu, Q; Zhang, YW				Mao, Baohong; Qiu, Jie; Zhao, Nan; Shao, Yawen; Dai, Wei; He, Xiaochun; Cui, Hongmei; Lin, Xiaojuan; Lv, Ling; Tang, Zhongfeng; Xu, Sijuan; Huang, Huang; Zhou, Min; Xu, Xiaoying; Qiu, Weitao; Liu, Qing; Zhang, Yawei			Maternal folic acid supplementation and dietary folate intake and congenital heart defects	PLOS ONE			English	Article							MULTIVITAMIN SUPPLEMENTATION; PRETERM BIRTH; RISK-FACTORS; POPULATION; PREVALENCE; SURVEILLANCE; ASSOCIATION; DISEASES; SMOKING; ORIGIN	Background It has been reported that folic acid supplementation before and/or during pregnancy could reduce the risk of congenital heart defects (CHDs). However, the results from limited epidemiologic studies have been inconclusive. We investigated the associations between maternal folic acid supplementation, dietary folate intake, and the risk of CHDs. Methods A birth cohort study was conducted in 2010-2012 at the Gansu Provincial Maternity & Child Care Hospital in Lanzhou, China. After exclusion of stillbirths and multiple births, a total of 94 births were identified with congenital heart defects, and 9,993 births without any birth defects. Unconditional logistic regression was used to estimate the associations. Results Compared to non-users, folic acid supplement users before pregnancy had a reduced risk of overall CHDs (OR: 0.42, 95% CI: 0.21-0.86, P-trend = 0.025) after adjusted for potential confounders. A protective effect was observed for certain subtypes of CHDs (OR: 0.37, 95% CI: 0.16-0.85 for malformation of great arteries; 0.26, 0.10-0.68 for malformation of cardiac septa; 0.34, 0.13-0.93 for Atrial septal defect). A similar protective effect was also seen for multiple CHDs (OR: 0.49, 95% CI: 0.26-0.93, P-trend = 0.004). Compared with the middle quartiles of dietary folate intake, lower dietary folate intake (< 149.88 mu g/day) during pregnancy were associated with increased risk of overall CHDs (OR: 1.63, 95% CI: 1.01-2.62) and patent ductus arteriosus (OR: 1.85, 95% CI: 1.03-3.32). Women who were non-user folic acid supplement and lower dietary folate intake have almost 2-fold increased CHDs risk in their offspring. Conclusions Our study suggested that folic acid supplementation before pregnancy was associated with a reduced risk of CHDs, lower dietary folate intake during pregnancy was associated with increased risk. The observed associations varied by CHD subtypes. A synergistic effect of dietary folate intake and folic acid supplementation was also observed.	[Mao, Baohong; Qiu, Jie; Shao, Yawen; Dai, Wei; He, Xiaochun; Cui, Hongmei; Lin, Xiaojuan; Lv, Ling; Tang, Zhongfeng; Xu, Sijuan; Zhou, Min; Xu, Xiaoying; Qiu, Weitao; Liu, Qing] Gansu Prov Matern & Child Care Hosp, Lanzhou, Gansu, Peoples R China; [Zhao, Nan; Huang, Huang; Zhang, Yawei] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	Yale University	Liu, Q (corresponding author), Gansu Prov Matern & Child Care Hosp, Lanzhou, Gansu, Peoples R China.; Zhang, YW (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	2305470816@qq.com; yawei.zhang@yale.edu	Huang, Huang/AAN-5671-2020; Zhao, Nan/GQH-3848-2022; Huang, Huang/GPC-6042-2022	Zhao, Nan/0000-0001-5358-866X; Huang, Huang/0000-0003-0147-9650	Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant [1204WCGA021]; National Institutes of Health [K02HD70324]	Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by internal funding from the Gansu Provincial maternity and Child Care Hospital, Gansu Provincial Science and Technology Department Grant (1204WCGA021), and the National Institutes of Health Grants (K02HD70324).	Bean LJH, 2011, BIRTH DEFECTS RES A, V91, P885, DOI 10.1002/bdra.22848; Bjornard K, 2013, BIRTH DEFECTS RES A, V97, P87, DOI 10.1002/bdra.23111; Botto LD, 2000, AM J EPIDEMIOL, V151, P878, DOI 10.1093/oxfordjournals.aje.a010291; Correa A, 2003, PEDIATRICS, V111, P1146; Csaky-Szunyogh M, 2014, PEDIATR CARDIOL, V35, P108, DOI 10.1007/s00246-013-0749-6; Csaky-Szunyogh M, 2013, AM J MED GENET A, V161, P2444, DOI 10.1002/ajmg.a.36118; Csaky-Szunyogh M, 2013, J MATERN-FETAL NEO M, V26, P738, DOI 10.3109/14767058.2012.755170; Czeizel AE, 2004, BIRTH DEFECTS RES A, V70, P853, DOI 10.1002/bdra.20086; Czeizel AE, 1998, EUR J OBSTET GYN R B, V78, P151, DOI 10.1016/S0301-2115(98)00061-X; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Fekete K, 2010, MATERN CHILD NUTR, V6, P23, DOI 10.1111/j.1740-8709.2010.00261.x; Hobbs CA, 2011, BIRTH DEFECTS RES A, V91, P195, DOI 10.1002/bdra.20784; Institute of Nutrition and Food Hygiene Chinese Academy of Preventive Medicine, 1999, TABLE OF FOOD COMPON; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Leirgul E, 2015, PAEDIATR PERINAT EP, V29, P391, DOI 10.1111/ppe.12212; Li H, 2015, IJC HEART VASC, V6, P25, DOI 10.1016/j.ijcha.2014.10.002; Li XH, 2013, PREV MED, V56, P385, DOI 10.1016/j.ypmed.2013.02.019; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133961; Liu XH, 2016, EUR J NUTR, V55, P1411, DOI 10.1007/s00394-015-0959-1; Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Obermann-Borst SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.10.911; Oyen N, 2009, AM HEART J, V157, P467, DOI 10.1016/j.ahj.2008.10.017; Qiu J, 2014, AM J EPIDEMIOL, V180, P94, DOI 10.1093/aje/kwu092; Rosenquist TH, 2013, DEV DYNAM, V242, P201, DOI 10.1002/dvdy.23922; Scanlon KS, 1998, EPIDEMIOLOGY, V9, P95, DOI 10.1097/00001648-199801000-00019; Shaw GM, 2010, BIRTH DEFECTS RES A, V88, P144, DOI 10.1002/bdra.20648; SHAW GM, 1995, AM J MED GENET, V59, P536, DOI 10.1002/ajmg.1320590428; Smedts HPM, 2008, EUR J NUTR, V47, P357, DOI 10.1007/s00394-008-0735-6; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; van Beynum IM, 2010, EUR HEART J, V31, P464, DOI 10.1093/eurheartj/ehp479; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Vereczkey A, 2013, BIRTH DEFECTS RES A, V97, P217, DOI 10.1002/bdra.23124; Verkleij-Hagoort AC, 2006, EUR J NUTR, V45, P478, DOI 10.1007/s00394-006-0622-y; Wang Y, 2015, EUR J CLIN NUTR, V69, P1145, DOI 10.1038/ejcn.2014.295; Werler MM, 1999, AM J EPIDEMIOL, V150, P675, DOI 10.1093/oxfordjournals.aje.a010070; Williams LJ, 2004, BIRTH DEFECTS RES A, V70, P59, DOI 10.1002/bdra.10145; Xie DH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147280; Zhang YL, 2011, J ULTRAS MED, V30, P989, DOI 10.7863/jum.2011.30.7.989	40	34	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187996	10.1371/journal.pone.0187996	http://dx.doi.org/10.1371/journal.pone.0187996			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145433	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800047
J	Piccoli, AB; Neiva-Silva, L; Mosmann, CP; Musher-Eizenman, D; Pellanda, LC				Piccoli, Angela Bein; Neiva-Silva, Lucas; Mosmann, Clarisse Pereira; Musher-Eizenman, Dara; Pellanda, Lucia C.			Adolescents' perception of parental feeding practices: Adaptation and validation of the Comprehensive Feeding Practices Questionnaire for Brazilian adolescents-The CFPQ-Teen	PLOS ONE			English	Article							CHILDHOOD OVERWEIGHT; BEHAVIORS; WEIGHT; STYLE	Background Parental feeding practices may play a key role in dietary habits and nutritional status of adolescents, but research from adolescents' point of view on this topic is scarce. Objective To adapt and validate an instrument of parental feeding practices as perceived by adolescents in a Brazilian setting. Methods The Comprehensive Feeding Practices Questionnaire was translated into Portuguese and adapted to be answered by adolescents (ages 12 to 18). Content analysis and FACE validity to assess cultural equivalence was undertaken by experts in the adolescent nutritional and psychological fields. Pilot study was evaluated in 23 adolescents. The final version was administered to 41 students to assess instrument reproducibility (Intraclass Correlation Coefficient). Internal consistency (Cronbach's Alpha) and construct validity (Confirmatory Factor Analysis) were assessed in a third sample of 307 adolescents. Results Experts and adolescents considered content validity as appropriate. In reproducibility analysis (Intraclass Correlation Coefficient), 10 of the 12 factors were above 0.7. The factors "teaching about nutrition" and "food as reward" obtained values of 0.60 and 0.68, respectively. The Cronbach's Alpha of the whole scale was 0.83 and alphas for subscales ranged from 0.52 to 0.85; the factors "teaching about nutrition" and "food as a reward" had the lowest values (0.52). After removing these two factors, the Confirmatory Factor Analysis indicated that the structural model was appropriate. The final scale was made up of 10 factors with 43 questions. Conclusions The Comprehensive Feeding Practices Questionnaire-Teen demonstrates validity and reliability, and is a suitable tool to evaluate the perceptions of adolescents regarding parental feeding practices.	[Piccoli, Angela Bein; Pellanda, Lucia C.] Fundacao Univ Cardiol, Post Grad Program Hlth Sci Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil; [Neiva-Silva, Lucas] Univ Fed Rio Grande, Post Grad Program Publ Hlth, Psychol Grad Program, Rio Grande, Brazil; [Mosmann, Clarisse Pereira] Univ Vale Rio dos Sinos, Psychol Grad Program, Sao Leopoldo, Brazil; [Musher-Eizenman, Dara] Bowling Green State Univ, Dept Psychol, Bowling Green, OH 43403 USA; [Pellanda, Lucia C.] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil	Fundacao Universitaria de Cardiologia; Universidade Federal do Rio Grande; Universidade do Vale do Rio dos Sinos (Unisinos); University System of Ohio; Bowling Green State University; Universidade Federal de Ciencias da Saude de Porto Alegre	Pellanda, LC (corresponding author), Fundacao Univ Cardiol, Post Grad Program Hlth Sci Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil.; Pellanda, LC (corresponding author), Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil.	pellanda.pesquisa@gmail.com	Mosmann, Clarisse/S-7394-2019; Mosmann, Clarisse/HDM-9499-2022; Pellanda, Lucia/ABC-1687-2020; Pellanda, Lucia C/B-4701-2010	Pellanda, Lucia C/0000-0002-8776-2248				Alia KA, 2013, J PEDIATR PSYCHOL, V38, P321, DOI 10.1093/jpepsy/jss127; Anderson AD, 2009, AFRICAN AM PARENTS N; Birch LL, 2000, AM J CLIN NUTR, V71, P1054; Black MM, 2006, J AM DIET ASSOC, V106, P80, DOI 10.1016/j.jada.2005.09.049; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Chen AY, 2010, PREV CHRONIC DIS, V7; de Camargo APPD, 2013, CIENC SAUDE COLETIVA, V18, P323, DOI 10.1590/S1413-81232013000200004; DeVellis R. F., 2016, SCALE DEV THEORY APP, V4th; Doaei S., 2013, Zahedan Journal of Research in Medical Sciences, V15, P42; Faith MS, 2008, J AM DIET ASSOC, V108, P624, DOI 10.1016/j.jada.2008.01.007; Forza C, 2002, INT J OPER PROD MAN, V22, P152, DOI 10.1108/01443570210414310; Garson GD, 2012, STRUCTURAL EQUATION; Gliem JA, 2003, 2003 MIDW RES TO PRA; Hart K., 2003, J HUMAN NUTR DIETETI, V16, P365, DOI [10.1046/j.1365-277X.2003.04672.x, DOI 10.1046/J.1365-277X.2003.04672.X]; Haszard JJ, 2013, APPETITE, V62, P110, DOI 10.1016/j.appet.2012.11.017; Hughes SO, 2005, APPETITE, V44, P83, DOI 10.1016/j.appet.2004.08.007; Huneault L, 2011, OBES REV, V12, pe64, DOI 10.1111/j.1467-789X.2010.00817.x; Kaur H, 2006, APPETITE, V47, P36, DOI 10.1016/j.appet.2006.01.020; Mais Lais Amaral, 2015, Front Nutr, V2, P35, DOI 10.3389/fnut.2015.00035; Marx RG, 2003, J CLIN EPIDEMIOL, V56, P730, DOI 10.1016/S0895-4356(03)00084-2; Melbye EL, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-113; Moens E, 2007, J PEDIATR PSYCHOL, V32, P52, DOI 10.1093/jpepsy/jsl011; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Musher-Eizenman DR, 2009, APPETITE, V52, P89, DOI 10.1016/j.appet.2008.08.007; PROENCA R. P. C, 2010, CIENC CULT, V62, P43; Proenca RP, 1998, CADERNOS DEBATE, V6, P1; Rhee K, 2008, ANN AM ACAD POLIT SS, V615, P12, DOI 10.1177/0002716207308400; RYAN RM, 1989, CHILD DEV, V60, P340, DOI 10.2307/1130981; Sander GB, 2004, DIGEST DIS SCI, V49, P1822, DOI 10.1007/s10620-004-9578-z; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Silva DF, 2016, CIENC SAUDE COLETIVA, V21, P181; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Solano-Flores G, 2006, REDIE, V8; Thompson B., 1994, EDUC PSYCHOL MEAS, V54, P837; Toral N, 2009, CAD SAUDE PUBLICA; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Warkentin S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3282-8; Weber Lidia Natalia Dobrianskyj, 2004, Psicol. Reflex. Crit., V17, P323, DOI 10.1590/S0102-79722004000300005; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2012, POP BAS APPR CHILDH; Zeinstra GG, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-30	41	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187041	10.1371/journal.pone.0187041	http://dx.doi.org/10.1371/journal.pone.0187041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145485	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800007
J	Santasalo-Aarnio, A; Galfi, I; Virtanen, J; Gasik, MM				Santasalo-Aarnio, Annukka; Galfi, Istvan; Virtanen, Jorma; Gasik, Michael M.			New analytical methodology for analysing S (IV) species at low pH solutions by one stage titration method (bichromatometry) with a clear colour change. Could potentially replace the state-of-art-method iodometry at low pH analysis due higher accuracy	PLOS ONE			English	Article							SCREEN-PRINTED ELECTRODES; SULFUR-DIOXIDE; SO2-DEPOLARIZED ELECTROLYZER; AQUEOUS-SOLUTIONS; SOLUBILITY; ABSORPTION; ACID	A new, faster and more reliable analytical methodology for S(IV) species analysis at low pH solutions by bichromatometry is proposed. For decades the state of the art methodology has been iodometry that is still well justified method for neutral solutions, thus at low pH media possess various side reactions increasing inaccuracy. In contrast, the new methodology has no side reactions at low pH media, requires only one titration step and provides a clear color change if S(IV) species are present in the solution. The method is validated using model solutions with known concentrations and applied to analyses of gaseous SO2 from purged solution in low pH media samples. The results indicate that bichromatometry can accurately analyze SO2 from liquid samples having pH even below 0 relevant to metallurgical industrial processes.	[Santasalo-Aarnio, Annukka; Galfi, Istvan; Virtanen, Jorma; Gasik, Michael M.] Aalto Univ, Dept Chem & Met Engn, Sch Chem Engn, Aalto, Finland	Aalto University	Santasalo-Aarnio, A (corresponding author), Aalto Univ, Dept Chem & Met Engn, Sch Chem Engn, Aalto, Finland.	annukka.santasalo@aalto.fi	Gasik, Michael/G-2224-2013; Santasalo-Aarnio, Annukka/E-2879-2013	Gasik, Michael/0000-0002-5782-7987; Santasalo-Aarnio, Annukka/0000-0003-0077-966X	European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking of the SOL2HY2 project [325320]	European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking of the SOL2HY2 project	The European Union's Seventh Framework Programme (FP7), the Fuel Cell and Hydrogen Joint Undertaking, under grant agreement no 325320 of the SOL2HY2 project. The funding was received by prof. M.M. Gasik. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Devaramani S, 2012, ELECTROCHIM ACTA, V85, P579, DOI 10.1016/j.electacta.2012.08.105; Gasik MM, 2017, INT J HYDROGEN ENERG, V42, P13407, DOI 10.1016/j.ijhydene.2017.03.003; Ghoseyri A, 2013, ADV MATER RES-SWITZ, V605-607, P1387, DOI 10.4028/www.scientific.net/AMR.605-607.1387; GOVINDARAO VMH, 1993, IND ENG CHEM RES, V32, P2111, DOI 10.1021/ie00021a037; Hart JP, 2002, BIOSENS BIOELECTRON, V17, P389, DOI 10.1016/S0956-5663(01)00308-6; HAYDUK W, 1988, J CHEM ENG DATA, V33, P506, DOI 10.1021/je00054a033; HUNGER T, 1990, J CHEM ENG DATA, V35, P453, DOI 10.1021/je00062a024; Jeffry G.H., 1989, VOGELS TXB QUANTITAT, V5th, P398; JUDA W, 1967, CHEM ENG PROG, V63, P59; Maass CE, 1928, J AM CHEM SOC, V50, P1352, DOI 10.1021/ja01392a016; Molinero-Abad B, 2013, MICROCHIM ACTA, V180, P1351, DOI 10.1007/s00604-013-1074-8; Mondal MK, 2007, FLUID PHASE EQUILIBR, V253, P98, DOI 10.1016/j.fluid.2007.01.015; Rabe A.E., 1963, J CHEM ENG DATA, V8, P333, DOI [10.1021/je60018a017, DOI 10.1021/JE60018A017]; Ramos RM, 2016, ELECTROCHEM COMMUN, V63, P52, DOI 10.1016/j.elecom.2015.12.010; Santasalo-Aarnio A, 2016, J SOLID STATE ELECTR, V20, P1655, DOI 10.1007/s10008-016-3169-8; Santasalo-Aarnio A, 2016, J POWER SOURCES, V306, P1, DOI 10.1016/j.jpowsour.2015.11.104; Shaw AC, 2011, INT J HYDROGEN ENERG, V36, P4749, DOI 10.1016/j.ijhydene.2011.01.105; Sivasubramanian P, 2007, INT J HYDROGEN ENERG, V32, P463, DOI 10.1016/j.ijhydene.2006.06.056; Steimke JL, 2015, INT J HYDROGEN ENERG, V40, P13281, DOI 10.1016/j.ijhydene.2015.08.041; Streeter I, 2005, J PHYS CHEM B, V109, P18500, DOI 10.1021/jp058119n; WEST PW, 1956, ANAL CHEM, V28, P1816, DOI 10.1021/ac60120a005; Xiang CX, 2016, MATER HORIZ, V3, P169, DOI 10.1039/c6mh00016a; Xue LL, 2013, INT J HYDROGEN ENERG, V38, P11017, DOI 10.1016/j.ijhydene.2012.12.120; Zhang QL, 1998, IND ENG CHEM RES, V37, P1167, DOI 10.1021/ie9706119	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188227	10.1371/journal.pone.0188227	http://dx.doi.org/10.1371/journal.pone.0188227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145479	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800093
J	Schembri, R; Spong, J; Peters, A; Rochford, P; Wilksch, P; O'Donoghue, FJ; Greenwood, KM; Barnes, M; Kennedy, GA; Berlowitz, DJ				Schembri, Rachel; Spong, Jo; Peters, Allison; Rochford, Peter; Wilksch, Philip; O'Donoghue, Fergal J.; Greenwood, Kenneth M.; Barnes, Maree; Kennedy, Gerard A.; Berlowitz, David J.			Light sensors for objective light measurement in ambulatory polysomnography	PLOS ONE			English	Article							SLEEP-APNEA; DIAGNOSIS; DEVICE	Ambulatory polysomnography (PSG) does not commonly include an objective measure of light to determine the time of lights off (Loff), and thus cannot be used to calculate important indices such as sleep onset latency and sleep efficiency. This study examined the technical specifications and appropriateness of a prototype light sensor (LS) for use in ambulatory Compumedics Somte PSG. Two studies were conducted. The first examined the light measurement characteristics of the LS when used with a portable PSG device, specifically recording trace range, linearity, sensitivity, and stability. This involved the LS being exposed to varying incandescent and fluorescent light levels in a light controlled room. Secondly, the LS was trialled in 24 home and 12 hospital ambulatory PSGs to investigate whether light levels in home and hospital settings were within the recording range of the LS, and to quantify the typical light intensity reduction at the time of Loff. A preliminary exploration of clinical utility was also conducted. Linearity between LS voltage and lux was demonstrated, and the LS trace was stable over 14 hours of recording. The observed maximum voltage output of the LS/PSG device was 250 mV, corresponding to a maximum recording range of 350 lux and 523 lux for incandescent and fluorescent light respectively. At the time of Loff, light levels were within the recording range of the LS, and on average dropped by 72 lux (9-245) in the home and 76 lux (4-348) in the hospital setting. Results suggest that clinical utility was greatest in hospital settings where patients are less mobile. The LS was a simple and effective objective marker of light level in portable PSG, which can be used to identify Loff in ambulatory PSG. This allows measurement of additional sleep indices and support with clinical decisions.	[Schembri, Rachel; Spong, Jo; Rochford, Peter; O'Donoghue, Fergal J.; Barnes, Maree; Kennedy, Gerard A.; Berlowitz, David J.] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia; [Schembri, Rachel; O'Donoghue, Fergal J.; Barnes, Maree; Berlowitz, David J.] Univ Melbourne, Dept Med Dent & Hlth Sci, Parkville, Vic, Australia; [Spong, Jo] La Trobe Univ, La Trobe Rural Hlth Sch, Coll Sci Hlth & Engn, Bendigo, Vic, Australia; [Peters, Allison] Melbourne Sleep Disorders Ctr, Melbourne, Vic, Australia; [Wilksch, Philip] RMIT Univ, Sch Sci, Melbourne, Vic, Australia; [Greenwood, Kenneth M.] James Cook Univ, Singapore, Singapore; [Kennedy, Gerard A.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; La Trobe University; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Schembri, R (corresponding author), Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia.; Schembri, R (corresponding author), Univ Melbourne, Dept Med Dent & Hlth Sci, Parkville, Vic, Australia.	rachel.schembri@austin.org.au	Spong, Jo/AAC-7745-2019; Wilksch, Philip/I-3888-2019; Spong, Jo/D-1941-2018; Berlowitz, David/D-4939-2011	Wilksch, Philip/0000-0003-1552-0263; Spong, Jo/0000-0001-7066-1996; Berlowitz, David/0000-0003-2543-8722	National Health and Medical Research Council postgraduate stipend [616605, 1080020]; Transport Accident Commission, Victoria, Australia	National Health and Medical Research Council postgraduate stipend; Transport Accident Commission, Victoria, Australia	This study was supported by National Health and Medical Research Council postgraduate stipend (Rachel Schembri, #616605) and project grant (#1080020 to David J Berlowitr); The COSAQ study is proudly supported by the Transport Accident Commission, Victoria, Australia. This study was led from the Institute for Breathing and Sleep with data collection undertaken across multiple sites. The technical sensor testing was performed at the Institute for Breathing and Sleep, and RMIT University. Overnight polysomnography was performed in participants' homes, or in hospital beds of the centres participating in the COSAQ study.	Berlowitz DJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-181; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bruyneel M, 2011, J SLEEP RES, V20, P201, DOI 10.1111/j.1365-2869.2010.00859.x; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Endo T, 2007, BRAIN, V130, P2951, DOI 10.1093/brain/awm237; Kingshott RN, 2000, SLEEP, V23, P1109, DOI 10.1093/sleep/23.8.1j; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; Schembri R, 2010, AUSTR SLEEP ASS ANN; Zou D, 2006, SLEEP, V29, P367, DOI 10.1093/sleep/29.3.367	10	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188124	10.1371/journal.pone.0188124	http://dx.doi.org/10.1371/journal.pone.0188124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145507	Green Published, Green Accepted, gold			2022-12-27	WOS:000415378800070
J	Whitmire, LE; Ling, L; Bugay, V; Carver, CM; Timilsina, S; Chuang, HH; Jaffe, DB; Shapiro, MS; Cavazos, JE; Brenner, R				Whitmire, Luke E.; Ling, Ling; Bugay, Vladslav; Carver, Chase M.; Timilsina, Santosh; Chuang, Hui-Hsiu; Jaffe, David B.; Shapiro, Mark S.; Cavazos, Jose E.; Brenner, Robert			Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; DEPENDENT POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; BETA-SUBUNIT; PYRAMIDAL NEURONS; UP-REGULATION; CELLS; RAT; EXCITABILITY	A major challenge is to understand maladaptive changes in ion channels that sets neurons on a course towards epilepsy development. Voltage-and calcium-activated K+ (BK) channels contribute to early spike timing in neurons, and studies indicate that the BK channel plays a pathological role in increasing excitability early after a seizure. Here, we have investigated changes in BK channels and their accessory beta 4 subunit (KCNMB4) in dentate gyrus (DG) granule neurons of the hippocampus, key neurons that regulate excitability of the hippocampus circuit. Two days after pilocarpine-induced seizures, we found that the predominant effect is a downregulation of the beta 4 accessory subunit mRNA. Consistent with reduced expression, single channel recording and pharmacology indicate a switch in the subtype of channels expressed; from iberiotoxin-resistant, type II BK channels (BK alpha/beta 4) that have higher channel open probability and slow gating, to iberiotoxin-sensitive type I channels (BK a alone) with low open probability and faster gating. The switch to a majority of type I channel expression following seizure activity is correlated with a loss of BK channel function on spike threshold while maintaining the channel's contribution to increased early spike frequency. Using heterozygous beta 4 knockout mice, we find reduced expression is sufficient to increase seizure sensitivity. We conclude that seizure-induced downregulation of KCNMB4 is an activity dependent mechanism that increases the excitability of DG neurons. These novel findings indicate that BK channel subtypes are not only defined by cell-specific expression, but can also be plastic depending on the recent history of neuronal excitability.	[Whitmire, Luke E.; Ling, Ling; Bugay, Vladslav; Carver, Chase M.; Timilsina, Santosh; Chuang, Hui-Hsiu; Shapiro, Mark S.; Brenner, Robert] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Jaffe, David B.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Cavazos, Jose E.] Univ Texas Hlth Sci Ctr San Antonio, Neurol, San Antonio, TX 78229 USA; [Whitmire, Luke E.] Brain Sentinel, San Antonio, TX USA; [Ling, Ling] Cent S Univ, Xiangya Sch Med, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; Central South University	Brenner, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu	Cavazos, Jose/J-4122-2016	Cavazos, Jose/0000-0001-5777-2608; Brenner, Robert/0000-0002-1036-8031	National Institute of Health [NS052574, NS043394]; National Science Foundation [1456862]; Xiangya Medical Student Research Program; Institute for Integration of Medicine and Science, at UT Health San Antonio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Xiangya Medical Student Research Program; Institute for Integration of Medicine and Science, at UT Health San Antonio; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the National Institute of Health NS052574 and NS043394, National Science Foundation 1456862, the Xiangya Medical Student Research Program, the Institute for Integration of Medicine and Science, at UT Health San Antonio.	Alle H, 2011, J NEUROSCI, V31, P8001, DOI 10.1523/JNEUROSCI.0972-11.2011; Balzekas I, 2016, NEUROSCI LETT, V622, P30, DOI 10.1016/j.neulet.2016.04.033; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; CLIFFORD DB, 1987, NEUROSCIENCE, V23, P953, DOI 10.1016/0306-4522(87)90171-0; DiFrancesco JC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00071; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Ermolinsky BS, 2011, NEUROSCI RES, V69, P73, DOI 10.1016/j.neures.2010.09.011; Gu N, 2007, J PHYSIOL-LONDON, V580, P859, DOI 10.1113/jphysiol.2006.126367; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; IKEMOTO Y, 1989, BIOPHYS J, V56, P207, DOI 10.1016/S0006-3495(89)82665-7; Jaffe DB, 2011, NEUROSCIENCE, V192, P205, DOI 10.1016/j.neuroscience.2011.06.028; Kaufmann WA, 2010, NEUROSCIENCE, V169, P974, DOI 10.1016/j.neuroscience.2010.05.070; Khan SA, 1998, J PHARMACOL EXP THER, V284, P838; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Mehranfard N, 2014, IRAN J PHARM RES, V13, P125; Misonou H, 2006, J COMP NEUROL, V496, P289, DOI 10.1002/cne.20931; Montgomery JR, 2013, AM J PHYSIOL-CELL PH, V304, pC299, DOI 10.1152/ajpcell.00302.2012; Montgomery JR, 2012, P NATL ACAD SCI USA, V109, P18997, DOI 10.1073/pnas.1205573109; Nguyen Nguyen V, 2013, Methods Mol Biol, V998, P133, DOI 10.1007/978-1-62703-351-0_10; Peng BW, 2013, EPILEPSIA, V54, P1223, DOI 10.1111/epi.12150; Petrik D, 2011, EUR J NEUROSCI, V34, P695, DOI 10.1111/j.1460-9568.2011.07799.x; Powell KL, 2014, EPILEPSIA, V55, P609, DOI 10.1111/epi.12563; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rehak R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061844; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI 10.1073/pnas.0802805105; Sharma AK, 2007, TOXICOL PATHOL, V35, P984, DOI 10.1080/01926230701748305; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Shruti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033429; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Stegen M, 2009, EPILEPSIA, V50, P646, DOI 10.1111/j.1528-1167.2009.02025.x; Van Goor F, 2001, J NEUROSCI, V21, P5902, DOI 10.1523/JNEUROSCI.21-16-05902.2001; Wang B, 2009, J GEN PHYSIOL, V133, P283, DOI 10.1085/jgp.200810141; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746	44	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188064	10.1371/journal.pone.0188064	http://dx.doi.org/10.1371/journal.pone.0188064			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145442	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800059
J	Yang, AL; Guo, ZY; Ren, QQ; Wu, LW; Ma, Y; Hu, AB; Wang, DP; Ye, HD; Zhu, XF; Ju, WQ; He, XS				Yang, Anli; Guo, Zhiyong; Ren, Qingqi; Wu, Linwei; Ma, Yi; Hu, Anbin; Wang, Dongping; Ye, Haidan; Zhu, Xiaofeng; Ju, Weiqiang; He, Xiaoshun			Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study	PLOS ONE			English	Article							RECEIVING LAMIVUDINE PROPHYLAXIS; HBV VACCINE; RECURRENCE; RECIPIENTS; ANTIBODY; IMMUNOGLOBULIN; EOSINOPHIL; FAILURE	Introduction Prophylactic administration of hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues (NAs) is the standard treatment for controlling hepatitis B virus (HBV) recurrence after liver transplantation (LT). Since lifelong use of HBIG is expensive and inconvenient and the antibodies level in anti-hepatitis B surface (HBs) is not sustainable and stable, an alternative strategy is to produce anti-HBs antibodies by active immunization. Our present study aimed to prospectively investigate the efficacy and safety of procedural HBV vaccination in transplanted patients. Methods Recipients who had undergone LT for hepatitis B related liver diseases more than one year before, with no evidence of HBV recurrence or rejection and normal liver function were enrolled. All subjects received the hepatitis B vaccine (40 mu g) by intramuscular injection at months 0, 1, 2, 6 and 12 after enrollment with continuous administration of NAs. The liver function and anti-HBs titers were measured before each vaccination and HBIG (400U) was administrated intramuscularly when anti-HBs titer was lower than 30 IU/L during the course. The results of routine blood tests, liver function, concentration of immunosuppressant, and HBV-DNA copies were monitored during the research. After completion of the vaccination procedure, recipients were regarded as responders if their anti-HBs greater than 30 IU/L were maintained for up to six months without using HBIG and vaccine. Results Twenty-seven patients were enrolled in this study and the average anti-HBs titer before vaccination was 19.86 +/- 14.80 IU/L. The average anti-HBs titer of the nine responders at the end of the follow-up was 57.14 +/- 22.75 IU/L, giving an overall response rate of 33.3% (9/27). There were no reports of reactivation of HBV, rejection, severe anaphylaxis or other adverse events. Responders and non-responders showed their significant difference in anti-HBs titers after the fourth vaccination (P<0.01). Moreover, the majority of non-responders (11/18, 63.64%) had high LY/EO rates (lymphocyte number/eosinophil number>15) while most responders (8/9, 88.89%) had low LY/EO rates at the beginning of vaccination (P = 0.019). Conclusions Active immunization is an effective, cost-saving, and safe method for the prevention of HBV reactivation in patients transplanted for hepatitis B virus related liver diseases. The LY/EO rate may be a valuable indicator in selecting potential recipients for vaccination.	[Yang, Anli; Guo, Zhiyong; Ren, Qingqi; Wu, Linwei; Ma, Yi; Hu, Anbin; Wang, Dongping; Ye, Haidan; Zhu, Xiaofeng; Ju, Weiqiang; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou, Guangdong, Peoples R China; [Yang, Anli; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Organ Donat & Transplant Im, Guangzhou, Guangdong, Peoples R China; [Yang, Anli; Guo, Zhiyong; He, Xiaoshun] Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Int Cooperat Base Sci & Technol Org, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Ju, WQ; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou, Guangdong, Peoples R China.; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Organ Donat & Transplant Im, Guangzhou, Guangdong, Peoples R China.; He, XS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Guangdong Prov Int Cooperat Base Sci & Technol Org, Guangzhou, Guangdong, Peoples R China.	weiqiangju@163.com; gdtrc@163.com			National High Technology Research and Development Program of China (863 Program) [2012AA021008]; Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation) [2015B050501002]; Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology [2013A061401007]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation); Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology	This study was supported by grants from National High Technology Research and Development Program of China (863 Program; 2012AA021008), Guangdong Provincial International Cooperation Base Construction Project of Science and Technology (organ transplantation) (2015B050501002) and Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China/Guangdong Provincial Key Laboratory Construction Project on Organ Donation and Transplant Immunology (2013A061401007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelico M, 2002, HEPATOLOGY, V35, P176, DOI 10.1053/jhep.2002.30278; Bosse M, 1996, IMMUNOLOGY, V87, P149; Brescia G, 2016, AM J OTOLARYNG, V37, P339, DOI 10.1016/j.amjoto.2016.02.002; Huprikar S, 2015, AM J TRANSPLANT, V15, P1162, DOI 10.1111/ajt.13187; Ishigami M, 2015, WORLD J GASTROENTERO, V21, P10290, DOI 10.3748/wjg.v21.i36.10290; Ishigami M, 2011, J GASTROENTEROL, V46, P367, DOI 10.1007/s00535-010-0313-6; Lee S, 2016, LIVER TRANSPLANT, V22, P247, DOI 10.1002/lt.24372; Lo CM, 2007, AM J TRANSPLANT, V7, P434, DOI 10.1111/j.1600-6143.2006.01636.x; Lo CM, 2003, HEPATOLOGY, V37, P36, DOI 10.1053/jhep.2003.50035; Lo CM, 2005, J HEPATOL, V43, P283, DOI 10.1016/j.jhep.2005.03.013; Lu SC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/764234; Matsunaga J, 2000, BRIT J PHARMACOL, V130, P1539, DOI 10.1038/sj.bjp.0703473; Meireles LC, 2015, WORLD J HEPATOL, V7, P2127, DOI 10.4254/wjh.v7.i18.2127; Millan O, 2010, CLIN IMMUNOL, V137, P337, DOI 10.1016/j.clim.2010.08.004; Ohno Y, 2014, TRANSPL P, V46, P721, DOI 10.1016/j.transproceed.2013.12.005; Orlando R, 2015, EUR J CLIN MICROBIOL, V34, P1059, DOI 10.1007/s10096-015-2341-x; Patel SS, 2016, CURR OPIN PEDIATR, V28, P653, DOI 10.1097/MOP.0000000000000391; Shouval D, 2015, MED MICROBIOL IMMUN, V204, P57, DOI 10.1007/s00430-014-0374-x; Starkel P, 2005, LIVER TRANSPLANT, V11, P1228, DOI 10.1002/lt.20464; Sundaram V, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4263; Tahara H, 2009, TRANSPL INT, V22, P805, DOI 10.1111/j.1432-2277.2009.00864.x; Takaki A, 2015, HEPATOL RES, V45, P38, DOI 10.1111/hepr.12368; Takaki A, 2013, J GASTROENTEROL, V48, P1373, DOI 10.1007/s00535-013-0763-8; Togashi J, 2016, HEPATOL RES, V46, pE51, DOI 10.1111/hepr.12526; Usui M, 2016, TRANSPL P, V48, P1179, DOI 10.1016/j.transproceed.2015.12.110; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wong TW, 2014, J IMMUNOL, V192, P3548, DOI 10.4049/jimmunol.1302241; Yenigun A, 2016, AM J RHINOL ALLERGY, V30, pE21, DOI 10.2500/ajra.2016.30.4296; Yenigun Alper, 2015, Kulak Burun Bogaz Ihtis Derg, V25, P193, DOI 10.5606/kbbihtisas.2015.10734; Yoshizawa A, 2016, HEPATOL RES, V46, P541, DOI 10.1111/hepr.12586; Zhang XY, 2014, CLIN EXP ALLERGY, V44, P1137, DOI 10.1111/cea.12345	31	7	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188190	10.1371/journal.pone.0188190	http://dx.doi.org/10.1371/journal.pone.0188190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145470	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800084
J	Burstein, O; Franko, M; Gale, E; Handelsman, A; Barak, S; Motsan, S; Shamir, A; Toledano, R; Simhon, O; Hirshler, Y; Chen, G; Doron, R				Burstein, Or; Franko, Motty; Gale, Eyal; Handelsman, Assaf; Barak, Segev; Motsan, Shai; Shamir, Alon; Toledano, Roni; Simhon, Omri; Hirshler, Yafit; Chen, Gang; Doron, Ravid			Escitalopram and NHT normalized stress-induced anhedonia and molecular neuroadaptations in a mouse model of depression	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ANIMAL-MODELS; NEUROTROPHIC FACTOR; MAJOR DEPRESSION; DOPAMINE RELEASE; HERBAL TREATMENT; REMISSION RATES; MILD STRESS; ALCOHOL; ANTIDEPRESSANT	Anhedonia is defined as a diminished ability to obtain pleasure from otherwise positive stimuli. Anxiety and mood disorders have been previously associated with dysregulation of the reward system, with anhedonia as a core element of major depressive disorder (MDD). The aim of the present study was to investigate whether stress-induced anhedonia could be prevented by treatments with escitalopram or novel herbal treatment (NHT) in an animal model of depression. Unpredictable chronic mild stress (UCMS) was administered for 4 weeks on ICR outbred mice. Following stress exposure, animals were randomly assigned to pharmacological treatment groups (i.e., saline, escitalopram or NHT). Treatments were delivered for 3 weeks. Hedonic tone was examined via ethanol and sucrose preferences. Biological indices pertinent to MDD and anhedonia were assessed: namely, hippocampal brain-derived neurotrophic factor (BDNF) and striatal dopamine receptor D2 (Drd2) mRNA expression levels. The results indicate that the UCMS-induced reductions in ethanol or sucrose preferences were normalized by escitalopram or NHT. This implies a resemblance between sucrose and ethanol in their hedonic-eliciting property. On a neurobiological aspect, UCMS-induced reduction in hippocampal BDNF levels was normalized by escitalopram or NHT, while UCMS-induced reduction in striatal Drd2 mRNA levels was normalized solely by NHT. The results accentuate the association of stress and anhedonia, and pinpoint a distinct effect for NHT on striatal Drd2 expression.	[Burstein, Or; Franko, Motty; Motsan, Shai; Toledano, Roni; Simhon, Omri; Doron, Ravid] Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel; [Burstein, Or; Gale, Eyal; Hirshler, Yafit; Doron, Ravid] Open Univ, Dept Educ & Psychol, Raanana, Israel; [Handelsman, Assaf; Barak, Segev] Tel Aviv Univ, Sch Psychol Sci, Tel Aviv, Israel; [Handelsman, Assaf; Barak, Segev] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Shamir, Alon] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Shamir, Alon] Mazor Mental Hlth Ctr, Akko, Israel; [Chen, Gang] Nanjing Univ Chinese Med, Ctr Translat Syst Biol & Neurosci, Nanjing, Jiangsu, Peoples R China; [Chen, Gang] Nanjing Univ Chinese Med, Key Lab Integrat Biomed Brain Dis, Nanjing, Jiangsu, Peoples R China	Open University Israel; Tel Aviv University; Tel Aviv University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Doron, R (corresponding author), Acad Coll Tel Aviv Yaffo, Sch Behav Sci, Tel Aviv, Israel.; Doron, R (corresponding author), Open Univ, Dept Educ & Psychol, Raanana, Israel.	raviddor@mta.ac.il	Barak, Segev/ABG-4080-2020	Barak, Segev/0000-0002-3143-6777; Burstein, Or/0000-0003-2638-8018	Israel Science Foundation (ISF) [738/11]; National Institute for Psychobiology in Israel (NIPI) [7-2011-12]; Open University of Israel	Israel Science Foundation (ISF)(Israel Science Foundation); National Institute for Psychobiology in Israel (NIPI); Open University of Israel	Funding for this study was provided by the Israel Science Foundation (ISF, http://www.isf.org.il, Grant 738/11), by the National Institute for Psychobiology in Israel (NIPI, http://www.psychobiology.org.il, Grant 7-2011-12) and by the Open University of Israel research fund (http://www.openu.ac.il) (all funds received by R.D.); the ISF, NIPI and the Open University of Israel had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2011, COMMUNICATION; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Baker-Herman TL, 2004, NAT NEUROSCI, V7, P48, DOI 10.1038/nn1166; Becker HC, 2013, CURR TOP BEHAV NEURO, V13, P355, DOI 10.1007/7854_2012_203; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Berridge KC, 2008, PSYCHOPHARMACOLOGY, V199, P457, DOI 10.1007/s00213-008-1099-6; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bessa JM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.39; Bjornebekk A, 2007, NEUROREPORT, V18, P1039; Blum K., 2014, ANHEDONIA COMPREHENS, P179, DOI [10.1007/978-94-017-8591-4_9, DOI 10.1007/978-94-017-8591-4_9]; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; Carnicella S, 2014, ALCOHOL, V48, P243, DOI 10.1016/j.alcohol.2014.01.006; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chourbaji S, 2011, NEUROSCI BIOBEHAV R, V35, P599, DOI 10.1016/j.neubiorev.2010.07.003; Cicero TJ, 1979, BIOCH PHARM ETHANOL, P533; Clayton AH, 2002, J CLIN PSYCHIAT, V63, P357, DOI 10.4088/JCP.v63n0414; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Der-Avakian A, 2012, TRENDS NEUROSCI, V35, P68, DOI 10.1016/j.tins.2011.11.005; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Doron R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091455; Doron R, 2014, LIFE SCI, V94, P151, DOI 10.1016/j.lfs.2013.10.025; Doron R, 2012, LIFE SCI, V90, P995, DOI 10.1016/j.lfs.2012.05.014; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dziedzicka-Wasylewska M, 1997, BEHAV PHARMACOL, V8, P607, DOI 10.1097/00008877-199711000-00017; Ebert D, 1996, PSYCHOPHARMACOLOGY, V126, P91, DOI 10.1007/BF02246416; Eisch AJ, 2003, BIOL PSYCHIAT, V54, P994, DOI 10.1016/j.biopsych.2003.08.003; Grant KA, 2003, PHARMACOL THERAPEUT, V100, P235, DOI 10.1016/j.pharmthera.2003.08.004; HRUSKA RE, 1988, J NEUROCHEM, V50, P1929, DOI 10.1111/j.1471-4159.1988.tb02499.x; Jansen K, 2016, ACTA PSYCHIAT SCAND, V134, P281, DOI 10.1111/acps.12551; Kasch KL, 2002, J ABNORM PSYCHOL, V111, P589, DOI 10.1037//0021-843X.111.4.589; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Keane H., 2009, Critical Public Health, V19, P135, DOI 10.1080/09581590802350957; Keltner NL, 2002, PERSPECT PSYCHIATR C, V38, P111; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Klimke A, 1999, PSYCHIAT RES-NEUROIM, V90, P91, DOI 10.1016/S0925-4927(99)00009-8; Larisch R, 1997, NEUROIMAGE, V5, P251, DOI 10.1006/nimg.1997.0267; Licinio J, 2009, ARCH GEN PSYCHIAT, V66, P488, DOI 10.1001/archgenpsychiatry.2009.38; Loas G, 1996, J AFFECT DISORDERS, V41, P39, DOI 10.1016/0165-0327(96)00065-1; Lutz CM, 2012, LABORATORY MOUSE, P37, DOI 10.1016/B978-0-12-382008-2.00003-9; Malone DA, 2009, BIOL PSYCHIAT, V65, P267, DOI 10.1016/j.biopsych.2008.08.029; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McGough NNH, 2004, J NEUROSCI, V24, P10542, DOI 10.1523/JNEUROSCI.3714-04.2004; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nollet M., 2013, CURR PROTOC PHARM; Oswald LM, 2005, NEUROPSYCHOPHARMACOL, V30, P821, DOI 10.1038/sj.npp.1300667; Overstreet DH, 2005, NEUROSCI BIOBEHAV R, V29, P739, DOI 10.1016/j.neubiorev.2005.03.015; Owens MJ, 2001, BIOL PSYCHIAT, V50, P345, DOI 10.1016/S0006-3223(01)01145-3; Palm S, 2011, ALCOHOL, V45, P607, DOI 10.1016/j.alcohol.2010.11.005; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Pardo M, 2015, PSYCHOPHARMACOLOGY, V232, P2377, DOI 10.1007/s00213-015-3872-7; Paredes RG, 2004, PROG NEUROBIOL, V73, P179, DOI 10.1016/j.pneurobio.2004.05.001; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Sanchez C, 2003, PSYCHOPHARMACOLOGY, V167, P353, DOI 10.1007/s00213-002-1364-z; Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408; Smith JW, 1996, BR J PHARM, V118; Smith JW, 1996, EUR NEUROPSYCHOPHARM, V6, pS4; Spanagel R, 2003, BEST PRACT RES CL GA, V17, P507, DOI 10.1016/S1521-6918(03)00031-3; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Surget A, 2009, EXPT ANIMAL MODELS N, P79; Thase ME, 2005, J CLIN PSYCHIAT, V66, P974, DOI 10.4088/JCP.v66n0803; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Timofeeva E, 2013, SUCROSE PROPERTIES B, P75; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Vrieze E, 2014, J AFFECT DISORDERS, V155, P35, DOI 10.1016/j.jad.2013.10.020; Willner P, 2005, J AFFECT DISORDERS, V86, P37, DOI 10.1016/j.jad.2004.12.010; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T; Zhang Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv006; Zhu XZ, 2011, BEHAV BRAIN RES, V223, P329, DOI 10.1016/j.bbr.2011.04.052; Zipori D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02177-2	89	23	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188043	10.1371/journal.pone.0188043	http://dx.doi.org/10.1371/journal.pone.0188043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141007	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400047
J	Stroffolini, T; Sagnelli, E; Andriulli, A; Colloredo, G; Furlan, C; Gaeta, GB; Morisco, F; Pirisi, M; Rosina, F; Sagnelli, C; Smedile, A; Almasio, PL				Stroffolini, Tommaso; Sagnelli, Evangelista; Andriulli, Angelo; Colloredo, Guido; Furlan, Caterina; Gaeta, Giovanni Battista; Morisco, Filomena; Pirisi, Mario; Rosina, Floriano; Sagnelli, Caterina; Smedile, Antonina; Almasio, Piero Luigi		EPACRON Study Grp	Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis	PLOS ONE			English	Article							LIVER-DISEASE; MULTICENTER PREVALENCE; INFECTION; CONSUMPTION; CLASSIFICATION; PROGRESSION; DIAGNOSIS; SEVERITY; FIBROSIS; CARRIERS	Background The joint effect of the interaction of alcohol intake, hepatitis B virus (HBV) and hepatitis C virus (HCV) on the risk of cirrhosis is still unexplored because a large sample size is required for this investigation. Objective Evaluation of interaction of HBV, HCV and alcohol abuse on the risk of cirrhosis. Design We analysed 12,262 consecutive patients with chronic liver disease of various aetiologies referring to 95 Italian liver units in 2001 or 2014. To evaluate the interaction between alcohol abuse, HBV infection, and HCV infection, patients unexposed to either factors were used as reference category. Adjustment for BMI and age was done by multiple logistic regression analysis. Results Females were older than males (p<0.01) and less frequently showed HBV and alcoholic aetiology (p<0.01). In both sexes, an overtime increasing age and an increasing proportion of subjects with liver cirrhosis was observed, reflecting a better survival (0.01). An additive interaction is observed in females: the O.R. generated by the simultaneous presence of HBV, HCV, and alcohol (5.09; 95% C.I. 1.06-24.56) exceeds the sum (4.14) of the O.R. generated by a single exposure (O.R. = 0.72 for HBsAg positivity, OR = 1.34 for anti-HCV positivity, and O.R. = 2.08 for alcohol intake). No interaction is observed in male sex. Conclusions The observed gender difference suggests that the simultaneous presence of HBV/HCV coinfection and risky alcohol intake enhances the mechanism of liver damage to a greater extent in females than in males.	[Stroffolini, Tommaso; Furlan, Caterina] Policlin Umberto 1, Dept Trop & Infect Dis, Rome, Italy; [Sagnelli, Evangelista; Sagnelli, Caterina] Campania Univ Luigi Vanvitelli, Dept Mental Hlth & Publ Med, Naples, Italy; [Andriulli, Angelo] Casa Sollievo Sofferenza Hosp, IRCCS, Div Gastroenterol, San Giovanni Rotondo, Italy; [Colloredo, Guido] San Pietro Hosp, Dept Internal Med, Ponte San Pietro, Italy; [Gaeta, Giovanni Battista] Campania Univ Luigi Vanvitelli, Dept Mental & Phys Hlth & Prevent Med, Infect Dis, Naples, Italy; [Morisco, Filomena] Univ Naples Federico II, Dept Clin Med & Surg, Gastroenterol Unit, Naples, Italy; [Pirisi, Mario] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Rosina, Floriano] Hosp G Garibaldi Catania, Liver Unit, Catania, Italy; [Smedile, Antonina] Univ Turin, Dept Med Sci, Liver Physiopathol Lab, Turin, Italy; [Almasio, Piero Luigi] Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy	Sapienza University Rome; University Hospital Sapienza Rome; Universita della Campania Vanvitelli; IRCCS Casa Sollievo Della Sofferenza; Universita della Campania Vanvitelli; University of Naples Federico II; University of Eastern Piedmont Amedeo Avogadro; University of Turin; University of Palermo	Almasio, PL (corresponding author), Univ Palermo, Biomed Dept Internal Med & Special DiBiMIS, Palermo, Italy.	piero.almasio@unipa.it	Pirisi, Mario/ABF-2102-2020; Gaeta, Giovanni/AAQ-4294-2021; Morisco, Filomena/AHI-0851-2022; Sagnelli, Caterina/AAD-4950-2022	Sagnelli, Caterina/0000-0002-6413-7810; Pirisi, Mario/0000-0001-9740-0155; Crisanti, Andrea/0000-0002-2406-4426	Gilead Sciences	Gilead Sciences(Gilead Sciences)	The unrestricted grant offered by Gilead Sciences was used exclusively for the overheads of the study. Author who received the funding is Professor Piero Luigi Almasio. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PC, 1998, GASTROENTEROLOGY, V114, P319, DOI 10.1016/S0016-5085(98)70483-4; Aloman C, 2007, GASTROENTEROLOGY, V132, P698, DOI 10.1053/j.gastro.2006.11.016; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Angulo P, 2002, J GASTROEN HEPATOL, V17, pS186, DOI 10.1046/j.1440-1746.17.s1.10.x; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bissell DM, 1999, HEPATOLOGY, V29, P988, DOI 10.1002/hep.510290351; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; Di Marco V, 1999, HEPATOLOGY, V30, P257, DOI 10.1002/hep.510300109; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Gaeta GB, 2003, J HEPATOL, V39, P1036, DOI 10.1016/S0168-8278(03)00470-7; Gaiani S, 1997, J HEPATOL, V27, P979, DOI 10.1016/S0168-8278(97)80140-7; Lin S, 2017, VIRUSES, V18; Loguercio C, 2003, FREE RADICAL BIO MED, V34, P1, DOI 10.1016/S0891-5849(02)01167-X; MCMAHON BJ, 1990, ARCH INTERN MED, V150, P1051, DOI 10.1001/archinte.150.5.1051; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; PARES A, 1990, HEPATOLOGY, V12, P1295, DOI 10.1002/hep.1840120608; Pianko S, 2000, J GASTROEN HEPATOL, V15, P798, DOI 10.1046/j.1440-1746.2000.02083.x; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Sagnelli E, 2000, HEPATOLOGY, V32, P1106, DOI 10.1053/jhep.2000.19288; Sagnelli E, 2005, J MED VIROL, V75, P522, DOI 10.1002/jmv.20313; Sagnelli E, 2016, DIGEST LIVER DIS, V48, P1066, DOI 10.1016/j.dld.2016.05.014; Stroffolini T, 2006, J VIRAL HEPATITIS, V13, P351, DOI 10.1111/j.1365-2893.2005.00690.x; Stroffolini T, 2015, J MED VIROL, V87, P1899, DOI 10.1002/jmv.24243; Stroffolini T, 2010, LIVER INT, V30, P867, DOI 10.1111/j.1478-3231.2010.02261.x; TAAL BG, 1983, HEPATO-GASTROENTEROL, V30, P178; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0	27	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0185710	10.1371/journal.pone.0185710	http://dx.doi.org/10.1371/journal.pone.0185710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140988	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400002
J	Fujishima, H; Fumoto, S; Shibata, T; Nishiki, K; Tsukamoto, Y; Etoh, T; Moriyama, M; Shiraishi, N; Inomata, M				Fujishima, Hajime; Fumoto, Shoichi; Shibata, Tomotaka; Nishiki, Kohei; Tsukamoto, Yoshiyuki; Etoh, Tsuyoshi; Moriyama, Masatsugu; Shiraishi, Norio; Inomata, Masafumi			A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer	PLOS ONE			English	Article							PERIOPERATIVE CHEMOTHERAPY; TRIMODALITY THERAPY; GENE-EXPRESSION; FLUOROURACIL; SENSITIVITY; CARCINOMA; SURGERY; CHEMORADIOTHERAPY; CHEMOSENSITIVITY; PHARMACOGENOMICS	Background Recently, neoadjuvant chemotherapy with docetaxel/cisplatin/5-fluorouracil (NAC-DCF) was identified as a novel strong regimen with a high rate of pathological complete response (pCR) in advanced esophageal cancer in Japan. Predicting pCR will contribute to the therapeutic strategy and the prevention of surgical invasion. However, a predictor of pCR after NAC-DCF has not yet been developed. The aim of this study was to identify a novel predictor of pCR in locally advanced esophageal cancer treated with NAC-DCF. Patients and methods A total of 32 patients who received NAC-DCF followed by esophagectomy between June 2013 and March 2016 were enrolled in this study. We divided the patients into the following 2 groups: pCR group (9 cases) and non-pCR group (23 cases), and compared gene expressions between these groups using DNA microarray data and KeyMolnet. Subsequently, a validation study of candidate molecular expression was performed in 7 additional cases. Results Seventeen molecules, including transcription factor E2F, T-cell-specific transcription factor, Src (known as "proto-oncogene tyrosine-protein kinase of sarcoma-), interferon regulatory factor 1, thymidylate synthase, cyclin B, cyclin-dependent kinase (CDK) 4, CDK, caspase-1, vitamin D receptor, histone deacetylase, MAPK/ERK kinase, bcl-2-associated X protein, runt-related transcription factor 1, PR domain zinc finger protein 1, platelet-derived growth factor receptor, and interleukin 1, were identified as candidate molecules. The molecules were mainly associated with pathways, such as transcriptional regulation by SMAD, RB/E2F, and STAT. The validation study indicated that 12 of the 17 molecules (71%) matched the trends of molecular expression. Conclusions A 17-molecule set that predicts pCR after NAC-DCF for locally advanced esophageal cancer was identified.	[Fujishima, Hajime; Shibata, Tomotaka; Etoh, Tsuyoshi; Inomata, Masafumi] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita, Japan; [Fumoto, Shoichi; Nishiki, Kohei] Oita Nakamura Hosp, Dept Surg, Oita, Japan; [Tsukamoto, Yoshiyuki; Moriyama, Masatsugu] Oita Univ, Dept Mol Pathol, Fac Med, Oita, Japan; [Shiraishi, Norio] Oita Univ, Fac Med, Comprehens Surg Community Med, Oita, Japan	Oita University; Oita University; Oita University	Fujishima, H (corresponding author), Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita, Japan.	hajime-f@oita-u.ac.jp		Fujishima, Hajime/0000-0002-0858-8967	Grants-in-Aid for Scientific Research [15K08405, 15K10106] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adenis A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-413; Ando N, 2012, ANN SURG ONCOL, V19, P68, DOI 10.1245/s10434-011-2049-9; Ando T, 2008, DIS ESOPHAGUS, V21, P15, DOI 10.1111/j.1442-2050.2007.00700.x; Bancewicz J, 2002, LANCET, V359, P1727; Batchu RB, 2014, PHARMACEUTICALS, V7, P46, DOI 10.3390/ph7010046; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Empuku S, 2016, MOL CLIN ONCOL, V4, P733, DOI 10.3892/mco.2016.806; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fumoto S, 2008, INT J ONCOL, V32, P413; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Hara H, 2013, CANCER SCI, V104, P1455, DOI 10.1111/cas.12274; Harpole DH, 2001, CLIN CANCER RES, V7, P562; Hato SV, 2017, ONCOTARGET; Hiyoshi Y, 2017, WORLD J SURG, V41, P480, DOI 10.1007/s00268-016-3649-0; Huang RW, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-170; Japan Esophageal Soc, 2017, ESOPHAGUS-TOKYO, V14, P37, DOI 10.1007/s10388-016-0556-2; Japan Esophageal Soc, 2017, ESOPHAGUS-TOKYO, V14, P1, DOI 10.1007/s10388-016-0551-7; Joshi MBM, 2005, CLIN CANCER RES, V11, P2215; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kitagawa Y, 2015, ASIAN J ENDOSC SURG, V8, P114, DOI 10.1111/ases.12185; Kurtyka CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096357; Kuzuhara T, 2007, J CANCER RES CLIN, V133, P287, DOI 10.1007/s00432-006-0169-6; Li L, 2015, ONCOL REP, V34, P2325, DOI 10.3892/or.2015.4211; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Molena D, 2014, DIS ESOPHAGUS, V27, P355, DOI 10.1111/dote.12126; Mori R, 2008, ONCOL REP, V20, P1345, DOI 10.3892/or_00000150; Nakano J, 2006, BRIT J CANCER, V95, P607, DOI 10.1038/sj.bjc.6603297; Nomura M, 2015, CANCER CHEMOTH PHARM, V76, P357, DOI 10.1007/s00280-015-2806-8; Ojima T, 2016, ANTICANCER RES, V36, P829; Reed MF, 2007, J SURG RES, V142, P364, DOI 10.1016/j.jss.2007.03.038; Romano G, 2016, ONCOTARGET, V7, P22077, DOI 10.18632/oncotarget.7895; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Satoh J, 2007, NEUROSCI LETT, V422, P30, DOI 10.1016/j.neulet.2007.05.056; Satoh J, 2015, J CENT NERV SYST DIS, V7, P1, DOI [10.4137/JCNSNSD.S23210, 10.4137/JCNSD.S23210]; Smit JK, 2013, RADIOTHER ONCOL, V107, P434, DOI 10.1016/j.radonc.2013.03.027; Sohda M, 2014, ANTICANCER RES, V34, P909; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Sun ZF, 2006, CANCER EPIDEM BIOMAR, V15, P2063, DOI 10.1158/1055-9965.EPI-06-0505; Tanaka Y, 2012, ASIAN J ENDOSC SURG, V5, P179, DOI [10.1111/j.1758-5910.2012.00147.x, 10.1111/j.1758-5910.2012.00131.x]; Wang W, 2014, THORAC CANCER, V5, P139, DOI 10.1111/1759-7714.12061; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Watanabe M, 2014, ANN SURG ONCOL, V21, P2838, DOI 10.1245/s10434-014-3684-8; Wendling J, 2003, MOL PHARMACOL, V64, P707, DOI 10.1124/mol.64.3.707; Ychou M, 2011, J CLIN ONCOL, V29, P1715, DOI 10.1200/JCO.2010.33.0597	46	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188098	10.1371/journal.pone.0188098	http://dx.doi.org/10.1371/journal.pone.0188098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136005	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200065
J	Eidsaa, M; Stubbs, L; Almaas, E				Eidsaa, Marius; Stubbs, Lisa; Almaas, Eivind			Comparative analysis of weighted gene co-expression networks in human and mouse	PLOS ONE			English	Article							ORGANIZATION; CONSERVATION; DISCOVERY; PATTERNS; ELEMENTS; ATLAS	The application of complex network modeling to analyze large co-expression data sets has gained traction during the last decade. In particular, the use of the weighted gene co-expression network analysis framework has allowed an unbiased and systems-level investigation of genotype-phenotype relationships in a wide range of systems. Since mouse is an important model organism for biomedical research on human disease, it is of great interest to identify similarities and differences in the functional roles of human and mouse orthologous genes. Here, we develop a novel network comparison approach which we demonstrate by comparing two gene-expression data sets from a large number of human and mouse tissues. The method uses weighted topological overlap alongside the recently developed network-decomposition method of s-core analysis, which is suitable for making genecentrality rankings for weighted networks. The aim is to identify globally central genes separately in the human and mouse networks. By comparing the ranked gene lists, we identify genes that display conserved or diverged centrality-characteristics across the networks. This framework only assumes a single threshold value that is chosen from a statistical analysis, and it may be applied to arbitrary network structures and edge-weight distributions, also outside the context of biology. When conducting the comparative network analysis, both within and across the two species, we find a clear pattern of enrichment of transcription factors, for the homeobox domain in particular, among the globally central genes. We also perform gene-ontology term enrichment analysis and look at disease-related genes for the separate networks as well as the network comparisons. We find that gene ontology terms related to regulation and development are generally enriched across the networks. In particular, the genes FOXE3, RHO, RUNX2, ALX3 and RARA, which are disease genes in either human or mouse, are on the top-10 list of globally central genes in the human and mouse networks.	[Eidsaa, Marius; Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway; [Stubbs, Lisa] Univ Illinois Urbana Champaigne, Cell & Dev Biol, Inst Genom Biol, Neurosci Program, Urbana, IL 61801 USA; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, N-7491 Trondheim, Norway.; Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway.	eivind.almaas@ntnu.no		Stubbs, Lisa/0000-0002-9556-1972; Almaas, Eivind/0000-0002-9125-326X	NTNU Faculty of Natural Sciences and Technology; Research Council of Norway (RCN) [245160]	NTNU Faculty of Natural Sciences and Technology; Research Council of Norway (RCN)(Research Council of Norway)	ME was supported by a strategic research grant from NTNU Faculty of Natural Sciences and Technology. EA would like to thank The Research Council of Norway (RCN) grant 245160 (ERASysAPP: WineSys) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000043; [Anonymous], 2016, ONL MEN INH MAN; [Anonymous], 2017, TOOL DISC VIS ENR GO; Barrenas F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008090; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Dickerson JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027368; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eidsaa M, 2016, PHYSICA A, V449, P111, DOI 10.1016/j.physa.2015.12.115; Eidsaa M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062819; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Holder-Espinasse M, 2007, EUR J HUM GENET, V15, P1115, DOI 10.1038/sj.ejhg.5201888; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kultz D, 2015, J PROT; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Monaco G, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0534-7; Netotea S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-106; Nowick K, 2009, P NATL ACAD SCI USA, V106, P22358, DOI 10.1073/pnas.0911376106; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Saris CGJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-405; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tsaparas P, 2006, BMC EVOLUTIONARY BIO, V6, P1; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Voigt A, INFLUENCE C IN PRESS; Wang SQ, 2016, J CLIN INVEST, V126, P948, DOI 10.1172/JCI83778; Wuchty S, 2005, PROTEOMICS, V5, P444, DOI 10.1002/pmic.200400962; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	49	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187611	10.1371/journal.pone.0187611	http://dx.doi.org/10.1371/journal.pone.0187611			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161290	Green Submitted, gold, Green Published			2022-12-27	WOS:000415987000012
J	Siu, JY; Liu, CH; Zhou, YF				Siu, Jun Yang; Liu, Chenhui; Zhou, Yufeng			High-intensity focused ultrasound ablation around the tubing	PLOS ONE			English	Article							LARGE BLOOD-VESSELS; IN-VITRO; HIFU; SIMULATION; EXPOSURE; THERAPY	High-intensity focused ultrasound (HIFU) has been emerging as an effective and noninvasive modality in cancer treatment with very promising clinical results. However, a small vessel in the focal region could be ruptured, which is an important concern for the safety of HIFU ablation. In this study, lesion formation in the polyacrylamide gel phantom embedded with different tubing (inner diameters of 0.76 mm and 3 mm) at varied flow speeds (17-339 cm/s) by HIFU ablation was photographically recorded. Produced lesions have decreased length (similar to 30%) but slightly increased width (similar to 6%) in comparison to that without the embedded tubing. Meanwhile, bubble activities during the exposures were measured by passive cavitation detection (PCD) at the varied pulse repetition frequency (PRF, 10-30 Hz) and duty cycle (DC, 10%-20%) of the HIFU bursts. High DC and low flow speed were found to produce stronger bubble cavitation whereas no significant influence of the PRF. In addition, high-speed photography illustrated that the rupture of tubing was produced consistently after the first HIFU burst within 20 ms and then multiple bubbles would penetrate into the intraluminal space of tubing through the rupture site by the acoustic radiation force. Alignment of HIFU focus to the anterior surface, middle, and posterior surface of tubing led to different characteristics of vessel rupture and bubble introduction. In summary, HIFU-induced vessel rupture is possible as shown in this phantom study; produced lesion sizes and shapes are dependent on the focus alignment to the tubing, flow speed, and tubing properties; and bubble cavitation and the formation liquid jet may be one of the major mechanisms of tubing rupture as shown in the high-speed photography.	[Siu, Jun Yang; Liu, Chenhui; Zhou, Yufeng] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Zhou, YF (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.	yfzhou@ntu.edu.sg	Zhou, Yufeng/A-1127-2011	Zhou, Yufeng/0000-0003-4086-2150				CHEN H, 2011, PHYS REV LETT, V106; Curra FP, 2000, IEEE T ULTRASON FERR, V47, P1077, DOI 10.1109/58.852092; DORR LN, 1992, INT J HYPERTHER, V8, P45, DOI 10.3109/02656739209052878; HAHL J, 1990, LASER SURG MED, V10, P319, DOI 10.1002/lsm.1900100403; Hariharan P, 2007, PHYS MED BIOL, V52, P3493, DOI 10.1088/0031-9155/52/12/011; Hoerig CL, 2014, J THER ULTRASOUND, V2, DOI 10.1186/2050-5736-2-14; Hynynen K, 1996, ULTRASOUND MED BIOL, V22, P1071, DOI 10.1016/S0301-5629(96)00143-3; Khokhlova TD, 2011, J ACOUST SOC AM, V130, P3498, DOI 10.1121/1.3626152; Lafon C, 2005, ULTRASOUND MED BIOL, V31, P1383, DOI 10.1016/j.ultrasmedbio.2005.06.004; LANG NP, 1991, AM J SURG, V162, P629, DOI 10.1016/0002-9610(91)90124-V; Mahoney K, 2000, ULTRASON, P1405, DOI 10.1109/ULTSYM.2000.921585; MARTINOT VL, 1994, LASER SURG MED, V15, P168, DOI 10.1002/lsm.1900150204; Miller DL, 2006, ULTRASOUND MED BIOL, V32, P1097, DOI 10.1016/j.ultrasmedbio.2006.03.013; Miller MW, 1996, ULTRASOUND MED BIOL, V22, P1131, DOI 10.1016/S0301-5629(96)00089-0; Nandlall SD, 2011, ULTRASOUND MED BIOL, V37, P922, DOI 10.1016/j.ultrasmedbio.2011.02.016; Nyborg WL, 2001, ULTRASOUND MED BIOL, V27, P301, DOI 10.1016/S0301-5629(00)00333-1; Parsons JE, 2006, ULTRASOUND MED BIOL, V32, P115, DOI 10.1016/j.ultrasmedbio.2005.09.005; Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F; Serrone J, 2012, J CLIN NEUROSCI, V19, P214, DOI 10.1016/j.jocn.2011.07.003; Shadwick RE, 1999, J EXP BIOL, V202, P3305; Solovchuk M, 2015, COMMUN COMPUT PHYS, V18, P1050, DOI 10.4208/cicp.171214.200715s; Solovchuk M, 2013, J ACOUST SOC AM, V134, P3931, DOI 10.1121/1.4821201; Solovchuk MA, 2012, INT J HEAT MASS TRAN, V55, P1261, DOI 10.1016/j.ijheatmasstransfer.2011.09.023; Sturtevant B., 1996, SMITHS TXB ENDOUROLO, P529; Tokarczyk A, 2013, PHYS MED BIOL, V58, P2281, DOI 10.1088/0031-9155/58/7/2281; Tortora G.J., 2012, PRINCIPLES ANATOMY P, V13th ed., P610; Wright C, 2012, INVEST RADIOL, V47, P217, DOI 10.1097/RLI.0b013e31823cc75c; Wu F, 2002, ULTRASOUND MED BIOL, V28, P535, DOI 10.1016/S0301-5629(01)00515-4; Yu T, 2014, SCI WORLD J, V2014; Yu TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026110; Zhang L, 2009, EUR RADIOL, V19, P437, DOI 10.1007/s00330-008-1137-0; Zhou YF, 2011, WORLD J CLIN ONCOL, V2, P8, DOI 10.5306/wjco.v2.i1.8; Zhou YF, 2006, J ACOUST SOC AM, V120, P676, DOI 10.1121/1.2214131; Zhou YF, 2016, PHYS MED BIOL, V61, P6651, DOI 10.1088/0031-9155/61/18/6651	34	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188206	10.1371/journal.pone.0188206	http://dx.doi.org/10.1371/journal.pone.0188206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161293	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000036
J	Kyeong, S; Cha, YJ; Ahn, SG; Suh, SH; Son, EJ; Ahn, SJ				Kyeong, Sunghyon; Cha, Yoon Jin; Ahn, Sung Gwe; Suh, Sang Hyun; Son, Eun Ju; Ahn, Sung Jun			Subtypes of breast cancer show different spatial distributions of brain metastases	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; NERVOUS-SYSTEM METASTASES; LUNG-CANCER; PROGNOSTIC-FACTORS; VASCULAR-RESPONSE; SURVIVAL; TRASTUZUMAB; SINGLE; WOMEN; RISK	The aim of our study was to test the hypothesis that the spatial distribution of breast cancer brain metastases (BM) differ according to their biological subtypes. MR images of 100 patients with BM from primary breast cancer were retrospectively reviewed. Patients were divided according to the biological subtype of the primary tumor, (triple-negative: 24, HER2 positive: 48, luminal: 28). All images marked with BMs were standardized to the human brain MRI atlas provided by the Montreal Neurological Institute 152 database. Distribution pattern of BM was evaluated with intra-group and intergroup analysis. In intra-group analysis, hot spots of metastases from triple-negative are evenly distributed in the brain, meanwhile BMs from HER2 positive and luminal type occur dominantly in occipital lobe and cerebellum. In intergroup analysis, BMs from triple-negative type occurred more often in frontal lobe, limbic region, and parietal lobe, compared with other types (P <.05). Breast cancer subtypes tend to demonstrate different spatial distributions of their BMs. These findings may have direct implications for dose modulation in prophylactic irradiation as well as for differential diagnoses. Thus, this result should be validated in future study with a larger population.	[Kyeong, Sunghyon] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Cha, Yoon Jin] Yonsei Univ, Dept Pathol, Gangnam Severance Hosp, Seoul, South Korea; [Ahn, Sung Gwe] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; [Suh, Sang Hyun; Son, Eun Ju; Ahn, Sung Jun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ahn, SJ (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	aahng77@yuhs.ac	Suh, Sang Hyun/M-5515-2015	Suh, Sang Hyun/0000-0002-7098-4901; Ahn, Sung Jun/0000-0003-0075-2432; Kyeong, Sunghyon/0000-0002-9095-5219; Son, Eun Ju/0000-0002-7895-0335	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1C1B5014927]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No.2017R1C1B5014927). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendell JC, 2003, CANCER-AM CANCER SOC, V97, P2972, DOI 10.1002/cncr.11436; Bender ET, 2011, BRIT J RADIOL, V84, P649, DOI 10.1259/bjr/30173406; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Dawood S, 2009, ANN ONCOL, V20, P621, DOI 10.1093/annonc/mdn682; DELATTRE JY, 1988, ARCH NEUROL-CHICAGO, V45, P741, DOI 10.1001/archneur.1988.00520310047016; Elkholy, 2008, J CLIN ONCOL, V26; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gabos Z, 2006, J CLIN ONCOL, V24, P5658, DOI 10.1200/JCO.2006.07.0250; Gandhi AK, 2015, INDIAN J MED PAEDIAT, V36, P77, DOI 10.4103/0971-5851.158822; Gil-Gil MJ, 2014, CLIN TRANSL ONCOL, V16, P436, DOI 10.1007/s12094-013-1110-5; Gori S, 2007, ONCOLOGIST, V12, P766, DOI 10.1634/theoncologist.12-7-766; Hendrikse J, 2004, STROKE, V35, P882, DOI 10.1161/01.STR.0000120312.26163.EC; Hengel K, 2013, INT J CLIN ONCOL, V18, P396, DOI 10.1007/s10147-012-0392-x; Ito H, 2000, J CEREBR BLOOD F MET, V20, P1264, DOI 10.1097/00004647-200008000-00011; Lee SS, 2008, BREAST CANCER RES TR, V111, P523, DOI 10.1007/s10549-007-9806-2; Li N, 2015, ANN ONCOL, V26, P504, DOI 10.1093/annonc/mdu567; Lin NU, 2004, J CLIN ONCOL, V22, P3608, DOI 10.1200/JCO.2004.01.175; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagao E, 2011, AM J NEURORADIOL, V32, P664, DOI 10.3174/ajnr.A2343; Nam BH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1870; Niikura N, 2014, BREAST CANCER RES TR, V147, P103, DOI 10.1007/s10549-014-3090-8; Niwinska A, 2011, EJSO-EUR J SURG ONC, V37, P635, DOI 10.1016/j.ejso.2011.05.002; Niwinska A, 2010, ANN ONCOL, V21, P942, DOI 10.1093/annonc/mdp407; Quattrocchi CC, 2012, J NEURO-ONCOL, V110, P79, DOI 10.1007/s11060-012-0937-x; Ribatti D, 2006, CLIN EXP MED, V6, P145, DOI 10.1007/s10238-006-0117-4; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Sperduto PW, 2013, J NEURO-ONCOL, V112, P467, DOI 10.1007/s11060-013-1083-9; Takano K, 2016, NEURO-ONCOLOGY, V18, P716, DOI 10.1093/neuonc/nov266; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; TSUKADA Y, 1983, CANCER-AM CANCER SOC, V52, P2349, DOI 10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Laar PJ, 2006, NEUROIMAGE, V29, P136, DOI 10.1016/j.neuroimage.2005.07.011; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7	37	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188542	10.1371/journal.pone.0188542	http://dx.doi.org/10.1371/journal.pone.0188542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155879	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700063
J	Pillai, VV; Weber, DM; Phinney, BS; Selvaraj, V				Pillai, Viju Vijayan; Weber, Darren M.; Phinney, Brett S.; Selvaraj, Vimal			Profiling of proteins secreted in the bovine oviduct reveals diverse functions of this luminal microenvironment	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; APOLIPOPROTEIN-A-I; EARLY EMBRYO DEVELOPMENT; SPERM-EGG BINDING; GENE-EXPRESSION; GROWTH-FACTOR; FLUID PROTEINS; RABBIT OVIDUCT; MESSENGER-RNA; VITRO FERTILIZATION	The oviductal microenvironment is a site for key events that involve gamete maturation, fertilization and early embryo development. Secretions into the oviductal lumen by either the lining epithelium or by transudation of plasma constituents are known to contain elements conducive for reproductive success. Although previous studies have identified some of these factors involved in reproduction, knowledge of secreted proteins in the oviductal fluid remains rudimentary with limited definition of function even in extensively studied species like cattle. In this study, we used a shotgun proteomics approach followed by bioinformatics sequence prediction to identify secreted proteins present in the bovine oviductal fluid ( ex vivo) and secretions from the bovine oviductal epithelial cells (in vitro). From a total of 2087 proteins identified, 266 proteins could be classified as secreted, 109 (41%) of which were common for both in vivo and in vitro conditions. Pathway analysis indicated different classes of proteins that included growth factors, metabolic regulators, immune modulators, enzymes, and extracellular matrix components. Functional analysis revealed mechanisms in the oviductal lumen linked to immune homeostasis, gamete maturation, fertilization and early embryo development. These results point to several novel components that work together with known elements mediating functional homeostasis, and highlight the diversity of machinery associated with oviductal physiology and early events in cattle fertility.	[Pillai, Viju Vijayan; Selvaraj, Vimal] Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA; [Weber, Darren M.; Phinney, Brett S.] Univ Calif Davis, Genome Ctr, Prote Core Facil, Davis, CA 95616 USA	Cornell University; University of California System; University of California Davis	Selvaraj, V (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Anim Sci, Ithaca, NY 14853 USA.	vs88@cornell.edu	Selvaraj, Vimal/AAC-2853-2022; Pillai, Viju/L-7557-2019; Phinney, Brett/S-6404-2016	Pillai, Viju/0000-0002-2696-0451; Phinney, Brett/0000-0003-3870-3302	USDA-NIFA [2013-00986]; USDA Multi State [NE1227 NYC-127806]	USDA-NIFA(United States Department of Agriculture (USDA)); USDA Multi State	This study was supported by grants USDA-NIFA 2013-00986 to Vimal Selvaraj and USDA Multi State NE1227 NYC-127806 to Vimal Selvaraj. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1995, MOL REPROD DEV, V42, P226, DOI 10.1002/mrd.1080420212; Aguilar J., 2005, Animal Reproduction, V2, P91; AKERLOF E, 1991, BIOCHEMISTRY-US, V30, P8986; Al Darwich A, 2010, PROSTAG OTH LIPID M, V93, P30, DOI 10.1016/j.prostaglandins.2010.06.002; Al-Dossary AA, 2015, J BIOL CHEM, V290, P17710, DOI 10.1074/jbc.M114.633156; Al-Dossary AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080181; Aleporou-Marinou V, 2001, COMP BIOCHEM PHYS B, V128, P537, DOI 10.1016/S1096-4959(00)00359-6; ANDERSON DJ, 1993, P NATL ACAD SCI USA, V90, P10051, DOI 10.1073/pnas.90.21.10051; Argraves WS, 2004, MOL REPROD DEV, V69, P419, DOI 10.1002/mrd.20174; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; Barrera AD, 2017, REPRODUCTION, V154, P1, DOI 10.1530/REP-16-0651; Bauersachs S, 2007, J DAIRY SCI, V90, P4420, DOI 10.3168/jds.2007-0132; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BOICE ML, 1990, BIOL REPROD, V43, P457, DOI 10.1095/biolreprod43.3.457; CARLSON D, 1970, J REPROD FERTIL, V22, P549, DOI 10.1530/jrf.0.0220549; Carrasco LC, 2008, REPROD FERT DEVELOP, V20, P808, DOI 10.1071/RD08113; Cebrian-Serrano A, 2013, REPROD DOMEST ANIM, V48, P331, DOI 10.1111/j.1439-0531.2012.02157.x; Chen S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42298; Cordova A, 2014, THERIOGENOLOGY, V81, P1163, DOI 10.1016/j.theriogenology.2014.01.012; Coy P, 2012, HUM REPROD, V27, P1985, DOI 10.1093/humrep/des146; D'Souza SS, 2007, BIOL REPROD, V77, P433, DOI 10.1095/biolreprod.107.061317; de Almeida PG, 2016, DEV DYNAM, V245, P520, DOI 10.1002/dvdy.24391; deMoraes AAS, 1997, BIOL REPROD, V57, P1060, DOI 10.1095/biolreprod57.5.1060; DESOUZA MM, 1995, ENDOCRINOLOGY, V136, P2485, DOI 10.1210/en.136.6.2485; Diaz MJ, 2000, MOL REPROD DEV, V55, P47, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;47::AID-MRD7&gt;3.0.CO;2-J; Dietzel E, 2013, DEV CELL, V25, P106, DOI 10.1016/j.devcel.2013.03.001; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; Eliyahu E, 2007, FASEB J, V21, P1403, DOI 10.1096/fj.06-7016com; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EYESTONE WH, 1989, J REPROD FERTIL, V85, P715, DOI 10.1530/jrf.0.0850715; FRY RC, 1992, BIOL REPROD, V46, P470, DOI 10.1095/biolreprod46.3.470; Gabler C, 2003, REPRODUCTION, V126, P721, DOI 10.1530/rep.0.1260721; Gabler C, 1996, ARCH TIERZUCHT, V39, P29; Gabler C, 2001, REPRODUCTION, V122, P121, DOI 10.1530/rep.0.1220121; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Garcia EV, 2017, REPRODUCTION, V153, P631, DOI 10.1530/REP-16-0654; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; Georgiou AS, 2005, MOL CELL PROTEOMICS, V4, P1785, DOI 10.1074/mcp.M500119-MCP200; GERENA RL, 1990, J EXP ZOOL, V256, P113, DOI 10.1002/jez.1402560114; Goncalves RF, 2007, THERIOGENOLOGY, V67, P468, DOI 10.1016/j.theriogenology.2006.08.013; Goncalves RF, 2008, REPROD DOMEST ANIM, V43, P720, DOI 10.1111/j.1439-0531.2007.00978.x; Gonella-Diaza AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145321; Guo ZH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170808; Hao YH, 2008, MOL REPROD DEV, V75, P291, DOI 10.1002/mrd.20794; Hao YH, 2006, BIOL REPROD, V75, P726, DOI 10.1095/biolreprod.106.052589; Hawksworth OA, 2014, STEM CELLS, V32, P3278, DOI 10.1002/stem.1801; Ibrahim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119388; JAFFE RC, 1989, MOL ENDOCRINOL, V3, P1807, DOI 10.1210/mend-3-11-1807; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kan FWK, 2006, MOL REPROD DEV, V73, P756, DOI 10.1002/mrd.20459; Kawakami E, 2004, J VET MED SCI, V66, P1027, DOI 10.1292/jvms.66.1027; KILLIAN GJ, 1989, J REPROD FERTIL, V86, P419, DOI 10.1530/jrf.0.0860419; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamy J, 2016, REPRODUCTION, V152, P629, DOI 10.1530/REP-16-0397; LARSON RC, 1992, J REPROD FERTIL, V96, P289, DOI 10.1530/jrf.0.0960289; LARSON RC, 1992, MOL REPROD DEV, V33, P432, DOI 10.1002/mrd.1080330409; LARSON RC, 1992, DEVELOPMENT, V115, P821; Lavery K, 2004, ANIM REPROD SCI, V84, P13, DOI 10.1016/j.anireprosci.2003.12.010; Lee KF, 2005, J CELL BIOCHEM, V95, P740, DOI 10.1002/jcb.20444; Lee YL, 2004, J BIOL CHEM, V279, P12763, DOI 10.1074/jbc.M311160200; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Libreros S, 2013, IMMUNOL RES, V57, P99, DOI 10.1007/s12026-013-8459-y; Liu Jiangang, 2014, Evid Based Complement Alternat Med, V2014, P141938, DOI 10.1155/2014/141938; Liu Q, 2015, ZYGOTE, V23, P622, DOI 10.1017/S0967199414000483; Lloyd RE, 2009, REPRODUCTION, V137, P679, DOI 10.1530/REP-08-0405; LU R-Z, 1992, Journal of Reproduction and Development, V38, P79, DOI 10.1262/jrd.38.79; Luo HL, 2002, J VET MED SCI, V64, P967, DOI 10.1292/jvms.64.967; Maillo V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.127969; MANJUNATH P, 1989, J BIOL CHEM, V264, P16853; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; Martinez-Leon E, 2015, HUM REPROD, V30, P2138, DOI 10.1093/humrep/dev154; Martus NS, 1998, J REPROD FERTIL, V113, P323, DOI 10.1530/jrf.0.1130323; MCLAUGHLIN KC, 1975, BIOL REPROD, V12, P556, DOI 10.1095/biolreprod12.5.556; Memili E, 2000, ZYGOTE, V8, P87, DOI 10.1017/S0967199400000861; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mo XH, 2014, MOL REPROD DEV, V81, P608, DOI 10.1002/mrd.22327; Mugnier S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-129; Nahar A, 2016, REPROD FERT DEVELOP; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; OLDS D, 1957, FERTIL STERIL, V8, P345; OLIPHANT G, 1978, BIOL REPROD, V18, P516, DOI 10.1095/biolreprod18.3.516; Palter SF, 2001, J CLIN ENDOCR METAB, V86, P2660, DOI 10.1210/jc.86.6.2660; PANRUCKER DE, 1983, AM J PHYSIOL, V245, pE138, DOI 10.1152/ajpendo.1983.245.2.E138; Pedersen ME, 2005, REPROD FERT DEVELOP, V17, P751, DOI 10.1071/RD05048; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PROVOST PR, 1995, MOL CELL ENDOCRINOL, V109, P225, DOI 10.1016/0303-7207(95)03506-3; Ptak G, 2006, THERIOGENOLOGY, V65, P1891, DOI 10.1016/j.theriogenology.2005.10.018; Qu F, 2007, REPRODUCTION, V134, P569, DOI 10.1530/REP-07-0145; Reinhart KC, 1998, MOL HUM REPROD, V4, P301, DOI 10.1093/molehr/4.3.301; Rief S, 2002, REPRODUCTION, V124, P543, DOI 10.1530/rep.0.1240543; RIEGER D, 1995, J REPROD FERTIL, V105, P91, DOI 10.1530/jrf.0.1050091; ROBERTS GP, 1976, J REPROD FERTIL, V48, P99; ROBERTS GP, 1975, J REPROD FERTIL, V45, P301, DOI 10.1530/jrf.0.0450301; Rodriguez C, 1998, ANIM REPROD SCI, V54, P1, DOI 10.1016/S0378-4320(98)00139-0; Roldan-Olarte M, 2005, ZYGOTE, V13, P115, DOI 10.1017/S0967199405003175; Roy M, 2008, THERIOGENOLOGY, V70, P836, DOI 10.1016/j.theriogenology.2008.05.042; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Srivastava MD, 1999, AM J REPROD IMMUNOL, V42, P347; STAMBAUGH R, 1974, FERTIL STERIL, V25, P352, DOI 10.1016/S0015-0282(16)40335-3; STANKE DF, 1974, J REPROD FERTIL, V38, P493, DOI 10.1530/jrf.0.0380493; Staros AL, 1998, J REPROD FERTIL, V112, P131, DOI 10.1530/jrf.0.1120131; STONE SL, 1975, GYNECOL OBSTET INVES, V6, P234, DOI 10.1159/000301520; SUAREZ SS, 1982, BIOL REPROD, V27, P473, DOI 10.1095/biolreprod27.2.473; TAYLOR CT, 1994, HUM REPROD, V9, P907, DOI 10.1093/oxfordjournals.humrep.a138615; Therien I, 1997, BIOL REPROD, V57, P1080, DOI 10.1095/biolreprod57.5.1080; Thimon V, 2006, REPRODUCTION, V132, P899, DOI 10.1530/REP-06-0077; Tse PK, 2008, ENDOCRINOLOGY, V149, P1268, DOI 10.1210/en.2007-1277; Tutuncu L, 2004, DEV BIOL, V270, P246, DOI 10.1016/j.ydbio.2004.02.008; VITAIOLI L, 1985, HISTOCHEM J, V17, P883, DOI 10.1007/BF01004183; VITAIOLI L, 1984, ACTA HISTOCHEM, V75, P141, DOI 10.1016/S0065-1281(84)80050-1; Wandernoth PM, 2015, J BIOL CHEM, V290, P29202, DOI 10.1074/jbc.M115.698597; Wandernoth PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015061; Wijayagunawardane MPB, 2003, BIOL REPROD, V69, P1341, DOI 10.1095/biolreprod.103.017327; Winger QA, 1997, BIOL REPROD, V56, P1415, DOI 10.1095/biolreprod56.6.1415; YOUNIS AI, 1989, GAMETE RES, V23, P189, DOI 10.1002/mrd.1120230206; Zampini R, 2014, REPROD DOMEST ANIM, V49, P492, DOI 10.1111/rda.12317; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181; Zhang K, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130278; Zumoffen CM, 2013, HUM REPROD, V28, P1297, DOI 10.1093/humrep/det016	122	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188105	10.1371/journal.pone.0188105	http://dx.doi.org/10.1371/journal.pone.0188105			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155854	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700030
J	Coroller, TP; Bi, WL; Huynh, E; Abedalthagafi, M; Aizer, AA; Greenwald, NF; Parmar, C; Narayan, V; Wu, WW; de Moura, SM; Gupta, S; Beroukhim, R; Wen, PY; Al-Mefty, O; Dunn, IF; Santagata, S; Alexander, BM; Huang, RY; Aerts, HJWL				Coroller, Thibaud P.; Bi, Wenya Linda; Huynh, Elizabeth; Abedalthagafi, Malak; Aizer, Ayal A.; Greenwald, Noah F.; Parmar, Chintan; Narayan, Vivek; Wu, Winona W.; de Moura, Samuel Miranda; Gupta, Saksham; Beroukhim, Rameen; Wen, Patrick Y.; Al-Mefty, Ossama; Dunn, Ian F.; Santagata, Sandro; Alexander, Brian M.; Huang, Raymond Y.; Aerts, Hugo J. W. L.			Radiographic prediction of meningioma grade by semantic and radiomic features	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; DIFFUSION; REPRODUCIBILITY; HETEROGENEITY; ASSOCIATION; TUMORS	Objectives The clinical management of meningioma is guided by tumor grade and biological behavior. Currently, the assessment of tumor grade follows surgical resection and histopathologic review. Reliable techniques for pre-operative determination of tumor grade may enhance clinical decision-making. Methods A total of 175 meningioma patients (103 low-grade and 72 high-grade) with pre-operative contrast-enhanced T1-MRI were included. Fifteen radiomic (quantitative) and 10 semantic (qualitative) features were applied to quantify the imaging phenotype. Area under the curve (AUC) and odd ratios (OR) were computed with multiple-hypothesis correction. Random-forest classifiers were developed and validated on an independent dataset (n = 44). Results Twelve radiographic features (eight radiomic and four semantic) were significantly associated with meningioma grade. High-grade tumors exhibited necrosis/hemorrhage (ORsem = 6.6, AUC(rad) = 0.62 +/- 0.68), intratumoral heterogeneity (ORsem = 7.9, AUC(rad) = 0.65), non-spherical shape (AUC(rad) = 0.61), and larger volumes (AUC(rad) = 0.69) compared to lowgrade tumors. Radiomic and sematic classifiers could significantly predict meningioma grade (AUC(sem) = 0.76 and AUC(rad) = 0.78). Furthermore, combining them increased the classification power (AUC(radio) = 0.86). Clinical variables alone did not effectively predict tumor grade (AUC(clin) = 0.65) or show complementary value with imaging data (AUC(comb) = 0.84). Conclusions We found a strong association between imaging features of meningioma and histopathologic grade, with ready application to clinical management. Combining qualitative and quantitative radiographic features significantly improved classification	[Coroller, Thibaud P.; Huynh, Elizabeth; Aizer, Ayal A.; Parmar, Chintan; Narayan, Vivek; Alexander, Brian M.; Aerts, Hugo J. W. L.] Harvard Med Sch, Dana Farber Canc Inst, Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA USA; [Bi, Wenya Linda; Greenwald, Noah F.; Wu, Winona W.; de Moura, Samuel Miranda; Gupta, Saksham; Al-Mefty, Ossama; Dunn, Ian F.] Harvard Med Sch, Dept Neurosurg, Brigham & Womens Hosp, Boston, MA USA; [Bi, Wenya Linda; Beroukhim, Rameen] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Abedalthagafi, Malak; Santagata, Sandro] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Abedalthagafi, Malak] King Fahad Med City, King Abdulaziz City Sci & Technol & Res Ctr, Saudi Human Genome Project, Riyadh, Saudi Arabia; [Beroukhim, Rameen; Wen, Patrick Y.] Dana Farber Canc Inst, Dept Neurooncol, Boston, MA 02115 USA; [Huang, Raymond Y.; Aerts, Hugo J. W. L.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; King Fahad Medical City; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Huang, RY (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.	tcoroller@lroc.harvard.edu; ryhuang@bwh.harvard.edu	Greenwald, Noah/GNH-3982-2022; parmar, chintan/J-2977-2019; Wen, Patrick/AAE-3776-2022; Abedalthagafi, Malak/Q-7434-2019; Aerts, Hugo/ABF-2821-2020	Greenwald, Noah/0000-0002-7836-4379; parmar, chintan/0000-0002-2140-814X; Aerts, Hugo/0000-0002-2122-2003; Santagata, Sandro/0000-0002-7528-9668; Abedalthagafi, Malak/0000-0003-1786-3366; Coroller, Thibaud/0000-0001-7662-8724; Huang, Raymond/0000-0001-7661-797X	National Institute of Health [NIH-USA U24CA194354, NIH-USA U01CA190234]; Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; King Abdulaziz City for Science and Technology grant	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kaye Scholar Award; Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant; King Abdulaziz City for Science and Technology grant	Authors acknowledge financial support from the National Institute of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234). This project was partially funded by the Kaye Scholar Award, the Brigham and Women's Hospital Department of Radiation Oncology Clinical Translational Grant, and King Abdulaziz City for Science and Technology grant (MA).	Abedalthagafi MS, 2014, LAB INVEST, p433A; Aerts HJWL, 2016, JAMA ONCOL; Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Antunes J, 2016, TRANSL ONCOL, V9, P155, DOI 10.1016/j.tranon.2016.01.008; Backer-Grondahl T, 2012, INT J CLIN EXP PATHO, V5, P231; Balagurunathan Y, 2014, TRANSL ONCOL, V7, P72, DOI 10.1593/tlo.13844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bi WL, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00040; Bi WL, 2016, J NEUROSURG, V125, P525, DOI 10.3171/2015.6.JNS15591; Bi WL, 2016, IMMUNOTHERAPY-UK, V8, P721, DOI 10.2217/imt-2016-0017; Bondy M, 1996, J NEURO-ONCOL, V29, P197, DOI 10.1007/BF00165649; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUETOW MP, 1991, RADIOGRAPHICS, V11, P1087, DOI 10.1148/radiographics.11.6.1749851; Chernov MF, 2011, CLIN NEUROL NEUROSUR, V113, P202, DOI 10.1016/j.clineuro.2010.11.008; Coroller TP, 2017, J THORAC ONCOL, V12, P467, DOI 10.1016/j.jtho.2016.11.2226; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Coroller TP, 2016, RADIOTHER ONCOL; Desseroit M-C, 2016, J NUCL MED OFF PUBL; Desseroit MC, 2016, EUR J NUCL MED MOL I, V43, P1477, DOI 10.1007/s00259-016-3325-5; Dolnicar S, 2007, J RETAIL CONSUM SERV, V14, P108, DOI 10.1016/j.jretconser.2006.09.006; Fried DV, 2014, INT J RAD ONCOL; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gillies RJ, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.2015151169; Gimenez Francisco, 2012, AMIA Annu Symp Proc, V2012, P257; Hakyemez B, 2006, NEURORADIOLOGY, V48, P513, DOI 10.1007/s00234-006-0094-z; Hassan I, 2016, SCI REP-UK, V6, DOI 10.1038/srep25295; Hatt M, 2016, J NUCL MED; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Huynh E, 2016, RADIOTHER ONCOL; Huynh E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169172; Ingrisch M, 2017, INVEST RADIOL; Kickingereder P, 2016, CLIN CANCER RES, V22, P5765, DOI 10.1158/1078-0432.CCR-16-0702; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2016, BRIT J RADIOL; Lee HJ, 2013, RADIOLOGY, V268, P254, DOI 10.1148/radiol.13112553; Leijenaar RTH, 2015, ACTA ONCOL, V54, P1423, DOI 10.3109/0284186X.2015.1061214; Liu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118908; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nakasu S, 1999, J NEUROSURG, V90, P455, DOI 10.3171/jns.1999.90.3.0455; PARMAR C, 2015, SCI REP UK, V5; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pavlisa G, 2008, CLIN IMAG, V32, P22, DOI 10.1016/j.clinimag.2007.07.007; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Piper RJ, 2016, MAGN RESON IMAGING, V34, P596, DOI 10.1016/j.mri.2015.12.006; R Development Core Team, 2009, R LANG ENV STAT COMP; ROHRINGER M, 1989, J NEUROSURG, V71, P665, DOI 10.3171/jns.1989.71.5.0665; Sachdeva J, 2012, INT J NUMER METH BIO, V28, P1107, DOI 10.1002/cnm.2481; Santelli L, 2010, ACTA NEUROCHIR, V152, P1315, DOI 10.1007/s00701-010-0657-y; Sanverdi SE, 2012, EUR J RADIOL, V81, P2389, DOI 10.1016/j.ejrad.2011.06.031; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; SERVO A, 1990, NEURORADIOLOGY, V32, P94, DOI 10.1007/BF00588556; Surov A, 2016, WORLD NEUROSURG, V88, P598, DOI 10.1016/j.wneu.2015.10.049; Surov A, 2015, TRANSL ONCOL, V8, P517, DOI 10.1016/j.tranon.2015.11.012; Tang Y, 2014, AM J ROENTGENOL, V202, P1303, DOI 10.2214/AJR.13.11637; van den Burg EL, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00190; Wang H, 2015, CLIN LUNG CANCER, V16, pE141, DOI 10.1016/j.cllc.2015.05.007; Yanagawa M, 2010, LUNG CANCER, V70, P286, DOI 10.1016/j.lungcan.2010.03.009; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	61	67	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187908	10.1371/journal.pone.0187908	http://dx.doi.org/10.1371/journal.pone.0187908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145421	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800037
J	Graf, M; Riedel, T				Graf, Michael; Riedel, Thomas			Electrical impedance tomography: Amplitudes of cardiac related impedance changes in the lung are highly position dependent	PLOS ONE			English	Article							PULMONARY PERFUSION; EIT; RECONSTRUCTION; VENTILATION; POSTURE; VOLUME	Background Electrical impedance tomography (EIT) is used on the thorax to measure impedance changes due to the presence of air and blood in the lung. This experimental study was performed to investigate the effect of posture on cardiac and respiratory related impedance changes. Methods EIT measurements were performed on 14 healthy subjects in left-, right lateral, prone, supine and upright positions. Simultaneously, tidal volume was recorded with an ultrasonic flowmeter. For image reconstruction, the classic Sheffield back-projection and three variants of the modern GREIT algorithm were applied with two different reference frames. Amplitudes of cardiac-and respiratory impedance changes were extracted and compared between the positions. Results We found significant differences in both cardiac and respiratory amplitudes between postures. Especially, supine and upright positions showed dramatic changes in amplitude. These differences between postures were unaffected by the change of reference frames in all reconstruction methods except of the classic Sheffield back projection. Possible sources that explain the observed posture dependency are discussed. Conclusion Researchers and clinicians need to be aware of this phenomenon when comparing EIT amplitudes in different body positions.	[Graf, Michael; Riedel, Thomas] Univ Childrens Hosp, Inselspital, Dept Paediat, Div Paediat Pulmonol, Bern, Switzerland; [Graf, Michael; Riedel, Thomas] Univ Bern, Bern, Switzerland; [Graf, Michael] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lab Nanoscale Biol, Lausanne, Switzerland; [Riedel, Thomas] Cantonal Hosp Graubuenden, Dept Paediat, Chur, Switzerland	University of Bern; University Hospital of Bern; University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Riedel, T (corresponding author), Univ Childrens Hosp, Inselspital, Dept Paediat, Div Paediat Pulmonol, Bern, Switzerland.; Riedel, T (corresponding author), Univ Bern, Bern, Switzerland.; Riedel, T (corresponding author), Cantonal Hosp Graubuenden, Dept Paediat, Chur, Switzerland.	thomas.riedel@ksgr.ch		Graf, Michael/0000-0001-6201-7471; Riedel, Thomas/0000-0002-7153-5251				Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; BARBER DC, 1984, J PHYS E SCI INSTRUM, V17, P723, DOI 10.1088/0022-3735/17/9/002; BROWN BH, 1994, IEEE T BIO-MED ENG, V41, P729, DOI 10.1109/10.310088; Conover W.J., 1999, PRACTICAL NONPARAMET, V350; Dunlop S, 2006, PHYSIOL MEAS, V27, P1151, DOI 10.1088/0967-3334/27/11/008; Ericsson E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155913; EYUBOGLU BM, 1989, IEEE ENG MED BIOL, V8, P39, DOI 10.1109/51.32404; Fagerberg A, 2009, ACTA ANAESTH SCAND, V53, P152, DOI 10.1111/j.1399-6576.2008.01847.x; Frerichs I, 2000, PHYSIOL MEAS, V21, pR1, DOI 10.1088/0967-3334/21/2/201; Frerichs I, 2009, RESPIRATION, V77, P282, DOI 10.1159/000193994; Grant CA, 2011, CRIT CARE, V15, DOI 10.1186/cc9985; Grychtol B, 2014, PHYSIOL MEAS, V35, P1035, DOI 10.1088/0967-3334/35/6/1035; Grychtol B, 2013, PHYSIOL MEAS, V34, P579, DOI 10.1088/0967-3334/34/6/579; Grychtol B, 2012, IEEE T MED IMAGING, V31, P1754, DOI 10.1109/TMI.2012.2200904; Hahn G, 1996, PHYSIOL MEAS, V17, pA159, DOI 10.1088/0967-3334/17/4A/020; Hall J. E., 2015, TXB MED PHYSL; Harris N D, 1987, Clin Phys Physiol Meas, V8 Suppl A, P155, DOI 10.1088/0143-0815/8/4A/020; Kosuda S, 2000, EUR J NUCL MED, V27, P529, DOI 10.1007/s002590050539; Leonhardt S, 2012, IEEE ENG MED BIO, P122, DOI 10.1109/EMBC.2012.6345886; Oppenheim A. V., 2010, DISCRETE TIME SIGNAL; Riedel T, 2005, INTENS CARE MED, V31, P1522, DOI 10.1007/s00134-005-2734-x; Schnidrig S, 2013, EUR J APPL PHYSIOL, V113, P591, DOI 10.1007/s00421-012-2469-7; Smit HJ, 2004, EUR J APPL PHYSIOL, V92, P45, DOI 10.1007/s00421-004-1043-3; Soille P, 2004, MORPHOLOGICAL IMAGE, DOI 10.1007/978-3-662-05088-0; WANG Y, 1960, J CLIN INVEST, V39, P1051, DOI 10.1172/JCI104120; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269; Zhao ZQ, 2014, PHYSIOL MEAS, V35, P1083, DOI 10.1088/0967-3334/35/6/1083	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188313	10.1371/journal.pone.0188313	http://dx.doi.org/10.1371/journal.pone.0188313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145478	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800109
J	Haralambieva, IH; Gibson, MJ; Kennedy, RB; Ovsyannikova, IG; Warner, ND; Grill, DE; Poland, GA				Haralambieva, Iana H.; Gibson, Michael J.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Warner, Nathaniel D.; Grill, Diane E.; Poland, Gregory A.			Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CONGENITAL-RUBELLA; HEMAGGLUTINATION INHIBITION; INTERNATIONAL UNITS; VIRUS ANTIBODIES; RESPONSES; INFECTION; MEASLES; IMMUNOASSAYS; PROTECTION	Introduction//Background The lack of standardization of the currently used commercial anti-rubella IgG antibody assays leads to frequent misinterpretation of results for samples with low/equivocal antibody concentration. The use of alternative approaches in rubella serology could add new information leading to a fuller understanding of rubella protective immunity and neutralizing antibody response after vaccination. Methods We applied microarray technology to measure antibodies to all rubella virus proteins in 75 high and 75 low rubella virus-specific antibody responders after two MMR vaccine doses. These data were used in multivariate penalized logistic regression modeling of rubella-specific neutralizing antibody response after vaccination. Results We measured antibodies to all rubella virus structural proteins (i.e., the glycoproteins E1 and E2 and the capsid C protein) and to the non-structural protein P150. Antibody levels to each of these proteins were: correlated with the neutralizing antibody titer (p<0.006); demonstrated differences between the high and the low antibody responder groups (p<0.008); and were components of the model associated with/predictive of vaccine-induced rubella virus-specific neutralizing antibody titers (misclassification error = 0.2). Conclusion Our study supports the use of this new technology, as well as the use of antibody profiles/ patterns (rather than single antibody measures) as biomarkers of neutralizing antibody response and correlates of protective immunity in rubella virus serology.	[Haralambieva, Iana H.; Gibson, Michael J.; Kennedy, Richard B.; Ovsyannikova, Inna G.; Poland, Gregory A.] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Warner, Nathaniel D.; Grill, Diane E.] Mayo Clin & Mayo Fdn, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	Poland.gregory@mayo.edu		Poland, Gregory/0000-0001-5057-4457; Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [R37AI048793, R01AI033144, R37AI048793-11]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI033144, R01AI048793] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R37AI048793 and R01AI033144 (GAP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Mayo Clinic Vaccine Research Group staff and the study participants. We thank Caroline L. Vitse for her editorial assistance with the manuscript. This work was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Numbers R37AI048793-11 and R01AI033144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P226; Bouthry E, 2016, J CLIN MICROBIOL, V54, P1720, DOI 10.1128/JCM.00383-16; Brier G.W., 1950, MON WEATHER REV, V78, P1, DOI [10.1175/1520-0493(1950)0782.0.CO,2, DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2, 10.1175/1520-0493(1950)0782.0.CO;2]; Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006; Cordoba P, 2000, CLIN DIAGN LAB IMMUN, V7, P964, DOI 10.1128/CDLI.7.6.964-966.2000; CUSI MG, 1988, ARCH VIROL, V101, P25, DOI 10.1007/BF01314649; CUSI MG, 1989, ARCH VIROL, V106, P63, DOI 10.1007/BF01311038; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Dhiman N, 2010, CYTOKINE, V50, P24, DOI 10.1016/j.cyto.2009.12.002; DIMECH W, 1992, J CLIN MICROBIOL, V30, P633, DOI 10.1128/JCM.30.3.633-641.1992; Dimech W, 2008, J CLIN MICROBIOL, V46, P1955, DOI 10.1128/JCM.00231-08; Dimech W, 2016, VACCINE, V34, P4119, DOI 10.1016/j.vaccine.2016.06.006; Dimech W, 2016, CLIN MICROBIOL REV, V29, P163, DOI 10.1128/CMR.00045-15; Dimech W, 2013, CLIN VACCINE IMMUNOL, V20, P255, DOI 10.1128/CVI.00603-12; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Haralambieva IH, 2015, VIRUSES-BASEL, V7, P1113, DOI 10.3390/v7031113; Haralambieva IH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099997; Haralambieva LH, 2014, VACCINE, V32, P1946, DOI 10.1016/j.vaccine.2014.01.090; Huzly D, 2016, J CLIN VIROL, V74, P13, DOI 10.1016/j.jcv.2015.11.022; Hyde TB, 2015, J INFECT DIS, V212, P57, DOI 10.1093/infdis/jiu604; Katow S, 2004, PEDIATR INT, V46, P207, DOI 10.1046/j.1442-200x.2004.01866.x; Katow S, 1998, INTERVIROLOGY, V41, P163, DOI 10.1159/000024931; Kennedy RB, 2014, HUM GENET, V133, P1407, DOI 10.1007/s00439-014-1471-z; Kennedy RB, 2014, IMMUNOGENETICS, V66, P493, DOI 10.1007/s00251-014-0776-3; Kennedy RB, 2014, EXPERT REV VACCINES, V13, P657, DOI 10.1586/14760584.2014.905744; Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998; Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0; Lambert ND, 2015, J INFECT DIS, V211, P898, DOI 10.1093/infdis/jiu553; Lambert ND, 2014, CLIN VACCINE IMMUNOL, V21, P340, DOI 10.1128/CVI.00681-13; Lambert ND, 2014, IMMUNOL RES, V58, P1, DOI 10.1007/s12026-013-8475-y; LeBaron CW, 2009, J INFECT DIS, V200, P888, DOI 10.1086/605410; Lin CC, 2012, CLIN VACCINE IMMUNOL, V19, P1, DOI 10.1128/CVI.05334-11; Luevano M, 2010, VIROLOGY, V405, P31, DOI 10.1016/j.virol.2010.05.011; Matter L, 1997, J INFECT DIS, V175, P749, DOI 10.1086/513967; MAURACHER CA, 1993, J IMMUNOL, V151, P2041; MEEGAN JM, 1982, J CLIN MICROBIOL, V16, P644, DOI 10.1128/JCM.16.4.644-649.1982; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Mitchell LA, 1996, J CLIN MICROBIOL, V34, P2210, DOI 10.1128/JCM.34.9.2210-2218.1996; Ovsyannikova IG, 2010, J INFECT DIS, V201, P207, DOI 10.1086/649588; Pankratz VS, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-48; Petrova EK, 2016, VACCINE, V34, P1006, DOI 10.1016/j.vaccine.2016.01.010; Plotkin S, 2008, RUBELLA VACCINE VACC, P471; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805; Skendzel LP, 1996, AM J CLIN PATHOL, V106, P170; Tosh PK, 2009, VIRAL IMMUNOL, V22, P451, DOI 10.1089/vim.2009.0068; TRUANT AL, 1983, J CLIN MICROBIOL, V17, P106, DOI 10.1128/JCM.17.1.106-108.1983; Watson J C, 1998, MMWR Recomm Rep, V47, P1; Wilson KM, 2006, CLIN VACCINE IMMUNOL, V13, P380, DOI 10.1128/CVI.13.3.380-386.2006; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; ZREIN M, 1993, J CLIN MICROBIOL, V31, P1521, DOI 10.1128/JCM.31.6.1521-1524.1993	53	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188149	10.1371/journal.pone.0188149	http://dx.doi.org/10.1371/journal.pone.0188149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145521	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800076
J	Mao, LG; Jiang, HY; Zhang, L; Zhang, YN; Sial, MU; Yu, HT; Cao, AC				Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Sial, Muhammad Umair; Yu, Haitao; Cao, Aocheng			Replacing methyl bromide with a combination of 1,3-dichloropropene and metam sodium for cucumber production in China	PLOS ONE			English	Article							CHEMICAL ALTERNATIVES; STRAWBERRY NURSERIES; DIMETHYL DISULFIDE; SOILBORNE PESTS; SOIL; CHLOROPICRIN; FUMIGANTS; TOMATO; FUMIGATION; EFFICACY	The combination of 1,3-dichloropropene (1,3-D) and metam sodium (MNa) is a potential resource to replace methyl bromide (MB) as a soil fumigant. The efficacy of 1,3-D+MNa as a crucial factor to limit soil-borne pests was evaluated in one laboratory experiment and two cucumber greenhouse studies conducted in commercial operations. Laboratory results revealed that 1,3-D and MNa (10+20 mg a.i.kg(-1) soil) provided the best complementary control of the root-knot nematode, Fusarium oxysporum and two species of weed seeds. Greenhouse trials revealed that the blend of 1,3-D and MNa (10+20 ga. i. m(-2)) greatly inhibited the ability of Meloidogyne incognita to form root galls. In addition, the number of colonyforming units of F. oxysporum declined substantially after growth on media, resulting in higher fruit yields and greater economic benefits. The combined use of 1,3-D and MNa exhibited a higher control efficacy than when 1,3-D or MNa was utilized alone. The ability of this chemical combination to control soil-borne organisms did not differ significantly from the MB treatment and maintained high cucumber yields, enhancing the income of the farmers. Compared to the untreated control group, all the chemical treatments prominently improved the control of the pests. These results show that applying a combination of 1,3-D and MNa provides a promising alternative to MB that enables the sustained growth of cucumber production in China.	[Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Sial, Muhammad Umair; Yu, Haitao; Cao, Aocheng] Chinese Acad Agr Sci, Dept Pesticides, Inst Plant Protect, Minist Agr, Beijing, Peoples R China; [Mao, Liangang; Jiang, Hongyun; Zhang, Lan; Zhang, Yanning; Cao, Aocheng] State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Jiang, HY; Cao, AC (corresponding author), Chinese Acad Agr Sci, Dept Pesticides, Inst Plant Protect, Minist Agr, Beijing, Peoples R China.; Jiang, HY; Cao, AC (corresponding author), State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	ptnpc@vip.163.com; aochengcao@ippcaas.cn	Sial, Muhammad Umair/ABH-2902-2021	Sial, Muhammad Umair/0000-0002-5865-8927; Sial, Maqbool/0000-0003-4394-1460	Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China [2016YFD0200500, 2017YFD0201600]	Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China	The funding for this experiment was provided by "Beijing Team-Innovation, Modern Agricultural and Industrial Technology Innovation System of China and National Key Research Development Program of China (No. 2016YFD0200500 and 2017YFD0201600)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwa Husein A., 2003, Phytopathologia Mediterranea, V42, P220; Cao AC, 2014, PEST MANAG SCI, V70, P219, DOI 10.1002/ps.3535; COLBY SR, 1967, WEEDS-U, V15, P20, DOI 10.2307/4041058; Csinos AS, 2002, CROP PROT, V21, P973, DOI 10.1016/S0261-2194(02)00077-7; De Cal A, 2004, PLANT DIS, V88, P210, DOI 10.1094/PDIS.2004.88.2.210; Desaeger JA, 2008, PEST MANAG SCI, V64, P230, DOI 10.1002/ps.1503; Garcia-Mendez E, 2008, HORTSCIENCE, V43, P177, DOI 10.21273/HORTSCI.43.1.177; Giannakou IO, 2005, CROP PROT, V24, P499, DOI 10.1016/j.cropro.2004.09.007; Gilreath JP, 2006, CROP PROT, V25, P79, DOI 10.1016/j.cropro.2005.03.007; Gilreath JP, 2004, CROP PROT, V23, P347, DOI 10.1016/j.cropro.2003.09.006; Guo MX, 2005, PEST MANAG SCI, V61, P467, DOI 10.1002/ps.960; Hernandes I, 2017, ACTA AGR SCAND B S P; Klose S, 2006, SOIL BIOL BIOCHEM, V38, P1243, DOI 10.1016/j.soilbio.2005.09.025; KOMADA H, 1975, Review of Plant Protection Research, V8, P114; Larson K.D., 1998, ANN INT RES C METH B; Liu W, 2000, PLANT PATHOGENIC NEM, P373; Liu XM, 2015, CHEMOSPHERE, V139, P379, DOI 10.1016/j.chemosphere.2015.07.034; Lopez-Aranda JM, 2009, HORTTECHNOLOGY, V19, P187, DOI 10.21273/HORTSCI.19.1.187; Mao LG, 2016, J INTEGR AGR, V15, P145, DOI 10.1016/S2095-3119(15)61065-6; Mao LG, 2012, PEST MANAG SCI, V68, P602, DOI 10.1002/ps.2303; Mao LG, 2014, J AGR FOOD CHEM, V62, P4864, DOI 10.1021/jf501255w; MBTOC, 2010, REP METH BROM TECHN, P72; MBTOC, 2006, REP METH BROM TECHN, P101; McKinney HH, 1923, J AGRIC RES, V26, P0195; Nelson SD, 2002, HORTSCIENCE, V37, P1057, DOI 10.21273/HORTSCI.37.7.1057; Peng D, 2014, PEST MANAG SCI, V70, P258, DOI 10.1002/ps.3551; Qiao K, 2011, J AGR FOOD CHEM, V59, P2362, DOI 10.1021/jf104553f; Santos BM, 2006, CROP PROT, V25, P690, DOI 10.1016/j.cropro.2005.09.015; Thomson W. T., 1992, AGR CHEM, P206; Van Wambeke E, 2009, Commun Agric Appl Biol Sci, V74, P75; Van Wambeke E, 2007, Commun Agric Appl Biol Sci, V72, P61; Wang QX, 2013, CROP PROT, V48, P24, DOI 10.1016/j.cropro.2013.02.002; Yates SR, 2002, PHYTOPATHOLOGY, V92, P1344, DOI 10.1094/PHYTO.2002.92.12.1344; Zheng W, 2004, J AGR FOOD CHEM, V52, P3002, DOI 10.1021/jf0498564	34	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188137	10.1371/journal.pone.0188137	http://dx.doi.org/10.1371/journal.pone.0188137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145472	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800074
J	Silveira, LJ; Strand, M; Van Dyke, MV; Mroz, MM; Faino, AV; Dabelea, DM; Maier, LA; Fingerlin, TE				Silveira, Lori J.; Strand, Matthew; Van Dyke, Michael V.; Mroz, Margaret M.; Faino, Anna V.; Dabelea, Dana M.; Maier, Lisa A.; Fingerlin, Tasha E.			Clinical tool for disease phenotyping in granulomatous lung disease	PLOS ONE			English	Article							CHRONIC BERYLLIUM DISEASE; CYSTIC-FIBROSIS; SEVERITY; HLA-DPB1; RISK; SENSITIZATION; POLYMORPHISMS; EXPOSURE; WORKERS	Background Exposure to beryllium may lead to granuloma formation and fibrosis in those who develop chronic beryllium disease (CBD). Although disease presentation varies from mild to severe, little is known about CBD phenotypes. This study characterized CBD disease phenotypes using longitudinal measures of lung function. Methods Using a case-only study of 207 CBD subjects, subject-specific trajectories over time were estimated from longitudinal pulmonary function and exercise-tolerance tests. To estimate linear combinations of the 30-year values that define underlying patterns of lung function, we conducted factor analysis. Cluster analysis was then performed on all the predicted lung function values at 30 years. These estimates were used to identify underlying features and subgroups of CBD. Results Two factors, or composite measures, explained nearly 70% of the co-variation among the tests; one factor represented pulmonary function in addition to oxygen consumption and workload during exercise, while the second factor represented exercise tests related to gas exchange. Factors were associated with granulomas on biopsy, exposure, steroid use and lung inflammation. Three clusters of patients (n = 53, n = 59 and, n = 95) were identified based on the collection of test values. Lower levels of each of the factor composite scores and cluster membership were associated with baseline characteristics of patients. Conclusions Using factor analysis and cluster analysis, we identified disease phenotypes that were associated with baseline patient characteristics, suggesting that CBD is a heterogeneous disease with varying severity. These clinical tools may be used in future basic and clinical studies to help define the mechanisms and risk factors for disease severity.	[Silveira, Lori J.; Strand, Matthew; Faino, Anna V.] Natl Jewish Hlth, Div Biostat & Informat, Denver, CO USA; [Silveira, Lori J.; Strand, Matthew; Dabelea, Dana M.; Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA; [Van Dyke, Michael V.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Mroz, Margaret M.; Maier, Lisa A.] Natl Jewish Hlth, Div Environm & Occupat Hlth, Denver, CO USA; [Maier, Lisa A.; Fingerlin, Tasha E.] Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Fingerlin, Tasha E.] Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA	National Jewish Health; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado Department of Public Health & Environment; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Fingerlin, TE (corresponding author), Univ Colorado, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (corresponding author), Univ Colorado, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.; Fingerlin, TE (corresponding author), Natl Jewish Hlth, Ctr Genes Environm & Hlth, Denver, CO 80206 USA.	mrozp@njhealth.org; maieril@njhealth.org; fingerlint@njhealth.org	Strand, Matt/AAU-3762-2021; Maier, Lisa/AAA-4378-2020	Strand, Matt/0000-0002-9083-5989; 	National Institute of Environmental Health Sciences [P01 ES11810-A1]; Colorado Clinical and Translational Sciences Institute; National Institutes of Health/National Center for Advancing Translational Sciences [UL1 TR000154]	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Colorado Clinical and Translational Sciences Institute; National Institutes of Health/National Center for Advancing Translational Sciences	This work was supported by National Institute of Environmental Health Sciences Grant number P01 ES11810-A1 (to LAM) and by the Colorado Clinical and Translational Sciences Institute, which was supported in part by National Institutes of Health/National Center for Advancing Translational Sciences Grant number UL1 TR000154 to the Colorado Clinical and Translational Science Award program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SASSTAT 9 2 USER S G; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Deubner D, 2001, Appl Occup Environ Hyg, V16, P579; Kumar M, 2007, COMPUT STAT DATA AN, V51, P6084, DOI 10.1016/j.csda.2006.12.012; Mack DG, 2010, AM J RESP CRIT CARE, V181, P1241, DOI 10.1164/rccm.201001-0025OC; Maier LA, 1999, AM J RESP CRIT CARE, V159, P1342, DOI 10.1164/ajrccm.159.4.9806106; McCanlies EC, 2003, AM J EPIDEMIOL, V157, P388, DOI 10.1093/aje/kwg001; McCarthy C, 2013, CHEST, V143, P1358, DOI 10.1378/chest.12-2022; Mroz MM, 2009, AM J IND MED, V52, P762, DOI 10.1002/ajim.20736; NEWMAN LS, 1994, AM J RESP CRIT CARE, V150, P135, DOI 10.1164/ajrccm.150.1.8025739; NEWMAN LS, 1992, AM REV RESPIR DIS, V146, P39, DOI 10.1164/ajrccm/146.1.39; Palmer BE, 2007, J ALLERGY CLIN IMMUN, V120, P184, DOI 10.1016/j.jaci.2007.03.009; PAPPAS GP, 1993, AM REV RESPIR DIS, V148, P661, DOI 10.1164/ajrccm/148.3.661; RICHELDI L, 1993, SCIENCE, V262, P242, DOI 10.1126/science.8105536; Rodrigues EG, 2008, AM J IND MED, V51, P512, DOI 10.1002/ajim.20585; Rossman MD, 2009, AM J RESP CRIT CARE, V179, P173, DOI 10.1164/ajrccm.179.2.173a; Rummel R., UNDERSTANDING FACTOR; Sarcoidosis, 2011, MED CLIN N AM; Sato H, 2010, EUR RESPIR J, V36, P331, DOI 10.1183/09031936.00107809; Schluchter MD, 2006, AM J RESP CRIT CARE, V174, P780, DOI 10.1164/rccm.200512-1919OC; Schuler CR, 2012, SCAND J WORK ENV HEA, V38, P270, DOI 10.5271/sjweh.3192; Silveira LJ, 2012, J IMMUNOL, V189, P4014, DOI 10.4049/jimmunol.1200798; Tinkle SS, 2003, SEMIN RESP CRIT CARE, V24, P169, DOI 10.1055/s-2003-39016; Van Dyke MV, 2011, OCCUP ENVIRON MED, V68, P842, DOI 10.1136/oem.2010.064220; Van Dyke MV, 2011, AM J RESP CRIT CARE, V183, P1680, DOI 10.1164/rccm.201002-0254OC; Wasfi YS, 2006, CHEST, V129, P1234, DOI 10.1378/chest.129.5.1234	27	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188119	10.1371/journal.pone.0188119	http://dx.doi.org/10.1371/journal.pone.0188119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145499	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800067
J	Wen, YC; Chen, LK; Hsiao, FY				Wen, Yao-Chun; Chen, Liang-Kung; Hsiao, Fei-Yuan			Predicting mortality and hospitalization of older adults by the multimorbidity frailty index	PLOS ONE			English	Article							RESEARCH DATABASE; ELDERLY-PEOPLE; OUTCOMES; RISK; ACCUMULATION; COHORT	Background Existing operational definitions of frailty are personnel-costly and time-consuming, resulting in estimates with a small sample size that cannot be generalized to the population level. The objectives were to develop a multimorbidity frailty index using Taiwan's claim database, and to understand its ability to predict adverse event. Methods This is a retrospective cohort study. Subjects aged 65 to 100 years who have full National Health Insurance coverage in 2005 were included. We constructed the multimorbidity frailty index using cumulative deficit approach and categorized study population according to the multimorbidity frailty index quartiles: fit, mild frailty, moderate frailty and severe frailty. The multimorbidity frailty index included deficits from outpatient and inpatient diagnosis. Associations with all-cause mortality, unplanned hospitalization and intensive care unit admission were assessed using Kaplan-Meier curves and Cox regression analyses. Results The multimorbidity frailty index incorporated 32 deficits, with mean multimorbidity frailty index score of 0.052 (standard deviation = 0.060) among 86,133 subjects included. Compared to subjects in fit category, subjects with severe frailty were associated with a 5.0-fold (adjusted hazard ratio, aHR 4.97; 95% confidence interval, 95% CI 4.49-5.50) increased risk of death at 1 year after adjusting for age and gender. Subjects with moderate frailty or mild frailty was associated with 3.1-(adjusted HR 3.08; 95% CI 2.80-3.39) or 1.9-(adjusted HR 1.86; 95% CI 1.71-2.01) folds increased risk, respectively. 4.49-5.50). The risk trend of unplanned hospitalization and intensive care unit admission is similar among the study population. Besides, the association between the frailty categories and all three outcomes was slightly stronger among women. Conclusion The multimorbidity frailty index was highly associated with all-cause mortality, unplanned hospitalization and ICU admission. It could serve as an efficient tool for stratifying older adults into different risk groups for planning care management programs.	[Wen, Yao-Chun; Hsiao, Fei-Yuan] Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan; [Wen, Yao-Chun] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei, Taiwan; [Chen, Liang-Kung] Natl Yang Ming Univ, Sch Med, Inst Publ Hlth, Taipei, Taiwan; [Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Hsiao, Fei-Yuan] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan; [Hsiao, Fei-Yuan] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Hsiao, FY (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Pharm, Taipei, Taiwan.; Hsiao, FY (corresponding author), Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan.; Hsiao, FY (corresponding author), Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan.	fyshsiao@ntu.edu.tw		HSIAO, FEI-YUAN/0000-0003-1660-9120; Chen, Liang-Kung/0000-0002-2387-8508	Ministry of Science and Technology, Taiwan [MOST104-2410-H-002-225-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was funded by the Ministry of Science and Technology, Taiwan (grant no. MOST104-2410-H-002-225-MY3) to Fei-Yuan Hsiao. The funding source had no role in conducting this study, including study design, data collection and analysis, manuscript preparation and review and decision to submit the manuscript for publication.	Bouillon K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-64; Centers for Medicare & Medicaid Services, MED PROGR GEN INF OV; Chamberlain AM, 2016, J AM GERIATR SOC, V64, P285, DOI 10.1111/jgs.13944; Chen XJ, 2014, CLIN INTERV AGING, V9, P433, DOI 10.2147/CIA.S45300; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Clegg A, 2016, AGE AGEING, V45, P353, DOI 10.1093/ageing/afw039; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; de Vries OJ, 2013, OSTEOPOROSIS INT, V24, P2397, DOI 10.1007/s00198-013-2303-z; Dent E, 2016, EUR J INTERN MED, V31, P3, DOI 10.1016/j.ejim.2016.03.007; Evans SJ, 2014, AGE AGEING, V43, P127, DOI 10.1093/ageing/aft156; Hoogendijk EO, 2016, AGING CLIN EXP RES, P1; Hsiao FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124973; Kim DH, 2014, PHARMACOEPIDEM DR S, V23, P891, DOI 10.1002/pds.3674; KOJIMA G, 2015, BMC GERIATR, V15; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Lin CW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41035; Lin SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161456; Lu WH, 2015, CAN MED ASSOC J, V187, pE130, DOI 10.1503/cmaj.141219; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Romero-Ortuno R, 2012, AGE AGEING, V41, P684, DOI 10.1093/ageing/afs051; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2010, J AM GERIATR SOC, V58, P681, DOI 10.1111/j.1532-5415.2010.02764.x; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009	26	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187825	10.1371/journal.pone.0187825	http://dx.doi.org/10.1371/journal.pone.0187825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145407	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800031
J	Agren, J; Schafer, MO; Forsgren, E				Agren, Joakim; Schaefer, Marc Oliver; Forsgren, Eva			Using whole genome sequencing to study American foulbrood epidemiology in honeybees	PLOS ONE			English	Article							PAENIBACILLUS-LARVAE; TYPING SCHEME; BACTERIA; OUTBREAK; MLST	American foulbrood (AFB), caused by Paenibacillus larvae, is a devastating disease in honeybees. In most countries, the disease is controlled through compulsory burning of symptomatic colonies causing major economic losses in apiculture. The pathogen is endemic to honeybees world-wide and is readily transmitted via the movement of hive equipment or bees. Molecular epidemiology of AFB currently largely relies on placing isolates in one of four ERIC-genotypes. However, a more powerful alternative is multi-locus sequence typing (MLST) using whole-genome sequencing (WGS), which allows for high-resolution studies of disease outbreaks. To evaluate WGS as a tool for AFB-epidemiology, we applied core genome MLST (cgMLST) on isolates from a recent outbreak of AFB in Sweden. The high resolution of the cgMLST allowed different bacterial clones involved in the disease outbreak to be identified and to trace the source of infection. The source was found to be a beekeeper who had sold bees to two other beekeepers, proving the epidemiological link between them. No such conclusion could have been made using conventional MLST or ERIC-typing. This is the first time that WGS has been used to study the epidemiology of AFB. The results show that the technique is very powerful for high-resolution tracing of AFB-outbreaks.	[Agren, Joakim] Natl Vet Inst, Dept Microbiol, Uppsala, Sweden; [Schaefer, Marc Oliver] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Insel Riems, Germany; [Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	National Veterinary Institute SVA; Friedrich Loeffler Institute; Swedish University of Agricultural Sciences	Forsgren, E (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	eva.forsgren@slu.se		Forsgren, Eva/0000-0002-8244-7265				Antwerpen MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123298; Aring;ogren J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089112; Azarian T, 2015, INFECT CONT HOSP EP, V36, P777, DOI 10.1017/ice.2015.73; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Djukic M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090914; ECDC, 2015, EXP OP INTR NEXT GEN; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Forsgren E, 2014, APIDOLOGIE, V45, P10, DOI 10.1007/s13592-013-0225-6; Genersch E, 2008, J VERBRAUCH LEBENSM, V3, P429, DOI 10.1007/s00003-008-0379-8; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2003, APIDOLOGIE, V34, P195, DOI 10.1051/apido:2003025; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Jordbruksverket, 2001, 48 JORDBR; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kohl TA, 2014, J CLIN MICROBIOL, V52, P2479, DOI 10.1128/JCM.00567-14; Leopold SR, 2014, J CLIN MICROBIOL, V52, P2365, DOI 10.1128/JCM.00262-14; Maiden MCJ, 2013, NAT REV MICROBIOL, V11, P728, DOI 10.1038/nrmicro3093; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; Morrissey BJ, 2015, ENVIRON MICROBIOL, V17, P1414, DOI 10.1111/1462-2920.12625; Nordstrom S, 1995, J APICULT RES, V34, P97, DOI 10.1080/00218839.1995.11100894; Nordstrom S, 2002, J APIC SCI, V46, P1643; Pentikainen J, 2009, APIDOLOGIE, V40, P73, DOI 10.1051/apido:2008061; Pinholt M, 2015, J ANTIMICROB CHEMOTH, V70, P2474, DOI 10.1093/jac/dkv142; Ruppitsch W, 2015, J CLIN MICROBIOL, V53, P2869, DOI 10.1128/JCM.01193-15; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Weterings V, 2015, EUR J CLIN MICROBIOL, V34, P1647, DOI 10.1007/s10096-015-2401-2	29	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187924	10.1371/journal.pone.0187924	http://dx.doi.org/10.1371/journal.pone.0187924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140998	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400037
J	Farias, ME; Rasuk, MC; Gallagher, KL; Contreras, M; Kurth, D; Fernandez, AB; Poire, D; Novoa, F; Visscher, PT				Eugenia Farias, Maria; Cecilia Rasuk, Maria; Gallagher, Kimberley L.; Contreras, Manuel; Kurth, Daniel; Beatriz Fernandez, Ana; Poire, Daniel; Novoa, Fernando; Visscher, Pieter T.			Prokaryotic diversity and biogeochemical characteristics of benthic microbial ecosystems at La Brava, a hypersaline lake at Salar de Atacama, Chile	PLOS ONE			English	Article							MODERN MARINE STROMATOLITES; CARBONATE PRECIPITATION; CYANOBACTERIAL MATS; BACTERIAL DIVERSITY; SULFATE REDUCTION; HIGHBORNE CAY; ARCHAEA; GYPSUM; GEOCHEMISTRY; SEDIMENTS	Benthic microbial ecosystems of Laguna La Brava, Salar de Atacama, a high altitude hypersaline lake, were characterized in terms of bacterial and archaeal diversity, biogeochemistry, (including O-2 and sulfide depth profiles and mineralogy), and physicochemical characteristics. La Brava is one of several lakes in the Salar de Atacama where microbial communities are growing in extreme conditions, including high salinity, high solar insolation, and high levels of metals such as lithium, arsenic, magnesium, and calcium. Evaporation creates hypersaline conditions in these lakes and mineral precipitation is a characteristic geomicrobiological feature of these benthic ecosystems. In this study, the La Brava non-lithifying microbial mats, microbialites, and rhizome-associated concretions were compared to each other and their diversity was related to their environmental conditions. All the ecosystems revealed an unusual community where Euryarchaeota, Crenarchaeota, Acetothermia, Firmicutes and Planctomycetes were the most abundant groups, and cyanobacteria, typically an important primary producer in microbial mats, were relatively insignificant or absent. This suggests that other microorganisms, and possibly novel pathways unique to this system, are responsible for carbon fixation. Depth profiles of O-2 and sulfide showed active production and respiration. The mineralogy composition was calcium carbonate (as aragonite) and increased from mats to microbialites and rhizome-associated concretions. Halite was also present. Further analyses were performed on representative microbial mats and microbialites by layer. Different taxonomic compositions were observed in the upper layers, with Archaea dominating the non-lithifying mat, and Planctomycetes the microbialite. The bottom layers were similar, with Euryarchaeota, Crenarchaeota and Planctomycetes as dominant phyla. Sequences related to Cyanobacteria were very scarce. These systems may contain previously uncharacterized community metabolisms, some of which may be contributing to net mineral precipitation. Further work on these sites might reveal novel organisms and metabolisms of biotechnological interest.	[Eugenia Farias, Maria; Cecilia Rasuk, Maria; Kurth, Daniel; Beatriz Fernandez, Ana] Consejo Nacl Invest Cient & Tecn, CCT Tucuman, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Argentina; [Contreras, Manuel; Novoa, Fernando] CEA, Santiago, Chile; [Poire, Daniel] Univ Nacl La Plata, Conicet, Ctr Invest Geol, La Plata, Buenos Aires, Argentina; [Gallagher, Kimberley L.; Visscher, Pieter T.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Visscher, Pieter T.] Univ New South Wales, Australian Ctr Astrobiol, Sydney, NSW, Australia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Connecticut; University of New South Wales Sydney	Farias, ME (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT Tucuman, Planta Piloto Proc Ind Microbiol PROIMI, LIMLA, San Miguel De Tucuman, Argentina.	mefarias2009@gmail.com	Rasuk, Maria/AAN-5887-2021; Kurth, Daniel/AAG-4696-2019; Visscher, Pieter/T-7464-2017	Rasuk, Maria/0000-0002-4852-0924; Kurth, Daniel/0000-0001-8481-4359; Visscher, Pieter/0000-0001-6911-1532; Gallagher, Kimberley/0000-0001-5835-3608; Farias, Maria Eugenia/0000-0002-2771-8915; FERNANDEZ, ANA BEATRIZ/0000-0003-3301-6503; Poire, Daniel G./0000-0003-0966-122X	Centro de Ecologia Aplicada Chile; MinCyT Argentina [PICT 1788, PICT 3825]; NASA Exobiology CAN [NNX12AD64G]	Centro de Ecologia Aplicada Chile; MinCyT Argentina; NASA Exobiology CAN	This work was supported by Centro de Ecologia Aplicada Chile and the projects PICT 1788 and PICT 3825 from MinCyT Argentina to MEF. PTV acknowledges support from NASA Exobiology CAN NNX12AD64G.	Ali-Bik MW, 2011, ENVIRON EARTH SCI, V62, P151, DOI 10.1007/s12665-010-0510-x; Alonso H, 1996, REV GEOL CHILE, V23, P113; Arp G, 2012, GEOMICROBIOL J, V29, P29, DOI 10.1080/01490451.2010.521436; BARDOU P, 2014, BMC BIOINFORMATICS, V15, P17060, DOI DOI 10.1128/AEM.00062-07; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Baumgartner LK, 2009, ASTROBIOLOGY, V9, P861, DOI 10.1089/ast.2008.0329; Baumgartner LK, 2009, ENVIRON MICROBIOL, V11, P2710, DOI 10.1111/j.1462-2920.2009.01998.x; BEVACQUA P, 1992, GEOMORFOLOGIA SALAR, P17060, DOI DOI 10.3389/FMICB.2017.00646; Beveridge T J, 1981, Int Rev Cytol, V72, P229, DOI 10.1016/S0074-7696(08)61198-5; Bolhuis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063166; Braissant O, 2009, FEMS MICROBIOL ECOL, V67, P293, DOI 10.1111/j.1574-6941.2008.00614.x; CABRERA D, 1992, ARCH HYDROBIOL, V43, P123, DOI DOI 10.1016/S0012-8252(03)00037-0; Caceres L, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000344; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Rasuk MC, 2014, MICROB ECOL, V68, P483, DOI 10.1007/s00248-014-0431-4; Cockbain A. E., 1976, STROMATOLITES, P389, DOI 10.1016/S0070-4571(08)71147-6; CODY AM, 1989, J CRYST GROWTH, V98, P721, DOI 10.1016/0022-0248(89)90310-2; Costa KC, 2009, EXTREMOPHILES, V13, P447, DOI 10.1007/s00792-009-0230-x; Decho AW, 2000, MICROBIAL SEDIMENTS, P9; DESMARAIS DJ, 1995, BIOGEOCHEMISTRY HYPE, P251, DOI DOI 10.1007/978-1-4684-7724-5_6; Douglas S, 2005, AM J SCI, V305, P503, DOI 10.2475/ajs.305.6-8.503; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Dupraz C, 2004, SEDIMENTOLOGY, V51, P745, DOI 10.1111/j.1365-3091.2004.00649.x; Dupraz C., 2011, ENCY GEOBIOLOGY, P617, DOI [DOI 10.1007/978-1-4020-9212-1, DOI 10.1007/978-1-4020-9212-1_195]; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Eaton A. D., 2005, STANDARD METHODS EXA; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Farias ME, 2014, EXTREMOPHILES, V18, P311, DOI 10.1007/s00792-013-0617-6; Farias ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053497; Fenchel T, 1998, AQUAT MICROB ECOL, V14, P253, DOI 10.3354/ame014253; Fernandez AB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01284; Gallagher KL, 2012, GEOBIOLOGY, V10, P518, DOI 10.1111/j.1472-4669.2012.00342.x; GOLDIN A, 1987, COMMUN SOIL SCI PLAN, V18, P1111, DOI 10.1080/00103628709367886; Gomez FJ, 2014, PALAIOS, V29, P233, DOI 10.2110/palo.2013.049; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; Hoffman P, 1976, STROMATOLITES, V20, P261, DOI DOI 10.1016/S0070-4571(08)71139-7; Houghton J, 2014, GEOBIOLOGY, V12, P557, DOI 10.1111/gbi.12113; Hu P, 2016, MBIO, V7, DOI 10.1128/mBio.01669-15; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ionescu D, 2015, GEOBIOLOGY, V13, P170, DOI 10.1111/gbi.12120; Jahnke LL, 2014, GEOBIOLOGY, V12, P62, DOI 10.1111/gbi.12068; Kazmierczak Jozef, 2015, Life-Basel, V5, P744, DOI 10.3390/life5010744; KELLY DP, 1969, ANAL CHEM, V41, P898, DOI 10.1021/ac60276a029; Kim J.J., 2014, COMPENDIUM METHODS M; Knittel K, 2005, APPL ENVIRON MICROB, V71, P467, DOI 10.1128/AEM.71.1.467-479.2005; Kubo K, 2012, ISME J, V6, P1949, DOI 10.1038/ismej.2012.37; Kurth D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00896-0; Lara J, 2012, EXTREMOPHILES, V16, P523, DOI 10.1007/s00792-012-0452-1; LEE JZ, 2014, FRONT MICROBIOL, V5, P17060, DOI DOI 10.1089/AST.2008.0329; Ley RE, 2006, APPL ENVIRON MICROB, V72, P3685, DOI 10.1128/AEM.72.5.3685-3695.2006; Leyval C, 1997, MYCORRHIZA, V7, P139, DOI 10.1007/s005720050174; Louyakis A, 2017, ASTROBIOLOG IN PRESS; Marvasi M, 2012, GEOMICROBIOL J, V29, P916, DOI 10.1080/01490451.2011.636145; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Myshrall KL, 2010, GEOBIOLOGY, V8, P337, DOI 10.1111/j.1472-4669.2010.00245.x; Nielsen M, 2015, SENSOR ACTUAT B-CHEM, V215, P1, DOI 10.1016/j.snb.2015.03.035; Nubel U, 2002, APPL ENVIRON MICROB, V68, P4593, DOI 10.1128/AEM.68.9.4593-4603.2002; Orell A, 2012, EXTREMOPHILES, V16, P573, DOI 10.1007/s00792-012-0457-9; Pace A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31495; Pages A, 2014, MAR CHEM, V167, P102, DOI 10.1016/j.marchem.2014.05.003; Pedley M, 2000, MICROBIAL SEDIMENTS, P179; Rascovan N, 2016, ISME J, V10, P299, DOI 10.1038/ismej.2015.109; REID RP, 1995, FACIES, V33, P1, DOI 10.1007/BF02537442; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; Risacher F, 2003, EARTH-SCI REV, V63, P249, DOI 10.1016/S0012-8252(03)00037-0; Robertson CE, 2009, APPL ENVIRON MICROB, V75, P1801, DOI 10.1128/AEM.01811-08; Roos JC, 1998, J PHYCOL, V34, P118, DOI 10.1046/j.1529-8817.1998.340118.x; Russell JA, 2014, GEOBIOLOGY, V12, P250, DOI 10.1111/gbi.12082; Ruvindy R, 2016, ISME J, V10, P183, DOI 10.1038/ismej.2015.87; Schneider DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082402; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; SHERWOOD JE, 1991, LIMNOL OCEANOGR, V36, P235, DOI 10.4319/lo.1991.36.2.0235; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V, 2012, ASTROBIOLOGY, V12, P641, DOI 10.1089/ast.2011.0675; Spring S, 2016, ISME J, V10, P2801, DOI 10.1038/ismej.2016.84; Stivaletta N, 2011, GEOMICROBIOL J, V28, P83, DOI 10.1080/01490451003653102; Takai K, 1999, GENETICS, V152, P1285; TAKAMI H, 2012, PLOONE PUBLIC LIB, V7, DOI DOI 10.1371/JOURNAL.PONE.0062901; Takashima C., 2005, J GEOL SOC JAPAN, V111, P751, DOI DOI 10.1128/AEM.01811-08; Takashima C, 2008, SEDIMENT GEOL, V208, P114, DOI 10.1016/j.sedgeo.2008.06.001; Ter Braak CJF, 2002, ENV MICROBIOL; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Teske A, 1998, APPL ENVIRON MICROB, V64, P2943; TONEATTI DM, 2017, FRONT MICROBIOL, V8, P17060, DOI DOI 10.3389/FMICB.2017.00646; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Vasconcelos C, 2006, SEDIMENT GEOL, V185, P175, DOI 10.1016/j.sedgeo.2005.12.022; Vick TJ, 2010, GEOBIOLOGY, V8, P140, DOI 10.1111/j.1472-4669.2009.00228.x; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; Visscher PT, 2005, PALAEOGEOGR PALAEOCL, V219, P87, DOI 10.1016/j.palaeo.2004.10.016; VISSCHER PT, 1992, FEMS MICROBIOL ECOL, V86, P283, DOI 10.1016/0378-1097(92)90792-M; VISSCHER PT, 1991, LIMNOL OCEANOGR, V36, P1476, DOI 10.4319/lo.1991.36.7.1476; VISSCHER PT, 2010, CELLULAR ORIGIN LIFE, V14, P443, DOI DOI 10.1128/AEM.01812-08; WALTER MR, 1972, SCIENCE, V178, P402, DOI 10.1126/science.178.4059.402; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WANG S, 2013, PLOS ONE, V8, P17060, DOI DOI 10.1128/AEM.72.5.3685-3695.2006; WHITMAN WB, 2015, BERGEYS MANUAL SYSTE, P17060, DOI DOI 10.1093/BIOINFORMATICS/BTQ461; Wong H, 2017, NAT SCI REPORTS	103	30	31	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186867	10.1371/journal.pone.0186867	http://dx.doi.org/10.1371/journal.pone.0186867			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140980	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400012
J	Hohmann, L; Bradt, J; Stegemann, T; Koelsch, S				Hohmann, Louisa; Bradt, Joke; Stegemann, Thomas; Koelsch, Stefan			Effects of music therapy and music-based interventions in the treatment of substance use disorders: A systematic review	PLOS ONE			English	Review							WORKING ALLIANCE; LYRIC ANALYSIS; DETOXIFICATION UNIT; MOOD STATES; MOTIVATION; CLIENTS; ADOLESCENTS; READINESS; OUTCOMES; PROGRAM	Music therapy (MT) and music-based interventions (MBIs) are increasingly used for the treatment of substance use disorders (SUD). Previous reviews on the efficacy of MT emphasized the dearth of research evidence for this topic, although various positive effects were identified. Therefore, we conducted a systematic search on published articles examining effects of music, MT and MBIs and found 34 quantitative and six qualitative studies. There was a clear increase in the number of randomized controlled trials (RCTs) during the past few years. We had planned for a meta-analysis, but due to the diversity of the quantitative studies, effect sizes were not computed. Beneficial effects of MT/MBI on emotional and motivational outcomes, participation, locus of control, and perceived helpfulness were reported, but results were inconsistent across studies. Furthermore, many RCTs focused on effects of single sessions. No published longitudinal trials could be found. The analysis of the qualitative studies revealed four themes: emotional expression, group interaction, development of skills, and improvement of quality of life. Considering these issues for quantitative research, there is a need to examine social and health variables in future studies. In conclusion, due to the heterogeneity of the studies, the efficacy of MT/MBI in SUD treatment still remains unclear.	[Hohmann, Louisa] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany; [Hohmann, Louisa; Koelsch, Stefan] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Bradt, Joke] Drexel Univ, Coll Nursing & Hlth Profess, Dept Creat Arts Therapies, Philadelphia, PA 19104 USA; [Stegemann, Thomas] Univ Mus & Performing Arts, Dept Mus Therapy, Vienna, Austria	Free University of Berlin; University of Bergen; Drexel University	Hohmann, L (corresponding author), Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany.; Hohmann, L (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	louisa.hohmann@fu-berlin.de	Koelsch, Stefan/AAV-1556-2020; bradt, joke/C-5930-2014	bradt, joke/0000-0001-7313-9829; Hohmann, Louisa/0000-0002-1055-4467				Abdollahnejad MR, 2006, THERAPEUTIC COMMUNIT, V27, P147; Albornoz Y, 2011, NORD J MUSIC THER, V20, P208, DOI 10.1080/08098131.2010.522717; Aletraris L, 2014, J ADDICT NURS, V25, P190, DOI 10.1097/JAN.0000000000000048; American Music Therapy Association, 2008, MUS THERP INT TRAUM; American Music Therapy Association, 2006, MUS THER MENT HLTH; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Auerbach SM, 2008, INT J CLIN HLTH PSYC, V8, P617; Baker FA, 2007, ART PSYCHOTHER, V34, P321, DOI 10.1016/j.aip.2007.04.005; Baker FA, 2012, THERAPEUTIC USES OF RAP AND HIP-HOP, P321; Barber JP, 2001, J CONSULT CLIN PSYCH, V69, P119, DOI 10.1037/0022-006X.69.1.119; Bradt J, 2016, J MUSIC THER, V53, P178, DOI 10.1093/jmt/thw004; Bradt J, 2015, SUPPORT CARE CANCER, V23, P1261, DOI 10.1007/s00520-014-2478-7; Buehringer G, 2011, KLIN PSYCHOL PSYCHOT, P697; C A Malchiodi, 2005, EXPRESSIVE THERAPIES, P1; Cassileth BR, 2003, CANCER, V98, P2723, DOI 10.1002/cncr.11842; Center for Behavioral Health Statistics and Quality, 2015, RES 2014 NAT SURV DR; Cevasco AM, 2005, J MUSIC THER, V42, P64, DOI 10.1093/jmt/42.1.64; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Conners GJ, 1997, J CONSULT CLIN PSYCH, V65, P588, DOI 10.1037/0022-006X.65.4.588; Cook S, 2015, PSYCHOL ADDICT BEHAV, V29, P371, DOI 10.1037/adb0000058; DELEON G, 1994, AM J DRUG ALCOHOL AB, V20, P495; Dickerson DL, 2014, AM INDIAN ALASKA NAT, V21, P35, DOI 10.5820/aian.2101.2014.35; Dingle GA, 2008, DRUG ALCOHOL REV, V27, P190, DOI 10.1080/09595230701829371; Dougherty KM, 1984, MUSIC THER, V4, P47, DOI DOI 10.1093/MT/4.1.47]; Dundon WD, 2008, DRUG ALCOHOL DEPEN, V95, P230, DOI 10.1016/j.drugalcdep.2008.01.010; Eagle Charles T., 1972, J MUSIC THER, V9, P23, DOI DOI 10.1093/JMT/9.1.23; Eid M, 2015, STAT FORSCHUNGSMETHO; Fisher CG, 2007, SPINE, V32, pS66, DOI 10.1097/BRS.0b013e318145308d; Fritz TH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00300; GALLAGHER L. M., 2002, MUSIC THERAPY PERSPE, V20, P117, DOI [10.1093/mtp/20.2.117, DOI 10.1093/MTP/20.2.117]; Gallant W. A., 1997, GROUPWORK, V10, P155; Gardstrom SC, 2013, VOICES WORLD FORUM M, P13; Gardstrom SC, 2010, MUSIC THER PERSPECT, V28, P147, DOI 10.1093/mtp/28.2.147; Gardstrom SC, 2013, MUSIC THER PERSPECT, V31, P116, DOI 10.1093/mtp/31.2.116; Gaston Thayer, 1970, J MUSIC THER, V7, P3, DOI DOI 10.1093/JMT/7.1.3; Ghetti CM, 2004, MUSIC THER PERSPECT, V22, P84, DOI DOI 10.1093/MTP/22.2.84; Gold C, 2013, PSYCHOTHER PSYCHOSOM, V82, P319, DOI 10.1159/000348452; Gooding LF, 2011, J MUSIC THER, V48, P440, DOI 10.1093/jmt/48.4.440; GOTTHEIL E, 1977, AM J DRUG ALCOHOL AB, V4, P31, DOI 10.3109/00952997709002745; Groshkova T, 2010, ADDICT RES THEORY, V18, P494, DOI 10.3109/16066350903362875; Hammer SE, 1996, J MUSIC THER, V33, P47, DOI 10.1093/jmt/33.1.47; Howard A.A., 1997, J POETRY THER, V11, P81, DOI [DOI 10.1023/B:J0PT.0000010860.98970.16, https://doi.org/10.1023/B:JOPT.0000010860.98970.16]; Hwang EY., 2013, MUSIC MED, V5, P136, DOI [10.1177/1943862113495894, DOI 10.1177/1943862113495894]; Ilgen MA, 2006, J SUBST ABUSE TREAT, V31, P157, DOI 10.1016/j.jsat.2006.04.001; JAMES MR, 1988, J MUSIC THER, V25, P206, DOI 10.1093/jmt/25.4.206; James MR, 1987, MUSIC THERAPY PERSPE, V4, P29; Jansma A, 2000, ADDICT BEHAV, V25, P619, DOI 10.1016/S0306-4603(99)00037-4; Jhanjee Sonali, 2014, Indian J Psychol Med, V36, P112, DOI 10.4103/0253-7176.130960; Jones JD, 2005, J MUSIC THER, V42, P94, DOI 10.1093/jmt/42.2.94; Knuuttila V, 2012, CLIN PSYCHOL-UK, V16, P123, DOI 10.1111/j.1742-9552.2012.00049.x; KOELSCH S., 2012, MUSIC HLTH WELLBEING, P436, DOI DOI 10.1016/J.PLREV.2011.04.003; Koelsch S, 2009, ANN NY ACAD SCI, V1169, P374, DOI 10.1111/j.1749-6632.2009.04592.x; Kotarba J A, 1991, AIDS Educ Prev, V3, P47; Liebowitz M, 2015, ARTS HEALTH, V7, P137, DOI 10.1080/17533015.2014.999246; Lin ST, 2011, HARVARD REV PSYCHIAT, V19, P34, DOI 10.3109/10673229.2011.549769; Long CG, 2000, ADDICT BEHAV, V25, P573, DOI 10.1016/S0306-4603(99)00018-0; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Magee WL, 2002, J MUSIC THER, V39, P20, DOI 10.1093/jmt/39.1.20; Maratos AS, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004517.pub2; Mays KL, 2008, SUBST ABUS, V29, P51, DOI 10.1080/08897070802418485; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Meier PS, 2006, DRUG ALCOHOL DEPEN, V83, P57, DOI 10.1016/j.drugalcdep.2005.10.010; Melnyk BM, 2005, EVIDENCE BASED PRACT; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Murphy KM, 2008, EFFECTS GROUP GUIDED; Murphy M., 1983, MUSIC THERAPY, V3, P52, DOI DOI 10.1093/MT/3.1.52; NERAD J, 1989, INT J PSYCHOPHYSIOL, V7, P334, DOI 10.1016/0167-8760(89)90270-5; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Oklan A.M., 2014, PSYCHOMUSICOLOGY, V24, P231, DOI [DOI 10.1037/, 10.1037/pmu0000058, DOI 10.1037/PMU0000058]; Pelletier CL, 2004, J MUSIC THER, V41, P192, DOI 10.1093/jmt/41.3.192; Porter S, 2017, J CHILD PSYCHOL PSYC, V58, P586, DOI 10.1111/jcpp.12656; PROCHASKA JO, 1982, PSYCHOTHER-THEOR RES, V19, P276, DOI 10.1037/h0088437; Puffer S, 2005, J EVAL CLIN PRACT, V11, P479, DOI 10.1111/j.1365-2753.2005.00568.x; Rio R., 2005, NORD J MUSIC THER, V14, P107, DOI DOI 10.1080/08098130509478133; Rosenthal R., 1968, URBAN REV, P16, DOI [10.1007/BF02322211, DOI 10.1007/BF02322211]; Ross S, 2008, J ADDICT DIS, V27, P41, DOI 10.1300/J069v27n01_05; ROTTER JB, 1966, PSYCHOL MONOGR, V80, P1, DOI 10.1037/h0092976; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Sharma M., 2011, PAKISTAN J PSYCHOL R, V27, P53; Short AD, 2015, PSYCHOL MUSIC, P559; Shuman J, 2016, ART PSYCHOTHER, V49, P50, DOI 10.1016/j.aip.2016.05.014; Silverman MJ, 2016, SUBST USE MISUSE, V51, P241, DOI 10.3109/10826084.2015.1092990; Silverman Michael J., 2015, [Korean Journal of Music Therapy, 한국음악치료학회지], V17, P81, DOI 10.21330/kjmt.2015.17.2.81; Silverman MJ, 2015, J MUSIC THER, V52, P117, DOI 10.1093/jmt/thu057; Silverman MJ, 2014, J ADDICT NURS, V25, P172, DOI 10.1097/JAN.0000000000000047; Silverman MJ, 2012, J MUSIC THER, V49, P414, DOI 10.1093/jmt/49.4.414; Silverman MJ, 2011, J ADDICT NURS, V22, P185, DOI 10.3109/10884602.2011.616606; Silverman MJ, 2011, J MUSIC THER, V48, P509, DOI 10.1093/jmt/48.4.509; Silverman MJ, 2009, MUSIC THER PERSPECT, V27, P115, DOI 10.1093/mtp/27.2.115; Silverman MJ, 2010, ART PSYCHOTHER, V37, P197, DOI 10.1016/j.aip.2010.04.001; Silverman MJ, 2010, ART PSYCHOTHER, V37, P1, DOI 10.1016/j.aip.2009.11.005; Silverman MJ, 2009, ART PSYCHOTHER, V36, P123, DOI 10.1016/j.aip.2008.10.005; Silverman MJ, 2003, ART PSYCHOTHER, V30, P273, DOI 10.1016/j.aip.2003.08.004; Stevens JR, 2009, J EDUC BEHAV STAT, V34, P46, DOI 10.3102/1076998607309080; Substance Abuse and Mental Health Services Administration, 2014, HHS PUBLICATION NO S; Substance Abuse and Mental Health Services Administration, 2009, DAS SER S, VS-46; United Nations Office on Drugs and Crime, 2016, INT STAND TREATM DRU; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Winkelman M, 2003, AM J PUBLIC HEALTH, V93, P647, DOI 10.2105/AJPH.93.4.647; Yun SH, 2010, J EVID-INFORM SOC WO, V7, P361, DOI 10.1080/15433710903323870; ZANKER A, 1956, Monatsschr Psychiatr Neurol, V131, P215; Zatorre RJ, 2015, ANN NY ACAD SCI, V1337, P202, DOI 10.1111/nyas.12677	102	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187363	10.1371/journal.pone.0187363	http://dx.doi.org/10.1371/journal.pone.0187363			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141012	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400022
J	Kokkinakis, AV; Cowling, PI; Drachen, A; Wade, AR				Kokkinakis, Athanasios V.; Cowling, Peter I.; Drachen, Anders; Wade, Alex R.			Exploring the relationship between video game expertise and fluid intelligence	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; SIMPLE REACTION-TIME; SPACE FORTRESS GAME; COGNITIVE-ABILITIES; INDIVIDUAL-DIFFERENCES; SELECTIVE ATTENTION; AGE-DIFFERENCES; CHESS PLAYERS; ONLINE GAME; PERFORMANCE	Hundreds of millions of people play intellectually-demanding video games every day. What does individual performance on these games tell us about cognition? Here, we describe two studies that examine the potential link between intelligence and performance in one of the most popular video games genres in the world (Multiplayer Online Battle Arenas: MOBAs). In the first study, we show that performance in the popular MOBA League of Legends' correlates with fluid intelligence as measured under controlled laboratory conditions. In the second study, we also show that the age profile of performance in the two most widely-played MOBAs (League of Legends and DOTA II) matches that of raw fluid intelligence. We discuss and extend previous videogame literature on intelligence and videogames and suggest that commercial video games can be useful as 'proxy' tests of cognitive performance at a global population level.	[Kokkinakis, Athanasios V.; Wade, Alex R.] Univ York, Dept Psychol, York, N Yorkshire, England; [Kokkinakis, Athanasios V.; Cowling, Peter I.; Drachen, Anders] Univ York, Dept Comp Sci, York, N Yorkshire, England	University of York - UK; University of York - UK	Wade, AR (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	alex.wade@york.ac.uk	Drachen, Anders/L-4690-2017; Cowling, Peter/L-4732-2017	Drachen, Anders/0000-0002-1002-0414; Kokkinakis, Athanasios/0000-0002-9048-340X; Cowling, Peter/0000-0003-1310-6683; Wade, Alexander Robert/0000-0003-4871-2747	Engineering and Physical Sciences Research Council [EP/L015846/1]; EPSRC [EP/M023265/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1517965, EP/M023265/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council, https://mw.epsrc.ac.uk/, EP/L015846/1 to PC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2014, INTELLIGENCE, V45, P6, DOI 10.1016/j.intell.2013.04.009; Adams D, 2012, P COGN SCI SOC 2012; Quiroga MA, 2015, INTELLIGENCE, V53, P1, DOI 10.1016/j.intell.2015.08.004; Quiroga MA, 2011, INT J ONLINE PEDAGOG, V1, P18, DOI 10.4018/ijopcd.2011070102; Bailey K, 2013, BRAIN RES, V1504, P35, DOI 10.1016/j.brainres.2013.02.019; Baker CA, 2014, INTELLIGENCE, V44, P78, DOI 10.1016/j.intell.2014.03.001; Baniqued PL, 2013, ACTA PSYCHOL, V142, P74, DOI 10.1016/j.actpsy.2012.11.009; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1111/1469-7610.00715; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Bonny JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169947; Bonny JW, 2017, COMPUT HUM BEHAV, V66, P377, DOI 10.1016/j.chb.2016.10.005; Bonny JW, 2016, 34TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, CHI 2016, P3473, DOI 10.1145/2858036.2858190; Boot WR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00003; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Burgoyne AP, 2016, INTELLIGENCE, V59, P72, DOI 10.1016/j.intell.2016.08.002; BYRNES MM, 1977, AM J MENT DEF, V81, P561; Cain MS, 2012, ATTEN PERCEPT PSYCHO, V74, P641, DOI 10.3758/s13414-012-0284-1; Colom R, 2004, INTELLIGENCE, V32, P277, DOI 10.1016/j.intell.2003.12.002; Colom R, 2006, MEMORY, V14, P804, DOI 10.1080/09658210600680020; Colzato LS, 2013, PSYCHOL RES-PSYCH FO, V77, P234, DOI 10.1007/s00426-012-0415-2; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; de Bruin ABH, 2014, INTELLIGENCE, V45, P18, DOI 10.1016/j.intell.2013.07.004; Deary IJ, 2010, PERS INDIV DIFFER, V49, P337, DOI 10.1016/j.paid.2009.11.012; Deary IJ, 2010, NAT REV NEUROSCI, V11, P201, DOI 10.1038/nrn2793; DONCHIN E, 1995, BEHAV RES METH INSTR, V27, P217, DOI 10.3758/BF03204735; Elo A., 2008, RATING CHESSPLAYERS; Engel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115212; Foroughi CK, 2016, INTELLIGENCE, V56, P58, DOI 10.1016/j.intell.2016.02.011; Foster JL, 2015, MEM COGNITION, V43, P226, DOI 10.3758/s13421-014-0461-7; FOZARD JL, 1994, J GERONTOL, V49, pP179, DOI 10.1093/geronj/49.4.P179; Gignac GE, 2014, INTELLIGENCE, V47, P122, DOI 10.1016/j.intell.2014.09.004; Gong DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09763; Gosling SD, 2004, SHOULD WE TRUST WEB; GOTTSDANKER R, 1982, J GERONTOL, V37, P342, DOI 10.1093/geronj/37.3.342; Grabner RH, 2007, ACTA PSYCHOL, V124, P398, DOI 10.1016/j.actpsy.2006.07.008; Grabner RH, 2014, INTELLIGENCE, V45, P26, DOI 10.1016/j.intell.2013.07.023; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Green CS, 2010, CURR BIOL, V20, P1573, DOI 10.1016/j.cub.2010.07.040; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; HORN JL, 1966, J GERONTOL, V21, P210, DOI 10.1093/geronj/21.2.210; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kaufman A.S., 2005, ASSESSING ADOLESCENT; Kaufman AS, 2008, J PSYCHOEDUC ASSESS, V26, P350, DOI 10.1177/0734282908314108; Kaufman AS, 2001, INTELLIGENCE, V29, P131, DOI 10.1016/S0160-2896(00)00046-5; Kim YJ, 2016, ACAD MANAGE P, V2016, P13564; Kokkinakis AV, 2016, COMPUT HUM BEHAV, V55, P605, DOI 10.1016/j.chb.2015.09.034; Kou Y., 2014, P 1 ACM SIGCHI ANN S, P161; Krishnan L, 2013, BRAIN TOPOGR, V26, P83, DOI 10.1007/s10548-012-0232-3; Kuhn S, 2014, MOL PSYCHIATR, V19, P265, DOI 10.1038/mp.2013.120; Kuhn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091506; KYLLONEN PC, 1990, INTELLIGENCE, V14, P389, DOI 10.1016/S0160-2896(05)80012-1; Lara J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0470-9; Latham AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00941; MANE A, 1989, ACTA PSYCHOL, V71, P17, DOI 10.1016/0001-6918(89)90003-6; Palaus M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00248; Quiroga MA, 2009, COMPUT EDUC, V53, P414, DOI 10.1016/j.compedu.2009.02.017; RABBITT P, 1989, ACTA PSYCHOL, V71, P243, DOI 10.1016/0001-6918(89)90011-5; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Saperstein AM, 2006, SCHIZOPHRENIA BULL, V32, P498, DOI 10.1093/schbul/sbj072; Schweizer S, 2011, BEHAV RES THER, V49, P498, DOI 10.1016/j.brat.2011.05.007; Sharma V.K., 1975, CAN J STAT, V3, P119, DOI [10.2307/3315104, DOI 10.2307/3315104]; Spitz HH, 1978, AM J MENTAL DEFICIEN; Spitz HH, 1978, INTELLIGENCE, V2, P371, DOI [10.1016/0160-2896(78)90026-0, DOI 10.1016/0160-2896(78)90026-0]; Spitz HH, 1977, INTELLIGENCE, V1, P108; Stafford T, 2014, PSYCHOL SCI, V25, P511, DOI 10.1177/0956797613511466; Tekofsky S., 2013, 2013 IEEE C COMP INT, P1; Tekofsky S, 2015, IEEE T COMP INTEL AI, V7, P292, DOI 10.1109/TCIAIG.2015.2393433; Thompson JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094215; Unsworth N, 2015, PSYCHOL SCI, V26, P759, DOI 10.1177/0956797615570367; Wechsler D, 2011, WECHSLER ABBREVIATED; West GL, 2017, MOL PSYCHIAT; WILKINSON RT, 1989, J GERONTOL, V44, pP29, DOI 10.1093/geronj/44.2.P29; Wongupparaj P, 2015, INTELLIGENCE, V53, P166, DOI 10.1016/j.intell.2015.10.007	77	30	31	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186621	10.1371/journal.pone.0186621	http://dx.doi.org/10.1371/journal.pone.0186621			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141019	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000415260400008
J	Yamako, G; Chosa, E; Totoribe, K; Fukao, Y; Deng, G				Yamako, Go; Chosa, Etsuo; Totoribe, Koji; Fukao, Yuu; Deng, Gang			Quantification of the sit-to-stand movement for monitoring age-related motor deterioration using the Nintendo Wii Balance Board	PLOS ONE			English	Article							PRESSURE MEASURES; MUSCLE STRENGTH; ELDERLY PERSONS; FORCE PLATFORM; RISK-FACTORS; CHAIR-RISE; BIOMECHANICS; STRATEGIES; MOBILITY; WOMEN	Simple methods for quantitative evaluations of individual motor performance are crucial for the early detection of motor deterioration. Sit-to-stand movement from a chair is a mechanically demanding component of activities of daily living. Here, we developed a novel method using the ground reaction force and center of pressure measured from the Nintendo Wii Balance Board to quantify sit-to-stand movement (sit-to-stand score) and investigated the agerelated change in the sit-to-stand score as a method to evaluate reduction in motor performance. The study enrolled 503 participants (mean age +/- standard deviation, 51.0 +/- 19.7 years; range, 20 +/- 88 years; male/female ratio, 226/277) without any known musculoskeletal conditions that limit sit-to-stand movement, which were divided into seven 10-year age groups. The participants were instructed to stand up as quickly as possible, and the sit-tostand score was calculated as the combination of the speed and balance indices, which have a tradeoff relationship. We also performed the timed up and go test, a well-known clinical test used to evaluate an individual's mobility. There were significant differences in the sit-to-stand score and timed up and go time among age groups. The mean sit-to-stand score for 60s, 70s, and 80s were 77%, 68%, and 53% of that for the 20s, respectively. The timed up and go test confirmed the age-related decrease in mobility of the participants. In addition, the sit-to-stand score measured using the Wii Balance Board was compared with that from a laboratory-graded force plate using the Bland-Altman plot (bias = -3.1 [ms](-1), 95% limit of agreement: -11.0 to 3.9 [ms](-1)). The sit-to-stand score has good inter-device reliability (intraclass correlation coefficient = 0.87). Furthermore, the test-retest reliability is substantial (intraclass correlation coefficient = 0.64). Thus, the proposed STS score will be useful to detect the early deterioration of motor performance.	[Yamako, Go] Univ Miyazaki, Org Promot Tenure Track, Miyazaki, Japan; [Chosa, Etsuo; Totoribe, Koji; Fukao, Yuu] Univ Miyazaki, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Fac Med, Miyazaki, Japan; [Deng, Gang] Univ Miyazaki, Dept Mech Design Syst, Fac Engn, Miyazaki, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki	Yamako, G (corresponding author), Univ Miyazaki, Org Promot Tenure Track, Miyazaki, Japan.	g.yamako@cc.miyazaki-u.ac.jp		Yamako, Go/0000-0001-9270-0212	Japan Science and Technology Agency [MP27115658746]; LEXI Co., Ltd.; Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [17K01362] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); LEXI Co., Ltd.; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Science and Technology Agency (MP27115658746, URL: http://www.jst.go.jp/EN/index.html), by LEXI Co., Ltd., URL: https://www.lexi.co.jp/en/), and by the Program to Disseminate Tenure Tracking from the Ministry of Education, Culture, Sports, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujaber S, 2015, GAIT POSTURE, V41, P676, DOI 10.1016/j.gaitpost.2015.01.023; Abujaber SB, 2015, J ARTHROPLASTY, V30, P2027, DOI 10.1016/j.arth.2015.05.024; Bartlett HL, 2014, GAIT POSTURE, V39, P224, DOI 10.1016/j.gaitpost.2013.07.010; Bishop M, 2005, CLIN BIOMECH, V20, P112, DOI 10.1016/j.clinbiomech.2004.08.002; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Chen HB, 2010, GAIT POSTURE, V32, P576, DOI 10.1016/j.gaitpost.2010.08.005; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; CLEMENT FJ, 1974, J GERONTOL, V29, P423, DOI 10.1093/geronj/29.4.423; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DOHERTY TJ, 1993, CAN J APPL PHYSIOL, V18, P331, DOI 10.1139/h93-029; Frontera WR, 1985, J APPL PHYSIOL, V1991, P644; Goble DJ, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-12; Granacher U, 2011, GERONTOLOGY, V57, P304, DOI 10.1159/000320250; Gross MM, 1998, GAIT POSTURE, V8, P175, DOI 10.1016/S0966-6362(98)00033-2; Hsu WL, 2013, AGE, V35, P1299, DOI 10.1007/s11357-012-9422-x; HUGHES MA, 1994, CLIN BIOMECH, V9, P187, DOI 10.1016/0268-0033(94)90020-5; Huurnink A, 2013, J BIOMECH, V46, P1392, DOI 10.1016/j.jbiomech.2013.02.018; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Leach JM, 2014, SENSORS-BASEL, V14, P18244, DOI 10.3390/s141018244; Lindemann U, 2003, EUR J APPL PHYSIOL, V89, P466, DOI 10.1007/s00421-003-0837-z; Mazza C, 2005, GAIT POSTURE, V21, P425, DOI 10.1016/j.gaitpost.2004.05.006; Narumi K, 2017, J ORTHOP SCI, V22, P765, DOI 10.1016/j.jos.2017.03.012; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; RODOSKY MW, 1989, J ORTHOPAED RES, V7, P266, DOI 10.1002/jor.1100070215; Roy G, 2007, CLIN BIOMECH, V22, P795, DOI 10.1016/j.clinbiomech.2007.03.007; Sibella F, 2003, CLIN BIOMECH, V18, P745, DOI 10.1016/S0268-0033(03)00144-X; Spyropoulos G, 2013, GAIT POSTURE, V38, P62, DOI 10.1016/j.gaitpost.2012.10.013; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Taylor ME, 2013, INT PSYCHOGERIATR, V25, P148, DOI 10.1017/S1041610212001184; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tsai YC, 2014, J BIOMECH, V47, P482, DOI 10.1016/j.jbiomech.2013.10.047; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157968; Yamako G, 2016, J ORTHOP SCI, V21, P517, DOI 10.1016/j.jos.2016.04.006; Young W, 2011, GAIT POSTURE, V33, P303, DOI 10.1016/j.gaitpost.2010.10.089	37	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188165	10.1371/journal.pone.0188165	http://dx.doi.org/10.1371/journal.pone.0188165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136031	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200074
J	Alemar, B; Gregorio, C; Herzog, J; Bittar, CM; Netto, CBO; Artigalas, O; Schwartz, IVD; Coffa, J; Camey, SA; Weitzel, J; Ashton-Prolla, P				Alemar, Baarbara; Gregorio, Cleandra; Herzog, Josef; Bittar, Camila Matzenbacher; Oliveira Netto, Cristina Brinckmann; Artigalas, Osvaldo; Schwartz, Ida Vanessa D.; Coffa, Jordy; Camey, Suzi Alves; Weitzel, Jeffrey; Ashton-Prolla, Patricia			BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?	PLOS ONE			English	Article							GERMLINE MUTATIONS; RISK-ASSESSMENT; GUIDELINES; STATEMENT; VARIANTS; FAMILIES; GENETICS; GENOMICS; SOCIETY; GENES	Background Germline pathogenic variants in BRCA1 and BRCA2 (BRCA) are the main cause of Hereditary Breast and Ovarian Cancer syndrome (HBOC). Methods In this study we evaluated the mutational profile and prevalence of BRCA pathogenic/likely pathogenic variants among probands fulfilling the NCCN HBOC testing criteria. We characterized the clinical profile of these individuals and explored the performance of international testing criteria. Results A pathogenic/likely pathogenic variant was detected in 19.1% of 418 probands, including seven novel frameshift variants. Variants of uncertain significance were found in 5.7% of individuals. We evaluated 50 testing criteria and mutation probability algorithms. There was a significant odds-ratio (OR) for mutation prediction (p <= 0.05) for 25 criteria; 14 of these had p <= 0.001. Using a cutoff point of four criteria, the sensitivity is 83.8%, and the specificity is 53.5% for being a carrier. The prevalence of pathogenic/likely pathogenic variants for each criterion ranged from 22.1% to 55.6%, and criteria with the highest ORs were those related to triple-negative breast cancer or ovarian cancer. Conclusions This is the largest study of comprehensive BRCA testing among Brazilians to date, and the first to analyze clinical criteria for genetic testing. Several criteria that are not included in the NCCN achieved a higher predictive value. Identification of the most informative criteria for each population will assist in the development of a rational approach to genetic testing, and will enable the prioritization of high-risk individuals as a first step towards offering testing in low-income countries.	[Alemar, Baarbara; Gregorio, Cleandra; Bittar, Camila Matzenbacher; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil; [Alemar, Baarbara; Gregorio, Cleandra; Bittar, Camila Matzenbacher; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil; [Herzog, Josef; Weitzel, Jeffrey] City Hope Natl Med Ctr, Div Clin Canc Genom, Dept Populat Sci, Duarte, CA USA; [Oliveira Netto, Cristina Brinckmann; Schwartz, Ida Vanessa D.; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil; [Artigalas, Osvaldo] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [Schwartz, Ida Vanessa D.; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Coffa, Jordy] MRC Holland, Amsterdam, Netherlands; [Camey, Suzi Alves] Univ Fed Rio Grande do Sul, Dept Estat, Programa Posgrad Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; City of Hope; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil.; Ashton-Prolla, P (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	pprolla@gmail.com	Ashton-Prolla, Patricia/T-3515-2019; Ashton-Prolla, Patricia/H-2927-2012; Schwartz, Ida/M-1422-2015; Schwartz, Ida Vanessa Doederlein/ABG-5471-2020; Camey, Suzi Alves/Y-2756-2019	Schwartz, Ida/0000-0002-7933-6687; Schwartz, Ida Vanessa Doederlein/0000-0002-7933-6687; Camey, Suzi Alves/0000-0002-5564-081X; Gregorio Silva, Cleandra/0000-0002-6476-219X	Breast Cancer Research Foundation [02-2013-044]; National Institute of Health/National Cancer Institute grant [RC4 CA153828-01]; Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)	Breast Cancer Research Foundation; National Institute of Health/National Cancer Institute grant; Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported in part by a grant from the Breast Cancer Research Foundation, Avon grant #02-2013-044 (JW), and National Institute of Health/National Cancer Institute grant #RC4 CA153828-01 (JW) for the Clinical Cancer Genomics Community Research Network. Support in part was provided by grants from Fundo de Incentivo a Pesquisa e Eventos (FIPE) from Hospital de Clinicas de Porto Alegre (PAP) and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BA). PAP is a researcher from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - Brazil) and BA and CG received a grant from the same agency. Funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors (Jordy Coffa) is employed by a commercial company (MRC-Holland) and we declare that "The funder provided support in the form of salaries for authors (JC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alemar B, 2016, CANCER GENET-NY, V209, P417, DOI 10.1016/j.cancergen.2016.06.008; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2015, PROTOCOL 2 BRCA1 BRC; Ashton-Prolla P, 2015, J COMMUN GENET, V6, P275, DOI 10.1007/s12687-015-0238-0; Azzollini J, 2016, EUR J INTERN MED, V32, P65, DOI 10.1016/j.ejim.2016.03.010; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Carraro DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057581; Clinical Practice Guidelines in Oncology, 2017, GEN FAM HIGH RISK AS; Clinical Practice Guidelines in Oncology, 2014, GEN FAM HIGH RISK AS; Evans DGR, 2004, J MED GENET, V41, P474, DOI 10.1136/jmg.2003.017996; Felix GE, 2014, GERMLINE MUTATIONS B; Fernandes GC, 2016, ONCOTARGET; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Grana B, 2011, CLIN TRANSL ONCOL, V13, P580, DOI 10.1007/s12094-011-0701-2; Hamel N, 2011, EUR J HUM GENET, V19, P300, DOI 10.1038/ejhg.2010.203; Heidemann S, 2012, BREAST CANCER RES TR, V134, P1229, DOI 10.1007/s10549-012-2050-4; Lalloo F, 2012, CLIN GENET, V82, P105, DOI 10.1111/j.1399-0004.2012.01859.x; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy-Lahad E, 2007, BRIT J CANCER, V96, P11, DOI 10.1038/sj.bjc.6603535; Lu KH, 2014, J CLIN ONCOL, V32, P833, DOI 10.1200/JCO.2013.50.9257; Maistro S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2966-x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ready K, 2011, BREAST J, V17, P210, DOI 10.1111/j.1524-4741.2010.01055.x; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Silva FC, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-55; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Team RC., 2013, R LANG ENV STAT COMP; Tung N, 2016, J CLIN ONCOL, V34, P1460, DOI 10.1200/JCO.2015.65.0747; Weitzel JN, 2011, CA-CANCER J CLIN, V61, P327, DOI 10.3322/caac.20128	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187630	10.1371/journal.pone.0187630	http://dx.doi.org/10.1371/journal.pone.0187630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161300	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000013
J	Contu, S; Hussain, A; Kager, S; Budhota, A; Deshmukh, VA; Kuah, CWK; Yam, LHL; Xiang, LM; Chua, KSG; Masia, L; Campolo, D				Contu, Sara; Hussain, Asif; Kager, Simone; Budhota, Aamani; Deshmukh, Vishwanath A.; Kuah, Christopher W. K.; Yam, Lester H. L.; Xiang, Liming; Chua, Karen S. G.; Masia, Lorenzo; Campolo, Domenico			Proprioceptive assessment in clinical settings: Evaluation of joint position sense in upper limb post-stroke using a robotic manipulator	PLOS ONE			English	Article							ASSISTED THERAPY; MOTOR RECOVERY; BASAL GANGLIA; ARM MOVEMENTS; STROKE; REHABILITATION; SHOULDER; PATTERNS; FINGER; ELBOW	Proprioception is a critical component for motor functions and directly affects motor learning after neurological injuries. Conventional methods for its assessment are generally ordinal in nature and hence lack sensitivity. Robotic devices designed to promote sensorimotor learning can potentially provide quantitative precise, accurate, and reliable assessments of sensory impairments. In this paper, we investigate the clinical applicability and validity of using a planar 2 degrees of freedom robot to quantitatively assess proprioceptive deficits in post-stroke participants. Nine stroke survivors and nine healthy subjects participated in the study. Participants' hand was passively moved to the target position guided by the H-Man robot (Criterion movement) and were asked to indicate during a second passive movement towards the same target (Matching movement) when they felt that they matched the target position. The assessment was carried out on a planar surface for movements in the forward and oblique directions in the contralateral and ipsilateral sides of the tested arm. The matching performance was evaluated in terms of error magnitude (absolute and signed) and its variability. Stroke patients showed higher variability in the estimation of the target position compared to the healthy participants. Further, an effect of target was found, with lower absolute errors in the contralateral side. Pairwise comparison between individual stroke participant and control participants showed significant proprioceptive deficits in two patients. The proposed assessment of passive joint position sense was inherently simple and all participants, regardless of motor impairment level, could complete it in less than 10 minutes. Therefore, the method can potentially be carried out to detect changes in proprioceptive deficits in clinical settings.	[Contu, Sara; Hussain, Asif; Budhota, Aamani; Masia, Lorenzo; Campolo, Domenico] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Robot Res Ctr, Singapore, Singapore; [Kager, Simone] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Budhota, Aamani] Nanyang Technol Univ, Interdisciplinary Grad Sch, Singapore, Singapore; [Deshmukh, Vishwanath A.; Kuah, Christopher W. K.; Yam, Lester H. L.; Chua, Karen S. G.] Tan Tock Seng Hosp, Dept Rehabil Med, Ctr Adv Rehabil Therapeut, Singapore, Singapore; [Xiang, Liming] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Campolo, D (corresponding author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Robot Res Ctr, Singapore, Singapore.	d.campolo@ntu.edu.sg	Campolo, Domenico/G-5648-2010; Xiang, Liming/AGF-0351-2022; Xiang, Liming/B-6966-2011	Campolo, Domenico/0000-0001-6930-0413; Xiang, Liming/0000-0003-0698-5173; Xiang, Liming/0000-0003-0698-5173; Chua, Karen/0000-0001-9809-3425	'H-Man' project, Ministry of Health, Singapore [NMRC/BnB/0006b/2013]; Interdisciplinary Graduate School, Nanyang Technological University, Singapore	'H-Man' project, Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore	Part of this work was supported by the 'H-Man' project (NMRC/BnB/0006b/2013), Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Part of this work was supported by the 'H-Man' project (NMRC/BnB/0006b/2013), Ministry of Health, Singapore; Interdisciplinary Graduate School, Nanyang Technological University, Singapore.	Aisen ML, 1997, ARCH NEUROL-CHICAGO, V54, P443, DOI 10.1001/archneur.1997.00550160075019; Balasubramanian Sivakumar, 2012, Am J Phys Med Rehabil, V91, pS255, DOI 10.1097/PHM.0b013e31826bcdc1; Beer RF, 2004, EXP BRAIN RES, V156, P458, DOI 10.1007/s00221-003-1807-8; Beer RF, 1999, ARCH PHYS MED REHAB, V80, P766, DOI 10.1016/S0003-9993(99)90225-3; Beer RF, 2000, EXP BRAIN RES, V131, P305, DOI 10.1007/s002219900275; BEVAN L, 1994, J NEUROPHYSIOL, V71, P1862, DOI 10.1152/jn.1994.71.5.1862; Brewer B. R., 2014, TOP STROKE REHABIL; Campolo D, 2014, J NEUROSCI METH, V235, P285, DOI 10.1016/j.jneumeth.2014.07.003; Cappello L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00198; Carey LM, 1995, CRITICAL REV, V7; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Contu S, 2016, IEEE ENG MED BIO, P4614, DOI 10.1109/EMBC.2016.7591755; Desmurget M, 2003, EXP BRAIN RES, V153, P197, DOI 10.1007/s00221-003-1593-3; DEWALD JPA, 1995, BRAIN, V118, P495, DOI 10.1093/brain/118.2.495; Dewald JPA, 2001, MUSCLE NERVE, V24, P273, DOI 10.1002/1097-4598(200102)24:2<273::AID-MUS130>3.0.CO;2-Z; Dukelow SP, 2010, NEUROREHAB NEURAL RE, V24, P178, DOI 10.1177/1545968309345267; Ellis MD, 2007, EXP BRAIN RES, V176, P594, DOI 10.1007/s00221-006-0637-x; Frisoli A, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-36; Fuentes CT, 2010, J NEUROPHYSIOL, V103, P164, DOI 10.1152/jn.00494.2009; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; Goble DJ, 2010, PHYS THER, V90, P1176, DOI 10.2522/ptj.20090399; GOBLE DJ, 2016, PHYS THER, V90, P1176, DOI DOI 10.2522/PTJ.20090399; Gradwell E., 2003, 8 INT C REHABILITATI, P55; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; HALL LA, 1983, J PHYSIOL-LONDON, V335, P519, DOI 10.1113/jphysiol.1983.sp014548; Han J, 2011, APPL MECH MATER, V66-68, P620, DOI 10.4028/www.scientific.net/AMM.66-68.620; Hesse S, 2003, ARCH PHYS MED REHAB, V84, P915, DOI 10.1016/S0003-9993(02)04954-7; Hillier S., 2015, NEUROREHAB NEURAL RE; HUANG CY, 1987, J NEUROL NEUROSUR PS, V50, P720, DOI 10.1136/jnnp.50.6.720; Hussain A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00477; Ingemanson ML, 2016, EXP BRAIN RES, V234, P83, DOI 10.1007/s00221-015-4440-4; Ishii S, 1989, Rinsho Shinkeigaku, V29, P269; Janwantanakul P, 2001, ARCH PHYS MED REHAB, V82, P840, DOI 10.1053/apmr.2001.21865; Konczak J, 2009, J MOTOR BEHAV, V41, P543, DOI 10.3200/35-09-002; Kosinski R.J, 2008, LIT REV REACTION TIM; Kumral Emre, 2003, J Stroke Cerebrovasc Dis, V12, P66, DOI 10.1053/jscd.2003.11; Kwakkel G., 2007, NEUROREHABILITATION; Leibowitz N, 2008, DISABIL REHABIL, V30, P1829, DOI 10.1080/09638280701640145; Lincoln NB, 1998, PHYSIOTHERAPY, V84, P358, DOI [10.1016/S0031-9406(05)61454-X, DOI 10.1016/S0031-9406(05)61454-X]; Lo AC, 2010, NEW ENGL J MED, V362, P1772, DOI 10.1056/NEJMoa0911341; Lum PS, 2002, ARCH PHYS MED REHAB, V83, P952, DOI 10.1053/apmr.2001.33101; Marini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161155; Maschke M, 2003, BRAIN, V126, P2312, DOI 10.1093/brain/awg230; MCCLATCHIE G, 1980, MED J AUSTRALIA, V1, P649, DOI 10.5694/j.1326-5377.1980.tb135209.x; Niessen MH, 2008, ARCH PHYS MED REHAB, V89, P333, DOI 10.1016/j.apmr.2007.08.157; Nordin N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-137; Norouzi-Gheidari N, 2012, J REHABIL RES DEV, V49, P479, DOI 10.1682/JRRD.2010.10.0210; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; REFSHAUGE KM, 1995, J PHYSIOL-LONDON, V488, P231, DOI 10.1113/jphysiol.1995.sp020961; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Salles JI, 2011, NEUROSCI LETT, V501, P61, DOI 10.1016/j.neulet.2011.05.005; Santisteban L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154792; Schmidt RA, 1988, HUMAN KINETICS; Semrau JA, 2015, STROKE, V46, P3459, DOI 10.1161/STROKEAHA.115.010750; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Simo LS, 2011, IEEE ENG MED BIO, P8227, DOI 10.1109/IEMBS.2011.6092029; Stinear CM, 2007, BRAIN, V130, P170, DOI 10.1093/brain/awl333; Tyson S., 2007, NEUROREHABILITATION; Wilson ET, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011851; Winward CE, 2002, CLIN REHABIL, V16, P523, DOI 10.1191/0269215502cr522oa	60	22	25	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0183257	10.1371/journal.pone.0183257	http://dx.doi.org/10.1371/journal.pone.0183257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161264	Green Published, gold			2022-12-27	WOS:000415987000002
J	Rossetti, B; Gagliardini, R; Meini, G; Sterrantino, G; Colangeli, V; Re, MC; Latini, A; Colafigli, M; Vignale, F; Rusconi, S; Micheli, V; Di Biagio, A; Orofino, G; Ghisetti, V; Fantauzzi, A; Vullo, V; Grima, P; Francisci, D; Mastroianni, C; Antinori, A; Trezzi, M; Lisi, L; Navarra, P; Canovari, B; Monforte, AD; Lamonica, S; D'Avino, A; Zazzi, M; Di Giambenedetto, S; De Luca, A				Rossetti, Barbara; Gagliardini, Roberta; Meini, Genny; Sterrantino, Gaetana; Colangeli, Vincenzo; Re, Maria Carla; Latini, Alessandra; Colafigli, Manuela; Vignale, Francesca; Rusconi, Stefano; Micheli, Valeria; Di Biagio, Antonio; Orofino, Giancarlo; Ghisetti, Valeria; Fantauzzi, Alessandra; Vullo, Vincenzo; Grima, Pierfrancesco; Francisci, Daniela; Mastroianni, Claudio; Antinori, Andrea; Trezzi, Michele; Lisi, Lucia; Navarra, Pierluigi; Canovari, Benedetta; Monforte, Antonella D'Arminio; Lamonica, Silvia; D'Avino, Alessandro; Zazzi, Maurizio; Di Giambenedetto, Simona; De Luca, Andrea		GUSTA Trial Study Grp	Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial	PLOS ONE			English	Article							TREATMENT-NAIVE PATIENTS; RITONAVIR PLUS LAMIVUDINE; ONCE-DAILY MARAVIROC; OPEN-LABEL; TRIPLE TREATMENT; DUAL TREATMENT; REGIMEN; MAINTENANCE; COMBINATION; EFFICACY	Objectives Primary study outcome was absence of treatment failure (virological failure, VF, or treatment interruption) per protocol at week 48. Methods Patients on 3-drug ART with stable HIV-1 RNA <50 copies/mL and CCR5-tropic virus were randomized 1:1 to maraviroc with darunavir/ritonavir qd (study arm) or continue current ART (continuation arm). Results In June 2015, 115 patients were evaluable for the primary outcome (56 study, 59 continuation arm). The study was discontinued due to excess of VF in the study arm (7 cases, 12.5%, vs 0 in the continuation arm, p = 0.005). The proportion free of treatment failure was 73.2% in the study and 59.3% in the continuation arm. Two participants in the study and 10 in the continuation arm discontinued therapy due to adverse events (p = 0.030). At VF, no emergent drug resistance was detected. Co-receptor tropism switched to non-R5 in one patient. Patients with VF reported lower adherence and had lower plasma drug levels. Femoral bone mineral density was significantly improved in the study arm. Conclusion Switching to maraviroc with darunavir/ritonavir qd in virologically suppressed patients was associated with improved tolerability but was virologically inferior to 3-drug therapy.	[Rossetti, Barbara; De Luca, Andrea] Azienda Osped Univ Senese, Infect Dis Unit, Siena, Italy; [Rossetti, Barbara; Gagliardini, Roberta; Lamonica, Silvia; D'Avino, Alessandro; Di Giambenedetto, Simona] Univ Cattolica Sacro Cuore, Clin Infect Dis, Rome, Italy; [Meini, Genny; Zazzi, Maurizio; De Luca, Andrea] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Sterrantino, Gaetana] Azienda Osped Univ Careggi, Clin Infect Dis, Florence, Italy; [Colangeli, Vincenzo] Azienda Osped Univ S Orsola Malpighi, Clin Infect Dis, Bologna, Italy; [Re, Maria Carla] Azienda Osped Univ S Orsola Malpighi, Microbiol, Bologna, Italy; [Latini, Alessandra; Colafigli, Manuela] IRCCS IFO, Infect Dermatol & Allergol, Rome, Italy; [Vignale, Francesca] Univ G DAnnunzio, Clin Infect Dis, Chieti, Italy; [Rusconi, Stefano] Univ Milan, DIBIC L Sacco Hosp, Infect & Trop Dis Unit, Milan, Italy; [Micheli, Valeria] L Sacco Hosp Vialba, Microbiol & Virol Lab, Milan, Italy; [Di Biagio, Antonio] IRCCS S Martino IST, Infect Dis Unit, Genoa, Italy; [Orofino, Giancarlo] Amedeo Savoia Hosp, Infect Dis Unit A, Turin, Italy; [Ghisetti, Valeria] Amedeo Savoia Hosp, Microbiol & Virol Lab, Turin, Italy; [Fantauzzi, Alessandra] Sapienza Univ Rome, Dept Clin Med, Rome, Italy; [Vullo, Vincenzo] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Grima, Pierfrancesco] S Caterina Novella Hosp, Div Infect Dis, Lecce, Italy; [Francisci, Daniela] Univ Perugia, Clin Infect Dis, Perugia, Italy; [Mastroianni, Claudio] Sapienza Univ, Infect Dis Unit, SM Goretti Hosp, Dept Publ Hlth & Infect Dis, Latina, Italy; [Antinori, Andrea] IRCCS L Spallanzani, Infect Dis Unit, Rome, Italy; [Trezzi, Michele] Pistoia Hosp, Infect Dis Unit, Pistoia, Italy; [Lisi, Lucia; Navarra, Pierluigi] Univ Cattolica Sacro Cuore, Pharmacol Dept, Rome, Italy; [Canovari, Benedetta] Pesaro Hosp, Infect Dis Unit, Pesaro, Italy; [Monforte, Antonella D'Arminio] Univ Milan, San Paolo Hosp, Dept Hlth Sci, Infect & Trop Dis Inst, Milan, Italy	University of Siena; University Hospital of Siena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Istituti Fisioterapici Ospitalieri (IFO); G d'Annunzio University of Chieti-Pescara; University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital; Sapienza University Rome; Sapienza University Rome; University of Perugia; Sapienza University Rome; IRCCS Lazzaro Spallanzani; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; San Paolo-Polo Universitaria Hospital; University of Milan	Rossetti, B (corresponding author), Azienda Osped Univ Senese, Infect Dis Unit, Siena, Italy.; Rossetti, B (corresponding author), Univ Cattolica Sacro Cuore, Clin Infect Dis, Rome, Italy.	brossetti1982@gmail.com	Navarra, Pierluigi/AAL-4307-2020; Antinori, Andrea/K-7125-2016; GHISETTI, VALERIA/AAW-4460-2021; Micheli, Valeria/G-4927-2018; Rusconi, Stefano/H-9263-2012; digiambenedetto, simona/AAL-4429-2020; MASTROIANNI, Claudio Maria/O-9741-2019; Zazzi, Maurizio/K-3422-2018; Grima, Pierfrancesco/HDN-1703-2022; latini, alessandra/J-8186-2018; gagliardini, roberta/AAA-7253-2019; Gagliardini, Roberta/AAT-6951-2020; Colafigli, Manuela/K-5167-2018; Lisi, Lucia/AAL-1063-2020; Rossetti, Barbara/AAA-5989-2019; Di Biagio, Antonio/J-4901-2019; De Luca, Andrea/G-8810-2011	Antinori, Andrea/0000-0003-2121-4684; Micheli, Valeria/0000-0001-5629-3875; Rusconi, Stefano/0000-0002-0375-9990; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Zazzi, Maurizio/0000-0002-0344-6281; Colafigli, Manuela/0000-0003-1610-6347; Di Biagio, Antonio/0000-0003-1436-5089; De Luca, Andrea/0000-0002-9561-9193; Lisi, Lucia/0000-0003-1397-2426; /0000-0003-1659-9241; Ghisetti, Valeria/0000-0002-4698-598X; Ciotti, Gabriella Maria Pia/0000-0002-7708-6637; Gagliardini, Roberta/0000-0002-6351-2623; Latini, Alessandra/0000-0002-9421-6560	Ministero della Salute, ISS, for Programma Nazionale AIDS project [40H94]; ViiV Healthcare Italy	Ministero della Salute, ISS, for Programma Nazionale AIDS project; ViiV Healthcare Italy	This work was partially funded by grants from Ministero della Salute, ISS, for Programma Nazionale AIDS project number 40H94. Janssen Europe provided Darunavir tablets for patients in the study arm and supported the pharmacovigilance of the study and ViiV Healthcare Italy supported tropism testing for all patients for conducting the study. ViiV Healthcare Italy also supported plasma antiretroviral drug monitoring for patients in the study arm for conducting the study. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; [Anonymous], 2016, GUID US ANT AG HIV 1; [Anonymous], 2016, JAMA-J AM MED ASSOC, V316, P191, DOI DOI 10.1001/JAMA.2016.8900; Armenia D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105853; Arribas JR, 2015, LANCET INFECT DIS, V15, P785, DOI 10.1016/S1473-3099(15)00096-1; Calza L, 2017, AIDS RES HUM RETROV, V33, P632, DOI [10.1089/aid.2016.0291, 10.1089/AID.2016.0291]; Cooper DA, 2014, AIDS, V28, P717, DOI 10.1097/QAD.0000000000000131; Di Giambenedetto S, 2017, J ANTIMICROB CHEMOTH, V72, P1163, DOI 10.1093/jac/dkw557; European AIDS Clinical Society (EACS), 2017, GUID CLIN MAN TREATM; Fabbiani M, 2016, J INFECTION, V73, P619, DOI 10.1016/j.jinf.2016.08.011; Fisher M, 2014, J INT AIDS SOC, V17, P203, DOI 10.7448/IAS.17.4.19824; Gagliardini R, 2016, INT C HIV DRUG THERP; Grant PM, 2016, CURR OPIN HIV AIDS, V11, P326, DOI 10.1097/COH.0000000000000248; Grivel JC, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S6; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Llibre JM, 2017, 24 C RETR RUS OPP IN; Meini G, 2014, J ANTIMICROB CHEMOTH, V69, P735, DOI 10.1093/jac/dkt426; Mills A, 2013, JAIDS-J ACQ IMM DEF, V62, P164, DOI 10.1097/QAI.0b013e31827b51b5; Mugavero MJ, 2011, CLIN INFECT DIS, V53, P927, DOI 10.1093/cid/cir526; Murri R, 2010, JAIDS-J ACQ IMM DEF, V55, P411, DOI 10.1097/QAI.0b013e3181ed1932; Okoli C, 2012, J ANTIMICROB CHEMOTH, V67, P671, DOI 10.1093/jac/dkr493; Pedrol E, 2015, HIV CLIN TRIALS, V16, P43, DOI 10.1179/1528433614Z.0000000001; Perez-Molina JA, 2015, LANCET INFECT DIS, V15, P775, DOI 10.1016/S1473-3099(15)00097-3; Pett SL, 2016, CLIN INFECT DIS; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Pulido F, 2016, INT C HIV DRUG THER; Sabin CA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0588-4; Stellbrink HJ, 2016, AIDS, V30, P1229, DOI 10.1097/QAD.0000000000001058; Svicher V, 2014, INFECTION, V42, P61, DOI 10.1007/s15010-013-0510-3; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Taiwo BO, 2015, CLIN INFECT DIS, V61, P1179, DOI 10.1093/cid/civ455; Valantin MA, 2012, J ANTIMICROB CHEMOTH, V67, P691, DOI 10.1093/jac/dkr504; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187393	10.1371/journal.pone.0187393	http://dx.doi.org/10.1371/journal.pone.0187393			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161288	Green Published, gold			2022-12-27	WOS:000415987000009
J	Wang, XQ; Congdon, N; Ma, Y; Hu, M; Zhou, Y; Liao, WQ; Jin, L; Xiao, BX; Wu, XY; Ni, M; Yi, HM; Huang, YW; Varga, B; Zhang, H; Cun, YK; Li, XS; Yang, LH; Liang, CG; Huang, W; Rozelle, S; Ma, XC				Wang, Xiuqin; Congdon, Nathan; Ma, Yue; Hu, Min; Zhou, Yuan; Liao, Weiqi; Jin, Ling; Xiao, Baixiang; Wu, Xiaoyi; Ni, Ming; Yi, Hongmei; Huang, Yiwen; Varga, Beatrice; Zhang, Hong; Cun, Yongkang; Li, Xianshun; Yang, Luhua; Liang, Chaoguang; Huang, Wan; Rozelle, Scott; Ma, Xiaochen			Cluster-randomized controlled trial of the effects of free glasses on purchase of children's glasses in China: The PRICE (Potentiating Rural Investment in Children's Eyecare) study	PLOS ONE			English	Article							PEDIATRIC-REFRACTIVE-ERROR; SCHOOL-AGED CHILDREN; STUDY X-PRES; VISUAL IMPAIRMENT; SPECTACLE USE; SEE-WELL; PREVALENCE; STUDENTS	Background Offering free glasses can be important to increase children's wear. We sought to assess whether "Upgrade glasses" could avoid reduced glasses sales when offering free glasses to children in China. Methods In this cluster-randomized, controlled trial, children with uncorrected visual acuity (VA)< = 6/12 in either eye correctable to >6/12 in both eyes at 138 randomly-selected primary schools in 9 counties in Guangdong and Yunnan provinces, China, were randomized by school to one of four groups: glasses prescription only (Control); Free Glasses; Free Glasses + offer of $15 Upgrade Glasses; Free Glasses + offer of $30 Upgrade Glasses. Spectacle purchase (main outcome) was assessed 6 months after randomization. Results Among 10,234 children screened, 882 (8.62%, mean age 10.6 years, 45.5% boys) were eligible and randomized: 257 (29.1%) at 37 schools to Control; 253 (28.7%) at 32 schools to Free Glasses; 187 (21.2%) at 31 schools to Free Glasses + $15 Upgrade; and 185 (21.0%) at 27 schools to Free Glasses +$30 Upgrade. Baseline ownership among these children needing glasses was 11.8% (104/882), and 867 (98.3%) children completed follow-up. Glasses purchase was significantly less likely when free glasses were given: Control: 59/250 = 23.6%; Free glasses: 32/252 = 12.7%, P = 0.010. Offering Upgrade Glasses eliminated this difference: Free + $15 Upgrade: 39/183 = 21.3%, multiple regression relative risk (RR) 0.90 (0.56-1.43), P = 0.65; Free + $30 Upgrade: 38/182 = 20.9%, RR 0.91 (0.59, 1.42), P = 0.69. Conclusions Upgrade glasses can prevent reductions in glasses purchase when free spectacles are provided, providing important program income.	[Wang, Xiuqin; Congdon, Nathan; Liao, Weiqi; Jin, Ling; Xiao, Baixiang; Wu, Xiaoyi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wang, Xiuqin; Congdon, Nathan; Liao, Weiqi; Jin, Ling; Xiao, Baixiang; Wu, Xiaoyi] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Div Prevent Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Wang, Xiuqin] Guangdong Med Univ, Affiliated Hosp, Zhanjiang, Guangdong, Peoples R China; [Congdon, Nathan] Orbis Int, New York, NY USA; [Congdon, Nathan] Queens Univ Belfast, Ctr Publ Hlth, Translat Res Equitable Eyecare, Belfast, Antrim, North Ireland; [Ma, Yue] Shaanxi Normal Univ, Ctr Expt Econ Educ, Xian, Shaanxi, Peoples R China; [Hu, Min; Zhou, Yuan] Second Peoples Hosp Yunnan Prov, Kunming, Yunnan, Peoples R China; [Ni, Ming; Huang, Yiwen; Huang, Wan] Fred Hollows Fdn China, Kunming, Yunnan, Peoples R China; [Yi, Hongmei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Ctr Chinese Agr Policy, Beijing, Peoples R China; [Varga, Beatrice] Fred Hollows Fdn Australia, Sydney, NSW, Australia; [Zhang, Hong] First Peoples Hosp Honghe Prefecture, Kunming, Yunnan, Peoples R China; [Cun, Yongkang] Dehong Prefecture Peoples Hosp, Kunming, Yunnan, Peoples R China; [Li, Xianshun] Chuxiong Prefecture Peoples Hosp, Kunming, Yunnan, Peoples R China; [Yang, Luhua] Jianchuan Cty Peoples Hosp, Kunming, Yunnan, Peoples R China; [Liang, Chaoguang] First Peoples Hosp Lancang Cty, Kunming, Yunnan, Peoples R China; [Rozelle, Scott] Stanford Univ, Freeman Spogli Inst Int Studies, Palo Alto, CA 94304 USA; [Ma, Xiaochen] Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangdong Medical University; Queens University Belfast; Shaanxi Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Stanford University; Peking University	Ma, XC (corresponding author), Peking Univ, China Ctr Hlth Dev Studies, Beijing, Peoples R China.	mxc4068@gmail.com		Liao, Weiqi/0000-0002-8605-3749; Congdon, Nathan/0000-0001-9866-3416	Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Division of Preventive Ophthalmology, Sun Yat-sen University, Guangzhou, China; Fred Hollows Foundation; Orbis International; US Agency for International Development Children Blindness Program [PGRD-14-0001-03]; Luxottica-China (Shanghai); Essilor-China (Shanghai); Chinese government's Thousand Man Plan [83000-3281201]; Ulverscroft Foundation	Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Division of Preventive Ophthalmology, Sun Yat-sen University, Guangzhou, China; Fred Hollows Foundation; Orbis International; US Agency for International Development Children Blindness Program(United States Agency for International Development (USAID)); Luxottica-China (Shanghai); Essilor-China (Shanghai); Chinese government's Thousand Man Plan; Ulverscroft Foundation	This work was supported by Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Division of Preventive Ophthalmology, Sun Yat-sen University, Guangzhou, China; The Fred Hollows Foundation; Orbis International; US Agency for International Development Children Blindness Program (PGRD-14-0001-03); Luxottica-China (Shanghai); Essilor-China (Shanghai). Prof Congdon is supported by the Chinese government's Thousand Man Plan (83000-3281201) and by the Ulverscroft Foundation. The free glasses used in this study were supplied by OneSight, Luxottica-China, and Essilor-China, producers of frames and lenses in China. The authors have no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Congdon N, 2008, ARCH OPHTHALMOL-CHIC, V126, P1717, DOI 10.1001/archopht.126.12.1717; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Congdon N, 2011, OPHTHALMOLOGY, V118, P2343, DOI 10.1016/j.ophtha.2011.06.016; Congdon NG, 2008, BRIT J OPHTHALMOL, V92, P13, DOI 10.1136/bjo.2007.122028; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; DUNNETT CW, 1964, BIOMETRICS, V20, P482, DOI 10.2307/2528490; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; Li LP, 2008, INVEST OPHTH VIS SCI, V49, P2895, DOI 10.1167/iovs.07-1531; Li LP, 2010, ARCH OPHTHALMOL-CHIC, V128, P759, DOI 10.1001/archophthalmol.2010.73; Ma XC, 2015, AM J OPHTHALMOL, V160, P897, DOI 10.1016/j.ajo.2015.08.013; Ma XC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5740; Odedra N, 2008, OPHTHAL EPIDEMIOL, V15, P410, DOI 10.1080/09286580802399094; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Ramasamy D, 2013, OPHTHAL EPIDEMIOL, V20, P308, DOI 10.3109/09286586.2013.822897; Ramke J, 2012, OPHTHAL EPIDEMIOL, V19, P231, DOI 10.3109/09286586.2012.680528; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Wang XQ, 2015, JAMA OPHTHALMOL, V133, P1399, DOI 10.1001/jamaophthalmol.2015.3513; Wedner S, 2008, BRIT J OPHTHALMOL, V92, P19, DOI 10.1136/bjo.2007.119198; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yi HM, 2015, AM J OPHTHALMOL, V160, P889, DOI 10.1016/j.ajo.2015.08.006; Zhang MZ, 2009, INVEST OPHTH VIS SCI, V50, P2011, DOI 10.1167/iovs.08-2849; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3; Zhou ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088857; Zhou ZQ, 2014, INVEST OPHTH VIS SCI, V55, P154, DOI 10.1167/iovs.13-13250	27	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187808	10.1371/journal.pone.0187808	http://dx.doi.org/10.1371/journal.pone.0187808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161286	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000020
J	Sagar, A; Dai, W; Minot, M; LeCover, R; Varner, JD				Sagar, Adithya; Dai, Wei; Minot, Mason; LeCover, Rachel; Varner, Jeffrey D.			Reduced order modeling and analysis of the human complement system	PLOS ONE			English	Article							ALTERNATIVE PATHWAY; ACTIVATION; CASCADE; IMMUNE; IMMUNOLOGY; INHIBITOR; COMPONENT; ANTIBODY; THERAPY; ASSAYS	Complement is an important pathway in innate immunity, inflammation, and many disease processes. However, despite its importance, there are few validated mathematical models of complement activation. In this study, we developed an ensemble of experimentally validated reduced order complement models. We combined ordinary differential equations with logical rules to produce a compact yet predictive model of complement activation. The model, which described the lectin and alternative pathways, was an order of magnitude smaller than comparable models in the literature. We estimated an ensemble of model parameters from in vitro dynamic measurements of the C3a and C5a complement proteins. Subsequently, we validated the model on unseen C3a and C5a measurements not used for model training. Despite its small size, the model was surprisingly predictive. Global sensitivity and robustness analysis suggested complement was robust to any single therapeutic intervention. Only the simultaneous knockdown of both C3 and C5 consistently reduced C3a and C5a formation from all pathways. Taken together, we developed a validated mathematical model of complement activation that was computationally inexpensive, and could easily be incorporated into pre-existing or new pharmacokinetic models of immune system function. The model described experimental data, and predicted the need for multiple points of therapeutic intervention to fully disrupt complement activation.	[Sagar, Adithya; Dai, Wei; Minot, Mason; LeCover, Rachel; Varner, Jeffrey D.] Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA	Cornell University	Varner, JD (corresponding author), Cornell Univ, Robert Frederick Smith Sch Chem & Biomol Engn, Ithaca, NY 14850 USA.	jdv27@cornell.edu		Varner, Jeffrey/0000-0002-2558-7026; LeCover, Rachel/0000-0003-3044-5804; Minot, Mason/0000-0003-0225-9107	U.S. Army Research Laboratory; U.S. Army Research Office [W911NF1020114]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number W911NF1020114 to JDV.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bansal R, 2014, US Patent, Patent No. 8664362; Bassen DM, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-016-0380-2; Bergseth G, 2013, MOL IMMUNOL, V56, P232, DOI 10.1016/j.molimm.2013.05.221; Bezanson J, ARXIV14111607V4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Chauhan AK, 2006, CLIN EXP IMMUNOL, V145, P398, DOI 10.1111/j.1365-2249.2006.03135.x; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Epstein D, 2007, US Patent App., Patent No. [12/224,708, 12224708]; GERLOWSKI LE, 1983, J PHARM SCI, V72, P1103, DOI 10.1002/jps.2600721003; Herman J, SENSITIVITY ANAL LIB; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Hirayama H, 1996, BIOSYSTEMS, V39, P173, DOI 10.1016/0303-2647(96)01617-6; Hu XZ, 2013, MOL IMMUNOL, V54, P302, DOI 10.1016/j.molimm.2012.12.018; Jamei Masoud, 2016, Curr Pharmacol Rep, V2, P161; Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Kuepfer L, 2016, CPT-PHARMACOMET SYST, V5, P516, DOI 10.1002/psp4.12134; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028; Morad HOJ, 2015, J IMMUNOL METHODS, V427, P13, DOI 10.1016/j.jim.2015.09.001; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Nayak S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002016; Noris M, 2014, BLOOD, V124, P1715, DOI 10.1182/blood-2014-02-558296; NUTTALL G, 1888, Z HYG, V4, P353, DOI DOI 10.1007/BF02188097; PANGBURN MK, 1984, SPRINGER SEMIN IMMUN, V7, P163, DOI 10.1007/BF01893019; Rawal N, 2008, J BIOL CHEM, V283, P7853, DOI 10.1074/jbc.M707591200; Rice NT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154127; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roguska M, 2014, INVEST OPHTH VIS SCI, V55; Rother K., 2012, COMPLEMENT SYSTEM; Sagar A, 2017, BIOTECHNOL J; Sagar A, 2015, PROCESSES, V3, P178, DOI 10.3390/pr3010178; Sager JE, 2015, DRUG METAB DISPOS, V43, P1823, DOI 10.1124/dmd.115.065920; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schwaeble HW, 2011, US Patent, Patent No. [7,919,094, 7919094]; SISSONS JGP, 1977, J CLIN INVEST, V59, P704, DOI 10.1172/JCI108689; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; SWAAK AJG, 1982, RHEUMATOL INT, V2, P161, DOI 10.1007/BF00286138; Tasseff R, 2011, INTEGR BIOL-UK, V3, P578, DOI 10.1039/c0ib00141d; Tasseff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008864; Tolson BA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004723; van Vuuren BJ, 2014, J IMMUNOL METHODS, V402, P50, DOI 10.1016/j.jim.2013.11.010; Varnerlab, JUP CONSTR MULT OPT; Vogel CW, 2004, MOL IMMUNOL, V41, P191, DOI 10.1016/j.molimm.2004.03.011; WALKER DG, 1995, BRAIN RES, V675, P75, DOI 10.1016/0006-8993(95)00041-N; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weston-Davies WH, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4280.4280; Zewde N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152337	61	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187373	10.1371/journal.pone.0187373	http://dx.doi.org/10.1371/journal.pone.0187373			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155837	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700010
J	Yu, YS; Zhang, XY; Sun, CX; Zhou, HJ; Zhang, Q; Chen, C				Yu, Yushan; Zhang, Xiangyang; Sun, Caixia; Zhou, Huijie; Zhang, Qi; Chen, Chun			Reducing the rate of cesarean delivery on maternal request through institutional and policy interventions in Wenzhou, China	PLOS ONE			English	Article							PREDICTIVE MODEL; DOULA CARE; SECTION; CHILDBIRTH; BIRTH; FEAR	The objective of this study was to evaluate the effect of institutional and policy interventions on reducing the rate of cesarean delivery on maternal request (CDMR) in Wenzhou, China. Institutional interventions included health education, painless delivery introduction, and doula care. Additionally, a series of health policies were developed by the Chinese central and local governments to control cesarean section rates, mostly through controlling CDMR rates. We conducted a pre-/post-intervention study using 131,312 deliveries between 2006 and 2014 in three tertiary-level public hospitals in Wenzhou, China. Chi-square tests and predictive models were used to examine changes in the CDMR rate before and after institutional and policy interventions. After institutional interventions were introduced, the overall CDMR rate increased from 15.76% to 16.34% (p = 0.053), but the average annual growth rate (AAGR) of the overall CDMR rate quickly declined from 20.11% to -4.30%. After policy interventions were introduced, the overall CDMR rate, the AAGR of the overall CDMR rate, and the probability of performing CDMR declined. Further, the overall probability of a woman undergoing CDMR decreased in all three age groups (group one: <24; group two: 24-34; group three: >34) after institutional and policy interventions. These results show that institutional and policy interventions can reduce the CDMR rate. Additionally, the CDMR rate should be included in hospitals' performance assessment matrix to reduce the CDMR rate further.	[Yu, Yushan; Chen, Chun] Wenzhou Med Univ, Sch Publ Hlth & Management, Wenzhou, Peoples R China; [Yu, Yushan] Shihezi Univ, Med Sch, Dept Prevent Med, Shihezi, Peoples R China; [Zhang, Xiangyang; Sun, Caixia] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Peoples R China; [Zhou, Huijie] Wenzhou Peoples Hosp, Wenzhou, Peoples R China; [Zhang, Qi] Old Dominion Univ, Sch Community & Environm Hlth, Coll Hlth Sci, Norfolk, VA 23529 USA	Wenzhou Medical University; Shihezi University; Wenzhou Medical University; Old Dominion University	Chen, C (corresponding author), Wenzhou Med Univ, Sch Publ Hlth & Management, Wenzhou, Peoples R China.; Zhang, Q (corresponding author), Old Dominion Univ, Sch Community & Environm Hlth, Coll Hlth Sci, Norfolk, VA 23529 USA.	qzhang@odu.edu; chenchun408@126.com	Chen, Chun/E-9759-2011	Chen, Chun/0000-0002-5149-988X; Zhang, Xiangyang/0000-0003-0528-5474	National Natural Science Foundation of China [71603187]; Zhejiang Provincial Natural Science Foundation [LQ16G030011]; Key Social Science Project for University Teachers of Zhejiang, China [2014QN005]; 111 Project [616031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Key Social Science Project for University Teachers of Zhejiang, China; 111 Project(Ministry of Education, China - 111 Project)	This project was sponsored by the National Natural Science Foundation of China (Grant number: 71603187) to Chun Chen, Zhejiang Provincial Natural Science Foundation (Grant number: LQ16G030011) to Chun Chen, the Key Social Science Project for University Teachers of Zhejiang, China (Grant number: 2014QN005) to Chun Chen and 111 Project (Grant number: 616031) to Qi Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, NIH Consens State Sci Statements, V23, P1; Arefi Zohreh, 2015, J Family Reprod Health, V9, P101; de Oliveira RVB, 2012, ARCH GYNECOL OBSTET, V286, P893, DOI 10.1007/s00404-012-2397-0; Bodner K, 2011, ARCH GYNECOL OBSTET, V283, P1193, DOI 10.1007/s00404-010-1525-y; Cao Z, 2004, CHINESE OBSTET GYNEC, V2, P983; Chen CS, 2014, SOC SCI MED, V101, P47, DOI 10.1016/j.socscimed.2013.11.010; Chen C, 2014, SOC SCI MED, V120, P40, DOI 10.1016/j.socscimed.2014.05.033; Ganji F, 2006, J MED SCI, V6, P2525; Handelzalts JE, 2017, J REPROD INFANT PSYC, V35, P91, DOI 10.1080/02646838.2016.1253832; Handelzalts JE, 2012, ACTA OBSTET GYN SCAN, V91, P16, DOI 10.1111/j.1600-0412.2011.01287.x; Hanley GE, 2010, OBSTET GYNECOL, V115, P1201, DOI 10.1097/AOG.0b013e3181dd918c; He YQ, 2008, CHINESE J HLTH ED, V24, P636; Health and family planning committee of Zhejiang Province, 2011, PROJ MAT CHILD HLTH; Keeler EB, 1996, MED CARE RES REV, V53, P465, DOI 10.1177/107755879605300405; Kozhimannil KB, 2013, AM J PUBLIC HEALTH, V103, pE113, DOI 10.2105/AJPH.2012.301201; Lee ASM, 2008, HEALTH CARE WOMEN IN, V29, P448, DOI 10.1080/07399330801949574; Li H, 2014, PEDIATR OBES, V9, P10, DOI 10.1111/j.2047-6310.2013.00151.x; Li HT, 2017, JAMA-J AM MED ASSOC, V317, P69, DOI 10.1001/jama.2016.18663; Liu YJ, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0410-2; Mankuta D, 2007, AM J OBSTET GYNECOL, V197, pS77, DOI 10.1016/j.ajog.2007.10.247; Mao HF, 2015, MATERN CHILD HLTH J, V30, P3117; McComish JF, 2009, JOGNN-J OBST GYN NEO, V38, P148, DOI 10.1111/j.1552-6909.2009.01002.x; Moore B, 1986, INDIAN J PEDIATR, V2, P436; Mossialos E, 2005, EUR J PUBLIC HEALTH, V15, P288, DOI 10.1093/eurpub/cki002; Munten G., 2016, NEDERLANDS TIJDSCHRI, V14, P14, DOI [10.1007/s12468-016-0007-z, DOI 10.1007/S12468-016-0007-Z]; Nation Health and Family Planning Commission, 2011, MED QUAL MAN CONTR I; Nation Health and Family Planning Commission, 2011, REG MAN MAT HLTH CAR; National Peoples Congress of the Peoples Republic of China, AM POP FAM PLANN LAW; Peng P, 2008, EXTRAPERITONEAL CESA, P366; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Sun GQ, 2013, MATERN CHILD HLTH J, V53, P43; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Wang CB, 2009, ULTRASOUND OBST GYN, V34, P85, DOI 10.1002/uog.6405; Wang CK, 2011, INDIAN PEDIATR, V24, P275; Wang P, 2001, CHINESE J PRACTICAL, V17, P99; Wang W.M., 2003, MATERN CHILD HLTH J, V18, P84; Wenzhou Peoples Government, 2011, DEV PLAN WOM WENZH; Xiong Y, 2009, CHINESE HLTH SERVICE, V26, P178; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Zhang J, 1969, OBSTET GYNECOLOGY, V111, P1077; Zhou YB, 2015, PAEDIATR PERINAT EP, V29, P232, DOI 10.1111/ppe.12191	41	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186304	10.1371/journal.pone.0186304	http://dx.doi.org/10.1371/journal.pone.0186304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155824	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700003
J	Baldwin, CL; Lewis, BA				Baldwin, Carryl L.; Lewis, Bridget A.			Positive valence music restores executive control over sustained attention	PLOS ONE			English	Article							MEMORY LOAD; VIGILANCE; PERFORMANCE; DECREMENT; MIND	Music sometimes improves performance in sustained attention tasks. But the type of music employed in previous investigations has varied considerably, which can account for equivocal results. Progress has been hampered by lack of a systematic database of music varying in key characteristics like tempo and valence. The aims of this study were to establish a database of popular music varying along the dimensions of tempo and valence and to examine the impact of music varying along these dimensions on restoring attentional resources following performance of a sustained attention to response task (SART) vigil. Sixty-nine participants rated popular musical selections that varied in valence and tempo to establish a database of four musical types: fast tempo positive valence, fast tempo negative valence, slow tempo positive valence, and slow tempo negative valence. A second group of 89 participants performed two blocks of the SART task interspersed with either no break or a rest break consisting of 1 of the 4 types of music or silence. Presenting positive valence music (particularly of slow tempo) during an intermission between two successive blocks of the SART significantly decreased miss rates relative to negative valence music or silence. Results support an attentional restoration theory of the impact of music on sustained attention, rather than arousal theory and demonstrate a means of restoring sustained attention. Further, the results establish the validity of a music database that will facilitate further investigations of the impact of music on performance.	[Baldwin, Carryl L.; Lewis, Bridget A.] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	George Mason University	Baldwin, CL (corresponding author), George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA.	cbaldwi4@gmu.edu						Alikonis CR, 2002, P HUM FACTORS ERGON, P46; Beh HC, 1999, ERGONOMICS, V42, P1087, DOI 10.1080/001401399185153; Berardi A, 2001, EXP AGING RES, V27, P19, DOI 10.1080/03610730126014; Berto R, 2005, J ENVIRON PSYCHOL, V25, P249, DOI 10.1016/j.jenvp.2005.07.001; DAVIES DR, 1973, BRIT J PSYCHOL, V64, P383, DOI 10.1111/j.2044-8295.1973.tb01364.x; Dillard MB, 2014, HUM FACTORS; Droit-Volet S, 2010, ACTA PSYCHOL, V135, P226, DOI 10.1016/j.actpsy.2010.07.003; Finomore V, 2009, ERGONOMICS, V52, P791, DOI 10.1080/00140130802641627; Grier RA, 2003, HUM FACTORS, V45, P349, DOI 10.1518/hfes.45.3.349.27253; Helton WS, 2013, EXP BRAIN RES, V224, P429, DOI 10.1007/s00221-012-3322-2; Hitchcock EM, 1999, HUM FACTORS, V41, P365, DOI 10.1518/001872099779610987; Hockey G. R. J., 2011, COGNITIVE FATIGUE MU, P167, DOI [10.1037/12343-008, DOI 10.1037/12343-008]; Jiang J, 2011, INT J PSYCHOL, V46, P214, DOI 10.1080/00207594.2010.541255; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kay BP, 2012, BRAIN RES, V1447, P53, DOI 10.1016/j.brainres.2012.01.064; Kuhbandner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029287; Manly T, 1999, NEUROPSYCHOLOGIA, V37, P661, DOI 10.1016/S0028-3932(98)00127-4; Nelson JT, 2014, NEUROIMAGE, V85, P909, DOI 10.1016/j.neuroimage.2012.11.061; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; Pereira CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017016; Peretz I, 1998, COGNITION, V68, P111, DOI 10.1016/S0010-0277(98)00043-2; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Scerbo M. W., 1998, WHATS SO BORING VIGI; SEE JE, 1995, PSYCHOL BULL, V117, P230, DOI 10.1037/0033-2909.117.2.230; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Smallwood J, 2011, LANG LINGUIST COMPAS, V5, P63, DOI 10.1111/j.1749-818x.2010.00263.x; Warm J., 1993, WORKLOAD TRANSIT IMP; Warm J. S., 1996, VIGILANCE WORKLOAD A; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	30	9	9	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186231	10.1371/journal.pone.0186231	http://dx.doi.org/10.1371/journal.pone.0186231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145395	Green Submitted, gold, Green Published			2022-12-27	WOS:000415378800002
J	Letson, H; Dobson, G				Letson, Hayley; Dobson, Geoffrey			Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage	PLOS ONE			English	Article							7.5-PERCENT NACL ADENOSINE; RAT MODEL; TRAUMA; RESUSCITATION; EPIDEMIOLOGY; INFUSION; IMPACT; MECHANISMS; SURVIVAL; DAMPS	Background Systemic inflammation and coagulopathy are major drivers of injury progression following hemorrhagic trauma. Our aim was to examine the effect of small-volume 3% NaCl adenosine, lidocaine and Mg2+ (ALM) bolus and 0.9% NaCl/ALM 'drip' on inflammation and coagulation in a rat model of hemorrhagic shock. Methods Sprague-Dawley rats (429 +/- 4 g) were randomly assigned to: 1) shams, 2) no-treatment, 3) saline-controls, 4) ALM-therapy, and 5) Hextend (R). Hemorrhage was induced in anesthetized-ventilated animals by liver resection (60% left lateral lobe and 50% medial lobe). After 15 min, a bolus of 3% NaCl +/- ALM (0.7 ml/kg) was administered intravenously (Phase 1) followed 60 min later by 4 hour infusion of 0.9% NaCl +/- ALM (0.5 ml/kg/hour) with 1-hour monitoring (Phase 2). Plasma cytokines were measured on Magpix (R) and coagulation using Stago/Rotational Thromboelastometry. Results After Phase 1, saline-controls, no-treatment and Hextend (R) groups showed significant falls in white and red cells, hemoglobin and hematocrit (up to 30%), whereas ALM animals had similar values to shams (9-15% losses). After Phase 2, these deficits in non-ALM groups were accompanied by profound systemic inflammation. In contrast, after Phase 1 ALM-treated animals had undetectable plasma levels of IL-1 alpha and IL-1 beta, and IL-2, IL-6 and TNF-alpha were below baseline, and after Phase 2 they were less or similar to shams. Non-ALM groups (except shams) also lost their ability to aggregate platelets, had lower plasma fibrinogen levels, and were hypocoagulable. ALM-treated animals had 50-fold higher ADP-induced platelet aggregation, and 9.3-times higher collagen-induced aggregation compared to saline-controls, and had little or no coagulopathy with significantly higher fibrinogen shifting towards baseline. Hextend (R) had poor outcomes. Conclusions Small-volume ALM bolus/drip mounted a frontline defense against non-compressible traumatic hemorrhage by defending immune cell numbers, suppressing systemic inflammation, improving platelet aggregation and correcting coagulopathy. Saline-controls were equivalent to no-treatment. Possible mechanisms of ALM's immune-bolstering effect are discussed.	[Letson, Hayley; Dobson, Geoffrey] James Cook Univ, Heart Trauma & Sepsis Res Lab, Coll Med & Dent, Townsville, Qld, Australia	James Cook University	Dobson, G (corresponding author), James Cook Univ, Heart Trauma & Sepsis Res Lab, Coll Med & Dent, Townsville, Qld, Australia.	geoffrey.dobson@jcu.edu.au	Letson, Hayley Louise/V-4659-2019	Letson, Hayley Louise/0000-0003-0135-134X	USSOCOM [W81XWH-15-1-0002]; IACUC [W81XWH-15-1-0002, A2118]; USAMRMC [W81XWH-15-1-0002, S013004]	USSOCOM; IACUC; USAMRMC(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by USSOCOM, IACUC protocol A2118, USAMRMC proposal S013004 under Award No. W81XWH-15-1-0002. The opinions, interpretations, conclusions are those of the authors and are not necessarily endorsed by the US Department of Defense.	Aird WC, 2005, J THROMB HAEMOST, V3, P1392, DOI 10.1111/j.1538-7836.2005.01328.x; [Anonymous], 2011, RSBO, V8, P299; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brohi K, 2010, J ROY ARMY MED CORPS, V155, P320; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Butler FK., 2014, J SPEC OPER MED, V14, P13; Bynum JA, 2017, J TRAUMA AC IN PRESS, pXX; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; Davenport L, 2017, INNATE IMMUN-LONDON, V23, P482, DOI 10.1177/1753425917718921; de Bruin AM, 2014, BLOOD, V124, P2479, DOI 10.1182/blood-2014-04-568451; Djabir Y, 2013, SHOCK, V40, P222, DOI 10.1097/SHK.0b013e3182a03566; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; Dobson GP, 2016, J TRAUMA ACUTE CARE, V80, P135, DOI 10.1097/TA.0000000000000881; DOBSON GP, 2013, FRONT PHYSIOL, V4, P1, DOI DOI 10.3389/FPHYS.2013.00228; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Granfeldt A, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0682-y; Granfeldt A, 2014, CRIT CARE MED, V42, pE329, DOI 10.1097/CCM.0000000000000225; Griffin MJ, 2014, J TRAUMA ACUTE CARE, V77, P471, DOI 10.1097/TA.0000000000000361; Griffin MJ, 2016, CLIN VACCINE IMMUNOL, V23, P863, DOI 10.1128/CVI.00390-16; Groeneveld KM, 2011, CURR OPIN ANESTHESIO, V24, P219, DOI 10.1097/ACO.0b013e32834401e0; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Jackman RP, 2013, CURR OPIN ANESTHESIO, V26, P196, DOI 10.1097/ACO.0b013e32835d7160; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kheirbek T, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-65; Kisat M, 2013, J SURG RES, V184, P414, DOI 10.1016/j.jss.2013.05.099; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; Letson HL, 2017, J TRAUMA ACUTE CARE, V82, P1063, DOI 10.1097/TA.0000000000001454; Letson HL, 2016, THROMB RES, V141, P58, DOI 10.1016/j.thromres.2016.03.007; Letson HL, 2015, J TRAUMA ACUTE CARE, V78, P773, DOI 10.1097/TA.0000000000000587; Letson HL, 2012, CRIT CARE MED, V40, P2417, DOI 10.1097/CCM.0b013e31825334c3; Letson HL, 2011, J TRAUMA, V71, P708, DOI 10.1097/TA.0b013e3181fa27c7; Maegele M, 2014, EUR J TRAUMA EMERG S, V40, P113, DOI 10.1007/s00068-014-0389-4; Martin SJ, 2016, FEBS J, V283, P2599, DOI 10.1111/febs.13775; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Molina PE, 2005, SHOCK, V24, P3, DOI 10.1097/01.shk.0000167112.18871.5c; Moore EE, 2005, SHOCK, V24, P71, DOI 10.1097/01.shk.0000191336.01036.fe; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Pittman K, 2013, J INNATE IMMUN, V5, P315, DOI 10.1159/000347132; Sollberger G, 2014, INNATE IMMUN-LONDON, V20, P115, DOI 10.1177/1753425913484374; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Soreide K, 2014, INJURY, V45, P647, DOI 10.1016/j.injury.2012.12.027; Stahel PF, 2007, INJURY, V38, P1409, DOI 10.1016/j.injury.2007.09.023; Stannard A, 2013, J TRAUMA ACUTE CARE, V74, P830, DOI 10.1097/TA.0b013e31827a3704; Stow JL, 2013, CYTOKINE GROWTH F R, V24, P227, DOI 10.1016/j.cytogfr.2013.04.001; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Zedler S, 2006, CURR OPIN CRIT CARE, V12, P595, DOI 10.1097/MCC.0b013e3280106806	50	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188144	10.1371/journal.pone.0188144	http://dx.doi.org/10.1371/journal.pone.0188144			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145467	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800075
J	Ohba, T; Watanabe, H; Murakami, M; Iino, K; Adachi, T; Baba, Y; Kurosaki, T; Ono, K; Ito, H				Ohba, Takayoshi; Watanabe, Hiroyuki; Murakami, Manabu; Iino, Kenji; Adachi, Takeshi; Baba, Yoshihiro; Kurosaki, Tomohiro; Ono, Kyoichi; Ito, Hiroshi			Stromal interaction molecule 1 haploinsufficiency causes maladaptive response to pressure overload	PLOS ONE			English	Article							CALCIUM SENSOR STIM1; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; NUCLEAR FACTOR; HEART-FAILURE; ACTIVATION; EXPRESSION; GROWTH	Stromal interaction molecule 1 (STIM1), an endo/sarcoplasmic reticulum Ca2+ sensor, has been shown to control a Ca2+- dependent signal that promotes cardiac hypertrophy. However, whether STIM1 has adaptive role that helps to protect against cardiac overload stress remains unknown. We hypothesized that STIM1 deficiency causes a maladaptive response to pressure overload stress. We investigated STIM1 heterozygous KO (STIM1(+/)-) mice hearts, in which STIM1 protein levels decreased to 27% of wild-type (WT) with no compensatory increase in STIM2. Under stress-free conditions, no significant differences were observed in electrocardiographic and echocardiographic parameters or blood pressure between STIM1(+/)-and WT mice. However, when STIM1(+/)-mice were subjected to transverse aortic constriction (TAC), STIM1(+/-) mice had a higher mortality rate than WT mice. The TAC-induced increase in the heart weight to body weight ratio (mean mg/g +/- standard error of the mean) was significantly inhibited in STIM1(+/-) mice (WT sham, 4.12 +/- 0.14; WT TAC, 6.23 +/- 0.40; STIM1(+/-) sham, 4.53 +/- 0.16; STIM1(+/-) TAC, 4.63 +/- 0.08). Reverse transcription- polymerase chain reaction analysis of the left ventricles of TAC-treated STIM1(+/-) mice showed inhibited induction of cardiac fetal genes, including those encoding brain and atrial natriuretic proteins. Western blot analysis showed upregulated expression of transient receptor potential channel 1 (TRPC1) in TAC-treated WT mice, but suppressed expression in TAC-treated STIM1(+/-) mice. Taken together, the hearts of STIM1 haploinsufficient mice had a superficial resemblance to the WT phenotype under stress-free conditions; however, STIM1 haploinsufficient mice showed a maladaptive response to cardiac pressure overload.	[Ohba, Takayoshi; Adachi, Takeshi; Ono, Kyoichi] Akita Univ, Grad Sch Med, Dept Cell Physiol, Akita, Japan; [Watanabe, Hiroyuki; Iino, Kenji; Ito, Hiroshi] Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita, Japan; [Murakami, Manabu] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Aomori, Japan; [Baba, Yoshihiro; Kurosaki, Tomohiro] Osaka Univ, Lab Lymphocyte Differentiat, WPI Immunol Frontier Res Ctr, Osaka, Japan	Akita University; Akita University; Hirosaki University; Osaka University	Watanabe, H (corresponding author), Akita Univ, Grad Sch Med, Dept Cardiovasc & Resp Med, Akita, Japan.	hirow@doc.med.akita-u.ac.jp			JSPS KAKENHI; Saito-ho-onkai Foundation; Special Project of Three Northern Touhoku Universities; NENDOKEIKAKU research project; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Saito-ho-onkai Foundation; Special Project of Three Northern Touhoku Universities; NENDOKEIKAKU research project; Takeda Science Foundation(Takeda Science Foundation (TSF))	This research was sponsored by Grants-in-Aid for Scientific Research from JSPS KAKENHI (H.W, T.O, K.O, M.M), the Saito-ho-onkai Foundation (T.O), Special Project of Three Northern Touhoku Universities (T.O, M.M), the NENDOKEIKAKU research project (T.O) and the Takeda Science Foundation (T.O). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar IS, 2017, CELL CALCIUM, V63, P33, DOI 10.1016/j.ceca.2016.12.009; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Benard L, 2016, CIRCULATION, V133, P1458, DOI 10.1161/CIRCULATIONAHA.115.020678; Bohm J, 2013, AM J HUM GENET, V92, P271, DOI 10.1016/j.ajhg.2012.12.007; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Collins HE, 2014, AM J PHYSIOL-HEART C, V306, pH1231, DOI 10.1152/ajpheart.00075.2014; Correll RN, 2015, J MOL CELL CARDIOL, V87, P38, DOI 10.1016/j.yjmcc.2015.07.032; Faerber G, 2011, J THORAC CARDIOV SUR, V141, P492, DOI 10.1016/j.jtcvs.2010.03.029; Ferdaus MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095091; Fuchs S, 2012, J IMMUNOL, V188, P1523, DOI 10.4049/jimmunol.1102507; Hu P, 2003, AM J PHYSIOL-HEART C, V285, pH1261, DOI 10.1152/ajpheart.00108.2003; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Kar P, 2013, CHANNELS, V7, P374, DOI 10.4161/chan.25298; Kassiri Z, 2005, CIRC RES, V97, P380, DOI 10.1161/01.RES.0000178789.16929.cf; Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Ohba T, 2005, AKITA J MED, V32, P201; Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020; Ohba T, 2006, BIOCHEM BIOPH RES CO, V351, P764, DOI 10.1016/j.bbrc.2006.10.107; Ohba T, 2009, BIOCHEM BIOPH RES CO, V389, P172, DOI 10.1016/j.bbrc.2009.08.117; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Paria BC, 2003, J BIOL CHEM, V278, P37195, DOI 10.1074/jbc.M304287200; Picard C, 2009, NEW ENGL J MED, V360, P1971, DOI 10.1056/NEJMoa0900082; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Schaballie H, 2015, J ALLERGY CLIN IMMUN, V136, P816, DOI 10.1016/j.jaci.2015.03.009; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Voelkers M, 2010, J MOL CELL CARDIOL, V48, P1329, DOI 10.1016/j.yjmcc.2010.01.020; Wang Shumin, 2014, Biomed Res Int, V2014, P507353, DOI 10.1155/2014/507353; Zhou MH, 2014, J BIOL CHEM, V289, P29446, DOI 10.1074/jbc.M114.578492	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187950	10.1371/journal.pone.0187950	http://dx.doi.org/10.1371/journal.pone.0187950			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145451	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800042
J	Righetti, L; Rolli, E; Galaverna, G; Suman, M; Bruni, R; Dall'Asta, C				Righetti, Laura; Rolli, Enrico; Galaverna, Gianni; Suman, Michele; Bruni, Renato; Dall'Asta, Chiara			Plant organ cultures as masked mycotoxin biofactories: Deciphering the fate of zearalenone in micropropagated durum wheat roots and leaves	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CELL-SUSPENSION CULTURES; ARABIDOPSIS-THALIANA; BETA-ZEARALENOL; METABOLISM; AFLATOXIN; TRANSFORMATION; SEEDLINGS; MODEL; WATER	"Masked mycotoxins" senso strictu are conjugates of mycotoxins resulting from metabolic pathways activated by the interplay between pathogenic fungi and infected plants. Zearalenone, an estrogenic mycotoxin produced by Fusarium spp, was the first masked mycotoxin ever described in the literature, but its biotransformation has been studied to a lesser extent if compared to other compounds such as deoxynivalenol. We presented herein the first application of organ and tissue culture techniques to study the metabolic fate of zearalenone in durum wheat, using an untargeted HR-LCMS approach. A complete, quick absorption of zearalenone by uninfected plant organs was noticed, and its biotransformation into a large spectrum of phase I and phase II metabolites has been depicted. Therefore, wheat organ tissue cultures can be effectively used as a biocatalytic tool for the production of masked mycotoxins, as well as a replicable model for the investigation of the interplay between mycotoxins and wheat physiology.	[Righetti, Laura; Galaverna, Gianni; Bruni, Renato; Dall'Asta, Chiara] Univ Parma, Dept Food & Drug, Parma, Italy; [Rolli, Enrico] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Suman, Michele] Barilla GRFlli SpA, Adv Lab Res, Parma, Italy	University of Parma; University of Parma	Dall'Asta, C (corresponding author), Univ Parma, Dept Food & Drug, Parma, Italy.	chiara.dallasta@unipr.it	Galaverna, Gianni/GNW-5335-2022; Righetti, Laura/Y-6208-2019; Dall'Asta, Chiara/C-3173-2008	Galaverna, Gianni/0000-0001-9042-2378; Righetti, Laura/0000-0003-4238-0665; Dall'Asta, Chiara/0000-0003-0716-8394				Berthiller F, 2007, Mycotoxin Res, V23, P68, DOI 10.1007/BF02946028; Berthiller F, 2006, FOOD ADDIT CONTAM, V23, P1194, DOI 10.1080/02652030600778728; Berthiller F, 2005, J AGR FOOD CHEM, V53, P3421, DOI 10.1021/jf047798g; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Berthiller F, 2009, ANAL BIOANAL CHEM, V395, P1243, DOI 10.1007/s00216-009-2874-x; Buerstmayr H, 2015, WORLD MYCOTOXIN J, V8, P591, DOI 10.3920/WMJ2015.1889; Card ML, 2012, J AGR FOOD CHEM, V60, P8264, DOI 10.1021/jf3014074; Cirlini M, 2014, TOXINS, V6, P81, DOI 10.3390/toxins6010081; Cruciani Gabriele, 2013, Drug Discov Today Technol, V10, pe155, DOI 10.1016/j.ddtec.2012.11.001; Dall'Erta A, 2013, CHEM RES TOXICOL, V26, P305, DOI 10.1021/tx300438c; De Boevre M, 2014, WORLD MYCOTOXIN J, V7, P305, DOI 10.3920/WMJ2014.1717; Dellafiora L, 2016, TOXICON, V111, P139, DOI 10.1016/j.toxicon.2016.01.053; Dellafiora L, 2015, FOOD CHEM TOXICOL, V86, P65, DOI 10.1016/j.fct.2015.09.009; Drzymala SS, 2015, ANAL BIOANAL CHEM, V407, P3489, DOI 10.1007/s00216-015-8541-5; EFSA, 2016, EFSA J, V14, DOI 10.2903/j.efsa.2015.4359; Ehrlich V.A., 2015, ALTEX, V32, P201; Emidio ES, 2017, CHEMOSPHERE, V169, P146, DOI 10.1016/j.chemosphere.2016.11.042; ENGELHARDT G, 1988, NATURWISSENSCHAFTEN, V75, P309, DOI 10.1007/BF00367324; EVERETT DJ, 1987, J TOXICOL ENV HEALTH, V20, P435, DOI 10.1080/15287398709530995; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Frizzell C, 2011, TOXICOL LETT, V206, P210, DOI 10.1016/j.toxlet.2011.07.015; GAREIS M, 1990, J VET MED B, V37, P236, DOI 10.1111/j.1439-0450.1990.tb01052.x; Hariprasad P, 2015, ENVIRON SCI POLLUT R, V22, P6246, DOI 10.1007/s11356-014-3851-2; Hariprasad P, 2013, FOOD CHEM, V138, P1908, DOI 10.1016/j.foodchem.2012.11.093; Hartmann N, 2008, ENVIRON SCI TECHNOL, V42, P5455, DOI 10.1021/es8007326; Hildebrand A. A., 2012, TOXICOL LETT, V192, P379; Hildebrand Andreas A, 2012, Mycotoxin Res, V28, P1, DOI 10.1007/s12550-011-0109-4; HOWES AW, 1991, MYCOPATHOLOGIA, V113, P25, DOI 10.1007/BF00436382; Koppen R, 2012, J AGR FOOD CHEM, V60, P11733, DOI 10.1021/jf3037775; Macherius A, 2012, ENVIRON SCI TECHNOL, V46, P10797, DOI 10.1021/es3028378; Malchi T, 2014, ENVIRON SCI TECHNOL, V48, P9325, DOI 10.1021/es5017894; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Marsik P, 2017, ENVIRON POLLUT, V220, P383, DOI 10.1016/j.envpol.2016.09.074; Meng F. J., 1992, Progress in plant growth regulation. Proceedings of the 14th international conference on plant growth substances, Amsterdam, 21-26 July, 1991., P291; Meng-Reiterer J, 2016, TOXINS, V8, DOI 10.3390/toxins8120364; Meng-Reiterer J, 2015, ANAL BIOANAL CHEM, V407, P8019, DOI 10.1007/s00216-015-8975-9; MERTZ D, 1980, J AGR FOOD CHEM, V28, P963, DOI 10.1021/jf60231a003; MERTZ D, 1981, J AGR FOOD CHEM, V29, P1168, DOI 10.1021/jf00108a017; Molina-Molina JM, 2014, FOOD CHEM TOXICOL, V74, P233, DOI 10.1016/j.fct.2014.10.008; Nathanail AV, 2015, J AGR FOOD CHEM, V63, P7862, DOI 10.1021/acs.jafc.5b02697; Nathanail AV, 2015, ANAL BIOANAL CHEM, V407, P4745, DOI 10.1007/s00216-015-8676-4; Paris MPK, 2014, J AGR FOOD CHEM, V62, P1181, DOI 10.1021/jf405627d; Patterson AD, 2010, CHEM RES TOXICOL, V23, P851, DOI 10.1021/tx100020p; Pirselova B, 2011, MOL BIOL REP, V38, P3437, DOI 10.1007/s11033-010-0453-z; RAO GJ, 1982, PLANT SOIL, V66, P121, DOI 10.1007/BF02203410; Repka V, 2014, EUR J PLANT PATHOL, V138, P787, DOI 10.1007/s10658-013-0351-z; RUHLAND M, 1994, NATURWISSENSCHAFTEN, V81, P453, DOI 10.1007/BF01136647; Snigdha M, 2015, CHEMOSPHERE, V119, P524, DOI 10.1016/j.chemosphere.2014.07.033; Vendl O, 2009, ANAL BIOANAL CHEM, V395, P1347, DOI 10.1007/s00216-009-2873-y; zearalenol, 2014, EUR J PLANT PATHOLOL, V138, P787; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	51	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187247	10.1371/journal.pone.0187247	http://dx.doi.org/10.1371/journal.pone.0187247			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145415	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800013
J	Stein, EV; Duewer, DL; Farkas, N; Romsos, EL; Wang, LL; Cole, KD				Stein, Erica V.; Duewer, David L.; Farkas, Natalia; Romsos, Erica L.; Wang, Lili; Cole, Kenneth D.			Steps to achieve quantitative measurements of microRNA using two step droplet digital PCR	PLOS ONE			English	Article							QUANTIFICATION; DNA; TRACEABILITY; TARGETS; PLASMA	Droplet digital PCR (ddPCR) is being advocated as a reference method to measure rare genomic targets. It has consistently been proven to be more sensitive and direct at discerning copy numbers of DNA than other quantitative methods. However, one of the largest obstacles to measuring microRNA (miRNA) using ddPCR is that reverse transcription efficiency depends upon the target, meaning small RNA nucleotide composition directly effects primer specificity in a manner that prevents traditional quantitation optimization strategies. Additionally, the use of reagents that are optimized for miRNA measurements using quantitative real-time PCR (qRT-PCR) appear to either cause false positive or false negative detection of certain targets when used with traditional ddPCR quantification methods. False readings are often related to using inadequate enzymes, primers and probes. Given that two-step miRNA quantification using ddPCR relies solely on reverse transcription and uses proprietary reagents previously optimized only for qRT-PCR, these barriers are substantial. Therefore, here we outline essential controls, optimization techniques, and an efficacy model to improve the quality of ddPCR miRNA measurements. We have applied two-step principles used for miRNA qRT-PCR measurements and leveraged the use of synthetic miRNA targets to evaluate ddPCR following cDNA synthesis with four different commercial kits. We have identified inefficiencies and limitations as well as proposed ways to circumvent identified obstacles. Lastly, we show that we can apply these criteria to a model system to confidently quantify miRNA copy number. Our measurement technique is a novel way to quantify specific miRNA copy number in a single sample, without using standard curves for individual experiments. Our methodology can be used for validation and control measurements, as well as a diagnostic technique that allows scientists, technicians, clinicians, and regulators to base miRNA measures on a single unit of measurement rather than a ratio of values.	[Stein, Erica V.; Wang, Lili; Cole, Kenneth D.] NIST, Biosyst & Biomat Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Duewer, David L.] NIST, Chem Sci Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA; [Farkas, Natalia] NIST, Engn Phys Div, Phys Measurement Lab, Gaithersburg, MD 20899 USA; [Romsos, Erica L.] NIST, Biomol Measurement Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA	Stein, EV (corresponding author), NIST, Biosyst & Biomat Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA.	Erica.Stein@nist.gov	wang, lili/HDL-7210-2022	Stein, Erica/0000-0001-8778-8846	National Institute of Standards and Technology	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA)	This research was supported by the National Institute of Standards and Technology under the Scientific and Technical Research and Services Program. Certain commercial equipment, instruments or materials are identified in this manuscript to adequately specify the experimental procedure. Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the materials or equipment identified are necessarily the best available for the purpose.	Apte A, 2009, COLD SPRING HARB PRO, V2009; Bhat S, 2010, ANAL CHEM, V82, P7185, DOI 10.1021/ac100845m; Brunet-Vega A, 2015, ANAL BIOCHEM, V488, P28, DOI 10.1016/j.ab.2015.07.018; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Dagata J., 2016, NATL I STAND TECHNOL, V260, P185; De Bievre P, 2009, CLIN BIOCHEM, V42, P246, DOI 10.1016/j.clinbiochem.2008.09.007; DESTGROTH SF, 1982, J IMMUNOL METHODS, V49, pR11, DOI 10.1016/0022-1759(82)90269-1; Gantier MP, 2013, J LEUKOCYTE BIOL, V94, P575, DOI 10.1189/jlb.1012539; Graff JW, 2012, J BIOL CHEM, V287, P21816, DOI 10.1074/jbc.M111.327031; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Ho J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1555-3; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Jang JS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-144; Kline MC, 2017, ANAL CHEM, V89, P4648, DOI 10.1021/acs.analchem.7b00240; Kline MC, 2016, ANAL CHEM, V88, P2132, DOI 10.1021/acs.analchem.5b03692; Kline MC, 2009, ANAL BIOANAL CHEM, V394, P1183, DOI 10.1007/s00216-009-2782-0; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/nmeth.3014, 10.1038/NMETH.3014]; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Morenos L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042951; Munro SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6125; Palma CA, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-79; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Prediger EL, OLIGO QUANTIFICATION; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Redshaw N, 2013, BIOTECHNIQUES, V54, P155, DOI 10.2144/000114002; Roux KH, 2009, COLD SPRING HARB PRO, V2009; RStudio Inc, 2016, RSTUDIO INT DEV ENV; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; Thomas Koepke AL, 2017, TOMAN BLAZA NIST CON; Thompson K, 2015, TOOLS MICRORNA DIS S; Wacker Michael J, 2005, J Biomol Tech, V16, P266; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zheng Q, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-87	37	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188085	10.1371/journal.pone.0188085	http://dx.doi.org/10.1371/journal.pone.0188085			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145448	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800064
J	Schaudinn, C; Dittmann, C; Jurisch, J; Laue, M; Gunday-Tureli, N; Blume-Peytavi, U; Vogt, A; Rancan, F				Schaudinn, Christoph; Dittmann, Christin; Jurisch, Jana; Laue, Michael; Guenday-Tuereli, Nazende; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza			Development, standardization and testing of a bacterial wound infection model based on ex vivo human skin	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BIOFILMS; CELLS; EAR; PIG	Current research on wound infections is primarily conducted on animal models, which limits direct transferability of these studies to humans. Some of these limitations can be overcome by using-otherwise discarded-skin from cosmetic surgeries. Superficial wounds are induced in fresh ex vivo skin, followed by intradermal injection of Pseudomonas aeruginosa under the wound. Subsequently, the infected skin is incubated for 20 hours at 37 degrees C and the CFU/wound are determined. Within 20 hours, the bacteria count increased from 10(7) to 10(9) bacteria per wound, while microscopy revealed a dense bacterial community in the collagen network of the upper wound layers as well as numerous bacteria scattered in the dermis. At the same time, IL-1alpha and IL-1beta amounts increased in all infected wounds, while-due to bacteria-induced cell lysis-the IL-6 and IL-8 concentrations rose only in the uninfected samples. High-dosage ciprofloxacin treatment resulted in a decisive decrease in bacteria, but consistently failed to eradicate all bacteria. The main benefits of the ex vivo wound model are the use of healthy human skin, a quantifiable bacterial infection, a measureable donor-dependent immune response and a good repeatability of the results. These properties turn the ex vivo wound model into a valuable tool to examine the mechanisms of host-pathogen interactions and to test antimicrobial agents.	[Schaudinn, Christoph; Dittmann, Christin; Laue, Michael] Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Charite, Clin Res Ctr Hair & Skin Sci, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Jurisch, Jana; Blume-Peytavi, Ulrike; Vogt, Annika; Rancan, Fiorenza] Charite, Berlin Inst Hlth, Berlin, Germany; [Guenday-Tuereli, Nazende] MJR PharmJet GmbH, Uberherrn, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schaudinn, C (corresponding author), Robert Koch Inst, Adv Light & Electron Microscopy, Berlin, Germany.	schaudinnc@rki.de		Vogt, Annika/0000-0001-9134-8413; Gunday-Tureli, Nazende/0000-0002-6310-4785; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Rancan, Fiorenza/0000-0003-3903-3240	 [KF2928204MD4]		We hereby disclose that the authors CS and ML are employees of the federal Robert Koch Institute of Germany, JJ, UBP, AV and FR are employees of the Charite Universitatsmedizin of the city of Berlin, and NGT is an employee of the private company MJR PharmJet GmbH. Each of the above mentioned institutions/company received an equal part of the federal funding grant [KF2928204MD4], which was granted to the authors CS, NGT and FR. The funders provided support in the form of research materials and salaries for authors [Robert Koch Institute: CS, ML - Charite: UBP, AV, FR - MJR PharmJet GmbH: NGT grant salary support [KF2928204MD4]: CD, JJ]. However, any of the funders had an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AHN ST, 1990, ANN PLAS SURG, V24, P17, DOI 10.1097/00000637-199001000-00004; Berthet A, 2017, ARCH TOXICOL; Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108; Contassot E, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13590; Dalton T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027317; DIENER B, 1973, INFECT IMMUN, V7, P212, DOI 10.1128/IAI.7.2.212-217.1973; Doge N, 2016, EUR J PHARM BIOPHARM; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Hassett DJ, 1996, J BACTERIOL, V178, P3996, DOI 10.1128/jb.178.14.3996-4003.1996; HAUSER C, 1986, J IMMUNOL, V136, P3317; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Konrat K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157663; LaFayette SL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500199; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Okuda J, 2011, J INFECT CHEMOTHER, V17, P782, DOI 10.1007/s10156-011-0257-7; Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326; Percival SL, 2015, ADV WOUND CARE, V4, P373, DOI 10.1089/wound.2014.0557; Rancan F, 2017, EUR J PHARM BIOPHARM, V116, P4, DOI 10.1016/j.ejpb.2016.11.017; Rancan F, 2014, J CONTROL RELEASE, V176, P115, DOI 10.1016/j.jconrel.2013.12.022; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Surgeons ASoP, 2015, PLAST SURG STAT; Thompson BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117491; Wall GM, 2009, PEDIATR INFECT DIS J, V28, P141, DOI 10.1097/INF.0b013e31818b0c9c; Wang H., 2010, J CYST FIBROS, V9, pS41, DOI 10.1016/S1569-1993(10)60158-0; Wang JF, 2001, COMPARATIVE MED, V51, P341	29	32	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186946	10.1371/journal.pone.0186946	http://dx.doi.org/10.1371/journal.pone.0186946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140982	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400013
J	Tian, T; Mijiti, P; Huang, BX; Zhang, FD; Ainiwaer, A; Sang, GY; Zhang, ZL; Mahan, Y; Tuo, XQ; Gong, Z; Dai, JH				Tian Tian; Mijiti, Peierdun; Huang Bingxue; Zhang Fadong; Ainiwaer, Abidan; Sang Guoyao; Zhang Zhanlin; Mahan, Yeledan; Tuo Xiaoqin; Gong Zheng; Dai Jianghong			Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; HPV INFECTION; CANCER; IDENTITIES; DIAGNOSIS; ASSAY	Background Infection with human papillomavirus (HPV) is the most common sexually transmitted infection among men who have sex with men (MSM). Study on prevalence and risk factors of anal HPV infection among HIV-negative MSM in Northwestern China was rare. Methods We performed a cross-sectional study of HPV prevalence using anal swab specimens among HIV-negative MSM in Urumqi city of Xinjiang Uyghur Autonomous Region, China between April 1st and October 30th in 2016. Prevalence of any anal HPV infection, high-risk and low-risk HPV infection was estimated. Risk factors associated with any anal HPV infection was analyzed using univariate and multivariate logistic regression models. Results Among 538 potential participants, 500(92.9%) were recruited in this study. The genotyping results of anal HPV infection were available for all. Of them, 259 (51.8%), 190 (38.0%) and 141(28.2%) were positive for at least one of the targeted 37 HPV genotypes, high-risk HPV genotypes, and any low-risk HPV genotypes. The most prevalent anal HPV genotype was HPV 6(11.8%), followed by HPV 16(11.2%), HPV 11(10.8%), HPV 51(7.0%) and HPV 18 (5.4%). Among those infected with at least one of the targeted 37 anal HPV genotypes, 75 (29.0%), 155(59.8%) and 191(73.7%) were infected with 2-valent, quadrivalent and 9-valent HPV vaccine-covered genotypes. Receptive anal intercourse in the past year was the only predictor of any anal HPV infection in multivariate logistic regression model. Conclusion Prevalence of any anal HPV infection and high-risk HPV infection among HIV-negative MSM in Urumqi city of Xinjiang is high. The majority of genotypes detected in our study were covered by quadrivalent and 9-valent HPV vaccines. Regular anal exams and early HPV vaccination among MSM may be considered in future HPV prevention programs in Xinjiang, China.	[Tian Tian; Mijiti, Peierdun; Huang Bingxue; Ainiwaer, Abidan; Zhang Zhanlin; Mahan, Yeledan; Tuo Xiaoqin; Gong Zheng; Dai Jianghong] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Zhang Fadong] Toutunhe Dist Gen Hosp, Surg Dept, Urumqi, Xinjiang, Peoples R China; [Sang Guoyao] Xinjiang Med Univ, Affiliated Hosp 1, Clin Lab, Urumqi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Dai, JH (corresponding author), Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China.	438263678@qq.com		Tian, Tian/0000-0002-6103-1666	Natural Science Foundation of China [81560539]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (grant number 81560539) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benevolo M, 2016, EXPERT REV ANTI-INFE, V14, P465, DOI 10.1586/14787210.2016.1174065; Blas MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139524; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Cobos C, 2014, INT REV IMMUNOL, V33, P383, DOI 10.3109/08830185.2014.911857; Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7; Guimaraes MDC, 2011, JAIDS-J ACQ IMM DEF, V57, pS217, DOI 10.1097/QAI.0b013e31821e9994; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Fox P, 2009, CURR OPIN HIV AIDS, V4, P64, DOI 10.1097/COH.0b013e32831a6fe0; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015256; Geskus RB, 2016, AIDS, V30, P37, DOI 10.1097/QAD.0000000000000874; Giuliano AR, 2010, GYNECOL ONCOL, V117, pS15, DOI 10.1016/j.ygyno.2010.01.026; Glick SN, 2014, J INFECT DIS, V209, P369, DOI 10.1093/infdis/jit441; Goldstone S, 2011, J INFECT DIS, V203, P66, DOI 10.1093/infdis/jiq016; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2009, HUM PAP REV HUM CA B, V100B, P255; Jaspal R, 2012, CULT HEALTH SEX, V14, P767, DOI 10.1080/13691058.2012.693626; Jaspal R, 2010, BRIT J SOC PSYCHOL, V49, P849, DOI 10.1348/014466609X485025; Li XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21368; Li ZK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127355; Liu SS, 2010, J CLIN MICROBIOL, V48, P758, DOI 10.1128/JCM.00989-09; Machalek DA, 2012, SEX HEALTH, V9, P527, DOI 10.1071/SH12043; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Molijn A, 2005, J CLIN VIROL, V32, pS43, DOI 10.1016/j.jcv.2004.12.004; Muller EE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1706-9; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Pan SW, 2016, JAIDS-J ACQ IMM DEF, V73, P463, DOI 10.1097/QAI.0000000000001127; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Phanuphak N, 2013, JAIDS-J ACQ IMM DEF, V63, P472, DOI 10.1097/QAI.0b013e3182918a5a; Ren XQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2641259; Sonnex C, 1999, SEX TRANSM INFECT, V75, P317, DOI 10.1136/sti.75.5.317; Supindham T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124499; Tao PP, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/938780; van Doorn L J, 2001, Expert Rev Mol Diagn, V1, P394; van Rijn VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092208; Wong OGW, 2012, J CLIN MICROBIOL, V50, P1691, DOI 10.1128/JCM.05933-11; Zhang DZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100793; Zou HC, 2016, HUM VACC IMMUNOTHER, V12, P1551, DOI 10.1080/21645515.2015.1099771	39	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187928	10.1371/journal.pone.0187928	http://dx.doi.org/10.1371/journal.pone.0187928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141014	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400038
J	Jeon, HG; Yoo, JH; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Ferrari, M; Brooks, JD; Chung, BI				Jeon, Hwang Gyun; Yoo, Jae Ho; Jeong, Byong Chang; Seo, Seong Il; Jeon, Seong Soo; Choi, Han-Yong; Lee, Hyun Moo; Ferrari, Michelle; Brooks, James D.; Chung, Benjamin I.			Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; ASIAN MEN; LOW-RISK; OUTCOMES; VOLUME; VALIDATION; PREDICTORS; MORTALITY; PATHOLOGY; AMERICAN	Purpose To investigate the impact of race on the risk of pathological upgrading and upstaging at radical prostatectomy (RP) in an Asian (Korean) and Western (Caucasian) cohort eligible for active surveillance (AS). Materials and methods We performed a retrospective cohort study of 854 patients eligible for AS who underwent RP in United States (n = 261) and Korea (n = 593) between 2006 and 2015. After adjusting for age, PSA level, and prostate volume, we utilized multivariate logistic regression analysis to assess the effect of race on upgrading or upstaging. Results There were significant differences between Caucasian and Korean patients in terms of age at surgery (60.2 yr. vs. 64.1 yr.), PSA density (0.115 ng/mL/mL vs. 0.165 ng/mL/mL) and mean number of positive cores (3.5 vs. 2.4), but not in preoperative PSA values (5.11 ng/mL vs. 5.05 ng/mL). The rate of upstaging from cT1 or cT2 to pT3 or higher was not significantly different between the two cohorts (8.8% vs. 11.0%, P = 0.341). However, there were higher rates of upgrading to high-grade cancer (Gleason 4+3 or higher) in Korean patients (9.1%) when compared to Caucasian counterparts (2.7%) (P = 0.003). Multivariate logistic regression analysis showed that age (OR 1.07, P < 0.001) and smaller prostate volume (OR 0.97, P < 0.001), but not race, were significantly associated with upstaging or upgrading. Conclusions There were no differences in rates of upgrading or upstaging between Caucasian and Korean men eligible for active surveillance.	[Jeon, Hwang Gyun; Yoo, Jae Ho; Jeong, Byong Chang; Seo, Seong Il; Jeon, Seong Soo; Choi, Han-Yong; Lee, Hyun Moo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Ferrari, Michelle; Brooks, James D.; Chung, Benjamin I.] Stanford Univ, Med Ctr, Dept Urol, Stanford, CA 94305 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Stanford University	Lee, HM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea.	hyunmoo.lee@samsung.com		Chung, Benjamin/0000-0001-9660-2732				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Busch J, 2014, BJU INT, V114, P517, DOI 10.1111/bju.12466; Choo SH, 2014, PROSTATE INT, V2, P70, DOI 10.12954/PI.14042; Chung BH, 2006, BJU INT, V97, P742, DOI 10.1111/j.1464-410X.2006.06016.x; Chung MS, 2013, YONSEI MED J, V54, P902, DOI 10.3349/ymj.2013.54.4.902; Cooperberg M.R., 2015, JAMA-J AM MED ASSOC, V314, P80, DOI DOI 10.1001/JAMA.2015.6036; Dall'Era MA, 2009, J UROLOGY, V181, P1622, DOI 10.1016/j.juro.2008.11.123; Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Huland H, 2015, EUR UROL, V68, P175, DOI 10.1016/j.eururo.2015.02.020; Jeong IG, 2015, UROL ONCOL, V34, pe9; Kim TH, 2014, INT J UROL, V21, P377, DOI 10.1111/iju.12326; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Kulkarni GS, 2007, CANCER, V109, P2432, DOI 10.1002/cncr.22712; Latini DM, 2006, CANCER, V106, P789, DOI 10.1002/cncr.21675; Lichtensztajn DY, 2014, J UROLOGY, V191, P952, DOI 10.1016/j.juro.2013.10.075; Liu JJ, 2011, J UROLOGY, V185, P2108, DOI 10.1016/j.juro.2011.02.053; Man A, 2003, J UROLOGY, V170, P901, DOI 10.1097/01.ju.0000081423.37043.b4; Newcomb LF, 2016, J UROLOGY, V195, P313, DOI 10.1016/j.juro.2015.08.087; Robbins AS, 2007, CANCER, V110, P1255, DOI 10.1002/cncr.22872; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Soloway MS, 2010, EUR UROL, V58, P831, DOI 10.1016/j.eururo.2010.08.027; Tosoian JJ, 2013, J UROLOGY, V190, P1218, DOI 10.1016/j.juro.2013.04.071; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Turley RS, 2008, J UROLOGY, V179, P523, DOI 10.1016/j.juro.2007.09.078; van den Bergh RCN, 2007, EUR UROL, V52, P1560, DOI 10.1016/j.eururo.2007.05.011; Vellekoop A, 2014, J UROLOGY, V191, P350, DOI 10.1016/j.juro.2013.09.034; Wong MC, 2016, EUROPEAN UROLOGY; Yamada Y, 2016, INT J UROL, V23, P49, DOI 10.1111/iju.12952; Yashi M, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-43	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186026	10.1371/journal.pone.0186026	http://dx.doi.org/10.1371/journal.pone.0186026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136019	gold, Green Published			2022-12-27	WOS:000415121200003
J	Pozzoli, T; Gini, G; Altoe, G				Pozzoli, Tiziana; Gini, Gianluca; Altoe, Gianmarco			Associations between facial emotion recognition and young adolescents' behaviors in bullying	PLOS ONE			English	Article							SOCIAL COGNITION; SEX-DIFFERENCES; EXPRESSIONS; PERCEPTION; CHILDREN; VICTIMS; PEER; BYSTANDERS; KNOWLEDGE; SELF	This study investigated whether different behaviors young adolescents can act during bullying episodes were associated with their ability to recognize morphed facial expressions of the six basic emotions, expressed at high and low intensity. The sample included 117 middle-school students (45.3% girls; mean age = 12.4 years) who filled in a peer nomination questionnaire and individually performed a computerized emotion recognition task. Bayesian generalized mixed-effects models showed a complex picture, in which type and intensity of emotions, students' behavior and gender interacted in explaining recognition accuracy. Results were discussed with a particular focus on negative emotions and suggesting a "neutral" nature of emotion recognition ability, which does not necessarily lead to moral behavior but can also be used for pursuing immoral goals.	[Pozzoli, Tiziana; Gini, Gianluca; Altoe, Gianmarco] Univ Padua, Dept Dev & Social Psychol, Padua, Italy	University of Padua	Pozzoli, T (corresponding author), Univ Padua, Dept Dev & Social Psychol, Padua, Italy.	tiziana.pozzoli@unipd.it		Gini, Gianluca/0000-0002-8251-7550; Altoe, Gianmarco/0000-0003-1154-9528	University of Padua; Fondazione Cassa di Risparmio di Padova e Rovigo within "Starting Grants" initiative	University of Padua; Fondazione Cassa di Risparmio di Padova e Rovigo within "Starting Grants" initiative	This research was supported by a grant from the University of Padua and Fondazione Cassa di Risparmio di Padova e Rovigo, within the "Starting Grants" initiative (2015 edition). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; B?rkner P.-C, 2016, BRMS BAYESIAN REGRES; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyce W, 2006, SOC INDIC RES, V78, P473, DOI 10.1007/s11205-005-1607-6; Ciucci E, 2014, J GENET PSYCHOL, V175, P382, DOI 10.1080/00221325.2014.934653; CLARK RD, 1974, J PERS SOC PSYCHOL, V29, P279, DOI 10.1037/h0036000; Ferreira GCDS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01460; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Fawcett JM, 2016, J EXP PSYCHOL GEN, V145, P56, DOI 10.1037/xge0000128; Fine SE, 2003, DEV PSYCHOPATHOL, V15, P331, DOI 10.1017/S095457940300018X; Fiorentini C, 2011, J VISION, V11, DOI 10.1167/11.3.17; Fox CL, 2005, BRIT J EDUC PSYCHOL, V75, P313, DOI 10.1348/000709905X25517; Gasser L, 2009, SOC DEV, V18, P798, DOI 10.1111/j.1467-9507.2008.00516.x; Gelman A., 2021, BAYESIAN DATA ANAL; Gini G, 2006, AGGRESSIVE BEHAV, V32, P528, DOI 10.1002/ab.20153; Goodfellow S, 2009, J GENET PSYCHOL, V170, P234, DOI 10.1080/00221320903218281; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Jenkins LN, 2016, J SCH VIOLENCE, V15, P259, DOI 10.1080/15388220.2014.986675; Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kruschke J. K., 2017, PSYCHONOMIC B REV; Latane B., 1970, UNRESPONSIVE BYSTAND; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; McElreath R., 2016, STAT RETHINKING BAYE, V122; Menesini E, 2003, AGGRESSIVE BEHAV, V29, P515, DOI 10.1002/ab.10060; Menesini E, 2008, BRIT J DEV PSYCHOL, V26, P183, DOI 10.1348/026151007X205281; Meter DJ, 2015, DEV REV, V38, P222, DOI 10.1016/j.dr.2015.08.001; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Mostow AJ, 2002, CHILD DEV, V73, P1775, DOI 10.1111/1467-8624.00505; Nansel TR, 2001, JAMA-J AM MED ASSOC, V285, P2094, DOI 10.1001/jama.285.16.2094; Neal RM, 2011, CH CRC HANDB MOD STA, P113; Nickerson AB, 2015, SCHOOL PSYCHOL REV, V44, P372, DOI 10.17105/spr-15-0035.1; Nowicki S., 2013, MANUAL RECEPTIVE TES; Nowicki S. J., 2005, MANUAL DIAGNOSTIC AN; Obermann M.-L., 2011, J SCH VIOLENCE, V10, P239, DOI [10.1080/15388220.2011.578276, DOI 10.1080/15388220.2011.578276]; Pozzoli T, 2017, J ADOLESCENCE, V61, P87, DOI 10.1016/j.adolescence.2017.09.011; Pozzoli T, 2016, J SCHOOL PSYCHOL, V59, P67, DOI 10.1016/j.jsp.2016.09.005; Pozzoli T, 2013, J EARLY ADOLESCENCE, V33, P315, DOI 10.1177/0272431612440172; Pozzoli T, 2010, J ABNORM CHILD PSYCH, V38, P815, DOI 10.1007/s10802-010-9399-9; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Salmivalli C, 1996, AGGRESSIVE BEHAV, V22, P1, DOI 10.1002/(SICI)1098-2337(1996)22:1<1::AID-AB1>3.0.CO;2-T; Salmivalli C, 2010, AGGRESS VIOLENT BEH, V15, P112, DOI 10.1016/j.avb.2009.08.007; SHOTLAND RL, 1979, J PERS SOC PSYCHOL, V37, P1822, DOI 10.1037/0022-3514.37.10.1822; Stan Development Team, 2017, STAN MOD LANG US GUI; Sutton J, 1999, BRIT J DEV PSYCHOL, V17, P435, DOI 10.1348/026151099165384; Trentacosta CJ, 2010, SOC DEV, V19, P1, DOI 10.1111/j.1467-9507.2009.00543.x; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; van Noorden THJ, 2015, J YOUTH ADOLESCENCE, V44, P637, DOI 10.1007/s10964-014-0135-6; Wilton MMM, 2000, SOC DEV, V9, P226, DOI 10.1111/1467-9507.00121; Woods S, 2009, CHILD ABUSE NEGLECT, V33, P307, DOI 10.1016/j.chiabu.2008.11.002; Zych I., 2016, TRAUMA VIOLENCE ABUS	53	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188062	10.1371/journal.pone.0188062	http://dx.doi.org/10.1371/journal.pone.0188062			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131871	Green Submitted, Green Published, gold			2022-12-27	WOS:000414997800043
J	Legramante, JM; Mastropasqua, M; Susi, B; Porzio, O; Mazza, M; Agrippino, GM; D'Agostini, C; Brandi, A; Giovagnoli, G; Di Lecce, VN; Bernardini, S; Minieri, M				Legramante, Jacopo Maria; Mastropasqua, Maria; Susi, Beniamino; Porzio, Ottavia; Mazza, Marta; Agrippino, Grazia Miranda; D'Agostini, Cartesio; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito Nicola; Bernardini, Sergio; Minieri, Marilena			Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB	PLOS ONE			English	Article							MORTALITY; PROADRENOMEDULLIN; DERIVATION; ADMISSION; PEPTIDE; MARKER; INDEX; TOOL	Aim (i) evaluate the performance of MR-pro-ADM in reflecting the outcome and risk for CAP patients in the emergency department, and (ii) compare the prognostic performance of MR-pro-ADM with that of clinical scores PSI and CURB65. Methods Observational prospective, single-center study in patients with suspected community acquired pneumonia (CAP). Eighty one patients underwent full clinical and laboratory assessment as by protocol, and were followed up a 28 days. Primary endpoints measured were: death, death at 14 days, non-invasive mechanical ventilation (NIMV), endotracheal intubation (EI), ICU admission, overall hospital stay > 10 days, emergency department stay > 4 days. The discriminative performance of MR-pro-ADM and clinical scores was assessed by AUROC analysis. Results The distribution for MR-pro-ADM followed an upward trend, increasing with the increase of both PSI (p<0.001) and CURB65 (p<0.001) classes. However, the difference between MRproADM values and score classes was significant only in the case of CURB65 classes 0 and 1 (p = 0.046), 2 (p = 0.013), and 3 (p = 0.011); and with PSI classes 5, 3 (p = 0.044), and 1 (p = 0.020). As to the differences among variables for the six end-points, MR-pro-ADM values in the two groups selected for each considered end-point differed in a statistically significant manner for all endpoints. Both PSI and CURB65 differed significantly for all end-points, except for stay in the ED longer than 4 days and the hospital stay longer than 10 days and endotracheal intubation (only PSI classes differed with statistical significance). ROC analyses evidenced that MR-pro-ADM values gave the greatest AUC for the prediction of death, endotracheal intubation, hospital stay >10 days and DE stay >4 days, compared to the PSI and CURB (though difference not statistically significant). For each endpoint measured, the best thresholds values for Mr-pro-ADM were: 1.6 (specificity 76.5%; sensitivity 77.8%) for death; 2.5 (specificity 88.9%; sensitivity 80.0%) for death at 14 days; 1.5 (specificity 77.0%; sensitivity 87.5%) for NIMV; 2.4 (specificity 88.7%; sensitivity 83.3%) for endotracheal intubation; 0.9 (specificity 53.5%; sensitivity 70.6%) for DE stay greater than 4 days; 1.9 (specificity 82.1%; sensitivity 55.3%) for hospital stay greater than 10 days. The AUC for the combination of MR-pro-ADM and PSI was 81.29% [63.41%-99.17%], but not in a statistically significant manner compared to the AUCs of the single predictors. Conversely, the AUC for the combination of MR-pro-ADM and CURB65 was 87.58% [75.54%-99.62%], which was significantly greater than the AUC of CURB65 (p = 0.047) or PSI (p = 0.017) alone. Conclusions The present study confirms that assessment of MR-pro-ADM levels in CAP patients in addition to CURB scores increases the prognostic accuracy of CURB alone and may help rule out discrepancies arising from flawed clinical severity classification. With particular reference to patients scoring in the upper classes of CURB and PSI, MR-pro-ADM values provided additional information towards a better risk stratification of those patients. In particular, our results pointed towards two MR-pro-ADM threshold values that appear to predict with a good degree of accuracy the patient's need for non-invasive mechanical ventilation, endotracheal intubation, or intensive care. This aspect, however, deserves further investigation.	[Legramante, Jacopo Maria; Mastropasqua, Maria; Susi, Beniamino; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito Nicola] Policlin Tor Vergata, Emergency Dept, Rome, Italy; [Legramante, Jacopo Maria] Univ Tor Vergata, Dept Med Syst, Rome, Italy; [Porzio, Ottavia] Osped Pediat Bambino Gesu, IRCCS, Clin Lab, Rome, Italy; [Porzio, Ottavia; Bernardini, Sergio; Minieri, Marilena] Univ Tor Vergata, Dept Expt Med & Surg, Rome, Italy; [Mazza, Marta] Osped Maria Vittoria, Med & Chirurg Accettaz & Urgenza, Turin, Italy; [Agrippino, Grazia Miranda] AOU Careggi, Med Alta Complessita Assistenziale 3, Florence, Italy; [D'Agostini, Cartesio] Policlin Tor Vergata, Lab Clin Microbiol, Rome, Italy; [Bernardini, Sergio; Minieri, Marilena] Policlin Tor Vergata, Dept Lab Med, Lab Clin Biochem, Rome, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; IRCCS Bambino Gesu; University of Rome Tor Vergata; Maria Vittoria Hospital; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Rome Tor Vergata; Policlin Tor Vergata; University of Rome Tor Vergata; Policlin Tor Vergata	Legramante, JM (corresponding author), Policlin Tor Vergata, Emergency Dept, Rome, Italy.; Legramante, JM (corresponding author), Univ Tor Vergata, Dept Med Syst, Rome, Italy.	legraman@uniroma2.it	Minieri, Marilena/AAD-1763-2020; Minieri, Marilena/ABC-4897-2021	MINIERI, MARILENA/0000-0002-2512-4793; PORZIO, OTTAVIA/0000-0001-5931-8679				Albrich WC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-112; Alcoba G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1095-5; Aujesky D, 2008, CLIN INFECT DIS, V47, pS133, DOI 10.1086/591394; Bauer TT, 2006, J INTERN MED, V260, P93, DOI 10.1111/j.1365-2796.2006.01657.x; Blasi F, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-44; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; Christ-Crain M, 2005, CRIT CARE, V9, pR816, DOI 10.1186/cc3885; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; Courtais C, 2013, AM J EMERG MED, V31, P215, DOI 10.1016/j.ajem.2012.07.017; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng JC, 2005, CLIN CHEST MED, V26, P1, DOI 10.1016/j.ccm.2004.10.009; Espana P, 2014, J INFECT; Fine M, 1997, NEW ENGL J MED, V336, P240; Heron M., 2009, NATL VITAL STAT REPO, V57, P1; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hirata Y, 1996, J CLIN ENDOCR METAB, V81, P1449, DOI 10.1210/jc.81.4.1449; Huang DT, 2009, CHEST, V136, P823, DOI 10.1378/chest.08-1981; Ioachimescu OC, 2004, INT J ANTIMICROB AG, V24, P485, DOI 10.1016/j.ijantimicag.2004.05.006; Jain Saransh, 2014, BMC Res Notes, V7, P458, DOI 10.1186/1756-0500-7-458; KELLY BJ, 1993, CHEST, V104, P1818, DOI 10.1378/chest.104.6.1818; Khan F, 2016, COMMUNITY ACQUIR INF, V3, P36; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Koutroulis I, 2014, INT SCHOLARLY RES NO; Kutz A, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-102; Lamy Olivier, 2004, Eur J Intern Med, V15, P28, DOI 10.1016/j.ejim.2003.11.003; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Magrini L, 2013, EUR REV MED PHARMACO, V17, P133; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mortensen EM, 2003, CLIN INFECT DIS, V37, P1617, DOI 10.1086/379712; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pieralli Filippo, 2015, J Clin Med Res, V7, P706, DOI 10.14740/jocmr2251w; Rodriguez A, 2009, INTENS CARE MED, V35, P430, DOI 10.1007/s00134-008-1363-6; Roson B, 2001, CLIN INFECT DIS, V33, P158, DOI 10.1086/321808; Suberviola B, 2012, SWISS MED WEEKLY, P142; SUGO S, 1994, BIOCHEM BIOPH RES CO, V201, P1160, DOI 10.1006/bbrc.1994.1827; Tanenao E, 2001, PEPTIDES, V22, P1693; Travaglino F, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-184; Valenzuela-Sanchez F, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.65	39	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187702	10.1371/journal.pone.0187702	http://dx.doi.org/10.1371/journal.pone.0187702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161297	gold, Green Submitted, Green Published			2022-12-27	WOS:000415987000018
J	Sobhkhez, M; Krasnov, A; Chang, CJ; Robertsen, B				Sobhkhez, Mehrdad; Krasnov, Aleksej; Chang, Chia Jung; Robertsen, Borre			Transcriptome analysis of plasmid-induced genes sheds light on the role of type I IFN as adjuvant in DNA vaccine against infectious salmon anemia virus	PLOS ONE			English	Article							HEMATOPOIETIC NECROSIS VIRUS; ATLANTIC SALMON; RAINBOW-TROUT; CHEMOKINE RECEPTORS; B-CELLS; IMMUNE-RESPONSES; MX1 PROMOTER; T-CELLS; INTERFERON; EXPRESSION	A previous study showed that a plasmid expressing IFNa (pIFNa) strongly enhanced protection and antibody production of a DNA vaccine against infectious salmon anemia virus (ISAV) in Atlantic salmon. The vaccine consisted of a plasmid (pHE) expressing the virus hemagglutinin-esterase as an antigen. To increase the understanding of the adjuvant effect of pIFNa, we here compared transcriptome responses in salmon muscle at the injection site at week 1 and 2 after injection of pIFNa, pHE, plasmid control (pcDNA3.3) and PBS, respectively. The results showed that the IFNa plasmid mediates an increase in gene transcripts of at least three major types in the muscle; typical IFN-I induced genes (ISGs), certain chemokines and markers of B-cells, T-cells and antigen-presenting cells. The latter suggests recruitment of cells to the plasmid injection site. Attraction of lymphocytes was likely caused by the induction of chemokines homologous to mammalian CCL5, CCL8, CCL19 and CXCL10. IFN may possibly also co-stimulate activation of lymphocytes as suggested by studies in mammals. A major finding was that both pcDNA3.3 and pHE caused responses similar to pIFNa, but at lower magnitude. Plasmid DNA may thus by itself have adjuvant activity as observed in mammalian models. Notably, pHE had a lower effect on many immune genes including ISGs and chemokines than pcDNA3.3, which suggests an inhibitory effect of HE expression on the immune genes. This hypothesis was supported by an Mx-reporter assay. The present study thus suggests that a main role for pIFNa as adjuvant in the DNA vaccine against ISAV may be to overcome the inhibitory effect of HE-expression on plasmid-induced ISGs and chemokines.	[Sobhkhez, Mehrdad; Chang, Chia Jung; Robertsen, Borre] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway; [Krasnov, Aleksej] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway	UiT The Arctic University of Tromso; Nofima	Robertsen, B (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Tromso, Norway.	borre.robertsen@uit.no	Chang, Chia-Jung/AAX-2264-2020	Chang, Chia-Jung/0000-0002-4945-5802	Aquaculture programme of the Research Council of Norway [237315/E40, 254907/E40]; Research Council of Norway; Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Aquaculture programme of the Research Council of Norway; Research Council of Norway(Research Council of Norway); Ministry of Trade, Industry and Fisheries; Norwegian Seafood Research Fund (FHF)	Borre Robertsen received funding from the Aquaculture programme of the Research Council of Norway (https://www.forskningsradet.no/en/Home_page/1177315753906), grants no. 237315/E40 and 254907/E40. NOFIMA AS (https://nofima.no/en/research/) provided support in the form of salaries for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. NOFIMA AS is a non-profit research institution supported by grants from the following sources: The Research Council of Norway; The Ministry of Trade, Industry and Fisheries; The Norwegian Seafood Research Fund (FHF).; This work was funded by the Aquaculture Programme of the Research Council of Norway, grants no. 237315/E40 and 254907/E40.	Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Castro R, 2014, VACCINE, V32, P1160, DOI 10.1016/j.vaccine.2013.11.062; Castro R, 2014, J IMMUNOL, V192, P1257, DOI 10.4049/jimmunol.1302471; Chang CJ, 2016, FISH SHELLFISH IMMUN, V57, P35, DOI 10.1016/j.fsi.2016.08.020; Chang CJ, 2015, VACCINE, V33, P2442, DOI 10.1016/j.vaccine.2015.03.093; Chang CJ, 2014, VACCINE, V32, P4695, DOI 10.1016/j.vaccine.2014.05.059; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Coban C, 2013, HUM VACC IMMUNOTHER, V9, P2216, DOI 10.4161/hv.25893; Collet B, 2004, DEV COMP IMMUNOL, V28, P793, DOI 10.1016/j.dci.2003.12.005; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Comerford I, 2013, CYTOKINE GROWTH F R, V24, P269, DOI 10.1016/j.cytogfr.2013.03.001; Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683; Grimholt U, 2015, DEV COMP IMMUNOL, V49, P79, DOI 10.1016/j.dci.2014.11.009; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Johansen LH, 2016, MOL IMMUNOL, V73, P138, DOI 10.1016/j.molimm.2016.04.007; Jorgensen SM, 2006, FISH SHELLFISH IMMUN, V21, P548, DOI 10.1016/j.fsi.2006.03.004; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Krasnov A, 2011, MOL IMMUNOL, V49, P163, DOI 10.1016/j.molimm.2011.08.007; Krasnov A, 2011, COMP BIOCHEM PHYS D, V6, P31, DOI 10.1016/j.cbd.2010.04.006; Kurath G, 2008, REV SCI TECH OIE, V27, P175, DOI 10.20506/rst.27.1.1793; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Liu Y, 2008, DEV COMP IMMUNOL, V32, P26, DOI 10.1016/j.dci.2007.03.015; Lorenzen N, 2005, REV SCI TECH OIE, V24, P201, DOI 10.20506/rst.24.1.1565; Montero J, 2011, J VIROL, V85, P4046, DOI 10.1128/JVI.02519-10; Peatman E, 2007, IMMUNOGENETICS, V59, P613, DOI 10.1007/s00251-007-0228-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proost P, 1996, J LEUKOCYTE BIOL, V59, P67, DOI 10.1002/jlb.59.1.67; Purcell MK, 2006, MOL IMMUNOL, V43, P2089, DOI 10.1016/j.molimm.2005.12.005; Seppola M, 2007, DEV COMP IMMUNOL, V31, P156, DOI 10.1016/j.dci.2006.05.009; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Shirota H, 2007, J IMMUNOL, V179, P329, DOI 10.4049/jimmunol.179.1.329; Sun BJ, 2011, J VIROL, V85, P9188, DOI 10.1128/JVI.00319-11; Syed M, 2003, MAR BIOTECHNOL, V5, P253, DOI 10.1007/s10126-002-0063-4; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; van Hateren Andy, 2017, F1000Res, V6, P158, DOI 10.12688/f1000research.10474.1; Xu C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1302-1	42	14	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188456	10.1371/journal.pone.0188456	http://dx.doi.org/10.1371/journal.pone.0188456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161315	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000057
J	Trewin, AJ; Levinger, I; Parker, L; Shaw, CS; Serpiello, FR; Anderson, MJ; McConell, GK; Hare, DL; Stepto, NK				Trewin, Adam J.; Levinger, Itamar; Parker, Lewan; Shaw, Christopher S.; Serpiello, Fabio R.; Anderson, Mitchell J.; McConell, Glenn K.; Hare, David L.; Stepto, Nigel K.			Acute exercise alters skeletal muscle mitochondrial respiration and H2O2 emission in response to hyperinsulinemic-euglycemic clamp in middle-aged obese men	PLOS ONE			English	Article							HIGH-INTENSITY EXERCISE; INSULIN SENSITIVITY; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; TBC1D1 PHOSPHORYLATION; AS160 PHOSPHORYLATION; SIGNALING PATHWAYS; PROTEIN-SYNTHESIS; ATP PRODUCTION; IN-VIVO	Obesity, sedentary lifestyle and aging are associated with mitochondrial dysfunction and impaired insulin sensitivity. Acute exercise increases insulin sensitivity in skeletal muscle; however, whether mitochondria are involved in these processes remains unclear. The aim of this study was to investigate the effects of insulin stimulation at rest and after acute exercise on skeletal muscle mitochondrial respiratory function (JO(2)) and hydrogen peroxide emission (JH(2)O(2)), and the associations with insulin sensitivity in obese, sedentary men. Nine men (means +/- SD: 57 +/- 6 years; BMI 33 +/- 5 kg. m(2)) underwent hyperinsulinemic-euglycemic clamps in two separate trials 1-3 weeks apart: one under resting conditions, and another 1 hour after high-intensity exercise (4x4 min cycling at 95% HRpeak). Muscle biopsies were obtained at baseline, and pre/post clamp to measure JO(2) with high-resolution respirometry and JH(2)O(2) via Amplex UltraRed from permeabilized fibers. Post-exercise, both JO(2) and JH(2)O(2) during ADP stimulated state-3/OXPHOS respiration were lower compared to baseline (P<0.05), but not after subsequent insulin stimulation. JH(2)O(2) was lower post-exercise and after subsequent insulin stimulation compared to insulin stimulation in the rest trial during succinate supported state-4/leak respiration (P<0.05). In contrast, JH(2)O(2) increased during complex-I supported leak respiration with insulin after exercise compared with resting conditions (P<0.05). Resting insulin sensitivity and JH(2)O(2) during complex-I leak respiration were positively correlated (r = 0.77, P<0.05). We conclude that in obese, older and sedentary men, acute exercise modifies skeletal muscle mitochondrial respiration and H2O2 emission responses to hyperinsulinemia in a respiratory state-specific manner, which may have implications for metabolic diseases involving insulin resistance.	[Trewin, Adam J.; Levinger, Itamar; Parker, Lewan; Shaw, Christopher S.; Serpiello, Fabio R.; Anderson, Mitchell J.; McConell, Glenn K.; Stepto, Nigel K.] Victoria Univ, ISEAL, Melbourne, Vic, Australia; [Levinger, Itamar; Stepto, Nigel K.] Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Australia; [Parker, Lewan; Shaw, Christopher S.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia; [Hare, David L.] Univ Melbourne, Melbourne, Vic, Australia; [Hare, David L.] Austin Hlth, Dept Cardiol, Melbourne, Vic, Australia; [Stepto, Nigel K.] Monash Univ, MCHRI, Clayton, Vic, Australia; [Stepto, Nigel K.] Monash Hlth, Clayton, Vic, Australia; [Trewin, Adam J.] Univ Rochester, Med Ctr, Dept Anesthesiol & Perioperat Med, Rochester, NY 14642 USA	Victoria University; Victoria University; Deakin University; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Rochester	Stepto, NK (corresponding author), Victoria Univ, ISEAL, Melbourne, Vic, Australia.; Stepto, NK (corresponding author), Victoria Univ, Australian Inst Musculoskeletal Sci AIMSS, St Albans, Australia.; Stepto, NK (corresponding author), Monash Univ, MCHRI, Clayton, Vic, Australia.; Stepto, NK (corresponding author), Monash Hlth, Clayton, Vic, Australia.	Nigel.Stepto@vu.edu.au	Trewin, Adam/M-1584-2019	Trewin, Adam/0000-0001-7322-4054; McConell, Glenn/0000-0002-8572-9065; Levinger, Itamar/0000-0001-9194-2033; Stepto, Nigel/0000-0002-0875-6836; Parker, Lewan/0000-0002-5372-1851	Victoria University Research Development Grant Scheme; Australian Government through the National Collaborative Research Network Grant Scheme	Victoria University Research Development Grant Scheme; Australian Government through the National Collaborative Research Network Grant Scheme	This research was funded by the Victoria University Research Development Grant Scheme (I.L., D.L.H. and G.K.M.) This funding was from the authors institution and they had no input into study design and data analysis. They have no embargo on publication of results. Two authors received funding to support their salaries to undertake this investigator initiated research. I.L. is a Heart Foundation Future Leader Fellow (ID No.100040). N.K.S. was supported by the Australian Government through the National Collaborative Research Network Grant Scheme.	Amati F, 2009, DIABETES CARE, V32, P1547, DOI 10.2337/dc09-0267; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Aon MA, 2012, J GEN PHYSIOL, V139, P479, DOI 10.1085/jgp.201210772; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Barazzoni R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1117, DOI 10.1152/ajpendo.00067.2012; Brand MD, 2016, CELL METABOLISM; Campbell PT, 2010, MED SCI SPORT EXER, V42, P1448, DOI 10.1249/MSS.0b013e3181cfc908; Chow LS, 2016, DIABETOLOGIA, P1; ConstantinTeodosiu D, 1996, EUR J APPL PHYSIOL, V73, P186, DOI 10.1007/BF00262830; COSTILL DL, 1988, J APPL PHYSIOL, V64, P2245, DOI 10.1152/jappl.1988.64.5.2245; Fabbri E, 2016, DIABETES; Fisher-Wellman Kelsey, 2009, Dyn Med, V8, P1, DOI 10.1186/1476-5918-8-1; Fisher-Wellman KH, 2014, DIABETES, V63, P132, DOI 10.2337/db13-0940; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Funai K, 2009, AM J PHYSIOL-ENDOC M, V297, pE242, DOI 10.1152/ajpendo.00194.2009; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GOLLNICK PD, 1990, PFLUG ARCH EUR J PHY, V415, P407, DOI 10.1007/BF00373617; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Green HJ, 2008, J APPL PHYSIOL, V104, P931, DOI 10.1152/japplphysiol.01151.2007; Hawley JA, 2007, DIABETOLOGIA, V50, P699, DOI 10.1007/s00125-007-0595-2; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Hickey AJR, 2012, J COMP PHYSIOL B, V182, P91, DOI 10.1007/s00360-011-0599-6; Hordern MD, 2012, J SCI MED SPORT, V15, P25, DOI 10.1016/j.jsams.2011.04.005; Howlett KF, 2008, AM J PHYSIOL-ENDOC M, V294, pE401, DOI 10.1152/ajpendo.00542.2007; Jessen N, 2011, AM J PHYSIOL-ENDOC M, V301, pE164, DOI 10.1152/ajpendo.00042.2011; Konopka AR, 2015, DIABETES, V64, P2104, DOI 10.2337/db14-1701; Kramer PA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00347; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Levinger I, 2007, DIABETES CARE, V30, P2205, DOI 10.2337/dc07-0841; Levinger I, 2014, J BONE MINER RES, V29, P2571, DOI 10.1002/jbmr.2285; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Makrecka-Kuka M, 2015, BIOMOLECULES, V5, P1319, DOI 10.3390/biom5031319; MIKINES KJ, 1988, AM J PHYSIOL, V254, pE248, DOI 10.1152/ajpendo.1988.254.3.E248; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Parker L, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00087; Parker L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171613; Parker L, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00411; Perry CGR, 2012, J PHYSIOL-LONDON, V590, P5475, DOI 10.1113/jphysiol.2012.234682; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Phielix E, 2008, DIABETES, V57, P2943, DOI 10.2337/db08-0391; Powers SK, 2011, J PHYSIOL-LONDON, V589, P2129, DOI 10.1113/jphysiol.2010.201327; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Stephenson EJ, 2012, J APPL PHYSIOL, V113, P1403, DOI 10.1152/japplphysiol.00788.2012; Stephenson EJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1541, DOI 10.1152/ajpendo.00590.2011; Stepto NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053080; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Timpani C. A., 2016, NEUROTHERAPEUTICS, P1; Tonkonogi M, 1998, J PHYSIOL-LONDON, V510, P279, DOI 10.1111/j.1469-7793.1998.279bz.x; Tonkonogi M, 1999, PFLUG ARCH EUR J PHY, V437, P562, DOI 10.1007/s004240050818; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Trewin AJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE388, DOI 10.1152/ajpendo.00605.2014; Votion DM, 2010, EQUINE VET J, V42, P268, DOI 10.1111/j.2042-3306.2010.00271.x; Widegren U, 1998, FASEB J, V12, P1379, DOI 10.1096/fasebj.12.13.1379; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Zhao XL, 2014, J PROTEOME RES, V13, P2359, DOI 10.1021/pr401163t; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	67	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188421	10.1371/journal.pone.0188421	http://dx.doi.org/10.1371/journal.pone.0188421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161316	Green Published, gold, Green Accepted			2022-12-27	WOS:000415987000053
J	Hoermann, R; Midgley, JEM; Larisch, R; Wolfgang, J; Dietrich, C				Hoermann, Rudolf; Midgley, John Edward Maurice; Larisch, Rolf; Wolfgang, Johannes; Dietrich, Christian			Advances in applied homeostatic modelling of the relationship between thyrotropin and free thyroxine	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; FREE T4 RELATIONSHIP; FEEDBACK-CONTROL; MATHEMATICAL-MODEL; REFERENCE RANGE; TSH; HORMONE; AGE; ASSOCIATION; GUIDELINES	Introduction The relationship between pituitary TSH and thyroid hormones is central to our understanding of thyroid physiology and thyroid function testing. Here, we generated distribution patterns by using validated tools of thyroid modelling. Methods We simulated patterns of individual set points under various conditions, based on a homeostatic model of thyroid feedback control. These were compared with observed data points derived from clinical trials. Results A random mix of individual set points was reconstructed by simulative modelling with defined structural parameters. The pattern displayed by the cluster of hypothetical points resembled that observed in a natural control group. Moderate variation of the TSH-FT4 gradient over the functional range introduced further flexibility, implementing a scenario of adaptive set points. Such a scenario may be a realistic possibility for instance in treatment where relationships and equilibria between thyroid parameters are altered by various influences such as LT4 dose and conversion efficiency. Conclusions We validated a physiologically based homeostatic model that permits simulative reconstruction of individual set points. This produced a pattern resembling the observed data under various conditions. Applied modelling, although still experimental at this stage, shows a potential to aid our physiological understanding of the interplay between TSH and thyroid hormones. It should eventually benefit personalised clinical decision making.	[Hoermann, Rudolf; Larisch, Rolf] Klinikum Ludenscheid, Dept Nucl Med, Paulmannshoherstr, Ludenscheid, Germany; [Midgley, John Edward Maurice] North Lakes Clin, 20 Wheatley Ave, Ilkley, England; [Dietrich, Christian] Ruhr Univ Bochum, Med Dept 1, Endocrinol & Diabetol, Bergmannsheil Univ Hosp, Bochum, Germany; [Dietrich, Christian] Ruhr Univ Bochum, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany; [Dietrich, Christian] Witten Herdecke Univ, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Dietrich, C (corresponding author), Ruhr Univ Bochum, Med Dept 1, Endocrinol & Diabetol, Bergmannsheil Univ Hosp, Bochum, Germany.; Dietrich, C (corresponding author), Ruhr Univ Bochum, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany.; Dietrich, C (corresponding author), Witten Herdecke Univ, Ruhr Ctr Rare Dis CeSER, Alexandrinenstr 5, Bochum, Germany.	johannes.dietrich@ruhr-uni-bochum.de	Dietrich, Johannes W./C-3498-2009	Dietrich, Johannes W./0000-0002-1185-3549; Hoermann, Rudolf/0000-0002-1326-4270	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sanofi-Henning; Hexal AG; Bristol-Myers Squibb; Pfizer	DFG Open Access Publication Funds of the Ruhr-Universitat Bochum; Sanofi-Henning; Hexal AG; Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector. We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. JWD received funding and personal fees by Sanofi-Henning, Hexal AG, Bristol-Myers Squibb and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2003, THYROID, V13, P1069, DOI 10.1089/105072503770867237; [Anonymous], 2021, LANG ENV STAT COMP; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Benhadi N, 2010, EUR J ENDOCRINOL, V162, P323, DOI 10.1530/EJE-09-0655; Brown SJ, 2016, CLIN ENDOCRINOL, V85, P789, DOI 10.1111/cen.13107; Chatzitomaris A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00163; Clark PM, 2012, J CLIN PATHOL, V65, P463, DOI 10.1136/jclinpath-2011-200433; De Grande LAC, 2015, EUR THYROID J, V4, P69, DOI 10.1159/000369796; Dietrich JW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00057; Dietrich JW, 2015, LANCET DIABETES ENDO, V3, P932, DOI 10.1016/S2213-8587(15)00421-0; Dietrich JW, 2012, J THROID RES, V2012, DOI 10.1155/2012/351864; Dietrich Johannes W, 2008, BMC Endocr Disord, V8, P13, DOI 10.1186/1472-6823-8-13; Dietrich JW, 2004, CYBERNET SYST, V35, P315, DOI 10.1080/01969720490443354; Dietrich JW, 2016, SCHILDDRUSE 2015, P107; Dietrich JW., 2006, CYBERNET SYST, V2006, P269; Dietrich JW., 2001, HYPOPHYSEN SCHILDDR, V2, DOI [10.13140/RG.2.1.4845.9368, DOI 10.13140/RG.2.1.4845.9368]; Eisenberg M, 2008, THYROID, V18, P1071, DOI 10.1089/thy.2007.0388; Fitzgerald SP, 2016, J THROID RES, V2016, DOI 10.1155/2016/6351473; Fliers E, 2014, EUR J ENDOCRINOL, V171, pR197, DOI 10.1530/EJE-14-0285; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Goede SL, 2014, B MATH BIOL, V76, P1270, DOI 10.1007/s11538-014-9955-5; Goede SL, 2014, MATH BIOSCI, V249, P1, DOI 10.1016/j.mbs.2014.01.001; Goede SL, 2013, WIPO number WO/2014/088516, Patent No. 2014088516; Goede SL, 2016, J CLIN ENDOCR METAB, V101, pL56; Hadlow NC, 2013, J CLIN ENDOCR METAB, V98, P2936, DOI 10.1210/jc.2012-4223; Hoermann R, 2015, HORM METAB RES, V47, P674, DOI 10.1055/s-0034-1398616; Hoermann R, 2012, J THYROID RES, V2012, P1, DOI [10.1089/thy.2008.0155, DOI 10.1089/THY.2008.0155]; Hoermann R, 2017, J ENDOCR SOC, V1, P874, DOI 10.1210/js.2017-00057; Hoermann R, 2017, THER ADV ENDOCRINOL, V8, P83, DOI 10.1177/2042018817716401; Hoermann R, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00142; Hoermann R, 2016, EUR THYROID J, V5, P171, DOI 10.1159/000447967; Hoermann R, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00177; Hoermann R, 2016, EUR J ENDOCRINOL, V174, P735, DOI 10.1530/EJE-16-0031; Hoermann R, 2014, CLIN ENDOCRINOL, V81, P907, DOI 10.1111/cen.12527; Hoermann R, 2013, EUR J ENDOCRINOL, V168, P271, DOI 10.1530/EJE-12-0819; Hoermann R, 2010, EUR J ENDOCRINOL, V162, P1123, DOI 10.1530/EJE-10-0106; Ito M, 2017, THYROID, V27, P484, DOI 10.1089/thy.2016.0426; Ito M, 2015, EUR J ENDOCRINOL, V173, P333, DOI 10.1530/EJE-15-0138; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Larisch R, 2015, NUKLEARMED-NUCL MED, V54, P112, DOI 10.3413/Nukmed-0671-14-06; Laurberg P, 2011, NAT REV ENDOCRINOL, V7, P232, DOI 10.1038/nrendo.2011.13; Leow MKS, 2007, J THEOR BIOL, V248, P275, DOI 10.1016/j.jtbi.2007.05.016; Leow MKS, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00064; Leow MKS, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-35; Mariotti S, 2011, NORMAL PHYSL HYPOTHA, P1; McAninch EA, 2015, LANCET DIABETES ENDO, V3, P756, DOI 10.1016/S2213-8587(15)00325-3; Midgley John E M, 2016, J Clin Endocrinol Metab, V101, pL40, DOI 10.1210/jc.2016-1115; Midgley JEM, 2015, ENDOCR CONNECT, V4, P196, DOI [10.1530/EC-150056, 10.1530/EC-15-0056]; Midgley JEM, 2013, J CLIN PATHOL, V66, P335, DOI 10.1136/jclinpath-2012-201213; REICHLIN S, 1967, J CLIN ENDOCR METAB, V27, P251, DOI 10.1210/jcem-27-2-251; Rothacker KM, 2016, J CLIN ENDOCR METAB, V101, P1151, DOI 10.1210/jc.2015-4011; Rugge JB, 2015, ANN INTERN MED, V162, P35, DOI 10.7326/M14-1456; Soetaert K, 2009, PRACTICAL GUIDE ECOL, P1; Strich D, 2016, EUR J ENDOCRINOL, V175, P49, DOI 10.1530/EJE-16-0007; van Deventer HE, 2011, CLIN CHEM, V57, P122, DOI 10.1373/clinchem.2010.154088; Winther KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156925	56	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187232	10.1371/journal.pone.0187232	http://dx.doi.org/10.1371/journal.pone.0187232			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155897	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700008
J	Nandi, S; Schneider, H; Dixit, P				Nandi, Sulakshana; Schneider, Helen; Dixit, Priyanka			Hospital utilization and out of pocket expenditure in public and private sectors under the universal government health insurance scheme in Chhattisgarh State, India: Lessons for universal health coverage	PLOS ONE			English	Article							LOW-INCOME; CARE; SERVICES; SYSTEMS; AFRICA; EQUITY; IMPACT	Research on impact of publicly financed health insurance has paid relatively little attention to the nature of healthcare provision the schemes engage. India's National Health Insurance Scheme or RSBY was made universal by Chhattisgarh State in 2012. In the State, public and private sectors provide hospital services in a context of extensive gender, social, economic and geographical inequities. This study examined enrolment, utilization (public and private) and out of pocket (OOP) expenditure for the insured and uninsured, in Chhattisgarh. The Chhattisgarh State Central sample (n = 6026 members) of the 2014 National Sample Survey (71st Round) on Health was extracted and analyzed. Variables of enrolment, hospitalization, out of pocket (OOP) expenditure and catastrophic expenditure were descriptively analyzed. Multivariate analyses of factors associated with enrolment, hospitalization (by sector) and OOP expenditure were conducted, taking into account gender, socio-economic status, residence, type of facility and ailment. Insurance coverage was 38.8%. Rates of hospitalization were 33/1000 population among the insured and 29/1000 among the uninsured. Of those insured and hospitalized, 67.2% utilized the public sector. Women, rural residents, Scheduled Tribes and poorer groups were more likely to utilize the public sector for hospitalizations. Although the insured were less likely to incur out of pocket (OOP) expenditure, 95.1% of insured private sector users and 66.0% of insured public sector users, still incurred costs. Median OOP payments in the private sector were eight times those in the public sector. Of households with at least one member hospitalized, 35.5% experienced catastrophic health expenditures (>10% monthly household consumption expenditure). The study finds that despite insurance coverage, the majority still incurred OOP expenditure. The public sector was nevertheless less expensive, and catered to the more vulnerable groups. It suggests the need to further examine the roles of public and private sectors in financial risk protection through government health insurance.	[Nandi, Sulakshana] Publ Hlth Resource Network, Raipur, Chhattisgarh, India; [Nandi, Sulakshana] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa; [Schneider, Helen] Univ Western Cape, UWC MRC Hlth Serv Syst Unit, Sch Publ Hlth, Bellville, South Africa; [Dixit, Priyanka] TISS, SHSS, Bombay, Maharashtra, India	University of the Western Cape; University of the Western Cape; Tata Institute of Social Sciences	Nandi, S (corresponding author), Publ Hlth Resource Network, Raipur, Chhattisgarh, India.; Nandi, S (corresponding author), Univ Western Cape, Sch Publ Hlth, Bellville, South Africa.	sulakshana@phrnindia.org	Nandi, Sulakshana/AAX-2698-2020	Nandi, Sulakshana/0000-0002-4366-4566; Schneider, Helen/0000-0002-0418-1828	Institute of Tropical Medicine, Belgium	Institute of Tropical Medicine, Belgium	This paper is part of the PhD of the first author for which a part fellowship had been provided by the Institute of Tropical Medicine, Belgium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A., 2012, IMPACT NATL HLTH INS; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Barraza-Llorens M, 2013, REV PANAM SALUD PUBL, V33, P122, DOI 10.1590/S1020-49892013000200007; Basu S, 2012, PLOS MED, V9; Council for Tribal and Rural Development (CTRD), 2012, FIN REP EV RASHTR SW; Criel B., 2014, STUDIES HLTH SERVICE, V32; CTRD, 2013, IND ASS STUD PROC EN; Dipa Sinha, 2015, Economic and Political Weekly, V50, P16; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; Dror DM, 2012, INDIAN J MED RES, V135, P56, DOI 10.4103/0971-5916.93425; Employees' State Insurance Corporation (ESIC), ANN REP 2013 14; Fan VY, 2012, INT J HEALTH CARE FI, V12, P189, DOI 10.1007/s10754-012-9110-5; Federation of Indian Chambers of Commerce and Industry (FICCI), 2013, HLTH INS VIS 2020; Frenz P, 2010, GLOB S HLTH SYST RES; FSI, 2011, IND STAT FOR REP 201; Galarraga O, 2010, EUR J HEALTH ECON, V11, P437, DOI 10.1007/s10198-009-0180-3; Ghosh, 2014, ECON POLIT WEEKLY, V49, P93; Ghosh S, 2014, INT J HEALTH POLICY, V2, P29, DOI 10.15171/ijhpm.2014.06; GIZ, 2015, HLTH INS IND POOR M; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Grogger J., 2014, HLTH POLICY PLANNING, V30; House Chatham, 2014, SHAR RESP HLTH COH G; Hsu Justine, 2010, RELATIVE EFFICIENCY; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Jain N, 2015, EC POLITICAL WKLY, V46, P84; Jain N., 2014, 3 GLOB S HLTH SYST R; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Joe W., 2008, Economic and Political Weekly, V43, P41; Joint Learning Network (JLN), IND CHHATT STAT APPR; Kapilashrami A., 2013, WORKING PAPER; Katyal A, 2013, NATL MED J INDIA, V26, P291; Khera, 2010, ECON POLIT WEEKLY, V45, P54; Kumar AKS, 2011, LANCET, V377, P668, DOI 10.1016/S0140-6736(10)61884-3; Kusi A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-014-0130-2; Kutzin J, 2016, B WORLD HEALTH ORGAN, V94, P2, DOI 10.2471/BLT.15.165050; Kutzin J, 2013, B WORLD HEALTH ORGAN, V91, P602, DOI 10.2471/BLT.12.113985; Kutzin J, 2012, B WORLD HEALTH ORGAN, V90, P867, DOI 10.2471/BLT.12.113654; LaForgia G, 2012, DIR DEV, P1, DOI 10.1596/978-0-8213-9618-6; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Liu XY, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-10; Macha J, 2012, HEALTH POLICY PLANN, V27, pi46, DOI 10.1093/heapol/czs024; Mackintosh M, 2016, LANCET, V388, P596, DOI 10.1016/S0140-6736(16)00342-1; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; McIntyre D., 2016, LANCET, V6736; McIntyre D, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-36; Meng QY, 2011, HEALTH POLICY PLANN, V26, P93, DOI 10.1093/heapol/czq038; Ministry of Rural Development, 2016, DEM PROF; Nagpal S., 2013, UNIVERSAL HLTH COVER; Nandi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066296; Nandi S, 2012, HLTH CULT SOC, V2, P1, DOI [DOI 10.5195/HCS.2012.61, 10.5195/hcs.2012.61]; Nandi S, 2016, INDIAN J GEND STUD, V23, P43, DOI 10.1177/0971521515612863; Narayana D., 2010, ECON POLIT WEEKLY, V45, P13; National Health Systems Resource Center (NHSRC), 2012, NRHM 11 5 YEAR PLAN; National Sample Survey Office, 2015, KEY IND SOC CONS IND; Nundy M, 2013, RASHTRIYA SWASTHYA B; Odeyemi IAO, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-9; Ooms G, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-3; Oxfam, 2013, UN HLTH COV WHY HLTH; Palacios Robert, 2011, INDIAS HLTH INSURANC, P153; Palacios Robert, 2012, INDIAS HLTH INSURANC, P84; Patel V, 2015, LANCET, V386, P2422, DOI 10.1016/S0140-6736(15)00955-1; PHFI, 2011, CRITICAL ASSESSMENT; Prasad N. P., 2012, EC POLITICAL WEEKLY, V47; Prinja S., 2013, EC POLITICAL WEEKLY, V48; Prinja S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170996; Rajan Shukla, 2011, Economic and Political Weekly, V46, P38; Rajasekhar D, 2011, EC POLITICAL WKLY, V46, P56; Rajib Dasgupta, 2013, Social Change, V43, P227, DOI 10.1177/0049085713493043; Rama Baru, 2010, Economic and Political Weekly, V45, P49; Rao M, 2012, BMC P, V6, pO4, DOI DOI 10.1186/1753-6561-6-S1-O4; Rao M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004471; Rathi Prateek, 2012, EVALUATION RASHTRIYA; Ravi S., 2016, HLTH MORBIDITY INDIA; Registrar General India (RGI), 2011, PROV POP TOT CHHATT; Rent P, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015614607; Roberts MJ, 2015, HEALTH SYST REFORM, V1, P22, DOI 10.1080/23288604.2014.995981; Sakthivel Selvaraj, 2012, Economic and Political Weekly, V47, P60; Sapna Desai, 2009, Economic and Political Weekly, V44, P18; Sen, 2015, GUARDIAN LONDON; Shroff ZC, 2015, HEALTH SYST REFORM, V1, P107, DOI 10.1080/23288604.2015.1034310; Singh J., 2016, LIVE MINT; Sood N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5114; Spaan E, 2012, B WORLD HEALTH ORGAN, V90, P685, DOI 10.2471/BLT.12.102301; State Nodal Agency-RSBY and MSBY, INF UT RSBY MSBY FIN; State Nodal Agency-RSBY and MSBY, INF ENR RSBY MSBY 30; Sundararaman T., 2016, QUESTIONING FRAMEWOR, V51, P85; Virk AK, 2015, PUBLIC HEALTH, V129, P810, DOI 10.1016/j.puhe.2015.02.002; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; World Health Organization, 2013, ARG UN COV; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH; 2010, WORLD HLTH REP HLTH, P1	91	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187904	10.1371/journal.pone.0187904	http://dx.doi.org/10.1371/journal.pone.0187904			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149181	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100017
J	Hummel, C; Provenzale, A; van der Meer, J; Wijnhoven, S; Nolte, A; Poursanidis, D; Janss, G; Jurek, M; Andresen, M; Poulin, B; Kobler, J; Beierkuhnlein, C; Honrado, J; Razinkovas, A; Stritih, A; Bargmann, T; Ziemba, A; Bonet-Garcia, F; Adamescu, MC; Janssen, G; Hummel, H				Hummel, Christiaan; Provenzale, Antonello; van der Meer, Jaap; Wijnhoven, Sander; Nolte, Arno; Poursanidis, Dimitris; Janss, Guyonne; Jurek, Matthias; Andresen, Magnus; Poulin, Brigitte; Kobler, Johannes; Beierkuhnlein, Carl; Honrado, Joao; Razinkovas, Arturas; Stritih, Ana; Bargmann, Tessa; Ziemba, Alex; Bonet-Garcia, Francisco; Adamescu, Mihai Cristian; Janssen, Gerard; Hummel, Herman			Ecosystem services in European protected areas: Ambiguity in the views of scientists and managers?	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; ECOLOGY; TRAITS; INDEX	Protected Areas are a key component of nature conservation. They can play an important role in counterbalancing the impacts of ecosystem degradation. For an optimal protection of a Protected Area it is essential to account for the variables underlying the major Ecosystem Services an area delivers, and the threats upon them. Here we show that the perception of these important variables differs markedly between scientists and managers of Protected Areas in mountains and transitional waters. Scientists emphasise variables of abiotic and biotic nature, whereas managers highlight socio-economic, cultural and anthropogenic variables. This indicates fundamental differences in perception. To be able to better protect an area it would be advisable to bring the perception of scientists and managers closer together. Intensified and harmonised communication across disciplinary and professional boundaries will be needed to implement and improve Ecosystem Service oriented management strategies in current and future Protected Areas.	[Hummel, Christiaan; Hummel, Herman] NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands; [Hummel, Christiaan; Hummel, Herman] Univ Utrecht, Yerseke, Netherlands; [Hummel, Christiaan; van der Meer, Jaap] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Provenzale, Antonello] CNR, Rome, Italy; [van der Meer, Jaap] NIOZ Royal Netherlands Inst Sea Res, Dept Coastal Syst, Texel, Netherlands; [van der Meer, Jaap] Univ Utrecht, Texel, Netherlands; [Wijnhoven, Sander] EcoAuthor, Heinkenszand, Netherlands; [Nolte, Arno; Ziemba, Alex] Deltares, Delft, Netherlands; [Poursanidis, Dimitris] Fdn Res & Technol, Iraklion, Greece; [Janss, Guyonne] CSIC, Estn Biol Donana, Almonte, Spain; [Jurek, Matthias; Andresen, Magnus] United Nations Environm, Vienna, Austria; [Poulin, Brigitte] Res Inst Conservat Mediterranean Wetlands, Tour Du Valat, Le Sambuc, France; [Kobler, Johannes] Umweltbundesamt, Vienna, Austria; [Beierkuhnlein, Carl] Univ Bayreuth, BayCEER, Bayreuth, Germany; [Honrado, Joao] Univ Porto, Fac Ciencias, InBIO CIBIO, Oporto, Portugal; [Razinkovas, Arturas] Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania; [Stritih, Ana] Swiss Fed Inst Technol, Zurich, Switzerland; [Bargmann, Tessa] Univ Bergen, Bergen, Norway; [Bonet-Garcia, Francisco] Univ Granada, Granada, Spain; [Adamescu, Mihai Cristian] Univ Bucharest, Bucharest, Romania; [Janssen, Gerard] Rijkswaterstaat, Leeuwarden, Netherlands	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Vrije Universiteit Amsterdam; Consiglio Nazionale delle Ricerche (CNR); Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Deltares; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Bayreuth; Universidade do Porto; Klaipeda University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bergen; University of Granada; University of Bucharest	Hummel, C (corresponding author), NIOZ Royal Netherlands Inst Sea Res, Dept Estuarine & Delta Syst, Yerseke, Netherlands.; Hummel, C (corresponding author), Univ Utrecht, Yerseke, Netherlands.; Hummel, C (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	christiaan.hummel@nioz.nl	Beierkuhnlein, Carl/ABF-8797-2021; Bonet-García, Francisco/A-3551-2011; Wijnhoven, Sander/A-8866-2011; Poursanidis, Dimitris/M-8957-2013; Kobler, Johannes/E-7042-2012; Beierkuhnlein, Carl/ABF-9693-2021; Adamescu, Cristian Mihai/AFX-5768-2022; Adamescu, Cristian Mihai/AAM-6873-2020; Hummel, Herman/A-9610-2011; Janss, Guyonne F E/C-4157-2011; Honrado, Joao/L-8365-2013	Bonet-García, Francisco/0000-0002-4627-1442; Wijnhoven, Sander/0000-0001-5850-1383; Poursanidis, Dimitris/0000-0003-3228-280X; Beierkuhnlein, Carl/0000-0002-6456-4628; Adamescu, Cristian Mihai/0000-0002-3056-8444; Adamescu, Cristian Mihai/0000-0002-3056-8444; Hummel, Herman/0000-0001-6902-5773; Ziemba, Alexander/0000-0002-8293-6376; Stritih, Ana/0000-0001-5323-8176; Kobler, Johannes/0000-0003-0052-4245; Janss, Guyonne F E/0000-0003-4318-6602; Bargmann, Tessa/0000-0001-9096-7511; Honrado, Joao/0000-0001-8443-4276	European Union's Horizon research and innovation programme [641762]	European Union's Horizon research and innovation programme	This study was done in the frame of the EcoPotential project. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 641762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was done in the frame of the EcoPotential project. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 641762. We would like to thank all PA managers, and scientists for their contribution to the tables by filling in the survey, and especially the PA manager of Samaria, Antonios Barnias, the PA manager of Gran Paradiso, Ramona Viterbi, and the scientist responsible for Samaria, Dr. Nektarios Chrysoulakis.	Adams J.S., 1992, MYTH WILD AFRICA CON; Agardy T, 2000, B MAR SCI, V66, P875; Atkins JP, 2011, MAR POLLUT BULL, V62, P215, DOI 10.1016/j.marpolbul.2010.12.012; Bagstad KJ, 2014, ECOL SOC, V19, DOI 10.5751/ES-06523-190264; Bishop K, 2004, SPEAKING COMMON LANG; Bonet-Garcia FJ, 2015, BIOL CONSERV, V187, P221, DOI 10.1016/j.biocon.2015.04.027; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Carvalho-Santos C, 2015, HYDROLOGICAL PROCESS; Coad L., 2008, COSTS BENEFITS PROTE; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Draper MA, 2004, CULTURE ORG, V10; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fisher JA, 2014, ECOL ECON, V108, P257, DOI 10.1016/j.ecolecon.2014.11.004; Fitter A, 2010, ISS ENVIRON SCI TECH, V30, P1, DOI 10.1039/9781849731058-00001; Gattuso JP, 2015, SCIENCE, V349, DOI 10.1126/science.aac4722; Haines-Young R., 2010, ECOSYSTEM ECOLOGY NE, DOI DOI 10.1017/CBO9780511750458.007; Haines-Young R., 2012, COMMON INT CLASSIFIC, P33; Hattam C, 2015, ECOL INDIC, V49, P61, DOI 10.1016/j.ecolind.2014.09.026; Hauck J, 2013, ENVIRON SCI POLICY, V25, P13, DOI 10.1016/j.envsci.2012.08.001; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hein L, 2006, ECOL ECON, V57, P209, DOI 10.1016/j.ecolecon.2005.04.005; Honrado JP, 2013, ENVIRON IMPACT ASSES, V40, P14, DOI 10.1016/j.eiar.2012.12.002; IBM Corporation, 2016, IBM SPSS STAT WIND V; ISCBD Interim Secretariat of the Convention on Biological Diversity, 1994, UNEPCBD941 ISCBD; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lamarque P, 2011, REG ENVIRON CHANGE, V11, P791, DOI 10.1007/s10113-011-0214-0; Likert R, 1932, TECHNIQUE MEASUREMEN; Maes J, 2015, LANDSCAPE ECOL, V30, P517, DOI 10.1007/s10980-014-0083-2; McClanahan T, 2005, ENVIRON CONSERV, V32, P42, DOI 10.1017/S0376892904001791; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Nagendra H, 2015, INT J APPL EARTH OBS, V37, P124, DOI 10.1016/j.jag.2014.10.010; Nolte A, 2016, SYNTHESIS REPORT ANA; Norling K, 2007, MAR ECOL PROG SER, V332, P11, DOI 10.3354/meps332011; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Parrish JD, 2003, BIOSCIENCE, V53, P851, DOI 10.1641/0006-3568(2003)053[0851:AWCWWS]2.0.CO;2; Paruelo JM, 2016, ECOL INDIC, V71, P145, DOI 10.1016/j.ecolind.2016.06.054; Petrosillo I, 2009, MAR POLLUT BULL, V58, P1454, DOI 10.1016/j.marpolbul.2009.06.013; Phillips, 2007, SHORT HIST INT SYST; Pomeroy RS, 2005, OCEAN COAST MANAGE, V48, P485, DOI 10.1016/j.ocecoaman.2005.05.004; Potts T, 2014, MAR POLICY, V44, P139, DOI 10.1016/j.marpol.2013.08.011; Ridder B, 2008, BIODIVERS CONSERV, V17, P781, DOI 10.1007/s10531-008-9316-5; Sil A, 2016, MT RES DEV, V36, P452, DOI 10.1659/MRD-JOURNAL-D-16-00035.1; TEEB, 2008, EC ECOSYSTEMS BIODIV; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Tornroos A, 2015, J SEA RES, V98, P49, DOI 10.1016/j.seares.2014.04.010; UNEP, 2016, MAR COAST EC HUM WEL; Upton C, 2008, ORYX, V42, P19, DOI 10.1017/S0030605307001044; Van der Biest K, 2014, ECOL INDIC, V37, P252, DOI 10.1016/j.ecolind.2013.04.006; Vassallo P, 2013, MAR POLLUT BULL, V75, P157, DOI 10.1016/j.marpolbul.2013.07.044; Vermaat JE, 2016, AMBIO, P1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	55	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187143	10.1371/journal.pone.0187143	http://dx.doi.org/10.1371/journal.pone.0187143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29140983	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400017
J	Chambers, SA; Rowa-Dewar, N; Radley, A; Dobbie, F				Chambers, Stephanie A.; Rowa-Dewar, Neneh; Radley, Andrew; Dobbie, Fiona			A systematic review of grandparents' influence on grandchildren's cancer risk factors	PLOS ONE			English	Review							TOBACCO-SMOKE EXPOSURE; YOUNG-CHILDREN; PHYSICAL-ACTIVITY; FEEDING PRACTICES; ADULT CANCER; MATERNAL EMPLOYMENT; FOLLOW-UP; OVERWEIGHT; OBESITY; CHILDHOOD	Many lifestyle patterns are established when children are young. Research has focused on the potential role of parents as a risk factor for non communicable disease in children, but there is limited investigation of the role of other caregivers, such as grandparents. The aim of this review was to identify and synthesise evidence for any influence grandparents' care practices may have on their grandchildren's long term cancer risk factors. A systematic review was carried out with searches across four databases (MEDLINE, Embase, Web of Science, PsycINFO) as well as searches of reference lists and citing articles, and Google Scholar. Search terms were based on six areas of risk that family care could potentially influence-weight, diet, physical activity, tobacco, alcohol and sun exposure. All study designs were included, as were studies that provided an indication of the interaction of grandparents with their grandchildren. Studies were excluded if grandparents were primary caregivers and if children had serious health conditions. Study quality was assessed using National Institute for Health and Care Excellence checklists. Grandparent impact was categorised as beneficial, adverse, mixed or as having no impact. Due to study heterogeneity a meta-analysis was not possible. Qualitative studies underwent a thematic synthesis of their results. Results from all included studies indicated that there was a sufficient evidence base for weight, diet, physical activity and tobacco studies to draw conclusions about grandparents' influence. One study examined alcohol and no studies examined sun exposure. Evidence indicated that, overall, grandparents had an adverse impact on their grandchildren's cancer risk factors. The theoretical work in the included studies was limited. Theoretically underpinned interventions designed to reduce these risk factors must consider grandparents' role, as well as parents', and be evaluated robustly to inform the evidence base further.	[Chambers, Stephanie A.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Rowa-Dewar, Neneh] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland; [Radley, Andrew] NHS Tayside, Directorate Publ Hlth, Dundee, Scotland; [Dobbie, Fiona] Univ Stirling, Fac Heath Sci & Sport, Stirling, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Edinburgh; University of Dundee; University of Stirling	Chambers, SA (corresponding author), Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	stephanie.chambers@glasgow.ac.uk	Radley, Andrew/AAO-7068-2021; Dobbie, Fiona/L-5858-2016	Radley, Andrew/0000-0003-4772-2388; Chambers, Stephanie/0000-0001-9607-6242; Dobbie, Fiona/0000-0002-8294-8203	Cancer Research UK Population Research Committee BUPA Foundation Fund - Innovation Grant [C53245/A19672]; Medical Research Council [MC_PC_13027, MC_UU_12017/12, MC_UU_12017/14]; Chief Scientist Office of the Scottish Government Health Directorates [SPHSU12, SPHSU14]; MRC [MC_UU_12017/12, MC_UU_12017/14, MC_PC_13027] Funding Source: UKRI; Cancer Research UK [19672] Funding Source: researchfish; Chief Scientist Office [SPHSU14, SPHSU12] Funding Source: researchfish	Cancer Research UK Population Research Committee BUPA Foundation Fund - Innovation Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Chief Scientist Office	This work was supported via a Cancer Research UK Population Research Committee BUPA Foundation Fund - Innovation Grant C53245/A19672. Additional support was provided via a Medical Research Council Strategic Award MC_PC_13027, and Medical Research Council Grants MC_UU_12017/12 and MC_UU_12017/14, and the Chief Scientist Office of the Scottish Government Health Directorates Grants SPHSU12 and SPHSU14. Cancer Research UK provided feedback on the original study proposal. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Anderson SE, 2011, ARCH PEDIAT ADOL MED, V165, P235, DOI 10.1001/archpediatrics.2010.292; Auld G. W., 1994, Family and Consumer Sciences Research Journal, V23, P118, DOI 10.1177/1077727X94232003; Australia Bureau of Statistics, 2014, CHILDH ED CAR; Bengtson VL, 2001, J MARRIAGE FAM, V63, P1, DOI 10.1111/j.1741-3737.2001.00001.x; Boni Z., 2015, Anthropology of Food, P7782; Bronfenbrenner U, 2005, MAKING HUMAN BEINGS, P3; Cancer Research UK, 2014, STAT PREV CANC 2014; Carlsson N, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-76; Carlsson N, 2010, J CLIN NURS, V19, P507, DOI 10.1111/j.1365-2702.2009.02847.x; Chen XG, 2011, J PEDIATR HEALTH CAR, V25, P365, DOI 10.1016/j.pedhc.2010.04.014; Cochrane Collaboration, 2014, DAT EXTR TEMPL 2014; Department for Work and Pensions, 2013, MAK SUR IT COUNTS YO; Di Gessa G, 2016, SOC SCI MED, V152, P166, DOI 10.1016/j.socscimed.2016.01.041; Di Gessa G, 2016, J GERONTOL B-PSYCHOL, V71, P141, DOI 10.1093/geronb/gbv007; Dixey R., 2001, BNF Nutrition Bulletin, V26, P71, DOI 10.1046/j.1467-3010.2001.00078.x; Duarte R, 2016, J SUBST USE, V21, P268, DOI 10.3109/14659891.2015.1018970; Dwyer J, 2008, APPL PHYSIOL NUTR ME, V33, P338, DOI 10.1139/H07-195; Eli K, 2017, APPETITE, V112, P133, DOI 10.1016/j.appet.2017.01.011; Eli K, 2016, SOC SCI MED, V154, P28, DOI 10.1016/j.socscimed.2016.02.030; Escario JJ, 2015, J COMMUN HEALTH, V40, P912, DOI 10.1007/s10900-015-0013-5; Farrow C, 2014, EAT BEHAV, V15, P339, DOI 10.1016/j.eatbeh.2014.04.006; Frankel S, 1998, BMJ-BRIT MED J, V316, P499, DOI 10.1136/bmj.316.7130.499; Freedman Kit S, 2012, Prev Chronic Dis, V9, pE05; Fuemmeler BF, 2009, OBESITY FACTS, V2, P179, DOI 10.1159/000220605; Gao Y, 2008, J PUBLIC HEALTH-UK, V30, P436, DOI 10.1093/pubmed/fdm057; Glassman ME, 2011, FAM COMMUNITY HEALTH, V34, P4, DOI 10.1097/FCH.0b013e3181fdeb7e; Goh ECL, 2013, BRIT FOOD J, V115, P365, DOI 10.1108/00070701311314192; Green J, 2003, CHILD CARE HLTH DEV, V29, P441, DOI 10.1046/j.1365-2214.2003.00363.x; Griggs J, 2010, CHILD SOC, V24, P200, DOI 10.1111/j.1099-0860.2009.00215.x; Hank K, 2009, J FAM ISSUES, V30, P53, DOI 10.1177/0192513X08322627; Hawkins SS, 2008, INT J OBESITY, V32, P30, DOI 10.1038/sj.ijo.0803682; Hayslip B, 2005, GERONTOLOGIST, V45, P262, DOI 10.1093/geront/45.2.262; HM Treasury, 2015, CHANC ANN MAJ NEW EX; Hoare Alexandria, 2014, BMC Res Notes, V7, P430, DOI 10.1186/1756-0500-7-430; Hopper JA, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e47; Hruba Drahoslava, 2008, Central European Journal of Public Health, V16, P178; Hughes ME, 2007, J GERONTOL B-PSYCHOL, V62, pS108, DOI 10.1093/geronb/62.2.S108; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Ikeda N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175726; Jain A, 2001, PEDIATRICS, V107, P1138, DOI 10.1542/peds.107.5.1138; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Johnson CM, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-21; Kagamimori S, 1999, CHILD CARE HLTH DEV, V25, P235, DOI 10.1046/j.1365-2214.1999.00127.x; Kaplan M, 2006, J NUTR EDUC BEHAV, V38, P298, DOI 10.1016/j.jneb.2006.02.010; Kavle JA, 2015, MATERN CHILD NUTR, V11, P346, DOI 10.1111/mcn.12165; King K, 2009, PEDIATRICS, V123, pE559, DOI 10.1542/peds.2008-2317; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Lako JH, 2014, EUR J MENT HEALTH, V9, P178; Lam TH, 1999, HUM EXP TOXICOL, V18, P218, DOI 10.1191/096032799678839941; Li B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0251-z; Li B, 2014, INT J BEHAV MED, V21, P700, DOI 10.1007/s12529-013-9333-y; Lindsay AC, 2009, HEALTH EDUC BEHAV, V36, P81, DOI 10.1177/1090198107308375; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Mao AM, 2015, HEALTH EDUC RES, V30, P13, DOI 10.1093/her/cyu019; Mashita RJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-58; Maynard M, 2003, J EPIDEMIOL COMMUN H, V57, P218, DOI 10.1136/jech.57.3.218; Mena NZ, 2015, CHILD OBES, V11, P347, DOI 10.1089/chi.2014.0118; Minkler M, 1999, AM J PUBLIC HEALTH, V89, P1384, DOI 10.2105/AJPH.89.9.1384; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moorman SM, 2014, GERONTOLOGIST; National Institute for Health and Care Excellence (NICE), 2012, METH DEV NICE PUBL H, VThird; Pearce A, 2010, INT J OBESITY, V34, P1160, DOI 10.1038/ijo.2010.15; Pocock M, 2010, OBES REV, V11, P338, DOI 10.1111/j.1467-789X.2009.00648.x; Potischman N, 2013, AM J EPIDEMIOL, V178, P184, DOI 10.1093/aje/kwt101; Profe W, 2017, J FAM ISSUES, V38, P776, DOI 10.1177/0192513X15583069; Pulgaron ER, 2016, FAM SYST HEALTH, V34, P260, DOI 10.1037/fsh0000212; Pulgaron ER, 2013, FAM SYST HEALTH, V31, P274, DOI 10.1037/a0034208; RIAS, 2015, BRIT GRANDP SAV MUMS; Robinson J, 2011, SOCIOL HEALTH ILL, V33, P66, DOI 10.1111/j.1467-9566.2010.01273.x; Ruiz SA, 2007, J SOC ISSUES, V63, P793, DOI 10.1111/j.1540-4560.2007.00537.x; Russell CG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2801-y; Sata M, 2015, J EPIDEMIOL, V25, P600, DOI 10.2188/jea.JE20140078; Scottish Government, 2015, KEY MESS 10 YEARS GR; Shloim N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01849; Sleddens EFC, 2011, INT J PEDIATR OBES, V6, pE12, DOI 10.3109/17477166.2011.566339; Sowan N A, 2000, MCN Am J Matern Child Nurs, V25, P234, DOI 10.1097/00005721-200009000-00004; Speirs K. E., 2009, ICAN: Infant, Child & Adolescent Nutrition, V1, P332; Styles JL, 2007, FAM COMMUNITY HEALTH, V30, P279, DOI 10.1097/01.FCH.0000290541.02834.e0; Tanskanen AO, 2013, EVOL PSYCHOL-US, V11, P417, DOI 10.1177/147470491301100212; Thiangtham Weena, 2013, Journal of the Medical Association of Thailand, V96, pS55; Toftemo I, 2013, FAM PRACT, V30, P719, DOI 10.1093/fampra/cmt056; Townsend N, 2015, EUR HEART J, V36, P2696, DOI 10.1093/eurheartj/ehv428; US Census Bureau, 2011, WHOS MIND KIDS CHILD; van der Pols JC, 2007, AM J CLIN NUTR, V86, P1722; Vrieling A, 2010, INT J CANCER, V126, P2394, DOI 10.1002/ijc.24907; Wang Y-T, 2016, TOB CONTROL; Wasser HM, 2013, APPETITE, V71, P7, DOI 10.1016/j.appet.2013.06.096; Watanabe E, 2011, INT J OBESITY, V35, P945, DOI 10.1038/ijo.2011.82; Wilkinson LL, 2010, INT J OBESITY, V34, P1442, DOI 10.1038/ijo.2010.72; Yousey Y, 2007, MCN-AM J MATERN-CHIL, V32, P178, DOI 10.1097/01.NMC.0000269568.17432.72; Zong XN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2265-5	92	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0185420	10.1371/journal.pone.0185420	http://dx.doi.org/10.1371/journal.pone.0185420			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135979	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000415121200002
J	Lei, FL; Li, SS; Mi, BB; Liu, DM; Yang, JM; Qu, PF; Zhang, R; Zhang, XF; Ying, J; Dang, SN; Yan, H				Lei, Fangliang; Li, Shanshan; Mi, Baibing; Liu, Danmeng; Yang, Jiaomei; Qu, Pengfei; Zhang, Ruo; Zhang, Xiaofeng; Ying, Jia; Dang, Shaonong; Yan, Hong			Association between birth season and physical development in children under 3 years old residing in low-income counties in western China	PLOS ONE			English	Article							PRENATAL VITAMIN-D; WEIGHT; HEIGHT; GROWTH; LENGTH; JAPAN; SIZE	Objective To explore the association between birth season and physical development and provide a necessary reference value to inform the implementation of public health services. Design Cross-sectional study. Setting Forty-five counties in ten provinces in western China in 2005. Subjects A sample of 13,387 children under 3 years old and their mothers were recruited using a stratified, multistage, cluster random sampling method. Results The results of the circular distribution analysis suggested that stunting and underweight exhibited time aggregation (Z = 32.57, P< 0.05; Z = 10.42, P< 0.05) among children under 3 years old. The Z -value for wasting, however, was not statistically significant (P> 0.05). The generalized linear mixed models showed that children born in the summer were less likely to exhibit stunting (OR: 0.74 similar to 0.97) than were children born in the winter after adjusting for confounders, but no significant differences were identified for the other seasons. In addition, among children aged 25 to 36 months, those born in the summer and autumn were less likely to exhibit stunting after adjusting for confounders than were children born in the winter, but the association between birth in spring and stunting was not statistically significant. Conclusions Stunting was associated with season of birth among children under 3 years old in lowincome counties in western China, especially children aged 25 to 36 months, and children born in the summer and autumn were less likely to exhibit stunting than were children born in the winter.	[Lei, Fangliang; Li, Shanshan; Mi, Baibing; Liu, Danmeng; Yang, Jiaomei; Zhang, Ruo; Dang, Shaonong] Xi An Jiao Tong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Qu, Pengfei] Northwest Women & Childrens Hosp, Assisted Reprod Ctr, Xian, Shaanxi, Peoples R China; [Zhang, Xiaofeng] Luoyang Matern & Child Care Hosp, Luoyang, Henan, Peoples R China; [Ying, Jia] Putuo Ctr Dis Prevent & Control, Dept Dis Prevent & Control, Zhoushan, Zhejiang, Peoples R China; [Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China; [Yan, Hong] Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China; [Yan, Hong] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China.; Yan, H (corresponding author), Nutr & Food Safety Engn Res Ctr Shaanxi Prov, Xian, Shaanxi, Peoples R China.; Yan, H (corresponding author), Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China.	xjtu_yh.paper@aliyun.com	Shaonong, Dang/J-7421-2019; mi, baibing/ABO-1246-2022	Shaonong, Dang/0000-0002-6980-8169; mi, baibing/0000-0002-5208-7633	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF) [YH001]; National Natural Science Foundation of China [81230016]; Shaanxi Health and Family Planning Commission [Sxwsjswzfcght2016-013]	Chinese Ministry of Health (MOH); United Nations Children's Fund (UNICEF); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Health and Family Planning Commission	The study was sponsored the Chinese Ministry of Health (MOH), the United Nations Children's Fund (UNICEF) (grant number YH001); National Natural Science Foundation of China (grant number 81230016); and Shaanxi Health and Family Planning Commission (grant number Sxwsjswzfcght2016-013). The MOH and UNICEF selected the counties that were sampled in the present study, and these sponsors had no role in the design, analysis, interpretation of data, or composition of this article or the decision to submit the paper for publication.	Chen Mingxia, 2003, Wei Sheng Yan Jiu, V32, P249; DECASTRO JM, 1991, PHYSIOL BEHAV, V50, P243, DOI 10.1016/0031-9384(91)90527-U; Gloria-Bottini F, 2009, EARLY HUM DEV, V85, P439, DOI 10.1016/j.earlhumdev.2009.02.004; GloriaBottini F, 1997, HUM GENET, V101, P158, DOI 10.1007/s004390050606; GOLDEN MHN, 1994, EUR J CLIN NUTR, V48, pS58; Jensen CB, 2015, EARLY HUM DEV, V91, P361, DOI 10.1016/j.earlhumdev.2015.03.010; Koscinski K, 2004, AM J HUM BIOL, V16, P31, DOI 10.1002/ajhb.10232; Krenz-Niedbala M, 2011, AM J HUM BIOL, V23, P190, DOI 10.1002/ajhb.21101; Li C, 2015, J NUTR, V145, P1844, DOI 10.3945/jn.114.207795; Lund R., 2003, J AM             SEP; MATSUDA S, 1993, HUM BIOL, V65, P481; MATSUDA S, 1995, HUM BIOL, V67, P641; McGrath JJ, 2005, EARLY HUM DEV, V81, P609, DOI 10.1016/j.earlhumdev.2005.03.013; McGrath J, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-45; McMichael AJ, 2001, HUMAN FRONTIERS ENV, DOI [10.1017/CBO9781139106924, DOI 10.1017/CBO9781139106924]; Pomeroy E, 2014, AM J PHYS ANTHROPOL, V154, P115, DOI 10.1002/ajpa.22484; Qu Peng-fei, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P346; Robert R, 2000, KIMBERLEE GAUVREAU P; Schwekendiek D, 2009, HOMO, V60, P59, DOI 10.1016/j.jchb.2008.03.001; Sohn K, 2015, AM J PHYS ANTHROPOL, V157, P659, DOI 10.1002/ajpa.22763; Sun Jian-wei, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1026; Torche F, 2010, ANN EPIDEMIOL, V20, P818, DOI 10.1016/j.annepidem.2010.08.005; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Waldie KE, 2000, EARLY HUM DEV, V60, P35, DOI 10.1016/S0378-3782(00)00102-X; Wang Yuying, 2007, Wei Sheng Yan Jiu, V36, P203; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS72; Weber GW, 1998, NATURE, V391, P754, DOI 10.1038/35781; Wohlfahrt J, 1998, LANCET, V352, P1990, DOI 10.1016/S0140-6736(05)61336-0; World Health Organization, 2006, WHO CHILD GROWTH STA; Xu X, 2001, EUR J CLIN NUTR, V55, P714, DOI 10.1038/sj.ejcn.1601212	30	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187029	10.1371/journal.pone.0187029	http://dx.doi.org/10.1371/journal.pone.0187029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136010	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200013
J	Thisted, DLA; Mortensen, LH; Hvidman, L; Krebs, L				Thisted, Dorthe L. A.; Mortensen, Laust H.; Hvidman, Lone; Krebs, Lone			Operative technique at caesarean delivery and risk of complete uterine rupture in a subsequent trial of labour at term. A registry case-control study	PLOS ONE			English	Article							DOUBLE-LAYER CLOSURE; VAGINAL BIRTH; SINGLE-LAYER; SECTION; INCISION	Objective To estimate the relation of single-layer closure at previous caesarean delivery, and other pre-labour and intra-partum risk factors for complete uterine rupture in trial of vaginal birth after a caesarean (TOLAC) at term. Study design Population-based case-control study. We identified all women (n = 39 742) recorded in the Danish Medical Birth Registry (DMBR) during a 12-year period (1997 - 2008) with a singleton pregnancy at term and TOLAC. Among these, all women with a complete uterine rupture were identified (cases). Information from the registry was validated against medical records. Controls were selected in the DMBR as the following two births with TOLAC at term and no uterine rupture. Detailed information from cases and controls was collected from manual review of medical records. Main outcome measure was complete uterine rupture during TOLAC at term. Results Upon validation, 175 cases and 272 controls met the above criteria. After adjustment for possible confounding factors there was no association between single layer closure and uterine rupture (aOR 1.38, CI: 0.88 - 2.17). Significant risk factors were: Induction with an unfavourable cervix (aOR 2.10 CI: 1.19 - 3.71), epidural (aOR 2.17 CI 1.31 - 3.57), augmentation by oxytocin for more than one hour (aOR 2.03 CI: 1.20 - 3.44), and birth weight >= 4000g (aOR 2.65 CI 1.05 - 6.64). Previous vaginal delivery (aOR 0.41 CI: 0.25 - 0.68) and inter-delivery interval of more than 24 months (aOR 0.38 CI: 0.18 - 0.78) reduced the risk of uterine rupture. Conclusion Single-layer uterine closure did not remain significantly associated to uterine rupture during TOLAC at term after adjustment for confounding factors. Induction of labour with an unfavourable cervix, birth weight >= 4000g and indicators of prolonged labour were all major risk factors for uterine rupture.	[Thisted, Dorthe L. A.] Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Kettegaard Alle 30, Hvidovre, Denmark; [Mortensen, Laust H.] Stat Denmark, Methods & Anal, Sejeroegade 11, Copenhagen, Denmark; [Mortensen, Laust H.] Univ Copenhagen, Sect Social Med, Copenhagen, Denmark; [Hvidman, Lone] Aarhus Univ Hosp, Dept Obstet & Gynaecol, Aarhus, Denmark; [Krebs, Lone] Univ Copenhagen, Holbaek Hosp, Dept Obstet & Gynaecol, Holbaek, Denmark	University of Copenhagen; University of Copenhagen; Aarhus University; Holbaek Hospital; University of Copenhagen	Thisted, DLA (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Obstet & Gynaecol, Fetal Med Unit, Kettegaard Alle 30, Hvidovre, Denmark.	thiding@yahoo.dk	Krebs, Lone/AAD-8273-2021	Krebs, Lone/0000-0001-5433-4776; Thisted, Dorthe Louise Ahrenkiel/0000-0002-0201-9552				Brocklehurst P., 2016, LANCET; Brocklehurst P, 2010, BJOG-INT J OBSTET GY, V117, P1366, DOI 10.1111/j.1471-0528.2010.02686.x; Bujold E, 2002, AM J OBSTET GYNECOL, V186, P1326, DOI 10.1067/mob.2002.122416; Bujold E, 2010, OBSTET GYNECOL, V116, P43, DOI 10.1097/AOG.0b013e3181e41be3; Bujold E, 2010, OBSTET GYNECOL, V115, P1003, DOI 10.1097/AOG.0b013e3181d992fb; Cahill AG, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.001; Colmorn LB, 2015, ACTA OBSTET GYN SCAN, V94, P734, DOI 10.1111/aogs.12639; Committee NM-S, 2007, NOMESCO CLASS SURG P; Dodd JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004732.pub3; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Gyamfi C, 2006, J MATERN-FETAL NEO M, V19, P639, DOI 10.1080/14767050600849383; Hesselman S, 2014, BJOG; Kieser KE, 2002, OBSTET GYNECOL, V100, P749, DOI 10.1016/S0029-7844(02)02161-0; Landon MB, 2008, CLIN PERINATOL, V35, P491, DOI 10.1016/j.clp.2008.07.004; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Lorentzen U, 1998, Ugeskr Laeger, V160, P2517; Roberge S, 2015, AM J OBSTET GYNECOL; Roberge S, 2014, AM J OBSTET GYNECOL; Roberge S, 2011, INT J GYNECOL OBSTET, V115, P5, DOI 10.1016/j.ijgo.2011.04.013; Sorensen HT, 1996, INT J EPIDEMIOL, V25, P435, DOI 10.1093/ije/25.2.435; Spong CY, 2007, OBSTET GYNECOL, V110, P801, DOI 10.1097/01.AOG.0000284622.71222.b2; Studsgaard A, 2013, ACTA OBSTET GYN SCAN, V92, P1256, DOI 10.1111/aogs.12240; Thisted DLA, 2014, EUR J OBSTET GYN R B, V173, P23, DOI 10.1016/j.ejogrb.2013.10.033; Turner MJA, 2006, BJOG-INT J OBSTET GY, V113, P729, DOI 10.1111/j.1471-0528.2006.00940.x; Weimar CHE, 2010, EUR J OBSTET GYN R B, V151, P41, DOI 10.1016/j.ejogrb.2010.03.023; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Zwart JJ, 2009, BJOG-INT J OBSTET GY, V116, P1069, DOI 10.1111/j.1471-0528.2009.02136.x	27	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187850	10.1371/journal.pone.0187850	http://dx.doi.org/10.1371/journal.pone.0187850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136026	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200037
J	Wang, SH; Lin, HJ; Lin, YY; Chen, YJ; Pan, YH; Tung, CT; Mersmann, HJ; Ding, ST				Wang, Siou-Huei; Lin, Han-Jen; Lin, Yuan-Yu; Chen, Yu-Jen; Pan, Yu-Hui; Tung, Cheng-Ting; Mersmann, Harry John; Ding, Shih-Torng			Embryonic cholesterol esterification is regulated by a cyclic AMP-dependent pathway in yolk sac membrane-derived endodermal epithelial cells	PLOS ONE			English	Article							HMG-COA REDUCTASE; ACYL-COENZYME-A; CHICK-EMBRYO; GALLUS-DOMESTICUS; LIPID-METABOLISM; FATTY-ACIDS; ACYLTRANSFERASE; GROWTH; LIVER; RAT	During avian embryonic development, endodermal epithelial cells (EECs) absorb yolk through the yolk sac membrane. Sterol O-acyltransferase (SOAT) is important for esterification and yolk lipid utilization during development. Because the major enzyme for yolk sac membrane cholesteryl ester synthesis is SOAT1, we cloned the avian SOAT1 promoter and elucidated the cellular functions of SOAT1. Treatments with either glucagon, isobutylmethyl-xanthine (IBMX), an adenylate cyclase activator (forskolin), a cAMP analog (dibutyryl-cAMP), or a low glucose concentration all increased SOAT1 mRNA accumulation in EECs from Japanese quail, suggesting that SOAT1 is regulated by nutrients and hormones through a cAMP-dependent pathway. Activity of protein kinase A (PKA) was increased by IBMX, whereas co-treatment with the PKA inhibitor, H89 negated the increase in PKA activity. Cyclic AMP-induced EECs had greater cholesterol esterification than untreated EECs. By promoter deletion and point-mutation, the cAMP-response element (-349 to -341 bp) was identified as critical in mediating transcription of SOAT1. In conclusion, expression of SOAT1 was regulated by a cAMP-dependent pathway and factors that increase PKA will increase SOAT1 to improve the utilization of lipids in the EECs and potentially modify embryonic growth.	[Wang, Siou-Huei; Lin, Han-Jen; Pan, Yu-Hui; Tung, Cheng-Ting; Mersmann, Harry John; Ding, Shih-Torng] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Lin, Yuan-Yu] Tunghai Univ, Dept Anim Sci & Biotechnol, Taichung, Taiwan; [Chen, Yu-Jen; Ding, Shih-Torng] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan	National Taiwan University; Tunghai University; National Taiwan University	Ding, ST (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Ding, ST (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.	sding@ntu.edu.tw	Lin, Yuan-Yu/AAD-5190-2021	Ding, Shih-Torng/0000-0002-9866-1776; Lin, Yuan-Yu/0000-0002-3397-3218	Ministry of Science and Technology in Taiwan [104-2313-B-002-039-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology, under Grant 104-2313-B-002-039-MY3 in Taiwan to Shih-Torng Ding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Science and Technology, under Grant 104-2313-B-002-039-MY3 in Taiwan. We declare that the experiments comply with the current Taiwan laws, the place in which the experiments were performed. There is no conflict of interest.	Banner K H, 1995, Monaldi Arch Chest Dis, V50, P286; Bauer R, 2013, J BIOL CHEM, V288, P1088, DOI 10.1074/jbc.M112.393090; BEINS DM, 1982, BIOCHEM J, V202, P631, DOI 10.1042/bj2020631; BOTHAM KM, 1992, BIOCHEM SOC T, V20, P454, DOI 10.1042/bst0200454; Cheng DH, 1999, LIPIDS, V34, P261, DOI 10.1007/s11745-999-0362-z; De Groef B, 2008, MOL CELL ENDOCRINOL, V293, P17, DOI 10.1016/j.mce.2008.06.002; Ding ST, 2000, POULTRY SCI, V79, P1460, DOI 10.1093/ps/79.10.1460; ERICKSON SK, 1980, J LIPID RES, V21, P930; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; FIELD FJ, 1987, J LIPID RES, V28, P50; GARCIAGONZALEZ M, 1992, MOL CELL BIOCHEM, V115, P173; Ge J, 2013, J CELL BIOCHEM, V114, P2188, DOI 10.1002/jcb.24568; Geng F, 2016, CLIN CANCER RES, V22, P5337, DOI 10.1158/1078-0432.CCR-15-2973; Gopalakrishnan S, 2011, JOVE-J VIS EXP, DOI 10.3791/3138; GREER JL, 1992, COMP BIOCHEM PHYS B, V103, P9, DOI 10.1016/0305-0491(92)90405-G; HEIDER JG, 1983, J LIPID RES, V24, P1127; Hussein A, 2005, INT J ONCOL, V27, P155; Kim JW, 2010, ASIAN AUSTRAL J ANIM, V23, P1668, DOI 10.5713/ajas.2010.10329; Lee SML, 2013, JOVE-J VIS EXP, DOI 10.3791/50615; Lin HJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53624; Lin HJ, 2017, J BIOMED SCI ENG, V10, P37; Lu JW, 2007, POULTRY SCI, V86, P673, DOI 10.1093/ps/86.4.673; NOBLE RC, 1986, P NUTR SOC, V45, P17, DOI 10.1079/PNS19860030; NOBLE RC, 1984, WORLD POULTRY SCI J, V40, P114, DOI 10.1079/WPS19840009; NOBLE RC, 1984, POULTRY SCI, V63, P558, DOI 10.3382/ps.0630558; Pereira MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128949; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Powell KA, 2004, J COMP PHYSIOL B, V174, P163, DOI 10.1007/s00360-003-0401-5; Rogers MA, 2015, J STEROID BIOCHEM, V151, P102, DOI 10.1016/j.jsbmb.2014.09.008; Sahan U, 2014, POULTRY SCI, V93, P2069, DOI 10.3382/ps.2013-03850; SHAND JH, 1993, LIPIDS, V28, P621, DOI 10.1007/BF02536056; STONE BG, 1989, J LIPID RES, V30, P1681; Thonpho A, 2010, BIOCHEM BIOPH RES CO, V393, P714, DOI 10.1016/j.bbrc.2010.02.067; Tokusoglu O, 2006, INT J FOOD SCI NUTR, V57, P537, DOI 10.1080/09637480601049725; Vieira SL, 2007, BRAZ J POULTRY SCI, V9, P1, DOI 10.1590/S1516-635X2007000100001; Yadgary L, 2010, POULTRY SCI, V89, P2441, DOI 10.3382/ps.2010-00681	36	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187560	10.1371/journal.pone.0187560	http://dx.doi.org/10.1371/journal.pone.0187560			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161294	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000011
J	Wu, CP; Vellend, M; Yuan, WG; Jiang, B; Liu, JJ; Shen, AH; Liu, JL; Zhu, JR; Yu, MJ				Wu, Chuping; Vellend, Mark; Yuan, Weigao; Jiang, Bo; Liu, Jiajia; Shen, Aihua; Liu, Jinliang; Zhu, Jinru; Yu, Mingjian			Patterns and determinants of plant biodiversity in non-commercial forests of eastern China	PLOS ONE			English	Article							SPECIES COMPOSITION; TROPICAL FOREST; BETA-DIVERSITY; TREE DIVERSITY; RAIN-FOREST; HABITAT HETEROGENEITY; SECONDARY SUCCESSION; SUBTROPICAL FORESTS; TOPOGRAPHY; MANAGEMENT	Non-commercial forests represent important habitats for the maintenance of biodiversity and ecosystem function in China, yet no studies have explored the patterns and determinants of plant biodiversity in these human dominated landscapes. Here we test the influence of (1) forest type (pine, mixed, and broad-leaved), (2) disturbance history, and (3) environmental factors, on tree species richness and composition in 600 study plots in eastern China. In total, we found 143 species in 53 families of woody plants, with a number of species rare and endemic in the study region. Species richness in mixed forest and broad-leaved forest was higher than that in pine forest, and was higher in forests with less disturbance. Species composition was influenced by environment factors in different ways in different forest types, with important variables including elevation, soil depth and aspect. Surprisingly, we found little effect of forest age after disturbance on species composition. Most non-commercial forests in this region are dominated by species poor pine forests and mixed young forests. As such, our results highlight the importance of broad-leaved forests for regional plant biodiversity conservation. To increase the representation of broad-leaved non-commercial forests, specific management practices such as thinning of pine trees could be undertaken.	[Wu, Chuping; Liu, Jiajia; Liu, Jinliang; Yu, Mingjian] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Wu, Chuping; Yuan, Weigao; Jiang, Bo; Shen, Aihua; Zhu, Jinru] Zhejiang Acad Forestry, Hangzhou, Zhejiang, Peoples R China; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	Zhejiang University; University of Sherbrooke	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	fishmj202@hotmail.com	Liu, Jiajia/I-5253-2019; Liu, Jinliang/B-1716-2015	Liu, Jiajia/0000-0002-1923-5964; Liu, Jinliang/0000-0002-2476-1803; Chuping, Wu/0000-0002-7372-9332; yu, ming jian/0000-0001-8060-8427	Major Cooperation Project of Zhejiang Province; Chinese Academy of Forestry [2014SY01]; Science and Technology Project of Zhejiang Province [2015C02016]; Zhejiang Provincial Natural Science Foundation [LY16C160003]	Major Cooperation Project of Zhejiang Province; Chinese Academy of Forestry; Science and Technology Project of Zhejiang Province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This research was funded by Major Cooperation Project of Zhejiang Province and Chinese Academy of Forestry (No. 2014SY01), http://www.caf.ac.cn; Science and Technology Project of Zhejiang Province (No. 2015C02016), http://www.zjinfo.gov.cn; Zhejiang Provincial Natural Science Foundation (No. LY16C160003), http://www.zjinfo.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, VEGETATION CHINA; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Arroyo-Rodriguez V., 2015, BIOL REV; Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Barwell LJ, 2015, J ANIM ECOL, V84, P1112, DOI 10.1111/1365-2656.12362; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Chai SL, 2011, J ECOL, V99, P113, DOI 10.1111/j.1365-2745.2010.01742.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cramer MJ, 2002, J MAMMAL, V83, P743, DOI 10.1644/1545-1542(2002)083&lt;0743:HHHAAR&gt;2.0.CO;2; Cubbage F, 2007, FOREST POLICY ECON, V9, P833, DOI 10.1016/j.forpol.2006.03.010; Davies RG, 2007, GLOBAL ECOL BIOGEOGR, V16, P220, DOI 10.1111/j.1466-8238.2007.00282.x; De Caceres M, 2012, GLOBAL ECOL BIOGEOGR, V21, P1191, DOI 10.1111/j.1466-8238.2012.00770.x; Diniz JAF, 2004, OECOLOGIA, V140, P633, DOI 10.1007/s00442-004-1577-4; Echeverria C, 2007, GLOBAL ECOL BIOGEOGR, V16, P426, DOI 10.1111/j.1466-8238.2007.00311.x; FAO, 2015, CHIN GLOB FOR RES AS; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; Feng G, 2016, BIOL CONSERVATION; Forestry Department of Zhejiang Province, 2011, ZHEJ EC NONC FOR REP; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Goosem M, 2016, J VEG SCI, V27, P504, DOI 10.1111/jvs.12376; Hu Z, 2008, FRONT BIOL CHINA, V3, P45, DOI DOI 10.1007/S11515-008-0011-4; Hua F, 2016, NATURE COMMUNICATION; Jones ET, 2007, FOREST ECOL MANAG, V246, P29, DOI 10.1016/j.foreco.2007.03.048; Kaboli M, 2006, J BIOGEOGR, V33, P133, DOI 10.1111/j.1365-2699.2005.01379.x; Katovai E, 2016, FOREST ECOL MANAG, V372, P53, DOI 10.1016/j.foreco.2016.03.052; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Lewis SL, 2015, SCIENCE, V349, P827, DOI 10.1126/science.aaa9932; Li MS, 2012, ADV MATER RES-SWITZ, V433-440, P1286, DOI 10.4028/www.scientific.net/AMR.433-440.1286; Liebsch D, 2008, BIOL CONSERV, V141, P1717, DOI 10.1016/j.biocon.2008.04.013; Lin D, 2012, PLOS ONE; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; Liu JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep35926; [刘世荣 Liu Shirong], 2015, [生态学报, Acta Ecologica Sinica], V35, P1; Liu YN, 2015, APPL VEG SCI, V18, P34, DOI 10.1111/avsc.12101; Lu Pin, 2013, Biodiversity Science, V21, P554, DOI 10.3724/SP.J.1003.2013.10049; Maeshiro R, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00125.1; Marcelo T, 2004, BIODIVERS CONSERV, V13, P1419; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Matthews JW, 2010, J APPL ECOL, V47, P1128, DOI 10.1111/j.1365-2664.2010.01862.x; Meng JH, 2014, FORESTS, V5, P3199, DOI 10.3390/f5123199; Minden V, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0284; Mo XX, 2011, BIOL CONSERV, V144, P1832, DOI 10.1016/j.biocon.2011.03.019; Osazuwa-Peters OL, 2015, FOREST ECOL MANAG, V357, P10, DOI 10.1016/j.foreco.2015.08.002; Qian H, 2013, PLOS ONE; Qian H, 2009, ACTA OECOL, V35, P819, DOI 10.1016/j.actao.2009.08.009; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Shen GC, 2013, ECOLOGY, V94, P2436, DOI 10.1890/12-1983.1; [沈琪 Shen Qi], 2005, [生态学报, Acta Ecologica Sinica], V25, P2131; Slik J, 2008, OECOLOGIA, V158, P579, DOI 10.1007/s00442-008-1163-2; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Song C, 2009, REFORESTING LANDSCAP, P10; Swinfield T, 2016, FOREST ECOL MANAG, V381, P209, DOI 10.1016/j.foreco.2016.09.020; Ticktin T, 2002, CONSERV BIOL, V16, P691, DOI 10.1046/j.1523-1739.2002.00372.x; Wang DP, 2006, FOREST ECOL MANAG, V222, P384, DOI 10.1016/j.foreco.2005.10.053; Wang QG, 2014, CHINESE SCI BULL, V59, P5113, DOI 10.1007/s11434-014-0453-9; Wang SP, 2012, ECOGRAPHY, V35, P1168, DOI 10.1111/j.1600-0587.2012.00045.x; Warren-Thomas E, 2014, FOREST ECOL MANAG, V334, P369, DOI 10.1016/j.foreco.2014.09.022; Xu CG, 2012, CLIMATIC CHANGE, V110, P53, DOI 10.1007/s10584-011-0098-5; Xu JC, 2011, NATURE, V477, P370, DOI 10.1038/477371a; Yu MJ, 2012, J BIOGEOGR, V39, P1124, DOI 10.1111/j.1365-2699.2011.02676.x; Yuan Jin-Feng, 2011, Bulletin of Botanical Research, V31, P61; Zeng De-hui, 2004, Journal of Forestry Research (Harbin), V15, P127, DOI 10.1007/BF02856747; Zhang ZJ, 2011, BIOL LETTERS, V7, P403, DOI 10.1098/rsbl.2010.1081; Zhou Zhi-chun, 2004, Forest Research, V17, P420	70	10	14	7	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188409	10.1371/journal.pone.0188409	http://dx.doi.org/10.1371/journal.pone.0188409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161324	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000050
J	Yu, SJ; Yang, HL; Wang, R; Luan, ZZ; Qian, DP				Yu, Shijie; Yang, Hailong; Wang, Rui; Luan, Zhongzhi; Qian, Depei			Evaluating architecture impact on system energy efficiency	PLOS ONE			English	Article							REGENERATIVE BRAKING; PERFORMANCE; HARDWARE; POWER	As the energy consumption has been surging in an unsustainable way, it is important to understand the impact of existing architecture designs from energy efficiency perspective, which is especially valuable for High Performance Computing (HPC) and datacenter environment hosting tens of thousands of servers. One obstacle hindering the advance of comprehensive evaluation on energy efficiency is the deficient power measuring approach. Most of the energy study relies on either external power meters or power models, both of these two methods contain intrinsic drawbacks in their practical adoption and measuring accuracy. Fortunately, the advent of Intel Running Average Power Limit (RAPL) interfaces has promoted the power measurement ability into next level, with higher accuracy and finer time resolution. Therefore, we argue it is the exact time to conduct an in-depth evaluation of the existing architecture designs to understand their impact on system energy efficiency. In this paper, we leverage representative benchmark suites including serial and parallel workloads from diverse domains to evaluate the architecture features such as Non Uniform Memory Access (NUMA), Simultaneous Multithreading (SMT) and Turbo Boost. The energy is tracked at subcomponent level such as Central Processing Unit (CPU) cores, uncore components and Dynamic Random-Access Memory (DRAM) through exploiting the power measurement ability exposed by RAPL. The experiments reveal non-intuitive results: 1) the mismatch between local compute and remote memory node caused by NUMA effect not only generates dramatic power and energy surge but also deteriorates the energy efficiency significantly; 2) for multithreaded application such as the Princeton Application Repository for Shared-Memory Computers (PARSEC), most of the workloads benefit a notable increase of energy efficiency using SMT, with more than 40% decline in average power consumption; 3) Turbo Boost is effective to accelerate the workload execution and further preserve the energy, however it may not be applicable on system with tight power budget.	[Yu, Shijie; Yang, Hailong; Wang, Rui; Luan, Zhongzhi; Qian, Depei] Beihang Univ, Sinogerman Joint Software Inst, Sch Comp Sci & Engn, Beijing, Peoples R China; [Qian, Depei] Sun Yat Sen Univ, Sch Data & Comp Sci, Guangzhou, Guangdong, Peoples R China	Beihang University; Sun Yat Sen University	Wang, R (corresponding author), Beihang Univ, Sinogerman Joint Software Inst, Sch Comp Sci & Engn, Beijing, Peoples R China.	wangrui@buaa.edu.cn	yang, hailong/GXH-9625-2022		National Natural Science Foundation of China [61502019]; National Key Research and Development Program of China [2016YFB1000304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This work was supported by National Natural Science Foundation of China (Grant No. 61502019), http://www.nsfc.gov.cn/, HLY, and National Key Research and Development Program of China (Grant No. 2016YFB1000304), http:// www.most.gov.cr/, HLY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work is supported by National Key Research and Development Program of China (Grant No. 2016YFB1000304) and National Natural Science Foundation of China (Grant No. 61502019).	Andri R, 2016, IEEE COMP SOC ANN, P236, DOI 10.1109/ISVLSI.2016.111; [Anonymous], 2011, INTEL 64 AND IA32 AR, V3B-2; Balaji B., 2012, P HOTPOWER, P8; Barroso LA, 2007, COMPUTER, V40, P33, DOI 10.1109/MC.2007.443; Bienia C, 2008, PACT'08: PROCEEDINGS OF THE SEVENTEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P72, DOI 10.1145/1454115.1454128; Cao T, 2012, CONF PROC INT SYMP C, P225; Chandrasekar K, 2013, P 50 ANN DES AUT C A, P23; Chen Yu-Hsin, 2016, IEEE J SOLID STATE C; Chen YJ, 2016, COMMUN ACM, V59, P105, DOI 10.1145/2996864; De Vuyst M., 2006, Proceedings. 20th International Parallel and Distributed Processing Symposium (IEEE Cat. No.06TH8860); Dongarra J, 2012, SECOND INTERNATIONAL CONFERENCE ON CLOUD AND GREEN COMPUTING / SECOND INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING AND ITS APPLICATIONS (CGC/SCA 2012), P274, DOI 10.1109/CGC.2012.113; ESMAEILZADEH H, 2011, ASPLOS 16 16 INT C, P319, DOI DOI 10.1145/1950365.1950402; Esmaeilzadeh H, 2012, ACM T COMPUT SYST, V30, DOI 10.1145/2324876.2324879; Esmaeilzadeh H, 2012, IEEE MICRO, V32, P110, DOI 10.1109/MM.2012.20; Esmaeilzadeh H, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P365, DOI 10.1145/2024723.2000108; Ferdman M, 2012, ASPLOS XVII: SEVENTEENTH INTERNATIONAL CONFERENCE ON ARCHITECTURAL SUPPORT FOR PROGRAMMING LANGUAGES AND OPERATING SYSTEMS, P37; Hackenberg Daniel, 2013, IEEE International Symposium on Performance Analysis of Systems and Software (ISPASS 2013), P194; Hahnel Marcus, 2012, Performance Evaluation Review, V40, P13; Huang W, 2012, INT SYMP MICROARCH, P224, DOI 10.1109/MICRO.2012.29; Inoue H., 2010, 2010 IEEE INT S WORK, P1; Khan RA, 2011, ELECTRON J QUAL THEO, P1; Lv C., 2017, IEEE T IND ELECTRON, V99, P1, DOI DOI 10.1109/TCYB.2017.2738003; Lv C, 2018, IEEE T CYBERNETICS, V48, P2357, DOI 10.1109/TCYB.2017.2738003; Lv C, 2015, ENERG CONVERS MANAGE, V92, P469, DOI 10.1016/j.enconman.2014.12.092; Majo Z., 2012, P 10 INT S COD GEN O, P230; Ovtcharov K, 2015, MICROSOFT RESEARCH W, V2; Ramirez Tanausu, 2008, 2008 IEEE 14th International Symposium on High Performance Computer Architecture, P149, DOI 10.1109/HPCA.2008.4658635; Reagen B, 2016, CONF PROC INT SYMP C, P267, DOI 10.1109/ISCA.2016.32; Rountree B, 2012, IEEE SYM PARA DISTR, P947, DOI 10.1109/IPDPSW.2012.116; Sato T, 2012, PROCEEDINGS OF THE T, V122, P107; Schone R., 2011, P HOTPOWER, P10; Su C., 2012, SIGMETRICS PERFORM E, V40, P106, DOI DOI 10.1145/2381056.2381079; Subramaniam B., 2013, ICPE 13, P15, DOI DOI 10.1145/2479871.2479878; Tang LJ, 2011, ISCA 2011: PROCEEDINGS OF THE 38TH ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE, P283; van der Wijngaart R. F., 2002, NAS02007; Weaver V. M., 2012, 2012 41st International Conference on Parallel Processing Workshops (ICPPW 2012), P262, DOI 10.1109/ICPPW.2012.39; WHO, 2012, FRAM IMPL SET REC MA, P1, DOI [10.1145/1186736.1186737, DOI 10.1145/1186736.1186737]; Zhang JZ, 2012, P I MECH ENG D-J AUT, V226, P1289, DOI 10.1177/0954407012441884; Zhu YH, 2013, INT S HIGH PERF COMP, P13, DOI 10.1109/HPCA.2013.6522303	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188428	10.1371/journal.pone.0188428	http://dx.doi.org/10.1371/journal.pone.0188428			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161317	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000054
J	Maina, AN; Klein, TA; Kim, HC; Chong, ST; Yang, Y; Mullins, K; Jiang, J; St John, H; Jarman, RG; Hang, J; Richards, AL				Maina, Alice N.; Klein, Terry A.; Kim, Heung-Chul; Chong, Sung-Tae; Yang, Yu; Mullins, Kristin; Jiang, Ju; St John, Heidi; Jarman, Richard G.; Hang, Jun; Richards, Allen L.			Molecular characterization of novel mosquitoborne Rickettsia spp. from mosquitoes collected at the Demilitarized Zone of the Republic of Korea	PLOS ONE			English	Article							SPOTTED-FEVER GROUP; SOUTH-KOREA; PHYLOGENETIC ANALYSIS; FELIS INFECTION; TICKS; GYEONGGI; HUMANS; IDENTIFICATION; MONACENSIS; PROVINCES	Rickettsiae are associated with a diverse range of invertebrate hosts. Of these, mosquitoes could emerge as one of the most important vectors because of their ability to transmit significant numbers of pathogens and parasites throughout the world. Recent studies have implicated Anopheles gambiae as a potential vector of Rickettsia felis. Herein we report that a metagenome sequencing study identified rickettsial sequence reads in culicine mosquitoes from the Republic of Korea. The detected rickettsiae were characterized by a genus-specific quantitative real-time PCR assay and sequencing of rrs, gltA, 17kDa, ompB, and sca4 genes. Three novel rickettsial genotypes were detected (Rickettsia sp. A12.2646, Rickettsia sp. A12.2638 and Rickettsia sp. A12.3271), from Mansonia uniformis, Culex pipiens, and Aedes esoensis, respectively. The results underscore the need to determine the Rickettsia species diversity associated with mosquitoes, their evolution, distribution and pathogenic potential.	[Maina, Alice N.; Mullins, Kristin; Jiang, Ju; St John, Heidi; Richards, Allen L.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Klein, Terry A.] 65th Med Brigade, Med Dept Act Korea, Unit 15281, Seoul, South Korea; [Kim, Heung-Chul; Chong, Sung-Tae] 65th Med Brigade, Med Dept Act Korea, Unit 15247, Seoul, South Korea; [Yang, Yu; Jarman, Richard G.; Hang, Jun] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD USA; [Mullins, Kristin] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore	Maina, AN (corresponding author), Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	alice.n.maina.ctr@mail.mil			Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS) [188M.0931.001-A0074, P0015-17-ME, 17-WR-1.2.1]	Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS)	This research was funded by the Armed Forces Health Surveillance Branch, Global Emerging Infections Surveillance and Response System (AFHSB-GEIS), Work Unit Numbers: 188M.0931.001-A0074, P0015-17-ME and 17-WR-1.2.1. The grant(s) were awarded to ALR, TAK and RGJ. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae JS, 2008, J VET SCI, V9, P285, DOI 10.4142/jvs.2008.9.3.285; Chung MH, 2006, EMERG INFECT DIS, V12, P1122, DOI 10.3201/eid1207.051372; Dieme C, 2015, P NATL ACAD SCI USA, V112, P8088, DOI 10.1073/pnas.1413835112; Fournier PE, 2003, J CLIN MICROBIOL, V41, P5456, DOI 10.1128/JCM.41.12.5456-5465.2003; Fournier PE, 1998, INT J SYST BACTERIOL, V48, P839, DOI 10.1099/00207713-48-3-839; Guo WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep38770; Hang J, 2016, GENE ANNOUNC, V4; Hechemy KE, ANN NY ACAD SCI, V990, P17; Hertig M, 1924, J MED RES, V44, P329; Jang WJ, 2005, MICROBIOL IMMUNOL, V49, P17, DOI 10.1111/j.1348-0421.2005.tb03635.x; Jang WJ, 2004, J CLIN MICROBIOL, V42, P2310, DOI 10.1128/JCM.42.5.2310-2313.2004; Jiang J, 2005, ANN NY ACAD SCI, V1063, P337, DOI 10.1196/annals.1355.054; Jiang J, 2015, EMERG INFECT DIS, V21, P1073, DOI 10.3201/eid2106.141487; Jiang J, 2013, VECTOR-BORNE ZOONOT, V13, P550, DOI 10.1089/vbz.2012.1123; Jiang J, 2012, VECTOR-BORNE ZOONOT, V12, P175, DOI 10.1089/vbz.2011.0614; Kang SW, 2013, PARASITOL INT, V62, P276, DOI 10.1016/j.parint.2013.02.002; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kilianski A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0840-5; Ko S, 2011, VECTOR-BORNE ZOONOT, V11, P1243, DOI 10.1089/vbz.2010.0261; Korkusol A, 2017, J GEN VIROL, V98, P1122, DOI 10.1099/jgv.0.000746; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee JH, 2003, MICROBIOL IMMUNOL, V47, P301, DOI 10.1111/j.1348-0421.2003.tb03399.x; Lee K. W., 1998, REVISION ILLUSTRATED; Lee KM, 2013, MICROBIOL IMMUNOL, V57, P487, DOI 10.1111/1348-0421.12062; Liu D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1885-7; Ma JS, 2006, EMERG INFECT DIS, V12, P531, DOI 10.3201/eid1203.050957; Maina AN, 2012, EMERG INFECT DIS, V18, P328, DOI 10.3201/eid1802.111372; Mediannikov O, 2013, EMERG INFECT DIS, V19, P1775, DOI 10.3201/eid1911.130361; Noh Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1955-x; Parola P, 2016, LANCET INFECT DIS, V16, P1112, DOI 10.1016/S1473-3099(16)30331-0; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Roux V, 2000, INT J SYST EVOL MICR, V50, P1449, DOI 10.1099/00207713-50-4-1449; Sakamoto JM, 2007, APPL ENVIRON MICROB, V73, P6637, DOI 10.1128/AEM.00923-07; Shin SH, 2013, EXP APPL ACAROL, V61, P337, DOI 10.1007/s10493-013-9699-1; Socolovschi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048254; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1687, DOI 10.3201/eid1810.120178; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanaka K., 1979, CONTRIB AM ENTOMOL I, V16, P43; Vayssier-Taussat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081439; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Xiang L, 2017, ANTON LEEUW INT J G, V110, P105, DOI 10.1007/s10482-016-0780-8; Zhang JL, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.107; Zhang JL, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0682-1	43	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188327	10.1371/journal.pone.0188327	http://dx.doi.org/10.1371/journal.pone.0188327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155880	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700047
J	Roell, M; Viarouge, A; Houde, O; Borst, G				Roell, Margot; Viarouge, Arnaud; Houde, Olivier; Borst, Gregoire			Inhibitory control and decimal number comparison in school-aged children	PLOS ONE			English	Article							ARITHMETIC WORD-PROBLEMS; REACTION-TIME; COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTIONS; STUDENTS; FRACTION; TASK; BIAS; KNOWLEDGE; ERRORS	School-aged children erroneously think that 1.45 is larger 1.5 because 45 is larger than 5. Using a negative priming paradigm, we investigated whether the ability to compare the magnitude of decimal numbers in the context in which the smallest number has the greatest number of digits after the decimal point (1.45 vs. 1.5) is rooted in part on the ability to inhibit the "greater the number of digits the greater its magnitude" misconception derived from a property of whole numbers. In Experiment 1, we found a typical negative priming effect with 7 th graders requiring more time to compare decimal numbers in which the largest number has the greatest number of digits after the decimal point (1.65 vs. 1.5) after comparing decimal numbers in which the smallest number has the greatest number of digits after the decimal point (1.45 vs. 1.5) than after comparing decimal numbers with the same number of digits after the decimal point (1.5 vs. 1.6). In Experiment 2, we found a negative priming effect when decimal numbers preceded items in which 7 th graders had to compare the length of two lines. Taken together our results suggest that the ability to compare decimal numbers in which the smallest number has the greatest number of digits is rooted in part on the ability to inhibit the "greater the number of digits the greater its magnitude" misconception and in part on the ability to inhibit the length of the decimal number per se.	[Roell, Margot; Viarouge, Arnaud; Houde, Olivier; Borst, Gregoire] Univ Paris 05, Univ Sorbonne Paris Cite, Lab Psychol Dev & Educ Enfant LaPsyDE, UMR CNRS, F-8240 Paris, France; [Roell, Margot; Viarouge, Arnaud; Houde, Olivier; Borst, Gregoire] Univ Caen, Caen, France; [Roell, Margot] Ecole Neurosci Paris ENP, Paris, France; [Houde, Olivier; Borst, Gregoire] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Caen Normandie; Institut Universitaire de France	Borst, G (corresponding author), Univ Paris 05, Univ Sorbonne Paris Cite, Lab Psychol Dev & Educ Enfant LaPsyDE, UMR CNRS, F-8240 Paris, France.; Borst, G (corresponding author), Univ Caen, Caen, France.; Borst, G (corresponding author), Inst Univ France, Paris, France.	gregoire.borst@parisdescartes.fr	Roell, Margot/AAG-5715-2019	Borst, Gregoire/0000-0002-5815-3419; Garbui, Maria Cristina/0000-0003-2100-9461; Roell, Margot/0000-0002-4462-3483				Ahr E, 2016, J EXP CHILD PSYCHOL, V145, P157, DOI 10.1016/j.jecp.2015.12.009; [Anonymous], 1998, TEACHING MATH NEW TI; Attridge N, 2015, ZDM-MATH EDUC, V47, P723, DOI 10.1007/s11858-014-0656-1; Babai R, 2012, INT J SCI MATH EDUC, V10, P763, DOI 10.1007/s10763-011-9287-y; Bell AW, 1984, BRIT J EDUC STUD, V32, P280; Birngruber T, 2014, ATTEN PERCEPT PSYCHO, V76, P814, DOI 10.3758/s13414-013-0602-2; Bjorklund D. F, 1995, NEW PERSPECTIVES INT, P141, DOI DOI 10.1016/B978-012208930-5/50006-4; Borst G, 2013, DEV PSYCHOL, V49, P1366, DOI 10.1037/a0029622; Borst G., 2013, NEW APPROACHES REASO, P34, DOI DOI 10.4324/9781315879857; Borst G, 2015, DEV MED CHILD NEUROL, V57, P21, DOI 10.1111/dmcn.12688; Borst G, 2015, PSYCHON B REV, V22, P228, DOI 10.3758/s13423-014-0663-9; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Bull R, 2014, CHILD DEV PERSPECT, V8, P36, DOI 10.1111/cdep.12059; Cicchini GM, 2014, P NATL ACAD SCI USA, V111, P7867, DOI 10.1073/pnas.1402785111; Clayton S, 2015, ZDM-MATH EDUC, V47, P759, DOI 10.1007/s11858-014-0655-2; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; DALRYMPLEALFORD EC, 1966, PERCEPT MOTOR SKILL, V23, P1211, DOI 10.2466/pms.1966.23.3f.1211; Dehaene S., 2005, MONKEY BRAIN HUMAN B, P133; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Demetriou A, 2015, INTELLIGENCE, V50, P131, DOI 10.1016/j.intell.2015.03.008; Dempster F.N., 1995, INTERFERENCE INHIBIT; DeWolf M, 2015, LEARN INSTR, V37, P39, DOI 10.1016/j.learninstruc.2014.07.002; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dormal V, 2009, HUM BRAIN MAPP, V30, P2466, DOI 10.1002/hbm.20677; Durkin K, 2015, LEARN INSTR, V37, P21, DOI 10.1016/j.learninstruc.2014.08.003; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Gebuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037426; Gillard E, 2009, EXP PSYCHOL, V56, P92, DOI 10.1027/1618-3169.56.2.92; Gilmore C, 2015, ZDM-MATH EDUC, V47, P771, DOI 10.1007/s11858-014-0659-y; Gilmore C, 2014, MIND BRAIN EDUC, V8, P132, DOI 10.1111/mbe.12050; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Grosse CS, 2007, LEARN INSTR, V17, P612, DOI 10.1016/j.learninstruc.2007.09.008; Grossman AS, 1983, ARITHMETIC TEACHER, V30, P32; Houde O, 2000, COGNITIVE DEV, V15, P63, DOI 10.1016/S0885-2014(00)00015-0; Houde O, 2001, DEVELOPMENTAL SCI, V4, P119, DOI 10.1111/1467-7687.00156; Houde O, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00616; Houde O, 2011, J EXP CHILD PSYCHOL, V110, P332, DOI 10.1016/j.jecp.2011.04.008; Irwin KC, 2001, J RES MATH EDUC, V32, P399, DOI 10.2307/749701; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Kunde W, 2012, ADV COGN PSYCHOL, V8, P9, DOI [10.2478/v10053-008-0097-x, 10.5709/acp-0097-x]; Liu RD, 2014, SCHOOL SCI MATH, V114, P326, DOI 10.1111/ssm.12085; Lortie-Forgues H, 2015, DEV REV, V38, P201, DOI 10.1016/j.dr.2015.07.008; Lubin A, 2016, LEARN INSTR, V45, P40, DOI 10.1016/j.learninstruc.2016.06.004; Lubin A, 2013, J EDUC PSYCHOL, V105, P701, DOI 10.1037/a0032625; Moloney K., 1997, MATH EDUC RES J, V9, P25, DOI [10.1007/BF03217300, DOI 10.1007/BF03217300]; Moutier S, 2003, THINK REASONING, V9, P185, DOI 10.1080/13546780343000213; Moutier S., 2002, THINK REASONING, V8, P205, DOI [10.1080/13546780244000033, DOI 10.1080/13546780244000033]; Nesher P., 1986, EDUC STUD MATH, V17, P61, DOI [10.1007/BF00302379, DOI 10.1007/BF00302379, 10. 1007/ BF00302379]; Obersteiner A, 2013, LEARN INSTR, V28, P64, DOI 10.1016/j.learninstruc.2013.05.003; Perret P, 2003, DEVELOPMENTAL SCI, V6, P283, DOI 10.1111/1467-7687.00284; Piaget J., 1952, ORIGINS INTELLIGENCE; Piazza M, 2009, NEUROSCIENTIST, V15, P261, DOI 10.1177/1073858409333073; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Potvin P, 2015, INT J SCI MATH EDUC, V13, P21, DOI 10.1007/s10763-014-9520-6; Pritchard VE, 2004, DEV PSYCHOL, V40, P191, DOI 10.1037/0012-1649.40.2.191; Pritchard VE, 2009, DEV PSYCHOL, V45, P272, DOI 10.1037/a0014168; Putt I. J., 1995, FOCUS LEARN PROBL MA, V17, P1; RESNICK LB, 1989, J RES MATH EDUC, V20, P8, DOI 10.2307/749095; Reyna V. F, 2003, EMERGING PERSPECTIVE, P201, DOI DOI 10.1017/CBO9780511609978.009; Roche A., 2005, AUSTR PRIMARY MATH C, V10, P11; Sackur- Grisvard C., 1985, COGNITION INSTRUCT, V2, P157, DOI [DOI 10.1207/S1532690XCI0202_3, 10. 1207/ s1532690xci0202_ 3]; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Simoneau M, 2003, DEV PSYCHOL, V39, P964, DOI 10.1037/0012-1649.39.6.964; Smith CL, 2005, COGNITIVE PSYCHOL, V51, P101, DOI 10.1016/j.cogpsych.2005.03.001; Stafylidou S, 2004, LEARN INSTR, V14, P503, DOI 10.1016/j.learninstruc.2004.06.015; Szucs D, 2013, CORTEX, V49, P2674, DOI 10.1016/j.cortex.2013.06.007; Tang YY, 2006, P NATL ACAD SCI USA, V103, P10775, DOI 10.1073/pnas.0604416103; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Townsend J. T., 1983, STOCHASTIC MODELING; Vamvakoussi X, 2012, J MATH BEHAV, V31, P344, DOI 10.1016/j.jmathb.2012.02.001; Vamvakoussi X, 2013, EDUC STUD MATH, V82, P323, DOI 10.1007/s10649-012-9432-8; Vamvakoussi X, 2010, COGNITION INSTRUCT, V28, P181, DOI 10.1080/07370001003676603; Van Dooren W, 2015, LEARN INSTR, V37, P1, DOI 10.1016/j.1earninstruc.2015.01.001; Van Hoof J, 2015, ZDM-MATH EDUC, V47, P849, DOI 10.1007/s11858-014-0650-7; Van Hoof J, 2015, LEARN INSTR, V37, P30, DOI 10.1016/j.learninstruc.2014.03.004; Van Hoof J, 2013, RES MATH EDUCAT, V15, P154, DOI 10.1080/14794802.2013.797747; Vosniadou S., 2008, INT HDB RES CONCEPTU, P3, DOI DOI 10.4324/9780203154472.CH1; Vosniadou S, 2014, SCI EDUC-NETHERLANDS, V23, P1427, DOI 10.1007/s11191-013-9640-3; WEARNE D, 1988, J RES MATH EDUC, V19, P371, DOI 10.2307/749172	83	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188276	10.1371/journal.pone.0188276	http://dx.doi.org/10.1371/journal.pone.0188276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155893	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700041
J	Li, JW; Zhang, WM; Zeng, WQ; Chen, GL; Qiu, ZC; Cao, XY; Gao, XY				Li, Jianwei; Zhang, Weimin; Zeng, Weiqin; Chen, Guolong; Qiu, Zhongchao; Cao, Xinyuan; Gao, Xuanyi			Estimation of stress distribution in ferromagnetic tensile specimens using low cost eddy current stress measurement system and BP neural network	PLOS ONE			English	Article							X-RAY; RESIDUAL-STRESSES; METALS	Estimation of the stress distribution in ferromagnetic components is very important for evaluating the working status of mechanical equipment and implementing preventive maintenance. Eddy current testing technology is a promising method in this field because of its advantages of safety, no need of coupling agent, etc. In order to reduce the cost of eddy current stress measurement system, and obtain the stress distribution in ferromagnetic materials without scanning, a low cost eddy current stress measurement system based on Archimedes spiral planar coil was established, and a method based on BP neural network to obtain the stress distribution using the stress of several discrete test points was proposed. To verify the performance of the developed test system and the validity of the proposed method, experiment was implemented using structural steel (Q235) specimens. Standard curves of sensors at each test point were achieved, the calibrated data were used to establish the BP neural network model for approximating the stress variation on the specimen surface, and the stress distribution curve of the specimen was obtained by interpolating with the established model. The results show that there is a good linear relationship between the change of signal modulus and the stress in most elastic range of the specimen, and the established system can detect the change in stress with a theoretical average sensitivity of -0.4228 mV/MPa. The obtained stress distribution curve is well consonant with the theoretical analysis result. At last, possible causes and improving methods of problems appeared in the results were discussed. This research has important significance for reducing the cost of eddy current stress measurement system, and advancing the engineering application of eddy current stress testing.	[Li, Jianwei; Zhang, Weimin; Zeng, Weiqin; Chen, Guolong; Cao, Xinyuan] Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China; [Li, Jianwei] Henan Agr Univ, Coll Mech & Elect Engn, Zhengzhou, Henan, Peoples R China; [Zeng, Weiqin] Beijing Carduo Informat Technol Co Ltd, Beijing, Peoples R China; [Qiu, Zhongchao] Shandong Management Univ, Sch Mech & Elect Engn, Jinan, Shandong, Peoples R China; [Gao, Xuanyi] Beijing Inst Technol, Sch Informat & Elect, Beijing, Peoples R China	Beijing Institute of Technology; Henan Agricultural University; Shandong Management University; Beijing Institute of Technology	Zhang, WM (corresponding author), Beijing Inst Technol, Sch Mech Engn, Beijing, Peoples R China.	zhangwm@bit.edu.cn	li, jian/GSE-0245-2022; Chen, Guolong/HDM-8516-2022; LI, JIAN/GRY-2197-2022	Chen, Guolong/0000-0001-6070-3881; 	National Natural Science Foundation of China [51275048]; Beijing Carduo Information Technology Company Limited	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Carduo Information Technology Company Limited	This research was supported by the National Natural Science Foundation of China (Grant No.51275048). The website of the funder is http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Beijing Carduo Information Technology Company Limited provided support in the form of salaries for author [Weiqin Zeng], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Abrantes RF, 2016, MEASUREMENT, V77, P351, DOI 10.1016/j.measurement.2015.09.026; Abu-Nabah BA, 2007, NDT&E INT, V40, P405, DOI 10.1016/j.ndteint.2007.01.003; BROWN WF, 1949, PHYS REV, V75, P147, DOI 10.1103/PhysRev.75.147; Chelabi M, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/15/155303; Dahia A, 2015, J PHYS D APPL PHYS, V48, DOI 10.1088/0022-3727/48/19/195002; Dobrocka E, 2017, APPL SURF SCI, V395, P16, DOI 10.1016/j.apsusc.2016.06.060; Garcia-Martin J, 2011, SENSORS-BASEL, V11, P2525, DOI 10.3390/s110302525; Habibalahi A, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/5/055601; Harati E, 2017, MATERIALS, V10, DOI 10.3390/ma10060593; Hatafuku H, 2002, IEEE T MAGN, V38, P3309, DOI 10.1109/TMAG.2002.802299; Hecht-Nielsen R, 1989, IJCNN INT JOINT C NE; JILES DC, 1984, J APPL PHYS, V55, P2115, DOI 10.1063/1.333582; JILES DC, 1995, J PHYS D APPL PHYS, V28, P1537, DOI 10.1088/0022-3727/28/8/001; Kim JM, 2017, NDT&E INT, V87, P93, DOI 10.1016/j.ndteint.2017.02.002; KITTEL C, 1956, SOLID STATE PHYS, V3, P437; Lera G, 2002, IEEE T NEURAL NETWOR, V13, P1200, DOI 10.1109/TNN.2002.1031951; Li ZB, 2017, IEEE T MAGN, V53, DOI 10.1109/TMAG.2017.2701773; Mahmoodi M, 2012, MATER DESIGN, V40, P516, DOI 10.1016/j.matdes.2012.03.029; Martinez-Perez ML, 2004, ACTA MATER, V52, P5303, DOI 10.1016/j.actamat.2004.07.036; Rosado LS, 2015, NDT&E INT, V70, P29, DOI 10.1016/j.ndteint.2014.09.009; Schoenekess HC, 2007, IEEE SENS J, V7, P1200, DOI 10.1109/JSEN.2007.900961; Sekine Y, 2012, J NONDESTRUCT EVAL, V31, P99, DOI 10.1007/s10921-011-0125-5; Shu D, 2015, J MAGN MAGN MATER, V394, P195, DOI 10.1016/j.jmmm.2015.06.059; Singhal D, 2011, INT J ELEC POWER, V33, P550, DOI 10.1016/j.ijepes.2010.12.009; Sutherland J, 1997, MATER EVAL, V55, P85; Wang ZD, 2010, NDT&E INT, V43, P513, DOI 10.1016/j.ndteint.2010.05.007; Withers PJ, 2007, CR PHYS, V8, P806, DOI 10.1016/j.crhy.2007.09.015; Wu B, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/904826; Xiu CZ, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7060538; Xiu CZ, 2017, SENSOR REV, V37, P43, DOI 10.1108/SR-08-2016-0145; Yu F, 2005, J NONDESTRUCT EVAL, V24, P143, DOI 10.1007/s10921-005-8783-9; Zhan Y, 2017, ULTRASONICS, V73, P271, DOI 10.1016/j.ultras.2016.08.013; Zhang WM, 2017, NONDESTRUCT TEST EVA, V32, P152, DOI 10.1080/10589759.2016.1184266; Zhou DQ, 2017, MEASUREMENT, V105, P136, DOI 10.1016/j.measurement.2017.04.001; Zilberstein V, 2002, J PRESS VESS-T ASME, V124, P375, DOI 10.1115/1.1491273	35	4	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188197	10.1371/journal.pone.0188197	http://dx.doi.org/10.1371/journal.pone.0188197			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145500	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800087
J	Onyango, DO; Yuen, CM; Cain, KP; Ngari, F; Masini, EO; Borgdorff, MW				Onyango, Dickens O.; Yuen, Courtney M.; Cain, Kevin P.; Ngari, Faith; Masini, Enos O.; Borgdorff, Martien W.			Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya	PLOS ONE			English	Article							RISK-FACTORS; SOUTH-AFRICA; INFECTED ADULTS; THERAPY; DEATH; COHORT; PREVALENCE; PROGRAM; INDIA	Background Mortality from TB continues to be a global public health challenge. TB ranks alongside Human Immunodeficiency Virus (HIV) as the leading infectious causes of death globally. HIV is a major driver of TB related morbidity and mortality while TB is the leading cause of mortality among people living with HIV/AIDS. We sought to determine excess mortality associated with HIV and the effect of antiretroviral therapy on reducing mortality among tuberculosis patients in Kenya. Methods We conducted a retrospective analysis of Kenya national tuberculosis program data of patients enrolled from 2013 through 2014. We used direct standardization to obtain standardized mortality ratios for tuberculosis patients compared with the general population. We calculated the population attributable fraction of tuberculosis deaths due to HIV based on the standardized mortality ratio for deaths among TB patients with HIV compared to TB patients without HIV. We used Cox proportional hazards regression for assessing risk factors for mortality. Results Of 162,014 patients included in the analysis, 6% died. Mortality was 10.6 (95% CI: 10.4-10.8) times higher among TB patients than the general population; 42% of deaths were attributable to HIV infection. Patients with HIV who were not receiving ART had an over four-fold risk of death compared to patients without HIV (aHR = 4.2, 95% CI 3.9-4.6). In contrast, patients with HIV who were receiving ART had only 2.6 times the risk of death (aHR = 2.6, 95% CI 2.5-2.7). Conclusion HIV was a significant contributor to TB-associated deaths in Kenya. Mortality among HIV-infected individuals was higher among those not on ART than those on ART. Early initiation of ART among HIV infected people (a "test and treat" approach) should further reduce TB-associated deaths.	[Onyango, Dickens O.] Kisumu Cty Dept Hlth, Kisumu, Kenya; [Yuen, Courtney M.] Harvard Med Sch, Boston, MA USA; [Cain, Kevin P.; Borgdorff, Martien W.] US Ctr Dis Control & Prevent Kenya, Kisumu, Kenya; [Ngari, Faith; Masini, Enos O.] Natl TB Leprosy & Lung Dis Program, Nairobi, Kenya	Harvard University; Harvard Medical School	Onyango, DO (corresponding author), Kisumu Cty Dept Hlth, Kisumu, Kenya.	macdickens2002@gmail.com	Onyango, Dickens/AAF-9545-2020	Onyango, Dickens/0000-0002-1634-0531; Yuen, Courtney/0000-0002-5219-2599	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	A portion of the staffing support for this project was funded by U.S. President's Emergency Plan for AIDS Relief (PEPFAR).	Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; [Anonymous], 2010, TREATM TUB GUID; Ayele HT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1089-3; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Borgdorff MW, 1998, EUR RESPIR J, V11, P816, DOI 10.1183/09031936.98.11040816; COLOMBIA. MINISTERIO DE SALUD. CINETS, 2013, GUID MAN TUB LEPR KE, P21; Dimairo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011849; Field N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0679-9; Fox GJ, 2016, INT J INFECT DIS; Garcia-Garcia MD, 2002, EMERG INFECT DIS, V8, P1327; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Harries AD, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17396; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-921; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kenya National Bureau of Statistics, 2012, 2009 KEN POP HOUS CE; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Kipruto H., 2013, ASSESSMENT PERFORMAN; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kolappan C, 2006, B WORLD HEALTH ORGAN, V84, P555, DOI 10.2471/BLT.05.022087; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; Lesko CR, 2016, INT J EPIDEMIOL, V45, P140, DOI 10.1093/ije/dyv352; Lighter Jennifer, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P61, DOI 10.1016/j.cppeds.2008.12.003; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Measure DHS, 2006, METH DHS MORT RAT ES; Mendelson M, 2007, BRIT MED BULL, V81-82, P149, DOI 10.1093/bmb/ldm009; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; Moosazadeh M, 2015, E MEDITERR HEALTH J, V21, P287, DOI 10.26719/2015.21.4.287; Nakiyingi L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0812-4; Nyang'au LO, 2016, 1 LINE ANTITB DRUG R; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Pina JM, 2006, REV CLIN ESP, V206, P560, DOI 10.1016/S0014-2565(06)72897-1; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Schreiber YS, 2009, INT J TUBERC LUNG D, V13, P1274; Stagg HR, 2014, ANN INTERN MED, V161, P419, DOI 10.7326/M14-1019; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; UNAIDS, FACT SHEET LAT STAT; van't Hoog AH, 2012, INT J TUBERC LUNG D, V16, P1649, DOI 10.5588/ijtld.12.0135; Wang WB, 2015, B WORLD HEALTH ORGAN, V93, P826, DOI 10.2471/BLT.15.154161; WHO, 2014, GLOB TUB REP 2014; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2012, POL COLL IB HIV ACT; World Health Organization, 2015, GUID START ANT THER; World Health Organization (WHO), 2016, END TB STRAT; Yan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160481; Yuen CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099880	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188235	10.1371/journal.pone.0188235	http://dx.doi.org/10.1371/journal.pone.0188235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145454	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800097
J	Parajuli, A; Gronroos, M; Kauppi, S; Plociniczak, T; Roslund, MI; Galitskaya, P; Laitinen, OH; Hyoty, H; Jumpponen, A; Strommer, R; Romantschuk, M; Hui, N; Sinkkonen, A				Parajuli, Anirudra; Gronroos, Mira; Kauppi, Sari; Plociniczak, Tomasz; Roslund, Marja I.; Galitskaya, Polina; Laitinen, Olli H.; Hyoty, Heikki; Jumpponen, Ari; Strommer, Rauni; Romantschuk, Martin; Hui, Nan; Sinkkonen, Aki			The abundance of health-associated bacteria is altered in PAH polluted soils-Implications for health in urban areas?	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; MICROBIAL COMMUNITY STRUCTURE; GUT MICROBIOTA; OCCUPATIONAL-EXPOSURE; CONTAMINATED SOIL; CANCER-RISK; DEGRADATION; DIVERSITY; BIODEGRADATION; BIOREMEDIATION	Long-term exposure to polyaromatic hydrocarbons (PAHs) has been connected to chronic human health disorders. It is also well-known that i) PAH contamination alters soil bacterial communities, ii) human microbiome is associated with environmental microbiome, and iii) alteration in the abundance of members in several bacterial phyla is associated with adverse or beneficial human health effects. We hypothesized that soil pollution by PAHs altered soil bacterial communities that had known associations with human health. The rationale behind our study was to increase understanding and potentially facilitate reconsidering factors that lead to health disorders in areas characterized by PAH contamination. Large containers filled with either spruce forest soil, pine forest soil, peat, or glacial sand were left to incubate or contaminated with creosote. Biological degradation of PAHs was monitored using GC-MS, and the bacterial community composition was analyzed using 454 pyrosequencing. Proteobacteria had higher and Actinobacteria and Bacteroidetes had lower relative abundance in creosote contaminated soils than in non-contaminated soils. Earlier studies have demonstrated that an increase in the abundance of Proteobacteria and decreased abundance of the phyla Actinobacteria and Bacteroidetes are particularly associated with adverse health outcomes and immunological disorders. Therefore, we propose that pollution-induced shifts in natural soil bacterial community, like in PAH-polluted areas, can contribute to the prevalence of chronic diseases. We encourage studies that simultaneously address the classic "adverse toxin effect" paradigm and our novel "altered environmental microbiome" hypothesis.	[Parajuli, Anirudra; Gronroos, Mira; Roslund, Marja I.; Strommer, Rauni; Romantschuk, Martin; Hui, Nan; Sinkkonen, Aki] Univ Helsinki, Sect Environm Ecol, Dept Environm Sci, Lahti, Finland; [Kauppi, Sari] SYKE, Finnish Environm Inst, Ctr Sustainable Consumpt & Prod Contaminants, Helsinki, Finland; [Plociniczak, Tomasz] Univ Silesia, Dept Microbiol, Katowice, Poland; [Galitskaya, Polina; Romantschuk, Martin; Sinkkonen, Aki] Kazan Fed Univ, Kazan, Russia; [Laitinen, Olli H.; Hyoty, Heikki] Univ Tampere, Sch Med, Dept Virol, Tampere, Finland; [Hyoty, Heikki] Pirkanmaa Hosp Dist, Fimlab Labs, Tampere, Finland; [Hyoty, Heikki] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS USA	University of Helsinki; Finnish Environment Institute; University of Silesia in Katowice; Kazan Federal University; Tampere University; Pirkanmaa Hospital District; Kansas State University	Hui, N; Sinkkonen, A (corresponding author), Univ Helsinki, Sect Environm Ecol, Dept Environm Sci, Lahti, Finland.; Sinkkonen, A (corresponding author), Kazan Fed Univ, Kazan, Russia.	nan.hui@helsinki.fi; aki.sinkkonen@helsinki.fi	Romantschuk, Martin/A-6405-2008; Roslund, M.I./ABH-9506-2020; Laitinen, Olli H/A-6618-2016; Hui, Nan/H-3560-2018; Galitskaya, Polina/AAR-3186-2021	Roslund, M.I./0000-0002-3153-7375; Laitinen, Olli H/0000-0002-3751-9952; Hui, Nan/0000-0001-8517-8454; Galitskaya, Polina/0000-0002-5070-786X; Gronroos, Mira/0000-0002-8210-8837; sinkkonen, aki/0000-0002-6821-553X; Plociniczak, Tomasz/0000-0001-9594-4378; Kauppi, Sari/0000-0001-7641-200X; Hyoty, Heikki/0000-0003-0370-4145	Finnish Funding Agency for Technology and InnovationTekes [40333/14]; Tekes [40333/14]	Finnish Funding Agency for Technology and InnovationTekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Tekes(Finnish Funding Agency for Technology & Innovation (TEKES))	The research was funded by Finnish Funding Agency for Technology and InnovationTekes (decision number 40333/14), https://www.tekes.fiien/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Heidi Jaaskelainen provided chemical analytical assistance. The research was funded by Tekes (decision number 40333/14). We thank the reviewers for their constructive feedbacks on the manuscript.	Abdel-Shafy Hussein I., 2016, Egyptian Journal of Petroleum, V25, P107, DOI 10.1016/j.ejpe.2015.03.011; Antizar-Ladislao B, 2008, INT BIODETER BIODEGR, V61, P357, DOI 10.1016/j.ibiod.2007.10.002; Belz RG, 2016, SCI TOTAL ENVIRON, V566, P1205, DOI 10.1016/j.scitotenv.2016.05.176; Boffetta P, 1997, CANCER CAUSE CONTROL, V8, P444, DOI 10.1023/A:1018465507029; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Cachada A, 2012, SCI TOTAL ENVIRON, V430, P184, DOI 10.1016/j.scitotenv.2012.04.075; Cerniglia Carl E., 1993, Current Opinion in Biotechnology, V4, P331, DOI [10.1016/0958-1669(93)90104-5, 10.1007/BF00129093]; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Ciaccio CE, 2015, J ASTHMA, V52, P873, DOI 10.3109/02770903.2015.1028076; Cousins IT, 1999, SCI TOTAL ENVIRON, V228, P5, DOI 10.1016/S0048-9697(99)00015-7; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Diggs DL, 2011, J ENVIRON SCI HEAL C, V29, P324, DOI 10.1080/10590501.2011.629974; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferrarese E, 2008, J HAZARD MATER, V152, P128, DOI 10.1016/j.jhazmat.2007.06.080; Garrels W, 2016, SCI REP-UK, V6, DOI 10.1038/srep21953; Haahtela T, 2015, CLIN EXP ALLERGY, V45, P891, DOI 10.1111/cea.12527; Hansi M, 2014, ENVIRON POLLUT, V184, P443, DOI 10.1016/j.envpol.2013.09.027; Hanski I., 2014, Ethics in Science and Environmental Politics (ESEP), V14, P19, DOI 10.3354/esep00150; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Honkonen O, 2013, ENVIRON MONIT ASSESS, V185, P1437, DOI 10.1007/s10661-012-2643-8; Hui N, 2012, BOREAL ENV RES; Jacobson MC, 2000, REV GEOPHYS, V38, P267, DOI 10.1029/1998RG000045; Jensen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056418; Johnsen AR, 2007, APPL ENVIRON MICROB, V73, P1474, DOI 10.1128/AEM.02236-06; JUHASZ A. L., 2000, INT BIODETERIOR, V45, P88; Karstensen KH, 1996, NORDIC GUIDELINES CH; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kauppi S, 2012, ENVIRON SCI POLLUT R, V19, P53, DOI 10.1007/s11356-011-0528-y; Kaushik CP, 2012, POLYCYCL AROMAT COMP, V32, P626, DOI 10.1080/10406638.2012.695318; Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kulik N, 2006, J ENVIRON MANAGE, V78, P382, DOI 10.1016/j.jenvman.2005.05.005; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Llado S, 2015, J HAZARD MATER, V283, P35, DOI 10.1016/j.jhazmat.2014.08.065; Lors C, 2010, CHEMOSPHERE, V81, P1263, DOI 10.1016/j.chemosphere.2010.09.021; Lotfabad SK, 2002, APPL MICROBIOL BIOT, V60, P361, DOI 10.1007/s00253-002-1104-7; Mah Ka Weng, 2008, Allergol Int, V57, P65, DOI 10.2332/allergolint.O-07-501; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsland BJ, 2014, NAT REV IMMUNOL, V14, P827, DOI 10.1038/nri3769; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Masih A, 2006, CHEMOSPHERE, V65, P449, DOI 10.1016/j.chemosphere.2006.01.062; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mcgenity T.J., 2010, HDB HYDROCARBON LIPI, P3847, DOI [10.1007/978-3-540-77587-4_301, DOI 10.1007/978-3-540-77587-4_301]; Mehta CM, 2016, COMPOST SCI UTIL, V24, P105, DOI 10.1080/1065657X.2015.1087894; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; MUELLER JG, 1989, ENVIRON SCI TECHNOL, V23, P1197, DOI 10.1021/es00068a003; Mukherjee S, 2014, ISME J, V8, P2131, DOI 10.1038/ismej.2014.151; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Olsson AC, 2010, OCCUP ENVIRON MED, V67, P98, DOI 10.1136/oem.2009.046680; Panzer AR, 2015, CURR OPIN RHEUMATOL, V27, P373, DOI 10.1097/BOR.0000000000000191; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Peng JJ, 2013, BIORESOURCE TECHNOL, V143, P608, DOI 10.1016/j.biortech.2013.06.039; Piters WAAD, 2016, ISME J, V10, P97, DOI 10.1038/ismej.2015.99; Plociniczak T, 2013, APPL SOIL ECOL, V63, P1, DOI 10.1016/j.apsoil.2012.09.009; Plociniczak T, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpla.2016.00101, 10.3389/fpls.2016.00101]; Rantalainen ML, 2006, SCI TOTAL ENVIRON, V369, P99, DOI 10.1016/j.scitotenv.2006.05.005; Rivas FJ, 2006, J HAZARD MATER, V138, P234, DOI 10.1016/j.jhazmat.2006.07.048; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Ruokolainen L, 2015, ALLERGY, V70, P195, DOI 10.1111/all.12545; Sawulski P, 2014, BIODEGRADATION, V25, P835, DOI 10.1007/s10532-014-9703-4; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Singleton DR, 2006, ENVIRON MICROBIOL, V8, P1736, DOI 10.1111/j.1462-2920.2006.01112.x; Sinkkonen A, 2014, J ENVIRON SCI HEAL B, V49, P756, DOI 10.1080/03601234.2014.929865; Sinkkonen A, 2013, J SOIL SEDIMENT, V13, P1430, DOI 10.1007/s11368-013-0742-y; Sinkkonen A, 2013, ENVIRON SCI POLLUT R, V20, P1737, DOI 10.1007/s11356-012-1047-1; Sun JH, 2009, ECOTOX ENVIRON SAFE, V72, P1614, DOI 10.1016/j.ecoenv.2008.05.010; Tejeda-Agredano MC, 2013, SOIL BIOL BIOCHEM, V57, P830, DOI 10.1016/j.soilbio.2012.08.008; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Torneman N, 2008, ENVIRON TOXICOL CHEM, V27, P1039, DOI 10.1897/07-440.1; Unwin J, 2006, ANN OCCUP HYG, V50, P395, DOI [10.1093/annhyg/mel010, 10.1093/annhyg/mei010]; Valderrama C, 2008, J HAZARD MATER, V157, P386, DOI 10.1016/j.jhazmat.2007.12.119; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y., 2016, FRONTIERS MICROBIOLO, V7; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012; WILD SR, 1995, ENVIRON POLLUT, V88, P91, DOI 10.1016/0269-7491(95)91052-M; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ying S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141842; Yu D, 2015, APPL SOIL ECOL, V92, P47, DOI 10.1016/j.apsoil.2015.03.005; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	85	33	36	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187852	10.1371/journal.pone.0187852	http://dx.doi.org/10.1371/journal.pone.0187852			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145477	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800035
J	Garbuz, T; Arrizabalaga, G				Garbuz, Tamila; Arrizabalaga, Gustavo			Lack of mitochondrial MutS homolog 1 in Toxoplasma gondii disrupts maintenance and fidelity of mitochondrial DNA and reveals metabolic plasticity	PLOS ONE			English	Article							MISMATCH-REPAIR ACTIVITY; PLASMODIUM-FALCIPARUM; CYTOCHROME-B; ATOVAQUONE-RESISTANCE; MALARIAL PARASITE; SACCHAROMYCES-CEREVISIAE; DIHYDROFOLATE-REDUCTASE; EXTRACHROMOSOMAL DNAS; ELECTRON-TRANSPORT; RIBOSOMAL-RNA	The importance of maintaining the fidelity of the mitochondrial genome is underscored by the presence of various repair pathways within this organelle. Presumably, the repair of mitochondrial DNA would be of particular importance in organisms that possess only a single mitochondrion, like the human pathogens Plasmodium falciparum and Toxoplasma gondii. Understanding the machinery that maintains mitochondrial DNA in these parasites is of particular relevance, as mitochondrial function is a validated and effective target for anti-parasitic drugs. We previously determined that the Toxoplasma MutS homolog TgMSH1 localizes to the mitochondrion. MutS homologs are key components of the nuclear mismatch repair system in mammalian cells, and both yeast and plants possess MutS homologs that localize to the mitochondria where they regulate DNA stability. Here we show that the lack of TgMSH1 results in accumulation of single nucleotide variations in mitochondrial DNA and a reduction in mitochondrial DNA content. Additionally, parasites lacking TgMSH1 function can survive treatment with the cytochrome b inhibitor atovaquone. While the Tgmsh1 knockout strain has several missense mutations in cytochrome b, none affect amino acids known to be determinants of atovaquone sensitivity and atovaquone is still able to inhibit electron transport in the Tgmsh1 mutants. Furthermore, culture of Tgmsh1 mutant in the presence atovaquone leads to parasites with enhanced atovaquone resistance and complete shutdown of respiration. Thus, parasites lacking TgMSH1 overcome the disruption of mitochondrial DNA by adapting their physiology allowing them to forgo the need for oxidative phosphorylation. Consistent with this idea, the Tgmsh1 mutant is resistant to mitochondrial inhibitors with diverse targets and exhibits reduced ability to grow in the absence of glucose. This work shows TgMSH1 as critical for the maintenance and fidelity of the mitochondrial DNA in Toxoplasma, reveals a novel mechanism for atovaquone resistance, and exposes the physiological plasticity of this important human pathogen.	[Garbuz, Tamila; Arrizabalaga, Gustavo] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Arrizabalaga, Gustavo] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Arrizabalaga, G (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Arrizabalaga, G (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	garrizab@iu.edu			National Institutes of Health [RO1AI89808, R01AI123457]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123457, R01AI089808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants RO1AI89808 and R01AI123457 to G.A. from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr. John Boothroyd for providing the atovaquone resistant parasite strain as well as its parental strain. We also extend special gratitude to Dr. Jessie Kissinger for sharing her unpublished data on the sequencing of Toxoplasma's mitochondrial genome and providing the sequence of primers validated for specific amplification of mitochondrial DNA fragments. We also thank the Sullivan lab and members of the IUSM Biology of Intracellular Pathogens (BIP) group for their helpful discussions and suggestions. This research was supported by grants RO1AI89808 and R01AI123457 to G.A. from the National Institutes of Health.	Abdelnoor RV, 2006, J MOL EVOL, V63, P165, DOI 10.1007/s00239-005-0226-9; Abdelnoor RV, 2003, P NATL ACAD SCI USA, V100, P5968, DOI 10.1073/pnas.1037651100; [Anonymous], 1998, MICROSATELLITE INSTA, P17, DOI 10.1038sjonc1202112; Birth D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5029; Camps M, 2002, MOL MICROBIOL, V43, P1309, DOI 10.1046/j.1365-2958.2002.02825.x; CHI NW, 1994, J BIOL CHEM, V269, P29984; CHOI I, 1990, EXP PARASITOL, V71, P452, DOI 10.1016/0014-4894(90)90071-J; de Souza-Pinto NC, 2009, DNA REPAIR, V8, P704, DOI 10.1016/j.dnarep.2009.01.021; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; DONALD RGK, 1994, MOL BIOCHEM PARASIT, V63, P243, DOI 10.1016/0166-6851(94)90060-4; Esser L, 2014, CURR PHARM DESIGN, V20, P704, DOI 10.2174/138161282005140214163327; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; FEAGIN JE, 1991, J PROTOZOOL, V38, P243, DOI 10.1111/j.1550-7408.1991.tb04436.x; FEAGIN JE, 1994, ANNU REV MICROBIOL, V48, P81, DOI 10.1146/annurev.mi.48.100194.000501; FRENKEL J. K., 1957, ANTIBIOT AND CHE MOTHER, V7, P630; Fruth IA, 2007, INT J PARASITOL, V37, P1559, DOI 10.1016/j.ijpara.2007.05.010; FRY M, 1984, BIOCHEM PHARMACOL, V33, P2115, DOI 10.1016/0006-2952(84)90581-1; GARDNER MJ, 1988, MOL BIOCHEM PARASIT, V31, P11, DOI 10.1016/0166-6851(88)90140-5; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Garrison EM, 2009, MOL MICROBIOL, V72, P425, DOI 10.1111/j.1365-2958.2009.06655.x; Goodman CD, 2017, TRENDS PARASITOL, V33, P185, DOI 10.1016/j.pt.2016.10.002; Jones JL, 2014, AM J TROP MED HYG, V90, P794, DOI 10.4269/ajtmh.13-0722; JOSEPH JT, 1989, MOL CELL BIOL, V9, P3621, DOI 10.1128/MCB.9.9.3621; Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Lavine MD, 2011, ANTIMICROB AGENTS CH, V55, P745, DOI 10.1128/AAC.01092-10; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mather MW, 2008, J BIOENERG BIOMEMBR, V40, P425, DOI 10.1007/s10863-008-9176-4; McFadden DC, 1999, J EUKARYOT MICROBIOL, V46, p81S; McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849; McFadden DC, 2000, MOL BIOCHEM PARASIT, V108, P1, DOI 10.1016/S0166-6851(00)00184-5; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Mookerjee SA, 2005, CURR GENET, V47, P84, DOI 10.1007/s00294-004-0537-1; Nixon GL, 2013, J ANTIMICROB CHEMOTH, V68, P977, DOI 10.1093/jac/dks504; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; OSSORIO PN, 1991, J MOL BIOL, V222, P525, DOI 10.1016/0022-2836(91)90494-Q; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; PFEFFERKORN ER, 1993, J PARASITOL, V79, P559, DOI 10.2307/3283383; Plucinski MM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu059; Pogorzala L, 2009, GENETICS, V182, P699, DOI 10.1534/genetics.109.103796; REENAN RAG, 1992, GENETICS, V132, P975; Sakamoto W, 1996, PLANT CELL, V8, P1377, DOI 10.1105/tpc.8.8.1377; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; SMALL ID, 1987, EMBO J, V6, P865, DOI 10.1002/j.1460-2075.1987.tb04832.x; Smilkstein MJ, 2009, DRUG SELECTED PLASMO, V159, P64; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Srivastava IK, 1997, J BIOL CHEM, V272, P3961, DOI 10.1074/jbc.272.7.3961; SUPLICK K, 1988, MOL BIOCHEM PARASIT, V30, P289, DOI 10.1016/0166-6851(88)90098-9; Suswam E, 2001, EXP PARASITOL, V98, P180, DOI 10.1006/expr.2001.4639; Syafruddin D, 1999, MOL BIOCHEM PARASIT, V104, P185, DOI 10.1016/S0166-6851(99)00148-6; VAIDYA AB, 1987, MOL BIOCHEM PARASIT, V22, P249, DOI 10.1016/0166-6851(87)90056-9; VAIDYA AB, 1989, MOL BIOCHEM PARASIT, V35, P97, DOI 10.1016/0166-6851(89)90112-6; Vaidya AB, 2000, DRUG RESIST UPDATE, V3, P283, DOI 10.1054/drup.2000.0157; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Vercesi AE, 1998, J BIOL CHEM, V273, P31040, DOI 10.1074/jbc.273.47.31040; WALTER RD, 1986, MOL BIOCHEM PARASIT, V19, P61, DOI 10.1016/0166-6851(86)90066-6; Winter RW, 2006, EXP PARASITOL, V114, P47, DOI 10.1016/j.exppara.2006.03.014	61	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188040	10.1371/journal.pone.0188040	http://dx.doi.org/10.1371/journal.pone.0188040			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141004	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400046
J	Beall, L; Myers, TA; Kotcher, JE; Vraga, EK; Maibach, EW				Beall, Lindsey; Myers, Teresa A.; Kotcher, John E.; Vraga, Emily K.; Maibach, Edward W.			Controversy matters: Impacts of topic and solution controversy on the perceived credibility of a scientist who advocates	PLOS ONE			English	Article							SCIENCE; TRUST; INTENTIONALITY; COMMUNICATION; INFERENCES; MESSAGES; MOTIVES; OPINION; POLICY	In this article, we focus on the potential influence of a scientist's advocacy position on the public's perceived credibility of scientists as a whole. Further, we examine how the scientist's solution position (information only, non-controversial, and controversial) affects the public's perception of the scientist's motivation for sharing information about specific issues (flu, marijuana, climate change, severe weather). Finally, we assess how perceived motivations mediate the relationship between solution position and credibility. Using data from a quota sample of American adults obtained by Qualtrics (n = 2,453), we found that in some conditions advocating for a solution positively predicted credibility, while in one condition, it negatively predicted scientist credibility. We also found that the influence of solution position on perceived credibility was mediated by several motivation perceptions; most notably through perception that the scientist was motivated to: (a) serve the public and (b) persuade the public. Further results and implications are discussed.	[Beall, Lindsey; Myers, Teresa A.; Kotcher, John E.; Vraga, Emily K.; Maibach, Edward W.] George Mason Univ, Dept Commun, Fairfax, VA 22030 USA	George Mason University	Beall, L (corresponding author), George Mason Univ, Dept Commun, Fairfax, VA 22030 USA.	LBeall3@gmu.edu	Vraga, Emily/K-9325-2019; Kotcher, John/P-7866-2019	Vraga, Emily/0000-0002-3016-3869; Kotcher, John/0000-0003-4789-1384	National Aeronautics and Space Association [NNX11AQ80G]	National Aeronautics and Space Association	This research was supported by the National Aeronautics and Space Association (NASA.gov) [Award #: NNX11AQ80G]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2010, P ASPA ANN M 2010 SE; Carlston D.E., 2013, OXFORD HDB SOCIAL CO, P95, DOI [10.1093/oxfordhb/9780199730018.013.0006, DOI 10.1093/OXFORDHB/9780199730018.013.0006]; Combs DJY, 2010, BASIC APPL SOC PSYCH, V32, P328, DOI 10.1080/01973533.2010.519246; Corner A, 2014, NAT CLIM CHANGE, V4, P743, DOI 10.1038/nclimate2348; Critchley CR, 2008, PUBLIC UNDERST SCI, V17, P309, DOI 10.1177/0963662506070162; Donner SD, 2014, CLIMATIC CHANGE, V124, P1, DOI 10.1007/s10584-014-1108-1; EAGLY AH, 1978, J PERS SOC PSYCHOL, V36, P424, DOI 10.1037/0022-3514.36.4.424; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13593, DOI 10.1073/pnas.1317505111; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Kaiser J, 2000, SCIENCE, V287, P1188, DOI 10.1126/science.287.5456.1188; KASPERSON RE, 1992, J SOC ISSUES, V48, P161, DOI 10.1111/j.1540-4560.1992.tb01950.x; Kotcher JE, 2017, ENV COMMUN IN PRESS; Lach D, 2003, BIOSCIENCE, V53, P170, DOI 10.1641/0006-3568(2003)053[0170:AACOES]2.0.CO;2; Lackey RT, 2007, CONSERV BIOL, V21, P12, DOI 10.1111/j.1523-1739.2006.00639.x; Malle B.F., 2011, THEORIES SOCIAL PSYC, P72; Malle BF, 2012, J PERS SOC PSYCHOL, V102, P661, DOI 10.1037/a0026790; McCroskey JC, 1999, COMMUN MONOGR, V66, P90, DOI 10.1080/03637759909376464; Myers TA, 2016, PUBLIC UNDERST SCI; Nelson MP, 2009, CONSERV BIOL, V23, P1090, DOI 10.1111/j.1523-1739.2009.01250.x; Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474; Peters RG, 1997, RISK ANAL, V17, P43, DOI 10.1111/j.1539-6924.1997.tb00842.x; Pew Research Center, 2015, PUBLIC SCI VIEWS SCI; Pielke R.A.J., 2007, HONEST BROKER MAKING; Pirlott AG, 2016, J EXP SOC PSYCHOL, V66, P29, DOI 10.1016/j.jesp.2015.09.012; Rabinovich A, 2012, J ENVIRON PSYCHOL, V32, P11, DOI 10.1016/j.jenvp.2011.09.002; Reeder GD, 2009, PSYCHOL INQ, V20, P1, DOI 10.1080/10478400802615744; Ruggiero LF, 2010, J WILDLIFE MANAGE, V74, P1179, DOI 10.2193/2009-437; Singh GG, 2014, FRONT ECOL ENVIRON, V12, P161, DOI 10.1890/130011; WOOD W, 1981, J PERS SOC PSYCHOL, V40, P246, DOI 10.1037/0022-3514.40.2.246; 2007, WOODHEAD PUBL FOOD S, P1	30	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187511	10.1371/journal.pone.0187511	http://dx.doi.org/10.1371/journal.pone.0187511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136643	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200021
J	Brateanu, A; Barwacz, T; Kou, L; Wang, SH; Misra-Hebert, AD; Hu, B; Deshpande, A; Kobaivanova, N; Rothberg, MB				Brateanu, Andrei; Barwacz, Thomas; Kou, Lei; Wang, Sihe; Misra-Hebert, Anita D.; Hu, Bo; Deshpande, Abhishek; Kobaivanova, Nana; Rothberg, Michael B.			Determining the optimal screening interval for type 2 diabetes mellitus using a risk prediction model	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; TOLERANCE; SCORE; SMOKING; ADULTS; A1C	Background Progression to diabetes mellitus (DM) is variable and the screening time interval not well defined. The American Diabetes Association and US Preventive Services Task Force suggest screening every 3 years, but evidence is limited. The objective of the study was to develop a model to predict the probability of developing DM and suggest a risk-based screening interval. Methods We included non-diabetic adult patients screened for DM in the Cleveland Clinic Health System if they had at least two measurements of glycated hemoglobin (HbA1c), an initial one less than 6.5% (48 mmol/mol) in 2008, and another between January, 2009 and December, 2013. Cox proportional hazards models were created. The primary outcome was DM defined as HbA1C greater than 6.4% (46 mmol/mol). The optimal rescreening interval was chosen based on the predicted probability of developing DM. Results Of 5084 participants, 100 (4.4%) of the 2281 patients with normal HbA1c and 772 (27.5%) of the 2803 patients with prediabetes developed DM within 5 years. Factors associated with developing DM included HbA1c (HR per 0.1 units increase 1.20; 95% CI, 1.13-1.27), family history (HR 1.31; 95% CI, 1.13-1.51), smoking (HR 1.18; 95% CI, 1.03-1.35), triglycerides (HR 1.01; 95% CI, 1.00-1.03), alanine aminotransferase (HR 1.07; 95% CI, 1.03-1.11), body mass index (HR 1.06; 95% CI, 1.01-1.11), age (HR 0.95; 95% CI, 0.91-0.99) and high-density lipoproteins (HR 0.93; 95% CI, 0.90-0.95). Five percent of patients in the highest risk tertile developed DM within 8 months, while it took 35 months for 5% of the middle tertile to develop DM. Only 2.4% percent of the patients in the lowest tertile developed DM within 5 years. Conclusion A risk prediction model employing commonly available data can be used to guide screening intervals. Based on equal intervals for equal risk, patients in the highest risk category could be rescreened after 8 months, while those in the intermediate and lowest risk categories could be rescreened after 3 and 5 years respectively.	[Brateanu, Andrei; Misra-Hebert, Anita D.; Deshpande, Abhishek; Kobaivanova, Nana; Rothberg, Michael B.] Cleveland Clin, Med Inst, Cleveland, OH 44106 USA; [Barwacz, Thomas] Univ Hosp, Dept Med, Cleveland, OH USA; [Kou, Lei; Misra-Hebert, Anita D.; Hu, Bo] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Wang, Sihe] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University Hospitals of Cleveland; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Brateanu, A (corresponding author), Cleveland Clin, Med Inst, Cleveland, OH 44106 USA.	abratean@ccf.org	Deshpande, Abhishek/A-7695-2012	Deshpande, Abhishek/0000-0001-5522-2995; Misra-Hebert, Anita/0000-0003-3079-7025				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Brantsma AH, 2005, DIABETES CARE, V28, P2525, DOI 10.2337/diacare.28.10.2525; Gray LJ, 2010, DIABETIC MED, V27, P887, DOI 10.1111/j.1464-5491.2010.03037.x; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Kao WHL, 2001, AM J EPIDEMIOL, V154, P748, DOI 10.1093/aje/154.8.748; Khavandi K, 2013, THER ADV CHRONIC DIS, V4, P242, DOI 10.1177/2040622313494986; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Link CL, 2009, ETHNIC DIS, V19, P288; Luo JH, 2013, AM J EPIDEMIOL, V178, P937, DOI 10.1093/aje/kwt071; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mortaz S, 2012, CLINICOECONOMIC OUTC, V4, P91, DOI 10.2147/CEOR.S30547; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Rahman M, 2008, FAM PRACT, V25, P191, DOI 10.1093/fampra/cmn024; Rasmussen SS, 2008, DIABETOLOGIA, V51, P249, DOI 10.1007/s00125-007-0893-8; Ruchat SM, 2010, ANN MED, V42, P196, DOI 10.3109/07853890903559716; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Takahashi O, 2010, DIABETES CARE, V33, P2016, DOI 10.2337/dc10-0588; Tuso Phillip, 2014, Perm J, V18, P88, DOI 10.7812/TPP/14-002; Waugh N, 2007, HEALTH TECHNOL ASSES, V11, P1; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhang XP, 2010, DIABETES CARE, V33, P1665, DOI 10.2337/dc09-1939	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187695	10.1371/journal.pone.0187695	http://dx.doi.org/10.1371/journal.pone.0187695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135987	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200027
J	Guo, J; Martin, PR; Zhang, CX; Zhang, JE				Guo, Jing; Martin, Pablo R.; Zhang, Chunxia; Zhang, Jia-en			Predation risk affects growth and reproduction of an invasive snail and its lethal effect depends on prey size	PLOS ONE			English	Article							FRESH-WATER SNAIL; POMACEA-CANALICULATA GASTROPODA; GOLDEN APPLE SNAIL; BIOLOGICAL-CONTROL; CAENOGASTROPODA AMPULLARIIDAE; ALARM RESPONSE; TRADE-OFF; MARINE SNAIL; LIFE-HISTORY; COMMON CARP	The behavior of invasive species under predation risk has been studied extensively, but their growth and reproductive responses have rarely been investigated. We conducted experiments with juveniles and adults of the invasive freshwater snail Pomacea canaliculata, and we observed changes in growth and reproduction in response to predation risk from a caged predator (Trachemys scripta elegans). P. canaliculata produced eggs earlier in the presence of predators and injured conspecifics compared with the control group (no risk), although the total number of egg masses laid by per female was exceeded by that of the controls after 15 days. Egg hatching success noticeably decreased under predation risk, and the incubation period was significantly prolonged; however, the oviposition height of the snails was not affected. A lethal effect of predation risk was detected in juvenile snails but not in adults. The growth of juvenile P. canaliculata was inhibited under predation risk, probably due to a reduction in food intake. Adult females exhibited a greater reduction in growth under predation risk than males, which likely resulted in part from the high reproductive investment of females in egg laying. These results indicate that P. canaliculata snails under predation risk face a trade-off between predator avoidance and growth and reproduction, where the lethal effect of predation risk is linked to the size of the prey.	[Guo, Jing; Zhang, Chunxia; Zhang, Jia-en] South China Agr Univ, Coll Nat Resources & Environm, Dept Ecol, Guangzhou, Guangdong, Peoples R China; [Martin, Pablo R.] Univ Nacl Sur, CONICET, Dept Biol Bioquim & Farm, Lab Ecol,INBIOSUR,UNS, Bahia Blanca, Buenos Aires, Argentina; [Zhang, Jia-en] Minist Agr, Key Lab Agroenvironm Trop, Guangzhou, Guangdong, Peoples R China; [Zhang, Jia-en] Guangdong Engn Res Ctr Modern Ecoagr & Circular A, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; Ministry of Agriculture & Rural Affairs	Zhang, JE (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Dept Ecol, Guangzhou, Guangdong, Peoples R China.; Zhang, JE (corresponding author), Minist Agr, Key Lab Agroenvironm Trop, Guangzhou, Guangdong, Peoples R China.; Zhang, JE (corresponding author), Guangdong Engn Res Ctr Modern Ecoagr & Circular A, Guangzhou, Guangdong, Peoples R China.	jeanzh@scau.edu.cn	Martín, Pablo/P-4916-2019	Martin, Pablo/0000-0002-2987-7901	National Natural Science Foundation of China [U1131006, 30770403]; National Natural Science Foundation of China; Science and Technology Planning Project of Guangdong Province [20156090903077]; Guangdong Provincial Department of Science and Technology; South China Agricultural University [2017LHPY017]; South China Agricultural University; People's Government of Guangdong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Guangdong Provincial Department of Science and Technology; South China Agricultural University; South China Agricultural University; People's Government of Guangdong Province	This work was supported by the National Natural Science Foundation of China (grant number U1131006). URL: ittp.//www.nsfc.gov.cn/; National Natural Science Foundation of China and People's Government of Guangdong Province to JZ; National Natural Science Foundation of China (grant number 30770403). URL: http://www.nsfc. gov.cn/; National Natural Science Foundation of China to JZ; Science and Technology Planning Project of Guangdong Province (grant number 20156090903077) URL: http://www.gdstc.gov.cn/; Guangdong Provincial Department of Science and Technology to JZ; Overseas Joint Doctoral Training Program of South China Agricultural University (grant number 2017LHPY017). URL: http://www.scau.edu.cn/ and South China Agricultural University to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki K, 2010, MALACOLOGIA, V52, P21, DOI 10.4002/040.052.0102; Aizaki K, 2009, J ETHOL, V27, P175, DOI 10.1007/s10164-008-0103-2; Albrecht EA, 1996, VELIGER, V39, P142; Auld JR, 2015, EVOLUTION, V69, P2793, DOI 10.1111/evo.12769; Auld JR, 2010, EVOLUTION, V64, P3476, DOI 10.1111/j.1558-5646.2010.01079.x; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; Burela S, 2011, J MOLLUS STUD, V77, P54, DOI 10.1093/mollus/eyq035; Carlsson N, 2004, FRESHWATER BIOL, V49, P1269, DOI 10.1111/j.1365-2427.2004.01269.x; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COWIE RH, 2002, MOLLUSCS CROP PESTS; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; De Roeck ERM, 2005, HYDROBIOLOGIA, V542, P103, DOI 10.1007/s10750-004-2411-z; Dong SZ, 2012, SCI AGR, V69, P142, DOI 10.1590/S0103-90162012000200009; Estebenet AL, 2003, J MOLLUS STUD, V69, P301, DOI 10.1093/mollus/69.4.301; Estebenet AL, 2002, BIOCELL, V26, P83; Estebenet AL, 2006, BIOCELL, V30, P329; FRASER DF, 1992, ECOLOGY, V73, P959, DOI 10.2307/1940172; Ghalambor CK, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0154; Gilal Arfan Ahmed, 2015, Journal of Entomology and Zoology Studies, V3, P254; Guo J, 2016, BIOCONTROL SCI TECHN, V26, P1100, DOI 10.1080/09583157.2016.1185511; Guo Jing, 2015, Shengtaixue Zazhi, V34, P2943; HALWART M, 1994, INT J PEST MANAGE, V40, P199, DOI 10.1080/09670879409371882; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2015, MALACOLOGIA, V58, P245, DOI 10.4002/040.058.0209; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Ichinose K, 2003, BEHAVIOUR, V140, P935, DOI 10.1163/156853903770238391; Ichinose K, 2003, ECOL RES, V18, P213, DOI 10.1046/j.1440-1703.2003.00548.x; Ichinose K, 2002, J CHEM ECOL, V28, P2017, DOI 10.1023/A:1020749911877; Ichinose K, 2002, INT J PEST MANAGE, V48, P133, DOI 10.1080/09670870110100703; Ip KKL, 2014, BIOL CONTROL, V71, P16, DOI 10.1016/j.biocontrol.2013.12.009; Ireland DH, 2007, OECOLOGIA, V152, P162, DOI 10.1007/s00442-006-0637-3; Ito K, 2002, APPL ENTOMOL ZOOL, V37, P655, DOI 10.1303/aez.2002.655; Koch N, 2007, INVERTEBR BIOL, V126, P257, DOI 10.1111/j.1744-7410.2007.00095.x; Liang KM, 2013, BIOCONTROL SCI TECHN, V23, P674, DOI 10.1080/09583157.2013.790933; Lindsay MK, 2013, AMPHIBIA-REPTILIA, V34, P75, DOI 10.1163/15685381-00002871; Liu D., 2011, B BIOL FR BELG, V46, P18, DOI DOI 10.3969/J.ISSN.0006-3193.2011.3906.3006; Manriquez PH, 2013, MAR ECOL PROG SER, V472, P169, DOI 10.3354/meps10055; Matsukura K, 2013, BIOL INVASIONS, V15, P2039, DOI 10.1007/s10530-013-0431-1; McCauley SJ, 2011, ECOLOGY, V92, P2043, DOI 10.1890/11-0455.1; McPeek MA, 2001, ECOLOGY, V82, P1535, DOI 10.1890/0012-9658(2001)082[1535:PABRTP]2.0.CO;2; MINCHELLA DJ, 1981, AM NAT, V118, P876, DOI 10.1086/283879; Miner BG, 2010, OECOLOGIA, V163, P69, DOI 10.1007/s00442-010-1570-z; MOCHIDA O, 1991, MICRONESICA-SERIES, P51; Nystrom P, 2005, FRESHWATER BIOL, V50, P1938, DOI 10.1111/j.1365-2427.2005.01438.x; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; Pavlova V, 2010, J THEOR BIOL, V264, P787, DOI 10.1016/j.jtbi.2010.03.009; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preston DL, 2014, FUNCT ECOL, V28, P1472, DOI 10.1111/1365-2435.12293; RAWLINGS TA, 1994, J EXP MAR BIOL ECOL, V181, P67, DOI 10.1016/0022-0981(94)90104-X; Rigby MC, 2000, P ROY SOC B-BIOL SCI, V267, P171, DOI 10.1098/rspb.2000.0983; Sandland GJ, 2006, ENVIRON TOXICOL CHEM, V25, P2216, DOI 10.1897/05-596R.1; Dreon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063782; Seuffert ME, 2010, BIOL INVASIONS, V12, P1695, DOI 10.1007/s10530-009-9582-5; Song HM, 2014, CELL STRESS CHAPERON, V19, P579, DOI 10.1007/s12192-013-0485-0; Steiner UK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006160; Stone AI, 2007, AM J PRIMATOL, V69, P127, DOI 10.1002/ajp.20334; Tamburi NE, 2016, CURR ZOOL, V62, P369, DOI 10.1093/cz/zow023; Tamburi NE, 2011, BIOL INVASIONS, V13, P2351, DOI 10.1007/s10530-011-0047-2; Ueshima E, 2015, J MOLLUS STUD, V81, P51, DOI 10.1093/mollus/eyu057; Urban MC, 2007, ECOLOGY, V88, P2587, DOI 10.1890/06-1946.1; Xu WB, 2014, J MOLLUS STUD, V80, P117, DOI 10.1093/mollus/eyt054; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713; Yoshie H, 2008, APPL ENTOMOL ZOOL, V43, P475, DOI 10.1303/aez.2008.475; Yusa Y, 2006, BIOL INVASIONS, V8, P137, DOI 10.1007/s10530-004-1790-4; Yusa Y, 2007, GENETICS, V175, P179, DOI 10.1534/genetics.106.060400; ZHOU W. C., 2003, FUJIAN J AGR SCI, V18, P25	67	11	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187747	10.1371/journal.pone.0187747	http://dx.doi.org/10.1371/journal.pone.0187747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136660	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200030
J	Kangwankai, K; Sani, S; Panpisut, P; Xia, W; Ashley, P; Petridis, H; Young, AM				Kangwankai, Kanokrat; Sani, Sarah; Panpisut, Piyaphong; Xia, Wendy; Ashley, Paul; Petridis, Haralampos; Young, Anne Margaret			Monomer conversion, dimensional stability, strength, modulus, surface apatite precipitation and wear of novel, reactive calcium phosphate and polylysine-containing dental composites	PLOS ONE			English	Article							RESIN-COMPOSITES; HYGROSCOPIC EXPANSION; MECHANICAL-PROPERTIES; TOOTHBRUSHING ALTERS; SECONDARY CARIES; COLOR-CHANGE; IN-VITRO; POLYMERIZATION; ROUGHNESS; SHRINKAGE	Purpose The aim was to assess monomer conversion, dimensional stability, flexural strength/modulus, surface apatite precipitation and wear of mono/tri calcium phosphate (CaP) and polylysine (PLS)-containing dental composites. These were formulated using a new, high molecular weight, fluid monomer phase that requires no polymerisation activator. Materials and methods Urethane and Polypropylene Glycol Dimethacrylates were combined with low levels of an adhesion promoting monomer and a light activated initiator. This liquid was mixed with a hybrid glass containing either 10 wt% CaP and 1 wt% PLS (F1) or 20 wt% CaP and 2 wt% PLS (F2). Powder to liquid mass ratio was 5: 1. Commercial controls included Gradia Direct Posterior (GD) and Filtek Z250 (FZ). Monomer conversion and polymerisation shrinkage were calculated using Fourier Transform Infrared (FTIR). Subsequent volume increases in water over 7 weeks were determined using gravimetric studies. Biaxial flexural strength (BFS)/modulus (BFM) reduction and surface apatite precipitation upon 1 and 4 weeks immersion in water versus simulated body fluid (SBF) were assessed using a mechanical testing frame and scanning electron microscope (SEM). Mass/volume loss and surface roughness (R-a) following 7 weeks water immersion and subsequent accelerated toothbrush abrasion were examined using gravimetric studies and profilometer. Results F1 and F2 exhibited much higher monomer conversion (72%) than FZ (54%) and low calculated polymerization shrinkage (2.2 vol%). Final hygroscopic expansions decreased in the order; F2 (3.5 vol%) > F1 (1.8 vol%) similar to Z250 (1.6 vol%) > Gradia (1.0 vol%). BFS and BFM were unaffected by storage medium type. Average BFS/BFM upon 4 weeks immersion reduced from 144 MPa/8 GPa to 107 MPa/5 GPa for F1 and 105 MPa/6 GPa to 82 MPa/4 GPa for F2. Much of this change was observed in the first week of immersion when water sorption rate was high. Surface apatite layers were incomplete at 1 week, but around 2 and 15 micron thick for F1 and F2 respectively following 4 weeks in SBF. Mass and volume loss following wear were equal. Average results for F1 (0.5%), F2 (0.7%), and FZ (0.5%) were comparable but lower than that of GD (1%). R-a, however, decreased in the order; F1 (15 mu m) > F2 (11 mu m) > GD (9 mu m) > FZ (5 mu m). Conclusions High monomer conversion in combination with large monomer size and lack of amine activator should improve cytocompatibility of the new composites. High monomer molecular weight and powder content enables low polymerisation shrinkage despite high conversion. Increasing active filler provides enhanced swelling to balance shrinkage, which, in combination with greater surface apatite precipitation, may help seal gaps and reduce bacterial microleakage. High monomer conversion also ensures competitive mechanical/wear characteristics despite enhanced water sorption. Furthermore, increased active filler could help reduce surface roughness upon wear.	[Kangwankai, Kanokrat; Sani, Sarah; Petridis, Haralampos] UCL Eastman Dent Inst, Unit Prosthodont, Dept Restorat Dent, London, England; [Kangwankai, Kanokrat] UCL Eastman Dent Inst, Unit Orthodont, London, England; [Panpisut, Piyaphong; Xia, Wendy; Young, Anne Margaret] UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England; [Panpisut, Piyaphong] Thammasat Univ, Fac Dent, Pathum Thani, Thailand; [Ashley, Paul] UCL Eastman Dent Inst, Unit Paediat Dent, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Thammasat University; University of London; University College London	Young, AM (corresponding author), UCL Eastman Dent Inst, Dept Biomat & Tissue Engn, London, England.	Anne.Young@ucl.ac.uk	panpisut, piyaphong/L-7363-2019; Panpisut, Piyaphong/AAW-1712-2020; Panpisut, Piyaphong/AAJ-5419-2021	Panpisut, Piyaphong/0000-0002-8649-857X; Ashley, Paul/0000-0003-0312-5311; Young, Anne/0000-0001-8485-2056	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation i4i); UK EPSRC (Engineering and Physical Sciences Research Council) [EP/I022341/1]; Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche) [ISSF/FHCE/0079]; Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP) [II-LB-0214-20002]; Engineering and Physical Sciences Research Council [EP/I022341/1] Funding Source: researchfish; National Institute for Health Research [II-LB-0214-20002] Funding Source: researchfish; EPSRC [EP/I022341/1] Funding Source: UKRI	Royal Thai Government (Ministry of Sciences and Technology); National Institute for Health Research (Invention for Innovation i4i); UK EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche); Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by The Royal Thai Government (Ministry of Sciences and Technology) (PP); National Institute for Health Research (Invention for Innovation i4i, https://nihr.ac.uk/research-and-impact/research/nihr-studies/invention-for-innovation.htm);Optimisation and commercial manufacture of tooth-coloured composite dental-fillings with added polyantimicrobial (PAM) and remineralising calcium phosphate (CaP)), grant number II-LB-0214-20002 (WX); UK EPSRC (Engineering and Physical Sciences Research Council, https./www.epsrc.ac.uk), grant number EP/I022341/1 (WX); and Wellcome Trust (Institutional Strategic Support Fund (Issf) Third Tranche, www.wellcome.ac.uk/Funding/WTP057769.htm), grant number ISSF/FHCE/0079 (WX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Neel EA, 2016, INT J NANOMED, V11, P4743, DOI 10.2147/IJN.S107624; Aljabo A, 2015, DENT MATER, V31, P1279, DOI 10.1016/j.dental.2015.08.149; Aljabo A, 2016, MAT SCI ENG C-MATER, V60, P285, DOI 10.1016/j.msec.2015.11.047; Alrahlah A, 2014, DENT MATER, V30, P143, DOI 10.1016/j.dental.2013.10.010; Aoba T, 2004, ORAL DIS, V10, P249, DOI 10.1111/j.1601-0825.2004.01030.x; Asmussen E, 1998, DENT MATER, V14, P51, DOI 10.1016/S0109-5641(98)00009-8; Atai M, 2005, BIOMATERIALS, V26, P5015, DOI 10.1016/j.biomaterials.2005.01.022; Bakhurji E, 2017, J PUBLIC HEALTH DENT, V77, P207, DOI 10.1111/jphd.12198; Benetti AR, 2015, OPER DENT, V40, P190, DOI 10.2341/13-324-L; Bicalho A, 2014, OPER DENT, V39, P83, DOI DOI 10.2341/12-442-L; Bicalho A A, 2014, Oper Dent, V39, pE83, DOI 10.2341/12-442-L; Blackham JT, 2009, OPER DENT, V34, P697, DOI 10.2341/08-118-L; British Standard, 2012, 23317 BS ISO; British Standard, 2009, 40492009 BS EN; British Standards, 2007, 1456912007 PD ISOTR; Chen Q, 2009, WEAR, V267, P1153, DOI 10.1016/j.wear.2008.12.058; Chen RS, 2003, J DENT, V31, P223, DOI 10.1016/S0300-5712(02)00088-X; Cheng L, 2016, INT J ORAL SCI, V8, P172, DOI 10.1038/ijos.2016.13; Curtis AR, 2008, J DENT, V36, P186, DOI 10.1016/j.jdent.2007.11.015; Derchi G, 2016, J PROSTHET DENT; Dorozhkin SV, 2009, MATERIALS, V2, P221, DOI 10.3390/ma2010221; Farrugia C, 2015, DENT MATER, V31, pE89, DOI 10.1016/j.dental.2014.12.005; Ferracane JL, 2006, DENT MATER, V22, P211, DOI 10.1016/j.dental.2005.05.005; Finan L, 2013, DENT MATER, V29, P906, DOI 10.1016/j.dental.2013.05.008; Gandolfi MG, 2011, DENT MATER, V27, P1055, DOI 10.1016/j.dental.2011.07.007; Hatamleh MM, 2010, DENT MATER, V26, P185, DOI 10.1016/j.dental.2009.10.001; Herrera D, 2003, J CLIN PERIODONTOL, V30, P307, DOI 10.1034/j.1600-051X.2003.00341.x; Hubbezoglu I, 2008, DENT MATER J, V27, P105, DOI 10.4012/dmj.27.105; Ilie N, 2017, DENT MATER, V33, P880, DOI 10.1016/j.dental.2017.04.013; Jokstad A, 2016, DENT MATER, V32, P11, DOI 10.1016/j.dental.2015.09.006; Kamonkhantikul K, 2016, DENT MATER J, V35, P225, DOI 10.4012/dmj.2015-228; Kamonkhantikul K, 2014, DENT MATER J, V33, P599, DOI 10.4012/dmj.2014-111; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Lepri CP, 2012, DENT MATER J, V31, P689, DOI 10.4012/dmj.2012-063; Marovic D, 2014, DENT MATER, V30, P1052, DOI 10.1016/j.dental.2014.06.001; Mehdawi I, 2009, ACTA BIOMATER, V5, P2525, DOI 10.1016/j.actbio.2009.03.030; Mehdawi IM, 2013, DENT MATER, V29, P473, DOI 10.1016/j.dental.2013.01.010; Nedeljkovic I, 2015, DENT MATER, V31, pE247, DOI 10.1016/j.dental.2015.09.001; Nomura Y, 2006, J MATER SCI-MATER M, V17, P29, DOI 10.1007/s10856-006-6326-2; Panpisut P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164653; Park JW, 2014, J DENT RES, V93, P195, DOI 10.1177/0022034513513905; Pemberton Michael N, 2016, Dent Update, V43, P272; Pick B, 2010, DENT MATER, V26, P83, DOI 10.1016/j.dental.2009.09.002; Regnault WF, 2008, J MATER SCI-MATER M, V19, P507, DOI 10.1007/s10856-007-3178-3; Roselino Lourenço de Moraes Rego, 2015, Braz. Dent. J., V26, P507, DOI 10.1590/0103-6440201300399; Lessa FCR, 2010, J APPL ORAL SCI, V18, P50, DOI 10.1590/S1678-77572010000100010; Santos M, 2013, J DENT, V41, P802, DOI 10.1016/j.jdent.2013.06.011; Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012; Shin DH, 2009, DENT MATER, V25, P1030, DOI 10.1016/j.dental.2009.03.004; Skrtic D, 2007, J BIOMATER APPL, V21, P375, DOI 10.1177/0885328206064823; Suiter EA, 2016, J DENT RES, V95, P543, DOI 10.1177/0022034516633450; Sumino N, 2013, ACTA ODONTOL SCAND, V71, P820, DOI 10.3109/00016357.2012.734405; Versluis A, 2011, DENT MATER, V27, P126, DOI 10.1016/j.dental.2010.09.007; Walters NJ, 2016, DENT MATER, V32, P264, DOI 10.1016/j.dental.2015.11.017; Wei YJ, 2013, DENT MATER, V29, pE218, DOI 10.1016/j.dental.2013.05.010; Young AM, 2004, BIOMATERIALS, V25, P823, DOI 10.1016/S0142-9612(03)00599-4; Zhang L, 2016, DENT MATER, V32, P285, DOI 10.1016/j.dental.2015.11.015	57	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187757	10.1371/journal.pone.0187757	http://dx.doi.org/10.1371/journal.pone.0187757			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136013	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200031
J	Arystarkhova, E; Bouley, R; Liu, YBS; Sweadner, KJ				Arystarkhova, Elena; Bouley, Richard; Liu, Yi Bessie; Sweadner, Kathleen J.			Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport	PLOS ONE			English	Article							PROTEIN-KINASE-C; NA+-K+-ATPASE; RENAL COLLECTING DUCT; AQUAPORIN-2 WATER CHANNEL; RAT SKELETAL-MUSCLE; CARDIAC NA/K-ATPASE; LC-MS/MS ANALYSIS; PLASMA-MEMBRANE; DEPENDENT REGULATION; PHOSPHOLEMMAN FXYD1	The final adjustment of urine volume occurs in the inner medullary collecting duct (IMCD), chiefly mediated by the water channel aquaporin 2 (AQP2). With vasopressin stimulation, AQP2 accumulation in the apical plasma membrane of principal cells allows water reabsorption from the lumen. We report that FXYD1 (phospholemman), better known as a regulator of Na, K-ATPase, has a role in AQP2 trafficking. Daytime urine of Fxyd1 knockout mice was more dilute than WT despite similar serum vasopressin, but both genotypes could concentrate urine during water deprivation. FXYD1 was found in IMCD. In WT mice, phosphorylated FXYD1 was detected intracellularly, and vasopressin induced its dephosphorylation. We tested the hypothesis that the dilute urine in knockouts was caused by alteration of AQP2 trafficking. In WT mice at baseline, FXYD1 and AQP2 were not strongly co-localized, but elevation of vasopressin produced translocation of both FXYD1 and AQP2 to the apical plasma membrane. In kidney slices, baseline AQP2 distribution was more scattered in the Fxyd1 knockout than in WT. Apical recruitment of AQP2 occurred in vasopressin-treated Fxyd1 knockout slices, but upon vasopressin washout, there was more rapid reversal of apical AQP2 localization and more heterogeneous cytoplasmic distribution of AQP2. Notably, in sucrose gradients, AQP2 was present in a detergent-resistant membrane domain that had lower sedimentation density in the knockout than in WT, and vasopressin treatment normalized its density. We propose that FXYD1 plays a role in regulating AQP2 retention in apical membrane, and that this involves transfers between raft-like membrane domains in endosomes and plasma membranes.	[Arystarkhova, Elena; Liu, Yi Bessie; Sweadner, Kathleen J.] Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA; [Arystarkhova, Elena; Bouley, Richard; Liu, Yi Bessie; Sweadner, Kathleen J.] Harvard Med Sch, Boston, MA 02115 USA; [Bouley, Richard] Massachusetts Gen Hosp, Program Membrane Biol, Ctr Syst Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Div Nephrol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Arystarkhova, E; Sweadner, KJ (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Lab Membrane Biol, Boston, MA 02114 USA.; Arystarkhova, E; Sweadner, KJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	aristarkhova@helix.mgh.harvard..edu; sweadner@helix.mgh.harvard.edu		Sweadner, Kathleen J/0000-0002-2817-5262	National Institutes of Health (BADERC, Boston Area Diabetes Endocrinology Research Center) [5P30DK057521-12]; National Institutes of Health [EY014390, NS050696, NS045083, DK096586]; Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship; NIH [S10 RR031563-01]; Boston Area Diabetes and Endocrinology Research Center [DK057521]; MGH Center for the Study of Inflammatory Bowel Disease [DK043351]	National Institutes of Health (BADERC, Boston Area Diabetes Endocrinology Research Center); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Area Diabetes and Endocrinology Research Center; MGH Center for the Study of Inflammatory Bowel Disease	The work was supported by National Institutes of Health Grants 5P30DK057521-12 (Pilot Feasibility Grant, BADERC, Boston Area Diabetes Endocrinology Research Center) (to E.A.); EY014390, NS050696 and NS045083 (to K.J.S.), DK096586 (to Dennis Brown), and a grant from Harvard Medical School 50th Anniversary Scholars in Medicine, a Margaret Walters and Daughters Fellowship in memory of Carl Walters '32 (to E.A.). The Nikon A1R confocal in the PMB Microscopy Core was purchased using an NIH Shared Instrumentation Grant S10 RR031563-01 (Dennis Brown). Additional support for the Program in Membrane Biology Microscopy Core came from the Boston Area Diabetes and Endocrinology Research Center (DK057521) and the MGH Center for the Study of Inflammatory Bowel Disease (DK043351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arystarkhova E, 2002, AM J PHYSIOL-RENAL, V282, pF393, DOI 10.1152/ajprenal.00146.2001; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Bell JR, 2008, AM J PHYSIOL-HEART C, V294, pH613, DOI 10.1152/ajpheart.01332.2007; Bibert S, 2011, J BIOL CHEM, V286, P18562, DOI 10.1074/jbc.M110.184101; BlotChabaud M, 1996, J MEMBRANE BIOL, V153, P233, DOI 10.1007/s002329900126; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bouley R, 2011, J AM SOC NEPHROL, V22, P59, DOI 10.1681/ASN.2009121267; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Brown D, 1996, HISTOCHEM CELL BIOL, V105, P261, DOI 10.1007/BF01463929; Brown D, 2015, BRENNER RECTORS KIDN, P281; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chassin C, 2007, J EXP MED, V204, P2837, DOI 10.1084/jem.20071032; Cheung JY, 2013, ADV EXP MED BIOL, V961, P175, DOI 10.1007/978-1-4614-4756-6_15; Cheung PW, 2017, AM J PHYSIOL-RENAL, V313, pF404, DOI 10.1152/ajprenal.00004.2017; Cheung PW, 2016, J AM SOC NEPHROL, V27, P3105, DOI 10.1681/ASN.2015080903; Choi YS, 1997, ARCH BIOCHEM BIOPHYS, V344, P165, DOI 10.1006/abbi.1997.0183; Coutry N, 1997, ANN NY ACAD SCI, V834, P545, DOI 10.1111/j.1749-6632.1997.tb52314.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; El-Armouche A, 2011, FASEB J, V25, P4467, DOI 10.1096/fj.11-184903; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Fuller W, 2013, CELL MOL LIFE SCI, V70, P1357, DOI 10.1007/s00018-012-1134-y; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Fushimi K, 1997, J BIOL CHEM, V272, P14800, DOI 10.1074/jbc.272.23.14800; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Hafver TL, 2016, J BIOL CHEM, V291, P4561, DOI 10.1074/jbc.M115.677898; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Han F, 2010, AM J PHYSIOL-CELL PH, V299, pC1363, DOI 10.1152/ajpcell.00027.2010; Hara M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07767-8; Hasler U, 2009, AM J PHYSIOL-RENAL, V297, pF10, DOI 10.1152/ajprenal.00053.2009; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Jeon US, 2003, NEPHRON EXP NEPHROL, V93, pE36, DOI 10.1159/000066651; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; JONES LR, 1979, J BIOL CHEM, V254, P530; Jung HJ, 2016, AM J PHYSIOL-RENAL, V311, pF1318, DOI 10.1152/ajprenal.00485.2016; Katsura T, 1997, Am J Physiol, V272, pF817; Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005; Lansbery KL, 2006, AM J PHYSIOL-CELL PH, V290, pC1275, DOI 10.1152/ajpcell.00110.2005; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lin MJ, 2013, ELIFE, V2, DOI 10.7554/eLife.01295; Liu CC, 2013, FREE RADICAL BIO MED, V65, P563, DOI 10.1016/j.freeradbiomed.2013.06.040; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Moshitzky S, 2012, J BIOL CHEM, V287, P21130, DOI 10.1074/jbc.M112.347807; Nikolaeva S, 2016, J AM SOC NEPHROL, V27, P2997, DOI 10.1681/ASN.2015091055; Olesen ETB, 2017, AM J PHYSIOL-RENAL, V312, pF744, DOI 10.1152/ajprenal.00010.2017; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Patel HH, 2009, ANTIOXID REDOX SIGN, V11, P1357, DOI [10.1089/ars.2008.2365, 10.1089/ARS.2008.2365]; Pavlovic D, 2013, J MOL CELL CARDIOL, V61, P83, DOI 10.1016/j.yjmcc.2013.05.002; Rice WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131719; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; Shi HK, 2001, AM J PHYSIOL-RENAL, V280, pF505, DOI 10.1152/ajprenal.2001.280.3.F505; Silverman BD, 2005, CARDIOVASC RES, V65, P93, DOI 10.1016/j.cardiores.2004.09.005; Song JL, 2002, AM J PHYSIOL-HEART C, V283, pH576, DOI 10.1152/ajpheart.00197.2002; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; SWEADNER KJ, 1985, J BIOL CHEM, V260, P9016; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Tokonami N, 2014, J AM SOC NEPHROL, V25, P1430, DOI 10.1681/ASN.2013060641; Tulloch LB, 2011, J BIOL CHEM, V286, P36020, DOI 10.1074/jbc.M111.282145; WALAAS O, 1977, FEBS LETT, V80, P417, DOI 10.1016/0014-5793(77)80489-4; Walaas O, 1999, BIOCHEM J, V343, P151, DOI 10.1042/0264-6021:3430151; WALAAS SI, 1994, BIOCHEM J, V304, P635, DOI 10.1042/bj3040635; Wetzel RK, 2003, AM J PHYSIOL-RENAL, V285, pF121, DOI 10.1152/ajprenal.00241.2002; Wuerzner G, 2014, NEPHROL DIAL TRANSPL, V29, P1475, DOI 10.1093/ndt/gft525; Wypijewski KJ, 2015, MOL CELL PROTEOMICS, V14, P596, DOI 10.1074/mcp.M114.038570; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Yu MJ, 2008, AM J PHYSIOL-CELL PH, V295, pC661, DOI 10.1152/ajpcell.90650.2007; Yu MJ, 2006, MOL CELL PROTEOMICS, V5, P2131, DOI 10.1074/mcp.M600177-MCP200; Yui N, 2013, AM J PHYSIOL-CELL PH, V304, pC38, DOI 10.1152/ajpcell.00109.2012; Yui N, 2012, BIOL OPEN, V1, P101, DOI 10.1242/bio.2011042; Zhang LQ, 2007, MOL CELL BIOCHEM, V303, P231, DOI 10.1007/s11010-007-9479-5; Zhang XQ, 2015, J MOL CELL CARDIOL, V84, P104, DOI 10.1016/j.yjmcc.2015.04.017; Zuber AM, 2009, P NATL ACAD SCI USA, V106, P16523, DOI 10.1073/pnas.0904890106	77	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188006	10.1371/journal.pone.0188006	http://dx.doi.org/10.1371/journal.pone.0188006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155857	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700026
J	Ateka, E; Alicai, T; Ndunguru, J; Tairo, F; Sseruwagi, P; Kiarie, S; Makori, T; Kehoe, MA; Boykin, LM				Ateka, Elijah; Alicai, Titus; Ndunguru, Joseph; Tairo, Fred; Sseruwagi, Peter; Kiarie, Samuel; Makori, Timothy; Kehoe, Monica A.; Boykin, Laura M.			Unusual occurrence of a DAG motif in the Ipomovirus Cassava brown streak virus and implications for its vector transmission	PLOS ONE			English	Article							CUCUMBER MOSAIC-VIRUS; HELPER COMPONENT-PROTEINASE; WHITEFLY-TRANSMITTED MEMBER; AMINO-ACID SUBSTITUTIONS; VEIN-YELLOWING-VIRUS; COAT PROTEIN; APHID TRANSMISSION; EAST-AFRICA; CODING REGION; POTYVIRUS TRANSMISSION	Cassava is the main staple food for over 800 million people globally. Its production in eastern Africa is being constrained by two devastating Ipomoviruses that cause cassava brown streak disease (CBSD); Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV), with up to 100% yield loss for smallholder farmers in the region. To date, vector studies have not resulted in reproducible and highly efficient transmission of CBSV and UCBSV. Most virus transmission studies have used Bemisia tabaci (whitefly), but a maximum of 41% U/CBSV transmission efficiency has been documented for this vector. With the advent of next generation sequencing, researchers are generating whole genome sequences for both CBSV and UCBSV from throughout eastern Africa. Our initial goal for this study was to characterize U/CBSV whole genomes from CBSD symptomatic cassava plants sampled in Kenya. We have generated 8 new whole genomes (3 CBSV and 5 UCBSV) from Kenya, and in the process of analyzing these genomes together with 26 previously published sequences, we uncovered the aphid transmission associated DAG motif within coat protein genes of all CBSV whole genomes at amino acid positions 52-54, but not in UCBSV. Upon further investigation, the DAG motif was also found at the same positions in two other Ipomoviruses: Squash vein yellowing virus (SqVYV), Coccinia mottle virus (CocMoV). Until this study, the highly-conserved DAG motif, which is associated with aphid transmission was only noticed once, in SqVYV but discounted as being of minimal importance. This study represents the first comprehensive look at Ipomovirus genomes to determine the extent of DAG motif presence and significance for vector relations. The presence of this motif suggests that aphids could potentially be a vector of CBSV, SqVYV and CocMov. Further transmission and ipomoviral protein evolutionary studies are needed to confirm this hypothesis.	[Ateka, Elijah; Kiarie, Samuel; Makori, Timothy] JKUAT, Dept Hort, Nairobi, Kenya; [Alicai, Titus] Natl Crops Resources Res Inst NaCRRI, Kampala, Uganda; [Ndunguru, Joseph; Tairo, Fred; Sseruwagi, Peter] MARI, Dar Es Salaam, Tanzania; [Kehoe, Monica A.] DPIRD Diagnost Lab Serv, Dept Primary Ind & Reg Dev, S Perth, WA, Australia; [Boykin, Laura M.] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia	Jomo Kenyatta University of Agriculture & Technology; University of Western Australia	Boykin, LM (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.	laura.boykin@uwa.edu.au	Alicai, Titus/AEN-1873-2022; Boykin, Laura/H-8876-2014	Alicai, Titus/0000-0002-4489-3133; Boykin, Laura/0000-0002-6101-1921	Bill and Melinda Gates Foundation [51466]; Australian Government; Government of Western Australia	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Australian Government(Australian GovernmentCGIAR); Government of Western Australia	The Bill and Melinda Gates Foundation Grant no. 51466 "Regional Cassava Virus Diseases Diagnostic Project" was awarded to Mikocheni Agricultural Research Institute, Tanzania, and a sub-grant to JKUAT supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Benson Ongori for assistance with field collections in Kenya. Computational resources provided by the Pawsey Supercomputing Centre who are supported by the Australian Government and the Government of Western Australia supported this work. In addition, Prof. Alice Vrielink provided assistance with the protein structure of CBSV.	Abarshi MM, 2012, J VIROL METHODS, V179, P176, DOI 10.1016/j.jviromet.2011.10.020; Adkins S, 2007, PHYTOPATHOLOGY, V97, P145, DOI 10.1094/PHYTO-97-2-0145; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Alicai T, 2016, SCI REP-UK, V6, DOI 10.1038/srep36164; AMMAR ED, 1994, PHYTOPATHOLOGY, V84, P1054, DOI 10.1094/Phyto-84-1054; [Anonymous], 1994, POTYVIRIDAE; ATREYA CD, 1990, VIROLOGY, V178, P161, DOI 10.1016/0042-6822(90)90389-9; ATREYA PL, 1995, J GEN VIROL, V76, P265, DOI 10.1099/0022-1317-76-2-265; ATREYA PL, 1991, P NATL ACAD SCI USA, V88, P7887, DOI 10.1073/pnas.88.17.7887; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bigirimana S., 2011, New Disease Reports, V24, P26; Blanc S, 2014, ANNU REV PHYTOPATHOL, V52, P403, DOI 10.1146/annurev-phyto-102313-045920; Bock K.R., 1994, Tropical Science, V34, P134; Brunt A, 1990, VIRUS DIS TROPICAL P; Carbonell A, 2012, MOL PLANT MICROBE IN, V25, P151, DOI 10.1094/MPMI-08-11-0216; CARRINGTON JC, 1993, J VIROL, V67, P6995, DOI 10.1128/JVI.67.12.6995-7000.1993; Colvin J, 2004, P 2 EUR WHIT S 5 9 O; Congdon BS, 2017, VIRUS RES; Desbiez C, 2016, ARCH VIROL, V161, P2913, DOI 10.1007/s00705-016-2981-x; Dombrovsky A, 2005, ARCH VIROL, V150, P287, DOI 10.1007/s00705-004-0407-7; Dombrovsky A, 2013, PLANT PATHOL, V62, P750, DOI 10.1111/ppa.12004; Dombrovsky A, 2014, PEST MANAG SCI, V70, P1553, DOI 10.1002/ps.3735; Dombrovsky A, 2012, VIRUS GENES, V44, P329, DOI 10.1007/s11262-011-0686-5; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Doyle JJ., 1987, FOCUS, V19, P11, DOI DOI 10.2307/2419362; Drummond AJ, 2010, GENEIOUS V5 1; Flasinski S, 1998, ARCH VIROL, V143, P2159, DOI 10.1007/s007050050449; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; GOVIER DA, 1974, VIROLOGY, V57, P285, DOI 10.1016/0042-6822(74)90129-9; Goytia E, 2006, J GEN VIROL, V87, P3413, DOI 10.1099/vir.0.82301-0; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; Hillocks RJ, 1996, INT J PEST MANAGE, V42, P285, DOI 10.1080/09670879609372008; Hillocks R, 2016, J PHYTOPATHOL, V164, P86, DOI 10.1111/jph.12430; Janssen D, 2005, ARCH VIROL, V150, P1439, DOI 10.1007/s00705-005-0515-z; Jeremiah S, 2014, ROLE WHITEFLY BEMISI; Jeremiah SC, 2015, PHYTOPATHOLOGY, V105, P646, DOI 10.1094/PHYTO-05-14-0146-R; Johansen IE, 1996, J GEN VIROL, V77, P1329, DOI 10.1099/0022-1317-77-6-1329; Kalleshwaraswamy CM, 2008, PHYTOPATHOLOGY, V98, P541, DOI 10.1094/PHYTO-98-5-0541; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kehoe MA, 2014, PLANT DIS, V98, P739, DOI [10.1094/PDIS-11-13-1144-RE, 10.1094/PDIS-11-13-1144-]; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kinyanjui G, 2016, B ENTOMOL RES, V106, P63, DOI 10.1017/S0007485315000796; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Lennon AM, 1986, CASSAVA VIRUSES AFRI, P168; Llave C, 2002, ARCH VIROL, V147, P2365, DOI 10.1007/s00705-002-0884-5; Lopez-Moya JJ, 1999, J GEN VIROL, V80, P3281, DOI 10.1099/0022-1317-80-12-3281; Maruthi MN, 2005, J PHYTOPATHOL, V153, P307, DOI 10.1111/j.1439-0434.2005.00974.x; Masinde E. A., 2016, African Journal of Agricultural Research, V11, P2064; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Mulimbi W., 2012, New Disease Reports, V26, P11, DOI 10.5197/j.2044-0588.2012.026.011; MURPHY JF, 1990, VIROLOGY, V178, P285, DOI 10.1016/0042-6822(90)90405-G; Mware B, 2009, JGMV, V1, P040, DOI [DOI 10.1007/S007050070078, 10.5897/JGMV.9000003, DOI 10.5897/JGMV.9000003]; Mware B. O., 2009, Journal of Applied Biosciences, V16, P864; Ndunguru J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139321; Ndunguru J, 2009, AFR J AGR RES, V4, P334; NICHOLS R. F. W., 1950, EAST AFRICAN AGRIC JOUR, V15, P154; Njoroge Moffat K., 2016, Journal of Entomology and Zoology Studies, V4, P258; Nweke FI, 1996, 14 COSCA; Ogwok E, 2016, VIRUS RES, V215, P1, DOI 10.1016/j.virusres.2016.01.015; Osogo A.K., 2014, J AGRI FOOD APPL SCI, V2, P184; Perry KL, 1998, VIROLOGY, V242, P204, DOI 10.1006/viro.1998.8991; Pirone TP, 2002, ADV BOT RES, V36, P1, DOI 10.1016/S0065-2296(02)36056-7; Power AG, 2000, CURR OPIN PLANT BIOL, V3, P336, DOI 10.1016/S1369-5266(00)00090-X; RACCAH B, 1985, ANN APPL BIOL, V106, P451, DOI 10.1111/j.1744-7348.1985.tb03135.x; RESTREPOHARTWIG MA, 1994, J VIROL, V68, P2388, DOI 10.1128/JVI.68.4.2388-2397.1994; Revers F, 2015, ADV VIRUS RES, V92, P101, DOI 10.1016/bs.aivir.2014.11.006; RODRIGUEZCEREZO E, 1993, J GEN VIROL, V74, P1945, DOI 10.1099/0022-1317-74-9-1945; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schaad MC, 1997, EMBO J, V16, P4049, DOI 10.1093/emboj/16.13.4049; SHUKLA DD, 1989, ADV VIRUS RES, V36, P273, DOI 10.1016/S0065-3527(08)60588-6; SHUKLA DD, 1991, CAN J PLANT PATHOL, V13, P178, DOI 10.1080/07060669109500953; SOUMOUNOU Y, 1994, J GEN VIROL, V75, P2567, DOI 10.1099/0022-1317-75-10-2567; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Susko E, 2004, MOL BIOL EVOL, V21, P1629, DOI 10.1093/molbev/msh159; TORDO VMJ, 1995, J GEN VIROL, V76, P939, DOI 10.1099/0022-1317-76-4-939; VERCHOT J, 1991, VIROLOGY, V185, P527, DOI 10.1016/0042-6822(91)90522-D; WALKEY DGA, 1994, PLANT PATHOL, V43, P931, DOI 10.1111/j.1365-3059.1994.tb01638.x; Wikoff WR, 1997, VIROLOGY, V232, P91, DOI 10.1006/viro.1997.8543; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Wylie SJ, 2002, ARCH VIROL, V147, P1813, DOI 10.1007/s00705-002-0846-y; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yuan C, 1996, PHYTOPATHOLOGY, V86, P698, DOI 10.1094/Phyto-86-698	87	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187883	10.1371/journal.pone.0187883	http://dx.doi.org/10.1371/journal.pone.0187883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155849	gold, Green Published, Green Submitted			2022-12-27	WOS:000415756700019
J	Guendisch, U; Weiss, J; Ecoeur, F; Riker, JC; Kaupmann, K; Kallen, J; Hintermann, S; Orain, D; Dawson, J; Billich, A; Guntermann, C				Guendisch, Ulf; Weiss, Jessica; Ecoeur, Florence; Riker, Julia Christina; Kaupmann, Klemens; Kallen, Joerg; Hintermann, Samuel; Orain, David; Dawson, Janet; Billich, Andreas; Guntermann, Christine			Pharmacological inhibition of ROR gamma t suppresses the Th17 pathway and alleviates arthritis in vivo	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CYTOKINE GM-CSF; CELL-DIFFERENTIATION; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; RECEPTOR-GAMMA; T(H)17 CELLS; MICE; INFLAMMATION; INDUCTION	Retinoic acid receptor-related-orphan-receptor-C (ROR gamma t) is the key transcription factor that is driving the differentiation of IL-17 producing T-helper 17 (Th17) cells that are implicated in the pathology of various autoimmune and inflammatory diseases. Based on the importance of ROR gamma t in promoting Th17-driven pathology, there is considerable interest to develop low-molecular-weight compounds with the aim of inhibiting the transcriptional activity of this nuclear hormone receptor. In this article, we describe the in vitro and in vivo pharmacology of a potent and selective small-molecular-weight ROR gamma t inverse agonist. The compound binds to the ligand binding domain (LBD) of ROR gamma t leading to displacement of a co-activator peptide. We show for the first time that a ROR gamma t inverse agonist down-regulates permissive histone H3 acetylation and methylation at the IL17A and IL23R promoter regions, thereby providing insight into the transcriptional inhibition of ROR gamma t-dependent genes. Consistent with this, the compound effectively reduced IL-17A production by polarized human T-cells and gamma delta T-cells and attenuated transcription of ROR gamma t target genes. The inhibitor showed good in vivo efficacy in an antigen-induced arthritis model in rats and reduced the frequencies of IL-17A producing cells in ex vivo recall assays. In summary, we demonstrate that inhibiting ROR gamma t by a low-molecular-weight inhibitor results in efficient and selective blockade of the pro-inflammatory Th17/IL-17A pathway making it an attractive target for Th17-mediated disorders.	[Guendisch, Ulf; Weiss, Jessica; Ecoeur, Florence; Riker, Julia Christina; Kaupmann, Klemens; Dawson, Janet; Billich, Andreas; Guntermann, Christine] Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland; [Kallen, Joerg] Novartis Inst BioMed Res, Chem Biol & Therapeut, Basel, Switzerland; [Hintermann, Samuel; Orain, David] Novartis Inst BioMed Res, Global Discovery Chem, Basel, Switzerland	Novartis; Novartis; Novartis	Guntermann, C (corresponding author), Novartis Inst BioMed Res, Autoimmun Transplantat & Inflammat, Basel, Switzerland.	christine.guntermann@novartis.com		Kaupmann, Klemens/0000-0001-8903-2508; Dawson, Janet/0000-0003-4615-4091	NIBR	NIBR	NIBR provided support in the form of salaries to all authors (UG, JW, FE, JCR, KK, JK, SH, DO, JD, AB, CG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Baek SY, 2014, ACTA PHARMACOL SIN, V35, P1177, DOI 10.1038/aps.2014.58; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Banerjee D, 2016, IMMUNOLOGY, V147, P399, DOI 10.1111/imm.12570; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bhattacharya P, 2015, CYTOKINE, V75, P261, DOI 10.1016/j.cyto.2015.05.030; Bhattacharya P, 2015, J INTERF CYTOK RES, V35, P585, DOI 10.1089/jir.2014.0149; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chang MR, 2014, ARTHRITIS RHEUMATOL, V66, P579, DOI 10.1002/art.38272; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cornelissen F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2893; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Cyr P, 2016, BIOORG MED CHEM LETT, V26, P4387, DOI 10.1016/j.bmcl.2016.08.012; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Farooq SM, 2014, J CELL MOL MED, V18, P2512, DOI 10.1111/jcmm.12376; Farooq SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048635; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Guntermann C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91127; Hintermann S, 2016, CHEMMEDCHEM, V11, P2640, DOI 10.1002/cmdc.201600500; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kallen J, 2017, CHEMMEDCHEM, V12, P1014, DOI 10.1002/cmdc.201700278; Kleinewietfeld M, 2013, SEMIN IMMUNOL, V25, P305, DOI 10.1016/j.smim.2013.10.009; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Liljevald M, 2016, AUTOIMMUN REV, V15, P1062, DOI 10.1016/j.autrev.2016.07.036; Luan L, 2014, CELL IMMUNOL, V290, P196, DOI 10.1016/j.cellimm.2014.06.007; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rowin J, 2012, MUSCLE NERVE, V46, P449, DOI 10.1002/mus.23488; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Senisterra GA, 2006, J BIOMOL SCREEN, V11, P940, DOI 10.1177/1087057106294699; SHIMONKEVITZ R, 1993, P NATL ACAD SCI USA, V90, P923, DOI 10.1073/pnas.90.3.923; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Smith SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147979; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sonnenberg GF, 2010, J EXP MED, V207, P1293, DOI 10.1084/jem.20092054; Sutton CE, 2012, EUR J IMMUNOL, V42, P2221, DOI 10.1002/eji.201242569; Ueda E, 2002, CANCER RES, V62, P901; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wang YH, 2014, BIOORGAN MED CHEM, V22, P692, DOI 10.1016/j.bmc.2013.12.021; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wu QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16355; WUCHERPFENNIG KW, 1992, P NATL ACAD SCI USA, V89, P4588, DOI 10.1073/pnas.89.10.4588; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xie HM, 2005, J IMMUNOL, V175, P3800, DOI 10.4049/jimmunol.175.6.3800; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang LL, 2015, INT IMMUNOPHARMACOL, V25, P96, DOI 10.1016/j.intimp.2015.01.014	62	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188391	10.1371/journal.pone.0188391	http://dx.doi.org/10.1371/journal.pone.0188391			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155882	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700054
J	Sotgiu, G; Falzon, D; Hollo, V; Kodmon, C; Lefebvre, N; Dadu, A; van der Werf, M				Sotgiu, Giovanni; Falzon, Dennis; Hollo, Vahur; Kodmon, Csaba; Lefebvre, Nicolas; Dadu, Andrei; van der Werf, Marieke			Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014	PLOS ONE			English	Article							EXTRA-PULMONARY TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; UNITED-STATES; EPIDEMIOLOGY; REGION; UNION; RISK; ERA	Background We explored host-related factors associated with the site of tuberculosis (TB) disease using variables routinely collected by the 31 EU/EEA countries for national surveillance. Methods Logistic regression models were fitted to case-based surveillance data reported to the European Centre for Disease Prevention and Control for TB cases notified from 2003 to 2014. Missing data on HIV infection and on susceptibility to isoniazid and rifampicin for many patients precluded the inclusion of these variables in the analysis. Records from Finland, Lithuania, Spain and the United Kingdom were excluded for lack of exact details of disease localisation; other records without one or more variable (e.g. previous treatment history, geographical origin) or who had mixed pulmonary and extrapulmonary disease or more than one form of extrapulmonary disease were also removed (total exclusion = 38% of 913,637 notifications). Results 564,916 TB cases reported by 27 EU/EEA countries had exclusive pulmonary (PTB; 83%) or extrapulmonary (EPTB; 17%) disease. EPTB was associated with age <15 years (aOR: 5.50), female sex (aOR: 1.60), no previous TB treatment (aOR: 3.10), and geographic origin (aOR range: 0.52-3.74). Origin from the Indian subcontinent or Africa was most strongly associated with lymphatic, osteo-articular and peritoneal/digestive localization (aOR>3.7), and age <15 years with lymphatic (aOR: 17.96) and central nervous system disease (aOR: 11.41). Conclusions Awareness of host-related determinants of site of TB is useful for diagnosis. The predilection for EPTB among patients originating from countries outside Europe may reflect strain preferences for disease localization, geographic/ethnic differences in disease manifestation and other factors, like HIV.	[Sotgiu, Giovanni] Univ Sassari, Clin Epidemiol & Med Stat Unit, Med Educ & Profess Dev Unit, Dept Biomed Sci, Sassari, Italy; [Falzon, Dennis] WHO, Global TB Programme, Geneva, Switzerland; [Hollo, Vahur; Kodmon, Csaba; van der Werf, Marieke] European Ctr Dis Prevent & Control ECDC, Stockholm, Sweden; [Lefebvre, Nicolas] CHU Strasbourg, Strasbourg, France; [Dadu, Andrei] WHO, Reg Off Europe, Copenhagen, Denmark	University of Sassari; World Health Organization; European Centre for Disease Prevention & Control; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; World Health Organization	Sotgiu, G (corresponding author), Univ Sassari, Clin Epidemiol & Med Stat Unit, Med Educ & Profess Dev Unit, Dept Biomed Sci, Sassari, Italy.	gsotgiu@uniss.it	Sotgiu, Giovanni/N-1032-2017; Ködmön, Csaba/AAP-8247-2021	Sotgiu, Giovanni/0000-0002-1600-4474; Ködmön, Csaba/0000-0001-8040-6753; DADU, Andrei/0000-0002-3080-8321	USAID	USAID(United States Agency for International Development (USAID))	The study described in this paper was done in the normal course of work and did not benefit from any ad hoc financing. USAID was a principal salary supporter of the WHO co-author involved in this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada H, 2014, INT J TUBERC LUNG D, V18, P1516, DOI 10.5588/ijtld.14.0319; [Anonymous], 2016, TUB SURV MON EUR 201; Beek LAMT, 2006, EMERG INFECT DIS, V12, P1375, DOI 10.3201/eid1209.050553; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Cobat A, 2013, PUBLIC HEALTH GENOM, V16, P44, DOI 10.1159/000341499; FARER LS, 1979, AM J EPIDEMIOL, V109, P205, DOI 10.1093/oxfordjournals.aje.a112675; Forssbohm M, 2008, EUR RESPIR J, V31, P99, DOI 10.1183/09031936.00020607; Fortun J, 2014, INT J TUBERC LUNG D, V18, P478, DOI 10.5588/ijtld.13.0555; Fox GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099496; Horne DJ, EXTRAPULMONARY TUBER; Kamboj M, 2006, CLIN INFECT DIS, V42, P1592, DOI 10.1086/503917; Lin CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063936; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; MEHTA JB, 1991, CHEST, V99, P1134, DOI 10.1378/chest.99.5.1134; Mokrousov I, 2015, TUBERCULOSIS, V95, pS167, DOI 10.1016/j.tube.2015.02.031; Mor Z, 2013, INT J TUBERC LUNG D, V17, P229, DOI 10.5588/ijtld.12.0375; Musellim B, 2005, INT J TUBERC LUNG D, V9, P1220; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Noertjojo K, 2002, INT J TUBERC LUNG D, V6, P879; Padberg I, 2015, INT J TUBERC LUNG D, V19, P723, DOI 10.5588/ijtld.14.0735; Perez-Guzman C, 2014, SALUD PUBLICA MEXICO, V56, P189; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559; Quddus M A, 2014, Mymensingh Med J, V23, P758; *R PROJ, 2013, R LANG ENV STAT COMP; Reed MB, 2009, J CLIN MICROBIOL, V47, P1119, DOI 10.1128/JCM.02142-08; Rieder HL, 1996, EUR RESPIR J, V9, P1097, DOI 10.1183/09031936.96.09051097; Sandgren A, 2013, EUROSURVEILLANCE, P183; Schwoebel V, 2000, EUR RESPIR J, V16, P364, DOI 10.1034/j.1399-3003.2000.16b28.x; Solovic I, 2013, EUROSURVEILLANCE, V18, P34; Sotgiu G, 2014, INT J TUBERC LUNG D, V18, P1389, DOI 10.5588/ijtld.14.0569; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Veen J, 2011, EUR RESPIR J, V37, P950, DOI 10.1183/09031936.00019410; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; Wilberschied L A, 1999, J Immigr Health, V1, P65, DOI 10.1023/A:1021828321167; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yang JH, 2014, TUBERCULOSIS, V94, P657, DOI 10.1016/j.tube.2014.08.014; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644	39	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186499	10.1371/journal.pone.0186499	http://dx.doi.org/10.1371/journal.pone.0186499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155819	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700004
J	Xie, LJ; Jiang, L; Yang, ZG; Shi, K; Xu, HY; Li, R; Diao, KY; Guo, YK				Xie, Lin-jun; Jiang, Li; Yang, Zhi-gang; Shi, Ke; Xu, Hua-yan; Li, Rui; Diao, Kai-yue; Guo, Ying-kun			Assessment of transposition of the great arteries associated with multiple malformations using dual-source computed tomography	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SURGERY; ANGIOGRAPHY; CT	Purpose To determine the value of dual-source computed tomography (DSCT) in depicting the morphological characteristics and diagnosing the associated malformations for patients with transposition of the great arteries (TGA) before surgery. Materials and methods Twenty-five patients with TGA who underwent DSCT and transthoracic echocardiography (TTE) examination were retrospectively reviewed. The morphological types of TGA, the spatial relationship between the pulmonary artery and the aorta, as well as coronary arteryassociated abnormalities were assessed by DSCT. In contrast to TTE, the diagnostic accuracy of associated malformations on DSCT were analyzed and calculated with reference to surgical or digital subtraction angiography (DSA) findings. Effective doses (EDs) were also calculated. Results Among the 25 patients, 12 (48%) had ventricular septal defects and left ventricular outflow tract stenosis. Sixteen patients (16/25, 64%) had great arteries with an oblique spatial relationship on DSCT. In addition, we found seven patients (7/25, 28%) with coronary artery malformation, including five with an abnormal coronary origin and two with signs of a myocardial bridge. According to DSA or surgical findings, DSCT was superior to TTE in demonstrating extracardiac anomalies (sensitivity, anomalies of great vessels: 100% vs. 93.33%, other anomalies: 100% vs. 46.15%). The mean estimated ED for those aged < 10 years was < 2 mSv (1.59 +/- 0.95 mSv). Conclusions DSCT can achieve an overall assessment of patients with TGA, including any associated malformations as well as the identification of the spatial relationship of the great arteries. DSCT can therefore be considered as an alternative imaging modality for surgical decision making.	[Xie, Lin-jun; Jiang, Li; Yang, Zhi-gang; Shi, Ke; Xu, Hua-yan; Li, Rui; Diao, Kai-yue] Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China; [Xie, Lin-jun; Guo, Ying-kun] Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Radiol,Key Lab Obstet & Gynecol & Pediat Dis, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Yang, ZG (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, Chengdu, Sichuan, Peoples R China.; Guo, YK (corresponding author), Sichuan Univ, West China Univ Hosp 2, Minist Educ, Dept Radiol,Key Lab Obstet & Gynecol & Pediat Dis, Chengdu, Sichuan, Peoples R China.	yangzg666@163.com; gykpanda@163.com			National Key Research and Development Program of China [2016YFC1300300]; Program for New Century Excellent Talents in University [NCET-13-0386]; Program for Young Scholars and Innovative Research Team in Sichuan Province of China [2017TD0005]	National Key Research and Development Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Young Scholars and Innovative Research Team in Sichuan Province of China	This work was supported by the National Key Research and Development Program of China (2016YFC1300300 to YKG), Program for New Century Excellent Talents in University (No: NCET-13-0386 to YKG), and Program for Young Scholars and Innovative Research Team in Sichuan Province (2017TD0005 to YKG) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2017, EUR RADIOL, V27, P660, DOI 10.1007/s00330-016-4411-6; Files MD, 2015, SEMIN CARDIOTHORAC V, V19, P210, DOI 10.1177/1089253215581851; Groves DW, 2017, INT J CARDIOL, V228, P180, DOI 10.1016/j.ijcard.2016.11.108; Ihlenburg S, 2014, THORAC CARDIOV SURG, V62, P203, DOI 10.1055/s-0033-1349791; Iriart X, 2012, ARCH CARDIOVASC DIS, V105, P432, DOI 10.1016/j.acvd.2012.05.005; Jaggers JJ, 2000, ANN THORAC SURG, V69, P1282; Jia QJ, 2017, EUR J RADIOL, V86, P190, DOI 10.1016/j.ejrad.2016.10.017; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Limperopoulos C, 2010, CIRCULATION, V121, P26, DOI 10.1161/CIRCULATIONAHA.109.865568; Liu X, 2016, EUR J RADIOL, V85, P1601, DOI 10.1016/j.ejrad.2016.06.012; Nie P, 2012, EUR RADIOL, V22, P2057, DOI 10.1007/s00330-012-2479-1; Ou P, 2008, JACC-CARDIOVASC IMAG, V1, P331, DOI 10.1016/j.jcmg.2008.02.005; Owen M, 2011, J CHILD NEUROL, V26, P743, DOI 10.1177/0883073811402073; Schallert EK, 2013, RADIOGRAPHICS, V33, pE33, DOI 10.1148/rg.332125086; Schidlow DN, 2017, J AM COLL CARDIOL, V69, P43, DOI 10.1016/j.jacc.2016.10.051; Shi K, 2017, INT J CARDIOL, V228, P80, DOI 10.1016/j.ijcard.2016.11.169; Sithamparanathan S, 2013, JACC-CARDIOVASC IMAG, V6, P624, DOI 10.1016/j.jcmg.2012.10.027; Squarcia U, 2011, CURR OPIN PEDIATR, V23, P518, DOI 10.1097/MOP.0b013e32834aa551; Thadani SR, 2015, ECHOCARDIOGR-J CARD, V32, P157; Villafane J, 2014, J AM COLL CARDIOL, V64, P498, DOI 10.1016/j.jacc.2014.06.1150; Warnes CA, 2006, CIRCULATION, V114, P2699, DOI 10.1161/CIRCULATIONAHA.105.592352; Warnes CA, 2008, J AM COLL CARDIOL, V52, P1890, DOI 10.1016/j.jacc.2008.10.002; Yacoub M, 2017, J AM COLL CARDIOL, V69, P52, DOI 10.1016/j.jacc.2016.10.050	24	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187578	10.1371/journal.pone.0187578	http://dx.doi.org/10.1371/journal.pone.0187578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155835	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700012
J	Ghoubay-Benallaoua, D; de Sousa, C; Martos, R; Latour, G; Schanne-Klein, MC; Dupin, E; Borderie, V				Ghoubay-Benallaoua, Djida; de Sousa, Celine; Martos, Raphael; Latour, Gael; Schanne-Klein, Marie-Claire; Dupin, Elisabeth; Borderie, Vincent			Easy xeno-free and feeder-free method for isolating and growing limbal stromal and epithelial stem cells of the human cornea	PLOS ONE			English	Article							NEURAL CREST DERIVATIVES; CULTURE-CONDITIONS; PROGENITOR CELLS; TRANSPLANTATION; TISSUE; PAX6; EXPRESSION; THERAPY; NICHE	Epithelial and stromal stem cells are required to maintain corneal transparency. The aim of the study was to develop a new method to isolate and grow both corneal stromal (SSC) and epithelial limbal (LSC) stem cells from small human limbal biopsies under culture conditions in accordance with safety requirements mandatory for clinical use in humans. Superficial limbal explants were retrieved from human donor corneo-scleral rims. Human limbal cells were dissociated by digestion with collagenase A, either after epithelial scraping or with no scraping. Isolated cells were cultured with Essential 8 medium (E8), E8 supplemented with EGF (E8+) or Green's medium with 3T3 feeder-layers. Cells were characterized by immunostaining, RT-qPCR, colony forming efficiency, sphere formation, population doubling, second harmonic generation microscopy and differentiation potentials. LSC were obtained from unscraped explants in E8, E8+ and Green's media and were characterized by colony formation and expression of PAX6, Delta NP63 alpha, Bmi1, ABCG2, SOX9, CK14, CK15 and vimentin, with a few cells positive for CK3. LSC underwent 28 population doublings still forming colonies. SSC were obtained from both scraped and unscraped explants in E8 and E8+ media and were characterized by sphere formation, expression of PAX6, SOX2, BMI1, NESTIN, ABCG2, KERATOCAN, VIMENTIN, SOX9, SOX10 and HNK1, production of collagen fibrils and differentiation into keratocytes, fibroblasts, myofibroblasts, neurons, adipocytes, chondrocytes and osteocytes. SSC underwent 48 population doublings still forming spheres, Thus, this new method allows both SSC and LSC to be isolated from small superficial limbal biopsies and to be primary cultured in feeder-free and xeno-free conditions, which will be useful for clinical purposes.	[Ghoubay-Benallaoua, Djida; Martos, Raphael; Dupin, Elisabeth; Borderie, Vincent] UPMC Univ Paris 06, CNRS, UMR 7210, Inst Vis,Sorbonne Univ,INSERM, Paris, France; [Ghoubay-Benallaoua, Djida; Borderie, Vincent] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [de Sousa, Celine] Etab Francais Sang Ile France, Paris, France; [Latour, Gael] Univ Paris Saclay, Univ Paris Sud, Lab Imagerie & Modelisat Neurobiol & Cancerol, CNRS, Orsay, France; [Schanne-Klein, Marie-Claire] Univ Paris Saclay, INSERM, CNRS, Lab Opt & Biosci,U1182,Ecole Polytech, Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Ghoubay-Benallaoua, D (corresponding author), UPMC Univ Paris 06, CNRS, UMR 7210, Inst Vis,Sorbonne Univ,INSERM, Paris, France.; Ghoubay-Benallaoua, D (corresponding author), Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.	djida.ghoubay@inserm.fr	Latour, Gaël/R-6629-2017; Schanne-Klein, Marie-Claire/E-6490-2011; Borderie, Vincent/AAT-1092-2021; Ghoubay, Djida/AAE-3971-2022; Dupin, Elisabeth/X-8757-2019	Latour, Gaël/0000-0002-6244-6556; Schanne-Klein, Marie-Claire/0000-0003-3026-8932; Borderie, Vincent/0000-0002-1395-8483; MARTOS, Raphael/0000-0002-0228-9229; Ghoubay-Benallaoua, Djida/0000-0002-2282-5172	Fondation pour la Recherche Medicale [DCM20121225759]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from the "Fondation pour la Recherche Medicale" No.: DCM20121225759 to Vincent Borderie. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors want to thank Dr K. Grieve for the English corrections to the manuscript, S. Fouquet and D. Godefroy for the imaging facility. This work was supported by grants from the "Fondation pour la Recherche Medicale" No.: DCM20121225759	Basu S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009644; Behaegel J, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6978253; Borderie VM, 1998, BRIT J OPHTHALMOL, V82, P382, DOI 10.1136/bjo.82.4.382; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.tec.2010.0609, 10.1089/ten.TEC.2010.0609]; Cheng J, 2013, OPHTHALMOLOGY, V120, P34, DOI 10.1016/j.ophtha.2012.07.037; Creuzet S, 2005, J ANAT, V207, P447, DOI 10.1111/j.1469-7580.2005.00485.x; Creuzet S, 2005, INT J DEV BIOL, V49, P161, DOI 10.1387/ijdb.041937sc; Davies SB, 2010, STEM CELLS DEV, V19, P1651, DOI 10.1089/scd.2010.0201; Di Iorio E, 2010, OCUL SURF, V8, P146, DOI 10.1016/S1542-0124(12)70225-2; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Du YQ, 2009, STEM CELLS, V27, P1635, DOI 10.1002/stem.91; Dziasko MA, 2016, OCUL SURF, V14, P322, DOI 10.1016/j.jtos.2016.04.002; Funderburgh ML, 2005, FASEB J, V19, P1371, DOI 10.1096/fj.04-2770fje; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Ghoubay-Benallaoua D, 2011, MOL VIS, V17, P341; Ghoubay-Benallaoua D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081965; Ghoubay-Benallaoua D, 2012, CURR EYE RES, V37, P644, DOI 10.3109/02713683.2012.669510; Gisoldi RAMC, 2010, CORNEA, V29, P715, DOI 10.1097/ICO.0b013e3181c91ac4; Grieve K, 2015, EXP EYE RES, V140, P75, DOI 10.1016/j.exer.2015.08.003; Gruenauer-Kloevekorn C, 2009, GRAEF ARCH CLIN EXP, V247, P93, DOI 10.1007/s00417-008-0931-3; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Kureshi AK, 2014, INVEST OPHTH VIS SCI, V55, P7583, DOI 10.1167/iovs.14-14448; Latour G, 2012, BIOMED OPT EXPRESS, V3, P1, DOI 10.1364/BOE.3.000001; Levis HJ, 2016, CURR EYE RES, V41, P1153, DOI 10.3109/02713683.2015.1095932; Li G, 2015, J BIOL CHEM, V290, P20448, DOI 10.1074/jbc.M115.662940; Li HY, 2015, TISSUE CELL, V47, P39, DOI 10.1016/j.tice.2014.10.008; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Lwigale PY, 2005, DEV BIOL, V288, P284, DOI 10.1016/j.ydbio.2005.09.046; Matthyssen S, 2017, INVEST OPHTH VIS SCI, V58, P2659, DOI 10.1167/iovs.17-21676; Na KS, 2015, OPHTHALMIC RES, V53, P217, DOI 10.1159/000375110; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nieto-Nicolau N, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3032128; Pavone F. S., 2013, 2 HARMONIC GENERATIO; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reichman S, 2017, STEM CELLS, V35, P1176, DOI 10.1002/stem.2586; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; Stasi K, 2014, INVEST OPHTH VIS SCI, V55, P375, DOI 10.1167/iovs.13-12517; Thanos M, 2010, CORNEA, V29, P462, DOI 10.1097/ICO.0b013e3181b442ea; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Tidu A, 2015, ACTA BIOMATER, V22, P50, DOI 10.1016/j.actbio.2015.04.018; Uchida S, 2005, INVEST OPHTH VIS SCI, V46, P1620, DOI 10.1167/iovs.04-0288; Varghese VM, 2010, MICROSC RES TECHNIQ, V73, P1045, DOI 10.1002/jemt.20831; WARING GO, 1982, OPHTHALMOLOGY, V89, P531; Wu J, 2014, EXP EYE RES, V120, P71, DOI 10.1016/j.exer.2014.01.005; Wu J, 2013, TISSUE ENG PT A, V19, P2063, DOI [10.1089/ten.TEA.2012.0545, 10.1089/ten.tea.2012.0545]; Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zakaria N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-58; Zhang JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117089; Zhao Y, 2015, CORNEA, V34, P592, DOI 10.1097/ICO.0000000000000398	57	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188398	10.1371/journal.pone.0188398	http://dx.doi.org/10.1371/journal.pone.0188398			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149196	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100042
J	Kar, SK; Jansman, AJM; Benis, N; Ramiro-Garcia, J; Schokker, D; Kruijt, L; Stolte, EH; Taverne-Thiele, JJ; Smits, MA; Wells, JM				Kar, Soumya K.; Jansman, Alfons J. M.; Benis, Nirupama; Ramiro-Garcia, Javier; Schokker, Dirkjan; Kruijt, Leo; Stolte, Ellen H.; Taverne-Thiele, Johanna J.; Smits, Mari A.; Wells, Jerry M.			Dietary protein sources differentially affect microbiota, mTOR activity and transcription of mTOR signaling pathways in the small intestine	PLOS ONE			English	Article							CELL; RECOGNITION; ACTIVATION; PROTECTION; CYTOSCAPE; PLASMA	Dietary protein sources can have profound effects on host-microbe interactions in the gut that are critically important for immune resilience. However more knowledge is needed to assess the impact of different protein sources on gut and animal health. Thirty-six wildtype male C57BL/6J mice of 35 d age (n = 6/group; mean +/- SEM body weight 21.9 +/- 0.25 g) were randomly assigned to groups fed for four weeks with semi synthetic diets prepared with one of the following protein sources containing (300 g/kg as fed basis): soybean meal (SBM), casein, partially delactosed whey powder, spray dried plasma protein, wheat gluten meal and yellow meal worm. At the end of the experiment, mice were sacrificed to collect ileal tissue to acquire gene expression data, and mammalian (mechanistic) target of rapamycin (mTOR) activity, ileal digesta to study changes in microbiota and serum to measure cytokines and chemokines. By genome-wide transcriptome analysis, we identified fourteen high level regulatory genes that are strongly affected in SBM-fed mice compared to the other experimental groups. They mostly related to the mTOR pathway. In addition, an increased (P < 0.05) concentration of granulocyte colony-stimulating factor was observed in serum of SBM-fed mice compared to other dietary groups. Moreover, by 16S rRNA sequencing, we observed that SBM-fed mice had higher (P < 0.05) abundances of Bacteroidales family S24-7, compared to the other dietary groups. We showed that measurements of genome-wide expression and microbiota composition in the mouse ileum reveal divergent responses to diets containing different protein sources, in particular for a diet based on SBM.	[Kar, Soumya K.; Benis, Nirupama; Stolte, Ellen H.; Taverne-Thiele, Johanna J.; Smits, Mari A.; Wells, Jerry M.] Wageningen Univ & Res, Host Microbe Interact Grp, Wageningen, Netherlands; [Kar, Soumya K.; Benis, Nirupama; Schokker, Dirkjan; Kruijt, Leo; Smits, Mari A.] Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands; [Kar, Soumya K.; Jansman, Alfons J. M.; Benis, Nirupama; Schokker, Dirkjan; Kruijt, Leo; Smits, Mari A.] Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Top Inst Food & Nutr, Wageningen, Netherlands; [Ramiro-Garcia, Javier] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Smits, Mari A.] Wageningen Univ & Res, Wageningen Biovet Res, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kar, SK (corresponding author), Wageningen Univ & Res, Host Microbe Interact Grp, Wageningen, Netherlands.; Kar, SK (corresponding author), Wageningen Univ & Res, Anim Breeding & Genom Ctr, Wageningen, Netherlands.; Kar, SK (corresponding author), Wageningen Univ & Res, Wageningen Livestock Res, Wageningen, Netherlands.	soumya.kar@wur.nl	Ramiro-Garcia, Javier/ABA-6236-2020; Kar, Soumya/AAQ-1711-2021; Schokker, Dirkjan/AAB-2668-2020	Ramiro-Garcia, Javier/0000-0003-3896-3833; Kar, Soumya/0000-0002-7892-9034; Schokker, Dirkjan/0000-0001-6082-7227	IPOP Customized Nutrition [4417801270]; Dutch Ministry of Economic Affairs; Nutreco; Darling Ingredients Inc.	IPOP Customized Nutrition; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Nutreco; Darling Ingredients Inc.	This work was supported by Grant number: 4417801270 IPOP Customized Nutrition (http://www.wageningenur.nl/Onderzoek-Resultaten/Projecten-EZ/Expertisegebieden/Kennisbasis-onderzoeka/Afgaronde- projecten-KB/Gezond-en-veilig-voedsel-in-ketenperspectief/IPOPcustomized-nutrition-3.htm); Funding Institutes: 1. the Dutch Ministry of Economic Affairs (http://www.wageningenur.nl/nl/project/IPOP-Customized-nutrition-5.htm); 2. Nutreco (http://www.nutreco.com/); 3. Darling Ingredients Inc. (https://www.darlingii.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettini ML, 2014, J IMMUNOL, V193, P258, DOI 10.4049/jimmunol.1400322; Boding L, 2010, MOL IMMUNOL, V47, P2450, DOI 10.1016/j.molimm.2010.06.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capper J, 2013, 53 CAST; Chaimowitz NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060640; Chobert Jean-Marc, 2003, Adv Food Nutr Res, V47, P1, DOI 10.1016/S1043-4526(03)47001-0; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Fujiwara D, 2011, AM J PHYSIOL-GASTR L, V300, pG939, DOI 10.1152/ajpgi.00032.2010; Funkat A, 2004, J NUTR, V134, P3264, DOI 10.1093/jn/134.12.3264; Gao YY, 2011, J ANIM SCI, V89, P150, DOI 10.2527/jas.2010-2967; Germena G, 2015, J IMMUNOL, V194, P728, DOI 10.4049/jimmunol.1401646; Ghaly A.E., 2009, American Journal of Agricultural and Biological Sciences, V4, P319; Gilbert R, 2004, WORLD ANIMAL FEED IN; Haks MC, 2002, J EXP MED, V196, P1, DOI 10.1084/jem.20020268; Hall WL, 2003, BRIT J NUTR, V89, P239, DOI 10.1079/BJN2002760; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Hernandez-Ledesma B, 2011, ADV COLLOID INTERFAC, V165, P23, DOI 10.1016/j.cis.2010.11.001; Heuze A V, 2016, FEEDIPEDIA PROGRAMME; Jahan-Mihan A, 2011, NUTRIENTS, V3, P574, DOI 10.3390/nu3050574; Kar SK, 2016, J ANIM SCI, V94, P30, DOI 10.2527/jas.2015-9677; Karr-Lilienthal LK, 2005, LIVEST PROD SCI, V97, P1, DOI 10.1016/j.livprodsci.2005.01.015; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Lee CY, 2013, CLIN TRANSLATIONAL G; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Madureira AR, 2007, FOOD RES INT, V40, P1197, DOI 10.1016/j.foodres.2007.07.005; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Ni Gabhann J, 2014, PLOS ONE, V9; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Pingitore A, 2015, NUTRITION, V31, P916, DOI 10.1016/j.nut.2015.02.005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RAMIROGARCIA J, 2016, F1000RESEARCH, V5; Ruth MR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-27; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siggs OM, 2015, J IMMUNOL, V194, P2587, DOI 10.4049/jimmunol.1400326; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Loeff IS, 2014, J IMMUNOL, V193, P2873, DOI 10.4049/jimmunol.1400858; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; van Neerven RJJ, 2012, J ALLERGY CLIN IMMUN, V130, P853, DOI 10.1016/j.jaci.2012.06.050; Wager CML, 2014, J IMMUNOL, V193, P4060, DOI 10.4049/jimmunol.1400318; Wang XM, 2014, J EXP MED, V211, P2351, DOI 10.1084/jem.20140646; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901	50	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188282	10.1371/journal.pone.0188282	http://dx.doi.org/10.1371/journal.pone.0188282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149221	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100035
J	Lasa, R; Tadeo, E; Toledo-Hernandez, RA; Carmona, L; Lima, I; Williams, T				Lasa, Rodrigo; Tadeo, Eduardo; Toledo-Hernandez, Ricardo A.; Carmona, Lino; Lima, Itzel; Williams, Trevor			Improved capture of Drosophila suzukii by a trap baited with two attractants in the same device	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; MATSUMURA DIPTERA DROSOPHILIDAE; UNITED-STATES; PEST-MANAGEMENT; ACETIC-ACID; PARASITOIDS; INVASION; COMBINATIONS; INFESTATION; RASPBERRIES	The improvement of trap-lure combinations is an important part of integrated pest management programs that involve monitoring pests for timely insecticide applications, or for their use in control strategies such as mass trapping or bait stations. In this study improvements in the capture of Drosophila suzukii were not observed following the inclusion of different color stimuli with respect to a red-black stripe cup trap. This red-black stripe trap with a hemispherical dome-shaped lid had a significantly improved physical retention of flies compared to traps fitted with a flat lid. Retention was further improved when an additional tube device, which could be baited with a supplemental attractant, was introduced through the dome-shaped lid. Under laboratory conditions, this trap, in which apple cider vinegar + 10% ethanol was present as the drowning solution and the additional tube device was baited with a fermenting mixture of sugar and yeast, was significantly more effective in catching D. suzukii flies than other conventional attractants or a commercial lure. The capture rate of this traplure combination remained higher than that of a commercial lure, even after 20 days of use under laboratory conditions. In a guava orchard this trap was 15-fold more effective in catching D. suzukii flies than similar traps baited with apple cider vinegar alone, 4 to 7 fold more effective than similar traps baited with a commercial lure, and 1.7-fold more effective than a fermenting mixture of yeasts and wheat flour. In commercial blackberry orchards, this trap was 6-fold more effective in trapping D. suzukii flies than the clear trap baited with apple cider vinegar used by growers. The efficacy of this trap presents a promising line of future research for monitoring and control of D. suzukii and likely other drosophilid pests.	[Lasa, Rodrigo; Tadeo, Eduardo; Carmona, Lino; Lima, Itzel; Williams, Trevor] Inst Ecol AC, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico; [Toledo-Hernandez, Ricardo A.] Driscolls, Dept Invest Aplicada, Zapopan, Jalisco, Mexico	Instituto de Ecologia - Mexico	Lasa, R (corresponding author), Inst Ecol AC, Red Manejo Biorrac Plagas & Vectores, Xalapa, Veracruz, Mexico.	rodrilasa@gmail.com	Williams, Trevor/ABG-3961-2020; Williams, Trevor/F-1447-2011; Tadeo, Eduardo/AAG-2671-2020; Lasa, Rodrigo/Q-6288-2018	Williams, Trevor/0000-0003-3414-3440; Tadeo, Eduardo/0000-0003-4293-6731; Lasa, Rodrigo/0000-0003-1175-7538	Mexican National Science and Technology Council (CONACyT) [1028]	Mexican National Science and Technology Council (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	One of the authors (RATH) is an employee of Driscoll's, Zapopan, Mexico. Driscoll's had no part in funding this study. The study was funded by the Mexican National Science and Technology Council (CONACyT) project number 1028 (Problemas Nacionales, Convocatoria 2015) granted to RL. The funder provided support in the form of a student stipend for one author [LC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Basoalto E, 2013, J APPL ENTOMOL, V137, P561, DOI 10.1111/jen.12053; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; Burrack HJ, 2015, ENVIRON ENTOMOL, V44, P704, DOI 10.1093/ee/nvv022; Carroll J., 2016, SPOTTED WING DROSOPH; Cini A, 2012, B INSECTOL, V65, P149; Cohnstaedt LW, 2012, ANN ENTOMOL SOC AM, V105, P135, DOI 10.1603/AN11127; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; eFly SWD Working Group, 2012, SPOTT WING DROS IMP; Epsky ND, 2014, FLA ENTOMOL, V97, P85, DOI 10.1653/024.097.0111; Frewin AJ, 2017, J ECON ENTOMOL, V110, P1156, DOI 10.1093/jee/tox081; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Hamby KA, 2016, J PEST SCI, V89, P605, DOI 10.1007/s10340-016-0756-5; Hamby KA, 2016, J PEST SCI, V89, P621, DOI 10.1007/s10340-016-0768-1; Hamby KA, 2012, APPL ENVIRON MICROB, V78, P4869, DOI 10.1128/AEM.00841-12; Hampton E, 2014, J ECON ENTOMOL, V107, P1849, DOI 10.1603/EC14232; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; Iglesias LE, 2014, J ECON ENTOMOL, V107, P1508, DOI 10.1603/EC13538; Landolt PJ, 2012, J APPL ENTOMOL, V136, P148, DOI 10.1111/j.1439-0418.2011.01646.x; Lasa R, 2017, ENTOMOL EXP APPL, V162, P4, DOI 10.1111/eea.12519; Lebreton S, 2012, J INSECT PHYSIOL, V58, P125, DOI 10.1016/j.jinsphys.2011.10.009; Lee JC, 2012, J ECON ENTOMOL, V105, P1350, DOI 10.1603/EC12132; Lee JC, 2013, ENVIRON ENTOMOL, V48, P2; Marcus M., 2014, THESIS; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Mazzetto F, 2016, J PEST SCI, V89, P783, DOI 10.1007/s10340-016-0754-7; Mazzetto F, 2016, J PEST SCI, V89, P837, DOI 10.1007/s10340-016-0746-7; Renkema JM, 2014, J ECON ENTOMOL, V107, P2107, DOI 10.1603/EC14254; SAGARPA-SENASICA, 2014, MAN MAN FIT MOSC VIN; Santo Ramos M. de los, 2014, Journal of Food, Agriculture & Environment, V12, P349; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Wang XG, 2016, J PEST SCI, V89, P701, DOI 10.1007/s10340-016-0747-6; Wang XG, 2016, BIOL CONTROL, V96, P64, DOI 10.1016/j.biocontrol.2016.02.004; Wiman NG, 2016, J PEST SCI, V89, P653, DOI 10.1007/s10340-016-0757-4	39	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188350	10.1371/journal.pone.0188350	http://dx.doi.org/10.1371/journal.pone.0188350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149190	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100039
J	Long, LN; Chen, JS; Zhang, YG; Liang, X; Ni, HJ; Zhang, B; Yin, YL				Long, Lina; Chen, Jiashun; Zhang, Yonggang; Liang, Xiao; Ni, Hengjia; Zhang, Bin; Yin, Yulong			Comparison of porous and nano zinc oxide for replacing high-dose dietary regular zinc oxide in weaning piglets (vol 12, e0182550, 2017)	PLOS ONE			English	Correction																		Long LN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182550	1	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188587	10.1371/journal.pone.0188587	http://dx.doi.org/10.1371/journal.pone.0188587			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149209	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100045
J	Carneiro, SR; Fagundes, MD; do Rosario, PDO; Neves, LMT; Souza, GD; Pinheiro, MDN				Carneiro, Saul Rassy; Fagundes, Marcela de Araujo; Oliveira do Rosario, Pricila de Jesus; Tomazi Neves, Laura Maria; Souza, Givago da Silva; Nascimento Pinheiro, Maria da Conceicao			Five-year survival and associated factors in women treated for cervical cancer at a reference hospital in the Brazilian Amazon	PLOS ONE			English	Article							QUALITY-OF-LIFE; PROGNOSTIC-FACTORS; STAGE; CARCINOMA; TRENDS; IMPACT; STATE	Cervical cancer (CC) is the most common type of cancer in women and is the third leading cause of death in most developing countries, causing more than 288,000 deaths in women worldwide each year. The most favourable survival rate is in developed countries, since CC mortality has recently declined in those countries. The purpose of this study was to determine the survival rate and associated factors of CC patients at a reference hospital in the Amazon region. The patient sample included records of 339 patients with cervical cancer who had been hospitalized in Bele A m, Para A, Brazil from January 2005 to December 2010; the socioeconomic and clinical data were collected between June and September 2016. A survival rate of approximately 84% was observed, and it was found that disease stage (p < 0.01), metastasis (p < 0.01) and readmission (p < 0.01) had significant influences on patient outcome. The impact of these factors on the general survival rate was higher in the Amazon region compared with other regions of Brazil, and the primary survival factors were associated with earlier stages of the disease. However, more national studies are needed on this subject. Our findings may contribute to the development of regional strategies for the prevention of cervical cancer, a reduction in its incidence and mortality rate, an increase in survival time and an improvement in the quality of life of these women.	[Carneiro, Saul Rassy; Fagundes, Marcela de Araujo; Oliveira do Rosario, Pricila de Jesus] Univ Fed Para, Hosp Univ Joao de Barros Barreto, Belem, Para, Brazil; [Carneiro, Saul Rassy; Souza, Givago da Silva; Nascimento Pinheiro, Maria da Conceicao] Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil; [Tomazi Neves, Laura Maria] Univ Fed Para, Fac Fisioterapia & Terapia Ocupac, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Carneiro, SR (corresponding author), Univ Fed Para, Hosp Univ Joao de Barros Barreto, Belem, Para, Brazil.; Carneiro, SR (corresponding author), Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil.	saul@ufpa.br	Souza, Givago/W-6393-2019; Carneiro, Saul/HGV-1549-2022	Souza, Givago/0000-0002-4525-3971; Carneiro, Saul/0000-0002-6825-0239	Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA	Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA	This work was supported by Pro-Reitoria de Pesquisa e Pos-Graduacao - UFPA.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; American Cancer Society, 2016, CERV CANC STAG; Ashing-Giwa KT, 2010, GYNECOL ONCOL, V118, P35, DOI 10.1016/j.ygyno.2010.02.027; Bifulco G, 2012, GYNECOL ONCOL, V124, P444, DOI 10.1016/j.ygyno.2011.11.033; Bustamante-Teixeira Maria Teresa, 2002, Cad. Saúde Pública, V18, P579, DOI 10.1590/S0102-311X2002000300003; Schneider IJC, 2009, CAD SAUDE PUBLICA, V25, P1285, DOI 10.1590/S0102-311X2009000600011; do Carmo CC, 2011, REV SAUDE PUBL, V45, P661, DOI 10.1590/S0034-89102011005000029; Donze J, 2014, J HOSP MED, V9, P310, DOI 10.1002/jhm.2173; Donze J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7171; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ibfelt EH, 2013, BRIT J CANCER, V109, P2489, DOI 10.1038/bjc.2013.558; Instituto Nacional de Cancer Jose A Alencar Gomes da Silva. INCA D Instituto Nacional de Cancer, 2016, EST 2016; Lee E, 2013, STAT METHODS SURVIVA; Lorin L, 2015, EUR J OBSTET GYN R B, V191, P1, DOI 10.1016/j.ejogrb.2015.04.007; Mendis S, 2014, GLOBAL STATUS REPORT; Nakagawa JT, 2011, ACTA PAUL ENFERM, V24, P631, DOI 10.1590/S0103-21002011000500006; Nowakowski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155849; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Gonzaga CMR, 2013, CAD SAUDE PUBLICA, V29, P599, DOI 10.1590/S0102-311X2013000300017; Rudtanasudjatum K, 2011, INT J GYNECOL OBSTET, V115, P183, DOI 10.1016/j.ijgo.2011.06.011; Sales L., 2015, 14 SALES L MULHERES; Schlichte MJ, 2015, J CLIN MED, V4, P918, DOI 10.3390/jcm4050918; Shrivastava S, 2013, J CANCER RES THER, V9, P672, DOI 10.4103/0973-1482.126480; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Teke F, 2014, ASIAN PAC J CANCER P, V15, P2815, DOI 10.7314/APJCP.2014.15.6.2815; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377	27	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187579	10.1371/journal.pone.0187579	http://dx.doi.org/10.1371/journal.pone.0187579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145414	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800019
J	Davidson, AD; Shoemaker, KT; Weinstein, B; Costa, GC; Brooks, TM; Ceballos, G; Radeloff, VC; Rondinini, C; Graham, CH				Davidson, Ana D.; Shoemaker, Kevin T.; Weinstein, Ben; Costa, Gabriel C.; Brooks, Thomas M.; Ceballos, Gerardo; Radeloff, Volker C.; Rondinini, Carlo; Graham, Catherine H.			Geography of current and future global mammal extinction risk	PLOS ONE			English	Article							NONRANDOM EXTINCTION; RANDOM FORESTS; BODY-SIZE; CLIMATE; CONSERVATION; CLASSIFICATION; BIODIVERSITY; DECLINE; DIVERSITY; PATTERNS	Identifying which species are at greatest risk, what makes them vulnerable, and where they are distributed are central goals for conservation science. While knowledge of which factors influence extinction risk is increasingly available for some taxonomic groups, a deeper understanding of extinction correlates and the geography of risk remains lacking. Here, we develop a predictive random forest model using both geospatial and mammalian species' trait data to uncover the statistical and geographic distributions of extinction correlates. We also explore how this geography of risk may change under a rapidly warming climate. We found distinctive macroecological relationships between species-level risk and extinction correlates, including the intrinsic biological traits of geographic range size, body size and taxonomy, and extrinsic geographic settings such as seasonality, habitat type, land use and human population density. Each extinction correlate exhibited ranges of values that were especially associated with risk, and the importance of different risk factors was not geographically uniform across the globe. We also found that about 10% of mammals not currently recognized as at-risk have biological traits and occur in environments that predispose them towards extinction. Southeast Asia had the most actually and potentially threatened species, underscoring the urgent need for conservation in this region. Additionally, nearly 40% of currently threatened species were predicted to experience rapid climate change at 0.5 km/year or more. Biological and environmental correlates of mammalian extinction risk exhibit distinct statistical and geographic distributions. These results provide insight into species-level patterns and processes underlying geographic variation in extinction risk. They also offer guidance for future conservation research focused on specific geographic regions, or evaluating the degree to which species-level patterns mirror spatial variation in the pressures faced by populations within the ranges of individual species. The added impacts from climate change may increase the susceptibility of at-risk species to extinction and expand the regions where mammals are most vulnerable globally.	[Davidson, Ana D.; Weinstein, Ben; Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Davidson, Ana D.] NatureServe, Arlington, VA 22203 USA; [Shoemaker, Kevin T.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Costa, Gabriel C.] Auburn Univ, Dept Biol, Montgomery, AL 36117 USA; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Brooks, Thomas M.] Univ Philippines Los Banos, World Agroforestry Ctr, Laguna, Philippines; [Brooks, Thomas M.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ceballos, Gerardo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City, DF, Mexico; [Radeloff, Volker C.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Rondinini, Carlo] Sapienza Univ Rome, Dept Biol & Biotechnol, Global Mammal Assessment Program, Rome, Italy; [Graham, Catherine H.] Swiss Fed Res Inst, Unit Biodivers & Conservat, WSL, Birmensdorf, Switzerland; [Davidson, Ana D.] Colorado State Univ, Colorado Nat Heritage Program, Warner Coll Nat Resources, Ft Collins, CO 80523 USA; [Davidson, Ana D.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Warner Coll Nat Resources, Ft Collins, CO 80523 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Nature Conservancy; Nevada System of Higher Education (NSHE); University of Nevada Reno; Auburn University System; Auburn University; CGIAR; World Agroforestry (ICRAF); University of the Philippines System; University of the Philippines Los Banos; University of Tasmania; Universidad Nacional Autonoma de Mexico; University of Wisconsin System; University of Wisconsin Madison; Sapienza University Rome; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Colorado State University; Colorado State University	Davidson, AD (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.; Davidson, AD (corresponding author), NatureServe, Arlington, VA 22203 USA.; Davidson, AD (corresponding author), Colorado State Univ, Colorado Nat Heritage Program, Warner Coll Nat Resources, Ft Collins, CO 80523 USA.; Davidson, AD (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Warner Coll Nat Resources, Ft Collins, CO 80523 USA.	ana.davidson@colostate.edu	Graham, Catherine/A-9560-2011; Rondinini, Carlo/E-9027-2011; Radeloff, Volker C/B-6124-2016	Graham, Catherine/0000-0001-9267-7948; Radeloff, Volker C/0000-0001-9004-221X; Rondinini, Carlo/0000-0002-6617-018X; Davidson, Ana/0000-0003-4701-5923	National Science Foundation's Dimensions of Biodiversity program [DEB-1136586]; NSF [DEB-1136586, DEB-1146198]; CNPq [302776/2012-5, 563352/2010-8]; CAPES/Science without Borders grant [PVE 018/2012]; NASA Biodiversity Program	National Science Foundation's Dimensions of Biodiversity program(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF(National Science Foundation (NSF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Science without Borders grant; NASA Biodiversity Program(National Aeronautics & Space Administration (NASA))	Our research was funded by the National Science Foundation's Dimensions of Biodiversity program (grant DEB-1136586). ADD, BW, and CHG were supported by NSF grant DEB-1136586, and KTS was supported by NSF grant DEB-1146198. GCC was supported by CNPq grants 302776/2012-5 and 563352/2010-8. GCC, CHG., and ADD were also supported by CAPES/Science without Borders grant PVE 018/2012, and VCR by the NASA Biodiversity Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bruce Young and Blair Hedges, co-PIs partly responsible for obtaining NSF DEB-1136586 grant. We thank Brody Sandel for sharing R code to produce Fig 3, and Joshua Ginsberg and an anonymous reviewer for helpful comments on a previous version of our manuscript.	Akcakaya HR, 2006, GLOBAL CHANGE BIOL, V12, P2037, DOI 10.1111/j.1365-2486.2006.01253.x; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Biradar CM, 2009, INT J APPL EARTH OBS, V11, P114, DOI 10.1016/j.jag.2008.11.002; Bland LM, 2014, COMP INT MULT UND IW, V28, P1; Bontemps S., 2011, GLOBCOVER 2009 PRODU; Bright E.A., 2012, LANDSCAN 2011; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Cardillo M, 2006, P NATL ACAD SCI USA, V103, P4157, DOI 10.1073/pnas.0510541103; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cooper EJ, 2014, WARMER SHORTER WINTE; Coops NC, 2009, ECOL INDIC, V9, P948, DOI 10.1016/j.ecolind.2008.11.003; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davidson AD, 2012, DRIVERS HOTSPOTS EXT, V109; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Davies TJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0343; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Di Marco M, 2015, GLOBAL CHANGE BIOL, V21, P2169, DOI 10.1111/gcb.12834; Di Marco M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0198; Di Marco M, 2012, CONSERV LETT, V5, P134, DOI 10.1111/j.1755-263X.2011.00219.x; Durant SM, 2012, SCIENCE, V336, P1379, DOI 10.1126/science.336.6087.1379; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fisher DO, 2014, GLOBAL ECOL BIOGEOGR, V23, P181, DOI 10.1111/geb.12088; Fisher DO, 2003, P ROY SOC B-BIOL SCI, V270, P1801, DOI 10.1098/rspb.2003.2447; Foden W., 2008, 2008 REV IUCN RED LI, P77; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; GRUMPv1, 2010, GRUMPV1 POPULATION L; Hamilton MJ, 2011, P ROY SOC B-BIOL SCI, V278, P560, DOI 10.1098/rspb.2010.1056; Hapfelmeier A, 2012, STAT COMPUT, V24; Hijmans RJ., 2016, INTRO RASTER PACKAGE, P1; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hothorn T, 1999, PARTY LAB RECURSIVE; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 2017, IUCN RED LIST SUMM T; IUCN, 2013, IUCN RED LIST OF THR; Jones KE, 2011, PHILOS T R SOC B, V366, P2451, DOI 10.1098/rstb.2011.0090; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Jones MJ, 2006, BIODIVERS CONSERV, V15, P1993, DOI 10.1007/s10531-005-4316-1; Jono CMA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046235; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Laidre KL, 2015, ARCTIC MARINE MAMMAL, P29; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Machado N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072283; Mahlstein I, 2013, NAT CLIM CHANGE, V3, P739, DOI [10.1038/NCLIMATE1876, 10.1038/nclimate1876]; McKee JK, 2004, BIOL CONSERV, V115, P161, DOI 10.1016/S0006-3207(03)00099-5; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Murray KA, 2014, GLOBAL CHANGE BIOL, V20, P483, DOI 10.1111/gcb.12366; Nijman V, 2010, BIODIVERS CONSERV, V19, P1101, DOI 10.1007/s10531-009-9758-4; NOAA, 2006, VIIRS NIGHTT LIGHTS; Olden JD, 2008, Q REV BIOL, V83, P171, DOI 10.1086/587826; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Price SA, 2007, P R SOC B, V274, P1845, DOI 10.1098/rspb.2007.0505; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Rastogi A, 2012, J ENVIRON MANAGE, V113, P328, DOI 10.1016/j.jenvman.2012.10.003; Reynolds John D., 2003, P195; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Rodriguez MA, 2008, GLOBAL ECOL BIOGEOGR, V17, P274, DOI 10.1111/j.1466-8238.2007.00363.x; Rondinini C, 2014, CONSERV LETT, V7, P126, DOI 10.1111/conl.12040; Rondinini C, 2011, PHILOS T R SOC B, V366, P2633, DOI 10.1098/rstb.2011.0113; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Sibly RM, 2009, AM NAT, V173, pE185, DOI 10.1086/598680; Sodhi NS, 2010, BIODIVERS CONSERV, V19, P317, DOI 10.1007/s10531-009-9607-5; Stanton JC, 2015, GLOBAL CHANGE BIOL, V21, P1066, DOI 10.1111/gcb.12721; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Visconti P, 2011, PHILOS T R SOC B, V366, P2693, DOI 10.1098/rstb.2011.0105	78	21	21	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186934	10.1371/journal.pone.0186934	http://dx.doi.org/10.1371/journal.pone.0186934			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145486	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000415378800006
J	Nakayama, TJ; Rodrigues, FA; Neumaier, N; Marcolino-Gomes, J; Molinari, HBC; Santiago, TR; Formighieri, EF; Basso, MF; Farias, JRB; Emygdio, BM; de Oliveira, ACB; Campos, AD; Borem, A; Harmon, FG; Mertz-Henning, LM; Nepomuceno, AL				Nakayama, Thiago J.; Rodrigues, Fabiana A.; Neumaier, Norman; Marcolino-Gomes, Juliana; Molinari, Hugo B. C.; Santiago, Thais R.; Formighieri, Eduardo F.; Basso, Marcos F.; Farias, Jose R. B.; Emygdio, Beatriz M.; de Oliveira, Ana C. B.; Campos, Angela D.; Borem, Aluizio; Harmon, Frank G.; Mertz-Henning, Liliane M.; Nepomuceno, Alexandre L.			Insights into soybean transcriptome reconfiguration under hypoxic stress: Functional, regulatory, structural, and compositional characterization	PLOS ONE			English	Article							MEDIATOR COMPLEX SUBUNIT16; TRANSFER-RNA MODIFICATIONS; BETA-AMINOBUTYRIC ACID; GENE-EXPRESSION; ABIOTIC STRESS; ARABIDOPSIS-THALIANA; OXYGEN DEPRIVATION; PROTEOMIC ANALYSIS; FLOODING STRESS; OSMOTIC-STRESS	Soybean (Glycine max) is one of the major crops worldwide and flooding stress affects the production and expansion of cultivated areas. Oxygen is essential for mitochondrial aerobic respiration to supply the energy demand of plant cells. Because oxygen diffusion in water is 10,000 times lower than in air, partial (hypoxic) or total (anoxic) oxygen deficiency is important component of flooding. Even when oxygen is externally available, oxygen deficiency frequently occurs in bulky, dense or metabolically active tissues such as phloem, meristems, seeds, and fruits. In this study, we analyzed conserved and divergent root transcriptional responses between flood-tolerant Embrapa 45 and flood-sensitive BR 4 soybean cultivars under hypoxic stress conditions with RNA-seq. To understand how soybean genes evolve and respond to hypoxia, stable and differentially expressed genes were characterized structurally and compositionally comparing its mechanistic relationship. Between cultivars, Embrapa 45 showed less up-and more down-regulated genes, and stronger induction of phosphoglucomutase (Glyma05g34790), unknown protein related to N-terminal protein myristoylation (Glyma06g03430), protein suppressor of phyA-105 (Glyma06g37080), and fibrillin (Glyma10g32620). RNA-seq and qRT-PCR analysis of non-symbiotic hemoglobin (Glyma11g12980) indicated divergence in gene structure between cultivars. Transcriptional changes for genes in amino acids and derivative metabolic process suggest involvement of amino acids metabolism in tRNA modifications, translation accuracy/efficiency, and endoplasmic reticulum stress in both cultivars under hypoxia. Gene groups differed in promoter TATA box, ABREs (ABA-responsive elements), and CRT/DREs (C-repeat/dehydrationresponsive elements) frequency. Gene groups also differed in structure, composition, and codon usage, indicating biological significances. Additional data suggests that cis-acting ABRE elements can mediate gene expression independent of ABA in soybean roots under hypoxia.	[Nakayama, Thiago J.; Borem, Aluizio] Univ Fed Vicosa, Dept Fitotecn, Vicosa, MG, Brazil; [Rodrigues, Fabiana A.; Neumaier, Norman; Marcolino-Gomes, Juliana; Farias, Jose R. B.; Mertz-Henning, Liliane M.; Nepomuceno, Alexandre L.] Empresa Brasileira Pesquisa Agr, Embrapa Soja, Londrina, Parana, Brazil; [Molinari, Hugo B. C.; Santiago, Thais R.; Formighieri, Eduardo F.; Basso, Marcos F.] Empresa Brasileira Pesquisa Agr, Embrapa Agroenergia, Brasilia, DF, Brazil; [Emygdio, Beatriz M.; de Oliveira, Ana C. B.; Campos, Angela D.] Empresa Brasileira Pesquisa Agr, Embrapa Clima Temperado, Pelotas, RS, Brazil; [Harmon, Frank G.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of California System; University of California Berkeley	Nepomuceno, AL (corresponding author), Empresa Brasileira Pesquisa Agr, Embrapa Soja, Londrina, Parana, Brazil.	alexandre.nepomuceno@embrapa.br	Mertz-Henning, Liliane Marcia/AAC-9171-2020; Formighieri, Eduardo/W-9242-2019; Formighieri, Eduardo F/F-2993-2012; Santiago, Thaís/D-3366-2018; Santiago, Thais/AAC-6911-2019	Mertz-Henning, Liliane Marcia/0000-0001-7622-0649; Santiago, Thaís/0000-0001-5740-8400; Santiago, Thais/0000-0002-5890-557X; Nakayama, Thiago/0000-0001-5033-6790; Basso, Marcos Fernando/0000-0001-8192-8959	FAPEMIG; Embrapa/Monsanto partnership	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Embrapa/Monsanto partnership	This study was funded by Embrapa/Monsanto partnership. TJN were supported by graduate fellowship from FAPEMIG.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Arbona V, 2008, J PLANT GROWTH REGUL, V27, P241, DOI 10.1007/s00344-008-9051-x; Argamasilla R, 2014, J PLANT GROWTH REGUL, V33, P169, DOI 10.1007/s00344-013-9359-z; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; Bai G, 2013, PLANT MOL BIOL, V83, P651, DOI 10.1007/s11103-013-0114-4; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bailey-Serres J, 2012, PLANT PHYSIOL, V160, P1698, DOI 10.1104/pp.112.208173; Bailey-Serres J, 2012, TRENDS PLANT SCI, V17, P129, DOI 10.1016/j.tplants.2011.12.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DL, 2014, NAT REV GENET, V15, P163, DOI 10.1038/nrg3662; Bonham AJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp424; Boyce JM, 2003, PLANT J, V34, P395, DOI 10.1046/j.1365-313X.2003.01734.x; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Carvalho HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086661; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01044; Cohen YR, 2002, PLANT DIS, V86, P448, DOI 10.1094/PDIS.2002.86.5.448; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Elhaik E, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-23; Ellis MH, 1999, PLANT PHYSIOL, V119, P57, DOI 10.1104/pp.119.1.57; Eyboulet F, 2015, NUCLEIC ACIDS RES, V43, P9214, DOI 10.1093/nar/gkv782; Fessele S, 2002, TRENDS GENET, V18, P60, DOI 10.1016/S0168-9525(02)02591-X; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Glemin S, 2014, TRENDS GENET, V30, P263, DOI 10.1016/j.tig.2014.05.002; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Gupta KJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00369; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; He LR, 2013, BIOCHEM BIOPH RES CO, V435, P209, DOI 10.1016/j.bbrc.2013.04.080; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hsu FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028888; HWANG SY, 1991, PLANT PHYSIOL, V97, P593, DOI 10.1104/pp.97.2.593; Jackman JE, 2013, WIRES RNA, V4, P35, DOI 10.1002/wrna.1144; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kidokoro S, 2015, PLANT J, V81, P505, DOI 10.1111/tpj.12746; KIM JL, 1994, NAT STRUCT BIOL, V1, P638, DOI 10.1038/nsb0994-638; Kim YJ, 2011, EMBO J, V30, P814, DOI 10.1038/emboj.2011.3; Knight H, 2009, PLANT J, V58, P97, DOI 10.1111/j.1365-313X.2008.03763.x; Komatsu S, 2013, J PROTEOME RES, V12, P4769, DOI 10.1021/pr4001898; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Korner CJ, 2015, INT J MOL SCI, V16, P26582, DOI 10.3390/ijms161125964; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; LAANBROEK HJ, 1990, AQUAT BOT, V38, P109, DOI 10.1016/0304-3770(90)90101-P; Lamers LPM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00268; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li WX, 2011, J PLANT PHYSIOL, V168, P1837, DOI 10.1016/j.jplph.2011.05.020; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luna E, 2014, NAT CHEM BIOL, V10, P450, DOI [10.1038/nchembio.1520, 10.1038/NCHEMBIO.1520]; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; Marchetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056043; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Mickelbart MV, 2015, NAT REV GENET, V16, P237, DOI 10.1038/nrg3901; Minocha R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00175; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Morot-Gaudry JF, 2001, PLANT NITROGEN, P167; Mutava RN, 2015, PLANT PHYSIOL BIOCH, V86, P109, DOI 10.1016/j.plaphy.2014.11.010; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nakayama TJ, 2014, GENET MOL RES, V13, P860, DOI 10.4238/2014.February.13.4; Nanjo Y, 2011, PLANT MOL BIOL, V77, P129, DOI 10.1007/s11103-011-9799-4; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Nikolov DB, 1997, P NATL ACAD SCI USA, V94, P15, DOI 10.1073/pnas.94.1.15; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; Oliveira HC, 2013, AMINO ACIDS, V44, P743, DOI 10.1007/s00726-012-1399-3; Paul E, 2015, MOL CELL BIOL, V35, P331, DOI 10.1128/MCB.00991-14; Reis PAA, 2011, PLANT PHYSIOL, V157, P1853, DOI 10.1104/pp.111.179697; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; Rodrigues FA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1731-x; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shabala S, 2014, PLANT CELL ENVIRON, V37, P2216, DOI 10.1111/pce.12339; Shukla S, 2012, BBA-GENE REGUL MECH, V1819, P673, DOI 10.1016/j.bbagrm.2012.01.014; Silva PA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1952-z; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Singh DK, 2010, PLANT PHYSIOL, V154, P1281, DOI 10.1104/pp.110.164095; Sorenson R, 2014, P NATL ACAD SCI USA, V111, P2373, DOI 10.1073/pnas.1314851111; Takuno S, 2013, P NATL ACAD SCI USA, V110, P1797, DOI 10.1073/pnas.1215380110; Tamang BG, 2014, PLANT CELL ENVIRON, V37, P2350, DOI 10.1111/pce.12277; Tatarinova T, 2013, GENOME BIOL EVOL, V5, P1443, DOI 10.1093/gbe/evt103; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Tora L, 2010, TRENDS BIOCHEM SCI, V35, P309, DOI 10.1016/j.tibs.2010.01.007; van Dongen JT, 2009, ANN BOT-LONDON, V103, P269, DOI 10.1093/aob/mcn126; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; VanToai TT, 2001, CROP SCI, V41, P1247, DOI 10.2135/cropsci2001.4141247x; Wang CG, 2015, PLANT PHYSIOL, V169, P856, DOI 10.1104/pp.15.00351; Wang X, 2016, J PROTEOMICS, V130, P42, DOI 10.1016/j.jprot.2015.09.007; Wathugala DL, 2012, NEW PHYTOL, V195, P217, DOI 10.1111/j.1469-8137.2012.04138.x; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yang Y, 2016, J INTEGR PLANT BIOL, V58, P106, DOI 10.1111/jipb.12377; Yin X, 2016, PLANT MOL BIOL; Zaborske JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002015; Zallot R, 2014, ACS CHEM BIOL, V9, P1812, DOI 10.1021/cb500278k; Zhang XD, 2012, PLANT CELL, V24, P4294, DOI 10.1105/tpc.112.103317; Zheng Y, 2012, ANN BOT-LONDON, V110, P743, DOI 10.1093/aob/mcs133	98	13	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187920	10.1371/journal.pone.0187920	http://dx.doi.org/10.1371/journal.pone.0187920			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145496	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800038
J	Taurozzi, AJ; Beekharry, R; Wantoch, M; Labarthe, MC; Walker, HF; Seed, RI; Simms, M; Rodrigues, G; Bradford, J; van der Horst, G; van der Pluijm, G; Collins, AT				Taurozzi, Alberto J.; Beekharry, Ramprakash; Wantoch, Michelle; Labarthe, Marie-Christine; Walker, Hannah F.; Seed, Robert I.; Simms, Matthew; Rodrigues, Greta; Bradford, James; van der Horst, Geertje; van der Pluijm, Gabri; Collins, Anne T.			Spontaneous development of Epstein-Barr Virus associated human lymphomas in a prostate cancer xenograft program	PLOS ONE			English	Article							IMMUNODEFICIENT MICE; TUMOR XENOGRAFTS; DRUG DEVELOPMENT; MODELS; CELLS; METASTASIS; SAMPLES; MOUSE	Prostate cancer research is hampered by the lack of in vivo preclinical models that accurately reflect patient tumour biology and the clinical heterogeneity of human prostate cancer. To overcome these limitations we propagated and characterised a new collection of patient-derived prostate cancer xenografts. Tumour fragments from 147 unsupervised, surgical prostate samples were implanted subcutaneously into immunodeficient Rag2(-/-)gamma C-/- mice within 24 hours of surgery. Histologic and molecular characterisation of xenografts was compared with patient characteristics, including androgen-deprivation therapy, and exome sequencing. Xenografts were established from 47 of 147 (32%) implanted primary prostate cancers. Only 14% passaged successfully resulting in 20 stable lines; derived from 20 independent patient samples. Surprisingly, only three of the 20 lines (15%) were confirmed as prostate cancer; one line comprised of mouse stroma, and 16 were verified as human donor-derived lymphoid neoplasms. PCR for Epstein-Barr Virus (EBV) nuclear antigen, together with exome sequencing revealed that the lymphomas were exclusively EBV-associated. Genomic analysis determined that 14 of the 16 EBV+ lines had unique monoclonal or oligoclonal immunoglobulin heavy chain gene rearrangements, confirming their B-cell origin. We conclude that the generation of xenografts from tumour fragments can commonly result in B-cell lymphoma from patients carrying latent EBV. We recommend routine screening, of primary outgrowths, for latent EBV to avoid this phenomenon.	[Taurozzi, Alberto J.; Walker, Hannah F.; Seed, Robert I.; Collins, Anne T.] Univ York, Canc Res Unit, Dept Biol, York, N Yorkshire, England; [Beekharry, Ramprakash] St James Univ Hosp, Dept Urol, Leeds, W Yorkshire, England; [Wantoch, Michelle] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Labarthe, Marie-Christine] Univ York, Dept Chem, York, N Yorkshire, England; [Simms, Matthew] Castle Hill Hosp, Dept Urol, Cottingham, England; [Simms, Matthew] Univ York, Hull York Med Sch, York, N Yorkshire, England; [Rodrigues, Greta] Hull Royal Infirm, Dept Pathol, Kingston Upon Hull, N Humberside, England; [Bradford, James] Univ Sheffield, Dept Oncol & Metab, Sheffield Inst Nucle Acids, Sheffield, S Yorkshire, England; [van der Horst, Geertje; van der Pluijm, Gabri] Leiden Univ, Med Sch, Dept Urol, Leiden, Netherlands	University of York - UK; Saint James's University Hospital; University of Leeds; University of York - UK; University of Hull; University of Hull; University of York - UK; University of Hull; University of Sheffield; Leiden University; Leiden University - Excl LUMC	Collins, AT (corresponding author), Univ York, Canc Res Unit, Dept Biol, York, N Yorkshire, England.	anne.collins@york.ac.uk		Seed, Robert/0000-0002-7588-9903; van der Horst, Geertje/0000-0003-1696-160X; van der Pluijm, Gabri/0000-0002-1351-1884; Taurozzi, Alberto John/0000-0003-0378-1626; Collins, Anne/0000-0002-2991-2703; Wantoch, Michelle/0000-0001-5313-158X	Movember Foundation [GAP1 0201]; Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium) [UL2014-7058]; Prostate Cancer UK [PG12-01]; Yorkshire Cancer Research [Y257PA]	Movember Foundation; Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium); Prostate Cancer UK; Yorkshire Cancer Research	This work was supported by the Movember Foundation (grant No. GAP1 0201), (ATC), Dutch Cancer Society (Alpe dHuZes/KWF fund, PROPER consortium) (grant No. UL2014-7058), (GvdP, GvdH, ATC), Prostate Cancer UK (grant No. PG12-01) (M-CL, ATC), and Yorkshire Cancer Research (Grant No.Y257PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2006, INT J UROL, V13, P47, DOI 10.1111/j.1442-2042.2006.01220.x; Chen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039294; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056903; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Craft N, 1999, CANCER RES, V59, P5030; Ellis LM, 2010, NAT MED, V16, P974, DOI 10.1038/nm0910-974; Ellis WJ, 1996, CLIN CANCER RES, V2, P1039; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; Ichinohasama R, 1996, CANCER, V77, P2592, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2592::AID-CNCR25>3.0.CO;2-M; John T, 2012, J THORAC ONCOL, V7, P1101, DOI 10.1097/JTO.0b013e3182519d4d; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Kroon P, 2013, CANCER RES, V73, P5288, DOI 10.1158/0008-5472.CAN-13-0874; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Lopez-Barcons LA, 2010, ASIAN J ANDROL, V12, P509, DOI 10.1038/aja.2010.17; McCulloch DR, 2005, PROSTATE, V65, P35, DOI 10.1002/pros.20255; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; MOSS DJ, 1988, NATURE, V331, P719, DOI 10.1038/331719a0; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Park HS, 2013, TRANSL ONCOL, V6, P370, DOI 10.1593/tlo.13250; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Subramanian C, 2001, NAT MED, V7, P350, DOI 10.1038/85499; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; TLSTY TD, 1995, MUTAT RES-DNA REPAIR, V337, P1, DOI 10.1016/0921-8777(95)00016-D; Toivanen R, 2012, J STEROID BIOCHEM, V131, P122, DOI 10.1016/j.jsbmb.2012.01.005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; vanWeerden WM, 1996, AM J PATHOL, V149, P1055; Wetterauer C, 2015, EARLY DEV HUMAN LYMP; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188228	10.1371/journal.pone.0188228	http://dx.doi.org/10.1371/journal.pone.0188228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145505	gold, Green Accepted, Green Published			2022-12-27	WOS:000415378800094
J	Van de Ven, RM; Murre, JMJ; Buitenweg, JIV; Veltman, DJ; Aaronson, JA; Nijboer, TCW; Kruiper-Doesborgh, SJC; van Bennekom, CAM; Ridderinkhof, KR; Schmand, B				van de Ven, Renate M.; Murre, Jaap M. J.; Buitenweg, Jessika I. V.; Veltman, Dick J.; Aaronson, Justine A.; Nijboer, Tanja C. W.; Kruiper-Doesborgh, Suzanne J. C.; van Bennekom, Coen A. M.; Ridderinkhof, K. Richard; Schmand, Ben			The influence of computer-based cognitive flexibility training on subjective cognitive well-being after stroke: A multi-center randomized controlled trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACQUIRED BRAIN-INJURY; WORKING-MEMORY; INSTRUMENTAL ACTIVITIES; FAILURES QUESTIONNAIRE; EXECUTIVE DYSFUNCTION; ATTENTIONAL DEFICITS; UTRECHT SCALE; HEALTH SURVEY; REHABILITATION	Background Stroke can result in cognitive complaints that can have a large impact on quality of life long after its occurrence. A number of computer-based training programs have been developed with the aim to improve cognitive functioning. Most studies investigating their efficacy used only objective outcome measures, whereas a reduction of subjective cognitive complaints may be equally important for improving quality of life. A few studies used subjective outcome measures but were inconclusive, partly due to methodological shortcomings such as lack of proper active and passive control groups. Objective The aim of the current study was to investigate whether computer-based cognitive flexibility training can improve subjective cognitive functioning and quality of life after stroke. Methods We performed a randomized controlled double blind trial (RCT). Adults (30-80 years old) who had a stroke 3 months to 5 years ago, were randomly assigned to either an intervention group (n = 38), an active control group (i.e., mock training; n = 35), or a waiting list control group (n = 24). The intervention and mock training consisted of 58 half-hour sessions within 12 weeks. The primary subjective outcome measures were cognitive functioning (Cognitive Failure Questionnaire), executive functioning (Dysexecutive Functioning Questionnaire), quality of life (Short Form Health Survey), instrumental activities of daily living (IADL; Lawton & Brody IADL scale), and participation in society (Utrecht Scale for Evaluation of Rehabilitation-Participation). Secondary subjective outcome measures were recovery after stroke, depressive symptoms (Hospital Anxiety Depression Scale-depression subscale), fatigue (Checklist Individual Strength D Fatigue subscale), and subjective cognitive improvement (exit list). Finally, a proxy of the participant rated the training effects in subjective cognitive functioning, subjective executive functioning, and IADL. Results and conclusions All groups improved on the two measures of subjective cognitive functioning and subjective executive functioning, but not on the other measures. These cognitive and executive improvements remained stable 4 weeks after training completion. However, the intervention group did not improve more than the two control groups. This suggests that improvement was due to training-unspecific effects. The proxies did not report any improvements. We, therefore, conclude that the computer-based cognitive flexibility training did not improve subjective cognitive functioning or quality of life after stroke.	[van de Ven, Renate M.; Murre, Jaap M. J.; Buitenweg, Jessika I. V.; Ridderinkhof, K. Richard; Schmand, Ben] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Aaronson, Justine A.; van Bennekom, Coen A. M.] Heliomare Rehabil Ctr, Dept Res & Dev, Wijk Aan Zee, Netherlands; [Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Hoogstr Rehabil, Utrecht, Netherlands; [Nijboer, Tanja C. W.] Univ Utrecht, Dept Expt Psychol, Utrecht, Netherlands; [Kruiper-Doesborgh, Suzanne J. C.] Reade, Amsterdam Rehabil Res Ctr, Amsterdam, Netherlands; [Ridderinkhof, K. Richard] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Schmand, Ben] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Van de Ven, RM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	r.m.vandeven@uva.nl	Murre, Jaap MJ/A-3813-2010	van Bennekom, coen/0000-0002-9754-261X	Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research (NWO) [056-14-013]	Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research (NWO)	This project is part of the research program "Treatment of cognitive disorders based on functional brain imaging" funded by the Netherlands Initiative Brain and Cognition, a part of the Organization for Scientific Research (NWO) under grant number 056-14-013 to JMJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Akerlund E, 2013, BRAIN INJURY, V27, P1649, DOI 10.3109/02699052.2013.830195; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Blomer AMV, 2015, ARCH PHYS MED REHAB, V96, P456, DOI 10.1016/j.apmr.2014.09.003; Boelen DHE, 2009, NEUROPSYCHOL REHABIL, V19, P625, DOI 10.1080/09602010802613853; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS39, DOI 10.1097/PHM.0b013e31823d4df7; Corbett A, 2015, J AM MED DIR ASSOC, V16, P990, DOI 10.1016/j.jamda.2015.06.014; De Luca R, 2014, DISABIL HEALTH J, V7, P356, DOI 10.1016/j.dhjo.2014.04.003; Evans, 1996, BEHAV ASSESSMENT DYS; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fride Y, 2015, TOP STROKE REHABIL, V22, P317, DOI 10.1179/1074935714Z.0000000013; Gauggel S, 1996, INT J REHABIL RES, V19, P229, DOI 10.1097/00004356-199609000-00004; Gray JM, 1992, NEUROPSYCHOL REHABIL, V2, P97, DOI [10.1080/09602019208401399, DOI 10.1080/09602019208401399]; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gunaydin R, 2011, ARCH GERONTOL GERIAT, V53, P19, DOI 10.1016/j.archger.2010.06.004; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Hauke J, 2011, NEUROPSYCHOL REHABIL, V21, P164, DOI 10.1080/09602011.2010.541792; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Katona M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0258-9; Kielbergerova L, 2015, TRANSL STROKE RES, V6, P375, DOI 10.1007/s12975-015-0418-6; LAWTON MP, 1988, PSYCHOPHARMACOL BULL, V24, P789; Liu KPY, 2016, EUR J NEUROL, V23, P1351, DOI 10.1111/ene.13037; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Maaijwee NAMM, 2014, J NEUROL, V261, P1300, DOI 10.1007/s00415-014-7346-3; Oczkowski C, 2010, J STROKE CEREBROVASC, V19, P410, DOI 10.1016/j.jstrokecerebrovasdis.2009.08.002; Olazaran J, 2005, NEUROLOGIA, V20, P395; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Post MWM, 2009, CLIN REHABIL, V23, P909, DOI 10.1177/0269215509341524; Prokopenko SV, 2013, J NEUROL SCI, V325, P148, DOI 10.1016/j.jns.2012.12.024; RUFF R, 1994, BRAIN INJURY, V8, P3, DOI 10.3109/02699059409150954; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Saghaei Mahmoud, 2011, J Med Signals Sens, V1, P55; Schwarz KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130492; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Van de Ven R. M., 2015, BIOMED CENTRAL NEURO, V20, P15; van de Ven RM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00150; van de Ven RM, 2017, PLOS ONE, P12; van der Zee CH, 2010, J REHABIL MED, V42, P752, DOI 10.2340/16501977-0589; van Rijsbergen MWA, 2015, J STROKE CEREBROVASC, V24, P1823, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.017; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Vercoulen JHMM, 1997, J PSYCHIATR RES, P31; Vittengl JR, 2006, AGING MENT HEALTH, V10, P40, DOI 10.1080/13607860500307944; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wentink MM, 2016, NEUROPSYCHOL REHABIL, V26, P847, DOI 10.1080/09602011.2016.1162175; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilz G, 2007, BRAIN INJURY, V21, P39, DOI 10.1080/02699050601121996; Worm-Smeitink M, 2017, J PSYCHOSOM RES, V98, P40, DOI 10.1016/j.jpsychores.2017.05.007; Zigmond AS, 1983, ACTA PSYCHIAT SCAND, P67; Zinn S, 2004, ARCH PHYS MED REHAB, V85, P1084, DOI 10.1016/j.apmr.2003.10.022	54	15	16	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187582	10.1371/journal.pone.0187582	http://dx.doi.org/10.1371/journal.pone.0187582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145410	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800020
J	de Andrade, LGM; Contti, MM; Nga, HS; Bravin, AM; Takase, HM; Viero, RM; da Silva, TN; Chagas, KD; Palma, LMP				de Andrade, Luis Gustavo Modelli; Contti, Mariana Moraes; Nga, Hong Si; Bravin, Ariane Moyses; Takase, Henrique Mochida; Viero, Rosa Marlene; da Silva, Trycia Nunes; Chagas, Kelem De Nardi; Pereira Palma, Lilian Monteiro			Long-term outcomes of the Atypical Hemolytic Uremic Syndrome after kidney transplantation treated with eculizumab as first choice	PLOS ONE			English	Article							COMPLEMENT INHIBITOR ECULIZUMAB; PROPHYLACTIC ECULIZUMAB; INVASIVE ASPERGILLOSIS; RENAL-TRANSPLANTATION; SYNDROME RECURRENCE; AHUS; MUTATIONS; IMPACT	Introduction The treatment of choice for Atypical Hemolytic Uremic Syndrome (aHUS) is the monoclonal antibody eculizumab. The objective of this study was to assess the efficacy and safety of eculizumab in a cohort of kidney transplant patients suffering from aHUS. Methods Description of the prospective cohort of all the patients primarily treated with eculizumab after transplantation and divided into the therapeutic (onset of aHUS after transplantation) and prophylactic use (patients with previous diagnosis of aHUS undergoing kidney transplantation). Results Seven cases were outlined: five of therapeutic use and two, prophylactic. From the five cases of therapeutic use, there was improvement of the thrombotic microangiopathy in the 48 hours following the start of the drug and no patient experienced relapse during an average follow-up of 21 months in the continuous use of eculizumab (minimum of 6 and maximum of 42 months). One patient died at 6 months, due to Aspergillus infection. From the two cases of prophylactic use, one patient experienced relapsed thrombotic microangiopathy after 4 months and another patient remained asymptomatic after 16 months of follow-up, both on chronic treatment. Discussion The therapeutic use of eculizumab showed to be effective, with improvement of the microangiopathy parameters and persisting up to the end of the follow-up, without relapses. The additional risk of immunosuppression, leading to opportunistic infections, was well tolerated. The prophylactic use showed to be effective and safe; however, the doses and intervals should be individualized in order to avoid relapsed microangiopathy, especially in patients with factor H mutation.	[de Andrade, Luis Gustavo Modelli; Contti, Mariana Moraes; Nga, Hong Si; Bravin, Ariane Moyses; Takase, Henrique Mochida; Viero, Rosa Marlene; da Silva, Trycia Nunes; Chagas, Kelem De Nardi; Pereira Palma, Lilian Monteiro] Univ Sao Paulo State, Dept Internal Med, UNESP, Botucatu, SP, Brazil; [da Silva, Trycia Nunes] Hosp Estadual Bauru, Dept Internal Med, Bauru, SP, Brazil; [Chagas, Kelem De Nardi] Univ Sao Paulo, Dept Internal Med, Sao Paulo, SP, Brazil; [Pereira Palma, Lilian Monteiro] Univ Estadual Campinas, Dept Internal Med, UNICAMP, Campinas, SP, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Andrade, LGM (corresponding author), Univ Sao Paulo State, Dept Internal Med, UNESP, Botucatu, SP, Brazil.	landrade@fmb.unesp.br	Palma, Lilian Monteiro Pereira/U-6672-2018; de Andrade, Luis Gustavo Modelli/I-4146-2013	Palma, Lilian Monteiro Pereira/0000-0002-0334-8470; Modelli de Andrade, Luis Gustavo/0000-0002-0230-0766				Barbour T, 2012, NEPHROL DIAL TRANSPL, V27, P2673, DOI 10.1093/ndt/gfs279; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Bresin E, 2006, CLIN J AM SOC NEPHRO, V1, P88, DOI 10.2215/CJN.00050505; Bresin E, 2013, J AM SOC NEPHROL, V24, P475, DOI 10.1681/ASN.2012090884; Campistol JM, 2013, NEFROLOGIA, V33, P27, DOI 10.3265/Nefrologia.pre2012.Nov.11781; Caprioli J, 2006, BLOOD, V108, P1267, DOI 10.1182/blood-2005-10-007252; Cheshire C., 2014, PRESCRIBING INFORM; Coppo R, 2016, PEDIATR NEPHROL, V31, P759, DOI 10.1007/s00467-015-3278-0; Cugno M, 2014, J THROMB HAEMOST, V12, P1440, DOI 10.1111/jth.12615; Fehrman-Ekholm I, 2014, AUSTIN J NEPHROL HYP, V1, P1019; Fernandez-de Larrea C, 2010, TRANSPLANTATION, V89, P903, DOI 10.1097/TP.0b013e3181ccd80d; Heylen L, 2015, CLIN INFECT DIS, V60, P1505, DOI 10.1093/cid/civ103; Kasapoglu Umut, 2015, Ann Transplant, V20, P714; Kozel TR, 1996, CLIN MICROBIOL REV, V9, P34, DOI 10.1128/CMR.9.1.34; Krid S, 2012, AM J TRANSPLANT, V12, P1938, DOI 10.1111/j.1600-6143.2012.04051.x; Le Quintrec M, 2013, AM J TRANSPLANT, V13, P663, DOI 10.1111/ajt.12077; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Loirat C, 2016, PEDIATR NEPHROL, V31, P15, DOI 10.1007/s00467-015-3076-8; Mallett A, 2015, INTERN MED J, V45, P1054, DOI 10.1111/imj.12864; Matar D, 2014, TRANSPLANTATION, V98, P1205, DOI 10.1097/TP.0000000000000200; Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246; Noris M, 2013, CURR OPIN NEPHROL HY, V22, P704, DOI 10.1097/MNH.0b013e328365b3fe; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Nurnberger J, 2009, NEW ENGL J MED, V360, P542, DOI 10.1056/NEJMc0808527; Palma LMP, 2016, J BLOOD MED, V7, P39, DOI 10.2147/JBM.S36249; Riddell A, 2016, CLIN NEPHROL, V86, P200, DOI 10.5414/CN108808; Saland JM, 2009, J AM SOC NEPHROL, V20, P940, DOI 10.1681/ASN.2008080906; Sheerin NS, 2016, QJM-INT J MED, V109, P27, DOI 10.1093/qjmed/hcv082; Singh N, 2009, AM J TRANSPLANT, V9, pS180, DOI 10.1111/j.1600-6143.2009.02910.x; Vellanki VS, 2014, RENAL FAILURE, V36, P631, DOI 10.3109/0886022X.2014.882712; Verhave JC, 2014, NEPHROL DIAL TRANSPL, V29, P131, DOI 10.1093/ndt/gfu235; Woodward L, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0537-5; Zimmerhackl LB, 2010, NEW ENGL J MED, V362, P1746, DOI 10.1056/NEJMc1001060; Zuber J, 2012, AM J TRANSPLANT, V12, P3337, DOI 10.1111/j.1600-6143.2012.04252.x; Zuber J, 2012, NAT REV NEPHROL, V8, P643, DOI 10.1038/nrneph.2012.214; Zuber J, 2011, NAT REV NEPHROL, V7, P23, DOI 10.1038/nrneph.2010.155	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188155	10.1371/journal.pone.0188155	http://dx.doi.org/10.1371/journal.pone.0188155			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136640	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200071
J	Frelat, R; Lindegren, M; Denker, TS; Floeter, J; Fock, HO; Sguotti, C; Stabler, M; Otto, SA; Mollmann, C				Frelat, Romain; Lindegren, Martin; Denker, Tim Spaanheden; Floeter, Jens; Fock, Heino O.; Sguotti, Camilla; Staebler, Moritz; Otto, Saskia A.; Moellmann, Christian			Community ecology in 3D: Tensor decomposition reveals spatio-temporal dynamics of large ecological communities	PLOS ONE			English	Article							SINGULAR-VALUE DECOMPOSITION; CLIMATE-CHANGE; ATLANTIC; OSCILLATION; MANAGEMENT; ORDINATION; SEQUENCE; MODEL; SHIFT; ARRAY	Understanding spatio-temporal dynamics of biotic communities containing large numbers of species is crucial to guide ecosystem management and conservation efforts. However, traditional approaches usually focus on studying community dynamics either in space or in time, often failing to fully account for interlinked spatio-temporal changes. In this study, we demonstrate and promote the use of tensor decomposition for disentangling spatio-temporal community dynamics in long-term monitoring data. Tensor decomposition builds on traditional multivariate statistics (e.g. Principal Component Analysis) but extends it to multiple dimensions. This extension allows for the synchronized study of multiple ecological variables measured repeatedly in time and space. We applied this comprehensive approach to explore the spatio-temporal dynamics of 65 demersal fish species in the North Sea, a marine ecosystem strongly altered by human activities and climate change. Our case study demonstrates how tensor decomposition can successfully (i) characterize the main spatiotemporal patterns and trends in species abundances, (ii) identify sub-communities of species that share similar spatial distribution and temporal dynamics, and (iii) reveal external drivers of change. Our results revealed a strong spatial structure in fish assemblages persistent over time and linked to differences in depth, primary production and seasonality. Furthermore, we simultaneously characterized important temporal distribution changes related to the low frequency temperature variability inherent in the Atlantic Multidecadal Oscillation. Finally, we identified six major sub-communities composed of species sharing similar spatial distribution patterns and temporal dynamics. Our case study demonstrates the application and benefits of using tensor decomposition for studying complex community data sets usually derived from large-scale monitoring programs.	[Frelat, Romain; Floeter, Jens; Sguotti, Camilla; Otto, Saskia A.; Moellmann, Christian] Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Inst Hydrobiol & Fisheries Sci, KlimaCampus Hamburg,Grosse Elbstr 133, Hamburg, Germany; [Lindegren, Martin; Denker, Tim Spaanheden] Tech Univ Denmark, Natl Inst Aquat Resources, Ctr Ocean Life, Bygning 202, Lyngby, Denmark; [Fock, Heino O.] Thunen Inst Sea Fisheries, Palmaille 9, Hamburg, Germany; [Staebler, Moritz] Leibniz Ctr Trop Marine Ecol, Fahrenheitstr 6, Bremen, Germany	University of Hamburg; Technical University of Denmark; Johann Heinrich von Thunen Institute; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Frelat, R (corresponding author), Univ Hamburg, Ctr Earth Syst Res & Sustainabil CEN, Inst Hydrobiol & Fisheries Sci, KlimaCampus Hamburg,Grosse Elbstr 133, Hamburg, Germany.	romain.frelat@uni-hamburg.de	Romain, Frelat/G-9930-2018; Möllmann, Christian/C-4788-2011; Möllmann, Christian/M-8006-2019	Romain, Frelat/0000-0002-8631-4398; Möllmann, Christian/0000-0001-9161-6342; Stabler, Moritz/0000-0002-9987-2532; Lindegren, Martin/0000-0002-9185-951X; Dencker, Tim Spaanheden/0000-0001-7804-0828	European Union's Horizon research and innovation programme [675997]; Centre for Ocean Life; VKR center of excellence; VILLUM research grant [13159]; German Science Foundation; Villum Fonden [00007178, 00013159] Funding Source: researchfish	European Union's Horizon research and innovation programme; Centre for Ocean Life; VKR center of excellence; VILLUM research grant; German Science Foundation(German Research Foundation (DFG)); Villum Fonden(Villum Fonden)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 675997 (ITN MARmaED). ML received support from the Centre for Ocean Life, a VKR center of excellence, as well as a VILLUM research grant (#13159). The study is a contribution to the University of Hamburg Center of Excellence on "Integrated Climate System Analysis and Prediction" (CliSAP) funded by the German Science Foundation (to CM). The results of this publication reflect only the author's view and the Commission is not responsible for any use that may be made of the information it contains.	Beare DJ, 2004, MAR ECOL PROG SER, V284, P269, DOI 10.3354/meps284269; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Benjamini Y, 2001, ANN STAT, V29, P1165; Bro R, 2006, CRIT REV ANAL CHEM, V36, P279, DOI 10.1080/10408340600969965; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cichocki A, 2015, IEEE SIGNAL PROC MAG, V32, P145, DOI 10.1109/MSP.2013.2297439; DAAN N, 1990, NETH J SEA RES, V26, P343, DOI 10.1016/0077-7579(90)90096-Y; Daan N, 2006, INT COUNC EXPL SEA A, V20, P10; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; Emeis KC, 2015, J MARINE SYST, V141, P18, DOI 10.1016/j.jmarsys.2014.03.012; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Engelhard GH, 2015, ENVIRON CONSERV, V42, P227, DOI 10.1017/S0376892915000077; Engelhard GH, 2011, ICES J MAR SCI, V68, P580, DOI 10.1093/icesjms/fsq183; Fung T, 2012, ICES J MAR SCI, V69, P235, DOI 10.1093/icesjms/fsr206; Gauch Jr HG, 1982, MULTIVARIATE ANAL CO; Giordani P, 2014, J STAT SOFTW, V57; Goberville E, 2014, J MARINE SYST, V129, P189, DOI 10.1016/j.jmarsys.2013.05.008; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Heo MS, 1998, COMMUN STAT-SIMUL C, V27, P843, DOI 10.1080/03610919808813512; ICES, 2015, SER ICES SURV PROT; Jones PD, 1997, INT J CLIMATOL, V17, P1433, DOI 10.1002/(SICI)1097-0088(19971115)17:13<1433::AID-JOC203>3.0.CO;2-P; Kauppi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127231; Kenny AJ, 2009, PROG OCEANOGR, V81, P132, DOI 10.1016/j.pocean.2009.04.007; Kide SO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141566; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Leibovici D, 1998, LINEAR ALGEBRA APPL, V269, P307, DOI 10.1016/S0024-3795(97)81516-9; Leibovici DG, 2011, INT J IMAGE DATA FUS, V2, P105, DOI 10.1080/19479832.2010.542893; Leibovici DG, 2010, J STAT SOFTW, V34, P1; Lindegren M, 2012, GLOBAL CHANGE BIOL, V18, P3491, DOI 10.1111/j.1365-2486.2012.02799.x; Lindegren M, 2009, P NATL ACAD SCI USA, V106, P14722, DOI 10.1073/pnas.0906620106; Ros-Santaella JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112382; Maritorena S, 2010, REMOTE SENS ENVIRON, V114, P1791, DOI 10.1016/j.rse.2010.04.002; McNeice GW, 2001, GEOPHYSICS, V66, P158, DOI 10.1190/1.1444891; Mendes S, 2016, J APPL STAT, V4763, P1; Mollmann C, 2014, ICES J MAR SCI, V71, P1187, DOI 10.1093/icesjms/fst123; Morup M, 2011, WIRES DATA MIN KNOWL, V1, P24, DOI 10.1002/widm.1; Nunez-Riboni I, 2015, J MARINE SYST, V151, P15, DOI 10.1016/j.jmarsys.2015.06.003; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ovaskainen O, 2016, MAKE MORE OUT COMMUN, P561, DOI [10.1111/ele.12757, DOI 10.1111/ELE.12757]; Pecuchet L, 2017, GLOBAL ECOL BIOGEOGR, V26, P812, DOI 10.1111/geb.12587; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; R Development Core Team, 2009, R LANG ENV STAT COMP; Sparrevohn CR, 2013, FISH OCEANOGR, V22, P400, DOI 10.1111/fog.12030; Stabler M, 2016, ECOL MODEL, V331, P17, DOI 10.1016/j.ecolmodel.2016.01.020; THIOULOUSE J, 1987, ACTA OECOL-OEC GEN, V8, P463; Thioulouse J, 2004, ECOLOGY, V85, P272, DOI 10.1890/02-0605; Thioulouse J, 2011, ANN APPL STAT, V5, P2300, DOI 10.1214/10-AOAS372; Thorson JT, 2017, ICES J MAR SCI, V74, P1311, DOI 10.1093/icesjms/fsw193; Thorson JT, 2016, GLOBAL ECOL BIOGEOGR, V25, P1144, DOI 10.1111/geb.12464; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; Weinert M, 2016, ESTUAR COAST SHELF S, V175, P157, DOI 10.1016/j.ecss.2016.03.024	57	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188205	10.1371/journal.pone.0188205	http://dx.doi.org/10.1371/journal.pone.0188205			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136658	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200077
J	Syed, S; Schober, J; Blanco, A; Zustiak, SP				Syed, Sana; Schober, Joseph; Blanco, Alexandra; Zustiak, Silviya Petrova			Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; MECHANICAL MEMORY; FOCAL ADHESION; STIFFNESS; PROLIFERATION; ACTIVATION; COMPLEXITY; RESPONSES; DYNAMICS	Standard tissue culture practices involve propagating cells on tissue culture polystyrene (TCP) dishes, which are flat, 2-dimensional (2D) and orders of magnitude stiffer than most tissues in the body. Such simplified conditions lead to phenotypical cell changes and altered cell behaviors. Hence, much research has been focused on developing novel biomaterials and culture conditions that more closely emulate in vivo cell microenvironments. In particular, biomaterial stiffness has emerged as a key property that greatly affects cell behaviors such as adhesion, morphology, proliferation and motility among others. Here we ask whether cells that have been conditioned to TCP, would still show significant dependence on substrate stiffness if they are first pre-adapted to a more physiologically relevant environment. We used two commonly utilized breast cancer cell lines, namely MDA-MB-231 and MCF-7, and examined the effect of prolonged cell culturing on polyacrylamide substrates of varying compliance. We followed changes in cell adhesion, proliferation, shape factor, spreading area and spreading rate. After pre-adaptation, we noted diminished differences in cell behaviors when comparing between soft (1 kPa) and stiff (103 kPa) gels as well as rigid TCP control. Prolonged culturing of cells on complaint substrates further influenced responses of pre-adapted cells when transferred back to TCP. Our results have implications for the study of stiffness-dependent cell behaviors and indicate that cell pre-adaptation to the substrate needs consideration.	[Syed, Sana; Blanco, Alexandra; Zustiak, Silviya Petrova] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA; [Schober, Joseph] Southern Illinois Univ Edwardsville, Dept Pharmaceut Sci, Edwardsville, IL USA	Saint Louis University; Washington University (WUSTL); Southern Illinois University System; Southern Illinois University Edwardsville	Zustiak, SP (corresponding author), St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.	szustiak@slu.edu		Blanco, Alexandra/0000-0001-5090-7565	Saint Louis University	Saint Louis University	This work was supported by start-up funds provided to Dr. Zustiak by Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by start-up funds provided to Dr. Zustiak by Saint Louis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Barcus CE, 2016, ONCOTARGET, V7, P48093, DOI 10.18632/oncotarget.10137; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bioptechs, 2015, DELT T PETR DISH; Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9; Carrel A, 1924, PHYSIOL REV, V4, P1; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Domura R, 2017, J MATER CHEM B, V5, P2588, DOI 10.1039/c7tb00207f; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Fusco S, 2015, ACTA BIOMATER, V23, P63, DOI 10.1016/j.actbio.2015.05.008; Geiger B, 2009, NATURE REV MOL CELL, V10; Georges PC, 2005, J APPL PHYSIOL, V98, P1547, DOI 10.1152/japplphysiol.01121.2004; Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gilbert PM, 2017, CELLULAR ADAPTATION; Heo S-J, 2015, SCI REPORTS, P5; Hoesel B, COMPLEXITY NF SIGNAL; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Ishihara S, 2013, EXP CELL RES, V319, P2916, DOI 10.1016/j.yexcr.2013.09.018; Kaushik S, 2016, CANCER METAST REV, V35, P655, DOI 10.1007/s10555-016-9650-0; Kirkpatrick CJ, 2007, BIOMATERIALS, V28, P5193, DOI 10.1016/j.biomaterials.2007.08.012; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Lee MYK, 2010, J VASC RES, V47, P287, DOI 10.1159/000265563; Lee MYK, 2009, MOL IMMUNOL, V46, P1050, DOI 10.1016/j.molimm.2008.09.027; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03910; Liao HH, 2014, CYTOTECHNOLOGY, V66, P229, DOI 10.1007/s10616-013-9560-8; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mason B. N., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929; Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1; Nisenholz N, 2014, SOFT MATTER, V10, P7234, DOI 10.1039/c4sm00780h; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007; Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320; Rianna C, 2017, EUR BIOPHYS J BIOPHY, V46, P309, DOI 10.1007/s00249-016-1168-4; Sazonova OV, 2011, BIOPHYS J, V101, P622, DOI 10.1016/j.bpj.2011.06.051; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Sero JE, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145644; Shi Q, 2004, DNA CELL BIOL, V23, P502, DOI 10.1089/1044549041562294; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Stowers RS, 2017, CELL MOL BIOENG, V10, P114, DOI 10.1007/s12195-016-0468-1; Syed S, 2015, JOVE-J VIS EXP, DOI 10.3791/52643; Talele NP, 2015, STEM CELL REP, V4, P1016, DOI 10.1016/j.stemcr.2015.05.004; Tilghman RW, 2012, MATRIX RIGIDITY REGU, V7, DOI DOI 10.1371/J0URNAL.P0NE.0037231; Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109; Tse J. R., 2001, PREPARATION HYDROGEL; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/nmat3889, 10.1038/NMAT3889]; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097; Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q; Zustiak SP, 2015, MACROMOL BIOSCI, V15, P589, DOI 10.1002/mabi.201400507	59	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187853	10.1371/journal.pone.0187853	http://dx.doi.org/10.1371/journal.pone.0187853			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136040	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200038
J	Xu, JY; Hu, J; Yu, P; Wang, WW; Hu, XX; Hou, JS; Fang, SL; Liu, XQ				Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hu, Xingxue; Hou, Jinsong; Fang, Silian; Liu, Xiqiang			Perioperative risk factors for postoperative pneumonia after major oral cancer surgery: A retrospective analysis of 331 cases	PLOS ONE			English	Article							PULMONARY COMPLICATIONS; RESPIRATORY COMPLICATIONS; SURGICAL-PATIENTS; NECK-SURGERY; HEAD; MORTALITY; ANESTHESIA; MORBIDITY; OUTCOMES	Objective Postoperative pneumonia (POP) is common and results in prolonged hospital stays, higher costs, increased morbidity and mortality. However, data on the incidence and risk factors of POP after oral and maxillofacial surgery are rare. This study aims to identify perioperative risk factors for POP after major oral cancer (OC) surgery. Methods Perioperative data and patient records of 331 consecutive subjects were analyzed in the period of April 2014 to March 2016. We individually traced each OC patient for a period to discharge from the hospital or 45 days after surgery, whichever occur later. Results The incidence of POP after major OC surgery with free flap construction or major OC surgery was 11.6% or 4.5%, respectively. Patient-related risk factors for POP were male sex, T stage, N stage, clinical stage and preoperative serum albumin level. Among the investigated procedure-related variables, incision grade, mandibulectomy, free flap reconstruction, tracheotomy, intraoperative blood loss, and the length of the operation were shown to be associated with the development of POP. Postoperative hospital stay was also significantly related to increased incidence of POP. Using a multivariable logistic regression model, we identified male sex, preoperative serum albumin level, operation time and postoperative hospital stay as independent risk factors for POP. Conclusion Several perioperative risk factors can be identified that are associated with POP. At-risk oral cancer patients should be subjected to intensified postoperative pulmonary care.	[Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hou, Jinsong; Liu, Xiqiang] Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou, Guangdong, Peoples R China; [Xu, Jieyun; Hu, Jing; Yu, Pei; Wang, Weiwang; Hou, Jinsong; Liu, Xiqiang] Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China; [Hu, Xingxue] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA; [Hu, Xingxue] Ohio State Univ, Coll Dent, Div Gen Practice & Mat Sci, Columbus, OH 43210 USA; [Fang, Silian] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Harvard University; Forsyth Institute; University System of Ohio; Ohio State University; Sun Yat Sen University	Liu, XQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou, Guangdong, Peoples R China.; Liu, XQ (corresponding author), Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China.; Fang, SL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China.	fangsilian@126.com; liuxiq@mail.sysu.edu.cn			National Natural Science Foundation of China [81372885, 81772889, 81702699]; Major Special Research Collaborative Innovation of Guangzhou [201604020160]; China Postdoctoral Science Foundation [2017M612826]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Special Research Collaborative Innovation of Guangzhou; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The present study was supported by grants from the National Natural Science Foundation of China (81372885, 81772889, 81702699), the Major Special Research Collaborative Innovation of Guangzhou (201604020160), and the China Postdoctoral Science Foundation (2017M612826).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2017, J THORAC CARDIOV SUR, V153, P1384, DOI 10.1016/j.jtcvs.2016.12.055; Akutsu Y, 2008, DIGEST SURG, V25, P93, DOI 10.1159/000121903; Chen P, 2014, ARCH GERONTOL GERIAT, V59, P186, DOI 10.1016/j.archger.2014.03.007; Chughtai Morad, 2017, J Clin Med Res, V9, P466, DOI 10.14740/jocmr3002w; Correa RD, 2014, J BRAS PNEUMOL, V40, P643, DOI 10.1590/S1806-37132014000600008; Damian D, 2016, J CLIN ANESTH, V28, P12, DOI 10.1016/j.jclinane.2015.08.007; Dillon JK, 2011, HEAD NECK-J SCI SPEC, V33, P112, DOI 10.1002/hed.21411; Dupont H, 2003, INTENS CARE MED, V29, P179, DOI 10.1007/s00134-002-1603-0; Guay J, 2014, ANESTH ANALG, V119, P716, DOI 10.1213/ANE.0000000000000339; Hausman MS, 2015, ANESTH ANALG, V120, P1405, DOI 10.1213/ANE.0000000000000574; Li L, 2016, J ORAL MAXIL SURG, V74, P415, DOI 10.1016/j.joms.2015.08.018; Ligh CA, 2016, J PLAST SURG HAND SU, V50, P85, DOI 10.3109/2000656X.2015.1106407; Liu YT, 2017, FRONT MED-PRC, V11, P239, DOI 10.1007/s11684-017-0509-8; Loeffelbein DJ, 2016, J CRANIO MAXILL SURG, V44, P952, DOI 10.1016/j.jcms.2016.05.007; Longo WE, 1998, ANN SURG, V228, P64, DOI 10.1097/00000658-199807000-00010; McMahon JD, 2013, BRIT J ORAL MAX SURG, V51, P689, DOI 10.1016/j.bjoms.2013.04.015; Molena D, 2014, SEMIN THORAC CARDIOV, V26, P287, DOI 10.1053/j.semtcvs.2014.12.002; Moolchandani K, 2017, J CLIN DIAGN RES, V11, pDC1, DOI 10.7860/JCDR/2017/23717.9247; Patil Harsha V, 2017, J Nat Sci Biol Med, V8, P46, DOI 10.4103/0976-9668.198360; Petrar S, 2012, LARYNGOSCOPE, V122, P1057, DOI 10.1002/lary.23228; Poelaert J, 2014, J THORAC CARDIOV SUR, V148, P1622, DOI 10.1016/j.jtcvs.2014.05.085; Sabate S, 2014, CURR OPIN ANESTHESIO, V27, P201, DOI 10.1097/ACO.0000000000000045; Sachdev G, 2012, SURG CLIN N AM, V92, P321, DOI 10.1016/j.suc.2012.01.013; Schwam ZG, 2015, LARYNGOSCOPE, V125, P1869, DOI 10.1002/lary.25328; Semenov YR, 2012, LARYNGOSCOPE, V122, P1994, DOI 10.1002/lary.23446; Shah JP, 2009, ORAL ONCOL, V45, P394, DOI 10.1016/j.oraloncology.2008.05.017; Silberstein JL, 2012, BJU INT, V110, P1276, DOI 10.1111/j.1464-410X.2012.11103.x; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Sok M, 2002, EUR J CARDIO-THORAC, V22, P23, DOI 10.1016/S1010-7940(02)00244-0; Trinh VQ, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/6019416; Tusman G, 2012, CURR OPIN ANESTHESIO, V25, P1, DOI 10.1097/ACO.0b013e32834dd1eb; Yeung JK, 2013, LARYNGOSCOPE, V123, P2996, DOI 10.1002/lary.24241; Yoo SH, 2016, J CANCER RES CLIN, V142, P1343, DOI 10.1007/s00432-016-2141-4	33	12	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188167	10.1371/journal.pone.0188167	http://dx.doi.org/10.1371/journal.pone.0188167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135994	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200075
J	Zhao, R; Wang, X; Zou, LY; Li, GH; Chen, Y; Li, CD; Zhang, WY				Zhao, Rong; Wang, Xin; Zou, Liying; Li, Guanghui; Chen, Yi; Li, Changdong; Zhang, Weiyuan			Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries	PLOS ONE			English	Article							ULIPRISTAL ACETATE; INCREASED RISK; LEIOMYOMAS; COMPLICATIONS; PREVALENCE; MANAGEMENT; GROWTH	Objective To estimate the association between uterine fibroids and adverse obstetric outcomes. Methods This was a retrospective cross-sectional study of 112,403 deliveries from 14 provinces and 39 different hospitals in 2011 in mainland China. We compared pregnancy outcomes in women with and without uterine fibroids who underwent detailed second trimester obstetric ultrasonography during 18 to 22 weeks. Obstetric outcomes include cesarean delivery, breech presentation, preterm delivery, placenta previa, placental abruption, premature rupture of membranes and neonatal birthweight. Univariate analyses and multivariate logistic regression analyses were performed. Results Of 112,403 women who underwent routine obstetric survey, 3,012 (2.68%) women were identified with at least 1 fibroid. By univariate and multivariate analyses, the presence of uterine fibroids was significantly associated with cesarean delivery (Adjusted odds radio [AOR] 1.8, 95% confidence interval [CI] 1.7-2.0), breech presentation (AOR 1.3, 95% CI 1.2-1.5) and postpartum hemorrhage (AOR 1.2, 95% CI 1.1-1.4). The size of uterine fibroids and location in uterus had important effect on the mode of delivery. The rates of PPH were significantly higher with increasing size of the uterine fibroid (P<0.001). And the location of fibroid (intramural, submucosal or subserosal) also have a statistically significant impact on the risk of PPH (5.6% [subserosal] vs 4.7% [submucosal] vs 8.6% [intramural]). Conclusion Pregnant women with uterine fibroids are at increased risk for cesarean delivery, breech presentation and postpartum hemorrhage. And different characteristics of uterine fibroids affect obstetric outcomes through different ways. Such detailed information may be useful in risk-stratifying pregnant women with fibroids.	[Zhao, Rong; Wang, Xin; Zou, Liying; Li, Guanghui; Chen, Yi; Li, Changdong; Zhang, Weiyuan] Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstetr Med, Beijing, Peoples R China	Capital Medical University	Zhang, WY (corresponding author), Capital Med Univ, Beijing Obstet & Gynecol Hosp, Dept Obstetr Med, Beijing, Peoples R China.	zhangwy9921@hotmail.com			Special Research Fund in Nonprofit Health Care Industry of the People's Republic of China [201002013]; Beijing Health Bureau	Special Research Fund in Nonprofit Health Care Industry of the People's Republic of China; Beijing Health Bureau	This project was supported by the Special Research Fund in Nonprofit Health Care Industry of the People's Republic of China granted to Weiyuan Zhang (201002013) and the Research Fund for High-level Talented Individuals of Beijing Health Bureau granted to Weiyuan Zhang (2009-2-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YH, 2009, HUM REPROD, V24, P3049, DOI 10.1093/humrep/dep320; Ciavattini A, 2015, J MATERN-FETAL NEO M, V28, P484, DOI 10.3109/14767058.2014.921675; Coronado GD, 2000, OBSTET GYNECOL, V95, P764, DOI 10.1016/S0029-7844(99)00605-5; Donnez J, 2015, FERTIL STERIL, V103, P519, DOI 10.1016/j.fertnstert.2014.10.038; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Drayer SM, 2015, INT J GYNECOL OBSTET, V131, P117, DOI 10.1016/j.ijgo.2015.04.051; Ezzedine D, 2016, CLIN OBSTET GYNECOL, V59, P119, DOI 10.1097/GRF.0000000000000169; Febo G., 1997, Clinical and Experimental Obstetrics and Gynecology, V24, P76; Islam MS, 2016, BEST PRACT RES CL OB, V34, P25, DOI 10.1016/j.bpobgyn.2015.08.018; Klatsky PC, 2008, AM J OBSTET GYNECOL, V198, P357, DOI 10.1016/j.ajog.2007.12.039; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Lai J, 2012, J MATERN-FETAL NEO M, V25, P710, DOI 10.3109/14767058.2011.572205; Lam SJ, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.066; Laughlin SK, 2009, OBSTET GYNECOL, V113, P630, DOI 10.1097/AOG.0b013e318197bbaf; Levy BS, 2008, ACTA OBSTET GYN SCAN, V87, P812, DOI 10.1080/00016340802146912; Medikare Veronica, 2011, J Reprod Infertil, V12, P181; Michels KA, 2014, ANN EPIDEMIOL, V24, P122, DOI 10.1016/j.annepidem.2013.10.017; MOISE KJ, 1993, OBSTET GYNECOL, V82, P881; Morgan Ortiz Fred, 2011, Ginecol Obstet Mex, V79, P467; Navid Sarwat, 2012, J Ayub Med Coll Abbottabad, V24, P90; Noor Shehla, 2009, J Ayub Med Coll Abbottabad, V21, P37; Parazzini F, 2016, BEST PRACT RES CL OB, V34, P74, DOI 10.1016/j.bpobgyn.2015.11.017; Qidwai GI, 2006, OBSTET GYNECOL, V107, P376, DOI 10.1097/01.AOG.0000196806.25897.7c; Roberts WE, 1999, AUST NZ J OBSTET GYN, V39, P43, DOI 10.1111/j.1479-828X.1999.tb03442.x; ROSATI P, 1992, J ULTRAS MED, V11, P511; Shavell VI, 2012, FERTIL STERIL, V97, P107, DOI 10.1016/j.fertnstert.2011.10.009; Sheiner E, 2004, J REPROD MED, V49, P182; Stout MJ, 2010, OBSTET GYNECOL, V116, P1056, DOI 10.1097/AOG.0b013e3181f7496d; Vergani P, 2007, OBSTET GYNECOL, V109, P410, DOI 10.1097/01.AOG.0000250470.78700.f0; Wu JL, 2015, FERTIL STERIL, V104, P559, DOI 10.1016/j.fertnstert.2015.06.034	30	27	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187821	10.1371/journal.pone.0187821	http://dx.doi.org/10.1371/journal.pone.0187821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136018	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200034
J	Yun, KW; Choi, EH; Lee, HJ				Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong			Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; SEROTYPE DISTRIBUTION; ELICIT PROTECTION; PSPA SEQUENCE; UNITED-STATES; OTITIS-MEDIA; IMMUNIZATION; ANTIBODIES; DISEASE	Pneumococcal surface protein A (PspA) is an important virulence factor of pneumococci and has been investigated as a primary component of a capsular serotype-independent pneumococcal vaccine. Thus, we sought to determine the genetic diversity of PspA to explore its potential as a vaccine candidate. Among the 190 invasive pneumococcal isolates collected from Korean children between 1991 and 2016, two (1.1%) isolates were found to have no pspA by multiple polymerase chain reactions. The full length pspA genes from 185 pneumococcal isolates were sequenced. The length of pspA varied, ranging from 1,719 to 2,301 base pairs with 55.7-100% nucleotide identity. Based on the sequences of the clade-defining regions, 68.7% and 49.7% were in PspA family 2 and clade 3/family 2, respectively. PspA clade types were correlated with genotypes using multilocus sequence typing and divided into several subclades based on diversity analysis of the N-terminal a-helical regions, which showed nucleotide sequence identities of 45.7-100% and amino acid sequence identities of 23.1-100%. Putative antigenicity plots were also diverse among individual clades and subclades. The differences in antigenicity patterns were concentrated within the N-terminal 120 amino acids. In conclusion, the N-terminal a-helical domain, which is known to be the major immunogenic portion of PspA, is genetically variable and should be further evaluated for antigenic differences and cross-reactivity between various PspA types from pneumococcal isolates.	[Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea; [Yun, Ki Wook; Choi, Eun Hwa; Lee, Hoan Jong] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Pediat, Coll Med, Seoul, South Korea.; Lee, HJ (corresponding author), Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea.	hoanlee@snu.ac.kr			National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology [20110023092]	National Research Foundation (NRF) of Korea - Ministry of Education, Science, and Technology	HJL is the recipient of a Grant of the the Basic Science Research Program through the National Research Foundation (NRF,http://www.nrf.re.kr) of Korea, which is funded by the Ministry of Education, Science, and Technology (20110023092). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barocchi MA, 2007, VACCINE, V25, P2963, DOI 10.1016/j.vaccine.2007.01.065; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Beddows S, 1999, J VIROL, V73, P1740, DOI 10.1128/JVI.73.2.1740-1745.1999; Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009; Cho EY, 2016, J KOREAN MED SCI, V31, P1082, DOI 10.3346/jkms.2016.31.7.1082; Cho EY, 2014, DIAGN MICR INFEC DIS, V78, P481, DOI 10.1016/j.diagmicrobio.2013.12.016; Coral MCV, 2001, EMERG INFECT DIS, V7, P832; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Eun BW, 2010, DIAGN MICR INFEC DIS, V68, P345, DOI 10.1016/j.diagmicrobio.2010.07.008; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Heeg C, 2007, VACCINE, V25, P1030, DOI 10.1016/j.vaccine.2006.09.061; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Kim L, 2016, CLIN MICROBIOL REV, V29, P525, DOI 10.1128/CMR.00058-15; MCDANIEL LS, 1994, MICROB PATHOGENESIS, V17, P323, DOI 10.1006/mpat.1994.1078; McDaniel LS, 1998, INFECT IMMUN, V66, P4748, DOI 10.1128/IAI.66.10.4748-4754.1998; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mollerach M, 2004, EPIDEMIOL INFECT, V132, P177, DOI 10.1017/S0950268803001626; Moore CE, 2014, J INFECT DIS, V210, P1001, DOI 10.1093/infdis/jiu213; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Vadesilho CFM, 2014, CLIN VACCINE IMMUNOL, V21, P940, DOI 10.1128/CVI.00239-14; White P, 1999, ORL J OTO-RHINO-LARY, V61, P206, DOI 10.1159/000027672; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Yamamoto M, 1998, J IMMUNOL, V161, P4115; Yatim MM, 2013, J MICROBIOL IMMUNOL, V46, P180, DOI 10.1016/j.jmii.2012.04.004; Yun KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134055; Yun KW, 2011, J KOREAN MED SCI, V26, P971, DOI 10.3346/jkms.2011.26.8.971; 김경호, 2005, Clinical and Experimental Pediatrics, V48, P1206	32	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0183968	10.1371/journal.pone.0183968	http://dx.doi.org/10.1371/journal.pone.0183968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131872	Green Submitted, gold, Green Published			2022-12-27	WOS:000414997800001
J	Colombaioni, L; Onor, M; Benedetti, E; Bramanti, E				Colombaioni, Laura; Onor, Massimo; Benedetti, Edoardo; Bramanti, Emilia			Thallium stimulates ethanol production in immortalized hippocampal neurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBROSPINAL-FLUID; ENDOGENOUS ETHANOL; IN-VITRO; ADULT NEUROGENESIS; NORTHERN TUSCANY; TAP WATER; CELLS; APOPTOSIS; MITOCHONDRIAL	Lactate and ethanol (EtOH) were determined in cell culture medium (CCM) of immortalized hippocampal neurons (HN9.10e cell line) before and after incubation with Thallium (Tl). This cell line is a reliable, in vitro model of one of the most vulnerable regions of central nervous system. Cells were incubated for 48 h with three different single Tl doses: 1, 10, 100 mu g/L (corresponding to 4.9, 49 and 490 nM, respectively). After 48 h, neurons were "reperfused" with fresh CCM every 24/48 h until 7 days after the treatment and the removed CCM was collected and analysed. Confocal microscopy was employed to observe morphological changes. EtOH was determined by head space-solid phase microextraction -gas chromatography -mass spectrometry (HS-SPME-GCMS), lactate by RP-HPLC with UV detection. Tl exposure had significant effects on neuronal growth rate and morphology. The damage degree was dose-dependent. In not exposed cells, EtOH concentration was 0.18 +/- 0.013 mM, which represents about 5% of lactate concentration (3.4 +/- 0.10 mM). After Tl exposure lactate and EtOH increased. In CCM of 100 and 10 mu g/L Tl-treated cells, lactate increased 24 h after reperfusion up to 2 and 3.3 times the control value, respectively. In CCM of 10 and 100 mu g/L Tl-treated cells 24 h after reperfusion, EtOH increased up to 0.3 and 0.58 mmol/L. respectively. These results are consistent with significant alterations in energy metabolism, despite the low doses of Tl employed and the relatively short incubation time.	[Colombaioni, Laura] CNR, Area Ric, Neurosci Inst, Pisa, Italy; [Onor, Massimo; Bramanti, Emilia] Inst Chem Organo Metall Cpds ICCOM, Natl Res Council Italy, CNR, Pisa, Italy; [Benedetti, Edoardo] Univ Pisa, Dept Oncol, Hematol Unit, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Pisa	Bramanti, E (corresponding author), Inst Chem Organo Metall Cpds ICCOM, Natl Res Council Italy, CNR, Pisa, Italy.	bramanti@pi.iccom.cnr.it	Colombaioni, Laura/O-2580-2015; Bramanti, Emilia/AAQ-9425-2021; Bramanti, Emilia/E-1114-2011; Onor, Massimo/A-4382-2012; benedetti, edoardo/AAB-3717-2019	Colombaioni, Laura/0000-0001-6273-9239; Bramanti, Emilia/0000-0001-8478-7370; Onor, Massimo/0000-0003-3023-1072; Benedetti, Edorado/0000-0001-5295-2087				AGAPEJEV S, 1992, ACTA NEUROL SCAND, V86, P496, DOI 10.1111/j.1600-0404.1992.tb05131.x; Antoshechkin AG, 2001, ALCOHOL ALCOHOLISM, V36, P608, DOI 10.1093/alcalc/36.6.608; Apple DM, 2017, BRAIN RES, V1655, P270, DOI 10.1016/j.brainres.2016.01.023; Bacman SR, 2006, MOL NEUROBIOL, V33, P113, DOI 10.1385/MN:33:2:113; Bartsch T, 2015, NEUROSCIENCE, V309, P1, DOI 10.1016/j.neuroscience.2015.07.084; Biagi S, 2012, BIOMED CHROMATOGR, V26, P1408, DOI 10.1002/bmc.2713; Biagioni C, 2017, SCI TOTAL ENVIRON, V587, P491, DOI 10.1016/j.scitotenv.2017.02.177; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Campanella B, 2017, TALANTA, V171, P255, DOI 10.1016/j.talanta.2017.05.009; Campanella B, 2016, SCI TOTAL ENVIRON, V548, P33, DOI 10.1016/j.scitotenv.2016.01.010; Caracelli I, 2014, COORDIN CHEM REV, V281, P50, DOI 10.1016/j.ccr.2014.09.001; Casiot C, 2011, ENVIRON SCI TECHNOL, V45, P2056, DOI 10.1021/es102064r; Cerrato L, 2009, TOXICOL APPL PHARM, V238, P111, DOI 10.1016/j.taap.2009.05.005; Cobelo-Garcia A, 2015, ENVIRON SCI POLLUT R, V22, P15188, DOI 10.1007/s11356-015-5221-0; Colombaioni L, 2002, DEV BRAIN RES, V134, P93, DOI 10.1016/S0165-3806(01)00326-1; Colombaioni L, 2002, NEUROCHEM INT, V40, P327, DOI 10.1016/S0197-0186(01)00090-0; Costa J, 2016, CLIN CHIM ACTA, V455, P7, DOI 10.1016/j.cca.2016.01.011; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Doonan F, 2008, METHODS, V44, P200, DOI 10.1016/j.ymeth.2007.11.006; Dorokhov YL, 2015, PHYSIOL REV, V95, P603, DOI 10.1152/physrev.00034.2014; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOUGLAS KT, 1990, INT J BIOCHEM, V22, P429, DOI 10.1016/0020-711X(90)90254-Z; Hanzel CE, 2009, TOXICOL APPL PHARM, V236, P59, DOI 10.1016/j.taap.2008.12.029; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; Filipiak W, 2016, CURR MED CHEM, V23, P2112, DOI 10.2174/0929867323666160510122913; Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162; Flynn Kevin C, 2013, Bioarchitecture, V3, P86; Galvan-Arzate S, 1998, TOXICOL LETT, V99, P1, DOI 10.1016/S0378-4274(98)00126-X; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gray E, 2015, AMYOTROPH LAT SCL FR, V16, P456, DOI 10.3109/21678421.2015.1053490; GREGOTTI C, 1992, J TOXICOL ENV HEALTH, V36, P59, DOI 10.1080/15287399209531623; Hanzel CE, 2006, TOXICOL APPL PHARM, V216, P485, DOI 10.1016/j.taap.2006.07.003; Hurtley SM, 2016, SCIENCE, V352, P48; Jin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.78; Rodriguez-Mercado JJ, 2013, DRUG CHEM TOXICOL, V36, P369, DOI 10.3109/01480545.2012.710633; KAYNE FJ, 1971, ARCH BIOCHEM BIOPHYS, V143, P232, DOI 10.1016/0003-9861(71)90204-9; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Komarova TV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090239; Korr H, 1980, ADV ANATOMY EMBRYOLO; KRAHWINKEL W, 1988, J NUCL MED, V29, P1582; Krasnodebska-Ostrega B, 2005, J SOIL SEDIMENT, V5, P71, DOI 10.1065/jss2005.05.136; LEE HJ, 1990, J NEUROSCI, V10, P1779; LESTER D, 1961, Q J STUD ALCOHOL, V22, P554; Llorente C, 2015, CELL MOL GASTROENTER, V1, P275, DOI 10.1016/j.jcmgh.2015.04.003; MANZO L, 1988, HDB TOXICITY INORGAN, P677; Martin F, 2004, SOIL SEDIMENT CONTAM, V13, P25, DOI 10.1080/10588330490269769; MCMANUS IR, 1960, SCIENCE, V131, P102, DOI 10.1126/science.131.3393.102; Meshitsuka S, 2001, CLIN CHIM ACTA, V312, P25, DOI 10.1016/S0009-8981(01)00587-3; Mori K, 1998, NEUROL RES, V20, P19; Nava-Ruiz C, POLLUTANT DIS REMEDI, P321; Nordberg M, 2005, ESSENTIALS MED GEOLO, P212; Peter ALJ, 2005, ENVIRON INT, V31, P9; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; REPETTO G, 1994, TOXICOL IN VITRO, V8, P609, DOI 10.1016/0887-2333(94)90028-0; Rietze R, 2000, J COMP NEUROL, V424, P397; Riveros-Rosas H, 1997, ARCH MED RES, V28, P453; Standards CN, 2006, GB57492006 STAND CN; TALAS A, 1983, ARCH TOXICOL, V53, P1, DOI 10.1007/BF01459996; United States Environmental Protection Agency, 2009, EPA635R08001F; van der Voet G.B., 2011, ENCY ENV HLTH, P713, DOI 10.1016 /B978-0-444-52272-6.00236-1; van Waarde A, 1993, SURVIVING HYPOXIA ME; Viraraghavan T, 2011, ENCY ENV HLTH, P39, DOI [10.1016/B978-0-444-63951-6.00643-4, DOI 10.1016/B978-0-444-52272-6.00643-7]; Voccoli V, 2007, BRAIN RES, V1147, P1, DOI 10.1016/j.brainres.2007.01.145; Voccoli V, 2009, BRAIN RES, V1252, P15, DOI 10.1016/j.brainres.2008.11.026; WALKER GW, 1966, NATURE, V210, P1368, DOI 10.1038/2101368a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu KY, 2014, J BIOL CHEM, V289, P20193, DOI 10.1074/jbc.C114.561860; Xiao TF, 2012, SCI TOTAL ENVIRON, V421, P51, DOI 10.1016/j.scitotenv.2011.04.008	74	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188351	10.1371/journal.pone.0188351	http://dx.doi.org/10.1371/journal.pone.0188351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161327	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000044
J	Gao, MZ; Yu, B; Qiu, ZQ; Yin, XG; Li, SW; Liu, Q				Gao, Mingzhong; Yu, Bin; Qiu, Zhiqiang; Yin, Xiangang; Li, Shengwei; Liu, Qiang			Derivation and application of an analytical rock displacement solution on rectangular cavern wall using the inverse mapping method	PLOS ONE			English	Article							STRESS; HOLE	Rectangular caverns are increasingly used in underground engineering projects, the failure mechanism of rectangular cavern wall rock is significantly different as a result of the crosssectional shape and variations in wall stress distributions. However, the conventional computational method always results in a long-winded computational process and multiple displacement solutions of internal rectangular wall rock. This paper uses a Laurent series complex method to obtain a mapping function expression based on complex variable function theory and conformal transformation. This method is combined with the Schwarz-Christoffel method to calculate the mapping function coefficient and to determine the rectangular cavern wall rock deformation. With regard to the inverse mapping concept, the mapping relation between the polar coordinate system within plane. and a corresponding unique plane coordinate point inside the cavern wall rock is discussed. The disadvantage of multiple solutions when mapping from the plane to the polar coordinate system is addressed. This theoretical formula is used to calculate wall rock boundary deformation and displacement field nephograms inside the wall rock for a given cavern height and width. A comparison with ANSYS numerical software results suggests that the theoretical solution and numerical solution exhibit identical trends, thereby demonstrating the method's validity. This method greatly improves the computing accuracy and reduces the difficulty in solving for cavern boundary and internal wall rock displacements. The proposed method provides a theoretical guide for controlling cavern wall rock deformation failure.	[Gao, Mingzhong; Qiu, Zhiqiang; Li, Shengwei; Liu, Qiang] Sichuan Univ, Coll Water Resource & Hydropower, State Key Lab Hydraul & Mt River Engn, Chengdu, Sichuan, Peoples R China; [Gao, Mingzhong; Qiu, Zhiqiang; Li, Shengwei; Liu, Qiang] Sichuan Univ, Minist Educ, Key Lab Energy Engn Safety & Mech Disaster, Chengdu, Sichuan, Peoples R China; [Yu, Bin] Datong Coal Mine Grp Co Ltd, Datong, Peoples R China; [Yin, Xiangang] Min Res Co Ltd, Changsha Inst, Changsha, Hunan, Peoples R China	Sichuan University; Sichuan University	Yu, B (corresponding author), Datong Coal Mine Grp Co Ltd, Datong, Peoples R China.	42498410@qq.com			National Key Research and Development Program of China [2016YFC0600701]; National Natural Science Foundation of China [51674170]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was financially supported by the National Key Research and Development Program of China (Grant No. 2016YFC0600701) and National Natural Science Foundation of China (Grant No. 51674170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financially supported by the National Key Research and Development Program of China (Grant No. 2016YFC0600701) and National Natural Science Foundation of China (Grant No. 51674170).	Akbarov SD, 2004, J STRAIN ANAL ENG, V39, P615, DOI 10.1243/0309324042379257; Barber J.R., 2002, ELASTICITY; Charles J, 1988, ROCK MECH ENG; de Saint-Venant B., 1855, ME MOIRE TORSION PRI, P555; Fahimifar A, 2010, TUNN UNDERGR SP TECH, V25, P297, DOI 10.1016/j.tust.2010.01.002; Grigorios T, 2013, 4 ECCOMAS THEM C COM; He M.C., 2004, THEORY PRACTICE BOLT; Huo H, 2006, TUNN UNDERGR SP TECH, V21, P613, DOI 10.1016/j.tust.2005.12.135; [蒋斌松 JIANG Binsong], 2007, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V26, P982; Lei GH, 2001, J ENG MECH-ASCE, V127, P880, DOI 10.1061/(ASCE)0733-9399(2001)127:9(880); Lu A.Z., 1995, CHINESE J ROCK MECH, V14, P269; Lv AZ., 2007, COMPLEX VARIABLE FUN; Muskhelishvili N.I., 1962, SOME BASIC PROBLEMS; Sarason D., 2007, COMPLEX FUNCTION THE, V2, DOI [10.1090/mbk/049, DOI 10.1090/MBK/049]; Savin GM., 1961, STRESS CONCENTRATION; Sellers EJ, 2000, TUNN UNDERGR SP TECH, V15, P463, DOI 10.1016/S0886-7798(01)00015-3; Sharan SK, 2005, INT J ROCK MECH MIN, V42, P542, DOI 10.1016/j.ijrmms.2005.03.019; Sharan SK, 2003, INT J ROCK MECH MIN, V40, P817, DOI 10.1016/S1365-1609(03)00040-6; Sharma DS, 2012, ENG LET, V20, P1; Wang SL, 2012, TUNN UNDERGR SP TECH, V30, P155, DOI 10.1016/j.tust.2012.02.016	20	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188336	10.1371/journal.pone.0188336	http://dx.doi.org/10.1371/journal.pone.0188336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155892	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700048
J	Lucas, JE; Bazemore, TC; Alo, C; Monahan, PB; Voora, D				Lucas, Joseph E.; Bazemore, Taylor C.; Alo, Celan; Monahan, Patrick B.; Voora, Deepak			An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System	PLOS ONE			English	Article							NONADHERENCE; PHYSICIAN; THERAPY; PATIENT	HMG-CoA reductase inhibitors (or "statins") are important and commonly used medications to lower cholesterol and prevent cardiovascular disease. Nearly half of patients stop taking statin medications one year after they are prescribed leading to higher cholesterol, increased cardiovascular risk, and costs due to excess hospitalizations. Identifying which patients are at highest risk for not adhering to long-term statin therapy is an important step towards individualizing interventions to improve adherence. Electronic health records (EHR) are an increasingly common source of data that are challenging to analyze but have potential for generating more accurate predictions of disease risk. The aim of this study was to build an EHR based model for statin adherence and link this model to biologic and clinical outcomes in patients receiving statin therapy. We gathered EHR data from the Military Health System which maintains administrative data for active duty, retirees, and dependents of the United States armed forces military that receive health care benefits. Data were gathered from patients prescribed their first statin prescription in 2005 and 2006. Baseline billing, laboratory, and pharmacy claims data were collected from the two years leading up to the first statin prescription and summarized using non-negative matrix factorization. Follow up statin prescription refill data was used to define the adherence outcome (> 80 percent days covered). The subsequent factors to emerge from this model were then used to build cross-validated, predictive models of 1) overall disease risk using coalescent regression and 2) statin adherence (using random forest regression). The predicted statin adherence for each patient was subsequently used to correlate with cholesterol lowering and hospitalizations for cardiovascular disease during the 5 year follow up period using Cox regression. The analytical dataset included 138 731 individuals and 1840 potential baseline predictors that were reduced to 30 independent EHR "factors". A random forest predictive model taking patient, statin prescription, predicted disease risk, and the EHR factors as potential inputs produced a cross-validated c-statistic of 0.736 for classifying statin non-adherence. The addition of the first refill to the model increased the c-statistic to 0.81. The predicted statin adherence was independently associated with greater cholesterol lowering (correlation = 0.14, p < 1e-20) and lower hospitalization for myocardial infarction, coronary artery disease, and stroke (hazard ratio = 0.84, p = 1.87E-06). Electronic health records data can be used to build a predictive model of statin adherence that also correlates with statins' cardiovascular benefits.	[Lucas, Joseph E.] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Bazemore, Taylor C.; Voora, Deepak] Duke Univ, Dept Med, Durham, NC 27708 USA; [Alo, Celan; Monahan, Patrick B.] US Air Force, Air Force Med Operat Agcy, Joint Base Lackland Kell, TX USA; [Voora, Deepak] Duke Univ, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA	Duke University; Duke University; United States Department of Defense; United States Air Force; Duke University	Voora, D (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.; Voora, D (corresponding author), Duke Univ, Ctr Appl Genom & Precis Med, Durham, NC 27708 USA.	Deepak.voora@duke.edu		Voora, Deepak/0000-0003-0015-5179	United States Air Force [FA8650-13-2-6375]	United States Air Force(United States Department of Defense)	This work was supported by the United States Air Force (FA8650-13-2-6375).	Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chan DC, 2010, MED CARE, V48, P196, DOI 10.1097/MLR.0b013e3181c132ad; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Franklin JM, 2015, HLTH SERV RES; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldstein BA, 2016, J AM MED INF ASS; Harrison T, 2011, CLIN MED RES, V9, P150, DOI 10.3121/cmr.2011.1020.c-a4-01; Henao R, 2016, ARXIV E PRINTS, P1608; Ho PM, 2008, AM HEART J, V155, P772, DOI 10.1016/j.ahj.2007.12.011; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Li L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9364; Molfenter TD, 2012, PATIENT PREFER ADHER, V6, P643, DOI 10.2147/PPA.S34711; Murdoch TB, 2013, JAMA-J AM MED ASSOC, V309, P1351, DOI 10.1001/jama.2013.393; Ng K, 2014, J BIOMED INFORM, V48, P160, DOI 10.1016/j.jbi.2013.12.012; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pedan A, 2007, J MANAGE CARE PHARM, V13, P487, DOI 10.18553/jmcp.2007.13.6.487; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Raebel MA, 2012, J GEN INTERN MED, V27, P57, DOI 10.1007/s11606-011-1829-z; Ruokoniemi P, 2011, BRIT J CLIN PHARMACO, V71, P766, DOI 10.1111/j.1365-2125.2010.03895.x; Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606; Singer SR, 2012, AM J MANAG CARE, V18; Stojanovic J, 2016, IEEE ACM T COMPUT BI, V99, P1; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thompson Paul D, 2010, Prev Cardiol, V13, P104, DOI 10.1111/j.1751-7141.2009.00063.x; Yurkovich M, 2015, J CLIN EPIDEMIOL, V68, P3, DOI 10.1016/j.jclinepi.2014.09.010	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187809	10.1371/journal.pone.0187809	http://dx.doi.org/10.1371/journal.pone.0187809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155848	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700017
J	Rong-Mullins, X; Ravishankar, A; McNeal, KA; Lonergan, ZR; Biega, AC; Creamer, JP; Gallagher, JEG				Rong-Mullins, Xiaoqing; Ravishankar, Apoorva; McNeal, Kirsten A.; Lonergan, Zachery R.; Biega, Audrey C.; Creamer, J. Philip; Gallagher, Jennifer E. G.			Genetic variation in Dip5, an amino acid permease, and Pdr5, a multiple drug transporter, regulates glyphosate resistance in S. cerevisiae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; HERBICIDE GLYPHOSATE; MULTIDRUG-RESISTANCE; MOLECULAR-BASIS; YEAST; SYNTHASE; GENOME; AMPLIFICATION; ARCHITECTURE	S. cerevisiae from different environments are subject to a wide range of selective pressures, whether intentional or by happenstance. Chemicals classified by their application, such as herbicides, fungicides and antibiotics, can affect non-target organisms. First marketed as RoundUp T, glyphosate is the most widely used herbicide. In plants, glyphosate inhibits EPSPS, of the shikimate pathway, which is present in many organisms but lacking in mammals. The shikimate pathway produces chorismate which is the precursor to all the aromatic amino acids, para-aminobenzoic acid, and Coenzyme Q10. Crops engineered to be resistant to glyphosate contain a homolog of EPSPS that is not bound by glyphosate. Here, we show that S. cerevisiae has a wide-range of glyphosate resistance. Sequence comparison between the target proteins, i.e., the plant EPSPS and the yeast orthologous protein Aro1, predicted that yeast would be resistant to glyphosate. However, the growth variation seen in the subset of yeast tested was not due to polymorphisms within Aro1, instead, it was caused by genetic variation in an ABC multiple drug transporter, Pdr5, and an amino acid permease, Dip5. Using genetic variation as a probe into glyphosate response, we uncovered mechanisms that contribute to the transportation of glyphosate in and out of the cell. Taking advantage of the natural genetic variation within yeast and measuring growth under different conditions that would change the use of the shikimate pathway, we uncovered a general transport mechanism of glyphosate into eukaryotic cells.	[Rong-Mullins, Xiaoqing; Ravishankar, Apoorva; McNeal, Kirsten A.; Lonergan, Zachery R.; Biega, Audrey C.; Creamer, J. Philip; Gallagher, Jennifer E. G.] West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA; [Lonergan, Zachery R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	West Virginia University; Vanderbilt University	Gallagher, JEG (corresponding author), West Virginia Univ, Dept Biol, Morgantown, WV 26506 USA.	jegallagher@mail.wvu.edu		Lonergan, Zachery/0000-0001-7694-2166; Rong-Mullins, Xiaoqing/0000-0002-2122-552X; Creamer, John/0000-0002-5147-3866; Gallagher, Jennifer/0000-0002-6163-3181	West Virginia University PSCoR; West Virginia University Senate Grant; WVU Summer Undergraduate Research Experience; NSF REU-Biological Responses [DBI 1156627]; NSF-MCB [1614573]	West Virginia University PSCoR; West Virginia University Senate Grant; WVU Summer Undergraduate Research Experience; NSF REU-Biological Responses; NSF-MCB(National Science Foundation (NSF))	West Virginia University PSCoR and West Virginia University Senate Grant provided initial funding. ACB was funded by WVU Summer Undergraduate Research Experience. ZRL was funded by NSF REU-Biological Responses to the Environment from Genes to the Ecosystem DBI 1156627. This work was funded by NSF-MCB 1614573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ashok Bidwai for critical reading of the manuscript. Thanks to Luke Evans for suggesting the use of RoundUp (TM). Barbara Dunn and Gavin Sherlock provided the yeast used here and pGS36. Angela Lee generously shared the entire BY4741 yeast knockout collection. Zhenglong Gu and Xiaoxian Guo shared the YJM789 pdr5 knockout. West Virginia University PSCoR and West Virginia University Senate Grant provided initial funding. ACB was funded by WVU Summer Undergraduate Research Experience. ZRL was funded by NSF REU-Biological Responses to the Environment from Genes to the Ecosystem DBI 1156627. This work was funded by NSF-MCB 1614573.	AMRHEIN N, 1980, PLANT PHYSIOL, V66, P830, DOI 10.1104/pp.66.5.830; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bradberry Sally M, 2004, Toxicol Rev, V23, P159, DOI 10.2165/00139709-200423030-00003; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Cakmak I, 2009, EUR J AGRON, V31, P114, DOI 10.1016/j.eja.2009.07.001; Christie KR, 2009, TRENDS MICROBIOL, V17, P286, DOI 10.1016/j.tim.2009.04.005; Collart MA, 2001, PREPARATION YEAST RN; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DUNCAN K, 1987, BIOCHEM J, V246, P375, DOI 10.1042/bj2460375; Eschenburg S, 2002, PLANTA, V216, P129, DOI 10.1007/s00425-002-0908-0; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Gallagher JEG, 2014, GENE DEV, V28, P409, DOI 10.1101/gad.228940.113; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Guan WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011309; Haderlie LC, 1972, PLANT PATHOL, V60, P40; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; LEPPERT G, 1990, GENETICS, V125, P13; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MADSEN HEL, 1978, ACTA CHEM SCAND A, V32, P79, DOI 10.3891/acta.chem.scand.32a-0079; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; O'Donnell AF, 2013, J BIOL CHEM, V288, P24063, DOI 10.1074/jbc.M113.478511; Pollegioni L, 2011, FEBS J, V278, P2753, DOI 10.1111/j.1742-4658.2011.08214.x; Reeds PJ, 2000, J NUTR, V130, p1835S; Regenberg B, 1998, CURR GENET, V33, P171, DOI 10.1007/s002940050324; ROGERS SG, 1983, APPL ENVIRON MICROB, V46, P37, DOI 10.1128/AEM.46.1.37-43.1983; Rong-Mullins X, 2017, METALLOMICS, V9, P1304, DOI 10.1039/c7mt00147a; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Sirisattha Sophon, 2004, Environ Sci, V11, P313; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tanney JB, 2010, CAN J MICROBIOL, V56, P138, DOI [10.1139/w09-122, 10.1139/W09-122]; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	44	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187522	10.1371/journal.pone.0187522	http://dx.doi.org/10.1371/journal.pone.0187522			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155836	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700011
J	van der Heijden, EMDL; Chileshe, J; Vernooij, JCM; Gortazar, C; Juste, RA; Sevilla, I; Crafford, JE; Rutten, VPMG; Michel, AL				van der Heijden, E. M. D. L.; Chileshe, J.; Vernooij, J. C. M.; Gortazar, C.; Juste, R. A.; Sevilla, I.; Crafford, J. E.; Rutten, V. P. M. G.; Michel, A. L.			Immune response profiles of calves following vaccination with live BCG and inactivated Mycobacterium bovis vaccine candidates	PLOS ONE			English	Article							TUBERCULOUS PLEURITIS; IFN-GAMMA; CATTLE; WILDLIFE; PROTECTION; DIFFERENCE; INFECTION; DIAGNOSIS; ANTIGENS; PROGRESS	Conventional control and eradication strategies for bovine tuberculosis (BTB) face tremendous difficulties in developing countries; countries with wildlife reservoirs, a complex wildlife-livestock- human interface or a lack of veterinary and veterinary public health surveillance. Vaccination of cattle and other species might in some cases provide the only suitable control strategy for BTB, while in others it may supplement existing test-and-slaughter schemes. However, the use of live BCG has several limitations and the global rise of HIV/AIDS infections has furthermore warranted the exploration of inactivated vaccine preparations. The aim of this study was to compare the immune response profiles in response to parenteral vaccination with live BCG and two inactivated vaccine candidates in cattle. Twenty-four mixed breed calves (Bos taurus) aged 4-6 months, were allocated to one of four groups and vaccinated sub-cutaneously with live M. bovis BCG (Danish 1331), formalin-inactivated M. bovis BCG, heat-killed M. bovis or PBS/Montanide T (control). Interferon. responsiveness and antibody production were measured prior to vaccination and at weekly intervals thereafter for twelve weeks. At nine weeks post-priming, animals were skin tested using tuberculins and MTBC specific protein cocktails and subsequently challenged through intranodular injection of live M. bovis BCG. The animals in the heat-killed M. bovis group demonstrated strong and sustained cellmediated and humoral immune responses, significantly higher than the control group in response to vaccination, which may indicate a protective immune profile. Animals in this group showed reactivity to the skin test reagents, confirming good vaccine take. Lastly, although not statistically significant, recovery of BCG after challenge was lowest in the heatkilled M. bovis group. In conclusion, the parenteral heat-killed M. bovis vaccine proved to be clearly immunogenic in cattle in the present study, urging further evaluation of the vaccine in challenge studies using virulent M. bovis and assessment of vaccine efficacy in field conditions.	[van der Heijden, E. M. D. L.; Rutten, V. P. M. G.] Univ Utrecht, Fac Vet Med, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands; [van der Heijden, E. M. D. L.; Chileshe, J.; Crafford, J. E.; Rutten, V. P. M. G.; Michel, A. L.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Pretoria, South Africa; [Vernooij, J. C. M.] Univ Utrecht, Dept Farm Anim Hlth, Fac Vet Med, Utrecht, Netherlands; [Gortazar, C.] UCLM, JCCM, CSIC, SaBio Inst Invest Recursos Cinegeticos IREC, Ciudad Real, Spain; [Juste, R. A.; Sevilla, I.] Inst Vasco Invest & Desarrollo Agrario, Dept Anim Hlth, NEIKER, Bizkaia Sci & Technology Pk, Derio, Bizkaia, Spain; [Juste, R. A.] SERIDA, Villaviciosa, Asturias, Spain; [Michel, A. L.] Natl Zool Gardens South Africa, Pretoria, South Africa	Utrecht University; University of Pretoria; Utrecht University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA; National Research Foundation - South Africa; National Zoological Gardens of South Africa	van der Heijden, EMDL (corresponding author), Univ Utrecht, Fac Vet Med, Div Immunol, Dept Infect Dis & Immunol, Utrecht, Netherlands.; van der Heijden, EMDL (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Bovine TB & Brucellosis Res Programme, Pretoria, South Africa.	e.m.d.l.vanderheijden@uu.nl	Sevilla, Iker A/O-6060-2014; Vernooij, Johannes/J-3991-2019; Rutten, Victor PMG/AAB-6833-2022; Michel, Anita/N-8996-2014; Juste, Ramon A./C-3570-2008; Gortazar, Christian/E-7918-2012	Sevilla, Iker A/0000-0003-3968-3390; Vernooij, Johannes/0000-0002-2646-9216; Rutten, Victor PMG/0000-0002-6171-1805; Michel, Anita/0000-0001-9240-2653; Juste, Ramon A./0000-0001-6037-5873; van der Heijden, Elisabeth Margaretha Diana Louise/0000-0002-8444-6928; Crafford, Jan/0000-0001-7343-8327; Gortazar, Christian/0000-0003-0012-4006	NWO-WOTRO Science for Global Development [W01.65.321.00]; NWO-WOTRO; Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease; Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium; IRT; MINECO; FEDER Plan Nacional [AGL2014-56305]; MINECO FEDER; EUROSA	NWO-WOTRO Science for Global Development; NWO-WOTRO(Netherlands Organization for Scientific Research (NWO)); Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease; Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium; IRT; MINECO(Spanish Government); FEDER Plan Nacional; MINECO FEDER(Spanish Government); EUROSA	This work was supported by NWO-WOTRO Science for Global Development (grant W01.65.321.00) to VR & AL (https://www.nwo.nl/en/about-nwo/organisation/nwo-domains/wotro), and NWO-WOTRO funding was used towards all experimental costs, including purchase of animals, consumables, test kits etc.; The Institutional Research Theme of the University of Pretoria on Animal Zoonotic Disease and the Third Framework Agreement Programme (FA3-III) through the Institute of Tropical Medicine, Antwerp, Belgium to VR & AL (https://www.itg.be), and IRT funding was used towards all experimental costs, including purchase of animals, consumables, test kits etc.; MINECO and FEDER Plan Nacional (grant AGL2014-56305) to CG(http://www.idi.mineco.gob.es/portal/site/MICINN/menuitem.26172fcf4eb029fa6ec7da6901432ea0/?vgnextoid=4d494d861a299210VgnVCM1000001d04140aRCRD), and MINECO & FEDER funding was used towards coordination among IREC members; and the Erasmus Mundus Action 2 EUROSA scholarship to EvdH (https://www.uantwerpen.be/en/projects/eurosa/), and EUROSA funding was used towards the stipendium of EvdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; BARNES PF, 1989, J IMMUNOL, V142, P1114; BARNES PF, 1990, J IMMUNOL, V145, P149; Beltran-Beck B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098048; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Buddle BM, 2013, TRANSBOUND EMERG DIS, V60, P136, DOI 10.1111/tbed.12092; Buddle BM, 2006, VET MICROBIOL, V112, P191, DOI 10.1016/j.vetmic.2005.11.027; Buddle BM, 2003, INT J PARASITOL, V33, P555, DOI 10.1016/S0020-7519(03)00060-2; Buddle BM, 2002, VACCINE, V20, P1126, DOI 10.1016/S0264-410X(01)00436-4; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2004, VACCINE, V22, P1063, DOI 10.1016/j.vaccine.2003.05.002; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; de Lisle GW, 2001, REV SCI TECH OIE, V20, P86, DOI 10.20506/rst.20.1.1262; Dunn PK, DGLM DOUBLE GENERALI; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gcebe N., 2015, OCCURRENCE MOL CHARA; Haile M, 2004, VACCINE, V22, P1498, DOI 10.1016/j.vaccine.2003.10.016; Heisterkamp S., 2016, COMPUTER SOFTWARE, V3, P1, DOI DOI 10.1016/J.CR0PR0.2007.08.015; Hewinson RG, 2003, TUBERCULOSIS, V83, P119, DOI 10.1016/S1472-9792(02)00062-8; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Jones GJ, 2012, CLIN VACCINE IMMUNOL, V19, P620, DOI 10.1128/CVI.00024-12; Jones GJ, 2010, CLIN VACCINE IMMUNOL, V17, P1344, DOI 10.1128/CVI.00261-10; Juste RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165607; Lopez V, 2016, VET IMMUNOL IMMUNOP, V172, P21, DOI 10.1016/j.vetimm.2016.03.003; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Michel AL, 2014, REV SCI TECH OIE, V33, P583, DOI 10.20506/rst.33.2.2310; Michel AL, 2011, PREV VET MED, V98, P142, DOI 10.1016/j.prevetmed.2010.10.016; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Millington KA, 2011, P NATL ACAD SCI USA, V108, P5730, DOI 10.1073/pnas.1015153108; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Santema W, 2013, INFECT IMMUN, V81, P1990, DOI 10.1128/IAI.01121-12; SHIMOKATA K, 1982, AM REV RESPIR DIS, V126, P822; Skinner MA, 2003, IMMUNOLOGY, V108, P548, DOI 10.1046/j.1365-2567.2003.01589.x; UNAIDS, 2016, GLOB AIDS UPD REP; Villarreal-Ramos B, 2014, VACCINE; Vordermeier HM, 2014, RES VET SCI, V97, pS53, DOI 10.1016/j.rvsc.2014.04.015; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier M, 2006, VET IMMUNOL IMMUNOP, V112, P38, DOI 10.1016/j.vetimm.2006.03.010; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005; World Organisation for Animal H, MAN DIAGN TESTS VACC	46	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188448	10.1371/journal.pone.0188448	http://dx.doi.org/10.1371/journal.pone.0188448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155877	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700060
J	Rohani, F; Richter, H; Van den Bogert, AJ				Rohani, Farbod; Richter, Hanz; Van den Bogert, Antonie J.			Optimal design and control of an electromechanical transfemoral prosthesis with energy regeneration	PLOS ONE			English	Article							ANKLE-FOOT PROSTHESIS; AMPUTATION; GAIT; AMBULATION; AMPUTEES; WALKING; LEVEL; COST; LEG	In this paper, we present the design of an electromechanical above-knee active prosthesis with energy storage and regeneration. The system consists of geared knee and ankle motors, parallel springs for each motor, an ultracapacitor, and controllable four-quadrant power converters. The goal is to maximize the performance of the system by finding optimal controls and design parameters. A model of the system dynamics was developed, and used to solve a combined trajectory and design optimization problem. The objectives of the optimization were to minimize tracking error relative to human joint motions, as well as energy use. The optimization problem was solved by the method of direct collocation, based on joint torque and joint angle data from ten subjects walking at three speeds. After optimization of controls and design parameters, the simulated system could operate at zero energy cost while still closely emulating able-bodied gait. This was achieved by controlled energy transfer between knee and ankle, and by controlled storage and release of energy throughout the gait cycle. Optimal gear ratios and spring parameters were similar across subjects and walking speeds.	[Rohani, Farbod] Cleveland State Univ, Dept Elect & Comp Engn, Cleveland, OH 44115 USA; [Rohani, Farbod; Richter, Hanz; Van den Bogert, Antonie J.] Cleveland State Univ, Dept Mech Engn, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Rohani, F (corresponding author), Cleveland State Univ, Dept Elect & Comp Engn, Cleveland, OH 44115 USA.; Rohani, F (corresponding author), Cleveland State Univ, Dept Mech Engn, Cleveland, OH 44115 USA.	f.rohani@csuohio.edu	van den Bogert, Antonie J/A-7809-2009	van den Bogert, Antonie J/0000-0002-3791-3749	National Science Foundation [1344954, 1544702]	National Science Foundation(National Science Foundation (NSF))	Financial support was received from the National Science Foundation under grants No. 1344954 and 1544702. The financial support was received by allauthors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Bellman RD, 2008, P IEEE RAS-EMBS INT, P511, DOI 10.1109/BIOROB.2008.4762887; Betts J.T, 2010, PRACTICAL METHODOP; Bishop R. H., 2007, MECHATRONICS HDB, V2nd; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Conway B. E., 2013, ELECTROCHEMICAL SUPE, DOI DOI 10.1017/CBO9781107415324.004; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Fan H., 2014, ANALOG APPL J, P20; Gailey R, 2008, J REHABIL RES DEV, V45, P15, DOI 10.1682/JRRD.2006.11.0147; GITTER A, 1995, AM J PHYS MED REHAB, V74, P332, DOI 10.1097/00002060-199509000-00002; Graham LE, 2007, ARCH PHYS MED REHAB, V88, P801, DOI 10.1016/j.apmr.2007.02.028; HENCH JJ, 1994, IEEE T AUTOMAT CONTR, V39, P1197, DOI 10.1109/9.293179; Herr HM, 2012, P ROY SOC B-BIOL SCI, V279, P457, DOI 10.1098/rspb.2011.1194; Highsmith MJ, 2010, PROSTHET ORTHOT INT, V34, P362, DOI 10.3109/03093646.2010.520054; Hitt JK, 2010, J MED DEVICES, V4, DOI 10.1115/1.4001139; HUANG CT, 1979, ARCH PHYS MED REHAB, V60, P18; Johansson JL, 2005, AM J PHYS MED REHAB, V84, P563, DOI 10.1097/01.phm.0000174665.74933.0b; Khademi G, 2016, 55 IEEE C DEC CONTR; Khalaf P, 2016, IEEE ASME INT C ADV, P1424, DOI 10.1109/AIM.2016.7576970; Moore JK, 2015, PEERJ, V3, DOI 10.7717/peerj.918; Orendurff MS, 2006, J REHABIL RES DEV, V43, P239, DOI 10.1682/JRRD.2005.06.0095; Seth B., 1987, THESIS MIT CAMBRIDGE; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; Tabor K. A., 1988, THESIS; Unal R, 2012, P IEEE RAS-EMBS INT, P1949, DOI 10.1109/BioRob.2012.6290837; van den Bogert AJ, 2012, P I MECH ENG P-J SPO, V226, P123, DOI 10.1177/1754337112440644; van den Bogert AJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006680; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Warner H. E., 2015, THESIS; WATERS RL, 1976, J BONE JOINT SURG AM, V58, P42, DOI 10.2106/00004623-197658010-00007; WINTER DA, 1983, CLIN ORTHOP RELAT R, P147	31	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188266	10.1371/journal.pone.0188266	http://dx.doi.org/10.1371/journal.pone.0188266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149213	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100034
J	Meleiro, LP; Salgado, JCS; Maldonado, RF; Carli, S; Moraes, LAB; Ward, RJ; Jorge, JA; Furriel, RPM				Meleiro, Luana Parras; Santos Salgado, Jose Carlos; Maldonado, Raquel Fonseca; Carli, Sibeli; Beraldo Moraes, Luiz Alberto; Ward, Richard John; Jorge, Joao Atilio; Melo Furriel, Rosa Prazeres			Engineering the GH1 beta-glucosidase from Humicola insolens: Insights on the stimulation of activity by glucose and xylose	PLOS ONE			English	Article							MICROBIAL METAGENOME; TOLERANT; HYDROLYSIS; CLONING; OVEREXPRESSION; PURIFICATION; PROTEINS	The activity of the GH1 beta-glucosidase from Humicola insolens (Bglhi) against p-nitrophenyl-beta-D-glucopyranoside (pNP-Glc) and cellobiose is enhanced 2-fold by glucose and/or xylose. Kinetic and transglycosylation data showed that hydrolysis is preferred in the absence of monosaccharides. Stimulation involves allosteric interactions, increased transglycosylation and competition of the substrate and monosaccharides for the -1 glycone and the +1/+2 aglycone binding sites. Protein directed evolution has been used to generate 6 mutants of Bglhi with altered stimulation patterns. All mutants contain one of three substitutions (N235S, D237V or H307Y) clustered around the +1/+2 aglycone binding sites. Two mutants with the H307Y substitution preferentially followed the transglycosylation route in the absence of xylose or glucose. The strong stimulation of their pNP-glucosidase and cellobiase activities was accompanied by increased transglycosylation and higher monosaccharide tolerance. The D237V mutation favoured hydrolysis over transglycosylation and the pNP-glucosidase activity, but not the cellobiase activity, was stimulated by xylose. The substitution N235S abolished the preference for hydrolysis or transglycosylation; the cellobiase, but not the pNP-glucosidase activity of the mutants was strongly inhibited by xylose. Both the D237V and N235S mutations lowered tolerance to the monosaccharides. These results provide evidence that the fine modulation of the activity of Bglhi and mutants by glucose and/or xylose is regulated by the relative affinities of the glycone and aglycone binding sites for the substrate and the free monosaccharides.	[Meleiro, Luana Parras; Carli, Sibeli; Beraldo Moraes, Luiz Alberto; Ward, Richard John; Melo Furriel, Rosa Prazeres] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil; [Santos Salgado, Jose Carlos] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Maldonado, Raquel Fonseca] Inst Fed Educ Ciencia & Tecnol Sao Paulo, Sao Jose Dos Campos, SP, Brazil; [Jorge, Joao Atilio] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Federal de Sao Paulo (IFSP); Universidade de Sao Paulo	Meleiro, LP (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, Ribeirao Preto, SP, Brazil.	luanapm@usp.br	Salgado, Jose CS/S-3128-2016; Moraes, Luiz Alberto B/K-2282-2012; Carli, Sibeli/N-7329-2016; Ward, Richard John/C-2460-2012; Meleiro, Luana/C-2684-2013	Salgado, Jose CS/0000-0002-3422-9474; Moraes, Luiz Alberto B/0000-0002-0853-1944; Ward, Richard John/0000-0003-1136-5737; Meleiro, Luana/0000-0001-7104-0358	FAPESP [2014/14415-0, 2010/18850-2, 2016/17582-0]; CNPq [457960/2014-0, 301560/2013-7, 152972/2012-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by FAPESP Grants 2014/14415-0 (RPMF) and 2010/18850-2 (RJW), CNPq Grants 457960/2014-0 (RPMF) and 301560/2013-7 (JAJ), FAPESP fellowship 2016/17582-0 (LPM) and CNPq fellowship 152972/2012-9 (JCSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram F, 2016, J MOL CATAL B-ENZYM, V124, P92, DOI 10.1016/j.molcatb.2015.12.005; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; Bohlin C, 2013, APPL MICROBIOL BIOT, V97, P159, DOI 10.1007/s00253-012-3875-9; Bras NF, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P117, DOI 10.5772/52019; Cairns JRK, 2015, PLANT SCI, V241, P246, DOI 10.1016/j.plantsci.2015.10.014; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Cao L., 2015, SHOCK VIB, V2015, P8, DOI DOI 10.1186/S13068-015-0383-Z; Cota J, 2015, NEW BIOTECHNOL, V32, P13, DOI 10.1016/j.nbt.2014.07.009; de Giuseppe PO, 2014, ACTA CRYSTALLOGR D, V70, P1631, DOI 10.1107/S1399004714006920; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Guo BY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147301; Gupta VK, 2016, TRENDS BIOCHEM SCI, V41, P633, DOI 10.1016/j.tibs.2016.04.006; Hodge DB, 2009, APPL BIOCHEM BIOTECH, V152, P88, DOI 10.1007/s12010-008-8217-0; Kuusk S, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-016-0690-z; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leone FA, 2005, BIOCHEM MOL BIOL EDU, V33, P399, DOI 10.1002/bmb.2005.49403306399; Li YD, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-85; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Matsuzawa T, 2017, APPL MICROBIOL BIOT, V101, P633, DOI 10.1007/s00253-016-7803-2; Matsuzawa T, 2016, FEBS J, V283, P2340, DOI 10.1111/febs.13743; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Meleiro LP, 2015, J MOL CATAL B-ENZYM, V122, P131, DOI 10.1016/j.molcatb.2015.09.003; Meleiro LP, 2014, APPL BIOCHEM BIOTECH, V173, P391, DOI 10.1007/s12010-014-0847-9; Souza FHM, 2014, J MOL CATAL B-ENZYM, V106, P1, DOI 10.1016/j.molcatb.2014.04.007; Souza FHM, 2013, J MOL CATAL B-ENZYM, V94, P119, DOI 10.1016/j.molcatb.2013.05.012; Souza FHM, 2010, PROCESS BIOCHEM, V45, P272, DOI 10.1016/j.procbio.2009.09.018; Nascimento CV, 2010, J MICROBIOL, V48, P53, DOI 10.1007/s12275-009-0159-x; Pei JJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-31; Rajasree KP, 2013, J IND MICROBIOL BIOT, V40, P967, DOI 10.1007/s10295-013-1291-5; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Saha BC, 1996, APPL ENVIRON MICROB, V62, P3165, DOI 10.1128/AEM.62.9.3165-3170.1996; Singh KP, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-015-0352-z; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Sorensen A, 2013, BIOMOLECULES, V3, DOI 10.3390/biom3030612; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00548; Uchiyama T, 2013, J BIOL CHEM, V288, P18325, DOI 10.1074/jbc.M113.471342; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; Xia W, 2016, SCI REP-UK, V6, DOI 10.1038/srep27062; Xu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31108; Yang F, 2015, APPL MICROBIOL BIOT, V99, P8903, DOI 10.1007/s00253-015-6619-9; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17296; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhao LG, 2013, J MOL CATAL B-ENZYM, V95, P62, DOI 10.1016/j.molcatb.2013.05.027	45	17	17	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188254	10.1371/journal.pone.0188254	http://dx.doi.org/10.1371/journal.pone.0188254			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145480	gold, Green Published			2022-12-27	WOS:000415378800101
J	Yilmaz, O; Patinote, A; Nguyen, TV; Com, E; Lavigne, R; Pineau, C; Sullivan, CV; Bobe, J				Yilmaz, Ozlem; Patinote, Amelie; Thao Vi Nguyen; Com, Emmanuelle; Lavigne, Regis; Pineau, Charles; Sullivan, Craig V.; Bobe, Julien			Scrambled eggs: Proteomic portraits and novel biomarkers of egg quality in zebrafish (Danio rerio)	PLOS ONE			English	Article							PROTEIN; FISH; GENE; EXPRESSION; MATURATION; AUTOPHAGY; EMBRYOS; LECTIN; WNT	Egg quality is a complex biological trait and a major determinant of reproductive fitness in all animals. This study delivered the first proteomic portraits of egg quality in zebrafish, a leading biomedical model for early development. Egg batches of good and poor quality, evidenced by embryo survival for 24 h, were sampled immediately after spawning and used to create pooled or replicated sample sets whose protein extracts were subjected to different levels of fractionation before liquid chromatography and tandem mass spectrometry. Obtained spectra were searched against a zebrafish proteome database and detected proteins were annotated, categorized and quantified based on normalized spectral counts. Manually curated and automated enrichment analyses revealed poor quality eggs to be deficient of proteins involved in protein synthesis and energy and lipid metabolism, and of some vitellogenin products and lectins, and to have a surfeit of proteins involved in endo-lysosomal activities, autophagy, and apoptosis, and of some oncogene products, lectins and egg envelope proteins. Results of pathway and network analyses suggest that this aberrant proteomic profile results from failure of oocytes giving rise to poor quality eggs to properly transit through final maturation, and implicated Wnt signaling in the etiology of this defect. Quantitative comparisons of abundant proteins in good versus poor quality eggs revealed 17 candidate egg quality markers. Thus, the zebrafish egg proteome is clearly linked to embryo developmental potential, a phenomenon that begs further investigation to elucidate the root causes of poor egg quality, presently a serious and intractable problem in livestock and human reproductive medicine.	[Yilmaz, Ozlem; Patinote, Amelie; Thao Vi Nguyen; Bobe, Julien] INRA, Lab Fish Physiol & Genom, UR1037, Rennes, France; [Com, Emmanuelle; Lavigne, Regis; Pineau, Charles] INSERM, Irset, Protim, U1085, Rennes, France; [Sullivan, Craig V.] Carolina AquaGyn, Raleigh, NC USA; [Yilmaz, Ozlem] Univ Bergen, Dept Biol, Bergen, Norway	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Bergen	Bobe, J (corresponding author), INRA, Lab Fish Physiol & Genom, UR1037, Rennes, France.	julien.bobe@inra.fr	, Protim/C-4687-2012; Com, Emmanuelle/E-8656-2011; Yilmaz, Ozlem/W-9645-2019; Com, Emmanuelle/AAD-2312-2020; Pineau, Charles G/D-9185-2013; Bobe, Julien/I-6851-2017	Com, Emmanuelle/0000-0002-7401-817X; Yilmaz, Ozlem/0000-0002-7810-7487; Com, Emmanuelle/0000-0002-7401-817X; Pineau, Charles G/0000-0002-7461-5433; ali, sara/0000-0002-6303-3059; Bobe, Julien/0000-0002-9355-8227	Marie Skfodowska-Curie actions (MSCA) [626272]; Region Bretagne- SAD [FISHEGG (8210)]; French National Research Agency [ANR-13-BSV7-0015]; Carolina Aquagyn	Marie Skfodowska-Curie actions (MSCA); Region Bretagne- SAD; French National Research Agency(French National Research Agency (ANR)); Carolina Aquagyn	This work was supported by: (OY) Marie Skfodowska-Curie actions (MSCA)-FP7-PEOPLE-2013-IEF - 626272, http://cordis.europa.eu/project/ rcn/189931_en.html; (OY) Region Bretagne- SAD (2013)-FISHEGG (8210); (JB) French National Research Agency (ANR-13-BSV7-0015), http: //www.agence-nationale-recherche.fr/?Project=ANR-13-BSV7-0015; and (CVS) Carolina Aquagyn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1983, P NATL ACAD SCI-BIOL, V80, P1397, DOI 10.1073/pnas.80.5.1397; Babin Patrick J., 2007, P39, DOI 10.1007/978-1-4020-6235-3_2; Banerjee R, 2010, TRENDS NEUROSCI, V33, P541, DOI 10.1016/j.tins.2010.09.001; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bobe J., 2015, Animal Frontiers, V5, P66, DOI 10.2527/af.2015-0010; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brooks S, 1997, REV FISH BIOL FISHER, V7, P387, DOI 10.1023/A:1018400130692; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Castets MD, 2012, THERIOGENOLOGY, V78, P432, DOI 10.1016/j.theriogenology.2012.02.023; Cerda J, 1998, BIOL REPROD, V59, P53, DOI 10.1095/biolreprod59.1.53; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; Chapman RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096818; Chapovetsky Victoria, 2007, P99, DOI 10.1007/978-1-4020-6235-3_4; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crespel A, 2008, CYBIUM, V32, P205; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Finn RN, 2010, AQUAC RES, V41, P684, DOI 10.1111/j.1365-2109.2009.02220.x; Gioacchini G, 2013, REPROD FERT DEVELOP, V25, P1115, DOI 10.1071/RD12187; Groh KJ, 2011, FISH PHYSIOL BIOCHEM, V37, P619, DOI 10.1007/s10695-010-9464-x; Hoo JY, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9732780; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imamura Shintaro, 2008, Bulletin of Fisheries Research Agency, P29; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KJORSVIK E, 1990, ADV MAR BIOL, V26, P71, DOI 10.1016/S0065-2881(08)60199-6; Kohn YY, 2015, FISH PHYSIOL BIOCHEM, V41, P1403, DOI 10.1007/s10695-015-0095-0; Lahnsteiner F., 2009, P149; Lavigne R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012682; Le Menn Francoise, 2007, P1; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu KC, 2013, GEN COMP ENDOCR, V181, P288, DOI 10.1016/j.ygcen.2012.07.032; Lossner C, 2012, PROTEOMICS, V12, P1879, DOI 10.1002/pmic.201100576; Lubzens E, 2017, AQUACULTURE, V472, P107, DOI 10.1016/j.aquaculture.2016.10.029; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lucitt MB, 2008, MOL CELL PROTEOMICS, V7, P981, DOI 10.1074/mcp.M700382-MCP200; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nejedla M, 2016, MOL BIOL CELL, V27, P2381, DOI 10.1091/mbc.E15-11-0799; OPPENBERNTSEN DO, 1990, DEV BIOL, V137, P258, DOI 10.1016/0012-1606(90)90252-E; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Peisajovich A, 2008, EXPERT REV CLIN IMMU, V4, P379, DOI 10.1586/1744666X.4.3.379; Rime Helene, 2004, Reprod Biol Endocrinol, V2, P26, DOI 10.1186/1477-7827-2-26; Stitzel ML, 2007, SCIENCE, V316, P407, DOI 10.1126/science.1138236; Sullivan CV, 2015, GEN COMP ENDOCR, V221, P23, DOI 10.1016/j.ygcen.2015.02.012; Sullivan CV, 2003, FISH PHYSIOL BIOCHEM, V28, P481, DOI 10.1023/B:FISH.0000030635.92568.0a; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Ummanni R, 2008, FEBS J, V275, P5703, DOI 10.1111/j.1742-4658.2008.06697.x; van der Plas-Duivesteijn SJ, 2014, J PROTEOME RES, V13, P1537, DOI 10.1021/pr4010585; Verkade Heather, 2008, V469, P225, DOI 10.1007/978-1-60327-469-2_17; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YS, 2016, FISH SHELLFISH IMMUN, V52, P23, DOI 10.1016/j.fsi.2016.03.016; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Ziv T, 2008, COMP BIOCHEM PHYS D, V3, P12, DOI 10.1016/j.cbd.2007.06.004	60	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188084	10.1371/journal.pone.0188084	http://dx.doi.org/10.1371/journal.pone.0188084			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145436	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800063
J	Aversano, R; Basile, B; Buonincontri, MP; Carucci, F; Carputo, D; Frusciante, L; Di Pasquale, G				Aversano, Riccardo; Basile, Boris; Buonincontri, Mauro Paolo; Carucci, Francesca; Carputo, Domenico; Frusciante, Luigi; Di Pasquale, Gaetano			Dating the beginning of the Roman viticultural model in the Western Mediterranean: The case study of Chianti (Central Italy)	PLOS ONE			English	Article							GRAPEVINE VITIS-VINIFERA; ORIGIN; DNA; MICROSATELLITES; WILD; IDENTIFICATION; DOMESTICATION; VARIABILITY; ASSIGNMENT; REGIONS	Although domestication of the grapevine (Vitis vinifera L.) has been extensively documented, the history of genotype selection and evolution of vineyard management remain relatively neglected fields of study. The find of 454 waterlogged grapevine pips from a well-dated Etrusco-Roman site in the Chianti district (Tuscany, Central Italy) is an extraordinary chance to gain insights into the progress of viticulture occurring in a key historical period in one of the world's most famous wine regions. The molecular and geometrical analyses of grape seeds showed (a) the presence in the site of different grapevine individuals and (b) a sudden increase in pip size, occurring at around 200 BC, whic explainable by the selection and introduction of new varieties. In this period, the Etruscans settlers in Chianti were stimulated by northward-expanding Roman culture to use novel vineyard management practices. We hypothesize that one of the most important innovations may have been the introduction of pruning, inducing vine physiological conditions more favorable to pip growth. Such changes were the consequence of specific entrepreneurial choices made by the Romans in a period of economic investment in grape cultivation and wine making to satisfy the increased trade demand after the conquest of the Central-Western Mediterranean basin.	[Aversano, Riccardo; Basile, Boris; Buonincontri, Mauro Paolo; Carucci, Francesca; Carputo, Domenico; Frusciante, Luigi; Di Pasquale, Gaetano] Univ Naples Federico II, Dept Agr Sci, Portici, Italy	University of Naples Federico II	Buonincontri, MP (corresponding author), Univ Naples Federico II, Dept Agr Sci, Portici, Italy.	mauropaolo.buonincontri@unina.it	Buonincontri, Mauro/W-4331-2019; Aversano, Riccardo/O-4678-2019	Buonincontri, Mauro/0000-0003-4751-460X; Aversano, Riccardo/0000-0002-4041-3702				Archer E, 2007, S AFR J ENOL VITIC, V28, P107; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; BACILIERI R, 2013, BMC PLANT BIOL, V13, P17060, DOI DOI 10.1111/AJGW.12021; Bacilieri R, 2016, VEG HIST ARCHAEOBOT; Bertoldi T., 2012, GUIDA ALLE ANFORE RO; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Cappellini E, 2010, NATURWISSENSCHAFTEN, V97, P205, DOI 10.1007/s00114-009-0629-3; Carandini A., 1992, ITAL DAUG TIEN ACT C, P167; Carandini A, 1989, AMPHORES ROMAINES HI, P505; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Cianferoni GC, 1991, CHIANTI STORIA ARTE, V15, P19; Cresci M, 1995, ETRUSCAN STUD J ETRU, V2, P141; de Grummond N. T., 2015, ETRUSCAN STUDIES J E, V18, P3, DOI DOI 10.1515/ETST-2015-0007; de Grummond N. T, 2009, SANCTUARY ETRUSCAN A; De Mattia F, 2008, REND LINCEI-SCI FIS, V19, P223, DOI 10.1007/s12210-008-0016-6; DELPINO F., 1997, NECROPOLI ARCAICHE V, P185; Di Vora A., 1995, RIV ARCHEOL DELLANTI, V176, P333; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Edlund Berry I, PORTSMOUTH J ROMAN A, P68; Forni G., 2002, STORIA AGRICOLTURA I, VI, P58; Forni G., 1996, 2500 ANNI CULTURA VI, P19; FORNI G, 1975, RIV ST AGR, V15, P15, DOI DOI 10.1016/J.TIG.2006.07.008; Frankel R., 1999, WINE OIL PRODUCTION; Fregoni M., 1991, ORIGINI VITE VITICOL; Gil M, 2013, J AGR FOOD CHEM, V61, P4968, DOI 10.1021/jf400722z; Gismondi A, 2016, J ARCHAEOL SCI, V69, P75, DOI 10.1016/j.jas.2016.04.014; Grassi F, 2003, THEOR APPL GENET, V107, P1315, DOI 10.1007/s00122-003-1321-1; Hardie WJ, 1996, AUST J GRAPE WINE R, V2, P1; Houel C, 2013, AUST J GRAPE WINE R, V19, P208, DOI 10.1111/ajgw.12021; Imazio S, 2006, GENET RESOUR CROP EV, V53, P1003, DOI 10.1007/s10722-004-6896-0; JACKSON RS, 2008, WINE SCI, P17060, DOI DOI 10.1021/JF400722Z; Jacquat C, 1999, VEG HIST ARCHAEOBOT, V8, P25, DOI 10.1007/BF02042839; Lamboglia N., 1955, RIV STUDI LIGURI, V21, P241; Manen JF, 2003, J ARCHAEOL SCI, V30, P721, DOI 10.1016/S0305-4403(02)00244-3; Mangafa M, 1996, J ARCHAEOL SCI, V23, P409, DOI 10.1006/jasc.1996.0036; Marvelli S, 2013, ANN BOT-COENOL PLANT, V3, P155, DOI 10.4462/annbotrm-10326; Milanesi C, 2011, J ARCHAEOL SCI, V38, P3675, DOI 10.1016/j.jas.2011.08.038; Orru M, 2013, VEG HIST ARCHAEOBOT, V22, P231, DOI 10.1007/s00334-012-0362-2; Pagnoux C, 2015, VEG HIST ARCHAEOBOT, V24, P75, DOI 10.1007/s00334-014-0482-y; Pugliese L., 2014, ANFORE GRECO ITALICH; Rossiter J. J., 1981, PHOENIX, V35, P345; Schlumbaum A, 2008, VEG HIST ARCHAEOBOT, V17, P233, DOI 10.1007/s00334-007-0125-7; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sefc KM, 2000, THEOR APPL GENET, V100, P498, DOI 10.1007/s001220050065; Sereni E, 1964, ATTI MEMORIE ACCADEM, V29, P75; SNEATH PHA, 1973, NUMERICAL TAXONOMY P, P17060, DOI DOI 10.1007/S00122-004-1760-3; Stummer A, 1911, MITTEILUNGEN ANTHR G, V61, P283; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; This P, 2004, THEOR APPL GENET, V109, P1448, DOI 10.1007/s00122-004-1760-3; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Thurmond DL, 2006, HDB FOOD PROCESSING; Torelli M., 1995, STUDIES ROMANIZATION; TORELLI M, 2000, AVVENTURA VINO NEL B, P89, DOI DOI 10.1016/J.JAS.2016.05.014; Vandermersch C., 1994, VINS AMPHORES GRANDE; Villano C, 2014, MOL BIOTECHNOL, V56, P1011, DOI 10.1007/s12033-014-9780-y; Wales N, 2016, J ARCHAEOL SCI, V72, P57, DOI 10.1016/j.jas.2016.05.014; Wales N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086827; WILL EL, 1982, HESPERIA, V51, P338, DOI 10.2307/147955	59	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186298	10.1371/journal.pone.0186298	http://dx.doi.org/10.1371/journal.pone.0186298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29140987	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400006
J	Best, A; Holt, B; Troy, K; Hamill, J				Best, Andrew; Holt, Brigitte; Troy, Karen; Hamill, Joseph			Trabecular bone in the calcaneus of runners	PLOS ONE			English	Article							CANCELLOUS BONE; ARCHITECTURE; ADAPTATION; PATTERNS; HOMO; MICROARCHITECTURE; MICROSTRUCTURE; BIOMECHANICS; ANISOTROPY; STIFFNESS	Trabecular bone of the human calcaneus is subjected to extreme repetitive forces during endurance running and should adapt in response to this strain. To assess possible bone functional adaptation in the posterior region of the calcaneus, we recruited forefoot-striking runners (n = 6), rearfoot-striking runners (n = 6), and non-runners (n = 6), all males aged 20-41 for this institutionally approved study. Foot strike pattern was confirmed for each runner using a motion capture system. We obtained high resolution peripheral computed tomography scans of the posterior calcaneus for both runners and non-runners. No statistically significant differences were found between runners and nonrunners or forefoot strikers and rearfoot strikers. Mean trabecular thickness and mineral density were greatest in forefoot runners with strong effect sizes (<0.80). Trabecular thickness was positively correlated with weekly running distance (r(2) = 0.417, p<0.05) and years running (r(2) = 0.339, p<0.05) and negatively correlated with age at onset of running (r(2) = 0.515, p<0.01) Trabecular thickness, mineral density and bone volume ratio of nonrunners were highly correlated with body mass (r(2) = 0.824, p<0.05) and nonrunners were significantly heavier than runners (p<0.05). Adjusting for body mass revealed significantly thicker trabeculae in the posterior calcaneus of forefoot strikers, likely an artifact of greater running volume and earlier onset of running in this subgroup; thus, individuals with the greatest summative loading stimulus had, after body mass adjustment, the thickest trabeculae. Further study with larger sample sizes is necessary to elucidate the role of footstrike on calcaneal trabecular structure. To our knowledge, intraspecific body mass correlations with measures of trabecular robusticity have not been reported elsewhere. We hypothesize that early adoption of running and years of sustained moderate volume running stimulate bone modeling in trabeculae of the posterior calcaneus.	[Best, Andrew; Holt, Brigitte] Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA; [Troy, Karen] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Hamill, Joseph] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; Worcester Polytechnic Institute; University of Massachusetts System; University of Massachusetts Amherst	Best, A (corresponding author), Univ Massachusetts, Dept Anthropol, Amherst, MA 01003 USA.	abest@umass.edu	Troy, Karen L/AAH-1184-2019	Troy, Karen L/0000-0002-8135-0066; Best, Andrew/0000-0003-1561-2272	WPI	WPI	Joseph Hamill provided funding for participant transportation to and from WPI.	Barak MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077687; Barak MM, 2011, BONE, V49, P1141, DOI 10.1016/j.bone.2011.08.020; Biewener AA, 1996, BONE, V19, P1, DOI 10.1016/8756-3282(96)00116-0; Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chirchir H, 2015, P NATL ACAD SCI USA, V112, P366, DOI 10.1073/pnas.1411696112; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COWIN SC, 1985, MECH MATER, V4, P137, DOI 10.1016/0167-6636(85)90012-2; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Diederichs G, 2009, BONE, V44, P976, DOI 10.1016/j.bone.2009.01.372; Doube M, 2011, P ROY SOC B-BIOL SCI, V278, P3067, DOI 10.1098/rspb.2011.0069; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Fajardo RJ, 2013, ANAT REC, V296, P210, DOI 10.1002/ar.22632; Feldman S, 2012, MED SCI SPORT EXER, V44, P1580, DOI 10.1249/MSS.0b013e31824e10b6; GALANTE J, 1970, CALC TISS RES, V5, P236, DOI 10.1007/BF02017552; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; Griffin NL, 2010, J HUM EVOL, V59, P202, DOI 10.1016/j.jhevol.2010.06.006; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hsu A., 1989, THESIS U SO CALIFORN, P1; Huiskes R, 2000, J ANAT, V197, P145, DOI 10.1046/j.1469-7580.2000.19720145.x; Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3282(03)00212-6; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Khosla S, 2006, J BONE MINER RES, V21, P124, DOI 10.1359/JBMR.050916; Kulmala JP, 2013, MED SCI SPORT EXER, V45, P2306, DOI 10.1249/MSS.0b013e31829efcf7; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Lara B, 2016, EUR J APPL PHYSIOL, V116, P327, DOI 10.1007/s00421-015-3285-7; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lin JC, 1998, OSTEOPOROSIS INT, V8, P16, DOI 10.1007/s001980050043; Lockhart RD, 1959, ANATOMY HUMAN BODY; MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002; Mullender MG, 1996, J ORTHOPAED RES, V14, P972, DOI 10.1002/jor.1100140618; Odgaard A, 1997, J BIOMECH, V30, P487, DOI 10.1016/S0021-9290(96)00177-7; OXNARD CE, 1993, J BIOMECH, V26, P63, DOI 10.1016/0021-9290(93)90080-X; Pontzer H, 2006, J EXP BIOL, V209, P57, DOI 10.1242/jeb.01971; PUGH JW, 1973, J BIOMECH, V6, P475, DOI 10.1016/0021-9290(73)90006-7; RAUX P, 1975, J BIOMECH, V8, P1, DOI 10.1016/0021-9290(75)90037-8; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ryan TM, 2015, P NATL ACAD SCI USA, V112, P372, DOI 10.1073/pnas.1418646112; Ryan TM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0172; Shaw CN, 2013, J HUM EVOL, V64, P242, DOI 10.1016/j.jhevol.2013.01.004; Shaw CN, 2012, AM J PHYS ANTHROPOL, V147, P187, DOI 10.1002/ajpa.21635; Stephens NB, 2016, AM J PHYS ANTHROPOL, V161, P603, DOI 10.1002/ajpa.23061; Su A, 2013, J HUM EVOL, V64, P667, DOI 10.1016/j.jhevol.2013.03.003; Swartz SM, 1998, J EXP BIOL, V201, P573; TOWNSEND PR, 1975, J BIOMECH, V8, P363, DOI 10.1016/0021-9290(75)90071-8; van der Meulen MCH, 2006, BONE, V38, P871, DOI 10.1016/j.bone.2005.11.026; WEAVER JK, 1966, J BONE JOINT SURG AM, VA 48, P289, DOI 10.2106/00004623-196648020-00007; Wilks DC, 2009, BONE, V45, P91, DOI 10.1016/j.bone.2009.03.660; Wolff J, 1892, GESETZ TRANSFORMATIO; WRONSKI TJ, 1987, CALCIFIED TISSUE INT, V40, P155, DOI 10.1007/BF02555700; Zeininger A, 2016, J HUM EVOL, V97, P145, DOI 10.1016/j.jhevol.2016.05.009	52	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188200	10.1371/journal.pone.0188200	http://dx.doi.org/10.1371/journal.pone.0188200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM7MC	29141022	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400069
J	Butler, WE; Agarwalla, PK; Codd, P				Butler, William E.; Agarwalla, Pankaj K.; Codd, Patrick			CSF in the ventricles of the brain behaves as a relay medium for arteriovenous pulse wave phase coupling	PLOS ONE			English	Article							INTRACRANIAL-PRESSURE; PULSATION ABSORBER; ULTRASOUND; TRANSFORM	The ventricles of the brain remain perhaps the largest anatomic structure in the human body without established primary purpose, even though their existence has been known at least since described by Aristotle. We hypothesize that the ventricles help match a stroke volume of arterial blood that arrives into the rigid cranium with an equivalent volume of ejected venous blood by spatially configuring cerebrospinal fluid (CSF) to act as a low viscosity relay medium for arteriovenous pulse wave (PW) phase coupling. We probe the hypothesis by comparing the spatiotemporal behavior of vascular PW about the ventricular surfaces in piglets to internal observations of ventricle wall motions and adjacent CSF pressure variations in humans. With wavelet brain angiography data obtained from piglets, we map the travel relative to brain pulse motion of arterial and venous PWs over the ventricle surfaces. We find that arterial PWs differ in CF phase from venous PWs over the surfaces of the ventricles consistent with arteriovenous PW phase coupling. We find a spatiotemporal difference in vascular PW phase between the ventral and dorsal ventricular surfaces, with the PWs arriving slightly sooner to the ventral surfaces. In humans undergoing neuroendoscopic surgery for hydrocephalus, we measure directly ventricle wall motions and the adjacent internal CSF pressure variations. We find that CSF pressure peaks slightly earlier in the ventral Third Ventricle than the dorsal Lateral Ventricle. When matched anatomically, the peri-ventricular vascular PW phase distribution in piglets complements the endo-ventricular CSF PW phase distribution in humans. This is consistent with a role for the ventricles in arteriovenous PW coupling and may add a framework for understanding hydrocephalus and other disturbances of intracranial pressure.	[Butler, William E.; Agarwalla, Pankaj K.] Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA; [Codd, Patrick] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27710 USA	Harvard University; Massachusetts General Hospital; Duke University	Butler, WE (corresponding author), Massachusetts Gen Hosp, Neurosurg Serv, Boston, MA 02114 USA.	wbutler@mgh.harvard.edu		Butler, William/0000-0002-4249-565X				Abramovich F, 2000, J ROY STAT SOC D-STA, V49, P1, DOI 10.1111/1467-9884.00216; Aristotle, HIST ANIMALIUM; Butler WE, PLOS ONE; Faubel R, 2016, SCIENCE, V353, P176, DOI 10.1126/science.aae0450; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Jalalvand E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10002; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Meairs S, 2007, PROG BIOPHYS MOL BIO, V93, P354, DOI 10.1016/j.pbiomolbio.2006.07.019; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Park EH, 2010, J NEUROSURG-PEDIATR, V6, P159, DOI 10.3171/2010.5.PEDS09142; Persson EK, 2005, ACTA PAEDIATR, V94, P726, DOI 10.1080/08035250510027336; Pewsey A, 2013, CIRCULAR STAT R, P25; Pewsey A, 2013, CIRCULAR STAT R, P144; Pewsey A, 2013, CIRCULAR STAT R, P134; Pewsey A, 2013, CIRCULAR STAT R, P132; Provost J, 2014, PHYS MED BIOL, V59, pL1, DOI 10.1088/0031-9155/59/19/L1; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vo A, 2011, SIGNAL PROCESS, V91, P114, DOI 10.1016/j.sigpro.2010.06.014; Wagshul ME, 2009, J NEUROSURG-PEDIATR, V3, P354, DOI 10.3171/2009.1.PEDS08109; Wilson MH, 2016, J CEREBR BLOOD F MET, V36, P1338, DOI 10.1177/0271678X16648711; Zhao XY, 2011, ULTRASOUND MED BIOL, V37, P1292, DOI 10.1016/j.ultrasmedbio.2011.05.003; Zou R, 2008, J NEUROS-PEDIATR, V2, P83, DOI 10.3171/PED/2008/2/7/083	24	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0181025	10.1371/journal.pone.0181025	http://dx.doi.org/10.1371/journal.pone.0181025			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141045	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400001
J	Chen, I; Kelkar, YD; Gu, Y; Zhou, J; Qiu, X; Wu, HL				Chen, Iris; Kelkar, Yogeshwar D.; Gu, Yu; Zhou, Jie; Qiu, Xing; Wu, Hulin			High-dimensional linear state space models for dynamic microbial interaction networks	PLOS ONE			English	Article							VECTOR AUTOREGRESSIVE PROCESSES; SUBSET-SELECTION; ADAPTIVE LASSO; DIVERSITY; ODES	Medical researchers are increasingly interested in knowing how the complex community of micro-organisms living on human body impacts human health. Key to this is to understand how the microbes interact with each other. Time-course studies on human microbiome indicate that the composition of microbiome changes over short time periods, primarily as a consequence of synergistic and antagonistic interactions of the members of the microbiome with each other and with the environment. Knowledge of the abundance of bacteria-which are the predominant members of the human microbiome-in such time-course studies along with appropriate mathematical models will allow us to identify key dynamic interaction networks within the microbiome. However, the high-dimensional nature of these data poses significant challenges to the development of such mathematical models. We propose a high-dimensional linear State Space Model (SSM) with a new Expectation-Regularization-Maximization (ERM) algorithm to construct a dynamic (M) under bar icrobial (I) under bar nteraction (N) under bar etwork (MIN). System noise and measurement noise can be separately specified through SSMs. In order to deal with the problem of high-dimensional parameter space in the SSMs, the proposed new ERM algorithm employs the idea of the adaptive LASSO-based variable selection method so that the sparsity property of MINs can be preserved. We performed simulation studies to evaluate the proposed ERM algorithm for variable selection. The proposed method is applied to identify the dynamic MIN from a time-course vaginal microbiome study of women. This method is amenable to future developments, which may include interactions between microbes and the environment.	[Chen, Iris; Gu, Yu; Qiu, Xing; Wu, Hulin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Kelkar, Yogeshwar D.] Univ Rochester, Dept Biol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Zhou, Jie] Xidian Univ, Dept Stat, Xian 71007, Shanxi, Peoples R China; [Chen, Iris] Amgen Inc, Global Biostat Sci, Thousand Oaks, CA 91320 USA; [Wu, Hulin] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA	University of Rochester; University of Rochester; Xidian University; Amgen; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Qiu, X; Wu, HL (corresponding author), Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY 14642 USA.; Wu, HL (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA.	xing_qiu@urmc.rochester.edu; Hulin.Wu@uth.tmc.edu		Kelkar, Yogeshwar/0000-0002-4440-0191	National Institutes of Health [5 P30 AI078498-08, AI087135, 5 T32AI083206-05]; National Institutes of Health / National Center for Advancing Translational Sciences [UL1 TR002001]; National Institutes of Health / National Institute of Allergy and Infectious Diseases [HHSN272201200005C]; NIH [5 P30 AI078498-08, AI087135, 5 T32AI083206-05]; NIH/NCATS [UL1 TR002001]; NIH/NIAID [HHSN272201200005C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498, T32AI083206, R01AI087135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health / National Center for Advancing Translational Sciences; National Institutes of Health / National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by 5 P30 AI078498-08, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; AI087135, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; UL1 TR002001, granting institute: National Institutes of Health / National Center for Advancing Translational Sciences (URL: https://ncats.nih.gov), recipient: HW; 5 T32AI083206-05, granting institute: National Institutes of Health (URL: https://www.nih.gov/), recipient: HW; and HHSN272201200005C, granting institute: National Institutes of Health / National Institute of Allergy and Infectious Diseases (URL: https://www.niaid.nih.gov/), recipient: HW.; This research was supported in part by NIH 5 P30 AI078498-08, NIH AI087135, NIH 5 T32AI083206-05, NIH/NCATS UL1 TR002001, and NIH/NIAID HHSN272201200005C.	Antonio MAD, 2009, J INFECT DIS, V199, P1506, DOI 10.1086/598686; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Biswas S, 2015, LECT N BIOINFORMAT, V9029, P32, DOI 10.1007/978-3-319-16706-0_6; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Danielsson D, 2011, ANN NY ACAD SCI, V1230, P48, DOI 10.1111/j.1749-6632.2011.06041.x; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Backer E, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-115; Durbin J, 2012, TIME SERIES ANAL STA, V38; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Harvey AC, 1990, FORECASTING STRUCTUR; Hsu NJ, 2008, COMPUT STAT DATA AN, V52, P3645, DOI 10.1016/j.csda.2007.12.004; Huang J, 2008, STAT SINICA, V18, P1603; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kojima K, 2009, GENOME INFORM, V22, P56; Lu T, 2011, J AM STAT ASSOC, V106, P1242, DOI 10.1198/jasa.2011.ap10194; Marino S, 2014, P NATL ACAD SCI USA, V111, P439, DOI 10.1073/pnas.1311322111; Paine RT, 1995, JSTOR; Quach M, 2007, BIOINFORMATICS, V23, P3209, DOI 10.1093/bioinformatics/btm510; Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093; Ravel J, 2013, STUDIES, V19, P20; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Ren YW, 2010, STAT PROBABIL LETT, V80, P1705, DOI 10.1016/j.spl.2010.07.013; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Shumway R. H., 1982, Journal of Time Series Analysis, V3, P253, DOI 10.1111/j.1467-9892.1982.tb00349.x; Stapleton AE, 2011, CLIN INFECT DIS, V52, P1212, DOI 10.1093/cid/cir183; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; West M, 1997, HDB ECONOMETRICS; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187822	10.1371/journal.pone.0187822	http://dx.doi.org/10.1371/journal.pone.0187822			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141044	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400032
J	Van de Wouw, AP; Elliott, VL; Chang, S; Lopez-Ruiz, FJ; Marcroft, SJ; Idnurm, A				Van de Wouw, Angela P.; Elliott, Vicki L.; Chang, Steven; Lopez-Ruiz, Francisco J.; Marcroft, Steven J.; Idnurm, Alexander			Identification of isolates of the plant pathogen Leptosphaeria maculans with resistance to the triazole fungicide fluquinconazole using a novel In Planta assay	PLOS ONE			English	Article							MAJOR GENE RESISTANCE; RAPE BRASSICA-NAPUS; PHOMA STEM CANKER; OILSEED RAPE; STEROL 14-ALPHA-DEMETHYLASE; STROBILURIN FUNGICIDES; AZOLE FUNGICIDES; MATING-TYPE; AUSTRALIA; CYP51	Leptosphaeria maculans is the major pathogen of canola (oilseed rape, Brassica napus) worldwide. In Australia, the use of azole fungicides has contributed to the 50-fold increase in canola production in the last 25 years. However, extensive application of fungicides sets the stage for the selection of fungal populations with resistance. A high-throughput in planta assay was developed to allow screening of thousands of isolates from multiple populations. Using this screen, isolates were identified with decreased sensitivity to the fungicide fluquinconazole when applied at field rates as a protective seed dressing: these isolates cause significantly larger lesions on cotyledons and true leaves and increased disease severity at plant maturity. This increased in planta resistance was specific to fluquinconazole, with no cross resistance to flutriafol or tebuconazole/prothioconazole. In a limited set of 22 progeny from a cross between resistant and susceptible parents, resistance segregated in a 1:1 ratio, suggesting a single gene is responsible. A survey of 200 populations from across canola growing regions of Australia revealed fungicide resistance was present in 15% of the populations. Although in vitro analysis of the fungicide resistant isolates showed a significant shift in the average EC50 compared to the sensitive isolates, this was not as evident as the in planta assays. The development of this novel, high-throughput in planta assay has led to the identification of the first fungicide resistant L. maculans isolates, which may pose a threat to the productivity of the Australian canola industry.	[Van de Wouw, Angela P.; Idnurm, Alexander] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Elliott, Vicki L.; Marcroft, Steven J.] Marcroft Grains Pathol, Grains Innovat Pk, Horsham, Australia; [Chang, Steven; Lopez-Ruiz, Francisco J.] Curtin Univ, Dept Environm & Agr, Ctr Crop & Dis Management, Bentley, WA, Australia	University of Melbourne; Curtin University	Van de Wouw, AP (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.	apvdw2@unimelb.edu.au	Idnurm, Alexander/GPX-9055-2022; Van de Wouw, Angela/AAY-1163-2021; Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013	Idnurm, Alexander/0000-0001-5995-7040; Van de Wouw, Angela/0000-0001-5147-0393; Idnurm, Alexander/0000-0001-5995-7040; Marcroft, Steve/0000-0002-1339-2694	Australian Grains Research and Development Corporation; Grains Research and Development Corporation [UM00051, CUR00023]	Australian Grains Research and Development Corporation(Grains R&D Corp); Grains Research and Development Corporation(Grains R&D Corp)	All research was funded by the Grains Research and Development Corporation through UM00051 to Alexander Idnurm and CUR00023 to Francisco J Lopez-Ruiz. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Australian Grains Research and Development Corporation for funding this research and the agronomists, farmers and researchers that contributed stubble for screening in the large-scale survey.	Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Call AD, 2013, HORTSCIENCE, V48, P53, DOI 10.21273/HORTSCI.48.1.53; Canas-Gutierrez GP, 2009, PEST MANAG SCI, V65, P892, DOI 10.1002/ps.1770; Carter HE, 2014, MOL PLANT PATHOL, V15, P513, DOI 10.1111/mpp.12106; Cools HJ, 2002, J PHYTOPATHOL, V150, P444, DOI 10.1046/j.1439-0434.2002.00776.x; Cools HJ, 2013, PEST MANAG SCI, V69, P105; Cozijnsen AJ, 2003, CURR GENET, V43, P351, DOI 10.1007/s00294-003-0391-6; Cozijnsen AJ, 2000, MOL PLANT PATHOL, V1, P293, DOI 10.1046/j.1364-3703.2000.00033.x; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Eckert MR, 2010, PEST MANAG SCI, V66, P396, DOI 10.1002/ps.1890; Elliott VL, 2016, PLANT BREEDING, V135, P200, DOI 10.1111/pbr.12343; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Fraser M, 2017, CAN J PLANT SCI, V97, P83, DOI 10.1139/cjps-2015-0382; Griffiths KM, 2002, FEMS MICROBIOL LETT, V217, P81, DOI 10.1016/S0378-1097(02)01038-8; Hollomon DW, 2015, PLANT PROTECT SCI, V51, P170, DOI 10.17221/42/2015-PPS; JosephHorne T, 1997, FEMS MICROBIOL LETT, V149, P141, DOI 10.1111/j.1574-6968.1997.tb10321.x; Kirui KR, 2016, ADV PLANTS AGR RES, V5; KOCH E, 1991, MOL PLANT MICROBE IN, V4, P341, DOI 10.1094/MPMI-4-341; Leadbeater A, 2015, PLANT PROTECT SCI, V51, P163, DOI 10.17221/83/2015-PPS; Liu C, 2013, CAN J PLANT PATHOL, V35, P119; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marcroft SJ, 2012, PLANT PATHOL, V61, P934, DOI 10.1111/j.1365-3059.2011.02580.x; Marcroft SJ, 2004, AUST J EXP AGR, V44, P601, DOI 10.1071/EA03087; Marcroft SJ, 2012, CROP PASTURE SCI, V63, P338, DOI 10.1071/CP11341; Morzfeld J, 2004, Z PFLANZENK PFLANZEN, V111, P105; Price CL, 2015, PEST MANAG SCI, V71, P1054, DOI 10.1002/ps.4029; Sexton AC, 2000, MOL GEN GENET, V263, P463, DOI 10.1007/s004380051190; Sierotzki H, 2013, PHYTOPATHOLOGY, V103, P880, DOI 10.1094/PHYTO-01-13-0009-RVW; Sprague SJ, 2006, PLANT DIS, V90, P190, DOI 10.1094/PD-90-0190; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; TINLINE R. D., 1960, CANADIAN JOUR BOT, V38, P275, DOI 10.1139/b60-028; Van De Wouw AP, 2016, CROP PASTURE SCI, V67, P273, DOI 10.1071/CP15221; Van de Wouw AP, 2014, FIELD CROP RES, V166, P144, DOI 10.1016/j.fcr.2014.06.023; Van de Wouw AP, 2017, CROP PASTUR IN PRESS; Yan LY, 2009, CROP PROT, V28, P376, DOI 10.1016/j.cropro.2008.12.011	36	23	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188106	10.1371/journal.pone.0188106	http://dx.doi.org/10.1371/journal.pone.0188106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141039	Green Published, gold			2022-12-27	WOS:000415260400057
J	Vergara, J; Acosta, LE; Gonzalez-Ittig, RE; Vaschetto, LM; Gardenal, CN				Vergara, Julia; Acosta, Luis E.; Gonzalez-Ittig, Raul E.; Vaschetto, Luis M.; Gardenal, Cristina N.			The disjunct pattern of the Neotropical harvestman Discocyrtus dilatatus (Gonyleptidae) explained by climate-driven range shifts in the Quaternary: Paleodistributional and molecular evidence	PLOS ONE			English	Article							MESOPOTAMIAN-YUNGAS DISJUNCTION; DRY TROPICAL FORESTS; DISTRIBUTION MODELS; SEA-LEVEL; SPECIES DISTRIBUTIONS; ENVELOPE MODELS; SOUTH-AMERICA; RAIN-FOREST; OPILIONES; NICHE	The disjunct distribution of the harvestman Discocyrtus dilatatus (Opiliones, Gonyleptidae) is used as a case study to test the hypothesis of a trans-Chaco Pleistocene paleobridge during range expansion stages. This would have temporarily connected humid regions ('Mesopotamia' in northeastern Argentina, and the 'Yungas' in the northwest, NWA) in the subtropical and temperate South American lowlands. The present study combines two independent approaches: paleodistributional reconstruction, using the Species Distribution Modeling method MaxEnt and projection onto Quaternary paleoclimates (6 kya, 21 kya, 130 kya), and phylogeographic analyses based on the cytochrome oxidase subunit I molecular marker. Models predict a maximal shrinkage during the warm Last Interglacial (130 kya), and the rise of the hypothesized paleobridge in the Last Glacial Maximum (21 kya), revealing that cold-dry stages (not warm-humid ones, as supposed) enabled the range expansion of this species. The disjunction was formed in the mid-Holocene (6 kya) and is intensified under current conditions. The median-joining network shows that NWA haplotypes are peripherally related to different Mesopotamian lineages; haplotypes from Santa Fe and Cordoba Provinces consistently occupy central positions in the network. According to the dated phylogeny, Mesopotamia-NWA expansion events would have occurred in the last glacial period, in many cases closely associated to the Last Glacial Maximum, with most divergence events occurring shortly thereafter. Only two (out of nine) NWA haplotypes are shared with Mesopotamian localities. A single, presumably relictual NWA haplotype was found to have diverged much earlier, suggesting an ancient expansion event not recoverable by the paleodistributional models. Different measures of sequence statistics, genetic diversity, population structure and history of demographic changes are provided. This research offers the first available evidence for the historical origin of NWA disjunct populations of a Mesopotamian harvestman.	[Vergara, Julia; Acosta, Luis E.; Gonzalez-Ittig, Raul E.; Vaschetto, Luis M.; Gardenal, Cristina N.] Univ Nacl Cordoba, CONICET, IDEA, Cordoba, Argentina; [Vergara, Julia; Acosta, Luis E.; Vaschetto, Luis M.] UNC, Fac Ciencias Exactas Fis & Nat, Catedra Diversidad Anim 1, Cordoba, Argentina; [Gonzalez-Ittig, Raul E.; Gardenal, Cristina N.] UNC, Fac Ciencias Exactas Fis & Nat, Catedra Genet Poblac & Evoluc, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Vergara, J; Acosta, LE (corresponding author), Univ Nacl Cordoba, CONICET, IDEA, Cordoba, Argentina.; Vergara, J; Acosta, LE (corresponding author), UNC, Fac Ciencias Exactas Fis & Nat, Catedra Diversidad Anim 1, Cordoba, Argentina.	juliavofi@gmail.com; luis.acosta@unc.edu.ar	Vaschetto, Luis Maria/L-4151-2019	Vaschetto, Luis Maria/0000-0002-9290-4335; Gonzalez-Ittig, Raul/0000-0001-6761-3379	Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP) [918/10]; Agencia Nacional de Promocion Cientifica y Teconologica [FONCYT PICT 1296/07]; SECYT - Universidad Nacional de Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Teconologica; SECYT - Universidad Nacional de Cordoba, Argentina(Secretaria de Ciencia y Tecnologia (SECYT))	This work received partial funding from Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP Res. 918/10), Agencia Nacional de Promocion Cientifica y Teconologica (FONCYT PICT 1296/07), and SECYT - Universidad Nacional de Cordoba, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta LE, 2017, J NAT HIST, V51, P17, DOI 10.1080/00222933.2016.1245450; Acosta LE, 2014, ZOOTAXA, V3821, P301, DOI 10.11646/zootaxa.3821.3.1; Acosta LE, 2013, ZOOTAXA, V 3736, P143, DOI 10.11646/zootaxa.3736.2.3; Acosta Luis E., 2002, Revista Iberica de Aracnologia, V6, P69; Acosta LE, 2008, J ARACHNOL, V36, P574, DOI 10.1636/T07-36.1; Acosta Luis Eduardo, 1995, Revue Arachnologique, V10, P207; Adamoli J., 2005, MISCELANEA, V14, P245; AVISE JC, 2001, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behling H, 1998, REV PALAEOBOT PALYNO, V99, P143, DOI 10.1016/S0034-6667(97)00044-4; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Behling H, 2001, QUATERNARY RES, V56, P383, DOI 10.1006/qres.2001.2264; Boyer SL, 2007, MOL ECOL, V16, P4999, DOI 10.1111/j.1365-294X.2007.03555.x; Bragagnolo C, 2015, INVERTEBR SYST, V29, P386, DOI 10.1071/IS15009; Caetano S, 2008, MOL ECOL, V17, P3147, DOI 10.1111/j.1365-294X.2008.03817.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Clouse RM, 2016, ORG DIVERS EVOL, V16, P167, DOI 10.1007/s13127-015-0233-7; Collevatti RG, 2013, J BIOGEOGR, V40, P345, DOI 10.1111/jbi.12005; Collevatti RG, 2012, MOL ECOL, V21, P5845, DOI 10.1111/mec.12071; COLTRINARI L, 1993, GLOBAL PLANET CHANGE, V7, P11, DOI 10.1016/0921-8181(93)90037-O; Curtis David J., 2007, P280; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Bartoleti LFD, 2017, J BIOGEOGR, V44, P2007, DOI 10.1111/jbi.12998; DELSAL G, 1989, BIOTECHNIQUES, V7, P514; Derkarabetian S, 2011, MOL PHYLOGENET EVOL, V61, P844, DOI 10.1016/j.ympev.2011.08.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Edgecombe GD, 2002, SYST ENTOMOL, V27, P31, DOI 10.1046/j.0307-6970.2001.00163.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBRIDGE RW, 1960, SCI AM, V202, P70, DOI 10.1038/scientificamerican0560-70; Flantua SGA, 2015, REV PALAEOBOT PALYNO, V223, P104, DOI 10.1016/j.revpalbo.2015.09.008; Franklin J., 2010, MAPPING SPECIES DIST, DOI [10.1017/CBO9780511810602, DOI 10.1017/CBO9780511810602]; Fu YX, 1997, GENETICS, V147, P915; Ginzburg R., 2006, SITUACION AMBIENTAL, P103; Fernandez MJG, 2016, GENETICA, V144, P711, DOI 10.1007/s10709-016-9937-7; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Iriondo Martin H., 2007, P7, DOI 10.1007/978-3-540-70624-3_1; Katinas L, 2008, J BIOGEOGR, V35, P1374, DOI 10.1111/j.1365-2699.2007.01874.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krohling DM, 1999, QUATERN INT, V57-8, P149, DOI 10.1016/S1040-6182(98)00056-1; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Ledru MP, 1998, REV PALAEOBOT PALYNO, V99, P131, DOI 10.1016/S0034-6667(97)00049-3; LEDRU MP, 1993, QUATERNARY RES, V39, P90, DOI 10.1006/qres.1993.1011; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lowe JJ, 2007, ENCY QUATERNARY SCI, P28; Luoto M, 2005, GLOBAL ECOL BIOGEOGR, V14, P575, DOI 10.1111/j.1466-822x.2005.00186.x; Martínez Olga G, 2013, Darwiniana, nueva serie, V1, P279, DOI 10.14522/darwiniana.2013.12.536; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; Nei M., 1987, MOL EVOLUTIONARY GEN; Nores M, 2004, GLOBAL ECOL BIOGEOGR, V13, P149, DOI 10.1111/j.1466-882X.2004.00076.x; NORES M, 1992, AUK, V109, P346, DOI 10.2307/4088203; Nores M., 1989, THESIS; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Popolizio E, 2006, PARANA RIO HIST GEOM, V1, P1; Prado D. E., 2000, Edinburgh Journal of Botany, V57, P437, DOI 10.1017/S096042860000041X; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ringuelet R. A., 1959, Revista del Museo Argentino de las Ciencias Naturales Zool, V5, P127; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos Flavio H., 2007, P473; Schreve D, 2010, PROG PHYS GEOG, V34, P845, DOI 10.1177/0309133310386869; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Siddall M, 2007, DEV QUATER SCI, V7, P75, DOI 10.1016/S1571-0866(07)80032-7; Silva JMC, 1994, AUK, V111, P495, DOI DOI 10.2307/4088618; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Speranza PR, 2007, J BIOGEOGR, V34, P427, DOI 10.1111/j.1365-2699.2006.01622.x; Stevaux JC, 2000, QUATERN INT, V72, P73, DOI 10.1016/S1040-6182(00)00023-9; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Tajima F, 1996, GENETICS, V143, P1457; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thomas SM, 2008, MOL PHYLOGENET EVOL, V46, P645, DOI 10.1016/j.ympev.2007.10.013; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trujillo-Arias N, 2017, MOL PHYLOGENET EVOL, V112, P107, DOI 10.1016/j.ympev.2017.03.025; Vaschetto LM, 2015, J ZOOL SYST EVOL RES, V53, P211, DOI 10.1111/jzs.12093; Vergara J, 2015, ZOOLOGIA-CURITIBA, V32, P445, DOI [10.1590/S1984-46702015000600003, 10.1590/s1984-46702015000600003]; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Werneck FP, 2012, J BIOGEOGR, V39, P1695, DOI 10.1111/j.1365-2699.2012.02715.x; Werneck FP, 2011, GLOBAL ECOL BIOGEOGR, V20, P272, DOI 10.1111/j.1466-8238.2010.00596.x; Whitney BS, 2014, VEG HIST ARCHAEOBOT, V23, P1, DOI 10.1007/s00334-013-0395-1; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120056	103	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187983	10.1371/journal.pone.0187983	http://dx.doi.org/10.1371/journal.pone.0187983			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141036	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400040
J	Garriga, C; Manzanares-Laya, S; de Olalla, PG; Gorrindo, P; Lens, S; Sola, R; Martinez-Rebollar, M; Laguno, M; Navarro, J; Torras, X; Gurgui, M; Barbera, MJ; Quer, J; Masdeu, E; Simon, P; Ros, M; de Andres, A; Cayla, JA				Garriga, Cesar; Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Gorrindo, Pilar; Lens, Sabela; Sola, Ricard; Martinez-Rebollar, Maria; Laguno, Montserrat; Navarro, Jordi; Torras, Xavier; Gurgui, Merce; Barbera, Maria-Jesus; Quer, Josep; Masdeu, Eva; Simon, Pere; Ros, Miriam; de Andres, Anna; Cayla, Joan A.			Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns	PLOS ONE			English	Article							HIV-POSITIVE MEN; SEXUAL TRANSMISSION; DRUG INJECTORS; SPAIN; HCV; PREVALENCE; EPIDEMIOLOGY; BARCELONA; BEHAVIOR; COUPLES	The aims of this study were to describe the evolution of acute hepatitis C virus (HCV) infections since 2004 and to determine its associated factors. Acute HCV infections diagnosed in Barcelona from 2004 to 2015 were included. Incidence ratios (IR) were then estimated for sex and age groups. Cases were grouped between 2004-2005, 2006-2011 and 2012-2015, and their incidence rate ratios (IRR) were calculated. In addition, risk factors for acute HCV infection were identified using multinomial logistic regression for complete, available and multiple imputed data. 204 new HCV cases were identified. Two peaks of higher IR of acute HCV infection in 2005 and 2013 were observed. Men and those aged 35-54 had higher IR. IRR for men was 2.9 times greater than in women (95% confidence intervals (CI): 1.8 - 4.7). Factors related to the period 2012-2015 (versus 2006-2011) were: a) sexual risk factor for transmission versus nosocomial (relative-risk ratio (RRR): 13.0; 95% CI: 2.3 - 72.1), b) higher educated versus lower (RRR: 5.4; 95% CI: 1.6 -18.7), and c) HIV coinfected versus not HIV-infected (RRR: 53.1; 95% CI: 5.7 - 492.6). This is one of the few studies showing IR and RRRs of acute HCV infections and the first focused on a large city in Spain. Sexual risk for transmission between men, higher educational level and HIV co-infection are important factors for understanding current HCV epidemic. There has been a partial shift in the pattern of the risk factor for transmission from nosocomial to sexual.	[Garriga, Cesar; Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Gorrindo, Pilar; Masdeu, Eva; Simon, Pere; Ros, Miriam; de Andres, Anna; Cayla, Joan A.] Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain; [Garriga, Cesar] Inst Salud Carlos III, Natl Ctr Epidemiol, Spanish Field Epidemiol Training Programme FETP P, Madrid, Spain; [Manzanares-Laya, Sandra; Garcia de Olalla, Patricia; Cayla, Joan A.] CIBERESP, Madrid, Spain; [Lens, Sabela] Barcelona IDIBAPS, Hosp Clin, Liver Unit, Barcelona, Spain; [Lens, Sabela; Torras, Xavier] CIBER Hepat & Digest Dis CIBERehd, Madrid, Spain; [Sola, Ricard] Hosp del Mar, Internal Med Infect Dis, Barcelona, Spain; [Martinez-Rebollar, Maria; Laguno, Montserrat] Univ Barcelona, Hosp Clin, August Pi & Sunyer Biomed Res Inst, Barcelona, Spain; [Navarro, Jordi] Univ Autonoma Barcelona, Hosp Vall Hebron, Infect Dis, Barcelona, Spain; [Torras, Xavier] Hosp Santa Creu & Sant Pau, Dept Gastroenterol, CIBERehd, Barcelona, Spain; [Gurgui, Merce] Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Infect Dis Unit, Barcelona, Spain; [Barbera, Maria-Jesus] Univ Autonoma Barcelona, Hosp Vall Hebron, Sexually Transmitted Infect Unit, Barcelona, Spain; [Quer, Josep] Univ Autonoma Barcelona, Lab Malalties Hepat, Liver Unit, Internal Med,VHIR,HUVH, Barcelona, Spain; [Garriga, Cesar] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England	Public Health Agency of Barcelona; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Oxford	Garriga, C; Manzanares-Laya, S (corresponding author), Publ Hlth Agcy Barcelona, Epidemiol Serv, Barcelona, Spain.; Garriga, C (corresponding author), Inst Salud Carlos III, Natl Ctr Epidemiol, Spanish Field Epidemiol Training Programme FETP P, Madrid, Spain.; Manzanares-Laya, S (corresponding author), CIBERESP, Madrid, Spain.; Garriga, C (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, Oxon, England.	cesar.garriga-fuentes@ndorms.ox.ac.uk; smanzana@aspb.cat	Navarro, Jordi/N-5499-2015; Quer, Josep/A-6741-2012; Navarro, Jordi/AGO-2330-2022; Garriga, Cesar/AEV-9080-2022; Lens, Sabela/L-4750-2018	Navarro, Jordi/0000-0002-7187-0367; Quer, Josep/0000-0003-0014-084X; Navarro, Jordi/0000-0002-7187-0367; Garriga, Cesar/0000-0001-7073-3611; Lens, Sabela/0000-0003-4900-411X; Laguno Centeno, Montserrat/0000-0002-7798-6352	Spanish Field Epidemiology Training Programme (FETP) [12/PEAC-06]	Spanish Field Epidemiology Training Programme (FETP)	Cesar Garriga developed the present study as part of his fellowship in the Spanish Field Epidemiology Training Programme (FETP) (file number: 12/PEAC-06; see https://goo.gl/RXhCX3 and Official Gazette number 167 of Friday July 13th 2012, pp. 50417, act 9361 in https://goo.gl/3q2c4h). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INF CUEST ACT PREV V; [Anonymous], 2005, INF CUEST ACT PREV V; Barcelona council technical programming office, 2014, DISTR TERR REND FAM; Barrio G, 2012, ADDICTION, V107, P1111, DOI 10.1111/j.1360-0443.2011.03759.x; Bottieau E, 2010, EUROSURVEILLANCE, V15, P19673; Bravo MJ, 2008, GAC SANIT, V22, P128, DOI 10.1157/13119320; Bruguera M, 2006, MED CLIN-BARCELONA, V127, P113, DOI 10.1157/13090276; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carvalho C, 2013, HIV MED, V14, P15, DOI 10.1111/hiv.12058; Castilla J, 2000, MED CLIN-BARCELONA, V115, P85, DOI 10.1016/S0025-7753(00)71473-4; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Danta M, 2011, CURR OPIN HIV AIDS, V6, P451, DOI 10.1097/COH.0b013e32834b4974; Daskalopoulou M, 2014, LANCET HIV, V1, pE22, DOI 10.1016/S2352-3018(14)70001-3; Ponde RAD, 2011, MED MICROBIOL IMMUN, V200, P7, DOI 10.1007/s00430-010-0159-9; Declaration of Helsiki, 2013, ETH PRINC MED RES IN; Diaz A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1093; Dietze P, 2012, INT J DRUG POLICY, V23, P257, DOI 10.1016/j.drugpo.2012.02.006; European Centre for Disease Prevention and Control, 2015, HEP C SURV EUR 2013, P9; Folch C, 2016, SUBST USE MISUSE, V51, P250, DOI 10.3109/10826084.2015.1092991; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Garg S, 2013, CLIN INFECT DIS, V56, P1480, DOI 10.1093/cid/cit054; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Heymann DL, 2008, CONTROL COMMUNICABLE; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hygiene NYCDoHaM, 2014, HEP B C ANN REP; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Klevens RM, 2014, AM J PUBLIC HEALTH, V104, P482, DOI 10.2105/AJPH.2013.301601; Martinez-Rebollar M, 2015, ENFERM INFEC MICR CL, V33, P3, DOI 10.1016/j.eimc.2014.05.013; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Owen G, 2008, CULT HEALTH SEX, V10, P601, DOI 10.1080/13691050802061673; Panella H, 2008, EMERG INFECT DIS, V14, P333, DOI 10.3201/eid1402.060763; Panneer N, 2014, CLIN INFECT DIS, V59, P875, DOI 10.1093/cid/ciu396; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; de la Hoya PS, 2011, EUR J CLIN MICROBIOL, V30, P857, DOI 10.1007/s10096-011-1166-5; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Sanchez-Niubo A, 2009, ADDICTION, V104, P248, DOI 10.1111/j.1360-0443.2008.02451.x; Statistics department, STAT YB BARC CIT; Terrault NA, 2013, HEPATOLOGY, V57, P881, DOI 10.1002/hep.26164; Vallejo F, 2006, 24 REUN CIENT AN SOC; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187893	10.1371/journal.pone.0187893	http://dx.doi.org/10.1371/journal.pone.0187893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135988	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200042
J	Schmickl, T; Karsai, I				Schmickl, Thomas; Karsai, Istvan			Resilience of honeybee colonies via common stomach: A model of self-regulation of foraging	PLOS ONE			English	Article							DIVISION-OF-LABOR; COLLECTIVE DECISION-MAKING; INTRACOLONIAL POPULATION-DYNAMICS; APIS-MELLIFERA; NEST CONSTRUCTION; BEES HYMENOPTERA; INSECT SOCIETIES; QUEUING DELAY; BEHAVIOR; TASK	We propose a new regulation mechanism based on the idea of the "common stomach" to explain several aspects of the resilience and homeostatic regulation of honeybee colonies. This mechanism exploits shared pools of substances (pollen, nectar, workers, brood) that modulate recruitment, abandonment and allocation patterns at the colony-level and enable bees to perform several survival strategies to cope with difficult circumstances: Lack of proteins leads to reduced feeding of young brood, to early capping of old brood and to regaining of already spent proteins through brood cannibalism. We modeled this system by linear interaction terms and mass-action law. To test the predictive power of the model of this regulatory mechanism we compared our model predictions to experimental data of several studies. These comparisons show that the proposed regulation mechanism can explain a variety of colony level behaviors. Detailed analysis of the model revealed that these mechanisms could explain the resilience, stability and self-regulation observed in honeybee colonies. We found that manipulation of material flow and applying sudden perturbations to colony stocks are quickly compensated by a resulting counter-acting shift in task selection. Selective analysis of feedback loops allowed us to discriminate the importance of different feedback loops in self-regulation of honeybee colonies. We stress that a network of simple proximate mechanisms can explain significant colony-level abilities that can also be seen as ultimate reasoning of the evolutionary trajectory of honeybees.	[Schmickl, Thomas] Karl Franzens Univ Graz, Artificial Life Lab, Graz, Austria; [Schmickl, Thomas] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Karsai, Istvan] East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA	University of Graz; University of Graz; East Tennessee State University	Karsai, I (corresponding author), East Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	karsai@etsu.edu		Schmickl, Thomas/0000-0001-8598-7462	Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University	Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University	This work was supported by Basler Chair of Excellence for the Integration of the Arts, Rhetoric and Science at East Tennessee State University (TS and IK) (http://www.etsu.edu/cas/basler.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145560; Anderson C, 1999, AM NAT, V154, P521, DOI 10.1086/303255; ARON S, 1989, BIOL BEHAV, V14, P207; BARTHOLDI JJ, 1993, J THEOR BIOL, V160, P23, DOI 10.1006/jtbi.1993.1002; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Beshers SN, 2001, ANNU REV ENTOMOL, V46, P413, DOI 10.1146/annurev.ento.46.1.413; Blaschon B, 1999, ENTOMOL GEN, V24, P49; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; Collignon B, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150473; COOPER PD, 1985, J EXP BIOL, V114, P1; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; de Vries H, 1998, BEHAV ECOL SOCIOBIOL, V44, P109, DOI 10.1007/s002650050522; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P169, DOI 10.1007/BF01417910; Dornhaus A, 2006, BEHAV ECOL, V17, P336, DOI 10.1093/beheco/arj036; Dreller C, 2000, ANIM BEHAV, V59, P91, DOI 10.1006/anbe.1999.1303; Dussutour A, 2006, BEHAV ECOL SOCIOBIOL, V61, P17, DOI 10.1007/s00265-006-0233-x; Dussutour A, 2010, P NATL ACAD SCI USA, V107, P4607, DOI 10.1073/pnas.0912198107; EBERLEIN RL, 1992, EUR J OPER RES, V59, P216, DOI 10.1016/0377-2217(92)90018-5; Forrester JW., 1969, URBAN DYN, P358; Franks NR, 2001, ANIM BEHAV, V62, P635, DOI 10.1006/anbe.2001.1794; FRANKS NR, 1994, ANIM BEHAV, V48, P470, DOI 10.1006/anbe.1994.1261; GAROFALO CA, 1977, J APICULT RES, V16, P3; Gautrais J, 2002, J THEOR BIOL, V215, P363, DOI 10.1006/jtbi.2001.2506; Gregson AM, 2003, J THEOR BIOL, V222, P1, DOI 10.1016/S0022-5193(02)00487-3; Hamann H, 2013, B MATH BIOL, V75, P1181, DOI 10.1007/s11538-013-9851-4; Hilbun A, PLOS ONE, V11, P1016; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B, 2008, SUPERORGANISM BEAUTY, P1; Huang MH, 2003, INSECT SOC, V50, P330, DOI 10.1007/s00040-003-0682-4; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; HUANG ZY, 1991, J INSECT BEHAV, V4, P177, DOI 10.1007/BF01054610; Jeanson R, 2005, ANIM BEHAV, V69, P169, DOI 10.1016/j.anbehav.2004.02.009; Johnson BR, 2005, BEHAV ECOL SOCIOBIOL, V58, P219, DOI 10.1007/s00265-005-0949-z; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Karsai I, 2000, J INSECT BEHAV, V13, P111, DOI 10.1023/A:1007771727503; Karsai I, 2011, BEHAV ECOL, V22, P819, DOI 10.1093/beheco/arr060; Karsai I, 2002, J THEOR BIOL, V218, P549, DOI 10.1006/jtbi.2002.3099; Karsai I, 2012, MATH COMP MODEL DYN, V18, P13, DOI 10.1080/13873954.2011.601423; Karsai I, 2012, J THEOR BIOL, V294, P98, DOI 10.1016/j.jtbi.2011.10.037; Kengyel D, 2015, LECT NOTES ARTIF INT, V9387, P201, DOI 10.1007/978-3-319-25524-8_13; Kernbach S, 2013, INT J ROBOT RES, V32, P35, DOI 10.1177/0278364912468636; Kernbach S, 2009, ADAPT BEHAV, V17, P237, DOI 10.1177/1059712309104966; KORST PJAM, 1982, INSECT SOC, V29, P209, DOI 10.1007/BF02228753; Kovac H, 2010, J INSECT PHYSIOL, V56, P1834, DOI 10.1016/j.jinsphys.2010.08.002; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Middleton EJT, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1022; OMHOLT SW, 1986, J APICULT RES, V25, P9, DOI 10.1080/00218839.1986.11100686; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Ratnieks FLW, 1999, AM NAT, V154, P536, DOI 10.1086/303256; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1992, ETHOLOGY, V90, P336, DOI 10.1111/j.1439-0310.1992.tb00844.x; Rotjan RD, 2002, APIDOLOGIE, V33, P367, DOI 10.1051/apido:2002026; Schmickl T, 2008, MATH COMP MODEL DYN, V14, P101, DOI 10.1080/13873950701846662; Schmickl T, 2004, ADAPT BEHAV, V12, P263, DOI 10.1177/105971230401200311; Schmickl T, 2004, APIDOLOGIE, V35, P249, DOI 10.1051/apido:2004019; Schmickl T, 2003, INSECT SOC, V50, P174, DOI 10.1007/s00040-003-0644-x; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Schmickl T, 2001, J COMP PHYSIOL A, V187, P541, DOI 10.1007/s003590100226; Schmickl T, 2012, ECOLOGICAL MODELING, P223; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schmickl T, 2016, J THEOR BIOL, V389, P274, DOI 10.1016/j.jtbi.2015.10.036; Schmickl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114611; Schmickl T, 2012, NEURAL COMPUT APPL, V21, P251, DOI 10.1007/s00521-010-0357-9; Schmickl Thomas, 2009, Denisia, V25, P141; Schmickl T, 2009, AUTON AGENT MULTI-AG, V18, P133, DOI 10.1007/s10458-008-9058-5; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; SEELEY TD, 1989, BEHAV ECOL SOCIOBIOL, V24, P181, DOI 10.1007/BF00292101; SEELEY TD, 1994, ANIM BEHAV, V47, P311, DOI 10.1006/anbe.1994.1044; Seeley TD, 2004, APIDOLOGIE, V35, P101, DOI 10.1051/apido:2004004; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1985, FORTS ZOOL, V31, P75; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V31, P375, DOI 10.1007/BF00170604; Seeley TD., 1995, WISDOM HIVE SOCIAL P, P1; Stein W., 2005, SIGSAM Bulletin, V39, P61, DOI 10.1145/1101884.1101889; Szopek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076250; Thenius R, 2008, CONNECT SCI, V20, P193, DOI 10.1080/09540090802091982; TOFTS C, 1993, B MATH BIOL, V55, P891, DOI 10.1007/BF02460691; WEBSTER TC, 1987, PHYSIOL ENTOMOL, V12, P225, DOI 10.1111/j.1365-3032.1987.tb00745.x; WEBSTER TC, 1985, ENVIRON ENTOMOL, V14, P683, DOI 10.1093/ee/14.6.683; Wilson E.O, 1971, INSECT SOC, P1; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; WOYKE J, 1977, J APICULT RES, V16, P84, DOI 10.1080/00218839.1977.11099866; Zahadat P, 2013, 12 EUR C ART LIF ECA, P609; Zahadat P, 2016, ADAPT BEHAV, V24, P87, DOI 10.1177/1059712316633028; Zahadat P, 2015, BIOINSPIR BIOMIM, V10, DOI 10.1088/1748-3190/10/6/066005	95	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188004	10.1371/journal.pone.0188004	http://dx.doi.org/10.1371/journal.pone.0188004			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161278	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000028
J	Dencker, M; Tanha, T; Karlsson, MK; Wollmer, P; Andersen, LB; Thorsson, O				Dencker, Magnus; Tanha, Tina; Karlsson, Magnus K.; Wollmer, Per; Andersen, Lars B.; Thorsson, Ola			Cystatin B, cathepsin L and D related to surrogate markers for cardiovascular disease in children	PLOS ONE			English	Article							LEFT ATRIAL SIZE; PHYSICAL-ACTIVITY; RISK; ATHEROSCLEROSIS; EXPRESSION; ASSOCIATION; MACROPHAGES; ADULTS; CELLS	Objective This study investigated potential associations between novel biomarkers for cardiovascular disease and other surrogate markers for health. Methods Community sample of 170 (92 boys and 78 girls) children aged 8-11 years. Total fat mass (TBF) and abdominal fat (AFM) were measured by Dual-energy x-ray absorptiometry (DXA). Total body fat was also expressed as percentage of total body mass (BF%), and body fat distribution was calculated as AFM/TBF. Maximal oxygen uptake (VO2PEAK), systolic and diastolic blood pressure (SBP and DBP) and pulse pressure (PP) were measured. Echocardiography was performed. Left atrial size (LA) and left ventricular mass (LVM) were measured. A follow-up DXA scan was available in 152 children (84 boys and 68 girls). Frozen serum samples were analyzed for cystatin B, cathepsin L and cathepsin D. Results Partial correlations between cystatin B versus lnTBF, lnBF%, lnAFM, AFM/TBF, VO2PEAK and PP were; r = 0.38, 0.36, 0.38, 0.29, -0.25 and 0.25, P = 0.001 or less for all. Weaker predominantly non-significant correlations were found for cathepsin L, whereas cathepsin D was not related to any surrogate markers for health. No significant correlations were found between biomarkers and change in body fat over 2 years. Conclusion Findings from this community-based cohort of young children show that surrogate markers for cardiovascular disease such as total fat mass, percent body fat, abdominal fat, body fat distribution, maximal oxygen uptake and pulse pressure were all associated with cystatin B. This was not found for cathepsin L or cathepsin D.	[Dencker, Magnus; Tanha, Tina; Wollmer, Per; Thorsson, Ola] Lund Univ, Dept Translat Med, Unit Med Imaging & Physiol, Skane Univ Hosp, Malmo, Sweden; [Karlsson, Magnus K.] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Skane Univ Hosp, Malmo, Sweden; [Andersen, Lars B.] Sogn & Fjordane Univ Coll, Sogndal, Norway; [Andersen, Lars B.] Norwegian Sch Sport Sci, Dept Sports Med, Oslo, Norway	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Western Norway University of Applied Sciences; Norwegian School of Sport Sciences	Dencker, M (corresponding author), Lund Univ, Dept Translat Med, Unit Med Imaging & Physiol, Skane Univ Hosp, Malmo, Sweden.	magnus.dencker@skane.se	Wollmer, Per/S-5895-2019	Dencker, Magnus/0000-0001-9991-3712	Swedish Heart- Lung Foundation; Gyllenstierna Krapperup's Foundation; Lund University, Skane University Hospital; Region Skane; Gyllenstierna Krapperup 's Foundation	Swedish Heart- Lung Foundation(Swedish Heart-Lung Foundation); Gyllenstierna Krapperup's Foundation; Lund University, Skane University Hospital; Region Skane; Gyllenstierna Krapperup 's Foundation	Financial support for this study was received from the Swedish Heart- Lung Foundation, the Gyllenstierna Krapperup's Foundation and grants from Lund University, Skane University Hospital and Region Skane.	Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Armstrong N, 2000, PAEDIAT EXERCISE SCI; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Biswas B, 2015, INDIAN J PATHOL MICR, V58, P170, DOI 10.4103/0377-4929.155307; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Dencker M, 2006, J PEDIATR-US, V149, P38, DOI 10.1016/j.jpeds.2006.02.002; DUKE PM, 1980, PEDIATRICS, V66, P918; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; Goncalves I, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2015-000353; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; Jahn LA, 2016, J CLIN ENDOCR METAB, V101, P1198, DOI 10.1210/jc.2015-3293; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li W, 2004, ANN NY ACAD SCI, V1030, P427, DOI 10.1196/annals.1329.053; Liu J, 2006, ATHEROSCLEROSIS, V184, P302, DOI 10.1016/j.atherosclerosis.2005.05.012; Liu YX, 2009, AM J CARDIOL, V103, P476, DOI 10.1016/j.amjcard.2008.10.011; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Lv BJ, 2013, ATHEROSCLEROSIS, V230, P100, DOI 10.1016/j.atherosclerosis.2013.05.018; Nagarajarao HS, 2008, STROKE, V39, P2701, DOI 10.1161/STROKEAHA.108.515221; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Soltysiak J, 2014, ENDOKRYNOL POL, V65, P479, DOI 10.5603/EP.2014.0067; Walenbergh SMA, 2015, AM J GASTROENTEROL, V110, P462, DOI 10.1038/ajg.2015.29	25	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187494	10.1371/journal.pone.0187494	http://dx.doi.org/10.1371/journal.pone.0187494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149174	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100011
J	Rogal, SS; Udawatta, V; Akpan, I; Moghe, A; Chidi, A; Shetty, A; Szigethy, E; Bielefeldt, K; DiMartini, A				Rogal, Shari S.; Udawatta, Viyan; Akpan, Imo; Moghe, Akshata; Chidi, Alexis; Shetty, Amit; Szigethy, Eva; Bielefeldt, Klaus; DiMartini, Andrea			Risk factors for hospitalizations among patients with cirrhosis: A prospective cohort study	PLOS ONE			English	Article							MCGILL PAIN QUESTIONNAIRE; HEALTH-CARE; OPIOID USE; DEPRESSION; FIBROMYALGIA; INFLAMMATION; MORTALITY; QUALITY; ANXIETY; SLEEP	This study was designed to assess unique baseline factors associated with subsequent hospitalizations in a cohort of outpatients with cirrhosis. A cohort of 193 patients with cirrhosis was recruited from an outpatient liver disease clinic at a single, tertiary medical center. Comorbidities, prescription medications, liver disease symptoms and severity, and psychiatric and pain symptoms were assessed at baseline using validated instruments. Inflammatory markers were measured using standardized Luminex assays. Subsequent hospitalizations and the primary admission diagnoses were collected via chart review. Multivariable models were used to evaluate which baseline factors were associated with time to hospitalization and number of hospitalizations. The cohort consisted of 193 outpatients, with an average age of 58 +/- 9 and model for end-stage liver disease (MELD) score of 12 +/- 5. Over follow-up, 57 (30%) were admitted to the hospital. The factors associated with time to hospitalization included the severity of liver disease (HR/MELD point: 1.10, 95% CI: 1.04,1.16), ascites (HR: 1.90, 95% CI: 1.01, 3.58), baseline symptoms of depression (HR: 2.34, 95% CI: 1.28,4.25), sleep medications (HR: 1.81, 95% CI: 1.01, 3.22) and IL-6 (HR: 1.43, 95% CI: 1.10, 1.84). Similarly the number admissions was significantly associated with MELD (IIR: 1.08, CI: 1.07,1.09), ascites (IIR: 4.15, CI: 3.89, 4.43), depressive symptoms (IIR: 1.54, CI: 1.44,1.64), IL-6 (IIR: 1.26, CI: 1.23,1.30), sleep medications (IIR: 2.74, CI: 2.57, 2.93), and widespread pain (IIR: 1.61, CI: 1.50, 1.73). In conclusion, consistent with prior studies, MELD and ascites were associated with subsequent hospitalization. However, this study also identified other factors associated with hospitalization including inflammation, depressive symptoms, sleep medication use, and pain.	[Rogal, Shari S.; DiMartini, Andrea] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Rogal, Shari S.; Chidi, Alexis] VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA; [Rogal, Shari S.; Akpan, Imo; Bielefeldt, Klaus] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA; [Udawatta, Viyan; Moghe, Akshata; Chidi, Alexis] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Shetty, Amit] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Szigethy, Eva; DiMartini, Andrea] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Rogal, SS (corresponding author), VA Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15260 USA.	rogalss@upmc.edu	Moghe, Akshata/V-4963-2019; Moghe, Akshata/V-4632-2019	Rogal, Shari/0000-0001-8184-1546	National Institutes of Health [DK063922]; University of Pittsburgh	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh)	The primary data were collected while Shari S. Rogal was a T-32 fellow on the National Institutes of Health DK063922. The funds for the study were provided by the University of Pittsburgh, Thomas E. Starzl Young Investigator Award to Shari S. Rogal. Study sponsors had no involvement in the study design; in collection, analysis, interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication.	Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P2583, DOI 10.1097/MIB.0000000000000537; Andersen NLT, 2013, PSYCHOSOMATICS, V54, P132, DOI 10.1016/j.psym.2012.07.007; [Anonymous], [No title captured]; Berman K, 2011, CLIN GASTROENTEROL H, V9, P254, DOI 10.1016/j.cgh.2010.10.035; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Buysse D J, 1989, Psychiatry Res, V28, P193; Cervoni JP, 2012, J HEPATOL, V56, P1299, DOI 10.1016/j.jhep.2011.12.030; CHAMPANERIA S, 1989, BIOCHEM CELL BIOL, V67, P128, DOI 10.1139/o89-020; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chojnacki C, 2012, GASTROENT RES PRACT, V2012; Davies S, 2013, HEALTH SERV RES, V48, P1978, DOI 10.1111/1475-6773.12075; DiMartini A, 2011, CLIN LIVER DIS, V15, P727, DOI 10.1016/j.cld.2011.08.002; Dirchwolf M, 2015, WORLD J HEPATOL, V7, P1974, DOI 10.4254/wjh.v7.i16.1974; Fagan KJ, 2014, INTERN MED J, V44, P865, DOI 10.1111/imj.12491; Freedland KE, 2016, CLIN CARDIOL, V39, P257, DOI 10.1002/clc.22520; Ganesh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055140; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Guthrie EA, 2016, J PSYCHOSOM RES, V82, P54, DOI 10.1016/j.jpsychores.2014.10.002; Ho SB, 2015, CLIN GASTROENTEROL H; Kanwal F, 2014, GASTROENTEROLOGY, V147, P1204, DOI 10.1053/j.gastro.2014.10.029; Knudsen KB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2862-5; Lazzarotto Cesar, 2013, Ann Hepatol, V12, P599; Lee FY, 1996, SCAND J GASTROENTERO, V31, P500, DOI 10.3109/00365529609006772; Lotrich FE, 2011, J RHEUMATOL, V38, P48, DOI 10.3899/jrheum.110903; Martinez-Esparza M, 2015, WORLD J GASTROENTERO, V21, P11522, DOI 10.3748/wjg.v21.i41.11522; McBeth J, 2012, NAT REV RHEUMATOL, V8, P108, DOI 10.1038/nrrheum.2011.216; Melzack R, 2005, ANESTHESIOLOGY, V103, P199, DOI 10.1097/00000542-200507000-00028; MELZACK R, 1971, ANESTHESIOLOGY, V34, P50; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Moise N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003767; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Mosher HJ, 2014, J HOSP MED, V9, P82, DOI 10.1002/jhm.2113; Penn CA, 2016, OBSTET GYNECOL; R Core Team, 2012, R LANG ENV STAT COMP; Rogal SS, 2015, CLIN GASTROENTEROL H, V13, P1009, DOI 10.1016/j.cgh.2014.10.029; Rogal SS, 2013, LIVER INT, V33, P1497, DOI 10.1111/liv.12215; Rogal SS, 2013, DIGEST DIS SCI, V58, P2976, DOI 10.1007/s10620-013-2638-5; Rowan PJ, 2004, J CLIN GASTROENTEROL, V38, P530, DOI 10.1097/01.mcg.0000123203.36471.70; Spahr L, 2007, AM J GASTROENTEROL, V102, P744, DOI 10.1111/j.1572-0241.2006.01028.x; STEINDL PE, 1995, ANN INTERN MED, V123, P274, DOI 10.7326/0003-4819-123-4-199508150-00005; Tsai CF, 2016, ALIMENT PHARM THER; Venables WN., 2002, MODERN APPL STAT S; Vignali DA, 2000, J IMMUNOL METHODS, V243, P1; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187176	10.1371/journal.pone.0187176	http://dx.doi.org/10.1371/journal.pone.0187176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149171	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100007
J	Cui, ZH; Ai, C; Lv, L; Yin, FX				Cui, Zhihua; Ai, Chi; Lv, Lei; Yin, Fangxian			Effect of pulse pressure on borehole stability during shear swirling flow vibration cementing	PLOS ONE			English	Article							VISCOPLASTIC FLUIDS; ECCENTRIC ANNULI; MUD REMOVAL; OIL-WELL; PART 2; DISPLACEMENTS; PLACEMENT; LAYER	The shear swirling flow vibration cementing (SSFVC) technique rotates the downhole eccentric cascade by circulating cementing fluid. It makes the casing eccentrically revolve at high speed around the borehole axis. It produces strong agitation action to the annulus fluid, makes it in the state of shear turbulent flow, and results in the formation of pulse pressure which affects the surrounding rock stress. This study was focused on 1) the calculation of the pulse pressure in an annular turbulent flow field based on the finite volume method, and 2) the analysis of the effect of pulse pressure on borehole stability. On the upside, the pulse pressure is conducive to enhancing the liquidity of the annulus fluid, reducing the fluid gel strength, and preventing the formation of fluid from channeling. But greater pulse pressure may cause lost circulation and even formation fracturing. Therefore, in order to ensure smooth cementing during SSFVC, the effect of pulse pressure should be considered when cementing design.	[Cui, Zhihua; Lv, Lei] Yanan Univ, Sch Petr & Environm Engn, Yanan, Shaanxi, Peoples R China; [Cui, Zhihua; Ai, Chi] Northeast Petr Univ, Key Lab, Educ Minist Enhanced Oil Recovery, Daqing, Heilongjiang, Peoples R China; [Yin, Fangxian] North China Univ Technol, Sch Mech & Mat Engn, Beijing, Peoples R China	Yanan University; Northeast Petroleum University; North China University of Technology	Cui, ZH (corresponding author), Yanan Univ, Sch Petr & Environm Engn, Yanan, Shaanxi, Peoples R China.; Cui, ZH (corresponding author), Northeast Petr Univ, Key Lab, Educ Minist Enhanced Oil Recovery, Daqing, Heilongjiang, Peoples R China.	hi891012hi@163.com			Doctoral Scientific Research Start-up Foundation of Yan'an University [YDBK2017-27]	Doctoral Scientific Research Start-up Foundation of Yan'an University	This work was supported by the Doctoral Scientific Research Start-up Foundation of Yan'an University (Project No. YDBK2017-27).	Allouche M, 2000, J FLUID MECH, V424, P243, DOI 10.1017/S0022112000001956; Bin Z., 2011, THESIS; Bin Zhou, 2013, RES CEMENTING TECHNO; Bird R. B., 1987, FLUID MECH, V1, P12; Bittleston SH, 2002, J ENG MATH, V43, P229, DOI 10.1023/A:1020370417367; Carrasco-Teja M, 2008, J FLUID MECH, V605, P293, DOI 10.1017/S0022112008001535; Duvaut G, 1976, INEQUALITIES MECH PH, DOI DOI 10.1007/978-3-642-66165-5; Fitt AD, 2001, J ENG MATH, V39, P345, DOI 10.1023/A:1004834004732; Glowinski R., 1984, NUMERICAL METHODS NO; Haige Wang, 1993, J U PETROLEUM CHINA, V17, P26; Hussain QE, 2000, AICHE J, V46, P1937, DOI 10.1002/aic.690461006; Lavrov A, 2013, CHEM ENG SCI, V99, P81, DOI 10.1016/j.ces.2013.05.045; Li J, 2000, SIAM REV, V42, P417, DOI 10.1137/S0036144599354604; Li M., 2012, PET DRILL TECH, V40, P40; LIU KF, 1994, PHYS FLUIDS, V6, P2577, DOI 10.1063/1.868148; Mao ZS, 2012, CHINESE J CHEM ENG, V20, P191, DOI 10.1016/S1004-9541(12)60379-6; Meng C., 2009, THESIS; Meuric OFJ, 1998, CAN J CHEM ENG, V76, P27, DOI 10.1002/cjce.5450760105; Mitsoulis E, 2004, J NON-NEWTON FLUID, V122, P45, DOI 10.1016/j.jnnfm.2003.10.007; Moyers-Gonzalez MA, 2009, J ENG MATH, V65, P25, DOI 10.1007/s10665-008-9260-0; NOURI JM, 1994, J FLUID ENG-T ASME, V116, P821, DOI 10.1115/1.2911856; Pelipenko S, 2004, J ENG MATH, V48, P1, DOI 10.1023/B:ENGI.0000009499.63859.f0; Reddy MG, 2014, INT J HEAT TECHNOL, V32, P1; Ruihe Wang, 2013, NATURAL GAS IND, V33, P69; SABINS FL, 1990, J PETROL TECHNOL, V42, P398, DOI 10.2118/20005-PA; Shu Q.G., 2012, DRILLING TECHNOLOGY, V35, P29; Shuyun Zh, 2011, THESIS; SZABO P, 1992, J NON-NEWTON FLUID, V45, P149, DOI 10.1016/0377-0257(92)85001-D; Uner D, 1989, FLOW POWER LAW FLUID, V2, P269; Zhang S. J., 2012, DRILL PRODUCT TECHNO, V35, P15; Zhihua C, 2016, AIP C P, V1794	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187279	10.1371/journal.pone.0187279	http://dx.doi.org/10.1371/journal.pone.0187279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145408	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800014
J	Knafl, D; Muller, M; Pajenda, S; Genc, Z; Hecking, M; Wagner, L				Knafl, Daniela; Mueller, Markus; Pajenda, Sahra; Genc, Zeynep; Hecking, Manfred; Wagner, Ludwig			The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck (R) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CELL-CYCLE ARREST; DIAGNOSIS	Background Acute kidney injury (AKI) is frequently observed in serious infections, following nephrotoxic medication, surgery and trauma. Here we tested whether the detection of two recently identified biomarkers for AKI, Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) and Insulin-Like Growth Factor Binding Protein 7 (IGFBP7), depends on the expression of these proteins in cells of the urinary sediment. Method We collected urine samples of 33 kidney transplant recipients and 14 non-transplanted patients who all had AKI (stages 1-3 according to KDIGO), and measured [IGFBP7]x [TIMP-2] using the NephroCheck (R) Astute1 40 (TM) meter. Concomitantly, we analyzed IGFBP7 and TIMP-2 mRNA expression by quantitative polymerase chain reaction (qPCR) from urinary sediment of the same patients, and correlated the results with [IGFBP7] x [TIMP-2] (protein), by linear regression analysis. We also determined the association between [IGFBP7]x[TIMP-2] and estimated glomerular filtration rate (eGFR), and between IGFBP7 and TIMP-2 mRNA expression and markers of inflammation. Light microscopy and confocal immunofluorescence served to illustrate changes in the urinary sediment over the time course of renal function improvement. Results Of the 47 analyzed AKI patients, 14 presented with ascending urinary tract infection. Serum creatinine (sCr), blood urea nitrogen (BUN) and eGFR in all patients were 3.9 +/- 2.28 mg/dL, 47.59 +/- 23.1 mg/dL and 22.88 +/- 16.0 mL/min/1.73m(2), respectively, on average +/- standard deviation. [IGFBP7]x[TIMP-2] was 2.33 +/- 9.95 (ng/ml)(2)/1000, and did not associate with IGFBP7 and TIMP-2 gene expression (r = -0.0220, p = 0.4216; respectively r = 0.0972, p = 0.1909). [ IGFBP7] x[ TIMP-2] did not associate with eGFR; IGFBP7 and TIMP-2 mRNA expression. Improvement of renal function went along with disappearance of casts, decrease in aquaporin1 positive renal epithelial cells and leukocytes from the urinary sediment. Conclusion The gene expression pattern of IGFBP7 and TIMP-2 from urinary sediment, which contains desquamated renal tubular epithelial cells, did not correlate with [ IGFBP7] x[ TIMP-2] protein, indicating that IGFBP7 and TIMP-2 measured in the NephroCheck (R) test originated predominantly from intact but stressed cells of the kidney itself.	[Knafl, Daniela] Med Univ Vienna, Dept Internal Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Mueller, Markus] Med Univ Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; [Pajenda, Sahra; Genc, Zeynep; Hecking, Manfred; Wagner, Ludwig] Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Wagner, L (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria.	ludwig.wagner@meduniwien.ac.at	Hecking/AAK-7399-2021	Gerges, Daniela/0000-0001-6810-615X; Hecking, Manfred/0000-0002-8047-2395				Aregger F, 2014, KIDNEY INT, V85, P909, DOI 10.1038/ki.2013.363; Belcher JM, 2014, HEPATOLOGY, V60, P622, DOI 10.1002/hep.26980; Chawla LS, 2008, NEPHRON CLIN PRACT, V110, pC145, DOI 10.1159/000166605; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Daubin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169674; Dewitte A, 2015, CLIN J AM SOC NEPHRO, V10, P1900, DOI 10.2215/CJN.12651214; Druml W, 2015, INTENS CARE MED, V41, P1941, DOI 10.1007/s00134-015-3989-5; DUSSE F, 2016, BMC ANESTHESIOL, V16, DOI DOI 10.1186/S12871-016-0244-8; Emlet DR, 2017, AM J PHYSIOL-RENAL, V312, pF284, DOI 10.1152/ajprenal.00271.2016; Hoste EAJ, 2014, NEPHROL DIAL TRANSPL, V29, P2054, DOI 10.1093/ndt/gfu292; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kellum JA, 2016, NEPHROL DIAL TRANSPL, V31, P16, DOI 10.1093/ndt/gfv130; Koyner JL, 2015, J AM SOC NEPHROL, V26, P2023, DOI 10.1681/ASN.2014060535; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110865; Pajenda S, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0203-5; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Waikar SS, 2012, J AM SOC NEPHROL, V23, P13, DOI 10.1681/ASN.2010111124; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Wu XH, 2016, AM J INFECT CONTROL, V44, P1261, DOI 10.1016/j.ajic.2016.04.222; Zarbock A, 2015, JAMA-J AM MED ASSOC, V313, P2133, DOI 10.1001/jama.2015.4189	21	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188316	10.1371/journal.pone.0188316	http://dx.doi.org/10.1371/journal.pone.0188316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145491	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800111
J	Hironaka-Mitsuhashi, A; Matsuzaki, J; Takahashi, RU; Yoshida, M; Nezu, Y; Yamamoto, Y; Shiino, S; Kinoshita, T; Ushijima, T; Hiraoka, N; Shimizu, C; Tamura, K; Ochiya, T				Hironaka-Mitsuhashi, Ai; Matsuzaki, Juntaro; Takahashi, Ryou-u; Yoshida, Masayuki; Nezu, Yutaka; Yamamoto, Yusuke; Shiino, Sho; Kinoshita, Takayuki; Ushijima, Toshikazu; Hiraoka, Nobuyoshi; Shimizu, Chikako; Tamura, Kenji; Ochiya, Takahiro			A tissue microRNA signature that predicts the prognosis of breast cancer in young women	PLOS ONE			English	Article							CLINICAL ONCOLOGY/COLLEGE; LESS-THAN-35 YEARS; AMERICAN SOCIETY; EXPRESSION; ESTROGEN; RECOMMENDATIONS; AGE; IMMUNOHISTOCHEMISTRY; PROLIFERATION; RELAPSE	Since breast cancers in young women are generally aggressive, young patients tend to be intensively treated with anti-cancer drugs. To optimize the strategy for treatment, particularly in young women, prognostic biomarkers are urgently required. The objective of this study was to identify a tissue microRNA (miRNA) signature that predicts prognosis in young breast cancer patients. Total RNA from 45 breast cancer patients aged <35 years was extracted from formalin-fixed paraffin-embedded (FFPE) tissues and analyzed using miRNA microarrays. Patients were categorized into two groups according to recurrence status within the 5 year period after surgery: recurrence (n = 11) and non-recurrent (n = 34). Histological parameters of hormone receptors and Ki-67 were statistically compared between the two groups. Differentially expressed miRNAs were identified, and their associations with overall survival (OS) were evaluated by log-rank test. The median observation period was 5.8 years for the recurrent group, and 9.1 years for the non-recurrent group. Nine miRNAs were significantly differentially expressed between the recurrent and non-recurrent groups. Receiver Operating Characteristic curve analysis was performed to evaluate the prediction accuracy of the identified miRNAs, and the resultant area under the curve was >0.7. Five of the miRNAs were validated by qRT-PCR, and the expression levels of three of those five (miR-183-5p, miR-194-5p, and miR-1285-5p), both alone and in combination, were associated with OS. In conclusion, we identified three candidate miRNAs that could be used separately or in combination as prognostic biomarkers in young breast cancer patients. This miRNA signature may enable selection of better treatment choices for young women with this disease.	[Hironaka-Mitsuhashi, Ai; Matsuzaki, Juntaro; Takahashi, Ryou-u; Nezu, Yutaka; Yamamoto, Yusuke; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo, Japan; [Hironaka-Mitsuhashi, Ai; Kinoshita, Takayuki] Juntendo Univ, Grad Sch Med, Courses Adv Clin Res Canc, Tokyo, Japan; [Yoshida, Masayuki; Hiraoka, Nobuyoshi] Natl Canc Ctr, Dept Pathol & Clin Labs, Tokyo, Japan; [Shiino, Sho; Kinoshita, Takayuki] Natl Canc Ctr, Dept Breast Surg, Tokyo, Japan; [Ushijima, Toshikazu] Natl Canc Ctr, Res Inst, Div Epigen, Tokyo, Japan; [Shimizu, Chikako; Tamura, Kenji] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan	National Cancer Center - Japan; Juntendo University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Div Mol & Cellular Med, Tokyo, Japan.	tochiya@ncc.go.jp	Kinoshita, Takayuki/AAA-5722-2020; Ochiya, Takahiro/AAH-7585-2019; Matsuzaki, Juntaro/S-4107-2019; Ushijima, Toshikazu/AAP-5742-2021	Matsuzaki, Juntaro/0000-0002-3204-5049; Ushijima, Toshikazu/0000-0003-3405-7817	Japan Science and Technology Agency (JST) [16K08261]; Japan Agency for Medical Research and Development (AMED)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The present work was supported in part by a Grant-in-Aid from the Japan Science and Technology Agency (JST) grant 16K08261 to RT and the "Development of Diagnostic Technology for Detection of miRNA in Body Fluids" grant from the Japan Agency for Medical Research and Development (AMED) to TO.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allred DC, 1998, MODERN PATHOL, V11, P155; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Azim Hatem A Jr, 2016, Am Soc Clin Oncol Educ Book, V35, P23, DOI 10.14694/EDBK_159069; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cancello G, 2010, ANN ONCOL, V21, P1974, DOI 10.1093/annonc/mdq072; Cheng Y, 2016, REPROD BIOL, V16, P225, DOI 10.1016/j.repbio.2016.07.002; Chollet-Hinton L, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0736-y; Das R, 2016, CANC RES; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Han W, 2010, BREAST CANCER RES TR, V119, P193, DOI 10.1007/s10549-009-0388-z; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Hoppe R, 2013, EUR J CANCER, V49, P3598, DOI 10.1016/j.ejca.2013.07.145; Huiart L, 2012, EUR J CANCER, V48, P1939, DOI 10.1016/j.ejca.2012.03.004; Huo DZ, 2016, ONCOTARGET, V7, P55231, DOI 10.18632/oncotarget.10485; Johnson RH, 2015, ONCOTARGET, V6, P13688, DOI 10.18632/oncotarget.4051; Kataoka A, 2016, BREAST CANCER RES TR, V160, P163, DOI 10.1007/s10549-016-3984-8; Kataoka A, 2014, BREAST CANCER-TOKYO, V21, P643, DOI 10.1007/s12282-013-0466-2; Kim EK, 2011, WORLD J SURG, V35, P1244, DOI 10.1007/s00268-011-1071-1; Le Quesne J, 2012, J PATHOL, V227, P306, DOI 10.1002/path.3983; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Lowery AJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-502; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markou A, 2014, CLIN CHEM, V60, P197, DOI 10.1373/clinchem.2013.210542; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Nofech-Mozes R, 2016, CANCER MED-US, V5, P656, DOI 10.1002/cam4.631; Qiao ZW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114536; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Regan MM, 2016, J CLIN ONCOL, V34, P2221, DOI 10.1200/JCO.2015.64.3171; Ruddy KJ, 2014, J CLIN ONCOL, V32, P1151, DOI 10.1200/JCO.2013.52.8877; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Song CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24502; Tjokrowidjaja A, 2014, INTERN MED J, V44, P764, DOI 10.1111/imj.12481; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; YE XM, 2014, BMC CANCER, V14, DOI DOI 10.1038/ONC.2012.128; Zehentmayr F, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0198-1; Zhang PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6671; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077; Zhao YL, 2015, INT J CLIN EXP PATHO, V8, P12446	48	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187638	10.1371/journal.pone.0187638	http://dx.doi.org/10.1371/journal.pone.0187638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141042	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400026
J	Samuelsen, O; Overballe-Petersen, S; Bjornholt, JV; Brisse, S; Doumith, M; Woodford, N; Hopkins, KL; Aasnaes, B; Haldorsen, B; Sundsfjord, A				Samuelsen, Orjan; Overballe-Petersen, Soren; Bjornholt, Jorgen Vildershoj; Brisse, Sylvain; Doumith, Michel; Woodford, Neil; Hopkins, Katie L.; Aasnaes, Bettina; Haldorsen, Bjorg; Sundsfjord, Arnfinn		Norwegian Study Grp CPE	Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; CARBA NP TEST; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; BETA-LACTAMASE; RESISTANT ENTEROBACTERIACEAE; RAPID DETECTION; ACINETOBACTER-BAUMANNII; KPC CARBAPENEMASE; HIGH-PREVALENCE	The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) is increasing worldwide. Here we present associated patient data and molecular, epidemiological and phenotypic characteristics of all CPE isolates in Norway from 2007 to 2014 confirmed at the Norwegian National Advisory Unit on Detection of Antimicrobial Resistance. All confirmed CPE isolates were characterized pheno- and genotypically, including by whole genome sequencing (WGS). Patient data were reviewed retrospectively. In total 59 CPE isolates were identified from 53 patients. Urine was the dominant clinical sample source (37%) and only 15% of the isolates were obtained from faecal screening. The majority of cases (62%) were directly associated with travel or hospitalization abroad, but both intra-hospital transmission and one inter-hospital outbreak were observed. The number of CPE cases/year was low (2-14 cases/year), but an increasing trend was observed. Klebsiella spp. (n = 38) and E. coli (n = 14) were the dominant species and bla(KPC) (n = 20), bla(NDM) (n = 19), bla(OXA-48-like) (n = 12) and bla(VIM) (n = 7) were the dominant carbapenemase gene families. The CPE isolates were genetically diverse except for K. pneumoniae where clonal group 258 associated with blaKPC dominated. All isolates were multidrug-resistant and a significant proportion (21%) were resistant to colistin. Interestingly, all bla(OXA-48-like), and a large proportion of bla(NDM)-positive Klebsiella spp. (89%) and E. coli (83%) isolates were susceptible in vitro to mecillinam. Thus, mecillinam could have a role in the treatment of uncomplicated urinary tract infections caused by OXA-48- or NDM-producing E. coli or K. pneumoniae. In conclusion, the impact of CPE in Norway is still limited and mainly associated with travel abroad, reflected in the diversity of clones and carbapenemase genes.	[Samuelsen, Orjan; Aasnaes, Bettina; Haldorsen, Bjorg; Sundsfjord, Arnfinn] Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway; [Samuelsen, Orjan] UiT Arctic Univ Norway, Dept Pharm, Microbial Pharmacol & Populat Biol Res Grp, Tromso, Norway; [Overballe-Petersen, Soren; Sundsfjord, Arnfinn] UiT Arctic Univ Norway, Dept Med Biol, Res Grp Host Microbe Interact, Tromso, Norway; [Bjornholt, Jorgen Vildershoj] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway; [Brisse, Sylvain] Inst Pasteur, Biodivers & Epidemiol Bacterial Pathogens, Paris, France; [Doumith, Michel; Woodford, Neil; Hopkins, Katie L.] Publ Hlth England, Natl Infect Serv, Reference Unit, Antimicrobial Resistance & Healthcare Associated, London, England; [Bjornholt, Jorgen Vildershoj] Univ Oslo, Inst Clin Med, Oslo, Norway; [Bjornholt, Jorgen Vildershoj] Oslo Univ Hosp, Dept Clin Microbiol, Oslo, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Norwegian Institute of Public Health (NIPH); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Public Health England; University of Oslo; University of Oslo	Samuelsen, O (corresponding author), Univ Hosp North Norway, Dept Microbiol & Infect Control, Norwegian Natl Advisory Unit Detect Antimicrobial, Tromso, Norway.; Samuelsen, O (corresponding author), UiT Arctic Univ Norway, Dept Pharm, Microbial Pharmacol & Populat Biol Res Grp, Tromso, Norway.	orjan.samuelsen@unn.no	Brisse, Sylvain/M-8723-2013; Samuelsen, Ørjan/K-9068-2019; Sundsfjord, Arnfinn/F-9668-2018	Brisse, Sylvain/0000-0002-2516-2108; Samuelsen, Ørjan/0000-0002-5525-2614; Sundsfjord, Arnfinn/0000-0002-3728-2270; Doumith, Michel/0000-0002-8004-0314; Overballe-Petersen, Soren/0000-0002-1784-5128; Bjornholt, Jorgen Vildershoj/0000-0002-0079-8062; Hopkins, Katie/0000-0001-7279-5322				Albiger B, 2015, EUROSURVEILLANCE, V20, P17, DOI 10.2807/1560-7917.ES.2015.20.45.30062; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bialek-Davenet S, 2014, EMERG INFECT DIS, V20, P1812, DOI 10.3201/eid2011.140206; Borowiak M, 2017, J ANTIMICROB CHEMOTH, V72, P3317, DOI 10.1093/jac/dkx327; Carattoli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123063; Chen YT, 2014, J ANTIMICROB CHEMOTH, V69, P628, DOI 10.1093/jac/dkt409; Di Pilato V, 2016, ANTIMICROB AGENTS CH, V60, P5612, DOI 10.1128/AAC.01075-16; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P74, DOI 10.1055/s-0035-1544208; Dortet L, 2014, J MED MICROBIOL, V63, P772, DOI 10.1099/jmm.0.071340-0; Dortet L, 2014, J ANTIMICROB CHEMOTH, V69, P623, DOI 10.1093/jac/dkt433; Doumith M, 2015, J CLIN MICROBIOL, V53, P160, DOI 10.1128/JCM.02562-14; Falgenhauer L, 2016, LANCET INFECT DIS, V16, P282, DOI 10.1016/S1473-3099(16)00009-8; Giske CG, 2015, CLIN MICROBIOL INFEC, V21, P899, DOI 10.1016/j.cmi.2015.05.022; Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2; Hammerum AM, 2016, J ANTIMICROB CHEMOTH, V71, P3117, DOI 10.1093/jac/dkw289; Hammerum AM, 2015, INT J ANTIMICROB AG, V46, P597, DOI 10.1016/j.ijantimicag.2015.07.008; Hammerum AM, 2012, INT J ANTIMICROB AG, V40, P191, DOI 10.1016/j.ijantimicag.2012.05.003; Huang TD, 2014, J ANTIMICROB CHEMOTH, V69, P445, DOI 10.1093/jac/dkt367; Jakobsen L, 2014, J ANTIMICROB CHEMOTH, V69, P559, DOI 10.1093/jac/dkt356; Koren S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-126; Kristof K, 2010, J ANTIMICROB CHEMOTH, V65, P1303, DOI 10.1093/jac/dkq133; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Li AQ, 2016, ANTIMICROB AGENTS CH, V60, P4351, DOI 10.1128/AAC.00550-16; Literacka E, 2017, EUR J CLIN MICROBIOL, V36, P2281, DOI 10.1007/s10096-017-3062-0; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Liu Yi-Yun, LANCET INFECT DIS, V16, P161, DOI [DOI 10.1016/S1473-3099(15)00424-7, 10.1016/S1473-3099(15)00424-7]; Lofmark S, 2015, DRUG RESIST UPDATE, V20, P29, DOI 10.1016/j.drup.2015.05.001; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Maatallah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113539; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marrs ECL, 2014, J ANTIMICROB CHEMOTH, V69, P2873, DOI 10.1093/jac/dku204; Mataseje LF, 2016, ANTIMICROB AGENTS CH, V60, P1794, DOI 10.1128/AAC.02591-15; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Monaco M, 2014, EUROSURVEILLANCE, V19, P14, DOI 10.2807/1560-7917.ES2014.19.42.20939; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nielsen JB, 2012, J ANTIMICROB CHEMOTH, V67, P2049, DOI 10.1093/jac/dks149; Nordmann P, 2014, CLIN MICROBIOL INFEC, V20, P821, DOI 10.1111/1469-0691.12719; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; NORM/NORM-VET, 2016, US ANT AG OCC ANT RE; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Olaitan AO, 2014, INT J ANTIMICROB AG, V44, P500, DOI 10.1016/j.ijantimicag.2014.07.020; Olaitan AO, 2014, J ANTIMICROB CHEMOTH, V44, P500; Osterblad M, 2014, ANTIMICROB AGENTS CH, V58, P7553, DOI 10.1128/AAC.02761-13; Osterblad M, 2012, J ANTIMICROB CHEMOTH, V67, P2860, DOI 10.1093/jac/dks299; Oueslati S, 2015, J ANTIMICROB CHEMOTH, V70, P1059, DOI 10.1093/jac/dku524; Pannaraj PS, 2015, PEDIATR INFECT DIS J, V34, P11, DOI 10.1097/INF.0000000000000471; Peirano G, 2014, J CLIN MICROBIOL, V52, P1575, DOI 10.1128/JCM.00162-14; Perez F, 2016, EXPERT OPIN PHARMACO, V17, P761, DOI 10.1517/14656566.2016.1145658; Pitout JDD, 2015, ANTIMICROB AGENTS CH, V59, P5873, DOI 10.1128/AAC.01019-15; Poirel L, 2014, ANTIMICROB AGENTS CH, V58, P2472, DOI 10.1128/AAC.02571-13; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4405, DOI [10.1128/AAC.05289-11, 10.1128/AAC.00681-11]; Samuelsen O, 2011, CLIN MICROBIOL INFEC, V17, P1811, DOI 10.1111/j.1469-0691.2011.03532.x; Samuelsen O, 2013, J ANTIMICROB CHEMOTH, V68, P1682, DOI 10.1093/jac/dkt058; Samuelsen O, 2011, J ANTIMICROB CHEMOTH, V66, P670, DOI 10.1093/jac/dkq483; Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swayne RL, 2011, INT J ANTIMICROB AG, V38, P35, DOI 10.1016/j.ijantimicag.2011.03.010; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Tijet Nathalie, 2013, Antimicrob Agents Chemother, V57, P4578, DOI 10.1128/AAC.00878-13; Tofteland S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059015; Toleman MA, 2015, EMERG INFECT DIS, V21, P1027, DOI 10.3201/eid2106.141578; TREANGEN TJ, 2014, GENOME BIOL, V15, DOI DOI 10.1016/J.IJANTIMICAG.2011.03.010; Tumbarello M, 2015, J ANTIMICROB CHEMOTH, V70, P2133, DOI 10.1093/jac/dkv086; Wachino J, 2012, DRUG RESIST UPDATE, V15, P133, DOI 10.1016/j.drup.2012.05.001; Wang Mikala, 2016, Ugeskr Laeger, V178; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; XAVIER BB, 2016, ESCHERICHIA COLI, V21, DOI DOI 10.1055/S-0035-1544208; Yin W, 2017, MBIO, V8	73	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187832	10.1371/journal.pone.0187832	http://dx.doi.org/10.1371/journal.pone.0187832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141051	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400033
J	Cen, D; Chen, J; Li, ZY; Zhao, J; Cai, XJ				Cen, Dong; Chen, Jiang; Li, Zheyong; Zhao, Jie; Cai, Xiujun			Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis	PLOS ONE			English	Article							ENDOCRINE TUMORS; POWERFUL PREDICTOR; SURVIVAL; CK19; DIFFERENTIATION; ORGANIZATION; PARAMETERS; NEOPLASMS; CARCINOMA; KERATINS	Background Pancreatic neuroendocrine tumor (PNET) comprises 1-2% of all pancreatic tumors, but its incidence is increasing. Although many studies have investigated the correlation between cytokeratin 19 (CK-19) and PNET, the prognostic significance of CK-19 expression in PNET is inconclusive. Methods Eligible studies were retrieved from Pubmed, Elsevier, Embase, Cochrane Library and Web of Science databases. All relevant data were extracted to analyze the relationship between CK-19 and PNET. We utilized a fixed or random effects model to calculate the pooled odds ratio (OR) with 95% confidence intervals (CI). Results Pooled data indicated CK-19 expression was significantly associated with poor 3- and 5-year overall survival (OS) for PNET, but not for 1-year overall survival. Additionally, positive CK-19 expression was correlated with large tumor size, advanced differentiation grade in World Health Organization-2010 (WHO-2010) and WHO-2004, vascular invasion, lymph node metastasis and liver metastasis. Conclusions Positive CK-19 expression can be used as a predictor of poor prognosis of PNET.	[Cen, Dong; Chen, Jiang; Li, Zheyong; Zhao, Jie; Cai, Xiujun] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Inst Minimally Invas Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Cai, XJ (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Inst Minimally Invas Surg, Hangzhou, Zhejiang, Peoples R China.	0094417@zju.edu.cn			National Natural Science Foundation of China [81702981]; China Postdoctoral Science Foundation [2017M612007]; Medical science and technology project of Zhejiang province [2017187327]; Medical clinical research projects of Zhejiang province [2016ZYC-A27]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Medical science and technology project of Zhejiang province; Medical clinical research projects of Zhejiang province	This work was supported in part by funds from the National Natural Science Foundation of China (grant number: 81702981), China Postdoctoral Science Foundation Funded Project (grant number: 2017M612007), Medical science and technology project of Zhejiang province (grant number: 2017187327), Medical clinical research projects of Zhejiang province (grant number: 2016ZYC-A27). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2006, AM J SURG PATHOL, V30, P1588, DOI 10.1097/01.pas.0000213309.51553.01; Anderson CW, 2016, SURG ONCOL CLIN N AM, V25, P363, DOI 10.1016/j.soc.2015.12.003; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Bouwens L, 1997, DIABETOLOGIA, V40, P398, DOI 10.1007/s001250050693; Bouwens L, 1998, J PATHOL, V184, P234; Chan JA, 2016, SURG ONCOL CLIN N AM, V25, P423, DOI 10.1016/j.soc.2015.11.009; Cherenfant J, 2014, SURGERY, V156, P1504, DOI 10.1016/j.surg.2014.08.043; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; DeLellis R, 2004, PATHOLOGY GENETICS T; Deshpande V, 2004, AM J SURG PATHOL, V28, P1145, DOI 10.1097/01.pas.0000135525.11566.b4; Edge SB, 2010, AJCC CANC STAGING MA; Govaere O, 2017, ONCOGENE; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Guerra A, 2013, ENDOCRINE, V44, P165, DOI 10.1007/s12020-012-9843-4; Gurevich L, 2003, CANCER, V98, P1967, DOI 10.1002/cncr.11739; Han X, 2013, TUMOR BIOL, V34, P2881, DOI 10.1007/s13277-013-0850-8; Jonkers YMH, 2007, ENDOCR-RELAT CANCER, V14, P769, DOI 10.1677/ERC-07-0111; Jonkers YMH, 2006, CYTOGENET GENOME RES, V115, P289, DOI 10.1159/000095926; Kirfel J, 2003, CELL MOL LIFE SCI, V60, P56, DOI 10.1007/s000180300004; La Rosa S, 2007, HISTOPATHOLOGY, V50, P597, DOI 10.1111/j.1365-2559.2007.02662.x; Marchegiani G, 2011, PANCREATOLOGY, V11, P383, DOI 10.1159/000330212; Metz DC, 2008, GASTROENTEROLOGY, V135, P1469, DOI 10.1053/j.gastro.2008.05.047; Niederle MB, 2010, ENDOCR-RELAT CANCER, V17, P909, DOI 10.1677/ERC-10-0152; Oberg K, 2005, BEST PRACT RES CL GA, V19, P753, DOI 10.1016/j.bpg.2005.06.002; Ohtsuka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39557; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Reid MD, 2014, ENDOCR PATHOL, V25, P65, DOI 10.1007/s12022-013-9295-2; Rindi G, 2006, VIRCHOWS ARCH, V449, P395, DOI 10.1007/s00428-006-0250-1; Schurr PG, 2007, ANN SURG, V245, P273, DOI 10.1097/01.sla.0000232556.24258.68; Son EM, 2015, J PATHOL TRANSL MED, V49, P30, DOI 10.4132/jptm.2014.10.23; Sorbye H, 2013, ANN ONCOL, V24, P152, DOI 10.1093/annonc/mds276; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Vortmeyer AO, 2004, J CLIN ENDOCR METAB, V89, P1934, DOI 10.1210/jc.2003-031575; Wick M R, 2001, Am J Clin Pathol, V115 Suppl, pS28; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zhang LZ, 2011, HUM PATHOL, V42, P324, DOI 10.1016/j.humpath.2010.09.002; Zhou XJ, 1999, J BIOL CHEM, V274, P12861, DOI 10.1074/jbc.274.18.12861	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187588	10.1371/journal.pone.0187588	http://dx.doi.org/10.1371/journal.pone.0187588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136022	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200024
J	Friedlander, AM; Ballesteros, E; Clemente, S; Goncalves, EJ; Estep, A; Rose, P; Sala, E				Friedlander, Alan M.; Ballesteros, Enric; Clemente, Sabrina; Goncalves, Emanuel J.; Estep, Andrew; Rose, Paul; Sala, Enric			Contrasts in the marine ecosystem of two Macaronesian islands: A comparison between the remote Selvagens Reserve and Madeira Island	PLOS ONE			English	Article							DIADEMA AFF. ANTILLARUM; FISH ASSEMBLAGES; CANARY-ISLANDS; SEAWEED ASSEMBLAGES; SPATIAL VARIATION; TROPHIC CASCADES; MACROALGAL COVER; SEA; ARCHIPELAGO; ATLANTIC	The islands of Madeira and Selvagens are less than 300 km apart but offer a clear contrast between a densely populated and highly developed island (Madeira), and a largely uninhabited and remote archipelago (Selvagens) within Macaronesia in the eastern Atlantic. The Madeira Archipelago has similar to 260,000 inhabitants and receives over six million visitor days annually. The Selvagens Islands Reserve is one of the oldest nature reserves in Portugal and comprises two islands and several islets, including the surrounding shelf to a depth of 200 m. Only reserve rangers and a small unit of the maritime police inhabit these islands. The benthic community around Selvagens was dominated by erect and turf algae, while the community at Madeira was comprised of crustose coralline and turf algae, sessile invertebrates, and sea urchin barrens. The sea urchin Diadema africanum was 65% more abundant at Madeira than at Selvagens. Total fish biomass was 3.2 times larger at Selvagens than at Madeira, and biomass of top predators was more than 10 times larger at Selvagens. Several commercially important species (e.g., groupers, jacks), which have been overfished throughout the region, were more common and of larger size at Selvagens than at Madeira. Important sea urchin predators (e.g., hogfishes, triggerfishes) were also in higher abundance at Selvagens compared to Madeira. The effects of fishing and other anthropogenic influences are evident around Madeira. This is in stark contrast to Selvagens, which harbors healthy benthic communities with diverse algal assemblages and high fish biomass, including an abundance of large commercially important species. The clear differences between these two island groups highlights the importance of expanding and strengthening the protection around Selvagens, which harbors one of the last intact marine ecosystems in the North Atlantic, and the need to increase management and protection around Madeira.	[Friedlander, Alan M.; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Friedlander, Alan M.] Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Ballesteros, Enric; Clemente, Sabrina] CSIC, Ctr Estudis Avancats Blanes, Dept Ecol Marina, Blanes, Spain; [Clemente, Sabrina] Univ La Laguna, Dept Biol Anim, Tenerife, Canary Islands, Spain; [Goncalves, Emanuel J.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Estep, Andrew] Waitt Inst, La Jolla, CA USA; [Rose, Paul] Royal Geog Soc, London, England	National Geographic Society; University of Hawaii System; University of Hawaii Manoa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Universidad de la Laguna; Instituto Superior Psicologia Aplicada (ISPA)	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC USA.; Friedlander, AM (corresponding author), Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	; Clemente, Sabrina/C-6909-2013	Goncalves, Emanuel/0000-0002-3918-6215; Clemente, Sabrina/0000-0003-1930-2052	National Geographic Society; Blancpain; Davidoff Cool Water; Jynwel Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Lindblad Expeditions; Waitt Foundation; Fundacao para a Ciencia e a Tecnologia (FCT) [UID/MAR/04292/2013]	National Geographic Society(National Geographic Society); Blancpain; Davidoff Cool Water; Jynwel Foundation; Leona M. and Harry B. Helmsley Charitable Trust; Lindblad Expeditions; Waitt Foundation; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the National Geographic Society, www.nationalgeographic.com, ES; Blancpain, http://www.blancpain.com/, ES; Davidoff Cool Water, http://www.zinodavidoff.com/, ES; Jynwel Foundation, jynwelfoundation.org, ES; The Leona M. and Harry B. Helmsley Charitable Trust, www.helmsleytrust.org, ES; Lindblad Expeditions, www.expeditions.com, ES; and the Waitt Foundation, www.Waittfoundation.org, ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the captain and crew of the MY Plan B, as well as Pedro Vasconcelos and Hugo Silva of Focus Natura Dive Center for field support during the expeditions. Fundacao para a Ciencia e a Tecnologia (FCT) supported this work under the strategic project UID/MAR/04292/2013. We are grateful to the Servico do Parque Natural da Madeira, especially Paulo Oliveira and Carolina Jardim Santos, for their assistance with permits, logistics, and local knowledge. The Hydrographic Institute of Portugal graciously provided bathymetric information for Selvagens.	Almada F, 2015, MAR BIOL RES, V11, P49, DOI 10.1080/17451000.2014.889306; Almada VC., 2013, FRONT BIOGEOGR, V5, P1, DOI [10.21425/F55114493, DOI 10.21425/F5FBG14493, 10.21425/F5FBG14493]; Alves F, 2007, SCI MAR, V67, P307; Alves FMA, 2001, SCI MAR, V65, P383, DOI 10.3989/scimar.2001.65n4383; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrade C.A.P., 1995, Boletim do Museu Municipal do Funchal (Historia Natural) Suplemento, V4, P9; [Anonymous], 1989, JMP PRO 12 2; Baeta F, 2009, FISH RES, V97, P216, DOI 10.1016/j.fishres.2009.02.006; Baioni D, 2011, NAT HAZARD EARTH SYS, V11, P3035, DOI 10.5194/nhess-11-3035-2011; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Bianchi N. C., 1998, BOL MUS MUNIC FUNCHA, V05-A, P59; Brandmuller T, EUROSTAT REGIONAL YB; Brito A, 2008, ESTUDIO CIENTIFICO S; Hernandez JC, 2008, MAR ENVIRON RES, V66, P259, DOI 10.1016/j.marenvres.2008.03.002; Hernandez JC, 2008, AQUAT CONSERV, V18, P1091, DOI 10.1002/aqc.903; Clemente S, 2011, MAR ECOL PROG SER, V437, P119, DOI 10.3354/meps09243; Clemente S, 2008, REV BIOL TROP, V56, P229; Clemente S, 2010, MAR ECOL PROG SER, V413, P55, DOI 10.3354/meps08700; Cornish A, 2004, IUCN RED LIST THREAT; D'agata S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12000; DELGADO C, 1998, CARACTERIZACAO FAUNI; Falcon J. M., 2015, THESIS; Falcon JM, 1996, MAR BIOL, V125, P215, DOI 10.1007/BF00346302; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Friedlander AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087359; Friedlander AM, 2013, AQUAT CONSERV, V23, P515, DOI 10.1002/aqc.2333; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; FROESE R., 2012, FISHBASE; Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107; Gonzalez-Lorenzo G, 2015, BIOL CONSERV, V192, P428, DOI 10.1016/j.biocon.2015.11.005; Granadeiro JP, 2006, WATERBIRDS, V29, P56, DOI 10.1675/1524-4695(2006)29[56:NAPTOC]2.0.CO;2; Green R., 1979, SAMPLING DESIGN STAT; Grimmett R. F. A., 1989, TECHNICAL PUBLICATIO, V9; Hermida M, 2016, MAR POLICY, V73, P130, DOI 10.1016/j.marpol.2016.07.013; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kondraskov P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132091; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Fernandez-Palacios JM, 2011, J BIOGEOGR, V38, P226, DOI 10.1111/j.1365-2699.2010.02427.x; MARTINS AM, 2007, P SOC PHOTO-OPT INS, V6743; Menezes DM, 2004, AS ILHAS SELVAGENS; Nguyen HT, 2011, NAT HAZARD EARTH SYS, V11, P807, DOI 10.5194/nhess-11-807-2011; Olivera P, 2010, INTEGR ZOOL, V5, P70, DOI 10.1111/j.1749-4877.2010.00186.x; Pereira E, 2013, SCI TOTAL ENVIRON, V461, P469, DOI 10.1016/j.scitotenv.2013.05.025; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Ribeiro C, 2005, J FISH BIOL, V67, P1568, DOI 10.1111/j.1095-8649.2005.00861.x; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sangil C, 2014, J SEA RES, V85, P92, DOI 10.1016/j.seares.2013.10.009; Sangil C, 2013, ESTUAR COAST SHELF S, V128, P22, DOI 10.1016/j.ecss.2013.04.023; Sangil C, 2012, ESTUAR COAST SHELF S, V112, P207, DOI 10.1016/j.ecss.2012.07.025; Sangil C, 2011, ESTUAR COAST SHELF S, V94, P322, DOI 10.1016/j.ecss.2011.07.004; Santos F., PESCA HIST MADEIRA E, P354; Schunter C, 2011, J EXP MAR BIOL ECOL, V401, P126, DOI 10.1016/j.jembe.2011.01.021; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tuya F, 2006, BIOL CONSERV, V128, P13, DOI 10.1016/j.biocon.2005.09.012; Tuya F, 2006, FISH RES, V77, P24, DOI 10.1016/j.fishres.2005.07.017; Tuya F, 2005, MAR ECOL PROG SER, V302, P307, DOI 10.3354/meps302307; Tuya F, 2004, MAR ECOL PROG SER, V278, P157, DOI 10.3354/meps278157; Wirtz P, 1998, HELGOLANDER MEERESUN, V52, P197, DOI 10.1007/BF02908748; Wirtz P, 2008, ZOOTAXA, P1; Wolff WJ, 2000, BIOL CONSERV, V95, P209, DOI 10.1016/S0006-3207(00)00035-5; Zar JH., 1999, BIOSTAT ANAL, V663rd	62	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187935	10.1371/journal.pone.0187935	http://dx.doi.org/10.1371/journal.pone.0187935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136657	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200047
J	Matsuda, K; Miyoshi, H; Hiraoka, K; Yokoyama, S; Haraguchi, T; Hashiguchi, T; Hamada, T; Shiba, N; Ohshima, K				Matsuda, Kotaro; Miyoshi, Hiroaki; Hiraoka, Koji; Yokoyama, Shintaro; Haraguchi, Toshiaki; Hashiguchi, Toshihiro; Hamada, Tetsuya; Shiba, Naoto; Ohshima, Koichi			Clinicopathological and prognostic value of transforming acidic coiled-coil-containing protein 3 (TACC3) expression in soft tissue sarcomas	PLOS ONE			English	Article							POOR-PROGNOSIS; CANCER; P53; CARCINOMA; STEMNESS; MARKER	Transforming acidic coiled-coil-containing protein 3 (TACC3), a microtubule regulator, is associated with various cancers. However, the relationship between TACC3 and soft tissue sarcomas (STS) remains unclear. We investigated the expression of TACC3 in 136 STS patient samples using immunohistochemical (IHC) staining, and the statistical associations between TACC3 expression and clinicopathological characteristics were evaluated. Additionally, the expression levels of the tumor suppressor p53 and of the cell proliferation marker Ki-67 were also assessed by IHC. High TACC3 expression was detected in 94/136 of STS cases (69.1%), and significantly correlated with higher grade according to the French Fe A de A ration Nationale des Centres de Lutte Contre le Cancer system (P < 0.0001), poorer tumor differentiation (P < 0.0001), increased mitotic counts (P < 0.0001), advanced stage per American Joint Committee on Cancer guidelines (P < 0.0001), higher p53 expression (P = 0.0487), higher Ki-67 expression (P < 0.0001), and undergoing postoperative therapy (P = 0.0001). Disease-free survival (DFS) and overall survival (OS) of patients with high TACC3 expression were significantly shorter (P < 0.0001 and P< 0.0001, respectively). On multivariate analyses, high TACC3 expression was an independent negative prognostic factor for both DFS and OS (hazard ratio [HR]: 3.074; P = 0.0235 and HR: 8.521; P = 0.0415, respectively). Our results suggest that TACC3 is an independent prognostic factor and may be a novel therapeutic target for the treatment of STS.	[Matsuda, Kotaro; Miyoshi, Hiroaki; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Matsuda, Kotaro; Hiraoka, Koji; Haraguchi, Toshiaki; Hamada, Tetsuya; Shiba, Naoto] Kurume Univ, Dept Orthoped Surg, Sch Med, Kurume, Fukuoka, Japan; [Yokoyama, Shintaro; Hashiguchi, Toshihiro] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka, Japan	Kurume University; Kurume University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp	Yokoyama, Shintaro/HHC-8479-2022					Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Coindre JM, 1996, J CLIN ONCOL, V14, P869, DOI 10.1200/JCO.1996.14.3.869; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Du Y, 2016, ONCOTARGET, V7, P41885, DOI 10.18632/oncotarget.9628; GERDES J, 1984, J IMMUNOL, V133, P1710; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Ha GH, 2015, ONCOGENE, V34, P1667, DOI 10.1038/onc.2014.105; Ha GH, 2013, CANCER LETT, V336, P24, DOI 10.1016/j.canlet.2013.04.022; Ha GH, 2013, CANCER LETT, V332, P63, DOI 10.1016/j.canlet.2013.01.013; Haraguchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156524; Harris CC, 1996, JNCI-J NATL CANCER I, V88, P1442, DOI 10.1093/jnci/88.20.1442; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; He JC, 2016, ONCOTARGET, V7, P75441, DOI 10.18632/oncotarget.12254; Huang ZL, 2015, ONCOTARGET, V6, P6850, DOI 10.18632/oncotarget.3190; Jiang F, 2016, ONCOL REP, V35, P436, DOI 10.3892/or.2015.4373; Judson I, 2014, LANCET ONCOL, V15, P415, DOI 10.1016/S1470-2045(14)70063-4; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; KAWAI A, 1994, CANCER, V73, P2499, DOI 10.1002/1097-0142(19940515)73:10<2499::AID-CNCR2820731008>3.0.CO;2-G; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Nahm JH, 2016, TUMOR BIOL, V37, P393, DOI 10.1007/s13277-015-3810-7; Ohoka N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.471; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Schmidt S, 2010, ONCOGENE, V29, P6184, DOI 10.1038/onc.2010.354; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Song H, 2016, APPL IMMUNOHISTOCHEM; Takahiro T, 2003, CLIN CANCER RES, V9, P2204; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wurl P, 1997, J CANCER RES CLIN, V123, P502, DOI 10.1007/s004320050095; Yao R, 2014, ONCOGENE, V33, P4242, DOI 10.1038/onc.2013.382; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235; Yun M, 2015, ONCOL REP, V34, P1397, DOI 10.3892/or.2015.4093; Zhou DS, 2015, ONCOTARGET, V6, P24163, DOI 10.18632/oncotarget.4643	36	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188096	10.1371/journal.pone.0188096	http://dx.doi.org/10.1371/journal.pone.0188096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135996	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200064
J	Zhou, S; Sternglanz, R; Neiman, AM				Zhou, Sai; Sternglanz, Rolf; Neiman, Aaron M.			Developmentally regulated internal transcription initiation during meiosis in budding yeast	PLOS ONE			English	Article							SYNTHASE KINASE 3; NONCODING RNA EXPRESSION; PROTEIN-KINASE; MESSENGER-RNAS; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; GENOMIC ANALYSIS; SPORULATION; HOMOLOG; GENES	Sporulation of budding yeast is a developmental process in which cells undergo meiosis to generate stress-resistant progeny. The dynamic nature of the budding yeast meiotic transcriptome has been well established by a number of genome-wide studies. Here we develop an analysis pipeline to systematically identify novel transcription start sites that reside internal to a gene. Application of this pipeline to data from a synchronized meiotic time course reveals over 40 genes that display specific internal initiations in mid-sporulation. Consistent with the time of induction, motif analysis on upstream sequences of these internal transcription start sites reveals a significant enrichment for the binding site of Ndt80, the transcriptional activator of middle sporulation genes. Further examination of one gene, MRK1, demonstrates the Ndt80 binding site is necessary for internal initiation and results in the expression of an N-terminally truncated protein isoform. When the MRK1 paralog RIM11 is downregulated, the MRK1 internal transcript promotes efficient sporulation, indicating functional significance of the internal initiation. Our findings suggest internal transcriptional initiation to be a dynamic, regulated process with potential functional impacts on development.	[Zhou, Sai; Sternglanz, Rolf; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Zhou, Sai] SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Neiman, AM (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	aaron.neiman@stonybrook.edu		Neiman, Aaron/0000-0002-6600-6996	National Institutes of Health [R01 GM072540, P01 GM088297]; NIH [R01 GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM088297, R01GM072540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01 GM072540 to A.M.N. and P01 GM088297 to R.S. and A.M.N. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Bruce Futcher, Yuping Chen and Justin Gardin for extensive suggestions on the development of the algorithm, and Alisa Yurovski for general guidance on RNA-Seq data processing. We thank Nancy Hollingsworth for the 12CA5 anti-HA antibody, and Bruce Futcher and Gang Zhao for the CRISPR/Cas9 plasmid. We are greatly indebted to Bruce Futcher, Yifeng Xu and Folkert van Werven for the RNA-Seq data of the P<INF>CUP1</INF>-IME1 P<INF>CUP1</INF>-IME4 meiotic time-course. We also thank Janet Leatherwood, members of the Neiman and the Futcher labs for helpful discussions. This work was supported by NIH grant R01 GM072540 to A.M.N.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Andoh T, 2000, MOL CELL BIOL, V20, P6712, DOI 10.1128/MCB.20.18.6712-6720.2000; Arguello-Miranda O, 2017, DEV CELL, V40, P37, DOI 10.1016/j.devcel.2016.11.021; Bajgier BK, 2001, MOL BIOL CELL, V12, P1611, DOI 10.1091/mbc.12.6.1611; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Berchowitz LE, 2013, GENE DEV, V27, P2147, DOI 10.1101/gad.224253.113; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOWDISH KS, 1994, MOL CELL BIOL, V14, P7909, DOI 10.1128/MCB.14.12.7909; BOWDISH KS, 1995, MOL CELL BIOL, V15, P2955; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Carlile TM, 2008, CELL, V133, P280, DOI 10.1016/j.cell.2008.02.032; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041374; Chia MH, 2016, G3-GENES GENOM GENET, V6, P3553, DOI 10.1534/g3.116.034983; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Connolly JE, 2006, EUKARYOT CELL, V5, P112, DOI 10.1128/EC.5.1.112-124.2006; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; DAWES IW, 1974, MOL GEN GENET, V131, P281, DOI 10.1007/BF00264859; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Enyenihi AH, 2003, GENETICS, V163, P47; Erb I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024279; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Griffioen G, 2003, J BIOL CHEM, V278, P23460, DOI 10.1074/jbc.M210691200; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hirata Y, 2003, MOL BIOL CELL, V14, P302, DOI 10.1091/mbc.E02-05-0247; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Hurtado S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105058; Ikui AE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003099; Jin L, 2015, MOL CELL BIOL, V35, P3448, DOI 10.1128/MCB.00189-15; Jolly ER, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-275; KABACK DB, 1985, MOL CELL BIOL, V5, P751, DOI 10.1128/MCB.5.4.751; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lardenois A, 2011, P NATL ACAD SCI USA, V108, P1058, DOI 10.1073/pnas.1016459108; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Lo HC, 2008, MOL BIOL CELL, V19, P4956, DOI 10.1091/mbc.E08-07-0755; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malathi K, 1999, GENETICS, V153, P1145; Malathi K, 1997, MOL CELL BIOL, V17, P7230, DOI 10.1128/MCB.17.12.7230; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; NEIGEBORN L, 1991, GENE DEV, V5, P533, DOI 10.1101/gad.5.4.533; Neiman AM, 2011, GENETICS, V189, P737, DOI 10.1534/genetics.111.127126; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Pak J, 2002, MOL CELL BIOL, V22, P6430, DOI 10.1128/MCB.22.18.6430-6440.2002; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; PUZISS JW, 1994, MOL CELL BIOL, V14, P831, DOI 10.1128/MCB.14.1.831; Quan ZZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005282; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Rose MD., 1990, METHODS YEAST GENETI; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; Sasanuma H, 2013, GENETICS, V194, P859, DOI 10.1534/genetics.113.150615; SHERO JH, 1991, GENE DEV, V5, P549, DOI 10.1101/gad.5.4.549; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Werven FJ, 2011, PHILOS T R SOC B, V366, P3521, DOI 10.1098/rstb.2011.0081; Waern K, 2013, G3-GENES GENOM GENET, V3, P343, DOI 10.1534/g3.112.003640; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wiesner T, 2015, NATURE, V526, P453, DOI 10.1038/nature15258; Xiao Y, 2000, MOL CELL BIOL, V20, P5447, DOI 10.1128/MCB.20.15.5447-5453.2000; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	74	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188001	10.1371/journal.pone.0188001	http://dx.doi.org/10.1371/journal.pone.0188001			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136644	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200055
J	Ralli, M; Salvi, RJ; Greco, A; Turchetta, R; De Virgilio, A; Altissimi, G; Attanasio, G; Cianfrone, G; de Vincentiis, M				Ralli, Massimo; Salvi, Richard J.; Greco, Antonio; Turchetta, Rosaria; De Virgilio, Armando; Altissimi, Giancarlo; Attanasio, Giuseppe; Cianfrone, Giancarlo; de Vincentiis, Marco			Characteristics of somatic tinnitus patients with and without hyperacusis	PLOS ONE			English	Article							TEMPOROMANDIBULAR DISORDERS; PSYCHIATRIC COMORBIDITY; HEARING SENSITIVITY; PERSONALITY-TRAITS; MODULATE TINNITUS; COCHLEAR NUCLEUS; SOUND; HEALTH; QUESTIONNAIRE; PITCH	Objective Determine if somatic tinnitus patients with hyperacusis have different characteristics from those without hyperacusis. Patients and methods 172 somatic tinnitus patients with (n = 82) and without (n = 90) hyperacusis referred to the Tinnitus Unit of Sapienza University of Rome between June 2012 and June 2016 were compared for demographic characteristics, tinnitus features, self-administered questionnaire scores, nature of somatic modulation and history. Results Compared to those without hyperacusis, patients with somatic tinnitus and hyperacusis: (a) were older (43.38 vs 39.12 years, p = 0.05), (b) were more likely to have bilateral tinnitus (67.08% vs 55.56%, p = 0.04), (c) had a higher prevalence of somatic modulation of tinnitus (53.65% vs 36.66%, p = 0.02) and (d) scored significantly worse on tinnitus annoyance (39.34 vs 22.81, p<0.001) and subjective hearing level (8.04 vs 1.83, p<0.001). Conclusion Our study shows significantly higher tinnitus modulation and worse self-rating of tinnitus and hearing ability in somatic tinnitus patients with hyperacusis versus somatic tinnitus patients without hyperacusis. These differences could prove useful in developing a better understanding of the pathophysiology and establishing a course of treatment for these two groups of patients.	[Ralli, Massimo] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy; [Salvi, Richard J.] Univ Buffalo, Ctr Hearing & Deafness, Buffalo, NY USA; [Salvi, Richard J.] Asia Univ, Dept Audiol & Speech Language Pathol, Taichung, Taiwan; [Greco, Antonio; Turchetta, Rosaria; De Virgilio, Armando; Altissimi, Giancarlo; Attanasio, Giuseppe; Cianfrone, Giancarlo; de Vincentiis, Marco] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy	Sapienza University Rome; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Asia University Taiwan; Sapienza University Rome	Ralli, M (corresponding author), Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Rome, Italy.	massimo.ralli@uniroma1.it	Ralli, Massimo/E-1780-2018; De Virgilio, Armando/G-8710-2012	De Virgilio, Armando/0000-0003-0738-8223; Ralli, Massimo/0000-0001-8776-0421; greco, antonio/0000-0002-4824-9871	National Institute on Deafness and Other Communication Disorders [R01DC014452]; Italian Association for Research on Deafness (AIRS Onlus)	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Italian Association for Research on Deafness (AIRS Onlus)	Prof Richard J Salvi was supported by National Institute on Deafness and Other Communication Disorders, R01DC014452.r We thank Italian Association for Research on Deafness (AIRS Onlus) for support in the management of patients.	Aazh H, 2017, INT J AUDIOL, V56, P793, DOI 10.1080/14992027.2017.1335888; Aazh H, 2017, INT J AUDIOL, V56, P677, DOI 10.1080/14992027.2017.1335887; Aazh H, 2016, INT J AUDIOL, V55, P514, DOI 10.1080/14992027.2016.1178400; Ambrosini Anna, 2006, J Headache Pain, V7, P377, DOI 10.1007/s10194-006-0343-x; Anari M, 1999, SCAND AUDIOL, V28, P219, DOI 10.1080/010503999424653; Andersson G, 2005, INT J AUDIOL, V44, P671, DOI 10.1080/14992020500266720; [Anonymous], 1979, JAMA-J AM MED ASSOC, V241, P2055; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Baguley DM, 2006, OTOL NEUROTOL, V27, P220, DOI 10.1097/01.mao.0000172412.87778.28; Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bernhardt O, 2011, J ORAL REHABIL, V38, P891, DOI 10.1111/j.1365-2842.2011.02224.x; Bernhardt O, 2004, J ORAL REHABIL, V31, P311, DOI 10.1046/j.1365-2842.2003.01249.x; Brotherton H, 2015, AUDIOL NEURO-OTOL, V20, P273, DOI 10.1159/000430459; Buergers R, 2014, J PROSTHET DENT, V111, P222, DOI 10.1016/j.prosdent.2013.10.001; Cacace AT, 2003, HEARING RES, V175, P112, DOI 10.1016/S0378-5955(02)00717-7; Chen G, 2013, JARO-J ASSOC RES OTO, V14, P413, DOI 10.1007/s10162-013-0375-2; Chen YC, 2017, HEAR RES; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; Cook DB, 2004, J RHEUMATOL, V31, P364; Dehmel S, 2008, AM J AUDIOL, V17, pS193, DOI 10.1044/1059-0889(2008/07-0045); Saldanha ADD, 2012, CRANIO, V30, P166, DOI 10.1179/crn.2012.026; ERLANDSSON SI, 1992, AUDIOLOGY, V31, P168; Falkenberg Eva-Signe, 2012, Int J Otolaryngol, V2012, P375460, DOI 10.1155/2012/375460; Ferendiuk E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/824684; Fioretti A, 2015, ACTA OTORHINOLARYNGO, V35, P110; Fioretti AB, 2013, NOISE HEALTH, V15, P91, DOI 10.4103/1463-1741.110287; Gilles A, 2014, OTOL NEUROTOL, V35, P401, DOI 10.1097/MAO.0000000000000248; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Haider HF, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00207; Hebert S, 2007, NEUROSCI LETT, V411, P138, DOI 10.1016/j.neulet.2006.10.028; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; Hilgenberg PB, 2012, J ORAL REHABIL, V39, P239, DOI 10.1111/j.1365-2842.2011.02266.x; Juris L, 2013, INT J AUDIOL, V52, P230, DOI 10.3109/14992027.2012.743043; Khalfa S, 2002, ORL-J OTO-RHIN-LARYN, V64, P436, DOI 10.1159/000067570; Kumar P, 2017, AM J OTOLARYNG, V38, P163, DOI 10.1016/j.amjoto.2016.12.002; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee CF, 2016, EUR ARCH OTO-RHINO-L, V273, P203, DOI 10.1007/s00405-015-3491-2; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Levine RA, 1999, AM J OTOLARYNG, V20, P351, DOI 10.1016/S0196-0709(99)90074-1; Levine RA, 2003, EXP BRAIN RES, V153, P643, DOI 10.1007/s00221-003-1747-3; Manfredini Daniele, 2015, Int Tinnitus J, V19, P47, DOI 10.5935/0946-5448.20150008; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Meeus OM, 2010, INT J AUDIOL, V49, P7, DOI 10.3109/14992020903160868; Middleton JW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00035; Moller AR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/608437; Mols F, 2012, J AFFECT DISORDERS, V136, P26, DOI 10.1016/j.jad.2011.08.034; Monzani D, 2007, Acta Otorhinolaryngol Ital, V27, P186; Nelson Jeffrey J, 2004, Ear Nose Throat J, V83, P472; Nelting M, 2002, LARYNGO RHINO OTOL, V81, P327, DOI 10.1055/s-2002-28342; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; Passi Stefania, 2008, Int Tinnitus J, V14, P26; Pinchoff RJ, 1998, AM J OTOL, V19, P785; Ralli M, 2017, J INT MED RES; Ralli M, 2016, AUDIOL NEURO-OTOL, V21, P372, DOI 10.1159/000452472; Ralli M, 2010, OTOL NEUROTOL, V31, P823, DOI 10.1097/MAO.0b013e3181de4662; RUBINSTEIN B, 1990, Journal of Craniomandibular Disorders, V4, P186; Salviati M, 2013, PSYCHOSOMATICS, V54, P248, DOI 10.1016/j.psym.2012.05.007; Sanchez TG, 2011, CLINICS, V66, P1089, DOI 10.1590/S1807-59322011000600028; Sanchez TG, 2002, AUDIOL NEURO-OTOL, V7, P370, DOI 10.1159/000066155; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schecklmann M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/191479; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shekhawat GS, 2014, EUR ARCH OTO-RHINO-L, V271, P41, DOI 10.1007/s00405-013-2375-6; Sheppard A, 2014, ACTA OTORHINOLARYNGO, V34, P79; Shore SE, 2011, HEARING RES, V281, P38, DOI 10.1016/j.heares.2011.05.001; Shore S, 2007, PROG BRAIN RES, V166, P107, DOI 10.1016/S0079-6123(07)66010-5; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Simmons Richard, 2008, Seminars in Hearing, V29, P361, DOI 10.1055/s-0028-1095895; Song JJ, 2014, BRAIN STRUCT FUNCT, V219, P1113, DOI 10.1007/s00429-013-0555-1; Tyler RS, 2014, AM J AUDIOL, V23, P402, DOI 10.1044/2014_AJA-14-0010; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Villaume K, 2017, SCAND J PSYCHOL, V58, P158, DOI 10.1111/sjop.12350; Weber K, 2012, AGING MENT HEALTH, V16, P472, DOI 10.1080/13607863.2011.630375; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright, 1997, Int Tinnitus J, V3, P55	77	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188255	10.1371/journal.pone.0188255	http://dx.doi.org/10.1371/journal.pone.0188255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161302	gold, Green Submitted, Green Published			2022-12-27	WOS:000415987000037
J	Begum, T; Rahman, A; Nababan, H; Hoque, DME; Khan, A; Ali, T; Anwar, I				Begum, Tahmina; Rahman, Aminur; Nababan, Herfina; Hoque, Dewan Md. Emdadul; Khan, Al Fazal; Ali, Taslim; Anwar, Iqbal			Indications and determinants of caesarean section delivery: Evidence from a population-based study in Matlab, Bangladesh	PLOS ONE			English	Article							MATERNAL AGE; DEVELOPING-COUNTRIES; RATES; HEALTH; BIRTH; WOMEN; LABOR; RISK; COMPLICATIONS; METAANALYSIS	Background and methods Caesarean section (C-section) is a major obstetric intervention for saving lives of women and their newborns from pregnancy and childbirth related complications. Un-necessary C-sections may have adverse impact upon maternal and neonatal outcomes. In Bangladesh there is paucity of data on clinical indication of C-section at population level. We conducted a retrospective study in icddr, b Health and Demographic Surveillance System (HDSS) area of Matlab to look into the indications and determinants of C-sections. All resident women in HDSS service area who gave birth in 2013 with a known birth outcome, were included in the study. Women who underwent C-section were identified from birth and pregnancy files of HDSS and their indication for C-section were collected reviewing health facility records where the procedure took place, supplemented by face-to-face interview of mothers where data were missing. Indications of C-section were presented as frequency distribution and further divided into different groups following 3 distinct classification systems. Socio-demographic predictors were explored following statistical method of binary logistic regression. Findings During 2013, facility delivery rate was 84% and population based C-section rate was 35% of all deliveries in icddr, b service area. Of all C-sections, only 1.4% was conducted for Absolute Maternal Indications (AMIs). Major indications of C-sections included: repeat C-section (24%), foetal distress (21%), prolonged labour (16%), oligohydramnios (14%) and postmaturity (13%). More than 80% C-sections were performed in for-profit private facilities. Probability of C-section delivery increased with improved socio-economic status, higher education, lower birth order, higher age, and with more number of Antenatal Care use and presence of bad obstetric history. Eight maternal deaths occurred, of which five were delivered by C-section. Conclusions C-section rate in this area was much higher than national average as well as global recommendations. Very few of C-sections were undertaken for AMIs. Routine monitoring of clinical indication of C-section in public and private facilities is needed to ensure rational use of the procedure.	[Begum, Tahmina; Ali, Taslim; Anwar, Iqbal] Icddr, Hlth Syst & Populat Studies Div, Dhaka, Bangladesh; [Rahman, Aminur; Hoque, Dewan Md. Emdadul] Icddr, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Nababan, Herfina] Univ Melbourne, Nossal Inst Global Hlth, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Khan, Al Fazal] Icddr, Nutr & Clin Serv Div, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of Melbourne; International Centre for Diarrhoeal Disease Research (ICDDR)	Rahman, A (corresponding author), Icddr, Maternal & Child Hlth Div, Dhaka, Bangladesh.	draminur@icddrb.org	Hoque, Dewan/O-3606-2015; Hoque, Dewan Md. Emdadul/J-1999-2019; Rahman, Aminur/AAG-5391-2020	Hoque, Dewan/0000-0001-8219-9196; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Rahman, Aminur/0000-0003-1434-3883; Nababan, Herfina/0000-0002-7818-4132; Khan, Md Alfazal/0000-0002-7916-482X	School of Public health study at Dhaka, Bangladesh; European Union; Fogarty Fellowship	School of Public health study at Dhaka, Bangladesh; European Union(European Commission); Fogarty Fellowship	The first author, Tahmina Begum, received a student Fogarty grant during her MPH program at James P Grant of School of Public health study at Dhaka, Bangladesh. The authors also kindly acknowledge the European Union funded SHARE project at icddr,b to provide the publication charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aleem H, 2005, INT J GYNECOL OBSTET, V90, P94, DOI 10.1016/j.ijgo.2005.03.027; Ahmad Hina, 2009, JPMA Journal of the Pakistan Medical Association, V59, P691; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Aminu M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-130; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 2010, Obstet Gynecol, V116, P450, DOI 10.1097/AOG.0b013e3181eeb251; Anwar I, 2008, B WORLD HEALTH ORGAN, V86, P252, DOI 10.2471/BLT.07.042754; Anwar I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120309; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Bayrampour H, 2010, BIRTH-ISS PERINAT C, V37, P219, DOI 10.1111/j.1523-536X.2010.00409.x; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Betran A, 2015, BJOG INT J OBSTET GY; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98; Biswas A, 2014, MPDR NEWSLETTER; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chowdhury LR, 2014, NEEDS ASSESSMENT STU; Cockcroft A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-S2-S8; Collin Simon M, 2007, Int J Equity Health, V6, P9, DOI 10.1186/1475-9276-6-9; DUBOURG D, 2007, UON NETWORK TACKLING; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Ecker JL, 2001, AM J OBSTET GYNECOL, V185, P883, DOI 10.1067/mob.2001.117364; Festin MR, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-17; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gamble JA, 2001, BIRTH-ISS PERINAT C, V28, P101, DOI 10.1046/j.1523-536X.2001.00101.x; Gholitabar M, 2011, BMJ-BRIT MED J, P343; Gibbons L, 2010, GLOBAL NUMBERS COSTS; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Heffner LJ, 2003, OBSTET GYNECOL, V102, P287, DOI 10.1016/S0029-7844(03)00531-3; Hofmeyr GJ, 2014, COCHRANE LIB; HPNSDP, 2012, BANGL HLTH FAC SURV; Huda FA, 2012, J HEALTH POPUL NUTR, V30, P131, DOI 10.3329/jhpn.v30i2.11295; icddr b, 2015, REG MATL HLTH DEM EV, P126; Khawaja M, 2004, HEALTH POLICY, V69, P273, DOI 10.1016/j.healthpol.2004.05.006; Koblinsky M, 2008, J HEALTH POPUL NUTR, V26, P280; Lewis G, 2003, BRIT MED BULL, V67, P27, DOI 10.1093/bmb/ldg009; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; Mansur Ahmed M S A, 2014, J Family Reprod Health, V8, P175; MDSR action network B, 2016, BANGL ROLL OUT MPDSR; Morris RK, 2014, BJOG-INT J OBSTET GY, V121, P686, DOI 10.1111/1471-0528.12589; National Institute of Population Research and Training (NIPORT), 2015, BANGL DEM HLTH SURV; Nazneen R, 2011, JBCPS, V29, P126; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Penn Z, 2001, BEST PRACT RES CL OB, V15, P1, DOI 10.1053/beog.2000.0146; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Program EHC, 2012, STRATEGIES REDUCE CE; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Rahman A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-914; Rebelo F, 2010, ACTA OBSTET GYN SCAN, V89, P903, DOI 10.3109/00016349.2010.484044; Roberts CL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001725; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; Sakae Thiago Mamôru, 2009, Rev. Saúde Pública, V43, P472, DOI 10.1590/S0034-89102009000300011; Sanavi Fariba Shahraki, 2012, J Reprod Infertil, V13, P237; Satyanarayana P, 2015, J INFECT DIS THERAPY; Stanton C, 2008, BIRTH-ISS PERINAT C, V35, P204, DOI 10.1111/j.1523-536X.2008.00241.x; Taspinar A, 2014, CUMHURIYET TIP DERGI, V36, P442; Teguete I., 2012, DETERMINING FACTORS; Walker R, 2002, BIRTH-ISS PERINAT C, V29, P28, DOI 10.1046/j.1523-536X.2002.00153.x; WHO H, 2015, WHO STAT CAES SECT R; World Health Organization, 1994, IND MON MAT HLTH GOA; World Health Organization, 2004, INT STAT CLASS DIS R	64	51	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188074	10.1371/journal.pone.0188074	http://dx.doi.org/10.1371/journal.pone.0188074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155840	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700029
J	Chen, YM; Chen, HH; Huang, WN; Liao, TL; Chen, JP; Chao, WC; Lin, CT; Hung, WT; Hsieh, CW; Hsieh, TY; Chen, YH; Chen, DY				Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Liao, Tsai-Ling; Chen, Jun-Peng; Chao, Wen-Cheng; Lin, Ching-Tsai; Hung, Wei-Ting; Hsieh, Chia-Wei; Hsieh, Tsu-Yi; Chen, Yi-Hsing; Chen, Der-Yuan			Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis	PLOS ONE			English	Article							MINERAL DENSITY; DISEASE-ACTIVITY; INADEQUATE RESPONSE; FRACTURE RISK; METHOTREXATE; THERAPY; COHORT; INTERLEUKIN-6; OSTEOPOROSIS; PROGRESSION	Rheumatoid arthritis (RA) is associated with a high risk of osteoporosis and fracture. Interleukin (IL)-6 inhibitors may suppress osteoclast activation. Anticitrullinated protein antibody (ACPA) titers are inversely associated with bone mineral density (BMD). However, the differential effect of ACPA on bone turnover marker (BTM) and BMD changes after IL-6 inhibition remains unclear. This prospective study recruited patients with active RA with inadequate response to methotrexate or biologics. BMD was measured before and after 2-year tocilizumab (TCZ) treatment. Serum osteocalcin, N-terminal propeptide of type I collagen (P1NP), and C-terminal cross-linking telopeptide of type I collagen (CTX) levels were assessed at the baseline and after treatment. We enrolled 76 patients with RA (89.5% women, age: 57.2 +/- 13.3 years) receiving TCZ. The 28-joint disease activity score was negatively correlated with BMD and T-scores of the lumbar spine and bilateral femoral neck. ACPA-positive patients had lower lumbar spine and femoral neck T-scores. After 2-year TCZ treatment, CTX levels significantly decreased (0.32 +/- 0.21 vs. 0.26 +/- 0.17, p = 0.038). Femoral neck BMD increased significantly (0.71 +/- 0.22 vs. 0.69 +/- 0.55, p = 0.008). Decreased CTX levels and improved BMD were observed only in ACPA-positive patients. After treatment, femoral neck BMD significantly increased only in patients receiving a glucocorticoid dose of >= 5 mg/day. Two-year TCZ treatment reduced bone resorption and increased femoral BMD in ACPA-positive patients. The net effects of glucocorticoids and IL-6 inhibition on BMD imply that strict inflammation control might affect bone metabolism.	[Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Chao, Wen-Cheng; Lin, Ching-Tsai; Hung, Wei-Ting; Hsieh, Chia-Wei; Hsieh, Tsu-Yi; Chen, Yi-Hsing; Chen, Der-Yuan] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Liao, Tsai-Ling; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Huang, Wen-Nan; Chen, Yi-Hsing; Chen, Der-Yuan] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Chen, Yi-Ming; Chen, Hsin-Hua; Hsieh, Chia-Wei; Chen, Der-Yuan] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Jun-Peng] Biostat Task Force Taichung Vet Gen Hosp, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Div Chest Med, Taichung, Taiwan; [Hung, Wei-Ting; Hsieh, Tsu-Yi; Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Hsieh, Chia-Wei] Feng Chia Univ, PhD Program Business, Taichung, Taiwan; [Chen, Der-Yuan] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Feng Chia University; National Chung Hsing University	Chen, DY (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, DY (corresponding author), Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan.; Chen, DY (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.	dychen@vghtc.gov.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Hsieh, Tsu-Yi/0000-0001-9897-6957	Taichung Veterans General Hospital, Taiwan [TCVGH-1067308C, 1067326D]	Taichung Veterans General Hospital, Taiwan	This study was supported by grants from Taichung Veterans General Hospital, Taiwan (TCVGH-1067308C & 1067326D).	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Balasubramanian A, 2016, OSTEOPOROSIS INT, V27, P3239, DOI 10.1007/s00198-016-3646-z; Book C, 2008, SCAND J RHEUMATOL, V37, P248, DOI 10.1080/03009740801998747; Briot K, 2015, JOINT BONE SPINE, V82, P109, DOI 10.1016/j.jbspin.2014.10.015; Bugatti S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1116-9; Burmester GR, 2017, ANN RHEUM DIS, V76, P1279, DOI 10.1136/annrheumdis-2016-210561; Edwards CJ, 2010, OSTEOPOROSIS INT, V21, P1287, DOI 10.1007/s00198-010-1192-7; Finzel S, 2013, ANN RHEUM DIS, V72, P396, DOI 10.1136/annrheumdis-2011-201075; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Garnero P, 2010, ARTHRITIS RHEUM-US, V62, P33, DOI 10.1002/art.25053; Harre U, 2012, J CLIN INVEST, V122, P1791, DOI 10.1172/JCI60975; Hashimoto J, 2011, MOD RHEUMATOL, V21, P10, DOI 10.1007/s10165-010-0325-3; Karsdal MA, 2012, SEMIN ARTHRITIS RHEU, V42, P131, DOI 10.1016/j.semarthrit.2012.01.004; Kawai VK, 2013, ARTHRIT CARE RES, V65, P1085, DOI 10.1002/acr.21937; Kim SY, 2012, J BONE MINER RES, V27, P789, DOI 10.1002/jbmr.1489; Krieckaert CLM, 2013, RHEUMATOLOGY, V52, P547, DOI 10.1093/rheumatology/kes320; Kume K, 2014, RHEUMATOLOGY, V53, P900, DOI 10.1093/rheumatology/ket468; Lin YC, 2015, OSTEOPOROSIS INT, V26, P811, DOI 10.1007/s00198-014-2968-y; Llorente I, 2017, RHEUMATOL INT, V37, P799, DOI 10.1007/s00296-017-3674-9; Martin-Mola E, 2016, RHEUMATOL INT, V36, P1043, DOI 10.1007/s00296-016-3506-3; Meguid MHA, 2013, RHEUMATOL INT, V33, P697, DOI 10.1007/s00296-012-2375-7; Meng J, 2017, MEDICINE, V96, P6677; Mohammad A, 2014, RHEUMATOLOGY, V53, P821, DOI 10.1093/rheumatology/ket353; Mori Y, 2017, J BONE MINER METAB, V35, P52, DOI 10.1007/s00774-015-0716-9; Orsolini G, 2017, CALCIFIED TISSUE INT, V101, P17, DOI 10.1007/s00223-017-0253-8; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Siu S, 2015, ARTHRIT CARE RES, V67, P754, DOI 10.1002/acr.22519; Straub RH, 2015, SEMIN ARTHRITIS RHEU, V45, P220, DOI 10.1016/j.semarthrit.2015.04.014; Szulc P, 2017, OSTEOPOROS INT; Tanaka K, 2014, CLIN EXP IMMUNOL, V175, P172, DOI 10.1111/cei.12201; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; van der Goes MC, 2013, OSTEOPOROSIS INT, V24, P1429, DOI 10.1007/s00198-012-2073-z; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; Wijbrandts CA, 2009, ANN RHEUM DIS, V68, P373, DOI 10.1136/ard.2008.091611; Zerbini CAF, 2017, OSTEOPOROSIS INT, V28, P429, DOI 10.1007/s00198-016-3769-2	36	22	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188454	10.1371/journal.pone.0188454	http://dx.doi.org/10.1371/journal.pone.0188454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155868	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700061
J	Durbeej, N; Elgan, TH; Jalling, C; Gripenberg, J				Durbeej, Natalie; Elgan, Tobias H.; Jalling, Camilla; Gripenberg, Johanna			Alcohol intoxication at Swedish football matches: A study using biological sampling to assess blood alcohol concentration levels among spectators	PLOS ONE			English	Article							TARGETING LICENSED PREMISES; SPORTING EVENTS; BINGE DRINKING; BEER; PREVENTION; STOCKHOLM; VIOLENCE; IMPLEMENTATION; CONSUMPTION; MANAGEMENT	Alcohol use and alcohol-related problems, including accidents, vandalism and violence, at sporting events are of increased concern in Sweden and other countries. The relationship between alcohol use and violence has been established and can be explained by the level of intoxication. Given the occurrence of alcohol use and alcohol-related problems at sporting events, research has assessed intoxication levels measured through biological sampling among spectators. This cross-sectional study aimed to assess the level of alcohol intoxication among spectators at football matches in the Swedish Premier Football League. Spectators were randomly selected and invited to participate in the study. Alcohol intoxication was measured with a breath analyser for Blood Alcohol Concentration levels, and data on gender, age, and recent alcohol use were gathered through a face-to-face interview. Blood Alcohol Concentration samples from 4420 spectators were collected. Almost half (46.8%) had a positive Blood Alcohol Concentration level, with a mean value of 0.063%, while 8.9% had a Blood Alcohol Concentration level >= 0.1%, with a mean value of 0.135%. Factors that predicted a higher Blood Alcohol Concentration level included male gender (p = 0.005), lower age (p < 0.001), attending a local derby (p < 0.001), alcohol use prior to having entered the arena (p < 0.001), attending a weekend match (p < 0.001), and being a spectator at supporter sections (p < 0.001). About half of all spectators at football matches in the Swedish Premier Football League drink alcohol in conjunction with the match. Approximately one tenth have a high level of alcohol intoxication.	[Durbeej, Natalie] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, STAD, Stockholm, Sweden; Stockholm Hlth Care Serv, Stockholm Cty Council, Stockholm, Sweden	Karolinska Institutet; Stockholm County Council	Durbeej, N (corresponding author), Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, STAD, Stockholm, Sweden.	Natalie.Durbeej@ki.se	Elgan, Tobias/AAD-5281-2019; Gripenberg, Johanna/AAD-3611-2022; Elgan, Tobias H/B-8573-2017	Elgan, Tobias/0000-0001-6406-4685; Elgan, Tobias H/0000-0001-6406-4685; Jalling, Camilla/0000-0001-5905-2110	Public Health Agency of Sweden [05603-2014-6.2]; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly [2014-0027]	Public Health Agency of Sweden; Alcohol Research Council of the Swedish Alcohol Retailing Monopoly	The study was funded by the Public Health Agency of Sweden (grant no. 05603-2014-6.2, URL: www.folkhalsomyndigheten.se/) and the Alcohol Research Council of the Swedish Alcohol Retailing Monopoly (grant no. 2014-0027, URL: www.can.se/sra). THE and JG received the funding. The study funders had no role in the design, collection, analysis, or interpretation of the data, or in the preparation of the manuscript or decision to submit the manuscript for publication.	Barrocas A, 2014, J ABNORM CHILD PSYCH, P1; Baumberg B, 2006, DRUG ALCOHOL REV, V25, P537, DOI 10.1080/09595230600944479; Boles SM, 2003, AGGRESS VIOLENT BEH, V8, P155, DOI 10.1016/S1359-1789(01)00057-X; Bormann CA, 2001, J AM COLL HEALTH, V50, P81, DOI 10.1080/07448480109596011; Casswell S, 2011, ADDICTION, V106, P1087, DOI 10.1111/j.1360-0443.2011.03361.x; Champion Heather, 2009, Int J Adolesc Med Health, V21, P249, DOI 10.1515/IJAMH.2009.21.2.249; Durbeej N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3145-3; Erickson DJ, 2011, ALCOHOL CLIN EXP RES, V35, P689, DOI 10.1111/j.1530-0277.2010.01386.x; Farrington D. P., 1994, AGGRESSIVE BEHAV CUR, P215, DOI DOI 10.1007/978-1-4757-9116-7_9; Felson RB, 2010, CRIM JUSTICE BEHAV, V37, P1343, DOI 10.1177/0093854810382003; Glassman T., 2011, J ALCOHOL DRUG EDUC, V55, P55; Gripenberg-Abdon J, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-7; Holder HD, 2000, ADDICT BEHAV, V25, P843, DOI 10.1016/S0306-4603(00)00121-0; Jones L, 2011, HEALTH PLACE, V17, P508, DOI 10.1016/j.healthplace.2010.12.006; Kingsland M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0183-y; Kingsland M, 2015, DRUG ALCOHOL REV, V34, P447, DOI 10.1111/dar.12252; Lenk KM, 2009, DRUG-EDUC PREV POLIC, V16, P451, DOI 10.1080/09687630802278478; Lloyd B, 2013, ADDICTION, V108, P701, DOI 10.1111/add.12041; Lundholm L, 2013, DRUG ALCOHOL DEPEN, V129, P110, DOI 10.1016/j.drugalcdep.2012.09.019; Lyne M, 2012, AUST NZ J PUBL HEAL, V36, P55, DOI 10.1111/j.1753-6405.2011.00813.x; Mansdotter AM, 2007, EUR J PUBLIC HEALTH, V17, P618, DOI 10.1093/eurpub/ckm017; Muller D, 2014, VARNING STAN STUDIE; Neal DJ, 2007, ADDICT BEHAV, V32, P2681, DOI 10.1016/j.addbeh.2007.06.020; Peitersen B., 2009, Soccer and Society, V10, P374, DOI 10.1080/14660970902771431; Ramstedt M, 2013, DRUG ALCOHOL REV, V32, P561, DOI 10.1111/dar.12069; Rees DI, 2009, J SPORT ECON, V10, P68, DOI 10.1177/1527002508327389; Reichenheim ME, 2011, LANCET, V377, P1962, DOI 10.1016/S0140-6736(11)60053-6; Roiu I, 2013, FORENSIC SCI INT, V232, P125, DOI 10.1016/j.forsciint.2013.07.002; Room R, 2001, J SUBST USE, V4, P218, DOI DOI 10.1080/146598901753325048; Rowland BC, 2015, AUST NZ J PUBL HEAL, V39, P210, DOI 10.1111/1753-6405.12280; Tabachnick BG., USING MULTIVARIATE S; The National Council For Crime Prevention, 2008, STRAT MOT FOTB ORD; Toomey TL, 2008, ALCOHOL CLIN EXP RES, V32, P1859, DOI 10.1111/j.1530-0277.2008.00770.x; Trolldal B, 2013, ADDICTION, V108, P89, DOI 10.1111/j.1360-0443.2012.04004.x; Voas RB, 2006, EVALUATION REV, V30, P44, DOI 10.1177/0193841X05277285; Wallin E, 2004, PREV SCI, V5, P221, DOI 10.1023/B:PREV.0000045356.37507.86; Wallin E, 2003, J STUD ALCOHOL, V64, P270, DOI 10.15288/jsa.2003.64.270; Wallin E, 2002, ADDICTION, V97, P901, DOI 10.1046/j.1360-0443.2002.00160.x; WHO, 2007, DRINK DRIV ROAD SAF; Wolfe J, 1998, ANN EMERG MED, V31, P629, DOI 10.1016/S0196-0644(98)70209-4; Wright NR, 2006, ADDICT RES THEORY, V14, P133, DOI 10.1080/16066350500505850	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188284	10.1371/journal.pone.0188284	http://dx.doi.org/10.1371/journal.pone.0188284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155885	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700042
J	Najafi, H; Yarijani, ZM; Changizi-Ashtiyani, S; Mansouri, K; Modarresi, M; Madani, SH; Bastani, B				Najafi, Houshang; Yarijani, Zeynab Mohamadi; Changizi-Ashtiyani, Saeed; Mansouri, Kamran; Modarresi, Masoud; Madani, Seyed Hamid; Bastani, Bahar			Protective effect of Malva sylvestris L. extract in ischemia-reperfusion induced acute kidney and remote liver injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INDUCED HEPATOTOXICITY; ANTIOXIDANT ACTIVITY; RATS; INFLAMMATION; DYSFUNCTION; TARGETS; DAMAGE; PATHOPHYSIOLOGY; POLYSACCHARIDE	Mallow (Malva sylvestris L.) has had medicinal and therapeutic uses in addition to its oral consumption. The present study was conducted to examine the protective effect of Malva sylvestris L. extract on ischemia-reperfusion-induced kidney injury and remote organ injuries in the liver. Before ischemia-reperfusion, rats in the different groups received intraperitoneal normal saline or mallow extract at the doses of 200, 400 or 600 mg/kg of body weight. After 30-minutes of bilateral renal ischemia followed by 24-hours of reperfusion, tissue damage in the kidney and liver samples were determined through studying H&E-stained slides under a light microscope. The degree of leukocyte infiltration and tissue mRNA expressions of TNF- and ICAM-1 were then measured to examine the degree of renal inflammation. The renal tissue MDA and FRAP levels were measured for determining the amount of oxidative stress. Plasma concentrations of creatinine, urea, ALT and ALP were also measured. Ischemia- reperfusion led to a significant increase in plasma concentrations of creatinine, urea, ALT and ALP, and renal tissue MDA, and a significant decrease in renal tissue FRAP. The expression of pro-inflammatory factors in the kidney tissue, the level of leukocyte infiltration and the amount of tissue damage in the kidney and liver also increased. Pretreatment by mallow extract led to a significant improvement in all the variables measured. The 200- and 400-mg doses yielded better results in most parameters compared to the 600-mg dose. The findings showed that mallow extract protects the kidney against ischemia-reperfusion and reduces remote organ injury in the liver.	[Najafi, Houshang; Yarijani, Zeynab Mohamadi; Mansouri, Kamran] Kermanshah Univ Med Sci, Med Biol Res Ctr, Kermanshah, Iran; [Changizi-Ashtiyani, Saeed] Arak Univ Med Sci, Sch Paramed Sci, Dept Physiol, Arak, Iran; [Modarresi, Masoud] Kermanshah Univ Med Sci, Fac Pharm, Sch Paramed Sci, Dept Physiol, Kermanshah, Iran; [Madani, Seyed Hamid] Kermanshah Univ Med Sci, Sch Med, Dept Pathol, Kermanshah, Iran; [Bastani, Bahar] St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63103 USA	Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Saint Louis University	Bastani, B (corresponding author), St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63103 USA.	bastanib@slu.edu	Najafi, Houshang/K-1597-2017; yarijani, zeynab mohamadi/AAY-4850-2020; SaberiNajafi, Hashem/AFS-6719-2022	Mohamadi Yarijani, Zeynab/0000-0002-0693-6788; Bastani, Bahar/0000-0002-2138-4248; Najafi, Houshang/0000-0001-9642-9124	Kermanshah University of Medical Sciences [93422]	Kermanshah University of Medical Sciences	This work was funded by grant # 93422, research deputy of Kermanshah University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the research deputy of Kermanshah University of medical sciences for financial support (research project 93422 to HN).	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Akcay A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/137072; Anders HJ, 2014, J AM SOC NEPHROL, V25, P1387, DOI 10.1681/ASN.2014010117; Arabaci G, J CHEM, V2013; Ashtiyani SC, 2012, IRAN J KIDNEY DIS, V6, P275; Barros L, 2010, FOOD CHEM TOXICOL, V48, P1466, DOI 10.1016/j.fct.2010.03.012; Basile David P., 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P3; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; Benso B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162728; Benso B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140331; BILLETER M, 1991, PHYTOCHEMISTRY, V30, P987, DOI 10.1016/0031-9422(91)85292-8; Blunden G, 2001, PHYTOCHEMISTRY, V58, P451, DOI 10.1016/S0031-9422(01)00263-1; Bonventre JV, 2003, J AM SOC NEPHROL, V14, P2199, DOI 10.1097/01.ASN.0000079785.13922.F6; Changizi-Ashtiyani S, 2016, CANCER GENE THER, V23, P235, DOI 10.1038/cgt.2016.24; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chiclana CF, 2009, LAT AM J PHARM, V28, P275; Choi KS, 2014, ARCH BIOCHEM BIOPHYS, V559, P38, DOI 10.1016/j.abb.2014.05.016; Classen B, 2002, PLANTA MED, V68, P232, DOI 10.1055/s-2002-23127; Conforti F, 2008, J ETHNOPHARMACOL, V116, P144, DOI 10.1016/j.jep.2007.11.015; Cutillo F, 2006, PHYTOCHEMISTRY, V67, P481, DOI 10.1016/j.phytochem.2005.11.023; Dagher PC, 2003, J AM SOC NEPHROL, V14, P2188, DOI 10.1097/01.ASN.0000079790.91292.4A; Doi K, 2016, KIDNEY INT, V89, P555, DOI 10.1016/j.kint.2015.11.019; Donnahoo KK, 1999, J UROLOGY, V162, P196, DOI 10.1097/00005392-199907000-00068; Elsagh M, 2015, COMPLEMENT THER CLIN, V21, P105, DOI 10.1016/j.ctcp.2015.02.003; Fadillioglu E, 2008, ARCH PHARM RES, V31, P705, DOI 10.1007/s12272-001-1216-3; Martins CAF, 2014, BIOMED CHROMATOGR, V28, P986, DOI 10.1002/bmc.3106; Ganai BA, 1997, PHYTOCHEMISTRY, V45, P879, DOI 10.1016/S0031-9422(97)82709-4; Ganai BA, 2006, J IND POLLUT CONTR, V22, P77; Gardner DS, 2016, AM J PHYSIOL-RENAL, V310, pF259, DOI 10.1152/ajprenal.00389.2015; Gasparetto JC, 2012, J PHARM PHARMACOL, V64, P172, DOI 10.1111/j.2042-7158.2011.01383.x; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; GONDA R, 1990, CARBOHYD RES, V198, P323, DOI 10.1016/0008-6215(90)84302-B; Grams ME, 2012, KIDNEY INT, V81, P942, DOI 10.1038/ki.2011.241; Guarrera PM, 2005, FITOTERAPIA, V76, P1, DOI 10.1016/j.fitote.2004.09.006; Guil JL, 1996, J CHROMATOGR A, V719, P229, DOI 10.1016/0021-9673(95)00414-9; Hamedi A, 2016, J EVID-BASED INTEGR, V21, P14, DOI 10.1177/2156587215589184; Hicsonmez U, 2009, BIOL TRACE ELEM RES, V128, P248, DOI 10.1007/s12011-008-8270-0; Hussain L, 2014, TURK J BIOL, V38, P396, DOI 10.3906/biy-1312-32; Javanmardi J, 2003, FOOD CHEM, V83, P547, DOI 10.1016/S0308-8146(03)00151-1; Kauss T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2372; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee CG, 2014, KIDNEY INT, V86, P943, DOI 10.1038/ki.2014.117; Mahmoudzadeh L, 2017, NEPHROLOGY, V22, P748, DOI 10.1111/nep.12849; Marouane W, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-65; Matejovic M, 2016, J AM SOC NEPHROL, V27, P49, DOI 10.1681/ASN.2015030234; Najafi H, 2016, EXP PHYSIOL, V101, P913, DOI 10.1113/EP085583; Prudente AS, 2013, FOOD CHEM TOXICOL, V58, P324, DOI 10.1016/j.fct.2013.04.042; Rabb H, 2016, J AM SOC NEPHROL, V27, P371, DOI 10.1681/ASN.2015030261; Samavati V, 2013, INT J BIOL MACROMOL, V60, P427, DOI 10.1016/j.ijbiomac.2013.04.050; Sleiman NH, 2009, PLANTA MED, V75, P1010; Sreelatha S, 2009, FOOD CHEM TOXICOL, V47, P702, DOI 10.1016/j.fct.2008.12.022; Sutton TA, 2002, KIDNEY INT, V62, P1539, DOI 10.1046/j.1523-1755.2002.00631.x; Thurman JM, 2007, CLIN IMMUNOL, V123, P7, DOI 10.1016/j.clim.2006.09.008; Yarijani ZM, 2016, IRAN J BASIC MED SCI, V19, P337	56	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188270	10.1371/journal.pone.0188270	http://dx.doi.org/10.1371/journal.pone.0188270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155898	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700040
J	DeCamp, AC; Rolland, M; Edlefsen, PT; Sanders-Buell, E; Hall, B; Magaret, CA; Fiore-Gartland, AJ; Juraska, M; Carpp, LN; Karuna, ST; Bose, M; LePore, S; Miller, S; O'Sullivan, A; Poltavee, K; Bai, HJ; Dommaraju, K; Zhao, H; Wong, K; Chen, LN; Ahmed, H; Goodman, D; Tay, MZ; Gottardo, R; Koup, RA; Bailer, R; Mascola, JR; Graham, BS; Roederer, M; O'Connell, RJ; Michael, NL; Robb, ML; Adams, E; D'Souza, P; Kublin, J; Corey, L; Geraghty, DE; Frahm, N; Tomaras, GD; McElrath, MJ; Frenkel, L; Styrchak, S; Tovanabutra, S; Sobieszczyk, ME; Hammer, SM; Kim, JH; Mullins, JI; Gilbert, PB				DeCamp, Allan C.; Rolland, Morgane; Edlefsen, Paul T.; Sanders-Buell, Eric; Hall, Breana; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; Zhao, Hong; Wong, Kim; Chen, Lennie; Ahmed, Hasan; Goodman, Derrick; Tay, Matthew Z.; Gottardo, Raphael; Koup, Richard A.; Bailer, Robert; Mascola, John R.; Graham, Barney S.; Roederer, Mario; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Adams, Elizabeth; D'Souza, Patricia; Kublin, James; Corey, Lawrence; Geraghty, Daniel E.; Frahm, Nicole; Tomaras, Georgia D.; McElrath, M. Juliana; Frenkel, Lisa; Styrchak, Sheila; Tovanabutra, Sodsai; Sobieszczyk, Magdalena E.; Hammer, Scott M.; Kim, Jerome H.; Mullins, James I.; Gilbert, Peter B.			Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120	PLOS ONE			English	Article							PROPORTIONAL HAZARDS MODELS; DNA CANDIDATE VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; IMMUNOGENICITY EVALUATION; ENVELOPE GLYCOPROTEIN; CONTINUOUS MARKS; IMMUNE PRESSURE; PHASE-1 SAFETY; T-CELLS	Although the HVTN 505 DNA/recombinant adenovirus type 5 vector HIV-1 vaccine trial showed no overall efficacy, analysis of breakthrough HIV-1 sequences in participants can help determine whether vaccine-induced immune responses impacted viruses that caused infection. We analyzed 480 HIV-1 genomes sampled from 27 vaccine and 20 placebo recipients and found that intra-host HIV-1 diversity was significantly lower in vaccine recipients (P <= 0.04, Q-values <= 0.09) in Gag, Pol, Vif and envelope glycoprotein gp120 (Env-gp120). Furthermore, Env-gp120 sequences from vaccine recipients were significantly more distant from the subtype B vaccine insert than sequences from placebo recipients (P = 0.01, Q-value = 0.12). These vaccine effects were associated with signatures mapping to CD4 binding site and CD4-induced monoclonal antibody footprints. These results suggest either (i) no vaccine efficacy to block acquisition of any viral genotype but vaccine-accelerated Env evolution post-acquisition; or (ii) vaccine efficacy against HIV-1s with Env sequences closest to the vaccine insert combined with increased acquisition due to other factors, potentially including the vaccine vector.	[DeCamp, Allan C.; Edlefsen, Paul T.; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Gottardo, Raphael; Kublin, James; Corey, Lawrence; Frahm, Nicole; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [DeCamp, Allan C.; Edlefsen, Paul T.; Magaret, Craig A.; Fiore-Gartland, Andrew J.; Juraska, Michal; Carpp, Lindsay N.; Karuna, Shelly T.; Gottardo, Raphael; Kublin, James; Corey, Lawrence; Frahm, Nicole; McElrath, M. Juliana; Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Rolland, Morgane; Sanders-Buell, Eric; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Tovanabutra, Sodsai] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Rolland, Morgane; Sanders-Buell, Eric; Bose, Meera; LePore, Steven; Miller, Shana; O'Sullivan, Annemarie; Poltavee, Kultida; Bai, Hongjun; Dommaraju, Kalpana; O'Connell, Robert J.; Michael, Nelson L.; Robb, Merlin L.; Adams, Elizabeth; Tovanabutra, Sodsai] Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA; [Edlefsen, Paul T.; Gottardo, Raphael; Gilbert, Peter B.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Hall, Breana; Zhao, Hong; Wong, Kim; Chen, Lennie; Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Ahmed, Hasan] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Goodman, Derrick; Tay, Matthew Z.; Tomaras, Georgia D.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA; [Koup, Richard A.; Bailer, Robert; Mascola, John R.; Graham, Barney S.; Roederer, Mario] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Adams, Elizabeth; D'Souza, Patricia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Geraghty, Daniel E.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Frahm, Nicole; Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Med, Seattle, WA USA; [Frenkel, Lisa; Mullins, James I.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Frenkel, Lisa; Styrchak, Sheila] Seattle Childrens Res Inst, Seattle, WA USA; [Frenkel, Lisa] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Sobieszczyk, Magdalena E.; Hammer, Scott M.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Columbia University; International Vaccine Institute	DeCamp, AC; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA.; DeCamp, AC; Gilbert, PB (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA.; Rolland, M (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA.; Rolland, M (corresponding author), Henry M Jackson Fdn Adv Mil Med Inc, Bethesda, MD USA.; Gilbert, PB (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	adecamp@scharp.org; mrolland@hivresearch.org; pgilbert@scharp.org	Carpp, Lindsay/AAM-1148-2021; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019; Roederer, Mario/G-1887-2011; Gottardo, Raphael/HCH-3169-2022; Corey, Lawrence/AAE-1796-2020; Tay, Matthew/GYQ-6959-2022	Graham, Barney S./0000-0001-8112-0853; Corey, Lawrence/0000-0002-2179-2436; deCamp, Allan/0000-0003-1404-4322; Gottardo, Raphael/0000-0002-3867-0232; Bai, Hongjun/0000-0002-3501-3974; Tay, Matthew Zirui/0000-0002-1763-913X	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [R37AI054165, UM1AI068635]; HVTN 505 trial; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054165, UM1AI068635, UM1AI068614, UM1AI068618] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HVTN 505 trial; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) under award numbers R37AI054165 and UM1AI068635. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the participants, investigators, and sponsors of the HVTN 505 trial.; The authors thank the participants, investigators, and sponsors of the HVTN 505 trial. The authors also thank the HVTN Core staff; the Statistical Center for HIV/AIDS Research and Prevention; the HVTN laboratories; Susan Zolla-Pazner for help in identifying V3 and gp41 immunodominant hotspots; Adi Ferrara for assistance with technical writing; and R. Glenn Overman, Pinghuang Liu, Vicki Ashley, Kristy Long, Sheetal Sawant, Judith Lucas, Michael Archibald, Sarah Thiebaud, and April Randhawa for help with the ADCP assay.	[Anonymous], 2014, TOD HIV AIDS EP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Churchyard GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021225; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Day TA, 2013, CURR HIV RES, V11, P441, DOI 10.2174/1570162X113116660051; Dommaraju K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111334; Edlefsen PT, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003973; Edlefsen PT, 2013, CURR OPIN HIV AIDS, V8, P432, DOI 10.1097/COH.0b013e328362db2b; Fauci AS, 2014, SCIENCE, V344, P49, DOI 10.1126/science.1250672; Fiore-Gartland A, 2017, BIOINFORMATICS; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Gach JS, 2011, CURR TOP MED CHEM, V11, P2997; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gilbert PB, 2008, BIOMETRICS, V64, P198, DOI 10.1111/j.1541-0420.2007.00845.x; Gilbert PB, 2015, J R STAT SOC C-APPL, V64, P49, DOI 10.1111/rssc.12067; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Hertz T, 2016, VACCINE, V34, P5792, DOI 10.1016/j.vaccine.2016.09.054; HOLM S, 1979, SCAND J STAT, V6, P65; Hu HT, 2014, P NATL ACAD SCI USA, V111, P13439, DOI 10.1073/pnas.1400446111; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Iyer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135903; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Janes HE, 2017, J INFECT DIS, V215, P1376, DOI 10.1093/infdis/jix086; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Juraska M, 2013, BIOMETRICS, V69, P328, DOI 10.1111/biom.12016; Land A, 2003, FASEB J, V17, P1058, DOI 10.1096/fj.02-0811com; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lewis GK, 2014, P NATL ACAD SCI USA, V111, P15614, DOI 10.1073/pnas.1413550111; Mancl LA, 2001, BIOMETRICS, V57, P126, DOI 10.1111/j.0006-341X.2001.00126.x; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Moodie Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137666; Mullins Lab, WEB PSSM 2007 2009; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pharris A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.47.20968; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, 19 C RETR OPP INF SE; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Sterrett S, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu056; Sun YQ, 2009, ANN STAT, V37, P394, DOI 10.1214/07-AOS554; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; THALI M, 1992, J VIROL, V66, P5635, DOI 10.1128/JVI.66.9.5635-5641.1992; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Tomaras GD, 2014, VACCINES, V2, P15, DOI 10.3390/vaccines2010015; UNAIDS, 2014, THE GAP REP; Williams WB, 2015, SCIENCE, V349, DOI 10.1126/science.aab1253; Yang X, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S77099; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022	59	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0185959	10.1371/journal.pone.0185959	http://dx.doi.org/10.1371/journal.pone.0185959			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149197	Green Submitted, Green Published, gold			2022-12-27	WOS:000415646100002
J	Huynh, MP; Meihls, LN; Hibbard, BE; Lapointe, SL; Niedz, RP; Ludwick, DC; Coudron, TA				Huynh, Man P.; Meihls, Lisa N.; Hibbard, Bruce E.; Lapointe, Stephen L.; Niedz, Randall P.; Ludwick, Dalton C.; Coudron, Thomas A.			Diet improvement for western corn rootworm (Coleoptera: Chrysomelidae) larvae	PLOS ONE			English	Article							ARTIFICIAL DIET; RESISTANCE; SUSCEPTIBILITY; CURCULIONIDAE; INSECTICIDES; OPTIMIZATION; VARIABLES; SURVIVAL; NEBRASKA; CRY3BB1	The western corn rootworm (WCR), Diabrotica virgifera virgifera LeConte, is the most serious insect pest of corn (Zea mays L.) in the United States and parts of Europe, and arguably one of the world's most expensive pests to control. Several diet formulations are currently used by industry and public researchers to evaluate WCR larvae in diet-toxicity bioassays. However, a publicly available diet that produces normative insects that are physiologically similar to WCR larvae reared on corn roots will accelerate development of management technologies. We report a new diet formulation that supports improved weight gain, larval development and survival compared with the only public diet for WCR that is currently available in the refereed literature. The formulation was created by using response surface methods combined with n-dimensional mixture designs to identify and improve the formulation of key ingredients. Weight gain increased two-fold, and survival and molting rates increased from 93% and 90%, respectively when reared on the public diet, to approximately 99% for both survival and molting at 11 days when reared on our new formulation. This new formulation provides a standardized growth medium for WCR larvae that will facilitate comparison of research results from various working groups and compliance with regulatory requirements.	[Huynh, Man P.; Ludwick, Dalton C.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Huynh, Man P.] Can Tho Univ, Dept Plant Protect, Can Tho, Vietnam; [Meihls, Lisa N.; Hibbard, Bruce E.] USDA ARS, Plant Genet Res Unit, Columbia, MO USA; [Lapointe, Stephen L.; Niedz, Randall P.] USDA ARS, Hort Res Lab, Ft Pierce, FL USA; [Coudron, Thomas A.] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	University of Missouri System; University of Missouri Columbia; Can Tho University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Coudron, TA (corresponding author), USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA.	tom.coudron@ars.usda.gov		Huynh, Man/0000-0002-7736-3809; Hibbard, Bruce/0000-0001-8067-4416	Monsanto Corn Rootworm Knowledge Research Grant Program; USDA-Agricultural Research Service [5070-22000-037-00-D, 5070-21000-038-00-D, 6034-21000-014-00-D, 6034-22320-004-00-D]	Monsanto Corn Rootworm Knowledge Research Grant Program; USDA-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Research for this study was funded, in part, by the Monsanto Corn Rootworm Knowledge Research Grant Program [https://monsanto.com/products/product-stewardship/corn-rootworm-managernent/corn-rootworm-knowledge-research-program/] to BEH which was not involved in the research design, data collection and analysis, decision to publish, or reparation of the manuscript. Funding was also provided by the USDA-Agricultural Research Service through projects numbered 5070-22000-037-00-D (to TAC), 5070-21000-038-00-D (to BEH), 6034-21000-014-00-D (to RPN) and 6034-22320-004-00-D (to SLL).	ALLEN DM, 1971, TECHNOMETRICS, V13, P469, DOI 10.2307/1267161; Anderson M. J., 2007, Quality Engineering, V19, P111, DOI 10.1080/08982110701241434; BALL HJ, 1963, J ECON ENTOMOL, V56, P553, DOI 10.1093/jee/56.5.553; Cohen A. C., 2015, INSECT DIETS SCI TEC; Cornell J.A., 2002, EXPT MIXTURES DESIGN, Vthird, DOI DOI 10.1198/004017002320256620; CULY MD, 1992, J ECON ENTOMOL, V85, P2440, DOI 10.1093/jee/85.6.2440; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; [E.P.A Agency USEP], 2014, EPA PROP IMPR CORN R; [E.P.A Agency USEP], 2016, EPA NEEDS BETT DAT P; [E.P.A Agency USEP], 2016, EPA DOCK CORN ROOTW; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Lapointe SL, 2008, J INSECT PHYSIOL, V54, P1157, DOI 10.1016/j.jinsphys.2008.04.020; Lapointe SL, 2010, ENVIRON ENTOMOL, V39, P670, DOI 10.1603/EN09304; Lapointe SL, 2010, FLA ENTOMOL, V93, P56, DOI 10.1653/024.093.0108; Levine Eli, 2002, American Entomologist, V48, P94; Ludwick D, 2016, CAB REV; Ludwick DC, 2017, J APPL ENTOMOL, V141, P28, DOI 10.1111/jen.12377; MARRONE PG, 1985, J ECON ENTOMOL, V78, P290, DOI 10.1093/jee/78.1.290; Meinke LJ, 1998, J ECON ENTOMOL, V91, P594, DOI 10.1093/jee/91.3.594; Mitchell P., 2011, 24 IWGO C 3 INT C DI; Myers R.H., 2016, RESPONSE SURFACE MET; Myers RH., 2016, RESPONSE SURFACE MET; Niedz RP, 2016, IN VITRO CELL DEV-PL, V52, P547, DOI 10.1007/s11627-016-9786-1; Pascacio-Villafan C, 2014, J CHEM ECOL, V40, P297, DOI 10.1007/s10886-014-0404-6; Pereira AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142299; Pleau MJ, 2002, ENTOMOL EXP APPL, V105, P1, DOI 10.1023/A:1021703530932; ROSE RI, 1973, J ECON ENTOMOL, V66, P398, DOI 10.1093/jee/66.2.398; Ruohonen K, 2004, AQUACULT NUTR, V10, P145, DOI 10.1111/j.1365-2095.2004.00277.x; SCHEFFE H, 1958, J ROY STAT SOC B, V20, P344; Siegfried BD, 2005, J ECON ENTOMOL, V98, P1320, DOI 10.1603/0022-0493-98.4.1320; Smith W.F., 2005, EXPT DESIGN FORMULAT; SUTTER GR, 1971, J ECON ENTOMOL, V64, P65, DOI 10.1093/jee/64.1.65; Swaisgood H., 2008, FENNEMAS FOOD CHEM; The SAS Institute, 2013, SAS VERS 9 4; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Weisberg S., 1985, APPL LINEAR REGRESSI; Whitcomb P.J., 2004, RSM SIMPLIFIED OPTIM, DOI [DOI 10.1201/9781315382326, 10.1201/9781315382326]; Wilson TA, 2004, ENVIRON ENTOMOL, V33, P1102, DOI 10.1603/0046-225X-33.4.1102; Zukoff SN, 2016, J EC ENTOMOL	41	12	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187997	10.1371/journal.pone.0187997	http://dx.doi.org/10.1371/journal.pone.0187997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149192	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100022
J	Yoon, Y				Yoon, Young			Per-service supervised learning for identifying desired WoT apps from user requests in natural language	PLOS ONE			English	Article								Web of Things (WoT) platforms are growing fast so as the needs for composing WoT apps more easily and efficiently. We have recently commenced the campaign to develop an interface where users can issue requests for WoT apps entirely in natural language. This requires an effort to build a system that can learn to identify relevant WoT functions that fulfill user's requests. In our preceding work, we trained a supervised learning system with thousands of publicly-available IFTTT app recipes based on conditional random fields (CRF). However, the sub-par accuracy and excessive training time motivated us to devise a better approach. In this paper, we present a novel solution that creates a separate learning engine for each trigger service. With this approach, parallel and incremental learning becomes possible. For inference, our system first identifies the most relevant trigger service for a given user request by using an information retrieval technique. Then, the learning engine associated with the trigger service predicts the most likely pair of trigger and action functions. We expect that such two-phase inference method given parallel learning engines would improve the accuracy of identifying related WoT functions. We verify our new solution through the empirical evaluation with training and test sets sampled from a pool of refined IFTTT app recipes. We also meticulously analyze the characteristics of the recipes to find future research directions.	[Yoon, Young] Hongik Univ, Dept Comp Engn, Seoul, South Korea	Hongik University	Yoon, Y (corresponding author), Hongik Univ, Dept Comp Engn, Seoul, South Korea.	young.yoon@hongik.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2016R1D1A1B03931324]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2016R1D1A1B03931324).; This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (NRF-2016R1D1A1B03931324).	[Anonymous], 2001, CONDITIONAL RANDOM F; Cameron Jones M, 2009, P 4 INT C COMM TECHN, P195; Compton M, 2012, J WEB SEMANT, V17, P25, DOI 10.1016/j.websem.2012.05.003; Fors SL, 2007, METHOD SYSTEM UTILIZ; Gormley C., 2015, ELASTICSEARCH DEFINI; Guinard D., 2009, 6 INSS, P1, DOI DOI 10.1109/INSS.2009.5409925; Heflin J., 2000, SEMANTIC INTEROPERAB; HEILER S, 1995, ACM COMPUT SURV, V27, P271, DOI 10.1145/210376.210392; Hyun L, 2015, P SESS 16 INT MIDDL; Kiros R, 2015, P ADV NEURAL INFORM, P3294; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; McIlraith SA, 2001, IEEE INTELL SYST APP, V16, P46, DOI 10.1109/5254.920599; Myers JL, 2003, RES DESIGN STAT ANAL; Ouksel Aris M., 1999, ACM SIGMOD REC, V28, P5, DOI DOI 10.1145/309844.309849; Santorini B., 1990, PART OF SPEECH TAGGI; SmartThings, 2014, INTR PHYS GRAPH; Sutskever I., 2014, P 27 INT C NEUR INF, V3104, P3112, DOI DOI 10.1021/acs.analchem.7b05329; Sutton C, 2012, FOUND TRENDS MACH LE, V4, P267, DOI 10.1561/2200000013; Thompson CW, 2005, IEEE INTERNET COMPUT, V9, P75, DOI 10.1109/MIC.2005.135; Wallach H.M, 2004, MSCIS0421 U PENNS; Wang Y, 2003, GEN PURPOSE DISTRIBU; Yoon Y, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3012-9	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187955	10.1371/journal.pone.0187955	http://dx.doi.org/10.1371/journal.pone.0187955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149217	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100018
J	Candeo, LC; Rigonato-Oliveira, NC; Brito, AA; Marcos, RL; Franca, CM; Fernandes, KPS; Mesquita-Ferrari, RA; Bussadori, SK; Vieira, RP; Lino-dos-Santos-Franco, A; Ligeiro-Oliveira, AP; Horliana, ACRT				Candeo, Larissa Carbonera; Rigonato-Oliveira, Nicole Cristine; Brito, Aurileia Aparecida; Marcos, Rodrigo Labat; Franca, Cristiane Miranda; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil; Vieira, Rodolfo Paula; Lino-dos-Santos-Franco, Adriana; Ligeiro-Oliveira, Ana Paula; Ratto Tempestini Horliana, Anna Carolina			Effects of periodontitis on the development of asthma: The role of photodynamic therapy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; DIABETES-MELLITUS; METHYLENE-BLUE; ASSOCIATION; HEALTH; MODEL; INFECTIONS; MECHANISMS; RESISTANCE; REDUCTION	To evaluate whether periodontitis modulates lung inflammation in an experimental model of asthma as well as the photodynamic therapy (PDT) is associated with a reduction of lung inflammation. Seventy-two BALB/c male mice (similar to 2 months) were randomly divided into 8 groups (n = 9): Basal, Periodontitis (P), P+PT, P+PT+PDT, Asthma (A), A+P, A+P+PT, and A+P+PT+PDT. Periodontitis was induced by using the ligature technique and asthma was induced by ovalbumin (OVA). PT was performed with curettes and PDT with methylene blue (0.005%), lambda = 660nm, with a radiant exposure of 318J/cm(2). After 43 days, euthanasia was carried out prior to lung and mandible morphological analyzes. All of the manipulations of the animals were performed by only one operator. The total and differential cell counts and cytokines IL-4, IL-5, IL-10, IFN-gamma, TNF-alpha, IL-1 beta, and IL-6 were evaluated in the bronchoalveolar lavage (BAL) and in the serum. Mucus and alkaline phosphatase were also quantified. Statistical analyzes were performed by a blinded statistician. One-way analysis of variance (ANOVA) was employed, followed by the Student-Newman-Keuls test. Periodontitis group (P) increased alkaline phosphatase and bone resorption (p<0.05), validating the experimental model of periodontitis. The A group and the P group increased the total amount of cells (p<0.05) in the BAL. However, in the A+P group, there was a decrease in these cells, except for in the A+P+PT+PDT group (p< 0.05). The asthma group increased the Th2 cytokines and P group increased the Th1 cytokine profile, and A+P+PT+PDT group increased IL-10 cytokine. Mucus was increased for the A and P groups. In conclusion, periodontitis in the asthmatic mice reduced the inflammatory migrated cells in the BAL (eosinophils, lymphocytes, macrophages). In addition, it reduced the levels of the IL-4 and TNF-alpha cytokines, which was also accompanied by a decreased mucus production. After PDT treatment the total cell count increased however, this increase was not accompanied by a pro-inflammatory cytokines release. Only in PDT group the anti-inflammatory IL-10 was increased. Further studies are needed to understand this mechanism of action.	[Candeo, Larissa Carbonera; Rigonato-Oliveira, Nicole Cristine; Brito, Aurileia Aparecida; Marcos, Rodrigo Labat; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil; Lino-dos-Santos-Franco, Adriana; Ligeiro-Oliveira, Ana Paula; Ratto Tempestini Horliana, Anna Carolina] Univ Nove Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Franca, Cristiane Miranda] OHSU Sch Dent, Dept Restorat Dent, Div Biomat & Biomech, Portland, OR USA; [Mesquita-Ferrari, Raquel Agnelli; Bussadori, Sandra Kalil] Univ Nove Julho, UNINOVE, Post Grad Program Rehabil Sci, Sao Paulo, Brazil; [Vieira, Rodolfo Paula] Inst Brasileiro Ensino Pesquisa Imunol Pulm & Exer, Sao Jose Dos Campos, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho	Horliana, ACRT (corresponding author), Univ Nove Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil.	annacrth@gmail.com	Fernandes, Kristianne Porta Santos/I-4417-2016; Ferrari, Raquel/I-4419-2016; Franco, Adriana Lino dos Santos/AAA-7081-2019; Marcos, Rodrigo Labat/F-3524-2015; Lino-dos-Santos-Franco, Adriana/F-6336-2012; Bussadori, Sandra/J-5458-2014; Horliana, Anna Carolina Ratto Tempestini/J-3257-2015; Horliana, Anna/ABH-9640-2020; Franca, Cristiane/B-2563-2014; de Paula Vieira, Rodolfo/E-9315-2011	Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; Ferrari, Raquel/0000-0001-5142-9526; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; Marcos, Rodrigo Labat/0000-0002-9750-6491; Bussadori, Sandra/0000-0002-9853-1138; Horliana, Anna Carolina Ratto Tempestini/0000-0003-3476-9064; Franca, Cristiane/0000-0002-9285-4622; de Paula Vieira, Rodolfo/0000-0001-6379-1143; Brito, Aurileia/0000-0001-9683-4410; Ligeiro de Oliveira, Ana Paula/0000-0001-6089-5107	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2015/20535-1, 2012/16498-5, 2015/00830-9]; FAPESP [2015/23152-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP: Process Number #2015/20535-1 (Dr. Anna Carolina Ratto Tempestini Horliana), Process Number #2012/16498-5 (Dr. Ana Paula Ligeiro-Oliveira), Process Number #2015/00830-9 (Dr. Adriana Lino-dos-Santos-Franco) and a Grant from FAPESP # 2015/23152-6 (Nicole Cristine Rigonato-Oliveira- PhD student). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2013, J IMMUNOL METHODS, V394, P49, DOI 10.1016/j.jim.2013.05.002; Aimbire F, 2006, PHOTOMED LASER SURG, V24, P33, DOI 10.1089/pho.2006.24.33; Alvarenga LH, 2015, PHOTODIAGN PHOTODYN, V12, P131, DOI 10.1016/j.pdpdt.2014.10.002; Arbes SJ, 2011, J ALLERGY CLIN IMMUN, V127, P1119, DOI 10.1016/j.jaci.2011.03.023; Armitage GC, 2003, J PERIODONTOL, V74, P1237, DOI 10.1902/jop.2003.74.8.1237; Azarpazhooh A, 2006, J PERIODONTOL, V77, P1465, DOI 10.1902/jop.2006.060010; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Betsy J, 2014, J CLIN PERIODONTOL, V41, P573, DOI 10.1111/jcpe.12249; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Cai JL, 2007, DEV BIOL, V304, P499, DOI 10.1016/j.ydbio.2007.01.002; Card JW, 2010, INFECT IMMUN, V78, P2488, DOI 10.1128/IAI.01270-09; Carvalho VF, 2015, J CLIN PERIODONTOL, V42, P440, DOI 10.1111/jcpe.12393; Castro A, 2005, PLOS MED, V2, P1217, DOI 10.1371/journal.pmed.0020338; CHEN AC, 1995, SCAND J INFECT DIS, V27, P289, DOI 10.3109/00365549509019023; da Silva MD, 2015, MOL NEUROBIOL, V51, P19, DOI 10.1007/s12035-014-8790-x; dos Santos JD, 2017, MICROB PATHOGENESIS, V110, P507, DOI 10.1016/j.micpath.2017.07.045; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Evangelista EE, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0757-3; Friedrich N, 2006, CLIN EXP ALLERGY, V36, P495, DOI 10.1111/j.1365-2222.2006.02455.x; Gemmell E, 2004, PERIODONTOL 2000, V35, P21, DOI 10.1111/j.0906-6713.2004.003557.x; Gollnick SO, 2003, BRIT J CANCER, V88, P1772, DOI 10.1038/sj.bjc.6600864; Gomes-Filho IS, 2014, J PERIODONTOL, V85, pE82, DOI [10.1902/jop.2013.130369, 10.1902/jop.2013.130509]; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hujoel PP, 2008, J PERIODONTOL, V79, P1330, DOI [10.1902/jop.2008.070648, 10.1902/jop.2008.070648 ]; HYYPPA T, 1981, J CLIN PERIODONTOL, V8, P500, DOI 10.1111/j.1600-051X.1981.tb00899.x; Irwin C R, 1998, Oral Dis, V4, P43; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Kharkwal GB, 2011, LASER SURG MED, V43, P755, DOI 10.1002/lsm.21080; Kim JH, 2015, J PERIODONTOL, V86, P1005, DOI 10.1902/jop.2015.150083; Komerik N, 2003, ANTIMICROB AGENTS CH, V47, P932, DOI 10.1128/AAC.47.3.932-940.2003; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Kornman KS, 1997, J CLIN PERIODONTOL, V24, P72, DOI 10.1111/j.1600-051X.1997.tb01187.x; Kubota M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155594; Kunna R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0578-y; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lee SW, 2017, J PERIODONTOL, V88, P575, DOI 10.1902/jop.2017.160706; Lenander-Lumikari M, 1998, ARCH ORAL BIOL, V43, P151, DOI 10.1016/S0003-9969(97)00110-6; de Oliveira APL, 2007, AM J PHYSIOL-CELL PH, V293, pC1120, DOI 10.1152/ajpcell.00286.2006; de Oliveira APL, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-115; McDevitt MJ, 2000, J PERIODONTOL, V71, P156, DOI 10.1902/jop.2000.71.2.156; Mistry A, 2016, J LASERS MED SCI, V7, P250, DOI 10.15171/jlms.2016.44; NAKASHIMA K, 1994, J CLIN PERIODONTOL, V21, P327, DOI 10.1111/j.1600-051X.1994.tb00721.x; Nibali L, 2013, CURR PHARM DESIGN, V19, P2687, DOI 10.2174/1381612811319150003; Peron JP, 2015, PLOS ONE, V31; Prates RA, 2011, PHOTOMED LASER SURG, V29, P835, DOI 10.1089/pho.2010.2984; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Rai M, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/4/046009; Rams TE, 2014, J PERIODONTOL, V85, P160, DOI 10.1902/jop.2013.130142; Rivera R, 2016, J CLIN PERIODONTOL, V43, P566, DOI 10.1111/jcpe.12553; Rocha JA, 2016, AM J PHYSIOL-REG I, V310, pR697, DOI 10.1152/ajpregu.00328.2015; Sabino CP, 2016, J PHOTOCH PHOTOBIO B, V160, P72, DOI 10.1016/j.jphotobiol.2016.03.047; Santana CD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122042; Segarra-Vidal M, 2017, J CLIN PERIODONTOL, V44, P915, DOI 10.1111/jcpe.12768; Sperandio Felipe F, 2013, Recent Pat Antiinfect Drug Discov, V8, P108; Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081; Stensson M, 2010, CARIES RES, V44, P540, DOI 10.1159/000321566; Sullivan PW, 2018, J ASTHMA, V55, P659, DOI 10.1080/02770903.2017.1350972; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Tegos GP, 2006, ANTIMICROB AGENTS CH, V50, P196, DOI 10.1128/AAC.50.1.196-203.2006; Thomas MS, 2010, AUST DENT J, V55, P128, DOI 10.1111/j.1834-7819.2010.01226.x; Tillie-Leblond I, 2005, ALLERGY, V60, P23, DOI 10.1111/j.1398-9995.2005.00632.x; Umeda M, 2011, J INVESTIG CLIN DENT, V2, P268, DOI 10.1111/j.2041-1626.2011.00071.x; Vargas MH, 2015, J ASTHMA, V52, P376, DOI 10.3109/02770903.2014.974816; Vieira RP, 2014, INT J SPORTS MED, V35, P629, DOI 10.1055/s-0033-1358477; von Hertzen L, 2006, J ALLERGY CLIN IMMUN, V117, P334, DOI 10.1016/j.jaci.2005.11.013; Yaghobee S., 2008, Journal of Dentistry of Tehran University of Medical Sciences, V5, P47; Zeng XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046508	69	9	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187945	10.1371/journal.pone.0187945	http://dx.doi.org/10.1371/journal.pone.0187945			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145431	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800041
J	Chrabaszcz, JS; Tidwell, JW; Dougherty, MR				Chrabaszcz, Jeffrey S.; Tidwell, Joe W.; Dougherty, Michael R.			Crowdsourcing prior information to improve study design and data analysis	PLOS ONE			English	Article							AGGREGATION	Though Bayesian methods are being used more frequently, many still struggle with the best method for setting priors with novel measures or task environments. We propose a method for setting priors by eliciting continuous probability distributions from naive participants. This allows us to include any relevant information participants have for a given effect. Even when prior means are near-zero, this method provides a principle way to estimate dispersion and produce shrinkage, reducing the occurrence of overestimated effect sizes. We demonstrate this method with a number of published studies and compare the effect of different prior estimation and aggregation methods.	[Chrabaszcz, Jeffrey S.] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Tidwell, Joe W.; Dougherty, Michael R.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Carnegie Mellon University; University System of Maryland; University of Maryland College Park	Chrabaszcz, JS (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	jchrabas@andrew.cmu.edu	Chrabaszcz, Jeffrey/A-4460-2016	Chrabaszcz, Jeffrey/0000-0002-8434-9511; Dougherty, Michael/0000-0001-9547-1937				Alter AL, 2009, PSYCHOL SCI, V20, P1414, DOI 10.1111/j.1467-9280.2009.02461.x; Armstrong JS, 2001, PRINCIPLES FORECASTI, V30; Balcetis E, 2009, PSYCHOL SCI; Bauer MA, 2012, PSYCHOL SCI, V23, P517, DOI 10.1177/0956797611429579; Brooks LC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004382; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carpenter B., 2015, J STAT SOFTWARE; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Damisch L, 2010, PSYCHOL SCI, V21, P1014, DOI 10.1177/0956797610372631; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; Francis G, 2014, PSYCHON B REV, V21, P1180, DOI 10.3758/s13423-014-0601-x; Garcia SM, 2009, PSYCHOL SCI, V20, P871, DOI 10.1111/j.1467-9280.2009.02385.x; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Hart W, 2009, PSYCHOL SCI, V20, P238, DOI 10.1111/j.1467-9280.2009.02277.x; Hora SC, 2013, DECIS ANAL, V10, P279, DOI 10.1287/deca.2013.0282; Jose VRR, 2014, MANAGE SCI, V60, P463, DOI 10.1287/mnsc.2013.1781; LEE MD, 2010, J MATH PSYCHOL; Li XP, 2010, PSYCHOL SCI, V21, P1047, DOI 10.1177/0956797610376653; Stan Development Team, 2015, STAN C LIB PROB SAMP; Stan Development Team, 2017, PRIOR CHOIC REC; Team RC., 2013, R LANG ENV STAT COMP; Tidwell JW, 2015, DAFTHM PROBABILISTIC; Turner BM, 2014, MACH LEARN, V95, P261, DOI 10.1007/s10994-013-5401-4; Wallsten TS, 1997, J BEHAV DECIS MAKING, V10, P243, DOI 10.1002/(SICI)1099-0771(199709)10:3<243::AID-BDM268>3.0.CO;2-M	26	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188246	10.1371/journal.pone.0188246	http://dx.doi.org/10.1371/journal.pone.0188246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145511	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800099
J	Du Mont, J; Kosa, D; Macdonald, S; Benoit, A; Forte, T				Du Mont, Janice; Kosa, Daisy; Macdonald, Sheila; Benoit, Anita; Forte, Tonia			A comparison of Indigenous and non-Indigenous survivors of sexual assault and their receipt of and satisfaction with specialized health care services	PLOS ONE			English	Article							DOMESTIC VIOLENCE SERVICES; WOMEN; RAPE; OUTCOMES; VICTIMS; ABUSE	In Canada, Indigenous women are more likely than non-Indigenous women to be survivors of sexual assault and experience sexual assaults that are more serious in terms of physical injury and other health-related consequences. Despite their related needs for care and support, there is a paucity of research to date that has examined their uptake of specialized acute health services post sexual assault. To address this gap, we explored the presentation, sociodemographic, assailant, assault, and service use characteristics of Indigenous women, as compared to non-Indigenous adult and adolescent women aged 12 and older presenting to 30 of 35 hospital-based sexual assault treatment centres in Ontario from 2009 to 2011, using bivariate analyses. Of the 948 women in our sample, 116 (12%) identified as being Indigenous. Indigenous survivors differed significantly from non-Indigenous survivors on many presentation, sociodemographic, and assault characteristics. For example, they were more likely to present to a hospital within 24 hours of being assaulted and a treatment centre serving a primarily rural population. They tended to be younger, were more likely to be living in an institutional setting, report community or group affiliations and government or community services as sources of social support, and be assaulted by a parent, guardian, or other relative. In terms of receipt of services, they were more likely to have undergone safety planning and to be referred to child protection or community agencies. They reported high levels of satisfaction with the services received, however, were less likely than non-Indigenous survivors to rate the overall care provided as excellent or good. On the whole, the results of our study suggest that Indigenous women value acute hospital-based sexual assault services. However, they experience sexual assaults in contexts different from non-Indigenous survivors. It is important for health care providers to be attuned to this so that they can appropriately respond to their unique needs.	[Du Mont, Janice; Kosa, Daisy; Benoit, Anita; Forte, Tonia] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Du Mont, Janice] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kosa, Daisy; Macdonald, Sheila] Ontario Network Sexual Assault Domest Violence Tre, Toronto, ON, Canada; [Benoit, Anita] Univ Toronto, Waakebiness Bryce Inst Indigenous Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto	Du Mont, J (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.; Du Mont, J (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	janice.dumont@wchospital.ca		Kosa, Sarah Daisy/0000-0002-0887-8884	Atkinson Foundation; Ministry of Community Safety and Correctional Services, Government of Ontario	Atkinson Foundation; Ministry of Community Safety and Correctional Services, Government of Ontario	Janice Du Mont is supported in part by the Atkinson Foundation (http://atkinsonfoundation.ca/). This research was funded in part by the Ministry of Community Safety and Correctional Services, Government of Ontario, for whom a report was prepared. The views expressed in the publication are the views of the authors and do not necessarily reflect those of the Ministry of Community Safety and Correctional Services, Government of Ontario (http://www.mcscs.jus.gov.on.ca/english/default.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alempijevic Djordje, 2007, J Forensic Leg Med, V14, P266, DOI 10.1016/j.jcfm.2006.08.008; Amnesty International, 2007, MAZ INJ FAIL PROT IN; Amnesty International, 2004, STOL SIST HUM RIGHT; Amnesty International Canada, 2014, VIOL IND WOM GIRLS C; [Anonymous], 2007, USES IMPACTS MED LEG; Arriagada Paula, 2016, STAT CANADA, V15, P51; Bachman R., 2008, VIOLENCE AM INDIAN A; Bachman R, 2010, AUST NZ J CRIMINOL, V43, P199, DOI 10.1375/acri.43.2.199; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Bletzer KV, 2006, VIOLENCE AGAINST WOM, V12, P5, DOI 10.1177/1077801205277352; Bubar Roe., 2004, SOCIAL JUSTICE, V31, P70; Campbell R, 2005, TRAUMA VIOLENCE ABUS, V6, P313, DOI 10.1177/1524838005280328; Canadian Institutes of Health Research, 2007, CIHR GUID HLTH RES I; Collin-Vezina D., 2009, Pimatisiwin - A Journal of Aboriginal and Indigenous Community Health, V7, P27; Cox LH, 2010, J PRIV CONFID, V1, P8; Du Mont J., 2002, OVERVIEW SEXUAL ASSA; Du Mont J, 2014, J FORENSIC NURS, V10, P122, DOI 10.1097/JFN.0000000000000035; Du Mont J, 2013, J FORENSIC NURS, V9, P129, DOI 10.1097/JFN.0b013e31829e9608; Du Mont Janice, 2011, Open AIDS J, V5, P102, DOI 10.2174/1874613601105010102; Du Mont J, 2009, SOC SCI MED, V68, P774, DOI 10.1016/j.socscimed.2008.11.010; Dylan A, 2008, VIOLENCE AGAINST WOM, V14, P678, DOI 10.1177/1077801208317291; Eckert LO, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.021; Figueiredo Filho Dalson Britto, 2013, Bras. political sci. rev., V7, P31; Garcia-Moreno C, 2015, LANCET, V385, P1567, DOI 10.1016/S0140-6736(14)61837-7; Hamby S, 2008, J PREV INTERV COMMUN, V36, P89, DOI 10.1080/10852350802022340; Herrenkohl TI, 2008, TRAUMA VIOLENCE ABUS, V9, P84, DOI 10.1177/1524838008314797; Hylton JH, 2006, ABORIGINAL SEXUAL OF; International Association of Forensic Nurses, 2017, SANE PROGR LIST; Johnson H, 2013, FACT SHEET VIOLENCE; Kilpatrick D.G., 2007, DRUG FACILITATED INC; Kingsley C, 2010, SACRED LIVES; Lovett J, 2004, HOME OFFICE RES STUD, V285; Mazor KM, 2002, HEALTH SERV RES, V37, P1403, DOI 10.1111/1475-6773.11194; McFarlane J, 2005, OBSTET GYNECOL, V105, P99, DOI 10.1097/01.AOG.0000146641.98665.b6; McLean IA, 2004, MED SCI LAW, V44, P165, DOI 10.1258/rsmmsl.44.2.165; Native Child and Family Services of Toronto, 2011, COMM WE SERV; O'Donnell V., 2011, 1 NATIONS METIS INUI; Ontario Association of Children's Aid Societies, 2015, DUT TO REP; Ontario Federation of Indigenous Friendship Centres, 2016, OFIFIC RES; Ontario Network of Sexual Assault and Domestic Violence Treatment Centres, 2012, STAND CAR; Paterson M, 2016, SERVICE USE INDIGENO; Paterson M, 2016, PROFILE INDIGENOUS S; Perrault S., 2016, CRIMINAL VICTIMIZATI; Proquest Nursing and Allied Health Source, 2003, J PSYCHOSOC NURS MEN, V41, P10; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Royal Commission on Aboriginal Peoples, 1996, LOOK FORW LOOK BACK, V1; Rusnak D., 2010, RTM INSIGHTS, P1; Scrim K., 2010, ABORIGINAL VICTIMIZA; Sinha M., 2013, MEASURING VIOLENCE W; Spotton N., 2006, PROFILE ABORIGINAL P; Statistics Canada, 2006, FAM VIOL CAN STAT PR; Stermac Lana, 2005, J Forensic Nurs, V1, P124; Sternberg KJ, 2006, DEV REV, V26, P89, DOI 10.1016/j.dr.2005.12.001; Stott Tim, 2015, TRUTH REC COMM CAN C, V3; Wahab Stephanie, 2004, Trauma Violence Abuse, V5, P353, DOI 10.1177/1524838004269489; Wilson K, 2011, SOC SCI MED, V72, P355, DOI 10.1016/j.socscimed.2010.09.022; Yuan NP, 2015, PSYCHOL VIOLENCE, V5, P367, DOI 10.1037/a0038507	57	9	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188253	10.1371/journal.pone.0188253	http://dx.doi.org/10.1371/journal.pone.0188253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145501	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800100
J	Fuller, TL; Calvet, G; Estevam, CG; Angelo, JR; Abiodun, GJ; Halai, UA; De Santis, B; Sequeira, PC; Araujo, EM; Sampaio, SA; de Mendonca, MCL; Fabri, A; Ribeiro, RM; Harrigan, R; Smith, TB; Gabaglia, CR; Brasil, P; de Filippis, AMB; Nielsen-Saines, K				Fuller, Trevon L.; Calvet, Guilherme; Estevam, Camila Genaro; Angelo, Jussara Rafael; Abiodun, Gbenga J.; Halai, Umme-Aiman; De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Harrigan, Ryan; Smith, Thomas B.; Gabaglia, Claudia Raja; Brasil, Patricia; Bispo de Filippis, Ana Maria; Nielsen-Saines, Karin			Behavioral, climatic, and environmental risk factors for Zika and Chikungunya virus infections in Rio de Janeiro, Brazil, 2015-16	PLOS ONE			English	Article							GLOBAL BURDEN; DENGUE; TRANSMISSION; OUTBREAK; DISEASES; STATES	The burden of arboviruses in the Americas is high and may result in long-term sequelae with infants disabled by Zika virus infection (ZIKV) and arthritis caused by infection with Chikungunya virus (CHIKV). We aimed to identify environmental drivers of arbovirus epidemics to predict where the next epidemics will occur and prioritize municipalities for vector control and eventual vaccination. We screened sera and urine samples (n = 10,459) from residents of 48 municipalities in the state of Rio de Janeiro for CHIKV, dengue virus (DENV), and ZIKV by molecular PCR diagnostics. Further, we assessed the spatial pattern of arbovirus incidence at the municipal and neighborhood scales and the timing of epidemics and major rainfall events. Lab-confirmed cases included 1,717 infections with ZIKV (43.8%) and 2,170 with CHIKV (55.4%) and only 29 (< 1%) with DENV. ZIKV incidence was greater in neighbor-hoods with little access to municipal water infrastructure (r = -0.47, p = 1.2x10(-8)). CHIKV incidence was weakly correlated with urbanization (r = 0.2, p = 0.02). Rains began in October 2015 and were followed one month later by the largest wave of ZIKV epidemic. ZIKV cases markedly declined in February 2016, which coincided with the start of a CHIKV outbreak. Rainfall predicted ZIKV and CHIKV with a lead time of 3 weeks each time. The association between rainfall and epidemics reflects vector ecology as the larval stages of Aedes aegypti require pools of water to develop. The temporal dynamics of ZIKV and CHIKV may be explained by the shorter incubation period of the viruses in the mosquito vector; 2 days for CHIKV versus 10 days for ZIKV.	[Fuller, Trevon L.; Harrigan, Ryan; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA; [Calvet, Guilherme; Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil; [Estevam, Camila Genaro] Univ Estadual Sao Paulo, Rio Claro, SP, Brazil; [Angelo, Jussara Rafael] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Abiodun, Gbenga J.] Fdn Profess Dev, Pretoria, Gauteng, South Africa; [Halai, Umme-Aiman; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Los Angeles, CA USA; [De Santis, Bianca; Sequeira, Patricia Carvalho; Araujo, Eliane Machado; Sampaio, Simone Alves; Lima de Mendonca, Marco Cesar; Fabri, Allison; Ribeiro, Rita Maria; Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Referencia Flavivirus, Rio De Janeiro, Brazil; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gabaglia, Claudia Raja] Cty Biomed Res Inst Southern Calif, Oceanside, CA USA; [Halai, Umme-Aiman] Cty Los Angeles Dept Publ Hlth, Los Angeles, CA USA	University of California System; University of California Los Angeles; Fundacao Oswaldo Cruz; Universidade Estadual Paulista; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; Los Angeles County Department of Public Health	Fuller, TL (corresponding author), Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA 90095 USA.	fullertl@ucla.edu	Brasil, Patricia/P-3536-2014; Sequeira, Patricia/AAK-3739-2021; Calvet, GA/G-6959-2013; Fuller, Trevon/B-8087-2014	Calvet, GA/0000-0002-3545-5238; Fuller, Trevon/0000-0001-9954-4267; Genaro Estevam, Camila/0000-0001-6971-9580; Abiodun, Gbenga/0000-0002-6805-2128; Brasil, Patricia/0000-0001-9555-7976	European Union's Horizon research and innovation program (Zika action) [734857]; European Union's Horizon research and innovation program (Zika plan) [734584]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-18/2015TXB]; National Council for Scientific and Technological Development of Brazil; Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health; National Science Foundation [1243524, AI28697, 1R21AI129534-01, D43TW009343]; University of California Global Health Institute; Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI129534] Funding Source: NIH RePORTER	European Union's Horizon research and innovation program (Zika action); European Union's Horizon research and innovation program (Zika plan); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Council for Scientific and Technological Development of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health; National Science Foundation(National Science Foundation (NSF)); University of California Global Health Institute; Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by: the European Union's Horizon 2020 research and innovation program (Zika action grant agreement no. 734857 and Zika plan grant agreement no. 734584), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro grant no. E-18/2015TXB, National Council for Scientific and Technological Development of Brazil, Oswaldo Cruz Foundation/General Coordination of Public Health Laboratories/Ministry of Health, National Science Foundation grant number 1243524, a University of California Global Health Institute grant, National Institutes of Health grants AI28697, 1R21AI129534-01, and D43TW009343, and by the Pan American Health Organization Small Grants Programme for Research on the Zika Virus Outbreak in the Americas.	de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016; Battiston D, 2013, SOC INDIC RES, V112, P291, DOI 10.1007/s11205-013-0249-3; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; City Health Department of Rio de Janeiro, 2015, CAS CHIK MONTH SYMPT; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; de Lima-Camara TN, 2017, CABI CLIM CHANGE SER, P127, DOI 10.1079/9781780645377.0127; de Oliveira AF, 2015, CIENC SAUDE COLETIVA, V20, P1027, DOI 10.1590/1413-81232015204.00372014; dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064; Flauzino RF, 2011, SAUDE SOC-SAO PAULO, V20, P225, DOI 10.1590/S0104-12902011000100023; Flauzino Regina Fernandes, 2009, Rev. Saúde Pública, V43, P1035, DOI 10.1590/S0034-89102009005000064; Flauzino RF, 2009, REV PANAM SALUD PUBL, V25, P456, DOI 10.1590/S1020-49892009000500012; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; INMET, 2017, BANC DAD MET GIC ENS; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747, DOI 10.1056/NEJMra993360; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203; LaBeaud AD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000247; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004; Ministerio da Saude, 2013, LEV RAPIND AED AEG L; Ministerio da Saude, 2017, MON INT ALT CRESC DE; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X; Rodriguez-Morales AJ, 2017, RHEUMATOL INT, V37, P1757, DOI 10.1007/s00296-017-3795-1; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588; Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65; van Genderen FT, 2016, PLOS NEGLECT TROP D, V10, P18; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358; Vincenti-Gonzalez MF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005317; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006; Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211; Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921; *WHO, 2016, ZIK STRAT RESP PLAN, DOI DOI 10.1128/CMR.00072-15; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	51	36	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188002	10.1371/journal.pone.0188002	http://dx.doi.org/10.1371/journal.pone.0188002			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145452	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800048
J	Herzlinger, G; Wynn, T; Goren-Inbar, N				Herzlinger, Gadi; Wynn, Thomas; Goren-Inbar, Naama			Expert cognition in the production sequence of Acheulian cleavers at Gesher Benot Ya'aqov, Israel: A lithic and cognitive analysis	PLOS ONE			English	Article							WORKING-MEMORY; TECHNOLOGY; EVOLUTION; MIND	Stone cleavers are one of the most distinctive components of the Acheulian toolkit. These tools were produced as part of a long and complex reduction sequence and they provide indications for planning and remarkable knapping skill. These aspects hold implications regarding the cognitive complexity and abilities of their makers and users. In this study we have analyzed a cleaver assemblage originating from the Acheulian site of Gesher Benot Ya'aqov, Israel, to provide a reconstruction of the chaine operatoire which structured their production. This reduction sequence was taken as the basis for a cognitive analysis which allowed us to draw conclusion regarding numerous behavioral and cognitive aspects of the GBY hominins. The results indicate that the cleavers production incorporated a highly specific sequence of decisions and actions which resulted in three distinct modes of cleavers modification. Furthermore, the decision to produce a cleaver must have been taken very early in the sequence, thus differentiating its production from that of handaxes. The substantial predetermination and the specific reduction sequence provide evidence that the Gesher Benot Ya'aqov hominins had a number of cognitive categories such as a general 'tool concept' and a more specific 'cleaver concept', setting them apart from earlier tool-producing hominins and extant tool-using non-human primates. Furthermore, it appears that the Gesher Benot Ya'aqov lithic technology was governed by expert cognition, which is the kind of thinking typical of modern human experts in their various domains. Thus, the results provide direct indications that important components of modern cognition have been well established in the minds of the Gesher Benot Ya` aqov hominins.	[Herzlinger, Gadi; Goren-Inbar, Naama] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Herzlinger, Gadi] Hebrew Univ Jerusalem, Jack Joseph & Morton Mandel Sch Adv Studies Humani, Jerusalem, Israel; [Wynn, Thomas] Univ Colorado, Dept Anthropol, Colorado Springs, CO 80907 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Colorado System; University of Colorado at Colorado Springs	Herzlinger, G (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.; Herzlinger, G (corresponding author), Hebrew Univ Jerusalem, Jack Joseph & Morton Mandel Sch Adv Studies Humani, Jerusalem, Israel.	gadi.herzlinger@mail.huji.ac.il	Herzlinger, Gadi/AAZ-6584-2021	Herzlinger, Gadi/0000-0002-6437-607X	Israel Science Foundation [27/12]; ISF [27/12]	Israel Science Foundation(Israel Science Foundation); ISF(Israel Science Foundation)	The study was funded by the Israel Science Foundation grant number 27/12 awarded to Naama Goren-Inbar This study was generously funded by ISF grant no. 27/12 given to NG-I. The authors thank Noa Lichtinger for the production of Figs 1 and 2 and the Computerized Archaeology Laboratory at the Hebrew University for their assistance in scanning the artifacts and the processing of the digital models. We want to thank Ceri Shipton and an anonymous reviewer for their valuable and helpful comments.	Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Botha R, 2008, LANG COMMUN, V28, P197, DOI 10.1016/j.langcom.2007.05.002; Cole JM, 2017, ROUTLEDGE RES TAIWAN, P157; Coolidge F. L., 2009, RISE HOMOSAPIENS EVO, P301; deBono H., 2001, MITEKUFAT HAEVEN, V31, P9; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Ericsson KA, 1999, MODELS WORKING MEMOR, P257, DOI DOI 10.1017/CBO9781139174909.011; Gibson K.R., 1990, P97, DOI 10.1017/CBO9780511665486.005; Gobet F, 1998, COGNITION, V66, P115, DOI 10.1016/S0010-0277(98)00020-1; Gobet F, 2000, COGNITIVE SCI, V24, P651, DOI 10.1207/s15516709cog2404_4; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goren Inbar N, ACHEULIAN SITE GESHE; Goren-Inbar N, 2011, J ARCHAEOL SCI, V38, P1901, DOI 10.1016/j.jas.2011.03.037; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; GorenInbar N, 1996, J FIELD ARCHAEOL, V23, P15, DOI 10.1179/009346996791974007; Gowlett J.A.J., 2006, AXE AGE ACHEULIAN TO, P203; Hecht EE, 2015, BRAIN STRUCT FUNCT, V220, P2315, DOI 10.1007/s00429-014-0789-6; Hecht EE, 2015, NEUROIMAGE, V108, P124, DOI 10.1016/j.neuroimage.2014.12.039; Keller C.M., 1996, COGNITION TOOL USE B; Madsen B., 2004, EURASIAN PREHISTORY, V2, P3; Marder O., 2006, AXE AGE ACHEULIAN TO, P223; Matskevich Z., 2001, VERY REMOTE PERIOD I, P120; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mourre V, 2003, THESIS, V10; Orban G. A., 2014, FRONTIERS PSYCHOL, V5; Orban GA, 2006, NEUROPSYCHOLOGIA, V44, P2647, DOI 10.1016/j.neuropsychologia.2005.11.001; Sharon G., 2007, INT SERIES; Shipton C, 2010, CAMB ARCHAEOL J, V20, P197, DOI 10.1017/S0959774310000235; Stout D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121804; Stout D, 2014, J ARCHAEOL SCI, V41, P576, DOI 10.1016/j.jas.2013.10.001; Stout D, 2011, EUR J NEUROSCI, V33, P1328, DOI 10.1111/j.1460-9568.2011.07619.x; Tixier J., 1957, CONGRES PREHISTORIQU, P914; Wynn T, 2004, J HUM EVOL, V46, P467, DOI 10.1016/j.jhevol.2004.01.005; Wynn T., SQUEEZING MINDS STON; Wynn T, 2014, PRAGMAT COGN, V22, P45, DOI 10.1075/pc.22.1.03wyn; Wynn T, 2011, EVOL ANTHROPOL, V20, P181, DOI 10.1002/evan.20323; Wynn T, 2010, STONE TOOLS AND THE EVOLUTION OF HUMAN COGNITION, P83; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106	39	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188337	10.1371/journal.pone.0188337	http://dx.doi.org/10.1371/journal.pone.0188337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145489	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800114
J	Koesema, E; Kodadek, T				Koesema, Eric; Kodadek, Thomas			Global analysis of gene expression mediated by OX1 orexin receptor signaling in a hypothalamic cell line	PLOS ONE			English	Article							H295R ADRENOCORTICAL-CELLS; EPITHELIAL NA+ CHANNEL; SYNAPTIC PLASTICITY; HYPOCRETIN NEURONS; SLEEP-DEPRIVATION; REGULATED KINASE; RESPONSE ELEMENT; PHOSPHOLIPASE-C; ADIPOSE-TISSUE; CA2+ INFLUX	The orexins and their cognate G-protein coupled receptors have been widely studied due to their associations with various behaviors and cellular processes. However, the detailed downstream signaling cascades that mediate these effects are not completely understood. We report the generation of a neuronal model cell line that stably expresses the OX1 orexin receptor (OX1) and an RNA-Seq analysis of changes in gene expression seen upon receptor activation. Upon treatment with orexin, several families of related transcription factors are transcriptionally regulated, including the early growth response genes (Egr), the Kruppel- like factors (Klf), and the Nr4a subgroup of nuclear hormone receptors. Furthermore, some of the transcriptional effects observed have also been seen in data from in vivo sleep deprivation microarray studies, supporting the physiological relevance of the data set. Additionally, inhibition of one of the most highly regulated genes, serum and glucocorticoid-regulated kinase 1 (Sgk1), resulted in the diminished orexin-dependent induction of a subset of genes. These results provide new insight into the molecular signaling events that occur during OX1 signaling and support a role for orexin signaling in the stimulation of wakefulness during sleep deprivation studies.	[Koesema, Eric; Kodadek, Thomas] Scripps Florida, Dept Chem, Scripps Res Inst, Jupiter, FL 33458 USA	Scripps Research Institute; State University System of Florida; University of Florida	Kodadek, T (corresponding author), Scripps Florida, Dept Chem, Scripps Res Inst, Jupiter, FL 33458 USA.	kodadek@scripps.edu		Kodadek, Thomas/0000-0003-1930-4795; Koesema, Eric/0000-0002-7743-0127				Allard JS, 2007, NEUROPEPTIDES, V41, P329, DOI 10.1016/j.npep.2007.04.006; Amato R, 2013, ONCOGENE, V32, P4572, DOI 10.1038/onc.2012.470; Ammoun S, 2006, J BIOL CHEM, V281, P834, DOI 10.1074/jbc.M508603200; Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; ANDERS S, 2010, GENOME BIOL, V11; Appelbaum L, 2009, P NATL ACAD SCI USA, V106, P21942, DOI 10.1073/pnas.906637106; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Bridi MS, 2013, NEUROBIOL LEARN MEM, V105, P151, DOI 10.1016/j.nlm.2013.06.020; Broberger C, 1998, J COMP NEUROL, V402, P460; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Chang XC, 2015, MOL MED REP, V12, P7582, DOI 10.3892/mmr.2015.4381; Chen J, 2015, CELL SIGNAL, V27, P1426, DOI 10.1016/j.cellsig.2015.03.027; Cheng MC, 2015, BRAIN RES, V1629, P126, DOI 10.1016/j.brainres.2015.10.021; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; dela Pena I, 2013, PSYCHOPHARMACOLOGY, V230, P399, DOI 10.1007/s00213-013-3168-8; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; Digby JE, 2006, J ENDOCRINOL, V191, P129, DOI 10.1677/joe.1.06886; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ekholm ME, 2007, BIOCHEM BIOPH RES CO, V353, P475, DOI 10.1016/j.bbrc.2006.12.045; Elbaz I, 2012, J NEUROSCI, V32, P12961, DOI 10.1523/JNEUROSCI.1284-12.2012; Esmaeili-Mahani S, 2013, NEUROCHEM INT, V63, P719, DOI 10.1016/j.neuint.2013.09.022; Feng Y, 2014, NEUROSCI LETT, V579, P35, DOI 10.1016/j.neulet.2014.07.014; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Guarnieri DJ, 2012, BIOL PSYCHIAT, V71, P358, DOI 10.1016/j.biopsych.2011.06.028; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hamuro J, 2011, BIOCHEM BIOPH RES CO, V408, P293, DOI 10.1016/j.bbrc.2011.04.020; Harris DM, 2002, PANCREAS, V25, P405, DOI 10.1097/00006676-200211000-00014; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harris GC, 2007, BEHAV BRAIN RES, V183, P43, DOI 10.1016/j.bbr.2007.05.025; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Heller EA, 2015, J NEUROCHEM, V132, P243, DOI 10.1111/jnc.12925; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Hollander JA, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00047; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; Holmqvist T, 2002, FEBS LETT, V526, P11, DOI 10.1016/S0014-5793(02)03101-0; Honda H, 2006, J BIOL CHEM, V281, P21433, DOI 10.1074/jbc.M603767200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082563; Jaeger LB, 2002, PEPTIDES, V23, P1683, DOI 10.1016/S0196-9781(02)00110-9; Jantti MH, 2012, BRIT J PHARMACOL, V165, P1109, DOI 10.1111/j.1476-5381.2011.01565.x; Johansson L, 2007, BRIT J PHARMACOL, V150, P97, DOI 10.1038/sj.bjp.0706959; Johnson LA, 2014, NEUROBIOL DIS, V64, P150, DOI 10.1016/j.nbd.2013.12.016; Karteris E, 2005, AM J PHYSIOL-ENDOC M, V288, pE1089, DOI 10.1152/ajpendo.00351.2004; Karteris E, 2001, J CLIN ENDOCR METAB, V86, P4512, DOI 10.1210/jc.86.9.4512; Korotkova TM, 2003, J NEUROSCI, V23, P7; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Kukkonen JP, 2016, CELL SIGNAL, V28, P51, DOI 10.1016/j.cellsig.2015.11.009; Kukkonen JP, 2014, BIOCHIMIE, V96, P158, DOI 10.1016/j.biochi.2013.06.015; Lang F, 2016, NEPHROL DIAL TRANSPL, V31, P200, DOI 10.1093/ndt/gfv270; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Galvao MDL, 2009, PSYCHONEUROENDOCRINO, V34, P1176, DOI 10.1016/j.psyneuen.2009.03.003; Larsson KP, 2003, BIOCHEM BIOPH RES CO, V309, P209, DOI 10.1016/S0006-291X(03)01563-8; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Leonard CS, 2014, BRIT J PHARMACOL, V171, P294, DOI 10.1111/bph.12296; Li JY, 2005, J NEUROENDOCRINOL, V17, P394, DOI 10.1111/j.1365-2826.2005.01317.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Malendowicz LK, 1999, J STEROID BIOCHEM, V70, P185, DOI 10.1016/S0960-0760(99)00110-7; Mehta R, 2015, NEUROSCI LETT, V590, P62, DOI 10.1016/j.neulet.2015.01.067; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mieda M, 2011, J NEUROSCI, V31, P6518, DOI 10.1523/JNEUROSCI.6506-10.2011; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Minatohara K, 2016, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00078; Miranda P, 2013, J NEUROSCI, V33, P2684, DOI 10.1523/JNEUROSCI.3442-12.2013; Mulder M, 2007, NEUROSCI RES, V59, P251, DOI 10.1016/j.neures.2007.07.004; Muschamp JW, 2014, P NATL ACAD SCI USA, V111, pE1648, DOI 10.1073/pnas.1315542111; Nanmoku T, 2002, REGUL PEPTIDES, V104, P125, DOI 10.1016/S0167-0115(01)00356-1; Nanmoku T, 2000, BIOCHEM BIOPH RES CO, V274, P310, DOI 10.1006/bbrc.2000.3137; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Noda S, 2013, MOL NUTR FOOD RES, V57, P2019, DOI 10.1002/mnfr.201300045; Nonogaki K, 2006, BIOCHEM BIOPH RES CO, V344, P696, DOI 10.1016/j.bbrc.2006.03.196; Putula J, 2011, NEUROSCI LETT, V494, P57, DOI 10.1016/j.neulet.2011.02.055; Ramanjaneya M, 2008, ENDOCRINOLOGY, V149, P4106, DOI 10.1210/en.2007-1739; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; RISHI AK, 1995, CANCER RES, V55, P4999; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Saint-Preux F, 2013, NEUROSCIENCE, V243, P89, DOI 10.1016/j.neuroscience.2013.03.052; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Segal JP, 2005, J NEUROSCI, V25, P4181, DOI 10.1523/JNEUROSCI.0158-05.2005; Selbach O, 2004, NEUROSCIENCE, V127, P519, DOI 10.1016/j.neuroscience.2004.05.012; Selbach O, 2010, ACTA PHYSIOL, V198, P277, DOI 10.1111/j.1748-1716.2009.02021.x; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; Tang JY, 2008, CELL SIGNAL, V20, P1651, DOI 10.1016/j.cellsig.2008.05.010; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Turunen PM, 2012, MOL PHARMACOL, V82, P156, DOI 10.1124/mol.112.078063; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Wang CM, 2014, BBA-MOL CELL RES, V1843, P652, DOI 10.1016/j.bbamcr.2013.12.010; Wang HF, 2010, PHYSIOL GENOMICS, V42, P427, DOI 10.1152/physiolgenomics.00205.2009; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; Wesch D, 2010, AM J PHYSIOL-CELL PH, V299, pC779, DOI 10.1152/ajpcell.00184.2010; Wieland HA, 2002, EUR J BIOCHEM, V269, P1128, DOI 10.1046/j.0014-2956.2001.02739.x; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Xu A, 2010, J PHARMACOL SCI, V114, P444, DOI 10.1254/jphs.10177FP; Yokogawa T, 2007, PLOS BIOL, V5, P2379, DOI 10.1371/journal.pbio.0050277; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	109	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188082	10.1371/journal.pone.0188082	http://dx.doi.org/10.1371/journal.pone.0188082			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145494	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800062
J	Cao, Y; Ye, Q; Zhuang, MF; Xie, SW; Zhong, RH; Cui, JG; Zhou, JY; Zhu, Y; Zhang, TT; Cao, L				Cao, Yang; Ye, Qing; Zhuang, Mengfei; Xie, Shuwu; Zhong, Ruihua; Cui, Jingang; Zhou, Jieyun; Zhu, Yan; Zhang, Tingting; Cao, Lin			Ginsenoside Rg3 inhibits angiogenesis in a rat model of endometriosis through the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; EXPRESSION; STRATEGIES; RAPAMYCIN; TARGET; CELLS; AKT	Objective This study aimed to investigate the link between the inhibitory effect of ginsenoside Rg3 on the ectopic endometrium growth and the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, a mechanism known to inhibit angiogenesis and induce ectopic endometrial cell apoptosis. Materials and methods A model of endometriosis was established by allotransplantation in rats. The rats were randomly divided into 5 groups: the ginsenoside Rg3 low-dose group (group A,5mg/kgBW/d of ginsenoside Rg3), the ginsenoside Rg3 high-dose group (group B, 10mg/kgBW/d of ginsenoside Rg3), the gestrinone group (group C, 0.5mg/kgBW/d of gestrinone), the control group (groupD, 10ml/kg BW/d of 0.5% CMC-Na) and the ovariectomized group (group E, 10ml/kgBW/d of 0.5% CMC-Na). Rats were executed after 21 days of continuous administration. The ectopic endometrium volume was measured and the inhibitory rate was calculated. The levels of serum estradiol (E-2) and progesterone (P) were detected by Electro-Chemiluminescence Immunoassay (ECLI). The protein expression of VEGF, VEGFR-2, pAkt, and p-mTOR inthe ectopic endometrium wastested by immunohistochemistry(IHC) and Western Blotting. The mRNA expression levels of VEGF, VEGFR-2, Akt, and mTOR were tested by Real-Time Polymerase Chain Reaction (PCR). The apoptosis rate of the ectopic endometrial cells was detected by Terminal Deoxynucleotidyl Transferase-mediated Digoxigenin-dUTP Nick-End Labeling Assay(TUNEL). Main results Tissue measurements revealed a dose-dependent inhibition effect of ginsenoside Rg3 on the growth of the ectopic endometrium in treated rats compared to controls. Immunohistochemical and Western Blotting assays confirmed that the expression of VEGF, p-Akt, and p-mTOR was down-regulated in ginsenoside Rg3 -treated lesions. Real-time PCR results also showed that the mRNA expression levels of VEGF, Akt, and mTOR in the ectopic endometrium were reduced. Conclusions The present study demonstrates, for the first time, that ginsenoside Rg3 suppresses angiogenesis in developing endometrial lesions. The ginsenoside Rg3 inhibitory effect on the growth of the ectopic endometrium in EMs rats might occur through the blocking of the VEGFR-2-mediated PI3K/Akt/mTOR signaling pathway, thus halting angiogenesis and promoting the apoptosis of ectopic endometrial cells.	[Cao, Yang; Zhuang, Mengfei; Zhang, Tingting] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Gynecol, Shanghai, Peoples R China; [Ye, Qing] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Neurol, Shanghai, Peoples R China; [Xie, Shuwu; Zhong, Ruihua; Zhou, Jieyun; Zhu, Yan; Cao, Lin] Shanghai Inst Planned Parenthood Res, Dept Reprod Pharmacol, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China; [Cui, Jingang] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Zhang, TT (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Gynecol, Shanghai, Peoples R China.; Zhu, Y (corresponding author), Shanghai Inst Planned Parenthood Res, Dept Reprod Pharmacol, NPFPC Key Lab Contracept & Devices, Shanghai, Peoples R China.	zhuyan0311@163.com; tingting185@aliyun.com	庄, 梦斐/GWV-0486-2022	zhang, tingting/0000-0002-1919-1471	National Natural Science Foundation of China [81302996]; Shanghai Municipal population and Family Planning commission [ZY3-CCCX-3-3019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal population and Family Planning commission	This project was supported by the National Natural Science Foundation of China (No. 81302996) and Shanghai Municipal population and Family Planning commission (No.ZY3-CCCX-3-3019). The funders provide only financial aid, and there was no individuals employed or contracted by the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang KK, 2013, INT J CLIN EXP PATHO, V6, P2030; Chen SH, 2011, CHINESE MED FRONTIER, V6, P26; Djokovic D, 2014, ACTA MEDICA PORT, V27, P489, DOI 10.20344/amp.5244; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Guo SW, 2009, HUM REPROD UPDATE, V15, P441, DOI 10.1093/humupd/dmp007; Hull ML, 2003, J CLIN ENDOCR METAB, V88, P2889, DOI 10.1210/jc.2002-021912; Jie H, 2011, CHIN J NEW DRUGS, V20, P2415; JONES RC, 1984, ACTA ENDOCRINOL-COP, V106, P282, DOI 10.1530/acta.0.1060282; Kang ZC, 2013, BASIC CLIN PHARMACOL, V113, P221, DOI 10.1111/bcpt.12094; Kim JW, 2012, CANCER BIOL THER, V13, P504, DOI 10.4161/cbt.19599; Kodaman PH, 2015, OBSTET GYN CLIN N AM, V42, P87, DOI 10.1016/j.ogc.2014.10.005; Laschke MW, 2012, HUM REPROD UPDATE, V18, P682, DOI 10.1093/humupd/dms026; Leconte M, 2011, AM J PATHOL, V179, P880, DOI 10.1016/j.ajpath.2011.04.020; Liu JX, 2014, MAR DRUGS, V12, P2790, DOI 10.3390/md12052790; Liu SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166658; Matsumoto T, 2015, AM J CLIN PATHOL, V144, P452, DOI 10.1309/AJCPZ5T2POOFMQVN; Matsuzaki S, 2001, FERTIL STERIL, V76, P712, DOI 10.1016/S0015-0282(01)02003-9; Matsuzaki S, 2015, HUM REPROD, V30, P1606, DOI 10.1093/humrep/dev108; Mayerhofer M, 2002, BLOOD, V100, P3767, DOI 10.1182/blood-2002-01-0109; de Carvalho MDR, 2015, REV BRAS GINECOL OBS, V37, P77, DOI [10.1590/SO100-720320140005199, 10.1590/S0100-720320140005199]; Steven L, 2013, AVMA GUIDELINES EUTH, V2013, P20; Wang NN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/546479; Wei W, 2010, EXPT METHODOLOGY PHA, P68; Yeo SG, 2013, INT J MED SCI, V10, P1199, DOI 10.7150/ijms.5169; Zhang H, 2010, MOL CELL ENDOCRINOL, V317, P31, DOI 10.1016/j.mce.2009.11.009	26	46	50	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186520	10.1371/journal.pone.0186520	http://dx.doi.org/10.1371/journal.pone.0186520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140979	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400007
J	Yadav, N; Chandra, H				Yadav, Niket; Chandra, Harish			Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: Role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NF kappa B	PLOS ONE			English	Article							LPS; EXPRESSION; ACTIVATION; MICE; ANTIMICROBIALS; CYTOKINE; SIGNAL; SHOCK	Eucalyptus oil (EO) used in traditional medicine continues to prove useful for aroma therapy in respiratory ailments; however, there is a paucity of information on its mechanism of action and active components. In this direction, we investigated EO and its dominant constituent 1,8-cineole (eucalyptol) using the murine lung alveolar macrophage (AM) cell line MH-S. In an LPS-induced AM inflammation model, pre-treatment with EO significantly reduced (P <= 0.01 or 0.05) the pro-inflammatory mediators TNF-alpha, IL-1 (alpha and beta), and NO, albeit at a variable rate and extent; 1,8-cineole diminished IL-1 and IL-6. In a mycobacterial-infection AM model, EO pre-treatment or post-treatment significantly enhanced (P <= 0.01) the phagocytic activity and pathogen clearance. 1,8-cineole also significantly enhanced the pathogen clearance though the phagocytic activity was not significantly altered. EO or 1,8-cineole pre-treatment attenuated LPS-induced inflammatory signaling pathways at various levels accompanied by diminished inflammatory response. Among the pattern recognition receptors (PRRs) involved in LPS signaling, the TREM pathway surface receptor (TREM-1) was significantly downregulated. Importantly, the pre-treatments significantly downregulated (P <= 0.01) the intracellular PRR receptor NLRP3 of the inflammasome, which is consistent with the decrease in IL-1 beta secretion. Of the shared downstream signaling cascade for these PRR pathways, there was significant attenuation of phosphorylation of the transcription factor NF-kappa B and p38 (but increased phosphorylation of the other two MAP kinases, ERK1/2 and JNK1/2). 1,8-cineole showed a similar general trend except for an opposite effect on NF-kappa B and JNK1/2. In this context, either pre-treatment caused a significant downregulation of MKP-1 phosphatase, a negative regulator of MAPKs. Collectively, our results demonstrate that the anti-inflammatory activity of EO and 1,8-cineole is modulated via selective downregulation of the PRR pathways, including PRR receptors (TREM-1 and NLRP3) and common downstream signaling cascade partners (NF-kappa B, MAPKs, MKP-1). To our knowledge, this is the first report on the modulatory role of TREM-1 and NLRP3 inflammasome pathways and the MAPK negative regulator MKP-1 in context of the anti-inflammatory potential of EO and its constituent 1,8-cineole.	[Yadav, Niket; Chandra, Harish] Univ Cincinnati, Coll Med, Microbial Pathogenesis & Immunotoxicol Lab, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati	Chandra, H (corresponding author), Univ Cincinnati, Coll Med, Microbial Pathogenesis & Immunotoxicol Lab, Cincinnati, OH 45220 USA.	harish.chandra@uc.edu	chandra, Harish/GQB-5139-2022	Yadav, Niket/0000-0003-0544-2417	University of Cincinnati funds; Microbial Pathogenesis and Immunotoxicology Laboratory	University of Cincinnati funds; Microbial Pathogenesis and Immunotoxicology Laboratory	The study was supported in part by the University of Cincinnati funds. NY acknowledges the Microbial Pathogenesis and Immunotoxicology Laboratory for providing support for this research.; NY acknowledges the Microbial Pathogenesis and Immunotoxicology Laboratory for providing the opportunity and support for this research.	Alvarenga RFR, 2014, J NAT PROD, V77, P603, DOI 10.1021/np400872m; Angela E, 2010, ALTERN MED REV, V15, P33; Atochina-Vasserman EN, 2007, J IMMUNOL, V179, P8090, DOI 10.4049/jimmunol.179.12.8090; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bastos VPD, 2011, BASIC CLIN PHARMACOL, V108, P34, DOI 10.1111/j.1742-7843.2010.00622.x; Bode JG, 2012, CELL SIGNAL, V24, P1185, DOI 10.1016/j.cellsig.2012.01.018; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Camporese Alessandro, 2013, Infez Med, V21, P117; Cermelli C, 2008, CURR MICROBIOL, V56, P89, DOI 10.1007/s00284-007-9045-0; Chandra H, 2016, MOL IMMUNOL, V75, P168, DOI 10.1016/j.molimm.2016.05.020; Chandra H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083172; Chi HB, 2006, P NATL ACAD SCI USA, V103, P2274, DOI 10.1073/pnas.0510965103; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; Frank EA, 2016, TOXICOL PATHOL, V44, P211, DOI 10.1177/0192623315620587; Gochman E, 2012, ACTA HISTOCHEM, V114, P827, DOI 10.1016/j.acthis.2012.02.004; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gurung P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14488; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Juergens UR, 2004, PULM PHARMACOL THER, V17, P281, DOI 10.1016/j.pupt.2004.06.002; Jun YS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/502727; Khan NM, 2017, FREE RADICAL BIO MED, V106, P288, DOI 10.1016/j.freeradbiomed.2017.02.041; Kim YH, 2005, IMMUNOL LETT, V99, P45, DOI 10.1016/j.imlet.2004.12.007; Kumar H.D., 2011, INT J RES AYURVEDA P, V2, P1527; Laird K, 2012, LETT APPL MICROBIOL, V54, P169, DOI 10.1111/j.1472-765X.2011.03190.x; Lind M, 2017, BIOMED PHARMACOTHER, V93, P370, DOI 10.1016/j.biopha.2017.06.036; Lioberas J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00028; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Medina E, 2016, CURR TOP MICROBIOL, V398, P3, DOI 10.1007/82_2016_492; Moens U, 2013, GENES-BASEL, V4, P101, DOI 10.3390/genes4020101; Mulyaningsih, 2011, PHARM BIOL, V49, P893, DOI 10.3109/13880209.2011.553625; Murakami Y, 2007, J IMMUNOL, V178, P1144, DOI 10.4049/jimmunol.178.2.1144; Perez-Roses R, 2015, J AGR FOOD CHEM, V63, P1496, DOI 10.1021/jf504761m; Rantzsch U, 2009, EUR J MED RES, V14, P205, DOI 10.1186/2047-783X-14-S4-205; Santos FA, 2000, PHYTOTHER RES, V14, P240, DOI 10.1002/1099-1573(200006)14:4&lt;240::AID-PTR573&gt;3.0.CO;2-X; Sarkar S, 2016, CURR MED CHEM, V23, P1657, DOI 10.2174/0929867323666160418115540; Serafino A, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-17; Silva J, 2003, J ETHNOPHARMACOL, V89, P277, DOI 10.1016/j.jep.2003.09.007; Subramani R, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0848-9; Tabuti JRS, 2010, J ETHNOPHARMACOL, V127, P130, DOI 10.1016/j.jep.2009.09.035; Tsai ML, 2011, BIOSCI BIOTECH BIOCH, V75, P1977, DOI 10.1271/bbb.110377; Tucsek Z, 2011, J LEUKOCYTE BIOL, V89, P105, DOI 10.1189/jlb.0610355; Vuong QV, 2015, CHEM BIODIVERS, V12, P907, DOI 10.1002/cbdv.201400327; Yadav N, 2017, IMMUNOBIOL; Yadav N, 2012, ALT MED STU, V2, pE13; Zhao CZ, 2014, INFLAMMATION, V37, P566, DOI 10.1007/s10753-013-9770-4; ZHAO X, 2015, J CIV STRUCT HEALTH, V5, P1	46	32	38	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188232	10.1371/journal.pone.0188232	http://dx.doi.org/10.1371/journal.pone.0188232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141025	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400071
J	Chen, LS; Gong, T; Kosinski, M; Stillwell, D; Davidson, RL				Chen, Lushi; Gong, Tao; Kosinski, Michal; Stillwell, David; Davidson, Robert L.			Building a profile of subjective well-being for social media users	PLOS ONE			English	Article							SATISFACTION; SELECTION; HAPPINESS	Subjective well-being includes 'affect' and 'satisfaction with life' (SWL). This study proposes a unified approach to construct a profile of subjective well-being based on social media language in Facebook status updates. We apply sentiment analysis to generate users' affect scores, and train a random forest model to predict SWL using affect scores and other language features of the status updates. Results show that: the computer-selected features resemble the key predictors of SWL as identified in early studies; the machine-predicted SWL is moderately correlated with the self-reported SWL (r = 0.36, p < 0.01), indicating that language-based assessment can constitute valid SWL measures; the machine-assessed affect scores resemble those reported in a previous experimental study; and the machine-predicted subjective well-being profile can also reflect other psychological traits like depression (r = 0.24, p < 0.01). This study provides important insights for psychological prediction using multiple, machine-assessed components and longitudinal or dense psychological assessment using social media language.	[Chen, Lushi] Univ Edinburgh, Sch Informat, Inst Language Cognit & Computat, Edinburgh, Midlothian, Scotland; [Gong, Tao] Haskins Labs Inc, New Haven, CT USA; [Gong, Tao] Guangdong Univ Foreign Studies, Ctr Linguist & Appl Linguist, Guangzhou, Guangdong, Peoples R China; [Kosinski, Michal] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Stillwell, David] Univ Cambridge, Judge Business Sch, Cambridge, England; [Davidson, Robert L.] Two Cloaks Ltd, Glasgow, Lanark, Scotland; [Davidson, Robert L.] Scientists EU Ltd, London, England	University of Edinburgh; Yale University; Haskins Laboratories; Guangdong University of Foreign Studies; Stanford University; University of Cambridge	Chen, LS (corresponding author), Univ Edinburgh, Sch Informat, Inst Language Cognit & Computat, Edinburgh, Midlothian, Scotland.; Gong, T (corresponding author), Haskins Labs Inc, New Haven, CT USA.; Gong, T (corresponding author), Guangdong Univ Foreign Studies, Ctr Linguist & Appl Linguist, Guangzhou, Guangdong, Peoples R China.	lushi.chen@ed.ac.uk; gong@haskins.yale.edu	Kosinski, Michal/AAH-7375-2019; Davidson, Rob/C-8721-2015	Kosinski, Michal/0000-0003-2936-4775; Davidson, Rob/0000-0002-0311-9774; Chen, Lucia/0000-0002-6645-0130	US National Institutes of Health [HD-071988]; MOE of Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD071988] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MOE of Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Gong acknowledges support by the US National Institutes of Health Grant (HD-071988). The study is also supported in part by the MOE Project of the Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Gong acknowledges support by the US NIH Grant (HD-071988). The study is also supported in part by the MOE Project of the Center for Linguistics and Applied Linguistics, Guangdong University of Foreign Studies. The authors thank Chung-Hong Chan from the University of Hong Kong for offering suggestions on the text mining techniques, Maria Wolters from the University of Edinburgh for offering suggestions on the model. Roger Booth from Pennebaker Conglomerates, Inc. for providing the LIWC dictionary.	Barrett LF, 2006, J RES PERS, V40, P35, DOI 10.1016/j.jrp.2005.08.006; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064417, 10.1371/journal.pone.0052708]; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cambria E, 2017, SOCIO AFFECT COMPUT, V5, P1, DOI 10.1007/978-3-319-55394-8_1; Cambria E, 2016, IEEE COMPUT INTELL M, V11, P9, DOI 10.1109/MCI.2016.2572481; Cambria E, 2016, IEEE INTELL SYST, V31, P102, DOI 10.1109/MIS.2016.31; Collins Susan, 2015, Social Computing, Behavioral-Cultural Modeling and Prediction. 8th International Conference, SBP 2015. Proceedings: LNCS 9021, P24, DOI 10.1007/978-3-319-16268-3_3; Csikszentmihalyi M., 2014, THE J, P89, DOI [10.1007/978-94-017-9088-8_6, DOI 10.1023/A:1024409732742]; Davidov D, 2010, P 23 INT C COMP LING, P241; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; DIENER E, 1991, J PERS SOC PSYCHOL, V61, P492, DOI 10.1037/0022-3514.61.3.492; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dou W, 2012, P IEEE VISWEEK WORKS, P971; Hills T, 2015, CESIFO WORKING PAPER; Hu MQ, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P755; Hu X, 2013, P 6 ACM INT C WEB SE, P537, DOI DOI 10.1145/2433396.2433465; Hughes DJ, 2012, COMPUT HUM BEHAV, V28, P561, DOI 10.1016/j.chb.2011.11.001; Kahneman D., 2005, SCI WELL BEING, V1, P285, DOI DOI 10.1093/ACPROF:OSO/9780198567523.003.0011; Kahneman D., 1999, WELL BEING FDN HEDON, P3, DOI DOI 10.7758/9781610443258; KAMMANN R, 1983, AUST J PSYCHOL, V35, P259, DOI 10.1080/00049538308255070; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Lewis CA, 1999, J SOC PSYCHOL, V139, P533, DOI 10.1080/00224549909598413; Lucas R.E., 2008, HDB EMOTIONS, V3rd ed., P471; Mahmoud Jihan Saber Raja, 2012, Issues Ment Health Nurs, V33, P149, DOI 10.3109/01612840.2011.632708; Niu HN, 2003, INT CONF ACOUST SPEE, P125; Oh HJ, 2014, COMPUT HUM BEHAV, V30, P69, DOI 10.1016/j.chb.2013.07.053; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pennebaker JW., 2001, LINGUISTIC INQUIRY W; R Core Team, 2015, R LANGUAGE ENV STAT; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Sapolsky R., 1999, WELL BEING FDN HEDON, P453; Schwartz HA, 2016, BIOCOMPUT-PAC SYM, P516; Schwartz HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073791; Tang J, 2014, PR MACH LEARN RES, V32; Tausczik YR, 2010, J LANG SOC PSYCHOL, V29, P24, DOI 10.1177/0261927X09351676; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wu YY, 2015, P NATL ACAD SCI USA, V112, P1036, DOI 10.1073/pnas.1418680112; Yang C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150881; Zheng X., 2016, PSYCHOLOGY, V7, P885, DOI [10.4236/psych.2016.7609, DOI 10.4236/PSYCH.2016.7609]; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	47	22	24	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187278	10.1371/journal.pone.0187278	http://dx.doi.org/10.1371/journal.pone.0187278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135991	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200016
J	Ismail, M; Soliman, A; Ghazal, M; Switala, AE; Gimel'farb, G; Barnes, GN; Khalil, A; El-Baz, A				Ismail, Marwa; Soliman, Ahmed; Ghazal, Mohammed; Switala, Andrew E.; Gimel'farb, Georgy; Barnes, Gregory N.; Khalil, Ashraf; El-Baz, Ayman			A fast stochastic framework for automatic MR brain images segmentation	PLOS ONE			English	Article							TISSUE SEGMENTATION; LEVEL SET; MODEL; INTEGRATION	This paper introduces a new framework for the segmentation of different brain structures (white matter, gray matter, and cerebrospinal fluid) from 3D MR brain images at different life stages. The proposed segmentation framework is based on a shape prior built using a subset of co-aligned training images that is adapted during the segmentation process based on first-and second-order visual appearance characteristics of MR images. These characteristics are described using voxel-wise image intensities and their spatial interaction features. To more accurately model the empirical grey level distribution of the brain signals, we use a linear combination of discrete Gaussians (LCDG) model having positive and negative components. To accurately account for the large inhomogeneity in infant MRIs, a higher-order Markov-Gibbs Random Field (MGRF) spatial interaction model that integrates third-and fourth-order families with a traditional second-order model is proposed. The proposed approach was tested and evaluated on 102 3D MR brain scans using three metrics: the Dice coefficient, the 95-percentile modified Hausdorff distance, and the absolute brain volume difference. Experimental results show better segmentation of MR brain images compared to current open source segmentation tools.	[Ismail, Marwa; Soliman, Ahmed; Ghazal, Mohammed; Switala, Andrew E.; El-Baz, Ayman] Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA; [Ghazal, Mohammed; Khalil, Ashraf] Abu Dhabi Univ, Dept Elect & Comp Engn, Abu Dhabi, U Arab Emirates; [Gimel'farb, Georgy] Univ Auckland, Dept Comp Sci, Auckland, New Zealand; [Barnes, Gregory N.] Univ Louisville, Dept Pediat, Louisville, KY 40292 USA	University of Louisville; Abu Dhabi University; University of Auckland; University of Louisville	El-Baz, A (corresponding author), Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA.	ayman.elbaz@louisville.edu	El-Baz, Ayman/AAC-6689-2019; , CONTRACT_ADMIN/R-7014-2019; Soliman, Ahmed/I-1601-2013	El-Baz, Ayman/0000-0001-7264-1323; Ghazal, Mohammed/0000-0002-9045-6698; Soliman, Ahmed/0000-0002-1931-3416; Switala, Andrew/0000-0002-4438-3758; Khalil, Ashraf/0000-0003-1584-8525	University of Louisville 21st Century University Initiative on Big Data in Medicine	University of Louisville 21st Century University Initiative on Big Data in Medicine	This work has been supported by the University of Louisville 21st Century University Initiative on Big Data in Medicine.; This work has been supported by the University of Louisville 21st Century University Initiative on Big Data in Medicine.	Alansary A, 2016, IEEE J BIOMED HEALTH, V20, P925, DOI 10.1109/JBHI.2015.2415477; Altaye M, 2008, NEUROIMAGE, V43, P721, DOI 10.1016/j.neuroimage.2008.07.060; Anbeek P, 2008, PEDIATR RES, V63, P158, DOI 10.1203/PDR.0b013e31815ed071; Angelini ED, 2004, PROC SPIE, V5370, P526, DOI 10.1117/12.535860; [Anonymous], 2001, INT C MEDICAL IMAGE, DOI DOI 10.1007/3-540-45468-3_62; Artaechevarria X, 2009, IEEE T MED IMAGING, V28, P1266, DOI 10.1109/TMI.2009.2014372; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balafar MA, 2010, ARTIF INTELL REV, V33, P261, DOI 10.1007/s10462-010-9155-0; Barkovich AJ, 2005, J INHERIT METAB DIS, V28, P311, DOI 10.1007/s10545-005-5952-z; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; BESAG J, 1986, J R STAT SOC B, V48, P259; Bournan C, 1993, IEEE T IMAGE PROCESS, V2, P296, DOI 10.1109/83.236536; Bourouis S, 2010, INT J IMAGE GRAPH, V10, P135, DOI 10.1142/S0219467810003706; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Chen H, 2016, VOXRESNET DEEP VOXEL; Cherel M, 2015, PROC SPIE, V9413, DOI 10.1117/12.2082209; Ciofolo C, 2009, MED IMAGE ANAL, V13, P456, DOI 10.1016/j.media.2009.02.008; Colliot O, 2006, PATTERN RECOGN, V39, P1401, DOI 10.1016/j.patcog.2006.02.022; Dai YK, 2013, NEUROINFORMATICS, V11, P211, DOI 10.1007/s12021-012-9164-z; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; del Fresno M, 2009, COMPUT MED IMAG GRAP, V33, P369, DOI 10.1016/j.compmedimag.2009.03.002; Di Martino A, 2014, MOL PSYCHIATR, V19, P659, DOI 10.1038/mp.2013.78; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egekher V.S., 2012, MICCAI GRAND CHALLEN, P22; El-Baz A., 2015, STOCHASTIC MODELING; El-Baz A, 2012, IEEE T BIO-MED ENG, V59, P2019, DOI 10.1109/TBME.2012.2196434; Farag AA, 2006, IEEE T IMAGE PROCESS, V15, P952, DOI 10.1109/TIP.2005.863949; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hall D, 2012, NEUROINFORMATICS, V10, P331, DOI 10.1007/s12021-012-9151-4; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Huang A, 2009, IEEE T BIO-MED ENG, V56, P1838, DOI 10.1109/TBME.2009.2017509; Ismail M, 2016, I S BIOMED IMAGING, P6, DOI 10.1109/ISBI.2016.7493198; Ismail M, 2015, IEEE IMAGE PROC, P4327, DOI 10.1109/ICIP.2015.7351623; Janney JB, 2014, ADV INTELL SYST, V216, P111, DOI 10.1007/978-81-322-1299-7_11; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ledig C, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P896, DOI 10.1109/ISBI.2012.6235693; Li L, 2014, UNIFYING ELECT ENG E, P1233; Liu JX, 2009, J NEUROSCI METH, V183, P255, DOI 10.1016/j.jneumeth.2009.05.011; Lotjonen JMP, 2010, NEUROIMAGE, V49, P2352, DOI 10.1016/j.neuroimage.2009.10.026; Mahmood Q, 2015, IRBM, V36, P185, DOI 10.1016/j.irbm.2015.01.007; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Mayer A, 2009, IEEE T MED IMAGING, V28, P1238, DOI 10.1109/TMI.2009.2013850; Mewes AUJ, 2006, PEDIATRICS, V118, P23, DOI 10.1542/peds.2005-2675; Miri S, 2008, LECT NOTES COMPUT SC, V5099, P67, DOI 10.1007/978-3-540-69905-7_8; Moeskops P, 2015, NEUROIMAGE, V118, P628, DOI 10.1016/j.neuroimage.2015.06.007; Morin J., 2012, P IEEE COMP SOC C CO, P44; Ng HP, 2006, 7TH IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS AND INTERPRETATION, P61; Ortiz A, 2011, ELECTRON LETT, V47, P585, DOI 10.1049/el.2011.0322; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pohl KA, 2006, NEUROIMAGE, V31, P228, DOI 10.1016/j.neuroimage.2005.11.044; Ruogu Fang, 2010, Proceedings of 2010 Western New York Image Processing Workshop (WNYIPW), P10, DOI 10.1109/WNYIPW.2010.5649772; Sabuncu MR, 2010, IEEE T MED IMAGING, V29, P1714, DOI 10.1109/TMI.2010.2050897; Serag A, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00002; Shi F, 2010, NEUROIMAGE, V49, P391, DOI 10.1016/j.neuroimage.2009.07.066; Soliman A, 2017, IEEE T MED IMAGING, V36, P263, DOI 10.1109/TMI.2016.2606370; Song T, 2007, IEEE T NEURAL NETWOR, V18, P1424, DOI 10.1109/TNN.2007.891635; Song Z, 2007, LECT NOTES COMPUT SC, V4791, P883; Song Z, 2006, I S BIOMED IMAGING, P762; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; van der Lijn F, 2012, IEEE T MED IMAGING, V31, P276, DOI 10.1109/TMI.2011.2168420; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Wang L, 2013, LECT NOTES COMPUT SC, V8149, P703, DOI 10.1007/978-3-642-40811-3_88; Wang L, 2013, HUM BRAIN MAPP, V34, P956, DOI 10.1002/hbm.21486; Wang L, 2010, J NEUROSCI METH, V188, P316, DOI 10.1016/j.jneumeth.2010.03.004; Weber J, 2015, BILDVERARBEITUNG FUR DIE MEDIZIN 2015: ALGORITHMEN - SYSTEME - ANWENDUNGEN, P389, DOI 10.1007/978-3-662-46224-9_67; Weisenfeld NI, 2009, NEUROIMAGE, V47, P564, DOI 10.1016/j.neuroimage.2009.04.068; Xiao-hong Wang, 2014, Applied Mechanics and Materials, V536-537, P218, DOI 10.4028/www.scientific.net/AMM.536-537.218; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061; Zhao M, 2015, APPL MATH, V9, P1971, DOI DOI 10.12785/amis/090437	72	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187391	10.1371/journal.pone.0187391	http://dx.doi.org/10.1371/journal.pone.0187391			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136034	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200018
J	Knobloch, JKM; Tofern, S; Kunz, W; Schutze, S; Riecke, M; Solbach, W; Wuske, T				Knobloch, Johannes Karl-Mark; Tofern, Sabrina; Kunz, Wladimir; Schuetze, Sara; Riecke, Michael; Solbach, Werner; Wuske, Thomas			"Life-like" assessment of antimicrobial surfaces by a new touch transfer assay displays strong superiority of a copper alloy compared to silver containing surfaces	PLOS ONE			English	Article							CARE-ASSOCIATED INFECTIONS; CONTAMINATED SURFACES; NOSOCOMIAL PATHOGENS; ACQUIRED INFECTIONS; ENVIRONMENT; HOSPITALS; TRANSMISSION; ACQUISITION; ENTEROCOCCI; RESISTANCE	Transmission of bacteria from inanimate surfaces in healthcare associated environments is an important source of hospital acquired infections. A number of commercially available medical devices promise to fulfill antibacterial activity to reduce environmental contamination. In this study we developed a touch transfer assay modeling fingerprint transmission to investigate the antibacterial activity of surfaces, with confirmed antibacterial activity by a modified ISO 22196 (JIS Z 2801) assay to test such surfaces under more realistic conditions. Bacteria were taken up from a dry standardized primary contaminated surface (PCS) with disinfected fingers or fingers covered with sterile and moistened cotton gloves. Subsequently, bacteria were transferred by pressing on secondary contaminated surfaces (SCS) with or without potential antibacterial activity and the relative reduction rate was determined after 24 h. A stable transmission rate between PCS and SCS was observed using moistened sterile gloves. A copper containing alloy displayed at least a tenfold reduction of the bacterial load consistently reaching less than 2.5 cfu/cm(2). In contrast, no significant reduction of bacterial contamination by silver containing surfaces and matured pure silver was observed in the touch transfer assay. With the touch transfer assay we successfully established a new reproducible method modeling cross contamination. Using the new method we were able to demonstrate that several surfaces with confirmed antimicrobial activity in a modified ISO 22196 (JIS Z 2801) assay lacked effectiveness under defined ambient conditions. This data indicate that liquid based assays like the ISO 22196 should be critically reviewed before claiming antibacterial activity for surfaces in the setting of contamination of dry surfaces by contact to the human skin. We suggest the newly developed touch transfer assay as a new additional tool for the assessment of potential antimicrobial surfaces prior utilization in hospital environments.	[Knobloch, Johannes Karl-Mark] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Dept Hosp Hyg, Hamburg, Germany; [Knobloch, Johannes Karl-Mark; Solbach, Werner] German Ctr Infect Res, Partner Site Hamburg Lubeck Borstel, Hamburg, Germany; [Tofern, Sabrina; Kunz, Wladimir; Schuetze, Sara] Univ Hosp Schleswig Holstein, Clin Med Microbiol & Infectiol, Campus Lubeck, Lubeck, Germany; [Riecke, Michael; Wuske, Thomas] Dragerwerk AG & Co KGaA, Lubeck, Germany; [Solbach, Werner] Univ Lubeck, Ctr Infect & Inflammat Res ZIEL, Lubeck, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; University of Kiel; Schleswig Holstein University Hospital; Dragerwerk; University of Lubeck	Knobloch, JKM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Dept Hosp Hyg, Hamburg, Germany.; Knobloch, JKM (corresponding author), German Ctr Infect Res, Partner Site Hamburg Lubeck Borstel, Hamburg, Germany.	j.knobloch@uke.de	Solbach, Werner/O-8582-2015; Knobloch, Johannes K./D-6456-2011	Solbach, Werner/0000-0002-3608-8652; Knobloch, Johannes K./0000-0002-2591-6387	Dragerwerk AG Co. KGaA; Clinic for Medical Microbiology and Infectiology at the University Hospital of Schleswig-Holstein, Campus Libeck	Dragerwerk AG Co. KGaA; Clinic for Medical Microbiology and Infectiology at the University Hospital of Schleswig-Holstein, Campus Libeck	The study was funded by the Dragerwerk AG & Co. KGaA. The funder provided support in the form of salaries for authors [ST, WK, SS, MR, and TW] and by consumables. The funding of the study by the Dragerwerk AG & Co. KGaA does not alter our adherence to PLOS ONE policies on sharing data and materials. No financial interests of the funder influenced the design of the newly developed touch transfer assay. No financial interests of the funder influenced the data analysis. The decision to publish, and the preparation of the manuscript was not influenced by financial interests of the funder. The specific roles of these authors are articulated in the 'author contributions' section. There was no additional external funding received for this study and the rest of the study was financed by the regular budget resources of the Clinic for Medical Microbiology and Infectiology at the University Hospital of Schleswig-Holstein, Campus Libeck.	[Anonymous], 2012, E218007 ASTM; Arinder P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156390; Bhalla A, 2004, INFECT CONT HOSP EP, V25, P164, DOI 10.1086/502369; Claro T, 2015, AM J INFECT CONTROL, V43, P1000, DOI 10.1016/j.ajic.2015.05.009; Dancer SJ, 2004, J HOSP INFECT, V56, P10, DOI 10.1016/j.jhin.2003.09.017; Dancer SJ, 2008, LANCET INFECT DIS, V8, P101, DOI 10.1016/S1473-3099(07)70241-4; Dancer SJ, 2014, CLIN MICROBIOL REV, V27, P665, DOI 10.1128/CMR.00020-14; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; Humphreys H, 2014, CLIN INFECT DIS, V58, P848, DOI 10.1093/cid/cit765; ISO 22196:2011, 2011, MEASUREMENT ANTIBACT; Knobloch JKM, 2005, ANTIMICROB AGENTS CH, V49, P1216, DOI 10.1128/AAC.49.3.1216-1219.2005; Malik RE, 2003, AM J INFECT CONTROL, V31, P181, DOI 10.1067/mic.2003.34; Michels HT, 2015, HERD-HEALTH ENV RES, V9, P64, DOI 10.1177/1937586715592650; Muller MP, 2016, J HOSP INFECT, V92, P7, DOI 10.1016/j.jhin.2015.09.008; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Page K, 2009, J MATER CHEM, V19, P3819, DOI 10.1039/b818698g; Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207; Santo CE, 2008, APPL ENVIRON MICROB, V74, P977, DOI 10.1128/AEM.01938-07; Schmidt MG, 2017, AM J INFECT CONTROL; Schmidt MG, 2013, INFECT CONT HOSP EP, V34, P530, DOI 10.1086/670224; Schmidt MG, 2012, J CLIN MICROBIOL, V50, P2217, DOI 10.1128/JCM.01032-12; U.S. EPA (United States Environmental Protection Agency), 2015, PROT EV BACT ACT HAR; US environmental protection agency, 2009, TEST METH RES SELF S; US Environmental Protection Agency, 2009, TEST METH EFF COPP A; Warnes SL, 2011, APPL ENVIRON MICROB, V77, P6049, DOI 10.1128/AEM.00597-11; Weber DJ, 2013, CURR OPIN INFECT DIS, V26, P338, DOI 10.1097/QCO.0b013e3283630f04; West SA, 2012, TRENDS MICROBIOL, V20, P586, DOI 10.1016/j.tim.2012.09.004; Wojgani H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040171; World Health Organization, 2016, GUID COR COMP INF PR	31	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187442	10.1371/journal.pone.0187442	http://dx.doi.org/10.1371/journal.pone.0187442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135999	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200019
J	Larson-Meyer, DE; Ingold, BC; Fensterseifer, SR; Austin, KJ; Wechsler, PJ; Hollis, BW; Makowski, AJ; Alexander, BM				Larson-Meyer, D. Enette; Ingold, Bennett C.; Fensterseifer, Samanta R.; Austin, Kathleen J.; Wechsler, Perry J.; Hollis, Bruce W.; Makowski, Andrew J.; Alexander, Brenda M.			Sun exposure in pigs increases the vitamin D nutritional quality of pork	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; BREAST-CANCER; D DEFICIENCY; UNITED-STATES; RISK; HEALTH; SUNLIGHT; DIETARY; SUPPLEMENTATION; PREVENTION	There is a high prevalence of vitamin D insufficiency and deficiency worldwide likely because of both limited sun-exposure and inadequate dietary intake. Meat, including pork, is not typically considered a dietary source of vitamin D, possibly because of management practices that raise pigs in confinement. This experiment determined the vitamin D content of loin and subcutaneous adipose tissue in sun-exposed finisher pigs. Two separate groups of pigs were used. The first group (28 white Landrace-Duroc) was assigned at random to either sunlight exposure (SUN) in spring and summer or confinement per standard practice (Control). The second (24 Yorkshire-Duroc-Landrace) underwent the same exposure protocol but was exposed in summer and fall or assigned to control (Control). A subsample of five SUN and four Control pigs, matched for weight and body condition score, was selected for slaughter from each group. Pigs (n = 10 SUN, n = 8 Control) had blood drawn for analysis of 25(OH)D-3 concentration before/after sun exposure or control, and tissue samples were taken at slaughter for analysis of tissue vitamin D3 and 25(OH)D-3 concentration. Three random samples from a single loin chop and surrounding adipose were collected and analyzed. Serum concentrations of 25(OH)D-3 did not differ (P >= 0.376) between treatments prior to sun exposure in either group, but was increased (time*treatment interaction, P < 0.001) with SUN exposure. Total vitamin D content (D3 plus 25(OH)D-3) of loin tissue was increased (P < 0.001) with sun exposure and averaged 0.997 +/- 0.094 mu g/100g and 0.348 +/- 0.027 mu g/100g for sun and control pigs, respectively. While exposure to sunlight increased (P = 0.003) tissue content of 25(OH) D in subcutaneous adipose tissue, vitamin D-3 content was similar between treatments (P = 0.56). Sunlight exposure in pigs increased the vitamin D content of loin, and may provide an additional source of dietary vitamin D.	[Larson-Meyer, D. Enette; Ingold, Bennett C.] Univ Wyoming, Dept Family & Consumer Sci Human Nutr, Laramie, WY 82071 USA; [Fensterseifer, Samanta R.; Austin, Kathleen J.; Alexander, Brenda M.] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Wechsler, Perry J.] Univ Wyoming, Dept Atmospher Sci, Laramie, WY 82071 USA; [Hollis, Bruce W.] Med Univ South Carolina, Dept Pediat, Charleston, SC USA; [Makowski, Andrew J.] Heartland Assays, Ames, IA USA	University of Wyoming; University of Wyoming; University of Wyoming; Medical University of South Carolina	Larson-Meyer, DE (corresponding author), Univ Wyoming, Dept Family & Consumer Sci Human Nutr, Laramie, WY 82071 USA.	enette@uwyo.edu			University of Wyoming, Agriculture Experiment Station; Heartland Assays	University of Wyoming, Agriculture Experiment Station; Heartland Assays	This study was supported by University of Wyoming, Agriculture Experiment Station. Bruce W. Hollis and Andrew J. Makowski at Heartland Assays provided the analytical services for fee. There was no additional external funding received for this study. Andrew J. Makowski is employed by Heartland Assays. Heartland Assays provided support in the form of salary for author AJM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abboud M, 2014, J STEROID BIOCHEM, V144, P232, DOI 10.1016/j.jsbmb.2013.10.020; Ahonen MH, 2000, CANCER CAUSE CONTROL, V11, P847, DOI 10.1023/A:1008923802001; Baggerly CA, 2015, J AM COLL NUTR, V34, P359, DOI 10.1080/07315724.2015.1039866; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Brouwer DAJ, 1998, BRIT J NUTR, V79, P527, DOI 10.1079/BJN19980091; Burild A, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2015.28; Burild A, 2015, STEROIDS, V98, P72, DOI 10.1016/j.steroids.2015.02.017; Calvo MS, 2003, NUTR REV, V61, P107, DOI 10.1301/nr.2003.marr.107-113; Casas E, 2015, DOMEST ANIM ENDOCRIN, V52, P71, DOI 10.1016/j.domaniend.2015.03.003; Clausen I, 2003, J FOOD COMPOS ANAL, V16, P575, DOI 10.1016/S0889-1575(03)00064-4; Donald L., 2006, LIVESTOCK CARCASSES; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Grant WB, 2015, ANTICANCER RES, V35, P1154; Green TJ, 2013, STRATEGIES IMPROVING, P247; Heaney RP, 2013, J STEROID BIOCHEM, V136, P224, DOI 10.1016/j.jsbmb.2012.09.032; Heaney RP, 2013, J NUTR, V143, P571, DOI 10.3945/jn.112.168641; Heaney RP, 2009, J AM COLL NUTR, V28, P252, DOI 10.1080/07315724.2009.10719779; Holick MF, 2007, J BONE MINER RES, V22, pV28, DOI 10.1359/JBMR.07S211; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Kollias N, 2011, PHOTOCHEM PHOTOBIOL, V87, P1474, DOI 10.1111/j.1751-1097.2011.00980.x; Kristensen HL, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.7114; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Luxwolda MF, 2012, BRIT J NUTR, V108, P1557, DOI 10.1017/S0007114511007161; Macdonald HM, 2013, CALCIFIED TISSUE INT, V92, P163, DOI 10.1007/s00223-012-9634-1; Miller JR, 2016, J FOOT ANKLE SURG, V55, P117, DOI 10.1053/j.jfas.2015.08.002; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Mohr SB, 2011, ANTICANCER RES, V31, P2939; Moore CE, 2005, J NUTR, V135, P2478, DOI 10.1093/jn/135.10.2478; O'Mahony L, 2011, NUTRIENTS, V3, P1023, DOI 10.3390/nu3121023; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Roseland JM, 2016, J AGR FOOD CHEM, V64, P3167, DOI 10.1021/acs.jafc.5b05016; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sayer RD, 2015, AM J CLIN NUTR; Schutkowski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069418; Shen L, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0063-7; Taylor CL, 2014, J NUTR, V144, P654, DOI 10.3945/jn.113.189811; Turner AG, 2012, SCAND J CLIN LAB INV, V72, P65, DOI 10.3109/00365513.2012.681963; US Department of Agriculture ARS, NUTR DAT LIB USDA NA; Vieth R, 2004, J STEROID BIOCHEM, V89-90, P575, DOI 10.1016/j.jsbmb.2004.03.038	42	12	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187877	10.1371/journal.pone.0187877	http://dx.doi.org/10.1371/journal.pone.0187877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136033	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200040
J	Pyo, S; Lee, J; Cha, M; Jang, H				Pyo, Sujin; Lee, Jaewook; Cha, Mincheol; Jang, Huisu			Predictability of machine learning techniques to forecast the trends of market index prices: Hypothesis testing for the Korean stock markets	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; SUPPORT VECTOR MACHINES; MODELS	The prediction of the trends of stocks and index prices is one of the important issues to market participants. Investors have set trading or fiscal strategies based on the trends, and considerable research in various academic fields has been studied to forecast financial markets. This study predicts the trends of the Korea Composite Stock Price Index 200 (KOSPI 200) prices using nonparametric machine learning models: artificial neural network, support vector machines with polynomial and radial basis function kernels. In addition, this study states controversial issues and tests hypotheses about the issues. Accordingly, our results are inconsistent with those of the precedent research, which are generally considered to have high prediction performance. Moreover, Google Trends proved that they are not effective factors in predicting the KOSPI 200 index prices in our frameworks. Furthermore, the ensemble methods did not improve the accuracy of the prediction.	[Pyo, Sujin; Lee, Jaewook; Cha, Mincheol; Jang, Huisu] Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea	Seoul National University (SNU)	Jang, H (corresponding author), Seoul Natl Univ, Dept Ind Engn, Seoul, South Korea.	gmltn7798@snu.ac.kr			National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2016R1A2B3014030]	National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2016R1A2B3014030). Jaewook Lee is a recipient of the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Da Z, 2011, J FINANC, V66, P1461, DOI 10.1111/j.1540-6261.2011.01679.x; Guresen E, 2011, EXPERT SYST APPL, V38, P10389, DOI 10.1016/j.eswa.2011.02.068; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; Kim KJ, 2003, NEUROCOMPUTING, V55, P307, DOI 10.1016/S0925-2312(03)00372-2; Kohzadi N, 1996, NEUROCOMPUTING, V10, P169, DOI 10.1016/0925-2312(95)00020-8; Kumar D, 2016, J COMPUT SCI-NETH, V17, P1, DOI 10.1016/j.jocs.2016.07.006; Ni LP, 2011, EXPERT SYST APPL, V38, P5569, DOI 10.1016/j.eswa.2010.10.079; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Preethi G, 2013, J THEOR APPL INF TEC, V46; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Qiu MY, 2016, CHAOS SOLITON FRACT, V85, P1, DOI 10.1016/j.chaos.2016.01.004; Vapnik V., 2013, NATURE STAT LEARNING; Wang Y., 2014, INT J BUSINESS INTEL, V9, P145; Youngohc Yoon, 1991, Proceedings of the Twenty-Fourth Annual Hawaii International Conference on System Sciences (Cat. No.91TH0350-9), P156, DOI 10.1109/HICSS.1991.184055; Zahedi J, 2015, PHYSICA A, V438, P178, DOI 10.1016/j.physa.2015.06.033	17	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188107	10.1371/journal.pone.0188107	http://dx.doi.org/10.1371/journal.pone.0188107			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136004	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200066
J	Ahmadi, H				Ahmadi, Hamed			A mathematical function for the description of nutrient-response curve	PLOS ONE			English	Article							NUTRITIONAL-REQUIREMENTS; GROWING RATS; REGRESSION	Several mathematical equations have been proposed to modeling nutrient-response curve for animal and human justified on the goodness of fit and/or on the biological mechanism. In this paper, a functional form of a generalized quantitative model based on Rayleigh distribution principle for description of nutrient-response phenomena is derived. The three parameters governing the curve a) has biological interpretation, b) may be used to calculate reliable estimates of nutrient response relationships, and c) provide the basis for deriving relationships between nutrient and physiological responses. The new function was successfully applied to fit the nutritional data obtained from 6 experiments including a wide range of nutrients and responses. An evaluation and comparison were also done based simulated data sets to check the suitability of new model and four-parameter logistic model for describing nutrient responses. This study indicates the usefulness and wide applicability of the new introduced, simple and flexible model when applied as a quantitative approach to characterizing nutrient-response curve. This new mathematical way to describe nutritional-response data, with some useful biological interpretations, has potential to be used as an alternative approach in modeling nutritional responses curve to estimate nutrient efficiency and requirements.	[Ahmadi, Hamed] Tarbiat Modares Univ, Dept Poultry Sci, Biosci & Agr Modeling Res Unit, Tehran, Iran	Tarbiat Modares University	Ahmadi, H (corresponding author), Tarbiat Modares Univ, Dept Poultry Sci, Biosci & Agr Modeling Res Unit, Tehran, Iran.	hamed.ahmadi@modares.ac.ir		Ahmadi, Hamed/0000-0002-7445-3139	Research & Technology affair at the Tarbiat Modares University	Research & Technology affair at the Tarbiat Modares University	Financial support was provided by the Research & Technology affair at the Tarbiat Modares University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du FY, 2000, J NUTR, V130, P514, DOI 10.1093/jn/130.3.514; GAHL MJ, 1991, J NUTR, V121, P1720, DOI 10.1093/jn/121.11.1720; Hunt JR, 2008, J NUTR, V138, P1462, DOI 10.1093/jn/138.8.1462; Institute S, 2008, SAS STAT 9 2 US GUID; Krishnamoorthy K, 2006, STAT TEXTB MONOGR, P1; Lamberson WR, 2002, POULTRY SCI, V81, P481, DOI 10.1093/ps/81.4.481; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; MERCER LP, 1992, J NUTR, V122, P706, DOI 10.1093/jn/122.suppl_3.706; MERCER LP, 1978, J NUTR, V108, P1244, DOI 10.1093/jn/108.8.1244; MERCER LP, 1993, J NUTR, V123, P964, DOI 10.1093/jn/123.5.964; MERCER LP, 1982, J NUTR, V112, P560, DOI 10.1093/jn/112.3.560; MORGAN PH, 1975, P NATL ACAD SCI USA, V72, P4327, DOI 10.1073/pnas.72.11.4327; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Passlack N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149190; Pesti GM, 2009, BRIT POULTRY SCI, V50, P16, DOI 10.1080/00071660802530639; Rayleigh, 1919, PHILOS MAG, V37, P321, DOI 10.1080/14786440408635894; ROBBINS KR, 1979, J NUTR, V109, P1710, DOI 10.1093/jn/109.10.1710; Shan AS, 2003, POULTRY SCI, V82, P1154, DOI 10.1093/ps/82.7.1154; Strathe AB, 2011, POULTRY SCI, V90, P1496, DOI 10.3382/ps.2011-01345; Wen LM, 2015, FISH SHELLFISH IMMUN, V46, P501, DOI 10.1016/j.fsi.2015.07.001	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187292	10.1371/journal.pone.0187292	http://dx.doi.org/10.1371/journal.pone.0187292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161271	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000007
J	Nateghi, R; Mukherjee, S				Nateghi, Roshanak; Mukherjee, Sayanti			A multi-paradigm framework to assess the impacts of climate change on end-use energy demand	PLOS ONE			English	Article							ELECTRICITY; CONSUMPTION; OPTIMIZATION; SENSITIVITY; METHODOLOGY; MODELS; STATE	Projecting the long-term trends in energy demand is an increasingly complex endeavor due to the uncertain emerging changes in factors such as climate and policy. The existing energy-economy paradigms used to characterize the long-term trends in the energy sector do not adequately account for climate variability and change. In this paper, we propose a multi-paradigm framework for estimating the climate sensitivity of end-use energy demand that can easily be integrated with the existing energy-economy models. To illustrate the applicability of our proposed framework, we used the energy demand and climate data in the state of Indiana to train a Bayesian predictive model. We then leveraged the end-use demand trends as well as downscaled future climate scenarios to generate probabilistic estimates of the future end-use demand for space cooling, space heating and water heating, at the individual household and building level, in the residential and commercial sectors. Our results indicated that the residential load is much more sensitive to climate variability and change than the commercial load. Moreover, since the largest fraction of the residential energy demand in Indiana is attributed to heating, future warming scenarios could lead to reduced end-use demand due to lower space heating and water heating needs. In the commercial sector, the overall energy demand is expected to increase under the future warming scenarios. This is because the increased cooling load during hotter summer months will likely outpace the reduced heating load during the more temperate winter months.	[Nateghi, Roshanak; Mukherjee, Sayanti] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Nateghi, Roshanak] Purdue Univ, Div Environm & Ecol Engn, W Lafayette, IN 47907 USA; [Mukherjee, Sayanti] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mukherjee, S (corresponding author), Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA.; Mukherjee, S (corresponding author), Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA.	sayanti.purdue@gmail.com	Mukherjee, Sayanti/AAG-6266-2021; Nateghi, Roshanak/AAQ-2425-2020	Mukherjee, Sayanti/0000-0002-5833-1617	Purdue EEE-SER; NSF SEES [1555582]	Purdue EEE-SER; NSF SEES(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for this project was provided by Purdue EEE-SER seed grant, and the NSF SEES #1555582, entitled "Sustainable Energy Infrastructure Planning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpanda S, 2008, OIL CRISIS ENERGY SA; Amato AD, 2005, CLIMATIC CHANGE, V71, P175, DOI 10.1007/s10584-005-5931-2; Blum H, 2010, QUANTITATIVE ANAL PR; Chandramowli SN, 2014, SUSTAIN ENERGY TECHN, V5, P62, DOI 10.1016/j.seta.2013.11.003; Chipman HA, 2010, ANN APPL STAT, V4, P266, DOI 10.1214/09-AOAS285; Davis LW, 2012, NBER CONF R, P301; Derrible S, 2015, ENERG BUILDINGS, V108, P304, DOI 10.1016/j.enbuild.2015.09.022; DOE, 2015, CLIM CHANG US EN SEC; EIA, 2017, IND PROF AN; EIA, 2014, INDEPENDENT STAT ANA; Energy Information Administration 2014, 2000, EN REL CARB DIOX EM; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Griffith B., 2006, ASSESSMENT TECHNICAL; Hahn H, 2009, EUR J OPER RES, V199, P902, DOI 10.1016/j.ejor.2009.01.062; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Howard B, 2012, ENERG BUILDINGS, V45, P141, DOI 10.1016/j.enbuild.2011.10.061; Ilie L, 2006, EC CONSIDERATIONS RE; Kapelner A., 2013, ARXIV13122171; Kaza N, 2010, ENERG POLICY, V38, P6574, DOI 10.1016/j.enpol.2010.06.028; Kiran MS, 2012, ENERG CONVERS MANAGE, V53, P75, DOI 10.1016/j.enconman.2011.08.004; Krishnan V, 2016, ENERGY SYST, V7, P297, DOI 10.1007/s12667-015-0158-4; Levinson A, 2004, RESOUR ENERGY ECON, V26, P51, DOI [10.1016/S0928-7655(03)00047-2, 10.1016/50928-7655(03)00047-2]; Loulou R., 2005, DOCUMENTATION TIME 2, P1; Loulou R., DOCUMENTATION MARKAL; Min J, 2010, J IND ECOL, V14, P791, DOI 10.1111/j.1530-9290.2010.00279.x; Moss Richard, 2008, NEW SCENARIOS ANAL E; Mukherjee S, RISK ANAL; Mukherjee S, 2017, IEEE XPLORE; Mukhopadhyay S, 2017, ENERGY, V128, P688, DOI 10.1016/j.energy.2017.04.034; NOAA, 2017, CLIM DAT ONL DAT DIS; Sailor DJ, 2001, ENERGY, V26, P645, DOI 10.1016/S0360-5442(01)00023-8; Sailor DJ, 1997, ENERGY, V22, P987, DOI 10.1016/S0360-5442(97)00034-0; Sathaye J, 1989, END USE APPROACH DEV; SEDS, 2016, STAT DAT SYST SEDS 1; Steemers K, 2009, BUILD RES INF, V37, P625, DOI 10.1080/09613210903186661; Suganthi L, 2012, RENEW SUST ENERG REV, V16, P1223, DOI 10.1016/j.rser.2011.08.014; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Tohver IM, 2014, J AM WATER RESOUR AS, V50, P1461, DOI 10.1111/jawr.12199; Torcellini P., 2008, DOE COMMERCIAL BUILD, P17; United States Energy Information Administration, 2009, RECS RES EN CONS SUR; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Voit J., 2005, STAT MECH FINANCIAL; Winiarski DW, 2006, PNNL20346; Yalcintas M, 2006, INT J ENERG RES, V30, P1158, DOI 10.1002/er.1212; Yun GY, 2011, APPL ENERG, V88, P2191, DOI 10.1016/j.apenergy.2011.01.010	45	31	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188033	10.1371/journal.pone.0188033	http://dx.doi.org/10.1371/journal.pone.0188033			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155862	gold, Green Published, Green Submitted			2022-12-27	WOS:000415756700027
J	Su, K; Liu, S; Wu, T; Yin, YC; Zhang, RP; Li, SL; Zhang, YZ				Su, Ke; Liu, Song; Wu, Tao; Yin, Yingchao; Zhang, Ruipeng; Li, Shilun; Zhang, Yingze			Posterior column acetabular fracture fixation using a W-shaped angular plate: A biomechanical analysis	PLOS ONE			English	Article							OPERATIVE TREATMENT; SCREW FIXATION; WALL	Objective The purpose of this study was to compare the stability and feasibility of four fixation constructs in a posterior column acetabular fracture: one reconstruction plate, one reconstruction plate and lag screw, two reconstruction plates, and a W-shaped acetabular angular plate. Methods Twenty embalmed cadaveric pelvises with a posterior column acetabular fractures were allocated to one of four groups: 1) a reconstruction plate, 2) a reconstruction plate with a posterior column lag screw, 3) double reconstruction plates, and 4) a W-shaped acetabular angular plate. These constructs were mechanically loaded on a testing machine, and construct stiffness values were measured. Strain gauges were utilized to measure the mechanical behavior in the condition of compressive force. Results Final stiffness was not different between the two reconstruction plates (445.81 +/- 98.30 N/mm) and the W-shaped acetabular angular plate (447.43 +/- 98.45 N/mm, p = 0.524), both of which were superior to a single reconstruction plate (248.90 +/- 61.95 N/mm) and a combined plate and lag screw (326.41 +/- 94.34 N/mm). Following the fixation of the W-shaped acetabular angular plate, the strain distribution was similar to the intact condition around the acetabulum. The parameters of the W-shaped acetabular angular plate that were observed at the superior region of the acetabulum were less than those of a single reconstruction plate (p<0.05), a single reconstruction plate with lag screw (p<0.05), and two reconstruction plates (p<0.05). Conclusions The novel W-shaped acetabular angular plate fixation technique was able to provide the biomechanically stiffest construct for stabilization of a posterior column acetabular fracture; it also resulted in a partial restoration of joint loading parameters toward the intact state.	[Su, Ke] Cangzhou Cent Hosp, Dept Orthopaed Surg, Cangzhou, Hebei, Peoples R China; [Liu, Song; Wu, Tao; Yin, Yingchao; Zhang, Ruipeng; Li, Shilun; Zhang, Yingze] Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University	Zhang, YZ (corresponding author), Hebei Med Univ, Hosp 3, Dept Orthopaed Surg, Shijiazhuang, Hebei, Peoples R China.	yzzhangdr@126.com		Zhang, Yingze/0000-0003-1923-3659; Zhang, Ruipeng/0000-0002-1702-8988; Yin, Yingchao/0000-0002-0989-9556; Zhang, YIngze/0000-0001-8042-6105	Natural Science Foundation of China [81572125]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the Natural Science Foundation of China, Approval number: 81572125, http://www.nsfc.gov.cn/. The funders provided financial support, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JK, 2001, CLIN ORTHOP RELAT R, P433; DALSTRA M, 1995, J BIOMECH, V28, P715, DOI 10.1016/0021-9290(94)00125-N; Ebraheim N A, 1989, J Orthop Trauma, V3, P196, DOI 10.1097/00005131-198909000-00003; Feng XR, 2016, INJURY, V47, P702, DOI 10.1016/j.injury.2016.01.026; Fulkerson E, 2006, J TRAUMA, V60, P830, DOI 10.1097/01.ta.0000195462.53525.0c; Giordano V, 2009, INT J MED SCI, V6, P192; KNIGHT RA, 1958, J BONE JOINT SURG AM, V40, P1; Liu XW, 2010, CLIN BIOMECH, V25, P312, DOI 10.1016/j.clinbiomech.2010.01.008; MATTA JM, 1986, CLIN ORTHOP RELAT R, P230; Mehin R, 2009, CAN J SURG, V52, P221; OLSON SA, 1995, J BONE JOINT SURG AM, V77A, P1184, DOI 10.2106/00004623-199508000-00007; Ramos AMdT, 2017, CLIM DYNAM, P1; Russell GV, 2001, J TRAUMA, V51, P1098, DOI 10.1097/00005373-200112000-00014; SAWAGUCHI T, 1984, ACTA ORTHOP SCAND, V55, P601, DOI 10.3109/17453678408992404; SCHOPFER A, 1994, INT ORTHOP, V18, P96, DOI 10.1007/BF02484418; Schutz Michael, 2003, J Orthop Sci, V8, P252, DOI 10.1007/s007760300044; Shazar N, 1998, CLIN ORTHOP RELAT R, P215; Suzuki T, 2013, PATIENT SAF SURG, V7, DOI 10.1186/1754-9493-7-7; Uchida Kenzo, 2013, Eur J Orthop Surg Traumatol, V23, P155, DOI 10.1007/s00590-012-0938-7; Wu XB, 2010, J TRAUMA, V69, P423, DOI 10.1097/TA.0b013e3181ca05f6; Zhang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092210; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076464	22	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187886	10.1371/journal.pone.0187886	http://dx.doi.org/10.1371/journal.pone.0187886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155842	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700020
J	Xia, TT; Chai, XC; Shen, JQ				Xia, Tingting; Chai, Xichen; Shen, Jiaqing			Pancreatic exocrine insufficiency in patients with chronic heart failure and its possible association with appetite loss	PLOS ONE			English	Article							FECAL ELASTASE-1; CANCER ANOREXIA; OLDER-ADULTS; INFLAMMATION; GUIDELINES; DIAGNOSIS; PEPTIDES; CACHEXIA; DISEASE	Background Appetite loss is one complication of chronic heart failure (CHF), and its association with pancreatic exocrine insufficiency (PEI) is not well investigated in CHF. Aim We attempted to detect the association between PEI and CHF-induced appetite. Methods Patients with CHF were enrolled, and body mass index (BMI), left ventricular ejection fraction (LVEF), New York Heart Association (NYHA) cardiac function grading, B-type natriuretic peptide (BNP), serum albumin, pro-albumin and hemoglobin were evaluated. The pancreatic exocrine function was measured by fecal elastase-1 (FE-1) levels in the enrolled patients. Appetite assessment was tested by completing the simplified nutritional appetite questionnaire (SNAQ). The improvement of appetite loss by supplemented pancreatic enzymes was also researched in this study. Results The decrease of FE-1 levels was found in patients with CHF, as well as SNAQ scores. A positive correlation was observed between SNAQ scores and FE-1 levels (r = 0.694, p < 0.001). Pancreatic enzymes supplement could attenuate the decrease of SNAQ scores in CHF patients with FE-1 levels < 200 mu g/g stool and SNAQ < 14. Conclusions Appetite loss is commonly seen in CHF, and is partially associated with pancreatic exocrine insufficiency. Oral pancreatic enzyme replacement therapy attenuates the chronic heart failure-induced appetite loss. These results suggest a possible pancreatic-cardiac relationship in chronic heart failure, and further experiment is needed for clarifying the possible mechanisms.	[Xia, Tingting; Shen, Jiaqing] Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China; [Chai, Xichen] Soochow Univ, Affiliated Hosp 1, Dept Cardiol, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China	Shen, JQ (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Gastroenterol, Suzhou, Jiangsu, Peoples R China.	sjqsz@126.com			National Natrual Science Foundation of China [81300357]; Suzhou Municipal Science and Technology Development Program [SYS201333]	National Natrual Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Municipal Science and Technology Development Program	This work was supported by National Natrual Science Foundation of China (No. 81300357) and Suzhou Municipal Science and Technology Development Program (SYS201333).	Aguilera A, 2003, AM J KIDNEY DIS, V42, P787, DOI 10.1016/S0272-6386(03)00920-X; Barrett GL, 2011, REGUL PEPTIDES, V170, P24, DOI 10.1016/j.regpep.2011.05.004; Chronic Heart Failure, 2010, NAT CLIN GUID DIAGN, P38; Cubbon RM, 2011, CIRC-HEART FAIL, V4, P396, DOI 10.1161/CIRCHEARTFAILURE.110.959882; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dominguez-Munoz JE, 2011, ADV MED SCI-POLAND, V56, P1, DOI 10.2478/v10039-011-0005-3; Dominici R, 2002, CLIN CHEM LAB MED, V40, P325, DOI 10.1515/CCLM.2002.051; Gandhi PU, 2014, ANN GLOB HEALTH, V80, P46, DOI 10.1016/j.aogh.2013.12.005; Haug U, 2007, CLIN CHEM, V53, P787, DOI 10.1373/clinchem.2006.078188; Hubbard RE, 2008, J AM GERIATR SOC, V56, P279, DOI 10.1111/j.1532-5415.2007.01548.x; Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022; Irving G, 2013, INT J CARDIOL, V168, P2304, DOI 10.1016/j.ijcard.2013.01.189; Kaur S, 2008, ASIA PAC J CLIN NUTR, V17, P199; Kemp CD, 2012, CARDIOVASC PATHOL, V21, P365, DOI 10.1016/j.carpath.2011.11.007; Landi F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020069; Leeds JS, 2011, NAT REV GASTRO HEPAT, V8, P405, DOI 10.1038/nrgastro.2011.91; Lindkvist B, 2013, WORLD J GASTROENTERO, V19, P7258, DOI 10.3748/wjg.v19.i42.7258; Loncar G, 2015, INT J CARDIOL, V201, pE1, DOI 10.1016/j.ijcard.2015.10.115; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Meijers WC, 2014, AM HEART J, V167, P853, DOI 10.1016/j.ahj.2014.02.011; Molfino A, 2017, J CACHEXIA SARCOPENI, V8, P40, DOI 10.1002/jcsm.12156; Ozcan M, 2015, TURK KARDIYOL DERN A, V43, P131, DOI 10.5543/tkda.2015.06606; Phillips MB, 2010, ASIA PAC J CLIN NUTR, V19, P440; Pongprasobchai S, 2013, J GASTROEN HEPATOL, V28, P99, DOI 10.1111/jgh.12406; Rahman A, 2016, JPEN-PARENTER ENTER, V40, P475, DOI 10.1177/0148607114566854; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Gracia JR, 2017, REV CLIN ESP, V217, P161, DOI 10.1016/j.rce.2016.10.012; Saitoh M, 2016, WIEN KLIN WOCHENSCHR, V128, P455, DOI 10.1007/s00508-016-1100-z; Scheede-Bergdahl C, 2012, CLIN NUTR, V31, P85, DOI 10.1016/j.clnu.2011.07.010; Smiechowska J, 2010, J INVEST MED, V58, P554, DOI 10.231/JIM.0b013e3181cf91ca; Stevenson LW, 2011, CIRC-HEART FAIL, V4, P390, DOI 10.1161/CIRCHEARTFAILURE.111.963066; Suresh Kp, 2011, J Hum Reprod Sci, V4, P8, DOI 10.4103/0974-1208.82352; Turrin NP, 2004, CURR OPIN CLIN NUTR, V7, P419, DOI 10.1097/01.mco.0000134373.16557.92; Visvanathan R, 2009, GASTROENTEROL CLIN N, V38, P393, DOI 10.1016/j.gtc.2009.06.009; Whitcomb DC, 2016, PANCREAS, V45, P679, DOI 10.1097/MPA.0000000000000514; Wilson Margaret-Mary G, 2007, Mo Med, V104, P46; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074; Xu YP, 2012, PANCREAS, V41, P922, DOI 10.1097/MPA.0b013e31823d7f2d	38	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187804	10.1371/journal.pone.0187804	http://dx.doi.org/10.1371/journal.pone.0187804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155861	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700016
J	Core, JQ; Mehrabi, M; Robinson, ZR; Ochs, AR; McCarthy, LA; Zaragoza, MV; Grosberg, A				Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Zaragoza, Michael V.; Grosberg, Anna			Age of heart disease presentation and dysmorphic nuclei in patients with LMNA mutations	PLOS ONE			English	Article							GILFORD PROGERIA SYNDROME; ENVELOPE ALTERATIONS; IMAGE-ANALYSIS; SHAPE; CARDIOMYOPATHY; FIBROBLASTS; LAMINA; INVAGINATIONS; DEFORMATION; FAMILY	Nuclear shape defects are a distinguishing characteristic in laminopathies, cancers, and other pathologies. Correlating these defects to the symptoms, mechanisms, and progression of disease requires unbiased, quantitative, and high-throughput means of quantifying nuclear morphology. To accomplish this, we developed a method of automatically segmenting fluorescently stained nuclei in 2D microscopy images and then classifying them as normal or dysmorphic based on three geometric features of the nucleus using a package of Matlab codes. As a test case, cultured skin-fibroblast nuclei of individuals possessing LMNA splice-site mutation (c.357-2A>G), LMNA nonsense mutation (c. 736 C>T, pQ246X) in exon 4, LMNA missense mutation (c.1003C>T, pR335W) in exon 6, Hutchinson-Gilford Progeria Syndrome, and no LMNA mutations were analyzed. For each cell type, the percentage of dysmorphic nuclei, and other morphological features such as average nuclear area and average eccentricity were obtained. Compared to blind observers, our procedure implemented in Matlab codes possessed similar accuracy to manual counting of dysmorphic nuclei while being significantly more consistent. The automatic quantification of nuclear defects revealed a correlation between in vitro results and age of patients for initial symptom onset. Our results demonstrate the method's utility in experimental studies of diseases affecting nuclear shape through automated, unbiased, and accurate identification of dysmorphic nuclei.	[Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Grosberg, Anna] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Core, Jason Q.; Mehrabi, Mehrsa; Robinson, Zachery R.; Ochs, Alexander R.; McCarthy, Linda A.; Grosberg, Anna] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Techn, Irvine, CA 92697 USA; [Zaragoza, Michael V.] Univ Calif Irvine, Sch Med, Pediat Genet & Gen Div, Irvine, CA 92717 USA; [Zaragoza, Michael V.] Univ Calif Irvine, Biol Chem Sch Med, Irvine, CA USA; [Grosberg, Anna] Univ Calif Irvine, Chem Engn & Mat Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Grosberg, A (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.; Grosberg, A (corresponding author), Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Techn, Irvine, CA 92697 USA.; Grosberg, A (corresponding author), Univ Calif Irvine, Chem Engn & Mat Sci, Irvine, CA 92697 USA.	grosberg@uci.edu		Grosberg, Anna/0000-0002-8878-0843	National Institutes of Health [NIHR01 HL129008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116270, R01HL129008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health [grant number: NIHR01 HL129008 2015-2020 (PIs: Grosberg, Zaragoza)]. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, J CELL SCI, V117, P6523, DOI 10.1242/jcs.01574; Araujo T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177544; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Booth-Gauthier EA, 2013, INTEGR BIOL-UK, V5, P569, DOI 10.1039/c3ib20231c; BOURGEOIS CA, 1979, J ULTRA MOL STRUCT R, V68, P328, DOI 10.1016/S0022-5320(79)90165-5; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Cardillo G, 2009, COHENS KAPPA MATLAB; Chernov N., 2009, ELLIPSE FIT DIRECT M; Choi S, 2011, NUCLEUS-PHILA, V2, P570, DOI 10.4161/nucl.2.6.17798; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Clubb BH, 1998, TISSUE CELL, V30, P684, DOI 10.1016/S0040-8166(98)80087-6; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Drew NK, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004190; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Georgatos SD, 1997, J CELL SCI, V110, P2129; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupta P, 2010, BASIC RES CARDIOL, V105, P365, DOI 10.1007/s00395-010-0085-4; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hoshiba T, 2008, BIOCHEM BIOPH RES CO, V374, P688, DOI 10.1016/j.bbrc.2008.07.112; Jevtic P, 2014, CURR OPIN CELL BIOL, V28, P16, DOI 10.1016/j.ceb.2014.01.003; Kim HK, 2011, J KOREAN MED SCI, V26, P1642, DOI 10.3346/jkms.2011.26.12.1642; Kroon DJ, 2010, SNAKE ACTIVE CONTOUR; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langevin HM, 2010, HISTOCHEM CELL BIOL, V133, P405, DOI 10.1007/s00418-010-0680-3; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Lu JT, 2011, DIS MODEL MECH, V4, P562, DOI 10.1242/dmm.006346; MAKOUS N, 1962, AM HEART J, V64, P334, DOI 10.1016/0002-8703(62)90148-5; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Muchir A, 2004, MUSCLE NERVE, V30, P444, DOI 10.1002/mus.20122; Nikonenko AG, 2015, CYTOM PART A, V87A, P309, DOI 10.1002/cyto.a.22612; Ogura M, 2016, MED MOL MORPHOL, V49, P76, DOI 10.1007/s00795-015-0121-4; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paradisi M, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-27; Park WB, 2017, IUCRJ, V4, P486, DOI 10.1107/S205225251700714X; Ropers Hans-Hilger, 2010, Dialogues Clin Neurosci, V12, P95; Schirrmeister RT, 2017, HUM BRAIN MAPP, V38, P5391, DOI 10.1002/hbm.23730; Sommer H. J, 1998, POLYGEOM; Wang P, 2016, SIGNAL PROCESS, V122, P1, DOI 10.1016/j.sigpro.2015.11.011; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wiggan O, 2017, SCI REP-UK, V7, DOI 10.1038/srep40953; Yap M. H., 2017, IEEE J BIOMEDICAL HL; Zaragoza MV, 2017, CLIN GENET, V91, P499, DOI 10.1111/cge.12870; Zaragoza MV, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040040; Zaragoza MV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155421; Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430	52	8	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188256	10.1371/journal.pone.0188256	http://dx.doi.org/10.1371/journal.pone.0188256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149195	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100032
J	Grimston, SK; Fontana, F; Watkins, M; Civitelli, R				Grimston, Susan K.; Fontana, Francesca; Watkins, Marcus; Civitelli, Roberto			Heterozygous deletion of both sclerostin (Sost) and connexin43 (Gja1) genes in mice is not sufficient to impair cortical bone modeling	PLOS ONE			English	Article							OSTEOBLAST; MECHANISMS; INCREASES; STRENGTH; SKELETON; MASS; LOAD	Connexin43 (Cx43) is the main gap junction protein expressed in bone forming cells, where it modulates peak bone mass acquisition and cortical modeling. Genetic ablation of the Cx43 gene (Gja1) results in cortical expansion with accentuated periosteal bone formation associated with decreased expression of the Wnt inhibitor sclerostin. To determine whether sclerostin (Sost) down-regulation might contribute to periosteal expansion in Gja1 deficient bones, we took a gene interaction approach and crossed mice harboring germline null alleles for Gja1 or Sost to generate single Gja1(+/-) and Sost(+/-) and double Gja1(+/-); Sost(+/-) heterozygous mice. In vivo mu CT analysis of cortical bone at age 1 and 3 months confirmed increased thickness in Sost(-/-) mice, but revealed no cortical abnormalities in single Gja1(+/-) or Sost(+/-) mice. Double heterozygous Gja1(+/-) Sost(+/-) also showed no differences in mineral density, cortical thickness, width or geometry relative to wild type control mice. Likewise, 3-point bending measurement of bone strength revealed no significant differences between double Gja1(+/-); Sost(+/-) or single heterozygous and wild type mice. Although these data do not exclude a contribution of reduced sclerostin in the cortical expansion seen in Gja1 deficient bones, they are not consistent with a strong genetic interaction between Sost and Gja1 dictating cortical modeling.	[Grimston, Susan K.; Fontana, Francesca; Watkins, Marcus; Civitelli, Roberto] Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis,Musculoskeletal Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL)	Fontana, F (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Div Bone & Mineral Dis,Musculoskeletal Res Ctr, St Louis, MO 63110 USA.	francesca.fontana@wustl.edu	Civitelli, Roberto/AAA-8260-2019; Watkins, Marcus/V-8817-2019	Civitelli, Roberto/0000-0003-4076-4315; Watkins, Marcus/0000-0002-1224-3478; Fontana, Francesca/0000-0002-5889-9413	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR041255, P30-R057235]; Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235, R01AR041255] Funding Source: NIH RePORTER	National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Barnes Jewish Hospital Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from National Institute of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (www.niams.nih.gov) R01-AR041255 (RC), P30-R057235 (Core Center for Musculoskeletal Biology and Medicine), and funds from the Barnes Jewish Hospital Foundation (RC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bivi N, 2013, J ORTHOP RES; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Florio M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11505; Grimston SK, 2006, ANN NY ACAD SCI, V1068, P214, DOI 10.1196/annals.1346.023; Grimston SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044222; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Guerrero PA, 1997, J CLIN INVEST, V99, P1991, DOI 10.1172/JCI119367; Kelly JJ, 2015, CELL TISSUE RES, V360, P701, DOI 10.1007/s00441-014-2024-4; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Morse A, 2014, J BONE MINER RES, V29, P2456, DOI 10.1002/jbmr.2278; Moustafa A, 2012, OSTEOPOROSIS INT, V23, P1225, DOI 10.1007/s00198-011-1656-4; Nguyen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053813; Plotkin LI, 2015, CELL MOL LIFE SCI, V72, P2853, DOI 10.1007/s00018-015-1963-6; Portney LG, 1993, FDN CLIN RES APPL PR, P525; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Silva MJ, 2000, J BIOMECH, V33, P231, DOI 10.1016/S0021-9290(99)00158-X; Stains JP, 2016, SEMIN CELL DEV BIOL, V50, P31, DOI 10.1016/j.semcdb.2015.12.017; Stains JP, 2014, CALCIFIED TISSUE INT, V94, P55, DOI 10.1007/s00223-013-9742-6; Stolina M, 2014, BONE, V67, P305, DOI 10.1016/j.bone.2014.07.031; van der Heyden MAG, 1998, J CELL SCI, V111, P1741; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Watkins MP, 2012, BONE, V51, P787, DOI 10.1016/j.bone.2012.06.018	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187980	10.1371/journal.pone.0187980	http://dx.doi.org/10.1371/journal.pone.0187980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149200	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100020
J	Manabe, S; Morimoto, C; Hamano, Y; Fujimoto, S; Tamaki, K				Manabe, Sho; Morimoto, Chie; Hamano, Yuya; Fujimoto, Shuntaro; Tamaki, Keiji			Development and validation of open-source software for DNA mixture interpretation based on a quantitative continuous model	PLOS ONE			English	Article							LOW-TEMPLATE; INTERNATIONAL SOCIETY; FORENSIC GENETICS; PROFILES; CASEWORK; RECOMMENDATIONS; POPULATION; COMMISSION; LOCI	In criminal investigations, forensic scientists need to evaluate DNA mixtures. The estimation of the number of contributors and evaluation of the contribution of a person of interest (POI) from these samples are challenging. In this study, we developed a new open-source software "Kongoh" for interpreting DNA mixture based on a quantitative continuous model. The model uses quantitative information of peak heights in the DNA profile and considers the effect of artifacts and allelic drop-out. By using this software, the likelihoods of 1-4 persons' contributions are calculated, and the most optimal number of contributors is automatically determined; this differs from other open-source software. Therefore, we can eliminate the need to manually determine the number of contributors before the analysis. Kongoh also considers allele-or locus-specific effects of biological parameters based on the experimental data. We then validated Kongoh by calculating the likelihood ratio (LR) of a POI's contribution in true contributors and non-contributors by using 2-4 person mixtures analyzed through a 15 short tandem repeat typing system. Most LR values obtained from Kongoh during true-contributor testing strongly supported the POI's contribution even for small amounts or degraded DNA samples. Kongoh correctly rejected a false hypothesis in the non-contributor testing, generated reproducible LR values, and demonstrated higher accuracy of the estimated number of contributors than another software based on the quantitative continuous model. Therefore, Kongoh is useful in accurately interpreting DNA evidence like mixtures and small amounts or degraded DNA samples.	[Manabe, Sho; Morimoto, Chie; Hamano, Yuya; Fujimoto, Shuntaro; Tamaki, Keiji] Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan; [Hamano, Yuya] Kyoto Prefectural Police Headquarters, Forens Sci Lab, Kyoto, Japan	Kyoto University	Tamaki, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Forens Med, Kyoto, Japan.	ktamaki@fp.med.kyoto-u.ac.jp		Tamaki, Keiji/0000-0003-2664-0471	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H05273, 14J03372]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 16H05273 and 14J03372.; We are very grateful to Ryo Yamada for his critique and insightful discussion on the manuscript. This work was supported by JSPS KAKENHI Grant Number 16H05273 and 14J03372.	[Anonymous], R LANG ENV STAT COMP; [Anonymous], 2011, QUALITY ASSURANCE ST; Bleka O, 2016, FORENSIC SCI INT-GEN, V25, P85, DOI 10.1016/j.fsigen.2016.07.016; Bleka O, 2016, FORENSIC SCI INT-GEN, V21, P35, DOI 10.1016/j.fsigen.2015.11.008; Bright JA, 2016, FORENSIC SCI INT-GEN, V23, P226, DOI 10.1016/j.fsigen.2016.05.007; Bright JA, 2013, AUST J FORENSIC SCI, V45, P445, DOI 10.1080/00450618.2013.772235; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Clayton TM, 1998, FORENSIC SCI INT, V91, P55, DOI 10.1016/S0379-0738(97)00175-8; Cowell RG, 2015, J R STAT SOC C-APPL, V64, P1, DOI 10.1111/rssc.12071; Evett I, 2000, SCI JUSTICE, V40, P233, DOI 10.1016/S1355-0306(00)71993-9; Gibb AJ, 2009, SCI JUSTICE, V49, P24, DOI 10.1016/j.scijus.2008.05.002; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2012, FORENSIC SCI INT-GEN, V6, P679, DOI 10.1016/j.fsigen.2012.06.002; Gill P, 2015, FORENSIC SCI INT-GEN, V18, P100, DOI 10.1016/j.fsigen.2015.03.014; Haned H, 2012, FORENSIC SCI INT-GEN, V6, P762, DOI 10.1016/j.fsigen.2012.08.008; Haned H, 2016, SCI JUSTICE, V56, P104, DOI 10.1016/j.scijus.2015.11.007; Hill CR, 2013, FORENSIC SCI INT-GEN, V7, pE82, DOI 10.1016/j.fsigen.2012.12.004; Kelly H, 2014, SCI JUSTICE, V54, P66, DOI 10.1016/j.scijus.2013.07.003; Lohmueller KE, 2013, J FORENSIC SCI, V58, pS243, DOI 10.1111/1556-4029.12017; Manabe S, 2016, LEGAL MED-TOKYO, V19, P16, DOI 10.1016/j.legalmed.2016.01.007; Manabe S, 2015, FORENS SCI INT-GEN S, V5, pE104, DOI 10.1016/j.fsigss.2015.09.042; Perlin MW, 2011, J FORENSIC SCI, V56, P1430, DOI 10.1111/j.1556-4029.2011.01859.x; Petricevic S, 2010, FORENSIC SCI INT-GEN, V4, P305, DOI 10.1016/j.fsigen.2009.11.003; Presciuttini S, 2016, FORENSIC SCI INT-GEN, V25, pE18, DOI 10.1016/j.fsigen.2016.08.005; Puch-Solis R, 2013, FORENSIC SCI INT-GEN, V7, P555, DOI 10.1016/j.fsigen.2013.05.009; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2015, GUID VAL PROB GEN SY; Steele CD, 2016, STAT APPL GENET MOL, V15, P431, DOI 10.1515/sagmb-2016-0038; Steele CD, 2014, FORENSIC SCI INT-GEN, V13, P82, DOI 10.1016/j.fsigen.2014.06.018; Swaminathan H, 2016, FORENSIC SCI INT-GEN, V22, P149, DOI 10.1016/j.fsigen.2016.02.005; Taylor D, 2013, FORENSIC SCI INT-GEN, V7, P516, DOI 10.1016/j.fsigen.2013.05.011; Yoshida K, 2005, J FORENSIC SCI, V50, P718	31	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188183	10.1371/journal.pone.0188183	http://dx.doi.org/10.1371/journal.pone.0188183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149210	Green Submitted, Green Published, gold			2022-12-27	WOS:000415646100026
J	Kim, Y; Kim, BK; Choi, HJ; Ryu, SW; Kim, ES; Chang, YS; Kim, HJ; Cha, JH; Kim, JH; Shin, C; Lee, SH				Kim, Young; Kim, Byeong Ki; Choi, Hong Jo; Ryu, Sung Weon; Kim, Eui Sook; Chang, Yoon Soo; Kim, Hee Jin; Cha, Jae Hyung; Kim, Je Hyeong; Shin, Chol; Lee, Seung Heon			Lessons learned from continued TB outbreaks in a high school	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; TUBERCULOSIS INFECTION; GUIDELINES; DISEASE; COUNTRIES	We investigated the aftereffects of confirmatory QuantiFERON testing (QFT) added to a positive tuberculin skin test (TST). We reviewed the pre and post course of sequential tuberculosis (TB) outbreaks in a high school where massive 43 active TB cases had been found within one year before delayed contact investigation. And we investigated the TB development in relation to initial TST and QFT during mean follow-up of 3.9 +/- 0.9 years. After delayed contact investigation for two subsequent TB outbreaks, 925 contacts were divided into the following 3 groups: TST-(n = 632), TST+/QFT+(n = 24), TST+/QFT-(n = 258). QFT-was more prevalent than QFT + in contacts with 10mm <= TST < 15mm (158, 61.2%) compared with TST >= 15mm (100, 38.8%) among the TST + reactors (P < 0.001). Among the 258 TST+/QFT-subjects, 256 received no latent TB infection (LTBI) treatment, but 7 contacts developed TB during follow-up. Among these 7 patients, 4 had initial TST >= 15mm and 3 had 10mm <= TST < 15mm. In conclusion, the delayed contact investigation for LTBI in a high school resulted in continued TB developments. False-negative QFT performed late among the TST + reactors should not be considered criteria for LTBI treatment. Additionally, the contacts only with TST >= 15mm should be considered for LTBI treatment in congregate settings of intermediate-burden countries.	[Kim, Young; Kim, Byeong Ki; Kim, Je Hyeong; Shin, Chol; Lee, Seung Heon] Korea Univ, Coll Med, Ansan Hosp, Div Pulm Sleep & Crit Care Med,Dept Internal Med, Ansan, South Korea; [Kim, Young; Chang, Yoon Soo] Yonsei Univ, Coll Med, Seoul, South Korea; [Choi, Hong Jo; Ryu, Sung Weon; Kim, Hee Jin] Korea Inst TB, Osong, South Korea; [Kim, Eui Sook] Publ Healthcare Ctr, Ansan, South Korea; [Cha, Jae Hyung] Korea Univ, Coll Med, Ansan Hosp, Med Sci Res Ctr, Ansan, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Yonsei University Health System; Korea University; Korea University Medicine (KU Medicine)	Lee, SH (corresponding author), Korea Univ, Coll Med, Ansan Hosp, Div Pulm Sleep & Crit Care Med,Dept Internal Med, Ansan, South Korea.	lee-sh@korea.ac.kr	Lee, Seungheon/F-3246-2019	Lee, Seungheon/0000-0002-7180-3877; Kim, Je Hyeong/0000-0002-8995-7460; Ryoo, Sungweon/0000-0002-5085-0068; Chang, Yoon Soo/0000-0003-3340-4223				Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Denkinger CM, 2011, CLIN MICROBIOL INFEC, V17, P806, DOI 10.1111/j.1469-0691.2011.03555.x; Gaur RL, 2013, J CLIN MICROBIOL, V51, P3521, DOI 10.1128/JCM.01627-13; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Lee SH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1117-3; Lee SH, 2010, RESP MED, V104, P448, DOI 10.1016/j.rmed.2009.10.006; Lee YK, 2015, PUBLIC HLTH WKLY REP, V8, P651; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; National Tuberculosis Controllers Association, GUID INV CONT PERS I; NICE (National Institute of Clinical Excellence), 2016, TUB NICE GUID NG33 TUB NICE GUID NG33; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Park JS, 2012, CHEST, V142, P1461, DOI 10.1378/chest.11-3299; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; WHO, 2014, GLOB TUB REP 2014; WHO Tuberculosis Programme, 1994, WHO TUB PROGR FRAM E; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188076	10.1371/journal.pone.0188076	http://dx.doi.org/10.1371/journal.pone.0188076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145443	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800061
J	Hemingway, C; Berk, M; Anderson, ST; Wright, VJ; Hamilton, S; Eleftherohorinou, H; Kaforou, M; Goldgof, GM; Hickman, K; Kampmann, B; Schoeman, J; Eley, B; Beatty, D; Pienaar, S; Nicol, MP; Griffiths, MJ; Waddell, SJ; Newton, SM; Coin, LJ; Relman, DA; Montana, G; Levin, M				Hemingway, Cheryl; Berk, Maurice; Anderson, Suzanne T.; Wright, Victoria J.; Hamilton, Shea; Eleftherohorinou, Hariklia; Kaforou, Myrsini; Goldgof, Greg M.; Hickman, Katy; Kampmann, Beate; Schoeman, Johan; Eley, Brian; Beatty, David; Pienaar, Sandra; Nicol, Mark P.; Griffiths, Michael J.; Waddell, Simon J.; Newton, Sandra M.; Coin, Lachlan J.; Relman, David A.; Montana, Giovanni; Levin, Michael			Childhood tuberculosis is associated with decreased abundance of T cell gene transcripts and impaired T cell function	PLOS ONE			English	Article							CLASS-II TRANSACTIVATOR; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSE; ANTIGEN PRESENTATION; EXPRESSION; INFECTION; INNATE; IMMUNOSUPPRESSION	The WHO estimates around a million children contract tuberculosis (TB) annually with over 80 000 deaths from dissemination of infection outside of the lungs. The insidious onset and association with skin test anergy suggests failure of the immune system to both recognise and respond to infection. To understand the immune mechanisms, we studied genome-wide whole blood RNA expression in children with TB meningitis (TBM). Findings were validated in a second cohort of children with TBM and pulmonary TB (PTB), and functional T-cell responses studied in a third cohort of children with TBM, other extrapulmonary TB (EPTB) and PTB. The predominant RNA transcriptional response in children with TBM was decreased abundance of multiple genes, with 140/ 204 (68%) of all differentially regulated genes showing reduced abundance compared to healthy controls. Findings were validated in a second cohort with concordance of the direction of differential expression in both TBM (r(2) = 0.78 p = 2x10(-16)) and PTB patients (r(2) = 0.71 p = 2x10(-1)6) when compared to a second group of healthy controls. Although the direction of expression of these significant genes was similar in the PTB patients, the magnitude of differential transcript abundance was less in PTB than in TBM. The majority of genes were involved in activation of leucocytes (p = 2.67E(-11)) and T-cell receptor signalling (p = 6.56E(-07)). Less abundant gene expression in immune cells was associated with a functional defect in T-cell proliferation that recovered after full TB treatment (p<0.0003). Multiple genes involved in T-cell activation show decreased abundance in children with acute TB, who also have impaired functional T-cell responses. Our data suggest that childhood TB is associated with an acquired immune defect, potentially resulting in failure to contain the pathogen. Elucidation of the mechanism causing the immune paresis may identify new treatment and prevention strategies.	[Hemingway, Cheryl; Anderson, Suzanne T.; Wright, Victoria J.; Hamilton, Shea; Kaforou, Myrsini; Goldgof, Greg M.; Hickman, Katy; Kampmann, Beate; Newton, Sandra M.; Levin, Michael] Imperial Coll London, Dept Med, Div Infect Dis, Sect Paediat, Norfolk Pl, London, England; [Berk, Maurice; Montana, Giovanni] Imperial Coll London, Fac Nat Sci, Dept Math, 80 Queens Gate, London, England; [Eleftherohorinou, Hariklia; Coin, Lachlan J.] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, Norfolk Pl, London, England; [Schoeman, Johan] Univ Stellenbosch, Tygerberg Hosp, Cape Town, South Africa; [Eley, Brian; Beatty, David; Pienaar, Sandra] Univ Cape Town, Red Cross War Mem Childrens Hosp, Cape Town, South Africa; [Nicol, Mark P.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Nicol, Mark P.] Natl Hlth Lab Serv, Cape Town, South Africa; [Griffiths, Michael J.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England; [Waddell, Simon J.] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Relman, David A.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Montana, Giovanni] Kings Coll London, Dept Biomed Engn, London, England	Imperial College London; Imperial College London; Imperial College London; Stellenbosch University; Tygerberg Hospital; University of Cape Town; University of Cape Town; University of Liverpool; University of Brighton; University of Sussex; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of London; King's College London	Levin, M (corresponding author), Imperial Coll London, Dept Med, Div Infect Dis, Sect Paediat, Norfolk Pl, London, England.	m.levin@imperial.ac.uk	Coin, Lachlan/O-4976-2019; Nicol, Mark/W-4149-2019; Waddell, Simon J/A-9170-2013; Schoeman, Johan/J-6765-2013; Coin, Lachlan JM/A-9001-2014	Coin, Lachlan/0000-0002-4300-455X; Nicol, Mark/0000-0002-1366-4805; Waddell, Simon J/0000-0002-3684-9116; Schoeman, Johan/0000-0002-5057-311X; Coin, Lachlan JM/0000-0002-4300-455X; Kaforou, Myrsini/0000-0001-9878-4007; Levin, Michael/0000-0003-2767-6919; Newton, Sandra/0000-0001-6545-9558; Wright, Victoria/0000-0001-7826-1516; Relman, David A./0000-0001-8331-1354; Goldgof, Gregory/0000-0001-8732-9834	Burroughs-Wellcome Wellcome Trust [DPPED PC1291]; Beit Fellowship [DPPED PC0844]; Thomas C. and Joan M. Merigan Endowment at Stanford University; Horn Foundation; WT [077273/Z/05/Z]; EU [Sante-2006-105-061]; Medical Research Council [MC_UP_A900_1122, MC_EX_MR/K011944/1] Funding Source: researchfish; MRC [MC_EX_MR/K011944/1, MC_UP_A900_1122] Funding Source: UKRI	Burroughs-Wellcome Wellcome Trust(Burroughs Wellcome Fund); Beit Fellowship; Thomas C. and Joan M. Merigan Endowment at Stanford University; Horn Foundation; WT; EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by a Burroughs-Wellcome Wellcome Trust program grant to Prof Levin, Prof Relman and Prof Eley (grant no: DPPED PC1291; https://wellcome.ac.uk). Suzanne T. Anderson was funded by a Beit Fellowship (grant no: DPPED PC0844; www.beittrust.org.uk). David A. Relman is supported by the Thomas C. and Joan M. Merigan Endowment at Stanford University, and by the Horn Foundation. Beate Kampmann was funded by a WT grant (077273/Z/05/Z). Shea Hamilton and Victoria J. Wright are supported by an EU action for diseases of poverty grant (Sante-2006-105-061; https://ec.europa.eu).	Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Anderson ST, 2014, NEW ENGL J MED, V370, P1712, DOI 10.1056/NEJMoa1303657; BECK JS, 1985, CLIN EXP IMMUNOL, V60, P49; Berk M, 2011, BIOINFORMATICS, V27, P1979, DOI 10.1093/bioinformatics/btr289; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chang ST, 2005, P NATL ACAD SCI USA, V102, P4530, DOI 10.1073/pnas.0500362102; Chaudhary V, 2017, CAN ASS RADIOL J; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Chintu C, 2002, LANCET, V360, P985, DOI 10.1016/S0140-6736(02)11082-8; Cliff JM, 2013, J INFECT DIS, V207, P18, DOI 10.1093/infdis/jis499; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Di Liberto D, 2007, TUBERCULOSIS, V87, P322, DOI 10.1016/j.tube.2007.01.003; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; Donald PR, 1998, INT J TUBERC LUNG D, V2, P704; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Ghorpade DS, 2013, J BIOL CHEM, V288, P20592, DOI 10.1074/jbc.M113.472183; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Herberg JA, 2013, J INFECT DIS, V208, P1664, DOI 10.1093/infdis/jit348; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hoang LT, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0102-6; Holland SM, 2007, IMMUNOL RES, V38, P342, DOI 10.1007/s12026-007-0045-8; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kumar P, 2012, IMMUNOL CELL BIOL, V90, P411, DOI 10.1038/icb.2011.54; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Roberts T, 2007, J INFECT DIS, V195, P870, DOI 10.1086/511277; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Saraav I, 2014, IMMUNOL CELL BIOL, V92, P741, DOI 10.1038/icb.2014.52; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5; van Well Gijs T J, 2009, Pediatrics, V123, pe1, DOI 10.1542/peds.2008-1353; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Wang TS, 2008, J MOL MED, V86, P495, DOI 10.1007/s00109-007-0300-4; WEIR RE, 1994, J IMMUNOL METHODS, V176, P93, DOI 10.1016/0022-1759(94)90353-0; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0185973	10.1371/journal.pone.0185973	http://dx.doi.org/10.1371/journal.pone.0185973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140996	Green Published, Green Accepted, gold			2022-12-27	WOS:000415260400004
J	Wu, C; Woo, JG; Zhang, NH				Wu, Cynthia; Woo, Jessica G.; Zhang, Nanhua			Association between urinary manganese and blood pressure: Results from National Health and Nutrition Examination Survey (NHANES), 2011-2014	PLOS ONE			English	Article							OXIDATIVE STRESS; BIOMARKERS; EXPOSURE; TOENAIL	Manganese is a trace mineral required for metabolism, growth and tissue formation, and reproduction. It is mainly obtained through food and water, as well as through occupational exposure. This study used data from National Health and Nutrition Examination Survey, combining the 2011-12 and 2013-14 cycles. We conducted linear regression analyses on urinary manganese and blood pressure. Significant negative associations (p<0.01) between urinary manganese and both systolic and diastolic blood pressure existed after adjusting for age, sex, body mass index, race/ethnicity, and status of taking antihypertensive medication. These results indicate that urinary manganese may play some role in blood pressure and protecting against hypertension, a major risk factor for cardiovascular disease.	[Wu, Cynthia; Woo, Jessica G.; Zhang, Nanhua] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wu, Cynthia] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD USA	Cincinnati Children's Hospital Medical Center; Johns Hopkins University	Zhang, NH (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.	nanhua.zhang@cchmc.org	Woo, Jessica/M-4984-2015	Woo, Jessica/0000-0003-3644-8432; Zhang, Nanhua/0000-0001-5796-3404				Aguirre JD, 2012, J BIOL CHEM, V287, P13541, DOI 10.1074/jbc.R111.312181; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; *ATSDR, 2012, TOX PROF MAN; Baradaran A, 2014, J RES MED SCI, V19, P358; Benjamin EJ, 2017, CIRCULATION, V135, P146; Cameron AC, 1997, J ECONOMETRICS, V77, P329; ELYAZIGI A, 1991, DIABETES RES CLIN EX, V18, P129; Hassani H, 2016, IND HEALTH, V54, P79, DOI 10.2486/indhealth.2014-0250; Jiang YM, 2005, CARDIOVASC TOXICOL, V5, P345, DOI 10.1385/CT:5:4:345; Laohaudomchok W, 2011, J OCCUP ENVIRON MED, V53, P506, DOI 10.1097/JOM.0b013e31821854da; Lee Yeon-Kyung, 2015, Clin Nutr Res, V4, P259, DOI 10.7762/cnr.2015.4.4.259; LUCCHINI R, 1995, SCAND J WORK ENV HEA, V21, P143, DOI 10.5271/sjweh.1369; Mordukhovich I, 2012, ENVIRON HEALTH PERSP, V120, P98, DOI 10.1289/ehp.1002805; O'Neal Stefanie L, 2015, Curr Environ Health Rep, V2, P315, DOI 10.1007/s40572-015-0056-x; SARIC M, 1975, ENVIRON RES, V10, P314, DOI 10.1016/0013-9351(75)90092-4	15	22	22	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188145	10.1371/journal.pone.0188145	http://dx.doi.org/10.1371/journal.pone.0188145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141052	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400065
J	Bao, XA; Xiong, ZJ; Zhang, N; Qian, JY; Wu, B; Zhang, W				Bao, Xiaoan; Xiong, Zijian; Zhang, Na; Qian, Junyan; Wu, Biao; Zhang, Wei			Path-oriented test cases generation based adaptive genetic algorithm	PLOS ONE			English	Article							EVOLUTIONARY ALGORITHMS	The automatic generation of test cases oriented paths in an effective manner is a challenging problem for structural testing of software. The use of search-based optimization methods, such as genetic algorithms (GAs), has been proposed to handle this problem. This paper proposes an improved adaptive genetic algorithm (IAGA) for test cases generation by maintaining population diversity. It uses adaptive crossover rate and mutation rate in dynamic adjustment according to the differences between individual similarity and fitness values, which enhances the exploitation of searching global optimum. This novel approach is experimented and tested on a benchmark and six industrial programs. The experimental results confirm that the proposed method is efficient in generating test cases for path coverage.	[Bao, Xiaoan; Xiong, Zijian; Zhang, Na; Wu, Biao; Zhang, Wei] Zhejiang Sci Tech Univ, Dept Informat Technol, Hangzhou, Zhejiang, Peoples R China; [Qian, Junyan] Guilin Univ Elect Technol, Guangxi Key Lab Trusted Software, Guilin, Peoples R China	Zhejiang Sci-Tech University; Guilin University of Electronic Technology	Zhang, N (corresponding author), Zhejiang Sci Tech Univ, Dept Informat Technol, Hangzhou, Zhejiang, Peoples R China.	zhangna@zstu.edu.cn			National Natural Science Foundation of China [61379036, 61502430, 61562015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by the National Natural Science Foundation of China (grant Nos. 61379036, 61502430, and 61562015). The funder information can be found at http://npd.nsfc.gov.cn/fundingProjectSearchAction!search.action. There was no additional external funding received for this study.	Abdul-Rahman OA, 2013, INFORM SCIENCES, V233, P54, DOI 10.1016/j.ins.2013.01.005; Alba E, 2008, COMPUT OPER RES, V35, P3161, DOI 10.1016/j.cor.2007.01.016; Aleti A, 2015, J SYST SOFTWARE, V103, P343, DOI 10.1016/j.jss.2014.11.035; Aleti A, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1501; Arcuri A, 2013, SOFTW TEST VERIF REL, V23, P119, DOI 10.1002/stvr.457; Awedikian Z., 2009, P 11 ANN C GENETIC E, P1657; Ribeiro JCB, 2010, STUD COMPUT INTELL, V284, P185; Do HS, 2005, EMPIR SOFTW ENG, V10, P405, DOI 10.1007/s10664-005-3861-2; Eiben AE, 2011, SWARM EVOL COMPUT, V1, P19, DOI 10.1016/j.swevo.2011.02.001; Ferrer J, 2012, SOFTWARE PRACT EXPER, V42, P1331, DOI 10.1002/spe.1135; [傅博 Fu Bo], 2005, [计算机工程与应用, Computer Engineering and Application], V41, P82; Girgis M. R., 2014, INT, V89, P29; Harman M, 2010, IEEE T SOFTWARE ENG, V36, P226, DOI 10.1109/TSE.2009.71; Korel B., 1992, Software Testing, Verification and Reliability, V2, P203, DOI 10.1002/stvr.4370020405; Maragathavalli P., 2012, 2012 International Conference on Advances in Engineering, Science and Management (ICAESM), P349; Mc Ginley B, 2011, IEEE T EVOLUT COMPUT, V15, P692, DOI 10.1109/TEVC.2010.2046173; McMinn P, 2004, SOFTW TEST VERIF REL, V14, P105, DOI 10.1002/stvr.294; Mei J, 2014, CHINESE J ELECTRON, V23, P494; Miller W., 1976, IEEE Transactions on Software Engineering, VSE-2, P223, DOI 10.1109/TSE.1976.233818; Nirpal Premal B., 2011, International Journal of Advanced Networking and Applications, V2, P911; Pachauri A, 2013, J SYST SOFTWARE, V86, P1191, DOI 10.1016/j.jss.2012.11.045; Park T, 2010, IEEE T EVOLUT COMPUT, V14, P865, DOI 10.1109/TEVC.2010.2043362; Srivastava P R, 2009, SCI REPORTS, V3, P134; Tracey N, 1998, 13TH IEEE INTERNATIONAL CONFERENCE ON AUTOMATED SOFTWARE ENGINEERING, PROCEEDINGS, P285, DOI 10.1109/ASE.1998.732680; Varshney Sapna, 2013, Software Engineering Notes, V38, P146, DOI 10.1145/2492248.2492277; Wegener J, 2001, INFORM SOFTWARE TECH, V43, P841, DOI 10.1016/S0950-5849(01)00190-2; Windisch A, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1121; Xanthakis S, 1992, P 5 INT C SOFTW ENG; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613	29	11	12	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187471	10.1371/journal.pone.0187471	http://dx.doi.org/10.1371/journal.pone.0187471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136028	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200020
J	Takeuchi, S; Shiga, T; Koyama, Y; Nakanishi, T; Honma, Y; Morita, H; Goto, T				Takeuchi, Shinya; Shiga, Takashi; Koyama, Yasuaki; Nakanishi, Taizo; Honma, Yosuke; Morita, Hiroshi; Goto, Tadahiro			Longitudinal acquisition of endotracheal intubation skills in novice physicians	PLOS ONE			English	Article							TRACHEAL INTUBATION; MACINTOSH LARYNGOSCOPE; HEMODYNAMIC-RESPONSES; EMERGENCY-DEPARTMENT; AIRWAY MANAGEMENT; ANESTHESIA	Little is known about the acquisition of intubation skills among novice physicians during their one-year clinical training. Our primary objective was to determine the changes in the intubation skills of novice physicians between prior to the clinical training and after completion of the clinical training. We used data of a prospective longitudinal multicenter data registry developed to investigate factors associated with the improvement of intubation skills among novice physicians. The study participants included 90 postgraduate year 1 physicians in 2015-2016. We used 4 simulation scenarios based on the devices used (direct laryngoscope [DL] and Airway scope [AWS]) and difficulty of intubation (normal and difficult scenarios). As a marker of the intubation skills, we used the force applied on the maxillary incisors and the tongue with each intubation. We compared the data obtained prior to clinical training with those obtained after completion of one-year clinical training. When using DL, compared to prior, significantly less force were applied on the maxillary incisors and the tongue after clinical training in the normal scenario (28.0 N vs 19.5 N, p < 0.001, and 11.1 N vs 8.4 N, p = 0.004). Likewise, when using AWS, compared to prior, significantly less force were applied on the tongue after clinical training in the normal scenario (22.0 N vs 0 N, p < 0.001). The force on the tongue decreased after clinical training but not significant. These associations persisted in the difficult airway scenario. These findings suggest that force applied on oral structures can be quantified as a marker of intubation skills by using high-fidelity simulators, and the assessment of procedural competency is recommended for all novice physicians prior to performing intubation in the clinical setting to improve the quality of emergency care.	[Takeuchi, Shinya] Teikyo Univ, Dept Emergency Med, Tokyo, Japan; [Takeuchi, Shinya; Shiga, Takashi; Honma, Yosuke] Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency & Crit Care Med, Urayasu, Japan; [Shiga, Takashi] Int Univ Hlth & Welf, Dept Emergency Med, Minato, Japan; [Koyama, Yasuaki] Univ Tsukuba Hosp, Dept Emergency & Crit Care Med, Tsukuba, Ibaraki, Japan; [Nakanishi, Taizo] Fukui Prefectural Hosp, Dept Emergency Med, Fukui, Japan; [Morita, Hiroshi] Univ Fukui Hosp, Dept Emergency Med, Fukui, Japan; [Goto, Tadahiro] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA	Teikyo University; International University of Health & Welfare; University of Tsukuba; University of Fukui; Harvard University; Harvard Medical School; Massachusetts General Hospital	Takeuchi, S (corresponding author), Teikyo Univ, Dept Emergency Med, Tokyo, Japan.; Takeuchi, S (corresponding author), Tokyo Bay Urayasu Ichikawa Med Ctr, Dept Emergency & Crit Care Med, Urayasu, Japan.	shitakeuchi-koc@umin.ac.jp		Takeuchi, Shinya/0000-0001-9037-9816				[Anonymous], 2009, EMERG MED J, V26, P604; Clark Ted R, 2013, J Grad Med Educ, V5, P70, DOI 10.4300/JGME-D-11-00268.1; Dashti Majid, 2014, Res Cardiovasc Med, V3, pe17598, DOI 10.5812/cardiovascmed.17598; DERBYSHIRE DR, 1983, BRIT J ANAESTH, V55, P855, DOI 10.1093/bja/55.9.855; Goto T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006416; Goto Y, 2014, ACUTE MED SURG, P8; Goto Y, 2017, RESUSCITATION, V114, P14, DOI 10.1016/j.resuscitation.2017.02.009; Hagiwara Y, 2015, AM J EMERG MED, V33, P1492, DOI 10.1016/j.ajem.2015.06.038; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kim C, 2013, EMERG MED J, V30, P888, DOI 10.1136/emermed-2012-201708; Kovac AL, 1996, J CLIN ANESTH, V8, P63, DOI 10.1016/0952-8180(95)00147-6; Kovacs G, 2004, CAN J ANAESTH, V51, P174, DOI 10.1007/BF03018780; Koyama Y, 2011, ANAESTHESIA, V66, P895, DOI 10.1111/j.1365-2044.2011.06802.x; Lee H, 2013, KOREAN J ANESTHESIOL, V64, P315, DOI [10.4097/kjae.2013.64.1.34, 10.4097/kjae.2013.64.4.315]; Maria GR, 2010, DENT TRAUMATOL, V26, P459, DOI 10.1111/j.1600-9657.2010.00935.x; Nakanishi T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011039; Nishikawa K, 2009, J NEUROSURG ANESTH, V21, P292, DOI 10.1097/ANA.0b013e3181a9c6dc; Owen H, 2000, ANAESTH INTENS CARE, V28, P133, DOI 10.1177/0310057X0002800202; Quinn JB, 2005, ANESTH ANALG, V100, P594, DOI 10.1213/01.ANE.0000151390.71913.9B; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Soleimanpour H, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-8; Yohan N, 2012, INT C COMPL MED ENG	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188224	10.1371/journal.pone.0188224	http://dx.doi.org/10.1371/journal.pone.0188224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136003	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200078
J	Blackwell, SB; Nations, CS; Thode, AM; Kauffman, ME; Conrad, AS; Norman, RG; Kim, KH				Blackwell, Susanna B.; Nations, Christopher S.; Thode, Aaron M.; Kauffman, Mandy E.; Conrad, Alexander S.; Norman, Robert G.; Kim, Katherine H.			Effects of tones associated with drilling activities on bowhead whale calling rates	PLOS ONE			English	Article							SHALLOW BEAUFORT SEA; ACOUSTIC COMMUNICATION; ANTHROPOGENIC SOUNDS; BALAENA-MYSTICETUS; FREQUENCY-SHIFT; AMBIENT NOISE; URBAN NOISE; INFORMATION; LOCALIZATION; EVOLUTION	During summer 2012 Shell performed exploratory drilling at Sivulliq, a lease holding located in the autumn migration corridor of bowhead whales (Balaena mysticetus), northwest of Camden Bay in the Beaufort Sea. The drilling operation involved a number of vessels performing various activities, such as towing the drill rig, anchor handling, and drilling. Acoustic data were collected with six arrays of directional recorders (DASARs) deployed on the sea-floor over similar to 7 weeks in Aug-Oct. Whale calls produced within 2 km of each DASAR were identified and localized using triangulation. A "tone index" was defined to quantify the presence and amplitude of tonal sounds from industrial machinery. The presence of airgun pulses originating from distant seismic operations was also quantified. For each 10-min period at each of the 40 recorders, the number of whale calls localized was matched with the "dose" of industrial sound received, and the relationship between calling rates and industrial sound was modeled using negative binomial regression. The analysis showed that with increasing tone levels, bowhead whale calling rates initially increased, peaked, and then decreased. This dual behavioral response is similar to that described for bowhead whales and airgun pulses in earlier work. Increasing call repetition rates can be a viable strategy for combating decreased detectability of signals arising from moderate increases in background noise. Meanwhile, as noise increases, the benefits of calling may decrease because information transfer becomes increasingly error-prone, and at some point calling may no longer be worth the effort.	[Blackwell, Susanna B.; Conrad, Alexander S.; Norman, Robert G.; Kim, Katherine H.] Greeneridge Sci Inc, Santa Barbara, CA 93117 USA; [Nations, Christopher S.; Kauffman, Mandy E.] Western EcoSyst Technol Inc, Cheyenne, WY USA; [Thode, Aaron M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Blackwell, SB (corresponding author), Greeneridge Sci Inc, Santa Barbara, CA 93117 USA.	susanna@greeneridge.com		Blackwell, Susanna B./0000-0001-7158-6852	Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc.; Western EcoSystems Technology, Inc.	Greeneridge Sciences, Inc., and Western EcoSystems Technology, Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	AU WWL, 1985, J ACOUST SOC AM, V77, P726, DOI 10.1121/1.392341; Bermudez-Cuamatzin E, 2011, BIOL LETTERS, V7, P36, DOI 10.1098/rsbl.2010.0437; Blackwell SB, 2006, J ACOUST SOC AM, V119, P182, DOI 10.1121/1.2140907; Blackwell SB, 2009, JOINT MONITORING PRO; Blackwell SB, 2016, COMPREHENSIVE REPORT; Blackwell SB, 2007, ARCTIC, V60, P255; Blackwell SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125720; Blackwell SB, 2013, MAR MAMMAL SCI, V29, pE342, DOI 10.1111/mms.12001; Brewer KD, 1993, KUVLUM 1 EXPLORATION; Brumm H, 2006, BEHAV ECOL SOCIOBIOL, V60, P475, DOI 10.1007/s00265-006-0188-y; Brumm H, 2011, BEHAVIOUR, V148, P1173, DOI 10.1163/000579511X605759; Castellote M, 2012, BIOL CONSERV, V147, P115, DOI 10.1016/j.biocon.2011.12.021; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Doyle LR, 2008, ENTROPY, V10, P33, DOI 10.3390/entropy-e10020033; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Gallagher ML, 1992, AMOCO PRODUCTION CO; Givens GH, 2013, SCI COMM INT WHAL CO; Greene CR, 2004, J ACOUST SOC AM, V116, P799, DOI 10.1121/1.1765191; Greene Jr CR, 1987, RESPONSES BOWHEAD OF; Hage SR, 2013, P NATL ACAD SCI USA, V110, P4063, DOI 10.1073/pnas.1211533110; Hall JD, 1994, 1993 KUVLUM EXPLORAT, V1; Hall JD, 1993, 1993 KUVLUM EXPLORAT, V2; Holt MM, 2009, J ACOUST SOC AM, V125, pEL27, DOI 10.1121/1.3040028; Lengagne T, 1999, P ROY SOC B-BIOL SCI, V266, P1623, DOI 10.1098/rspb.1999.0824; LGL Alaska Research Associates Inc JASCO Applied Sciences Inc and Greeneridge Sciences Inc. Joint Monitoring Program in the Chukchi and Beaufort Seas, 2012, P12722 LGL AL US FIS; LGL and Greeneridge, 1987, RESP BOWH OFFSH DRIL; Moore Sue E., 1993, Society for Marine Mammalogy Special Publication, V2, P313; National Energy Board, 2011, REV OFFSH DRILL CAN; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; RICHARDSON WJ, 1990, MAR ENVIRON RES, V29, P135, DOI 10.1016/0141-1136(90)90032-J; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Scheifele PM, 2005, J ACOUST SOC AM, V117, P1486, DOI 10.1121/1.1835508; Schuster S, 2012, BIOL LETTERS, V8, P913, DOI 10.1098/rsbl.2012.0676; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shannon C. E., 1949, MATH THEORY COMMUNIC; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Sun JWC, 2005, BIOL CONSERV, V121, P419, DOI 10.1016/j.biocon.2004.05.017; Suzuki R, 2006, J ACOUST SOC AM, V119, P1849, DOI 10.1121/1.2161827; Thode AM, 2017, J ACOUST SOC AM, V142, P1482, DOI 10.1121/1.5001064; Thode AM, 2016, J ACOUST SOC AM, V140, P4288, DOI 10.1121/1.4968853; Thode AM, 2012, J ACOUST SOC AM, V131, P3726, DOI 10.1121/1.3699247; Van Trees H. L, 2004, OPTIMUM ARRAY PROC 4; Welsch R. E, 2004, REGRESSION DIAGNOSTI	45	5	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188459	10.1371/journal.pone.0188459	http://dx.doi.org/10.1371/journal.pone.0188459			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161308	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000059
J	Koping, M; Shehata-Dieler, W; Cebulla, M; Rak, K; Oder, D; Muntze, J; Nordbeck, P; Wanner, C; Hagen, R; Schraven, S				Koeping, Maria; Shehata-Dieler, Wafaa; Cebulla, Mario; Rak, Kristen; Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph; Hagen, Rudolf; Schraven, Sebastian			Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-ALPHA; SAFETY	Background Fabry disease (FD) is an X-linked recessive hereditary lysosomal storage disorder which results in the accumulation of globotriaosylceramid (Gb3) in tissues of kidney and heart as well as central and peripheral nervous system. Besides prominent renal and cardiac organ involvement, cochlear symptoms like high-frequency hearing loss and tinnitus are frequently found with yet no comprehensive data available in the literature. Objective To examine hearing loss in patients with FD depending on cardiac and renal function. Material and methods Single-center study with 68 FD patients enrolled between 2012 and 2016 at the Department of Oto-Rhino-Laryngology, Plastic, Aesthetic and Reconstructive Head and Neck Surgery of the University of Wurzburg. Every subject underwent an oto-rhino-laryngological examination as well as behavioral, electrophysiological and electroacoustical audiological testing. High-frequency thresholds were evaluated by using a modified PTA(6) (0.5, 1, 2, 4, 6, 8) and HF-PTA (6, 8 kHz). Renal function was measured by eGFR, cardiac impairment was graduated by NYHA class. Results Sensorineural hearing loss was detected in 58.8% of the cohort, which occurred typically in sudden episodes and affected especially high frequencies. Hearing loss is asymmetric, beginning unilaterally and affecting the contralateral ear later. Tinnitus was reported by 41.2%. Renal and cardiac impairment influenced the severity of hearing loss (p < 0.05). Conclusions High frequency hearing loss is a common problem in patients with FD. Although not life-threatening, it can seriously reduce quality of life and should be taken into account in diagnosis and therapy. Optimized extensive hearing assessment including higher frequency thresholds should be used.	[Koeping, Maria; Shehata-Dieler, Wafaa; Cebulla, Mario; Rak, Kristen; Hagen, Rudolf; Schraven, Sebastian] Univ Hosp Wurzburg, Comprehens Hearing Ctr, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany; [Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Dept Internal Med 1, Wurzburg, Germany; [Oder, Daniel; Muentze, Jonas; Nordbeck, Peter; Wanner, Christoph] Univ Hosp Wurzburg, Fabry Ctr Interdisciplinary Therapy FAZIT, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Koping, M (corresponding author), Univ Hosp Wurzburg, Comprehens Hearing Ctr, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany.	koeping_m@ukw.de	Schraven, Sebastian/AAA-3284-2020; Nordbeck, Peter/D-4771-2018; Rak, Kristen/AFM-2679-2022	Nordbeck, Peter/0000-0002-2560-4068; Rak, Kristen/0000-0003-2109-3536; Koping, Maria/0000-0003-2431-2511	Amicus; Sanofi-Genzyme; Shire; Actelion; Protalix	Amicus; Sanofi-Genzyme; Shire; Actelion; Protalix	DO received speaker's honoraria from Sanofi-Genzyme and travel assistance from Sanofi-Genzyme and Shire. JM received travel assistance from Sanofi-Genzyme, Shire and Amicus. PN received travel assistance, speaker's/advisory board honoraria, and research support from Amicus, Sanofi-Genzyme and Shire. CW received travel assistance, speaker's/advisory board honoraria, and research support from Actelion, Protalix, Sanofi-Genzyme and Shire. The other authors declare no conflicts of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biegstraaten MArngrAomssonR, 2015, ORPHANET J RARE DIS, V10, P3733; Conti G, 2003, ACTA PAEDIATR, V92, P33, DOI 10.1080/08035320310000447; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Abassi R, 2014, J NEUROL SCI, V344, P5, DOI 10.1016/j.jns.2014.06.029; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Germain Dominique P, 2002, BMC Med Genet, V3, P10, DOI 10.1186/1471-2350-3-10; Hajioff D, 2003, J INHERIT METAB DIS, V26, P787, DOI 10.1023/B:BOLI.0000009948.86528.72; Hegemann S, 2006, EUR J CLIN INVEST, V36, P654, DOI 10.1111/j.1365-2362.2006.01702.x; Hoffmann B, 2009, DTSCH ARZTEBL INT, V106, P440, DOI 10.3238/arztebl.2009.0440; Hughes DA, 2008, HEART, V94, P153, DOI 10.1136/hrt.2006.104026; Hwu WL, 2009, HUM MUTAT, V30, P1397, DOI 10.1002/humu.21074; Keilmann A, 2006, FABRY DIS PERSPECTIV; Keilmann A, 2006, FABRY DIS PERSPECTIV; Kuemmerle-Deschner JB, 2015, PEDIATR RHEUMATOL, V13, P1273; Limberger A, 2007, HNO, V55, P185, DOI 10.1007/s00106-006-1454-z; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Palla A, 2007, J NEUROL, V254, P1433, DOI 10.1007/s00415-007-0575-y; SCHACHERN PA, 1989, ANN OTO RHINOL LARYN, V98, P359, DOI 10.1177/000348948909800509; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Sergi B, 2010, ACTA OTORHINOLARYNGO, V30, P87; Spada M, 2006, AM J HUM GENET, V79, P31, DOI 10.1086/504601; Spoor A, 2009, INT AUDIOL, V6, P48; Vibert D, 2006, ANN OTO RHINOL LARYN, V115, P412, DOI 10.1177/000348940611500603; Wanner C, 2004, MORBUS FABRY KLINIK; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007	29	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188103	10.1371/journal.pone.0188103	http://dx.doi.org/10.1371/journal.pone.0188103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161295	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000030
J	Pegg, G; Taylor, T; Entwistle, P; Guymer, G; Giblin, F; Carnegie, A				Pegg, Geoff; Taylor, Tamara; Entwistle, Peter; Guymer, Gordon; Giblin, Fiona; Carnegie, Angus			Impact of Austropuccinia psidii (myrtle rust) on Myrtaceae-rich wet sclerophyll forests in south east Queensland	PLOS ONE			English	Article							PUCCINIA-PSIDII; EUCALYPTUS RUST; GUAVA RUST; DISEASE; AUSTRALIA; PATHOGEN	In April 2010, Austropuccinia psidii (formerly Puccinia psidii) was detected for the first time in Australia on the central coast of New South Wales. The fungus spread rapidly along the east coast and can now be found infecting vegetation in a range of native forest ecosystems with disease impacts ranging from minor leaf spots to severe shoot and stem blight and tree dieback. Localised extinction of some plant species has been recorded. In 2014, the impact of A. psidii was observed for the first time in a wet sclerophyll site with a rainforest under-story, dominated by species of Myrtaceae, in Tallebudgera Valley, south east Queensland, Australia. This study aimed to determine the impact of A. psidii on individual species and species composition. Here we provide quantitative and qualitative evidence on the significant impact A. psidii has in native ecosystems, on a broader range of species than previously reported. Archirhodomyrtus beckleri, Decaspermum humile, Gossia hillii and Rhodamnia maideniana are in serious decline, with significant increases in tree mortality over the period of our study. This research further highlights the potential of this invasive pathogen to negatively impact native ecosystems and biodiversity.	[Pegg, Geoff; Giblin, Fiona] Hort & Forestry Sci, Dept Agr & Fisheries, Brisbane, Qld, Australia; [Pegg, Geoff; Carnegie, Angus] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia; [Taylor, Tamara] Griffith Univ, Nathan, Qld, Australia; [Entwistle, Peter] North East Agr Serv, Parramatta, NSW, Australia; [Guymer, Gordon] Queensland Herbarium, Dept Sci Informat Technol & Innovat, Mt Coot Tha, Qld, Australia; [Carnegie, Angus] NSW Forest Sci, NSW Dept Primary Ind, Parramatta, NSW, Australia	Griffith University; NSW Department of Primary Industries	Pegg, G (corresponding author), Hort & Forestry Sci, Dept Agr & Fisheries, Brisbane, Qld, Australia.; Pegg, G (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.	geoff.pegg@daf.qld.gov.au	Carnegie, Angus James/H-6153-2015	Carnegie, Angus James/0000-0002-6854-4974; Pegg, Geoffrey/0000-0002-0957-9755	Plant Biosecurity Cooperative Research Centre [CRC2063]; Australian Government's Cooperative Research Centres Program	Plant Biosecurity Cooperative Research Centre; Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Financial support was provided by the Plant Biosecurity Cooperative Research Centre CRC2063 (www.pbcrc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Doug and Lyndria Cook for kindly allowing access to their property so that we could complete this study, Kristopher Kupsch for helping provide data from sites in NSW and Dr Helen Nahrung for reviewing the manuscript. The authors would like to acknowledge the support of the Australian Government's Cooperative Research Centres Program.	Ashton D. H., 1981, Fire and the Australian biota., P339; Ashton D.H., 1994, AUSTR VEGETATION, P157; Beadle NCW, 1981, ECOLOGICAL BIOGEOGRA, P407; Beenken L, 2017, PHYTOTAXA, V297, P53, DOI 10.11646/phytotaxa.297.1.5; Booth TH, 2012, AUSTRALAS PLANT PATH, V41, P425, DOI 10.1007/s13313-012-0130-x; Brophy JJ, 1996, FLAVOUR FRAG J, V11, P133, DOI [10.1002/(SICI)1099-1026(199603)11:2<133::AID-FFJ564>3.0.CO;2-2, 10.1002/(SICI)1099-1026(199603)11:2&lt;133::AID-FFJ564&gt;3.0.CO;2-2]; Carnegie AJ, 2010, AUSTRALAS PLANT PATH, V39, P463, DOI 10.1071/AP10102; Carnegie AJ, 2016, BIOL INVASIONS, V18, P127, DOI 10.1007/s10530-015-0996-y; Cummings J, 2007, RESTOR ECOL, V15, P156, DOI 10.1111/j.1526-100X.2006.00200.x; de Plessis E, 2017, PLANT DIS, V101, P1676, DOI [10.1094/pdis-04-17-0530-pdn, 10.1094/PDIS-04-17-0530-PDN]; Giblin F. R., 2014, PUCCINIA PSIDII MYRT; Giblin F. R., 2013, MYRTLE RUST REPORT N; Gooden B, 2009, BIOL CONSERV, V142, P2631, DOI 10.1016/j.biocon.2009.06.012; Kimbrough JW, 1980, P FLORIDA STATE HORT, V93, P111; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Kriticos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064479; Machado PD, 2015, AUSTRALAS PLANT PATH, V44, P455, DOI 10.1007/s13313-015-0364-5; Makinson R. O., 2014, Gardens' Bulletin (Singapore), V66, P173; McTaggart AR, 2016, AUSTRALAS PLANT PATH, V45, P83, DOI [10.1007/s13313-014-0323-6, 10.1007/s13313-015-0386-z]; Mellano V, 2006, HLTH GARD HLTH HOME, V1, P3; Myerscough Peter J., 1998, Cunninghamia, V5, P787; Peeters PJ, 2014, WET SCLEROPHYLL FORE; Pegg GS, 2014, PLANT PATHOL, V63, P1005, DOI 10.1111/ppa.12173; Pegg GS, 2012, CRC70186; Roux J, 2013, IMA FUNGUS, V4, P155, DOI 10.5598/imafungus.2013.04.01.14; Schomaker M.E., 2007, SRS102 USDA FOR SERV; Specht R.L., 1981, ECOLOGICAL BIOGEOGRA, P163; Uchida J, 2006, PLANT DIS, V90, P524, DOI 10.1094/PD-90-0524C; WESTAWAY JO, 2016, NORTH TERRIT NAT OCT, P13; Winter G, 1884, HEDWIGIA, V23, P164	30	37	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188058	10.1371/journal.pone.0188058	http://dx.doi.org/10.1371/journal.pone.0188058			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161305	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000029
J	Fischhoff, IR; Keesing, F; Ostfeld, RS				Fischhoff, Ilya R.; Keesing, Felicia; Ostfeld, Richard S.			The tick biocontrol agent Metarhizium brunneum (= M. anisopliae) (strain F52) does not reduce non-target arthropods	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; ENTOMOPATHOGENIC FUNGI; LYME-DISEASE; HYPOCREALES CLAVICIPITACEAE; BORRELIA-BURGDORFERI; BEAUVERIA-BASSIANA; STATISTICAL POWER; IXODIDAE; INSECTICIDES; HYMENOPTERA	Previous studies have found that Met52 (R), which contains the entomopathogenic fungus Metarhizium brunneum, is effective in reducing the abundance of Ixodes scapularis, the tick vector for the bacterium causing Lyme disease and for other tick-borne pathogens. Given widespread interest in effective, safe methods for controlling ticks, Met52 has the potential to be used at increasing scales. The non-target impacts of Met52, as applied for tick control, have not yet been assessed. A Before-After-Control-Impact experiment was conducted to assess the effects of Met52 on non-target arthropods in lawn and forest habitats typical of residential yards. Ground-dwelling arthropods were collected using bulk sampling of soil and litter, and pitfall sampling. Arthropods were sampled once before and twice after treatment of plots with either Met52 or water (control). Multivariate general linear models were used to jointly model the abundance of arthropod orders. For each sampling method and post-spray sampling occasion, Akaike Information Criterion values were used to compare the fits of two alternative models: one that included effects of period (before vs. after spray), habitat (lawn vs. forest), and treatment (Met52 vs. control), versus a nested null model that included effects of period, and habitat, but no treatment effect. The null model was consistently better supported by the data. Significant effects were found of period and habitat but not treatment. Retrospective power analysis indicated the study had 80% power to detect a 50% reduction in arthropod abundance, as measured by bulk samples taken before versus one week after treatment. The deployment of Met52 in suburban settings is unlikely to cause meaningful reductions in the abundance of non-target arthropods.	[Fischhoff, Ilya R.; Ostfeld, Richard S.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Keesing, Felicia] Bard Coll, Annandale On Hudson, NY USA	Cary Institute of Ecosystem Studies	Fischhoff, IR (corresponding author), Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA.	Fischhoff@gmail.com	Fischhoff, Ilya/B-6303-2014	Fischhoff, Ilya/0000-0001-6956-8284; Ostfeld, Richard/0000-0002-3707-9301	Steven & Alexandra Cohen Foundation	Steven & Alexandra Cohen Foundation	The work was funded by a grant from the Steven & Alexandra Cohen Foundation (http:// www.steveandalex.org) to FK and RSO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge major support for The Tick Project from the Steven and Alexandra Cohen Foundation. We thank Mike Fargione for guidance in use of pesticides, and Heather Malcolm for guidance in arthropod sorting. We thank Sophia Raithel for collecting and sorting the pitfall samples, and Alexandra Clarke for sorting bulk samples. We also thank the many other Project Assistants for their hard work gathering and sorting samples. James Burtis and two anonymous reviewers provided valuable comments on previous drafts. We thank Alison Hinckley, Lars Eisen, and Ben Beard for advice. This is a contribution to the program of the Cary Institute of Ecosystem Studies.	Abonyo EA, 2016, INT J TROP INSECT SC, V36, P128, DOI 10.1017/S1742758416000114; Aenishaenslin C, 2014, BMC PUBLIC HEALTH, V1, P1; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Babendreier D, 2015, J APPL ENTOMOL, V139, P457, DOI 10.1111/jen.12229; Barrett PN, 2013, EXPERT REV VACCINES, V12, P101, DOI [10.1586/ERV.12.141, 10.1586/erv.12.141]; Bharadwaj A, 2010, J MED ENTOMOL, V47, P862, DOI 10.1603/ME10020; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Blumel S, 2000, IOBC WPRS, P145; Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026; Conner MM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5526-6; CURRAN KL, 1993, J MED ENTOMOL, V30, P107, DOI 10.1093/jmedent/30.1.107; Dister SW, 1997, AM J TROP MED HYG, V57, P687, DOI 10.4269/ajtmh.1997.57.687; Dolan MC, 2004, J MED ENTOMOL, V41, P1043, DOI 10.1603/0022-2585-41.6.1043; Dromph KM, 2002, APPL SOIL ECOL, V21, P197, DOI 10.1016/S0929-1393(02)00092-6; Duan JJ, 2006, ECOL ENTOMOL, V31, P521, DOI 10.1111/j.1365-2311.2006.00811.x; Eisen L, 2016, J MED ENTOMOL, V53, P1063, DOI 10.1093/jme/tjw103; Elias SP, 2013, J MED ENTOMOL, V50, P126, DOI 10.1603/ME12124; Erler F, 2013, EGYPT J BIOL PEST CO, V23, P233; European Commission, 2008, INT RISK ASS PROV RA; European Commission, 2014, EUR COMM REV REP ACT; European Food Safety Authority, 2012, EFSA J, V8, P1; Fischhoff IR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187675; Garrido-Jurado I, 2011, BIOL CONTROL, V59, P239, DOI 10.1016/j.biocontrol.2011.07.001; Goble TA, 2015, J ECON ENTOMOL, V108, P433, DOI 10.1093/jee/tov013; Gould LH, 2008, VECTOR-BORNE ZOONOT, V8, P769, DOI 10.1089/vbz.2007.0221; Grear JS, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-292; Hinckley AF, 2016, J INFECT DIS, V214, P182, DOI 10.1093/infdis/jiv775; Hornbostel VL, 2005, J VECTOR ECOL, V30, P91; Johnson N. F., 2005, BORROR DELONGS INTRO; Kirchmair M, 2004, IOBC WRPS B, P157; Kivett JM, 2016, J ENTOMOL SCI, V51, P274, DOI 10.18474/JES16-07.1; Kugeler KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P337, DOI 10.1111/zph.12245; Kugeler KJ, 2015, EMERG INFECT DIS, V21, P1455, DOI 10.3201/eid2108.141878; Larson JL, 2012, PEST MANAG SCI, V68, P740, DOI 10.1002/ps.2321; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Mauchline N. A., 2013, New Zealand Plant Protection, V66, P324; Mowbray F, 2012, VECTOR-BORNE ZOONOT, V12, P817, DOI 10.1089/vbz.2011.0774; Myrand V, 2015, J ECON ENTOMOL, V108, P34, DOI 10.1093/jee/tou019; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; NIELSEN C, 2004, BIOL CONTROL WEEVILS; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2006, BIOSCIENCE, V56, P383, DOI 10.1641/0006-3568(2006)056[0383:CTATZW]2.0.CO;2; Peng GX, 2008, CROP PROT, V27, P1244, DOI 10.1016/j.cropro.2008.03.007; Perry JN, 2003, J APPL ECOL, V40, P17, DOI 10.1046/j.1365-2664.2003.00786.x; Peveling R, 1999, CROP PROT, V18, P323, DOI 10.1016/S0261-2194(99)00032-0; R Development Core Team, 2016, R NEWS; Richer LM, 2014, J INFECT DIS, V209, P1972, DOI 10.1093/infdis/jiu005; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; Saito T, 2016, BIOL CONTROL, V92, P92, DOI 10.1016/j.biocontrol.2015.10.003; Samish M, 2001, TRENDS PARASITOL, V17, P368, DOI 10.1016/S1471-4922(01)01985-7; Sanchez-Bayo F.P., 2012, J ENV ANAL TOXICOL, VS4, pS4; Schluns H, 2009, MYRMECOL NEWS, V12, P237; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Stafford KC, 2010, J MED ENTOMOL, V47, P1107, DOI 10.1603/ME10019; Stehr F.W., 1987, IMMATURE INSECTS; Tangtrakulwanich K., 2014, Journal of Agricultural Science (Toronto), V6, P1; U. S. Environmental Protection Agency, 2000, BIOSP REG ACT DOC ME; Vestergaard Susanne, 2000, IOBC-WPRS Bulletin, V23, P181; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2008, J AM STAT ASSOC, V103, P340, DOI 10.1198/016214508000000021	60	25	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187675	10.1371/journal.pone.0187675	http://dx.doi.org/10.1371/journal.pone.0187675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155838	gold, Green Published			2022-12-27	WOS:000415756700013
J	Wang, SS; Zhang, YX; Yang, F; Huang, ZQ; Tang, J; Hu, KD; Zhang, H				Wang, Sha-Sha; Zhang, Ying-Xin; Yang, Feng; Huang, Zhong-Qin; Tang, Jun; Hu, Kang-Di; Zhang, Hua			Sulfur dioxide alleviates programmed cell death in barley aleurone by acting as an antioxidant	PLOS ONE			English	Article							NITRIC-OXIDE; BETA-AMYLASE; METABOLISM; PLANTS	Sulfur dioxide (SO2), a gaseous signaling molecule in animal cells, has recently been found to play a physiological role in plants. Here we studied the role of SO2 in gibberellic acid (GA3)-induced programmed cell death (PCD) in barley (Hordeum vulgare L.) aleurone layers. The application of the SO2 donor (NaHSO3/Na2SO3, 1: 3 M/ M) effectively alleviated PCD in barley aleurone layers in a dose- dependent manner with an optimal concentration of 50 mu M. Further investigations showed that SO2 reduced the accumulation of hydrogen peroxide (H2O2), superoxide anion (center dot O-2(-)) and malondialdehyde (MDA) in aleurone layers. Moreover, the activities of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APX), glutathione reductase (GR) and guaiacol peroxidase (POD) were enhanced by SO2 donor treatment. Meanwhile, lipoxygenase (LOX) activity was attenuated by SO2 donor treatment. Furthermore, an induction of endogenous H2S and NO were also observed in SO2-treated aleurone layers, suggesting interactions of SO2 with other well- known signaling molecules. Taken together, we show that SO2 negatively regulated PCD by acting as an antioxidant to scavenge excessive reactive oxygen species (ROS) generated during PCD.	[Wang, Sha-Sha; Zhang, Ying-Xin; Hu, Kang-Di; Zhang, Hua] Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China; [Yang, Feng; Huang, Zhong-Qin; Tang, Jun] Xuzhou Inst Agr Sci Xuhuai Dist Jiangsu Prov, Xuzhou, Peoples R China	Hefei University of Technology; Jiangsu Academy of Agricultural Sciences	Hu, KD; Zhang, H (corresponding author), Hefei Univ Technol, Sch Food Sci & Engn, Hefei, Anhui, Peoples R China.	kangdihuhfut@gmail.com; hzhanglab@hfut.edu.cn			National Natural Science Foundation of China [31271803, 31470013, 31670278, 31300133]; Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS); Natural Science Foundations of Anhui Province [11040606M85]; Anhui Provincial Education Department [2012AJZR0028, ZD200910]; earmarked fund for China Agriculture Research System [CARS-10-B1]; Anhui Provincial Science and Technology Major Project [6030701073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS)(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Natural Science Foundations of Anhui Province; Anhui Provincial Education Department; earmarked fund for China Agriculture Research System; Anhui Provincial Science and Technology Major Project	This work was supported by National Natural Science Foundation of China (31271803, 31470013, 31670278 to Dr. Hua Zhang; 31300133 to Dr. Kang-Di Hu), Scientific Research Foundation for Returned Overseas Chinese Scholars (SRF for ROCS, MOE to Dr. Hua Zhang), Natural Science Foundations of Anhui Province (11040606M85 to Dr. Hua Zhang), Anhui Provincial Education Department (2012AJZR0028, ZD200910 to Dr. Hua Zhang), the earmarked fund for China Agriculture Research System (CARS-10-B1 to Jun Tang) and Anhui Provincial Science and Technology Major Project (6030701073 to Dr. Hua Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethke PC, 1999, PLANT CELL, V11, P1033, DOI 10.1105/tpc.11.6.1033; Bethke PC, 2001, PLANT J, V25, P19, DOI 10.1046/j.1365-313x.2001.00930.x; CHRISPEE.MJ, 1967, PLANT PHYSIOL, V42, P398, DOI 10.1104/pp.42.3.398; COLLINS GG, 1972, PLANT PHYSIOL, V49, P404, DOI 10.1104/pp.49.3.404; DELMAESTRO RF, 1981, MICROVASC RES, V22, P239, DOI 10.1016/0026-2862(81)90095-9; Fath A, 2001, PLANT PHYSIOL, V126, P156, DOI 10.1104/pp.126.1.156; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Garcia-Limones C, 2002, PHYSIOL MOL PLANT P, V61, P325, DOI 10.1006/pmpp.2003.0445; Giraud E, 2012, PLANT CELL ENVIRON, V35, P405, DOI 10.1111/j.1365-3040.2011.02379.x; GUERIN JR, 1992, J CEREAL SCI, V15, P5, DOI 10.1016/S0733-5210(09)80052-0; Hu KD, 2014, BIOL PLANTARUM, V58, P676, DOI 10.1007/s10535-014-0440-7; Huang YQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8961951; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Jabs T, 1999, BIOCHEM PHARMACOL, V57, P231, DOI 10.1016/S0006-2952(98)00227-5; Mur LAJ, 2011, PLANT SCI, V181, P509, DOI 10.1016/j.plantsci.2011.04.003; NOELTING G, 1948, HELV CHIM ACTA, V31, P286, DOI 10.1002/hlca.19480310149; Noji M, 2001, PLANT PHYSIOL, V126, P973, DOI 10.1104/pp.126.3.973; Rausch T, 2005, TRENDS PLANT SCI, V10, P503, DOI 10.1016/j.tplants.2005.08.006; REED GA, 1990, CARCINOGENESIS, V11, P1635, DOI 10.1093/carcin/11.9.1635; RENNENBERG H, 1984, ANNU REV PLANT PHYS, V35, P121, DOI 10.1146/annurev.pp.35.060184.001005; Scuffi D, 2014, PLANT PHYSIOL, V166, P2065, DOI 10.1104/pp.114.245373; SHAPIRO R, 1977, MUTAT RES, V39, P149, DOI 10.1016/0165-1110(77)90020-3; SURREY K, 1964, PLANT PHYSIOL, V39, P65, DOI 10.1104/pp.39.1.65; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; TSUCHIYA M, 1994, METHOD ENZYMOL, V233, P128; vanderKooij TAW, 1997, NEW PHYTOL, V135, P101, DOI 10.1046/j.1469-8137.1997.00619.x; Xue YF, 2016, J SCI FOOD AGR, V96, P909, DOI 10.1002/jsfa.7164; Zhang H, 2005, PLANTA, V220, P708, DOI 10.1007/s00425-004-1390-7; Zhu DB, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/612363	29	13	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188289	10.1371/journal.pone.0188289	http://dx.doi.org/10.1371/journal.pone.0188289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155872	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700043
J	Knoop, ST; Skrede, S; Langeland, N; Flaatten, HK				Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina; Flaatten, Hans Kristian			Epidemiology and impact on all-cause mortality of sepsis in Norwegian hospitals: A national retrospective study	PLOS ONE			English	Article							UNITED-STATES; COSTS; CODES; CARE	Background Although sepsis is the leading cause of death from infection, there are few population-level epidemiological sepsis reports. The impact of sepsis-related deaths on all-cause hospital mortality is insufficiently described, in particular in Europe where data are non-existent. The objective of this study was to provide nationwide epidemiological results on sepsis hospitalizations in Norway and to estimate sepsis' contribution to overall hospital mortality in a European setting. Methods We performed a retrospective study using data from the Norwegian Patient Registry and Statistics Norway. The occurrence, patient characteristics and outcomes of sepsis hospitalizations during the years 2011 and 2012 were estimated and compared with Norwegian population data. Sepsis was defined as organ dysfunction caused by a dysregulated host response to infection and identified with International Classification of Diseases 10 th revision codes. Results We identified 18 460 sepsis admissions occurring in 13 582 individuals. The annual population incidence of hospitalized sepsis was 140 patients per 100 000 inhabitants; ranging from 10 to 2270 per 100 000 in different age groups and with statistically significant male predominance in all adult cohorts. Hospital mortality for sepsis admissions was 19.4% and overall, 26.4% of the included patients died while hospitalized for sepsis. Sepsis related deaths constituted 12.9% of all hospital fatalities, while hospitalizations with sepsis accounted for 1.0% of the total number of admissions and 3.5% of the total admission days during 2011 and 2012. Conclusions This study confirms that hospitalized sepsis is frequent in Norway and a major contributor to hospital fatalities in a European setting. The incidence is higher among men than women. Sepsis is in particular a disease of the elderly, and its impact on health-care will assumingly continue to increase in parallel with an aging population. Improvements in treatment and survival of sepsis could influence population mortality, and sepsis should receive greater attention in official death statistics in the future.	[Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina] Haukeland Hosp, Dept Med, Bergen, Norway; [Knoop, Siri Tandberg; Skrede, Steinar; Langeland, Nina] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Flaatten, Hans Kristian] Haukeland Hosp, Dept Anaesthesia & Intens Care, Bergen, Norway; [Flaatten, Hans Kristian] Univ Bergen, Dept Clin Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen	Knoop, ST (corresponding author), Haukeland Hosp, Dept Med, Bergen, Norway.; Knoop, ST (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	siri.knoop@gmail.com	Flaatten, Hans/AAG-7030-2020	Flaatten, Hans/0000-0001-9186-3482; Skrede, Steinar/0000-0003-1615-4453	 [HV 1181]		This study was performed with internal funding only (grant number HV 1181, https://helsebergen.no/fag-og-forsking/innovasion-vedhaukeland-universitetssjukehus). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Bouza C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1497-9; Bouza Carmen, 2014, BMC Infect Dis, V14, P3863, DOI 10.1186/s12879-014-0717-7; Yebenes JC, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0241-1; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Epstein L, 2016, MMWR-MORBID MORTAL W, V65, P342, DOI 10.15585/mmwr.mm6513a2; Fedeli U, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1664-2; Flaatten H, 2004, CRIT CARE, V8, pR180, DOI 10.1186/cc2867; Fleischmann C, 2016, DTSCH ARZTEBL INT, V113, P159, DOI [10.3238/arztebl.2016.0159, 10.3238/arztebl.2016.0660b]; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Henriksen DP, 2015, CRIT CARE MED, V43, P13, DOI 10.1097/CCM.0000000000000611; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.02.004; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Mariansdatter SE, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0237-9; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McPherson D, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002586; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Nygard ST, 2017, ACTA ANAESTH SCAND, V61, P194, DOI 10.1111/aas.12848; Nygard ST, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-121; Rhee C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1266-9; Rhee C, 2014, NEW ENGL J MED, V370, P1673, DOI 10.1056/NEJMp1400276; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stoller J, 2016, J CRIT CARE, V31, P58, DOI 10.1016/j.jcrc.2015.09.034; Taniguchi LU, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0608-8; Whittaker SA, 2013, CRIT CARE MED, V41, P945, DOI 10.1097/CCM.0b013e31827466f1; Wilhelms SB, 2017, ACTA ANAESTH SCAND, V61, P186, DOI 10.1111/aas.12814; Wilhelms SB, 2010, CRIT CARE MED, V38, P1442, DOI 10.1097/CCM.0b013e3181de4406; Zhou JF, 2017, CRIT CARE MED, V45, P1168, DOI 10.1097/CCM.0000000000002414	36	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187990	10.1371/journal.pone.0187990	http://dx.doi.org/10.1371/journal.pone.0187990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149187	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100021
J	Hahn, SR; Bradt, P; Hewett, KA; Ng, DB				Hahn, Steven R.; Bradt, Pamela; Hewett, Kathleen A.; Ng, Daniel B.			Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study	PLOS ONE			English	Article							AMERICAN MIGRAINE COMMUNICATION; URINARY-INCONTINENCE; WOMEN; IMPACT	Introduction Overactive bladder (OAB) and urinary incontinence are common problems that have significant impact on quality of life (QOL). Less than half of sufferers seek help from their physicians; many who do are dissatisfied with treatment and their physicians' understanding of their problems. Little is known about the sociolinguistic characteristics of physician-patient communication about OAB in community practice. Methods An IRB-approved observational sociolinguistic study of dialogues between patients with OAB and treating physicians was conducted. Study design included semi-structured post-visit interviews, post-visit questionnaires, and follow-up phone calls. Conversations were analyzed using techniques from interactional sociolinguistics. Results Communication was physician-rather than patient-centered. Physicians spoke the majority of words and 83% of questions were closed-ended. The impact of OAB on QOL and concerns about and adherence to treatment were infrequently addressed by physicians, who were poorly aligned with patients in their understanding. These topics were addressed more frequently when open-ended questions successfully eliciting elaborated responses were used in ask-tell-ask or ask-tell sequences. Discussion Clinical dialogue around OAB is physician-centered; topics critical to managing OAB are infrequently and inadequately addressed. The use of patient-centered communication is correlated with more discussion of critical topics, and thus, more effective management of OAB.	[Hahn, Steven R.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Hahn, Steven R.] Jacobi Med Ctr, Bronx, NY USA; [Bradt, Pamela; Ng, Daniel B.] Amer Astellas Pharma Global Dev Inc, Med Affairs, Northbrook, IL USA; [Hewett, Kathleen A.] Ogilvy CommonHealth Behav Insights, Parsippany, NJ USA	Yeshiva University; Albert Einstein College of Medicine; Jacobi Medical Center	Hewett, KA (corresponding author), Ogilvy CommonHealth Behav Insights, Parsippany, NJ USA.	katy.hewett@ogilvy.com		Hewett, Kathleen/0000-0002-1865-5596	Astellas Pharma Global Development, Inc.	Astellas Pharma Global Development, Inc.	SRH is a paid consultant of Astellas Pharma Global Development, Inc., the sponsor of the study. PB and DBN are employees of Astellas Pharma Global Development, Inc. the sponsors of the study and the development of the manuscript. KAH is an employee of Ogilvy Com monHealth Behavioral Insights, and thus was a paid consultant to Astellas Pharma Global Development, Inc. in connection with performing this research and with the development of this manuscript. PB and DBN were consulted regarding study design, decision to publish, and preparation of the manuscript, but did not play a role in data collection and analysis. KAH and SRH were involved in study design, data collection, analysis, decision to publish, and preparation of the manuscript. The study was observational in nature and did not include an intervention. The goal of Astellas Pharma Global Development, Inc. in funding this research was to identify areas where they may help physicians and patients improve their communication, so that patients may receive the best care possible. The funder provided support in the form of salaries for authors PB and DBN and consultation fees for KAH and SRH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Avery JC, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-11; Benner JS, 2009, J UROLOGY, V181, P2591, DOI 10.1016/j.juro.2009.02.018; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Davidson Brad, 2007, J Support Oncol, V5, P139; Davidson Brad, 2007, J Support Oncol, V5, P36; Dmochowski RR, 2007, CURR MED RES OPIN, V23, P64, DOI 10.1185/030079907X159533; Dugan E, 2000, J AM GERIATR SOC, V48, P413, DOI 10.1111/j.1532-5415.2000.tb04699.x; Filipetto FA, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-96; Friedman DS, 2009, OPHTHALMOLOGY, V116, P2277, DOI 10.1016/j.ophtha.2009.04.052; Gumperz J., 1999, TALK WORK I ORDER DI, P453, DOI DOI 10.1515/9783110208375.4.453; Hahn SR, 2010, DOCTOR PATIENT COMMU; Hahn SR, 2008, CURR MED RES OPIN, V24, P1711, DOI 10.1185/03007990802122388; Hahn SR, 2010, OPHTHALMOLOGY, V117, P1339, DOI 10.1016/j.ophtha.2009.11.026; Hamilton Heidi E, 2004, Commun Med, V1, P59, DOI 10.1515/come.2004.006; Huang AJ, 2006, AM J OBSTET GYNECOL, V195, P1331, DOI 10.1016/j.ajog.2006.03.052; Huang AJ, 2006, ARCH INTERN MED, V166, P2000, DOI 10.1001/archinte.166.18.2000; Lipton RB, 2008, J GEN INTERN MED, V23, P1145, DOI 10.1007/s11606-008-0591-3; Melville JL, 2005, ARCH INTERN MED, V165, P537, DOI 10.1001/archinte.165.5.537; Newman DK, 2009, NURSE PRACT, V34, P33, DOI 10.1097/01.NPR.0000365126.88904.67; Thom DH, 1997, AGE AGEING, V26, P367, DOI 10.1093/ageing/26.5.367; Yip SO, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.010	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186122	10.1371/journal.pone.0186122	http://dx.doi.org/10.1371/journal.pone.0186122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140974	gold, Green Submitted, Green Published			2022-12-27	WOS:000415260400005
J	Lee, JY; Park, JE; Shim, WH; Jung, SC; Choi, CG; Kim, SJ; Kim, JH; Kim, HS				Lee, Ji Ye; Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Jeong Hoon; Kim, Ho Sung			Joint approach based on clinical and imaging features to distinguish non-neoplastic from neoplastic pituitary stalk lesions	PLOS ONE			English	Article							LYMPHOCYTIC HYPOPHYSITIS; EXPERIENCE; GLAND; SARCOIDOSIS; CARCINOMA; DIAGNOSIS; TUMORS; MRI	Purpose Distinguishing non-neoplastic pituitary stalk lesions (non-NPSLs) from neoplastic pituitary stalk lesions (NPSLs) is a major concern in guiding treatment for a thickened pituitary stalk. Our study aimed to aid provide preoperative diagnostic assistance by combining clinical and magnetic resonance imaging (MRI) findings to distinguish non-NPSLs from NPSLs. Materials and methods We recruited 158 patients with thickened pituitary stalk lesions visible on MRI. Laboratory findings included hypopituitarism, diabetes insipidus (DI), and hyperprolactinemia. MR images were assessed for anterior-posterior thickness (mm), diffuse pituitary stalk thickening, cystic changes, a high T1 signal, and glandular or extrasellar involvement. A diagnostic model was developed using a recursive partitioning logistic regression analysis. The model was validated in an independent dataset comprising 63 patients, and its diagnostic performance was compared with that of the original radiological reports. Results A univariate analysis found significant associations of DI (P = 0.006), absence of extrasellar involvement (P = 0.002), and lower stalk thickness (P = 0.031) with non-NPSLs. A diagnostic model was created using the following parameters (in order of priority): 1) lack of extrasellar involvement, 2) stalk thickness < 5.3 mm, and 3) presence of DI. The diagnostic performance (area under the curve; AUC) of this model in the independent set was 0.813, representing a significant improvement over the original radiological reports (AUC: 0.713, P = 0.029). Conclusion The joint diagnostic approach based on clinical and imaging-based factors robustly distinguished non-NPSLs from NPSLs. This approach could guide treatment strategies and prevent unnecessary surgery in patients with non-NPSL.	[Lee, Ji Ye] Soonchunhyang Univ, Dept Radiol, Bucheon Hosp, 170 Jomaru Ro, Bucheon, South Korea; [Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Ho Sung] Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Park, Ji Eun; Shim, Woo Hyun; Jung, Seung Chai; Choi, Choong Gon; Kim, Sang Joon; Kim, Ho Sung] Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Kim, Jeong Hoon] Univ Ulsan, Dept Neurosurg, Asan Med Ctr, Coll Med, Seoul, South Korea	Soonchunhyang University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, JE (corresponding author), Univ Ulsan, Dept Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.; Park, JE (corresponding author), Univ Ulsan, Res Inst Radiol, Asan Med Ctr, Coll Med, Seoul, South Korea.	jieunp@gmail.com	Lee, Ji Ye/ABA-7830-2021	Park, Ji Eun/0000-0002-4419-4682	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2017R1C1B2007258]; Ministry of Health and Welfare, Republic of Korea [1720030]	National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number: NRF-2017R1C1B2007258) and by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1720030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Institutional Review Board of Asan Medical Center approved this study ([http://eirb.amc.seoul.kr]:S2016-0555) and waived the requirement for written informed consent. This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (grant number: NRF-2017R1C1B2007258), by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (1720030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker FG, 2003, J CLIN ENDOCR METAB, V88, P4709, DOI 10.1210/jc.2003-030461; Buchfelder M, 2009, BEST PRACT RES CL EN, V23, P677, DOI 10.1016/j.beem.2009.05.002; Drange MR, 2000, J CLIN ENDOCR METAB, V85, P168, DOI 10.1210/jc.85.1.168; DUCHEN LW, 1966, J PATHOL BACTERIOL, V91, P347, DOI 10.1002/path.1700910208; Gutenberg A, 2005, AM J SURG PATHOL, V29, P329, DOI 10.1097/01.pas.0000149707.12335.8e; Gutenberg A, 2009, AM J NEURORADIOL, V30, P1766, DOI 10.3174/ajnr.A1714; Hamilton BE, 2007, AM J ROENTGENOL, V188, pW223, DOI 10.2214/AJR.05.2027; Honegger J, 1997, NEUROSURGERY, V40, P713, DOI 10.1097/00006123-199704000-00010; Hou N WC, 2014, AUSTIN J ENDOCRINOL, V1, P1025; Johnston PC, 2015, ENDOCRINE, V50, P531, DOI 10.1007/s12020-015-0707-6; Kinoshita M, 2015, AM J NEURORADIOL, V36, P904, DOI 10.3174/ajnr.A4220; KIOUMEHR F, 1994, NEURORADIOLOGY, V36, P93, DOI 10.1007/BF00588067; Kristof RA, 1999, J NEUROL NEUROSUR PS, V67, P398, DOI 10.1136/jnnp.67.3.398; Langrand C, 2012, QJM-INT J MED, V105, P981, DOI 10.1093/qjmed/hcs121; Lau GKK, 1998, J CLIN PATHOL, V51, P931, DOI 10.1136/jcp.51.12.931; Lee MH, 2001, ACTA RADIOL, V42, P129, DOI 10.1034/j.1600-0455.2001.042002129.x; Leung GKK, 2004, J NEUROSURG, V101, P262, DOI 10.3171/jns.2004.101.2.0262; Melmed S, 2011, J CLIN ENDOCR METAB, V96, P273, DOI 10.1210/jc.2010-1692; Nishioka H, 1997, NEUROSURGERY, V41, P684, DOI 10.1097/00006123-199709000-00037; Park M, 2015, AM J NEURORADIOL, V36, P1866, DOI 10.3174/ajnr.A4387; ROBERTSON GL, 1995, ENDOCRIN METAB CLIN, V24, P549, DOI 10.1016/S0889-8529(18)30031-8; Rupp D, 2008, CURR OPIN ENDOCRINOL, V15, P339, DOI 10.1097/MED.0b013e3283050844; Satogami N, 2010, AM J NEURORADIOL, V31, P355, DOI 10.3174/ajnr.A1836; Seidenwurm DJ, 2008, AM J NEURORADIOL, V29, P613; SELTZER S, 1991, AM J NEURORADIOL, V12, P1227; Toni R, 2000, ENDOTEXT; Turcu AF, 2013, J CLIN ENDOCR METAB, V98, P1812, DOI 10.1210/jc.2012-4171; Yoon Sung Chul, 2014, Ann Pediatr Endocrinol Metab, V19, P202, DOI 10.6065/apem.2014.19.4.202	28	10	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187989	10.1371/journal.pone.0187989	http://dx.doi.org/10.1371/journal.pone.0187989			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140989	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400042
J	Ojha, S; Dimov, L				Ojha, Santosh; Dimov, Luben			Variation in the diversity-productivity relationship in young forests of the eastern United States	PLOS ONE			English	Article							MIXED-SPECIES STANDS; FUNCTIONAL DIVERSITY; PLANT DIVERSITY; WOOD PRODUCTION; DENSITY INDEX; BIODIVERSITY; RICHNESS; SCALE; BIOMASS; TEMPERATE	The diversity-productivity relationship has not been studied as extensively in forests as in other ecosystems. We address this gap in our knowledge by examining the relationship of productivity (primarily the periodic annual increment in aboveground biomass, but also the mean annual increment) with five species diversity indices, stand, and environmental factors. We used 967 naturally regenerated Forest Inventory and Analysis plots with stand age <= 30 years, located in the conterminous thirty-one eastern states, and satisfying strict selection requirements. Generally, mixed-species (heterospecific) stands were as productive as or even somewhat more productive than pure (monospecific) stands. The periodic and mean annual increments were both positively correlated with species richness (R-2 = 0.04 and 0.20, p<0.001). Similarly, the zero-order and partial correlations with productivity were positive for four of the diversity indices (species richness, functional diversity, phylogenetic diversity, and phylogenetic species richness) and not significant for the fifth (functional dispersion). Greater diversity was more important on low-productivity sites and in stands with low stocking. As forests generally get more diverse and productive away from the poles, we tested if the nature of the productivity-diversity relationship changed latitudinally. Productivity was weakly positively correlated with four of the diversity indices north of 40 degrees latitude, but weakly negatively with three of the indices to the south. Our examination of the productivity-diversity relationship in stands containing either of the two most dominant species, quaking aspen or loblolly pine, revealed that pure loblolly pine stands were somewhat more productive than only three of the eight mixtures with loblolly in the composition, while pure aspen stands were no more productive than any of the aspen mixtures. Overall, monospecific stands did not seem to have a clear productivity advantage over mixtures. The findings of this study have implications for woody biomass production, carbon sequestration by forests, and biodiversity conservation.	[Ojha, Santosh; Dimov, Luben] Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA	Alabama A&M University	Dimov, L (corresponding author), Alabama A&M Univ, Dept Biol & Environm Sci, Normal, AL 35762 USA.	Luben.Dimov@gmail.com	Dimov, Luben/M-1814-2019; Dimov, Luben/M-8062-2019	Dimov, Luben/0000-0003-3148-6050; Ojha, Santosh/0000-0001-5697-9711	National Science Foundation's Alabama Experimental Program; National Science Foundation; Center of Research Excellence in Science and Technology (CREST); Center for Forest Ecosystem Assessment; CRESTCFEA [HRD 0420541]; United States Department of Agriculture, Forest Service Cooperative [06CA11330134074]; USDA National Institute of Food and Agriculture, McIntire-Stennis [1008953, 0218126]; CREST-CFEA [HRD 0420541]	National Science Foundation's Alabama Experimental Program; National Science Foundation(National Science Foundation (NSF)); Center of Research Excellence in Science and Technology (CREST); Center for Forest Ecosystem Assessment; CRESTCFEA; United States Department of Agriculture, Forest Service Cooperative; USDA National Institute of Food and Agriculture, McIntire-Stennis; CREST-CFEA	This work was supported by National Science Foundation's Alabama Experimental Program to Stimulate Competitive Research (Alabama EPSCoR) Graduate Research Scholars Program (GRSP) grant round 7, 8, and 9 (SO); the National Science Foundation, Center of Research Excellence in Science and Technology (CREST), Center for Forest Ecosystem Assessment, CRESTCFEA HRD 0420541 (LD); United States Department of Agriculture, Forest Service Cooperative Agreement number 06CA11330134074 (LD); and USDA National Institute of Food and Agriculture, McIntire-Stennis projects 1008953 and 0218126 (LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based upon work supported by the National Science Foundation's Alabama Experimental Program to Stimulate Competitive Research (Alabama EPSCoR) Graduate Research Scholars Program (GRSP) grant round 7, 8, and 9; the National Science Foundation, Center of Research Excellence in Science and Technology (CREST), Center for Forest Ecosystem Assessment, CREST-CFEA HRD 0420541; and by a United States Department of Agriculture, Forest Service Cooperative Agreement number 06CA11330134074. This work was also supported by the USDA National Institute of Food and Agriculture, McIntire-Stennis projects 1008953 and 0218126. We are thankful to the national forest inventory crews who collected the data and to Bill Burkman and Jeff Turner from the USDA Forest Service, Forest Inventory and Analysis (FIA) for their support in obtaining the data. We are grateful to Dr. Christopher W. Woodall for helpful suggestions concerning relative stand density and to Dr. Fernando Casanoves for guidance on using the Fdiversity software. We are also thankful to Dr. Andy Scott, Dr. Callie Schweitzer, Dr. Kozma Naka, Dr. Yong Wang, three anonymous reviewers and the Academic Editor of PLOS One for their reviews and valuable suggestions.	[Anonymous], 2009, FEDERAL FOREST HLTH; [Anonymous], 2010, MINNESOTA FOREST HLT; BEERS TW, 1966, J FOREST, V64, P691; Bell BA, 2013, INTERMEDIATE PRIMER; Belote RT, 2011, FOREST ECOL MANAG, V261, P1315, DOI 10.1016/j.foreco.2011.01.010; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Casanoves F., 2008, USER MANUAL FDIVERSI, V2; Casanoves F, FDIVERSITY VERSION 2; Casanoves F, 2011, METHODS ECOL EVOL, V2, P233, DOI 10.1111/j.2041-210X.2010.00082.x; Caspersen JP, 2001, ECOL RES, V16, P895, DOI 10.1046/j.1440-1703.2001.00455.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chhin S, 2016, FORESTS, V7, DOI 10.3390/f7100235; CURTIS JT, 1951, ECOLOGY, V32, P476, DOI 10.2307/1931725; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forrester DI, 2016, CURR FOR REP, V2, P45, DOI 10.1007/s40725-016-0031-2; Forrester DI, 2013, FOREST ECOL MANAG, V304, P233, DOI 10.1016/j.foreco.2013.04.038; Frayer WE, 1999, J FOREST, V97, P4; Hair J.F., 1998, MULTIVARIATE DATA AN, V5th ed.; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Hu LJ, 2013, NOT BOT HORTI AGROBO, V41, P36; Hulvey KB, 2013, NAT CLIM CHANGE, V3, P869, DOI [10.1038/NCLIMATE1862, 10.1038/nclimate1862]; Huston M A, 2000, Science, V289, P1255; Jenkins JC, 2003, FOREST SCI, V49, P12; John J. A., 1980, Applied Statistics, V29, P190, DOI 10.2307/2986305; Jucker T, 2014, J ECOL, V102, P1202, DOI 10.1111/1365-2745.12276; Kelty MJ, 2006, FOREST ECOL MANAG, V233, P195, DOI 10.1016/j.foreco.2006.05.011; KELTY MJ, 1992, FOR SCI, V40, P125; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Legendre P., 2012, NUMERICAL ECOLOGY, V24; Lohbeck M, 2012, PERSPECT PLANT ECOL, V14, P89, DOI 10.1016/j.ppees.2011.10.002; Long J. N., 1990, Western Journal of Applied Forestry, V5, P93; LONG JN, 1985, FOREST CHRON, V61, P23, DOI 10.5558/tfc61023-1; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; Michaelian M, 2011, GLOBAL CHANGE BIOL, V17, P2084, DOI 10.1111/j.1365-2486.2010.02357.x; Miles PD, 2009, NRS38 US DEP AGR FOR, P39; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Moore JC., 2001, ENCY BIODIVERSITY; Moser WK, 2009, P 8 ANN FOR INV AN S, P414; Moser WK, 2006, OAK COMPOSITION STRU; Neter J., 1996, APPL LINEAR STAT MOD; Ojha SK, 2015, TREE DIVERSITY PRODU; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Partel M, 2007, ECOLOGY, V88, P1091, DOI 10.1890/06-0997; Partel M, 2007, J ECOL, V95, P90, DOI 10.1111/j.1365-2745.2006.01185.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Pillon Y, 2006, BIOL CONSERV, V129, P4, DOI 10.1016/j.biocon.2005.06.036; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Potter KM, 2014, FOREST ECOL MANAG, V321, P117, DOI 10.1016/j.foreco.2013.06.026; Reineke LH, 1933, J AGRIC RES, V46, P0627; Rodriguez-Loinaz G, 2008, SOIL BIOL BIOCHEM, V40, P49, DOI 10.1016/j.soilbio.2007.04.015; Scheiner SM, 2002, EVOL ECOL RES, V4, P1097; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; Thoms C, 2010, SOIL BIOL BIOCHEM, V42, P1558, DOI 10.1016/j.soilbio.2010.05.030; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; USDA Forest Service, 2001, US FOR FACTS HIST TR; Vila M, 2005, ECOL STU AN, V176, P65; Vila M, 2003, OECOLOGIA, V135, P299, DOI 10.1007/s00442-003-1182-y; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Vila M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053530; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Woodall CW, 2005, FOREST ECOL MANAG, V216, P367, DOI 10.1016/j.foreco.2005.05.050; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033; Woudenberg, 2010, FOREST INVENTORY ANA, DOI 10.2737/RMRS-GTR-245; Zifan A, 2016, US MAP KOPPEN CLIMAT; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x	71	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187106	10.1371/journal.pone.0187106	http://dx.doi.org/10.1371/journal.pone.0187106			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140999	gold, Green Submitted, Green Published			2022-12-27	WOS:000415260400016
J	Triska, M; Solovyev, V; Baranova, A; Kel, A; Tatarinova, TV				Triska, Martin; Solovyev, Victor; Baranova, Ancha; Kel, Alexander; Tatarinova, Tatiana V.			Nucleotide patterns aiding in prediction of eukaryotic promoters	PLOS ONE			English	Article							ARABIDOPSIS INFORMATION RESOURCE; TRANSCRIPTION START SITES; FACTOR-BINDING SITES; R-LOOP FORMATION; GENE; DATABASE; IDENTIFICATION; EXPRESSION; SEQUENCE; ELEMENTS	Computational analysis of promoters is hindered by the complexity of their architecture. In less studied genomes with complex organization, false positive promoter predictions are common. Accurate identification of transcription start sites and core promoter regions remains an unsolved problem. In this paper, we present a comprehensive analysis of genomic features associated with promoters and show that probabilistic integrative algorithms-driven models allow accurate classification of DNA sequence into "promoters" and "non-promoters" even in absence of the full-length cDNA sequences. These models may be built upon the maps of the distributions of sequence polymorphisms, RNA sequencing reads on genomic DNA, methylated nucleotides, transcription factor binding sites, as well as relative frequencies of nucleotides and their combinations. Positional clustering of binding sites shows that the cells of Oryza sativa utilize three distinct classes of transcription factors: those that bind preferentially to the [-500,0] region (188 "promoter-specific" transcription factors), those that bind preferentially to the [0,500] region (282 "5' UTR-specific" TFs), and 207 of the "promiscuous" transcription factors with little or no location preference with respect to TSS. For the most informative motifs, their positional preferences are conserved between dicots and monocots.	[Triska, Martin] Univ Southern Calif, Childrens Hosp Los Angeles, Los Angeles, CA USA; [Triska, Martin] Univ South Wales, Fac Adv Technol, Pontypridd, M Glam, Wales; [Solovyev, Victor] Softberry Inc, Mt Kisco, NY USA; [Baranova, Ancha; Tatarinova, Tatiana V.] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Baranova, Ancha] Res Ctr Med Genet, Moscow, Russia; [Kel, Alexander] geneXplain GmbH, Wolfenbuettel, Germany; [Kel, Alexander] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Tatarinova, Tatiana V.] Univ La Verne, Div Nat Sci, Dept Biol, La Verne, CA 91750 USA; [Tatarinova, Tatiana V.] RAS, Bioinformat Ctr, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia; [Tatarinova, Tatiana V.] Vavilovs Inst Gen Genet, Moscow, Russia	Children's Hospital Los Angeles; University of Southern California; University of South Wales; George Mason University; Research Centre for Medical Genetics; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; University of La Verne; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute for the History of Science & Technology of the Russian Academy of Sciences; Vavilov Institute of General Genetics	Tatarinova, TV (corresponding author), George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA.; Tatarinova, TV (corresponding author), Univ La Verne, Div Nat Sci, Dept Biol, La Verne, CA 91750 USA.; Tatarinova, TV (corresponding author), RAS, Bioinformat Ctr, AA Kharkevich Inst Informat Transmiss Problems, Moscow, Russia.; Tatarinova, TV (corresponding author), Vavilovs Inst Gen Genet, Moscow, Russia.	ttatarinova@laverne.edu	Kel, Alexander E/I-7284-2013; Tatarinova, Tatiana Valerievna/AAU-4719-2021; Tatarinova, Tatiana/AAH-1915-2020; , Ancha/B-4608-2012; Baranova, Anna/HGB-3721-2022; Solovyev, Victor/C-4614-2013	Tatarinova, Tatiana/0000-0003-1787-1112; , Ancha/0000-0001-6810-5982; Solovyev, Victor/0000-0001-8885-493X	Federal Targeted Program "Research and development on priority directions of science and technology in Russia" [14.604.21.0101, RFMEFI60414X0101]; EU; NSF Division of Environmental Biology [1456634]; NSF STTR [1622840]; GeneXplain GmbH; Direct For Biological Sciences [1456634] Funding Source: National Science Foundation	Federal Targeted Program "Research and development on priority directions of science and technology in Russia"; EU(European Commission); NSF Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF STTR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); GeneXplain GmbH; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AK was supported by a grant of the Federal Targeted Program "Research and development on priority directions of science and technology in Russia, 2014-2010", Contract No 14.604.21.0101, unique identifier of the applied scientific project: RFMEFI60414X0101. AK's work was also supported by the following grants of the EU FP7 program: "SYSCOL", "SysMedl BD", "RESOLVE" and "MIMOMICS". TT and MT were supported by the NSF Division of Environmental Biology (1456634). TT, MT and AB were supported by NSF STTR award 1622840. Additional funding was provided by GeneXplain GmbH in the form of salaries for AK, and by Softberry, Inc in the form of salary for VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; "AK was supported by a grant of the Federal Targeted Program "Research and development on priority directions of science and technology in Russia, 2014-2010", Contract No 14.604.21.0101, unique identifier of the applied scientific project: RFMEFI60414X0101. AK's work was also supported by the following grants of the EU FP7 program: "SYSCOL", "SysMedIBD", "RESOLVE" and "MIMOMICS". TT and MT were supported by the NSF Division of Environmental Biology (1456634). TT, MT and AB were supported by NSF STTR award 1622840. Additional funding was provided by GeneXplain GmbH in the form of salaries for AK, and by Softberry, Inc in the form salaries for VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexandrov N, 2015, NUCLEIC ACIDS RES, V43, pD1023, DOI 10.1093/nar/gku1039; Alexandrov NN, 2009, PLANT MOL BIOL, V69, P179, DOI 10.1007/s11103-008-9415-4; Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Anwar F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-414; Azad AKM, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-19; Bajic VB, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s3; Batut P, 2013, CURR PROTOC MOL BIOL, V104, P11; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007; Elhaik E, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-23; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Ginno PA, 2013, GENOME RES, V23, P1590, DOI 10.1101/gr.158436.113; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hieno A, 2014, NUCLEIC ACIDS RES, V42, pD1188, DOI 10.1093/nar/gkt1027; Huala E, 2001, NUCLEIC ACIDS RES, V29, P102, DOI 10.1093/nar/29.1.102; Jenjaroenpun P, 2015, NUCLEIC ACIDS RES, V43, P10081, DOI 10.1093/nar/gkv974; Jenjaroenpun P, 2015, NUCLEIC ACIDS RES, V43, pD110, DOI 10.1093/nar/gku970; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Kawaji H, 2014, GENOME RES, V24, P708, DOI 10.1101/gr.156232.113; Kel A, 2006, BIOINFORMATICS, V22, P1190, DOI 10.1093/bioinformatics/btl041; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kiran K, 2006, PLANT PHYSIOL, V142, P364, DOI 10.1104/pp.106.084319; Kondrakhin Yu, 2016, EuPA Open Proteom, V13, P14, DOI 10.1016/j.euprot.2016.09.001; KONDRAKHIN YV, 1995, COMPUT APPL BIOSCI, V11, P477; Koschmann Jeannette, 2015, Microarrays (Basel), V4, P270, DOI 10.3390/microarrays4020270; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Law MY, 2015, PLANT PHYSIOL, V167, P25, DOI 10.1104/pp.114.245027; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morton T, 2014, PLANT CELL, V26, P2746, DOI 10.1105/tpc.114.125617; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; PULLEN SS, 1995, J VIROL, V69, P3575, DOI 10.1128/JVI.69.6.3575-3583.1995; Rye M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-120; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sanz LA, 2016, MOL CELL, V63, P167, DOI 10.1016/j.molcel.2016.05.032; Shahmuradov IA, 2005, NUCLEIC ACIDS RES, V33, P1069, DOI 10.1093/nar/gki247; Shahmuradov IA, 2012, 2012 INT C BIOM ENG; Shahmuradov IA, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1353; SHINYA E, 1994, NUCLEIC ACIDS RES, V22, P2143, DOI 10.1093/nar/22.11.2143; Solovyev V, 2003, NUCL ACIDS RES, V31; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Stepanova M, 2005, BIOINFORMATICS, V21, P1789, DOI 10.1093/bioinformatics/bti307; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Stracke R, 2010, NEW PHYTOL, V188, P985, DOI 10.1111/j.1469-8137.2010.03421.x; Stracke R, 2010, PLANT CELL ENVIRON, V33, P88, DOI 10.1111/j.1365-3040.2009.02061.x; Tatarinova T, 2014, QUANT BIOL, V1, P261, DOI DOI 10.1007/S40484-013-0022-2; Tatarinova T, 2003, BIOINFORMATICS, V19, pi313, DOI 10.1093/bioinformatics/btg1043; Tatarinova T, 2013, GENOME BIOL EVOL, V5, P1443, DOI 10.1093/gbe/evt103; Tatarinova TV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35730; Tatarinova TV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-308; Triska M, 2013, BIOINFORMATICS, V29, P2203, DOI 10.1093/bioinformatics/btt366; Troukhan M, 2009, OMICS, V13, P139, DOI 10.1089/omi.2008.0034; Umarov RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171410; van Heeringen SJ, 2011, GENOME RES, V21, P410, DOI 10.1101/gr.111724.110; Viola IL, 2011, BIOCHEM J, V435, P143, DOI 10.1042/BJ20101019; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wongsurawat T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1075; Yao H, 2005, PLANT MOL BIOL, V57, P445, DOI 10.1007/s11103-005-0271-1	66	17	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187243	10.1371/journal.pone.0187243	http://dx.doi.org/10.1371/journal.pone.0187243			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141011	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400020
J	De Silva, G; Somaratne, V; Senaratne, S; Vipuladasa, M; Wickremasinghe, R; Wickremasinghe, R; Ranasinghe, S				De Silva, Gayani; Somaratne, Vijani; Senaratne, Sujai; Vipuladasa, Manuja; Wickremasinghe, Rajitha; Wickremasinghe, Renu; Ranasinghe, Shalindra			Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani	PLOS ONE			English	Article							DNA; POLYMORPHISMS; SURVEILLANCE; DISTRICT; SAMPLES	Background Cutaneous leishmaniasis (CL) in Sri Lanka is caused by Leishmania donovani. This study assessed the diagnostic value of a new rapid diagnostic immunochromatographic strip (CL-Detect T IC-RDT), that captures the peroxidoxin antigen of Leishmania amastigotes. Methodology/Principal findings We sampled 74 clinically suspected CL lesions, of which 59 (79.7%) were positive by PCR, 43 (58.1%) by Giemsa stained slit skin smear (SSS) and 21 (28.4%) by the new IC-RDT. All samples which were positive either by SSS or IC-RDT or both were positive by PCR. The sensitivities of the IC-RDT and SSS compared to PCR were 36% and 73%, respectively. Fifteen patients from this endemic region were negative by all three tests. Twenty two clinically non-CL skin lesions from a CL non-endemic region were also negative by all three methods. Specificity and PPV of both IC-RDT and SSS compared to PCR were 100%; the NPVs of IC-RDT and SSS were 37% and 58%, respectively. The median parasite grading of the 59 PCR positive samples was 2+ (1-10 parasites/100 HPFs) and IC-RDT positive lesions was 3+ (1-10 parasites /10HPFs). The duration of the lesion was not associated with IC-RDT positivity. Conclusions/Significance The median parasite grade of Sri Lankan CL lesions is low. The low sensitivities of SSS and CL Detect T IC-RDT may be due to low parasite counts or low expression of peroxidoxin antigen in amastigotes of the Sri Lankan L. donovani strain. Our results indicate that negative SSS has to be combined with PCR for confirmation of CL in Sri Lanka. The current commercially available IC-RDT is not suitable to diagnose CL in Sri Lanka; an IC-RDT with improved sensitivity to detect L. donovani would be a valuable addition in the diagnostic tool kit for Sri Lanka.	[De Silva, Gayani; Senaratne, Sujai; Wickremasinghe, Renu; Ranasinghe, Shalindra] Univ Sri Jayewardenepura, Dept Parasitol, Nugegoda, Sri Lanka; [Somaratne, Vijani; Vipuladasa, Manuja] Dist Gen Hosp Hambantota, Hambantota, Sri Lanka; [Wickremasinghe, Rajitha] Univ Kelaniya, Dept Publ Hlth, Colombo, Sri Lanka	University Sri Jayewardenepura; University Kelaniya	Ranasinghe, S (corresponding author), Univ Sri Jayewardenepura, Dept Parasitol, Nugegoda, Sri Lanka.	ishalindra@sjp.ac.lk			University of Sri Jayewardenepura Sri Lanka [ASP/06/RE/MED/2012/30, ASP/06/RE/MED/2013/37]	University of Sri Jayewardenepura Sri Lanka	SR was funded by University of Sri Jayewardenepura Sri Lanka Grant number ASP/06/RE/MED/2012/30 and RW was funded by University of Sri Jayewardenepura Sri Lanka Grant number ASP/06/RE/MED/2013/37, http://research. sip.ac.ik/rersearch-grant/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ATHUKORALE DN, 1992, J TROP MED HYG, V95, P432; Barr SD, 2001, J BIOL CHEM, V276, P34279, DOI 10.1074/jbc.M104406200; Bayih AG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003391; Ben Salah A, 2014, CLIN EVALUATION CL D; Ben Salah ANB., 2012, CL DETECT SELECTION; Campbell MJ, 2009, STAT SQUARE ONE; Castro H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002325; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; El Tai NO, 2001, EXP PARASITOL, V97, P35, DOI 10.1006/expr.2001.4592; Epidemiology Unit, 2009, WEEKL EP REP; Gajapathy K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-302; Harder S, 2006, EUKARYOT CELL, V5, P861, DOI 10.1128/EC.5.5.861-870.2006; Jing Bao-qian, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P102; Kariyawasam KKGDUL, 2015, PATHOG GLOB HEALTH, V109, P336, DOI 10.1179/2047773215Y.0000000032; Karunaweera ND, 2003, T ROY SOC TROP MED H, V97, P380, DOI 10.1016/S0035-9203(03)90061-7; Kassi M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000259; Kolivand M, 2015, J RES HEALTH SCI, V15, P104; McCall LI, 2015, J PROTEOME RES, V14, P1033, DOI 10.1021/pr5010604; McCall LI, 2013, VACCINE, V31, P1420, DOI 10.1016/j.vaccine.2012.11.065; Medley GF, 2015, NATURE, V528, pS102, DOI 10.1038/nature16042; Nawaratna SSK, 2007, EMERG INFECT DIS, V13, P1068, DOI 10.3201/eid1307.070227; Nawaratna SSK, 2009, INT J INFECT DIS, V13, P513, DOI 10.1016/j.ijid.2008.08.023; Ranasinghe S, 2015, MEM I OSWALDO CRUZ, V110, P1017, DOI 10.1590/0074-02760150286; Ranasinghe S, 2013, AM J TROP MED HYG, V89, P742, DOI 10.4269/ajtmh.12-0640; Ranawaka RR, 2012, CEYLON MED J, V57, P149, DOI 10.4038/cmj.v57i4.5082; RODGERS MR, 1990, EXP PARASITOL, V71, P267, DOI 10.1016/0014-4894(90)90031-7; Ronet C, 2011, VIRULENCE, V2, P547, DOI 10.4161/viru.2.6.17839; Rosypal AC, 2010, J PARASITOL, V96, P230, DOI 10.1645/GE-2288; Rycroft RJG, 2002, COLOUR HDB DERMATOLO; Semage SN, 2014, INT J INFECT DIS, V25, P53, DOI 10.1016/j.ijid.2014.03.1382; Sirimanna G, 2013, GUIDELINES MANAGEMEN, P7; Siriwardana HVYD, 2010, ANN TROP MED PARASIT, V104, P213, DOI 10.1179/136485910X12647085215615; Spotin A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913510; Teixeira F, 2015, P NATL ACAD SCI USA, V112, pE616, DOI 10.1073/pnas.1419682112; Webb JR, 1998, INFECT IMMUN, V66, P3279, DOI 10.1128/IAI.66.7.3279-3289.1998; World Health Organization, 2010, CONTR LEISHM TECHN R; Zhang WW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004244	38	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187024	10.1371/journal.pone.0187024	http://dx.doi.org/10.1371/journal.pone.0187024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135995	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200012
J	Tang, L; Liu, ZC; Zhang, RP; Su, CM; Yang, WJ; Yao, YL; Zhao, SH				Tang, Li; Liu, Zichao; Zhang, Ruopeng; Su, Cunmei; Yang, Wenjuan; Yao, Youlin; Zhao, Shuhua			Imprinting alterations in sperm may not significantly influence ART outcomes and imprinting patterns in the cord blood of offspring	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; ABERRANT DNA METHYLATION; LOW-BIRTH-WEIGHT; FETAL-GROWTH; MALE-INFERTILITY; DISORDERS; GENES; LOCI; CONCEPTION	An increase in imprinting disorders in children conceived though assisted reproductive technologies (ARTs) has been the subject of several reports. The transmission of imprinting errors from the sperm of infertile fathers is believed to be a possible reason for the increased occurrence of these disorders. However, whether the imprinting alterations in sperm affect ART outcomes and the imprinting of offspring is unclear. In the current study, we analyzed the methylation of H19, SNRPN and KCNQ1OT1 by pyrosequencing sperm samples from 97 infertile patients and 31 proven fertile males as well as cord blood samples from 13 infantswho were conceived by infertile parents through intracytoplasmic sperm injection (ICSI) and 30 healthy newborns who were conceived naturally. After four cases were excluded owing to the lack of a sequencing signal, the infertile patients were subgrouped into normal (69 cases) and abnormal (24 cases) imprinting groups according to the reference range set by the control group. Between the groups, there were no significant differences in ART outcomes. Significantly different levels of methylation were detected in H19, but none of the imprinted genes were determined to be outside of the methylation reference range set by the values derived from the naturally conceived controls. Three CpG loci were found to be significantly hypomethylated in the maternally imprinted gene KCNQ1OT1 in two patients from the abnormal imprinting group, none of which were caused by sperm imprinting errors. In addition, the paternal H19 gene exhibited discrepant methylation patterns between the sperm controls and the cord blood controls. Our data suggest that increased imprinting errors in the sperm of infertile patients do not have an obvious influence on ART outcomes or the imprinting of offspring.	[Tang, Li; Su, Cunmei; Yang, Wenjuan; Yao, Youlin; Zhao, Shuhua] Kunming Med Univ, Affiliated Hosp 1, Dept Reprod & Genet, Kunming, Yunnan, Peoples R China; [Liu, Zichao] Kunming Univ, Dept Life Sci & Technol, Key Lab Special Biol Resource Dev & Utilizat Univ, Kunming, Yunnan, Peoples R China; [Zhang, Ruopeng] Dali Univ, Affiliated Hosp 1, Dept Reprod Med, Dali, Yunnan, Peoples R China; [Zhao, Shuhua] Yunnan Populat & Family Planning Res Inst, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming University; Dali University	Zhao, SH (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Reprod & Genet, Kunming, Yunnan, Peoples R China.; Zhao, SH (corresponding author), Yunnan Populat & Family Planning Res Inst, Kunming, Yunnan, Peoples R China.	kmshh1982@126.com			National Natural Science Foundation of China [81300542, 81260510]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under grants 81300542 and 81260510 (www.nsfc.gov.cn). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2006, CYTOGENET GENOME RES, V113, P262, DOI 10.1159/000090841; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Camprubi C, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108456; Camprubi C, 2012, EPIGENETICS-US, V7, P1115, DOI 10.4161/epi.21743; Chiba H, 2013, PEDIATR INT, V55, P542, DOI 10.1111/ped.12185; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Eroglu A, 2012, SEMIN REPROD MED, V30, P92, DOI 10.1055/s-0032-1307417; Hammoud SS, 2010, FERTIL STERIL, V94, P1728, DOI 10.1016/j.fertnstert.2009.09.010; Ibala-Romdhane S, 2011, EUR J HUM GENET, V19, P1138, DOI 10.1038/ejhg.2011.99; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kanber D, 2009, EUR J HUM GENET, V17, P22, DOI 10.1038/ejhg.2008.177; Kitamura A, 2015, CONGENIT ANOM, V55, P133, DOI 10.1111/cga.12113; Klaver R, 2014, ASIAN J ANDROL, V16, P669, DOI 10.4103/1008-682X.125412; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Kobayashi H, 2009, EUR J HUM GENET, V17, P1582, DOI 10.1038/ejhg.2009.68; Kuhtz J, 2014, HUM REPROD, V29, P1995, DOI 10.1093/humrep/deu155; Kuhtz J, 2014, EPIGENETICS-US, V9, P1648, DOI 10.4161/15592294.2014.988063; Laurentino S, 2015, HUM MOL GENET, V24, P1295, DOI 10.1093/hmg/ddu540; Lazaraviciute G, 2014, HUM REPROD UPDATE, V20, P840, DOI 10.1093/humupd/dmu033; Manipalviratn S, 2009, FERTIL STERIL, V91, P305, DOI 10.1016/j.fertnstert.2009.01.002; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Miozzo M, 2002, BIOL NEONATE, V81, P217, DOI 10.1159/000056752; Montjean D, 2013, FERTIL STERIL, V100, P1241, DOI 10.1016/j.fertnstert.2013.06.047; Moore GE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0074; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Oliver VF, 2012, FERTIL STERIL, V97, P147, DOI 10.1016/j.fertnstert.2011.10.027; Owen CM, 2009, SEMIN REPROD MED, V27, P417, DOI 10.1055/s-0029-1237430; Piedrahita JA, 2011, BIRTH DEFECTS RES A, V91, P682, DOI 10.1002/bdra.20795; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Sakian S, 2015, PLACENTA, V36, P1100, DOI 10.1016/j.placenta.2015.08.008; Sanchez-Delgado M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006427; Savage T, 2011, HUM REPROD, V26, P2392, DOI 10.1093/humrep/der212; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tabano S, 2010, EPIGENETICS-US, V5, P313, DOI 10.4161/epi.5.4.11637; Tierling S, 2010, J MED GENET, V47, P371, DOI 10.1136/jmg.2009.073189; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Uyar A, 2014, CURR OPIN OBSTET GYN, V26, P210, DOI 10.1097/GCO.0000000000000071; Whitelaw N, 2014, HUM REPROD, V29, P1452, DOI 10.1093/humrep/deu094; Wisborg K, 2010, FERTIL STERIL, V94, P2102, DOI 10.1016/j.fertnstert.2010.01.014; Zheng HY, 2013, HUM REPROD, V28, P265, DOI 10.1093/humrep/des358	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187869	10.1371/journal.pone.0187869	http://dx.doi.org/10.1371/journal.pone.0187869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136648	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200039
J	Zhang, YF; Alekseyenko, AV				Zhang, Yifei; Alekseyenko, Alexander V.			Phylogenic inference using alignment-free methods for applications in microbial community surveys using 16s rRNA gene	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTESTINAL MICROBIOTA; ANTIBIOTICS; DISTANCES; DATABASE; TOOL	The diversity of microbiota is best explored by understanding the phylogenetic structure of the microbial communities. Traditionally, sequence alignment has been used for phylogenetic inference. However, alignment-based approaches come with significant challenges and limitations when massive amounts of data are analyzed. In the recent decade, alignment-free approaches have enabled genome-scale phylogenetic inference. Here we evaluate three alignment-free methods: ACS, CVTree, and Kr for phylogenetic inference with 16s rRNA gene data. We use a taxonomic gold standard to compare the accuracy of alignment-free phylogenetic inference with that of common microbiome-wide phylogenetic inference pipelines based on PyNAST and MUSCLE alignments with FastTree and RAxML. We resimulate fecal communities from Human Microbiome Project data to evaluate the performance of the methods on datasets with properties of real data. Our comparisons show that alignment-free methods are not inferior to alignment-based methods in giving accurate and robust phylogenic trees. Moreover, consensus ensembles of alignment-free phylogenies are superior to those built from alignment-based methods in their ability to highlight community differences in low power settings. In addition, the overall running times of alignment-based and alignment-free phylogenetic inference are comparable. Taken together our empirical results suggest that alignment-free methods provide a viable approach for microbiome-wide phylogenetic inference.	[Zhang, Yifei; Alekseyenko, Alexander V.] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Alekseyenko, Alexander V.] Med Univ S Carolina, Biomed Informat Ctr, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Alekseyenko, Alexander V.] Med Univ S Carolina, Dept Oral Hlth Sci, Program Human Microbiome Res, Charleston, SC 29425 USA	New York University; Medical University of South Carolina; Medical University of South Carolina	Alekseyenko, AV (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.; Alekseyenko, AV (corresponding author), Med Univ S Carolina, Biomed Informat Ctr, Dept Publ Hlth Sci, Charleston, SC 29425 USA.; Alekseyenko, AV (corresponding author), Med Univ S Carolina, Dept Oral Hlth Sci, Program Human Microbiome Res, Charleston, SC 29425 USA.	alekseye@musc.edu		zhang, yifei/0000-0003-4981-5844; Alekseyenko, Alexander/0000-0002-5748-2085	NYU internal medicine fellowship; National Cancer Institute [5R01CA164964]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R21AR067459]	NYU internal medicine fellowship; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NYU internal medicine fellowship, National Cancer Institute, 5R01CA164964, National Institute of Arthritis and Musculoskeletal and Skin Diseases, 5R21AR067459.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; Ianiro G, 2015, HELICOBACTER, V20, P68, DOI 10.1111/hel.12260; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Kleiman SC, 2015, PSYCHOSOM MED, V77, P969, DOI 10.1097/PSY.0000000000000247; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Obata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103712; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ragan MA, 2014, RNA BIOL, V11, P176, DOI 10.4161/rna.27505; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Rup L, 2012, INDIAN J MICROBIOL, V52, P315, DOI 10.1007/s12088-012-0304-9; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Shin H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075729, 10.1371/journal.pone.0081330]; Song K, 2014, BRIEF BIOINFORM, V15, P343, DOI 10.1093/bib/bbt067; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424	30	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e187940	10.1371/journal.pone.0187940	http://dx.doi.org/10.1371/journal.pone.0187940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136663	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200049
J	Bien, SA; Auer, PL; Harrison, TA; Qu, CH; Connolly, CM; Greenside, PG; Chen, S; Berndt, SI; Bezieau, S; Kang, HM; Huyghe, J; Brenner, H; Casey, G; Chan, AT; Hopper, JL; Banbury, BL; Chang-Claude, J; Chanock, SJ; Haile, RW; Hoffmeister, M; Fuchsberger, C; Jenkins, MA; Leal, SM; Lemire, M; Newcomb, PA; Gallinger, S; Potter, JD; Schoen, RE; Slattery, ML; Smith, JD; Le Marchand, L; White, E; Zanke, BW; Abecasis, GR; Carlson, CS; Peters, U; Nickerson, DA; Kundaje, A; Hsu, L				Bien, Stephanie A.; Auer, Paul L.; Harrison, Tabitha A.; Qu, Conghui; Connolly, Charles M.; Greenside, Peyton G.; Chen, Sai; Berndt, Sonja I.; Bezieau, Stephane; Kang, Hyun M.; Huyghe, Jeroen; Brenner, Hermann; Casey, Graham; Chan, Andrew T.; Hopper, John L.; Banbury, Barbara L.; Chang-Claude, Jenny; Chanock, Stephen J.; Haile, Robert W.; Hoffmeister, Michael; Fuchsberger, Christian; Jenkins, Mark A.; Leal, Suzanne M.; Lemire, Mathieu; Newcomb, Polly A.; Gallinger, Steven; Potter, John D.; Schoen, Robert E.; Slattery, Martha L.; Smith, Joshua D.; Le Marchand, Loic; White, Emily; Zanke, Brent W.; Abecasis, Goncalo R.; Carlson, Christopher S.; Peters, Ulrike; Nickerson, Deborah A.; Kundaje, Anshul; Hsu, Li		GECCO CCFR	Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data	PLOS ONE			English	Article							AFRICAN-AMERICANS; CODING VARIANTS; COMMON; RARE; IMPUTATION; LOCI	Background The evaluation of less frequent genetic variants and their effect on complex disease pose new challenges for genomic research. To investigate whether epigenetic data can be used to inform aggregate rare-variant association methods (RVAM), we assessed whether variants more significantly associated with colorectal cancer (CRC) were preferentially located in non-coding regulatory regions, and whether enrichment was specific to colorectal tissues. Methods Active regulatory elements (ARE) were mapped using data from 127 tissues and cell-types from NIH Roadmap Epigenomics and Encyclopedia of DNA Elements (ENCODE) projects. We investigated whether CRC association p-values were more significant for common variants inside versus outside AREs, or 2) inside colorectal (CR) AREs versus AREs of other tissues and cell-types. We employed an integrative epigenomic RVAM for variants with allele frequency <1%. Gene sets were defined as ARE variants within 200 kilobases of a transcription start site (TSS) using either CR ARE or ARE from non-digestive tissues. CRC-set association p-values were used to evaluate enrichment of less frequent variant associations in CR ARE versus non-digestive ARE. Results ARE from 126/127 tissues and cell-types were significantly enriched for stronger CRC-variant associations. Strongest enrichment was observed for digestive tissues and immune cell types. CR-specific ARE were also enriched for stronger CRC-variant associations compared to ARE combined across non-digestive tissues (p-value = 9.6 x 10(-4)). Additionally, we found enrichment of stronger CRC association p-values for rare variant sets of CR ARE compared to non-digestive ARE (p-value = 0.029). Conclusions Integrative epigenomic RVAM may enable discovery of less frequent variants associated with CRC, and ARE of digestive and immune tissues are most informative. Although distance-based aggregation of less frequent variants in CR ARE surrounding TSS showed modest enrichment, future association studies would likely benefit from joint analysis of transcriptomes and epigenomes to better link regulatory variation with target genes.	[Bien, Stephanie A.; Harrison, Tabitha A.; Qu, Conghui; Connolly, Charles M.; Huyghe, Jeroen; Banbury, Barbara L.; Newcomb, Polly A.; Potter, John D.; White, Emily; Carlson, Christopher S.; Peters, Ulrike; Hsu, Li] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Auer, Paul L.] Univ Wisconsin Milwaukee, Joseph J Zilber Sch Publ Hlth, Milwaukee, WI USA; [Greenside, Peyton G.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Chen, Sai; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Berndt, Sonja I.; Chanock, Stephen J.] NIH, Div Canc Epidemiol & Genet, Natl Canc Inst, Bldg 10, Bethesda, MD 20892 USA; [Bezieau, Stephane] Ctr Hosp Univ Nantes, Serv Genet Med, Nantes, France; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Casey, Graham] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol C020, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Canc Ctr Hamburg, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Haile, Robert W.] Stanford Sch Med, Div Med Oncol, Stanford, CA USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Ctr Stat Genet, Houston, TX 77030 USA; [Lemire, Mathieu] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON, Canada; [Gallinger, Steven] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Smith, Joshua D.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [White, Emily; Carlson, Christopher S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Zanke, Brent W.] Univ Ottawa, Div Hematol, Ottawa, ON, Canada; [Zanke, Brent W.] Res Inst, Ottawa Hosp, Clin Epidemiol Program, Ottawa, ON, Canada; [Kundaje, Anshul] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hsu, Li] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Wisconsin System; University of Wisconsin Milwaukee; Stanford University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Virginia; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Melbourne; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; Stanford University; Baylor College of Medicine; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; Cancer Research Center of Hawaii; University of Hawaii System; University of Washington; University of Washington Seattle; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Stanford University; University of Washington; University of Washington Seattle	Bien, SA; Hsu, L (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Hsu, L (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.	sbien@fredhutch.org; lih@fredhutch.org	Brenner, Hermann/B-4627-2017; Auer, Paul/AAC-5060-2019; Hoffmeister, Michael/AAB-2321-2022; Kundaje, Anshul/Y-2739-2019; Brenner, Hermann/ABE-6383-2020; Fuchsberger, Christian/ABD-7127-2021; Hoffmeister, Michael/T-7187-2019; Kundaje, Anshul/Y-2598-2019; Jenkins, Mark/P-7803-2015	Brenner, Hermann/0000-0002-6129-1572; Hoffmeister, Michael/0000-0002-8307-3197; Kundaje, Anshul/0000-0003-3084-2287; Brenner, Hermann/0000-0002-6129-1572; Fuchsberger, Christian/0000-0002-5918-8947; Hoffmeister, Michael/0000-0002-8307-3197; Kundaje, Anshul/0000-0003-3084-2287; Harrison, Tabitha/0000-0002-4173-7530; Bien, Stephanie/0000-0002-8713-4583; Jenkins, Mark/0000-0002-8964-6160	Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Institutes of Health [R01 CA60987, R01 CA48998, P01 CA 055075, UM1 CM 67552, R01 137178, R01 CA151993, P50 CA127003, R37 CA54281, P01 CA033619, R01 CA63464, U01 CA074783, R01 CA076366, K05 CA154337]; National Cancer Institute [UM1 CM 67551]; Australasian Colorectal Cancer Family Registry [U01 CA074778, U01/U24 CA097735]; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01/U24 CA074800]; Ontario Familial Colorectal Cancer Registry [U01/U24 CA074783]; Seattle Colorectal Cancer Family Registry [U01/U24 CA074794]; University of Hawaii Colorectal Cancer Family Registry [U01/U24 CA074806]; USC Consortium Colorectal Cancer Family Registry [U01/U24 CA074799]; National Cancer Institute, National Institutes of Health [U01 CM 22839, R01 CA143237]; German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services [U01 CM 37088, R01 CA059045, R01 CM 20582, U01 CM 64930]; NHS by the National Institutes of Health [UM1 CM 86107, R01 CM 37178, P01 CA87969, R01 CM 51993, P50 CM 27003]; PHS by the National Institutes of Health [R01 CA042182]; Ontario Research Fund; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200, NIH U01 HG004446, NIH GEI U01 HG 004438]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [R01CA195789, R01CA189532, ZIACP010152, U01CA164930, UM1CA167551, U01CA137088, R01CA120582, R01CA059045] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australasian Colorectal Cancer Family Registry; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies; Ontario Familial Colorectal Cancer Registry; Seattle Colorectal Cancer Family Registry; University of Hawaii Colorectal Cancer Family Registry; USC Consortium Colorectal Cancer Family Registry; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHS by the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS by the National Institutes of Health; Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Intramural Research Program of the Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ASTERISK: a Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). COLO2&3: National Institutes of Health (R01 CA60987). CCFR: This work was supported by grant UM1 CM 67551 from the National Cancer Institute and through cooperative agreements with the following CCFR centers: Australasian Colorectal Cancer Family Registry (U01 CA074778 and U01/U24 CA097735), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01/U24 CA074800), Ontario Familial Colorectal Cancer Registry (U01/U24 CA074783), Seattle Colorectal Cancer Family Registry (U01/U24 CA074794), University of Hawaii Colorectal Cancer Family Registry (U01/U24 CA074806), and USC Consortium Colorectal Cancer Family Registry U01/U24 CA074799). The Colon CFR GWAS was supported by funding from the National Cancer Institute, National Institutes of Health (U01 CM 22839 and R01 CA143237 to Graham Casey). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Colon Cancer Family Registry (CCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the CCFR. DACHS: German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS: National Institutes of Health (R01 CA48998 to M.L. Slattery). GECCO: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CM 37088; R01 CA059045; R01 CM 20582; U01 CM 64930). HPFS is supported by the National Institutes of Health (P01 CA 055075, UM1 CM 67552, R01 137178, R01 CA151993 and P50 CA127003), NHS by the National Institutes of Health (UM1 CM 86107, R01 CM 37178, P01 CA87969, R01 CM 51993 and P50 CM 27003) and PHS by the National Institutes of Health (R01 CA042182). MEC: National Institutes of Health (R37 CA54281, P01 CA033619, and R01 CA63464). OFCCR: National Institutes of Health, through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section above. Additional funding toward genetic analyses of OFCCR includes the Ontario Research Fund, the Canadian Institutes of Health Research, and the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Additionally, a subset of control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS (Yeager, M et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007 May;39(5):645-9), Colon CGEMS pancreatic cancer scan (PanScan) (Amundadottir, L et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009 Sep;41(9):986-90, and Petersen, GM et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet.; r 2010 Mar;42(3):224-8), and the Lung Cancer and Smoking study (Landi MT, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009 Nov;85(5):679-91). The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems.cancer.gov/data/) accession numbers phs000207.v1.p1 and phs000206.v3.p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www.ncbi.nlm.nih.gov/gap) through accession number phs000093.v2.p2. Funding for the Lung Cancer and Smoking study was provided by National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) Z01 CP 010200, NIH U01 HG004446, and NIH GEI U01 HG 004438. For the lung study, the GENEVA Coordinating Center provided assistance with genotype cleaning and general study coordination, and the Johns Hopkins University Center for Inherited Disease Research conducted genotyping. PMH: National Institutes of Health (R01 CA076366). VITAL: National Institutes of Health (K05 CA154337). WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C.	1000 Genomes Project Consortium, 2010, Nature, V467, P1061, DOI 10.1038/nature09534; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962; Auer PL, 2012, AM J HUM GENET, V91, P794, DOI 10.1016/j.ajhg.2012.08.031; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Du MM, 2014, HUM MOL GENET, V23, P6607, DOI 10.1093/hmg/ddu361; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jiao S, 2014, HUM MOL GENET, V23, P3898, DOI 10.1093/hmg/ddu087; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Peters U, 2015, GUT; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; R Development Core Team, 2009, R LANG ENV STAT COMP; Roadmap Epigenomics Consortium, 2015, Nature, V518, P317, DOI 10.1038/nature14248; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Vucicevic D, 2015, CELL CYCLE, V14, P253, DOI 10.4161/15384101.2014.977641; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186518	10.1371/journal.pone.0186518	http://dx.doi.org/10.1371/journal.pone.0186518			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161273	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000005
J	Kimuda, SG; Andia-Biraro, I; Egesa, M; Bagaya, BS; Raynes, JG; Levin, J; Elliott, AM; Cose, S				Kimuda, Simon G.; Andia-Biraro, Irene; Egesa, Moses; Bagaya, Bernard S.; Raynes, John G.; Levin, Jonathan; Elliott, Alison M.; Cose, Stephen			Use of QuantiFERON (R)-TB Gold in-tube culture supernatants for measurement of antibody responses	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; ANTIGENS	QuantiFERON (R)-TB Gold in-tube (QFT-GIT) supernatants may be important samples for use in assessment of anti-tuberculosis (TB) antibodies when only limited volumes of blood can be collected and when a combination of antibody and cytokine measurements are required. These analytes, when used together, may also have the potential to differentiate active pulmonary TB (APTB) from latent TB infection (LTBI). However, few studies have explored the use of QFT-GIT supernatants for investigations of antibody responses. This study determined the correlation and agreement between anti-CFP-10 and anti-ESAT-6 antibody concentrations in QFT-GIT nil supernatant and serum pairs from 68 TB household contacts. We also explored the ability of Mycobacterium tuberculosis (M.tb) specific antibodies, or ratios of antibody to interferon gamma (IFN-gamma) in QFT-GIT supernatants, to differentiate 97 APTB cases from 58 individuals with LTBI. Sputum smear microscopy was used to define APTB, whereas the QFT-GIT and tuberculin skin test were used to define LTBI. There were strong and statistically significant correlations between anti-CFP-10 and anti-ESAT-6 antibodies in unstimulated QFT-GIT supernatants and sera (r = 0.89; p<0.0001 for both), and no significant differences in antibody concentration between them. Anti-CFP-10 & anti-ESAT-6 antibodies differentiated APTB from LTBI with sensitivities of 88.7% & 71.1% and specificities of 41.4% & 51.7% respectively. Anti-CFP-10 antibody/M. tb specific IFN-gamma and anti-ESAT-6 antibody/M. tb specific IFN-gamma ratios had sensitivities of 48.5% & 54.6% and specificities of 89.7% and 75.9% respectively. We conclude that QFT-GIT nil supernatants may be used in the place of sera when measuring antibody responses, reducing blood volumes needed for such investigations. Antibodies in QFT-GIT nil supernatants on their own discriminate APTB from LTBI with high sensitivity but have poor specificity, whereas the reverse is true when antibodies are used in combination withM. tb specific cytokines. Further antibody and antibody/cytokine combinations need to be explored to achieve better diagnostic accuracy.	[Kimuda, Simon G.; Egesa, Moses; Cose, Stephen] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda; [Kimuda, Simon G.; Andia-Biraro, Irene; Egesa, Moses; Levin, Jonathan; Elliott, Alison M.; Cose, Stephen] UVRI Uganda Res Unit AIDS, MRC, Entebbe, Uganda; [Andia-Biraro, Irene] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Immunol & Mol Biol, Kampala, Uganda; [Bagaya, Bernard S.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Internal Med, Kampala, Uganda; [Raynes, John G.; Elliott, Alison M.; Cose, Stephen] London Sch Hyg & Trop Med, London, England	Makerere University; Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine	Cose, S (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Med Microbiol, Kampala, Uganda.; Cose, S (corresponding author), UVRI Uganda Res Unit AIDS, MRC, Entebbe, Uganda.; Cose, S (corresponding author), London Sch Hyg & Trop Med, London, England.	stephen.cose@lshtm.ac.uk	Raynes, John G/G-7932-2011	Raynes, John G/0000-0002-8536-1328; Kimuda, Simon/0000-0001-6818-617X; Egesa, Moses/0000-0001-5136-868X; Ssentalo Bagaya, Bernard/0000-0002-3847-2615; Elliott, Alison/0000-0003-2818-9549; Cose, Stephen/0000-0002-5156-037X	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award [084344]; Commonwealth Scholarship Commission; DELTAS Africa Initiative [107743]; funding scheme of the African Academy of Sciences (AAS); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107743, 095778]; UK Government; MRC [MC_UP_1204/15] Funding Source: UKRI	Wellcome Trust Uganda PhD Fellowship in Infection and Immunity - Wellcome Trust Strategic Award; Commonwealth Scholarship Commission; DELTAS Africa Initiative; funding scheme of the African Academy of Sciences (AAS); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by a Wellcome Trust Uganda PhD Fellowship in Infection and Immunity held by SGK, funded by a Wellcome Trust Strategic Award grant no. 084344. SGK also received support from a Commonwealth Scholarship Commission Split Site PhD Fellowship and through the DELTAS Africa Initiative (grant no. 107743). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS), Alliance for Accelerating Excellence in Science in Africa (AESA), and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (grant no. 107743) and the UK Government. AME received funding from the Wellcome Trust, grant number 095778. The views expressed in this publication are those of the author(s) and not necessarily those of MS, NEPAD Agency, Wellcome Trust or the UK government.	Achkar JM, 2013, CELL HOST MICROBE, V13, P250, DOI 10.1016/j.chom.2013.02.009; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Ashenafi S, 2013, THORAX, V68, P269, DOI 10.1136/thoraxjnl-2012-201817; Biraro IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111517; Biraro IA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1201-8; Caraux A, 2010, HAEMATOL-HEMATOL J, V95, P1016, DOI 10.3324/haematol.2009.018689; Cellestis, 2013, QUANTIFERON TB GOLD, V96, P1; Chegou NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064226; Chegou Novel N, 2009, BMC Pulm Med, V9, P21, DOI 10.1186/1471-2466-9-21; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; Euser AM, 2008, J CLIN EPIDEMIOL, V61, P978, DOI 10.1016/j.jclinepi.2007.11.003; Fletcher HA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11290; Frahm M, 2011, TUBERCULOSIS, V91, P250, DOI 10.1016/j.tube.2011.02.006; Greenaway C, 2005, INT J TUBERC LUNG D, V9, P1112; Hanneman SK, 2008, AACN ADV CRIT CARE, V19, P223, DOI 10.1097/01.AACN.0000318125.41512.a3; Herrmann J-L, 2009, Pathol Biol (Paris), V57, pe49, DOI 10.1016/j.patbio.2008.02.010; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kimuda SG, 2017, J IMMUNOL RES, V2017, P8; Lalvani A, 2013, THORAX, V68, P204, DOI 10.1136/thoraxjnl-2012-202481; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Schnappinger D, 2016, NAT MED, V22, P1076, DOI 10.1038/nm.4186; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Sutherland JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074080; van Hooij A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34260; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; Wu XQ, 2010, CLIN VACCINE IMMUNOL, V17, P372, DOI [10.1128/CVI.00287-09, 10.3785/j.issn.1006-754X.2010.05.011]	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188396	10.1371/journal.pone.0188396	http://dx.doi.org/10.1371/journal.pone.0188396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161328	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000415987000049
J	Rais, A; Jabeen, Z; Shair, F; Hafeez, FY; Hassan, MN				Rais, Afroz; Jabeen, Zahra; Shair, Faluk; Hafeez, Fauzia Yusuf; Hassan, Muhammad Nadeem			Bacillus spp., a bio-control agent enhances the activity of antioxidant defense enzymes in rice against Pyricularia oryzae	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; PHENYLALANINE AMMONIA-LYASE; INDUCED SYSTEMIC RESISTANCE; PLANT DEFENSE; SALICYLIC-ACID; RED ROT; OXIDATIVE STRESS; GENE-EXPRESSION; GROWTH; DISEASE	Plant growth promoting rhizobacteria (PGPR) are found to control the plant diseases by adopting various mechanisms. Induced systemic resistance (ISR) is an important defensive strategy manifested by plants against numerous pathogens especially infecting at aerial parts. Rhizobacteria elicit ISR by inducing different pathways in plants through production of various metabolites. In the present study, potential of Bacillus spp. KFP-5, KFP-7, KFP-17 was assessed to induce antioxidant enzymes against Pyricularia oryzae infection in rice. The antagonistic Bacillus spp. significantly induced antioxidant defense enzymes i-e superoxide dismutase (1.7-1.9-fold), peroxidase (3.5-4.1-fold), polyphenol oxidase (3.0-3.8-fold), phenylalanine ammonia-lyase (3.9-4.4-fold), in rice leaves and roots under hydroponic and soil conditions respectively. Furthermore, the antagonistic Bacillus spp significantly colonized the rice plants (2.0E+00-9.1E+08) and secreted multiple biocontrol determinants like protease (1.1-5.5 U/mg of soil or U/mL of hydroponic solution), glucanase, (1.0-1.3 U/mg of soil or U/mL of hydroponic solution), siderophores (6.5-42.8 mu g/mL or mg) in the rhizosphere of different rice varieties. The results showed that treatment with Bacillus spp. enhanced the antioxidant defense activities in infected rice, thus alleviating P. oryzae induced oxidative damage and suppressing blast disease incidence.	[Rais, Afroz; Jabeen, Zahra; Shair, Faluk; Hafeez, Fauzia Yusuf; Hassan, Muhammad Nadeem] COMSATS Inst Informat Technol, Dept Biosci, Pk Rd, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Hassan, MN (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Pk Rd, Islamabad, Pakistan.	nadeem_hassan@comsats.edu.pk	Jabeen, Zahra/AAN-2584-2020; Hassan, Mohammad/GZA-7507-2022; Hafeez, Fauzia Yusuf/Q-9421-2019; Hassan, Muhammad/GWZ-4054-2022	Hassan, Mohammad/0000-0002-1712-0004; Hassan, Muhammad Nadeem/0000-0001-8219-4440	Pakistan science foundation [141]	Pakistan science foundation	The work was supported by Pakistan science foundation (141).	Ali MB, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-84; Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Anand T, 2007, J PLANT INTERACT, V2, P233, DOI 10.1080/17429140701708985; Antoun H, 2006, PGPR: BIOCONTROL AND BIOFERTILIZATION, P1, DOI 10.1007/1-4020-4152-7_1; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Ashwini N, 2014, 3 BIOTECH, V4, P127, DOI 10.1007/s13205-013-0134-4; Audenaert K, 2002, MOL PLANT MICROBE IN, V15, P1147, DOI 10.1094/MPMI.2002.15.11.1147; Bano A, 2017, PLANT BIOLOGY, V19, P406, DOI 10.1111/plb.12535; Barillot CDC, 2013, ANN MICROBIOL, V63, P471, DOI 10.1007/s13213-012-0491-y; Bolouri-Moghaddam MR, 2010, FEBS J, V277, P2022, DOI 10.1111/j.1742-4658.2010.07633.x; Chaiharn M, 2009, WORLD J MICROB BIOT, V25, P1919, DOI 10.1007/s11274-009-0090-7; Chandra S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15195; Choi HW, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0921-2; Conrath U, 2001, EUR J PLANT PATHOL, V107, P113, DOI 10.1023/A:1008768516313; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Dewi RTK, 2016, EMIR J FOOD AGR, V28, P116, DOI 10.9755/ejfa.2015-05-195; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Filippi MCC, 2011, BIOL CONTROL, V58, P160, DOI 10.1016/j.biocontrol.2011.04.016; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gupta D, 2016, PLANT CELL ENV, V50; Halo BA, 2015, J PLANT INTERACT, V10, P117, DOI 10.1080/17429145.2015.1033659; Hammerschmidt R, 1999, ANNU REV PHYTOPATHOL, V37, P285, DOI 10.1146/annurev.phyto.37.1.285; Hammerschmidt R, 1982, PHYSL PLANT PATHOLOG; Hassan MN, 2012, J PLANT PATHOL, V94, P325; Hassan MN, 2015, BIOCONTROL, V60, P691, DOI 10.1007/s10526-015-9673-4; Hassan MN, 2010, BIOCONTROL, V55, P531, DOI 10.1007/s10526-010-9268-z; Henkes GJ, 2011, J EXP BOT, V62, P4337, DOI 10.1093/jxb/err149; Hussain S, 2009, ADV AGRON, V102, P159, DOI 10.1016/S0065-2113(09)01005-0; Ishibashi Y, 2011, J PLANT PHYSIOL, V168, P1562, DOI 10.1016/j.jplph.2011.02.003; Jabeen Z, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1920-x; Jha AB., 2012, J BOT, V2012; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joo HS, 2002, PROCESS BIOCHEM, V38, P155, DOI 10.1016/S0032-9592(02)00061-4; Kombrink E, 2001, EUR J PLANT PATHOL, V107, P69, DOI 10.1023/A:1008736629717; KUC J, 1995, ANNU REV PHYTOPATHOL, V33, P275, DOI 10.1146/annurev.py.33.090195.001423; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Law JW-F, 2017, FRONTIERS MICROBIOLO, V8; Lethbridge G, SOIL BIOL BIOCH; Liu TT, 2011, BIOL TRACE ELEM RES, V144, P1186, DOI 10.1007/s12011-011-9053-6; Mandal SM, 2010, PLANT SIGNAL BEHAV, V5, P359, DOI 10.4161/psb.5.4.10871; Manhas RK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01869; MauchMani B, 1996, PLANT CELL, V8, P203, DOI 10.1105/tpc.8.2.203; MAYER AM, 1966, PHYTOCHEMISTRY, V5, P783, DOI 10.1016/S0031-9422(00)83660-2; MAYERHOFER HJ, 1973, APPL MICROBIOL, V25, P44, DOI 10.1128/AEM.25.1.44-48.1973; Mercado-Blanco J., 2014, CURR BIOTECHNOL, V3, P60, DOI [10.2174/22115501113026660038, DOI 10.2174/22115501113026660038]; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; ODIER E, 1981, APPL ENVIRON MICROB, V41, P337, DOI 10.1128/AEM.41.2.337-341.1981; PELLEGRINI L, 1994, PLANT PHYSIOL, V106, P877, DOI 10.1104/pp.106.3.877; POWELL PE, 1983, APPL ENVIRON MICROB, V46, P1080, DOI 10.1128/AEM.46.5.1080-1083.1983; Purwar S., 2012, AM J PLANT SCI, V3, P261, DOI DOI 10.4236/AJPS.2012.32031; Pusztahelyi T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00573; Qin S, 2011, APPL MICROBIOL BIOT, V89, P457, DOI 10.1007/s00253-010-2923-6; Rais A, 2016, BIOCONTROL, V61, P769, DOI 10.1007/s10526-016-9763-y; Raj TS, 2016, IJAPSA, V02, P106; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Reddy M.S., 2014, RECENT ADV BIOFERTIL; REEVES MW, 1983, J BACTERIOL, V154, P324, DOI 10.1128/JB.154.1.324-329.1983; Rodrigues F, 2013, BRAGANTIA, V72, P292; Rodrigues FA, 2015, J PHYTOPATHOL, V163, P554, DOI [10.1111/jph.12231, 10.1111/jph.12353]; Samalova M, 2014, NEW PHYTOL, V201, P556, DOI 10.1111/nph.12530; Sankaranarayanan R, 2015, APPL MICROBIOL BIOT, V99, P2339, DOI 10.1007/s00253-015-6411-x; Sarma BK, 2015, SOIL BIOL BIOCHEM, V87, P25, DOI 10.1016/j.soilbio.2015.04.001; SAUNDERS JA, 1975, PHYTOCHEMISTRY, V14, P1285, DOI 10.1016/S0031-9422(00)98612-6; Schmitt FJ, 2014, BBA-BIOENERGETICS, V1837, P835, DOI 10.1016/j.bbabio.2014.02.005; Senthilraja G, 2013, PHYSIOL MOL PLANT P, V82, P10, DOI 10.1016/j.pmpp.2012.12.002; Shafi J, 2017, BIOTECHNOL BIOTEC EQ, V31, P446, DOI 10.1080/13102818.2017.1286950; Sharma M., 2014, INT J CURR MICROBIOL, V3, P801, DOI DOI 10.20546/IJCMAS.2017.602.089; Sheridan C, 2016, MICROB ECOL, P1; Shi QingHua, 2006, Agricultural Sciences in China, V5, P767, DOI 10.1016/S1671-2927(06)60122-3; Sindhu SS, 1999, BIOL FERT SOILS, V29, P62, DOI 10.1007/s003740050525; Singh A, 2013, MICROBIOL RES, V168, P33, DOI 10.1016/j.micres.2012.07.001; Singh N, 2005, FOOD CHEM, V89, P253, DOI 10.1016/j.foodchem.2004.02.032; Singh SP, 2017, BIOL CONTROL, V104, P44, DOI 10.1016/j.biocontrol.2016.10.011; Song AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24640; Souguir D, 2011, ECOTOXICOLOGY, V20, P329, DOI 10.1007/s10646-010-0582-0; TAKAHASHI MA, 1983, ARCH BIOCHEM BIOPHYS, V226, P558, DOI 10.1016/0003-9861(83)90325-9; Nascimento KJT, 2016, BRAGANTIA, V75, P212, DOI 10.1590/1678-4499.281; Thakur A, 2017, THESIS AGR U ATHENS; Vaikuntapu PR, 2014, INDIAN J MICROBIOL, V54, P403, DOI 10.1007/s12088-014-0470-z; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; van Doorn WG, 2014, POSTHARVEST BIOL TEC, V95, P64, DOI 10.1016/j.postharvbio.2014.04.002; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wada KC, 2014, J PLANT PHYSIOL, V171, P895, DOI 10.1016/j.jplph.2014.03.008; Walters DR., 2005, BIOL, V52, P28; Wang MY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00262; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; YANG GZ, 1994, PATTERN RECOGN, V27, P53, DOI 10.1016/0031-3203(94)90017-5; Yasmin S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160688; Zhang X, 2014, PLANT PHYSIOL, P114; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597; Zhao Q, 2014, ANNU REV PHYTOPATHOL, V52, P69, DOI 10.1146/annurev-phyto-082712-102237; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	95	75	78	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187412	10.1371/journal.pone.0187412	http://dx.doi.org/10.1371/journal.pone.0187412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161274	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000010
J	Yeh, HM; Lin, TT; Yeh, CF; Huang, HS; Chang, SN; Lin, JW; Tsai, CT; Lai, LP; Huang, YY; Chu, CL				Yeh, Huei-Ming; Lin, Ting-Tse; Yeh, Chih-Fan; Huang, Ho-Shiang; Chang, Sheng-Nan; Lin, Jou-Wei; Tsai, Chia-Ti; Lai, Ling-Ping; Huang, Yi-You; Chu, Chun-Lin			Biomarkers and echocardiography for evaluating the improvement of the ventricular diastolic function after surgical relief of hydronephrosis	PLOS ONE			English	Article							SALT-SENSITIVE HYPERTENSION; BRAIN NATRIURETIC PEPTIDE; ACUTE KIDNEY INJURY; CARDIORENAL SYNDROME; DOPPLER-ECHOCARDIOGRAPHY; FILLING PRESSURES; STRAIN-RATE; DYSFUNCTION; CHILDREN; RELAXATION	The pathophysiology of cardio-renal syndrome (CRS) is complex. Hydronephrosis caused by urolithiasis may cause cytokine release and lead to cardiac dysfunction. The aim of this study was to evaluate cardiac function changes observed in patients who received double J placement using feasible biomarkers and echocardiography. This was a prospective, single-center study. Eighty-seven patients who presented with acute unilateral hydronephrosis and received ureteroscope stone manipulation were enrolled. Echocardiography and cytokines were measured on the day of the operation and 24 hours after the procedure. Changes before and after surgery were assessed by the paired t-test and Wilcoxon test. Correlation analyses between echocardiographic diastolic indices and cytokine levels were performed using Pearson's correlation coefficients. Patients with hydronephrosis showed a higher left atrium volume index (LAVI), decreased E', and increased E/E' ratio, which indicated diastolic dysfunction. Patients with hydronephrosis also exhibited decreased global strain rates during isovolumetric relaxation (SRIVR) and E/SRIVR, which confirmed the diastolic dysfunction. Significant reductions in LAVI, increases in SRIVR and decreases in E/SRIVR were observed after the operation. Biomarkers, such as TGF-beta and serum NT-proBNP, were significantly decreased after surgery. In addition, a significant correlation was observed between the post-surgical decrease in TGF-beta 1 and increase in SRIVR. Unilateral hydronephrosis causes cardiac diastolic dysfunction, and relieving hydronephrosis could improve diastolic function. Improvements in cardiac dysfunction can be evaluated by echocardiography and measuring cytokine levels. The results of this study will inform efforts to improve the early diagnosis of CRS and prevent further deterioration of cardiac function when treating patients with hydronephrosis.	[Yeh, Huei-Ming] Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Ting-Tse] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol,Hsinchu Branch, Hsinchu, Taiwan; [Yeh, Chih-Fan; Tsai, Chia-Ti; Lai, Ling-Ping] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Huang, Ho-Shiang] Natl Chengkong Univ Hosp, Dept Urol, Tainan, Taiwan; [Chang, Sheng-Nan; Lin, Jou-Wei] Natl Taiwan Univ, Coll Med & Hosp, Dept Internal Med, Div Cardiol,Yunlin Branch, Yunlin, Taiwan; [Huang, Yi-You; Chu, Chun-Lin] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Chu, Chun-Lin] Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Yunlin Branch, Yunlin, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chu, CL (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan.; Chu, CL (corresponding author), Natl Taiwan Univ, Coll Med & Hosp, Dept Anesthesiol, Yunlin Branch, Yunlin, Taiwan.	cclgenie@yahoo.com.tw	Yeh, Chih-Fan/AAC-6943-2022	Yeh, Chih-Fan/0000-0002-0678-2264; LAI, LING-PING/0000-0002-9651-7420; Chu, Chun-Lin/0000-0001-9122-4437; LIN, TING-TSE/0000-0002-8810-5127; CHANG, SHENG NAN/0000-0002-2663-5042; TSAI, CHIA-TI/0000-0002-4853-8665				Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Carlstrom M, 2007, ACTA PHYSIOL, V189, P293, DOI 10.1111/j.1748-1716.2006.01637.x; Carlstrom M, 2006, J HYPERTENS, V24, P1437, DOI 10.1097/01.hjh.0000234126.78766.00; Crepaldi C, 2012, CONTRIB NEPHROL, V178, P174, DOI 10.1159/000337849; GOTOH M, 1991, UROL INT, V47, P63, DOI 10.1159/000282253; Kasner M, 2010, EUROPEAN HEART J CAR; Kurishima C, 2015, J CARDIOL, V66, P175, DOI 10.1016/j.jjcc.2014.11.002; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Martin FL, 2012, AM J PHYSIOL-REG I, V302, pR292, DOI 10.1152/ajpregu.00194.2011; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Paulus WJ, 2007, EUROPEAN HEART J; Reinglas J, 2010, CURR OPIN CARDIOL, V25, P141, DOI 10.1097/HCO.0b013e328335fed7; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Stoylen A, 2001, J AM SOC ECHOCARDIOG, V14, P264, DOI 10.1067/mje.2001.110375; Tang WH, 2010, AM J PHYSIOL-CELL PH, V299, pC643, DOI 10.1152/ajpcell.00137.2010; Taub PR, 2012, EXPERT REV CARDIOVAS, V10, P657, DOI [10.1586/ERC.12.26, 10.1586/erc.12.26]; Tschope C, 2009, CIRCULATION, V120, P810, DOI 10.1161/CIRCULATIONAHA.109.869628; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Yap SC, 2012, ANESTHESIOLOGY, V116, P1139, DOI 10.1097/ALN.0b013e31824f951b; Zieg J, 2011, NEPHROLOGY, V16, P595, DOI 10.1111/j.1440-1797.2011.01459.x; Zoubiri H, 2015, ANN BIOL CLIN-PARIS, V73, P443, DOI 10.1684/abc.2015.1059	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188597	10.1371/journal.pone.0188597	http://dx.doi.org/10.1371/journal.pone.0188597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161313	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000065
J	Allen, A; Allen, S; Rodrigo, R; Perera, L; Shao, W; Li, C; Wang, DL; Olivieri, N; Weatherall, DJ; Premawardhena, A				Allen, Angela; Allen, Stephen; Rodrigo, Rexan; Perera, Lakshman; Shao, Wei; Li, Chao; Wang, Duolao; Olivieri, Nancy; Weatherall, David J.; Premawardhena, Anuja			Iron status and anaemia in Sri Lankan secondary school children: A cross-sectional survey	PLOS ONE			English	Article							MICRONUTRIENT DEFICIENCIES; HEMOGLOBIN CONCENTRATION; TRANSFERRIN RECEPTOR; REFERENCE VALUES; AGE; ADOLESCENTS; FERRITIN; COMMON; SERUM; GIRLS	Background Iron deficiency, the most common micronutrient disorder and cause of anaemia globally, impairs growth, cognition, behaviour and resistance to infection. Methods/Results As part of a national survey of inherited haemoglobin variants in 7526 students from 72 secondary schools purposefully selected from the 25 districts of Sri Lanka, we studied 5912 students with a normal haemoglobin genotype. Median age was 16.0 (IQR 15.0-17.0) years and 3189 (53.9%) students were males. Most students were Sinhalese (65.7%), with fewer Tamils (23.1%) and Muslims (11.2%). Anaemia occurred in 470 students and was more common in females (11.1%) than males (5.6%). Haemoglobin, serum ferritin, transferrin receptor and iron were determined in 1196 students with low red cell indices and a structured sample of those with normal red cell indices (n = 513). The findings were weighted to estimate the frequencies of iron deficiency and iron deficiency anaemia classified according to WHO criteria. Iron depletion (serum ferritin < 15ug/ml) occurred in 19.2% and cellular iron deficiency (low serum ferritin and transferrin receptor > 28.1 nmol/l) in 11.6% students. Iron deficiency anaemia (cellular iron deficiency with low haemoglobin) occurred in only 130/2794 (4.6%) females and 28/2789 (1.0%) males. Iron biomarkers were normal in 83/470 (14.6%) students with anaemia. In multiple regression analysis, the odds for iron depletion and cellular iron deficiency were about one-third in males compared with females, and the odds for iron deficiency anaemia were about one fifth in males compared to females. Tamil ethnicity and age < 16 years increased the risk of all three stages of iron deficiency and living at high altitude significantly reduced the risk of iron depletion. Conclusions Low iron status and anaemia remain common problems in Sri Lankan secondary school students especially females, younger students and the socioeconomically disadvantaged Tamil population. More research is needed to identify factors other than low iron status that contribute to anaemia in adolescents.	[Allen, Angela; Weatherall, David J.] Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England; [Allen, Angela; Allen, Stephen; Shao, Wei; Li, Chao; Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Rodrigo, Rexan; Perera, Lakshman; Premawardhena, Anuja] Univ Kelaniya, Fac Med, Ragama, Sri Lanka; [Shao, Wei] Second Mil Med Univ, Shanghai, Peoples R China; [Olivieri, Nancy] Univ Toronto, Dept Med & Publ Hlth Sci, Toronto, ON, Canada	University of Oxford; Liverpool School of Tropical Medicine; University Kelaniya; Naval Medical University; University of Toronto	Allen, A (corresponding author), Univ Oxford, MRC Weatherall Inst Mol Med, Oxford, England.; Allen, A (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.	aallengm@yahoo.co.uk	Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; Allen, Stephen/0000-0001-6675-249X; Wang, Duolao/0000-0003-2788-2464; Rodrigo, Rexan/0000-0002-2194-8453	Wellcome Trust [053267/Z98F]; Medical Research Council [4050189188]; MRC [MC_UU_12009/13, MC_UU_00016/12] Funding Source: UKRI; Medical Research Council [MC_UU_12009/13, MC_UU_00016/12] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Wellcome Trust; (www.wellcome.ac.uk) Grant number 053267/Z98F awarded to DJW; Medical Research Council; www.mrc.ac.uk Grant number 4050189188 awarded to DJW; The Anthony Cerami and Ann Dunne Foundation for World Health (www.acadforworldhealth.org) Donation to DJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 1998, CLIN CHEM, V44, P35; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Chong SS, 2000, BLOOD, V95, P360; Clarke GM, 2000, CLIN CHEM, V46, P1284; Cole TJ, 2014, ANN HUM BIOL, V41, P76, DOI 10.3109/03014460.2013.856472; Cook JD, 2005, BLOOD, V106, P1441, DOI 10.1182/blood-2004-12-4782; DALLMAN PR, 1978, AM J CLIN NUTR, V31, P377, DOI 10.1093/ajcn/31.3.377; Cairo RCD, 2014, NUTR HOSP, V29, P1240, DOI 10.3305/nh.2014.29.6.7245; de Lanerolle-Dias M, 2012, CEYLON MED J, V57, P74, DOI 10.4038/cmj.v57i1.4199; Fretham SJB, 2011, ADV NUTR, V2, P112, DOI 10.3945/an.110.000190; Garn S M, 1975, J Natl Med Assoc, V67, P91; GARN SM, 1981, AM J CLIN NUTR, V34, P1648, DOI 10.1093/ajcn/34.9.1648; Hess SY, 2010, BEST PRACT RES CL EN, V24, P117, DOI 10.1016/j.beem.2009.08.012; Hettiarachchi M, 2006, ASIA PAC J CLIN NUTR, V15, P56; HURTADO A, 1945, ARCH INTERN MED, V75, P284, DOI 10.1001/archinte.1945.00210290007002; Ji CJ, 2015, CLIN LAB, V61, P1831, DOI 10.7754/Clin.Lab.2015.150423; Jiang TN, 2005, J NUTR, V135, P1106, DOI 10.1093/jn/135.5.1106; Jonker FA, 2014, J INFECT S1, V69, P523, DOI DOI 10.1016/JJINF.2014.08.007; Klein JD, 2006, PEDIATRICS, V118, P2245, DOI 10.1542/peds.2006-2481; Lafferty JD, 1996, AM J CLIN PATHOL, V106, P201; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; MELIS MA, 1983, BLOOD, V62, P226; Milman N, 1996, INT J HEMATOL, V63, P103; Milman N, 2011, ANN NUTR METAB, V59, P50, DOI 10.1159/000332129; Nagai M, 2007, HEALTH POLICY, V83, P84, DOI 10.1016/j.healthpol.2006.12.001; PAN WH, 1991, AM J EPIDEMIOL, V134, P1410, DOI 10.1093/oxfordjournals.aje.a116046; Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249; PERRY GS, 1992, J NUTR, V122, P1417, DOI 10.1093/jn/122.7.1417; Roy S, 2015, MALAR RES TREAT, V2015; Sekhar DL, 2015, CLIN NUTR ESPEN, V10, pE118, DOI 10.1016/j.clnesp.2015.03.001; Siriwardhana Chesmal, 2014, Confl Health, V8, P22, DOI 10.1186/1752-1505-8-22; Sivarajah N, 2007, WAR HLTH NO SRI LANK; Steenbruggen TG, 2015, NUTRIENTS, V7, P1965, DOI 10.3390/nu7031965; TANNER JM, 1966, ARCH DIS CHILD, V41, P613, DOI 10.1136/adc.41.220.613; The World Bank, SRI LANK OV; Thoradeniya T, 2006, BRIT J NUTR, V95, P511, DOI 10.1079/BJN20051590; Vazquez-Lopez MA, 2015, J PEDIAT HEMATOL ONC, V37, P274, DOI 10.1097/MPH.0000000000000274; WHO, 2007, ASS IR STAT POP INCL; WHO, 2014, WHONMHNHDMNM146; Wickramasinghe V P, 2009, Ceylon Med J, V54, P26; World Health Organization, 2001, IR DEF AN ASS PREV C; Wray K, 2016, AM J HEMATOL	44	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188110	10.1371/journal.pone.0188110	http://dx.doi.org/10.1371/journal.pone.0188110			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155855	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000415756700031
J	Bicer, A; Orlando, S; Islam, ABMMK; Gallastegui, E; Besson, A; Aligue, R; Bachs, O; Pujol, MJ				Bicer, Atilla; Orlando, Serena; Islam, Abul B. M. M. K.; Gallastegui, Edurne; Besson, Arnaud; Aligue, Rosa; Bachs, Oriol; Jesuus Pujol, Maria			ChIP-Seq analysis identifies p27(Kip1)-target genes involved in cell adhesion and cell signalling in mouse embryonic fibroblasts	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; TYROSINE PHOSPHORYLATION; CDK INHIBITORS; TRANSCRIPTION; P27; CANCER; REGULATORS; SEQUENCES; BIOLOGY; PROTEIN	The protein p27(Kip1) (p27), a member of the Cip-Kip family of cyclin-dependent kinase inhibitors, is involved in tumorigenesis and a correlation between reduced levels of this protein in human tumours and a worse prognosis has been established. Recent reports revealed that p27 also behaves as a transcriptional regulator. Thus, it has been postulated that the development of tumours with low amounts of p27 could be propitiated by deregulation of transcriptional programs under the control of p27. However, these programs still remain mostly unknown. The aim of this study has been to define the transcriptional programs regulated by p27 by first identifying the p27-binding sites (p27-BSs) on the whole chromatin of quiescent mouse embryonic fibroblasts. The chromatin regions associated to p27 have been annotated to the most proximal genes and it has been considered that the expression of these genes could by regulated by p27. The identification of the chromatin p27-BSs has been performed by Chromatin Immunoprecipitation Sequencing (ChIP-seq). Results revealed that p27 associated with 1839 sites that were annotated to 1417 different genes being 852 of them protein coding genes. Interestingly, most of the p27-BSs were in distal intergenic regions and introns whereas, in contrast, its association with promoter regions was very low. Gene ontology analysis of the protein coding genes revealed a number of relevant transcriptional programs regulated by p27 as cell adhesion, intracellular signalling and neuron differentiation among others. We validated the interaction of p27 with different chromatin regions by ChIP followed by qPCR and demonstrated that the expressions of several genes belonging to these programs are actually regulated by p27. Finally, cell adhesion assays revealed that the adhesion of p27(-/-) cells to the plates was much higher that controls, revealing a role of p27 in the regulation of a transcriptional program involved in cell adhesion.	[Bicer, Atilla; Orlando, Serena; Gallastegui, Edurne; Aligue, Rosa; Bachs, Oriol; Jesuus Pujol, Maria] Univ Barcelona, Dept Biomed Sci, IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Islam, Abul B. M. M. K.] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh; [Besson, Arnaud] Canc Res Ctr Toulouse, INSERM UMR1037, Toulouse, France; [Besson, Arnaud] Univ Toulouse, Toulouse, France; [Besson, Arnaud] CNRS ERL5294, Toulouse, France	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Dhaka; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Bachs, O (corresponding author), Univ Barcelona, Dept Biomed Sci, IDIBAPS Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	obachs@ub.edu	Orlando, Serena/AAA-7963-2019; Besson, Arnaud/J-6254-2014; Aligue, Rosa/AAA-2520-2019; Bicer, Atilla/AAA-6738-2019	Besson, Arnaud/0000-0002-9599-3943; Aligue, Rosa/0000-0002-2085-325X; Bicer, Atilla/0000-0003-4032-6534; Islam, Abul/0000-0002-7274-0855; BACHS, ORIOL/0000-0003-1843-5929	Ministerio de Economia y Competitividad [SAF2012-38078, SAF2015-64344-R]; Fundacion La Caixa [2016-052.407]; Institute de Salud Carlos III [RD/120036/0054]; Fondation ARC pour la Reserche sur le Cancer; Ligue National Contre le Cancer; Institut National du Cancer; La Caixa [2016-052.407]	Ministerio de Economia y Competitividad(Spanish Government); Fundacion La Caixa(La Caixa Foundation); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondation ARC pour la Reserche sur le Cancer; Ligue National Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); La Caixa(La Caixa Foundation)	The work was supported by the following: Ministerio de Economia y Competitividad, SAF2012-38078 (OB); Ministerio de Economia y Competitividad, SAF2015-64344-R (OB); Fundacion La Caixa 2016-052.407 (RA); Institute de Salud Carlos III RD/120036/0054.AB is supported by grants from the Fondation ARC pour la Reserche sur le Cancer, Ligue National Contre le Cancer and Institut National du Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank to Dr. Pedro M. Fernandez for the kind gift of the anti-AHR antibody. This work was supported by grants from the Ministerio de Economia y competitividad (MINECO) SAF2012-38078, SAF2015-64244-R, La Caixa 2016-052.407 and from the Instituto de Salud Carlos III RD12/0036/0054. AB is supported by grants from the Fondation ARC pour la Reserche sur le Cancer, Ligue National Contre le Cancer and Institut National du Cancer. The data set has been deposited in ArrayExpress accession number E-MTAB-5105.	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Alonso-Colmenar LM, CELL ADH MIGR, V6, P100; Althammer S, 2011, BIOINFORMATICS, V27, P3333, DOI 10.1093/bioinformatics/btr570; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Cante-Barrett K, 2014, ONCOGENE, V33, P403, DOI 10.1038/onc.2013.56; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Cowie P, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2014.23; de Sousa EMF, 2016, CANC STEM CELL BIOL, P8; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Gallastegui E, 2016, ONCOGENE; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Groen JN, 2014, INT J BIOCHEM CELL B, V54, P350, DOI 10.1016/j.biocel.2014.05.008; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hukkelhoven E, 2012, J BIOL CHEM, V287, P38523, DOI 10.1074/jbc.M112.366542; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Katagiri T, 2016, COLD SPRING HARB PER, P8; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-441; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Melino G, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1033; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Orlando S, 2015, NUCLEIC ACIDS RES, V43, P6860, DOI 10.1093/nar/gkv593; Ou L, 2011, J BIOL CHEM, V286, P30142, DOI 10.1074/jbc.M111.244095; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pippa R, 2012, ONCOGENE, V31, P4207, DOI 10.1038/onc.2011.582; Ricciuti Biagio, 2014, Oncoscience, V1, P674; Rosen DG, 2005, CLIN CANCER RES, V11, P632; Schones DE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-19; Serres MP, 2011, ONCOGENE, V30, P2846, DOI 10.1038/onc.2011.9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Zambelli F, 2013, NUCLEIC ACIDS RES, V41, pW535, DOI 10.1093/nar/gkt448; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	49	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187891	10.1371/journal.pone.0187891	http://dx.doi.org/10.1371/journal.pone.0187891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155860	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700021
J	Wu, YT; Yu, JX; Jin, C; Li, Y; Su, JM; Wei, GQ; Zheng, XM; Gao, JS; Gao, WY; Wu, SL				Wu, Yuntao; Yu, Junxing; Jin, Cheng; Li, Yun; Su, Jinmei; Wei, Guoqing; Zheng, Xiaoming; Gao, Jingsheng; Gao, Wenyuan; Wu, Shouling			Longitudinal fasting blood glucose patterns and arterial stiffness risk in a population without diabetes	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; FOLLOW-UP; CARDIOVASCULAR MORTALITY; GLYCATED HEMOGLOBIN; SAS PROCEDURE; TOLERANCE; CHINESE; EVENTS; ATHEROSCLEROSIS	Objective To identify long-term fasting blood glucose trajectories and to assess the association between the trajectories and the risk of arterial stiffness in individuals without diabetes. Methods We enrolled 16,454 non-diabetic participants from Kailuan cohort. Fasting blood glucose concentrations were measured in 2006, 2008, and 2010 survey. Brachial-ankle pulse wave velocities were measured during 2011 to 2016. Multivariate regression model was used to estimate the difference of brachial-ankle pulse wave velocity levels and logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs) of arterial stiffness risk, according to the fasting blood glucose trajectories. Results We identified five distinct fasting blood glucose trajectories and each of the trajectories was labeled according to its range and change over 2006-2010 survey: elevated-stable pattern (5.0% of participants), elevated-decreasing pattern (6.6%), moderate-increasing pattern (10.9%), moderate-stable pattern (59.3%), and low-stable pattern (18.2%). After adjustment for potential confounders, individuals with elevated-stable pattern had a 42.6 cm/s (95% CI: 24.7 to 60.6 cm/s) higher brachial-ankle pulse wave velocity level and a 37% (OR 1.37, 95% CI: 1.14 to 1.66) higher arterial stiffness risk, and individuals with moderate-increasing pattern had a 19.6 cm/s (95% CI: 6.9 to 32.3 cm/s) higher brachial-ankle pulse wave velocity level and a 17% (OR 1.17, 95% CI: 1.03 to 1.33) higher arterial stiffness risk, related to individuals with moderate-stable pattern. We did not find significant associations of the elevated- decreasing or low-stable patterns with arterial stiffness. Consistently, the cumulative average, variability, and increased rate of fasting blood glucose during 2006-2010 survey were significantly associated with the arterial stiffness risk. Conclusion Discrete fasting blood glucose trajectories were associated with the arterial stiffness risk in non-diabetic individuals.	[Wu, Yuntao; Gao, Wenyuan] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China; [Wu, Yuntao; Jin, Cheng; Wei, Guoqing; Zheng, Xiaoming; Gao, Jingsheng; Wu, Shouling] North China Univ Sci & Technol, Dept Cardiol, Kailuan Gen Hosp, Tangshan, Peoples R China; [Yu, Junxing] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China; [Li, Yun] North China Univ Sci & Technol, Sch Publ Hlth, Tangshan, Peoples R China; [Su, Jinmei] Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing, Peoples R China; [Su, Jinmei] Chinese Acad Med Sci, Minist Educ, Key Lab Rheumatol & Clin Immunol, Beijing, Peoples R China	Tianjin University; North China University of Science & Technology; North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Gao, WY (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China.; Wu, SL (corresponding author), North China Univ Sci & Technol, Dept Cardiol, Kailuan Gen Hosp, Tangshan, Peoples R China.	pharmgao@tju.edu.cn; drwusl@163.com	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454				Cang Y, 2012, INTERNAL MED, V51, P2847, DOI 10.2169/internalmedicine.51.7718; CARDOSO CRL, 2016, INT J MOL SCI, V17; Centers for Disease Control, 2020, NATL DIABETES STAT R; Chen S, 2016, ARTERIOSCLEROSIS THR, V116; Chirinos JA, 2013, DIABETES CARE, V36, P2359, DOI 10.2337/dc12-1463; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Genuth S, 2003, DIABETES CARE, V26, P3160; Gottsater M, 2016, ARTERY RES, V16, P83; Henry RMA, 2003, CIRCULATION, V107, P2089, DOI 10.1161/01.CIR.0000065222.34933.FC; Huang Y, 2011, J CLIN ENDOCR METAB, V96, pE1461, DOI 10.1210/jc.2010-2697; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Lee YH, 2016, ATHEROSCLEROSIS, V247, P1, DOI 10.1016/j.atherosclerosis.2016.01.032; Li CH, 2012, J CLIN ENDOCR METAB, V97, pE658, DOI 10.1210/jc.2011-2595; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Maeda Y, 2014, DIABETES CARE, V37, P2383, DOI 10.2337/dc13-1886; Munakata M, 2015, PULSE, V3, P195; Ohnishi H, 2003, DIABETES CARE, V26, P437, DOI 10.2337/diacare.26.2.437; Prenner SB, 2015, ATHEROSCLEROSIS, V238, P370, DOI 10.1016/j.atherosclerosis.2014.12.023; Schram MT, 2004, HYPERTENSION, V43, P176, DOI 10.1161/01.HYP.0000111829.46090.92; Stevens LA, 2011, KIDNEY INT, V79, P555, DOI 10.1038/ki.2010.462; Sui XM, 2012, ANN EPIDEMIOL, V22, P617, DOI 10.1016/j.annepidem.2012.05.005; Takashima N, 2014, J HUM HYPERTENS, V28, P323, DOI 10.1038/jhh.2013.103; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tsuchikura S, 2010, J ATHEROSCLER THROMB, V17, P658, DOI 10.5551/jat.3616; van Popele NM, 2006, J AM GERIATR SOC, V54, P397, DOI 10.1111/j.1532-5415.2005.00614.x; Venkataraman V, 2012, J DIABETES COMPLICAT, V26, P526, DOI 10.1016/j.jdiacomp.2012.06.002; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang J, 2014, NEUROL RES, V36, P427, DOI 10.1179/1743132814Y.0000000345; Wang L, 2015, INT J EPIDEMIOL, V44, P689, DOI 10.1093/ije/dyv079; Wang XK, 2015, BIOORGAN MED CHEM, V23, P132, DOI 10.1016/j.bmc.2014.11.016; Xu L, 2010, METABOLISM, V59, P367, DOI 10.1016/j.metabol.2009.08.004; Yamashina A, 2003, HYPERTENS RES, V26, P615, DOI 10.1291/hypres.26.615; Zhao Hai-yan, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P645; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685; 2008, GUIDELINES PREVENTIO	36	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188423	10.1371/journal.pone.0188423	http://dx.doi.org/10.1371/journal.pone.0188423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155890	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700059
J	Valdes, L; Perez, I; de Menorval, LC; Altshuler, E; Fossum, JO; Rivera, A				Valdes, Leslie; Perez, Irela; de Menorval, Louis Charles; Altshuler, Ernesto; Fossum, Jon Otto; Rivera, Aramis			A simple way for targeted delivery of an antibiotic: In vitro evaluation of a nanoclay-based composite	PLOS ONE			English	Article							CLAY-MINERALS; DRUG; CIPROFLOXACIN; ADSORPTION; SYSTEMS; DISSOLUTION; RESISTANCE; MECHANISMS; SMECTITE; HYBRID	The sodium-modified form of fluorohectorite nanoclay (NaFh) is introduced as a potential drug carrier, demonstrating its ability for the controlled release of the broad-spectrum antibiotic Ciprofloxacin through in vitro tests. The new clay-drug composite is designed to target the local infections in the large intestine, where it delivers most of the incorporated drug thanks to its pH-sensitive behavior. The composite has been conceived to avoid the use of coating technology and to decrease the side-effects commonly associated to the burst-release of the ciprofloxacin at the stomach level. NaFh was obtained from lithium-fluorohectorite by ion exchange, and its lack of toxicity was demonstrated by in vivo studies. Ciprofloxacin hydrochloride (Cipro) was encapsulated into the clay at different values of the pH, drug initial concentration, temperature and time. Systematic studies by X-ray diffraction (XRD), infrared and visible spectrophotometry (FT-IR and UV-vis), and thermal analysis (TGA) indicated that the NaFh host exhibits a high encapsulation efficiency for Cipro, which reaches a 90% of the initial Cipro in solution at 65 degrees C, with initial concentration of drug in solution of 1.36 x 10(-2) mol L-1 at acid pH. XRD revealed that a true intercalation of Cipro takes place between clay layers. TG showed an increased thermal stability of the drug when intercalated into the clay, as compared to the "free" Cipro. IR suggested a strong clay-Cipro interaction via ketone group, as well as the establishment of hydrogen bonds between the two materials. In vitro drug release tests revealed that NaFh is a potentially efficient carrier to deliver Cipro in the large intestine, where the release process is mediated by more than just one mechanism.	[Valdes, Leslie; Perez, Irela] Univ Havana, Dept Pharm, Inst Pharm & Food IFAL, Havana, Cuba; [de Menorval, Louis Charles] Univ Montpellier 2, Equipe Agregats Interface & Mat Energie AIME, Inst Charles Gerhardt Montpellier, Montpellier, France; [Altshuler, Ernesto] Univ Havana, Phys Fac, Grp Complex Syst & Stat Phys, Havana, Cuba; [Fossum, Jon Otto] Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway; [Rivera, Aramis] Univ Havana, Inst Mat Sci & Technol IMRE, Zeolites Engn Lab, Havana, Cuba	Universidad de la Habana; Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universidad de la Habana; Norwegian University of Science & Technology (NTNU); Universidad de la Habana	Rivera, A (corresponding author), Univ Havana, Inst Mat Sci & Technol IMRE, Zeolites Engn Lab, Havana, Cuba.	aramis@imre.uh.cu	Fossum, Jon Otto/AAL-8903-2021; Fossum, Jon O/L-1510-2016	Fossum, Jon Otto/0000-0002-8952-303X; Fossum, Jon O/0000-0002-8952-303X; Rivera, Aramis/0000-0002-8579-7850; Altshuler, Ernesto/0000-0003-4192-5635	Ministerio de Educacion Superior	Ministerio de Educacion Superior	A. Rivera, L. Valdes, I. Perez and E. Altshuler acknowledge the Ministerio de Educacion Superior for partially funding this investigation, through providing salaries, laboratory area with standard working conditions, as well as basic expendables and reagents. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi C, 2007, APPL CLAY SCI, V36, P22, DOI 10.1016/j.clay.2006.06.015; Babic S, 2007, TRAC-TREND ANAL CHEM, V26, P1043, DOI 10.1016/j.trac.2007.09.004; Bergaya F, 2006, DEV CLAY SCI, V1, P1, DOI 10.1016/S1572-4352(05)01001-9; BERKHEISER V, 1975, CLAY CLAY MINER, V23, P404, DOI 10.1346/CCMN.1975.0230514; Blandon LM, 2016, COLLOID SURFACE B, V145, P706, DOI 10.1016/j.colsurfb.2016.05.078; Boehling P, 2017, EUR J PHARM SCI, V104, P72, DOI 10.1016/j.ejps.2017.03.031; Calabrese I, 2013, INT J PHARMACEUT, V457, P224, DOI 10.1016/j.ijpharm.2013.09.017; CAMPOLIRICHARDS DM, 1988, DRUGS, V35, P373, DOI 10.2165/00003495-198835040-00003; Carlson L, 2004, BENTONITE MINERALO 1; Carretero MI, 2002, APPL CLAY SCI, V21, P155, DOI 10.1016/S0169-1317(01)00085-0; Droy-Lefaix MT, 2006, DEV CLAY SCI, V1, P743, DOI 10.1016/S1572-4352(05)01025-1; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; El-Gamel NEA, 2012, J THERM ANAL CALORIM, V108, P253, DOI 10.1007/s10973-011-1584-8; Ezealisiji K., 2016, INT J DRUG DELIVERY, V8, P99; Farias T, 2009, COLLOID SURFACE A, V345, P51, DOI 10.1016/j.colsurfa.2009.04.022; FRANCES C, 1991, INT J PHARM, V77, P193, DOI 10.1016/0378-5173(91)90317-H; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gu C, 2005, ENVIRON SCI TECHNOL, V39, P9166, DOI 10.1021/es051109f; Hamilton AR, 2014, APPL CLAY SCI, V87, P129, DOI 10.1016/j.clay.2013.10.020; Hansen EL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00618; Hayes AW, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1, DOI 10.1201/b17359; Hemmen H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036315; HoogkampKorstanje JAA, 1997, J ANTIMICROB CHEMOTH, V40, P427, DOI 10.1093/jac/40.3.427; Janicijevic J, 2015, INT J PHARMACEUT, V496, P466, DOI 10.1016/j.ijpharm.2015.10.047; JAYNES WF, 1992, CLAY CLAY MINER, V40, P397, DOI 10.1346/CCMN.1992.0400404; Joshi GV, 2011, MICROPOR MESOPOR MAT, V142, P542, DOI 10.1016/j.micromeso.2010.12.040; Kaviratna PD, 1996, J PHYS CHEM SOLIDS, V57, P1897, DOI 10.1016/S0022-3697(96)00076-5; Kevadiya BD, 2012, EUR J PHARM SCI, V47, P265, DOI 10.1016/j.ejps.2012.04.009; Komadel P, 1996, CLAY CLAY MINER, V44, P228, DOI 10.1346/CCMN.1996.0440208; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; LaRock DL, 2015, NAT REV MICROBIOL, V13, P191, DOI 10.1038/nrmicro3420; LEBEL M, 1988, PHARMACOTHERAPY, V8, P3; Lopez-Galindo A, 2007, APPL CLAY SCI, V36, P51, DOI 10.1016/j.clay.2006.06.016; Lopez-Galindo A., 2004, INTERFACE SCI TECHNO, V1, P267, DOI DOI 10.1016/S1573-4285(04)80044-9; Molu ZB, 2010, MICROPOR MESOPOR MAT, V127, P50, DOI 10.1016/j.micromeso.2009.06.027; Mura P, 2016, INT J PHARMACEUT, V509, P8, DOI 10.1016/j.ijpharm.2016.05.028; Neugebauer U, 2005, SPECTROCHIM ACTA A, V61, P1505, DOI 10.1016/j.saa.2004.11.014; Organization for Economic Co-operation and Development, 2008, GUIDELINE 425 ACUTE; Organization for Economic Co-operation and Development (OECD), 2008, GUID DOC AC OR TOX T; Rivera A, 2005, MICROPOR MESOPOR MAT, V80, P337, DOI 10.1016/j.micromeso.2005.01.011; Rivera A, 2016, APPL CLAY SCI, P124; Rozynek Z, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12009-x; Schou M, 2001, J AFFECT DISORDERS, V67, P21, DOI 10.1016/S0165-0327(01)00380-9; Stuart B., 2004, INFRARED SPECTROSCOP, DOI DOI 10.1111/j.1750-3841.2008.00799.x; Stucki JW, 2006, DEV CLAY SCI, V1, P423, DOI 10.1016/S1572-4352(05)01013-5; Sun J, 2002, EUR J PHARM BIOPHARM, V54, P51, DOI 10.1016/S0939-6411(02)00018-8; Takahashi T, 2005, J CONTROL RELEASE, V107, P408, DOI 10.1016/j.jconrel.2005.03.031; Tenorio RP, 2010, LANGMUIR, V26, P9703, DOI 10.1021/la100377s; Thiebault T, 2015, J COLLOID INTERF SCI, V453, P1, DOI 10.1016/j.jcis.2015.04.029; Tiwari G, 2012, INT J PHARM INVESTIG, V2, P2, DOI 10.4103/2230-973X.96920; Trivedi P, 2007, ENVIRON SCI TECHNOL, V41, P3153, DOI 10.1021/es061921y; USDPI, 1993, DRUG INF HLTH CAR PR; Viseras C, 2008, MATER SCI TECH-LOND, V24, P1020, DOI 10.1179/174328408X341708; Viseras C, 2007, APPL CLAY SCI, V36, P37, DOI 10.1016/j.clay.2006.07.006; Viseras C, 2010, APPL CLAY SCI, V48, P291, DOI 10.1016/j.clay.2010.01.007; WOLFSON JS, 1985, ANTIMICROB AGENTS CH, V28, P581, DOI 10.1128/AAC.28.4.581	56	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187879	10.1371/journal.pone.0187879	http://dx.doi.org/10.1371/journal.pone.0187879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149176	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100016
J	Weber, I; Florin, E; von Papen, M; Timmermann, L				Weber, Immo; Florin, Esther; von Papen, Michael; Timmermann, Lars			The influence of filtering and downsampling on the estimation of transfer entropy	PLOS ONE			English	Article							LOCAL-FIELD POTENTIALS; INFORMATION-TRANSFER; GRANGER CAUSALITY; EFFECTIVE CONNECTIVITY; NEURAL-NETWORKS; TIME-SERIES; EEG; BRAIN; SYNCHRONIZATION; SIGNALS	Transfer entropy (TE) provides a generalized and model-free framework to study Wiener-Granger causality between brain regions. Because of its nonparametric character, TE can infer directed information flow also from nonlinear systems. Despite its increasing number of applications in neuroscience, not much is known regarding the influence of common electrophysiological preprocessing on its estimation. We test the influence of filtering and downsampling on a recently proposed nearest neighborhood based TE estimator. Different filter settings and downsampling factors were tested in a simulation framework using a model with a linear coupling function and two nonlinear models with sigmoid and logistic coupling functions. For nonlinear coupling and progressively lower low-pass filter cut-off frequencies up to 72% false negative direct connections and up to 26% false positive connections were identified. In contrast, for the linear model, a monotonic increase was only observed for missed indirect connections (up to 86%). High-pass filtering (1 Hz, 2 Hz) had no impact on TE estimation. After low-pass filtering interaction delays were significantly underestimated. Downsampling the data by a factor greater than the assumed interaction delay erased most of the transmitted information and thus led to a very high percentage (67-100%) of false negative direct connections. Low-pass filtering increases the number of missed connections depending on the filters cut-off frequency. Downsampling should only be done if the sampling factor is smaller than the smallest assumed interaction delay of the analyzed network.	[Weber, Immo; Timmermann, Lars] Univ Hosp Giessen & Marburg, Dept Neurol, Marburg, Germany; [Florin, Esther; von Papen, Michael] Heinrich Heine Univ, Med Fac, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany; [von Papen, Michael] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany	University Hospital of Giessen & Marburg; Heinrich Heine University Dusseldorf; University of Cologne	Weber, I; Timmermann, L (corresponding author), Univ Hosp Giessen & Marburg, Dept Neurol, Marburg, Germany.	immo.weber@staff.uni-marburg.de; lars.timmermann@uk-gm.de	Florin, Esther/GWC-1118-2022	Florin, Esther/0000-0001-8276-2508; Timmermann, Lars/0000-0002-5301-3580; Weber, Immo/0000-0003-2979-234X; von Papen, Michael/0000-0001-5030-1643	German Research Foundation [KFO 219, TI 319/2-1]; Volkswagen Foundation [89387]	German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen)	The study was supported by a grant from the German Research Foundation (http://www.dfg.de/en/, KFO 219; TI 319/2-1). E.Fgratefully acknowledges support from "Volkswagen Foundation'' (https://www.volkswagenstiftung.de/, grant number: 89387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K. L., 2009, CEREB CORTEX; [Anonymous], 1956, MODERN MATH ENG; Barnett L, 2017, J NEUROSCI METH, V275, P93, DOI 10.1016/j.jneumeth.2016.10.016; Barnett L, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.040101; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Battaglia D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002438; Boba P, 2015, COMPUT PHYS, V3, P10, DOI DOI 10.3389/FPHY.2015.00010/ABSTRACT; Breitung J, 2002, J TIME SER ANAL, V23, P651, DOI 10.1111/1467-9892.00284; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Canavier CC, 2015, CURR OPIN NEUROBIOL, V31, P206, DOI 10.1016/j.conb.2014.12.003; Chand GB, 2016, NEUROIMAGE, V134, P85, DOI 10.1016/j.neuroimage.2016.04.018; Chavez M, 2003, J NEUROSCI METH, V124, P113, DOI 10.1016/S0165-0270(02)00367-9; Dauwels J, 2010, NEUROIMAGE, V49, P668, DOI 10.1016/j.neuroimage.2009.06.056; Dhamala M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018701; Dickten H, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.062706; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; FINLAY BL, 1976, J NEUROPHYSIOL, V39, P1352, DOI 10.1152/jn.1976.39.6.1352; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Florin E, 2010, EUR J NEUROSCI, V31, P491, DOI 10.1111/j.1460-9568.2010.07083.x; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hahs DW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.128701; Honey CJ, 2008, HUM BRAIN MAPP, V29, P802, DOI 10.1002/hbm.20579; Huang CS, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00570; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; Korzeniewska A, 2014, NEUROIMAGE, V101, P96, DOI 10.1016/j.neuroimage.2014.06.078; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kraskov A., 2004, SYNCHRONIZATION INTE; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Kugiumtzis D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062918; Kus R, 2004, IEEE T BIO-MED ENG, V51, P1501, DOI 10.1109/TBME.2004.827929; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Ma CF, 2013, COGN NEURODYNAMICS, V7, P253, DOI 10.1007/s11571-012-9239-4; Maki-Marttunen V., 2013, BMC NEUROSCI S1, V14, P83; Marschinski R, 2002, EUR PHYS J B, V30, P275, DOI 10.1140/epjb/e2002-00379-2; Martini M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011919; May R. M., 2004, THEORY CHAOTIC ATTRA, P85; Montalto A, 2015, NEURAL NETWORKS, V71, P159, DOI 10.1016/j.neunet.2015.08.003; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; Moratti S, 2011, J NEUROSCI, V31, P17278, DOI 10.1523/JNEUROSCI.2917-11.2011; Pashaie R, 2009, IEEE T NEURAL NETWOR, V20, P597, DOI 10.1109/TNN.2008.2010703; Perea G, 2006, J NEURAL ENG, V3, P245, DOI 10.1088/1741-2560/3/3/007; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Protopapa F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00146; Ragwitz M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056201; Razak FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099462; Sameshima K, 1999, J NEUROSCI METH, V94, P93, DOI 10.1016/S0165-0270(99)00128-4; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schroeder KE, 2016, NEUROIMAGE, V134, P459, DOI 10.1016/j.neuroimage.2016.04.039; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shao SJ, 2014, PROCEEDINGS OF THE 2014 INTERNATIONAL CONFERENCE ON FIELD-PROGRAMMABLE TECHNOLOGY (FPT), P60, DOI 10.1109/FPT.2014.7082754; Sharott A, 2008, BRAIN, V131, P473, DOI 10.1093/brain/awm324; Smirnov DA, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/10005; Smirnov DA, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042917; Solo V, 2016, NEURAL COMPUT, V28, P914, DOI 10.1162/NECO_a_00828; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; SWADLOW HA, 1978, EXP BRAIN RES, V33, P455; Takens F., 1981, DYNAMICAL SYSTEMS TU, V898, P366, DOI [10.1007/bfb0091924, DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; Tass P, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016009; Trenado C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00325; Tsuda I, 2015, CURR OPIN NEUROBIOL, V31, P67, DOI 10.1016/j.conb.2014.08.011; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055809; Wibral M, 2012, IEEE ENG MED BIO, P3676, DOI 10.1109/EMBC.2012.6346764; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Wold H., 1938, STUDY ANAL STATIONAR	74	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188210	10.1371/journal.pone.0188210	http://dx.doi.org/10.1371/journal.pone.0188210			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149201	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100028
J	Basnett, J; Xie, V; Cisterne, A; Bradstock, K; Bendall, L				Basnett, Jordan; Xie, Vicki; Cisterne, Adam; Bradstock, Ken; Bendall, Linda			Regulation of the bone marrow microenvironment by G-CSF: Effects of G-CSF on acute lymphoblastic leukaemia	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; CELLS	It has been suggested that disruption of the lymphoid niche by G-CSF may be of therapeutic benefit to patients with acute lymphoblastic leukaemia. We used a xenograft model to determine the effect of G-CSF on ALL progression in a minimal residual disease setting. Consistent with the effects on normal murine B cell progenitors, G-CSF slowed disease in the majority of ALL xenografts tested, suggesting that G-CSF may provide benefits beyond neutrophil recovery for ALL patients. However, two of eight xenografts demonstrated accelerated disease progression. G-CSF could be detrimental for these patients due to expansion of the malignant clone.	[Basnett, Jordan; Xie, Vicki; Cisterne, Adam; Bendall, Linda] Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia; [Bradstock, Ken] Westmead Hosp, Dept Haematol, Sydney, NSW, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney	Bendall, L (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Sydney, NSW, Australia.	linda.bendall@sydney.edu.au	Cisterne, Adam/HGA-8311-2022		NHMRC [352326, 1042305]; Cancer Institute NSW	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	This work was supported by an NHMRC project grant (Grant No. 352326) and Senior Research Fellowship (1042305) and Cancer Institute NSW Fellowship to Linda Bendall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDALL LJ, 1993, BLOOD, V82, P3125; BENDALL LJ, 1994, EXP HEMATOL, V22, P1252; Crazzolara R, 2009, BLOOD, V113, P3297, DOI 10.1182/blood-2008-02-137752; Giebel S, 2012, EUR J CANCER, V48, P360, DOI 10.1016/j.ejca.2011.11.023; Juarez J, 2007, LEUKEMIA, V21, P1249, DOI 10.1038/sj.leu.2404684; Kobbe G, 1998, AM J HEMATOL, V58, P330, DOI 10.1002/(SICI)1096-8652(199808)58:4<330::AID-AJH14>3.0.CO;2-B; MAKRYNIKOLA V, 1991, EXP HEMATOL, V19, P674; MANABE A, 1992, BLOOD, V79, P2370; SHAPOSHNIKOV V L, 1979, Byulleten' Eksperimental'noi Biologii i Meditsiny, V87, P483; TSUCHIYA H, 1993, LEUKEMIA RES, V17, P809, DOI 10.1016/0145-2126(93)90116-3; Uy G, 2015, LEUKEMIA RE IN PRESS; Wallington-Beddoe CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036429; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; Winkler IG, 2013, HAEMATOLOGICA, V98, P325, DOI 10.3324/haematol.2012.069260; Wong J, 2014, ONCOTARGET, V5, P10460, DOI 10.18632/oncotarget.2260	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188042	10.1371/journal.pone.0188042	http://dx.doi.org/10.1371/journal.pone.0188042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145456	Green Submitted, gold, Green Published			2022-12-27	WOS:000415378800055
J	McCoy, D; McManus, MA; Kotubetey, K; Kawelo, AH; Young, C; D'Andrea, B; Ruttenberg, KC; Alegado, RA				McCoy, Daniel; McManus, Margaret A.; Kotubetey, Keli'iahonui; Kawelo, Angela Hi'ilei; Young, Charles; D'Andrea, Brandon; Ruttenberg, Kathleen C.; Alegado, Rosanna Anolani			Large-scale climatic effects on traditional Hawaiian fishpond aquaculture	PLOS ONE			English	Article							EL-NINO; NORTH PACIFIC; FREQUENCY; VARIABILITY; EVENTS; IMPACT	Aquaculture accounts for almost one-half of global fish consumption. Understanding the regional impact of climate fluctuations on aquaculture production thus is critical for the sustainability of this crucial food resource. The objective of this work was to understand the role of climate fluctuations and climate change in subtropical coastal estuarine environments within the context of aquaculture practices in He. eia Fishpond, O. ahu Island, Hawai'i. To the best of our knowledge, this was the first study of climate effects on traditional aquaculture systems in the Hawaiian Islands. Data from adjacent weather stations were analyzed together with in situ water quality instrument deployments spanning a 12-year period (November 2004 - November 2016). We found correlations between two periods with extremely high fish mortality at He. eia Fishpond (May and October 2009) and slackening trade winds in the week preceding each mortality event, as well as surface water temperatures elevated 2-3 degrees C higher than the background periods (March-December 2009). We posit that the lack of trade wind-driven surface water mixing enhanced surface heating and stratification of the water column, leading to hypoxic conditions and stress on fish populations, which had limited ability to move within net pen enclosures. Elevated water temperature and interruption of trade winds previously have been linked to the onset of El Nio in Hawai'i. Our results provide empirical evidence regarding El Nico effects on the coastal ocean, which can inform resource management efforts about potential impact of climate variation on aquaculture production. Finally, we provide recommendations for reducing the impact of warming events on fishponds, as these events are predicted to increase in magnitude and frequency as a consequence of global warming.	[McCoy, Daniel; McManus, Margaret A.; Young, Charles; D'Andrea, Brandon; Ruttenberg, Kathleen C.; Alegado, Rosanna Anolani] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Kotubetey, Keli'iahonui; Kawelo, Angela Hi'ilei] Paepae O Heeia, Kaneohe, HI USA; [Ruttenberg, Kathleen C.] Univ Hawaii Manoa, Dept Geol & Geophys, Honolulu, HI 96822 USA; [Alegado, Rosanna Anolani] Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA; [Young, Charles] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Alegado, RA (corresponding author), Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA.; Alegado, RA (corresponding author), Univ Hawaii Manoa, Sea Grant Coll Program, Honolulu, HI 96822 USA.	ralegado@hawaii.edu	McManus, Margaret Anne/AAA-2604-2020	McCoy, Daniel/0000-0002-1322-5474; Alegado, Rosanna/0000-0003-3615-5613	NOAA-NMFS [NA05NMF4521188]; Office of Hawaiian Affairs; Kamehameha Schools Bishop Estate; University of Hawaii Sea Grant College Program, SOEST [NA05OAR4171048, NA09OAR4170060, NA14OAR4170071]; NOAA Office of Sea Grant, Department of Commerce [R/EL-42, R/AQ-84, A/AS-1]; Direct For Biological Sciences [1558169] Funding Source: National Science Foundation	NOAA-NMFS(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Hawaiian Affairs; Kamehameha Schools Bishop Estate; University of Hawaii Sea Grant College Program, SOEST; NOAA Office of Sea Grant, Department of Commerce(National Oceanic Atmospheric Admin (NOAA) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Pacific threadfin aquaculture was funded by the NOAA-NMFS NA05NMF4521188, the Office of Hawaiian Affairs and the Kamehameha Schools Bishop Estate. Data from Na Kilo Honua o He'eia used in this contribution were collected with the support from the University of Hawaii Sea Grant College Program, SOEST, under Institutional Grant Nos. NA05OAR4171048, NA09OAR4170060, and NA14OAR4170071 from NOAA Office of Sea Grant, Department of Commerce: Project R/EL-42 (KCR, MM, B Glazer), Project R/AQ-84 (KCR, MM, B Glazer) and Project A/AS-1 (RAA).	Barnard PL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047707; Blunden J, 2014, B AM METEOROL SOC, V95, pS1, DOI 10.1175/2014BAMSStateoftheClimate.1; Boyd C. E., 1995, BOTTOM SOILS SEDIMEN, DOI DOI 10.1007/978-1-4615-1785-6; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Brix H, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002245; Cai WJ, 2015, NAT CLIM CHANGE, V5, P132, DOI [10.1038/NCLIMATE2492, 10.1038/nclimate2492]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Callan CK, 2012, 13 EUR C RAD ITS EFF, P1; Cao GX, 2007, J CLIMATE, V20, P1145, DOI 10.1175/JCLI4033.1; Caputi N, 2016, ECOL EVOL, V6, P3583, DOI 10.1002/ece3.2137; CHU PS, 1995, J CLIMATE, V8, P1697, DOI 10.1175/1520-0442(1995)008<1697:HRAAEN>2.0.CO;2; Cobb JN, 1902, 1901 US FISH COMM RE, P353; Cochrane K., 2009, FAO FISHERIES AQUACU; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; D'Andrea BT, 2015, WATER EXCHANGE CIRCU, P1; De Silva S.S., 2009, CLIMATE CHANGE IMPLI, P151; Demmke A., 2011, VULNERABILITY TROPIC, P733; Di Lorenzo E, 2010, NAT GEOSCI, V3, P762, DOI [10.1038/NGEO984, 10.1038/ngeo984]; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; FAO, 2016, STAT WORLD FISH AQ, P200; Handy Elizabeth Green, 1972, NATIVE PLANTERS OLD; Hargreaves J. A., 2003, POND MIXING, V4802; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hoover RS, 2006, MAR ECOL PROG SER, V318, P187, DOI 10.3354/meps318187; Horel J, 2002, B AM METEOROL SOC, V83, P211, DOI 10.1175/1520-0477(2002)083<0211:MCMITW>2.3.CO;2; Huo WJ, 2016, ATMOS OCEAN SCI LETT, V9, P428, DOI 10.1080/16742834.2016.1231567; Jokiel P.L., 2011, J MAR BIOL, V2011, DOI [10.1155/2011/151682, DOI 10.1155/2011/151682]; Keala G, 2007, COLL TROPICAL AGR HU, P1; Kelly M., 1975, LOKO HEEIA FISHPOND; MacIntyre S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044164; Malo David, 1903, HAWAIIAN ANTIQUITIES; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; RASMUSSON EM, 1983, SCIENCE, V222, P1195, DOI 10.1126/science.222.4629.1195; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Sanderson M., 1993, PREVAILING TRADE WIN; SANTERRE MT, 1977, AQUACULTURE, V10, P341, DOI 10.1016/0044-8486(77)90125-9; Scannell HA, 2016, GEOPHYS RES LETT, V43, P2069, DOI 10.1002/2015GL067308; Solomon S., 2007, CLIMATE CHANGE 2007; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Yeh SW, 2015, J CLIMATE, V28, P663, DOI 10.1175/JCLI-D-14-00137.1; Young CW, 2011, PERTURBATION NUTR IN	41	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187951	10.1371/journal.pone.0187951	http://dx.doi.org/10.1371/journal.pone.0187951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145446	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800043
J	Nunez, I; Matute, T; Herrera, R; Keymer, J; Marzullo, T; Rudge, T; Federici, F				Nunez, Isaac; Matute, Tamara; Herrera, Roberto; Keymer, Juan; Marzullo, Timothy; Rudge, Timothy; Federici, Fernan			Low cost and open source multi-fluorescence imaging system for teaching and research in biology and bioengineering	PLOS ONE			English	Article							OPEN-SOURCE HARDWARE; MICROSCOPY PLATFORM; PROTEIN; BRIGHT	The advent of easy-to-use open source microcontrollers, off-the-shelf electronics and customizable manufacturing technologies has facilitated the development of inexpensive scientific devices and laboratory equipment. In this study, we describe an imaging system that integrates low-cost and open-source hardware, software and genetic resources. The multi-fluorescence imaging system consists of readily available 470 nm LEDs, a Raspberry Pi camera and a set of filters made with low cost acrylics. This device allows imaging in scales ranging from single colonies to entire plates. We developed a set of genetic components (e.g. promoters, coding sequences, terminators) and vectors following the standard framework of Golden Gate, which allowed the fabrication of genetic constructs in a combinatorial, low cost and robust manner. In order to provide simultaneous imaging of multiple wavelength signals, we screened a series of long stokes shift fluorescent proteins that could be combined with cyan/green fluorescent proteins. We found CyOFP1, mBeRFP and sfGFP to be the most compatible set for 3-channel fluorescent imaging. We developed open source Python code to operate the hardware to run time-lapse experiments with automated control of illumination and camera and a Python module to analyze data and extract meaningful biological information. To demonstrate the potential application of this integral system, we tested its performance on a diverse range of imaging assays often used in disciplines such as microbial ecology, microbiology and synthetic biology. We also assessed its potential use in a high school environment to teach biology, hardware design, optics, and programming. Together, these results demonstrate the successful integration of open source hardware, software, genetic resources and customizable manufacturing to obtain a powerful, low cost and robust system for education, scientific research and bioengineering. All the resources developed here are available under open source licenses.	[Nunez, Isaac; Matute, Tamara] Pontificia Univ Catolica Chile, Sch Engn, Dept Chem & Bioproc Engn, Santiago, Chile; [Herrera, Roberto; Marzullo, Timothy] Backyard Brains, Santiago, Chile; [Keymer, Juan] Pontificia Univ Catolica Chile, Fac Fis, Inst Fis, Dept Ecol,Fac Ciencias Biol, Santiago, Chile; [Rudge, Timothy] Pontificia Univ Catolica Chile, Sch Engn, Inst Biol & Med Engn, Santiago, Chile; [Rudge, Timothy] Pontificia Univ Catolica Chile, Sch Med, Inst Biol & Med Engn, Santiago, Chile; [Rudge, Timothy] Pontificia Univ Catolica Chile, Sch Biol Sci, Inst Biol & Med Engn, Santiago, Chile; [Federici, Fernan] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Santiago, Chile; [Federici, Fernan] Pontificia Univ Catolica Chile, Fondo Desarrollo Areas Prioritarias, Ctr Genome Regulat, Millennium Nucleus Ctr Plant Syst & Synthet Biol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Rudge, T (corresponding author), Pontificia Univ Catolica Chile, Sch Engn, Inst Biol & Med Engn, Santiago, Chile.; Rudge, T (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Inst Biol & Med Engn, Santiago, Chile.; Rudge, T (corresponding author), Pontificia Univ Catolica Chile, Sch Biol Sci, Inst Biol & Med Engn, Santiago, Chile.	trudge@uc.cl; ffederici@bio.puc.cl		Matute, Tamara/0000-0002-0486-985X; Federici, Fernan/0000-0001-9200-5383; rudge, timothy/0000-0001-9446-9958; Nunez, Isaac/0000-0002-4439-3745	OpenPlant Fund; CONICYT Fondecyt lniciacion [11140776, 11161046]; Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation [15090007]; Millennium Nucleus Center for Plant Systems and Synthetic Biology [NC130030]; CONICYT Fondecyt Regular [1150430]; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH093334] Funding Source: NIH RePORTER; BBSRC [BB/L014130/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L014130/1] Funding Source: researchfish	OpenPlant Fund; CONICYT Fondecyt lniciacion(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Nucleus Center for Plant Systems and Synthetic Biology; CONICYT Fondecyt Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank the funders of this study: OpenPlant Fund for financial support to INN, TFM, RHP, JEK, TCM, TJR, and FF; CONICYT Fondecyt lniciacion 11140776 for providing financial support to FE; CONICYT Fondecyt Iniciacion 11161046 for providing support to TJR; Fondo de Desarrollo de Areas Prioritarias (FONDAP) Center for Genome Regulation (15090007) and Millennium Nucleus Center for Plant Systems and Synthetic Biology (NC130030) for providing financial support to FE; CONICYT Fondecyt Regular 1150430 for providing financial support to JEK and Bachrard Brains for providing support in the form of salaries for TCM and RHP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Black C, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa651f; Bosse JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143547; Chagas AM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002702; Chu J, 2016, NAT BIOTECHNOL, V34, P760, DOI 10.1038/nbt.3550; Crichton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104943; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; Gibney E, 2016, NATURE, V531, P147, DOI 10.1038/531147a; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Grant PK, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156590; Gualda EJ, 2013, NAT METHODS, V10, P599, DOI 10.1038/nmeth.2508; Guan Y, 2015, MOL BIOL CELL, V26, P2054, DOI 10.1091/mbc.E14-10-1473; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hol Felix J H, 2015, BMC Res Notes, V8, P245, DOI 10.1186/s13104-015-1169-x; Iverson SV, 2016, ACS SYNTH BIOL, V5, P99, DOI 10.1021/acssynbio.5b00124; Karikari TK, 2016, METAB BRAIN DIS, V31, P3, DOI 10.1007/s11011-015-9687-8; Kim H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168053; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; Lam AT, 2017, LAB CHIP, V17, P1442, DOI 10.1039/c7lc00131b; Liberti WA, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa6806; Magaraci MS, 2016, ACS SYNTH BIOL, V5, P781, DOI 10.1021/acssynbio.6b00057; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Nguyen V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166735; Pearce JM, 2016, SCI PUBL POLICY, V43, P192, DOI 10.1093/scipol/scv034; Pearce J. M., 2017, J OPEN HARDW, V1, P2; Pearce JM, 2014, NATURE, V505, P618, DOI 10.1038/505618d; Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Phillips ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124938; Pirnstill CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13368; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Rosenegger DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110475; Sharkey JP, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4941068; Switz NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095330; Wei QS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02395-8; Wijnen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107216; Wittbrodt BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134989; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064849; Zhang CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075164	41	36	36	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187163	10.1371/journal.pone.0187163	http://dx.doi.org/10.1371/journal.pone.0187163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140977	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400018
J	Li, DJ; Fan, ZY; Tang, WKS				Li, Doujie; Fan, Zhongyan; Tang, Wallace K. S.			Domain learning naming game for color categorization	PLOS ONE			English	Article							NETWORKS; LANGUAGE; UNIVERSALS; EMERGENCE; MEMORY	Naming game simulates the evolution of vocabulary in a population of agents. Through pairwise interactions in the games, agents acquire a set of vocabulary in their memory for object naming. The existing model confines to a one-to-one mapping between a name and an object. Focus is usually put onto name consensus in the population rather than knowledge learning in agents, and hence simple learning model is usually adopted. However, the cognition system of human being is much more complex and knowledge is usually presented in a complicated form. Therefore, in this work, we extend the agent learning model and design a new game to incorporate domain learning, which is essential for more complicated form of knowledge. In particular, we demonstrate the evolution of color categorization and naming in a population of agents. We incorporate the human perceptive model into the agents and introduce two new concepts, namely subjective perception and subliminal stimulation, in domain learning. Simulation results show that, even without any supervision or pre-requisition, a consensus of a color naming system can be reached in a population solely via the interactions. Our work confirms the importance of society interactions in color categorization, which is a long debate topic in human cognition. Moreover, our work also demonstrates the possibility of cognitive system development in autonomous intelligent agents.	[Li, Doujie; Fan, Zhongyan; Tang, Wallace K. S.] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China	City University of Hong Kong	Tang, WKS (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	eekstang@cityu.edu.hk		Tang, Wallace K.S./0000-0002-5786-418X				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125019; Barrat A, 2007, CHAOS, V17, DOI 10.1063/1.2734403; Berlin B., 1991, BASIC COLOR TERMS TH; Beuls K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058960; Bhattacherjee B, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062808; Bleys J., 2012, EXPT CULTURAL LANGUA, P61; Dall'Asta L, 2006, EUROPHYS LETT, V73, P969, DOI 10.1209/epl/i2005-10481-7; Dall'Asta L, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036105; Fu G, 2017, AM CONTR C ACC 2017; Hao J, 2012, ADV COMP INT ICACI 2; HEIDER ER, 1972, COGNITIVE PSYCHOL, V3, P337, DOI 10.1016/0010-0285(72)90011-4; HEIDER ER, 1972, J EXP PSYCHOL, V93, P10, DOI 10.1037/h0032606; HUNTER RS, 1958, J OPT SOC AM, V48, P985, DOI 10.1364/JOSA.48.000985; Jameson K, 1997, COLOR CATEGORIES THO, V295; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; KAY P, 1978, LANGUAGE, V54, P610, DOI 10.2307/412789; Ke J, 2008, COMMUN COMPUT PHYS, V3, P935; Lei CA, 2010, PHYSICA A, V389, P5628, DOI 10.1016/j.physa.2010.08.039; Li B, 2013, COMMUN NONLINEAR SCI, V18, P1214, DOI 10.1016/j.cnsns.2012.09.022; LOFTUS EF, 1992, AM PSYCHOL, V47, P761, DOI 10.1037/0003-066X.47.6.761; Lou Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12191; Luo MR, 2001, COLOR RES APPL, V26, P340, DOI 10.1002/col.1049; MacLaury R., 1997, COLOR COGNITION MESO; MCCONNELL JV, 1958, AM PSYCHOL, V13, P229, DOI 10.1037/h0042953; Mukherjee A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016677; Paravina Rade D, 2005, Odontology, V93, P46, DOI 10.1007/s10266-005-0048-7; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Regier T, 2005, P NATL ACAD SCI USA, V102, P8386, DOI 10.1073/pnas.0503281102; Roberson D, 2005, COGNITIVE PSYCHOL, V50, P378, DOI 10.1016/j.cogpsych.2004.10.001; Roberson D, 2000, J EXP PSYCHOL GEN, V129, P369, DOI 10.1037//0096-3445.129.3.369; Schuessler Zachary, 2015, ANN GITHUB; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Steels L., 2012, EXPT CULTURAL LANGUA; Treitman Y, 2013, NETW SCI WORKSH NSW; Tria F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120771; Webster MA, 2007, INDIVIDUAL POPULATIO; Witzel C, 2013, J VISION, V13, DOI 10.1167/13.7.1; Wu CW, 2011, CIRC SYST ISCAS 2011; Xie J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033215	42	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188164	10.1371/journal.pone.0188164	http://dx.doi.org/10.1371/journal.pone.0188164			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136661	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200073
J	Patel, S; Paulsen, C; Heffernan, C; Saunders, D; Sharma, M; King, M; Hoeppner, V; Orr, P; Kunimoto, D; Menzies, D; Christianson, S; Wolfe, J; Boffa, J; McMullin, K; Lopez-Hille, C; Senthilselvan, A; Long, R				Patel, Smit; Paulsen, Catherine; Heffernan, Courtney; Saunders, Duncan; Sharma, Meenu; King, Malcolm; Hoeppner, Vernon; Orr, Pamela; Kunimoto, Dennis; Menzies, Dick; Christianson, Sara; Wolfe, Joyce; Boffa, Jody; McMullin, Kathleen; Lopez-Hille, Carmen; Senthilselvan, Ambikaipakan; Long, Richard			Tuberculosis transmission in the Indigenous peoples of the Canadian prairies	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EPIDEMIOLOGY; ELIMINATION; COMMUNITIES; DYNAMICS; OUTCOMES; HISTORY; DISEASE	Setting The prairie provinces of Canada. Objective To characterize tuberculosis (TB) transmission among the Indigenous and non-Indigenous Canadian-born peoples of the prairie provinces of Canada. Design A prospective epidemiologic study of consecutively diagnosed adult (age >= 14 years) Canadian-born culture-positive pulmonary TB cases on the prairies, hereafter termed "potential transmitters," and the transmission events generated by them. "Transmission events" included new positive tuberculin skin tests (TSTs), TST conversions, and secondary cases among contacts. Results In the years 2007 and 2008, 222 potential transmitters were diagnosed on the prairies. Of these, the vast majority (198; 89.2%) were Indigenous peoples who resided in either an Indigenous community (135; 68.2%) or a major metropolitan area (44; 22.2%). Over the 4.5year period between July 1 st, 2006 and December 31 st 2010, 1085 transmission events occurred in connection with these potential transmitters. Most of these transmission events were attributable to potential transmitters who identified as Indigenous (94.5%). With a few notable exceptions most transmitters and their infected contacts resided in the same community type. In multivariate models positive smear status and a higher number of close contacts were associated with increased transmission; adjusted odds ratios (ORs) and 95% confidence intervals (CIs), 4.30 [1.88, 9.84] and 2.88 [1.31, 6.34], respectively. Among infected contacts, being Indigenous was associated with disease progression; OR and 95% CI, 3.59 [1.27, 10.14] and 6.89 [2.04, 23.25] depending upon Indigenous group, while being an infected casual contact was less likely than being a close contact to be associated with disease progression, 0.66 [0.44, 1.00]. Conclusion In the prairie provinces of Canada and among Canadian-born persons, Indigenous peoples account for the vast majority of cases with the potential to transmit as well as the vast majority of infected contacts. Active case finding and preventative therapy measures need to focus on high-incidence Indigenous communities.	[Patel, Smit; Paulsen, Catherine; Heffernan, Courtney; Kunimoto, Dennis; Boffa, Jody; Long, Richard] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Patel, Smit; Saunders, Duncan; Senthilselvan, Ambikaipakan; Long, Richard] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Sharma, Meenu] Natl Microbiol Lab, Natl Reference Ctr Mycobacteriol, Winnipeg, MB, Canada; [Sharma, Meenu] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [King, Malcolm] Canadian Inst Hlth Res, Inst Aboriginal Peoples Hlth, Sudbury, ON, Canada; [Hoeppner, Vernon; McMullin, Kathleen] Univ Saskatchewan, Dept Med, Coll Med, Saskatoon, SK, Canada; [Orr, Pamela; Lopez-Hille, Carmen] Univ Manitoba, Dept Med, Max Rady Coll Med, Winnipeg, MB, Canada; [Menzies, Dick] McGill Univ, Dept Med, Montreal, PQ, Canada; [Christianson, Sara] Natl Microbiol Lab, Enter Dis, Winnipeg, MB, Canada; [Wolfe, Joyce] Natl Microbiol Lab, Div Bacterial Dis, Winnipeg, MB, Canada	University of Alberta; University of Alberta; University of Manitoba; Institute for Work & Health; University of Saskatchewan; University of Manitoba; McGill University	Long, R (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.; Long, R (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	richard.long@ualberta.ca	Heffernan, Courtney E/G-5296-2016; Sharma, Meenu/AAE-2536-2022; Sharma, Meenu/GWM-5030-2022; Paulsen, Catherine/AAP-4665-2021	Sharma, Meenu/0000-0002-6020-9995; Kunimoto, Dennis/0000-0002-7691-5448; Boffa, Jody/0000-0002-8183-6461	Canadian Institute of Health Research [151631]; Health Canada	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Health Canada	Funding for this study was provided by the Canadian Institute of Health Research (Grant #151631) and Health Canada (http://www.cihr-irsc.gc.ca./e/193html; http://www.hc-sc.gc.ca/index-eng.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GG, 2014, PLOS ONE; Andrews JR, 2015, INT J TUBERC LUNG D, V19, P375, DOI 10.5588/ijtld.14.0423; [Anonymous], 2007, CAN TUB STAND; [Anonymous], 1982, CANADIAN CHARTER RIG; Aspler A, 2010, CAN J PUBLIC HEALTH, V101, P205, DOI 10.1007/BF03404391; Blackwood KS, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-18; Boffa J, 2011, SOC SCI MED, V72, P733, DOI 10.1016/j.socscimed.2010.10.033; Brancker A, 1992, Health Rep, V4, P103; Cegielski JP, 2014, AM J PUBLIC HEALTH, V104, pS225, DOI [10.2105/AJPH.2012.300781, 10.2105/AJPH.2012.300781r]; Clark M, 2002, INT J EPIDEMIOL, V31, P940, DOI 10.1093/ije/31.5.940; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Eisenbeis L, 2016, CAN J PUBLIC HEALTH, V107, pE106, DOI [10.17269/cjph.107.5255, 10.17269/CJPH.107.5255]; ENARSON DA, 1986, CAN MED ASSOC J, V134, P1149; Farmer P., 1999, INFECT INEQUALITIES; Ferebee SH, 1969, ADV TUBERC RES, V17, P29; Frost WH, 1937, AM J PUBLIC HEALTH N, V27, P759, DOI 10.2105/AJPH.27.8.759; GALTUNG J, 1969, J PEACE RES, P167; Greenwood CMT, 2000, AM J HUM GENET, V67, P405, DOI 10.1086/303012; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Koethe JR, 2016, INT J TUBERC LUNG D, V20, P857, DOI 10.5588/ijtld.15.0936; Larcombe L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049872; Lau A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154032; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Long R, 2016, INT J TUBERC LUNG D, V20, P1285, DOI 10.5588/ijtld.16.0447; Long R, 2013, CAN RESPIR J, V20, P223, DOI 10.1155/2013/429496; O'Neil JD, 1998, HUM ORGAN, V57, P230, DOI 10.17730/humo.57.2.b7628vwvg7q127m8; Ortblad KF, 2015, LANCET, V386, P2354, DOI 10.1016/S0140-6736(15)00324-4; Parhar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117036; Pepperell C, 2011, INT J TUBERC LUNG D, V15, P899, DOI 10.5588/ijtld.10.0556; Rosner B., 2015, FUNDAMENTALS BIOSTAT; Sloot R, 2014, AM J RESP CRIT CARE, V190, P1044, DOI 10.1164/rccm.201406-1159OC; Sun GQ, 2017, COMMUN NONLINEAR SCI, V45, P235, DOI 10.1016/j.cnsns.2016.10.007; Sun GQ, 2016, PHYS LIFE REV, V19, P43, DOI 10.1016/j.plrev.2016.08.002; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; The Canadian Tuberculosis Committee of the Centre for Infectious Disease Prevention and Control, 2007, CCDR, V33, p1 ; Tian Y, 2013, HEALTH EDUC BEHAV, V40, p98S, DOI 10.1177/1090198113493910; Tuite Ar, 2017, BMC PUBLIC HLTH; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Wherrett George J., 1977, MIRACLE EMPTY BEDS H; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Ziv E, 2001, AM J EPIDEMIOL, V153, P381, DOI 10.1093/aje/153.4.381	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188189	10.1371/journal.pone.0188189	http://dx.doi.org/10.1371/journal.pone.0188189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136652	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200076
J	Biswas, RK; Rahman, N; Kabir, E; Raihan, F				Biswas, Raaj Kishore; Rahman, Nusma; Kabir, Enamul; Raihan, Farabi			Women's opinion on the justification of physical spousal violence: A quantitative approach to model the most vulnerable households in Bangladesh	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; RURAL BANGLADESH; MARRIED-WOMEN; LOGISTIC-REGRESSION; DOMESTIC VIOLENCE; DECISION-MAKING; WIFE ABUSE; ATTITUDES; EMPOWERMENT; RESPONSES	Bangladesh is a culturally conservative nation with limited freedom for women. A number of studies have evaluated intimate partner violence (IPV) and spousal physical violence in Bangladesh; however, the views of women have been rarely discussed in a quantitative manner. Three nationwide surveys in Bangladesh (2007, 2011, and 2014) were analyzed in this study to characterize the most vulnerable households, where women themselves accepted spousal physical violence as a general norm. 31.3%, 31.9% and 28.7% women in the surveys found justification for physical violence in household in 2007, 2011 and 2014 respectively. The binary logistic model showed wealth index, education of both women and their partner, religion, geographical division, decision making freedom and marital age as significant household contributors for women's perspective in all the three years. Women in rich households and the highly educated were found to be 40% and 50% less likely to accept domestic physical violence compared to the poorest and illiterate women. Similarly, women who got married before 18 years were 20% more likely accept physical violence in the family as a norm. Apart from these particular groups (richest, highly educated and married after 18 years), other groups had around 30% acceptance rate of household violence. For any successful attempt to reduce spousal physical violence in the traditional patriarchal society of Bangladesh, interventions must target the most vulnerable households and the geographical areas where women experience spousal violence. Although this paper focuses on women's attitudes, it is important that any intervention scheme should be devised to target both men and women.	[Biswas, Raaj Kishore; Kabir, Enamul] Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia; [Rahman, Nusma] Jagannath Univ, Dept Stat, Dhaka, Bangladesh; [Raihan, Farabi] Univ Dhaka, Inst Res & Training ISRT, Dhaka, Bangladesh	University of Southern Queensland; University of Dhaka	Biswas, RK (corresponding author), Univ Southern Queensland, Sch Agr Computat & Environm Sci, Toowoomba, Qld, Australia.	RaajKishore.Biswas@usq.edu.au	Biswas, Raaj Kishore/K-4256-2018	Biswas, Raaj Kishore/0000-0003-4294-6323; Kabir, Enamul/0000-0002-6157-2753				Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Bates LM, 2007, STUD FAMILY PLANN, V38, P101, DOI 10.1111/j.1728-4465.2007.00121.x; Bates LM, 2004, INT FAM PLAN PERSPEC, V30, P190, DOI 10.1363/3019004; Benjamin D, 2017, REDEFINE STAT SIGNIF; Bolzendahl C, 2004, SOC FORCES, V83, P759, DOI DOI 10.1353/S0F.2005.0005; Bushamuka Victor N., 2005, Food and Nutrition Bulletin, V26, P17; Byerly C. M., 2008, WOMEN MEDIA CRITICAL, V1st; Chaudhuri S, 2014, VIOLENCE AGAINST WOM, V20, P141, DOI 10.1177/1077801214521326; Chowdhury FD., 2010, INT J LAW POLICY FAM, V24, P198, DOI DOI 10.1093/LAWFAM/EBQ003; Cornell VincentJ., 2007, VOICES OF ISLAM, P35; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Dalal K, 2009, J BIOSOC SCI, V41, P561, DOI 10.1017/S0021932009990046; Dewan AM, 2009, APPL GEOGR, V29, P390, DOI 10.1016/j.apgeog.2008.12.005; Dey S, 2017, ASIAN J WOMEN STUD, V23, P163, DOI 10.1080/12259276.2017.1317702; DHS, 2016, BANGL DEM HLTH SURV; Escobar A, 2011, ENCOUNTERING DEV; Feldman S, 2010, WOMEN STUD INT FORUM, V33, P305, DOI 10.1016/j.wsif.2010.02.004; Fung K, 2007, INT J SOC PSYCHIATR, V53, P216, DOI 10.1177/0020764006074541; Gage AJ, 2005, SOC SCI MED, V61, P343, DOI 10.1016/j.socscimed.2004.11.078; Hadi A, 2005, J FAM VIOLENCE, V20, P181, DOI 10.1007/s10896-005-3654-9; Hallman K, 2000, MOTHER FATHER RESOUR, P93; Haque M., 2011, BANGLADESH E J SOCIO, V8, P17; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Hasan MT, 2014, J INTERPERS VIOLENCE, V29, P3105, DOI 10.1177/0886260514534525; Herr RS, 2014, MERIDIANS, V12, P1, DOI 10.2979/meridians.12.1.1; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; Htun M., 2002, GENDER POLITICS RIGH, P32; Islam N, 2006, SLUMS OF URBAN BANGL; Johnston HB, 2008, J HEALTH POPUL NUTR, V26, P366; Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4; Kabeer N, 2011, DEV CHANGE, V42, P499, DOI 10.1111/j.1467-7660.2011.01703.x; Kabir I, 2012, MATERN CHILD NUTR, V8, P11, DOI 10.1111/j.1740-8709.2011.00379.x; Khan MMH, 2009, SINGAP MED J, V50, P804; Khandoker A, 2011, INT J TUBERC LUNG D, V15, P379; Khatun T., 2012, BANGLADESH E J SOCIO, V9, P19; Kishor S., 2008, UNDERSTANDING WOMENS; Koenig MA, 2003, DEMOGRAPHY, V40, P269, DOI 10.1353/dem.2003.0014; Mahmud S, 2012, WORLD DEV, V40, P610, DOI 10.1016/j.worlddev.2011.08.003; Mason KO, 2000, DEMOGRAPHY, V37, P299, DOI 10.2307/2648043; Nahar Papreen, 2011, Anthropol Med, V18, P327, DOI 10.1080/13648470.2011.615911; Naher A, 2010, WOMEN STUD INT FORUM, V33, P316, DOI 10.1016/j.wsif.2010.02.005; Naved RT, 2005, STUD FAMILY PLANN, V36, P289, DOI 10.1111/j.1728-4465.2005.00071.x; Naved RT, 2013, ARCH SEX BEHAV, V42, P595, DOI 10.1007/s10508-012-0045-1; Naved RT, 2010, J FAM ISSUES, V31, P830, DOI 10.1177/0192513X09357554; Othman N, 2006, WOMEN STUD INT FORUM, V29, P339, DOI 10.1016/j.wsif.2006.05.008; Park HA, 2013, J KOREAN ACAD NURS, V43, P154, DOI 10.4040/jkan.2013.43.2.154; Rahman MM, 2014, SEX REPROD HEALTHC, V5, P9, DOI 10.1016/j.srhc.2013.12.003; Rahman M, 2011, J FAM VIOLENCE, V26, P411, DOI 10.1007/s10896-011-9375-3; Rani Manju, 2004, Afr J Reprod Health, V8, P116, DOI 10.2307/3583398; Rani M, 2009, J INTERPERS VIOLENCE, V24, P1371, DOI 10.1177/0886260508322182; Rashid S F, 2000, Gend Dev, V8, P28, DOI 10.1080/741923625; Rutstein S. O., 2004, DHS WEALTH INDEX; Sambisa W, 2011, J INTERPERS VIOLENCE, V26, P2592, DOI 10.1177/0886260510388282; Sambisa W, 2010, STUD FAMILY PLANN, V41, P165, DOI 10.1111/j.1728-4465.2010.00241.x; Sato KN, 2015, VIOLENCE AGAINST WOM, V21, P1171, DOI 10.1177/1077801215591632; Sayem AM, 2012, J BIOSOC SCI, V44, P641, DOI 10.1017/S0021932012000223; Schuler SR, 2013, STUD FAMILY PLANN, V44, P243, DOI 10.1111/j.1728-4465.2013.00356.x; Schuler SR, 2012, VIOLENCE AGAINST WOM, V18, P1177, DOI 10.1177/1077801212465152; Shehabuddin E, 2012, RESHAPING HOLY DEMOC; Story WT, 2012, SOC SCI MED, V75, P2403, DOI 10.1016/j.socscimed.2012.09.017; Sultana A, 2010, ARTS FACULTY J, V4, P1, DOI DOI 10.3329/AFJ.V4I0.12929; Tareque MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103681; Treas J, 2000, SOC FORCES, V78, P1409, DOI 10.2307/3006179; Wadesango N, 2011, ANTHROPOLOGIST, V13, P121, DOI 10.1080/09720073.2011.11891187; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; White SC, 2010, WOMEN STUD INT FORUM, V33, P334, DOI 10.1016/j.wsif.2010.02.007; Yount KM, 2013, DEMOGRAPHY, V50, P333, DOI 10.1007/s13524-012-0143-7; Yount KM, 2011, SEX ROLES, V64, P43, DOI 10.1007/s11199-010-9884-1; Yount KM, 2009, J MARRIAGE FAM, V71, P1125, DOI 10.1111/j.1741-3737.2009.00659.x	70	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187884	10.1371/journal.pone.0187884	http://dx.doi.org/10.1371/journal.pone.0187884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN4OQ	29161277	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000024
J	Xu, H; Chen, XY; Ying, NJ; Wang, MX; Xu, XL; Shi, RY; Hua, YJ				Xu, Hong; Chen, Xuanyi; Ying, Nanjiao; Wang, Meixia; Xu, Xiaoli; Shi, Rongyi; Hua, Yuejin			Mass spectrometry-based quantification of the cellular response to ultraviolet radiation in HeLa cells	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; BIOLOGICAL FUNCTIONS; PHOSPHORYLATION; DIVISION; DIFFERENTIATION; INITIATION; PROTEINS; DYNAMICS; REPAIR; CYCLE	Ultraviolet (UV) irradiation is a common form of DNA damage that can cause pyrimidine dimers between DNA, which can cause gene mutations, even double-strand breaks and threaten genome stability. If DNA repair systems default their roles at this stage, the organism can be damaged and result in disease, especially cancer. To better understand the cellular response to this form of damage, we applied highly sensitive mass spectrometry to perform comparative proteomics of phosphorylation in HeLa cells. A total of 4367 phosphorylation sites in 2100 proteins were identified, many of which had not been reported previously. Comprehensive bioinformatics analysis revealed that these proteins were involved in many important biological processes, including signaling, localization and cell cycle regulation. The nuclear pore complex, which is very important for RNA transport, was changed significantly at phosphorylation level, indicating its important role in response to UV-induced cellular stress. Protein-protein interaction network analysis and DNA repair pathways crosstalk were also examined in this study. Proteins involved in base excision repair, nucleotide repair and mismatch repair changed their phosphorylation pattern in response to UV treatment, indicating the complexity of cellular events and the coordination of these pathways. These systematic analyses provided new clues of protein phosphorylation in response to specific DNA damage, which is very important for further investigation. And give macroscopic view on an overall phosphorylation situation under UV radiation.	[Xu, Hong; Chen, Xuanyi; Xu, Xiaoli; Shi, Rongyi; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Ying, Nanjiao] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Zhejiang, Peoples R China; [Wang, Meixia] Zhejiang Inst Microbiol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Hangzhou Dianzi University	Hua, YJ (corresponding author), Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China.	yjhua@zju.edu.cn		Chen, Xuanyi/0000-0001-7406-4806	National Basic Research Program of China [2015CB910600]; National Natural Science Foundation of China [31210103904]; Natural Science Foundation of Zhejiang Province [LY16C050003]; National Key R&D Program of China [2017YFA0503900]; Science Technology Department, Zhejiang Province [KN20160607]; PTM Biolabs	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Key R&D Program of China; Science Technology Department, Zhejiang Province; PTM Biolabs	The work was supported by the following: National Basic Research Program of China (2015CB910600 to YH); National Natural Science Foundation of China (31210103904 to YH), Natural Science Foundation of Zhejiang Province (LY16C050003 to HX), National Key R&D Program of China (2017YFA0503900 to YH), and The Science Technology Department, Zhejiang Province (KN20160607 to HX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MS analysis in our research is supported by PTM Biolabs.	Aslanian A, 2014, DNA REPAIR, V15, P29, DOI 10.1016/j.dnarep.2013.12.007; Awad S, 2015, J PATHOL, V235, P606, DOI 10.1002/path.4489; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Black WP, 2010, J BACTERIOL, V192, P4267, DOI 10.1128/JB.00403-10; Borgal L, 2016, CELL CYCLE, V15, P1034, DOI 10.1080/15384101.2016.1152429; Britt AB, 2004, PHOTOSYNTH RES, V81, P105, DOI 10.1023/B:PRES.0000035035.12340.58; Bukata L, 2013, CURR OPIN CELL BIOL, V25, P378, DOI 10.1016/j.ceb.2013.03.002; Chatterjee J, 2013, ANGEW CHEM INT EDIT, V52, P254, DOI 10.1002/anie.201205674; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Cousin C, 2013, FEMS MICROBIOL LETT, V346, P11, DOI 10.1111/1574-6968.12189; Fukukawa C, 2010, GENE CHROMOSOME CANC, V49, P861, DOI 10.1002/gcc.20795; Imai T, 2011, J VIROL, V85, P5003, DOI 10.1128/JVI.02314-10; Li F, 2016, DNA REPAIR, V38, P68, DOI 10.1016/j.dnarep.2015.11.021; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Rona G, 2014, CELL CYCLE, V13, P3551, DOI 10.4161/15384101.2014.960740; Tan L, 2011, P NATL ACAD SCI USA, V108, P16675, DOI 10.1073/pnas.1106748108; Teixeira FK, 2015, NAT CELL BIOL, V17, P689, DOI 10.1038/ncb3165; van der Harg JM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.354; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Wang AX, 2010, FASEB J, V24, P833, DOI 10.1096/fj.09-142976; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Wu LH, 2014, SCI CHINA LIFE SCI, V57, P482, DOI 10.1007/s11427-014-4631-4; Xu GQ, 2013, BIOTECHNOL GENET ENG, V29, P73, DOI 10.1080/02648725.2013.801232; Yuan CF, 2014, CELL CYCLE, V13, P807, DOI 10.4161/cc.27727	26	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186806	10.1371/journal.pone.0186806	http://dx.doi.org/10.1371/journal.pone.0186806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155820	gold, Green Submitted, Green Published			2022-12-27	WOS:000415756700005
J	Hutchinson, NX; Gibbs, A; Tonks, A; Hope-Gill, BD				Hutchinson, Nicola-xan; Gibbs, Allen; Tonks, Amanda; Hope-Gill, Benjamin D.			Airway expression of Transient Receptor Potential (TRP) Vanniloid-1 and Ankyrin-1 channels is not increased in patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; CHRONIC COUGH; SENSORY NEURONS; ALVEOLITIS; GUIDELINES; SELECTION; REFLEX; SYSTEM; NERVES; NGF	Dry cough is a common symptom described in patients with Idiopathic Pulmonary Fibrosis (IPF) and impairs quality of life. The exact mechanisms causing cough in IPF remain unclear, however evidence suggests altered cough neurophysiology and sensitisation plays a role; IPF patients have an enhanced cough reflex sensitivity to inhaled capsaicin. The Transient Receptor Potential Vanniloid-1 channel (TRPV-1) has a role in the cough reflex and airway expression is increased in patients with chronic cough. The Ankyrin-1 receptor (TRPA-1) is often co-expressed. It was hypothesised that, like chronic cough patients, IPF patients have increased airway TRP receptor expression. Bronchial biopsies were obtained from 16 patients with IPF, 11 patients with idiopathic chronic cough and 8 controls without cough. All other causes of cough were rigorously excluded. Real-time quantitative Polymerase Chain Reaction was used to detect TRPV-1 and TRPA-1 mRNA expression with Immunohistochemistry demonstrating protein expression. Mean TRPV-1 and TRPA-1 gene expression was higher in IPF patients compared with controls, but the difference did not reach statistical significance. Immunostaining supported these findings. This study suggests that structural up-regulation of central airway TRP receptors is not the key mechanism for cough in IPF patients. It is probable that IPF cough results from altered neuronal sensitivity at multiple levels of the cough pathway.	[Hutchinson, Nicola-xan] Princess Wales Hosp, Dept Resp Med, Bridgend, Wales; [Gibbs, Allen] Cardiff & Vale Univ Hlth Board, Dept Histopathol, Cardiff, S Glam, Wales; [Tonks, Amanda] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Hope-Gill, Benjamin D.] Cardiff & Vale Univ Hlth Board, Dept Resp Med, Cardiff, S Glam, Wales	Cardiff University	Hutchinson, NX (corresponding author), Princess Wales Hosp, Dept Resp Med, Bridgend, Wales.	nxhutch1@doctors.org.uk			Institutional Lung Research Endowment funds	Institutional Lung Research Endowment funds	The funding was entirely from Institutional Lung Research Endowment funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian AN, 2007, J PHYSIOL-LONDON, V583, P175, DOI 10.1113/jphysiol.2007.133231; Allen D, 2008, J DERMATOL SCI, V49, P217, DOI 10.1016/j.jdermsci.2007.10.001; Ando A, 2016, THORAX, V71, P323, DOI 10.1136/thoraxjnl-2015-207425; [Anonymous], 1994, Respir Med, V88, P165; Birring SS, 2008, EUR RESPIR J, V31, P1013, DOI 10.1183/09031936.00057407; Bonvini SJ, 2015, N-S ARCH PHARMACOL, V388, P401, DOI 10.1007/s00210-014-1082-1; Bradley B, 2008, THORAX, V63, P1029; Buch TRH, 2013, CHEM-BIOL INTERACT, V206, P462, DOI 10.1016/j.cbi.2013.08.012; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Doherty MJ, 2000, THORAX, V55, P1028, DOI 10.1136/thorax.55.12.1028; Grace MS, 2014, BRIT J PHARMACOL, V171, P2593, DOI 10.1111/bph.12538; Groneberg DA, 2004, AM J RESP CRIT CARE, V170, P1276, DOI 10.1164/rccm.200402-174OC; Gu QH, 2003, J NEUROPHYSIOL, V89, P1985, DOI 10.1152/jn.00748.2002; Harrison Nicholas Kim, 2013, Cough, V9, P9, DOI 10.1186/1745-9974-9-9; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hope-Gill BDM, 2003, AM J RESP CRIT CARE, V168, P995, DOI 10.1164/rccm.200304-597OC; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jie Shu, 2013, 2013 Seventh International Conference on Image and Graphics (ICIG), P937, DOI 10.1109/ICIG.2013.197; Key Angela L, 2010, Cough, V6, P4, DOI 10.1186/1745-9974-6-4; Mazzone SB, 2005, J PHYSIOL-LONDON, V569, P559, DOI 10.1113/jphysiol.2005.093153; Minner F, 2009, J INVEST DERMATOL, V129, P770, DOI 10.1038/jid.2008.247; Mitchell JE, 2005, EXP LUNG RES, V31, P295, DOI 10.1080/01902140590918803; Morice AH, 2007, EUR RESPIR J, V29, P1256, DOI 10.1183/09031936.00101006; OCONNELL F, 1995, AM J RESP CRIT CARE, V152, P2068, DOI 10.1164/ajrccm.152.6.8520777; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Sawynok J, 2005, CURR PHARM DESIGN, V11, P2995, DOI 10.2174/1381612054865019; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Sparrow MP, 1999, AM J RESP CELL MOL, V20, P550, DOI 10.1165/ajrcmb.20.4.3385; SUROWY CS, 2010, VANILLOID RECEPTOR T, P101; Swigris Jeffrey J, 2005, Health Qual Life Outcomes, V3, P61, DOI 10.1186/1477-7525-3-61; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takemura M, 2008, PULM PHARMACOL THER, V21, P833, DOI 10.1016/j.pupt.2008.09.005; Taylor-Clark TE, 2009, PULM PHARMACOL THER, V22, P71, DOI 10.1016/j.pupt.2008.12.019; TURNERWARWICK M, 1980, THORAX, V35, P171, DOI 10.1136/thx.35.3.171; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Watanabe N, 2005, PULM PHARMACOL THER, V18, P187, DOI 10.1016/j.pupt.2004.12.002; Wick MR, 2000, SEMIN DIAGN PATHOL, V17, P194; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	39	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187847	10.1371/journal.pone.0187847	http://dx.doi.org/10.1371/journal.pone.0187847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149168	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000415646100015
J	Lin, TH; Hu, HT; Wang, HC; Wu, MC; Wu, SW; Yeh, ML				Lin, Tzu-Hsiang; Hu, Hsin-Tai; Wang, Hsueh-Chun; Wu, Meng-Chian; Wu, Shu-Wei; Yeh, Ming-Long			Evaluation of osseous integration of titanium orthopedic screws with novel SLA treatment in porcine model	PLOS ONE			English	Article							TREATED MINI-IMPLANTS; SURFACE-TREATMENT; PEDICLE SCREWS; BONE RESPONSE; TORQUE; OSTEOPOROSIS; PREVALENCE; FRACTURES; ROUGHNESS; REMOVAL	The success of many endosseous implants in orthopaedic and dental applications depends on the surface characteristics, as they affect osseous integration. Previous investigations indicated that a novel large-grit sand-blasted and acid-etched (SLA) titanium (denoted as SLAffinity-Ti) implant had better bone integration than that of a comparably shaped implant with a plasma-sprayed titanium surface. The purpose of the present investigation was to create a SLAffinity surface on pedicle screws and trauma screws and to compare it with the surfaces of a sand-blasted-only implant and commercial implants in terms of bone integration. The cortical bone and spine of twelve minipigs were implanted with 3 and 4 implants, respectively, and the bone integration was evaluated using micro-computed tomography (micro-CT), mechanical tests (pull-out strength and stripping torque), and histological analysis (toluidine blue and hematoxylin and eosin staining) one and three months after implantation. The micro-CT images showed that the gap between the bone and implant was consistently higher in the sand-blasted-only and commercial groups compared to that in the SLAffinity group 1 and 3 months after implantation. Moreover, the bone volume of implant inserted into bone and the percentage of implant inside bone tissue were greater in the SLAffinity screws 1 and 3 months after implantation, as compared to the sand-blasted and commercial screws. In the mechanical tests, the removal torque and pull-out strength (p < 0.05) were higher in the SLAffinity group at 1 and 3 months. The histological results were consistent with mechanical testing, showing that the SLAffinity group had the most mineralized matrix, the most bone formation around the screws, and the most bone cells in bone tissue. These findings indicate that a SLAffinity surface can effectively enhance the holding strength and integration of pedicle screws and cortical screws, promoting early healing and improving outcomes, compared to sand-blasted-only and commercial implants.	[Lin, Tzu-Hsiang; Wang, Hsueh-Chun; Wu, Meng-Chian; Wu, Shu-Wei; Yeh, Ming-Long] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Hu, Hsin-Tai] Hung Chun Bio Sci Co, Dept Technol Dev, Kaohsiung Sci Pk, Kaohsiung, Taiwan; [Yeh, Ming-Long] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University	Yeh, ML (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.; Yeh, ML (corresponding author), Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan.	mlyeh@mail.ncku.edu.tw			Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C [102-EG-17-A-19-H-0092]	Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C	This work was supported by the Industrial Technology Develop Program (TDP) of the Ministry of Economic Affairs, R.O.C. Grant number is 102-EG-17-A-19-H-0092. The URL is https://www.moea.gov.tw/MNS/doit/content/Content.aspx?menu id=13394. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ABRASION DENT IMPLAN; Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f; Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625; Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P1652, DOI 10.2106/JBJS.I.01111; Buser D, 1991, Int J Oral Maxillofac Implants, V6, P405; BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708; Buser D, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P88; Chang CS, 2009, CLIN ORAL IMPLAN RES, V20, P1178, DOI 10.1111/j.1600-0501.2009.01728.x; Chiang HJ, 2016, J BIOMED MATER RES A, V104, P397, DOI 10.1002/jbm.a.35577; Chiang HJ, 2014, IMPLANT DENT, V23, P659, DOI 10.1097/ID.0000000000000181; Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x; Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q; Davies John E, 2003, J Dent Educ, V67, P932; Esses SI, 1993, SPINE, V18, P8; Jeon MS, 2008, KOREAN J ORTHOD, V38, P328, DOI 10.4041/kjod.2008.38.5.328; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kim SH, 2008, AM J ORTHOD DENTOFAC, V134, P36, DOI 10.1016/j.ajodo.2006.07.038; Kim SH, 2009, ANGLE ORTHOD, V79, P899, DOI 10.2319/090608-466.1; Klokkevold PR, 2001, CLIN ORAL IMPLAN RES, V12, P350, DOI 10.1034/j.1600-0501.2001.012004350.x; Kuo CK, 2006, CURR OPIN RHEUMATOL, V18, P64, DOI 10.1097/01.bor.0000198005.88568.df; Lee WF., 2013, J EXPE CLIN MEDI, V5, P92, DOI [10.1016/j.jecm.2013.04.002, DOI 10.1016/J.JECM.2013.04.002]; Lin YH, 2012, IMPLANT DENT, V21, P344, DOI 10.1097/ID.0b013e31825fed00; Mandelbaum BR, 1998, AM J SPORT MED, V26, P853, DOI 10.1177/03635465980260062201; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Okuyama K, 2001, Spine J, V1, P402, DOI 10.1016/S1529-9430(01)00078-X; Ou K-L, 2016, J STEM CELL RES THE, V06; Patel SS, 2016, J CLIN NEUROSCI, V24, P63, DOI 10.1016/j.jocn.2015.07.018; Pazianas M, 2007, CLIN THER, V29, P1548, DOI 10.1016/j.clinthera.2007.08.008; Pfeiffer M, 1996, SPINE, V21, P1037, DOI 10.1097/00007632-199605010-00009; PIATTELLI A, 1995, BIOMATERIALS, V16, P917, DOI 10.1016/0142-9612(95)93116-U; Plachokova AS, 2008, CLIN ORAL IMPLAN RES, V19, P539, DOI 10.1111/j.1600-0501.2008.01525.x; Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499; Sirisa-Ard A, 2015, EUROPEAN J ORTHODONT; Trisi P, 2003, J PERIODONTOL, V74, P945, DOI 10.1902/jop.2003.74.7.945; Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331; Wheeler S L, 1996, Int J Oral Maxillofac Implants, V11, P340; WILKE HJ, 1990, ADV BIOMAT, V9, P309; ZDEBLICK TA, 1993, SPINE, V18, P1673, DOI 10.1097/00007632-199309000-00016; 오남희, 2006, [The Korean Journal of Orthodontics, 대한치과교정학회지], V36, P324	39	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188364	10.1371/journal.pone.0188364	http://dx.doi.org/10.1371/journal.pone.0188364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149204	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100040
J	Sirich, TL; Aronov, PA; Fullman, J; Nguyen, K; Plummer, NS; Meyer, TW				Sirich, Tammy L.; Aronov, Pavel A.; Fullman, Jonathan; Khanh Nguyen; Plummer, Natalie S.; Meyer, Timothy W.			Untargeted mass spectrometry discloses plasma solute levels poorly controlled by hemodialysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PROTEIN-BOUND SOLUTES; UREMIC TOXINS; METABOLOMIC ANALYSIS; TUBULAR SECRETION; METABOLITES; MARKERS	Many solutes have been reported to remain at higher plasma levels relative to normal than the standard index solute urea in hemodialysis patients. Untargeted mass spectrometry was employed to compare solute levels in plasma and plasma ultrafiltrate of hemodialysis patients and normal subjects. Quantitative assays were employed to check the accuracy of untargeted results for selected solutes and additional measurements were made in dialysate and urine to estimate solute clearances and production. Comparison of peak areas indicated that many solutes accumulated to high levels in hemodialysis patients, with average peak areas in plasma ultrafiltrate of dialysis patients being more than 100 times greater than those in normals for 123 features. Most of these mass spectrometric features were identified only by their mass values. Untargeted analysis correctly ranked the accumulation of 5 solutes which were quantitatively assayed but tended to overestimate its extent. Mathematical modeling showed that the elevation of plasma levels for these solutes could be accounted for by a low dialytic to native kidney clearance ratio and a high dialytic clearance relative to the volume of the accessible compartment. Numerous solutes accumulate to high levels in hemodialysis patients because dialysis does not replicate the clearance provided by the native kidney. Many of these solutes remain to be chemically identified and their pathogenic potential elucidated.	[Sirich, Tammy L.] VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA; Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Sirich, TL (corresponding author), VA Palo Alto HCS, Dept Med, Palo Alto, CA 94304 USA.	tsirich@stanford.edu			Veterans Affairs Career Development Award [CX001036-01A1]; NIH [R01 DK101674]; Veterans Affairs [IK2CX001036] Funding Source: NIH RePORTER	Veterans Affairs Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by a Veterans Affairs Career Development Award (CX001036-01A1, to TLS) and the NIH (R01 DK101674, to TWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiar Ray, 2007, Journal of Pharmacological and Toxicological Methods, V55, P262, DOI 10.1016/j.vascn.2006.10.002; Boelaert J, 2014, METABOLOMICS, V10, P425, DOI 10.1007/s11306-013-0592-z; DUBOVSKA D, 1995, METHOD FIND EXP CLIN, V17, P67; Duranton F, 2012, J AM SOC NEPHROL, V23, P1258, DOI 10.1681/ASN.2011121175; Eloot S, 2014, SEMIN NEPHROL, V34, P209, DOI 10.1016/j.semnephrol.2014.02.011; Hocher B, 2017, NAT REV NEPHROL, V13, P269, DOI 10.1038/nrneph.2017.30; Huan T, 2015, ANAL CHEM, V87, P10619, DOI 10.1021/acs.analchem.5b03126; Ivanisevic J, 2013, ANAL CHEM, V85, P6876, DOI 10.1021/ac401140h; Kikuchi K, 2010, J CHROMATOGR B, V878, P1662, DOI 10.1016/j.jchromb.2009.11.040; Kirsch AH, 2017, NEPHROL DIAL TRANSPL, V32, P165, DOI 10.1093/ndt/gfw310; Luo FJG, 2009, AM J KIDNEY DIS, V53, P1042, DOI 10.1053/j.ajkd.2009.01.265; Meyer TW, 2016, J AM SOC NEPHROL, V27, P3469, DOI 10.1681/ASN.2015091035; Meyer TW, 2004, J AM SOC NEPHROL, V15, P1927, DOI 10.1097/01.asn.0000131521.62256.f0; Niwa T, 2011, MASS SPECTROM REV, V30, P510, DOI 10.1002/mas.20323; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Proudfoot Alex T., 2003, Toxicological Reviews, V22, P129, DOI 10.2165/00139709-200322030-00001; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rhee EP, 2010, J AM SOC NEPHROL, V21, P1041, DOI 10.1681/ASN.2009111132; Rivara MB, 2017, CLIN CHEM, V63, P915, DOI 10.1373/clinchem.2016.260117; Sato E, 2011, EUR J CLIN INVEST, V41, P241, DOI 10.1111/j.1365-2362.2010.02398.x; Sirich TL, 2014, J AM SOC NEPHROL, V25, P615, DOI 10.1681/ASN.2013060597; Sirich TL, 2013, KIDNEY INT, V84, P585, DOI 10.1038/ki.2013.154; Tanaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135657; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Viant MR, 2017, CURR OPIN CHEM BIOL, V36, P64, DOI 10.1016/j.cbpa.2017.01.001; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Zamboni N, 2015, MOL CELL, V58, P699, DOI 10.1016/j.molcel.2015.04.021; Zhang QB, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1231-x; Zickler D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169024	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188315	10.1371/journal.pone.0188315	http://dx.doi.org/10.1371/journal.pone.0188315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145509	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800110
J	Yang, JH; Peng, J; Zhang, D; Zheng, LL; Mo, L				Yang, Juanhua; Peng, Jun; Zhang, Dake; Zheng, Liling; Mo, Lei			Specific effects of working memory training on the reading skills of Chinese children with developmental dyslexia	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; EPISODIC BUFFER; RECOGNITION; PERFORMANCE; PHONOLOGY; COMPONENT; DEFICITS; SPEED	Most research on working memory (WM) training for children with developmental dyslexia (DD) has focused on western alphabetical languages. Moreover, most of these studies used a combination of training tasks targeting a variety of WM components, making it difficult to determine whether WM training generates a general improvement in overall reading, or improves specific cognitive skills corresponding to the WM components that are targeted in training. We tested the general and specific effects of WM training on the reading skills of 45 Chinese children with DD, grades 3 to 5. In Experiment 1, the experimental group received a program targeting the verbal WM component; in Experiment 2, the experimental group was trained with a program targeting visuospatial WM. In both experiments the control group played a placebo video game. In Experiment 1, the experimental group outperformed the control group on the visual rhyming task, which is highly correlated with verbal WM. In Experiment 2, the experimental group outperformed the control group on the orthographic awareness test, which is highly correlated with visuospatial WM. Furthermore, in both Experiment 1 and Experiment 2, the experimental groups outperformed the control groups on the fast word naming test, which is highly related to both visuospatial WM and verbal WM. Results indicated that WM training improved specific reading-related cognitive skills that are highly correlated with the specific WM components that were the target of training.	[Yang, Juanhua; Peng, Jun; Zheng, Liling; Mo, Lei] South China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China; [Yang, Juanhua; Peng, Jun; Zheng, Liling; Mo, Lei] South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Zhang, Dake] Rutgers State Univ, Dept Educ Psychol, New Brunswick, NJ USA; [Mo, Lei] South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University; Rutgers State University New Brunswick; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Ctr Study Appl Psychol, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China.; Mo, L (corresponding author), South China Normal Univ, Guangdong Prov Key Lab Mental Hlth & Cognit Sci, Guangzhou, Guangdong, Peoples R China.	molei@m.scnu.edu.cn			National Social Science Foundation of China [14ZDB159]; Key Institute of Humanities and Social Sciences, Ministry of Education, China [16JJD880025]	National Social Science Foundation of China; Key Institute of Humanities and Social Sciences, Ministry of Education, China(Ministry of Education, China)	This work was supported by grants from the National Social Science Foundation of China (Grant NO.14ZDB159 URL:http://www.npopss-cn.gov.cn/) and Project of the Key Institute of Humanities and Social Sciences, Ministry of Education, China (Grant NO.16JJD880025 URL: https://www.sinoss.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Social Science Foundation of China (14ZDB159) and Project of the Key Institute of Humanities and Social Sciences, Ministry of Education, China (16JJD880025). We thank the teachers and children for their participation in these experiments.	ACKERMAN PT, 1993, J LEARN DISABIL, V26, P597, DOI 10.1177/002221949302600910; Alloway TP, 2005, BRIT J DEV PSYCHOL, V23, P417, DOI 10.1348/026151005X26804; [Anonymous], 2013, DIAGN STAT MAN MENT; Atkins PWB, 1998, APPL PSYCHOLINGUIST, V19, P537, DOI 10.1017/S0142716400010353; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; Beneventi H, 2010, SCAND J PSYCHOL, V51, P192, DOI 10.1111/j.1467-9450.2010.00808.x; Chen H-C, 2001, J PSYCHOL CHINESE SO, V2, P155; Colom R, 2013, INTELLIGENCE, V41, P712, DOI 10.1016/j.intell.2013.09.002; Cowan N, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; Cowan Nelson, 2005, WORKING MEMORY CAPAC; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dawes E, 2015, AUST PSYCHOL, V50, P362, DOI 10.1111/ap.12120; Eden GF, 2004, NEURON, V44, P411, DOI 10.1016/j.neuron.2004.10.019; Ersland L, 2009, INT J NEUROSCI, P119; Fan X.D., 1993, ICD 10 CLASSIFICATIO; Fischer-Baum S, 2010, COGNITION, V115, P466, DOI 10.1016/j.cognition.2010.03.013; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; GATHERCOLE SE, 1990, J MEM LANG, V29, P336, DOI 10.1016/0749-596X(90)90004-J; Gathercole SE, 2006, ED RES REV, V1, P382; Goulandris N.E., 2003, DYSLEXIA DIFFERENT L; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Griffiths YM, 2003, J SPEECH LANG HEAR R, V46, P1352, DOI 10.1044/1092-4388(2003/105); Grossi G, 2001, J COGNITIVE NEUROSCI, V13, P610, DOI 10.1162/089892901750363190; Hernandez N, 2013, PSYCHOPHYSIOLOGY, V50, P1226, DOI 10.1111/psyp.12141; Ho C.S.-H., 2000, HONG KONG TEST SPECI; Horowitz-Kraus T, 2014, J LEARN DISABIL-US, V47, P208, DOI 10.1177/0022219412453084; Horowitz-Kraus T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007141; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jeffries S, 2004, DYSLEXIA, V10, P196, DOI 10.1002/dys.278; Jonides J, 1997, J COGNITIVE NEUROSCI, V9, P462, DOI 10.1162/jocn.1997.9.4.462; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Liao CH, 2008, READ WRIT, V21, P231, DOI 10.1007/s11145-007-9071-0; Lilienthal L, 2013, PSYCHON B REV, V20, P135, DOI 10.3758/s13423-012-0335-6; Logie R. H., 1995, VISUOSPATIAL WORKING; Luo Y, 2013, NEURAL REGEN RES, V8, P452, DOI 10.3969/j.issn.1673-5374.2013.05.009; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; Nation K, 1999, J EXP CHILD PSYCHOL, V73, P139, DOI 10.1006/jecp.1999.2498; Palmer S., 2000, J RES READ, V23, P28, DOI DOI 10.1111/1467-9817.00100; Papageorgiou C, 2009, BEHAV BRAIN FUNCT, V5, P1; Poblano A, 2000, ARCH MED RES, V31, P493, DOI 10.1016/S0188-4409(00)00096-5; Ramus F, 2003, J CHILD PSYCHOL PSYC, V44, P712, DOI 10.1111/1469-7610.00157; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Roden I, 2014, PSYCHOL MUSIC, V42, P284, DOI 10.1177/0305735612471239; Schwarb H, 2016, PSYCHOL RES-PSYCH FO, V80, P128, DOI 10.1007/s00426-015-0648-y; Seigneuric A, 2000, READ WRIT, V13, P81, DOI 10.1023/A:1008088230941; SERVICE E, 1992, Q J EXP PSYCHOL-A, V45, P21, DOI 10.1080/14640749208401314; Shiran A, 2011, J NEUROLINGUIST, V24, P524, DOI 10.1016/j.jneuroling.2010.12.001; SIEGEL LS, 1984, DEV PSYCHOL, V20, P200, DOI 10.1037/0012-1649.20.2.200; Smith-Spark JH, 2007, MEMORY, V15, P34, DOI 10.1080/09658210601043384; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Spironelli C, 2010, BRAIN, V133, P3385, DOI 10.1093/brain/awq199; Sun Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056688; Temple E, 2000, P NATL ACAD SCI USA, V97, P13907, DOI 10.1073/pnas.240461697; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Tilanus EAT, 2016, DYSLEXIA, V22, P214, DOI 10.1002/dys.1533; Vellutino FR, 2004, J CHILD PSYCHOL PSYC, V45, P2, DOI 10.1046/j.0021-9630.2003.00305.x; Wang M, 1999, CHINESE J CHILD HLTH, V7, P161; Wang SM, 2015, J EXP CHILD PSYCHOL, V133, P16, DOI 10.1016/j.jecp.2015.01.002; Wang X., 1993, CHINESE CHARACTER RE; Wu H, 2004, STUDY WORKING MEMORY, V8, P192; Zeng B, 2003, STUDY WORKING MEMORY	64	10	11	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186114	10.1371/journal.pone.0186114	http://dx.doi.org/10.1371/journal.pone.0186114			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145402	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800001
J	Bhasker, TV; Gowda, NKS; Pal, DT; Bhat, SK; Krishnamoorthy, P; Mondal, S; Pattanaik, AK; Verma, AK				Bhasker, T. Vijay; Gowda, N. K. S.; Pal, D. T.; Bhat, S. Karthik; Krishnamoorthy, P.; Mondal, S.; Pattanaik, A. K.; Verma, A. K.			Influence of boron supplementation on performance, immunity and antioxidant status of lambs fed diets with or without adequate level of calcium	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; BORIC-ACID; STRESS; PROFILE; GROWTH	Little is known about biological significance of effects of dietary Boron (B) and Calcium (Ca) interaction on health and production of farm animals. This is a preliminary investigation to evaluate the effects of B supplementation in lambs fed diets with (normal) or without adequate (low) levels of Ca. Twenty-four crossbred ram lambs were randomly distributed into four groups with six animals each in a 2x2 factorial design namely, normal-Ca diet (NCa) and low-Ca diet (LCa) fed without or with 40 ppm B (NCaB-40 and LCaB-40). The lambs were fed paddy straw and hybrid napier hay-based total mixed ration (60 roughage: 40 concentrate) during 180 days experimental period. Compared to control, the LCa diet lowered (P<0.01) average daily gain of lambs, but B-supplementation (LCaB-40) of the same nullified the effect. The lowered (P<0.05) total antioxidant activity and humoral immune response in lambs fed LCa diet were restored (P>0.05) to become at par with the control (NCa) upon supplementation of B (LCaB-40). The mRNA expression of SOD1 was lowered (P<0.05) due to LCa diet feeding which too was normalized on B-supplementation to become at par (P>0.05) with the control (NCa). Further, B-supplementation restored lowered (P<0.05) SOD1 gene expression on LCa diet, but enhanced (P<0.05) that in NCaB-40 group, when compared to the control (NCa) diet fed animals. However, these variations were not reflected in the SOD activity in the erythrocytes. The cell-mediated immune response was higher (P<0.05) in lambs fed LCa and LCaB-40 groups and there was no significant interaction between the levels of either Ca or B in diets with the period of immune response measurement. B-supplementation of LCa diet ameliorated tissue degenerative changes in liver and kidney. It was concluded that feeding LCa diet to lambs resulted in reduced growth rate, total antioxidant activity, humoral immune response along with degenerative changes in liver and kidney tissues, but B-supplementation of such diet restored most of these changes and ameliorated histopathological alterations.	[Bhasker, T. Vijay; Pattanaik, A. K.; Verma, A. K.] ICAR Indian Vet Res Inst, Anim Nutr Div, Izatnagar, Uttar Pradesh, India; [Gowda, N. K. S.; Pal, D. T.; Bhat, S. Karthik] ICAR Natl Inst Anim Nutr & Physiol, Anim Nutr Div, Bangalore, Karnataka, India; [Krishnamoorthy, P.] ICAR Natl Inst Vet Epidemiol & Dis Informat, Bangalore, Karnataka, India; [Mondal, S.] ICAR Natl Inst Anim Nutr & Physiol, Anim Physiol Div, Bangalore, Karnataka, India; [Bhasker, T. Vijay] Dept Anim Husb, Warangal, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology	Gowda, NKS (corresponding author), ICAR Natl Inst Anim Nutr & Physiol, Anim Nutr Div, Bangalore, Karnataka, India.	nksgowda@rediffmail.com	Krishnamoorthy, Paramanandham/ABC-3793-2021; nianp, Library/AAA-6956-2021; Mondal, S/AAF-9993-2020; Pattanaik, Ashok Kumar/P-1418-2018	Krishnamoorthy, Paramanandham/0000-0001-7495-1333; Pattanaik, Ashok Kumar/0000-0002-1824-4797; Tekulapally, Vijay Bhasker/0000-0001-5479-0720	University Grants Commission [F1-17.1/2012-13/RGNF-2012-13-SC-KAR-29658/(SA-III/VVebsite)]; ICAR-NIANP, Bangalore; ICAR-IVRI, lzatnagar; University Grants Commission, Government of India	University Grants Commission(University Grants Commission, India); ICAR-NIANP, Bangalore; ICAR-IVRI, lzatnagar; University Grants Commission, Government of India(University Grants Commission, India)	This work was funded by University Grants Commission (F1-17.1/2012-13/RGNF-2012-13-SC-KAR-29658/(SA-III/VVebsite)) to T. Vijay Bhasker. The facilities and support for this research work provided by Director, ICAR-NIANP, Bangalore and Director, ICAR-IVRI, lzatnagar are thankfully acknowledged. The Rajiv Gandhi National Fellowship to first author provided by University Grants Commission, Government of India is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The facilities and support for this research work provided by Director, ICAR-NIANP, Bangalore and Director, ICAR-IVRI, Izatnagar are thankfully acknowledged. The Rajiv Gandhi National Fellowship to first author provided by University Grants Commission, Government of India is duly acknowledged.	[Anonymous], 2000, METHODS MOL BIOL; AOAC, 2000, OFFICIAL METHODS ANA; Armstrong TA, 2003, J ANIM SCI, V81, P2552; Armstrong TA, 2001, J ANIM SCI, V79, P3120; Armstrong TA, 2001, J ANIM SCI, V79, P1549; Bancroft J.D., 1996, THEORY PRACTICAL HIS, V4th; Bhasker TV, 2016, J TRACE ELEM MED BIO, V36, P73, DOI 10.1016/j.jtemb.2016.04.007; Bhasker TV, 2015, ANIM FEED SCI TECH, V209, P280, DOI 10.1016/j.anifeedsci.2015.08.003; Coban FK, 2015, DRUG CHEM TOXICOL, V38, P391, DOI 10.3109/01480545.2014.974109; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Fry RS, 2011, RES VET SCI, V90, P78, DOI 10.1016/j.rvsc.2010.04.016; Henderson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006009; Henderson KA, 2015, BIOMETALS, V28, P133, DOI 10.1007/s10534-014-9809-5; Hu QQ, 2014, BIOL TRACE ELEM RES, V158, P73, DOI 10.1007/s12011-014-9899-5; ICAR, 2013, NUTR REQ COMP LAB CA; Ince S, 2014, CHEMOSPHERE, V108, P197, DOI 10.1016/j.chemosphere.2014.01.038; Ince S, 2012, DRUG CHEM TOXICOL, V35, P285, DOI 10.3109/01480545.2011.607825; Ince S, 2010, J TRACE ELEM MED BIO, V24, P161, DOI 10.1016/j.jtemb.2010.01.003; Jin EH, 2014, ITAL J ANIM SCI, V13, DOI 10.4081/ijas.2014.3152; Kabu M, 2012, REV MED VET-TOULOUSE, V163, P419; Kabu M, 2015, J ELEMENTOL, V20, P535, DOI 10.5601/jelem.2014.19.3.706; Kabu M, 2013, ARCH TIERZUCHT, V56, P733, DOI 10.7482/0003-9438-56-073; Krishnamoorthy P, 2015, FLUORIDE, V48, P123; Kurtoglu V, 2012, J ANIM VET ADV, V11, P1072, DOI 10.3923/javaa.2012.1072.1079; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MINAMI M, 1979, CLIN CHIM ACTA, V92, P337; Singh RP, 2004, VET MICROBIOL, V98, P3, DOI 10.1016/j.vetmic.2003.07.007; Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Wang J, 2015, PAK VET J, V35, P489	31	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187203	10.1371/journal.pone.0187203	http://dx.doi.org/10.1371/journal.pone.0187203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141035	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400019
J	Vidal, T; Lusley, P; Leconte, M; de Vallavieille-Pope, C; Huber, L; Saint-Jean, S				Vidal, Tiphaine; Lusley, Pauline; Leconte, Marc; de Vallavieille-Pope, Claude; Huber, Laurent; Saint-Jean, Sebastien			Cultivar architecture modulates spore dispersal by rain splash: A new perspective to reduce disease progression in cultivar mixtures	PLOS ONE			English	Article							SEPTORIA-TRITICI BLOTCH; MYCOSPHAERELLA-GRAMINICOLA; CANOPY ARCHITECTURE; ZYMOSEPTORIA-TRITICI; FOOD SECURITY; PLANT-DISEASE; WINTER-WHEAT; RESISTANCE; PATHOGENS; SPREAD	Cultivar mixtures can be used to improve the sustainability of disease management within farming systems by growing cultivars that differ in their disease resistance level in the same field. The impact of canopy aerial architecture on rain-splash dispersal could amplify disease reduction within mixtures. We designed a controlled conditions experiment to study single splash-dispersal events and their consequences for disease. We quantified this impact through the spore interception capacities of the component cultivars of a mixture. Two wheat cultivars, differing in their aerial architecture ( mainly leaf area density) and resistance to Septoria tritici blotch, were used to constitute pure stands and mixtures with 75% of resistant plants that accounted for 80% of the canopy leaf area. Canopies composed of 3 rows of plants were exposed to standardized spore fluxes produced by splashing calibrated rain drops on a linear source of inoculum. Disease propagation was measured through spore fluxes and several disease indicators. Leaf susceptibility was higher for upper than for lower leaves. Dense canopies intercepted more spores and mainly limited horizontal spore transfer to the first two rows. The presence of the resistant and dense cultivar made the mixed canopy denser than the susceptible pure stand. No disease symptoms were observed on susceptible plants of the second and third rows in the cultivar mixture, suggesting that the number of spores intercepted by these plants was too low to cause disease symptoms. Both lesion area and disease conditional severity were significantly reduced on susceptible plants within mixtures on the first row beside the inoculum source. Those reductions on one single-splash dispersal event, should be amplified after several cycle over the full epidemic season. Control of splash-dispersed diseases within mixtures could therefore be improved by a careful choice of cultivars taking into consideration both resistance and architecture.	[Vidal, Tiphaine; Lusley, Pauline; Huber, Laurent; Saint-Jean, Sebastien] Univ Paris Saclay, UMR ECOSYS INRA, AgroParisTech, F-78850 Thiverval Grignon, France; [Vidal, Tiphaine; Leconte, Marc; de Vallavieille-Pope, Claude] Univ Paris Saclay, UMR BIOGER INRA, AgroParisTech, F-78850 Thiverval Grignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Saint-Jean, S (corresponding author), Univ Paris Saclay, UMR ECOSYS INRA, AgroParisTech, F-78850 Thiverval Grignon, France.	Sebastien.Saint-Jean@AgroParisTech.fr	Saint-Jean, Sébastien/D-9069-2012	Saint-Jean, Sébastien/0000-0002-0401-0711	ABIES doctoral school for Tiphaine Vidal; National Agency of Research [ANR-13-AGRO-0008]	ABIES doctoral school for Tiphaine Vidal; National Agency of Research(French National Research Agency (ANR))	We thank the ABIES doctoral school for Tiphaine Vidal's PhD grant and the Wheatamix project financed by the National Agency of Research (ANR-13-AGRO-0008, www6.inra.fr/wheatamix/) for financial support.; We thank the ABIES doctoral school for Tiphaine Vidal's PhD grant and the Wheatamix project financed by the National Agency of Research (ANR-13-AGRO-0008, www6.inra.fr/wheatamix/) for financial support. We are grateful to Michel Burban, Pascal Duprix, Alain Fortineau, Laurent Gerard, Samuel Joseph and Francois Lecourt for technical assistance, to Frederic Suffert and Thierry Marcel for helpful discussions and advice, and to Bruno Andrieu, Christophe Gigot, Corinne Robert and the anonymous reviewers for their comments on the manuscript. We have special thoughts for Witho Anatinae. We also thank Jane Curtis for English corrections.	Brown JKM, 2015, FUNGAL GENET BIOL, V79, P33, DOI 10.1016/j.fgb.2015.04.017; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Calonnec A, 2013, EUR J PLANT PATHOL, V135, P479, DOI 10.1007/s10658-012-0111-5; Cevallos-Cevallos JM, 2012, J FOOD PROTECT, V75, P472, DOI 10.4315/0362-028X.JFP-11-399; Cowger C, 2002, PHYTOPATHOLOGY, V92, P617, DOI 10.1094/PHYTO.2002.92.6.617; de Vallavieille-Pope C, 2004, CR BIOL, V327, P611, DOI 10.1016/j.crvi.2003.11.014; de Vallavieille-Pope C, 2012, PLANT DIS, V96, P131, DOI 10.1094/PDIS-02-11-0078; Develey-Riviere MP, 2007, NEW PHYTOL, V175, P405, DOI 10.1111/j.1469-8137.2007.02130.x; Essah SYC, 2002, CAN J PLANT SCI, V82, P1; Fang Y, 2014, FIELD CROP RES, V156, P12, DOI 10.1016/j.fcr.2013.10.013; Finckh Maria R., 2006, P269, DOI 10.1007/1-4020-4581-6_10; Fones H, 2015, FUNGAL GENET BIOL, V79, P3, DOI 10.1016/j.fgb.2015.04.004; Fortineau A, 2012, DISPOSITIF COUPLE BA; Fournier C, 2003, ADEL WHEAT 3D ARCHIT, P54; Garin G, 2014, ANN BOT; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; Geagea L, 2000, AGR FOREST METEOROL, V101, P53, DOI 10.1016/S0168-1923(99)00155-0; Gigot C, 2013, PLANT PATHOL, V62, P1011, DOI 10.1111/ppa.12012; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Godin C, 2000, ANN FOREST SCI, V57, P413; Hiddink GA, 2010, SUSTAIN AGR REV, V4, P119, DOI 10.1007/978-90-481-8741-6_5; Jackson LF, 1997, FIELD CROP RES, V52, P261, DOI 10.1016/S0378-4290(97)00007-5; Leroux P, 2011, PEST MANAG SCI, V67, P44, DOI 10.1002/ps.2028; Lovell DJ, 1997, PLANT PATHOL, V46, P126, DOI 10.1046/j.1365-3059.1997.d01-206.x; Madden LV, 1997, CAN J PLANT PATHOL, V19, P225, DOI 10.1080/07060669709500557; Madden LV, 1997, PHYTOPATHOLOGY, V87, P828, DOI 10.1094/PHYTO.1997.87.8.828; McCartney H. A., 2006, P159; Newton AC, 2011, FIELD CROP RES, V123, P74, DOI 10.1016/j.fcr.2011.05.002; Orton ES, 2011, MOL PLANT PATHOL, V12, P413, DOI 10.1111/j.1364-3703.2010.00688.x; Pielaat A, 2002, ECOL MODEL, V151, P195, DOI 10.1016/S0304-3800(01)00484-7; Pradal C, 2008, FUNCT PLANT BIOL, V35, P751, DOI 10.1071/FP08084; Robert C, 2008, FUNCT PLANT BIOL, V35, P997, DOI 10.1071/FP08066; Saint-Jean S, 2006, AGR FOREST METEOROL, V141, P257, DOI 10.1016/j.agrformet.2006.10.009; Saint-Jean S, 2004, AGR FOREST METEOROL, V121, P183, DOI 10.1016/j.agrformet.2003.08.034; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoeny A, 2008, PLANT PATHOL, V57, P1073, DOI 10.1111/j.1365-3059.2008.01888.x; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Suffert F, 2013, PLANT PATHOL, V62, P1330, DOI 10.1111/ppa.12050; Team RDC, 2010, R LANG ENV STAT COMP; Tivoli B, 2013, EUR J PLANT PATHOL, V135, P471, DOI 10.1007/s10658-012-0066-6; Torriani SFF, 2015, FUNGAL GENET BIOL, V79, P8, DOI 10.1016/j.fgb.2015.04.010; ULBRICH CW, 1983, J CLIM APPL METEOROL, V22, P1764, DOI 10.1175/1520-0450(1983)022<1764:NVITAF>2.0.CO;2; Vidal T, 2017, AGR FOREST METEOROL, V246, P154, DOI 10.1016/j.agrformet.2017.06.014; WALKLATE PJ, 1989, PLANT PATHOL, V38, P56, DOI 10.1111/j.1365-3059.1989.tb01427.x; YANG XS, 1993, AGR FOREST METEOROL, V65, P1, DOI 10.1016/0168-1923(93)90035-G; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhu YY, 2005, PHYTOPATHOLOGY, V95, P433, DOI 10.1094/PHYTO-95-0433	47	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187788	10.1371/journal.pone.0187788	http://dx.doi.org/10.1371/journal.pone.0187788			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140990	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400030
J	Zhang, X; Xu, GH; Xie, J; Zhang, X				Zhang, Xin; Xu, Guanghua; Xie, Jun; Zhang, Xun			Brain response to luminance-based and motion-based stimulation using inter-modulation frequencies	PLOS ONE			English	Article							SSVEP-BCI; CORTEX	Steady state visual evoked potential (SSVEP)-based brain computer interface (BCI) has advantages of high information transfer rate (ITR), less electrodes and little training. So it has been widely investigated. However, the available stimulus frequencies are limited by brain responses. Simultaneous modulation of stimulus luminance is a novel method to resolve this problem. In this study, three experiments were devised to gain a deeper understanding of the brain response to the stimulation using inter-modulation frequencies. First, luminance-based stimulation using one to five inter-modulation frequencies was analyzed for the first time. The characteristics of the brain responses to the proposed stimulation were reported. Second, the motion-based stimulation with equal luminance using inter-modulation frequencies was also proposed for the first time. The response of the brain under these conditions were similar to that of luminance-based stimulation which can induce combination frequencies. And an elementary analysis was conducted to explain the reason of the occurrence of combination frequencies. Finally, the online test demonstrated the efficacy of our proposed two stimulation methods for BCI. The average ITRs reached 34.7836 bits/min and 39.2856 bits/min for luminance-based and motion-based stimulation respectively. This study demonstrated that the simultaneous modulation of stimulus luminance could extend to at least five frequencies to induce SSVEP and the brain response to the stimulus still maintained a certain positive correlation with luminance. And not only luminance-based stimulation, but also motion-based stimulation with equal luminance can elicit inter-modulation frequencies to effectively increase the number of targets for multi-class SSVEP.	[Zhang, Xin; Xu, Guanghua; Xie, Jun; Zhang, Xun] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China; [Xu, Guanghua] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Xu, GH (corresponding author), Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Shaanxi, Peoples R China.; Xu, GH (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian, Shaanxi, Peoples R China.	ghxu@mail.xjtu.edu.cn		Zhang, Xin/0000-0002-0827-6605	Integration Project of Major Research plan of the Natural Science Foundation of China [91420301]; science and technology plan project of Guangdong province [2015B020214001]; National Natural Science Foundation of China [51475360]	Integration Project of Major Research plan of the Natural Science Foundation of China; science and technology plan project of Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Integration Project of Major Research plan of the Natural Science Foundation of China (91420301), the National Natural Science Foundation of China (no. 51475360) and the science and technology plan project of Guangdong province under grant no. 2015B020214001. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; Belmonte M, 1998, COGNITIVE BRAIN RES, V6, P295, DOI 10.1016/S0926-6410(98)00007-X; Bromm B., 1989, PAIN, V39, P371; Chang MH, 2016, J NEUROSCI METH, V258, P104, DOI 10.1016/j.jneumeth.2015.11.001; Chang MH, 2014, CLIN NEUROPHYSIOL, V125, P1380, DOI 10.1016/j.clinph.2013.11.016; Chen XG, 2015, P NATL ACAD SCI USA, V112, pE6058, DOI 10.1073/pnas.1508080112; Chen XG, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066009; Chien YY, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa550d; Delon-Martin C, 2006, NEUROIMAGE, V31, P1567, DOI 10.1016/j.neuroimage.2006.02.013; Giani AS, 2012, NEUROIMAGE, V60, P1478, DOI 10.1016/j.neuroimage.2012.01.114; Hakvoort G, 2011, COMP PSDA CCA DETECT; Herrmann CS, 2001, EXP BRAIN RES, V137, P346, DOI 10.1007/s002210100682; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Mukesh TMS, 2006, PHYSIOL MEAS, V27, P61, DOI 10.1088/0967-3334/27/1/006; Muller SM, 2011, INT C IEEE ENG MED B; Ng KB, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036008; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Shyu KK, 2010, NEUROSCI LETT, V483, P28, DOI 10.1016/j.neulet.2010.07.043; Teng F, 2010, SE REG C 2010 OXF MS; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Volosyak I, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036020; Wang Y, 2006, IEEE T NEUR SYS REH, V14, P234, DOI 10.1109/TNSRE.2006.875576; Wang YT, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025018; Wu ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22801; Xiaogang C, 2017, J NEURAL ENG, V14; Xie J, 2011, PLOS ONE, V7; Yan Z, 2009, C INT C IEEE ENG MED; ZEMON V, 1984, BIOL CYBERN, V50, P401, DOI 10.1007/BF00335197; Zhang F, 2015, SHOCK VIB, V2015, P1, DOI DOI 10.2118/174384-MS	31	9	9	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188073	10.1371/journal.pone.0188073	http://dx.doi.org/10.1371/journal.pone.0188073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141030	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400054
J	Wu, CC; Chen, CH; Shete, S				Wu, Chih-Chieh; Chen, Chien-Hsiun; Shete, Sanjay			Assessing current temporal and space-time anomalies of disease incidence	PLOS ONE			English	Article							SURVEILLANCE DATA; PUBLIC-HEALTH; CLUSTERS; DENGUE; INFERENCE; ALGORITHM; OUTBREAKS; VALUES	Approaches used to early and accurately characterize epidemiologic patterns of disease incidence in a temporal and spatial series are becoming increasingly important. Cluster tests are generally designed for retrospective detection of epidemiologic anomalies in a temporal or space-time series. Timely identification of anomalies of disease or poisoning incidence during ongoing surveillance or an outbreak requires the use of sensitive statistical methods that recognize an incidence pattern at the time of occurrence. This report describes 2 novel analytical methods that focus on detecting anomalies of incidence at the time of occurrence in a temporal and space-time series. The first method describes the paucity of incidence at the time of occurrence in an ongoing surveillance and is designed to evaluate whether a decline in incidence occurs on the single current day or during the most recent few days. The second method provides an overall assessment of current clustering or paucity of incidence in a space-time series, allowing for several space regions. We illustrate the application of these methods using a subsample of a temporal series of data on the largest dengue outbreak in Taiwan in 2015 since World War II and demonstrate that they are useful to efficiently monitor incoming data for current clustering and paucity of incidence in a temporal and space-time series. In light of the recent global emergence and resurgence of Zika, dengue, and chikungunya infection, these approaching for detecting current anomalies of incidence in the ongoing surveillance of disease are particularly desired and needed.	[Wu, Chih-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Chen, Chien-Hsiun] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	National Cheng Kung University; Academia Sinica - Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Wu, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.	cc_wu@mail.ncku.edu.tw	Chen, Chien Hsiun/Q-3826-2018	Wu, Chih-Chieh/0000-0002-9846-4086	Taiwan Ministry of Science and Technology [MOST104-2118-M-0 06-006, 105-2118-M-006-008]; Academia Sinica Genomic Medicine Multicenter Study, Taiwan; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Taiwan Ministry of Science and Technology; Academia Sinica Genomic Medicine Multicenter Study, Taiwan(Academia Sinica - Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research presented in this manuscript was partially supported by the Taiwan Ministry of Science and Technology (https://www. most.gov.tw/en/public) grants MOST104-2118-M-0 06-006 and 105-2118-M-006-008 to C.C.W. The grant of the Academia Sinica Genomic Medicine Multicenter Study, Taiwan, to C.H.C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LANCET INFECT DIS; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; EDERER F, 1964, BIOMETRICS, V20, P626, DOI 10.2307/2528500; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Grimson RC, 2000, J TOXICOL-CLIN TOXIC, V38, P761, DOI 10.1081/CLT-100102389; GRIMSON RC, 1993, STAT MED, V12, P1773, DOI 10.1002/sim.4780121906; Grimson RC, 1996, STAT MED, V15, P851, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<851::AID-SIM255>3.0.CO;2-4; GRIMSON RC, 1992, STAT MED, V11, P761, DOI 10.1002/sim.4780110607; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HRYHORCZUK DO, 1992, J TOXICOL-CLIN TOXIC, V30, P459, DOI 10.3109/15563659209021560; Hutwagner LC, 1997, EMERG INFECT DIS, V3, P395, DOI 10.3201/eid0303.970322; JONES DR, 1982, INT J EPIDEMIOL, V11, P276, DOI 10.1093/ije/11.3.276; Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186; MANTEL N, 1976, AM J EPIDEMIOL, V104, P576, DOI 10.1093/oxfordjournals.aje.a112333; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408; Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Sonesson C, 2003, J R STAT SOC A STAT, V166, P5, DOI 10.1111/1467-985X.00256; THOMAS DC, 1985, AM J EPIDEMIOL, V122, P1080, DOI 10.1093/oxfordjournals.aje.a114189; WALLENSTEIN S, 1989, AM J EPIDEMIOL, V130, P1057, DOI 10.1093/oxfordjournals.aje.a115406; WALLENSTEIN S, 1987, STAT MED, V6, P197, DOI 10.1002/sim.4780060212; Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047; Wu CC, 2008, BIOMETRICAL J, V50, P86, DOI 10.1002/bimj.200610374; Wu CC, 2010, COMMUN STAT-SIMUL C, V39, P612, DOI 10.1080/03610910903528335	27	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188065	10.1371/journal.pone.0188065	http://dx.doi.org/10.1371/journal.pone.0188065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131869	Green Published, gold, Green Submitted			2022-12-27	WOS:000414997800044
J	Senapati, R; Nayak, B; Kar, SK; Dwibedi, B				Senapati, Rashmirani; Nayak, Bhagyalaxmi; Kar, Shantanu Kumar; Dwibedi, Bhagirathi			HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; HIGH-RISK; SOUTHERN CHINESE; MULTIPLE TYPES; COSTA-RICA; NEOPLASIA; WOMEN; PROTECTION; EFFICACY; CANCER	HPV is the major causative agent for cervical cancer. Study on the risk of cervical cancer associated with different hr-HPV genotypes would be useful for disease management and new vaccine strategy. With limited reports available, the present study aimed to investigate the pattern of HPV genotypes coinfections and risk of cervical carcinoma associated with them in Indian population. 15 HPV genotypes were detected by E6/E7 multiplex nested type-specific PCR in the HPV-positive cervical samples of 172 cervical cancer cases and 174 subjects with normal cytology. Association between the genotypes and cervical cancer was estimated by calculating the Odds ratio and 95% confidence interval. Risk of cervical carcinoma was associated with multiple genotypes excluding HPV16 (OR: 5.87; 95% CI-1.28-26-29; p=.02), multiple genotypes excluding HPV18 (OR = 2.5; 95% CI = 1.09-6.05; p=.03), multiple genotypes of alpha 9 species(OR = 5.3 95% CI = 1.14-24.03; p=.007), and multiple genotypes of alpha 7 species (OR = 2.5; 95% CI=.49-13.45; p=.2). Genotypes not targeted by quadrivalent vaccine types (OR = 2.94 95% CI = 1.48-5.80; p=.001) conferred 2.94 fold higher risk of cervical carcinoma. Cases those coinfected with phylogenetically related genotypes (OR = 2.29; 95% CI(.69-7.59) p=.17) were at 2.9 fold higher risk of invasive cervical carcinoma than those infected with other genotypes although it is not statistically significant. Whereas phylogenetically unrelated genotypes coinfection is negatively associated with cervical carcinoma (OR=.44 95% CI (.244-.8) p=.007) and it is statistically significant. Genotypes not targeted by 9-valent vaccines (OR=.40; 95% CI=.19-.85; p=.017) associated with lesser risk of cervical carcinoma as compared to other genotypes. Subjects infected with any HPV genotype/genotypes excluding HPV16 in association with HPV 18 (OR = 4.1; 95% CI = 1.81-9.25 P = <.001) were at 4.1 fold higher risk of developing invasive cervical carcinoma. In conclusion, the risk of development of cervical cancer is genotype specific and might be associated with type-specific interactions between the genotypes in multiple infections.	[Senapati, Rashmirani; Dwibedi, Bhagirathi] Reg Med Res Ctr ICMR, Viral Res & Diagnost Lab, Nalcosq, Bhubanewar, Odisha, India; [Nayak, Bhagyalaxmi] Acharya Hari Hara Reg Canc Ctr, Dept Gynecol Oncol, Cuttack, Odisha, India; [Kar, Shantanu Kumar] SOA Univ, IMS & SUM Hosp, Directorate Med Res, Bhubaneswar, Odisha, India	Siksha 'O' Anusandhan University	Dwibedi, B (corresponding author), Reg Med Res Ctr ICMR, Viral Res & Diagnost Lab, Nalcosq, Bhubanewar, Odisha, India.	bhagirathidwibedi@yahoo.com	Nayak, Bhagyalaxmi/AAB-2230-2021		Indian council of mrdical research, India [ICMR-80/780/2012-ECD-I]	Indian council of mrdical research, India	This work was supported by the Indian council of mrdical research, India, Grant no-ICMR-80/780/2012-ECD-I (www.icmr.nic.in). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chagas BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132570; Chan DPC, 2005, J INFECT DIS, V192, P1749, DOI 10.1086/497342; Chan PKS, 2007, J MED VIROL, V79, P970, DOI 10.1002/jmv.20805; Chan PKS, 2007, GYNECOL ONCOL, V105, P736, DOI 10.1016/j.ygyno.2007.02.013; Chan PKS, 2006, INT J CANCER, V118, P1430, DOI 10.1002/ijc.21528; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Chaturvedi AK, 2011, J INFECT DIS, V203, P910, DOI 10.1093/infdis/jiq139; Combita A, 2013, REV COLOMB CANCEROL, V17, P103, DOI 10.1016/S0123-9015(13)70012-X; Resende LSDA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-214; de Freitas AC, 2012, GYNECOL ONCOL, V126, P304, DOI 10.1016/j.ygyno.2012.03.047; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dickson EL, 2014, GYNECOL ONCOL, V133, P405, DOI 10.1016/j.ygyno.2014.03.552; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Hildesheim A, 2014, VACCINE, V32, P5087, DOI 10.1016/j.vaccine.2014.06.038; Kahn JA, 2012, PEDIATRICS, V130, pE249, DOI 10.1542/peds.2011-3587; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Luostarinen T, 1999, INT J CANCER, V80, P818, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;818::AID-IJC4&gt;3.0.CO;2-T; Mori S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-11; Munagala R, 2009, INT J ONCOL, V34, P263, DOI 10.3892/ijo_00000148; Orlando PA, 2012, J INFECT DIS, V205, P272, DOI 10.1093/infdis/jir717; Raychaudhuri S, 2012, ASIAN PAC J CANCER P, V13, P1093, DOI 10.7314/APJCP.2012.13.4.1093; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Silins I, 1999, J GEN VIROL, V80, P2931, DOI 10.1099/0022-1317-80-11-2931; Smith JF, 2007, HUM VACCINES, V3, P109, DOI 10.4161/hv.3.4.4058; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; Tao LX, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-1185, 10.1186/1471-2458-14-353]; Trottier H, 2006, CANCER EPIDEM BIOMAR, V15, P1274, DOI 10.1158/1055-9965.EPI-06-0129	30	25	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187844	10.1371/journal.pone.0187844	http://dx.doi.org/10.1371/journal.pone.0187844			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161285	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000022
J	Wells, CD; Sebens, KP				Wells, Christopher D.; Sebens, Kenneth P.			Individual marking of soft-bodied subtidal invertebrates in situ - A novel staining technique applied to the giant plumose anemone Metridium farcimen (Tilesius, 1809)	PLOS ONE			English	Article							ANTHOPLEURA-ELEGANTISSIMA BRANDT; TIDAL SEA-ANEMONES; XANTHOGRAMMICA BRANDT; METHYLENE-BLUE; BODY SIZE; DYE; REPRODUCTION; TADPOLES; HABITAT	The ability to recognize individuals and track growth over time is crucial to population dynamics research as well as studies of animal behavior. Invertebrates are particularly difficult to track as they often molt, have regenerative capabilities, or lack hard parts to attach markers. We tested, in laboratory and field studies, a new way of marking sea anemones (order Actiniaria) by injection of three vital stains (i.e., neutral red, methylene blue, and fluorescein). Neutral red and methylene blue did not affect growth or survival, but fluorescein was lethal at high concentrations. Marked individuals could be identified up to seven months after injection with neutral red, six weeks with methylene blue, and three days with low concentrations of fluorescein. Neutral red could be used for long-term monitoring of growth and survival in the field, and in combination with methylene blue could be used to mark individuals in distinguishable patterns for short-term studies such as examining predator-prey interactions, movement of individuals, and recruitment survival.	[Wells, Christopher D.; Sebens, Kenneth P.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Wells, Christopher D.; Sebens, Kenneth P.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Sebens, Kenneth P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington; University of Washington Seattle	Wells, CD (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.; Wells, CD (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	cdwells@uw.edu	Wells, Christopher/ABH-6827-2020	Wells, Christopher/0000-0002-5945-6171	Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department; Richard and Megumi Strathmann Fellowship from Friday Harbor Laboratory; Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory; American Museum of Natural History	Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department; Richard and Megumi Strathmann Fellowship from Friday Harbor Laboratory; Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory; American Museum of Natural History	This research was funded by the Robert T. Paine Experimental and Field Ecology Award from the University of Washington Biology Department (https/www.biology.washington.edu/programs/graduate/awards-and-fellowships) awarded to CDW, the Richard and Megumi Strathmann Fellowship and the Sebens Endowed Student Support Fellowship from Friday Harbor Laboratory (http://depts.washington.edu/fhl/studentFellowships.html) awarded to CDW, and the Lerner-Gray Grant for Marine Research from the American Museum of Natural History (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics -and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships#grants) awarded to CDW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOSA P, 1970, ENTOMOL EXP APPL, V13, P293, DOI 10.1007/BF00334315; Carlson BE, 2013, ETHOLOGY, V119, P167, DOI 10.1111/eth.12050; Caswell, 2000, MATRIX POPULATION MO; Drolet D, 2006, J CRUSTACEAN BIOL, V26, P540, DOI 10.1651/S-2717.1; Eerkes-Medrano D, 2015, INVERTEBR BIOL, V134, P1, DOI 10.1111/ivb.12072; Evans TA, 2000, SOCIOBIOLOGY, V36, P517; FEDER HOWARD M., 1955, CALIFORNIA FISH AND GAME, V41, P245; GRANICK MS, 1987, PLAST RECONSTR SURG, V79, P573, DOI 10.1097/00006534-198704000-00011; Hale JR, 2012, J SHELLFISH RES, V31, P789, DOI 10.2983/035.031.0324; HOWARD RK, 1985, MAR ECOL PROG SER, V22, P163, DOI 10.3354/meps022163; Jung RE, 2002, J HERPETOL, V36, P465, DOI 10.1670/0022-1511(2002)036[0465:AEOPIA]2.0.CO;2; KITCHELL JF, 1977, J FISH RES BOARD CAN, V34, P1922, DOI 10.1139/f77-258; Kraus Y, 2007, CURR BIOL, V17, pR874, DOI 10.1016/j.cub.2007.08.017; Kurth J, 2007, J N AM BENTHOL SOC, V26, P253, DOI 10.1899/0887-3593(2007)26[253:PTIEOF]2.0.CO;2; Nishizaki MT, 2015, J THERM BIOL, V54, P37, DOI 10.1016/j.jtherbio.2015.02.002; SEBENS KP, 1981, J EXP MAR BIOL ECOL, V54, P225, DOI 10.1016/0022-0981(81)90159-3; SEBENS KP, 1982, J EXP MAR BIOL ECOL, V59, P103, DOI 10.1016/0022-0981(82)90110-1; SEBENS KP, 1980, BIOL BULL-US, V158, P370, DOI 10.2307/1540863; Sebens KP., 1977, THESIS; Sebens KP, 1976, CAN J FISH AQUAT SCI, V33, P1407; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; TRAVIS J, 1981, COPEIA, P193, DOI 10.2307/1444054; Varghese P, 2008, BREAST J, V14, P61, DOI 10.1111/j.1524-4741.2007.00519.x; Voltzow J, 2015, J MORPHOL, V276, P787, DOI 10.1002/jmor.20379; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Wells C.L., 2013, THESIS	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188263	10.1371/journal.pone.0188263	http://dx.doi.org/10.1371/journal.pone.0188263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161292	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000038
J	Hintze, C; Morgen, TO; Drescher, M				Hintze, Christian; Morgen, Tobias O.; Drescher, Malte			Heavy-atom effect on optically excited triplet state kinetics	PLOS ONE			English	Article							DYNAMIC NUCLEAR-POLARIZATION; NANOMETER DISTANCE MEASUREMENTS; ELECTRON-SPIN ECHO; PROTON POLARIZATION; ORGANIC-MOLECULES; ROOM-TEMPERATURE; DOUBLE-RESONANCE; SPECTROSCOPY; CRYSTALS; ANTHRACENES	In several fields of research, like e.g. photosensitization, photovoltaics, organic electrolumi-nescent devices, dynamic nuclear polarization, or pulsed dipolar electron paramagnetic resonance spectroscopy, triplet state kinetics play an important role. It is therefore desirable to tailor the kinetics of photoexcited triplet states, e.g. by exploiting the intramolecular heavyatom effect, and to determine the respective kinetic parameters. In this work, we set out to systematically investigate the photoexcited triplet state kinetics of a series of haloanthracenes by time-resolved electron paramagnetic resonance spectroscopy in combination with synchronized laser excitation. For this purpose, a procedure to simulate time traces by solving the differential equation system governing the triplet kinetics numerically is developed. This way, spin lattice relaxation rates and zero-field triplet life times are obtained concurrently by a global fit to experimental data measured at three different cryogenic temperatures.	[Hintze, Christian; Morgen, Tobias O.; Drescher, Malte] Univ Konstanz, Fachbereich Chem, Constance, Germany	University of Konstanz	Drescher, M (corresponding author), Univ Konstanz, Fachbereich Chem, Constance, Germany.	malte.drescher@uni-konstanz.de		Morgen, Tobias/0000-0002-3866-1053	Deutsche Forschungsgemeinschaft [DR 743/10-1, SPP 1601]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (DR 743/10-1 and SPP 1601, dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAGAM A, 1978, REP PROG PHYS, V41, P395, DOI 10.1088/0034-4885/41/3/002; Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BECKER HD, 1993, CHEM REV, V93, P145, DOI 10.1021/cr00017a008; Bouas-Laurent H, 2000, CHEM SOC REV, V29, P43, DOI 10.1039/a801821i; BROWN R, 1994, J CHEM PHYS, V100, P7182, DOI 10.1063/1.466916; Carbonera D, 2009, PHOTOSYNTH RES, V102, P403, DOI 10.1007/s11120-009-9407-5; CLARKE RH, 1971, J CHEM PHYS, V54, P2962, DOI 10.1063/1.1675279; Cowan DO, 1978, ELEMENTS ORGANIC PHO, P19; Di Valentin M, 2016, CHEM-EUR J, V22, P17204, DOI 10.1002/chem.201603666; Di Valentin M, 2016, BBA-BIOENERGETICS, V1857, P1909, DOI 10.1016/j.bbabio.2016.09.008; Di Valentin M, 2014, J AM CHEM SOC, V136, P6582, DOI 10.1021/ja502615n; Eichhorn TR, 2014, NUCL INSTRUM METH A, V754, P10, DOI 10.1016/j.nima.2014.03.047; ELSAYED MA, 1975, ANNU REV PHYS CHEM, V26, P235, DOI 10.1146/annurev.pc.26.100175.001315; Grivet JP, 1969, CHEM PHYS LETT, V4, P104, DOI 10.1016/0009-2614(69)85082-7; Hintze C, 2017, CHEMPHYSCHEM, V18, P6, DOI 10.1002/cphc.201600868; Hintze C, 2016, J PHYS CHEM LETT, V7, P2204, DOI 10.1021/acs.jpclett.6b00765; HUPPERT D, 1982, J CHEM PHYS, V77, P1214, DOI 10.1063/1.443989; Montalti M., 2006, HDB PHOTOCHEMISTRY; SEIDEL H, 1984, CHEM PHYS LETT, V104, P552, DOI 10.1016/0009-2614(84)80026-3; Singh-Rachford TN, 2010, COORDIN CHEM REV, V254, P2560, DOI 10.1016/j.ccr.2010.01.003; SLOOP DJ, 1981, J CHEM PHYS, V75, P3746, DOI 10.1063/1.442520; Solovyov KN, 2005, PHYS-USP+, V48, P231, DOI 10.1070/PU2005v048n03ABEH001761; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Stoll S, 2014, MULTIFREQUENCY ELECTRON PARAMAGNETIC RESONANCE: DATA AND TECHNIQUES, P69; Takeda K, 2004, J PHYS SOC JPN, V73, P2313, DOI 10.1143/JPSJ.73.2313; Thompson NJ, 2014, NAT MATER, V13, P1039, DOI [10.1038/NMAT4097, 10.1038/nmat4097]; YU HL, 1984, J CHEM PHYS, V80, P102, DOI 10.1063/1.446491; Zhao JZ, 2013, CHEM SOC REV, V42, P5323, DOI 10.1039/c3cs35531d	29	3	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0184239	10.1371/journal.pone.0184239	http://dx.doi.org/10.1371/journal.pone.0184239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155822	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700001
J	Liu, CP; Zhang, X; Tan, QL; Xu, WX; Zhou, CY; Luo, M; Li, X; Huang, RY; Zeng, X				Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing			NF-kappa B pathways are involved in M1 polarization of RAW 264.7 macrophage by polyporus polysaccharide in the tumor microenvironment	PLOS ONE			English	Article							CELLS INDUCE; CANCER; PHENOTYPE; FRIES	Bladder cancer is one of the most malignant tumors closely associated with macrophages. Polyporus polysaccharide (PPS) has shown excellent efficacy in treating bladder cancer with minimal side effects. However, the molecular mechanisms underlying the effects of PPS in inhibiting bladder cancer remain unclear. In this study, we used macrophages cultured alone or with T24 human bladder cancer cell culture supernatant as study models. We found that PPS enhanced the activities of IFN-gamma-stimulated RAW 264.7 macrophages, as shown by the release of inducible nitric oxide synthase (INOS), secretion of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, phagocytosis activity, as well as expression of M1 phenotype indicators, such as CD40, CD284 and CD86. PPS acted upstream in activation cascade of nuclear factor (NF)-kappa B signaling pathways by interfering with I.B phosphorylation. In addition, PPS regulated NF-kappa B (P65) signaling by interfering with Toll-like receptor (TLR)-4, INOS and cyclooxygenase (COX)-2. Our results indicate that PPS activates macrophages through TLR4/NF-kappa B signaling pathways.	[Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Integrated Chinese Med Immunizat, Guangzhou, Guangdong, Peoples R China; [Liu, Chun-Ping; Zhang, Xian; Tan, Qing-Long; Xu, Wen-Xing; Zhou, Chang-Yuan; Luo, Min; Li, Xiong; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Sect Rheumatol Res, Guangzhou, Guangdong, Peoples R China; [Liu, Chun-Ping; Huang, Run-Yue; Zeng, Xing] Guangzhou Univ Chinese Med, Discipline Integrated Chinese & Western Med, Guangzhou, Guangdong, Peoples R China; [Huang, Run-Yue] Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Integrated Chinese Med Immunizat, Guangzhou, Guangdong, Peoples R China.; Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Sect Rheumatol Res, Guangzhou, Guangdong, Peoples R China.; Huang, RY; Zeng, X (corresponding author), Guangzhou Univ Chinese Med, Discipline Integrated Chinese & Western Med, Guangzhou, Guangdong, Peoples R China.; Huang, RY (corresponding author), Guangdong Prov Key Lab Clin Res Tradit Chinese Me, Guangzhou, Guangdong, Peoples R China.	ry_huang@hotmail.com; zengxing-china@163.com			National Natural Science Foundation of China [81573769]; Natural Science Foundation of Guangdong Province [2014A03031345]; Guangzhou University of Chinese Medicine [A1-AFD018161Z1511]; Macao University of Science and Technology [MUST-SKL-2016-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou University of Chinese Medicine; Macao University of Science and Technology	This study was supported by the National Natural Science Foundation of China (No. 81573769), the Natural Science Foundation of Guangdong Province (No.2014A03031345), and the grant from Guangzhou University of Chinese Medicine (A1-AFD018161Z1511) as well as Macao University of Science and Technology (MUST-SKL-2016-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 81573769), the Natural Science Foundation of Guangdong Province (No.2014A03031345), and the grant from Guangzhou University of Chinese Medicine (A1-AFD018161Z1511) as well as Macao University of Science and Technology (MUST-SKL-2016-08).	Ayari C, 2009, EUR UROL, V55, P1386, DOI 10.1016/j.eururo.2009.01.040; Beatty GL, 2017, EXPERT REV ANTICANC, V17, P175, DOI 10.1080/14737140.2017.1270208; Borchers AT, 2008, EXP BIOL MED, V233, P259, DOI 10.3181/0708-MR-227; Brandau S, 2009, J UROLOGY, V181, P1532, DOI 10.1016/j.juro.2009.01.066; Dai H, 2012, GLYCOBIOLOGY, V22, P1673, DOI 10.1093/glycob/cws099; Davis MJ, 2013, MBIO, V4, DOI 10.1128/mBio.00264-13; Deng XC, 2015, INT J MOL MED, V36, P449, DOI 10.3892/ijmm.2015.2230; Furudate S, 2016, EXP DERMATOL, V25, P107, DOI 10.1111/exd.12873; Galani V, 2017, CLIN EXP MED, V17, P281, DOI 10.1007/s10238-016-0432-3; [江泽波 Jiang Zebo], 2015, [中国免疫学杂志, Chinese Journal of Immunology], V31, P1049; Pedraza-Brindis EJ, 2016, CELL IMMUNOL, V310, P42, DOI 10.1016/j.cellimm.2016.07.001; Kalathil SG, 2016, CANCER IMMUNOL IMMUN, V65, P813, DOI 10.1007/s00262-016-1810-0; Kim KN, 2016, CHEM-BIOL INTERACT, V258, P108, DOI 10.1016/j.cbi.2016.08.022; Klopfleisch R, 2016, ACTA BIOMATER, V43, P3, DOI 10.1016/j.actbio.2016.07.003; Kolodziej A, 2016, CENT EUR J UROL, V69, P150, DOI 10.5173/ceju.2016.780; Lee JS, 2015, CARBOHYD POLYM, V120, P29, DOI 10.1016/j.carbpol.2014.11.059; Li CaiXia, 2011, Chinese Journal of Immunology, V27, P514; Li XQ, 2011, J ETHNOPHARMACOL, V135, P1, DOI 10.1016/j.jep.2010.06.028; Li XQ, 2010, CELL IMMUNOL, V265, P50, DOI 10.1016/j.cellimm.2010.07.002; Lin QQ, 2017, LIFE SCI, V170, P100, DOI 10.1016/j.lfs.2016.11.026; Liu CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054841; Liu XX, 2016, INFLAMMATION, V39, P1421, DOI 10.1007/s10753-016-0374-7; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mao YM, 2013, CANCER RES, V73, P3877, DOI 10.1158/0008-5472.CAN-12-4115; Price LA, 2010, FITOTERAPIA, V81, P914, DOI 10.1016/j.fitote.2010.06.002; Rhee I, 2016, ARCH PHARM RES, V39, P1588, DOI 10.1007/s12272-016-0820-y; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep25595; Sun YX, 2009, INT J BIOL MACROMOL, V44, P14, DOI 10.1016/j.ijbiomac.2008.09.010; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang M, 2017, CARBOHYD POLYM, V156, P390, DOI 10.1016/j.carbpol.2016.09.033; Xu XL, 2014, INFLAMMATION, V37, P956, DOI 10.1007/s10753-014-9816-2; Zeng X, 2010, CHIN J CELL MOL IMMU, V26, P440; Zhang GW, 2011, AM J CHINESE MED, V39, P135, DOI 10.1142/S0192415X11008701; Zhang GW, 2010, J ETHNOPHARMACOL, V128, P433, DOI 10.1016/j.jep.2010.01.032; Zhao YY, 2013, J ETHNOPHARMACOL, V149, P35, DOI 10.1016/j.jep.2013.06.031	36	70	74	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188317	10.1371/journal.pone.0188317	http://dx.doi.org/10.1371/journal.pone.0188317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155869	gold, Green Published, Green Submitted			2022-12-27	WOS:000415756700045
J	Montoliu-Gaya, L; Mulder, SD; Veerhuis, R; Villegas, S				Montoliu-Gaya, Laia; Mulder, Sandra D.; Veerhuis, Robert; Villegas, Sandra			Effects of an A beta-antibody fragment on A beta aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides	PLOS ONE			English	Article							AMYLOID-BETA; ALZHEIMERS-DISEASE; FIBRIL FORMATION; 3XTG-AD MICE; MOUSE MODEL; IN-VIVO; MECHANISMS; CLEARANCE; TOXICITY; A-BETA-1-42	A beta-Immunotherapy has long been studied in the treatment of Alzheimer's disease (AD), but not how other molecules involved in the disease can affect antibody performance. We previously designed an antibody fragment, scFv-h3D6, and showed that it precludes A beta-induced cytotoxicity by withdrawing A beta oligomers from the amyloid pathway towards a non-toxic, worm-like pathway. ScFv-h3D6 was effective at the behavioral, cellular, and molecular levels in the 3xTg-AD mouse model. Because scFv-h3D6 treatment restored apolipoprotein E (apoE) and J (apoJ) concentrations to non-pathological values, and A beta internalization by glial cells was found to be decreased in the presence of these apolipoproteins, we now aimed to test the influence of scFv-h3D6 on A beta aggregation and cellular uptake by primary human astrocytes in the presence of therapeutic apoE and apoJ mimetic peptides (MPs). Firstly, we demonstrated by CD and FTIR that the molecules used in this work were well folded. Next, interactions between apoE or apoJ-MP, scFv-h3D6 and A beta were studied by CD. The conformational change induced by the interaction of A beta with apoE-MP was much bigger than the induced with apoJ-MP, in line with the observed formation of protective worm-like fibrils by the scFv-h3D6/A beta complex in the presence of apoJ-MP, but not of apoE-MP. ScFv-h3D6, apoJ-MP, and apoE-MP to a different extent reduced A beta uptake by astrocytes, and apoE-MP partially interfered with the dramatic reduction by scFv-h3D6 while apoJ-MP had no effect on scFv-h3D6 action. As sustained A beta uptake by astrocytes may impair their normal functions, and ultimately neuronal viability, this work shows another beneficence of scFv-h3D6 treatment, which is not further improved by the use of apoE or apoJ mimetic peptides.	[Montoliu-Gaya, Laia; Villegas, Sandra] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, Barcelona, Spain; [Mulder, Sandra D.; Veerhuis, Robert] Vrije Univ Amsterdam, Clin Chem Dept, Med Ctr, Amsterdam, Netherlands; [Veerhuis, Robert] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat Dept, Med Ctr, Amsterdam, Netherlands	Autonomous University of Barcelona; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Villegas, S (corresponding author), Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim & Biol Mol, Barcelona, Spain.; Veerhuis, R (corresponding author), Vrije Univ Amsterdam, Clin Chem Dept, Med Ctr, Amsterdam, Netherlands.; Veerhuis, R (corresponding author), Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat Dept, Med Ctr, Amsterdam, Netherlands.	R.Veerhuis@vumc.nl; Sandra.Villegas@uab.cat	Villegas, Sandra/ABF-8206-2021; Villegas, Sandra/D-8789-2011; Mulder, Sandra D/L-5198-2013	Villegas, Sandra/0000-0001-8644-4304; Villegas, Sandra/0000-0001-8644-4304; 	Institute de Salud Carlos III [FIS-PI113-01330]; Generalitat de Catalunya [2014-PROD00032]; FEDER; Stichting Dioraphte [VSM 10030200, 14041401]; PIF-UAB; EMBO [ASTF 36-2016]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); FEDER(European Commission); Stichting Dioraphte; PIF-UAB; EMBO(European Molecular Biology Organization (EMBO))	This work was supported by Institute de Salud Carlos III [FIS-PI113-01330] and Generalitat de Catalunya [2014-PROD00032] to SV, both co-funded by FEDER, and Stichting Dioraphte [VSM 10030200 and 14041401] to RV, PIF-UAB student grant (LMG) and EMBO short-term fellowship (ASTF 36-2016) to LMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacskai BJ, 2002, J NEUROSCI, V22, P7873; Benilova I, 2012, NAT NEUROSCI, P349; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Bruggink KA, 2012, J ALZHEIMERS DIS, V28, P735, DOI 10.3233/JAD-2011-111421; Calero M, 1999, BIOCHEM J, V344, P375, DOI 10.1042/0264-6021:3440375; Cascella R, 2013, BBA-MOL BASIS DIS, V1832, P1217, DOI 10.1016/j.bbadis.2013.04.012; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; CHOIMIURA NH, 1992, ACTA NEUROPATHOL, V83, P260, DOI 10.1007/BF00296787; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Datta G, 2010, ATHEROSCLEROSIS, V208, P134, DOI 10.1016/j.atherosclerosis.2009.07.019; Davies DS, 2016, BRAIN PATHOL; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Dickson DW, 1997, J NEUROPATH EXP NEUR, V56, P321, DOI 10.1097/00005072-199704000-00001; Esquerda-Canals G, 2013, MABS-AUSTIN, V5, P660, DOI 10.4161/mabs.25428; Fu W, 2015, J BIOL CHEM, V290, P12504, DOI 10.1074/jbc.M114.618157; Garwood CJ, 2016, NEUROPATHOL APPL NEU; GHISO J, 1993, BIOCHEM J, V293, P27, DOI 10.1042/bj2930027; Gimenez-Llort L, 2013, MABS-AUSTIN, V5, P665, DOI 10.4161/mabs.25424; Handattu SP, 2013, J ALZHEIMERS DIS, V36, P335, DOI 10.3233/JAD-122377; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 2009, J NEUROCHEM, V110, P1129, DOI 10.1111/j.1471-4159.2009.06181.x; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kline A, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt135; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Magalhaes J, 2011, J NEUROPATH EXP NEUR, V70, P1097, DOI 10.1097/NEN.0b013e31823a44f4; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marin-Argany M, 2011, BIOCHEM J, V437, P25, DOI 10.1042/BJ20101712; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mishra VK, 2011, BBA-BIOMEMBRANES, V1808, P498, DOI 10.1016/j.bbamem.2010.10.011; Montoliu-Gaya L, 2017, PROTEIN SCI; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Naiki H, 1998, BIOCHEMISTRY-US, V37, P17882, DOI 10.1021/bi980550y; Navab M, 2005, ARTERIOSCL THROM VAS, V25, P1932, DOI 10.1161/01.ATV.0000174589.70190.e2; Navab M, 2008, TRENDS CARDIOVAS MED, V18, P61, DOI 10.1016/j.tcm.2007.12.006; Nayyar G, 2010, ATHEROSCLEROSIS, V213, P449, DOI 10.1016/j.atherosclerosis.2010.09.030; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Nielsen HM, 2009, GLIA, V57, P978, DOI 10.1002/glia.20822; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; Rivera-Hernandez G, 2013, MABS-AUSTIN, V5, P678, DOI 10.4161/mabs.25382; Rodriguez JJ, 2016, CURR ALZHEIMER RES, V13, P343, DOI 10.2174/1567205013666160229112911; Ryan TM, 2013, PEERJ, V1, DOI 10.7717/peerj.73; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Selkoe D J., 2008, BIOCH MOL BIOL AMYLO, P245; Sharifov OF, 2011, AM J CARDIOVASC DRUG, V11, P371, DOI 10.2165/11594190-000000000-00000; Skerrett R, 2015, J BIOL CHEM, V290, P21591, DOI 10.1074/jbc.M115.652008; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sollvander S, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0098-z; Thal DR, 2012, EXP NEUROL, V236, P1, DOI 10.1016/j.expneurol.2012.04.021; Veerhuis R, 2005, CNS NEUROL DISORD-DR, V4, P235, DOI 10.2174/1568007054038184; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Winkler K, 1999, J LIPID RES, V40, P447; Wood SJ, 1996, BIOCHEMISTRY-US, V35, P12623, DOI 10.1021/bi961074j; Wood SJ, 1996, CHEM BIOL, V3, P949, DOI 10.1016/S1074-5521(96)90183-0; Zhang ZG, 2015, ARCH IMMUNOL THER EX, V63, P333, DOI 10.1007/s00005-015-0351-0	60	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188191	10.1371/journal.pone.0188191	http://dx.doi.org/10.1371/journal.pone.0188191			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155887	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700034
J	Nakamura, Y; Sugano, A; Ohta, M; Takaoka, Y				Nakamura, Yutaka; Sugano, Aki; Ohta, Mika; Takaoka, Yutaka			Docking analysis and the possibility of prediction efficacy for an anti-IL-13 biopharmaceutical treatment with tralokinumab and lebrikizumab for bronchial asthma	PLOS ONE			English	Article							TO-SEVERE ASTHMA; GENETIC-VARIANTS; DOUBLE-BLIND; INHALED CORTICOSTEROIDS; UNCONTROLLED ASTHMA; IL-13; SAFETY; IL13; PERIOSTIN; CHILDREN	Interleukin-13 (IL-13) is associated with allergic airway inflammation and airway remodeling. Our group found a variant with a single nucleotide polymorphism in the IL13 gene at position + 2044G>A (rs20541) that was expected to result in the non-conservative replacement of a positively charged arginine (R) with a neutral glutamine (Q) at position 144. IL-13Q144 was associated with augmented allergic airway inflammation and bronchial asthma remodeling. There is some indication that anti-IL-13 monoclonal antibodies can demonstrate a positive effect on the clinical course of refractory asthmatic patients. To date, the binding stability of these agents for IL-13Q144 is unknown. The objective of this study was to investigate the prediction efficacy of the anti-IL-13 monoclonal antibodies tralokinumab and lebrikizumab in asthmatic patients with IL-13R144 and IL-13Q144. The three-dimensional (3-D) structure of tralokinumab was obtained from the Protein Data Bank (PDB ID: 5L6Y), and the complete 3-D structure of lebrikizumab was built through homology modeling. For the binding stability analysis, we performed and analyzed docking simulations of IL-13 with tralokinumab or lebrikizumab. The tralokinumab and lebrikizumab structures changed after binding to IL-13 to facilitate binding with IL-13Q144. The stability analysis with tralokinumab and lebrikizumab demonstrated that IL-13Q144 was more stable than IL-13R144 for both the Rosetta energy score and for the free energy of binding. IL-13Q144 might be a promising predictor of responsiveness to tralokinumab and lebrikizumab treatment for bronchial asthma.	[Nakamura, Yutaka] Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Sugano, Aki; Ohta, Mika; Takaoka, Yutaka] Kobe Univ, Grad Sch Med, Div Med Informat & Bioinformat, Kobe, Hyogo, Japan	Nippon Medical School; Kobe University	Nakamura, Y (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan.	ICB75097@nifty.com	Nakamura, Yutaka/AAE-1546-2019	Nakamura, Yutaka/0000-0001-8717-1475				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrews AL, 2007, J ALLERGY CLIN IMMUN, V120, P91, DOI 10.1016/j.jaci.2007.04.026; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brightling CE, 2015, LANCET RESP MED, V3, P692, DOI 10.1016/S2213-2600(15)00197-6; Corren J, 2011, NEW ENGL J MED, V365, P1088, DOI 10.1056/NEJMoa1106469; Danese S, 2015, GUT, V64, P243, DOI 10.1136/gutjnl-2014-308004; Davies DE, 2003, J ALLERGY CLIN IMMUN, V111, P215, DOI 10.1067/mai.2003.128; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Hanania NA, 2016, LANCET RESP MED, V4, P781, DOI 10.1016/S2213-2600(16)30265-X; Hanania NA, 2015, THORAX, V70, P748, DOI 10.1136/thoraxjnl-2014-206719; He JQ, 2003, GENES IMMUN, V4, P385, DOI 10.1038/sj.gene.6363985; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kanemitsu Y, 2013, J ALLERGY CLIN IMMUN, V132, P305, DOI 10.1016/j.jaci.2013.04.050; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu X, 2000, J ALLERGY CLIN IMMUN, V106, P167, DOI 10.1067/mai.2000.107935; Luttmann W, 1996, J IMMUNOL, V157, P1678; Murray LA, 2014, AM J RESP CELL MOL, V50, P985, DOI 10.1165/rcmb.2013-0342OC; Nagashima Hiromi, 2011, Allergology International, V60, P291, DOI 10.2332/allergolint.10-OA-0259; Nakamura Y, 2016, CLIN EXP ALLERGY, V46, P1152, DOI 10.1111/cea.12710; Nakamura Y, 2015, ALLERGOL INT, V64, P209, DOI 10.1016/j.alit.2015.01.001; Noonan M, 2013, J ALLERGY CLIN IMMUN, V132, P567, DOI 10.1016/j.jaci.2013.03.051; Ogasawara M, 2016, CANCER CHEMOTH PHARM, V77, P1019, DOI 10.1007/s00280-016-3021-y; Piper E, 2013, EUR RESPIR J, V41, P330, DOI 10.1183/09031936.00223411; Richter A, 2001, AM J RESP CELL MOL, V25, P385, DOI 10.1165/ajrcmb.25.3.4437; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Schwiebert LA, 1996, J ALLERGY CLIN IMMUN, V97, P143, DOI 10.1016/S0091-6749(96)80214-4; Shiobara T, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0342-7; Ultsch M, 2013, J MOL BIOL, V425, P1330, DOI 10.1016/j.jmb.2013.01.024	33	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188407	10.1371/journal.pone.0188407	http://dx.doi.org/10.1371/journal.pone.0188407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155876	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700056
J	Mitra, A; Snyder, AZ; Tagliazucchi, E; Laufs, H; Elison, J; Emerson, RW; Shen, MD; Wolff, JJ; Botteron, KN; Dager, S; Estes, AM; Evans, A; Gerig, G; Hazlett, HC; Paterson, SJ; Schultz, RT; Styner, MA; Zwaigenbaum, L; Schlaggar, BL; Piven, J; Pruett, JR; Raichle, M				Mitra, Anish; Snyder, Abraham Z.; Tagliazucchi, Enzo; Laufs, Helmut; Elison, Jed; Emerson, Robert W.; Shen, Mark D.; Wolff, Jason J.; Botteron, Kelly N.; Dager, Stephen; Estes, Annette M.; Evans, Alan; Gerig, Guido; Hazlett, Heather C.; Paterson, Sarah J.; Schultz, Robert T.; Styner, Martin A.; Zwaigenbaum, Lonnie; Schlaggar, Bradley L.; Piven, Joseph; Pruett, John R., Jr.; Raichle, Marcus		IBIS Network	Resting-state fMRI in sleeping infants more closely resembles adult sleep than adult wakefulness	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; SLOW-WAVE SLEEP; FUNCTIONAL CONNECTIVITY; ATTENTION NETWORKS; PRETERM INFANTS; BRAIN ACTIVITY; DEEP SLEEP; CHILDHOOD; EMERGENCE; GRADIENT	Resting state functional magnetic resonance imaging (rs-fMRI) in infants enables important studies of functional brain organization early in human development. However, rs-fMRI in infants has universally been obtained during sleep to reduce participant motion artifact, raising the question of whether differences in functional organization between awake adults and sleeping infants that are commonly attributed to development may instead derive, at least in part, from sleep. This question is especially important as rs-fMRI differences in adult wake vs. sleep are well documented. To investigate this question, we compared functional connectivity and BOLD signal propagation patterns in 6, 12, and 24 month old sleeping infants with patterns in adult wakefulness and non-REM sleep. We find that important functional connectivity features seen during infant sleep closely resemble those seen during adult sleep, including reduced default mode network functional connectivity. However, we also find differences between infant and adult sleep, especially in thalamic BOLD signal propagation patterns. These findings highlight the importance of considering sleep state when drawing developmental inferences in infant rs-fMRI.	[Mitra, Anish; Snyder, Abraham Z.; Botteron, Kelly N.; Raichle, Marcus] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Snyder, Abraham Z.; Schlaggar, Bradley L.; Raichle, Marcus] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Tagliazucchi, Enzo] Univ Buenos Aires, Dept Fis, Buenos Aires, DF, Argentina; [Laufs, Helmut] Christian Albrechts Univ Kiel, Dept Neurol, Kiel, Germany; [Elison, Jed; Wolff, Jason J.] Univ Minnesota, Inst Child Dev, 51 E River Rd, Minneapolis, MN 55455 USA; [Emerson, Robert W.; Shen, Mark D.; Hazlett, Heather C.; Styner, Martin A.; Piven, Joseph] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Dager, Stephen] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Estes, Annette M.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Evans, Alan] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Gerig, Guido] NYU, Dept Psychiat, 550 1St Ave, New York, NY 10016 USA; [Paterson, Sarah J.; Schultz, Robert T.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Zwaigenbaum, Lonnie; Schlaggar, Bradley L.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Pruett, John R., Jr.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); University of Buenos Aires; University of Kiel; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; McGill University; New York University; University of Pennsylvania; University of Alberta; Washington University (WUSTL)	Mitra, A (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	anishmmitra@gmail.com	Collins, D. Louis/ABD-7708-2021; Schlaggar, Bradley/AAZ-4153-2020; Styner, Martin/AAS-9949-2020; Laufs, Helmut/I-8562-2014; Evans, Alan C/B-2373-2013	Collins, D. Louis/0000-0002-8432-7021; Styner, Martin/0000-0002-8747-5118; Laufs, Helmut/0000-0003-0030-2781; Evans, Alan C/0000-0003-3841-6098; Gerig, Guido/0000-0002-9547-6233; Mitra, Anish/0000-0002-3362-2274; Shen, Mark D./0000-0002-1190-7981	National Institute of Health [NS080675, F30MH106253, R01MH093510, R01HD055741, K01-MH101653, P30-NS048056, U54-HD087011, R01-MH104324, U54-HD86984]; Bundesministerium fur Bildung und Forschung [01EV0703]; McDonnell Center for Systems Neuroscience, Autism Speaks [6020]; Simons Foundation [140209]; Infant Brain Imaging Study (IBIS) Network is an NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091, R01HD055741, U54HD087011, U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093510] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); McDonnell Center for Systems Neuroscience, Autism Speaks; Simons Foundation; Infant Brain Imaging Study (IBIS) Network is an NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Health (NS080675 to MER and AZS, F30MH106253 to AM, R01MH093510 to J.Pruett, R01HD055741 to J.Piven, K01-MH101653 to J.W., P30-NS048056 to A.Z.S., U54-HD087011 to B.L.S, R01-MH104324 to JTE, U54-HD86984 to RTS), the Bundesministerium fur Bildung und Forschung 01EV0703 to E.T. and H.L., the McDonnell Center for Systems Neuroscience, Autism Speaks (grant number #6020 to J.P.), and the Simons Foundation (grant number #140209 to J.P.).; The Infant Brain Imaging Study (IBIS) Network is an NIH funded Autism Centers of Excellence project and consists of a consortium of eight universities in the U.S. and Canada. Clinical Sites: University of North Carolina: J. Piven (IBIS Network PI), H.C. Hazlett, C. Chappell; University of Washington: S. Dager, A. Estes, D. Shaw; Washington University: K. Botteron, R. McKinstry, J. Constantino, J. Pruett; The Children's Hospital of Philadelphia: R. Schultz, S. Paterson; University of Alberta: L. Zwaigenbaum; University of Minnesota: J. Elison; Data Coordinating Center: Montreal Neurological Institute: A.C. Evans, D.L. Collins, G.B. Pike, V. Fonov, P. Kostopoulos; S. Das; Image Processing Core: New York University: G. Gerig; University of North Carolina: M. Styner; Statistical Analysis Core: University of North Carolina: H. Gu.	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; [Anonymous], 2016, NEUROIMAGE; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Carskadon MA, 2000, PRINCIPLES PRACTICE, P13; CHUGANI HT, 1986, SCIENCE, V231, P840, DOI 10.1126/science.3945811; Conel J.L., 1939, POSTNATAL DEV HUMAN; Doria V, 2010, P NATL ACAD SCI USA, V107, P20015, DOI 10.1073/pnas.1007921107; Eisermann M, 2013, NEUROPHYSIOL CLIN, V43, P35, DOI 10.1016/j.neucli.2012.09.091; Estes A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9117-6; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2007, P NATL ACAD SCI USA, V104, P15531, DOI 10.1073/pnas.0704380104; Fransson P, 2009, PEDIATR RES, V66, P301, DOI 10.1203/PDR.0b013e3181b1bd84; Friedrichs-Maeder CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177466; Gao W., 2016, NEUROSCIENTIST; Gao W, 2013, CEREB CORTEX, V23, P594, DOI 10.1093/cercor/bhs043; Gao W, 2009, P NATL ACAD SCI USA, V106, P6790, DOI 10.1073/pnas.0811221106; Gholipour A, 2008, IEEE ENG MED BIO, P94, DOI 10.1109/IEMBS.2008.4649099; Hacker CD, 2013, NEUROIMAGE, V82, P616, DOI 10.1016/j.neuroimage.2013.05.108; Hagne I., 1972, ACTA PAEDIATR, V61, P25, DOI 10.1111/j.1651-2227.1972.tb08271.x; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iber C., 2007, AASM MANUAL SCORING; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lee W, 2013, NEURORADIOLOGY, V55, P105, DOI 10.1007/s00234-013-1232-z; Lin W, 2008, AM J NEURORADIOL, V29, P1883, DOI 10.3174/ajnr.A1256; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Mitra A, 2014, J NEUROPHYSIOL, V111, P2374, DOI 10.1152/jn.00804.2013; Mitra A, 2016, P NATL ACAD SCI USA, V113, pE6868, DOI 10.1073/pnas.1607289113; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mitra A, 2015, ELIFE, V4, DOI 10.7554/eLife.10781; Mitra A, 2015, P NATL ACAD SCI USA, V112, pE2235, DOI 10.1073/pnas.1503960112; Nikolic D, 2007, J COMPUT NEUROSCI, V22, P5, DOI 10.1007/s10827-006-9441-7; Ojemann JG, 1997, NEUROIMAGE, V6, P156, DOI 10.1006/nimg.1997.0289; Picchioni D, 2013, NEUROIMAGE, V80, P387, DOI 10.1016/j.neuroimage.2013.05.067; Power J.D, 2016, NEUROIMAGE; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Pruett JR, 2015, DEV COGN NEUROS-NETH, V12, P123, DOI 10.1016/j.dcn.2015.01.003; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; Samann PG, 2011, CEREB CORTEX, V21, P2082, DOI 10.1093/cercor/bhq295; Schneider G, 2006, NEURAL COMPUT, V18, P2387, DOI 10.1162/neco.2006.18.10.2387; Shulman GL, 2010, J NEUROSCI, V30, P3640, DOI 10.1523/JNEUROSCI.4085-09.2010; Smyser CD, 2014, RESTING STATE NETWOR; Smyser CD, 2016, NEUROIMAGE, V136, P1, DOI 10.1016/j.neuroimage.2016.05.029; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Tagliazucchi E, 2013, P NATL ACAD SCI USA, V110, P15419, DOI 10.1073/pnas.1312848110; Wylie KP, 2014, NEUROPSYCH DIS TREAT, V10, P1349, DOI 10.2147/NDT.S63773	50	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188122	10.1371/journal.pone.0188122	http://dx.doi.org/10.1371/journal.pone.0188122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149191	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100025
J	Talbot, SL; Sage, GK; Sonsthagen, SA; Gravley, MC; Swem, T; Williams, JC; Longmire, JL; Ambrose, S; Flamme, MJ; Lewis, SB; Phillips, L; Anderson, C; White, CM				Talbot, Sandra L.; Sage, George K.; Sonsthagen, Sarah A.; Gravley, Meg C.; Swem, Ted; Williams, Jeffrey C.; Longmire, Jonathan L.; Ambrose, Skip; Flamme, Melanie J.; Lewis, Stephen B.; Phillips, Laura; Anderson, Clifford; White, Clayton M.			Intraspecific evolutionary relationships among peregrine falcons in western North American high latitudes	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; ALLELE FREQUENCY DATA; ISLAND POPULATIONS; GENETIC DIVERSITY; CONSERVATION BIOLOGY; MICROSATELLITE LOCI; COALESCENT APPROACH; PLUMAGE COLORATION; STATISTICAL TESTS; DNA POLYMORPHISM	Subspecies relationships within the peregrine falcon (Falco peregrinus) have been long debated because of the polytypic nature of melanin-based plumage characteristics used in subspecies designations and potential differentiation of local subpopulations due to philopatry. In North America, understanding the evolutionary relationships among subspecies may have been further complicated by the introduction of captive bred peregrines originating from non-native stock, as part of recovery efforts associated with mid 20th century population declines resulting from organochloride pollution. Alaska hosts all three nominal subspecies of North American peregrine falcons-F.p. tundrius, anatum, and pealei-for which distributions in Alaska are broadly associated with nesting locales within Arctic, boreal, and south coastal maritime habitats, respectively. Unlike elsewhere, populations of peregrine falcon in Alaska were not augmented by captive-bred birds during the late 20th century recovery efforts. Population genetic differentiation analyses of peregrine populations in Alaska, based on sequence data from the mitochondrial DNA control region and fragment data from microsatellite loci, failed to uncover genetic distinction between populations of peregrines occupying Arctic and boreal Alaskan locales. However, the maritime subspecies, pealei, was genetically differentiated from Arctic and boreal populations, and substructured into eastern and western populations. Levels of interpopulational gene flow between anatum and tundrius were generally higher than between pealei and either anatum or tundrius. Estimates based on both marker types revealed gene flow between augmented Canadian populations and unaugmented Alaskan populations. While we make no attempt at formal taxonomic revision, our data suggest that peregrine falcons occupying habitats in Alaska and the North Pacific coast of North America belong to two distinct regional groupings-a coastal grouping (pealei) and a boreal/Arctic grouping (currently anatum and tundrius)-each comprised of discrete populations that are variously intra-regionally connected.	[Talbot, Sandra L.; Sage, George K.; Sonsthagen, Sarah A.; Gravley, Meg C.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Swem, Ted; Ambrose, Skip] US Fish & Wildlife Serv, Fairbanks Fish & Wildlife Field Off, Fairbanks, AK USA; [Williams, Jeffrey C.] US Fish & Wildlife Serv, Alaska Maritime Natl Wildlife Refuge, Homer, AK USA; [Longmire, Jonathan L.] Los Alamos Natl Lab, Los Alamos, NM USA; [Flamme, Melanie J.] Natl Pk Serv, Yukon Charley River Natl Preserve & Gates Arctic, Fairbanks, AK USA; [Lewis, Stephen B.] US Fish & Wildlife Serv, Migratory Bird Management, Juneau, AK USA; [Phillips, Laura] Natl Pk Serv, Alaska Reg Off, Anchorage, AK USA; [Anderson, Clifford] Falcon Res Grp, Bow, WA USA; [White, Clayton M.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA; [White, Clayton M.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of the Interior; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; Brigham Young University; Brigham Young University	Talbot, SL (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	stalbot@usgs.gov		Sonsthagen, Sarah/0000-0001-6215-5874	Alaska Science Center; U. S. Geological Survey; U. S. Fishand Wild life Service; Brigham Young University; National Park Service; Falcon Research Group; Los Alamos National Laboratory; U. S. Bureau of Land Management; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER	Alaska Science Center; U. S. Geological Survey(United States Geological Survey); U. S. Fishand Wild life Service; Brigham Young University; National Park Service; Falcon Research Group; Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); U. S. Bureau of Land Management; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this research was provided by the Alaska Science Center, U. S. Geological Survey (SLT), U. S. Fishand Wild life Service (JCW,TS, SA, SBL), Brigham Young University (CMW), National Park Service (MJF, LP), Falcon Research Group (CA), Los Alamos National Laboratory (JLL), and U. S. Bureau of Land Management (TS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose R.E., 1988, P73; Ambrose S., 1990, PEREGRINE FALCON SUR; Ambrose S, 2016, J WILDLIFE MANAGE, V80, P1; AOU, 1957, CHECKL N AM BIRDS, V5th; BAKER AJ, 1990, EVOLUTION, V44, P981, DOI 10.1111/j.1558-5646.1990.tb03819.x; BANDELT HJ, 1995, GENETICS, V141, P743; BARROWCLOUGH GF, 1982, AUK, V99, P601; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bird Life International, 2015, IUCN RED LIST THREAT, p[2015, 2015]; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; Bruggeman JE, 2016, IBIS, V158, P61, DOI 10.1111/ibi.12313; CADE TJ, 1971, SCIENCE, V172, P955, DOI 10.1126/science.172.3986.955; Cade TJ, 1988, PEREGRINE FALCON POP; Cade TJ, 2003, RETURN PEREGRINE N A; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cooch G., 1961, Auk, V78, P72; Cornuet JM, 1996, GENETICS, V144, P2001; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Diamond J.M., 1984, P824; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Early TJ, 1982, RAPTOR MANAGEMENT BI, P99; Enderson, 2013, PEREGRINE FALCONS WO; ENDERSON JH, 1995, T N AM WILDL NAT RES, P142; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fair J., 2010, ORNITHOLOGICAL COUNC; Fisher R., 1970, STAT METHODS RES WOR; Frankham R, 1998, CONSERV BIOL, V12, P665, DOI 10.1046/j.1523-1739.1998.96456.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fu YX, 1997, GENETICS, V147, P915; Galvan I, 2015, J RAPTOR RES, V49, P59, DOI 10.3356/jrr-14-00018.1; Gangoso L, 2015, OECOLOGIA, V178, P1113, DOI 10.1007/s00442-015-3306-6; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT VERSION 2 9 3; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Haig S. M., 2010, ORNITHOLOGICAL MONOG, V67, P172, DOI DOI 10.1525/0M.2010.67.1.172; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HAUGH J R, 1976, Canadian Field-Naturalist, V90, P359; Heinrich W., 2009, PEREGRINE FALCON POP, P429; Holroyd GL, 1996, J RAPTOR RES, V30, P145; Hull JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-224; Jacobsen F, 2008, CONSERV GENET, V9, P581, DOI 10.1007/s10592-007-9373-4; Johnson JA, 2007, MOL ECOL, V16, P3145, DOI 10.1111/j.1365-294X.2007.03373.x; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Johnson JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014042; Kiff L.F., 1988, P123; Kuhner MK, 1998, GENETICS, V149, P429; Langella O., 1999, POPULATIONS 1 2 30 P; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Lewis SB, 2015, J RAPTOR RES, V49, P367, DOI 10.3356/rapt-49-04-367-375.1; Longmire JL, 1988, GENOMICS, V2, P14, DOI 10.1016/0888-7543(88)90104-8; MacCluskie M, 2010, ALASKA PARK SCI, V9, P28; Manly B.F.J., 1985, STAT NATURAL SELECTI; Marshall HD, 2002, MOL ECOL, V11, P685, DOI 10.1046/j.1365-294X.2002.01479.x; MARUYAMA T, 1985, GENETICS, V111, P675; MAYR E, 1982, AUK, V99, P593; MESTA R, 1995, FED REGISTER, V60, P34406; MESTA R., 1999, FED REGISTER, V64, P46542; Miller MP, 2012, J HERED, V103, P503, DOI 10.1093/jhered/ess024; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Murie O. J., 1959, N AM FAUNA, V61, P1, DOI DOI 10.3996/NAFA.61.0001; Myers N, 1979, SINKING ARK NEW LOOK; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Pierson BJ, 2017, PEREGRINE FALCON FAL; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowell P, 1997, STATUS PEREGRINE FAL; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SALE R., 2005, THE GYRFALCON; SHANK CC, 1993, WILSON BULL, V105, P188; SLATKIN M, 1995, GENETICS, V139, P457; SMITH FDM, 1993, TRENDS ECOL EVOL, V8, P375, DOI 10.1016/0169-5347(93)90223-C; Stangel PW, 1991, ACT 20 C INT ORN, V4, P2442; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Talbot SL, 2011, J AVIAN BIOL, V42, P415, DOI 10.1111/j.1600-048X.2011.05280.x; Tarr CL, 1998, MOL ECOL, V7, P719, DOI 10.1046/j.1365-294x.1998.00385.x; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Weckworth BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019582; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; White C.M., 1988, P789; White C.M., 2020, BIRDS OF THE WORLD; White CM, 2013, AUK, V130, P78, DOI 10.1525/auk.2012.11173; WHITE CM, 1968, AUK, V85, P179, DOI 10.2307/4083579; White CM, 1976, CAN F NAT, V90, P262; White CM, 1975, RAPTOR RES, V3, P33; White CM, 1976, P 1 WORLD C BIRDS PR, P63; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhan XJ, 2012, ANIM GENET, V43, P460, DOI 10.1111/j.1365-2052.2011.02263.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	102	7	7	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188185	10.1371/journal.pone.0188185	http://dx.doi.org/10.1371/journal.pone.0188185			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149202	gold, Green Submitted, Green Published			2022-12-27	WOS:000415646100027
J	Clark, AM; DeDiego, ML; Anderson, CS; Wang, J; Yang, HM; Nogales, A; Martinez-Sobrido, L; Zand, MS; Sangster, MY; Topham, DJ				Clark, Amelia M.; DeDiego, Marta L.; Anderson, Christopher S.; Wang, Jiong; Yang, Hongmei; Nogales, Aitor; Martinez-Sobrido, Luis; Zand, Martin S.; Sangster, Mark Y.; Topham, David J.			Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins	PLOS ONE			English	Article							AMINO-ACID SITES; HEMAGGLUTININ STALK ANTIBODIES; A VIRUS; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODY; FUNCTIONAL BALANCE; RECEPTOR-BINDING; MEMBRANE-FUSION; LINKED LECTIN; NEURAMINIDASE	Antigenic drift of the hemagglutinin (HA) and neuraminidase (NA) influenza virus proteins contributes to reduced vaccine efficacy. To analyze antigenic drift in human seasonal H1N1 viruses derived from the 2009 pandemic H1N1 virus (pH1N1-like viruses) accounts for the limited effectiveness (around 40%) of vaccination against pH1N1-like viruses during the 2015-2016 season, nasal washes/swabs collected from adult subjects in the Rochester, NY area, were used to sequence and isolate the circulating viruses. The HA and NA proteins from viruses circulating during the 2015-2016 season encoded eighteen and fourteen amino acid differences, respectively, when compared to A/California/04/2009, a strain circulating at the origin of the 2009 pandemic. The circulating strains belonged to subclade 6B.1, defined by HA amino acid substitutions S101N, S179N, and I233T. Hemagglutination-inhibiting (HAI) and HA-specific neutralizing serum antibody (Ab) titers from around 50% of pH1N1-like virus-infected subjects and immune ferrets were 2-4 fold lower for the 2015-2016 circulating strains compared to the vaccine strain. In addition, using a luminex-based mPlex HA assay, the binding of human sera from subjects infected with pH1N1-like viruses to the HA proteins from circulating and vaccine strains was not identical, strongly suggesting antigenic differences in the HA protein. Additionally, NA inhibition (NAI) Ab titers in human sera from pH1N1-like virus-infected subjects increased after the infection and there were measurable antigenic differences between the NA protein of circulating strains and the vaccine strain using both ferret and human antisera. Despite having been vaccinated, infected subjects exhibited low HAI Ab titers against the vaccine and circulating strains. This suggests that poor responses to the H1N1 component of the vaccine as well as antigenic differences in the HA and NA proteins of currently circulating pH1N1-like viruses could be contributing to risk of infection even after vaccination.	[Clark, Amelia M.; DeDiego, Marta L.; Anderson, Christopher S.; Sangster, Mark Y.; Topham, David J.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Wang, Jiong; Zand, Martin S.] Univ Rochester, Med Ctr, Dept Med, Div Nephrol, Rochester, NY 14642 USA; [Yang, Hongmei] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Nogales, Aitor; Martinez-Sobrido, Luis] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Topham, DJ (corresponding author), Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	Marta_Lopez@URMC.rohester.edu; David_Topham@URMC.rochester.edu	NOGALES, AITOR/AAY-1590-2020; Demchuk, Andrew M/E-1103-2012; Martinez-Sobrido, Luis/ACJ-7853-2022; DeDiego, Marta L./B-2307-2017	NOGALES, AITOR/0000-0002-2424-7900; Demchuk, Andrew M/0000-0002-4930-7789; Martinez-Sobrido, Luis/0000-0001-7084-0804; Knudsen-Clark, Amelia/0000-0002-1685-9413; Sangster, Mark/0000-0002-1599-5894; Wang, Jiong/0000-0002-4938-5074; DeDiego, Marta L./0000-0002-7888-7372	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS [HHSN272201400005C]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042, UL1TR002001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069351, R01AI098112, R01AI129518] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under CEIRS contract No. HHSN272201400005C, to DJT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160510; Anderson CS, 2017, SCI REPORTS; Appiah GD, 2015, INFLUENZA ACTIVITY U, P583; Baker SF, 2015, VACCINE, V33, P3562, DOI 10.1016/j.vaccine.2015.05.049; Baker SF, 2013, J VIROL, V87, P8591, DOI 10.1128/JVI.01081-13; Burke DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112302; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chai N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005702; Cohen M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-321; COLMAN PM, 1985, CURR TOP MICROBIOL, V114, P177; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; COUCH RB, 1974, J INFECT DIS, V129, P411, DOI 10.1093/infdis/129.4.411; Couch RB, 2013, J INFECT DIS, V207, P974, DOI 10.1093/infdis/jis935; Couzens L, 2014, J VIROL METHODS, V210, P7, DOI 10.1016/j.jviromet.2014.09.003; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Davlin SL, 2016, INFLUENZA ACTIVITY U, P567; DeDiego ML, 2016, J VIROL, V90, P9693, DOI 10.1128/JVI.01039-16; DeDiego ML, 2016, IMMUNOLOGY, V148, P160, DOI 10.1111/imm.12594; ECDC, 2016, INFL VIR CHAR SUMM E; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Gambaryan AS, 2015, BIOCHEMISTRY-MOSCOW+, V80, P872, DOI 10.1134/S000629791507007X; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaymard A, 2016, CLIN MICROBIOL INFEC, V22, P975, DOI 10.1016/j.cmi.2016.07.007; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Henry C, 2017, TRENDS IMMUNOL; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Hensley SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015190; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; JOHANSSON BE, 1993, J VIROL, V67, P5721, DOI 10.1128/JVI.67.10.5721-5723.1993; Katz J, 2017, RECOMMENDED COMPOSIT; KILBOURNE ED, 1990, P NATL ACAD SCI USA, V87, P786, DOI 10.1073/pnas.87.2.786; Klenk Hans-Dieter, 1994, Trends in Microbiology, V2, P39, DOI 10.1016/0966-842X(94)90123-6; Komissarov A, 2016, INFLUENZA OTHER RESP, V10, P247, DOI 10.1111/irv.12389; Kosik I, 2017, VIROLOGY, V500, P178, DOI 10.1016/j.virol.2016.10.024; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Laguio-Vila MR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu115; LAMBRE CR, 1990, J IMMUNOL METHODS, V135, P49, DOI 10.1016/0022-1759(90)90255-T; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAVER WG, 1982, VIROLOGY, V122, P450, DOI 10.1016/0042-6822(82)90244-6; Lee AJ, 2015, J VIROL, V89, P5427, DOI 10.1128/JVI.03636-14; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; Lu XH, 2014, VIROLOGY, V454, P169, DOI 10.1016/j.virol.2014.02.011; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Meyer AG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004940; Meyer AG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0334; Monto AS, 2015, J INFECT DIS, V212, P1191, DOI 10.1093/infdis/jiv195; Myers JL, 2013, J VIROL, V87, P11168, DOI 10.1128/JVI.01414-13; Neu KE, 2016, CURR OPIN IMMUNOL, V42, P48, DOI 10.1016/j.coi.2016.05.012; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Nielsen R, 1998, GENETICS, V148, P929; Nogales A., 2016, J VIROL; Ohmit SE, 2011, J INFECT DIS, V204, P1879, DOI 10.1093/infdis/jir661; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Petrie JG, 2016, J INFECT DIS, V214, P1947, DOI 10.1093/infdis/jiw479; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Pond S. L., 2007, ESTIMATING SELECTION; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Salzberg S, 2008, NATURE, V454, P160, DOI 10.1038/454160a; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Su YCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8952; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VIRELIZIER JL, 1975, J IMMUNOL, V115, P434; Wang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129858; WEBSTER RG, 1978, ANNU REV GENET, V12, P415, DOI 10.1146/annurev.ge.12.120178.002215; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12; Xu R, 2012, J VIROL, V86, P982, DOI 10.1128/JVI.06322-11; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	86	51	53	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188267	10.1371/journal.pone.0188267	http://dx.doi.org/10.1371/journal.pone.0188267			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145498	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800104
J	Kang, GX; Liu, K; Hou, BB; Zhang, NB				Kang, Guixia; Liu, Kui; Hou, Beibei; Zhang, Ningbo			3D multi-view convolutional neural networks for lung nodule classification	PLOS ONE			English	Article							COMPUTER-AIDED DIAGNOSIS	The 3D convolutional neural network (CNN) is able to make full use of the spatial 3D context information of lung nodules, and the multi-view strategy has been shown to be useful for improving the performance of 2D CNN in classifying lung nodules. In this paper, we explore the classification of lung nodules using the 3D multi-view convolutional neural networks (MV-CNN) with both chain architecture and directed acyclic graph architecture, including 3D Inception and 3D Inception-ResNet. All networks employ the multi-view-one-network strategy. We conduct a binary classification (benign and malignant) and a ternary classification (benign, primary malignant and metastatic malignant) on Computed Tomography (CT) images from Lung Image Database Consortium and Image Database Resource Initiative database (LIDC-IDRI). All results are obtained via 10-fold cross validation. As regards the MV-CNN with chain architecture, results show that the performance of 3D MV-CNN surpasses that of 2D MV-CNN by a significant margin. Finally, a 3D Inception network achieved an error rate of 4.59% for the binary classification and 7.70% for the ternary classification, both of which represent superior results for the corresponding task. We compare the multi-view-one-network strategy with the one-view-one-network strategy. The results reveal that the multi-view-one-network strategy can achieve a lower error rate than the one-view-one-network strategy.	[Kang, Guixia; Liu, Kui; Hou, Beibei; Zhang, Ningbo] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China; [Kang, Guixia] Beijing Ciji Network Technol Co Ltd, Beijing, Peoples R China	Beijing University of Posts & Telecommunications	Liu, K (corresponding author), Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China.	liukui_006@126.com		Liu, Kui/0000-0003-2715-5304	National Natural Science Foundation of China [61471064]; National High Technology Research and Development Program of China ("863" Program) [2015AA01A709]; Beijing Ciji Network Technology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China ("863" Program)(National High Technology Research and Development Program of China); Beijing Ciji Network Technology Co., Ltd	This work was supported by National Natural Science Foundation of China (61471064) to Guixia Kang and National High Technology Research and Development Program of China ("863" Program, No. 2015AA01A709) to Guixia Kang. Beijing Ciji Network Technology Co., Ltd provided support in the form of a salary for author Guixia Kang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. The funder provided support in the form of salaries for authors [Guixia Kang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by National Natural Science Foundation of China (61471064) and National High Technology Research and Development Program of China ("863" Program, No. 2015AA01A709).	Adetiba E, 2015, SCI WORLD J, V2015; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; CEicEekO E, 2016, INT C MED IM COMP CO; Chen L.C., 2014, ARXIV; Chollet, 2015, GITHUB REPOSITORY; Dou Q., 2016, IEEE T BIOMEDICAL EN, VPP, P1; Dou Q, 2016, IEEE T MED IMAGING, V35, P1182, DOI 10.1109/TMI.2016.2528129; Du Y, 2015, PROC CVPR IEEE, P1110, DOI 10.1109/CVPR.2015.7298714; Han FF, 2015, J DIGIT IMAGING, V28, P99, DOI 10.1007/s10278-014-9718-8; He K., 2015, DEEP RESIDUAL LEARNI, DOI DOI 10.1109/CVPR.2016.90; Hinton G. E., 2012, COMPUT SCI, DOI DOI 10.9774/GLEAF.978-1-909493-38-4_2; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Kamnitsas K., 2016, ARXIV160305959; Kim B C, 2016, DEEP FEATURE LEARNIN, P1, DOI [10.1109/iww-bci.2016.7457462, DOI 10.1109/IWW-BCI.2016.7457462]; Krizhevsky A., P 25 INT C NEUR INF, P1097; Kumar D, 2015, COMP ROB VIS CRV 201; Kumar D, 2017, LECT NOTES COMPUT SC, V10317, P54, DOI 10.1007/978-3-319-59876-5_7; Lampert TA, 2016, IEEE T IMAGE PROCESS; Langkvist M, 2014, PATTERN RECOGN LETT, V42, P11, DOI 10.1016/j.patrec.2014.01.008; LeCun Y, 1989, NEURAL COMPUT, V1, P541, DOI 10.1162/neco.1989.1.4.541; Lee MC, 2010, ARTIF INTELL MED, V50, P43, DOI 10.1016/j.artmed.2010.04.011; Li Q, 2005, SEMIN ULTRASOUND CT, V26, P357, DOI 10.1053/j.sult.2005.07.001; Lin M, 2014, PUBLIC HEALTH NUTR, V17, P2029, DOI [10.1017/S1368980013002176, 10.1109/PLASMA.2013.6634954]; Liu K, 2017, INT J IMAG SYST TECH, V27, P12, DOI 10.1002/ima.22206; Orozco HM, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0003-y; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qi Dou, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P149, DOI 10.1007/978-3-319-46723-8_18; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Shafiee M. J., 2015, ARXIV151103361; Shen W, 2017, PATTERN RECOGN, V61, P663, DOI 10.1016/j.patcog.2016.05.029; Shen Wei, 2015, Inf Process Med Imaging, V24, P588, DOI 10.1007/978-3-319-19992-4_46; Shewaye T N, 2016, ARXIV160508350; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tartar A, 2014, IEEE ENG MED BIO, P4651, DOI 10.1109/EMBC.2014.6944661; Tompson J, 2015, PROC CVPR IEEE, P648, DOI 10.1109/CVPR.2015.7298664	37	68	73	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188290	10.1371/journal.pone.0188290	http://dx.doi.org/10.1371/journal.pone.0188290			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145492	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800106
J	Loddo, C; Pupier, E; Amour, R; Monsaingeon-Henry, M; Mohammedi, K; Gatta-Cherifi, B				Loddo, Celine; Pupier, Emilie; Amour, Remy; Monsaingeon-Henry, Maud; Mohammedi, Kamel; Gatta-Cherifi, Blandine			Lifestyle intervention program in deprived obese adult patients and their non-deprived counterparts	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; DEPRIVATION; MORTALITY; COMPLICATIONS; ASSOCIATION; HEALTH; RISK	Introduction Although it is known that the prevalence of obesity is high in deprived patients, the link between deprivation and obesity, and the impact of deprivation on compliance and efficacy of a lifestyle intervention program are not known. Materials and methods Deprivation was assessed in 40 patients (23 Females, mean +/- SD age: 49 +/- 17 years) from the diabetology department and 140 patients (101 Females, age: 50 +/- 15 years) from the nutrition department of Bordeaux University hospital. Eighty-seven patients suffering from obesity were evaluated before and after a tailored, multidisciplinary lifestyle intervention. Deprivation was assessed using EPICES scores. Deprivation was defined with an EPICES score > 30. Results Deprived patients suffering from obesity had significantly higher current (43.8 +/- 8.4 versus 40.9 +/- 5.5 kg/m(2), p = 0,02) and maximal BMI (46.1 +/- 8.6 versus 42.3 +/- 5.2 kg/m(2), p = 0.002) compared to non-deprived obese. Percentage of body weight loss was not different according to deprivation (4.74 +/- 0.75 versus 4.65 +/- 1.04%, p = 0.9). EPICES scores were not different according to adherence to lifestyle intervention program (20.5 +/- 8.5 versus 29.9 +/- 3.9 versus 29.0 +/- 2.5, no follow up versus partial follow up versus total follow up, p = 0,58). Conclusion Deprived patients suffering from obesity have a more serious disease than non-deprived patients. However, neither compliance to the lifestyle intervention program nor body weight loss differed between deprived patients with obesity and non-deprived ones. Deprivation should not be a limitation when enrolling patients with obesity in lifestyle intervention programs.	[Loddo, Celine; Pupier, Emilie; Amour, Remy; Monsaingeon-Henry, Maud; Mohammedi, Kamel; Gatta-Cherifi, Blandine] Univ Hosp Bordeaux, Haut Leveque Hosp, Dept Endocrinol Diabetol & Nutr, Pessac, France; [Loddo, Celine; Mohammedi, Kamel; Gatta-Cherifi, Blandine] Univ Bordeaux, UFR Med Sci, Bordeaux, France; [Gatta-Cherifi, Blandine] Neuroctr France Magendie, INSERM, Physiopathol Plasticite Neuronale, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Loddo, C (corresponding author), Univ Hosp Bordeaux, Haut Leveque Hosp, Dept Endocrinol Diabetol & Nutr, Pessac, France.; Loddo, C (corresponding author), Univ Bordeaux, UFR Med Sci, Bordeaux, France.	celine.loddo@chu-bordeauz.fr	Mohammedi, Kamel/AAG-3129-2019	Mohammedi, Kamel/0000-0001-6139-1197; Monsaingeon-Henry, Maud/0000-0002-6382-8337; Cherifi, Blandine/0000-0002-7399-1330				American Thoracic Society, 2002, AM J RESP CRITICAL C; Baillot A, 2009, SCI SPORT, V24, P1, DOI 10.1016/j.scispo.2008.06.003; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Bihan H, 2012, DIABETES METAB, V38, P82, DOI 10.1016/j.diabet.2011.10.004; Brown AF, 2004, EPIDEMIOL REV, V26, P63, DOI 10.1093/epirev/mxh002; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Cetaf, 2005, SCOR EPICES IND PREC; Colbert JA, 2013, NEW ENGL J MED, V369, P1389, DOI 10.1056/NEJMp1306460; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; Eschwege E, 2013, OBEPI 2012 ENQUETE E; Feuillet T, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0002-z; Fysekidis M, 2016, SURG OBES RELAT DIS, V12, P1403, DOI 10.1016/j.soard.2016.01.028; Gatineau M., 2014, ADULT OBESITY TYPE 2; Gueguen R, 2005, EPICES SCORE INDIV 1; Insee, 2013, FICH THEM COND VIE; Jaffiol C, 2013, DIABETES METAB, V39, P56, DOI 10.1016/j.diabet.2012.09.002; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Laurent Auzet, 2007, NIVEAUX VIE PAUVRETE; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Mari-Dell'Olmo M, 2015, J EPIDEMIOL COMMUN H, V69, P432, DOI 10.1136/jech-2014-204312; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Moulin J-J, 2005, B EPIDEMIOLOGIQUE HE, V43, P1; Moulin JJ, 2006, B EPIDEMIOLOGIQUE HE, V14, P93; Observatoire National de la Pauvrete A et de l'Exclusion Sociale, 2011, IND ONPES 2011; Pornet C, 2012, J EPIDEMIOL COMMUN H, V66, P982, DOI 10.1136/jech-2011-200311; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Sass C, 2006, Sante Publique, V18, P513; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; STUNKARD AJ, 1993, NEW ENGL J MED, V329, P1036, DOI 10.1056/NEJM199309303291411; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Varadharajan KS, 2013, ASIA PAC J CLIN NUTR, V22, P326, DOI 10.6133/apjcn.2013.22.3.19; Webber L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004787; Windenberger F, 2012, EUR J PUBLIC HEALTH, V22, P347, DOI 10.1093/eurpub/ckr029; Wresinski J, 1987, DIRECTION JOURNAUX O; Zukiewicz-Sobczak W, 2014, ANN AGR ENV MED, V21, P590, DOI 10.5604/12321966.1120608	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188297	10.1371/journal.pone.0188297	http://dx.doi.org/10.1371/journal.pone.0188297			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145484	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800107
J	Srithanaviboonchai, K; Chariyalertsak, S; Nontarak, J; Assanangkornchai, S; Kessomboon, P; Putwatana, P; Taneepanichskul, S; Aekplakorn, W				Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat; Nontarak, Jiraluck; Assanangkornchai, Sawitri; Kessomboon, Pattapong; Putwatana, Panwadee; Taneepanichskul, Surasak; Aekplakorn, Wichai			Stigmatizing attitudes toward people living with HIV among general adult Thai population: Results from the 5th Thai National Health Examination Survey (NHES)	PLOS ONE			English	Article							TRANSGENDER WOMEN; HIV/AIDS; DISCRIMINATION; TRENDS; SEX; MEN; TRANSMISSION; PREVENTION; BEHAVIORS; EPIDEMIC	Background HIV-related stigma and discrimination is a significant driver of the HIV and AIDS epidemic. UNAIDS encourages all nations to monitor progress toward elimination of this problem. This study measured the level of stigmatizing attitudes toward people living with HIV (PLHIV) among Thai adults in the general population using recommended global tools. Methods Data from the 5th National Health Examination Survey, conducted in 2014 were used. The survey utilized six questions recommended by the Global Stigma and Discrimination Indicator Working Group and was administered to participants aged 20-59 years old. All analyses were weighted to take into account of the probability of sampling the same-age Thai population. Factors related to a discriminatory attitude according to UNAIDS, defined as agreed to at least one of the two discriminatory issues, were evaluated using Chi square tested and multivariable logistic regression. Results Of the 10,522 respondents, the most prevalent stigmatizing attitude was anticipated stigma (76.9%), followed by perceived stigma (69.2%), fear of HIV infection (57.0%), and social judgment (38.2%). Fifty-eight point six percent had discriminatory attitudes according to the UNAIDS global indicator. Independent predictors were being female (AOR = 1.21: 95% CI 1.14-1.29), aged 20-39 (AOR = 1.19: 95% CI 1.09-1.30) or 50-59 (AOR = 1.18: 95% CI 1.12-1.26), being Muslim (AOR = 2.03: 95% CI 1.55-2.66), earning < 10,000 Baht/month (AOR = 0.93: 95%CI 0.88-0.99), and living in the Northeast (AOR = 1.67: 95%CI 1.39-2.00) or in Bangkok (AOR = 1.73: 95% CI 1.45-2.07). Conclusions More than half of the general adult Thai population had stigmatizing attitudes toward PLHIV. The study provided valuable baseline information which could be used as comparison for follow-up surveys with other countries. Interventions to improve Thai society's knowledge and attitudes toward HIV/AIDS are urgently needed.	[Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand; [Srithanaviboonchai, Kriengkrai; Chariyalertsak, Suwat] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Nontarak, Jiraluck; Aekplakorn, Wichai] Natl Hlth Examinat Survey Off, Bangkok, Thailand; [Assanangkornchai, Sawitri] Prince Songkla Univ, Fac Med, Hat Yai, Thailand; [Kessomboon, Pattapong] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand; [Putwatana, Panwadee; Aekplakorn, Wichai] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand; [Taneepanichskul, Surasak] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	Chiang Mai University; Chiang Mai University; Prince of Songkla University; Khon Kaen University; Mahidol University; Chulalongkorn University	Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Fac Med, Chiang Mai, Thailand.; Srithanaviboonchai, K (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	kriengkrai.s@cmu.ac.th	Aekplakorn, Wichai/AAK-6867-2021; ., ksrithan/AAO-2228-2020	., ksrithan/0000-0002-1683-4259; Assanangkornchai, Sawitri/0000-0003-2174-3287; Nontarak, Jiraluck/0000-0002-6737-0829				Apinundecha C, 2007, AIDS CARE, V19, P1157, DOI 10.1080/09540120701335204; Boer H, 2004, AIDS CARE, V16, P167, DOI 10.1080/09540120410001641011; Busza JR, 2001, AIDS CARE, V13, P441, DOI 10.1080/09540120120057978; Chan BT, 2016, JAIDS-J ACQ IMM DEF, V72, P558, DOI 10.1097/QAI.0000000000001011; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Dapaah JM, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0123-3; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Fongkaew Warunee, 2014, J Int Assoc Provid AIDS Care, V13, P69, DOI 10.1177/1545109712463734; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P621, DOI 10.1089/apc.2013.0245; Hasnain Memoona, 2005, Harm Reduct J, V2, P23, DOI 10.1186/1477-7517-2-23; Heath AJ, 2016, J PUBLIC HEALTH-UK, V38, pE301, DOI 10.1093/pubmed/fdv143; Hua JX, 2014, AIDS BEHAV, V18, pS203, DOI 10.1007/s10461-013-0637-3; Nguyen HV, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-016-0127-9; King EJ, 2013, AIDS BEHAV, V17, P2597, DOI 10.1007/s10461-013-0447-7; Kingori C, 2017, INT J STD AIDS, V28, P910, DOI 10.1177/0956462416680764; Lau J, 2003, DISABIL REHABIL, V25, P1354, DOI 10.1080/09638280310001616349; Li L, 2009, AIDS CARE, V21, P1007, DOI 10.1080/09540120802614358; Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2216-0; Logie CH, 2016, AIDS PATIENT CARE ST, V30, P92, DOI 10.1089/apc.2015.0197; MASON CJ, 1995, AIDS, V9, P1061, DOI 10.1097/00002030-199509000-00012; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; National Health Security Office, ART PROGR MAN UN HLT; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Huy NV, 2016, GLOBAL HEALTH ACTION, V9, P77, DOI 10.3402/gha.v9.29247; Nyblade Laura C, 2006, Psychol Health Med, V11, P335, DOI 10.1080/13548500600595178; Punyacharoensin N, 2009, AIDS, V23, P1143, DOI 10.1097/QAD.0b013e32832baa1c; Sapsirisavat V, 2016, AIDS BEHAV, V20, pS398, DOI 10.1007/s10461-016-1456-0; Siraprapasiri T, 2016, J VIRUS ERAD, V2, P7; Srithanaviboonchai K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4172-4; Srithanaviboonchai Kriengkrai, 2014, Journal of the Medical Association of Thailand, V97, P225; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; STAPLETON D, 1986, CAN FAM PHYSICIAN, V32, P2510; Steward Wayne T, 2013, J Int Assoc Provid AIDS Care, V12, P103, DOI 10.1177/1545109711432315; Surkan PJ, 2010, AIDS CARE, V22, P803, DOI 10.1080/09540120903443392; Thai Network of People Living with HIV/AIDS (TNP+), IND STIGM DISCR PEOP; Thailand National AIDS Committee, 2014, THAIL NAT OP PLAN AC; The Global Stigma and Discrimination Indicator Working Group, MEASURING HIV STIGMA; Thisyakorn U, 2017, PAEDIATR INT CHILD H, V37, P99, DOI 10.1080/20469047.2017.1281873; UNAIDS, 2016, UN POL DECL END AIDS; UNAIDS, GUID 2014 GLOB AIDS; UNAIDS, 2007, RED HIV STIGM DISCR; van Griensven F, 2015, LANCET HIV, V2, pE64, DOI 10.1016/S2352-3018(14)00031-9; Vanlandingham MJ, 2005, J HEALTH SOC BEHAV, V46, P392, DOI 10.1177/002214650504600406; Yang Y, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-014-0160-3; Young SD, 2010, JAIDS-J ACQ IMM DEF, V55, P620, DOI 10.1097/QAI.0b013e3181fc6429	45	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187231	10.1371/journal.pone.0187231	http://dx.doi.org/10.1371/journal.pone.0187231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145519	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800012
J	Handy, K; Rosen, J; Gillan, A; Smith, R				Handy, Kyle; Rosen, Jebediah; Gillan, Andre; Smith, Rob			Fast, axis-agnostic, dynamically summarized storage and retrieval for mass spectrometry data	PLOS ONE			English	Article							FORMAT	Mass spectrometry, a popular technique for elucidating the molecular contents of experimental samples, creates data sets comprised of millions of three-dimensional (m/z, retention time, intensity) data points that correspond to the types and quantities of analyzed molecules. Open and commercial MS data formats are arranged by retention time, creating latency when accessing data across multiple m/z. Existing MS storage and retrieval methods have been developed to overcome the limitations of retention time-based data formats, but do not provide certain features such as dynamic summarization and storage and retrieval of point meta-data (such as signal cluster membership), precluding efficient viewing applications and certain data-processing approaches. This manuscript describes MzTree, a spatial database designed to provide real-time storage and retrieval of dynamically summarized standard and augmented MS data with fast performance in both m/z and RT directions. Performance is reported on real data with comparisons against related published retrieval systems.	[Handy, Kyle; Rosen, Jebediah; Gillan, Andre; Smith, Rob] Univ Montana, Dept Comp Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Smith, R (corresponding author), Univ Montana, Dept Comp Sci, Missoula, MT 59812 USA.	robert.smith@mso.umt.edu		Rosen, Jeb/0000-0002-8832-1276	National Science Foundation [1552240]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation under Grant No. 1552240 to R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This material is based upon work supported by the National Science Foundation under Grant No. 1552240 to R.S.	Bouyssie D, 2015, MOL CELL PROTEOMICS, V14, P771, DOI 10.1074/mcp.O114.039115; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deutsch E, 2008, PROTEOMICS, V8, P2776, DOI 10.1002/pmic.200890049; Guttman A., 1984, SIGMOD REC, P47, DOI DOI 10.1145/602259.602266; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Leutenegger ST, 1997, PROC INT CONF DATA, P497, DOI 10.1109/ICDE.1997.582015; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Rost HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125108; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith R, 2015, BMC BIOINFORMATICS, V16, P1; Smith R, 2013, BRIEFINGS BIOINFORMA; Smith R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S9; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Teleman J, 2016, J PROTEOME RES; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wilhelm M, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.011379	16	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188059	10.1371/journal.pone.0188059	http://dx.doi.org/10.1371/journal.pone.0188059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141005	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400050
J	Hodgens, C; Nimchuk, ZL; Kieber, JJ				Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.			indCAPS: A tool for designing screening primers for CRISPR/Cas9 mutagenesis events	PLOS ONE			English	Article							HISTIDINE PHOSPHOTRANSFER PROTEINS; B RESPONSE REGULATORS; CYTOKININ RECEPTORS; ARABIDOPSIS; STABILITY; DNA; LOCALIZATION; AHK4	Genetic manipulation of organisms using CRISPR/Cas9 technology generally produces small insertions/deletions (indels) that can be difficult to detect. Here, we describe a technique to easily and rapidly identify such indels. Sequence-identified mutations that alter a restriction enzyme recognition site can be readily distinguished from wild-type alleles using a cleaved amplified polymorphic sequence (CAPS) technique. If a restriction site is created or altered by the mutation such that only one allele contains the restriction site, a polymerase chain reaction (PCR) followed by a restriction digest can be used to distinguish the two alleles. However, in the case of most CRISPR-induced alleles, no such restriction sites are present in the target sequences. In this case, a derived CAPS (dCAPS) approach can be used in which mismatches are purposefully introduced in the oligonucleotide primers to create a restriction site in one, but not both, of the amplified templates. Web-based tools exist to aid dCAPS primer design, but when supplied sequences that include indels, the current tools often fail to suggest appropriate primers. Here, we report the development of a Python-based, species-agnostic web tool, called indCAPS, suitable for the design of PCR primers used in dCAPS assays that is compatible with indels. This tool should have wide utility for screening editing events following CRISPR/Cas9 mutagenesis as well as for identifying specific editing events in a pool of CRISPR-mediated mutagenesis events. This tool was field-tested in a CRISPR mutagenesis experiment targeting a cytokinin receptor (AHK3) in Arabidopsis thaliana. The tool suggested primers that successfully distinguished between wild-type and edited alleles of a target locus and facilitated the isolation of two novel ahk3 null alleles. Users can access indCAPS and design PCR primers to employ dCAPS to identify CRISPR/Cas9 alleles at http://indcaps.kieber.cloudapps.unc.edu/.	[Hodgens, Charles; Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Nimchuk, Zachary L.; Kieber, Joseph J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kieber, JJ (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Kieber, JJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC USA.	jkieber@unc.edu	Kieber, Joseph/GLN-6328-2022	Kieber, Joseph/0000-0002-5766-812X; Hodgens, Charles/0000-0002-0384-4458	National Science Foundation [IOS-1238051, IOS-1455607]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation (IOS-1238051 and IOS-1455607) https://www.nsf.gov/div/index.jsp?div=IOS. The funder had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.; We would like to thank G. Eric Schaller, Brian Nalley, Christian Burr, Amala John, Joanna Polko, Lauren Ross, and Ariel Aldrette for helping with the visual design of the website and the figures for this paper and Jamie Winshell for technical support. This work was supported by grants from the National Science Foundation (IOS-1238051 and IOS-1455607).	Argyros RD, 2008, PLANT CELL, V20, P2102, DOI 10.1105/tpc.108.059584; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Caesar K, 2011, J EXP BOT, V62, P5571, DOI 10.1093/jxb/err238; Cheng CY, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23393; Cheng CY, 2013, PLANT J, V73, P929, DOI 10.1111/tpj.12084; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Farboud B, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.287; Housden Benjamin E, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top086843; Hutchison CE, 2006, PLANT CELL, V18, P3073, DOI 10.1105/tpc.106.045674; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Karkute SG, 2017, FRONT PLANT SCI, V8; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kieber Joseph J, 2014, Arabidopsis Book, V12, pe0168, DOI 10.1199/tab.0168; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Peterson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162169; Punwani JA, 2010, PLANT SIGNAL BEHAV, V5, P896, DOI 10.4161/psb.5.7.12094; Punwani JA, 2010, PLANT J, V62, P473, DOI 10.1111/j.1365-313X.2010.04165.x; Simsek M, 2000, J Sci Res Med Sci, V2, P11; Sugimoto N, 1996, NUCLEIC ACIDS RES, V24, P4501, DOI 10.1093/nar/24.22.4501; Tandon P, 2017, DEV BIOL, V426, P325, DOI 10.1016/j.ydbio.2016.04.009; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Wulfetange K, 2011, PLANT PHYSIOL, V156, P1808, DOI 10.1104/pp.111.180539; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127	31	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188406	10.1371/journal.pone.0188406	http://dx.doi.org/10.1371/journal.pone.0188406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141013	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400074
J	Ortiz, AB; Garcia, D; Vicente, Y; Palka, M; Bellas, C; Martin, P				Ortiz, Angela B.; Garcia, Diego; Vicente, Yolanda; Palka, Magda; Bellas, Carmen; Martin, Paloma			Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ESTROGEN-RECEPTOR; CELL-CYCLE; CCND1 AMPLIFICATION; CANCER PATIENTS; POOR-PROGNOSIS; OVEREXPRESSION; ACTIVATION; REGULATORS; PHENOTYPE	The oncogenic capacity of cyclin D1 has long been established in breast cancer. CCND1 amplification has been identified in a subset of patients with poor prognosis, but there are conflicting data regarding the predictive value of cyclin D1 protein overexpression. This study was designed to analyze the expression of cyclin D1 and its correlation with CCND1 amplification and their prognostic implications in invasive breast cancer. By using the tissue microarray technique, we performed an immunohistochemical study of ER, PR, HER2, p53, cyclin D1, Ki67 and p16 in 179 invasive breast carcinoma cases. The FISH method was performed to detect HER2/Neu and CCND1 amplification. High cyclin D1 expression was identified in 94/179 (52%) of invasive breast cancers. Cyclin D1 overexpression and CCND1 amplification were significantly associated (p = 0.010). Overexpression of cyclin D1 correlated with ER expression, PR expression and Luminal subtypes (p < 0.001), with a favorable impact on overall survival in the whole series. However, in the Luminal A group, high expression of cyclin D1 correlated with shorter disease-free survival, suggesting that the prognostic role of cyclin D1 depends on the molecular subtype. CCND1 gene amplification was detected in 17 cases (9%) and correlated significantly with high tumor grade (p = 0.038), high Ki-67 protein expression (p = 0.002), and the Luminal B subtype (p = 0.002). Patients with tumors with high amplification of CCND1 had an increased risk of recurrence (HR = 2.5; 95% CI, 1.2-4.9, p = 0.01). These findings suggest that CCND1 amplification could be useful for predicting recurrence in invasive breast cancer.	[Ortiz, Angela B.; Garcia, Diego; Vicente, Yolanda; Bellas, Carmen; Martin, Paloma] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Pathol Dept, Madrid, Spain; [Palka, Magda] Inst Invest Sanitaria Puerta Hierro Majadahonda I, Med Oncol Dept, Madrid, Spain; [Bellas, Carmen; Martin, Paloma] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Martin, P (corresponding author), Inst Invest Sanitaria Puerta Hierro Majadahonda I, Pathol Dept, Madrid, Spain.; Martin, P (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.	pmartin@idiphim.org	Acosta, Paloma Martin/AAF-7998-2021	Acosta, Paloma Martin/0000-0002-3274-4595	Fundacion Mutua Madrilena; Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria [JR14/0018]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria	This work was supported by grant from the Fundacion Mutua Madrilena. PM is supported by a Juan Rodes contract (JR14/0018) from Instituto Salud Carlos III (FEDER) - Fondosde Investigacion Sanitaria. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen K, 2009, BREAST CANCER RES TR, V113, P75, DOI 10.1007/s10549-008-9908-5; Ahlin C, 2017, BREAST CANCER RES TR, V164, P667, DOI 10.1007/s10549-017-4294-5; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; Cho EY, 2008, PATHOL INT, V58, P17, DOI 10.1111/j.1440-1827.2007.02183.x; Chung J, 2014, J BREAST CANCER, V17, P47, DOI 10.4048/jbc.2014.17.1.47; Cianfrocca M, 2009, CA-CANCER J CLIN, V59, P303, DOI 10.3322/caac.20029; Gillett C, 1996, INT J CANCER, V69, P92, DOI 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.3.CO;2-I; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; HAN EKH, 1995, ONCOGENE, V10, P953; Han SW, 2001, BREAST CANCER RES TR, V70, P205, DOI 10.1023/A:1013047413895; Holm K, 2012, BREAST CANCER RES TR, V133, P583, DOI 10.1007/s10549-011-1817-3; Hwang TS, 2003, PATHOL INT, V53, P74, DOI 10.1046/j.1440-1827.2003.01441.x; Kenny FS, 1999, CLIN CANCER RES, V5, P2069; Lamb R, 2013, CELL CYCLE, V12, P2384, DOI 10.4161/cc.25403; Li ZS, 2016, AM J TRANSL RES, V8, P142; Lundgren K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3161; Malvezzi M, 2013, ANN ONCOL, V24, P792, DOI 10.1093/annonc/mdt010; MARTINEZ JC, 1995, J PATHOL, V177, P27, DOI 10.1002/path.1711770106; MCINTOSH GG, 1995, ONCOGENE, V11, P885; Milde-Langosch K, 2001, BREAST CANCER RES TR, V67, P61, DOI 10.1023/A:1010623308275; Mu K, 2011, HISTOPATHOLOGY, V58, P601, DOI 10.1111/j.1365-2559.2011.03780.x; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Mylona E, 2013, HISTOPATHOLOGY, V62, P472, DOI 10.1111/his.12013; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Peurala E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3376; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Reis JS, 2006, MODERN PATHOL, V19, P999, DOI 10.1038/modpathol.3800621; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Roy PG, 2010, INT J CANCER, V127, P355, DOI 10.1002/ijc.25034; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sugianto J, 2014, HUM PATHOL, V45, P802, DOI 10.1016/j.humpath.2013.11.013; Sutherland RL, 2002, BREAST CANCER RES, V4, P14, DOI 10.1186/bcr411; vanDiest PJ, 1997, AM J PATHOL, V150, P705; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	37	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188068	10.1371/journal.pone.0188068	http://dx.doi.org/10.1371/journal.pone.0188068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140993	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400053
J	Thorngren, L; Holthuis, TD; Lindegarth, S; Lindegarth, M				Thorngren, Linnea; Holthuis, Thomas Duner; Lindegarth, Susanne; Lindegarth, Mats			Developing methods for assessing abundance and distribution of European oysters (Ostrea edulis) using towed video	PLOS ONE			English	Article							MARINE PROTECTED AREA; UNDERWATER VIDEO; CRASSOSTREA-GIGAS; BENTHIC HABITATS; MULTIBEAM SONAR; REEFS; SEA; ECOSYSTEM; BIODIVERSITY; RESTORATION	Due to large-scale habitat losses and increasing pressures, benthic habitats in general, and perhaps oyster beds in particular, are commonly in decline and severely threatened on regional and global scales. Appropriate and cost-efficient methods for mapping and monitoring of the distribution, abundance and quality of remaining oyster populations are fundamental for sustainable management and conservation of these habitats and their associated values. Towed video has emerged as a promising method for surveying benthic communities in a both non-destructive and cost-efficient way. Here we examine its use as a tool for quantification and monitoring of oyster populations by (i) analysing how well abundances can be estimated and how living Ostrea edulis individuals can be distinguished from dead ones, (ii) estimating the variability within and among observers as well as the spatial variability at a number of scales, and finally (iii) evaluating the precision of estimated abundances under different scenarios for monitoring. Overall, the results show that the can be used to quantify abundance and occurrence of Ostrea edulis in heterogeneous environments. There was a strong correlation between abundances determined in the field and abundances estimated by video-analyses (r(2) = 0.93), even though video analyses underestimated the total abundance of living oysters by 20%. Additionally, the method was largely repeatable within and among observers and revealed no evident bias in identification of living and dead oysters. We also concluded that the spatial variability was an order of magnitude larger than that due to observer errors. Subsequent modelling of precision showed that the total area sampled was the main determinant of precision and provided general method for determining precision. This study provides a thorough validation of the application of towed video on quantitative estimations of live oysters. The results suggest that the method can indeed be very useful for this purpose and we therefor recommend it for future monitoring of oysters and other threatened habitats and species.	[Thorngren, Linnea; Holthuis, Thomas Duner] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Lindegarth, Susanne; Lindegarth, Mats] Univ Gothenburg, Dept Marine Sci Tjarno, Stromstad, Sweden	University of Gothenburg; University of Gothenburg	Thorngren, L (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	linnea.thorngren@marine.gu.se	Lindegarth, Mats Å/U-2665-2017	Lindegarth, Mats Å/0000-0001-5361-5437; Thorngren, Linnea/0000-0002-0735-5344	County Administrative board [29947-2013-1]; Radman och fru Ernst Collianders stiftelse for valgorande andamal	County Administrative board; Radman och fru Ernst Collianders stiftelse for valgorande andamal	This research was funded by The County Administrative board, Grant number 29947-2013-1, http://www.lansstyrelsen.se/VastraGotaland/En/Pages/default.aspx, and by Radman och fru Ernst Collianders stiftelse for valgorande andamal.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Allen YC, 2005, ESTUARIES, V28, P435, DOI 10.1007/BF02693925; Alleway HK, 2015, CONSERV BIOL, V29, P795, DOI 10.1111/cobi.12452; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; ANDREW NL, 1987, OCEANOGR MAR BIOL, V25, P39; Bates D, 2012, LME4 LINEAR MIXED EF; Beaman RJ, 2005, CONT SHELF RES, V25, P1657, DOI 10.1016/j.csr.2005.04.013; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2009, NATURE CONSERVANCY; BenedettiCecchi L, 1996, MAR ECOL PROG SER, V138, P93, DOI 10.3354/meps138093; Bernard ATF, 2013, J EXP MAR BIOL ECOL, V443, P75, DOI 10.1016/j.jembe.2013.02.039; Boman EM, 2016, J SHELLFISH RES, V35, P493, DOI 10.2983/035.035.0222; Bucas M, 2007, ESTUAR COAST SHELF S, V75, P308, DOI 10.1016/j.ecss.2007.04.038; Buhl-Mortensen L, 2012, HYDROBIOLOGIA, V685, P191, DOI 10.1007/s10750-011-0988-6; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Cano J, 1996, AQUACULT INT, V4, P67; CARLETON JH, 1995, CORAL REEFS, V14, P35, DOI 10.1007/BF00304070; Carstensen J, 2016, ECOL INDIC, V67, P306, DOI 10.1016/j.ecolind.2016.03.002; Chust G, 2010, ESTUAR COAST SHELF S, V89, P200, DOI 10.1016/j.ecss.2010.07.002; Cochran W.G., 2007, SAMPLING TECHNIQUES; Coen L. D, 2016, ENCY ESTUARIES, P89; Coen LD, 1999, AM FISHERIES SOC S; Coen LD, 2007, MAR ECOL PROG SER, V341, P303, DOI 10.3354/meps341303; Cognie B, 2006, AQUACULTURE, V259, P249, DOI 10.1016/j.aquaculture.2006.05.037; Commission O, 2008, BIODIVERSITY SERIES, V358, P1; Costa BM, 2009, REMOTE SENS ENVIRON, V113, P1082, DOI 10.1016/j.rse.2009.01.015; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Cranfield HJ, 1999, AQUAT CONSERV, V9, P461, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<461::AID-AQC353>3.0.CO;2-Z; Edwards E, 1997, TECHNICAL REPORT; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Francis FTY, 2014, MAR BIOL, V161, P1375, DOI 10.1007/s00227-014-2425-7; GIGUERE M, 1994, J SHELLFISH RES, V13, P25; Gillies C., 2015, SHELLF REEF HAB SYN; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Greco M., 2008, NATURAL OYSTER GROUN; Grizzle RE, 2008, J COASTAL RES, V24, P103, DOI 10.2112/06-0672.1; Grizzle RE, 2003, MAPPING CHARACTERIZI; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris PT, 2012, ELSEV INSIGHT, P1; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; HELCOM, 2013, RED LIST BALT SEA UN; Herbert RJH, 2016, BIODIVERS CONSERV, V25, P2835, DOI 10.1007/s10531-016-1209-4; Holmes KW, 2008, CONT SHELF RES, V28, P1800, DOI 10.1016/j.csr.2008.04.016; Ierodiaconou D, 2011, CONT SHELF RES, V31, pS28, DOI 10.1016/j.csr.2010.01.012; Kellogg ML, 2014, ESTUAR COAST SHELF S, V151, P156, DOI 10.1016/j.ecss.2014.09.025; Kennedy R, 1999, BIOL ENV P ROYAL IRI; Kenny AJ, 2003, ICES J MAR SCI, V60, P411, DOI 10.1016/S1054-3139(03)00006-7; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Laing I, 2005, FEASIBILITY STUDY NA; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Bris A, 2016, ESTUAR COAST SHELF S, V172, P1, DOI 10.1016/j.ecss.2016.01.039; Letessier TB, 2015, BIOL REV; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Lindegarth M, 2014, OSTRON OSTREA EDULIS, P43; Lirman D, 2007, ENVIRON MONIT ASSESS, V125, P59, DOI 10.1007/s10661-006-9239-0; Loo LO, 1888, OSTRON BLIR ALLMER S; Mallet D, 2014, FISH RES, V154, P44, DOI 10.1016/j.fishres.2014.01.019; Mann R, 2004, J SHELLFISH RES, V23, P387; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Nadon MO, 2006, CORAL REEFS, V25, P177, DOI 10.1007/s00338-005-0074-5; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Nieuwhof S, 2015, REMOTE SENS-BASEL, V7, P3710, DOI 10.3390/rs70403710; Ninio R, 2003, ESTIMATING COVER BEN; OSPAR, 2010, QUAL STAT REP 2010; Piazza BP, 2005, RESTOR ECOL, V13, P499, DOI 10.1111/j.1526-100X.2005.00062.x; Powell EN, 2006, ESTUAR COAST SHELF S, V69, P531, DOI 10.1016/j.ecss.2006.05.014; Roberts D.A., 2007, MAPPING SEAFLOOR HAB, P71; Rodney WS, 2006, J EXP MAR BIOL ECOL, V335, P39, DOI 10.1016/j.jembe.2006.02.017; Ross P., 2009, POPULATION ASSESSMEN; Schubert PR, 2015, MAR ECOL PROG SER, V522, P79, DOI 10.3354/meps11133; Sheehan EV, 2016, METHODS ECOL EVOL, V7, P843, DOI 10.1111/2041-210X.12540; Sheehan EV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014461; Smaal A., 2015, FEASIBILITY FLAT OYS; Smith J, 2015, ESTUAR COAST SHELF S, V164, P520, DOI 10.1016/j.ecss.2015.07.036; Soniat TM, 2014, J SHELLFISH RES, V33, P381, DOI 10.2983/035.033.0207; Stevens T, 2005, MAR FRESHWATER RES, V56, P111, DOI 10.1071/MF04233; Stevens TF, 2014, MAR POLICY, V45, P310, DOI 10.1016/j.marpol.2013.09.006; Stokesbury KDE, 2004, J SHELLFISH RES, V23, P33; Stunz GW, 2010, MAR ECOL PROG SER, V406, P147, DOI 10.3354/meps08556; Tarnowski M, 2005, MARYLAND OYSTER POPU; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; Team RC, 2016, R LANG ENV STAT COMP; Team RC, 2014, R LANG ENV STAT COMP; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Tyne JA, 2010, MAR FRESHWATER RES, V61, P1023, DOI 10.1071/MF09240; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; van Rein H, 2012, J MAR BIOL ASSOC UK, V92, P49, DOI 10.1017/S0025315411000233; Van Rein HB, 2009, UNDERWATER TECHNOL, V28, P99, DOI 10.3723/ut.28.099; Ventura D, 2016, ESTUAR COAST SHELF S, V171, P85, DOI 10.1016/j.ecss.2016.01.030; Waldbusser GG, 2011, J SHELLFISH RES, V30, P659, DOI 10.2983/035.030.0308; Wolff WJ, 2005, HELGOLAND MAR RES, V59, P31, DOI 10.1007/s10152-004-0204-4; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Zanini JM, 2000, CORAL REEFS, V19, P83, DOI 10.1007/s003380050231	93	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187870	10.1371/journal.pone.0187870	http://dx.doi.org/10.1371/journal.pone.0187870			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141028	gold, Green Submitted, Green Published			2022-12-27	WOS:000415260400035
J	Tonosu, J; Oka, H; Higashikawa, A; Okazaki, H; Tanaka, S; Matsudaira, K				Tonosu, Juichi; Oka, Hiroyuki; Higashikawa, Akiro; Okazaki, Hiroshi; Tanaka, Sakae; Matsudaira, Ko			The associations between magnetic resonance imaging findings and low back pain: A 10-year longitudinal analysis	PLOS ONE			English	Article							HIGH-INTENSITY ZONE; LUMBAR SPINE; DISC DEGENERATION; MRI FINDINGS; PREVALENCE; DISABILITY; DISEASE; ADULTS; RISK	Purpose To conduct a 10-year longitudinal analysis of the relationship between magnetic resonance imaging (MRI) findings and low back pain (LBP). Materials and methods Ninety-one volunteers with a history of LBP, but without current LBP were recruited between 2005 and 2006. Participants' baseline demographics and MRI findings were recorded. All volunteers were invited for a follow-up MRI in 2016; of these, 49 volunteers (53.8%) participated in the follow-up. We enquired whether they had LBP history during the 10 years between the baseline and follow-up examinations. Sagittal T1 and T2-weighted MRI were used to assess the intervertebral space from T12/L1 to L5/S1. We evaluated the presence of disc degeneration by Pfirrmann's grading system, disc bulging, high intensity zone (HIZ), spondylolisthesis, and any type of Modic changes in the follow-up MRIs. We compared the follow-up MRI findings with the baseline findings; the progress of each finding over the 10 years were also compared between the groups with (n = 36) and without (n = 13) LBP. Results Average age of the study participants at follow-up was 44.8 years; 25 were female and 24 were male. Average age, sex, body mass index, and smoking habits of those who did and did not participate in the follow-up study, as well as the demographic characteristics of those who did and did not have LBP history during the 10 years, were not significantly different. Compared with the group without LBP history, the group that had LBP history during the 10 years did not have a significantly increased prevalence of disc degeneration, disc bulging, and HIZ in the follow-up and baseline MRIs. Spondylolisthesis and any type of Modic changes were also not associated with LBP history during the 10 years. Conclusions Follow-up MRI findings consistent with Pfirrmann grading >= 4, disc bulging, HIZ, spondylolisthesis, and any type of Modic changes were not associated with LBP history during the 10 years between the baseline and follow-up study. The progresses of these findings were also not associated with the LBP history. In addition, baseline MRI findings were not associated with LBP history during the 10 years; therefore, our data suggest that baseline MRI findings cannot predict future LBP.	[Tonosu, Juichi; Higashikawa, Akiro; Okazaki, Hiroshi] Kanto Rosai Hosp, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan; [Oka, Hiroyuki; Matsudaira, Ko] Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Oka, H (corresponding author), Univ Tokyo, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr, Fac Med, Tokyo, Japan.	okah-tky@umin.ac.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Industrial Disease Clinical Research Grants [14020301]	Industrial Disease Clinical Research Grants	This work was supported by the Industrial Disease Clinical Research Grants No. 14020301 (URL:http://www.mhiw.go.jp/ seisakunitsuite/bunya/koyou_roudou/roudoukijun/ rousai/hojokin/0000051021.html) to KM and this fund is managed by Japanese public agencies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfieri A, 2013, J NEUROSURG SCI, V57, P103; APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Berg L, 2013, SKELETAL RADIOL, V42, P1593, DOI 10.1007/s00256-013-1700-x; Borenstein DG, 2001, J BONE JOINT SURG AM, V83A, P1306, DOI 10.2106/00004623-200109000-00002; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Brinjikji W, 2015, AM J NEURORADIOL, V36, P811, DOI 10.3174/ajnr.A4173; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dongfeng Ren, 2011, Spine (Phila Pa 1976), V36, pE429, DOI 10.1097/BRS.0b013e3181dfce9e; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Goldberg MS, 2000, SPINE, V25, P995, DOI 10.1097/00007632-200004150-00016; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; Jarvinen J, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0540-3; Kalichman L, 2009, SPINE, V34, P199, DOI 10.1097/BRS.0b013e31818edcfd; Kjaer P, 2005, SPINE, V30, P1173, DOI 10.1097/01.brs.0000162396.97739.76; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Maatta JH, 2015, SPINE, V40, P1187, DOI 10.1097/BRS.0000000000000937; McGregor A H, 1997, Eur Spine J, V6, P308, DOI 10.1007/BF01142676; McNee P, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-234; Mikkone P, 2016, EUR SPINE J, V25, P635, DOI 10.1007/s00586-015-4065-0; Mitra D, 2004, CLIN RADIOL, V59, P1002, DOI 10.1016/j.crad.2004.06.001; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Mok FPS, 2016, SPINE J, V16, P32, DOI 10.1016/j.spinee.2015.09.060; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Schellhas KP, 1996, SPINE, V21, P79, DOI 10.1097/00007632-199601010-00018; Shiri Rahman, 2010, Am J Med, V123, DOI 10.1016/j.amjmed.2009.05.028; Stadnik TW, 1998, RADIOLOGY, V206, P49, DOI 10.1148/radiology.206.1.9423651; Steffens D, 2014, EUR J PAIN, V18, P755, DOI 10.1002/j.1532-2149.2013.00427.x; Suri P, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-152; Tamcan O, 2010, PAIN, V150, P451, DOI 10.1016/j.pain.2010.05.019; Tonosu J, 2017, J PAIN RES, V10, P47, DOI 10.2147/JPR.S122380; Videman T, 2003, SPINE, V28, P582, DOI 10.1097/00007632-200303150-00013; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Weishaupt D, 1998, RADIOLOGY, V209, P661, DOI 10.1148/radiology.209.3.9844656	36	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188057	10.1371/journal.pone.0188057	http://dx.doi.org/10.1371/journal.pone.0188057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141001	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400049
J	Acuna, SM; Aoki, JI; Laranjeira-Silva, MF; Zampieri, RA; Fernandes, JCR; Muxel, SM; Floeter-Winter, LM				Acuna, Stephanie Maia; Aoki, Juliana Ide; Laranjeira-Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Ribeiro Fernandes, Juliane Cristina; Muxel, Sandra Marcia; Floeter-Winter, Lucile Maria			Arginase expression modulates nitric oxide production in Leishmania (Leishmania) amazonensis	PLOS ONE			English	Article							MAJOR AMASTIGOTES; COMPLEX I; PARASITE; NITRATION; OXIDOREDUCTASE; PROMASTIGOTES; MECHANISMS; SYNTHASE; GENE; CONSEQUENCES	Background Arginase is an enzyme that converts L-arginine to urea and L-ornithine, an essential substrate for the polyamine pathway supporting Leishmania (Leishmania) amazonensis replication and its survival in the mammalian host. L-arginine is also the substrate of macrophage nitric oxide synthase 2 (NOS2) to produce nitric oxide (NO) that kills the parasite. This competition can define the fate of Leishmania infection. Methodology/Principal findings The transcriptomic profiling identified a family of oxidoreductases in L. (L.) amazonensis wild-type (La-WT) and L. (L.) amazonensis arginase knockout (La-arg(-)) promastigotes and axenic amastigotes. We highlighted the identification of an oxidoreductase that could act as nitric oxide synthase-like (NOS-like), due to the following evidences: conserved domain composition, the participation of NO production during the time course of promastigotes growth and during the axenic amastigotes differentiation, regulation dependence on arginase activity, as well as reduction of NO amount through the NOS activity inhibition. NO quantification was measured by DAF-FM labeling analysis in a flow cytometry. Conclusions/Significance We described an arginase-dependent NOS-like activity in L. (L.) amazonensis and its role in the parasite growth. The increased detection of NO production in the mid-stationary and late-stationary growth phases of La-WT promastigotes could suggest that this production is an important factor to metacyclogenesis triggering. On the other hand, La-arg(-) showed an earlier increase in NO production compared to La-WT, suggesting that NO production can be arginase-dependent. Interestingly, La-WT and La-arg(-) axenic amastigotes produced higher levels of NO than those observed in promastigotes. As a conclusion, our work suggested that NOS-like is expressed in Leishmania in the stationary growth phase promastigotes and amastigotes, and could be correlated to metacyclogenesis and amastigotes growth in a dependent way to the internal pool of L-arginine and arginase activity.	[Acuna, Stephanie Maia; Aoki, Juliana Ide; Laranjeira-Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Ribeiro Fernandes, Juliane Cristina; Muxel, Sandra Marcia; Floeter-Winter, Lucile Maria] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil	Universidade de Sao Paulo	Muxel, SM; Floeter-Winter, LM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	sandrammuxel@usp.br; lucile@usp.br	Aoki, Juliana Ide/K-7927-2018; Laranjeira-Silva, Maria Fernanda/H-9056-2012; Floeter-Winter, Lucile Maria/AAE-7629-2019; Zampieri, Ricardo/D-3706-2018; Floeter-Winter, Lucile Maria/K-2618-2012; Muxel, Sandra/F-7464-2012; Maia Acuna, Stephanie/T-1571-2017; Fernandes, Juliane/R-6016-2017	Aoki, Juliana Ide/0000-0002-1745-0310; Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Muxel, Sandra/0000-0003-0118-5361; Maia Acuna, Stephanie/0000-0001-6074-4077; Fernandes, Juliane/0000-0001-7754-3925	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307587/2014-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/50717-1, 2016/19815-2]; FAPESP [2015/25942-4]; CNPq [307587/2014-2, 103563/2013-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br 307587/2014-2.) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, www. fapesp.br 2014/50717-1, 2016/19815-2). SMA received a fellowship from FAPESP (2015/25942-4) and CNPq (103563/2013-0), and LMFW received a research fellowship from CNPq (307587/2014-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Adhuna A, 2000, IMMUNOL LETT, V71, P171, DOI 10.1016/S0165-2478(00)00158-9; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Aoki JI, 2017, PLOS NEGL TROP DIS, V11; Aoki JI, 2017, PLOS NEGL TROP DIS; Balafanova Z, 2002, J BIOL CHEM, V277, P15021, DOI 10.1074/jbc.M112451200; Basu NK, 1997, FEMS MICROBIOL LETT, V156, P43, DOI 10.1016/S0378-1097(97)00401-1; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Boitz JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00554-16; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Castilho-Martins EA, 2015, ELECTROPHORESIS; Castilho-Martins EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027818; Cysne-Finkelstein L, 1998, EXP PARASITOL, V89, P58, DOI 10.1006/expr.1998.4276; da Silva ER, 2002, INT J PARASITOL, V32, P727, DOI 10.1016/S0020-7519(02)00002-4; da Silva Maria Fernanda Laranjeira, 2014, Subcell Biochem, V74, P103, DOI 10.1007/978-94-007-7305-9_4; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; Fiebig M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005186; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; FONTECAVE M, 1994, BIOMETALS, V7, P3; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Genestra M, 2006, ARCH MED RES, V37, P328, DOI 10.1016/j.arcmed.2005.07.011; Genestra M, 2003, MED MICROBIOL IMMUN, V192, P217, DOI 10.1007/s00430-003-0176-z; Genestra M, 2006, ARCH MICROBIOL, V185, P348, DOI 10.1007/s00203-006-0105-9; Goldman-Pinkovich A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005494; GREEN SJ, 1990, J IMMUNOL, V145, P4290; GREEN SJ, 1990, J IMMUNOL, V144, P278; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; HANUKOGLU I, 1993, ARCH BIOCHEM BIOPHYS, V305, P489, DOI 10.1006/abbi.1993.1452; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hodgkinson VH, 1996, EXP PARASITOL, V83, P94, DOI 10.1006/expr.1996.0053; Holzmuller P, 2006, INFECT GENET EVOL, V6, P187, DOI 10.1016/j.meegid.2005.03.003; Ji YB, 2006, J BIOL CHEM, V281, P1986, DOI 10.1074/jbc.M509480200; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; da Silva MFL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034022; Laranjeira-Silva MF, 2015, J PINEAL RES; Lemire BD, 2015, BBA-BIOENERGETICS, V1847, P451, DOI 10.1016/j.bbabio.2015.01.014; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; LOWENSTEIN CJ, 1994, ANN INTERN MED, V120, P227, DOI 10.7326/0003-4819-120-3-199402010-00009; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mauel J, 1997, EXP PARASITOL, V87, P98, DOI 10.1006/expr.1997.4205; May SW, 1999, CURR OPIN BIOTECH, V10, P370, DOI 10.1016/S0958-1669(99)80067-6; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Morina K, 2011, J BIOL CHEM, V286, P34627, DOI 10.1074/jbc.M111.274571; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; Muxel SM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44141; Nakagawa H, 2007, BIOL PHARM BULL, V30, P15, DOI 10.1248/bpb.30.15; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PAVETO C, 1995, J BIOL CHEM, V270, P16576, DOI 10.1074/jbc.270.28.16576; Pereira M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003683; Piacenza L, 2001, P NATL ACAD SCI USA, V98, P7301, DOI 10.1073/pnas.121520398; Planchet E, 2006, PLANT SIGNAL BEHAV, V1, P46, DOI 10.4161/psb.1.2.2435; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Salvati L, 2001, BBA-PROTEIN STRUCT M, V1545, P357, DOI 10.1016/S0167-4838(00)00297-1; Sarkar A, 2011, CYTOM PART A, V79A, P35, DOI 10.1002/cyto.a.21001; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; Seguin O, 2016, CELL IMMUNOL, V309, P1, DOI 10.1016/j.cellimm.2016.08.004; Souza JM, 2000, ARCH BIOCHEM BIOPHYS, V380, P360, DOI 10.1006/abbi.2000.1940; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Teixeira DE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003594; Temporal RM, 2005, J ENZYM INHIB MED CH, V20, P13, DOI 10.1080/14756360400015207; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Watmough NJ, 2010, BBA-BIOENERGETICS, V1797, P1910, DOI 10.1016/j.bbabio.2010.10.007; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550	74	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187186	10.1371/journal.pone.0187186	http://dx.doi.org/10.1371/journal.pone.0187186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135983	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200014
J	Garcia-Jimenez, A; Teruel-Puche, JA; Garcia-Ruiz, PA; Saura-Sanmartin, A; Berna, J; Garcia-Canovas, F; Rodriguez-Lopez, JN				Garcia-Jimenez, Antonio; Teruel-Puche, Jose Antonio; Garcia-Ruiz, Pedro Antonio; Saura-Sanmartin, Adrian; Berna, Jose; Garcia-Canovas, Francisco; Rodriguez-Lopez, Jose Neptuno			Structural and kinetic considerations on the catalysis of deoxyarbutin by tyrosinase	PLOS ONE			English	Article							CONSUMER SAFETY SCCS; MUSHROOM TYROSINASE; SCIENTIFIC COMMITTEE; DEPIGMENTING AGENT; COSMETIC PRODUCTS; CRYSTAL-STRUCTURE; CATECHOL OXIDASE; DIPHENOLASE ACTIVITIES; BIOSYNTHESIS PATHWAY; MICHAELIS CONSTANTS	Deoxyarbutin, a potent inhibitor of tyrosinase, could act as substrate of the enzyme. Oxytyrosinase is able to hydroxylate deoxyarbutin and finishes the catalytic cycle by oxidizing the formed o-diphenol to quinone, while the enzyme becomes deoxytyrosinase, which evolves to oxytyrosinase in the presence of oxygen. This compound is the only one described that does not release o-diphenol after the hydroxylation step. Oxytyrosinase hydroxylates the deoxyarbutin in ortho position of the phenolic hydroxyl group by means of an aromatic electrophilic substitution. As the oxygen orbitals and the copper atoms are not coplanar, but in axial/equatorial position, the concerted oxidation/reduction cannot occur and the release of a copper atom to bind again in coplanar position, enabling the oxidation/reduction or release of the o-diphenol from the active site to the medium. In the case of deoxyarbutin, the o-diphenol formed is repulsed by the water due to its hydrophobicity, and so can bind correctly and be oxidized to a quinone before being released. Deoxyarbutin has been characterized with:(kD-Arb)(cat) = 1.95 +/- 0.06 s(-1) and K-M(D-Arb) = 33 +/- 4 mu M. Computational simulations of the interaction of beta-arbutin, deoxyarbutin and their o-diphenol products with tyrosinase show how these ligands bind at the copper centre of tyrosinase. The presence of an energy barrier in the release of the o-diphenol product of deoxyarbutin, which is not present in the case of beta-arbutin, together with the differences in polarity and, consequently differences in their interaction with water help understand the differences in the kinetic behaviour of both compounds. Therefore, it is proposed that the release of the o-diphenol product of deoxyarbutin from the active site might be slower than in the case of beta-arbutin, contributing to its oxidation to a quinone before being released from the protein into the water phase.	[Garcia-Jimenez, Antonio; Garcia-Canovas, Francisco; Rodriguez-Lopez, Jose Neptuno] Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain; [Teruel-Puche, Jose Antonio] Univ Murcia, Grp Mol Interact Membranes, Dept Biochem & Mol Biol A, Murcia, Spain; [Garcia-Ruiz, Pedro Antonio] Univ Murcia, Fac Vet, Dept Organ Chem, Grp Chem Carbohydrates Ind Polymers & Addit, Murcia, Spain; [Saura-Sanmartin, Adrian; Berna, Jose] Univ Murcia, Fac Chem, Dept Organ Chem, Grp Synthet Organ Chem, Murcia, Spain	University of Murcia; University of Murcia; University of Murcia; University of Murcia	Garcia-Canovas, F (corresponding author), Univ Murcia, GENZ Grp Res Enzymol, Dept Biochem & Mol Biol A, Reg Campus Int Excellence,Campus Mare Nostrum, Murcia, Spain.	canovasf@um.es	Saura-Sanmartín, Adrián/B-6971-2017; Puche, José Antonio Teruel/R-4137-2018; Berna, Jose/C-9334-2011; Garcia-Canovas, Francisco/M-1290-2014	Saura-Sanmartín, Adrián/0000-0002-9099-3450; Puche, José Antonio Teruel/0000-0003-2256-3368; Berna, Jose/0000-0001-7775-3703; Garcia-Canovas, Francisco/0000-0002-8869-067X; Rodriguez-Lopez, Jose Neptuno/0000-0001-6863-1173	Fundacion Seneca (CARM, Murcia, Spain) [19545/PI/14, 19304/PI/14, 19240/PI/14]; MINECO [SAF2016-77241-R, CTQ2014-56887-P]; Fondos FEDER; University of Murcia (Murcia) [UMU15452, UMU17766]; FPU fellowship from the University of Murcia	Fundacion Seneca (CARM, Murcia, Spain)(Fundacion Seneca); MINECO(Spanish Government); Fondos FEDER(European Commission); University of Murcia (Murcia); FPU fellowship from the University of Murcia	This work was supported by the Fundacion Seneca (CARM, Murcia, Spain) under Projects 19545/PI/14, 19304/PI/14 and 19240/PI/14; MINECO under Projects SAF2016-77241-R and CTQ2014-56887-P (Co-financing with Fondos FEDER); and University of Murcia (Murcia) under Projects UMU15452 and UMU17766. A. Garcia-Jimenez has a FPU fellowship from the University of Murcia.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Alvarez-Parrilla E, 2007, FOOD CHEM, V101, P1346, DOI 10.1016/j.foodchem.2006.03.040; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boissy RE, 2005, EXP DERMATOL, V14, P601, DOI 10.1111/j.0906-6705.2005.00337.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chawla S, 2008, BRIT J DERMATOL, V159, P1267, DOI 10.1111/j.1365-2133.2008.08864.x; Cheng TJ, 2007, J CHEM INF MODEL, V47, P2140, DOI 10.1021/ci700257y; Degen GH, 2016, REGUL TOXICOL PHARM, V74, P77, DOI 10.1016/j.yrtph.2015.11.007; Degen GH, 2016, REGUL TOXICOL PHARM, V74, P75, DOI 10.1016/j.yrtph.2015.11.008; Degen GH, 2015, REGUL TOXICOL PHARM, V73, P866, DOI 10.1016/j.yrtph.2015.10.008; Garcia-Molina MD, 2014, REACT KINET MECH CAT, V112, P305, DOI 10.1007/s11144-014-0723-1; Garcia-Molina MD, 2014, BIOORGAN MED CHEM, V22, P3360, DOI 10.1016/j.bmc.2014.04.048; Deri B, 2016, SCI REP-UK, V6, DOI 10.1038/srep34993; Devece C, 1999, J AGR FOOD CHEM, V47, P4506, DOI 10.1021/jf981398+; Espin JC, 1998, J AGR FOOD CHEM, V46, P2968, DOI 10.1021/jf971045v; Espin JC, 2000, EUR J BIOCHEM, V267, P1270, DOI 10.1046/j.1432-1327.2000.01013.x; Espin JC, 1996, J FOOD SCI, V61, P1177, DOI 10.1111/j.1365-2621.1996.tb10955.x; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P332, DOI 10.1016/S1357-2725(01)00133-9; Fenoll LG, 2002, INT J BIOCHEM CELL B, V34, P1594, DOI 10.1016/S1357-2725(02)00076-6; Fenoll LG, 2001, BBA-PROTEIN STRUCT M, V1548, P1, DOI 10.1016/S0167-4838(01)00207-2; Garcia-Jimenez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177330; Garcia-Jimenez A, 2017, REACT KINET MECH CAT, V120, P1, DOI 10.1007/s11144-016-1106-6; Garcia-Jimenez A, 2017, INT J BIOL MACROMOL, V98, P622, DOI 10.1016/j.ijbiomac.2017.02.032; Garcia-Jimenez A, 2016, BIOORGAN MED CHEM, V24, P4434, DOI 10.1016/j.bmc.2016.07.048; Garcia-Jimenez A, 2016, IUBMB LIFE, V68, P663, DOI 10.1002/iub.1528; Garcia-Molina F, 2007, J AGR FOOD CHEM, V55, P9739, DOI 10.1021/jf0712301; Garcia-Molina F, 2005, J AGR FOOD CHEM, V53, P3702, DOI 10.1021/jf048340h; Garcia-Sevilla F, 2000, BIOSYSTEMS, V54, P151, DOI 10.1016/S0303-2647(99)00071-4; Gerald C.F., 1978, APPL NUMERICAL ANAL; Goldfeder M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5505; Hamed SH, 2006, J COSMET SCI, V57, P291; HERMANS J, 1984, BIOPOLYMERS, V23, P1513, DOI 10.1002/bip.360230807; Hu ZM, 2009, J DERMATOL SCI, V55, P179, DOI 10.1016/j.jdermsci.2009.06.003; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; Ito S, 2007, CHEM MELANINS PIGMEN, P282; JACKMAN MP, 1992, BIOCHEM J, V282, P915, DOI 10.1042/bj2820915; Joseph P, 1998, BRIT J CANCER, V78, P312, DOI 10.1038/bjc.1998.492; Kanteev M, 2015, PROTEIN SCI, V24, P1360, DOI 10.1002/pro.2734; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; Kolbe L, 2013, J EUR ACAD DERMATOL, V27, P19, DOI 10.1111/jdv.12051; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Lee S, 2016, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-016-0104-y; LERCH K, 1981, MET IONS BIOL SYST, V13, P143; Levin C Y, 2001, Am J Clin Dermatol, V2, P213, DOI 10.2165/00128071-200102040-00002; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Lin CC, 2011, INT J MOL SCI, V12, P5946, DOI 10.3390/ijms12095946; Madera Core, 2006, J SCI; Mary Sea Garcia-Molina, 2013, BIOSCI BIOTECH BIOCH, V77, P2383, DOI 10.1271/bbb.130500; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; MCEVILY AJ, 1992, CRIT REV FOOD SCI, V32, P253, DOI 10.1080/10408399209527599; Mendes E, 2014, EXPERT OPIN DRUG DIS, V9, P533, DOI 10.1517/17460441.2014.907789; Miao F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165338; Munoz JL, 2006, ANAL BIOCHEM, V351, P128, DOI 10.1016/j.ab.2006.01.011; Nokinsee D, 2015, ENZYME RES, V2015, DOI 10.1155/; Oostenbrink C, 2005, EUR BIOPHYS J BIOPHY, V34, P273, DOI 10.1007/s00249-004-0448-6; Park KL, 2017, ARCH PHARM RES, V40, P57, DOI 10.1007/s12272-016-0866-x; Pillaiyar T, 2015, EXPERT OPIN THER PAT, V25, P775, DOI 10.1517/13543776.2015.1039985; Rodriguez-Lopez JN, 2001, BBA-PROTEIN STRUCT M, V1548, P238, DOI 10.1016/S0167-4838(01)00237-0; Rodriguez-Lopez JN, 2000, BIOCHEMISTRY-US, V39, P10497, DOI 10.1021/bi000539+; RODRIGUEZLOPEZ JN, 1993, BIOCHEM J, V293, P859, DOI 10.1042/bj2930859; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sardana K, 2015, EXPERT REV CLIN PHAR, V8, P123, DOI 10.1586/17512433.2015.977255; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Si YX, 2011, INT J BIOL MACROMOL, V48, P700, DOI 10.1016/j.ijbiomac.2011.02.015; Solem E, 2016, ANGEW CHEM INT EDIT, V55, P2884, DOI 10.1002/anie.201508534; Solomon EI, 2014, CHEM REV, V114, P3659, DOI 10.1021/cr400327t; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Tofani RP, 2016, SCI PHARM, V84, P634, DOI 10.3390/scipharm84040634; Urabe K, 1998, MIXED EPIDERMAL DERM; Ortiz-Ruiz CV, 2016, J DERMATOL SCI, V82, P115, DOI 10.1016/j.jdermsci.2016.02.004; Ortiz-Ruiz CV, 2015, IUBMB LIFE, V67, P828, DOI 10.1002/iub.1439; Ortiz-Ruiz CV, 2015, J AGR FOOD CHEM, V63, P7032, DOI 10.1021/acs.jafc.5b02523; Wang ZJ, 2013, INT J BIOL MACROMOL, V55, P15, DOI 10.1016/j.ijbiomac.2012.12.040; Washington C, 2015, ARCH BIOCHEM BIOPHYS, V577, P24, DOI 10.1016/j.abb.2015.04.007; WEI CI, 1991, TOXICOL LETT, V59, P213, DOI 10.1016/0378-4274(91)90074-G; Won YK, 2014, ARCH DERMATOL RES, V306, P455, DOI 10.1007/s00403-014-1439-9; Wu Z, 2010, J PHYS CHEM B, V114, P10524, DOI 10.1021/jp1019763; Yang CH, 2013, BIOSCI BIOTECH BIOCH, V77, P1127, DOI 10.1271/bbb.130042; Yang CH, 2010, INT J MOL SCI, V11, P3977, DOI 10.3390/ijms11103977; Yoshimura M, 2005, BIOSCI BIOTECH BIOCH, V69, P2368, DOI 10.1271/bbb.69.2368; Zheng ZP, 2011, FOOD FUNCT, V2, P259, DOI 10.1039/c1fo10033e; Zhou HF, 2009, MOL PHARMACOL, V76, P579, DOI 10.1124/mol.109.057323	85	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187845	10.1371/journal.pone.0187845	http://dx.doi.org/10.1371/journal.pone.0187845			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136639	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200035
J	Guest, JF; Esteban, J; Manganelli, AG; Novelli, A; Rizzardini, G; Serra, M				Guest, Julian F.; Esteban, Jaime; Manganelli, Anton G.; Novelli, Andrea; Rizzardini, Giuliano; Serra, Miquel			Comparative efficacy and safety of antibiotics used to treat acute bacterial skin and skin structure infections: Results of a network meta-analysis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SOFT-TISSUE INFECTIONS; ONCE-WEEKLY DALBAVANCIN; MRSA COMPLICATED SKIN; IN-VITRO ACTIVITY; ISPOR TASK-FORCE; DOUBLE-BLIND; VANCOMYCIN; TIGECYCLINE; DAPTOMYCIN	Objective This NMA compared the efficacy and safety between IV antibiotics that are used in the current standard of care for managing adult patients (>= 18 years of age) with ABSSSI. Methods Comparators were chosen on the basis that both direct and indirect comparisons between the interventions of interest could be performed. Outcomes of the analysis were selected on the basis that they are frequently measured and reported in trials involving ABSSSI patients, and only published randomised control trials of any size and duration and with any blinding status were eligible for inclusion in the analysis. The NMA was performed using both a fixedeffect and random-effect model. Efficacy-related endpoints were (1) clinical treatment success and (2) microbiological success at TOC visit. Safety-related endpoints were (1) number of discontinuations due to AEs/ SAEs, (2) patients experiencing AEs, (3) patients experiencing SAEs and (4) all-cause mortality. Results Study interventions included daptomycin, dalbavancin, linezolid and tigecycline. Vancomycin was the comparator in all studies, except in two where it was linezolid and teicoplanin. The NMA showed that irrespective of patient subgroup, the likelihood of clinical and microbiological success with dalbavancin was statistically similar to the comparators studied. No statistically significant differences were observed between dalbavancin and any of the comparators in the discontinuation rate due to AEs/SAEs. In contrast, dalbavancin was associated with a significantly lower likelihood of experiencing an AE than linezolid, a significantly lower likelihood of experiencing a SAE than vancomycin and daptomycin, and a significantly lower risk of all-cause mortality than vancomycin, linezolid and tigecycline. Conclusion Dalbavancin affords a promising, new alternative IV antimicrobial agent which is as effective as traditional therapies, but with the added benefit of enabling clinicians to treat patients with ABSSSI in different organisational settings. Notwithstanding, any introduction of an effective treatment with a differential mode of administration into healthcare systems must be followed by a change in clinical practice and patient management in order to fully achieve desirable economic outcomes.	[Guest, Julian F.] Kings Coll London, Fac Life Sci & Med, London, England; [Guest, Julian F.] Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England; [Esteban, Jaime] UAM, Fdn Jimenez Diaz, IIS, Dept Clin Microbiol, Madrid, Spain; [Manganelli, Anton G.; Serra, Miquel] Univ Pompeu Fabra, Ctr Res Hlth & Econ CRES, Barcelona, Spain; [Novelli, Andrea] Univ Florence, Dept Hlth Sci, Florence, Italy; [Rizzardini, Giuliano] L Sacco Hosp Vialba, Dept Infect Dis, Milan, Italy; [Rizzardini, Giuliano] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa	University of London; King's College London; Autonomous University of Madrid; Fundacion Jimenez Diaz; Pompeu Fabra University; University of Florence; University of Milan; Luigi Sacco Hospital; University of Witwatersrand	Guest, JF (corresponding author), Kings Coll London, Fac Life Sci & Med, London, England.; Guest, JF (corresponding author), Catalyst Hlth Econ Consultants, Rickmansworth, Herts, England.	julian.guest@catalyst-health.com	Esteban, Jaime/S-6554-2018; Serra-Burriel, Miquel/D-5444-2019; Serra-Burriel, Miquel/M-8662-2019; Esteban, Jaime/W-2049-2019	Esteban, Jaime/0000-0002-8971-3167; Serra-Burriel, Miquel/0000-0001-8595-1224; Serra-Burriel, Miquel/0000-0001-8595-1224; Manganelli, Anton-Giulio/0000-0003-1787-7215; Guest, Julian F./0000-0003-0162-2007; NOVELLI, ANDREA/0000-0001-7840-5233	Angelini SpA, Rome, Italy	Angelini SpA, Rome, Italy	This study was funded by Angelini SpA, Rome, Italy. However, the funders had no role in study design, data collection and analysis or preparation of the manuscript. The funders commissioned Professor Julian F Guest from Catalyst Health Economics Consultants to write the manuscript.	Ades AE, 2006, PHARMACOECONOMICS, V24, P1, DOI 10.2165/00019053-200624010-00001; Aikawa N, 2013, J INFECT CHEMOTHER, V19, P447, DOI 10.1007/s10156-012-0501-9; An MM, 2013, INT J ANTIMICROB AG, V41, P426, DOI 10.1016/j.ijantimicag.2012.12.012; [Anonymous], DUR001301; [Anonymous], 2015, SYSTEMATIC LIT REV A; [Anonymous], DUR001302; Arbeit RD, 2004, CLIN INFECT DIS, V38, P1673, DOI 10.1086/420818; Baldoni D, 2013, INT J ANTIMICROB AG, V42, P220, DOI 10.1016/j.ijantimicag.2013.05.019; Ballya M, 2012, INT J ANTIMICROB AG, V40, P479, DOI 10.1016/j.ijantimicag.2012.08.004; Bliziotis IA, 2010, ANN PHARMACOTHER, V44, P97, DOI 10.1345/aph.1M264; Boucher HW, 2014, NEW ENGL J MED, V370, P2169, DOI 10.1056/NEJMoa1310480; Bounthavong M, 2010, CURR MED RES OPIN, V26, P407, DOI 10.1185/03007990903454912; Breedt J, 2005, ANTIMICROB AGENTS CH, V49, P4658, DOI 10.1128/AAC.49.11.4658-4666.2005; Degener F, 2015, VALUE HEALTH, V18, pA580, DOI 10.1016/j.jval.2015.09.1938; Dias S, 2011, 4 NICE DSU; Dias S, 2011, 3 NICE DSU; Dodds TJ, 2009, ANZ J SURG, V79, P629, DOI 10.1111/j.1445-2197.2009.05018.x; Dryden M., 2016, J ANTIMICROB CHEM S3, V65, piii35; Eckman C, 2010, EUR J MED RES, V15, P554; European Medicines Agency, 2016, AD CHMP M 25 8 JAN; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; FDA, 2013, GUID IND AC BACT SKI; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; Fu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058240; Guo Z, 2011, CHIN J INFECT CHEMOT, V11, P3; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Hoaglin DC, 2011, VALUE HEALTH, V14, P429, DOI 10.1016/j.jval.2011.01.011; Itani KMF, 2010, AM J SURG, V199, P804, DOI 10.1016/j.amjsurg.2009.08.045; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Jauregui LE, 2005, CLIN INFECT DIS, V41, P1407, DOI 10.1086/497271; Katz DE, 2008, INT J CLIN PRACT, V62, P1455, DOI 10.1111/j.1742-1241.2008.01854.x; Khachatryan A, 2016, VALUE HLTH, V16; Kohno S, 2007, J ANTIMICROB CHEMOTH, V60, P1361, DOI 10.1093/jac/dkm369; Konychev A, 2013, DRUG AGING, V30, P829, DOI 10.1007/s40266-013-0114-8; Lepak A, 2015, ANTIMICROB AGENTS CH, V59, P7833, DOI 10.1128/AAC.01717-15; Liang BB, 2010, INT J ANTIMICROB AG, V35, P3, DOI 10.1016/j.ijantimicag.2009.09.013; Lin DF, 2008, INT J ANTIMICROB AG, V32, P241, DOI 10.1016/j.ijantimicag.2008.04.004; Logman JFS, 2010, CURR MED RES OPIN, V26, P1565, DOI 10.1185/03007995.2010.481251; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McCurdy SP, 2015, ANTIMICROB AGENTS CH, V59, P5007, DOI 10.1128/AAC.00274-15; Nathwani D, 2009, INT J ANTIMICROB AG, V34, pS24, DOI 10.1016/S0924-8579(09)70546-1; Polyzos KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041870; Ray GT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-252; Rolston KVI, 2016, J ANTIBIOT, V69, P381, DOI 10.1038/ja.2015.120; Sacchidanand S, 2005, INT J INFECT DIS, V9, P251, DOI 10.1016/j.ijid.2005.05.003; Schardt C, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-16; Sharpe JN, 2005, AM J SURG, V189, P425, DOI 10.1016/j.amjsurg.2005.01.011; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Stevens DL, 2002, CLIN INFECT DIS, V34, P1481, DOI 10.1086/340353; Teras J, 2008, J CHEMOTHERAPY, V20, P20, DOI 10.1179/joc.2008.20.Supplement-1.20; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Thom H, 2015, CURR MED RES OPIN, V31, P1539, DOI 10.1185/03007995.2015.1058248; Vardakas KZ, 2012, MAYO CLIN PROC, V87, P349, DOI 10.1016/j.mayocp.2011.12.011; Verastegui JE, 2016, EXPERT REV CLIN PHAR, V9, P1039, DOI 10.1080/17512433.2016.1195683; Wang SZ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004744; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; Wilcox M, 2004, J ANTIMICROB CHEMOTH, V53, P335, DOI 10.1093/jac/dkh088; Wilcox MH, 2009, INT J ANTIMICROB AG, V34; Wilcox MH, 2009, CLIN INFECT DIS, V48, P203, DOI 10.1086/595686	61	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187792	10.1371/journal.pone.0187792	http://dx.doi.org/10.1371/journal.pone.0187792			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136035	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200033
J	Liu, F; Zeng, ZY; Jiang, R				Liu, Fei; Zeng, Zhiyuan; Jiang, Rong			A video-based real-time adaptive vehicle-counting system for urban roads	PLOS ONE			English	Article								In developing nations, many expanding cities are facing challenges that result from the overwhelming numbers of people and vehicles. Collecting real-time, reliable and precise traffic flow information is crucial for urban traffic management. The main purpose of this paper is to develop an adaptive model that can assess the real-time vehicle counts on urban roads using computer vision technologies. This paper proposes an automatic real-time background update algorithm for vehicle detection and an adaptive pattern for vehicle counting based on the virtual loop and detection line methods. In addition, a new robust detection method is introduced to monitor the real-time traffic congestion state of road section. A prototype system has been developed and installed on an urban road for testing. The results show that the system is robust, with a real-time counting accuracy exceeding 99% in most field scenarios.	[Liu, Fei; Zeng, Zhiyuan] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China; [Jiang, Rong] Huawei Corp, Shenzhen, Peoples R China	Huazhong University of Science & Technology; Huawei Technologies	Zeng, ZY (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China.	chengru2003@hust.edu.cn						Al-Gami SM, 2006, PROC WRLD ACAD SCI E, V18, P180; Chen T.H., 2007, 2 INT C INN COMP INF, P238; Chen TH, 2007, 2007 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, VOL II, PROCEEDINGS, P519; Coifman B, 1998, TRANSPORT RES C-EMER, V6, P271, DOI 10.1016/S0968-090X(98)00019-9; Cucchiara R, 2002, VIDEO-BASED SURVEILLANCE SYSTEMS: COMPUTER VISION AND DISTRIBUTED PROCESSING, P145; Cucchiara R, 2001, 2001 IEEE INTELLIGENT TRANSPORTATION SYSTEMS - PROCEEDINGS, P334, DOI 10.1109/ITSC.2001.948679; Gajda J, 2001, IEEE IMTC P, P460, DOI 10.1109/IMTC.2001.928860; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2016, IEEE T CONTR SYST T, V24, P1036, DOI 10.1109/TCST.2015.2476799; Hu XS, 2016, IEEE T IND ELECTRON, V63, P2645, DOI 10.1109/TIE.2015.2461523; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; HUSSAIN TM, 1995, IEEE T VEH TECHNOL, V44, P683, DOI 10.1109/25.406637; Kim SE, 1998, P 5 WORLD C INT TRAN; Lei M, 2008, SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, P523, DOI 10.1109/SITIS.2008.91; Li SG, 2014, IET INTELL TRANSP SY, V8, P164, DOI 10.1049/iet-its.2012.0099; Li ZX, 2006, J TRANSP ENG, V132, P565, DOI 10.1061/(ASCE)0733-947X(2006)132:7(565); Mimbela L.E.Y., 2007, SUMMARY VEHICLE DETE; Mohana HS, 2009, INTERNATIONAL CONFERENCE ON ADVANCED COMPUTER CONTROL : ICACC 2009 - PROCEEDINGS, P791, DOI 10.1109/ICACC.2009.149; Pornpanomchai C, 2008, INT C WAVEL ANAL PAT, P356, DOI 10.1109/ICWAPR.2008.4635804; Qi L, 2008, 2008 WORKSHOP ON POWER ELECTRONICS AND INTELLIGENT TRANSPORTATION SYSTEM, PROCEEDINGS, P529, DOI 10.1109/PEITS.2008.124; Robert K., 2009, P 2009 12 INT IEEE C, P1, DOI [10.1109/ITSC.2009.5309837, DOI 10.1109/ITSC.2009.5309837]; Rodriguez T, 2010, MACH VISION APPL, V21, P555, DOI 10.1007/s00138-009-0185-z; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Watanabe A., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P3170, DOI 10.1109/IJCNN.1999.836160; Yan XP, 2012, 2012 11TH INTERNATIONAL SYMPOSIUM ON DISTRIBUTED COMPUTING AND APPLICATIONS TO BUSINESS, ENGINEERING & SCIENCE (DCABES), P321, DOI 10.1109/DCABES.2012.107; Zhang L, 2015, J POWER SOURCES, V287, P129, DOI 10.1016/j.jpowsour.2015.04.043	26	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186098	10.1371/journal.pone.0186098	http://dx.doi.org/10.1371/journal.pone.0186098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135984	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200004
J	Delbarre, A; Amor, B; Bardoulat, I; Tetafort, A; Pelletier-Fleury, N				Delbarre, Angellique; Amor, Bernard; Bardoulat, Isabelle; Tetafort, Aymeric; Pelletier-Fleury, Nathalie			Do intra-articular hyaluronic acid injections delay total knee replacement in patients with osteoarthritis - A Cox model analysis	PLOS ONE			English	Article							RESTRICTED MEAN-LIFE; HIP OSTEOARTHRITIS; JOINT REPLACEMENT; EFFICACY; VISCOSUPPLEMENTATION; ARTHROPLASTY; PREVALENCE; BURDEN; COST; EPIDEMIOLOGY	Due to the growing worldwide prevalence of knee osteoarthritis, the optimal management of this issue is critical for reducing its burden. Objectives This study aimed to describe patients treated for knee osteoarthritis between 2006 and 2013 in France and to compare the delay from diagnosis to total knee replacement between patients who received intra-articular hyaluronic acid injections and those who did not receive the injections. A second objective was to compare direct medical costs for ambulatory care between treatment groups. Materials and methods Patients were selected from a representative sample of the real world administrative claims database using an algorithm developed by experts from the scientific committee of the study. Data were matched with the medico-administrative database for hospital care. A Cox proportional hazards model was stratified for the treatment group and adjusted for available socio-demographic and medical covariates to compare restricted mean survival times at different time points (1, 3, 5 and 7.5 years) between groups. Costs were expressed in 2013 euros. Results A total of 14,782 patients were treated for knee osteoarthritis (67% women; mean age = 68 years). Among this population, 1,662 patients had total knee replacement (11.2%). At each time point, restricted mean survival time without total knee replacement was significantly higher (p-values<0.001) for hyaluronic acid group, from +51 to +217 days at 1 and 7.5 years, respectively. For the year preceding total knee replacement, the means for total direct medical costs were similar between groups, (sic)744 vs (sic)805 for treatment and control groups, respectively, (p-value = 0.104). Intra-articular injections accounted for less than 10% of the total costs. Conclusion This is the first retrospective longitudinal study involving knee osteoarthritis patients using medico-administrative databases in France. The results support the effectiveness of hyaluronic acid injections in delaying total knee replacement and show that patients treated with hyaluronic acid have similar direct medical costs for ambulatory care compared to patients treated with corticosteroids only.	[Delbarre, Angellique; Pelletier-Fleury, Nathalie] Univ Paris Sud, INSERM, Ctr Res Epidemiol & Populat Hlth, Univ Paris Saclay,UVSQ, Villejuif, France; [Amor, Bernard] Univ Paris 05, Paris, France; [Bardoulat, Isabelle; Tetafort, Aymeric] QuintilesIMS, Paris 2, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; IQVIA	Delbarre, A (corresponding author), Univ Paris Sud, INSERM, Ctr Res Epidemiol & Populat Hlth, Univ Paris Saclay,UVSQ, Villejuif, France.	angelique.delbarre@inserm.fr	Pelletier-Fleury, Nathalie/R-4220-2018	Pelletier-Fleury, Nathalie/0000-0002-4821-4863	LCA Pharmaceutical, Chartres	LCA Pharmaceutical, Chartres	This French study was funded by LCA Pharmaceutical, Chartres. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Altman R, 2016, J KNEE SURG, V29, P564, DOI 10.1055/s-0035-1568992; Altman R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145776; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Assurance Maladie, 2012, PROP ASS MAL CHARG P; Bannay A, 2016, MED CARE, V54, P188, DOI 10.1097/MLR.0000000000000471; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannuru RR, 2014, SEMIN ARTHRITIS RHEU, V43, P593, DOI 10.1016/j.semarthrit.2013.10.002; Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925; Bedard NA, 2017, J ARTHROPLASTY; Bellamy N, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005321.pub2; Bennell KL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4934; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Bruyere O, 2015, SEMIN ARTHRITIS RHEU; Campbell KA, 2015, ARTHROSCOPY, V31, P2036, DOI 10.1016/j.arthro.2015.03.030; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen PY, 2001, BIOMETRICS, V57, P1030, DOI 10.1111/j.0006-341X.2001.01030.x; Colen S, 2012, BIODRUGS, V26, P257, DOI 10.2165/11632580-000000000-00000; Cooper C., 2017, ARTHRITIS CARE RES; Erturk C, 2016, KNEE SURG SPORT TR A, V24, P3653, DOI 10.1007/s00167-014-3398-2; Fautrel B, 2005, JOINT BONE SPINE, V72, P235, DOI 10.1016/j.jbspin.2004.08.009; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; Gioe TJ, 2007, CLIN ORTHOP RELAT R, P83, DOI 10.1097/BLO.0b013e31812f79a9; Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132; Guillemin F, 2011, OSTEOARTHR CARTILAGE, V19, P1314, DOI 10.1016/j.joca.2011.08.004; Guillemin F, 2012, JOINT BONE SPINE, V79, P597, DOI 10.1016/j.jbspin.2012.03.011; Henrotin Y, 2015, SEMIN ARTHRITIS RHEU, V45, P140, DOI 10.1016/j.semarthrit.2015.04.011; Indicators OE., 2015, HLTH GLANC 2011, DOI [10.1787/health_glance-2015-en, DOI 10.1787/HEALTH_GLANCE-2015-EN]; KARRISON T, 1987, J AM STAT ASSOC, V82, P1169, DOI 10.2307/2289396; Khan M, 2016, BONE JOINT J, V98B, P105, DOI [10.1302/0301-620X.98B1.36293, 10.1302/0301-620X.9881.36293]; Kostyuk A, 2015, VALUE HEALTH, V18, pA647, DOI 10.1016/j.jval.2015.09.2322; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lanes SF, 1997, ARTHRITIS RHEUM-US, V40, P1475, DOI 10.1002/art.1780400816; Le Pen C, 2005, JOINT BONE SPINE, V72, P567, DOI 10.1016/j.jbspin.2005.01.011; Leardini G, 2004, CLIN EXP RHEUMATOL, V22, P699; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Loza E, 2009, ARTHRIT RHEUM-ARTHR, V61, P158, DOI 10.1002/art.24214; Maheu E, 2016, SEMIN ARTHRITIS RHEU, V45, pS28, DOI 10.1016/j.semarthrit.2015.11.008; Mar J, 2013, Rev Esp Cir Ortop Traumatol, V57, P6, DOI 10.1016/j.recot.2012.08.006; March LM, 1997, BAILLIERE CLIN RHEUM, V11, P817, DOI 10.1016/S0950-3579(97)80011-8; Martin KR, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-219; Mazieres B, 2007, JOINT BONE SPINE, V74, P453, DOI 10.1016/j.jbspin.2007.01.037; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Merle-Vincent F, 2007, JOINT BONE SPINE, V74, P612, DOI 10.1016/j.jbspin.2007.01.038; Murphy LB, 2016, ARTHRIT CARE RES, V68, P55, DOI 10.1002/acr.22641; Neustadt DH, 2003, CLIN EXP RHEUMATOL, V21, P307; Nichols CI, 2016, J ARTHROPLASTY, V31, P1400, DOI 10.1016/j.arth.2016.01.022; Ong KL, 2016, J ARTHROPLASTY; Ozturk C, 2006, RHEUMATOL INT, V26, P314, DOI 10.1007/s00296-005-0584-z; Petrella RJ, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0513-6; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; Riddle DL, 2012, JOINT BONE SPINE, V79, P298, DOI 10.1016/j.jbspin.2011.05.005; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Tanna S, 2013, BACKGROUND PAPER 612; Thomas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173683; Turajane Thana, 2009, J Med Assoc Thai, V92 Suppl 6, pS63; Vignon E, 2006, JOINT BONE SPINE, V73, P442, DOI 10.1016/j.jbspin.2006.03.001; Waddell DD, 2016, J KNEE SURG, V29, P159, DOI 10.1055/s-0034-1395281; Weinstein AM, 2013, J BONE JOINT SURG AM, V95A, P385, DOI 10.2106/JBJS.L.00206; Zhang X, 2013, BIO-ALGORITHMS MED-S, V9, P183, DOI 10.1515/bams-2013-0101; Zucker DM, 1998, J AM STAT ASSOC, V93, P702, DOI 10.2307/2670120	62	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187227	10.1371/journal.pone.0187227	http://dx.doi.org/10.1371/journal.pone.0187227			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155833	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700007
J	Koessler, J; Schwarz, M; Weber, K; Etzel, J; Koessler, A; Boeck, M; Kobsar, A				Koessler, Juergen; Schwarz, Michaela; Weber, Katja; Etzel, Julia; Koessler, Angela; Boeck, Markus; Kobsar, Anna			The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions	PLOS ONE			English	Article							IN-VITRO; VASP PHOSPHORYLATION; STORED PLATELETS; MOLECULAR-BASIS; ADP RECEPTORS; ACTIVATION; STORAGE; 37-DEGREES-C; AGGREGATION; TRANSFUSION	Background Platelets are important for effective hemostasis and considered to be involved in pathophysiological processes, e.g. in cardiovascular diseases. Platelets provided for research or for therapeutic use are frequently separated from citrated whole blood (WB) stored for different periods of time. Although functionally intact platelets are required, the stability of platelet integrity, e.g. adenosine diphosphate (ADP) mediated responsiveness, has never been thoroughly investigated in citrated WB under ex vivo conditions. Objectives Platelet integrity was evaluated at different time points in citrated WB units, collected from healthy donors and stored for 5 days at ambient temperature. The analysis included the measurement of activation markers, of induced light transmission aggregometry and of purinergic receptor expression or function. Inhibitory pathways were explored by determination of basal vasodilator-stimulated phosphoprotein (VASP)-phosphorylation, intracellular cyclic nucleotide levels and the content of phosphodiesterase 5A. Fresh peripheral blood (PB) samples served as controls. Results On day 5 of storage, thrombin receptor activating peptide-6 (TRAP-6) stimulated CD62P expression and fibrinogen binding were comparable to PB samples. ADP induced aggregation continuously decreased during storage. Purinergic receptor expression remained unchanged, whereas the P2Y1 activity progressively declined in contrast to preserved P2Y12 and P2X1 function. Inhibitory pathways were unaffected except for a slight elevation of VASP phosphorylation at Ser(239) on day 5. Conclusion After 5 days of storage in citrated WB, platelet responsiveness to TRAP-6 is sufficiently maintained. However, ADP-mediated platelet integrity is more sensitive to deterioration, especially after storage for more than 2 days. Decreasing ADP-induced aggregation is particularly caused by the impairment of the purinergic receptor P2Y1 activity. These characteristics should be considered in the use of platelets from stored citrated WB for experimental or therapeutic issues.	[Koessler, Juergen; Schwarz, Michaela; Weber, Katja; Etzel, Julia; Koessler, Angela; Boeck, Markus; Kobsar, Anna] Univ Wurzburg, Inst Transfus Med & Haemotherapy, Wurzburg, Germany	University of Wurzburg	Koessler, J (corresponding author), Univ Wurzburg, Inst Transfus Med & Haemotherapy, Wurzburg, Germany.	koessler_j@ukw.de			German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleil B, 2005, THROMB HAEMOSTASIS, V94, P886; Bennett JS, 2001, ANN NY ACAD SCI, V936, P340; Bigalke B, 2006, EUR HEART J, V27, P2165, DOI 10.1093/eurheartj/ehl192; BOCK M, 1994, HAEMOSTASIS, V24, P230; BUTT E, 1994, J BIOL CHEM, V269, P14509; Cabeza N, 2004, DIABETES, V53, P2117, DOI 10.2337/diabetes.53.8.2117; Christie DJ, 2008, CLIN LAB STANDARDS I, V27, P46; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; de Stoppelaar SF, 2014, THROMB HAEMOSTASIS, V112, P666, DOI 10.1160/TH14-02-0126; Duerschmied D, 2014, THROMB HAEMOSTASIS, V112, P678, DOI 10.1160/TH14-02-0146; Fullard JF, 2004, CURR PHARM DESIGN, V10, P1567, DOI 10.2174/1381612043384682; Goforth CW, 2016, CRIT CARE NURSE, V36, P50, DOI 10.4037/ccn2016780; Gulliksson H, 2014, VOX SANG, V107, P205, DOI 10.1111/vox.12172; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOLME S, 1995, BRIT J HAEMATOL, V91, P212, DOI 10.1111/j.1365-2141.1995.tb05272.x; Hughes JD, 2007, TRANSFUSION, V47, P2050, DOI 10.1111/j.1537-2995.2007.01429.x; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Jobes D, 2011, TRANSFUSION, V51, P43, DOI 10.1111/j.1537-2995.2010.02772.x; Jurk K, 2005, SEMIN THROMB HEMOST, V31, P381, DOI 10.1055/s-2005-916671; Kendigelen P, 2016, ULUS TRAVMA ACIL CER, V22, P195, DOI 10.5505/tjtes.2015.40697; Kobsar A, 2014, TRANSFUSION, V54, P1782, DOI 10.1111/trf.12584; Kobsar A, 2014, TRANSFUSION, V54, P1008, DOI 10.1111/trf.12360; Kobsar AL, 2010, PLATELETS, V21, P112, DOI 10.3109/09537100903440937; Koessler J, 2016, BLOOD TRANSFUS-ITALY, V14, P545, DOI 10.2450/2015.0073-15; Koessler J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147370; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Kunapuli SP, 1998, PLATELETS, V9, P343, DOI 10.1080/09537109876401; Kunapuli SP, 2003, CURR OPIN PHARMACOL, V3, P175, DOI 10.1016/S1471-4892(03)00007-9; Lim YA, 2002, CLIN LAB HAEMATOL, V24, P377, DOI 10.1046/j.1365-2257.2002.00479.x; Liu ECK, 2006, ANAL BIOCHEM, V357, P216, DOI 10.1016/j.ab.2006.06.034; Macher S, 2010, VOX SANG, V99, P332, DOI 10.1111/j.1423-0410.2010.01353.x; McCullough J, 1973, Minn Med, V56, P980; Michelson A D, 1999, Curr Opin Hematol, V6, P342, DOI 10.1097/00062752-199909000-00012; RACZ Z, 1994, PLATELETS, V5, P40, DOI 10.3109/09537109409006039; Ramstrom S, 2008, THROMB RES, V121, P681, DOI 10.1016/j.thromres.2007.06.010; REINHARD M, 1992, EMBO J, V11, P2063, DOI 10.1002/j.1460-2075.1992.tb05264.x; Rijkers M, 2016, VOX SANG; Schwarz UR, 1999, THROMB HAEMOSTASIS, V82, P1145, DOI 10.1055/s-0037-1614344; Spinella PC, 2016, TRANSFUSION, V56, pS190, DOI 10.1111/trf.13491; Vial C, 2002, BRIT J PHARMACOL, V135, P363, DOI 10.1038/sj.bjp.0704486; WALLAS CH, 1979, TRANSFUSION, V19, P210, DOI 10.1046/j.1537-2995.1979.19279160297.x; WALTER U, 1993, ADV EXP MED BIOL, V344, P237	43	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188193	10.1371/journal.pone.0188193	http://dx.doi.org/10.1371/journal.pone.0188193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155852	Green Published, gold			2022-12-27	WOS:000415756700035
J	Ben Gharbia, H; Yahia, OKD; Cecchi, P; Masseret, E; Amzil, Z; Herve, F; Rovillon, G; Nouri, H; M'Rabet, C; Couet, D; Triki, HZ; Laabir, M				Ben Gharbia, Hela; Yahia, Ons Kefi-Daly; Cecchi, Philippe; Masseret, Estelle; Amzil, Zouher; Herve, Fabienne; Rovillon, Georges; Nouri, Habiba; M'Rabet, Charaf; Couet, Douglas; Triki, Habiba Zmerli; Laabir, Mohamed			New insights on the species-specific allelopathic interactions between macrophytes and marine HAB dinoflagellates	PLOS ONE			English	Article							OSTREOPSIS CF. OVATA; HARMFUL ALGAL BLOOMS; GRACILARIA-LEMANEIFORMIS RHODOPHYTA; ULVA-LINZA CHLOROPHYTA; WATER-SOLUBLE EXTRACTS; CYMODOCEA-NODOSA; PROROCENTRUM-LIMA; MYRIOPHYLLUM-SPICATUM; ZOSTERA-MARINA; MICROCYSTIS-AERUGINOSA	Macrophytes are known to release allelochemicals that have the ability to inhibit the proliferation of their competitors. Here, we investigated the effects of the fresh leaves of two magnoliophytes (Zostera noltei and Cymodocea nodosa) and thalli of the macroalgae Ulva rigida on three HAB-forming benthic dinoflagellates (Ostreopsis cf. ovata, Prorocentrum lima, and Coolia monotis). The effects of C. nodosa and U. rigida were also tested against the neurotoxic planktonic dinoflagellate Alexandrium pacificum Litaker sp. nov (former Alexandrium catenella). Co-culture experiments were conducted under controlled laboratory conditions and potential allelopathic effects of the macrophytes on the growth, photosynthesis and toxin production of the targeted dinoflagellates were evaluated. Results showed that U. rigida had the strongest algicidal effect and that the planktonic A. pacificum was the most vulnerable species. Benthic dinoflagellates seemed more tolerant to potential allelochemicals produced by macrophytes. Depending on the dinoflagellate/macrophyte pairs and the weight of leaves/thalli tested, the studied physiological processes were moderately to heavily altered. Our results suggest that the allelopathic activity of the macrophytes could influence the development of HAB species.	[Ben Gharbia, Hela; Yahia, Ons Kefi-Daly; M'Rabet, Charaf; Triki, Habiba Zmerli] Univ Tunis El Manar, Res Grp Oceanog & Plankton Ecol, Tunisian Natl Inst Agron INAT, IRESA Carthage Univ,UR 13ES36 Marine Biol, Tunis, Tunisia; [Cecchi, Philippe; Masseret, Estelle; Laabir, Mohamed] Montpellier Univ, CNRS, IFREMER,IRD, Ctr Marine Biodivers Exploitat & Conservat MARBEC, Montpellier, France; [Amzil, Zouher; Herve, Fabienne; Rovillon, Georges] IFREMER, Phycotoxins Lab, F-44311 Nantes 03, France; [Nouri, Habiba; Couet, Douglas] IRD, Tunis, Tunisia; [Cecchi, Philippe] CRO, Abidjan, Cote Ivoire	Universite de Tunis-El-Manar; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD)	Ben Gharbia, H (corresponding author), Univ Tunis El Manar, Res Grp Oceanog & Plankton Ecol, Tunisian Natl Inst Agron INAT, IRESA Carthage Univ,UR 13ES36 Marine Biol, Tunis, Tunisia.	hela.bg@hotmail.fr		Masseret, Estelle/0000-0001-6856-8637; Ben Gharbia, Hela/0000-0002-9878-6915; HERVE, Fabienne/0000-0002-5485-7611; Kefi Daly Yahia, Ons/0000-0001-9532-8989	LAGUNOTOX - Fondation TOTAL; LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens); IRD (Institut de Recherche pour le Developpement)	LAGUNOTOX - Fondation TOTAL; LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens); IRD (Institut de Recherche pour le Developpement)	This work was supported by the LAGUNOTOX project funded by Fondation TOTAL. Thanks to LMI COSYS-Med (Laboratoire Mixte International Contaminants et Ecosystemes Marins Sud Mediterraneens) and to IRD (Institut de Recherche pour le Developpement) for funding Hela Ben Gharbia's Ph.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie E, 2016, TOXINS, V8, DOI 10.3390/toxins8050136; Accoroni S, 2015, HARMFUL ALGAE, V49, P147, DOI 10.1016/j.hal.2015.08.007; Achamlale S, 2009, FOOD CHEM, V113, P878, DOI 10.1016/j.foodchem.2008.07.040; Achamlale S, 2009, J APPL PHYCOL, V21, P347, DOI 10.1007/s10811-008-9375-8; Alamsjah MA, 2005, BIOSCI BIOTECH BIOCH, V69, P2186, DOI 10.1271/bbb.69.2186; Alamsjah MA, 2007, BIOSCI BIOTECH BIOCH, V71, P265, DOI 10.1271/bbb.60475; Alamsjah MA, 2008, J APPL PHYCOL, V20, P713, DOI 10.1007/s10811-007-9257-5; Aligizaki K, 2006, HARMFUL ALGAE, V5, P717, DOI 10.1016/j.hal.2006.02.005; Aligizaki K, 2009, HARMFUL ALGAE, V8, P299, DOI 10.1016/j.hal.2008.07.002; Alsufyani T, 2014, CHEM PHYS LIPIDS, V183, P100, DOI 10.1016/j.chemphyslip.2014.05.008; Amzil Z, 2012, MAR DRUGS, V10, P477, DOI 10.3390/md10020477; ANDERSON DM, 1990, MAR BIOL, V104, P511, DOI 10.1007/BF01314358; Anderson DM, 2012, HARMFUL ALGAE, V14, P10, DOI 10.1016/j.hal.2011.10.012; Armi Z, 2010, ENVIRON MONIT ASSESS, V164, P423, DOI 10.1007/s10661-009-0903-z; Bechemin C, 1999, AQUAT MICROB ECOL, V20, P157, DOI 10.3354/ame020157; Ben-Gharbia H, 2016, TOXINS, V8, DOI 10.3390/toxins8100297; BOYER GL, 1987, MAR BIOL, V96, P123, DOI 10.1007/BF00394845; Brissard C, 2014, MAR DRUGS, V12, P2851, DOI 10.3390/md12052851; Cecchi P, 2016, MAR POLLUT BULL, V108, P120, DOI 10.1016/j.marpolbul.2016.04.041; Ciminiello P, 2006, ANAL CHEM, V78, P6153, DOI 10.1021/ac060250j; Ciminiello P, 2012, CHEM RES TOXICOL, V25, P1243, DOI 10.1021/tx300085e; Cohu S., 2012, THESIS; Custodio L, 2016, NAT PROD RES, V30, P724, DOI 10.1080/14786419.2015.1040791; de Wit R, 2012, HYDROBIOLOGIA, V699, P55, DOI 10.1007/s10750-012-1153-6; Dilday RH, 1992, ARKANSAS FARM RES, V41, P14; DREW EA, 1978, NEW PHYTOL, V81, P249, DOI 10.1111/j.1469-8137.1978.tb02631.x; Dziga D, 2007, ENVIRON TOXICOL, V22, P341, DOI 10.1002/tox.20276; Eigemann F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078463; Erhard D, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P433; Fertouna-Bellakhal M, 2015, HARMFUL ALGAE, V48, P69, DOI 10.1016/j.hal.2015.07.007; Foden J, 2005, HARMFUL ALGAE, V4, P1063, DOI 10.1016/j.hal.2005.03.004; FONG P, 1993, MAR ECOL PROG SER, V100, P97, DOI 10.3354/meps100097; Garrido M, 2013, DEEP-SEA RES PT I, V71, P38, DOI 10.1016/j.dsr.2012.09.004; Green E.P., 2003, WORLD ATLAS SEAGRASS, P5; Grignon-Dubois Micheline, 2012, Plants (Basel), V1, P27, DOI 10.3390/plants1010027; Grignon-Dubois M, 2013, BOT MAR, V56, P303, DOI 10.1515/bot-2013-0029; Grignon-Dubois M, 2012, ESTUAR COAST SHELF S, V114, P18, DOI 10.1016/j.ecss.2011.09.010; Gross E. M., 1994, Acta Horticulturae, P710; Gross EM, 1996, PHYTOCHEMISTRY, V41, P133, DOI 10.1016/0031-9422(95)00598-6; Gross EM, 1999, PRINCIPLES AND PRACTICES IN PLANT ECOLOGY, P179; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P290; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hallegraeff G.M., 2003, Monographs on Oceanographic Methodology, V11, P25; Harborne J.B., 1976, BIOCH SYSTEMTICS ECO, V4, P37, DOI [DOI 10.1016/0305-1978(76)90007-7, 10.1016/0305-1978(76)90007-7]; HARRISON PG, 1982, MAR BIOL, V67, P225, DOI 10.1007/BF00401288; HARRISON PG, 1985, MAR BIOL, V90, P117, DOI 10.1007/BF00428222; HARRISON PG, 1980, MAR BIOL, V61, P21, DOI 10.1007/BF00410338; HARRISON PJ, 1980, J PHYCOL, V16, P28, DOI 10.1111/j.1529-8817.1980.tb02994.x; Haslam E., 1989, PLANT POLYPHENOLS VE; Hilt S, 2006, AQUAT BOT, V85, P252, DOI 10.1016/j.aquabot.2006.05.004; Hongying Hu, 2008, Frontiers of Environmental Science and Engineering in China, V2, P421, DOI 10.1007/s11783-008-0070-4; Huang HM, 2015, TOXINS, V7, P66, DOI 10.3390/toxins7010066; Jeong JH, 2000, J APPL PHYCOL, V12, P37, DOI 10.1023/A:1008139129057; Jin Q, 2003, J EXP MAR BIOL ECOL, V293, P41, DOI 10.1016/S0022-0981(03)00214-4; Jin Q, 2005, EUR J PHYCOL, V40, P31, DOI 10.1080/09670260400019741; John U, 2014, PROTIST, V165, P779, DOI 10.1016/j.protis.2014.10.001; Kim HG, 2006, ECOL STU AN, V189, P327, DOI 10.1007/978-3-540-32210-8_25; Kim Hyung Seop, 2011, Ocean Science Journal, V46, P205, DOI 10.1007/s12601-011-0016-9; Kolsi RB, 2016, CARBOHYD POLYM, V151, P511, DOI 10.1016/j.carbpol.2016.05.098; Kontiza I, 2006, STEROIDS, V71, P177, DOI 10.1016/j.steroids.2005.09.004; Kontiza I, 2005, TETRAHEDRON LETT, V46, P2845, DOI 10.1016/j.tetlet.2005.02.123; Kontiza L, 2008, TETRAHEDRON, V64, P1696, DOI 10.1016/j.tet.2007.12.007; Laabir M, 2013, AQUAT BOT, V111, P16, DOI 10.1016/j.aquabot.2013.07.010; Laabir M, 2013, MAR DRUGS, V11, P1583, DOI 10.3390/md11051583; Laabir M, 2011, J PLANKTON RES, V33, P1550, DOI 10.1093/plankt/fbr050; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; Leu E, 2002, PLANT PHYSIOL, V130, P2011, DOI 10.1104/pp.011593; Lewitus AJ, 2012, HARMFUL ALGAE, V19, P133, DOI 10.1016/j.hal.2012.06.009; Mangialajo L, 2011, TOXICON, V57, P408, DOI 10.1016/j.toxicon.2010.11.019; MCMILLAN C, 1980, AQUAT BOT, V8, P267, DOI 10.1016/0304-3770(80)90055-8; Mezghani S., 2016, EUR J MED PLANT, V12, P1, DOI [10.9734/EJMP/2016/22935, DOI 10.9734/EJMP/2016/22935]; Mulderij G, 2003, HYDROBIOLOGIA, V491, P261, DOI 10.1023/A:1024483704903; MURAKAMI Y, 1982, B JPN SOC SCI FISH, V48, P69; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Nan CR, 2008, AQUAT BOT, V89, P9, DOI 10.1016/j.aquabot.2008.01.005; Nan CR, 2004, J SEA RES, V52, P259, DOI 10.1016/j.seares.2004.04.001; Nascimento SM, 2005, TOXICON, V45, P633, DOI 10.1016/j.toxicon.2004.12.023; Nelson TA, 2003, J PHYCOL, V39, P874, DOI 10.1046/j.1529-8817.2003.02157.x; Okolodkov YB, 2007, AQUAT MICROB ECOL, V47, P223, DOI 10.3354/ame047223; Pakdel FM, 2013, AQUAT BOT, V110, P24, DOI 10.1016/j.aquabot.2013.04.005; Park TG, 2013, HARMFUL ALGAE, V30, pS131, DOI 10.1016/j.hal.2013.10.012; Parsons ML, 2007, HARMFUL ALGAE, V6, P658, DOI 10.1016/j.hal.2007.01.001; Pelechata A, 2010, OCEANOL HYDROBIOL ST, V39, P95, DOI 10.2478/v10009-010-0004-x; Pichierri S, 2016, AQUAT TOXICOL, V179, P125, DOI 10.1016/j.aquatox.2016.08.018; Plus M, 2003, CONT SHELF RES, V23, P1877, DOI 10.1016/j.csr.2003.03.001; Plus M, 2003, ECOL MODEL, V161, P213, DOI 10.1016/S0304-3800(02)00350-2; Provasoli L., 1968, CULTURES COLLECTIONS, P63; Reigosa M. J., 2006, ALLELOPATHY PHYSL PR; Reigosa MJ, 1999, CRIT REV PLANT SCI, V18, P577, DOI [10.1016/S0735-2689(99)00392-5, 10.1080/07352689991309405]; RHODES LL, 2017, MAR DRUGS, V15; Rice EL, 1984, ALLELOPATHY; Rojo C, 2013, ECOL ENG, V58, P149, DOI 10.1016/j.ecoleng.2013.06.019; Rossi R, 2010, TOXICON, V56, P1381, DOI 10.1016/j.toxicon.2010.08.003; ROUNSEFELL GA, 1958, LARGE SCALE EXPT TES; Salon-Barros Jhon, 2016, Harmful Algae News, V53, P9; SFRISO A, 1994, ENVIRON TECHNOL, V15, P1, DOI 10.1080/09593339409385399; Sghaier Y.R., 2012, B LINSTITUT NATL SCI, V39, P117; SICA D, 1984, PHYTOCHEMISTRY, V23, P2609, DOI 10.1016/S0031-9422(00)84109-6; Singh IP, 2006, NAT PROD REP, V23, P558, DOI 10.1039/b600518g; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Smolders AJP, 2000, OIKOS, V91, P307, DOI 10.1034/j.1600-0706.2000.910211.x; Souad Turki, 2001, Harmful Algae News, V22, P10; Strasser RJ, 2000, PROBING PHOTOSYNTHES, V25, P445; Tang YZ, 2015, J APPL PHYCOL, V27, P531, DOI 10.1007/s10811-014-0338-y; Tang YZ, 2011, HARMFUL ALGAE, V10, P480, DOI 10.1016/j.hal.2011.03.003; Thomas S, 2000, FRESHWATER BIOL, V45, P43, DOI 10.1046/j.1365-2427.2000.00616.x; TORIGOE K, 1988, J AM CHEM SOC, V110, P7876, DOI 10.1021/ja00231a048; Treguer P., 1975, MANUEL ANAL SELS NUT; Trigui M, 2013, J APPL PHYCOL, V25, P319, DOI 10.1007/s10811-012-9866-5; Turki S, 2005, CAH BIOL MAR, V46, P29; Vanderstukken M, 2011, FRESHWATER BIOL, V56, P1837, DOI 10.1111/j.1365-2427.2011.02624.x; Vanucci S, 2012, HARMFUL ALGAE, V15, P78, DOI 10.1016/j.hal.2011.12.003; Vanucci S, 2010, HARMFUL ALGAE, V9, P590, DOI 10.1016/j.hal.2010.04.009; Wang RJ, 2007, J SEA RES, V58, P189, DOI 10.1016/j.seares.2007.03.002; Wang Y, 2007, AQUAT BOT, V86, P139, DOI 10.1016/j.aquabot.2006.09.013; WIUMANDERSEN S, 1982, OIKOS, V39, P187, DOI 10.2307/3544484; [吴程 WU Cheng], 2008, [生态学报, Acta Ecologica Sinica], V28, P2595; YANG RZ, 1988, ECON BOT, V42, P376, DOI 10.1007/BF02860162; Ye CP, 2013, IERI PROC, V5, P209, DOI 10.1016/j.ieri.2013.11.094; Ye CP, 2014, J SEA RES, V90, P10, DOI 10.1016/j.seares.2014.02.015; ZAPATA O, 1979, AQUAT BOT, V7, P307, DOI 10.1016/0304-3770(79)90032-9; Zhu JY, 2010, AQUAT TOXICOL, V98, P196, DOI 10.1016/j.aquatox.2010.02.011	123	25	25	9	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187963	10.1371/journal.pone.0187963	http://dx.doi.org/10.1371/journal.pone.0187963			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149214	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100019
J	Chipungu, J; Bosomprah, S; Zanolini, A; Thimurthy, H; Chilengi, R; Sharma, A; Holmes, CB				Chipungu, Jenala; Bosomprah, Samuel; Zanolini, Arianna; Thimurthy, Harsha; Chilengi, Roma; Sharma, Anjali; Holmes, Charles B.			Understanding linkage to care with HIV self-test approach in Lusaka, Zambia - A mixed method approach	PLOS ONE			English	Article							COMMUNITY	Introduction HIV self-testing (HIVST) is a novel approach designed to assist in achieving the goal of at least 90% of the population that learn their HIV status. A self-test user with a positive test is required to visit a clinic to link into HIV care, yet little is known about patient preferences for linkage strategies. We examined the intention to link to care amongst potential HIVST users and the suitability of three linkage to care strategies in Lusaka Province, Zambia. Methods We conducted a representative cross sectional survey of 1,617 individuals aged 16-49 years old in Lusaka Province. Participants were shown a video of the HIVST. Data on intention to link to care and preferred linkage to care strategies-text message, phone call and home visits were collected. Eight focus group discussions were held concurrently with survey respondents to understand their preferences between the three linkage to care strategies. Results Of 1617 enrolled, 60% were women, 40% were men, with an average age of 27years (IQR = 22, 35). More men than women had at least secondary education (84% vs 77%) and were either employed or self-employed (67% vs. 41%). 85% (95% CI = 83 to 86) of participants said they would link to care within the first week of a positive self-test. Income > 2,000 Kwacha (USD 200) per month versus income < 2,000 Kwacha (Adjusted odds ratio (AOR) = 0.59; 95% CI: 0.40 to 0.88; p = 0.009) and never versus prior HIV testers (AOR = 0.54; 95% CI: 0.32 to 0.91; p = 0.020) were associated with reduced odds of intention to link to care. 53% (95% CI = 50 to 55) preferred being prompted to link to care by home visits compared to phone call (30%) or SMS (17%). Conclusion We found almost nine out of ten potential HIVST users in the general population intend to link to care shortly after a positive test, and preferred home visits or phone calls to facilitate linkage, rather than SMS. Also, higher income earners and those who never tested for HIV were associated with reduced odds of intention to link to care. Policy guidelines and implementation strategies for HIVST should be responsive to patient preferences for linkage to care strategies to achieve the continuum of HIV care.	[Chipungu, Jenala; Bosomprah, Samuel; Zanolini, Arianna; Chilengi, Roma; Sharma, Anjali; Holmes, Charles B.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Zanolini, Arianna] Amer Inst Res, Lusaka, Zambia; [Thimurthy, Harsha] Univ North Carolina Chapel Hill, Gillings Sch Publ Hlth, Chapel Hill, NC USA; [Holmes, Charles B.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	University of Ghana; American Institutes for Research; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Johns Hopkins University	Chipungu, J (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	Jenala.Chipungu@cidrz.org		Sharma, Anjali/0000-0002-8189-0732; Bosomprah, PhD, Prof. Samuel/0000-0002-2826-3887	International Initiative for Impact Evaluation [TW2.1.26]; International Initiative for Impact Evaluation, Inc. (3ie)	International Initiative for Impact Evaluation; International Initiative for Impact Evaluation, Inc. (3ie)	This work was funded by the International Initiative for Impact Evaluation (see: www.3ieimpact.org/) Grant Number: TW2.1.26. CBH JC AZ HT received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Research discussed in this publication has been funded by the International Initiative for Impact Evaluation, Inc. (3ie). The views expressed in this article are not necessarily those of 3ie or its members.; Research discussed in this publication has been funded by the International Initiative for Impact Evaluation, Inc. (3ie). The views expressed in this article are not necessarily those of 3ie or its members. We would like to acknowledge Mazuba Mukanshi Mafwenko for coordinating the data collection process and the research assistants for collecting the data. We thank all the participants for taking part in the study.	Chanda-Kapata P, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0088-1; Cohen J., 2013, APPL MULTIPLE REGRES; Creswell JW, 2011, BEST PRACTICES MIXED, P10; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Layer EH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104961; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Lee VJ, 2007, JAIDS-J ACQ IMM DEF, V45, P449, DOI 10.1097/QAI.0b013e318095a3f3; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mekuria LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130649; Organization WH, 2013, HIV SELF TEST SUPPL; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pal K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166129; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Reed JB, 2009, AIDS PATIENT CARE ST, V23, P765, DOI 10.1089/apc.2008.0213; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Sidibe M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21133; Spyrelis A, 2016, AIDS CARE, P1; World Health Organization, 2012, GLOB HIV AIDS RESP; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	22	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187998	10.1371/journal.pone.0187998	http://dx.doi.org/10.1371/journal.pone.0187998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149194	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100023
J	Anilkumar, U; Weisova, P; Schmid, J; Bernas, T; Huber, HJ; Dussmann, H; Connolly, NMC; Prehn, JHM				Anilkumar, Ujval; Weisova, Petronela; Schmid, Jasmin; Bernas, Tytus; Huber, Heinrich J.; Dussmann, Heiko; Connolly, Niamh M. C.; Prehn, Jochen H. M.			Defining external factors that determine neuronal survival, apoptosis and necrosis during excitotoxic injury using a high content screening imaging platform	PLOS ONE			English	Article							CEREBELLAR GRANULE NEURONS; RAT HIPPOCAMPAL-NEURONS; N-TERMINAL KINASE; MITOCHONDRIAL DYSFUNCTION; GLUCOSE DEPRIVATION; CELL-DEATH; GLUTAMATE EXCITOTOXICITY; CALCIUM CONCENTRATIONS; MAMMALIAN TARGET; CORTICAL-NEURONS	Cell death induced by excessive glutamate receptor overactivation, excitotoxicity, has been implicated in several acute and chronic neurological disorders. While numerous studies have demonstrated the contribution of biochemically and genetically activated cell death pathways in excitotoxic injury, the factors mediating passive, excitotoxic necrosis are less thoroughly investigated. To address this question, we developed a high content screening (HCS) based assay to collect high volumes of quantitative cellular imaging data and elucidated the effects of intrinsic and external factors on excitotoxic necrosis and apoptosis. The analysis workflow consisted of robust nuclei segmentation, tracking and a classification algorithm, which enabled automated analysis of large amounts of data to identify and quantify viable, apoptotic and necrotic neuronal populations. We show that mouse cerebellar granule neurons plated at low or high density underwent significantly increased necrosis compared to neurons seeded at medium density. Increased extracellular Ca2+ sensitized neurons to glutamate-induced excitotoxicity, but surprisingly potentiated cell death mainly through apoptosis. We also demonstrate that inhibition of various cell death signaling pathways (including inhibition of calpain, PARP and AMPK activation) primarily reduced excitotoxic apoptosis. Excitotoxic necrosis instead increased with low extracellular glucose availability. Our study is the first of its kind to establish and implement a HCS based assay to investigate the contribution of external and intrinsic factors to excitotoxic apoptosis and necrosis.	[Anilkumar, Ujval; Weisova, Petronela; Schmid, Jasmin; Bernas, Tytus; Huber, Heinrich J.; Dussmann, Heiko; Connolly, Niamh M. C.; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland; Royal Coll Surgeons Ireland, RCSI Ctr Syst Med, Dublin, Ireland; [Anilkumar, Ujval] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Weisova, Petronela] Slovak Acad Sci, Inst Neuroimmunol, AD Ctr, Bratislava, Slovakia; [Bernas, Tytus] Nencki Inst Expt Biol, Lab Imaging Tissue Struct & Funct, Warsaw, Poland; [Huber, Heinrich J.] Otto von Guericke Univ, Inst Automat Engn, Syst Theory & Automat Control Lab, Magdeburg, Germany	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; University of Ottawa; Slovak Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Otto von Guericke University	Prehn, JHM (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin, Ireland.	prehn@rcsi.ie	Weisova, Petronela/AAM-5989-2020; Connolly, Niamh M. C./U-6083-2019; Prehn, Jochen HM/A-3928-2010	Connolly, Niamh M. C./0000-0002-6005-1307; Prehn, Jochen HM/0000-0003-3479-7794; Dussmann, Heiko/0000-0002-3582-8057	Science Foundation Ireland [14/JPND/B3077, 08/IN.1/B1949]; Higher Education Authority	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Higher Education Authority	This work was supported by grants from Science Foundation Ireland (14/JPND/B3077; 08/IN.1/B1949) and the Higher Education Authority Program on Research in Third Level Institutions Cycle 4 (National Biophotonics and Imaging Platform) granted to JHMP.	Almeida A, 2002, J NEUROCHEM, V81, P207, DOI 10.1046/j.1471-4159.2002.00827.x; Anilkumar U, 2013, J NEUROCHEM, V124, P721, DOI 10.1111/jnc.12108; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; [Anonymous], 1994, J NEUROSCI, V14, P5068; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Cebers G, 1998, BRAIN RES, V779, P194, DOI 10.1016/S0006-8993(97)01123-2; Centeno C, 2007, CELL DEATH DIFFER, V14, P240, DOI 10.1038/sj.cdd.4401988; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; Chong ZZ, 2012, PROG NEUROBIOL, V99, P128, DOI 10.1016/j.pneurobio.2012.08.001; Chua BT, 2000, J BIOL CHEM, V275, P5131, DOI 10.1074/jbc.275.7.5131; Coffey ET, 2002, J NEUROSCI, V22, P4335, DOI 10.1523/JNEUROSCI.22-11-04335.2002; Coffey ET, 2000, J NEUROSCI, V20, P7602; Concannon CG, 2010, J CELL BIOL, V189, P83, DOI 10.1083/jcb.200909166; Connolly NMC, 2014, J NEUROSCI, V34, P10192, DOI 10.1523/JNEUROSCI.3127-13.2014; D'Orsi B, 2012, J NEUROSCI, V32, P1847, DOI 10.1523/JNEUROSCI.2345-11.2012; Davila D, 2012, CELL DEATH DIFFER, V19, P1677, DOI 10.1038/cdd.2012.49; Gelles JD, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.332; Guan QH, 2005, BRAIN RES, V1035, P51, DOI 10.1016/j.brainres.2004.11.050; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Ioudina M, 2004, BRAIN RES, V1004, P188, DOI 10.1016/j.brainres.2003.12.046; Krohn AJ, 1998, J NEUROSCI, V18, P8186; Lankiewicz S, 2000, J BIOL CHEM, V275, P17064, DOI 10.1074/jbc.275.22.17064; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; Manfredi G, 2005, MITOCHONDRION, V5, P77, DOI 10.1016/j.mito.2005.01.002; MATTSON MP, 1993, EXP NEUROL, V121, P1, DOI 10.1006/exnr.1993.1066; MICHAELS RL, 1990, J NEUROSCI, V10, P283; Mielke K, 1999, NEUROSCIENCE, V91, P471, DOI 10.1016/S0306-4522(98)00667-8; Parnas D, 1997, DEV BRAIN RES, V101, P115, DOI 10.1016/S0165-3806(97)00057-6; Prehn JHM, 1997, J NEUROCHEM, V68, P1679; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Selfridge JE, 2013, NEUROBIOL DIS, V51, P3, DOI 10.1016/j.nbd.2011.12.057; Sengpiel B, 1998, EUR J NEUROSCI, V10, P1903, DOI 10.1046/j.1460-9568.1998.00202.x; Seo SY, 1999, J NEUROSCI, V19, P8849, DOI 10.1523/JNEUROSCI.19-20-08849.1999; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; TYMIANSKI M, 1993, BRAIN RES, V607, P319, DOI 10.1016/0006-8993(93)91523-U; Tymianski M, 1996, ADV NEUROL, V71, P85; Vogt A, 2008, MOL CANCER THER, V7, P330, DOI 10.1158/1535-7163.MCT-07-2165; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Ward MW, 2005, J NEUROCHEM, V92, P1081, DOI 10.1111/j.1471-4159.2004.02928.x; Ward MW, 2000, J NEUROSCI, V20, P7208; Weisova P, 2012, BBA-BIOENERGETICS, V1817, P744, DOI 10.1016/j.bbabio.2012.01.016; Weisova P, 2009, J NEUROSCI, V29, P2997, DOI 10.1523/JNEUROSCI.0354-09.2009; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xu GW, 2008, APOPTOSIS, V13, P413, DOI 10.1007/s10495-007-0175-4; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zanella F, 2010, ONCOGENE, V29, P2973, DOI 10.1038/onc.2010.58	54	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188343	10.1371/journal.pone.0188343	http://dx.doi.org/10.1371/journal.pone.0188343			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145487	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800116
J	Kang, SU; Kim, YS; Kim, YE; Park, JK; Lee, YS; Kang, HY; Jang, JW; Ryeo, JB; Lee, Y; Shin, YS; Kim, CH				Kang, Sung Un; Kim, Yeon Soo; Kim, Yang Eun; Park, Ju-Kyeong; Lee, Yun Sang; Kang, Hee Young; Jang, Jae Won; Ryeo, Jeong Beom; Lee, Yuijina; Shin, Yoo Seob; Kim, Chul-Ho			Opposite effects of non-thermal plasma on cell migration and collagen production in keloid and normal fibroblasts	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; GROWTH-FACTOR-BETA; IN-VITRO; PROLIFERATION; SUPPRESSION; EXPRESSION; PATHOGENESIS; MODULATION; INDUCTION; ARREST	Recent progress in the understanding non-thermal plasma (NTP) properties prompted its application in the treatment of various diseases. However, therapeutic effect of NTP on keloid cells has not been reported previously. We sought to investigate the effect of NTP treatment on keloid by comparing cell migration and collagen production of keloid (KFs) and normal fibroblasts (NFs) and determined the regulatory pathways involved. We assessed NTP effects on cell migration in KFs and NFs by the wound healing assay and measured the expression of the epidermal growth factor receptor (EGFR), signal transducer and activator of transcription-3 (STAT3), and collagen by western blot. Expression of the transforming growth factor-beta and Type I collagen following NTP treatment was determined by reverse transcription-polymerase chain reaction, immunofluorescence staining, and the Sircol collagen assay. NTP treatment increased cell migration and collagen production of NFs. However, it reduced these parameters in KFs. NTP reduced the expression of EGFR, STAT3, and Type I collagen in KFs but increased their levels in NFs. We revealed that NTP suppressed KF cell migration via down-regulation of EGFR and STAT3 and reduced collagen production via supressing transforming growth factor-beta. Our data suggest that NTP may be a new therapeutic strategy for keloids.	[Kang, Sung Un; Lee, Yun Sang; Shin, Yoo Seob; Kim, Chul-Ho] Ajou Univ, Dept Otolaryngol, Suwon, South Korea; [Kang, Sung Un; Kim, Yang Eun; Park, Ju-Kyeong; Lee, Yun Sang; Shin, Yoo Seob; Kim, Chul-Ho] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Kim, Yeon Soo] Konyang Univ, Myunggok Med Res Inst, Konyang Univ Hosp, Dept Otorhinolaryngol,Coll Med, Daejeon, South Korea; [Kang, Hee Young] Ajou Univ, Dept Dermatol, Suwon, South Korea; [Jang, Jae Won] Chungnam Natl Univ, Dept Otorhinolaryngol, Daejeon, South Korea; [Ryeo, Jeong Beom; Lee, Yuijina] ICD Co LTD, Anseong, South Korea	Ajou University; Ajou University; Konyang University; Konyang University Hospital; Ajou University; Chungnam National University	Kim, CH (corresponding author), Ajou Univ, Dept Otolaryngol, Suwon, South Korea.; Kim, CH (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea.	ostium@ajou.ac.kr	kang, sung un/AAK-8050-2021		National Research Foundation of Korea [2015R1A2A1A01002968]; Bio & Medical Technology Development Program [2012M3A9B2052870]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2016R1D1A3B03933948]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program; Basic Science Research Program through the National Research Foundation of Korea (NRF)	The funder (ICO co.) provided support in the form of salaries for authors JBR and YL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by the National Research Foundation of Korea (grant no. 2015R1A2A1A01002968) to CHK, the Bio & Medical Technology Development Program (grant no. 2012M3A9B2052870) to CHK, and the Basic Science Research Program through the National Research Foundation of Korea (NRF) (grant no. 2016R1D1A3B03933948) to YSK. The specific roles of these authors are articulated in the author contributions section.	Barara Meenu, 2012, J Cutan Aesthet Surg, V5, P185, DOI 10.4103/0974-2077.101376; Bettinger DA, 1996, PLAST RECONSTR SURG, V98, P827, DOI 10.1097/00006534-199610000-00012; CHANDRASEKHAR S, 1988, BIOCHEM BIOPH RES CO, V157, P1352, DOI 10.1016/S0006-291X(88)81024-6; Chang CH, 2014, PLOS ONE, V9; Chang JW, 2014, ARCH BIOCHEM BIOPHYS, V545, P133, DOI 10.1016/j.abb.2014.01.022; Chen M, 1999, Zhonghua Yan Ke Za Zhi, V35, P134; Chen M, 1999, ZHONGHUA YAN KE ZHI, V35, P6; Choi JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep28829; FERGUSON G, 1994, PLAST RECONSTR SURG, V93, P643; Fujiwara M, 2005, ARCH DERMATOL RES, V297, P161, DOI 10.1007/s00403-005-0596-2; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jagadeesan Jagajeevan, 2007, Int J Surg, V5, P278, DOI 10.1016/j.ijsu.2006.04.007; Kang SU, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.33; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kang SU, 2017, EXP DERMATOL, V26, P163, DOI 10.1111/exd.13229; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim CH, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3449575; Kramer A, 2008, GMS HYG INFECT CONTR, V3; Kuo YR, 2004, LASER SURG MED, V34, P104, DOI 10.1002/lsm.10206; Lee BS, 2012, CANCER LETT, V322, P45, DOI 10.1016/j.canlet.2012.02.007; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lim CP, 2009, J INVEST DERMATOL, V129, P851, DOI 10.1038/jid.2008.337; Lu Y, 2001, Zhonghua Shao Shang Za Zhi, V17, P345; Manuskiatti W, 2002, ARCH DERMATOL, V138, P1149, DOI 10.1001/archderm.138.9.1149; NARAYANAN AS, 1989, BIOCHEM J, V260, P463, DOI 10.1042/bj2600463; Phan TT, 2005, J PATHOL, V207, P232, DOI 10.1002/path.1826; Phan TT, 2003, BRIT J DERMATOL, V148, P544, DOI 10.1046/j.1365-2133.2003.05174.x; Ragoowansi R, 2003, PLAST RECONSTR SURG, V111, P1853, DOI 10.1097/01.PRS.0000056869.31142.DE; Satish L, 2004, WOUND REPAIR REGEN, V12, P183, DOI 10.1111/j.1067-1927.2004.012111.x; Taylor A, 2016, ACTA DERMATO VENEREO; Watts AE, 2006, AM J VET RES, V67, P2030, DOI 10.2460/ajvr.67.12.2030; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Wu WS, 2006, J INVEST DERMATOL, V126, P1264, DOI 10.1038/sj.jid.5700274; Xia W, 2006, AM J PHYSIOL-REG I, V290, pR501, DOI 10.1152/ajpregu.00472.2005; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Zippi M, 2012, CLIN TER, V163, pE435	39	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187978	10.1371/journal.pone.0187978	http://dx.doi.org/10.1371/journal.pone.0187978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145520	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800044
J	Seow, N; Fenati, RA; Connolly, AR; Ellis, AV				Seow, Nianjia; Fenati, Renzo A.; Connolly, Ashley R.; Ellis, Amanda V.			Hi-fidelity discrimination of isomiRs using G-quadruplex gatekeepers	PLOS ONE			English	Article							MICRORNA DETECTION; TELOMERIC DNA; HUMAN GENOME; CONFORMATION; MOTIF; RNA	Core microRNA (miRNA) sequences exist as populations of variants called isomiRs made up of different lengths and nucleotide compositions. In particular, the short sequences of miRNA make single-base isomiR mismatches very difficult to be discriminated. Non-specific hybridizations often arise when DNA probe-miRNA target hybridization is the primary, or initial, mode of detection. These errors then become exacerbated through subsequent amplification steps. Here, we present the design of DNA probes modified with poly-guanine (PG) tracts that were induced to form G-quadruplexes (G4) for hi-fidelity discrimination of miRNA core target sequence from single-base mismatched isomiRs. We demonstrate that, when compared to unmodified probes, this G4 'gate-keeping' function within the G4-modified probes enables more stringent hybridization of complementary core miRNA target transcripts while limiting non-specific hybridizations. This increased discriminatory power of the G4-modified probes over unmodified probes is maintained even after further reverse transcriptase extension of probe-target hybrids. Enzymatic extension also enhanced the clarity and sensitivity of readouts and allows different isomiRs to be distinguished from one another via the relative positions of the mismatches.	[Seow, Nianjia; Fenati, Renzo A.; Connolly, Ashley R.; Ellis, Amanda V.] Flinders Univ S Australia, Flinders Ctr Nanoscale Sci & Technol, Bedford Pk, SA, Australia; [Fenati, Renzo A.; Ellis, Amanda V.] Univ Melbourne, Sch Chem & Biomed Engn, Parkville, Vic, Australia	Flinders University South Australia; University of Melbourne	Ellis, AV (corresponding author), Flinders Univ S Australia, Flinders Ctr Nanoscale Sci & Technol, Bedford Pk, SA, Australia.; Ellis, AV (corresponding author), Univ Melbourne, Sch Chem & Biomed Engn, Parkville, Vic, Australia.	amanda.ellis@unimelb.edu.au	Ellis, Amanda V/AAD-3450-2019	Ellis, Amanda V/0000-0002-0053-5641; Connolly, Ashley/0000-0001-6584-0674	Australian Research Council [FT130100211]	Australian Research Council(Australian Research Council)	The authors acknowledge funding from the Australian Research Council grant number FT130100211.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Blazewicz J, 2003, THEOR COMPUT SCI, V290, P1459, DOI 10.1016/S0304-3975(02)00063-4; Chen ZB, 2014, ANAL METHODS-UK, V6, P8018, DOI 10.1039/c4ay01025f; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Collie GW, 2011, CHEM SOC REV, V40, P5867, DOI 10.1039/c1cs15067g; Connolly AR, 2016, CHEMBIOCHEM, V17, P2172, DOI 10.1002/cbic.201600452; Dellett M, 2016, EXPERT REV MOL DIAGN, V16, P407, DOI 10.1586/14737159.2016.1152184; Fuchs J, 2010, BIOPHYS J, V99, P1886, DOI 10.1016/j.bpj.2010.07.002; Guan Y, 2016, ROLLING CIRCLE AMPLI, P25; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Huang JF, 2016, ANAL BIOANAL CHEM, V408, P7437, DOI 10.1007/s00216-016-9829-9; Hunt EA, 2015, ANNU REV ANAL CHEM, V8, P217, DOI 10.1146/annurev-anchem-071114-040343; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Jin JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw399; Konig SLB, 2013, NUCLEIC ACIDS RES, V41, P7453, DOI 10.1093/nar/gkt476; LESNIK EA, 1995, BIOCHEMISTRY-US, V34, P10807, DOI 10.1021/bi00034a013; Li W, 2016, NUCLEIC ACIDS RES, V44, P7373, DOI 10.1093/nar/gkw634; Li Z, 2005, J AM CHEM SOC, V127, P11568, DOI 10.1021/ja053547s; Lin CT, 2011, J PHYS CHEM B, V115, P2360, DOI 10.1021/jp107623n; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; Lv WF, 2016, BIOSENS BIOELECTRON, V83, P250, DOI 10.1016/j.bios.2016.04.053; MARSH TC, 1994, BIOCHEMISTRY-US, V33, P10718, DOI 10.1021/bi00201a020; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; Phan AT, 2002, NUCLEIC ACIDS RES, V30, P4618, DOI 10.1093/nar/gkf597; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Seow N, 2016, BIOCONJUGATE CHEM, V27, P1236, DOI 10.1021/acs.bioconjchem.6b00084; Shen YT, 2015, BIOSENS BIOELECTRON, V71, P322, DOI 10.1016/j.bios.2015.04.057; Tan GC, 2014, NUCLEIC ACIDS RES, V42, P9424, DOI 10.1093/nar/gku656; Telonis AG, 2017, NUCLEIC ACIDS RES, V45, P2973, DOI 10.1093/nar/gkx082; Tian T, 2015, ORG BIOMOL CHEM, V13, P2226, DOI 10.1039/c4ob02104e; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wu ZS, 2008, BIOMATERIALS, V29, P2689, DOI 10.1016/j.biomaterials.2008.02.024; Zhang YW, 2016, BIOINFORMATICS, V32, P2069, DOI 10.1093/bioinformatics/btw070; Zhou H, 2017, BIOSENS BIOELECTRON, V87, P552, DOI 10.1016/j.bios.2016.07.060; Zhou XQ, 2016, BIOSENS BIOELECTRON, V80, P378, DOI 10.1016/j.bios.2016.01.059	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188163	10.1371/journal.pone.0188163	http://dx.doi.org/10.1371/journal.pone.0188163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145502	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800078
J	Chen, M; Qiu, L; Shen, S; Wang, F; Zhang, J; Zhang, CC; Liu, SR				Chen, Meng; Qiu, Lin; Shen, Si; Wang, Fei; Zhang, Jing; Zhang, Cici; Liu, Sirun			The influences of walking, running and stair activity on knee articular cartilage: Quantitative MRI using T1 rho and T2 mapping	PLOS ONE			English	Article							IN-VIVO; HEALTHY-SUBJECTS; RELAXATION-TIMES; OSTEOARTHRITIS; JOINT; T1RHO; T-2; STRESS; SLOPE	Objective To explore the different influences of walking, running and stair activity on knee articular cartilage with T1 rho and T2 mapping sequences. Materials and methods MRI (3.0-T) scans of the right knee were performed in twenty-three young healthy adults immediately after 30 minutes of rest, walking, running and stair activity respectively. Articular cartilage was quantitatively assessed based on T1 rho and T2 relaxation times. Analysis of variance for random block design data, bonferroni test and paired samples t tests were performed to estimate the different influences of physiological activities on articular cartilage. Results T1 rho and T2 values had reductions after physiological activities in all regions of articular cartilage. T1 rho and T2 values were decreased more after running than walking. T1 rho and T2 values were decreased more after stair activity than running, except for femoral cartilage. The superficial layer of patella cartilage had higher reduction rates than the deep layer. The T1 rho and T2 values of articular cartilage were reduced in the following order: patellofemoral cartilage> medial tibiofemoral cartilage> lateral tibiofemoral cartilage. Patellofemoral cartilage experienced reductions in the following order: lateral part> middle part> medial part. Tibiofemoral cartilage had reductions in the following order: posterior part> middle part> anterior part. Conclusions T1 rho and T2 mapping sequences can quantitatively reflect the different influences of physiological activities on knee articular cartilage. Fluid shifts, collagen fiber deformation, spatial heterogeneity, inherent differences in material properties and tissue stiffness have close relationship with cartilage loading characteristics.	[Chen, Meng; Qiu, Lin; Shen, Si; Wang, Fei; Zhang, Jing; Zhang, Cici; Liu, Sirun] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Chen, Meng] Soochow Univ, Affiliated Hosp 1, Radiol Dept, Suzhou, Jiangsu, Peoples R China; [Zhang, Jing] Guangzhou Med Univ, Affiliated Hosp 3, Radiol Dept, Guangzhou, Guangdong, Peoples R China; [Zhang, Cici] Guangzhou Red Cross Hosp, Radiol Dept, Guangzhou, Guangdong, Peoples R China	Jinan University; Soochow University - China; Guangzhou Medical University	Liu, SR (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	tlsr@jnu.edu.cn						Akbarshahi M, 2014, MED ENG PHYS, V36, P1122, DOI 10.1016/j.medengphy.2014.06.009; Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Brechter JH, 2002, GAIT POSTURE, V16, P115, DOI 10.1016/S0966-6362(02)00090-5; Buckley MR, 2010, J BIOMECH, V43, P796, DOI 10.1016/j.jbiomech.2009.10.012; Buckwalter JA, 2004, CURR OPIN RHEUMATOL, V16, P634, DOI 10.1097/01.bor.0000132647.55056.a9; Chinkulprasert C, 2011, J ORTHOP SPORT PHYS, V41, P241, DOI 10.2519/jospt.2011.3408; Cymet TC, 2006, J AM OSTEOPATH ASSOC, V106, P342; Eckstein F, 2005, ANN RHEUM DIS, V64, P291, DOI 10.1136/ard.2004.022400; Erdil M, 2016, ACTA CHIR ORTHOP TR, V83, P43; Goudakos IG, 2009, J BIOMECH, V42, P2590, DOI 10.1016/j.jbiomech.2009.07.007; Haddad B, 2012, ACTA ORTHOP BELG, V78, P757; Jackson BD, 2004, J SCI MED SPORT, V7, P347, DOI 10.1016/S1440-2440(04)80030-6; Kessler MA, 2008, AM J SPORT MED, V36, P966, DOI 10.1177/0363546507313093; Kim Keong-Hwan, 2012, Knee Surg Relat Res, V24, P158, DOI 10.5792/ksrr.2012.24.3.158; Lane NE, 1998, J RHEUMATOL, V25, P334; LANE NE, 1993, J RHEUMATOL, V20, P461; Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011; Luke AC, 2010, AM J SPORT MED, V38, P2273, DOI 10.1177/0363546510372799; Mosher TJ, 2005, RADIOLOGY, V234, P245, DOI 10.1148/radiol.2341040041; Rauscher I, 2008, RADIOLOGY, V249, P591, DOI 10.1148/radiol.2492071870; Silverberg JL, 2014, BIOPHYS J, V107, P1721, DOI 10.1016/j.bpj.2014.08.011; Silverberg JL, 2013, J ORTHOP RES, V31, P686, DOI 10.1002/jor.22303; Souza RB, 2010, OSTEOARTHR CARTILAGE, V18, P1557, DOI 10.1016/j.joca.2010.10.001; Stahl R, 2009, EUR RADIOL, V19, P132, DOI 10.1007/s00330-008-1107-6; Subburaj K, 2012, AM J SPORT MED, V40, P2134, DOI 10.1177/0363546512449816; Temple MM, 2007, OSTEOARTHR CARTILAGE, V15, P1042, DOI 10.1016/j.joca.2007.03.005; Virayavanich W, 2013, ARTHRIT CARE RES, V65, P1441, DOI 10.1002/acr.22017; Wang LG, 2015, J MAGN RESON IMAGING, V41, P586, DOI 10.1002/jmri.24677; Wang LG, 2014, ACAD RADIOL, V21, P463, DOI 10.1016/j.acra.2013.12.010; Zarins ZA, 2010, OSTEOARTHR CARTILAGE, V18, P1408, DOI 10.1016/j.joca.2010.07.012; Zhang WG, 2009, J TRANDITIONAL CHINE, V21, P15; Zhang Y, 2014, KNEE, V21, P694, DOI 10.1016/j.knee.2014.01.008	33	20	26	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187008	10.1371/journal.pone.0187008	http://dx.doi.org/10.1371/journal.pone.0187008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136015	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200011
J	Lay, P; An, S; Soeung, S; Srey, PS; Thai, S; Lynen, L; van Griensven, J				Lay, Phirum; An, Sokkab; Soeung, Sunpiseth; Srey, Pich Sovannary; Thai, Sopheak; Lynen, Lutgarde; van Griensven, Johan			Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SCALE-UP; SOUTH-AFRICA; THERAPY; FAILURE; PROGRAM; EXPANSION; CARE	Background Although HIV disease stage at ART initiation critically determines ART outcomes, few reports have longitudinally monitored this within Asia. Using prospectively collected data from a large ART program at Sihanouk Hospital Center of Hope in Cambodia, we report on the change in patient characteristics and outcomes over a ten-year period. Methods We conducted a retrospective analysis including all adults (>= 18 years old) starting ART from March 2003-March 2013 in a non-governmental hospital in Phnom Penh, Cambodia. The cumulative incidence of death, lost to follow-up (LTFU), attrition (death or LTFU) and first line treatment failure were calculated using Kaplan-Meier methods. Independent risk factors for these outcomes were determined using Cox regression modeling. Results Over the ten-year period, 3581 patients initiated ART with a median follow-up time of 4.8 years (IQR 2.87.2). The median age was 35 years (IQR 3041), 54% were female. The median CD4 count at ART initiation increased from 22 cells/mu L (IQR 4129) in 2003 to 218 (IQR 57302) in 2013. Over the 10 year period, a total of 282 (7.9%) individuals died and 433 (12.1%) were defined LTFU. Program attrition (died or LTFU) was 11.1% (95% CI: 10.1%- 12.4%) at one year, 16.3% (95% CI: 15.1%-17.6%) at three years, 19.8% (95% CI: 18.5%-21.2%) at five years and 23.3% (95% CI: 21.625.1) at ten years. Male sex and low baseline body mass index (BMI) were associated with increased attrition. Factors independently associated with mortality included a low baseline CD4 count, older age, male sex, low baseline BMI and hepatitis B co-infection. Individuals aged above 40 years old had an increased risk of mortality but were less likely to LTFU. There were a total of 137 individuals with first line ART failure starting second line treatment. The probability of first line failure was estimated at 2.8% (95% CI: 2.3%-3.4%) at 3 years, 4.6% (95% CI: 3.9%-5.5%) at 5 years and 7.8% (95% CI 4.8%-12.5%) at ten years of ART. The probability was particularly high in the first few program years. A lower risk was observed among individuals starting ART during the 20062008 period. Factors independently associated with an increased risk of treatment failure included ART-experience, NVP-based ART and a baseline CD4 count below 200 cells/mu L. Conclusions Overall program outcomes were fair, and generally compare well to other reports from the region. Despite gradually earlier initiation of ART over the ten year period, ART is still initiated at too low CD4 count levels, warranting increased efforts for early HIV diagnosis and enrolment/retention into HIV care. Tailored strategies for poor prognostic groups (older age, male, low BMI) should be designed and evaluated.	[Lay, Phirum; An, Sokkab; Soeung, Sunpiseth; Srey, Pich Sovannary; Thai, Sopheak] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Lay, P (corresponding author), Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia.	phirumlay@sihosp.org	Lynen, Lutgarde/AAT-9180-2020; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Lynen, Lutgarde/0000-0001-7183-4895	Belgian Directorate General of Development Cooperation; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide	Belgian Directorate General of Development Cooperation; Global Fund to fight AIDS, Tuberculosis and Malaria; Hope World Wide	The HIV program was supported by the Belgian Directorate General of Development Cooperation, the Global Fund to fight AIDS, Tuberculosis and Malaria, and Hope World Wide.	Alave J, 2013, REV CHIL INFECTOL, V30, P42, DOI 10.4067/S0716-10182013000100006; [Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2010, CONS GUID US ANT DRU; Authority TNA, 2014, CAMB COUNTR PROGR RE; Boulle A, 2010, S AFRICA AIDS, V24, P563; Castilho JL, 2014, AIDS RES HUM RETROV, V30, P446, DOI [10.1089/aid.2013.0208, 10.1089/AID.2013.0208]; Chasombat S, 2009, JAIDS-J ACQ IMM DEF, V50, P506, DOI 10.1097/QAI.0b013e3181967602; Chim B PS, 2013, J AIDS CLIN RES, V4, P6; Choun K, 2013, B WORLD HEALTH ORGAN, V91, P195, DOI 10.2471/BLT.12.111153; Farahani M, 2014, LANCET GLOB HEALTH, V2, pE44, DOI 10.1016/S2214-109X(13)70149-9; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; Fitzgerald M, 2010, AIDS CARE, V22, P355, DOI 10.1080/09540120903111536; Grimsrud A, 2014, JAIDS-J ACQ IMM DEF, V67, pE55, DOI 10.1097/QAI.0000000000000268; Guy R, 2013, AIDS PATIENT CARE ST, V27, P681, DOI 10.1089/apc.2012.0439; Jourdain G, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001494; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Pe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143320; Phan V, 2013, JAIDS-J ACQ IMM DEF, V62, P509, DOI 10.1097/QAI.0b013e318285d28c; Phan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030647; Pillay P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068995; Pujades-Rodriguez M, 2011, TROP MED INT HEALTH, V16, P205, DOI 10.1111/j.1365-3156.2010.02689.x; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; UNAIDS, 2016, UNAIDS REP GLOB AIDS; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; van Griensven J, 2011, T ROY SOC TROP MED H, V105, P694, DOI 10.1016/j.trstmh.2011.08.007; WHO, 2016, CONGUID UANT DRU; WHO, 2006, REC PUBL HLTH APPR 2; World Health Organization, 2003, SCAL ANT THER RES LI; Zhou J, 2007, HIV MED, V8, P8, DOI 10.1111/j.1468-1293.2007.00417.x	35	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0185348	10.1371/journal.pone.0185348	http://dx.doi.org/10.1371/journal.pone.0185348			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136011	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200001
J	Lin, TC; Hwang, DK; Hsu, CC; Peng, CH; Wang, ML; Chiou, SH; Chen, SJ				Lin, Tai-Chi; Hwang, De-Kuang; Hsu, Chih-Chien; Peng, Chi-Hsien; Wang, Mong-Lien; Chiou, Shih-Hwa; Chen, Shih-Jen			Protective effect of metformin against retinal vein occlusions in diabetes mellitus - A nationwide population-based study	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; GLYCEMIC CONTROL; GLUCOSE CONTROL; MORTALITY; THERAPY; PATHOPHYSIOLOGY; COMPLICATIONS; RANIBIZUMAB; ASSOCIATION	Previous studies have found that metformin can reduce cardiovascular risk, but its association with retinal vein occlusion (RVO) is unknown. In this population-based cohort study using the Taiwan National Health Insurance Research Database (NHIRD), we demonstrated the protective effect of metformin against RVO in diabetes mellitus (DM) and explored the incidence rate and factors associated with RVO development in general and diabetic populations. One million patients were randomly selected from the registry files of the NHIRD, and all their claims data were collected for the 1996-2011 period. Patients with a new diagnosis of central or branch RVO were identified using International Classification of Disease codes. DM was defined for patients with diagnoses and treatments. Factors associated with RVO development in the non-DM and DM cohorts were explored using Cox proportional regression models. In total, 1,018 RVO patients were identified from the database. The average incidence of RVO was 9.93 and 53.5 cases per 100,000 person-years in the non-DM and DM cohorts, respectively. Older age, DM, hypertension, and glaucoma were significant risk factors for RVO, whereas the prescription of anticoagulants was a significant protective factor. In the DM cohort, older age, hypertension, and diabetic retinopathy were significant risk factors for RVO, whereas metformin treatment was a significant protective factor. These results confirmed the risk factors for RVO and demonstrated the protective effect of metformin against RVO in DM patients. Prescribing metformin for DM patients may be beneficial for reducing the incidence of RVO, along with its hypoglycemic action.	[Lin, Tai-Chi; Hsu, Chih-Chien; Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lin, Tai-Chi; Hwang, De-Kuang; Hsu, Chih-Chien; Chiou, Shih-Hwa; Chen, Shih-Jen] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Hwang, De-Kuang] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Hwang, De-Kuang; Peng, Chi-Hsien; Chen, Shih-Jen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Peng, Chi-Hsien] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Peng, Chi-Hsien] Fu Jen Catholic Univ, Taipei, Taiwan; [Wang, Mong-Lien; Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Inst Pharmacol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Shin Kong Wu Ho Su Memorial Hospital; Fu Jen Catholic University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Chen, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	sjchen@vghtpe.gov.tw	Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485				Aboonabi A, 2016, BIOMED PHARMACOTHER, V83, P277, DOI 10.1016/j.biopha.2016.06.044; Angiolillo DJ, 2009, DIABETES CARE, V32, P531, DOI 10.2337/dc08-2064; Boyer D, 2010, OPHTHALMOLOGY, V117, P1860, DOI 10.1016/j.ophtha.2010.02.022; Braithwaite T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007325.pub2; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Brynskov T, 2014, RETINA-J RET VIT DIS, V34, P1637, DOI 10.1097/IAE.0000000000000111; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chang SH, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0123-x; Cheng YY, 2014, J STROKE CEREBROVASC, V23, pE99, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.001; Coch RW, 2016, CURRENT CARDIOVASCUL; COLLIER A, 1989, DIABETES METAB, V15, P420; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, P124; Derosa G, 2003, DIABETES RES CLIN PR, V60, P161, DOI 10.1016/S0168-8227(03)00057-3; Dodson P M, 1993, Eur J Ophthalmol, V3, P109; DODSON PM, 1992, EYE, V6, P66, DOI 10.1038/eye.1992.13; Dolasik I, 2013, PLATELETS, V24, P118, DOI 10.3109/09537104.2012.674165; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ferrannini E, 2015, EUR HEART J, V36, P2288, DOI 10.1093/eurheartj/ehv239; FORD I, 1991, DIABETIC MED, V8, P322, DOI 10.1111/j.1464-5491.1991.tb01604.x; Formoso G, 2008, DIABETES-METAB RES, V24, P231, DOI 10.1002/dmrr.794; Fuller JH, 2001, DIABETOLOGIA, V44, pS54, DOI 10.1007/PL00002940; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hayreh SS, 2011, OPHTHALMOLOGY, V118, P1603, DOI 10.1016/j.ophtha.2011.04.036; Hayreh SS, 2003, OPHTHALMOLOGICA, V217, P167, DOI 10.1159/000068980; Khan Z, 2013, CAN J OPHTHALMOL, V48, P40, DOI 10.1016/j.jcjo.2012.08.017; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Koh V, 2016, OPHTHAL EPIDEMIOL, V23, P6, DOI 10.3109/09286586.2015.1082604; Krentz AJ, 2007, DIABETES OBES METAB, V9, P781, DOI 10.1111/j.1463-1326.2007.00670.x; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Martinez F, 2014, INT J CLIN PRACT, V68, P871, DOI 10.1111/ijcp.12390; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; MUGGEO M, 1995, DIABETOLOGIA, V38, P672, DOI 10.1007/s001250050336; Natarajan A, 2008, DIABETES VASC DIS RE, V5, P138, DOI 10.3132/dvdr.2008.023; Nghiem-Buffet S, 2009, J FR OPHTALMOL, V32, P679, DOI 10.1016/j.jfo.2009.10.002; Papazafiropoulou A, 2015, J DIABETES COMPLICAT, V29, P846, DOI 10.1016/j.jdiacomp.2015.04.005; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rahman S, 2007, DIABETES OBES METAB, V9, P767, DOI 10.1111/j.1463-1326.2006.00655.x; RATH EZ, 1992, OPHTHALMOLOGY, V99, P509; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TREMOLI E, 1982, ATHEROSCLEROSIS, V41, P53, DOI 10.1016/0021-9150(82)90069-7; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Zhong CK, 2016, ATHEROSCLEROSIS, V247, P170, DOI 10.1016/j.atherosclerosis.2016.02.024; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033	47	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188136	10.1371/journal.pone.0188136	http://dx.doi.org/10.1371/journal.pone.0188136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136662	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200069
J	Hai, NK; Lawpoolsri, S; Jittamala, P; Huong, PTT; Kaewkungwal, J				Nguyen Khac Hai; Lawpoolsri, Saranath; Jittamala, Podjanee; Phan Thi Thu Huong; Kaewkungwal, Jaranit			Practices in security and confidentiality of HIV/AIDS patients' information: A national survey among staff at HIV outpatient clinics in Vietnam	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; STIGMA; DISCLOSURE; ATTITUDES; PERCEPTIONS; CARE	Introduction Breach of confidentiality or invasion of privacy from the collection and use of medical records, particularly those of patients with HIV/AIDS or other diseases sensitive to stigmatization, should be prevented by all related stakeholders in healthcare settings. The main focus of this study was to assess practices regarding security and confidentiality of HIV-related information among staff at HIV outpatient clinics (HIV-OPCs) in Vietnam. Methods A descriptive cross-sectional study was conducted at all 312 HIV-OPCs across the country using an online survey technique. Results In general, the staff practices for securing and protecting patient information were at acceptable levels. Most staff had proper measures and practices for maintaining data security; however, the protection of patient confidentiality, particularly for data access, sharing, and transfer still required improvement. Most HIV-OPC staff had good or moderate knowledge and positive perceptions towards security and confidentiality issues. Staff who were not trained in the practice of security measures differed significantly from those who were trained (OR: 3.74; 95% CI: 1.44-9.67); staff needing improved knowledge levels differed significantly from those with good (OR: 5.20; 95% CI: 2.39-11.32) and moderate knowledge levels (OR: 5.10; 95% CI: 2.36-11.00); and staff needing improved perception levels differed significantly from those with good (i. e., with 100% proper practices) and moderate perception levels (OR: 5.67; 95% CI: 2.93-10.95). Staff who were not trained in the protection of data confidentiality differed significantly from those who were trained (OR: 2.18; 95% CI: 1.29-3.65). Conclusions Training is an important factor to help raise the levels of proper practices regarding confidentiality and security, to improve knowledge and raise awareness about change among staff. The operation and management of HIV treatment and care in Vietnam are currently transitioning from separate healthcare clinics (HIV-OPC) into units integrated into general hospitals/healthcare facilities. The findings of this study highlight topics that could be used for improving management and operation of information system and revising guidelines and regulations on protection measures/strategies for data security and confidentiality of HIV/AIDS patients by Vietnam health authorities or other countries facing similar situations. Secure infrastructure and secure measures for data access and use are very important, worthwhile investments. The provision of continuous training and active enforcement and monitoring of the practices of healthcare personnel might lead to an improved understanding and acknowledegement of the importance of national policies/guidelines regarding HIV-related patient information.	[Nguyen Khac Hai] Hanoi Med Univ, Hanoi, Vietnam; [Lawpoolsri, Saranath; Jittamala, Podjanee; Kaewkungwal, Jaranit] Mahidol Univ, Dept Trop Hyg, Bangkok, Thailand; [Phan Thi Thu Huong] Minist Hlth, Vietnam Author HIV AIDS Control, Hanoi, Vietnam	Hanoi Medical University; Mahidol University	Kaewkungwal, J (corresponding author), Mahidol Univ, Dept Trop Hyg, Bangkok, Thailand.	jaranit.kae@mahidol.ac.th		Lawpoolsri, Saranath/0000-0003-4841-7924	Rockefeller Foundation; Faculty of Tropical Medicine, Mahidol University; Faculty of Tropical Medicine, Mahidol University, Thailand	Rockefeller Foundation; Faculty of Tropical Medicine, Mahidol University; Faculty of Tropical Medicine, Mahidol University, Thailand	This project was funded by a grant from the Rockefeller Foundation(no grant number, www.rockefellerfoundation.org) and the Faculty of Tropical Medicine, Mahidol University (no grant number, www.tm.mahidol.ac.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was funded by a grant from the Rockefeller Foundation and the Faculty of Tropical Medicine, Mahidol University, Thailand. The authors would like to extend their thanks to the funders for supporting the graduate students in the Biomedical and Health Informatics program at Mahidol University. Sincere appreciation goes to all heads of the HIV-OPCs and the staff at all of the clinics in Vietnam, the key groups participating in the study, for their time and willingness to respond.	Ali MG, 2015, INT J RES MED SCI, V3, P3080, DOI 10.18203/2320-6012.ijrms201511406; Allen AL, 2008, FACULTY SCHOLARSHIP, P186; [Anonymous], 2017, NEWS VN; [Anonymous], 2007, NGHI DINH QUY DINH C; [Anonymous], 2016, HIV SEC CONF POL; Beck EJ, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.32089; Beck EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-6; Brito-Mutunayagam SL, 2013, J MED INTERNET RES, V15, P294, DOI 10.2196/jmir.2650; Bureau of AIDS Tuberculosis and Sexually Transmitted Infections Department of Disease Control Ministry of Public Health, 2019, THAIL NAT GUID HIV A; CDC, 2014, VIETN FACTSH; Centers for Disease Control and Prevention, 2006, TECHN GUID HIV AIDS; Chandra PS, 2003, AIDS CARE, V15, P207, DOI 10.1080/0954012031000068353; Church K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17981; Cohen J, 2013, HEALTH HUM RIGHTS, V15, P7; Connecticut Department of Public Health, 2017, HIV STD TB HEP SURV; Cross S, 2000, J MED ETHICS, V26, P447, DOI 10.1136/jme.26.6.447; Farzandipour M, 2010, J MED SYST, V34, P629, DOI 10.1007/s10916-009-9276-7; Fernando J, 2008, ELECTRON J HEALTH IN, V3; Fernando JI, 2009, INT J MED INFORM, V78, P815, DOI 10.1016/j.ijmedinf.2009.08.006; Gostin L O, 1995, Health Matrix Clevel, V5, P1; Grossman CI, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18881; Hagey JM, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20123; Holt R, 1998, AIDS CARE, V10, P49, DOI 10.1080/09540129850124578; Ives Erickson Jeanette, 2005, Online J Issues Nurs, V10, P2; Kato caNHL Masaya, 2014, ENHANCING BENEFITS A; Kurtz Gary, 2003, J Healthc Inf Manag, V17, P41; Loutfy M, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19835; Fernandez-Aleman JL, 2013, J BIOMED INFORM, V46, P541, DOI 10.1016/j.jbi.2012.12.003; Maiorana A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-34; Naing CM, 2010, SE ASIAN J TROP MED, V41, P952; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Nyblade L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18718; Oosterhoff P, 2008, AIDS CARE, V20, P654, DOI 10.1080/09540120701687026; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Tarkang E.E., 2015, CENT AFRICAN J PUBLI, V1, P1, DOI [10.11648/j.cajph.20150101.11., DOI 10.11648/J.CAJPH.20150101.11]; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; The Office of the National Coordinator for Health Information Technology, 2015, GUID PRIV SEC EL HLT; Torres C G, 1991, Am J Public Health, V81, P210, DOI 10.2105/AJPH.81.2.210; UNAIDS, 2015, FACT SHEET HIV AIDS; UNAIDS, VIET NAM IS 1 COUNTR; UNAIDS, 2015, AIDS BY THE NUMB; UNAIDS GNP+ IPPF ICWG, 2011, PEOPL LIV HIV STIGM; UNAIDS/PEPFAR, 2007, INT GUID PROT CONF S; VanderMolen J, 2015, ED PERSPECTIVES  FAL; Varga CA, 2006, AIDS CARE, V18, P952, DOI 10.1080/09540120500356906; Vietnam Authority of HIV/AIDS Control, 2014, OPT VIET NAMS HIV RE; Vietnam Authority of HIV/ AIDS Control, 2015, NAT HIV AIDS PREV CO; Vietnam Authority of HIV/AIDS Control, 2014, VIETN AIDS RESP PROG; Vietnam Ministry of Health, 2014, QUYETDNH BANH QUY D; Vietnam National Network of People Living With HIV, 2012, VIET NAM STIGM IND; Vietnam National Network of People Living With HIV, 2014, PEOPL LIV HIV STIGM; Vietnamese National Assembly, 2006, LAW HIV AIDS PREV CO; Wiljer D, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1061	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188160	10.1371/journal.pone.0188160	http://dx.doi.org/10.1371/journal.pone.0188160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136017	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200072
J	Doublier, S; Zennaro, C; Musante, L; Spatola, T; Candiano, G; Bruschi, M; Besso, L; Cedrino, M; Carraro, M; Ghiggeri, GM; Camussi, G; Lupia, E				Doublier, Sophie; Zennaro, Cristina; Musante, Luca; Spatola, Tiziana; Candiano, Giovanni; Bruschi, Maurizio; Besso, Luca; Cedrino, Massimo; Carraro, Michele; Ghiggeri, Gian Marco; Camussi, Giovanni; Lupia, Enrico			Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; IDIOPATHIC NEPHROTIC SYNDROME; UROKINASE RECEPTOR; MESANGIAL CELLS; IN-VITRO; ALBUMIN; PATHWAY; NEPHRIN; PROTEINURIA; EXPRESSION	CD40/CD40 ligand (CD40L) dyad, a co-stimulatory bi-molecular complex involved in the adaptive immune response, has also potent pro-inflammatory actions in haematopoietic and non-haematopoietic cells. We describe here a novel role for soluble CD40L (sCD40L) as modifier of glomerular permselectivity directly acting on glomerular epithelial cells (GECs). We found that stimulation of CD40, constitutively expressed on GEC cell membrane, by the sCD40L rapidly induced redistribution and loss of nephrin in GECs, and increased albumin permeability in isolated rat glomeruli. Pre-treatment with inhibitors of CD40-CD40L interaction completely prevented these effects. Furthermore, in vivo injection of sCD40L induced a significant reduction of nephrin and podocin expression in mouse glomeruli, although no significant increase of urine protein/creatinine ratio was observed after in vivo injection. The same effects were induced by plasma factors partially purified from post-transplant plasma exchange eluates of patients with focal segmental glomerulosclerosis (FSGS), and were blocked by CD40-CD40L inhibitors. Moreover, 17 and 34 kDa sCD40L isoforms were detected in the same plasmapheresis eluates by Western blotting. Finally, the levels of sCD40Lwere significantly increased in serum of children both with steroid- sensitive and steroid-resistant nephrotic syndrome (NS), and in adult patients with biopsy-proven FSGS, compared to healthy subjects, but neither in children with congenital NS nor in patients with membranous nephropathy. Our results demonstrate that sCD40L directly modifies nephrin and podocin distribution in GECs. Moreover, they suggest that sCD40L contained in plasmapheresis eluates from FSGS patients with post-transplant recurrence may contribute, presumably cooperating with other mediators, to FSGS pathogenesis by modulating glomerular permeability.	[Doublier, Sophie] Univ Turin, Dept Oncol, Turin, Italy; [Doublier, Sophie; Spatola, Tiziana; Besso, Luca; Cedrino, Massimo; Camussi, Giovanni; Lupia, Enrico] Univ Turin, Dept Med Sci, Turin, Italy; [Zennaro, Cristina; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Musante, Luca; Candiano, Giovanni; Bruschi, Maurizio; Ghiggeri, Gian Marco] G Gaslini Children Hosp, Nephrol Dialysis Transplantat, Genoa, Italy; [Musante, Luca; Candiano, Giovanni; Bruschi, Maurizio; Ghiggeri, Gian Marco] G Gaslini Children Hosp, Lab Pathophysiol Uremia, Genoa, Italy	University of Turin; University of Turin; University of Trieste; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini	Camussi, G; Lupia, E (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it; enrico.lupia@unito.it	Bruschi, Maurizio/E-7090-2016; Stefanadis, Christodoulos/ABH-2232-2020; Lupia, Enrico/AAB-7505-2019; Musante, Luca/F-5086-2017; Candiano, Giovanni/J-9357-2018	Bruschi, Maurizio/0000-0001-6036-1500; Stefanadis, Christodoulos/0000-0001-5974-6454; Musante, Luca/0000-0003-0845-275X; Candiano, Giovanni/0000-0002-7385-2787; Ghiggeri, Gian Marco/0000-0003-3659-9062	"Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria"; Renal Child Foundation; Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale"); Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale; Italian Ministry of Health; Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte; Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project"); Fresenius Medical Care	"Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria"; Renal Child Foundation; Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale"); Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale; Italian Ministry of Health(Ministry of Health, Italy); Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte(Regione Piemonte); Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project"); Fresenius Medical Care	This study was supported by "Cinque per mille of IRPEF - Finanziamento della ricerca sanitaria", Italian Ministry of Health - "Ricerca Corrente- Contributo per la ricerca intramuraria" to Istituto Giannina Gaslini, Renal Child Foundation, and Fondazione La Nuova Speranza ("Progetto integrato per la definizione dei meccanismi implicati nella glomerulosclerosi focale") to G.M.G., by Fondazione la Nuova Speranza ONLUS - Lotta alla Glomerulosclerosi Focale" to C.Z and M.C., by Italian Ministry of Health Local project ex-60% and Progetto di Ricerca Sanitaria Finalizzata-Regione Piemonte to E.L., and by Italian Ministry of Health - PRIN Project ("Regione Piemonte, Piattaforme Biotecnologiche - PiSTEM Project") and Fresenius Medical Care to G.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar N, 2013, NEW ENGL J MED, V368, P971, DOI 10.1056/NEJMc1207233; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2001, J AM SOC NEPHROL, V12, P143, DOI 10.1681/ASN.V121143; Castellano G, 2005, J AM SOC NEPHROL, V16, P2003, DOI 10.1681/ASN.2002120972; Cathelin D, 2014, J AM SOC NEPHROL, V25, P1662, DOI 10.1681/ASN.2013040425; Charba DS, 2009, AM J PHYSIOL-RENAL, V297, pF138, DOI 10.1152/ajprenal.00122.2008; Conaldi PG, 1997, J VIROL, V71, P9180, DOI 10.1128/JVI.71.12.9180-9187.1997; Conaldi PG, 1998, J CLIN INVEST, V102, P2041, DOI 10.1172/JCI3480; DANTAL J, 1994, NEW ENGL J MED, V330, P7, DOI 10.1056/NEJM199401063300102; Dantal J, 1998, J AM SOC NEPHROL, V9, P1709; Davin JC, 2016, PEDIATR NEPHROL, V31, P207, DOI 10.1007/s00467-015-3082-x; Deambrosis I, 2005, INT J IMMUNOPATH PH, V18, P327, DOI 10.1177/039463200501800215; Delville M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008538; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Doublier S, 2005, INT J MOL MED, V16, P49; Esposito P, 2014, INT REV IMMUNOL, V33, P212, DOI 10.3109/08830185.2013.829470; Glassock RJ, 2003, J AM SOC NEPHROL, V14, P541, DOI 10.1097/01.ASN.0000051640.04273.75; Hassan GS, 2015, CANCER TREAT REV, V41, P431, DOI 10.1016/j.ctrv.2015.03.007; Hassan GS, 2012, IMMUNOBIOLOGY, V217, P521, DOI 10.1016/j.imbio.2011.03.010; HESLAN JM, 1986, NEPHRON, V42, P187, DOI 10.1159/000183664; Inwald DP, 2003, CIRC RES, V92, P1041, DOI 10.1161/01.RES.0000070111.98158.6C; Jefferson JA, 2013, KIDNEY INT, V84, P235, DOI 10.1038/ki.2013.204; Kairaitis L, 2003, KIDNEY INT, V64, P1265, DOI 10.1046/j.1523-1755.2003.00223.x; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kim EY, 2017, BBA-MOL BASIS DIS, V1863, P2342, DOI 10.1016/j.bbadis.2017.06.010; Klein D, 2005, DIABETOLOGIA, V48, P268, DOI 10.1007/s00125-004-1645-7; Korniluk A, 2014, TUMOR BIOL, V35, P9447, DOI 10.1007/s13277-014-2407-x; Kuo HL, 2017, NEPHROL DIAL TRANSPL; Laxmanan S, 2005, J AM SOC NEPHROL, V16, P2714, DOI 10.1681/ASN.2005010045; Lee HS, 2012, CELL TISSUE RES, V347, P129, DOI 10.1007/s00441-011-1169-7; Lee VWS, 2010, NEPHROL DIAL TRANSPL, V25, P717, DOI 10.1093/ndt/gfp569; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Lievens D, 2009, THROMB HAEMOSTASIS, V102, P206, DOI 10.1160/TH09-01-0029; Maas RJ, 2014, NEPHROL DIAL TRANSPL, V29, P2207, DOI 10.1093/ndt/gfu355; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Musante L, 2005, CLIN EXP IMMUNOL, V141, P491, DOI 10.1111/j.1365-2249.2005.02862.x; Palacios CRF, 2013, TRANSPLANTATION, V96, P394, DOI 10.1097/TP.0b013e3182977ab1; Pamukcu B, 2011, ANN MED, V43, P331, DOI 10.3109/07853890.2010.546362; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Reiser J, 2014, ADV CHRONIC KIDNEY D, V21, P417, DOI 10.1053/j.ackd.2014.05.010; Reynolds J, 2004, KIDNEY INT, V66, P1444, DOI 10.1111/j.1523-1755.2004.00907.x; Rigothier C, 2016, J CELL BIOCHEM, V117, P2737, DOI 10.1002/jcb.25571; Ripoll E, 2011, GENE THER, V18, P945, DOI 10.1038/gt.2011.39; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Ruth AJ, 2003, J AM SOC NEPHROL, V14, P2813, DOI 10.1097/01.ASN.0000091381.60059.FB; Savin VJ, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/6232616; Savin VJ, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/714964; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Savin VJ, 2003, SEMIN NEPHROL, V23, P147, DOI 10.1053/snep.2003.50024; Shankland SJ, 2011, NAT MED, V17, P926, DOI 10.1038/nm.2443; Sharma M, 1999, J AM SOC NEPHROL, V10, P552; Tanaka T, 2002, J AM SOC NEPHROL, V13, P2488, DOI 10.1097/01.ASN.0000029588.07166.20; Trimarchi Hernan, 2013, World J Nephrol, V2, P103, DOI 10.5527/wjn.v2.i4.103; Vincenti F, 2005, AM J TRANSPLANT, V5, P1179, DOI 10.1111/j.1600-6143.2005.00968.x; Wada T, 2015, CLIN KIDNEY J, V8, P708, DOI 10.1093/ckj/sfv090; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Xie JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08426-8; Yang X, 2004, NEPHROL DIAL TRANSPL, V19, P1378, DOI 10.1093/ndt/gfh144; Zennaro C, 2016, INT J NANOMED, V11, P4957, DOI 10.2147/IJN.S110201; Zhang BK, 2013, IMMUNOL LETT, V153, P58, DOI 10.1016/j.imlet.2013.07.005	63	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188045	10.1371/journal.pone.0188045	http://dx.doi.org/10.1371/journal.pone.0188045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155846	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700028
J	Liu, C; Dang, XL; Mayes, MA; Chen, LL; Zhang, YL				Liu, Chang; Dang, Xiuli; Mayes, Melanie A.; Chen, Leilei; Zhang, Yulong			Effect of long-term irrigation patterns on phosphorus forms and distribution in the brown soil zone	PLOS ONE			English	Article							FRESH-WATER WETLANDS; MANURE APPLICATIONS; SORPTION CAPACITY; CALCAREOUS SOILS; SANJIANG PLAIN; ORGANIC-CARBON; USE EFFICIENCY; ANIMAL MANURE; AVAILABILITY; PHOSPHATE	Continuous application of P fertilizers under different irrigation patterns can change soil phosphorus (P) chemical behavior and increase soil P levels that are of environmental concern. To assess the effect of long-term different irrigation patterns on soil P fractions and availability, this study examined sequential changes in soil organic P and inorganic P from furrow irrigation (FI), surface drip irrigation (SUR), and subsurface drip irrigation (SDI) in the brown soil zone (0-60 cm) during 1998 to 2011. Analyses of soil P behavior showed that the levels of total P are frequently high on top soil layers. The total P (TP) contents of the entire soil profiles under three irrigation treatments were 830.2-3180.1 mg/kg. The contents of available P (AP) were 72.6-319.3 mg P/kg soil through soil profiles. The greatest TP and AP contents were obtained within the upper soil layers in FI. Results of Hedley's P fractionation indicate that HCl-P is a dominant form and the proportion to TP ranges from 29% to 43% in all three methods. The contents of various fractions of P were positively correlated with the levels of total carbon (TC), total inorganic carbon (TIC), and calcium (Ca), whereas the P fractions had negative correlation with pH in all soil samples. Regression models proved that NaHCO3-P-o was an important factor in determining the amount of AP in FI. H2O-P-o, NaHCO3-P-o, and NaOH-P-i were related to available P values in SUR. NaHCO3-P-o and NaOH-P-o played important roles in SDI. The tomato yield under SUR was higher than SDI and FI. The difference of P availability was also controlled by the physicochemical soil properties under different irrigation schedule. SUR was a reasonable irrigation pattern to improve the utilization efficiency of water and fertilizer.	[Liu, Chang; Dang, Xiuli; Zhang, Yulong] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China; [Mayes, Melanie A.] Climate Change Sci Inst, Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN USA; [Chen, Leilei] Chifeng Environm Monitoring Cent Stn, Integrated Technol Dept, Chifeng, Inner Mongolia, Peoples R China	Shenyang Agricultural University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Zhang, YL (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China.	ylzsau@163.com	dang, xiuli/ABG-4716-2021	dang, xiuli/0000-0002-1702-9745	National Basic Research Program (973) of China [2011CB100502]; National Natural Science Foundation of China [41301530]; Scientific and Technological Projects of Shenyang City [FF11-117-3-00]; Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education [CEPF2012-123-1-7]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Projects of Shenyang City; Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education	This work was supported by the National Basic Research Program (973) of China (No. 2011CB100502), http://program.most.gov.cn/; National Natural Science Foundation of China (41301530), http://www.nsfc.gov.cn/; the Scientific and Technological Projects of Shenyang City (Grant No. FF11-117-3-00) http://www.syscg.gov.cn; and the Fifth session of Geping Green Action-123 Project of Liaoning Environmental Research and Education (No. CEPF2012-123-1-7), http://www.cepfln.com/List.asp?ID=634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami E, 2013, J SOIL SCI PLANT NUT, V13, P11, DOI [10.4067/S0718-95162012005000002, 10.4067/S0718-95162013005000002]; Alam M, 2002, J AM WATER RESOUR AS, V38, P1715, DOI 10.1111/j.1752-1688.2002.tb04376.x; Aldrich R.A, 1994, GREENHOUSE ENG; Alvarez-Rogel J, 2007, SCI TOTAL ENVIRON, V378, P71, DOI 10.1016/j.scitotenv.2007.01.016; Ann Y, 2000, ECOL ENG, V14, P157; [Anonymous], 2015, WETLAND SOILS GENESI; BACON PE, 1982, SOIL SCI SOC AM J, V46, P981, DOI 10.2136/sssaj1982.03615995004600050019x; BARROW NJ, 1984, J SOIL SCI, V35, P283, DOI 10.1111/j.1365-2389.1984.tb00283.x; BARYOSEF B, 1989, AGRON J, V81, P443, DOI 10.2134/agronj1989.00021962008100030009x; BECK MA, 1994, SOIL SCI SOC AM J, V58, P1424, DOI 10.2136/sssaj1994.03615995005800050021x; Ben-Gal A, 2003, SOIL SCI SOC AM J, V67, P1449, DOI 10.2136/sssaj2003.1449; Bertrand I, 2003, AUST J SOIL RES, V41, P61, DOI 10.1071/SR02021; Bisutti I, 2004, TRAC-TREND ANAL CHEM, V23, P716, DOI 10.1016/j.trac.2004.09.003; Bunemann EK, 2011, SOIL BIOL, V26, P37, DOI 10.1007/978-3-642-15271-9_2; Condron LM, 2006, AUST J SOIL RES, V44, P127, DOI 10.1071/SR05065; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Daly K, 2001, SOIL USE MANAGE, V17, P12, DOI 10.1111/j.1475-2743.2001.tb00003.x; de Carvalho AM, 2014, REV BRAS CIENC SOLO, V38, P972, DOI 10.1590/S0100-06832014000300029; Eveborn D, 2014, WATER RES, V64, P42, DOI 10.1016/j.watres.2014.06.034; Fixen P. E., 1990, SOIL TESTING PLANT A, V3, P141, DOI DOI 10.2136/sssabookser3.3ed.c7; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Goyal M.R., 2012, MANAGEMENT DRIP TRIC; Han L, 2010, AGR SCI CHINA, V9, P1175, DOI 10.1016/S1671-2927(09)60205-4; Hinsinger P, 2003, PLANT SOIL, V248, P43, DOI 10.1023/A:1022371130939; Hogan DM, 2004, WETLANDS, V24, P573, DOI 10.1672/0277-5212(2004)024[0573:PRASOC]2.0.CO;2; Howell TA, 2001, AGRON J, V93, P281, DOI 10.2134/agronj2001.932281x; Ige DV, 2005, CAN J SOIL SCI, V85, P417, DOI 10.4141/S04-064; Jalali M, 2010, SOIL SEDIMENT CONTAM, V19, P560, DOI 10.1080/15320383.2010.499927; Jensen ME, 1980, MONOGRAPH SERIES AM; Jimenez-Carceles FJ, 2008, GEODERMA, V144, P299, DOI 10.1016/j.geoderma.2007.11.024; Khademi Z, 2010, PLANT SOIL, V334, P151, DOI 10.1007/s11104-009-0215-7; Kleinman PJA, 2002, COMMUN SOIL SCI PLAN, V33, P1825, DOI 10.1081/CSS-120004825; Koopmans GF, 2007, J ENVIRON QUAL, V36, P305, DOI 10.2134/jeq2006.0131; Kumaragamage D, 2012, J ENVIRON QUAL, V41, P845, DOI 10.2134/jeq2011.0415; [罗先香 Luo Xianxiang], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P154; MBAGWU JSC, 1985, PLANT SOIL, V84, P181, DOI 10.1007/BF02143182; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Neumann G, 2000, ANN BOT-LONDON, V85, P909, DOI 10.1006/anbo.2000.1135; Pagliari PH, 2012, J ENVIRON QUAL, V41, P901, DOI 10.2134/jeq2011.0451; Reis THP, 2011, REV BRAS CIENC SOLO, V35, P503, DOI 10.1590/S0100-06832011000200019; Pizzeghello D, 2014, AGR ECOSYST ENVIRON, V189, P216, DOI 10.1016/j.agee.2014.03.047; Poach ME, 1998, ESTUAR COAST SHELF S, V46, P195, DOI 10.1006/ecss.1997.0252; Ponce P., 2014, GREENHOUSE DESIGN CO; Sharpley A, 2000, J ENVIRON QUAL, V29, P1462, DOI 10.2134/jeq2000.00472425002900050012x; Sharpley A, 2000, J ENVIRON QUAL, V29, P176, DOI 10.2134/jeq2000.00472425002900010022x; Sharpley AN, 2004, SOIL SCI SOC AM J, V68, P2048, DOI 10.2136/sssaj2004.2048; Sharpley AN, 2001, PLANT SOIL, V237, P287, DOI 10.1023/A:1013335814593; Shi B, 2002, ENG GEOL, V67, P63, DOI 10.1016/S0013-7952(02)00145-X; Silber A, 2003, PLANT SOIL, V253, P467, DOI 10.1023/A:1024857814743; Sims JT, 1998, J ENVIRON QUAL, V27, P277, DOI 10.2134/jeq1998.00472425002700020006x; Skhiri A, 2012, AGR WATER MANAGE, V103, P130, DOI 10.1016/j.agwat.2011.11.004; Tunesi S, 1999, NUTR CYCL AGROECOSYS, V53, P219, DOI 10.1023/A:1009709005147; Vaananen R., 2008, THESIS, DOI 10.14214/df.60; Valipour M, 2013, IRRIG DRAIN, V9, P2; von Wandruszka R, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-6; Wang GP, 2006, GEODERMA, V132, P59, DOI 10.1016/j.geoderma.2005.04.021; Wang YS, 2010, J PLANT NUTR SOIL SC, V173, P345, DOI 10.1002/jpln.200800284; Xu HC, 2012, WASTE BIOMASS VALORI, V3, P355, DOI 10.1007/s12649-011-9103-5; Yang LJ, 2011, PEDOSPHERE, V21, P712, DOI 10.1016/S1002-0160(11)60174-4; Yang WJ, 2012, GEODERMA, V189, P207, DOI 10.1016/j.geoderma.2012.06.025; Zhang TQ, 1997, PLANT SOIL, V192, P133, DOI 10.1023/A:1004232417658; Zohar I, 2010, GEODERMA, V159, P109, DOI 10.1016/j.geoderma.2010.07.002	63	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188361	10.1371/journal.pone.0188361	http://dx.doi.org/10.1371/journal.pone.0188361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155875	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700051
J	Plazy, M; Perriat, D; Gumede, D; Boyer, S; Pillay, D; Dabis, F; Seeley, J; Orne-Gliemann, J				Plazy, Melanie; Perriat, Delphine; Gumede, Dumile; Boyer, Sylvie; Pillay, Deenan; Dabis, Francois; Seeley, Janet; Orne-Gliemann, Joanna			Implementing universal HIV treatment in a high HIV prevalence and rural South African setting - Field experiences and recommendations of health care providers	PLOS ONE			English	Article							EARLY ANTIRETROVIRAL THERAPY; DIFFERENTIATED CARE; INCOME COUNTRIES; PREVENTION; INITIATION; TRIAL; ART; INFECTION; PERSPECTIVES; ADHERENCE	Background We aimed to describe the field experiences and recommendations of clinic-based health care providers (HCP) regarding the implementation of universal antiretroviral therapy (ART) in rural KwaZulu-Natal, South Africa. Methods In Hlabisa sub-district, the local HIV programme of the Department of Health (DoH) is decentralized in 18 clinics, where ART was offered at a CD4 count <= 500 cells/mu L from January 2015 to September 2016. Within the ANRS 12249 TasP trial, implemented in part of the sub-district, universal ART (no eligibility criteria) was offered in 11 mobile clinics between March 2012 and June 2016. A cross-sectional qualitative survey was conducted in April-July 2016 among clinic-based nurses and counsellors providing HIV care in the DoH and TasP trial clinics. In total, 13 individual interviews and two focus groups discussions (including 6 and 7 participants) were conducted, audio-recorded, transcribed, and thematically analyzed. Results All HCPs reported an overall good experience of delivering ART early in the course of HIV infection, with most patients willing to initiate ART before being symptomatic. Yet, HCPs underlined that not feeling sick could challenge early ART initiation and adherence, and thus highlighted the need to take time for counselling as an important component to achieve universal ART. HCPs also foresaw logistical challenges of universal ART, and were especially concerned about increasing workload and ART shortage. HCPs finally recommended the need to strengthen the existing model of care to facilitate access to ART, e.g., community-based and integrated HIV services. Conclusions The provision of universal ART is feasible and acceptable according to HCPs in this rural South-African area. However their experiences suggest that universal ART, and more generally the 90-90-90 UNAIDS targets, will be difficult to achieve without the implementation of new models of health service delivery.	[Plazy, Melanie; Perriat, Delphine; Dabis, Francois; Orne-Gliemann, Joanna] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Plazy, Melanie; Perriat, Delphine; Dabis, Francois; Orne-Gliemann, Joanna] INSERM, Bordeaux Populat Hlth Res Ctr, ISPED, UMR 1219, Bordeaux, France; [Gumede, Dumile; Pillay, Deenan; Seeley, Janet] Africa Hlth Res Inst, Somkhele, South Africa; [Boyer, Sylvie] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France; [Pillay, Deenan] UCL, Div Infect & Immun, London, England; [Seeley, Janet] London Sch Hyg & Trop Med, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Africa Health Research Institute; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Plazy, M (corresponding author), Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France.; Plazy, M (corresponding author), INSERM, Bordeaux Populat Hlth Res Ctr, ISPED, UMR 1219, Bordeaux, France.	melanie.plazy@u-bordeaux.fr	DABIS, FRANCOIS/S-9298-2019; Plazy, Melanie/T-9707-2019; Gumede, Dumile/GXZ-5278-2022; Orne-Gliemann, Joanna/T-2787-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Gumede, Dumile/0000-0002-8628-5726; Perriat, Delphine/0000-0001-7498-1700; Seeley, Janet/0000-0002-0583-5272; PLAZY, Melanie/0000-0002-8971-6878	French National Agency for AIDS and Viral Hepatitis Research (ANRS); ANRS; International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Wellcome Trust; French Charity Sidaction; French Ecole des Hautes Etudes en Sante Publique (EHESP)	French National Agency for AIDS and Viral Hepatitis Research (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ); Wellcome Trust(Wellcome TrustEuropean Commission); French Charity Sidaction; French Ecole des Hautes Etudes en Sante Publique (EHESP)	The French National Agency for AIDS and Viral Hepatitis Research (ANRS) is the sponsor and co-funder of the TasP trial within which this study was conducted. Research discussed in this publication has been co-funded by ANRS together with the International Initiative for Impact Evaluation, Inc. (3ie) with support from the Bill & Melinda Gates Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of 3ie or the Bill & Melinda Gates Foundation. The Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) co-funded the first part of the trial. Merck & Co. Inc. and Gilead Sciences provided the Atriplat drug supply. The Africa Health Research Institute (AHRI) receives core funding from the Wellcome Trust, which provides the platform for the population- and clinic-based research at Somkhele. Melanie Plazy is supported by the French Charity Sidaction and Delphine Perriat by the French Ecole des Hautes Etudes en Sante Publique (EHESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 2017, CONS GUID PERS CTR H; Barnighausen T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163960; Bor J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178249; Boyer S, 2016, AIDS CARE, V28, P39, DOI 10.1080/09540121.2016.1164808; Celletti F, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21185; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Dussault G, 2008, SOC SCI MED, V66, P2088, DOI 10.1016/j.socscimed.2008.01.035; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Evans C, 2015, AIDS CARE, V27, P753, DOI 10.1080/09540121.2014.1002826; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; Haberer JE, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21371; Hayes R, 2011, CURR HIV RES, V9, P429, DOI 10.2174/157016211798038515; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Inzaule SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167492; Iwuji C, 2016, AIDS C 18 22 JUL DUR; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Kurth AE, 2012, JAIDS-J ACQ IMM DEF, V61, pE65, DOI [10.1097/QAI.0b013e31826a184c., 10.1097/QAI.0b013e31826a184c]; Lebouche Bertrand, 2014, J Int Assoc Provid AIDS Care, V13, P160, DOI 10.1177/2325957413488196; Lebouche B, 2013, AIDS CARE, V25, P1284, DOI 10.1080/09540121.2013.764394; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; MacPherson P, 2014, JAMA-J AM MED ASSOC, V312, P372, DOI 10.1001/jama.2014.6493; Mao LM, 2013, AIDS CARE, V25, P1375, DOI 10.1080/09540121.2013.766304; Mbonye M, 2016, AIDS CARE, V28, P33, DOI 10.1080/09540121.2016.1164804; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Nachega JB, 2016, CURR HIV-AIDS REP, V13, P241, DOI 10.1007/s11904-016-0325-9; Orne-Gliemann J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1344-y; Perriat D, J INT AIDS IN PRESS; Peter T, 2017, LANCET INFECT DIS, V17, pE26, DOI 10.1016/S1473-3099(16)30212-2; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Plazy M, 2017, 9 IAS C HIV SCI 23 2; Plazy M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20913; South African Department of Health, 2017, ID CLIN MAN; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; UNAIDS, 2014, 90 90 90 AMB TREATM; Van Damme W, 2008, SOC SCI MED, V66, P2108, DOI 10.1016/j.socscimed.2008.01.043; Vernooij E, 2016, AIDS CARE, V28, P7, DOI 10.1080/09540121.2016.1178954; WHO, 2010, ANT THER HIV INF AD; WHO (World Health Organization), 2016, PROGR REP 2016 PREV; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2016, CONS GUID US ANT DRU	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0186883	10.1371/journal.pone.0186883	http://dx.doi.org/10.1371/journal.pone.0186883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155832	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000415756700006
J	Brini, I; Guerrero, A; Hannachi, N; Bouguila, J; Orth-Holler, D; Bouhlel, A; Boughamoura, L; Hetzer, B; Borena, W; Schiela, B; Von Laer, D; Boukadida, J; Stoiber, H				Brini, Ines; Guerrero, Aida; Hannachi, Naila; Bouguila, Jihene; Orth-Hoeller, Dorothea; Bouhlel, Amira; Boughamoura, Lamia; Hetzer, Benjamin; Borena, Wegene; Schiela, Britta; Von Laer, Dorothee; Boukadida, Jalel; Stoiber, Heribert			Epidemiology and clinical profile of pathogens responsible for the hospitalization of children in Sousse area, Tunisia	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; HUMAN METAPNEUMOVIRUS; PCR; ETIOLOGY; FEATURES; INFANTS; ASSAYS; UNIT	This study aimed to identify a broad spectrum of respiratory pathogens from hospitalized and not-preselected children with acute respiratory tract infections in the Farhat Hached University-hospital of Sousse, Tunisia. Between September 2013 and December 2014, samples from 372 children aged between 1 month and 5 years were collected, and tested using multiplex real-time RT-PCR by a commercial assay for 21 respiratory pathogens. In addition, samples were screened for the presence of Streptococcus pneumoniae 16S rDNA using real-time PCR. The viral distribution and its association with clinical symptoms were statistically analyzed. Viral pathogens were detected in 342 (91.93%) of the samples of which 28.76% were single positive and 63.17% had multiple infections. The most frequent detected viruses were rhinovirus (55.64%), respiratory syncytial virus A/B (33.06%), adenovirus (25.00%), coronavirus NL63, HKU1, OC43, and 229E (21.50%), and metapneumovirus A/B (16.12%). Children in the youngest age group (1-3 months) exhibited the highest frequencies of infection. Related to their frequency of detection, RSV A/B was the most associated pathogen with patient's demographic situation and clinical manifestations (p<0.05). Parainfluenza virus 1-4 and parechovirus were found to increase the risk of death (p<0.05). Adenovirus was statistically associated to the manifestation of gastroenteritis (p = 0.004). Rhinovirus infection increases the duration of oxygen support (p = 0.042). Coronavirus group was statistically associated with the manifestation of bronchiolitis (p = 0.009) and laryngitis (p = 0.017). Streptococcus pneumoniae DNA was detected in 143 (38.44%) of tested samples. However, only 53 samples had a concentration of C-reactive protein from equal to higher than 20 milligrams per liter, and 6 of them were single positive for Streptocuccus pneumoniae. This study confirms the high incidence of respiratory viruses in children hospitalized for acute respiratory tract infections in the Sousse area, Tunisia.	[Brini, Ines; Hannachi, Naila; Boukadida, Jalel] Univ Sousse, Fac Med Sousse, Lab Microbiol & Immunol, Sousse, Tunisia; [Brini, Ines; Hannachi, Naila; Boukadida, Jalel] Univ Hosp Farhat Hached Sousse, Res Unit Genom Characterizat Infect Agents UR12SP, Sousse, Tunisia; [Brini, Ines] Univ Monastir, Fac Pharm Monastir, Monastir, Tunisia; [Brini, Ines; Hetzer, Benjamin] Innsbruck Med Univ, Innsbruck, Austria; [Guerrero, Aida; Borena, Wegene; Schiela, Britta; Von Laer, Dorothee; Stoiber, Heribert] Innsbruck Med Univ, Div Virol, Innsbruck, Austria; [Bouhlel, Amira; Boughamoura, Lamia] Univ Hosp Farhat Hached Sousse Sousse, Pediat Serv, Sousse, Tunisia; [Orth-Hoeller, Dorothea] Innsbruck Med Univ, Div Hyg & Med Microbiol, Innsbruck, Austria	Universite de Sousse; Universite de Sousse; Hopital Farhat Hached; Universite de Monastir; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Brini, I (corresponding author), Univ Sousse, Fac Med Sousse, Lab Microbiol & Immunol, Sousse, Tunisia.; Brini, I (corresponding author), Univ Hosp Farhat Hached Sousse, Res Unit Genom Characterizat Infect Agents UR12SP, Sousse, Tunisia.; Brini, I (corresponding author), Univ Monastir, Fac Pharm Monastir, Monastir, Tunisia.; Brini, I (corresponding author), Innsbruck Med Univ, Innsbruck, Austria.; Stoiber, H (corresponding author), Innsbruck Med Univ, Div Virol, Innsbruck, Austria.	ines.brini@hotmail.com; Heribert.stoiber@i-med.ac.at		von Laer, Dorothee/0000-0001-5825-7237; Orth-Holler, Dorothea/0000-0003-2904-5192	FWF (Horos doctoral Program) [W1253-B24]; Innsbruck Medical University, Innsbruck, Austria; Unit Research for Genomic Characterization of Infectious Agents at Farhat Hached University-hospital of Sousse, Tunisia [UR12SP34]; Ministry of Higher Education and Scientific Research in Tunisia	FWF (Horos doctoral Program); Innsbruck Medical University, Innsbruck, Austria; Unit Research for Genomic Characterization of Infectious Agents at Farhat Hached University-hospital of Sousse, Tunisia; Ministry of Higher Education and Scientific Research in Tunisia	The FWF (Horos doctoral Program, W1253-B24) and Innsbruck Medical University, Innsbruck, Austria (HS): methodology of study. The Unit Research for Genomic Characterization of Infectious Agents UR12SP34 in Farhat Hached university-hospital of Sousse area in Tunisia and the Ministry of Higher Education and Scientific Research in Tunisia (J Boukadida): study design, data collection. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.; This study was in part supported by the FWF (Horos doctoral Program, W1253-B24), the Unit Research for Genomic Characterization of Infectious Agents UR12SP34 at Farhat Hached University-hospital of Sousse, Tunisia, and the Ministry of Higher Education and Scientific Research in Tunisia. The excellent technical assistance of Vicky Staudinger with the S. pneumoniae-qPCR is greatly appreciated. We thank statisticians from the Epidemiology ward at Farhat Hached University-hospital of Sousse, Tunisia, for providing additional instructions about the statistical calculations. We are also indebted to Pr. Khaled Ben Khadim Allah from the Medical English Department at Sousse Medical University, Tunisia, for improving the manuscript's spelling, vocabulary, and grammar.	Abroug F, 2014, EMERG INFECT DIS, V20, P1527, DOI 10.3201/eid2009.140378; Al-Ayed MS, 2014, SAUDI MED J, V35, P1348; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Ben M'hadheb M, 2015, CURR MICROBIOL, V70, P324, DOI 10.1007/s00284-014-0719-0; Bicer S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-22; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Damak H, 2011, INFLUENZA OTHER RESP, V5, P230, DOI 10.1111/j.1750-2659.2011.00196.x; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; Dominguez O, 2005, PEDIATR INFECT DIS J, V24, P733, DOI 10.1097/01.inf.0000172942.96436.2d; El Moussi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074064; Fodha I, 2004, ANN TROP PAEDIATR, V24, P275, DOI 10.1179/027249304225019055; Fodha I, 2004, ANN TROP PAEDIATR, V24, P219, DOI 10.1179/027249304225018966; Fodha I, 2004, J MED VIROL, V72, P683, DOI 10.1002/jmv.20038; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Harada Y, 2013, PEDIATR INFECT DIS J, V32, P441, DOI 10.1097/INF.0b013e31828ba08c; Hinman AR, 1998, VACCINE, V16, P1116, DOI 10.1016/S0264-410X(98)80107-2; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Jroundi I, 2016, EPIDEMIOL INFECT, V144, P516, DOI 10.1017/S095026881500151X; Jroundi I, 2014, J TROP PEDIATRICS, V60, P270, DOI 10.1093/tropej/fmu010; KADI Z, 1990, Revue Roumaine de Virologie, V41, P197; Khadadah M, 2010, J MED VIROL, V82, P1462, DOI 10.1002/jmv.21823; Liu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087818; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Marzouk M, 2015, MICROB DRUG RESIST, V21, P85, DOI 10.1089/mdr.2014.0084; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Mertz D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5061; Muhlemann K, 2006, CLIN MICROBIOL INFEC, V12, P873, DOI [10.1111/j.1469-0691.2006.1472_1.x, 10.1111/j.1469-0691.2006.01472.x]; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Navne JE, 2016, EPIDEMIOL INFECT, V144, P3226, DOI 10.1017/S0950268816001461; Nemerow GR, 2012, CURR OPIN VIROL, V2, P115, DOI 10.1016/j.coviro.2011.12.008; Pavia AT, 2011, CLIN INFECT DIS, V52, pS284, DOI 10.1093/cid/cir043; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Richter J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147041; Saikku Pekka, 1997, Clin Microbiol Infect, V3, P599, DOI 10.1111/j.1469-0691.1997.tb00464.x; Vandini S, 2016, PAEDIAT RESP REV; Vongphrachanh P, 2010, INFLUENZA OTHER RESP, V4, P47, DOI 10.1111/j.1750-2659.2009.00120.x; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Zhang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072606	46	14	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188325	10.1371/journal.pone.0188325	http://dx.doi.org/10.1371/journal.pone.0188325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149199	Green Submitted, Green Published, gold			2022-12-27	WOS:000415646100038
J	Jourdy, Y; Enjolras, N; Le Quellec, S; Bordet, JC; Negrier, C; Vinciguerra, C; Dargaud, Y				Jourdy, Yohann; Enjolras, Nathalie; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim			Why patients with THBD c.1611C > A (p.Cys537X) nonsense mutation have high levels of soluble thrombomodulin?	PLOS ONE			English	Article							PROTEIN-C ACTIVATION; THROMBIN GENERATION; ENDOTHELIAL-CELLS; MECHANISMS; EXPRESSION; COFACTOR; PLASMA; GENE; IDENTIFICATION; RELEASE	Background Recently our group has described a new autosomal dominant bleeding disorder characterized by very high plasma levels of soluble thrombomodulin (TM). The THBD c.1611C>A (p.Cys537X) mutation in heterozygous state was found in the propositus. This mutation leads to the synthesis of a truncated TM which has lost the last three amino-acids of the transmembrane domain and the cytoplasmic tail. Objective We investigated the mechanism responsible for TM shedding in endothelial cells with THBD c.1611C>A mutation. Methods Complementary DNA of TM wild type (TM-WT) was incorporated into a pcDNA3.1 vector for transient transfection in COS-1 cells. Mutagenesis was performed to create the c.1611C<A (TM1-536) mutant and 4 other TM mutants (TM1-515, TM1-525, TM1-533 and TM1-537) with a transmembrane domain having different lengths. The effect of shear stress, metalloprotease inhibitor, certain proteases and reducing agents were tested on TM shedding. Results Western blot and immunofluorescent analysis showed that TM1-536 was produced and a certain amount of TM1-536 was anchored on the cell membrane. A significantly higher levels of soluble TM was observed in the TM1-536 cell medium in comparison with TM-WT (56.3 +/- 5.2 vs 8.8 +/- 1.6 ng/mL, respectively, p = 0.001). The shedding of TM1-536 was 75% decreased in cells cultured in the presence of a metalloprotease inhibitor. No difference was observed between TM1-536 and TM-WT shedding after cell exposure to cathepsin G, elastase, several reducing agents and high shear stress (5000 s(-1)). Significantly higher levels of soluble TM were observed in the cell media of TM1-533, TM1-525, TM1-515 in comparison with TM-WT (p < 0.05). Conclusion The mechanism responsible for TM shedding is complex and is not completely understood: higher sensitivity of the TM1-536 to the proteolysis by metalloproteases and a defect of synthesis due to the decreased size of the transmembrane domain might explain the high levels of soluble TM in plasma of the carriers.	[Jourdy, Yohann; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim] Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Hematol Biol, Bron, France; [Jourdy, Yohann; Enjolras, Nathalie; Le Quellec, Sandra; Bordet, Jean Claude; Negrier, Claude; Vinciguerra, Christine; Dargaud, Yesim] Univ Claude Bernard, EAM Hemostase & Canc 4609, Lyon, France; [Le Quellec, Sandra; Negrier, Claude; Dargaud, Yesim] Hosp Civils Lyon, Hop Cardiol Louis Pradel, Unite Hemostase Clin, Bron, France	CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Jourdy, Y (corresponding author), Hosp Civils Lyon, Ctr Biol & Pathol Est, Serv Hematol Biol, Bron, France.; Jourdy, Y (corresponding author), Univ Claude Bernard, EAM Hemostase & Canc 4609, Lyon, France.	yohann.jourdy@chu-lyon.fr	Jourdy, Yohann/K-8831-2019; Dargaud, Yesim/AAM-3619-2021; Le Quellec, Sandra/B-7490-2018	Jourdy, Yohann/0000-0001-7408-6474; Dargaud, Yesim/0000-0002-4888-1463; VINCIGUERRA, Christine/0000-0002-1676-9872; Chamouard, Valerie/0000-0002-4443-1609; ENJOLRAS, Nathalie/0000-0002-4778-0724; Negrier, Claude/0000-0003-3569-0366; BORDET, Jean-Claude/0000-0003-1498-703X; Le Quellec, Sandra/0000-0002-6203-3946				Adams TE, 2006, ARTERIOSCL THROM VAS, V26, P1738, DOI 10.1161/01.ATV.0000228844.65168.d1; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Boehme MWJ, 2002, IMMUNOLOGY, V107, P340, DOI 10.1046/j.1365-2567.2002.01469.x; Boehme MWJ, 1996, IMMUNOLOGY, V87, P134; Burley K, 2016, BLOOD, V128, P1879, DOI 10.1182/blood-2016-05-716092; Cheng TL, 2011, J INVEST DERMATOL, V131, P2486, DOI 10.1038/jid.2011.230; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Dargaud Y, 2015, BLOOD, V125, P1497, DOI 10.1182/blood-2014-10-604553; Dargaud Y, 2010, BLOOD, V116, P5734, DOI 10.1182/blood-2010-06-291906; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Dharmasaroja P, 2012, CLIN APPL THROMB-HEM, V18, P289, DOI 10.1177/1076029611432744; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Kunz G, 2002, BLOOD, V99, P3646, DOI 10.1182/blood.V99.10.3646; Kunz G, 2000, BLOOD, V95, P569, DOI 10.1182/blood.V95.2.569; Kurosawa S, 2008, CRIT CARE MED, V36, P985, DOI 10.1097/CCM.0B013E318165FDA7; Langdown J, 2014, BLOOD, V124, P1951, DOI 10.1182/blood-2014-02-557538; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Menschikowski M, 2010, THROMB RES, V126, pE88, DOI 10.1016/j.thromres.2010.05.006; Ohlin AK, 2005, J THROMB HAEMOST, V3, P976, DOI 10.1111/j.1538-7836.2005.01267.x; Pike GN, 2015, BLOOD, V126, P397, DOI 10.1182/blood-2014-12-616565; STEARNS DJ, 1989, J BIOL CHEM, V264, P3352; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; Trossaert M, 2014, HAEMOPHILIA, V20, P550, DOI 10.1111/hae.12381; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188213	10.1371/journal.pone.0188213	http://dx.doi.org/10.1371/journal.pone.0188213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145514	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800089
J	Liu, S; Waqas, MA; Wang, SH; Xiong, XY; Wan, YF				Liu, Shuo; Waqas, Muhammad Ahmed; Wang, Song-he; Xiong, Xiang-yang; Wan, Yun-fan			Effects of increased levels of atmospheric CO2 and high temperatures on rice growth and quality	PLOS ONE			English	Article								The increased atmospheric temperatures resulting from the increased concentration of atmospheric carbon dioxide (CO2) have had a profound influence on global rice production. China serves as an important area for producing and consuming rice. Therefore, exploring the effects of the simultaneously rising levels of atmospheric CO2 and temperatures on rice growth and quality in the future is very important. The present study was designed to measure the most important aspects of variation for rice-related physiological, ecological and quality indices in different growing periods under a simultaneous increase of CO2 and temperature, through simulation experiments in climate-controlled growth chambers, with southern rice as the study object. The results indicated that the ecological indices, rice phenology, and leaf area would decrease under a simultaneous increase of CO2 and temperature. For the physiological indices, Malondialdehyde (MDA) levels increased significantly in the seedling period. However, it showed the trend of increase and subsequent decrease in the heading and filling periods. In addition, the decomposition of soluble protein (SP) and soluble sugar (SS) accelerated in filling period. The rice quality index of the Head Rice Rate showed the decreasing trend and subsequent increase, but the Chalky Rice Rate and Protein Content indices gradually decreased while the Gel Consistency gradually increased.	[Liu, Shuo; Waqas, Muhammad Ahmed; Wan, Yun-fan] Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China; [Wang, Song-he; Xiong, Xiang-yang] Yangtze Univ, Dept Agr, Jingzhou, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Yangtze University	Liu, S (corresponding author), Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Beijing, Peoples R China.	liushuo@caas.cn			Special funds for basic research and operation expenses of central level public welfare research institutes [BSRF201501, BSRF201713]; National Key Research and Development Program [2017YFD0300400]	Special funds for basic research and operation expenses of central level public welfare research institutes; National Key Research and Development Program	The study is funded by the project of "Special funds for basic research and operation expenses of central level public welfare research institutes (BSRF201501)", "Special funds for basic research and operation expenses of central level public welfare research institutes (BSRF201713)" and "National Key Research and Development Program (2017YFD0300400)". There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], THESIS; [包云轩 Bao Yunxuan], 2012, [中国农业气象, Chinese Journal of Agrometeorology], V33, P289; [蔡威威 Cai Weiwei], 2015, [中国农业气象, Chinese Journal of Agrometeorology], V36, P717; Chen N., 2012, THESIS; El-Sharkawy MA, 2014, PHOTOSYNTHETICA, V52, P161, DOI 10.1007/s11099-014-0028-7; HE S., 2014, THESIS; Ko JongHan, 2014, Journal of Crop Science and Biotechnology, V17, P117, DOI 10.1007/s12892-013-0110-x; Lai Shang-kun, 2015, Shengtaixue Zazhi, V34, P1253; Lee KyuJong, 2014, Journal of Crop Science and Biotechnology, V17, P53, DOI 10.1007/s12892-014-0032-2; Li HS, 2007, BIOCH EXPT PRINCIPLE; [李健陵 Li JianLing], 2013, [中国农业气象, Chinese Journal of Agrometeorology], V34, P23; Li WC, 2013, RELATIONSHIPS PHYSL, V29, P5; [李中阳 Li Zhongyang], 2013, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V19, P20; Liu HZ, 2006, FUJIAN J AGR SCI, V21, P168; Liu J. Y., 2010, THESIS; [刘书仁 LIU Shuren], 2010, [西北农业学报, Acat Agriculturae Boreali-Occidentalis Sinica], V19, P127; [刘媛媛 LIU Yuanyuan], 2008, [西南大学学报. 自然科学版, Journal of Southwest University. Natural Science Edition], V30, P59; [刘玉洁 Liu Yujie], 2013, [地理科学进展, Progress in Geography], V32, P416; Ma TC, 2015, CHINESE AGR SCI B, V31, P25; Melloy P, 2014, EUR J PLANT PATHOL, V140, P19, DOI 10.1007/s10658-014-0441-6; Na HY, 2008, THESIS; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Solomon S., 2007, ANTARCT RES SER, V9, P123; Sun CM., 2009, ENV SUSTAIN DEV, V34, P45; Wang H., 2014, THESIS; Wang Hongmei, 2008, Chinese Journal of Applied and Environmental Biology, V14, P757, DOI 10.3724/SP.J.1145.2008.00757; [王连喜 Wang Lianxi], 2014, [中国农业气象, Chinese Journal of Agrometeorology], V35, P206; [谢立勇 XIE Liyong], 2009, [东北农业大学学报, Journal of Northeast Agricultural University], V40, P1; [谢晓金 Xie Xiaojin], 2012, [中国农业气象, Chinese Journal of Agrometeorology], V33, P457; [张立极 Zhang Liji], 2015, [土壤, Soils], V47, P26; [赵贵林 ZHAO Guilin], 2011, [干旱地区农业研究, Agricultural Research in the Arid Areas], V29, P80	31	17	18	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187724	10.1371/journal.pone.0187724	http://dx.doi.org/10.1371/journal.pone.0187724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145420	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800027
J	Vazquez-Rowe, I; Larrea-Gallegos, G; Villanueva-Rey, P; Gilardino, A				Vazquez-Rowe, Ian; Larrea-Gallegos, Gustavo; Villanueva-Rey, Pedro; Gilardino, Alessandro			Climate change mitigation opportunities based on carbon footprint estimates of dietary patterns in Peru	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; LIFE-CYCLE ASSESSMENT; FOOD; IMPACTS; HOME; CONSUMPTION; QUALITY	Food consumption accounts for an important proportion of the world GHG emissions per capita. Previous studies have delved into the nature of dietary patterns, showing that GHG reductions can be achieved in diets if certain foods are consumed rather than other, more GHG intensive products. For instance, vegetarian and low-meat diets have proved to be less carbon intensive than diets that are based on ruminant meat. These environmental patterns, increasingly analyzed in developed nations, are yet to be assessed in countries liked Peru where food purchase represents a relatively high percentage of the average household expenditure, ranging from 38% to 51% of the same. Therefore, food consumption can be identified as a potential way to reduce GHG emissions in Peru. However, the Peruvian government lacks a specific strategy to mitigate emissions in this sector, despite the recent ratification of the Paris Accord. In view of this, the main objective of this study is to analyze the environmental impacts of a set of 47 Peruvian food diet profiles, including geographical and socioeconomic scenarios. In order to do this, Life Cycle Assessment was used as the methodological framework to obtain the overall impacts of the components in the dietary patterns observed and primary data linked to the composition of diets were collected from the Peruvian National Institute for Statistics (INEI). Life cycle inventories for the different products that are part of the Peruvian diet were obtained from a set of previous scientific articles and reports regarding food production. Results were computed using the IPCC 2013 assessment method to estimate GHG emissions. Despite variations in GHG emissions from a geographical perspective, no significant differences were observed between cities located in the three Peruvian natural regions (i.e., coast, Andes and Amazon basin). In contrast, there appears to be a strong, positive correlation between GHG emissions and social expenditure or academic status. When compared to GHG emissions computed in the literature for developed nations, where the average caloric intake is substantially higher, diet-related emissions in Peru were in the low range. Our results could be used as a baseline for policy support to align nutritional and health policies in Peru with the need to reduce the environmental impacts linked to food production.	[Vazquez-Rowe, Ian; Larrea-Gallegos, Gustavo; Villanueva-Rey, Pedro; Gilardino, Alessandro] Pontificia Univ Catolica Peru, Peruvian LCA Network, Dept Engn, Lima, Peru; [Villanueva-Rey, Pedro] Univ Santiago de Compostela, Dept Chem Engn, Inst Technol, Santiago De Compostela, Galicia, Spain	Pontificia Universidad Catolica del Peru; Universidade de Santiago de Compostela	Vazquez-Rowe, I (corresponding author), Pontificia Univ Catolica Peru, Peruvian LCA Network, Dept Engn, Lima, Peru.	ian.vazquez@pucp.pe	Villanueva-Rey, Pedro/A-4323-2017; Larrea, Gustavo/AAK-7031-2021	Vazquez-Rowe, Ian/0000-0002-7469-2033; Villanueva-Rey, Pedro/0000-0002-6625-384X; Larrea-Gallegos, Gustavo Martin/0000-0002-6283-7039	Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) of the WALAYA project; Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC); Galician Government	Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) of the WALAYA project; Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC); Galician Government	The authors wish to thank the Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) for the financial support of the WALAYA project. The project was won in a competitive call (CAP 2016) and was funded with 50,000 Peruvian soles for a one year period. Gustavo Larrea-Gallegos and Alessandro Gilardino were partially financed in 2016 with funding from the project. BSc Gustavo Larrea-Gallegos wishes to thank the Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) for financial support in the form of a scholarship for his master studies starting in March 2017. Dr. Pedro Villanueva-Rey wishes to thank the Galician Government for financial support (I2C postdoctoral student grants programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Direccion General de Investigacion from the Pontificia Universidad Catolica del Peru (PUCP) for the financial support of the WALAYA project. BSc Gustavo Larrea-Gallegos wishes to thank the Peruvian Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) for financial support. Dr. Pedro Villanueva-Rey wishes to thank the Galician Government for financial support (I2C postdoctoral student grants programme). Dr. Rosa Crujeiras, Isabel Quispe, Jair Santillan, Jonatan Rojas, Diego Echegaray, Dr. Karin Bartl and Sonnia Caceres are thanked for valuable scientific exchange.	Acosta AM, 2014, FOOD POLICY, V44, P26, DOI 10.1016/j.foodpol.2013.10.009; Anand S, 2015, J AM COLL CARDIOL, V66; [Anonymous], [No title captured]; [Anonymous], 2016, EL COMERCIO; [Anonymous], 2017, MILL DEV GOALS; Asner G, 2014, HIGH RESOLUTION CARB; Avadi A, 2015, AQUACULTURE, V435, P52, DOI 10.1016/j.aquaculture.2014.08.001; Avadi A, 2014, J CLEAN PROD, V70, P118, DOI 10.1016/j.jclepro.2014.01.047; Bartl K, 2012, ENVIRON SCI TECHNOL, V46, P9872, DOI 10.1021/es301644y; Bartl K, 2011, J CLEAN PROD, V19, P1494, DOI 10.1016/j.jclepro.2011.04.010; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Bhargava A, 2015, WORLD BANK RES OBSER, V30, P247, DOI 10.1093/wbro/lku011; Bustamante MMC, 2012, CLIMATIC CHANGE, V115, P559, DOI 10.1007/s10584-012-0443-3; Ciroth A, 2016, INT J LIFE CYCLE ASS, V21, P1338, DOI 10.1007/s11367-013-0670-5; Clune S, 2017, J CLEAN PROD, V140, P766, DOI 10.1016/j.jclepro.2016.04.082; Collins B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130770; El Comercio, 2016, FALT 132 RELL SAN CU; ENAPREF, 2012, CONS CAP PRINC AL 20; F.A.O, 2011, COUNTR PROF FOOD SEC; Fairlie-Reinoso A., 2016, QUINUA PERU CADENA E; Fan Judith, 2013, GASTRONOMICA, V13, P29, DOI DOI 10.1525/GFC.2013.13.2.29; Freon P, 2017, J CLEAN PROD, V145, P50, DOI 10.1016/j.jclepro.2017.01.036; Arancibia RG, 2013, CUAD ECON-BOGOTA, V32, P209; Garnett T, 2015, REV EVIDENCE EFFECTI; Garnett T., 2008, COOKING STORM FOOD G; Garnett T, 2011, FOOD POLICY, V36, pS23, DOI 10.1016/j.foodpol.2010.10.010; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Hallstrom E, 2015, J CLEAN PROD, V91, P1, DOI 10.1016/j.jclepro.2014.12.008; IDA, 2015, I DEM ALL QUAOT VEBU; INDECI, 2009, LECC APR SISM PISC; INEI, 2016, EVOLUCION POBREZA MO, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; INEI, 2014, PER ENF TRANSM TRANS; INEI, 2015, B AN IND PREC EC 201; International Standard Organization, 1997, 14040 ISO; IPCC, 2013, WORK GROUP I CONTR 5; Jensen HH, 1996, CAN J AGR ECON, V44, P67, DOI 10.1111/j.1744-7976.1996.tb00143.x; Larrea-Gallegos G, 2017, INT J LIFE CYCLE ASS, V22, P1109, DOI 10.1007/s11367-016-1221-7; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Levell P, 2016, LANCET, V387, P1907, DOI 10.1016/S0140-6736(16)30421-4; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; Manfredi S, 2009, WASTE MANAGE RES, V27, P825, DOI 10.1177/0734242X09348529; Matta R., 2013, ANTHR FOOD, pS8; MINAGRI, 2013, PRINC ASP CAD AGR; MINAGRI, 2017, SER HIST PROD AGR CO; MINAGRI, 2012, PRINC ASP CAD AGR PA; MINAM, 2015, CONSTR PART CONTR NA; MINSA, 2012, TABL PER COMP AL CTR; Munoz I, 2010, INT J LIFE CYCLE ASS, V15, P794, DOI 10.1007/s11367-010-0188-z; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nelson V, 2016, J CULT GEOGR, V33, P208, DOI 10.1080/08873631.2016.1153269; O'Riordan T, 1999, GLOBAL ENVIRON CHANG, V9, P81, DOI 10.1016/S0959-3780(98)00030-2; O'Riordan T, 2015, ENVIRONMENT, V57, P4, DOI 10.1080/00139157.2015.1069093; Pairotti MB, 2015, J CLEAN PROD, V103, P507, DOI 10.1016/j.jclepro.2013.12.082; Parker RWR, 2015, FISH FISH, V16, P684, DOI 10.1111/faf.12087; Perignon M, 2016, PUBLIC HEALTH NUTR, V19, P2662, DOI 10.1017/S1368980016000653; Porkka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082714; Pretty JN, 2006, ENVIRON SCI TECHNOL, V40, P1114, DOI 10.1021/es051670d; Pulkkinen H, 2016, INT J LIFE CYCLE ASS, V21, P621, DOI 10.1007/s11367-015-0913-8; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Risku-Norja Helmi, 2009, Progress in Industrial Ecology, V6, P340, DOI 10.1504/PIE.2009.032323; Roibas L, 2016, J CLEAN PROD, V112, P2441, DOI 10.1016/j.jclepro.2015.09.074; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; SENASA, 2017, SERV NAC SAN AGR; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; Thouret JC, 2014, NAT HAZARDS, V73, P1771, DOI 10.1007/s11069-014-1172-x; *UN, 2017, SUST DEV GOALS 17 GO; USDA, 2017, CHOOS MY PLAT; Vazquez-Rowe I, 2017, INT J LIFE CYCLE ASS, V22, P601, DOI 10.1007/s11367-016-1046-4; Vazquez-Rowe I, 2017, J CLEAN PROD, V142, P4369, DOI 10.1016/j.jclepro.2016.11.136; Vazquez-Rowe I, 2016, J CLEAN PROD, V112, P2505, DOI 10.1016/j.jclepro.2015.09.076; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Weber CL, 2008, ENVIRON SCI TECHNOL, V42, P3508, DOI 10.1021/es702969f; Weidema B.P., 1996, J CLEAN PROD, V4, P167, DOI [10.1016/S0959-6526(96)00043-1, DOI 10.1016/S0959-6526(96)00043-1]; Weidema B, 1998, INT J LIFE CYCLE ASS, V3, P237, DOI 10.1007/BF02977574; Werner LB, 2014, FOOD NUTR RES, V2014, P58; WFP, 2017, WORLD FOOD PROGR; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wilson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059648	81	33	34	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188182	10.1371/journal.pone.0188182	http://dx.doi.org/10.1371/journal.pone.0188182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145461	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800082
J	Eberhardt, M; Stueber, T; de la Roche, J; Herzog, C; Leffler, A; Reeh, PW; Kistner, K				Eberhardt, Mirjam; Stueber, Thomas; de la Roche, Jeanne; Herzog, Christine; Leffler, Andreas; Reeh, Peter W.; Kistner, Katrin			TRPA1 and TRPV1 are required for lidocaine-evoked calcium influx and neuropeptide release but not cytotoxicity in mouse sensory neurons	PLOS ONE			English	Article							HYPERBARIC 5-PERCENT LIDOCAINE; TRANSIENT NEUROLOGIC TOXICITY; LOCAL-ANESTHETICS; IN-VITRO; NEUROGENIC INFLAMMATION; SUBARACHNOID ANESTHESIA; MECHANISMS; NERVE; PAIN; ACTIVATION	Background Local anaesthetics (LA) reduce neuronal excitability by inhibiting voltage-gated Na+ channels. When applied at high concentrations in the direct vicinity of nerves, LAs can also induce relevant irritation and neurotoxicity via mechanisms involving an increase of intracellular Ca2+. In the present study we explored the role of the Ca2+-permeable ion channels TRPA1 and TRPV1 for lidocaine-induced Ca2+-influx, neuropeptide release and neurotoxicity in mouse sensory neurons. Methods Cultured dorsal root ganglion (DRG) neurons from wildtype and mutant mice lacking TRPV1, TRPA1 or both channels were explored by means of calcium imaging, whole-cell patch clamp recordings and trypan blue staining for cell death. Release of calcitonin gene-related peptide (CGRP) from isolated mouse peripheral nerves was determined with ELISA. Results Lidocaine up to 10 mM induced a concentration-dependent reversible increase in intracellular Ca2+ in DRG neurons from wildtype and mutant mice lacking one of the two receptors, but not in neurons lacking both TRPA1 and TRPV1. 30 mM lidocaine also released Ca2+ from intracellular stores, presumably from the endoplasmic reticulum. While 10 mM lidocaine evoked an axonal CGRP release requiring expression of either TRPA1 or TRPV1, CGRP release induced by 30 mM lidocaine again mobilized internal Ca2+ stores. Lidocaine-evoked cell death required neither TRPV1 nor TRPA1. Summary Depending on the concentration, lidocaine employs TRPV1, TRPA1 and intracellular Ca2+ stores to induce a Ca2+-dependent release of the neuropeptide CGRP. Lidocaine-evoked cell death does not seem to require Ca2+ influx through TRPV1 or TRPV1.	[Eberhardt, Mirjam; Reeh, Peter W.; Kistner, Katrin] Friedrich Alexander Univ Erlangen Nuernberg, Inst Physiol & Pathophysiol, Erlangen, Germany; [Eberhardt, Mirjam; Stueber, Thomas; de la Roche, Jeanne; Herzog, Christine; Leffler, Andreas] Hannover Med Sch, Dept Anaesthesia & Crit Care Med, Hannover, Germany; [de la Roche, Jeanne] Hannover Med Sch, Inst Neurophysiol, Hannover, Germany	University of Erlangen Nuremberg; Hannover Medical School; Hannover Medical School	Kistner, K (corresponding author), Friedrich Alexander Univ Erlangen Nuernberg, Inst Physiol & Pathophysiol, Erlangen, Germany.	katrin.kistner@physiologie1.med.uni-erlangen.de	Reeh, Peter W./J-8981-2012	Reeh, Peter W./0000-0002-4367-094X	Wilhelm Sander-Stiftung [2014.068.1]	Wilhelm Sander-Stiftung	This work was supported by grant number 2014.068.1, URL www.sanst.de, Wilhelm Sander-Stiftung (P.W.R. K.K.).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WE, 1993, ANESTH ANALG, V77, P1306, DOI 10.1213/00000539-199312000-00044; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bird GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-31; Butterworth JF, 2010, REGION ANESTH PAIN M, V35, P167, DOI 10.1097/AAP.0b013e3181d231b9; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; de la Roche J, 2013, J BIOL CHEM, V288, P20280, DOI 10.1074/jbc.M113.479337; Doan LV, 2014, ANESTHESIOLOGY, V120, P50, DOI 10.1097/ALN.0b013e3182a2a561; Docherty RJ, 2013, PAIN, V154, P1569, DOI 10.1016/j.pain.2013.04.030; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Gold MS, 1998, J PHARMACOL EXP THER, V285, P413; Hamilton NB, 2016, NATURE, V529, P523, DOI 10.1038/nature16519; Johnson ME, 2004, ANESTHESIOLOGY, V101, P1184, DOI 10.1097/00000542-200411000-00019; Johnson ME, 2002, ANESTHESIOLOGY, V97, P1466, DOI 10.1097/00000542-200212000-00019; Kim SR, 2006, J IMMUNOL, V177, P4322, DOI 10.4049/jimmunol.177.7.4322; Kitagawa N, 2004, ANESTHESIOLOGY, V100, P962, DOI 10.1097/00000542-200404000-00029; LAMBERT LA, 1994, ANESTHESIOLOGY, V80, P1082, DOI 10.1097/00000542-199405000-00017; Leffler A, 2008, J CLIN INVEST, V118, P763, DOI 10.1172/JCI32751; Leffler A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-62; MYERS RR, 1989, ANESTHESIOLOGY, V71, P757, DOI 10.1097/00000542-198911000-00021; Piao LH, 2009, BIOCHEM BIOPH RES CO, V379, P980, DOI 10.1016/j.bbrc.2008.12.183; Pollock JE, 2002, REGION ANESTH PAIN M, V27, P581, DOI 10.1053/rapm.2002.36457; Pollock Julia E, 2003, Best Pract Res Clin Anaesthesiol, V17, P471, DOI 10.1016/S1521-6896(02)00113-1; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; RIGLER ML, 1991, ANESTH ANALG, V72, P275; Saghy E, 2016, GLIA, V64, P2166, DOI 10.1002/glia.23051; SAKURA S, 1995, ANESTH ANALG, V81, P338, DOI 10.1097/00000539-199508000-00023; SCHNEIDER MC, 1994, ANESTH ANALG, V79, P610, DOI 10.1213/00000539-199409000-00053; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; Stenger B, 2015, ARCH TOXICOL, V89, P1631, DOI 10.1007/s00204-014-1414-4; Stueber T, 2016, ANESTHESIOLOGY, V124, P1153, DOI 10.1097/ALN.0000000000001050; Tomohiro D, 2013, LIFE SCI, V92, P368, DOI 10.1016/j.lfs.2013.01.011; van der Wal SEI, 2016, EUR J PAIN, V20, P655, DOI 10.1002/ejp.794; Verlinde M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030339; Wehrfritz A, 2011, EUR J PAIN, V15, P907, DOI 10.1016/j.ejpain.2011.03.011; Werdehausen R, 2015, PAIN, V156, P1647, DOI 10.1097/j.pain.0000000000000206; Werdehausen R, 2011, REGION ANESTH PAIN M, V36, P436, DOI 10.1097/AAP.0b013e318226ba62	38	10	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188008	10.1371/journal.pone.0188008	http://dx.doi.org/10.1371/journal.pone.0188008			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141003	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400044
J	Famuyide, AO; Laughlin-Tommaso, SK; Shazly, SA; Long, KH; Breitkopf, DM; Weaver, AL; McGree, ME; El-Nashar, SA; Lemens, MA; Hopkins, MR				Famuyide, Abimbola O.; Laughlin-Tommaso, Shannon K.; Shazly, Sherif A.; Long, Kirsten Hall; Breitkopf, Daniel M.; Weaver, Amy L.; McGree, Michaela E.; El-Nashar, Sherif A.; Lemens, Maureen A.; Hopkins, Matthew R.			Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis	PLOS ONE			English	Article							LEVONORGESTREL INTRAUTERINE SYSTEM; THERMAL BALLOON ABLATION; TRANSCERVICAL RESECTION; RANDOMIZED-TRIAL; BLOOD-LOSS; FOLLOW-UP; WOMEN; MANAGEMENT	Background Radiofrequency endometrial ablation (REA) is currently a second line treatment in women with heavy menstrual bleeding (MHB) if medical therapy (MTP) is contraindicated or unsatisfactory. Our objective is to compare the effectiveness and cost burden of MTP and REA in the initial treatment of HMB. Methods We performed a randomized trial at Mayo Clinic Rochester, Minnesota. The planned sample size was 60 patients per arm. A total of 67 women with HMB were randomly allocated to receive oral contraceptive pills (Nordette (R)) or Naproxen (Naprosyn (R)) (n = 33) or REA (n = 34). Primary 12-month outcome measures included menstrual blood loss using pictorial blood loss assessment chart (PBLAC), patients' satisfaction, and Menorrhagia Multi-Attribute Scale (MMAS). Secondary outcomes were total costs including direct medical and indirect costs associated with healthcare use, patient out-of-pocket costs, and lost work days and activity limitations over 12 months. Results Compared to MTP arm, women who received REA had a significantly lower PBLAC score (median [Interquartile range, IQR]: 0 [0-4] vs. 15 [0-131], p = 0.003), higher satisfaction rates (96.8% vs. 63.2%, p = 0.003) and higher MMAS (median [IQR]: 100 [100-100] vs. 100 [87-100], p = 0.12) at 12 months. Direct medical costs were higher for REA ($5,331vs. $2,901, 95% confidence interval (CI) of mean difference:$727,$4,852), however, when indirect costs are included, the difference did not reach statistical significance ($5,469 vs. $3,869, 95% CI of mean difference:-$339, $4,089). Conclusion For women with heavy menstrual bleeding, initial radiofrequency endometrial ablation compared to medical therapy offered superior reduction in menstrual blood loss and improvement in quality of life without significant differences in total costs of care.	[Famuyide, Abimbola O.; Laughlin-Tommaso, Shannon K.; Shazly, Sherif A.; Breitkopf, Daniel M.; Lemens, Maureen A.; Hopkins, Matthew R.] Mayo Clin, Minimally Invas Gynecol Surg, Dept Obstet & Gynecol, Rochester, MN 55905 USA; [Long, Kirsten Hall] K Long Hlth Econ Consulting LLC, St Paul, MN USA; [Weaver, Amy L.; McGree, Michaela E.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [El-Nashar, Sherif A.] Univ Hosp, Div Female Pelv Med & Reconstruct Surg, Cleveland, OH USA	Mayo Clinic; Mayo Clinic; University Hospitals of Cleveland	Famuyide, AO (corresponding author), Mayo Clin, Minimally Invas Gynecol Surg, Dept Obstet & Gynecol, Rochester, MN 55905 USA.	famuyide.abimbola@mayo.edu	Breitkopf, Daniel M./Z-1535-2019; El-Nashar, Sherif/H-3656-2019	Breitkopf, Daniel M./0000-0002-9161-0829; El-Nashar, Sherif/0000-0002-8905-1458; Famuyide, Abimbola/0000-0003-3667-2717	Hologic Inc.	Hologic Inc.	The study was funded by an unrestricted grant from Hologic Inc. Hologic Inc. has supported authors AOF in the form of honoraria for consultancy and speaking engagements. Hologic Inc. had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. K. Long Health Economics Consulting LLC is a private consulting firm owned by author KHL, and supported KHL in the form of salary. KHL was involved in data analysis and preparation of the manuscript.	Abbott J, 2003, FERTIL STERIL, V80, P203, DOI 10.1016/S0015-0282(03)00549-1; [Anonymous], 2010, Obstet Gynecol, V115, P206, DOI 10.1097/AOG.0b013e3181cb50b5; [Anonymous], 2007, OBSTET GYNECOL, V109, P1233, DOI DOI 10.1097/01.AOG.0000263898.22544.CD; Barrington JW, 2003, EUR J OBSTET GYN R B, V108, P72, DOI 10.1016/S0301-2115(02)00408-6; Briggs A, 1998, J Health Serv Res Policy, V3, P233; Cooper KG, 1999, BRIT J OBSTET GYNAEC, V106, P258, DOI 10.1111/j.1471-0528.1999.tb08240.x; Cooper KG, 1997, BRIT J OBSTET GYNAEC, V104, P1360, DOI 10.1111/j.1471-0528.1997.tb11004.x; Cooper KG, 1999, LANCET, V354, P1859, DOI 10.1016/S0140-6736(99)04101-X; Cooper KG, 2001, BRIT J OBSTET GYNAEC, V108, P1222, DOI 10.1016/S0306-5456(01)00275-3; Cote I, 2003, AM J OBSTET GYNECOL, V188, P343, DOI 10.1067/mob.2003.92; Cote I, 2002, OBSTET GYNECOL, V100, P683, DOI 10.1016/S0029-7844(02)02094-X; Cravello L, 2004, Gynecol Obstet Fertil, V32, P825, DOI 10.1016/j.gyobfe.2004.08.007; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Duleba AJ, 2003, J AM ASSOC GYN LAP, V10, P17, DOI 10.1016/S1074-3804(05)60229-0; El-Nashar SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.032; El-Nashar SA, 2009, OBSTET GYNECOL, V113, P97, DOI 10.1097/AOG.0b013e31818f5a8d; ELNASHAR SA, 2015, GYNECOLOGICAL SURG, P1; EPHRON B, 1998, MONOGRAPHS STAT APPL; Famuyide AO, 2014, J MINIM INVAS GYN, V21, P782, DOI 10.1016/j.jmig.2014.03.004; Fraser IS, 2012, CONTRACEPTION, V86, P96, DOI 10.1016/j.contraception.2011.11.011; FRASER IS, 1990, AUST NZ J OBSTET GYN, V30, P353, DOI 10.1111/j.1479-828X.1990.tb02028.x; FRASER IS, 1991, AUST NZ J OBSTET GYN, V31, P66, DOI 10.1111/j.1479-828X.1991.tb02769.x; Gervaise A, 1999, HUM REPROD, V14, P2743, DOI 10.1093/humrep/14.11.2743; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Lethaby A, 2008, CYCLICAL PROGESTOGEN; Lethaby A, 2009, ENDOMETRIAL RESECTIO; Miller L, 2001, OBSTET GYNECOL, V98, P771, DOI 10.1016/S0029-7844(01)01555-1; PINION SB, 1994, BRIT MED J, V309, P979, DOI 10.1136/bmj.309.6960.979; Provera DS, 2013, 104 PACKAGE INSERT; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Reid PC, 2005, BJOG-INT J OBSTET GY, V112, P1121, DOI 10.1111/j.1471-0528.2005.00642.x; SHAW RW, 1994, BRIT J OBSTET GYNAEC, V101, P15, DOI 10.1111/j.1471-0528.1994.tb13690.x; Tjarks M, 2000, OBSTET GYNECOL, V96, P886, DOI 10.1016/S0029-7844(00)01059-0; Weber A M, 1998, Medscape Womens Health, V3, P3; Wells GA., 2015, NEWCASTLE OTTAWA SCA	35	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188176	10.1371/journal.pone.0188176	http://dx.doi.org/10.1371/journal.pone.0188176			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141040	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400068
J	Sarnataro, S; Chiariello, AM; Esposito, A; Prisco, A; Nicodemi, M				Sarnataro, Sergio; Chiariello, Andrea M.; Esposito, Andrea; Prisco, Antonella; Nicodemi, Mario			Structure of the human chromosome interaction network	PLOS ONE			English	Article							SPATIAL-ORGANIZATION; GENOME ARCHITECTURE; GENE-EXPRESSION; GRANULAR MEDIA; CONTACT MAPS; CELL-NUCLEUS; 3D GENOME; SEGREGATION; DYNAMICS; DOMAINS	New Hi-C technologies have revealed that chromosomes have a complex network of spatial contacts in the cell nucleus of higher organisms, whose organisation is only partially understood. Here, we investigate the structure of such a network in human GM12878 cells, to derive a large scale picture of nuclear architecture. We find that the intensity of intra-chromosomal interactions is power-law distributed. Inter-chromosomal interactions are two orders of magnitude weaker and exponentially distributed, yet they are not randomly arranged along the genomic sequence. Intra-chromosomal contacts broadly occur between epigenomically homologous regions, whereas inter-chromosomal contacts are especially associated with regions rich in highly expressed genes. Overall, genomic contacts in the nucleus appear to be structured as a network of networks where a set of strongly individual chromosomal units, as envisaged in the 'chromosomal territory' scenario derived from microscopy, interact with each other via on average weaker, yet far from random and functionally important interactions.	[Sarnataro, Sergio] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Chiariello, Andrea M.; Esposito, Andrea; Nicodemi, Mario] Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy; [Chiariello, Andrea M.; Esposito, Andrea; Nicodemi, Mario] Complesso Univ Monte St Angelo, CNR SPIN, INFN Napoli, I-80126 Naples, Italy; [Prisco, Antonella] CNR IGB, Via Pietro Castellino 111, Naples, Italy; [Esposito, Andrea] Helmholtz Assoc MDC, Max Delbruck Ctr Mol Med, Berlin, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Istituto Nazionale di Fisica Nucleare (INFN); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sarnataro, S (corresponding author), Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.; Chiariello, AM (corresponding author), Univ Naples Federico II, Dipartimento Fis, I-80126 Naples, Italy.; Chiariello, AM (corresponding author), Complesso Univ Monte St Angelo, CNR SPIN, INFN Napoli, I-80126 Naples, Italy.	sarnatas@igbmc.fr; chiariello@na.infn.it	Prisco, Antonella/X-5749-2019; Esposito, Andrea/CAJ-1360-2022; Chiariello, Andrea Maria/AAA-1544-2020; Nicodemi, Mario/K-1815-2015	Esposito, Andrea/0000-0002-5903-8439; Chiariello, Andrea Maria/0000-0002-6112-0167; Nicodemi, Mario/0000-0002-8416-6416; Prisco, Antonella/0000-0001-8061-0068; Sarnataro, Sergio/0000-0002-6001-9892				Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Annunziatella C, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042402; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barbieri M, 2013, SOFT MATTER, V9, P8631, DOI 10.1039/c3sm51436f; Barbieri M, 2017, NAT STRUCT MOL BIOL, V24, P515, DOI 10.1038/nsmb.3402; Barbieri Mariano, 2013, Frontiers in Genetics, V4, P113, DOI 10.3389/fgene.2013.00113; Bianco S, 2017, CHROMOSOME RES, P1; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Brackley CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0909-0; Brackley CA, 2013, P NATL ACAD SCI USA, V110, pE3605, DOI 10.1073/pnas.1302950110; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Caglioti E, 1998, EUROPHYS LETT, V43, P591, DOI 10.1209/epl/i1998-00402-x; CATAUDELLA V, 1994, PHYS REV LETT, V72, P1541, DOI 10.1103/PhysRevLett.72.1541; Chiariello AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29775; Chiariello AM, 2015, MOD PHYS LETT B, V29, DOI 10.1142/S0217984915300033; Ciamarra MP, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058001; Coniglio A, 2000, J PHYS-CONDENS MAT, V12, P6601, DOI 10.1088/0953-8984/12/29/331; D'Agostino G, 2014, UNDERST COMPLEX SYST, pVII; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gao JX, 2012, NAT PHYS, V8, P40, DOI 10.1038/nphys2180; Gilarranz LJ, 2017, SCIENCE, V357, P199, DOI 10.1126/science.aal4122; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Grebenkov DS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078001; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Jost D, 2014, NUCLEIC ACIDS RES, V42, P9553, DOI 10.1093/nar/gku698; Kaufmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126125; Knight PA, 2013, IMA J NUMER ANAL, V33, P1029, DOI 10.1093/imanum/drs019; Kruse K, 2013, NUCLEIC ACIDS RES, V41, P701, DOI 10.1093/nar/gks1096; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Manning CD, 2009, INTRO INFORM RETRIEV; Morlot JB, 2016, EPJ NONLINEAR BIOMED, V4, DOI 10.1140/epjnbp/s40366-016-0029-5; Nicodemi M, 1998, PHYS REV LETT, V80, P1340, DOI 10.1103/PhysRevLett.80.1340; Nicodemi M, 1998, PHYS REV E, V57, pR39, DOI 10.1103/PhysRevE.57.R39; Nicodemi M, 2002, EUROPHYS LETT, V60, P684, DOI 10.1209/epl/i2002-00363-0; Nicodemi M, 2001, PHYS REV LETT, V86, P4378, DOI 10.1103/PhysRevLett.86.4378; Nicodemi M, 2008, GENETICS, V179, P717, DOI 10.1534/genetics.107.083154; Nicodemi M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108104; Nicodemi M, 2014, CURR OPIN CELL BIOL, V28, P90, DOI 10.1016/j.ceb.2014.04.004; Nicodemi M, 2009, BIOPHYS J, V96, P2168, DOI 10.1016/j.bpj.2008.12.3919; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Scialdone A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002229; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tanay A, 2013, CURR OPIN GENET DEV, V23, P197, DOI 10.1016/j.gde.2012.12.009; Tarzia M, 2004, EUROPHYS LETT, V66, P531, DOI 10.1209/epl/i2004-10015-y; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Valverde S, 2002, EUROPHYS LETT, V60, P512, DOI 10.1209/epl/i2002-00248-2	52	16	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188201	10.1371/journal.pone.0188201	http://dx.doi.org/10.1371/journal.pone.0188201			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141034	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000415260400070
J	Han, KN; Kim, HK; Choi, YH				Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho			Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection	PLOS ONE			English	Article							ASSISTED THORACIC-SURGERY; LUNG-CANCER; UNIPORTAL VATS; LOBECTOMY; THORACOTOMY; COMPLICATIONS; EXPERIENCE	Introduction Single-port thoracoscopic surgery has widened the current minimally invasive surgical techniques toward more less invasive procedures in terms of reducing the number of incisions. However, the current status of oncologic outcome with this technique is not well known for lung cancer surgery. The purpose of this study is to evaluate the oncologic outcomes in early stage lung cancer for impact of the survival outcomes with our experience of conversion to a single-port approach from the conventional three-port approach. Materials and methods Retrospective data of patients who underwent thoracoscopic major lung resection for non-small cell lung cancer between January 2006 and June 2015 were analyzed. Patients characteristics, perioperative outcomes, pathologic result, and postoperative follow-up data of thoracoscopic surgery were reviewed and surgical outcomes were compared between conventional three-port (n = 168), two-port (n = 68), and single-port thoracoscopic surgery (n = 203). Results Of the 203 single-port thoracoscopic surgeries, we performed 167 single-port thoracoscopic lobectomy and mediastinal lymph node dissections. During the learning period of each thoracoscopic approach, the mean operation time for single-port thoracoscopic surgery (189 +/- 62 min) was not significantly different from those of two-port (175 +/- 46 min) and three-port (195 +/- 75 min) thoracoscopic lobectomy (p = 0.165). Perioperative outcomes including drain indwelling time (p <0.001), complication (p = 0.185) and conversion event (p = 0.911) were not worsened during learning period with two-port. Midterm survival (p = 0.753) and recurrence free survival (p = 0.656) of single port thoracoscopic lobectomy showed acceptable results compared with two- and three-port approach. Conclusions Single-port thoracoscopic surgery is safe and a feasible option for major lung resection in lung malignancy and this approach following experiences of two-port approach may yield similar oncologic results to those of conventional multi-port approach during thoracoscopic lobectomy.	[Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho] Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Han, Kook Nam; Kim, Hyun Koo; Choi, Young Ho] Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, HK (corresponding author), Korea Univ, Guro Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.; Kim, HK (corresponding author), Korea Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	kimhyunkoo@korea.ac.kr	Han, Kook Nam/D-6036-2012; Han, Kook Nam/GSJ-1109-2022; Han, Kooknam/AAB-6677-2020	Han, Kook Nam/0000-0002-1508-0125; Han, Kooknam/0000-0002-1508-0125; Kim, Hyun Koo/0000-0001-7604-4729	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A121074]; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology [NRF2015R1A2A2A04005760, 2015R1A2A2A04005760 [A1]]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; National Research Foundation of Korea (NRF) grant - Ministry of Education, Science and Technology	This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (No: A121074), http://www.mohw.go.kr/eng/index. isp; and a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (No: NRF2015R1A2A2A04005760), http://english.moe.go kr/main.do?s=english.; This work was supported by a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A121074) and the National Research Foundation of Korea (NRF) grant funded by the Ministry of Education, Science and Technology (2015R1A2A2A04005760 [A1]).	Bertolaccini L, 2013, J THORAC DIS, V5, pS214, DOI 10.3978/j.issn.2072-1439.2013.04.06; Cattaneo SM, 2008, ANN THORAC SURG, V85, P231, DOI 10.1016/j.athoracsur.2007.07.080; Chen PR, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-58; Flores RM, 2011, J THORAC CARDIOV SUR, V142, P1412, DOI 10.1016/j.jtcvs.2011.09.028; Gonzalez-Rivas D, 2014, J THORAC DIS, V6, pS674, DOI 10.3978/j.issn.2072-1439.2014.09.17; Gonzalez-Rivas D, 2013, J THORAC CARDIOV SUR, V145, P1676, DOI 10.1016/j.jtcvs.2013.02.052; Gonzalez-Rivas D, 2013, ANN THORAC SURG, V95, P426, DOI 10.1016/j.athoracsur.2012.10.070; Gonzalez-Rivas D, 2012, J THORAC CARDIOV SUR, V143, P745, DOI 10.1016/j.jtcvs.2011.07.049; Han KN, 2016, J THORAC DIS, V8, pS279, DOI 10.3978/j.issn.2072-1439.2016.02.31; Han KN, 2016, EUR J CARDIO-THORAC, V49, P42, DOI 10.1093/ejcts/ezv406; Handy JR, 2010, EUR J CARDIO-THORAC, V37, P451, DOI 10.1016/j.ejcts.2009.07.037; Harris CG, 2016, ANN CARDIOTHORAC SUR, V5, P76, DOI [10.21037/acs.2016.03.17, 10.3978/j.issn.2225-319X.2015.12.04]; Kim HK, 2015, INTERACT CARDIOV TH, V20, P310, DOI 10.1093/icvts/ivu405; Kim HK, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-88; Lau R, 2014, CHEST, V145; McKenna Robert J Jr, 2008, Thorac Surg Clin, V18, P275, DOI 10.1016/j.thorsurg.2008.04.004; Ng CSH, 2007, EUR J CARDIO-THORAC, V31, P83, DOI 10.1016/j.ejcts.2006.10.019; Ng CSH, 2016, THORAC CARDIOV SURG, V64, P348, DOI 10.1055/s-0034-1396789; Ng CSH, 2016, WORLD J SURG, V40, P484, DOI 10.1007/s00268-015-3248-5; Nomori H, 2001, ANN THORAC SURG, V72, P879, DOI 10.1016/S0003-4975(01)02891-0; Nwogu CE, 2015, ANN THORAC SURG, V99, P399, DOI 10.1016/j.athoracsur.2014.09.018; Perna V, 2016, EUR J CARDIO-THORAC, V50, P411, DOI 10.1093/ejcts/ezw161; Rocco G, 2004, ANN THORAC SURG, V77, P726, DOI 10.1016/S0003-4975(03)01219-0; Rocco Gaetano, 2006, Interact Cardiovasc Thorac Surg, V5, P430, DOI 10.1510/icvts.2006.128603; Seely AJE, 2010, ANN THORAC SURG, V90, P936, DOI 10.1016/j.athoracsur.2010.05.014; Sihoe ADL, 2016, J THORAC DIS, V8, pS333, DOI 10.3978/j.issn.2072-1439.2016.02.41; Tamura M, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-153; Whitson BA, 2008, ANN THORAC SURG, V86, P2008, DOI 10.1016/j.athoracsur.2008.07.009; Yim APC, 2002, ANN THORAC SURG, V74, P615, DOI 10.1016/S0003-4975(02)03579-8	29	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186857	10.1371/journal.pone.0186857	http://dx.doi.org/10.1371/journal.pone.0186857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136038	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200008
J	Pires, MEL; Clarke, SR; Marcondes, S; Gibbins, JM				Pires, Maria E. Lopes; Clarke, Simon R.; Marcondes, Sisi; Gibbins, Jonathan M.			Lipopolysaccharide potentiates platelet responses via toll-like receptor 4-stimulated Akt-Erk-PLA(2) signalling	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; REACTIVE-OXYGEN; PATHOGEN RECOGNITION; PHOSPHOLIPASE A(2); BINDING-PROTEIN; INNATE IMMUNITY; KINASE CASCADES; ACTIVATION; AGGREGATION; LPS	Lipopolysaccharide (LPS) from the cell envelope of Gram-negative bacteria is a principal cause of the symptoms of sepsis. LPS has been reported to modulate the function of platelets although the underlying mechanisms of LPS action in these cells remain unclear. Platelets express the Toll-like receptor 4 (TLR4) which serves as a receptor for LPS, although the potential role of TLR4 and associated cell signalling in controlling platelet responses to LPS has not been extensively explored. In this study, we therefore investigated the actions of LPS prepared from different strains of Escherichia coli on platelet function, the underlying signalling mechanisms, and the potential role of TLR4 in orchestrating these. We report that LPS increased the aggregation of washed platelets stimulated by thromboxane (U46619) or GPVI collagen receptor agonists, effects that were prevented by a TLR4 antagonist. Associated with this, LPS enhanced fibrinogen binding, P-selectin exposure and reactive oxygen species (ROS) release. Increase of ROS was found to be important for the actions of LPS on platelets, since these were inhibited in the presence of superoxide dismutase or catalase. The effects of LPS were associated with phosphorylation of Akt, ERK1/2 and PLA2 in stimulated platelets, and inhibitors of PI3-kinase, Akt and ERK1/2 reduced significantly LPS enhanced platelet function and associated ROS production. Furthermore, inhibition of platelet cyclooxygenase or the thromboxane receptor, revealed an important role for thromboxane A2. We therefore conclude that LPS increases human platelet activation through a TLR4-PI3K-Akt-ERK1/2-PLA2 -dependent pathway that is dependent on ROS and TXA2 formation.	[Pires, Maria E. Lopes; Clarke, Simon R.; Gibbins, Jonathan M.] Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England; [Marcondes, Sisi] Univ Campinas UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	University of Reading; Universidade Estadual de Campinas	Gibbins, JM (corresponding author), Univ Reading, Inst Cardiovasc & Metab Res, Sch Biol Sci, Reading, Berks, England.	j.m.gibbins@reading.ac.uk			Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil; British Heart Foundation [RG/15/2/31224]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); British Heart Foundation(British Heart Foundation); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MELP received grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ), Brazil. Jonathan Gibbins received grants from British Heart Foundation: Programme Grant RG/15/2/31224. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) Brazil and by British Heart Foundation (RG/15/2/31224).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andonegui G, 2005, BLOOD, V106, P2417, DOI 10.1182/blood-2005-03-0916; Bakdash N, 2008, FREE RADICAL BIO MED, V45, P158, DOI 10.1016/j.freeradbiomed.2008.03.021; Boffa JJ, 2004, J AM SOC NEPHROL, V15, P2358, DOI 10.1097/01.ASN.0000136300.72480.86; Brooks AC, 2007, INFLAMM RES, V56, P154, DOI 10.1007/s00011-006-6151-6; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Burkholder TJ, 2009, BIOCHEM BIOPH RES CO, V386, P60, DOI 10.1016/j.bbrc.2009.05.150; Casarin AL, 2011, LIFE SCI, V89, P773, DOI 10.1016/j.lfs.2011.09.004; Cognasse F, 2005, IMMUNOL CELL BIOL, V83, P196, DOI 10.1111/j.1440-1711.2005.01314.x; Cognasse F, 2008, BRIT J HAEMATOL, V141, P84, DOI 10.1111/j.1365-2141.2008.06999.x; Cognasse F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00083; Davis MR, 2012, JOVE-J VIS EXP, DOI 10.3791/3916; Dong HP, 2010, KAOHSIUNG J MED SCI, V26, P584, DOI 10.1016/S1607-551X(10)70090-5; El-Achkar TM, 2007, AM J PHYSIOL-RENAL, V293, pF1187, DOI 10.1152/ajprenal.00217.2007; Lopes-Pires ME, 2012, PLATELETS, V23, P195, DOI 10.3109/09537104.2011.603065; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Frost RA, 2002, AM J PHYSIOL-REG I, V283, pR698, DOI 10.1152/ajpregu.00039.2002; Gangloff SC, 1999, CLIN INFECT DIS, V28, P491, DOI 10.1086/515176; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Iba T, 2016, BLOOD REV, V30, P149, DOI 10.1016/j.blre.2015.10.002; Ikezoe T, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0050-7; Kaiser WJ, 2009, J PROTEOME RES, V8, P2903, DOI 10.1021/pr900027j; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Kassouf N, 2015, CELL SIGNAL, V27, P1488, DOI 10.1016/j.cellsig.2015.03.008; Katagiri H, 2004, HEPATOLOGY, V39, P139, DOI 10.1002/hep.20000; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; KEEN RR, 1991, CRIT CARE MED, V19, P1114, DOI 10.1097/00003246-199109000-00004; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P1988, DOI 10.1161/01.ATV.0000145574.90840.7d; Krotz F, 2002, BLOOD, V100, P917, DOI 10.1182/blood.V100.3.917; Lee GL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091394; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Li X, 2015, IMMUNOBIOLOGY, V220, P399, DOI 10.1016/j.imbio.2014.10.008; Li ZY, 2011, THROMB RES, V127, P184, DOI 10.1016/j.thromres.2010.10.010; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Mathiak G, 2003, INT J MOL MED, V11, P41; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; MONCADA S, 1976, NATURE, V263, P663, DOI 10.1038/263663a0; Morganti RP, 2010, PLATELETS, V21, P260, DOI 10.3109/09537101003637240; MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337; Myhre O, 2003, BIOCHEM PHARMACOL, V65, P1575, DOI 10.1016/S0006-2952(03)00083-2; Nakae H, 1996, RES COMMUN MOL PATH, V92, P131; Nocella C, 2017, THROMB HAEMOSTASIS, V117, P1558, DOI 10.1160/TH16-11-0857; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Powers KA, 2006, J EXP MED, V203, P1951, DOI 10.1084/jem.20060943; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Rivadeneyra L, 2014, THROMB RES, V133, P235, DOI 10.1016/j.thromres.2013.11.028; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saponaro C, 2012, IMMUNOPHARM IMMUNOT, V34, P858, DOI 10.3109/08923973.2012.665461; SIESS W, 1989, PHYSIOL REV, V69, P58, DOI 10.1152/physrev.1989.69.1.58; Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574; Tavener SA, 2004, CIRC RES, V95, P700, DOI 10.1161/01.RES.0000144175.70140.8c; Woulfe DS, 2010, EXPERT REV HEMATOL, V3, P81, DOI 10.1586/EHM.09.75; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yin H, 2013, ARTERIOSCL THROM VAS, V33, P2529, DOI 10.1161/ATVBAHA.113.302339; Zhang GY, 2009, J IMMUNOL, V182, P7997, DOI 10.4049/jimmunol.0802884; ZHOU PH, 2016, MEDIAT INFLAMM, V2016, DOI DOI 10.1155/2016/720549	61	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186981	10.1371/journal.pone.0186981	http://dx.doi.org/10.1371/journal.pone.0186981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136006	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000415121200010
J	Giachin, G; Nepravishta, R; Mandaliti, W; Melino, S; Margon, A; Scaini, D; Mazzei, P; Piccolo, A; Legname, G; Paci, M; Leita, L				Giachin, Gabriele; Nepravishta, Ridvan; Mandaliti, Walter; Melino, Sonia; Margon, Alja; Scaini, Denis; Mazzei, Pierluigi; Piccolo, Alessandro; Legname, Giuseppe; Paci, Maurizio; Leita, Liviana			The mechanisms of humic substances self-assembly with biological molecules: The case study of the prion protein	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; NMR-SPECTROSCOPY; SECONDARY STRUCTURE; INFRARED-SPECTRA; ORGANIC-MATTER; SOIL PARTICLES; FATE; BINDING; ACID; CONFORMATION	Humic substances (HS) are the largest constituent of soil organic matter and are considered as a key component of the terrestrial ecosystem. HS may facilitate the transport of organic and inorganic molecules, as well as the sorption interactions with environmentally relevant proteins such as prions. Prions enter the environment through shedding from live hosts, facilitating a sustained incidence of animal prion diseases such as Chronic Wasting Disease and scrapie in cervid and ovine populations, respectively. Changes in prion structure upon environmental exposure may be significant as they can affect prion infectivity and disease pathology. Despite its relevance, the mechanisms of prion interaction with HS are still not completely understood. The goal of this work is to advance a structural-level picture of the encapsulation of recombinant, non-infectious, prion protein (PrP) into different natural HS. We observed that PrP precipitation upon addition of HS is mainly driven by a mechanism of "salting-out" whereby PrP molecules are rapidly removed from the solution and aggregate in insoluble adducts with humic molecules. Importantly, this process does not alter the protein folding since insoluble PrP retains its a-helical content when in complex with HS. The observed ability of HS to promote PrP insolubilization without altering its secondary structure may have potential relevance in the context of "prion ecology". These results suggest that soil organic matter interacts with prions possibly without altering the protein structures. This may facilitate prions preservation from biotic and abiotic degradation leading to their accumulation in the environment.	[Giachin, Gabriele; Legname, Giuseppe] SISSA, Dept Neurosci, Trieste, Italy; [Nepravishta, Ridvan; Mandaliti, Walter; Melino, Sonia; Paci, Maurizio] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Nepravishta, Ridvan] East Anglia Univ, Sch Pharm, Norwich, Norfolk, England; [Margon, Alja; Leita, Liviana] Council Agr Res & Econ, CREA Consiglio Ric Agr & Anal Econ Agr, Gorizia, Italy; [Scaini, Denis] Univ Trieste, Life Sci Dept, Trieste, Italy; [Scaini, Denis; Legname, Giuseppe] ELETTRA Synchrotron Light Source, Trieste, Italy; [Mazzei, Pierluigi; Piccolo, Alessandro] Univ Naples Federico II, Interdept Res Ctr CERMANU, Naples, Italy; [Giachin, Gabriele] European Synchrotron Radiat Facil, Struct Biol Grp, Grenoble, France	International School for Advanced Studies (SISSA); University of Rome Tor Vergata; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Trieste; Elettra Sincrotrone Trieste; University of Naples Federico II; European Synchrotron Radiation Facility (ESRF)	Giachin, G (corresponding author), SISSA, Dept Neurosci, Trieste, Italy.; Leita, L (corresponding author), Council Agr Res & Econ, CREA Consiglio Ric Agr & Anal Econ Agr, Gorizia, Italy.; Giachin, G (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, Grenoble, France.	gabriele.giachin@esrf.fr; liviana.leita@crea.gov.it	Legname, Giuseppe/C-1723-2012; Giachin, Gabriele/AAE-2348-2020; Nepravishta, Ridvan/AAW-6615-2020; Scaini, Denis/HGU-4752-2022	Legname, Giuseppe/0000-0003-0716-4393; Giachin, Gabriele/0000-0001-7550-0307; Nepravishta, Ridvan/0000-0002-0051-762X; Mazzei, Pierluigi/0000-0002-5312-4969; Scaini, Denis/0000-0001-8398-8074; MELINO, SONIA/0000-0001-7694-5279	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies)	This work was supported by the Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie - SCRASU" (Scrapie transmissibility reduction strategies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2003, J BIOL CHEM, V278, P22187, DOI 10.1074/jbc.M302130200; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Avena MJ, 2002, ENVIRON SCI TECHNOL, V36, P5100, DOI 10.1021/es025582u; Baumgarte S, 2005, MOL ECOL, V14, P2539, DOI 10.1111/j.1365-294X.2005.02592.x; Beauchamp KA, 2012, P NATL ACAD SCI USA, V109, P17807, DOI 10.1073/pnas.1201810109; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Benetti F, 2014, J MOL BIOL, V426, P3796, DOI 10.1016/j.jmb.2014.09.017; Cheng S, 2008, J MICROSC-OXFORD, V231, P384, DOI 10.1111/j.1365-2818.2008.02051.x; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Corsaro A, 2010, J BIOL REG HOMEOS AG, V24, P27; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; Dobbss LB, 2010, J AGR FOOD CHEM, V58, P3681, DOI 10.1021/jf904385c; Drosos M, 2017, SCI TOTAL ENVIRON, V586, P807, DOI 10.1016/j.scitotenv.2017.02.059; Giachin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100016; Giachin G, 2013, MOLECULES, V18, P9451, DOI 10.3390/molecules18089451; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hankins NP, 2006, SEP PURIF TECHNOL, V51, P48, DOI 10.1016/j.seppur.2005.12.022; Hasnain SS, 2001, J MOL BIOL, V311, P467, DOI 10.1006/jmbi.2001.4795; Hsu PH, 2005, GEOCHIM COSMOCHIM AC, V69, P4521, DOI 10.1016/j.gca.2005.05.005; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; IMRAN M, 2011, VIROL J, V8; Ishiguro M, 2007, COLLOID SURFACE A, V306, P29, DOI 10.1016/j.colsurfa.2006.12.024; Jacobson KH, 2013, ENVIRON SCI TECHNOL, V47, P6925, DOI 10.1021/es3045899; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Liu ZG, 2011, MICROSC MICROANAL, V17, P1015, DOI 10.1017/S1431927611012177; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; MCCARTHY JF, 1989, ENVIRON SCI TECHNOL, V23, P496, DOI 10.1021/es00063a602; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; MORRIS KF, 1992, J AM CHEM SOC, V114, P3139, DOI 10.1021/ja00034a071; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; Piccolo A, 2006, ANAL BIOANAL CHEM, V384, P994, DOI 10.1007/s00216-005-0254-8; Piccolo A, 2001, J IND MICROBIOL BIOT, V26, P70, DOI 10.1038/sj.jim.7000028; Piccolo A, 2001, SOIL SCI, V166, P810, DOI 10.1097/00010694-200111000-00007; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saunders SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044051; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Smejkalova D, 2008, ENVIRON SCI TECHNOL, V42, P699, DOI 10.1021/es071828p; Smith CB, 2014, SOIL BIOL BIOCHEM, V68, P309, DOI 10.1016/j.soilbio.2013.10.005; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Spevacek AR, 2013, STRUCTURE, V21, P236, DOI 10.1016/j.str.2012.12.002; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Wang YQ, 2008, BIOPOLYMERS, V89, P895, DOI 10.1002/bip.21022; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Wyckoff AC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01885; Wyckoff AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058630; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zularisam AW, 2007, DESALINATION, V212, P191, DOI 10.1016/j.desal.2006.10.010	60	8	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188308	10.1371/journal.pone.0188308	http://dx.doi.org/10.1371/journal.pone.0188308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161325	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000415987000043
J	Pauling, JK; Hermansson, M; Hartler, J; Christiansen, K; Gallego, SF; Peng, B; Ahrends, R; Ejsing, CS				Pauling, Josch K.; Hermansson, Martin; Hartler, Juergen; Christiansen, Klaus; Gallego, Sandra F.; Peng, Bing; Ahrends, Robert; Ejsing, Christer S.			Proposal for a common nomenclature for fragment ions in mass spectra of lipids	PLOS ONE			English	Article							OZONE-INDUCED DISSOCIATION; ELECTROSPRAY-IONIZATION; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; STRUCTURAL-CHARACTERIZATION; SHOTGUN LIPIDOMICS; FATTY-ACIDS; SPECTROMETRY; IDENTIFICATION; PHOSPHATIDYLCHOLINES	Advances in mass spectrometry-based lipidomics have in recent years prompted efforts to standardize the annotation of the vast number of lipid molecules that can be detected in biological systems. These efforts have focused on cataloguing, naming and drawing chemical structures of intact lipid molecules, but have provided no guidelines for annotation of lipid fragment ions detected using tandem and multi-stage mass spectrometry, albeit these fragment ions are mandatory for structural elucidation and high confidence lipid identification, especially in high throughput lipidomics workflows. Here we propose a nomenclature for the annotation of lipid fragment ions, describe its implementation and present a freely available web application, termed ALEX(123) lipid calculator, that can be used to query a comprehensive database featuring curated lipid fragmentation information for more than 430,000 potential lipid molecules from 47 lipid classes covering five lipid categories. We note that the nomenclature is generic, extendable to stable isotope-labeled lipid molecules and applicable to automated annotation of fragment ions detected by most contemporary lipidomics platforms, including LC-MS/MS-based routines.	[Pauling, Josch K.; Hermansson, Martin; Christiansen, Klaus; Gallego, Sandra F.; Ejsing, Christer S.] Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, Odense, Denmark; [Hartler, Juergen] Graz Univ Technol, Inst Computat Biotechnol, Graz, Austria; [Hartler, Juergen] BioTechMed Graz, Omics Ctr Graz, Graz, Austria; [Peng, Bing; Ahrends, Robert] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany; [Ejsing, Christer S.] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	University of Southern Denmark; Graz University of Technology; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); European Molecular Biology Laboratory (EMBL)	Ejsing, CS (corresponding author), Univ Southern Denmark, VILLUM Ctr Bioanalyt Sci, Dept Biochem & Mol Biol, Odense, Denmark.; Ejsing, CS (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany.	cse@bmb.sdu.dk	Hermansson, Martin/B-7854-2008	Hermansson, Martin/0000-0003-3387-8365; Ejsing, Christer S./0000-0003-4963-0276; F. Gallego, Sandra/0000-0001-7960-9860; Peng, Bing/0000-0001-5006-7041; Hartler, Jurgen/0000-0002-1095-6458	VILLUM Foundation [VKR023439]; VILLUM Center for Bioanalytical Sciences (Department of Biochemistry and Molecular Biology) [VKR023179]; Lundbeckfonden [R54-A5858]; Villum Fonden [00007292, 00007363] Funding Source: researchfish	VILLUM Foundation(Villum Fonden); VILLUM Center for Bioanalytical Sciences (Department of Biochemistry and Molecular Biology); Lundbeckfonden(Lundbeckfonden); Villum Fonden(Villum Fonden)	This work was supported by the VILLUM Foundation (VKR023439; CSE; http://villumfonden.dk), the VILLUM Center for Bioanalytical Sciences (VKR023179; Department of Biochemistry and Molecular Biology; http://Milumfonden.dk) and the Lundbeckfonden (R54-A5858; CSE; www.lundbeckfoundation com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimo L, 2015, BIOINFORMATICS, V31, P2860, DOI 10.1093/bioinformatics/btv285; Almeida R, 2015, J AM SOC MASS SPECTR, V26, P133, DOI 10.1007/s13361-014-1013-x; BIEMANN K, 1988, BIOMED ENVIRON MASS, V16, P99, DOI 10.1002/bms.1200160119; Blanksby SJ, 2010, ANNU REV ANAL CHEM, V3, P433, DOI 10.1146/annurev.anchem.111808.073705; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brown SHJ, 2011, BBA-MOL CELL BIOL L, V1811, P807, DOI 10.1016/j.bbalip.2011.04.015; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Casanovas A, 2015, CHEM BIOL, V22, P412, DOI 10.1016/j.chembiol.2015.02.007; Cheng CF, 2000, MASS SPECTROM REV, V19, P398; Cheng JM, 2015, ATHEROSCLEROSIS, V243, P560, DOI 10.1016/j.atherosclerosis.2015.10.022; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; COSTELLO CE, 1990, METHOD ENZYMOL, V193, P738, DOI 10.1016/0076-6879(90)93448-T; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Ecker J, 2014, PROG LIPID RES, V54, P14, DOI 10.1016/j.plipres.2014.01.002; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Ejsing CS, 2006, J MASS SPECTROM, V41, P372, DOI 10.1002/jms.997; Ekroos K, 2003, J LIPID RES, V44, P2181, DOI 10.1194/jlr.D300020-JLR200; Ekroos K, 2002, ANAL CHEM, V74, P941, DOI 10.1021/ac015655c; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Fauland A, 2011, J LIPID RES, V52, P2314, DOI 10.1194/jlr.D016550; Gallego SF, 2017, BBA-MOL CELL BIOL L, V1862, P145, DOI 10.1016/j.bbalip.2016.10.012; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810; Han XL, 1995, J AM SOC MASS SPECTR, V6, P1202, DOI 10.1016/1044-0305(95)00568-4; Hartler J, 2011, BIOINFORMATICS, V27, P572, DOI 10.1093/bioinformatics/btq699; Hill EA, 1900, J AM CHEM SOC, V22, P478, DOI 10.1021/ja02046a005; Hsu FF, 2016, BIOCHIMIE, V130, P63, DOI 10.1016/j.biochi.2016.07.012; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Husen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079736; Kainu V, 2008, J BIOL CHEM, V283, P3676, DOI 10.1074/jbc.M709176200; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Kozlowski RL, 2015, ANAL BIOANAL CHEM, V407, P5053, DOI 10.1007/s00216-014-8430-3; Liebisch G, 2015, CLIN CHEM, V61, P1542, DOI 10.1373/clinchem.2015.244830; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Maccarone AT, 2014, J LIPID RES, V55, P1668, DOI 10.1194/jlr.M046995; Murphy RC, 2001, CHEM REV, V101, P479, DOI 10.1021/cr9900883; Murphy RC, 2011, MASS SPECTROM REV, V30, P579, DOI 10.1002/mas.20284; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Ovcacikova M, 2016, J CHROMATOGR A, V1450, P76, DOI 10.1016/j.chroma.2016.04.082; Pham HT, 2014, ANALYST, V139, P204, DOI 10.1039/c3an01712e; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Sales S, 2016, SCI REP-UK, V6, DOI 10.1038/srep27710; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sato Y, 2013, J LIPID RES, V54, P2687, DOI 10.1194/jlr.M038075; Scholz C, 2011, J BIOL CHEM, V286, P13346, DOI 10.1074/jbc.M110.216416; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Taguchi R, 2010, J CHROMATOGR A, V1217, P4229, DOI 10.1016/j.chroma.2010.04.034; Tarasov K, 2014, J CLIN ENDOCR METAB, V99, pE45, DOI 10.1210/jc.2013-2559; Thomas MC, 2008, ANAL CHEM, V80, P303, DOI 10.1021/ac7017684; Triebl A, 2017, J CHROMATOGR B, V1053, P72, DOI 10.1016/j.jchromb.2017.03.027; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	59	55	55	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188394	10.1371/journal.pone.0188394	http://dx.doi.org/10.1371/journal.pone.0188394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161304	Green Published, gold			2022-12-27	WOS:000415987000048
J	Quintana-Villamandos, B; de Diego, JJG; Delgado-Martos, MJ; Munoz-Valverde, D; Soto-Montenegro, ML; Desco, M; Delgado-Baeza, E				Quintana-Villamandos, Begona; Gomez de Diego, Jose Juan; Jesus Delgado-Martos, Maria; Munoz-Valverde, David; Luisa Soto-Montenegro, Maria; Desco, Manuel; Delgado-Baeza, Emilio			Dronedarone produces early regression of myocardial remodelling in structural heart disease	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; LEFT-VENTRICULAR HYPERTROPHY; ANTIARRHYTHMIC AGENT; CARDIAC-HYPERTROPHY; NITRIC-OXIDE; AMIODARONE; METAANALYSIS; PERFORMANCE; PRESSURE; THERAPY	Background and aims Left ventricular hypertrophy (LVH) in hypertension is associated with a greater risk of sustained supraventricular/atrial arrhythmias. Dronedarone is an antiarrhythmic agent that was recently approved for the treatment of atrial fibrillation. However, its effect on early regression of LVH has not been reported. We tested the hypothesis that short-term administration of dronedarone induces early regression of LVH in spontaneously hypertensive rats (SHRs). Methods Ten-month-old male SHRs were randomly assigned to an intervention group (SHR-D), where animals received dronedarone treatment (100 mg/kg) for a period of 14 days, or to a control group (SHR) where rats were given vehicle. A third group with normotensive control rats (WKY) was also added. At the end of the treatment with dronedarone we studied the cardiac anatomy and function in all the rats using transthoracic echocardiogram, cardiac metabolism using the PET/CT study (2-deoxy-2[18F] fluoro-D-glucose) and cardiac structure by histological analysis of myocyte size and collagen content. Results The hypertensive vehicle treated SHR rats developed the classic cardiac pattern of hypertensive cardiomyopathy as expected for the experimental model, with increases in left ventricular wall thickness, a metabolic shift towards an increase in glucose use and increases in myocyte and collagen content. However, the SHR-D rats showed statistically significant lower values in comparison to SHR group for septal wall thickness, posterior wall thickness, ventricular mass, glucose myocardial uptake, size of left ventricular cardiomyocytes and collagen content. All these values obtained in SHR-D rats were similar to the values measured in the normotensive WKY control group. Conclusion The results suggest by three alternative and complementary ways ( analysis of anatomy and cardiac function, metabolism and histological structure) that dronedarone has the potential to reverse the LVH induced by arterial hypertension in the SHR model of compensated ventricular hypertrophy.	[Quintana-Villamandos, Begona] Hosp Gen Univ Gregorio Maranon, Dept Anestesiol, Madrid, Spain; [Quintana-Villamandos, Begona] Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid, Spain; [Quintana-Villamandos, Begona; Gomez de Diego, Jose Juan; Jesus Delgado-Martos, Maria; Luisa Soto-Montenegro, Maria; Desco, Manuel; Delgado-Baeza, Emilio] Inst Invest Sanitaria Gregorio Maranon, Dept Med & Cirug Expt, Madrid, Spain; [Gomez de Diego, Jose Juan] Hosp Clin San Carlos, Dept Cardiol, Madrid, Spain; [Gomez de Diego, Jose Juan] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Munoz-Valverde, David] Univ Autonoma Madrid, Dept Cirug Expt, Fac Med, Madrid, Spain; [Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Getafe, Spain; [Quintana-Villamandos, Begona] Hosp Gregorio Maranon, Dept Anaesthesiol, C Doctor Esquerdo, Madrid, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; Hospital Clinico San Carlos; Autonomous University of Madrid; Universidad Carlos III de Madrid; General University Gregorio Maranon Hospital	Quintana-Villamandos, B (corresponding author), Hosp Gen Univ Gregorio Maranon, Dept Anestesiol, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Dept Med & Cirug Expt, Madrid, Spain.; Quintana-Villamandos, B (corresponding author), Hosp Gregorio Maranon, Dept Anaesthesiol, C Doctor Esquerdo, Madrid, Spain.	begoquinti@gmail.com	Desco, Manuel/AAD-7137-2019; Soto-Montenegro, María Luisa/AFS-1781-2022	Desco, Manuel/0000-0003-0989-3231; Soto Montenegro, Maria Luisa/0000-0003-4350-4789	Spanish Health Ministry (Fondo de Investigaciones Sanitarias) [FIS 13/01261]; Fondos Feder	Spanish Health Ministry (Fondo de Investigaciones Sanitarias)(Instituto de Salud Carlos IIISpanish Government); Fondos Feder(European Commission)	This work was supported by a grant from the Spanish Health Ministry (Fondo de Investigaciones Sanitarias) under contract FIS 13/01261 and Fondos Feder.	Alexánderson Erick, 2004, Arch. Cardiol. Méx., V74, P220; Baroletti Steven, 2010, Crit Pathw Cardiol, V9, P94, DOI 10.1097/HPC.0b013e3181dda1e6; Brilla CG, 1996, HYPERTENSION, V28, P269, DOI 10.1161/01.HYP.28.2.269; Cappola TP, 2003, PHYSIOL GENOMICS, V14, P25, DOI 10.1152/physiolgenomics.00156.2002; Chatterjee S, 2014, AM J CARDIOL, V114, P1049, DOI 10.1016/j.amjcard.2014.07.015; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; Djandjighian L, 2000, J CARDIOVASC PHARM, V36, P376, DOI 10.1097/00005344-200009000-00014; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Ferreira C, 2010, CLINICS, V65, P723, DOI 10.1590/S1807-59322010000700012; FROHLICH ED, 1986, J HYPERTENS, V4, pS15; Gallego-Delgado J, 2009, HYPERTENS RES, V32, P347, DOI 10.1038/hr.2009.27; Gautier P, 2003, J CARDIOVASC PHARM, V41, P191, DOI 10.1097/00005344-200302000-00007; Guiraudou P, 2004, EUR J PHARMACOL, V496, P119, DOI 10.1016/j.ejphar.2004.05.046; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Handa N, 2007, ANN NUCL MED, V21, P569, DOI 10.1007/s12149-007-0067-2; HODEIGE D, 1995, EUR J PHARMACOL, V279, P25, DOI 10.1016/0014-2999(95)00130-D; Ishimitsu T, 2010, INT HEART J, V51, P359, DOI 10.1536/ihj.51.359; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Kober L, 2008, NEW ENGL J MED, V358, P2678, DOI 10.1056/NEJMoa0800456; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Lee EJ, 2014, J CLIN PHARM THER, V39, P112, DOI 10.1111/jcpt.12128; Linz W, 1999, HYPERTENSION, V34, P291, DOI 10.1161/01.HYP.34.2.291; Nascimben L, 2004, HYPERTENSION, V44, P662, DOI 10.1161/01.HYP.0000144292.69599.0c; Oyetayo OO, 2010, PHARMACOTHERAPY, V30, P904, DOI 10.1592/phco.30.9.904; Pantos C, 2002, EUR J PHARMACOL, V444, P191, DOI 10.1016/S0014-2999(02)01624-2; Pierdomenico SD, 2010, AM J HYPERTENS, V23, P876, DOI 10.1038/ajh.2010.80; Purushothaman S, 2011, MOL CELL BIOCHEM, V351, P59, DOI 10.1007/s11010-011-0711-y; Quintana-Villamandos B, 2013, LAB ANIM-UK, V47, P320, DOI 10.1177/0023677213495668; Quintana-Villamandos B, 2016, MED HYPOTHESES, V87, P44, DOI 10.1016/j.mehy.2015.12.016; Quintana-Villamandos B, 2017, CARDIOVASC PATHOL, V26, P51, DOI 10.1016/j.carpath.2016.11.002; Quintana-Villamandos B, 2013, HYPERTENS RES, V36, P408, DOI 10.1038/hr.2012.191; Reutter BW, 2011, INT J MOL IMAGING, V2011; Rosa GM, 2014, EXPERT OPIN DRUG MET, V28, P1; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sambandam Nandakumar, 2002, Heart Fail Rev, V7, P161; Simko F, 2002, MED HYPOTHESES, V58, P11, DOI 10.1054/mehy.2001.1399; Simko F, 2010, J HYPERTENS, V28, pS1, DOI 10.1097/01.hjh.0000388487.43460.db; Simko F, 2009, J HYPERTENS, V27, pS5, DOI 10.1097/01.hjh.0000358830.95439.e8; Sobrado LF, 2013, J CARDIOVASC ELECTR, V24, P914, DOI 10.1111/jce.12155; Tadros Rafik, 2016, Card Electrophysiol Clin, V8, P453, DOI 10.1016/j.ccep.2016.02.008; Wollert Kai C, 2002, Heart Fail Rev, V7, P317, DOI 10.1023/A:1020706316429	41	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188442	10.1371/journal.pone.0188442	http://dx.doi.org/10.1371/journal.pone.0188442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161309	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000056
J	Singh, A; Sharma, V; Dikshit, HK; Aski, M; Kumar, H; Thirunavukkarasu, N; Patil, BS; Kumar, S; Sarker, A				Singh, Akanksha; Sharma, Vinay; Dikshit, Harsh Kumar; Aski, Muraleedhar; Kumar, Harish; Thirunavukkarasu, Nepolean; Patil, Basavanagouda S.; Kumar, Shiv; Sarker, Ashutosh			Association mapping unveils favorable alleles for grain iron and zinc concentrations in lentil (Lens culinaris subsp. culinaris)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; GENETIC-LINKAGE MAP; POPULATION-STRUCTURE; MICROSATELLITE MARKERS; TRACE-ELEMENTS; DIVERSITY; DISEQUILIBRIUM; IDENTIFICATION; SEQUENCE	Lentil is a major cool-season grain legume grown in South Asia, West Asia, and North Africa. Populations in developing countries of these regions have micronutrient deficiencies; therefore, breeding programs should focus more on improving the micronutrient content of food. In the present study, a set of 96 diverse germplasm lines were evaluated at three different locations in India to examine the variation in iron (Fe) and zinc (Zn) concentration and identify simple sequence repeat (SSR) markers that associate with the genetic variation. The genetic variation among genotypes of the association mapping (AM) panel was characterized using a genetic distance-based and a general model-based clustering method. The model-based analysis identified six subpopulations, which satisfactorily explained the genetic structure of the AM panel. AM analysis identified three SSRs (PBALC 13, PBALC 206, and GLLC 563) associated with grain Fe concentration explaining 9% to 11% of phenotypic variation and four SSRs (PBALC 353, SSR 317-1, PLC 62, and PBALC 217) were associated with grain Zn concentration explaining 14%, to 21% of phenotypic variation. These identified SSRs exhibited consistent performance across locations. These candidate SSRs can be used in marker-assisted genetic improvement for developing Fe and Zn fortified lentil varieties. Favorable alleles and promising genotypes identified in this study can be utilized for lentil biofortification.	[Singh, Akanksha; Dikshit, Harsh Kumar; Aski, Muraleedhar; Kumar, Harish; Thirunavukkarasu, Nepolean] ICAR Res Complex, Indian Agr Res Inst, Div Genet, New Delhi, India; [Singh, Akanksha; Sharma, Vinay] Banasthali Univ, Dept Biosci & Biotechnol, Banasthali, Rajasthan, India; [Kumar, Harish] Punjab Agr Univ, RRS, Faridkot, Punjab, India; [Patil, Basavanagouda S.] ICAR Res Complex, Indian Agr Res Inst, Reg Ctr, Dharwad, Karnataka, India; [Kumar, Shiv] Rabat Inst, ICARDA, Stn Expt, INRA Quich, BP 6299,Rue Hafiane Cherkaoui Agdal, Rabat, Morocco; [Sarker, Ashutosh] South Asia & China Program ICARDA, NASC Complex, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Banasthali Vidyapith; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Dikshit, HK (corresponding author), ICAR Res Complex, Indian Agr Res Inst, Div Genet, New Delhi, India.	harshgeneticsiari@gmail.com		Singh, Akanksha/0000-0001-6480-2641	ICAR-IARI in house project [CRSIARISIL2014007239]; Harvest Plus through ICARDA	ICAR-IARI in house project; Harvest Plus through ICARDA	The research work was funded through ICAR-IARI in house project CRSIARISIL2014007239 and partial funding for this work was received from Harvest Plus through ICARDA. There was no additional funding received for this study.; Authors are thankful to Director, Joint Director Research and Head, Division of Genetics, for providing the necessary facilities for research. The authors also acknowledge the partial funding support received from Harvest Plus through ICARDA for carrying out the research work.	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Alloway Brian J., 2008, P1, DOI 10.1007/978-1-4020-6860-7_1; Alo F, 2011, J HERED, V102, P315, DOI 10.1093/jhered/esr015; Andeden E. E., 2013, P PLANT AN GEN C 21; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; [Anonymous], 2001, IRON DEFICIENCY ANAE; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bajait C, 2011, INDIAN J PHARMACOL, V43, P232, DOI 10.4103/0253-7613.81495; Bashir K, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00015, 10.3389/fpls.2013.00090]; Bauer P, 2004, PLANT PHYSIOL, V136, P4169, DOI 10.1104/pp.104.047233; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Choudhary S, 2009, THEOR APPL GENET, V118, P591, DOI 10.1007/s00122-008-0923-z; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; Cubero J. I., 1981, Lentils, P15; de Benoist B, 2008, WHO GLOBAL DATABASE; Decroocq V, 2003, THEOR APPL GENET, V106, P912, DOI 10.1007/s00122-002-1158-z; Diapari M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0252-2; Diapari M, 2014, GENOME, V57, P459, DOI 10.1139/gen-2014-0108; Dikshit HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138101; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El-Haramein F.J., 2008, P 10 INT BARL GEN S; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; Erskine W, 1998, EUPHYTICA, V101, P207, DOI 10.1023/A:1018306723777; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Fageria NK, 2012, COMMUN SOIL SCI PLAN, V43, P556, DOI 10.1080/00103624.2012.639431; Fageria N. K., 2002, ADV AGRON, V77, P85; Failla ML, 2003, J NUTR, V133, p1443S, DOI 10.1093/jn/133.5.1443S; Ferguson ME, 1998, EUPHYTICA, V102, P265, DOI 10.1023/A:1018331432580; Ford R, 1997, EUPHYTICA, V96, P247, DOI 10.1023/A:1003097600701; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Gernand AD, 2016, NAT REV ENDOCRINOL, V12, P274, DOI 10.1038/nrendo.2016.37; Goldstein DB, 1999, GENETICS, V151, P797; Gorafi YSA, 2018, PLANT GENET RESOUR-C, V16, P9, DOI 10.1017/S1479262116000265; Graham Robin D., 2008, P41; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta S, 2014, PLANT CELL REP, V33, P881, DOI 10.1007/s00299-014-1564-0; Gutierrez L, 2011, PLANT GENOME-US, V4, P256, DOI 10.3835/plantgenome2011.07.0020; Gutierrez MV, 2005, THEOR APPL GENET, V110, P1210, DOI 10.1007/s00122-005-1951-6; Gyawali S, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0496-5; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; Jain N, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200539; Jannink Jean-Luc, 2002, P59, DOI 10.1079/9780851996011.0059; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jin TT, 2013, BREEDING SCI, V63, P317, DOI 10.1270/jsbbs.63.317; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Koul PM, 2017, 3 BIOTECH, V7, DOI 10.1007/s13205-017-0683-z; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kujur A, 2015, SCI REP-UK, V5, DOI 10.1038/srep11166; Kumar S, 2014, LEGUMES IN OMICS ERA, P111, DOI 10.1007/978-1-4614-8370-0_6; Kumar S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00078; Kushwaha UKS, 2013, INT J APPL SCI BIOTE, V1, P16; Laborda PR, 2005, THEOR APPL GENET, V111, P1288, DOI 10.1007/s00122-005-0055-7; Ladizinski D, 1984, BOT GAZ, V145, P235; Le Gouis J, 2012, THEOR APPL GENET, V124, P597, DOI 10.1007/s00122-011-1732-3; Li XP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00833; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liewlaksaneeyanawin C, 2004, THEOR APPL GENET, V109, P361, DOI 10.1007/s00122-004-1635-7; Lim K, 2015, NUTRIENTS, V7, P2983, DOI 10.3390/nu7042983; Lou YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133054; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Mallikarjuna MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139067; Mei H, 2013, PLOS ONE, V26; Mekonnen F., 2014, J AGR CROP RES, V2, P104; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Mnejja M, 2010, TREE GENET GENOMES, V6, P689, DOI 10.1007/s11295-010-0284-z; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Norton GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089685; Paniego N, 2002, GENOME, V45, P34, DOI 10.1139/g01-120; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peng J. H., 2005, Functional & Integrative Genomics, V5, P80, DOI 10.1007/s10142-004-0128-8; PETERSON CJ, 1986, CEREAL CHEM, V63, P183; POWELL W, 1995, P NATL ACAD SCI USA, V92, P7759, DOI 10.1073/pnas.92.17.7759; Pritchard JK, 2000, GENETICS, V155, P945; Racedo J, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0829-x; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Rahman M. M., 2009, The lentil: botany, production and uses, P121, DOI 10.1079/9781845934873.0121; Rawat N, 2009, GENET RESOUR CROP EV, V56, P53, DOI 10.1007/s10722-008-9344-8; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; Rush D, 2000, AM J CLIN NUTR, V72, p212S, DOI 10.1093/ajcn/72.1.212S; Saha GC, 2010, EUPHYTICA, V175, P261, DOI 10.1007/s10681-010-0187-y; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Sharma SK, 1996, THEOR APPL GENET, V93, P751, DOI 10.1007/BF00224072; Singh D., 2005, MANUAL SOIL; Soranzo N, 1999, GENOME, V42, P158, DOI 10.1139/gen-42-1-158; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Taniguchi H, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-22; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Thavarajah D, 2011, EUPHYTICA, V180, P123, DOI 10.1007/s10681-011-0365-6; Thavarajah D, 2009, J AGR FOOD CHEM, V57, P5413, DOI 10.1021/jf900786e; Upadhyaya H. D., 2016, SCI REP, V6; Van Inghelandt D, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-56; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Wan JianMin, 2006, Acta Agronomica Sinica, V32, P455; Wang ML, 2011, THEOR APPL GENET, V123, P1307, DOI 10.1007/s00122-011-1668-7; Wei YY, 2012, J AGR FOOD CHEM, V60, P11433, DOI 10.1021/jf3036462; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wessells KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050568; West KP, 2012, NUTR GLOBAL HLTH DIS, P271; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; Wu YX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017271; Yamamoto T, 2001, THEOR APPL GENET, V102, P865, DOI 10.1007/s001220000524; Zhang MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094881; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zohary D, 1999, GENET RESOUR CROP EV, V46, P133, DOI 10.1023/A:1008692912820; Zoric M, 2012, GENETICA, V140, P259, DOI 10.1007/s10709-012-9677-2	124	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188296	10.1371/journal.pone.0188296	http://dx.doi.org/10.1371/journal.pone.0188296			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161321	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000040
J	Hailemariam, Z; Krucken, J; Baumann, M; Ahmed, JS; Clausen, PH; Nijhof, AM				Hailemariam, Zerihun; Kruecken, Juergen; Baumann, Maximilian; Ahmed, Jabbar S.; Clausen, Peter-Henning; Nijhof, Ard M.			Molecular detection of tick-borne pathogens in cattle from Southwestern Ethiopia	PLOS ONE			English	Article							LINE BLOT HYBRIDIZATION; ANAPLASMA-PHAGOCYTOPHILUM; GENETIC DIVERSITY; IXODID TICKS; EHRLICHIA; THEILERIA; SHEEP; IDENTIFICATION; HEMOPARASITES; INFECTIONS	Tick-borne diseases (TBDs) cause significant losses among livestock and impact the livelihoods of resource-poor farming communities worldwide. In Ethiopia, detailed studies on the epidemiology of tick-borne pathogens (TBPs) in cattle using sensitive molecular detection methods are scarce. The objective of this study was to determine the prevalence and species composition of bovine TBPs of veterinary significance in local cattle populations. A comprehensive cross-sectional epidemiological study was conducted in cattle populations of Illubabor zone in Southwestern Ethiopia from June to August 2013. For this purpose, blood samples were collected from 392 cattle. A combination of polymerase chain reaction (PCR) and a Reverse Line Blot (RLB) hybridization assay was employed for the detection of TBPs in these samples. The PCR/RLB results of the 392 blood samples indicated a high overall prevalence of 96.9% for TBPs, including Theileria mutans (66.1%), Theileria orientalis (51.8%), Anaplasma sp. Omatjenne (25.5%), Anaplasma marginale (14.5%), Babesia bigemina (14.0%) and Theileria velifera (13.0%) and minor occurrences of Ehrlichia ruminantium (0.5%) and Ehrlichia minasensis (0.26%). Moreover, three novel Anaplasma genotypes were detected in bovine blood samples. A phylogenetic analysis revealed that they most likely represent three, but at least two, new species. The prevalence of the three novel Anaplasma species, preliminary designated as Anaplasma sp. Hadesa, Anaplasma sp. Saso and Anaplasma sp. Dedessa, was 12.5%, 14.3% and 5.6%, respectively. Overall, a total of 227 cattle (57.9%) were found to be co-infected with two or more TBPs simultaneously and 86 different species combinations were observed. The findings show a very high burden of infection of cattle with TBPs in Ethiopia. The high frequency of co-infections suggests that clinical manifestations might be complex. Further research is required to determine the pathogenicity, host cell types and vector of the three novel Anaplasma species identified in this study.	[Hailemariam, Zerihun; Kruecken, Juergen; Ahmed, Jabbar S.; Clausen, Peter-Henning; Nijhof, Ard M.] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Hailemariam, Zerihun] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia; [Baumann, Maximilian] Free Univ Berlin, FAO Reference Ctr Vet Publ Hlth, Berlin, Germany	Free University of Berlin; Haramaya University; Free University of Berlin	Nijhof, AM (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	ard.nijhof@fu-berlin.de	Krücken, Jürgen/B-6794-2009; Krücken, Jürgen/CAF-6903-2022; Krücken, Jürgen/AAE-3133-2021	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Negasi, Zerihun Hailemariam/0000-0002-4028-4269; Nijhof, Ard/0000-0001-7373-2243	German Research Foundation (DFG) [AH 41/7-1]; German Academic Exchange Service (DAAD)	German Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was financially supported by the German Research Foundation (DFG) project AH 41/7-1 and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar DM, 2014, TICKS TICK-BORNE DIS, V5, P537, DOI 10.1016/j.ttbdis.2014.03.010; ANDREW HR, 1989, VET PARASITOL, V34, P261, DOI 10.1016/0304-4017(89)90056-3; Baneth G, 2014, INT J PARASITOL, V44, P591, DOI 10.1016/j.ijpara.2014.03.011; Battilani M, 2017, INFECT GENET EVOL, V49, P195, DOI 10.1016/j.meegid.2017.01.021; Bekker CPJ, 2002, VET MICROBIOL, V89, P223, DOI 10.1016/S0378-1135(02)00179-7; Bhoora R, 2009, VET PARASITOL, V159, P112, DOI 10.1016/j.vetpar.2008.10.004; Butler CM, 2008, VET REC, V162, P216, DOI 10.1136/vr.162.7.216; Cabezas-Cruz A, 2016, INT J SYSTEMATIC EVO; CHEN SM, 1994, J CLIN MICROBIOL, V32, P589, DOI 10.1128/JCM.32.3.589-595.1994; Chochlakis D, 2010, EMERG INFECT DIS, V16, P1031, DOI 10.3201/eid1606.090175; Cruz AC, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-291; CSA, 2013, STAT B, VII; Dobbelaere D., 2002, NONTRANSFORMING THEI, P93; Dreher UM, 2005, CLIN DIAGN LAB IMMUN, V12, P1177, DOI 10.1128/CDLI.12.10.1177-1183.2005; Gachohi JM, 2010, PREV VET MED, V95, P208, DOI 10.1016/j.prevetmed.2010.03.015; Georges K, 2001, VET PARASITOL, V99, P273, DOI 10.1016/S0304-4017(01)00488-5; Gubbels JM, 1999, J CLIN MICROBIOL, V37, P1782, DOI 10.1128/JCM.37.6.1782-1789.1999; Guo WP, 2016, SCI REP-UK, V6, DOI 10.1038/srep38770; Hailemariam Z, 2017, TICKS TICK-BORNE DIS, V8, P185, DOI 10.1016/j.ttbdis.2016.10.016; Herndon DR, 2010, J BACTERIOL, V192, P379, DOI 10.1128/JB.01330-09; IZOARD, 2013, ANN REP ILL ZON OFF; Jado I, 2006, J CLIN MICROBIOL, V44, P4572, DOI 10.1128/JCM.01227-06; Kabi F, 2008, SERO PREVALENCES TIC; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kocan KM, 2015, REV SCI TECH OIE, V34, P577, DOI 10.20506/rst.34.2.2381; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kumsa B, 2015, TICKS TICK-BORNE DIS, V6, P8, DOI 10.1016/j.ttbdis.2014.08.001; Kumsa B, 2014, TROP ANIM HEALTH PRO, V46, P27, DOI 10.1007/s11250-013-0442-z; Li H, 2015, LANCET INFECT DIS, V15, P663, DOI 10.1016/S1473-3099(15)70051-4; Lorusso V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1504-7; Malak AK, 2012, PREV VET MED, V104, P216, DOI 10.1016/j.prevetmed.2011.12.001; Mekonnen S., 2007, ETHIOPIAN VET J, V11, P1; Mekonnen S., 1996, EPIDEMIOLOGY TICKS T; Miller M.A., P GAT COMP ENV WORKS; Nijhof AM, 2005, J CLIN MICROBIOL, V43, P5907, DOI 10.1128/JCM.43.12.5907-5911.2005; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Oura CAL, 2004, INT J PARASITOL, V34, P603, DOI 10.1016/j.ijpara.2003.12.012; Putt S., 1987, VET EPIDEMIOLOGY ECO; Schnittger L, 2004, PARASITOL RES, V92, P189, DOI 10.1007/s00436-003-0980-9; Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999; Sergeant E.S.G., 2018, EPITOOLS EPIDEMIOLOG; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Teshale S, 2015, TICKS TICK-BORNE DIS, V6, P1, DOI 10.1016/j.ttbdis.2014.04.023; Theiler A, 1911, 1 DEP AGR UOSA; Toma B, 1999, APPL VET EPIDEMIOLOG; Tomassone L, 2012, EXP APPL ACAROL, V56, P391, DOI 10.1007/s10493-012-9528-y; Woolhouse MEJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400026; Yang JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1880-z	51	45	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188248	10.1371/journal.pone.0188248	http://dx.doi.org/10.1371/journal.pone.0188248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155863	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700038
J	Wullems, JA; Verschueren, SMP; Degens, H; Morse, CI; Onambele, GL				Wullems, Jorgen A.; Verschueren, Sabine M. P.; Degens, Hans; Morse, Christopher I.; Onambele, Gladys L.			Performance of thigh-mounted triaxial accelerometer algorithms in objective quantification of sedentary behaviour and physical activity in older adults	PLOS ONE			English	Article							ACTIVITY RECOGNITION; ENERGY-EXPENDITURE; CALIBRATION; WRIST; HIP; CLASSIFIERS; PREDICTION; MONITORS	Accurate monitoring of sedentary behaviour and physical activity is key to investigate their exact role in healthy ageing. To date, accelerometers using cut-off point models are most preferred for this, however, machine learning seems a highly promising future alternative. Hence, the current study compared between cut-off point and machine learning algorithms, for optimal quantification of sedentary behaviour and physical activity intensities in the elderly. Thus, in a heterogeneous sample of forty participants (aged >= 60 years, 50% female) energy expenditure during laboratory-based activities (ranging from sedentary behaviour through to moderate-to-vigorous physical activity) was estimated by indirect calorimetry, whilst wearing triaxial thigh-mounted accelerometers. Three cut-off point algorithms and a Random Forest machine learning model were developed and cross-validated using the collected data. Detailed analyses were performed to check algorithm robustness, and examine and benchmark both overall and participant-specific balanced accuracies. This revealed that the four models can at least be used to confidently monitor sedentary behaviour and moderate-to-vigorous physical activity. Nevertheless, the machine learning algorithm outperformed the cut-off point models by being robust for all individual's physiological and non-physiological characteristics and showing more performance of an acceptable level over the whole range of physical activity intensities. Therefore, we propose that Random Forest machine learning may be optimal for objective assessment of sedentary behaviour and physical activity in older adults using thigh-mounted triaxial accelerometry.	[Wullems, Jorgen A.; Morse, Christopher I.; Onambele, Gladys L.] Manchester Metropolitan Univ, Hlth Exercise & Act Living Res Ctr, Dept Exercise & Sport Sci, Crewe, England; [Wullems, Jorgen A.; Verschueren, Sabine M. P.] Katholieke Univ Leuven, Dept Rehabil Sci, Musculoskeletal Rehabil Res Grp, Leuven, Belgium; [Degens, Hans] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester, Lancs, England; [Degens, Hans] Lithuanian Sports Univ, Kaunas, Lithuania	Manchester Metropolitan University; KU Leuven; Manchester Metropolitan University; Lithuanian Sports University	Wullems, JA (corresponding author), Manchester Metropolitan Univ, Hlth Exercise & Act Living Res Ctr, Dept Exercise & Sport Sci, Crewe, England.; Wullems, JA (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Musculoskeletal Rehabil Res Grp, Leuven, Belgium.	jorgen.a.wullems@stu.mmu.ac.uk	Onambélé-Pearson, Gladys Leopoldine/F-1679-2013; Morse, Christopher/AAE-7913-2022; Verschueren, Sabine/K-4213-2015	Onambélé-Pearson, Gladys Leopoldine/0000-0002-1466-3265; Morse, Christopher/0000-0002-5261-2637; Degens, Hans/0000-0001-7399-4841; Wullems, Jorgen/0000-0002-4892-1349; Verschueren, Sabine/0000-0003-2592-494X	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme	European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme	This research was funded by the European Commission through MOVE-AGE, an Erasmus Mundus Joint Doctorate programme (2011-2015). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Attal F, 2015, SENSORS-BASEL, V15, P31314, DOI 10.3390/s151229858; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Bayat A, 2014, PROCEDIA COMPUT SCI, V34, P450, DOI 10.1016/j.procs.2014.07.009; Bedogni L, 2012, IFIP WIREL DAY; Bernmark E, 2002, APPL ERGON, V33, P541, DOI 10.1016/S0003-6870(02)00072-8; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen KY, 2012, MED SCI SPORT EXER, V44, pS13, DOI 10.1249/MSS.0b013e3182399bc8; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; Edwardson CL, 2016, MED SCI SPORT EXER, V48, P1085, DOI 10.1249/MSS.0000000000000865; Ellis K, 2014, FRONT PUBLIC HEALTH, P2; Ellis K, 2016, MED SCI SPORT EXER, V48, P933, DOI 10.1249/MSS.0000000000000840; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson P, 2012, MED SCI SPORT EXER, V44, pS1, DOI 10.1249/MSS.0b013e3182399b7e; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gao L, 2014, MED ENG PHYS, V36, P779, DOI 10.1016/j.medengphy.2014.02.012; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Heil DP, 2012, MED SCI SPORT EXER, V44, pS50, DOI 10.1249/MSS.0b013e3182399dcc; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; Kerr J, 2016, MED SCI SPORT EXER, V48, P951, DOI 10.1249/MSS.0000000000000841; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lenz EK, 2014, INT J KINESIOL SPORT, V2, P13, DOI [10.7575/aiac.ijkss.v.2n.1p.13, DOI 10.7575/AIAC.IJKSS.V.2N.1P.13]; Liu SP, 2012, MED SCI SPORT EXER, V44, P2138, DOI 10.1249/MSS.0b013e31825e825a; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Mannini A, 2017, MED SCI SPORT EXER, V49, P801, DOI 10.1249/MSS.0000000000001144; Mattocks C, 2007, INT J PEDIATR OBES, V2, P218, DOI 10.1080/17477160701408809; Miller NE, 2010, J AGING PHYS ACTIV, V18, P158, DOI 10.1123/japa.18.2.158; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Onambele-Pearson GL, 2010, AGE, V32, P139, DOI 10.1007/s11357-010-9141-0; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Pedisic Z, 2015, BRIT J SPORT MED, V49, P219, DOI 10.1136/bjsports-2013-093407; Preece SJ, 2009, PHYSIOL MEAS, V30, pR1, DOI 10.1088/0967-3334/30/4/R01; PROFESSIONAL M., 2004, ASSESSMENT FALLS RIS, P1; R Development CT, 2005, R LANG ENV STAT COMP; Rosenberg D, 2017, MED SCI SPORT EXER, V49, P610, DOI 10.1249/MSS.0000000000001121; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P1235, DOI 10.1249/MSS.0000000000000224; Ruch N, 2013, J APPL PHYSIOL, V115, P1229, DOI 10.1152/japplphysiol.01443.2012; Sasaki JE, 2016, COMPUTER ASSISTED WE, P33, DOI DOI 10.1016/B978-0-12-802075-3.00002-4; Sasaki JE, 2016, MED SCI SPORT EXER, V48, P941, DOI 10.1249/MSS.0000000000000844; Sport TE, 2015, SPORT TE, V2015; Stamatakis E, 2012, PREV MED, V54, P82, DOI 10.1016/j.ypmed.2011.10.009; Szanton SL, 2015, GERIATR NURS, V36, P131, DOI 10.1016/j.gerinurse.2014.12.008; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f; Wullems JA, 2016, BIOGERONTOLOGY, V17, P547, DOI 10.1007/s10522-016-9640-1; Yang CC, 2010, SENSORS-BASEL, V10, P7772, DOI 10.3390/s100807772	57	20	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188215	10.1371/journal.pone.0188215	http://dx.doi.org/10.1371/journal.pone.0188215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155839	Green Published, gold, Green Accepted			2022-12-27	WOS:000415756700036
J	Kertesz, M; Aszalos, R; Lengyel, A; Onodi, G				Kertesz, Miklos; Aszalos, Reka; Lengyel, Attila; Onodi, Gabor			Synergistic effects of the components of global change: Increased vegetation dynamics in open, forest-steppe grasslands driven by wildfires and year-to-year precipitation differences	PLOS ONE			English	Article							CLIMATE-CHANGE; FIRE; DIVERSITY; ECOLOGY; IMPACT	Climate change and land use change are two major elements of human-induced global environmental change. In temperate grasslands and woodlands, increasing frequency of extreme weather events like droughts and increasing severity of wildfires has altered the structure and dynamics of vegetation. In this paper, we studied the impact of wildfires and the year-to-year differences in precipitation on species composition changes in semi-arid grasslands of a forest-steppe complex ecosystem which has been partially disturbed by wildfires. Particularly, we investigated both how long-term compositional dissimilarity changes and species richness are affected by year-to-year precipitation differences on burnt and unburnt areas. Study sites were located in central Hungary, in protected areas characterized by partially-burnt, juniper-poplar forest-steppe complexes of high biodiversity. Data were used from two long-term monitoring sites in the Kiskunsa A g National Park, both characterized by the same habitat complex. We investigated the variation in species composition as a function of time using distance decay methodology. In each sampling area, compositional dissimilarity increased with the time elapsed between the sampling events, and species richness differences increased with increasing precipitation differences between consecutive years. We found that both the long-term compositional dissimilarity, and the year-to-year changes in species richness were higher in the burnt areas than in the unburnt ones. The long-term compositional dissimilarities were mostly caused by perennial species, while the year-to-year changes of species richness were driven by annual and biennial species. As the effect of the year-to-year variation in precipitation was more pronounced in the burnt areas, we conclude that canopy removal by wildfires and extreme inter-annual variability of precipitation, two components of global environmental change, act in a synergistic way. They enhance the effect of one another, resulting in greater long-term and year-to-year changes in the composition of grasslands.	[Kertesz, Miklos; Aszalos, Reka; Lengyel, Attila; Onodi, Gabor] MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary; [Kertesz, Miklos] GINOP Sustainable Ecosystems Grp, MTA Ctr Ecol Res, Tihany, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Kertesz, M (corresponding author), MTA Ctr Ecol Res, Inst Ecol & Bot, Vacratot, Hungary.; Kertesz, M (corresponding author), GINOP Sustainable Ecosystems Grp, MTA Ctr Ecol Res, Tihany, Hungary.	kertesz.miklos@okologia.mta.hu	Ónodi, Gábor/P-3267-2019	Ónodi, Gábor/0000-0003-4308-7997; Kertesz, Miklos/0000-0002-3565-4624	Orszagos Tudomanyos Kutatasi Alapprogramok (HU) [F5254, T29703, A08-1-2009-0051]; Nemzeti Kutatasi es Fejlesztesi Program (HU) [NKFP 3B-0008/2002, NKFP 6-0013/2005]; Sixth Framework Programme (BE) [GOCE-CT-2003-505298]; LIFE Programme (BE) [LIFE08 ENV/IT/000399]; Seventh Framework Programme (BE) [FP7-262060]; Gazdasagfejlesztesi es Innovacios Operativ Program (HU) [GINOP 2.3.3-15-2016-00019]	Orszagos Tudomanyos Kutatasi Alapprogramok (HU); Nemzeti Kutatasi es Fejlesztesi Program (HU); Sixth Framework Programme (BE); LIFE Programme (BE); Seventh Framework Programme (BE); Gazdasagfejlesztesi es Innovacios Operativ Program (HU)	Orszagos Tudomanyos Kutatasi Alapprogramok (HU) Grant Nos. F5254, T29703, and A08-1-2009-0051 funded field observation design, data acquisition, data managament, analysis, and preparing the publication. Nemzeti Kutatasi es Fejlesztesi Program (HU) Grant Nos. NKFP 3B-0008/2002 and NKFP 6-0013/2005 funded data acquisition and managament. Sixth Framework Programme (BE) GOCE-CT-2003-505298 funded data acquisition and managament. LIFE Programme (BE) Grant No. LIFE08 ENV/IT/000399 funded data acquisition and managament. Seventh Framework Programme (BE) FP7-262060 funded data acquisition and managament. Gazdasagfejlesztesi es Innovacios Operativ Program (HU) GINOP 2.3.3-15-2016-00019 funded preparing the publication.	Accatino F, 2010, J THEOR BIOL, V267, P235, DOI 10.1016/j.jtbi.2010.08.012; Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bartholy J, 2007, GLOBAL PLANET CHANGE, V57, P83, DOI 10.1016/j.gloplacha.2006.11.002; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; Csecserits A, 2016, AGR ECOSYST ENVIRON, V226, P88, DOI 10.1016/j.agee.2016.03.024; Deak B, 2014, APPL ECOL ENV RES, V12, P267, DOI 10.15666/aeer/1201_267283; Dray S., 2007, R NEWS, V7, P47, DOI DOI 10.1159/000323281; Dudney J, 2017, J ECOL, V105, P484, DOI 10.1111/1365-2745.12671; Erdos L, 2014, ECOL COMPLEX, V17, P107, DOI 10.1016/j.ecocom.2013.11.004; Fekete G, 2002, ACTA ZOOL ACAD SCI H, V48, P137; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; JAMESON DA, 1962, ECOLOGY, V43, P760, DOI 10.2307/1933475; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jones SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep20120; Keeley JE, 2005, DIVERS DISTRIB, V11, P525, DOI 10.1111/j.1366-9516.2005.00200.x; Knops JMH, 2006, OECOLOGIA, V150, P477, DOI 10.1007/s00442-006-0535-8; Kovacs-Lang E, 2000, PHYTOCOENOLOGIA, V30, P385; Kovacs-Lang E., 2008, KISKUN LTER LONG TER; Lett MS, 2005, AM MIDL NAT, V153, P217, DOI 10.1674/0003-0031(2005)153[0217:WPEARI]2.0.CO;2; McKenzie D, 2004, CONSERV BIOL, V18, P890, DOI 10.1111/j.1523-1739.2004.00492.x; Molnar Z, 2003, SAND DUNES HUNGARY K; Molnar Z., 2008, KANITZIA, V16, P93; Molnar Zs, 2012, EURASIAN STEPPES ECO, V6, P209, DOI DOI 10.1007/978-94-007-3886-7_7; Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Onodi G, 2014, COMMUNITY ECOL, V15, P121, DOI [10.1556/COMEC.15.2014.1.13, 10.1556/ComEc.15.2014.1.13]; Onodi G, 2008, ARID LAND RES MANAG, V22, P273, DOI 10.1080/15324980802388223; PARTON WJ, 1995, GLOBAL CHANGE BIOL, V1, P13, DOI 10.1111/j.1365-2486.1995.tb00002.x; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Podani J., 2000, INTRO EXPLORATION MU; R Development Core Team, 2009, R LANG ENV STAT COMP; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Webb JK, 2005, COPEIA, P894, DOI 10.1643/0045-8511(2005)005[0894:CRRHQF]2.0.CO;2; WINK RL, 1973, J RANGE MANAGE, V26, P326, DOI 10.2307/3896847; Xia Y, 2010, J ARID ENVIRON, V74, P378, DOI 10.1016/j.jaridenv.2009.08.016; Yan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125300; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100; Zolyomi B, 1997, INT CTR THEORETICAL, V12, P33	44	12	14	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188260	10.1371/journal.pone.0188260	http://dx.doi.org/10.1371/journal.pone.0188260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149208	gold, Green Accepted, Green Published			2022-12-27	WOS:000415646100033
J	Okada, R; Matsuda, S; Iida, T				Okada, Ryu; Matsuda, Shigeaki; Iida, Tetsuya			Vibrio parahaemolyticus VtrA is a membrane-bound regulator and is activated via oligomerization	PLOS ONE			English	Article							HELIX TRANSCRIPTION FACTORS; III SECRETION SYSTEM; DNA-BINDING PROTEIN; PATHOGENICITY ISLAND; SIGNAL-TRANSDUCTION; MEDIATED ACTIVATION; CHOLERAE; TOXR; IDENTIFICATION; GENE	Vibrio parahaemolyticus is a Gram-negative pathogen that causes food-borne gastroenteritis. A major virulence determinant of the organism is a type III secretion system (T3SS2) encoded on a pathogenicity island, Vp-PAI. Vp-PAI gene expression is regulated by two transcriptional regulators, VtrA and VtrB, whose N-terminal regions share homology with an OmpR-family DNA-binding domain. VtrA activates the gene expression of VtrB, which in turn activates Vp-PAI gene expression; however, the mechanism of this transcriptional activation by VtrA is not well understood. In this study, we determined that VtrA is a membrane protein with a transmembrane (TM) domain, which was required for its transcriptional regulatory activity. Although the N-terminal region of VtrA alone is insufficient for its transcriptional regulatory activity, forced oligomerization using the leucine-zipper dimerization domain of yeast GCN4 conferred transcriptional regulatory activity and a greater affinity for the promoter region of vtrB. A ToxR-based assay demonstrated that VtrA oligomerizes in vivo. We also showed that bile, a host-derived activator of VtrA, induces the oligomerization of VtrA, which requires the C-terminal domain. The promoter region of vtrB contained repetitive T-rich DNA elements, which are important for vtrB transcriptional activation and are conserved among T3SS2-possessing Vibrio species. These findings propose that VtrA is active as oligomers, which may facilitate its N-terminus binding the target DNA, thus enhancing its transcriptional regulatory activity.	[Okada, Ryu; Matsuda, Shigeaki; Iida, Tetsuya] Osaka Univ, Res Inst Microbial Dis, Dept Bacterial Infect, Suita, Osaka, Japan; [Okada, Ryu] Osaka Univ, Res Fdn Microbial Dis, Osaka, Kagawa, Japan	Osaka University; Osaka University	Matsuda, S (corresponding author), Osaka Univ, Res Inst Microbial Dis, Dept Bacterial Infect, Suita, Osaka, Japan.	matsudas@biken.oska-u.ac.jp			Japan Society for the Promotion of Science [26460526, 17K08828]; Grants-in-Aid for Scientific Research [17K08828] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (Grant numbers 26460526 and 17K08828 to S.M.) from the Japan Society for the Promotion of Science, URL: http://www.jsps.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ante VM, 2015, J BACTERIOL, V197, P3499, DOI 10.1128/JB.00419-15; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Dalia AB, 2014, MBIO, V5, DOI 10.1128/mBio.01028-13; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; DIRITA VJ, 1991, CELL, V64, P29, DOI 10.1016/0092-8674(91)90206-E; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Galan JE, 2014, ANNU REV MICROBIOL, V68, P415, DOI 10.1146/annurev-micro-092412-155725; Gauntlett JC, 2008, J BIOL CHEM, V283, P8591, DOI 10.1074/jbc.M709503200; Goss TJ, 2013, INFECT IMMUN, V81, P884, DOI 10.1128/IAI.00889-12; Goss TJ, 2010, INFECT IMMUN, V78, P4122, DOI 10.1128/IAI.00566-10; Gotoh K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013365; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Kodama T, 2015, CELL MICROBIOL, V17, P183, DOI 10.1111/cmi.12408; Kodama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008678; Li P, 2016, ELIFE, V5, DOI [10.7554/eLife.15718, 10.7554/elife.15718]; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Lindner E, 2014, J MOL BIOL, V426, P2942, DOI 10.1016/j.jmb.2014.06.006; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; Matsuda S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002803; Miller J. H, 1972, EXPT MOL GENETICS; MILLER VL, 1989, J BACTERIOL, V171, P1288, DOI 10.1128/jb.171.3.1288-1293.1989; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Okada N, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-302; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Ottemann KM, 1996, J BACTERIOL, V178, P156, DOI 10.1128/jb.178.1.156-162.1996; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; Shin OS, 2011, MBIO, V2, DOI 10.1128/mBio.00106-11; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Tetsch L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-74; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; van Hijum SAFT, 2009, MICROBIOL MOL BIOL R, V73, P481, DOI 10.1128/MMBR.00037-08; Yang MH, 2013, P NATL ACAD SCI USA, V110, P2348, DOI 10.1073/pnas.1218039110; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	42	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187846	10.1371/journal.pone.0187846	http://dx.doi.org/10.1371/journal.pone.0187846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149170	gold, Green Published, Green Submitted			2022-12-27	WOS:000415646100014
J	Abu-Elsaoud, AM; Nafady, NA; Abdel-Azeem, AM				Abu-Elsaoud, Abdelghafar M.; Nafady, Nivien A.; Abdel-Azeem, Ahmed M.			Arbuscular mycorrhizal strategy for zinc mycoremediation and diminished translocation to shoots and grains in wheat	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; OLIVE TREE; FUNGI; GROWTH; SOIL; L.; PARAMETERS; TOLERANCE; DIVERSITY; TOXICITY	Mycoremediation is an on-site remediation strategy, which employs fungi to degrade or sequester contaminants from the environment. The present work focused on the bioremediation of soils contaminated with zinc by the use of a native mycorrhizal fungi (AM) called Funneliformis geosporum (Nicol. & Gerd.) Walker & SchuBler. Experiments were performed using Triticum aestivum L. cv. Gemmeza-10 at different concentrations of Zn (50, 100, 200 mg kg(-1)) and inoculated with or without F. geosporum. The results showed that the dry weight of mycorrhizal wheat increased at Zn stressed plants as compared to the non-Zn-stressed control plants. The concentrations of Zn also had an inhibitory effect on the yield of dry root and shoot of non-mycorrhizal wheat. The photosynthetic pigment fractions were significantly affected by Zn treatments and mycorrhizal inoculation, where in all treatments, the content of the photosynthetic pigment fractions decreased as the Zn concentration increased in the soil. However, the level of minerals of shoots, roots, and grains was greatly influenced by Zn-treatment and by inoculation with F. geosporum. Treatment with Zn in the soil increased Cu and Zn concentrations in the root, shoot and grains, however, other minerals (P, S, K, Ca and Fe) concentration was decreased. Inoculation of wheat with AM fungi significantly reduced the accumulation of Zn and depressed its translocation in shoots and grains of wheat. In conclusion, inoculation with a native F. geosporum-improves yields of wheat under higher levels of Zn and is possible to be applied for the improvement of zinc contaminated soil.	[Abu-Elsaoud, Abdelghafar M.; Abdel-Azeem, Ahmed M.] Suez Canal Univ, Fac Sci, Dept Bot, Ismailia, Egypt; [Nafady, Nivien A.] Assiut Univ, Fac Sci, Dept Bot & Microbiol, Assiut, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University	Abu-Elsaoud, AM (corresponding author), Suez Canal Univ, Fac Sci, Dept Bot, Ismailia, Egypt.	Abuelsaoud@science.suez.edu.eg	Nafady, Nivien/ABD-3279-2020; Abdel-Azeem, Ahmed Mohamed Ahmed/I-3637-2015; Abu-Elsaoud, Abdelghafar/F-5115-2011	Abdel-Azeem, Ahmed Mohamed Ahmed/0000-0003-2897-3966; Abu-Elsaoud, Abdelghafar/0000-0002-6269-3418				ABBOTT LK, 1992, METHOD MICROBIOL, V24, P1, DOI 10.1016/S0580-9517(08)70084-9; Abdel-Azeem AM, 2007, WATER AIR SOIL POLL, V186, P233, DOI 10.1007/s11270-007-9480-3; Abdel-Azeem AM, 2015, MYCOSPHERE, V6, P228, DOI 10.5943/mycosphere/6/2/12; Al Naggar YA, 2013, HONEY BEES THEIR PRO; Al Naggar Y, 2014, TOXICOL ENVIRON CHEM, V96, P730, DOI 10.1080/02772248.2014.984496; Al-Karaki GN, 2002, J PLANT NUTR, V25, P1175, DOI 10.1081/PLN-120004381; Al-Karaki GN., 2013, DEV SOIL CLASSIFICAT, P823, DOI DOI 10.1007/978-94-007-5332-7_48; Allsopp D., 2004, INTRO BIODETERIORATI; Amir H, 2013, MYCORRHIZA, V23, P585, DOI 10.1007/s00572-013-0499-6; Awadalla AA, 1993, THESIS; Barot S, 2004, OIKOS, V106, P185, DOI 10.1111/j.0030-1299.2004.13038.x; Berruti A, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01559; Birhane E, 2012, OECOLOGIA, V169, P895, DOI 10.1007/s00442-012-2258-3; Bohm F, 2012, MOL NUTR FOOD RES, V56, P205, DOI 10.1002/mnfr.201100222; Bonfante P, 2008, TRENDS PLANT SCI, V13, P492, DOI 10.1016/j.tplants.2008.07.001; CHANEY RL, 1993, ZINC SOILS PLANTS, P135, DOI DOI 10.1007/978-94-011-0878-2_10; Dag A, 2009, CROP PASTURE SCI, V60, P427, DOI 10.1071/CP08143; DENNY HJ, 1987, NEW PHYTOL, V106, P525, DOI 10.1111/j.1469-8137.1987.tb00157.x; El-Sowfy DM, 1998, THESIS; Emsley J., 2011, NATURES BUILDING BLO; Ferrol N, 2002, MYCORRHIZAL TECHNOLOGY IN AGRICULTURE: FROM GENES TO BIOPRODUCTS, P113; Firmin S, 2015, SCI TOTAL ENVIRON, V527, P91, DOI 10.1016/j.scitotenv.2015.04.116; Garcia K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00337; GERDEMANN J. W., 1963, TRANS BRIT MYCOL SOC, V46, P235; Giasson P, 2005, REMEDIATION, V15, P113, DOI 10.1002/rem.20064; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Hough RL, 2003, SOIL USE MANAGE, V19, P19, DOI 10.1111/j.1475-2743.2003.tb00275.x; JACKSON ML, 1967, SOIL CHEM ANAL, P205, DOI DOI 10.1097/00010694-195806000-00014; Jamal A, 2002, INT J PHYTOREMEDIAT, V4, P205, DOI 10.1080/15226510208500083; Jolly YN, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-385; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Judy JD, 2014, ADV AGRON, V123, P1, DOI 10.1016/B978-0-12-420225-2.00001-7; Kaldorf M, 1999, J PLANT PHYSIOL, V154, P718, DOI 10.1016/S0176-1617(99)80250-8; Khabou W, 2014, ECOL ENG, V73, P290, DOI 10.1016/j.ecoleng.2014.09.054; Kloke A., 1980, DREI BEREICHE SYSTEM, P1117; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Lee EH, 2013, MYCOBIOLOGY, V41, P121, DOI 10.5941/MYCO.2013.41.3.121; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu H, 2015, APPL SOIL ECOL, V89, P44, DOI 10.1016/j.apsoil.2015.01.006; LONERAGAN JF, 1993, DEV PLANT SOIL SCI, V55, P119; Malekzadeh P, 2007, Pak J Biol Sci, V10, P1326, DOI 10.3923/pjbs.2007.1326.1330; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mathur N, 1995, J PLANT PHYSIOL, V147, P328, DOI 10.1016/S0176-1617(11)82161-9; Matsubara M, 2006, ENZYME MICROB TECH, V39, P1365, DOI 10.1016/j.enzmictec.2005.04.025; Mechri B, 2015, J PLANT PHYSIOL, V185, P40, DOI 10.1016/j.jplph.2015.06.015; Mohamed NA, 1990, THESIS; Morton JB, 1990, REVISED CLASSIFICATI; MYCOCALC, 2017, MYC; Navarro-Rodenas A, 2013, MOL PLANT MICROBE IN, V26, P1068, DOI 10.1094/MPMI-07-12-0178-R; Nejat N, 2016, PLANTA DANINHA, V34, P667, DOI [10.1590/S0100-83582016340400006, 10.1590/s0100-83582016340400006]; Noori A, 2017, J NANOPART RES, V19, DOI 10.1007/s11051-016-3650-4; Nriagu J.O., 1980, ZINC ENV 1; PACOVSKY RS, 1986, PLANT SOIL, V95, P379, DOI 10.1007/BF02374618; Page AL., 1982, CHEM MICROBIOLOGICAL, V15, P99, DOI DOI 10.2134/AGRONMONOGR9.2.2ED; Panda S.K., 2005, Braz. J. Plant Physiol., V17, P95, DOI 10.1590/S1677-04202005000100008; Pellegrino E, 2015, SOIL BIOL BIOCHEM, V84, P210, DOI 10.1016/j.soilbio.2015.02.020; PFEIFFER CM, 1988, NEW PHYTOL, V108, P315, DOI 10.1111/j.1469-8137.1988.tb04168.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Piper C.S, 1947, SOIL PLANT ANAL; Rajaie M, 2009, INT J PLANT PROD, V3, P39; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Roach T, 2014, CURR PROTEIN PEPT SC, V15, P351, DOI 10.2174/1389203715666140327105143; Rolf Wuthrich J.D.A.Z, 2015, MICROMACHINING USING, pIV; Samreen T., 2013, ARAB J CHEM; Sanchez-Blanco MJ, 2004, J PLANT PHYSIOL, V161, P675, DOI 10.1078/0176-1617-01191; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Shafiquzzaman Siddiquee, 2015, Journal of Microbial and Biochemical Technology, V7, P384; Shao HB, 2005, COLLOID SURFACE B, V45, P7, DOI 10.1016/j.colsurfb.2005.06.016; Sharma MP, 2011, INDIAN J MICROBIOL, V51, P384, DOI 10.1007/s12088-011-0134-1; Silvertown J, 2004, J ECOL, V92, P168, DOI 10.1111/j.1365-2745.2004.00853.x; Singh A, 2014, J CIV ENG ENV TECHNO, V1, p59 ; Singh H., 2006, FRONTMATTER MYCOREME, pi; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Soares CRFS, 2008, BIOL FERT SOILS, V44, P833, DOI 10.1007/s00374-007-0265-z; Srinivasagam Krishnakumar, 2013, African Journal of Agricultural Research, V8, P4706; Tangahu BV, 2011, INT J CHEM ENG, V2011, DOI 10.1155/2011/939161; Tchounwou Paul B, 2012, Exp Suppl, V101, P133, DOI 10.1007/978-3-7643-8340-4_6; Trappe JM, 1986, PHYSL GENETICAL ASPE, P133; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; USEPA, 1986, QUAL CRIT WAT; Varsha Mudgal, 2010, Agriculture and Biology Journal of North America, V1, P40; Vishnoi SR, 2008, ENV SCI, P1016; Walker C, 2004, MYCOLOGICAL RES, p979 ; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang FY, 2005, PLANT SOIL, V269, P225, DOI 10.1007/s11104-004-0517-8; WILLIAMS ML, 1993, NEW PHYTOL, V125, P367, DOI 10.1111/j.1469-8137.1993.tb03888.x; Wright C., 1939, SOIL ANAL HDB PHYS C; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Yang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02937-0; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yousif SA, 2015, WORLD ACAD SCI ENG T, V9, P323; Zayed M. S., 2013, Annals of Agricultural Science (Cairo), V58, P131, DOI 10.1016/j.aoas.2013.07.011; Zhu YG, 2001, ANN BOT-LONDON, V88, P941, DOI 10.1006/anbo.2001.1522	96	15	18	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188220	10.1371/journal.pone.0188220	http://dx.doi.org/10.1371/journal.pone.0188220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145471	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800092
J	Intapad, S; Dasinger, JH; Fahling, JM; Backstrom, MA; Alexander, BT				Intapad, Suttira; Dasinger, John Henry; Fahling, Joel M.; Backstrom, Miles A.; Alexander, Barbara T.			Testosterone is protective against impaired glucose metabolism in male intrauterine growth-restricted offspring	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NUTRITION EXAMINATION SURVEY; ENDOGENOUS SEX-HORMONES; 3RD NATIONAL-HEALTH; CARDIOVASCULAR EVENTS; REPLACEMENT THERAPY; INSULIN-RESISTANCE; BODY-COMPOSITION; BLOOD-PRESSURE; PROTEIN-DIET	Placental insufficiency alters the intrauterine environment leading to increased risk for chronic disease including impaired glucose metabolism in low birth weight infants. Using a rat model of low birth weight, we previously reported that placental insufficiency induces a significant increase in circulating testosterone in male intrauterine growth-restricted offspring (mIUGR) in early adulthood that is lost by 12 months of age. Numerous studies indicate testosterone has a positive effect on glucose metabolism in men. Female growthrestricted littermates exhibit glucose intolerance at 6 months of age. Thus, the aim of this paper was to determine whether mIUGR develop impaired glucose metabolism, and whether a decrease in elevated testosterone levels plays a role in its onset. Male growthrestricted offspring were studied at 6 and 12 months of age. No impairment in glucose tolerance was observed at 6 months of age when mIUGR exhibited a 2-fold higher testosterone level compared to age-matched control. Fasting blood glucose was significantly higher and glucose tolerance was impaired with a significant decrease in circulating testosterone in mIUGR at 12 compared with 6 months of age. Castration did not additionally impair fasting blood glucose or glucose tolerance in mIUGR at 12 months of age, but fasting blood glucose was significantly elevated in castrated controls. Restoration of elevated testosterone levels significantly reduced fasting blood glucose and improved glucose tolerance in mIUGR. Thus, our findings suggest that the endogenous increase in circulating testosterone in mIUGR is protective against impaired glucose homeostasis.	[Intapad, Suttira] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Intapad, Suttira; Dasinger, John Henry; Fahling, Joel M.; Backstrom, Miles A.; Alexander, Barbara T.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Tulane University; University of Mississippi; University of Mississippi Medical Center	Intapad, S (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.; Intapad, S (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	sintapad@tulane.edu		Intapad, Suttira/0000-0003-0750-3252	National Institutes of Health Grant (NIH) [HL074927]; American Heart Grant (AHA) [GRNT19900004]; NIH [P20GM104357, HL51971, T32HL105324]; AHA [12POST11980021, 16SDG27770041, PRE24700010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	National Institutes of Health Grant (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Grant (AHA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant (NIH) HL074927 and the American Heart Grant (AHA) GRNT19900004 to B. T. Alexander. Additional funding was provided by NIH P20GM104357 and HL51971. Intapad and J. Dasinger were supported by funding from the AHA, 12POST11980021 and 16SDG27770041. J. Dasinger also received support from a NIH T32HL105324 and from the AHA PRE24700010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afiadata A, 2014, Hosp Pract (1995), V42, P69, DOI 10.3810/hp.2014.12.1160; Al Salmi I, 2008, DIABETES CARE, V31, P159, DOI 10.2337/dc07-1170; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Basaria S, 2013, J GERONTOL A-BIOL, V68, P153, DOI 10.1093/gerona/gls138; Bhattacharya RK, 2011, BMC ENDOCR DISORD, V11, DOI 10.1186/1472-6823-11-18; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Boyanov M A, 2003, Aging Male, V6, P1; Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043; Chamson-Reig A, 2009, EXP BIOL MED, V234, P1425, DOI 10.3181/0902-RM-69; Christe N, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14216; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dasinger JH, 2016, AM J PHYSIOL-RENAL, V311, pF312, DOI 10.1152/ajprenal.00123.2016; De Pergola G, 2000, INT J OBESITY, V24, pS59, DOI 10.1038/sj.ijo.0801280; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Eriksson M, 2004, J INTERN MED, V255, P236, DOI 10.1046/j.1365-2796.2003.01289.x; Fernandez-Twinn DS, 2005, AM J PHYSIOL-REG I, V288, pR368, DOI 10.1152/ajpregu.00206.2004; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Gatford KL, 2008, ENDOCRINOLOGY, V149, P5118, DOI 10.1210/en.2008-0233; Grossmann M, 2015, CLIN ENDOCRINOL, V83, P344, DOI 10.1111/cen.12664; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hou WW, 2015, DIABETIC MED, V32, P505, DOI 10.1111/dme.12602; Intapad S, 2016, PEDIATR RES, V79, P962, DOI 10.1038/pr.2016.14; Intapad S, 2013, HYPERTENSION, V61, P828, DOI 10.1161/HYPERTENSIONAHA.111.00645; Jahan-Mihan A, 2015, NUTRIENTS, V7, P9185, DOI 10.3390/nu7115460; Jansson T, 1999, J HYPERTENS, V17, P1239, DOI 10.1097/00004872-199917090-00002; Jones TH, 2011, DIABETES CARE, V34, P828, DOI 10.2337/dc10-1233; Jornayvaz FR, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0389-2; Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166; Li J, 2017, J DIABETES COMPLICAT, V31, P318, DOI 10.1016/j.jdiacomp.2016.10.022; Magnussen LV, 2016, DIABETES OBES METAB, V18, P980, DOI 10.1111/dom.12701; MARIN P, 1992, INT J OBESITY, V16, P991; Mogren I, 2003, SCAND J PUBLIC HEALT, V31, P382, DOI 10.1080/14034940210165136; Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55; Ojeda NB, 2007, AM J PHYSIOL-REG I, V292, pR758, DOI 10.1152/ajpregu.00311.2006; Onasanya O, 2016, LANCET DIABETES ENDO, V4, P943, DOI 10.1016/S2213-8587(16)30215-7; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Petry C J, 2001, Int J Exp Diabetes Res, V2, P139; Saad F, 2009, ARQ BRAS ENDOCRINOL, V53, P901, DOI 10.1590/S0004-27302009000800002; Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579; Siebel AL, 2008, ENDOCRINOLOGY, V149, P3067, DOI 10.1210/en.2008-0128; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; Williamson JR, 1996, P NATL ACAD SCI USA, V56, P247; Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37032; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313; Zambrano E, 2005, J PHYSIOL-LONDON, V566, P225, DOI 10.1113/jphysiol.2005.086462; Zerradi M, 2014, CURR OBES REP, V3, P396, DOI 10.1007/s13679-014-0119-6; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Zimmermann E, 2015, DIABETES, V64, P4220, DOI 10.2337/db15-0494	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187843	10.1371/journal.pone.0187843	http://dx.doi.org/10.1371/journal.pone.0187843			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145418	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800034
J	Kang, MY; Kwon, HJ; Choi, KH; Kang, CW; Kim, H				Kang, Mo-Yeol; Kwon, Ho-Jang; Choi, Kyung-Hwa; Kang, Chung-Won; Kim, Hyunjoo			The relationship between shift work and mental health among electronics workers in South Korea: A cross-sectional study	PLOS ONE			English	Article							NIGHT WORK; DEPRESSION; ASSOCIATION; DISORDERS; SYMPTOMS; DISTRESS; INSOMNIA; ANXIETY; NURSES; IMPACT	Objective To determine the relationship between shift work and mental health, particularly insomnia, depression, and suicidal ideation, among electronics production workers. Methods A survey was conducted with 14,226 workers from an electronics manufacturer in South Korea. After excluding 112 individuals with incomplete responses, 14,114 respondents were analyzed. As part of a larger project, we collected data on respondents' general characteristics, work-related characteristics, and health status; however, in this study, we focused on the data related to shift work and mental health. Insomnia, depression, and suicidal ideation were set as dependent variables and working schedule as set as the independent variable. We performed multiple logistic regression analysis with daytime workers as the reference group. The model was adjusted for age, gender, body mass index, workplace, educational level, and marital status with or without children under 6 years of age. Results Relative to daytime workers, shift workers had 2.35, 1.23, and 1.17 greater odds of insomnia, depression, and suicidal ideation, respectively. Within the shift worker group, we found that the odds of depression and suicidal ideation increased dramatically when respondents had insomnia. The ORs for depression and suicidal ideation were 4.899 and 7.934, respectively. Conclusions Our findings suggest that shift work is related to an increased risk of mental health problems in production workers, and the sleep disturbance related with shift work is a central mechanism for this relationship. Since these results suggest that proactive management of sleep problems might attenuate their detrimental effects on shift worker's mental health.	[Kang, Mo-Yeol] Seoul St Marys Hosp, Dept Occupat & Environm Med, Seoul, South Korea; [Kwon, Ho-Jang] Dankook Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea; [Choi, Kyung-Hwa] Taean Environm Hlth Ctr, Taean, South Korea; [Kang, Chung-Won; Kim, Hyunjoo] Ewha Womans Univ, Mokdong Hosp, Dept Occupat & Environm Med, Seoul, South Korea	Seoul St. Mary's Hospital; Dankook University; Ewha Womans University	Kim, H (corresponding author), Ewha Womans Univ, Mokdong Hosp, Dept Occupat & Environm Med, Seoul, South Korea.	hyunjoo@ewha.ac.kr	Choi, Kyung-Hwa/G-4957-2015; Choi, Kyung-Hwa/ABC-4605-2021	Choi, Kyung-Hwa/0000-0001-8206-4574; Kim, Hyunjoo/0000-0003-0375-9939; Kang, Chungwon/0000-0001-5322-1438; Kim, Hyunjoo/0000-0002-9806-981X	SK Hynix Corporation	SK Hynix Corporation	This research was funded by the SK Hynix Corporation. The ideas and opinions expressed herein are those of the authors, and endorsement by contractors is not intended nor should be inferred. The funder had no role in study design, data analysis, decision to publish, and preparation of the manuscript except for data collection. The company and trade union had cooperated in arranging the time and place for the data collection of this study.	Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; Ardekani Z Zamanian, 2008, Pak J Biol Sci, V11, P1605, DOI 10.3923/pjbs.2008.1605.1609; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berthelsen M, 2015, J OCCUP ENVIRON MED, V57, P1127, DOI 10.1097/JOM.0000000000000532; CHEUNG T, 2016, INT J ENV RES PUB HE, V13; Diniz TB, 2012, WORK, V41, P2887, DOI 10.3233/WOR-2012-0539-2887; Driesen K, 2011, SCAND J WORK ENV HEA, V37, P402, DOI 10.5271/sjweh.3158; Eldevik MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070882; Eurofound, 2012, FIFTH EUROPEAN WORKI; Folkard S, 2005, IND HEALTH, V43, P20, DOI 10.2486/indhealth.43.20; Jansen NWH, 2004, SCAND J WORK ENV HEA, V30, P139, DOI 10.5271/sjweh.771; Jaradat YM, 2017, OCCUP MED-OXFORD, V67, P71, DOI 10.1093/occmed/kqw128; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Knutsson A., 1988, SCAND J SOC MED SUPP, V44, P1; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Kolstad HA, 2008, SCAND J WORK ENV HEA, V34, P5, DOI 10.5271/sjweh.1194; Labor MoEa, 2011, SURVEY ON WORKING HO; Li LQ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1075-3; Ljosa CH, 2011, SCAND J WORK ENV HEA, V37, P551, DOI 10.5271/sjweh.3191; Loudoun, 1997, Int J Occup Environ Health, V3, pS71; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Moon HJ, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0081-0; Norder G, 2015, SCAND J WORK ENV HEA, V41, P413, DOI 10.5271/sjweh.3501; Oyane NMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070228; Puttonen S, 2010, ANN RHEUM DIS, V69, P779, DOI 10.1136/ard.2008.099184; Rahman SA, 2010, EUR ARCH PSY CLIN N, V260, P327, DOI 10.1007/s00406-009-0080-7; Scott, 1997, Int J Occup Environ Health, V3, pS2; Selvi Y, 2010, DUNSEN ADAM, V23, P238, DOI 10.5350/DAJPN2010230403; Tepas DI, 2004, REV SAUDE PUBL, V38, P26, DOI 10.1590/S0034-89102004000700005; Thun E, 2014, WORK STRESS, V28, P376, DOI 10.1080/02678373.2014.969362; Vogel M, 2012, J NEURAL TRANSM, V119, P1121, DOI 10.1007/s00702-012-0800-4; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800	32	29	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188019	10.1371/journal.pone.0188019	http://dx.doi.org/10.1371/journal.pone.0188019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145440	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800052
J	Perez, EC; Xander, P; Laurindo, MFL; Brito, RRNE; Vivanco, BC; Mortara, RA; Mariano, M; Lopes, JD; Keller, AC				Perez, Elizabeth Cristina; Xander, Patricia; Lucatelli Laurindo, Maria Fernanda; Novaes e Brito, Ronni Romulo; Vivanco, Bruno Camolese; Mortara, Renato Arruda; Mariano, Mario; Lopes, Jose Daniel; Keller, Alexandre Castro			The axis IL-10/claudin-10 is implicated in the modulation of aggressiveness of melanoma cells by B-1 lymphocytes	PLOS ONE			English	Article							CANCER; NORMALIZATION; METASTASIS; CROSSTALK; PRECURSOR; MICE	B-1 lymphocytes are known to increase the metastatic potential of B16F10 melanoma cells via the extracellular signal-regulated kinase (ERK) pathway. Since IL-10 is associated with B-1 cells performance, we hypothesized that IL-10 could be implicated in the progression of melanoma. In the present work, we found that the C57BL/6 mice, inoculated with B16F10 cells that were co-cultivated with B-1 lymphocytes from IL-10 knockout mice, developed fewer metastatic nodules than the ones which were injected with the melanoma cells that were cultivated in the presence of wild-type B-1 cells. The impairment of metastatic potential of the B16F10 cells was correlated with low activation of the ERK signaling pathway, supporting the idea that the production of IL-10 by B-1 cells influences the behavior of the tumor. A microarray analysis of the B-1 lymphocytes revealed that IL-10 deficiency is associated with down-regulation of the genes that code for claudin-10, a protein that is involved in cell-to-cell contact and that has been linked to lung adenocarcinoma. In order to determine the impact of claudin-10 in the cross-talk between B-1 lymphocytes and the B16F10 tumor cells, we took advantage of small interfering RNA. The silencing of claudin-10 gene in B-1 lymphocytes inhibited activation of the ERK pathway and abrogated the B-1-induced aggressive behavior of the B16F10 cells. Thus, our findings suggest that the axis IL-10/claudin-10 is a promising target for the development of therapeutic agents against aggressive melanoma.	[Perez, Elizabeth Cristina; Mariano, Mario] Univ Paulista, Environm & Expt Pathol Program, Sao Paulo, SP, Brazil; [Perez, Elizabeth Cristina; Lucatelli Laurindo, Maria Fernanda; Vivanco, Bruno Camolese; Mortara, Renato Arruda; Mariano, Mario; Lopes, Jose Daniel; Keller, Alexandre Castro] Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil; [Xander, Patricia] Univ Fed Sao Paulo, Dept Pharmaceut Sci, Campus Diadema, Diadema, SP, Brazil; [Novaes e Brito, Ronni Romulo] Ctr Univ Sao Camilo, Sao Paulo, SP, Brazil; [Keller, Alexandre Castro] Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Nephrol Div, Dept Med, Sao Paulo, SP, Brazil	Universidade Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Centro Universitario Sao Camilo; Universidade Federal de Sao Paulo (UNIFESP)	Keller, AC (corresponding author), Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil.; Keller, AC (corresponding author), Univ Fed Sao Paulo Escola Paulista Med UNIFESP EPM, Nephrol Div, Dept Med, Sao Paulo, SP, Brazil.	elicristin@hotmail.com; ackeller.unifesp@gmail.com	Keller, Alexandre C/E-4621-2012; Pérez, Elizabeth C/E-8057-2012; Xander, Patricia/E-4682-2012; Mortara, Renato A./C-1864-2012	Keller, Alexandre C/0000-0002-7827-0292; Pérez, Elizabeth C/0000-0003-3038-9902; Xander, Patricia/0000-0002-6329-6449; Mortara, Renato A./0000-0002-2311-8349	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [11/50256-6, 08/50632-5, 2016/02189-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [472035/2011-8, 308374/2016-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; www.fapesp.br), grant numbers 11/50256-6; 08/50632-5 and 2016/02189-1; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; www.cnpq.br), grant numbers 472035/2011-8 and 308374/2016-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz M, 2015, IMMUNOL RES, V63, P153, DOI 10.1007/s12026-015-8708-3; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Choi EO, 2017, BIOMOL THER, V25, P213, DOI 10.4062/biomolther.2016.094; Eljaszewicz A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/831387; Fujimura T, 2016, J DERMATOL SCI, V83, P167, DOI 10.1016/j.jdermsci.2016.05.015; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lopes JD, 2009, AN ACAD BRAS CIENC, V81, P489, DOI 10.1590/S0001-37652009000300013; Neesse A, 2012, ARCH BIOCHEM BIOPHYS, V524, P64, DOI 10.1016/j.abb.2012.01.009; Neesse A, 2013, GUT, V62, P1034, DOI 10.1136/gutjnl-2012-302577; Popi AF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00138; Popi AF, 2008, MICROBES INFECT, V10, P817, DOI 10.1016/j.micinf.2008.04.012; Sindhava VJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00372; Singh AB, 2017, PFLUG ARCH EUR J PHY, V469, P69, DOI 10.1007/s00424-016-1919-1; Soini Y, 2012, INT J CLIN EXP PATHO, V5, P126; Staquicini FI, 2008, CANCER RES, V68, P8419, DOI 10.1158/0008-5472.CAN-08-1242; Vigna AF, 2006, MICROBES INFECT, V8, P589, DOI 10.1016/j.micinf.2005.06.033; Xander P, 2017, J PARASITOL; Xander P, 2013, IMMUNOBIOLOGY, V218, P1293, DOI 10.1016/j.imbio.2013.04.017; Zhang ZF, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-95	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187333	10.1371/journal.pone.0187333	http://dx.doi.org/10.1371/journal.pone.0187333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145406	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800015
J	Velez, R; Clune, J				Velez, Roby; Clune, Jeff			Diffusion-based neuromodulation can eliminate catastrophic forgetting in simple neural networks	PLOS ONE			English	Article							NITRIC-OXIDE; SYNAPTIC-TRANSMISSION; GLUTAMATE SPILLOVER; DOPAMINE; CONSTRAINTS; HIPPOCAMPUS; PLASTICITY; MODULARITY; RECEPTORS; EVOLUTION	A long-term goal of AI is to produce agents that can learn a diversity of skills throughout their lifetimes and continuously improve those skills via experience. A longstanding obstacle towards that goal is catastrophic forgetting, which is when learning new information erases previously learned information. Catastrophic forgetting occurs in artificial neural networks (ANNs), which have fueled most recent advances in AI. A recent paper proposed that catastrophic forgetting in ANNs can be reduced by promoting modularity, which can limit forgetting by isolating task information to specific clusters of nodes and connections (functional modules). While the prior work did show that modular ANNs suffered less from catastrophic forgetting, it was not able to produce ANNs that possessed task-specific functional modules, thereby leaving the main theory regarding modularity and forgetting untested. We introduce diffusion-based neuromodulation, which simulates the release of diffusing, neuromodulatory chemicals within an ANN that can modulate (i.e. up or down regulate) learning in a spatial region. On the simple diagnostic problem from the prior work, diffusion-based neuromodulation 1) induces task-specific learning in groups of nodes and connections (task-specific localized learning), which 2) produces functional modules for each subtask, and 3) yields higher performance by eliminating catastrophic forgetting. Overall, our results suggest that diffusion-based neuromodulation promotes task-specific localized learning and functional modularity, which can help solve the challenging, but important problem of catastrophic forgetting.	[Velez, Roby; Clune, Jeff] Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA; [Clune, Jeff] UberAI Labs, San Francisco, CA 94107 USA	University of Wyoming	Clune, J (corresponding author), Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA.; Clune, J (corresponding author), UberAI Labs, San Francisco, CA 94107 USA.	jeffclune@uwyo.edu			NSF CAREER award [CAREER: 1453549]; Wyoming NASA Space Grant Consortium Grant [NNX15AI08H]; Wyoming Space Consortium Grant [NNX10A095H]	NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wyoming NASA Space Grant Consortium Grant; Wyoming Space Consortium Grant	Jeff Clune and Roby Velez were supported by an NSF CAREER award (CAREER: 1453549). Jeff Clune was also supported by a Wyoming NASA Space Grant Consortium Grant (#NNX15AI08H) and Roby Velez was supported by a Wyoming Space Consortium Grant (#NNX10A095H). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Jeff Clune and Roby Velez were supported by an NSF CAREER award (CAREER: 1453549). Jeff Clune was also supported by a Wyoming NASA Space Grant Consortium Grant (#NNX15AI08H) and Roby Velez was supported by a Wyoming Space Consortium Grant (#NNX10A095H). All experiments were conducted on the Mount Moran computing cluster at the University of Wyoming Advanced Research Computing Center (ARCC). The authors thank the ARCC staff for their support, and the members of the Evolving AI Lab at the University of Wyoming for valuable feedback on this draft, especially Joost Huizinga, Kai Ellefsen, and Nicholas Cheney. We also thank James Kirkpatrick and one anonymous reviewer for their valuable insights, which improved the manuscript.	Agnati LF, 2006, ACTA PHYSIOL, V187, P329, DOI 10.1111/j.1748-1716.2006.01579.x; Agnati LF, 2010, BRAIN RES REV, V64, P137, DOI 10.1016/j.brainresrev.2010.03.003; Alon U., 2006, INTRO SYSTEMS BIOL D; [Anonymous], 2017, P NATL ACAD SCI; [Anonymous], 1998, NEURAL NETWORKS COMP; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Baldwin CY, 2000, DESIGN RULES POWER M, V1; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Christian SF, 1990, ADV NEURAL INFORM PR, V2; Clune J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2863; DAWSON TM, 1994, J NEUROSCI, V14, P5147; De-Miguel FF, 2005, CELL MOL NEUROBIOL, V25, P297, DOI 10.1007/s10571-005-3061-z; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM, DOI DOI 10.1007/S10589-007-9053-9; Descarries L, 1996, J COMP NEUROL, V375, P167; DESCARRIES L, 1975, BRAIN RES, V100, P563, DOI 10.1016/0006-8993(75)90158-4; Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; Ellefsen KO, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004128; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Esplugues JV, 2002, BRIT J PHARMACOL, V135, P1079, DOI 10.1038/sj.bjp.0704569; Fine P, 2006, LECT NOTES COMPUT SC, V4095, P546; Floreano D., 2008, BIOINSPIRED ARTIFICI; French R. M., 1992, Connection Science, V4, P365, DOI 10.1080/09540099208946624; French RM, 1999, TRENDS COGN SCI, V3, P128, DOI 10.1016/S1364-6613(99)01294-2; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Fuxe K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00136; GALLY JA, 1990, P NATL ACAD SCI USA, V87, P3547, DOI 10.1073/pnas.87.9.3547; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Goodfellow IJ, 2013, ARXIV131262112013; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Gutstein S, 2015, 2015 INT JOINT C NEU, P1, DOI [10.1109/IJCNN.2015.7280416, DOI 10.1109/IJCNN.2015.7280416]; Haykin S., 2009, NEURAL NETWORKS LEAR; Hebb D. O., 2005, ORG BEHAV NEUROPSYCH; Hinton G.E., 1987, P 9 ANN C COGNITIVE, P177; Hintze A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040023; Huang EP, 1998, CURR BIOL, V8, pR613, DOI 10.1016/S0960-9822(98)70389-6; Huizinga J, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P697, DOI 10.1145/2576768.2598232; Husbands P, 1998, CONNECT SCI, V10, P185, DOI 10.1080/095400998116404; Isaacson JS, 2000, CURR BIOL, V10, pR475, DOI 10.1016/S0960-9822(00)00551-0; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Klingenberg C.P., 2005, VARIATION CENTRAL CO, P1; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Levine S, 2016, J MACH LEARN RES, V17; Levitan IB, 2015, NEURON CELL MOL BIOL; Lipson Hod, 2007, Journal of Biological Physics and Chemistry, V7, P125, DOI 10.4024/40701.jbpc.07.04; Luders B, 2017, LECT NOTES COMPUT SC, V10199, P886, DOI 10.1007/978-3-319-55849-3_57; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; McHale G, 2004, FROM ANIMALS TO ANIMATS 8, P163; Mengistu H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004829; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mouret J. -B., 2010, EV COMP CEC 2010 IEE, P1; Mouret JB, 2012, EVOLUTIONARY COMPUTA, V1; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; Rice ME, 2011, NEUROSCIENCE, V198, P112, DOI 10.1016/j.neuroscience.2011.08.066; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Risi S, 2010, LECT NOTES ARTIF INT, V6226, P533, DOI 10.1007/978-3-642-15193-4_50; Robins A., 1995, Connection Science, V7, P123, DOI 10.1080/09540099550039318; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Rusu A. A., 2016, PROGR NEURAL NETWORK; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Sem'yanov A V, 2005, Neurosci Behav Physiol, V35, P253, DOI 10.1007/s11055-005-0051-z; Soltoggio Andrea, 2008, 2008 8th International Conference on Hybrid Intelligent Systems (HIS), P637, DOI 10.1109/HIS.2008.155; Soltoggio A., 2008, ARTIFICIAL LIFE, VXI, P569; Soltoggio A, 2007, IEEE C EVOL COMPUTAT, P2471, DOI 10.1109/CEC.2007.4424781; Stanley KO, 2007, GENET PROGRAM EVOL M, V8, P131, DOI 10.1007/s10710-007-9028-8; Susswein AJ, 2004, NEUROSCIENTIST, V10, P153, DOI 10.1177/1073858403261226; Taber KH, 2014, J NEUROPSYCHIATRY CL, V26, P4, DOI [10.1176/appi.neuropsych.13110351, DOI 10.1176/APPI.NEUR0PSYCH]; Tonelli P, 2011, GECCO-2011: PROCEEDINGS OF THE 13TH ANNUAL GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P1531; TRUETA C, 2012, FRONT PHYSIOL, V3; Velez R, 2016, GECCO'16: PROCEEDINGS OF THE 2016 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P181, DOI 10.1145/2908812.2908839; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; WIDROW B, 1990, P IEEE, V78, P1415, DOI 10.1109/5.58323; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; WOOD J, 1994, NEUROPHARMACOLOGY, V33, P1235, DOI 10.1016/0028-3908(94)90022-1; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219	85	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187736	10.1371/journal.pone.0187736	http://dx.doi.org/10.1371/journal.pone.0187736			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145413	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800028
J	Xia, D; Zhou, H; Qiu, L; Jiang, HC; Zhang, QL; Gao, GJ; He, YQ				Xia, Duo; Zhou, Hao; Qiu, Lei; Jiang, Haichao; Zhang, Qinglu; Gao, Guanjun; He, Yuqing			Mapping and verification of grain shape QTLs based on an advanced backcross population in rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NATURAL VARIATION; YIELD COMPONENTS; SIZE DIVERSITY; RARE ALLELE; MAJOR QTL; LENGTH; PROTEIN; WEIGHT; WIDTH	Grain shape is a key factor that influences both the appearance quality and grain yield of rice. To clarify the genetic basis of grain shape, an advanced backcross population was developed from the cross of a slender indica variety Jin23B and a round japonica variety QingGuAi, and a total of 10 quantitative trait loci (QTLs) for grain shape were detected over 2 years. Three QTLs, qGW1, qGS3 and qGS7 have large effects on grain shape and were detected in both years. To further validate their effects, the BC4F2 populations of the three QTLs were constructed. The alleles from QingGuAi of qGW1 and qGS7 both greatly increase grain width and the alleles from Jin23B of qGS3 greatly increase grain length. The allele variations of the three QTLs lead to the totally different grain shape of the two rice varieties. Our study provides insights into the genetic bases of grain shape and will promote the improvements of grain quality and yield in rice.	[He, Yuqing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China; Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	He, YQ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Hubei, Peoples R China.	yqhe@mail.hzau.edu.cn			National Natural Science Foundation [91435202]; National Program on R&D of Transgenic Plants [2016ZX08009003-004]; National 863 Project [2012AA10A303]; China Agriculture Research System of China [CARS-01-03]; Bill & Melinda Gates Foundation	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Program on R&D of Transgenic Plants; National 863 Project(National High Technology Research and Development Program of China); China Agriculture Research System of China; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by grants from the National Natural Science Foundation (91435202) to Yuqing He, the National Program on R&D of Transgenic Plants (2016ZX08009003-004) to Yuqing He, the National 863 Project (2012AA10A303) to Yuqing He and the earmarked fund for the China Agriculture Research System (CARS-01-03) of China to Yuqing He and and the Bill & Melinda Gates Foundation to Yuqing He. The funders did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernacchi D, 1998, THEOR APPL GENET, V97, P381, DOI 10.1007/s001220050908; Du A, 2017, MOL PLANT; Duan PG, 2017, MOL PLANT, V10, P685, DOI 10.1016/j.molp.2017.03.009; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fulton MR, 1997, OIKOS, V78, P291, DOI 10.2307/3546296; Fulton TM, 2002, EUPHYTICA, V127, P163, DOI 10.1023/A:1020209930031; Hu J, 2015, MOL PLANT, V8, P1455, DOI 10.1016/j.molp.2015.07.002; Jiang JF, 2015, RICE, V8, DOI 10.1186/s12284-015-0048-3; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lincoln S, 1992, CONSTRUCING GENETIC, V3rd; Liu JF, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.43; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Nemoto Y, 2016, PLANT J, V86, P221, DOI 10.1111/tpj.13168; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; Qiu Lei, 2014, Genomics and Applied Biology, V33, P828; Septiningsih EM, 2003, THEOR APPL GENET, V107, P1419, DOI 10.1007/s00122-003-1373-2; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Teng B, 2012, MOL BREEDING, V30, P583, DOI 10.1007/s11032-011-9647-x; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xu Q, 2014, MOL BREEDING, V33, P813, DOI 10.1007/s11032-013-9994-x; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang DP, 2015, J EXP BOT, V66, P6371, DOI 10.1093/jxb/erv350; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110	31	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187553	10.1371/journal.pone.0187553	http://dx.doi.org/10.1371/journal.pone.0187553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145412	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800018
J	Ajayi, IO; Ughasoro, MD; Ogunwale, A; Odeyinka, O; Babalola, O; Sharafadeen, S; Adamu, AY; Ajumobi, O; Orimogunje, T; Nguku, P				Ajayi, IkeOluwapo O.; Ughasoro, Maduka D.; Ogunwale, Akintayo; Odeyinka, Oluwaseun; Babalola, Obafemi; Sharafadeen, Salami; Adamu, Al-Mukhtar Y.; Ajumobi, Olufemi; Orimogunje, Taiwo; Nguku, Patrick			A qualitative exploration of malaria operational research situation in Nigeria	PLOS ONE			English	Article							ELIMINATION	Background Malaria, remains one of the leading causes of high morbidity and mortality in Nigeria despite implementation of several public health interventions for its control. Operational limitations and methodological gaps have been associated with malaria control interventions and research, and these have necessitated the need for a well-tailored Malaria Operational Research (MOR) agenda. However, there is paucity of evidence-based information on relevant stakeholders' experience, awareness, perceptions and use of MOR and suggestions on setting MOR agenda. As part of a larger study to provide data for national MOR agenda setting, we assessed the MOR research situation from the perspectives of key stakeholders in Nigeria and contribution of MOR to the malaria elimination agenda Methods We conducted key informant interviews among 40 purposively selected stakeholders from the six geo-political zones in Nigeria. Data was collected using a pre-tested key informant interview guide which comprised issues related to experience, awareness, use of MOR and MOR needs, and suggestions for MOR. We conducted a detailed content analysis. Results Half of the participants had participated in MOR. Participants perceived MOR as important. Only few were aware of existing framework for MOR in Nigeria while above half expressed that MOR is yet to be used to inform policy in Nigeria. Participants identified several MOR needs such as development of improved diagnostic techniques, and interventions for promoting early diagnosis, prompt treatment and quality programmatic data. Participants opined the need for country-specific prioritised MOR agenda that cut across malaria thematic areas including malaria prevention and case management. Participants suggested the involvement of various stakeholders and multi-disciplinary approach in setting MOR. Conclusion Although some stakeholders have been involved in MOR, it is still rarely used to inform policy and several needs exist across thematic areas. A broad-based stakeholder involvement, multi-disciplinary approach to agenda setting and its wide dissemination have been suggested.	[Ajayi, IkeOluwapo O.; Babalola, Obafemi; Sharafadeen, Salami; Ajumobi, Olufemi; Nguku, Patrick] Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria; [Ajayi, IkeOluwapo O.; Odeyinka, Oluwaseun] Univ Ibadan, Fac Publ Hlth, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria; [Ughasoro, Maduka D.] Univ Nigeria, Dept Paediat, Enugu Campus, Enugu, Nigeria; [Ogunwale, Akintayo] Univ Ibadan, Fac Publ Hlth, Dept Hlth Promot & Educ, Coll Med, Ibadan, Nigeria; [Ogunwale, Akintayo] Oyo State Coll Agr & Technol Igboora, Dept Gen Studies, Igboora, Oyo State, Nigeria; [Adamu, Al-Mukhtar Y.] Bayero Univ, Fac Clin Sci, Dept Med Microbiol & Parasitol, Kano, Nigeria; [Ajumobi, Olufemi; Nguku, Patrick] African Field Epidemiol Network, Abuja, Nigeria; [Orimogunje, Taiwo] Natl Malaria Eliminat Programme, Abuja, Nigeria	University of Ibadan; University of Nigeria; University of Ibadan; Bayero University	Ajayi, IO (corresponding author), Nigeria Field Epidemiol & Lab Training Programme, Abuja, Nigeria.; Ajayi, IO (corresponding author), Univ Ibadan, Fac Publ Hlth, Dept Epidemiol & Med Stat, Coll Med, Ibadan, Nigeria.	ikeajayi2003@yahoo.com	Babalola, Obafemi/V-6000-2018; Ajumobi, Olufemi/J-7389-2018; Orimogunje, Taiwo/HHC-8522-2022	Babalola, Obafemi/0000-0003-3468-3527; Ajumobi, Olufemi/0000-0002-2652-1205; ajayi, Ikeoluwapo/0000-0001-7719-8746	Centers for Disease Control and Prevention [(GH15-1619) U2GGH001876]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by cooperative agreement number (GH15-1619) U2GGH001876, from the Centers for Disease Control and Prevention, https://afenetnigeria.net, to PN. The funder has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Federal Ministry of Health National Malaria Elimination Programme, REP COUNTR DIAL MAL; Federal Ministry of Health National Malaria Elimination Programme, 2014, NAT MAL STRAT PLAN 2; National Population Commission (NPC) [Nigeria] and ICF International, 2014, NIG DEM HLTH SURV 20; President's Malaria Initiative, 2014, STRAT GUID OP RES; Ramsay A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1302-x; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Tanner M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0384-6; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.3305/NH.2010.25.2.4545; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2007, GLOB FUND 22 BOARD M; WHO, 2015, GLOB ACT FRAM RES SU; WHO, 2015, GLOB TECHN STRAT MAL; WHO, OP RES MAL CONTR; WHO, 2015, TDR POSTGR TRAIN SCH; WHO/HTM/RBM, 2003, OP RES MAL CONTR; WHO - World Health Organization, 2014, PLANN M OP RES MAL E; Zhou SS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-473	17	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188128	10.1371/journal.pone.0188128	http://dx.doi.org/10.1371/journal.pone.0188128			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141032	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400061
J	Yu, Z; Chen, Z; Wu, J; Li, Z; Wu, YG				Yu, Zhan; Chen, Zhen; Wu, Jian; Li, Zhong; Wu, Yugang			Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN; CLINICAL-SIGNIFICANCE; COLON-CANCER; FOLLOW-UP; CA-19-9; CEA; SURVIVAL; CA19-9; ASSOCIATION; STATISTICS	Background Carbohydrate antigen 19-9 (CA 19-9) is one of the most frequently used tumor markers for gastrointestinal cancer, particularly for diagnostic purposes. However, its value in predicting prognosis remains controversial. In this study, we sought to clarify this by conducting a meta-analysis of relevant studies. Methods We systematically searched several databases, including PubMed, EMBASE and Web of Science for articles pertaining to the relationship between pretreatment serum CA 19-9 levels and prognosis in patients with colorectal cancer (CRC). The reported hazard ratios (HR) of overall survival (OS), disease-free survival (DFS), pooled progression-free survival (PFS) and recurrence-free survival (RFS) in the analyzed studies were compared by fixed effects/random effects models. Results Seventeen studies involving 6434 patients with CRC were included in our meta-analysis. A comprehensive analysis of the collected data revealed that high serum CA 19-9 levels before treatment were significantly associated with poor OS (HR: 1.58, 95% CI: 1.36-1.83, P<0.001), DFS (HR: 1.71, 95% CI: 1.38-2.13, P<0.001), PFS (HR: 1.30,95% CI: 0.93-1.82, P = 0.121) and RFS (HR: 1.43, 95% CI: 1.11-1.83, P = 0.006). This association between high pretreatment serum CA 19-9 levels and poor survival held true across different geographical regions, analysis types, methods used for HR determination, sample size, and treatment methods. Conclusions The results of this study indicate that pretreatment serum CA 19-9 level can be used as a prognostic indicator for patients with CRC.	[Yu, Zhan; Wu, Jian; Li, Zhong; Wu, Yugang] Soochow Univ, Dept Gen Surg, Affiliated Hosp 3, Changzhou, Peoples R China; [Chen, Zhen] Soochow Univ, Dept Urol, Affiliated Hosp 3, Changzhou, Peoples R China; [Wu, Jian] Second Peoples Hosp Jiangyin, Dept Gen Surg, Jiangyin, Peoples R China	Soochow University - China; Soochow University - China	Wu, YG (corresponding author), Soochow Univ, Dept Gen Surg, Affiliated Hosp 3, Changzhou, Peoples R China.	wuyugang89@163.com			Changzhou Science and Technology Bureau [CE20125020]	Changzhou Science and Technology Bureau	This work was supported by Changzhou Science and Technology Bureau, CE20125020, YGW	Abe S, 2016, J SURG RES, V205, P384, DOI 10.1016/j.jss.2016.06.078; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Behbehani AI, 2000, INT J BIOL MARKER, V15, P51, DOI 10.1177/172460080001500109; Chen Y, 2015, CELL BIOCHEM BIOPHYS, V71, P1287, DOI 10.1007/s12013-014-0345-2; Dabelsteen E, 1996, J PATHOL, V179, P358; Fiala O, 2015, TARGET ONCOL, V10, P549, DOI 10.1007/s11523-015-0365-x; Galli C, 2013, CLIN CHEM LAB MED, V51, P1369, DOI 10.1515/cclm-2012-0744; Gao XH, 2013, CANCER-AM CANCER SOC, V119, P2212, DOI 10.1002/cncr.28052; GOLDBERG EM, 1989, HYBRIDOMA, V8, P569, DOI 10.1089/hyb.1989.8.569; Hong I, 2015, ANN COLOPROCTOL, V31, P84, DOI 10.3393/ac.2015.31.3.84; Ishizuka M, 2016, ANN SURG ONCOL, V23, P900, DOI 10.1245/s10434-015-4948-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lee S, 2016, J CANCER, V7, P957, DOI 10.7150/jca.14797; Li ZM, 2016, COLORECTAL DIS, V18, P255, DOI 10.1111/codi.13123; Martini F, 2000, ANTICANCER RES, V20, P1609; MENNINI G, 1985, Italian Journal of Surgical Sciences, V15, P37; Narita Y, 2014, CANCER CHEMOTH PHARM, V73, P409, DOI 10.1007/s00280-013-2367-7; Oliphant R, 2013, ANN SURG ONCOL, V20, P2132, DOI 10.1245/s10434-013-2959-9; Ozawa T, 2016, CLIN COLORECTAL CANC, V15, pE157, DOI 10.1016/j.clcc.2016.04.012; Park IJ, 2009, ANTICANCER RES, V29, P4303; Park IJ, 2009, ANN SURG ONCOL, V16, P3087, DOI 10.1245/s10434-009-0625-z; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Polat E, 2014, CURR ONCOL, V21, pE1, DOI 10.3747/co.21.1711; Reiter W, 2000, ANTICANCER RES, V20, P5195; Sato H, 2011, J SURG ONCOL, V104, P45, DOI 10.1002/jso.21914; Selcukbiricik F, 2013, TUMOR BIOL, V34, P2233, DOI 10.1007/s13277-013-0763-6; Shibutani M, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0609-3; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Song A, 2015, WORLD J GASTROENTERO, V21, P12410, DOI 10.3748/wjg.v21.i43.12410; STAAB HJ, 1985, KLIN WOCHENSCHR, V63, P106, DOI 10.1007/BF01734248; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Wang JT, 2015, INT J CLIN EXP PATHO, V8, P14853; Wang Q, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0289-9; Wu YC, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-1044-9; Yakabe T, 2010, ANN SURG ONCOL, V17, P2349, DOI 10.1245/s10434-010-1004-5; Yuan RX, 2013, J SURG RES, V183, P163, DOI 10.1016/j.jss.2013.01.017; ZENG ZS, 1993, DIS COLON RECTUM, V36, P1063, DOI 10.1007/BF02047301; Zhong W, 2015, PATHOL ONCOL RES, V21, P83, DOI 10.1007/s12253-014-9791-9	38	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188139	10.1371/journal.pone.0188139	http://dx.doi.org/10.1371/journal.pone.0188139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141049	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400064
J	Baird, JR; Feng, ZP; Xiao, HD; Friedman, D; Cottam, B; Fox, BA; Kramer, G; Leidner, RS; Bell, RB; Young, KH; Crittenden, MR; Gough, MJ				Baird, Jason R.; Feng, Zipeng; Xiao, Hong D.; Friedman, David; Cottam, Ben; Fox, Bernard A.; Kramer, Gwen; Leidner, Rom S.; Bell, R. Bryan; Young, Kristina H.; Crittenden, Marka R.; Gough, Michael J.			STING expression and response to treatment with STING ligands in premalignant and malignant disease	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; INTERFERON-ALPHA; MICE; CARCINOGENESIS; REGRESSION; TUMORS; ACTIVATION; IMMUNITY; HEAD	Human papilloma virus positive (HPV+) tumors represent a large proportion of anal, vulvar, vaginal, cervical and head and neck squamous carcinomas (HNSCC) and late stage invasive disease is thought to originate from a premalignant state. Cyclic dinucleotides that activate STimulator of INterferon Genes (STING) have been shown to cause rapid regression of a range of advanced tumors. We aimed to investigate STING ligands as a novel treatment for papilloma. We tested therapies in a spontaneous mouse model of papilloma of the face and anogenital region that histologically resembles human HPV-associated papilloma. We demonstrate that STING ligands cause rapid regression of papilloma, associated with T cell infiltration, and are significantly more effective than Imiquimod, a current immunotherapy for papilloma. In humans, we show that STING is expressed in the basal layer of normal skin and lost during keratinocyte differentiation. We found STING was expressed in all HPV-associated cervical and anal dysplasia and was strongly expressed in the cancer cells of HPV+ HNSCC but not in HPV-unrelated HNSCC. We found no strong association between STING expression and progressive disease in non-HPV oral dysplasia and oral pre-malignancies that are not HPV-related. These data demonstrate that STING is expressed in basal cells of the skin and is retained in HPV+ pre-malignancies and advanced cancers, but not in HPV-unrelated HNSCC. However, using a murine HNSCC model that does not express STING, we demonstrate that STING ligands are an effective therapy regardless of expression of STING by the cancer cells.	[Baird, Jason R.; Friedman, David; Cottam, Ben; Fox, Bernard A.; Kramer, Gwen; Leidner, Rom S.; Bell, R. Bryan; Young, Kristina H.; Crittenden, Marka R.; Gough, Michael J.] Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA; [Feng, Zipeng] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Xiao, Hong D.] Providence Portland Med Ctr, Pathol, Portland, OR USA; [Bell, R. Bryan] Head & Neck Surg Inst, Portland, OR USA; [Young, Kristina H.; Crittenden, Marka R.] Oregon Clin, Portland, OR USA	Providence Portland Medical Center; Oregon Health & Science University; Providence Portland Medical Center	Gough, MJ (corresponding author), Providence Portland Med Ctr, Robert W Franz Canc Ctr, Earle A Chiles Res Inst, Portland, OR 97213 USA.	michael.gough@providence.org	Gough, Michael/AAY-3419-2020	Gough, Michael/0000-0002-5575-0074; Leidner, Rom/0000-0003-0788-7938; Friedman, David/0000-0002-1295-1562; Bell, R. Bryan/0000-0002-3775-109X	Heath Foundation; American Cancer Society; National Cancer Institute [R01CM82311, R01CA208644]; Cancer Research Animal Division; NATIONAL CANCER INSTITUTE [R01CA182311] Funding Source: NIH RePORTER	Heath Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Animal Division; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a research grant from the Heath Foundation (JRB, RBB, MJG); a postdoctoral fellowship from the American Cancer Society (JRB); and the National Cancer Institute (MJG, MRC R01CM82311, R01CA208644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of the Cancer Research Animal Division in the execution of these studies.	Baird JR, 2017, INT J RADIAT ONCOL, V99, P362, DOI 10.1016/j.ijrobp.2017.04.014; Baird JR, 2016, CANCER RES, V76, P50, DOI 10.1158/0008-5472.CAN-14-3619; Buechner SA, 1997, J CLIN INVEST, V100, P2691, DOI 10.1172/JCI119814; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crittenden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069527; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Elson DA, 2000, CANCER RES, V60, P1267; Gades NM, 2008, COMPARATIVE MED, V58, P271; Gostout BS, 2001, INT J GYNECOL OBSTET, V74, P207, DOI 10.1016/S0020-7292(00)00389-1; Herber R, 1996, J VIROL, V70, P1873, DOI 10.1128/JVI.70.3.1873-1881.1996; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Khurana D, 2001, HEAD NECK-J SCI SPEC, V23, P899, DOI 10.1002/hed.1130; Lapouge G, 2011, P NATL ACAD SCI USA, V108, P7431, DOI 10.1073/pnas.1012720108; Moore E, 2016, CANCER IMMUNOL RES, V4, P1061, DOI 10.1158/2326-6066.CIR-16-0104; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Pachman DR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.06.105; Riley RR, 2003, CANCER RES, V63, P4862; RODRIGUEZVILLANUEVA J, 1995, INT J CANCER, V61, P110, DOI 10.1002/ijc.2910610119; Seitz CS, 2000, J CLIN INVEST, V105, P253, DOI 10.1172/JCI7630; Strati K, 2006, P NATL ACAD SCI USA, V103, P14152, DOI 10.1073/pnas.0606698103; Tang XH, 2004, CLIN CANCER RES, V10, P301, DOI 10.1158/1078-0432.CCR-0999-3; Ulrich C, 2007, BRIT J DERMATOL, V157, P25, DOI 10.1111/j.1365-2133.2007.08269.x	22	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187532	10.1371/journal.pone.0187532	http://dx.doi.org/10.1371/journal.pone.0187532			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135982	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200022
J	Ishida, M; Yamazaki, H				Ishida, Masanobu; Yamazaki, Hideo			Radioactive contamination in the Tokyo metropolitan area in the early stage of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident and its fluctuation over five years	PLOS ONE			English	Article							CESIUM ADSORPTION; CLAY-MINERALS; SOURCE-TERM; MICROPARTICLES; RADIONUCLIDES; RADIOCESIUM; SEDIMENTS; SOIL; PREFECTURE; ATMOSPHERE	Radioactive contamination in the Tokyo metropolitan area in the immediate aftermath of the Fukushima Daiichi Nuclear Power Plant (FDNPP) accident was analyzed via surface soil sampled during a two-month period after the accident. I-131, Cs-134, and Cs-137 were detected in these soil samples. The activity and inventory of radioactive material in the eastern part of Tokyo tended to be high. The Cs-134/Cs-137 activity ratio in soil was 0.978 +/- 0.053. The I-131/Cs-137 ratio fluctuated widely, and was 19.7 +/- 9.0 (weighted average 18.71 +/- 0.13, n = 14) in the Tokyo metropolitan area. The radioactive plume with high 131 I activity spread into the Tokyo metropolitan area and was higher than the weighted average of 6.07 +/- 0.04 (n = 26) in other areas. The radiocesium activity and inventory surveyed in soil from a garden in Chiyoda Ward in the center of Tokyo, fell approximately 85% in the four months after the accident, and subsequently tended to rise slightly while fluctuating widely. It is possible that migration and redistribution of radiocesium occurred. The behavior of radiocesium in Tokyo was analyzed via monitoring of radiocesium in sludge incineration ash. The radiocesium activity in the incineration ash was high at wastewater treatment centers that had catchment areas in eastern Tokyo and low at those with catchment areas in western Tokyo. Similar to the case of the garden soil, even in incineration ash, the radiocesium activity dropped rapidly immediately after the accident. The radiocesium activity in the incineration ash fell steadily from the tenth month after the accident until December 2016, and its half-life was about 500 days. According to frequency analysis, in central Tokyo, the cycles of fluctuation of radiocesium activity in incineration ash and rainfall conformed, clearly showing that radiocesium deposited in urban areas was resuspended and transported by rainfall run-off.	[Ishida, Masanobu; Yamazaki, Hideo] Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan	Kindai University (Kinki University)	Ishida, M (corresponding author), Kindai Univ, Grad Sch Sci & Engn, Higashiosaka, Osaka, Japan.	masanobuijp1989@gmail.com			JSPS KAKENHI [24310014, 26289155, 26303004];  [15J10109]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by JSPS KAKENHI (B) Grant Numbers 24310014, 26289155, and 26303004 and Grants-in-aid for JSPS Fellow Grant Number 15J10109.; The radiocesium activity in sludge incineration ash at Tokyo's wastewater treatment centers were obtained by referring to data published on the website of the Bureau of Sewerage, Tokyo Metropolitan Government. To perform the frequency analysis of the data, we obtained advice from Associate Professor Y. Ogawa of Kindai University. Mses. W. Ishii, Y. Sakai, N. Sawada, and A. Kinsaka helped us analyze and measure the samples and process the data. This work was supported by JSPS KAKENHI (B) Grant Numbers 24310014, 26289155, and 26303004 and Grants-in-aid for JSPS Fellow Grant Number 15J10109.	Abe Y, 2014, ANAL CHEM, V86, P8521, DOI 10.1021/ac501998d; Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; [Anonymous], 2006, CHERN FOR GROUP ENV; [Anonymous], 2004, J ENVIRON RADIOACTIV, V77, P247; Aoi Y, 2014, J MINER PETROL SCI, V109, P23, DOI 10.2465/jmps.130620c; Bostick BC, 2002, ENVIRON SCI TECHNOL, V36, P2670, DOI 10.1021/es0156892; Bureau of Sewerage Tokyo Metropolitan Government, 2017, TOK METR GOV MEAS RE; Bureau of Sewerage Tokyo Metropolitan Government, 2017, LIST TOK WAT RECL CT; Chaisan K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02520; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Comans RNJ, 1998, WATER RES, V32, P2846, DOI 10.1016/S0043-1354(98)00038-4; du Bois PB, 2012, J ENVIRON RADIOACTIV, V114, P2, DOI 10.1016/j.jenvrad.2011.11.015; EVANS DW, 1983, GEOCHIM COSMOCHIM AC, V47, P1041, DOI 10.1016/0016-7037(83)90234-X; Evrard O, 2014, SCI REP-UK, V4, DOI 10.1038/srep04574; Furuki G, 2017, SCI REP-UK, V7, DOI 10.1038/srep42731; Furuta S., 2011, JAEA REV; Gallego E, 2006, J ENVIRON RADIOACTIV, V85, P247, DOI 10.1016/j.jenvrad.2004.10.017; Garcia-Sanchez L, 2009, J ENVIRON RADIOACTIV, V100, P774, DOI 10.1016/j.jenvrad.2008.08.005; Gossuin Y, 2002, J MAGN RESON, V157, P132, DOI 10.1006/jmre.2002.2581; GSI (Geospatial Information Authority of Japan), 2014, EXT SIT DISTR MAP RA; IAEA, 2004, SOIL SAMPL ENV CONT; IAEA, 2006, CHERN LEG HLTH ENV S; IAEA, 2015, FUK DAIICH ACC REP D; Investigation Committee on the accident at the Fukushima Nuclear Power Stations of Tokyo Electric Power Company, 2012, FUK NUCL POW STAT TO; Itoh S, 2014, SOIL SCI PLANT NUTR, V60, P540, DOI 10.1080/00380768.2014.907735; Izrael YA, 2007, HEALTH PHYS, V93, P410, DOI 10.1097/01.HP.0000285092.10598.41; JMA (Japan Meteorological Agency), 2017, MONTHL RAINF DAT TOK; Kaneyasu N, 2012, ENVIRON SCI TECHNOL, V46, P5720, DOI 10.1021/es204667h; Koarashi J, 2012, SCI TOTAL ENVIRON, V431, P392, DOI 10.1016/j.scitotenv.2012.05.041; Kogure T, 2012, CHEM LETT, V41, P380, DOI 10.1246/cl.2012.380; Komori M, 2013, BUNSEKI KAGAKU, V62, P475, DOI 10.2116/bunsekikagaku.62.475; Koto Ward Government, AN RES RAD ACT SOIL; MAES A, 1985, CLAY CLAY MINER, V33, P251, DOI 10.1346/CCMN.1985.0330312; Matsunaga T, 1998, J CONTAM HYDROL, V35, P101, DOI 10.1016/S0169-7722(98)00119-3; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2012, RES SURV RES DISTR S; MEXT (Ministry of Education Culture Sports Science and Technology of Japan), 2011, CALC RES REAS INT EX; Monte L, 2004, J ENVIRON RADIOACTIV, V75, P83, DOI 10.1016/j.jenvrad.2003.11.004; Morino Y, 2013, ENVIRON SCI TECHNOL, V47, P2314, DOI 10.1021/es304620x; Motokawa R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06585; Mukai H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21543; NA Independent, 2014, FUK DAIICH NUCL POW; Nagakawa Yoshiyasu, 2011, Radioisotopes, V60, P467; NDJ (The National Diet of Japan), 2012, OFF REP FUK NUCL ACC; NILU (Norwegian Institute for Air Research), RES SIM ATM TRANSP 1; NISA (Nuclear and Industrial Safety Agency), 2011, EV STAT COR UN 1 2 3; Nishizawa Y, 2016, J NUCL SCI TECHNOL, V53, P468, DOI 10.1080/00223131.2015.1071721; NSAC (Nuclear Science Advisory Committee), 1980, AN 3 MIL ISL UN 2 AC; Ohara T., 2011, Journal of the National Institute of Public Health, V60, P292; Oza RB, 2013, ANN NUCL ENERGY, V58, P95, DOI 10.1016/j.anucene.2013.03.016; Qin HB, 2012, GEOCHEM J, V46, P297, DOI 10.2343/geochemj.2.0214; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; SCJ (Science Council of Japan), 2014, SECT COMM NUCL ACC R; Stohl A, 2012, ATMOS CHEM PHYS, V12, P2313, DOI 10.5194/acp-12-2313-2012; Tanaka K, 2012, GEOCHEM J, V46, P73, DOI 10.2343/geochemj.1.0137; TEPCO (Tokyo Electric Power Company), 2012, EST AMOUNT RAD MAT R; TEPCO (Tokyo Electric Power Company), 2012, INV REP FUK NUCL ACC; Tsuruta H., 2012, Chikyukagaku (Geochemistry), V46, P99; Wakiyama Y, 2014, GEOPHY RES, V16, P10185; Yamaguchi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep20548; Yasuhara M, 2005, MAR MICROPALEONTOL, V55, P63, DOI 10.1016/j.marmicro.2005.02.005; Yoshida N, 2012, SCIENCE, V336, P1115, DOI 10.1126/science.1219493; Zachara JM, 2002, GEOCHIM COSMOCHIM AC, V66, P193, DOI 10.1016/S0016-7037(01)00759-1	63	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187687	10.1371/journal.pone.0187687	http://dx.doi.org/10.1371/journal.pone.0187687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136641	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200026
J	Musumari, PM; Tangmunkongvorakul, A; Srithanavibooncha, K; Feldman, MD; Sitthi, W; Rerkasem, K; Techasrivichien, T; Suguimoto, SP; Ono-Kihara, M; Kihara, M				Musumari, Patou Masika; Tangmunkongvorakul, Arunrat; Srithanavibooncha, Kriengkrai; Feldman, Mitchell D.; Sitthi, Wathee; Rerkasem, Kittipan; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro			Socio-behavioral risk factors among older adults living with HIV in Thailand	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; ALCOHOL-USE; INFECTED INDIVIDUALS; GENDER-DIFFERENCES; LIFE EXPECTANCY; CIGARETTE-SMOKING; SUBSTANCE USE; CESSATION; MORTALITY; DISEASE	Background There has been a global increase in HIV infection in persons 50 years of age and older. This group is at risk for development of chronic illness that may be exacerbated by socio-behavioral risk factors such as smoking, unhealthy alcohol use, and sedentary lifestyle. However, socio-behavioral risk factors in this older HIV infected population are not well described. The current study aims to describe and document factors related to alcohol use, tobacco smoking, and physical exercise in older adults living with HIV (OALHIV). Methods This cross-sectional quantitative study was conducted between August and September 2015, and enrolled HIV-infected participants aged 50 years and older from 12 community hospitals in Chiang Mai Province, Northern Thailand. Results Of the 364 participants recruited in the study, 57.1% were female, and 67.3% were between 50-59 years of age. Respectively, 15.1%, 59.1%, and 18.7% were current smokers, currently engaged in physical exercises, and reported ever drank alcohol in the past year. 22.1% of those who drank alcohol reported experience of heavy episodic drinking. Male gender was one of the strongest predictors of ever drank alcohol in the past year (AOR, 4.66; CI, 2.28-9.49; P < 0.001) and of being a current smoker (AOR, 13.41; CI, 7.23-24.87; P < 0.001). Lower household income was associated with increased odds of ever drank alcohol in the past year (household income (1 USD = 35 THB) of <= 5,000 Baht versus > 20,000 Baht: AOR, 5.34; CI, 1.28-22.25; P = 0.021). Lower educational level was associated with decreased odds of physical exercises (no education versus secondary and higher: AOR, 0.22; CI, 0.08-0.55; P = 0.001). Conclusion Smoking and alcohol use is common among OALHIV, with a substantial proportion not engaging in physical exercises. Interventions for OALHIV should particularly target males and those of lower socio-economic status to deter smoking and alcohol use and to promote physical exercises.	[Musumari, Patou Masika; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Tangmunkongvorakul, Arunrat; Srithanavibooncha, Kriengkrai; Sitthi, Wathee; Rerkasem, Kittipan] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand; [Srithanavibooncha, Kriengkrai; Rerkasem, Kittipan] Chiang Mai Univ, Fac Med, Chiang Mai, Thailand; [Feldman, Mitchell D.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan	Kyoto University; Chiang Mai University; Chiang Mai University; University of California System; University of California San Francisco; Kyoto University	Tangmunkongvorakul, A (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai, Thailand.	arunrat@rihes.org	Suguimoto, S Pilar/P-6825-2018	Suguimoto, S. Pilar/0000-0002-8447-9172	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University under Thailand's Office of the Higher Education Commission; Kyoto University	Chiang Mai University Center of Excellence in HIV/AIDS Research; National Research University under Thailand's Office of the Higher Education Commission; Kyoto University	The study was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission.; This study was part of the main study "Health Behaviors, Health Conditions, and Quality of Life of Older Adults Living with HIV". It was supported by the Chiang Mai University Center of Excellence in HIV/AIDS Research and the National Research University Project under Thailand's Office of the Higher Education Commission. We thank the participants who contributed to this research. We also thank the Kyoto University "Strategic Young Researcher Overseas Visit Program for Accelerating Brain Circulation Program" for supporting the collaboration between Kyoto University and the Research Institute for Health Sciences, Chiang Mai University.	Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; Assanangkornchai S, 2010, ALCOHOL ALCOHOLISM, V45, P278, DOI 10.1093/alcalc/agq018; Babor T.F., 2001, AUDIT ALCOHOL USE DI, P1; Batista Joanna d’Arc Lyra, 2013, Rev. bras. epidemiol., V16, P432, DOI 10.1590/S1415-790X2013000200018; Baum MK, 2010, AIDS RES HUM RETROV, V26, P511, DOI 10.1089/aid.2009.0211; Blanco JR, 2010, AIDS REV, V12, P218; Brooks JT, 2012, AM J PUBLIC HEALTH, V102, P1516, DOI 10.2105/AJPH.2012.300844; Brown JL, 2013, CURR HIV-AIDS REP, V10, P356, DOI 10.1007/s11904-013-0174-8; Browning KK, 2013, CLIN CHEST MED, V34, P181, DOI 10.1016/j.ccm.2013.01.005; Calvo M, 2015, AIDS REV, V17, P47; Crombie IK, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-494; DIAZ T, 1994, AM J PREV MED, V10, P217, DOI 10.1016/S0749-3797(18)30594-4; Duncan DT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147520; Edelman EJ, 2014, CURR OPIN HIV AIDS, V9, P317, DOI 10.1097/COH.0000000000000069; Elzi L, 2006, ANTIVIR THER, V11, P787; Fiore MC, 2008, TREATING TOBACCO USE; Florindo AA, 2007, INT J STD AIDS, V18, P692, DOI 10.1258/095646207782193795; Fone DL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002337; Goar SG, 2011, AJDAS, V10; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Honjo K, 2000, TOB CONTROL, V9, P193, DOI 10.1136/tc.9.2.193; Ikeda ML, 2016, PLOS ONE, V11, P2016; Jitnarin N, 2011, ASIA-PAC J PUBLIC HE, V23, P672, DOI 10.1177/1010539509352200; Justice AC, 2016, DRUG ALCOHOL DEPEN, V161, P95, DOI 10.1016/j.drugalcdep.2016.01.017; Katz IT, 2017, LANCET HIV, V3018, P30086; Lifson Alan R, 2012, Curr HIV/AIDS Rep, V9, P223, DOI 10.1007/s11904-012-0121-0; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; McGinnis KA, 2013, ALCOHOL CLIN EXP RES, V37, P435, DOI 10.1111/j.1530-0277.2012.01937.x; Morrow M, 2003, HEALTH PROMOT INT, V18, P373, DOI 10.1093/heapro/dag403; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; National Health Examination Survey Office, 2009, THAIL NAT HLTH EX SU; NELSON KE, 1993, JAMA-J AM MED ASSOC, V270, P955, DOI 10.1001/jama.270.8.955; NELSON KE, 1994, AIDS, V8, P951, DOI 10.1097/00002030-199407000-00012; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Obel N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022698; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; Peters SAE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005663; Petrosillo N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-16; Pratt G, 2010, AGE AGEING, V39, P289, DOI 10.1093/ageing/afq009; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Sackoff JE, 2006, ANN INTERN MED, V145, P397, DOI 10.7326/0003-4819-145-6-200609190-00003; Samet JH, 2007, JAIDS-J ACQ IMM DEF, V46, P194, DOI 10.1097/QAI.0b013e318142aabb; Sankar A, 2011, AIDS CARE, V23, P1187, DOI 10.1080/09540121.2011.564115; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Siviroj Penprapa, 2013, Journal of Human Ecology, V42, P187; Somarriba G, 2010, HIV AIDS-RES PALLIAT, V2, P191, DOI 10.2147/HIV.S9069; Thai National AIDS Committee, 2014, 2014 THAIL AIDS RESP; Tsai YW, 2008, J WOMENS HEALTH, V17, P971, DOI 10.1089/jwh.2007.0621; UNAIDS, 2013, HIV AG SPEC SUPPL UN; UNAIDS, 2016, LESS THAIL INT HIV S; UNAIDS, 2014, THE GAP REP; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Wakabayashi M, 2015, BMC PUBLIC HEALTH, V15, P015; WALDRON I, 1991, SOC SCI MED, V32, P989, DOI 10.1016/0277-9536(91)90157-8; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; Webel AR, 2015, J ASSOC NURSE AIDS C, V26, DOI 10.1016/j.jana.2014.06.004; Weniger B G, 1991, AIDS, V5 Suppl 2, pS71, DOI 10.1097/00002030-199101001-00011; World Health Organization (WHO), 2005, ALC GEND DRINK PROBL	62	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188088	10.1371/journal.pone.0188088	http://dx.doi.org/10.1371/journal.pone.0188088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136655	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200061
J	Petricek, T; Svoboda, T				Petricek, Tomas; Svoboda, Tomas			Point cloud registration from local feature correspondences-Evaluation on challenging datasets	PLOS ONE			English	Article								Registration of laser scans, or point clouds in general, is a crucial step of localization and mapping with mobile robots or in object modeling pipelines. A coarse alignment of the point clouds is generally needed before applying local methods such as the Iterative Closest Point (ICP) algorithm. We propose a feature-based approach to point cloud registration and evaluate the proposed method and its individual components on challenging real-world datasets. For a moderate overlap between the laser scans, the method provides a superior registration accuracy compared to state-of-the-art methods including Generalized ICP, 3D Normal-Distribution Transform, Fast Point-Feature Histograms, and 4-Points Congruent Sets. Compared to the surface normals, the points as the underlying features yield higher performance in both keypoint detection and establishing local reference frames. Moreover, sign disambiguation of the basis vectors proves to be an important aspect in creating repeatable local reference frames. A novel method for sign disambiguation is proposed which yields highly repeatable reference frames.	[Petricek, Tomas; Svoboda, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, Prague, Czech Republic	Czech Technical University Prague	Petricek, T (corresponding author), Czech Tech Univ, Fac Elect Engn, Dept Cybernet, Prague, Czech Republic.	petrito1@fel.cvut.cz	Petříček, Tomáš/B-7238-2019; Svoboda, Tomas/H-1627-2012	Petříček, Tomáš/0000-0002-3136-5673; Svoboda, Tomas/0000-0002-7184-1785	European Unions Horizon research and innovation programme [692455]; Grant Agency of the Czech Technical University in Prague [SGS16/161/OHK3/2T/13]	European Unions Horizon research and innovation programme; Grant Agency of the Czech Technical University in Prague	This work has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No. 692455 Enable-S3 (TP, http://ec.europa.eu/programmes/horizon2020/en/) and from the Grant Agency of the Czech Technical University in Prague under grant SGS16/161/OHK3/2T/13 (TS, https://sgs.cvut.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 692455 Enable-S3 and from the Grant Agency of the Czech Technical University in Prague under grant SGS16/161/OHK3/2T/13.	Aiger D, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1360612.1360684; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bro R, 2008, J CHEMOMETR, V22, P135, DOI 10.1002/cem.1122; CHEN Y, 1992, IMAGE VISION COMPUT, V10, P145, DOI 10.1016/0262-8856(92)90066-C; Chum O, 2003, LECT NOTES COMPUT SC, V2781, P236; Das A, 2013, 2013 IEEE INT C ROB; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Fitzgibbon AW, 2003, IMAGE VISION COMPUT, V21, P1145, DOI 10.1016/j.imavis.2003.09.004; Hrabalik A., 2014, 3D POINT CLOUD REGIS; Johnson AE, 1999, IEEE T PATTERN ANAL, V21, P433, DOI 10.1109/34.765655; Magnusson M., 2013, RENEW ENERG; Magnusson M, 2015, IEEE INT CONF ROBOT, P3631, DOI 10.1109/ICRA.2015.7139703; Mian A, 2010, INT J COMPUT VISION, V89, P348, DOI 10.1007/s11263-009-0296-z; Mian A.S., 2005, INT J SHAPE MODEL, V11, P253, DOI [10.1142/S0218654305000797, DOI 10.1142/S0218654305000797]; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Petrelli A, 2011, IEEE I CONF COMP VIS, P2244, DOI 10.1109/ICCV.2011.6126503; Petricek T, 2012, INT C PATT RECOG, P1492; Pomerleau F, 2013, AUTON ROBOT, V34, P133, DOI 10.1007/s10514-013-9327-2; Pomerleau F, 2012, INT J ROBOT RES, V31, P1705, DOI 10.1177/0278364912458814; Rusu R., 2009, IEEE INT C ROB AUT I, P3212, DOI DOI 10.1109/R0B0T.2009.5152473; Segal A., 2009, ROBOTICS SCI SYSTEMS; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; Steder B, 2011, IEEE INT CONF ROBOT, P2601, DOI 10.1109/ICRA.2011.5980187; Stoyanov T, 2012, IEEE INT CONF ROBOT, P5196, DOI 10.1109/ICRA.2012.6224717; Theiler PW., 2013, ISPRS ANN PHOTOGRAM, V1, P283, DOI [10.5194/isprsannals-II-5-W2-283-2013, DOI 10.5194/ISPRSANNALS-II-5-W2-283-2013]; Tombari F, 2013, INT J COMPUT VISION, V102, P198, DOI 10.1007/s11263-012-0545-4; Tombari F, 2010, LECT NOTES COMPUT SC, V6313, P356, DOI 10.1007/978-3-642-15558-1_26; WALKER MW, 1991, CVGIP-IMAG UNDERSTAN, V54, P358, DOI 10.1016/1049-9660(91)90036-O; Yu Zhong, 2009, 2009 IEEE 12th International Conference on Computer Vision Workshops, ICCV Workshops, P689, DOI 10.1109/ICCVW.2009.5457637	29	11	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187943	10.1371/journal.pone.0187943	http://dx.doi.org/10.1371/journal.pone.0187943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136000	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200050
J	Aoto, Y; Hachiya, T; Okumura, K; Hase, S; Sato, K; Wakabayashi, Y; Sakakibara, Y				Aoto, Yoshimasa; Hachiya, Tsuyoshi; Okumura, Kazuhiro; Hase, Sumitaka; Sato, Kengo; Wakabayashi, Yuichi; Sakakibara, Yasubumi			DEclust: A statistical approach for obtaining differential expression profiles of multiple conditions	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; CANCER	High-throughput RNA sequencing technology is widely used to comprehensively detect and quantify cellular gene expression. Thus, numerous analytical methods have been proposed for identifying differentially expressed genes (DEGs) between paired samples such as tumor and control specimens, but few studies have reported methods for analyzing differential expression under multiple conditions. We propose a novel method, DEclust, for differential expression analysis among more than two matched samples from distinct tissues or conditions. As compared to conventional clustering methods, DEclust more accurately extracts statistically significant gene clusters from multi-conditional transcriptome data, particularly when replicates of quantitative experiments are available. DEclust can be used for any multi-conditional transcriptome data, as well as for extending any DEG detection tool for paired samples to multiple samples. Accordingly, DEclust can be used for a wide range of applications for transcriptome data analysis. DEclust is freely available at http://www.dna.bio.keio.ac.jp/software/DEclust.	[Aoto, Yoshimasa; Hase, Sumitaka; Sato, Kengo; Sakakibara, Yasubumi] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan; [Hachiya, Tsuyoshi] Iwate Med Univ, Disaster Reconstruct Ctr, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Okumura, Kazuhiro; Wakabayashi, Yuichi] Chiba Canc Ctr, Res Inst, Div Expt Anim Res, Dept Carcinogenesis Res, Chiba, Chiba, Japan	Keio University; Iwate Medical University; Chiba Cancer Center	Sakakibara, Y (corresponding author), Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa, Japan.	yasu@bio.keio.ac.jp	Sato, Kengo/D-6043-2012; Hachiya, Tsuyoshi/AAM-8691-2021	Sato, Kengo/0000-0001-6744-7390; Hachiya, Tsuyoshi/0000-0002-5274-3266	Ministry of Education, Culture, Sports, Science and Technology of Japan [221S0002, 23241066]; JSPS KAKENHI [16H06279]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for KAKENHI (Grant-in-Aid for Scientific Research) on Innovative Areas No. 221S0002, and Scientific Research (A) No. 23241066 from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and JSPS KAKENHI Grant Number 16H06279. and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kang GL, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1111-9; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	21	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188285	10.1371/journal.pone.0188285	http://dx.doi.org/10.1371/journal.pone.0188285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161291	Green Submitted, gold, Green Published			2022-12-27	WOS:000415987000039
J	Courtney, LP; Goco, N; Woja, J; Farris, T; Cummiskey, C; Smith, E; Makuach, L; Chun, HM				Courtney, Lauren P.; Goco, Norman; Woja, John; Farris, Tonya; Cummiskey, Chris; Smith, Emily; Makuach, Lia; Chun, Helen M.			HIV prevalence and behavioral risk factors in the Sudan People's Liberation Army: Data from South Sudan	PLOS ONE			English	Article							MENTAL-HEALTH PROBLEMS; BORDER-CROSSING ZONES; INFECTION; AFRICAN; AFGHANISTAN; COUNTRIES; IRAQ; CARE	Overview After two decades of civil war, South Sudan has limited published data on HIV prevalence and behavioral determinants of HIV infection risk. A surge in HIV/AIDS prevalence is a real concern for this new country with limited access to medical or HIV preventive services, and low education and literacy levels. We present findings from the first bio-behavioral surveillance survey conducted within the Sudan People's Liberation Army (SPLA). Methods A cross-sectional survey of 1,149 randomly selected soldiers from thirteen SPLA bases was conducted in two phases: July to August 2010 and April to May 2012. Consenting participants received HIV rapid tests, pre- and post-test counseling, and a personal interview. Demographics, knowledge, attitudes, and behaviors, including sexual behavior, alcohol use, and mental health were assessed using computer-assisted interviews. Findings The final sample included 1,063 survey participants (96.7% male). Education levels within the SPLA are low; only 16.4% attended school beyond the primary level. The overall HIV prevalence in the sample was 5.0% (95% confidence interval [CI]: 3.6-6.9). High-risk behaviors (e.g., multiple or concurrent sexual partners, heavy alcohol use, low condom use) were noted among SPLA members. High levels of HIV stigma were identified: 90.6% (n = 916) responded with one or more negative beliefs towards PLHIV, and 60.3% thought a healthy-looking person with HIV should not be allowed to remain in the SPLA. Conclusion Results from this first evaluation of risk behaviors and HIV prevalence among the SPLA highlight high-risk behaviors that may contribute to the spread of HIV. Understanding potential comorbid conditions will be critical to designing strategies to reduce HIV risk. This survey represents the first steps in understanding the HIV epidemic within the SPLA context.	[Courtney, Lauren P.; Farris, Tonya; Cummiskey, Chris; Smith, Emily] RTI Int, BiostatEpi, Washington, DC 20005 USA; [Goco, Norman] RTI Int, BiostatEpi, Res Triangle Pk, NC USA; [Woja, John; Makuach, Lia] Sudan Peoples Liberat Army, HIV Secretariat, Juba, South Sudan; [Chun, Helen M.] Naval Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA USA	Research Triangle Institute; Research Triangle Institute; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Courtney, LP (corresponding author), RTI Int, BiostatEpi, Washington, DC 20005 USA.	lcourtney@rti.org		Goco, Norman/0000-0003-4317-4556; Smith, Emily/0000-0002-3777-3328; Farris, Tonya/0000-0003-1072-8866; Courtney, Lauren/0000-0002-8943-4934; Cummiskey, Christopher/0000-0001-6785-5829	Department of Defense HIV/AIDS Prevention Program [N00244-09-1-0087]; Sudan People's Liberation Army; GoSS	Department of Defense HIV/AIDS Prevention Program; Sudan People's Liberation Army; GoSS	This work was supported by a grant from the Department of Defense HIV/AIDS Prevention Program (grant number N00244-09-1-0087). NG, LPC, TF, CC, ES, JW, LM received this funding. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy,Department of Defense, or the U.S. Government. Approved for public release; distribution is unlimited. The funder (HMC) played a key role in study design, analysis, decision to publish, and preparation of the manuscript. The funder did not provide support in the form of salaries for authors.; We would like to thank the Sudan People's Liberation Army and GoSS for their leadership and support, the SPLA study participants without whom this research would not have been possible, Dr. Fazle Khan from CDC, Carol Karutu from Intrahealth, and Major Gabriel Chinchilla for their key assistance in study planning discussions. We thank Mr. Kuol Deng Kuol (SPLA) for support and leadership in moving the study forward within the SPLA. We thank Mr. Jeffrey Mathews (RTI) for assistance on the background section and references.	Anastario M, 2011, INT J STD AIDS, V22, P73, DOI 10.1258/ijsa.2010.010274; Anastario MP, 2010, REV PANAM SALUD PUBL, V28, P361; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bing EG, 2008, AIDS BEHAV, V12, P384, DOI 10.1007/s10461-008-9368-2; Centers for Disease Control and Prevention (CDC), 2012, MMWR-MORBID MORTAL W, V62, P453; Central Intelligence Agency, 2012, WORLD FACTB AFR SO S; Cherpitel CJ, 2005, J STUD ALCOHOL, V66, P428, DOI 10.15288/jsa.2005.66.428; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hussain N. A. A., 2009, African Journal of Clinical and Experimental Microbiology, V10, P128; Iannacchione VG, 1982, P 7 ANN SAS US GROUP, P759; Ibrahim WMA, 2009, SUDAN J MED SCI, V4, P333; Joint United Nations Programme on HIV/AIDS, 2009, HIV REL STIGM DISCR; Joint United Nations Programme on HIV/AIDS, 2002, HIV AIDS UN SERV STO; Karunakara Unni Krishnan, 2004, Afr Health Sci, V4, P83; Mankayi N, 2009, SAHARA J-J SOC ASP H, V5, P33; Ministry of Health Government of Southern Sudan HIV/AIDS/STI Directorate, 2009, SO SUD ANT CAR CLIN; Mitike G, 2002, ETHIOPIA, V2002; Spiegel PB, 2007, LANCET, V369, P2187, DOI 10.1016/S0140-6736(07)61015-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Tavarez MI, 2011, AM J MENS HEALTH, V5, P65, DOI 10.1177/1557988310362097; Tull DM., 2005, SWP COMMENTS, V3, P1; United Nations General Assembly Special Session, 2008, HIV AIDS SO SUD HIV, P8; United Nations High Commissioner for Refugees, 2007, HIV BEH SURV SURV JU, P7; van der Ryst E, 2001, S AFR MED J, V91, P587; Wolter K. M., 1985, INTRO VARIANCE ESTIM	27	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187689	10.1371/journal.pone.0187689	http://dx.doi.org/10.1371/journal.pone.0187689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161275	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000016
J	Deng, FY; Guo, TW; Lefebvre, M; Scaglione, S; Antico, CJ; Jing, T; Yang, X; Shan, WX; Ramonell, KM				Deng, Fengyan; Guo, Tingwei; Lefebvre, Mitchell; Scaglione, Steven; Antico, Christopher J.; Jing, Tao; Yang, Xin; Shan, Weixing; Ramonell, Katrina M.			Expression and regulation of ATL9, an E3 ubiquitin ligase involved in plant defense	PLOS ONE			English	Article							RECOGNITION RECEPTOR FLS2; PROGRAMMED CELL-DEATH; ARABIDOPSIS-THALIANA; ABSCISIC-ACID; PEST-DOMAIN; NUCLEOCYTOPLASMIC TRAFFICKING; PROTEIN-DEGRADATION; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; CONJUGATING ENZYME	Plants are continually exposed to a variety of pathogenic organisms, including bacteria, fungi and viruses. In response to these assaults, plants have developed various defense pathways to protect themselves from pathogen invasion. An understanding of the expression and regulation of genes involved in defense signaling is essential to controlling plant disease. ATL9, an Arabidopsis RING zinc finger protein, is an E3 ubiquitin ligase that is induced by chitin and involved in basal resistance to the biotrophic fungal pathogen, Golovi-nomyces cichoracearum (G. cichoracearum). To better understand the expression and regulation of ATL9, we studied its expression pattern and the functions of its different protein domains. Using p(ATL9):GUS transgenic Arabidopsis lines we found that ATL9 is expressed in numerous tissues at various developmental stages and that GUS activity was induced rapidly upon wounding. Using a GFP control protein, we showed that ATL9 is a short-lived protein within plant cells and it is degraded via the ubiquitin-proteasome pathway. ATL9 contains two transmembrane domains (TM),a RING zinc-finger domain, and a PEST domain. Using a series of deletion mutants, we found that the PEST domain and the RING domain have effects on ATL9 degradation. Further infection assays with G. cichoracearum showed that both the RING domain and the TM domains are important for ATL9's resistance phenotype. Interestingly, the PEST domain was also shown to be significant for resistance to fungal pathogens. This study demonstrates that the PEST domain is directly coupled to plant defense regulation and the importance of protein degradation in plant immunity.	[Deng, Fengyan; Guo, Tingwei; Lefebvre, Mitchell; Scaglione, Steven; Antico, Christopher J.; Jing, Tao; Ramonell, Katrina M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Deng, Fengyan] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yang, Xin] Univ Alabama, Stat Res & Consulting Lab, Culverhouse Coll Commerce & Business Adm, Tuscaloosa, AL USA; [Shan, Weixing] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	University of Alabama System; University of Alabama Tuscaloosa; Northwest A&F University - China; University of Alabama System; University of Alabama Tuscaloosa; Northwest A&F University - China	Ramonell, KM (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	kramonel@ua.edu	Jing, Tao/AGN-9265-2022	LeFebvre, Mitchell/0000-0002-7641-7043; Jing, Tao/0000-0003-1936-4392; Scaglione, Steven/0000-0002-1947-5837	U.S. Department of Agriculture [2007-01652]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	U.S. Department of Agriculture (grant no. 2007-01652 to K. M. R.) ettps://wvmusda.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2006, PLANT CELL PHYSIOL, V47, P1683, DOI 10.1093/pcp/pcl034; Bae H, 2011, PLANT SCI, V180, P775, DOI 10.1016/j.plantsci.2011.02.008; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; Bopopi JM, 2010, J EXP BOT, V61, P297, DOI 10.1093/jxb/erp305; Copeland C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00309; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Deslandes L, 2011, PLANT SIGNAL BEHAV, V6, P42, DOI 10.4161/psb.6.1.13978; Downes BP, 2003, PLANT J, V35, P729, DOI 10.1046/j.1365-313X.2003.01844.x; Durrant WE, 2000, PLANT CELL, V12, P963, DOI 10.1105/tpc.12.6.963; Garcia AV, 2009, TRENDS PLANT SCI, V14, P479, DOI 10.1016/j.tplants.2009.07.004; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Guzman P, 2014, PLANT SCI, V215, P69, DOI 10.1016/j.plantsci.2013.10.017; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Liu HX, 2013, J BIOL CHEM, V288, P20267, DOI 10.1074/jbc.M113.465369; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Liu YC, 2011, MOL PLANT, V4, P938, DOI 10.1093/mp/ssr030; Liu ZP, 1997, GENE DEV, V11, P3413, DOI 10.1101/gad.11.24.3413; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; Lukov GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012692; Maekawa S, 2012, PLANT MOL BIOL, V79, P217, DOI 10.1007/s11103-012-9907-0; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Noda S, 2013, PLANT BIOTECHNOL-NAR, V30, P169, DOI 10.5511/plantbiotechnology.13.0304a; Obiri DD, 2012, ALLERGY, V67, P175, DOI 10.1111/j.1398-9995.2011.02731.x; Park GG, 2010, PLANT MOL BIOL, V74, P467, DOI 10.1007/s11103-010-9687-3; Park JJ, 2011, PLANT J, V65, P194, DOI 10.1111/j.1365-313X.2010.04416.x; Pauwels L, 2015, PLANT PHYSIOL, V169, P1405, DOI 10.1104/pp.15.00479; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Serrano M, 2006, J MOL EVOL, V62, P434, DOI 10.1007/s00239-005-0038-y; Serrano M, 2004, GENETICS, V167, P919, DOI 10.1534/genetics.104.028043; Slootweg E, 2010, PLANT CELL, V22, P4195, DOI 10.1105/tpc.110.077537; Sportoletti P, 2010, BRIT J HAEMATOL, V151, P404, DOI 10.1111/j.1365-2141.2010.08368.x; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Takai R, 2002, PLANT J, V30, P447, DOI 10.1046/j.1365-313X.2002.01299.x; Takemoto D, 2012, MOL PLANT MICROBE IN, V25, P379, DOI 10.1094/MPMI-11-10-0272; Tameling WIL, 2010, PLANT CELL, V22, P4176, DOI 10.1105/tpc.110.077461; Thangasamy S, 2011, NEW PHYTOL, V189, P869, DOI 10.1111/j.1469-8137.2010.03538.x; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wiermer M, 2007, CELL MICROBIOL, V9, P1880, DOI 10.1111/j.1462-5822.2007.00962.x; Wirthmueller L, 2007, CURR BIOL, V17, P2023, DOI 10.1016/j.cub.2007.10.042; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yang CW, 2006, PLANT CELL, V18, P1084, DOI 10.1105/tpc.105.039198; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255	57	14	14	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188458	10.1371/journal.pone.0188458	http://dx.doi.org/10.1371/journal.pone.0188458			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161311	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000058
J	Houston, DMJ; Bugert, JJ; Denyer, SP; Heard, CM				Houston, David M. J.; Bugert, Joachim J.; Denyer, Stephen P.; Heard, Charles M.			Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV (vol 12, e0179291, 2017)	PLOS ONE			English	Correction													Bugert, Joachim/AAK-6459-2021; Bugert, Joachim Jakob/D-1705-2012	Bugert, Joachim Jakob/0000-0002-0556-3211				Houston DMJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179291	1	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188609	10.1371/journal.pone.0188609	http://dx.doi.org/10.1371/journal.pone.0188609			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155888	Green Submitted, gold, Green Published			2022-12-27	WOS:000415756700064
J	Azuma, K; Uchiyama, I				Azuma, Kenichi; Uchiyama, Iwao			Association between environmental noise and subjective symptoms related to cardiovascular diseases among elderly individuals in Japan	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; POPULATION-BASED SURVEY; ISCHEMIC-HEART-DISEASE; AIR-POLLUTION; TRAFFIC NOISE; UNITED-STATES; EXPOSURE; HEALTH; PREVALENCE	Noise in housing environments may increase the risk of cardiovascular diseases (CVDs); however, the most significant sources of noise among elderly individuals remain poorly understood. A nationwide cross-sectional study comprised of 6,181 elderly people (age >= 65 years) was conducted using a web-based self-reported questionnaire in 2014. Questions pertaining to CVD-related subjective symptoms within the past year addressed symptoms of chest pain, disturbances in pulse, acute impaired tongue movement, limb paralysis, and foot pain or numbness during walking. Questions concerning noise included awakening during the night due to noise, automobile, neighborhood, construction, railway, and aircraft noise. The multivariable analyses revealed that all symptoms were significantly associated with awakening during the night due to noise. Automobile, construction, railway, and aircraft noise were significantly associated with more CVD-related symptoms at nighttime than at daytime. Our results suggest that noise at nighttime is an important risk factor for CVDs. Although several different sources of environmental noise, including automobile, neighborhood, construction, railway, and aircraft noise were found to be significantly associated with CVD-related symptoms, the strongest association was observed for construction noise, followed by neighborhood and automobile noise. The adjusted odds ratios (95% confidence intervals) for construction noise at nighttime were 1.12 (1.06-1.19) with disturbances in pulse, 1.21 (1.08-1.35) in acute impaired tongue movement, 1.25 (1.15-1.36) in limb paralysis, and 1.19 (1.12-1.28) in foot pain or numbness during walking. The associations with railway and aircraft noise were found to be weaker than those with automobile, neighborhood, and construction noise. Our study suggests that CVD-related symptoms may exhibit a greater association with construction, neighborhood, and automobile noise than with railway and aircraft noise.	[Azuma, Kenichi] Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan; [Azuma, Kenichi; Uchiyama, Iwao] Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan		Azuma, K (corresponding author), Kindai Univ, Fac Med, Dept Environm Med & Behav Sci, Osakasayama, Osaka, Japan.; Azuma, K (corresponding author), Louis Pasteur Ctr Med Res, Sick House Med Sci Lab, Div Basic Res, Kyoto, Japan.	kenazuma@med.kindai.ac.jp		Azuma, Kenichi/0000-0002-6382-9807	Japan Automobile Research Institute	Japan Automobile Research Institute	This work was financially supported by Research Grants FY 2014 and FY 2015 provided by Japan Automobile Research Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews EB, 2005, ALIMENT PHARM THER, V22, P935, DOI 10.1111/j.1365-2036.2005.02671.x; [Anonymous], 2011, BURDEN DIS ENV NOISE; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; Bareinboim E, 2016, P NATL ACAD SCI USA, V113, P7345, DOI 10.1073/pnas.1510507113; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chum A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1788-0; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fields JM, 2001, J SOUND VIB, V242, P641, DOI 10.1006/jsvi.2000.3384; Gan WQ, 2011, OCCUP ENVIRON MED, V68, P183, DOI 10.1136/oem.2010.055269; Golmohammadi R, 2013, J RES HEALTH SCI, V13, P201; Heritier H, 2017, EUR J EPIDEMIOL, V32, P307, DOI [10.1007/s10654, 10.1007/s10654-017-0234-2]; Ishii S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139639; *ISO, 2003, ISOTC43WG; Ito M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122969; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Kalsch H, 2014, EUR HEART J, V35, P853, DOI 10.1093/eurheartj/eht426; Konishi M, 2001, J Epidemiol, V11, pS57; Krogsgaard LR, 2013, SCAND J GASTROENTERO, V48, P523, DOI 10.3109/00365521.2013.775328; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Macromill, 2013, LIF SURV; McAloon CJ, 2016, INT J CARDIOL, V224, P256, DOI 10.1016/j.ijcard.2016.09.026; Ministry of Health, 2014, SUMM REP COMPR SURV; Ministry of Internal Affairs and Communications (MIAC), 2011, 2010 POP CENS; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Nafiu OO, 2014, J PERIANESTH NURS, V29, P84, DOI 10.1016/j.jopan.2013.03.010; Pyko A, 2015, OCCUP ENVIRON MED, V72, P594, DOI 10.1136/oemed-2014-102516; Reimer C, 2009, SCAND J GASTROENTERO, V44, P394, DOI 10.1080/00365520802600987; Roux AVD, 2003, J URBAN HEALTH, V80, P569, DOI 10.1093/jurban/jtg065; Sasaki M, 2016, ALLERGOL INT, V65, P420, DOI 10.1016/j.alit.2016.03.007; Stansfeld S, 2000, Rev Environ Health, V15, P43; Tetreault LF, 2013, INT J PUBLIC HEALTH, V58, P649, DOI 10.1007/s00038-013-0489-7; van Kempen EEMM, 2002, ENVIRON HEALTH PERSP, V110, P307, DOI 10.1289/ehp.02110307; Vandasova Z, 2016, NOISE HEALTH, V18, P338, DOI 10.4103/1463-1741.195800; Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023; WHO Europe, 2009, NIGHT NOIS GUID EUR; Xiao J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111045	37	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188236	10.1371/journal.pone.0188236	http://dx.doi.org/10.1371/journal.pone.0188236			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145457	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800098
J	Farahzadi, R; Fathi, E; Mesbah-Namin, SA; Zarghami, N				Farahzadi, Raheleh; Fathi, Ezzatollah; Mesbah-Namin, Seyed Alireza; Zarghami, Nosratollah			Zinc sulfate contributes to promote telomere length extension via increasing telomerase gene expression, telomerase activity and change in the TERT gene promoter CpG island methylation status of human adipose-derived mesenchymal stem cells	PLOS ONE			English	Article							DNA METHYLATION; HTERT EXPRESSION; STROMAL CELLS; HYPERMETHYLATION; DIFFERENTIATION; REGION	The use of mesenchymal stem cells (MSCs) for cell therapy and regenerative medicine has received widespread attention over the past few years, but their application can be complicated by factors such as reduction in proliferation potential, the senescent tendency of the MSCs upon expansion and their age-dependent decline in number and function. It was shown that all the mentioned features were accompanied by a reduction in telomerase activity and telomere shortening. Furthermore, the role of epigenetic changes in aging, especially changes in promoter methylation, was reported. In this study, MSCs were isolated from the adipose tissue with enzymatic digestion. In addition, immunocytochemistry staining and flow cytometric analysis were performed to investigate the cell-surface markers. In addition, alizarin red-S, sudan III, toluidine blue, and cresyl violet staining were performed to evaluate the multi-lineage differentiation of hADSCs. In order to improve the effective application of MSCs, these cells were treated with 1.5 x 10(-8) and 2.99 x 10(-10) M of ZnSO4 for 48 hours. The length of the absolute telomere, human telomerase reverse transcriptase (hTERT) gene expression, telomerase activity, the investigation of methylation status of the hTERT gene promoter and the percentage of senescent cells were analyzed with quantitative real-time PCR, PCR-ELISA TRAP assay, methylation specific PCR (MSP), and beta-galactosidase (SA-beta-gal) staining, respectively. The results showed that the telomere length, the hTERT gene expression, and the telomerase activity had significantly increased. In addition, the percentage of senescent cells had significantly decreased and changes in the methylation status of the CpG islands in the hTERT promoter region under treatment with ZnSO4 were seen. In conclusion, it seems that ZnSO4 as a proper antioxidant could improve the aging-related features due to lengthening of the telomeres, increasing the telomerase gene expression, telomerase activity, decreasing aging, and changing the methylation status of hTERT promoter; it could potentially beneficial for enhancing the application of aged-MSCs.	[Farahzadi, Raheleh] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran; [Farahzadi, Raheleh; Mesbah-Namin, Seyed Alireza] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran; [Fathi, Ezzatollah] Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Stem Cell Res Ctr, Tabriz, Iran; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Dept Med Biotechnol, Fac Adv Med Sci, Tabriz, Iran	Tabriz University of Medical Science; Tarbiat Modares University; University of Tabriz; Tabriz University of Medical Science; Tabriz University of Medical Science	Fathi, E (corresponding author), Univ Tabriz, Dept Clin Sci, Fac Vet Med, Tabriz, Iran.	ez.fathi@tabrizu.ac.ir	Farahzadi, Raheleh/W-4103-2019	Farahzadi, Raheleh/0000-0003-3159-9522	University of Tabriz [16-855]; Tarbiat Modares University [d/52/1872]	University of Tabriz; Tarbiat Modares University	Phenotypical characterization and multi lineage differentiation of hADSCs, calculation of PDT, SA-ss-gal staining, absolute telomere length measurement and PCR-ELISA TRAP assay, financially supported by University of Tabriz (No.16-855) and funding regarding the cultivation of hADSCs, hTERT gene expression and methylation specific PCR was supported by Tarbiat Modares University (No.d/52/1872).r The authors wish to thank Dr. Hojjatollah Nozad Charoudeh for donating primers. Phenotypical characterization and multi-lineage differentiation of hADSCs, calculation of PDT, SA-ss-gal staining, absolute telomere length measurement and PCR-ELISA TRAP assay, financially supported by University of Tabriz (No.16-855) and funding regarding the cultivation of hADSCs, hTERT gene expression and methylation specific PCR was supported by Tarbiat Modares University (No.d/52/1872).	Absalan A, 2016, AVICENNA J PHYTOMEDI, V6, P643; Aminizadeh N, 2016, IN VITRO CELL DEV-AN, V52, P772, DOI 10.1007/s11626-016-0021-5; Amirkhani MA, 2016, BIOIMPACTS, V6, P99, DOI 10.15171/bi.2016.14; [Anonymous], 2008, BIOTECHNIQUES, V44, P807; Asumda FZ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-44; Bao B, 2013, BIOL SIGNIFICANCE ZI; Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963; Bechter OE, 2002, EXP HEMATOL, V30, P26, DOI 10.1016/S0301-472X(01)00760-3; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; Brazvan B, 2016, ADV PHARM BULL, V6, P153, DOI 10.15171/apb.2016.022; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deng WG, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610579200; Desai N, 2010, UROLOGY, V75, P14, DOI 10.1016/j.urology.2009.05.025; Devereux TR, 1999, CANCER RES, V59, P6087; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Farahzadi R, 2016, INT J STEM CELLS, V9, P107, DOI 10.15283/ijsc.2016.9.1.107; Fathi E, 2017, VET RES FORUM; Fathi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173877; Fathi E, 2017, EXP BIOL MED, V242, P482, DOI 10.1177/1535370216685432; Fathi Ezzatollah, 2015, Romanian Journal of Biochemistry, V52, P67; Fathi E, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016150383; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Gholizadeh-Ghalehaziz S, 2015, INT J STEM CELLS, V8, P115, DOI 10.15283/ijsc.2015.8.2.115; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Guilleret I, 2004, BIOCHEM BIOPH RES CO, V325, P1037, DOI 10.1016/j.bbrc.2004.10.137; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Horikawa I, 1999, CANCER RES, V59, P826; Katsara O, 2011, STEM CELLS DEV, V20, P1550, DOI 10.1089/scd.2010.0280; Lai GJ, 2015, INT J NANOMED, V10, P567, DOI 10.2147/IJN.S73780; Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177; Li ZL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020526; Liu Q, 2004, BIOL TRACE ELEM RES, V100, P215, DOI 10.1385/BTER:100:3:215; Lu WS, 2013, EXP CELL RES, V319, P133, DOI 10.1016/j.yexcr.2012.09.005; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Mobarak H, 2017, VET RES COMMUN, V41, P41, DOI 10.1007/s11259-016-9670-9; Mortazavi Y, 2016, CELL J, V18; Nadri S, 2007, CYTOTHERAPY, V9, P729, DOI 10.1080/14653240701656061; Nemoto K, 2000, BIOCHEM PHARMACOL, V59, P401, DOI 10.1016/S0006-2952(99)00334-2; Nomoto K, 2002, JPN J CLIN ONCOL, V32, P3, DOI 10.1093/jjco/hyf001; Noori-Zadeh A, 2017, J NEUROL SCI, V375, P203, DOI 10.1016/j.jns.2017.01.060; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Pirmoradi S, 2017, DRUG RES; Prasad AS, 2014, J TRACE ELEM MED BIO, V28, P364, DOI 10.1016/j.jtemb.2014.07.019; Rafi MA, 2011, BIOIMPACTS, V1, P213, DOI 10.5681/bi.2011.030; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ramlee MK, 2016, GENES-BASEL, V7, DOI 10.3390/genes7080050; Ren LG, 2007, CHEMBIOCHEM, V8, P775, DOI 10.1002/cbic.200600554; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Saleh M, 2015, ADV PHARM BULL, V5, P299, DOI 10.15171/apb.2015.042; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Wan TSK, 1999, GENE CHROMOSOME CANC, V24, P83, DOI 10.1002/(SICI)1098-2264(199901)24:1<83::AID-GCC12>3.0.CO;2-C; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wright WE, 2005, J AM GERIATRICS SOC, V53; Xiao CW, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015013; Yu KR, 2013, GERONTOLOGY, V59, P557, DOI 10.1159/000353857; Yusa K, 2011, BIOCHEM BIOPH RES CO, V412, P273, DOI 10.1016/j.bbrc.2011.07.082; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	63	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188052	10.1371/journal.pone.0188052	http://dx.doi.org/10.1371/journal.pone.0188052			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145503	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800057
J	Han, JC; Ko, H; Kim, SH; Rhee, T; Nam, SW; Hwang, S; Lee, GI; Sung, J; Song, YM; Kee, C				Han, Jong Chul; Ko, Hyeonyoung; Kim, Seung Hoon; Rhee, Taekkwan; Nam, Seung Wan; Hwang, Sungsoon; Lee, Ga-In; Sung, Joohon; Song, Yun-Mi; Kee, Changwon			Heritability of the morphology of optic nerve head and surrounding structures: The Healthy Twin Study	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD DEFECTS; MYOPIA GEM TWIN; PARAPAPILLARY ATROPHY; OCULAR BIOMETRICS; DISC TILT; EYES; PROGRESSION; TOMOGRAPHY; DIAMETERS	Background Optic nerve head (ONH) and surrounding structures such as beta-zone peripapillary atrophy (PPA) are important structures in glaucomatous pathogenesis. Thus, for understanding genetic components in glaucoma pathogenesis, it is necessary to evaluate the heritability of ONH and surrounding structures. The present study investigated the genetic influences on ONH and surrounding structures such as beta-zone PPA and retinal vessels. Methods A total of 1,205 adult twins and their family members (362 monozygotic (MZ) twin subjects (181 pairs), 64 dizygotic (DZ) twin subjects (32 pairs), and 779 singletons from 261 families), were part of the Korean Healthy Twin Study. ONH parameters including the vertical cup-todisc ratio, the presence, the area and the location of beta-zone PPA and the angular location of retinal vein were measured. The genetic influences on the structures were evaluated using variance-component methods. Results The intraclass correlation coefficient (ICC) values of axial length were highest among the parameters. The ICCs of the area and location of PPA were similar to those of vertical cupto- disc ratio. However, retinal vessel angular locations showed low ICC values even in MZ twins. After age and sex adjustment, for axial length, vertical cup-to-disc ratio, the presence, area and location of PPA, the estimated narrow-sense heritability was 0.85, 0.48, 0.76, 0.50 and 0.65 in the right eye and 0.84, 0.47, 0.72, 0.46 and 0.72 in the left eye, respectively. The estimated narrow-sense heritability of angular location of the superior and inferior vein was 0.17 and 0.12 in the right eye and 0.13 and 0.05 in the left eye, respectively. Conclusions ONH and surrounding structures such as vertical cup-to-disc ratio and the presence, the area and the location of beta-zone PPA seemed to be determined by the substantial genetic influence, whereas the venous angular location did not.	[Han, Jong Chul; Kim, Seung Hoon; Rhee, Taekkwan; Nam, Seung Wan; Hwang, Sungsoon; Lee, Ga-In; Kee, Changwon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Ko, Hyeonyoung; Song, Yun-Mi] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Sung, Joohon] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU)	Kee, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.; Song, YM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea.	yunmisong@skku.edu; ckee@skku.edu		Kim, Seung Hoon/0000-0002-7704-6213; Kee, Changwon/0000-0002-7419-0316	Korea Health Industry Development Institute [HI14C0064]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was funded by the Korea Health Industry Development Institute, HI14C0064, MD Phd Joohon Sung.; Korea Health Industry Development Institute, HI14C0064, MD Phd Joohon Sung.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Budde WM, 2004, AM J OPHTHALMOL, V137, P646, DOI 10.1016/j.ajo.2003.11.021; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Cho BJ, 2013, OPHTHALMOLOGY, V120, P528, DOI 10.1016/j.ophtha.2012.09.004; Dirani M, 2008, INVEST OPHTH VIS SCI, V49, P3324, DOI 10.1167/iovs.07-1498; Dirani M, 2006, INVEST OPHTH VIS SCI, V47, P4756, DOI 10.1167/iovs.06-0270; Drobnjak D, 2011, ACTA OPHTHALMOL, V89, pE193, DOI 10.1111/j.1755-3768.2010.01923.x; Ehrlich JR, 2010, CLIN OPHTHALMOL, V4, P971, DOI 10.2147/OPTH.S12420; Han JC, 2016, AM J OPHTHALMOL, V169, P33, DOI 10.1016/j.ajo.2016.06.005; Han JC, 2016, INVEST OPHTH VIS SCI, V57, P486, DOI 10.1167/iovs.15-17722; He MG, 2008, INVEST OPHTH VIS SCI, V49, P4790, DOI 10.1167/iovs.08-2130; He MG, 2008, INVEST OPHTH VIS SCI, V49, P1350, DOI 10.1167/iovs.07-1146; Healey P, 2008, INVEST OPHTH VIS SCI, V49, P77, DOI 10.1167/iovs.07-0962; Healey PR, 2007, INVEST OPHTH VIS SCI, V48, P2529, DOI 10.1167/iovs.06-0714; Hewitt AW, 2007, INVEST OPHTH VIS SCI, V48, P2469, DOI 10.1167/iovs.06-1470; Huntzinger R S, 1978, Prog Clin Biol Res, V24 Pt C, P241; Hwang YH, 2012, J GLAUCOMA, V21, P394, DOI 10.1097/IJG.0b013e3182182567; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Jonas JB, 2014, EYE, V28, P113, DOI 10.1038/eye.2013.223; JONAS JB, 1992, ARCH OPHTHALMOL-CHIC, V110, P214, DOI 10.1001/archopht.1992.01080140070030; Jonas JB, 1999, SURV OPHTHALMOL, V43, P293, DOI 10.1016/S0039-6257(98)00049-6; Jonas JB, 2002, OPHTHALMOLOGY, V109, P1561, DOI 10.1016/S0161-6420(02)01098-9; Jonas Jost B, 2005, Curr Opin Ophthalmol, V16, P84, DOI 10.1097/01.icu.0000156135.20570.30; Kawano J, 2006, AM J OPHTHALMOL, V142, P40, DOI 10.1016/j.ajo.2006.01.087; Keller MC, 2009, TWIN RES HUM GENET, V12, P8, DOI 10.1375/twin.12.1.8; Kim MH, 2013, INVEST OPHTH VIS SCI, V54, P3644, DOI 10.1167/iovs.12-11254; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Lim DH, 2015, INVEST OPHTH VIS SCI, V56, P3919, DOI 10.1167/iovs.14-15763; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Ohno-Matsui K, 2011, AM J OPHTHALMOL, V152, P256, DOI 10.1016/j.ajo.2011.01.052; Park HYL, 2014, AM J OPHTHALMOL, V157, P876, DOI 10.1016/j.ajo.2014.01.007; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Sanfilippo PG, 2009, PROG RETIN EYE RES, V28, P227, DOI 10.1016/j.preteyeres.2009.05.004; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P9023, DOI 10.1167/iovs.11-8183; Song YM, 2010, TWIN RES HUM GENET, V13, P223, DOI 10.1375/twin.13.3.223; Sung J, 2006, TWIN RES HUM GENET, V9, P844, DOI 10.1375/183242706779462822; Taarnhoj NCBB, 2005, INVEST OPHTH VIS SCI, V46, P3850, DOI 10.1167/iovs.05-0177; Taarnhoj NCBB, 2006, INVEST OPHTH VIS SCI, V47, P3539, DOI 10.1167/iovs.05-1372; Teng CC, 2010, OPHTHALMOLOGY, V117, P909, DOI 10.1016/j.ophtha.2009.10.016; Tezel G, 2000, OPHTHALMOLOGY, V107, P1194, DOI 10.1016/S0161-6420(00)00114-7; Xu L, 2007, AM J OPHTHALMOL, V144, P541, DOI 10.1016/j.ajo.2007.05.038	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187498	10.1371/journal.pone.0187498	http://dx.doi.org/10.1371/journal.pone.0187498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145429	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800016
J	Patel, S; Fok, SYY; Stefen, H; Tomanic, T; Paric, E; Herald, R; Brettle, M; Djordjevic, A; Fath, T				Patel, Shrujna; Fok, Sandra Y. Y.; Stefen, Holly; Tomanic, Tamara; Paric, Esmeralda; Herald, Rosanna; Brettle, Merryn; Djordjevic, Aleksandra; Fath, Thomas			Functional characterisation of filamentous actin probe expression in neuronal cells	PLOS ONE			English	Article							DENDRITIC SPINES; F-ACTIN; BINDING DOMAIN; GROWTH CONES; LIVE CELLS; CYTOSKELETON; TROPOMYOSIN; PROTEINS; DYNAMICS; LIFEACT	Genetically encoded filamentous actin probes, Lifeact, Utrophin and F-tractin, are used as tools to label the actin cytoskeleton. Recent evidence in several different cell types indicates that these probes can cause changes in filamentous actin dynamics, altering cell morphology and function. Although these probes are commonly used to visualise actin dynamics in neurons, their effects on axonal and dendritic morphology has not been systematically characterised. In this study, we quantitatively analysed the effect of Lifeact, Utrophin and F-tractin on neuronal morphogenesis in primary hippocampal neurons. Our data show that the expression of actin-tracking probes significantly impacts on axonal and dendrite growth these neurons. Lifeact-GFP expression, under the control of a pBABE promoter, caused a significant decrease in total axon length, while another Lifeact-GFP expression, under the control of a CAG promoter, decreased the length and complexity of dendritic trees. Utr261-EGFP resulted in increased dendritic branching but Utr230-EGFP only accumulated in cell soma, without labelling any neurites. Lifeact-7-mEGFP and F-tractin-EGFP in a pEGFP-C1 vector, under the control of a CMV promoter, caused only minor changes in neuronal morphology as detected by Sholl analysis. The results of this study demonstrate the effects that filamentous actin tracking probes can have on the axonal and dendritic compartments of neuronal cells and emphasise the care that must be taken when interpreting data from experiments using these probes.	[Patel, Shrujna; Fok, Sandra Y. Y.; Stefen, Holly; Tomanic, Tamara; Paric, Esmeralda; Herald, Rosanna; Brettle, Merryn; Djordjevic, Aleksandra; Fath, Thomas] Univ New South Wales, Sch Med Sci, NRU, Sydney, NSW, Australia; [Stefen, Holly; Fath, Thomas] Univ New South Wales, NCCF, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Fath, T (corresponding author), Univ New South Wales, Sch Med Sci, NRU, Sydney, NSW, Australia.; Fath, T (corresponding author), Univ New South Wales, NCCF, Sydney, NSW, Australia.	t.fath@unsw.edu.au	Patel, Shrujna/GRR-4623-2022	Patel, Shrujna/0000-0003-4928-692X; Tomanic, Tamara/0000-0002-3266-1271; Herold, Rosanna/0000-0002-2583-9131; Fath, Thomas/0000-0002-6877-7567	Australian National Health and Medical Research Council (NHMRC) [APP1083209]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC), TF https://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff of the Biological Resources Center of the Wallace Wurth animal facility for continuing support with mice. This work was supported by Project Grant APP1083209 from the Australian National Health and Medical Research Council (NHMRC) (T.F.).	BANKER G, 1998, CULTURING NERVE CELL; Belin Brittany J, 2014, Bioarchitecture, V4, P189, DOI 10.1080/19490992.2014.1047714; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Brock AR, 2012, J CELL SCI, V125, P5667, DOI 10.1242/jcs.107490; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Chen Q, 2012, J STRUCT BIOL, V177, P32, DOI 10.1016/j.jsb.2011.10.005; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; DANCKER P, 1975, BIOCHIM BIOPHYS ACTA, V400, P407, DOI 10.1016/0005-2795(75)90196-8; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; Du J, 2015, CYTOSKELETON, V72, P570, DOI 10.1002/cm.21262; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Falnikar A, 2013, CURR BIOL, V23, P1215, DOI 10.1016/j.cub.2013.05.027; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Frandemiche ML, 2014, J NEUROSCI, V34, P6084, DOI 10.1523/JNEUROSCI.4261-13.2014; Goins LM, 2015, MOL BIOL CELL, V26, P2491, DOI 10.1091/mbc.E14-12-1619; Habig K, 2013, BBA-MOL BASIS DIS, V1832, P2352, DOI 10.1016/j.bbadis.2013.09.009; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Inoue S, 2015, BIOMATER SCI-UK, V3, P1539, DOI 10.1039/c5bm00205b; Jang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039815; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Johnson HW, 2009, MOL BIOL CELL, V20, P5166, DOI 10.1091/mbc.E09-01-0083; Ladt K, 2016, METHOD CELL BIOL, V131, P91, DOI 10.1016/bs.mcb.2015.07.003; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Marsick BM, 2010, DEV NEUROBIOL, V70, P565, DOI 10.1002/dneu.20800; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Mishra M, 2014, FEMS MICROBIOL REV, V38, P213, DOI 10.1111/1574-6976.12064; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Neukirchen D, 2011, J NEUROSCI, V31, P1528, DOI 10.1523/JNEUROSCI.3983-10.2011; Penzes P, 2011, BRAIN RES REV, V67, P184, DOI 10.1016/j.brainresrev.2011.01.003; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; Saengsawang W, 2013, J CELL SCI, V126, P2411, DOI 10.1242/jcs.117473; Schevzov G, 1997, MOL CELL NEUROSCI, V8, P439, DOI 10.1006/mcne.1997.0599; Schevzov G, 2012, INT REV CEL MOL BIO, V298, P33, DOI 10.1016/B978-0-12-394309-5.00002-X; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Spracklen AJ, 2014, DEV BIOL, V393, P209, DOI 10.1016/j.ydbio.2014.06.022; Sun Y, 2011, J NEUROSCI, V31, P17123, DOI 10.1523/JNEUROSCI.2359-11.2011; Tanokashira D, 2012, J NEUROSCI, V32, P14583, DOI 10.1523/JNEUROSCI.2380-12.2012; Tsushima H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8781; Wilson C, 2015, J CELL SCI, V128, P2989, DOI 10.1242/jcs.168567; WINDER SJ, 1995, J CELL SCI, V108, P63; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187979	10.1371/journal.pone.0187979	http://dx.doi.org/10.1371/journal.pone.0187979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145435	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800045
J	Sauter, TC; Iten, N; Schwab, PR; Hautz, WE; Ricklin, ME; Exadaktylos, AK				Sauter, Thomas C.; Iten, Nora; Schwab, Patrik R.; Hautz, Wolf E.; Ricklin, Meret E.; Exadaktylos, Aristomenis K.			Out-of-hospital cardiac arrests in Switzerland: Predictors for emergency department mortality in patients with ROSC or on-going CPR on admission to the emergency department	PLOS ONE			English	Article							RESUSCITATION OUTCOMES CONSORTIUM; INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; EURECA ONE-27 NATIONS; STROKE FOUNDATION; SOUTHERN AFRICA; ONE REGISTRY; ONE EUROPE; SURVIVAL; GENDER	Background One of the leading causes of death is out-of-hospital cardiac arrest (OHCA) with an in-hospital mortality of about 70%. To identify predictors for the high mortality of OHCA patients and especially for women, that are considered at high risk for in-hospital mortality, we evaluated one specific setting of in-hospital treatment after OHCA: the emergency department (ED). Methods Retrospective analysis of consecutive ED admissions with OHCA at the Inselspital Bern, Switzerland from 1st June 2012 to 31th Mai 2015. Demographic, preclinical and ED medical data were compared for patient groups with return of circulation (ROSC) and on-going resuscitation (CPR) on admission, as well as for subgroups with and without ED mortality. Predictors for ED mortality were investigated using univariate analysis with logistic regression. Results In 354 patients (228 (64.4%) with ROSC; 126 (35.6%) with on-going CPR) we found an overall ED mortality of 28.5% (5.7% ROSC group; 69.8% on-going CPR group). Female gender (OR 7.053 (CI 95% 2.085; 24.853), p = 0.002) and greater age (OR 1.052 (95% CI 1.006-1.101), p = 0.029) were associated with ED mortality in the ROSC but not in the ongoing CPR group. Ventricular fibrillation as initially monitored rhythm (OR 0.126 (95% CI 0.027-0.582), p = 0.008) and shorter CPR duration (OR 1.055 (95% CI 1.024; 1.088), p = 0.001) were associated with ED survival in patients with ROSC but not in patients with ongoing CPR on admission. In ROSC patients a higher lactate and lower pH were associated with mortality (pH: OR 0.009 (CI95% 0.000; 0.420), p = 0.016; lactate: OR 1.183 (95% CI 1.037; 1.349), p = 0.013); similar in on-going CPR patients (pH 0.061 (95% CI 0.007, 0.558), p = 0.013, lactate: 1.146 (95% CI 1.041; 1.261), p = 0.005). Conclusion Patients with ROSC who died during ED care were predominantly women and older patients, as well as patients with non-shockable initial heart rhythm and long CPR durations. In patients with on-going CPR on admission, no clinical or demographic predictors for ED mortality were found. Higher lactate and lower pH were predictors in both OHCA groups.	[Sauter, Thomas C.; Iten, Nora; Schwab, Patrik R.; Hautz, Wolf E.; Ricklin, Meret E.; Exadaktylos, Aristomenis K.] Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland; [Schwab, Patrik R.] Sanitaetspolizei Bern, Emergency Med Serv, Bern, Switzerland	University of Bern; University Hospital of Bern	Sauter, TC (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, Bern, Switzerland.	thomas.sauter@insel.ch	Ricklin, Meret Elisabeth/AAY-7948-2021	Ricklin, Meret Elisabeth/0000-0003-3047-9350; Sauter, Thomas C/0000-0002-6646-5789; Hautz, Wolf/0000-0002-2445-984X				Bougouin W, 2015, RESUSCITATION, V94, P55, DOI 10.1016/j.resuscitation.2015.06.018; Daya MR, 2015, RESUSCITATION, V91, P108, DOI 10.1016/j.resuscitation.2015.02.003; Exadaktylos A, 2015, ICU MANAG 2015, V15, P160; Grasner JT, 2016, RESUSCITATION, V105, P188, DOI 10.1016/j.resuscitation.2016.06.004; Hasan OF, 2014, CURR MED RES OPIN, V30, P2169, DOI 10.1185/03007995.2014.936552; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Morrison LJ, 2007, RESUSCITATION, V74, P266, DOI 10.1016/j.resuscitation.2007.01.009; Morrison LJ, 2016, RESUSCITATION, V100, P76, DOI 10.1016/j.resuscitation.2015.12.002; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Verbeek PR, 2002, ACAD EMERG MED, V9, P671, DOI 10.1197/aemj.9.7.671; Whittaker A, 2016, POSTGRAD MED J, V92, P250, DOI 10.1136/postgradmedj-2015-133575; Wnent J, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0093-3	16	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188180	10.1371/journal.pone.0188180	http://dx.doi.org/10.1371/journal.pone.0188180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145510	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800081
J	Lomax, S; Harris, C; Windsor, PA; White, PJ				Lomax, Sabrina; Harris, Charissa; Windsor, Peter A.; White, Peter J.			Topical anaesthesia reduces sensitivity of castration wounds in neonatal piglets	PLOS ONE			English	Article							SURGICAL CASTRATION; PAIN MANAGEMENT; RESPONSES; LAMBS; FORMULATION; ALLEVIATION; BEHAVIOR; CALVES; PIGS	The aim of this study was to do determine the efficacy of the topical anaesthetic Tri-Solfen (R) in the amelioration of the pain of castration in piglets. The trial was conducted over a three day period, and blocked across six litters with 12 piglets treated on days one and two, and 16 on day three. The piglets were randomly allocated by weight and litter to 1 of 4 treatment groups: (i) sham castration (SHAM; n = 10); (ii) surgical castration with no anaesthetic intervention (CAST; n = 10); (iii) surgical castration with post-operative topical anaesthesia (TRI; n = 10); (iv) surgical castration with a pre-operative intra-testicular lignocaine hydrochloride injection (LIG; n = 10). Wound sensitivity testing involved von Frey monofilaments of weights 4g and 300g, and an 18 gauge needle, used to stimulate the wound and surrounding skin respectively, at various pre-determined sites. Neonatal piglets receiving topical anaesthesia (Tri-Solfen (R)) spray into castration wounds had significantly lower wound sensitivity responses for up to 4h, compared to those castrated following intra-testicular lignocaine injection or those with no treatment. The use of topical anaesthetic is suggested as a practical and affordable method of improving piglet welfare during castration.	[Lomax, Sabrina; Harris, Charissa; Windsor, Peter A.] Univ Sydney, Sch Life & Environm Sci, Fac Sci, Camperdown, NSW, Australia; [White, Peter J.] Univ Sydney, Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia	University of Sydney; University of Sydney	White, PJ (corresponding author), Univ Sydney, Sch Vet Sci, Fac Sci, Camperdown, NSW, Australia.	p.white@sydney.edu.au	White, Peter J/B-5208-2013	Lomax, Sabrina/0000-0002-6417-5788; White, Peter/0000-0002-9742-4939	Australian Pork Limited	Australian Pork Limited(Australian Pork Limited)	This work was funded by Australian Pork Limited with topical anaesthetic formulation supplied by Bayer Animal Health. The funder had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarpal, 2002, J VET MED A, V49, P3, DOI 10.1046/j.1439-0442.2002.00385.x; Beteg F, 2011, VET MED, V57, P217; Brofeldt B T, 1989, J Burn Care Rehabil, V10, P63, DOI 10.1097/00004630-198901000-00009; Espinoza C, 2013, J DAIRY SCI, V96, P2894, DOI 10.3168/jds.2012-5954; Hay M, 2003, APPL ANIM BEHAV SCI, V82, P201, DOI 10.1016/S0168-1591(03)00059-5; Jaggin N., 2006, ACTA VET SCAND, V48, P12; Jellish WS, 1999, ANN SURG, V229, P115, DOI 10.1097/00000658-199901000-00015; Kokinsky E, 1999, ACTA ANAESTH SCAND, V43, P225, DOI 10.1034/j.1399-6576.1999.430219.x; Lomax S, 2008, AUST VET J, V86, P159, DOI 10.1111/j.1751-0813.2008.00285.x; Lomax S, 2013, J ANIM SCI, V91, P4945, DOI 10.2527/jas.2012-5984; Lomax S, 2013, AUST VET J, V91, P160, DOI 10.1111/avj.12031; Lomax S, 2010, AUST VET J, V88, P67, DOI 10.1111/j.1751-0813.2009.00546.x; MCGLONE JJ, 1988, J ANIM SCI, V66, P3049; MCGLONE JJ, 1993, J ANIM SCI, V71, P1441, DOI 10.2527/1993.7161441x; Meyer H, 2007, J VET MED A, V54, P384, DOI 10.1111/j.1439-0442.2007.00942.x; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; Paull DR, 2007, AUST VET J, V85, P98, DOI 10.1111/j.1751-0813.2007.00115.x; Prunier A, 2006, ANIM WELFARE, V15, P277; Ren Ke, 1999, ILAR J, V40, P111; Sutherland MA, 2015, NEW ZEAL VET J, V63, P52, DOI 10.1080/00480169.2014.961990; Sutherland MA, 2010, ANIMAL, V4, P2071, DOI 10.1017/S1751731110001291; Telles FG, 2016, VET ANIM SCI, V1-2, P36, DOI 10.1016/j.vas.2016.11.003; Turton J. D., 1962, Animal Breeding Abstracts, V30, P447; US National Library of Medicine, 2010, EPH EPIN INJ SOL; WHITE RG, 1995, J ANIM SCI, V73, P381	25	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187988	10.1371/journal.pone.0187988	http://dx.doi.org/10.1371/journal.pone.0187988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140997	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400041
J	Nilsson, A; Salo, I; Plaza, M; Bjorck, I				Nilsson, Anne; Salo, Ilkka; Plaza, Merichel; Bjorck, Inger			Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults	PLOS ONE			English	Article							SUPPLEMENTATION IMPROVES MEMORY; ANTIOXIDANT CAPACITY; WORKING-MEMORY; LIQUID-CHROMATOGRAPHY; UNIVERSAL RESPONSE; METABOLIC SYNDROME; INSULIN; MEN; DISEASE; GLUCOSE	Background Berries and associated bioactive compounds, e.g. polyphenols and dietary fibre (DF), may have beneficial implications with respect to the metabolic syndrome, including also cognitive functions. The aim of this study was to evaluate effects on cognitive functions and cardiometabolic risk markers of 5 wk intervention with a mixture of berries, in healthy humans. Methods Forty healthy subjects between 50-70 years old were provided a berry beverage based on a mixture of berries (150g blueberries, 50g blackcurrant, 50g elderberry, 50g lingonberries, 50g strawberry, and 100g tomatoes) or a control beverage, daily during 5 weeks in a randomized crossover design. The control beverage (water based) was matched with respect to monosaccharides, pH, and volume. Cognitive tests included tests of working memory capacity, selective attention, and psychomotor reaction time. Cardiometabolic test variables investigated were blood pressure, fasting blood concentrations of glucose, insulin, blood lipids, inflammatory markers, and markers of oxidative stress. Results The daily amounts of total polyphenols and DF from the berry beverage were 795 mg and 11g, respectively. There were no polyphenols or DF in the control beverage. The berry intervention reduced total- and LDL cholesterol compared to baseline (both P<0.05), and in comparison to the control beverage (P<0.005 and P<0.01, respectively). The control beverage increased glucose concentrations (P<0.01) and tended to increase insulin concentrations (P = 0.064) from base line, and increased insulin concentrations in comparison to the berry beverage (P<0.05). Subjects performed better in the working memory test after the berry beverage compared to after the control beverage (P<0.05). No significant effects on the other test variables were observed. Conclusions The improvements in cardiometabolic risk markers and cognitive performance after the berry beverage suggest preventive potential of berries with respect to type 2 diabetes, cardiovascular disease, and associated cognitive decline. Possibly the polyphenols and DF contributed to the beneficial effects.	[Nilsson, Anne; Bjorck, Inger] Lund Univ, Food Hlth Sci Ctr, Lund, Sweden; [Nilsson, Anne] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Salo, Ilkka] Lund Univ, Dept Psychol, Lund, Sweden; [Plaza, Merichel] Lund Univ, Dept Chem, Ctr Anal & Synth, Lund, Sweden; [Plaza, Merichel] Univ Alcala, Dept Analyt Chem Phys Chem & Chem Engn, Madrid, Spain	Lund University; Lund University; Lund University; Lund University; Universidad de Alcala	Nilsson, A (corresponding author), Lund Univ, Food Hlth Sci Ctr, Lund, Sweden.; Nilsson, A (corresponding author), Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden.	anne.nilsson@food-health-science.lu.se	Plaza, Merichel/J-6770-2013	Plaza, Merichel/0000-0002-9636-6458; Nilsson, Anne/0000-0002-9780-7876	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University [2009-04511]	Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University	This study was supported by the Antidiabetic Food Centre, a VINNOVA VINN Excellence Center at Lund University (grant no. 2009-04511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL: http://www.food-health-science.lu.se/en/afc.	Basu A, 2010, J NUTR, V140, P1582, DOI 10.3945/jn.110.124701; Bielli A, 2015, LIFE SCI, V143, P209, DOI 10.1016/j.lfs.2015.11.012; Brand-Miller JC, 2003, NUTR REV, V61, pS49, DOI 10.1301/nr.2003.may.S49-S55; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Chen L, 2014, J SCI FOOD AGR, V94, P180, DOI 10.1002/jsfa.6216; Chiou JF, 1999, CLIN BIOCHEM, V32, P189, DOI 10.1016/S0009-9120(98)00110-6; Ciocoiu M, 2016, PHARM BIOL, P1; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; de Villiers A, 2007, J CHROMATOGR A, V1161, P183, DOI 10.1016/j.chroma.2007.05.078; Devore EE, 2013, AM J EPIDEMIOL, V177, P33, DOI 10.1093/aje/kws202; Devore EE, 2012, ANN NEUROL, V72, P135, DOI 10.1002/ana.23594; Edirisinghe I, 2011, BRIT J NUTR, V106, P913, DOI 10.1017/S0007114511001176; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Erlund I, 2008, AM J CLIN NUTR, V87, P323, DOI 10.1093/ajcn/87.2.323; Escudero-Lopez B, 2013, J AGR FOOD CHEM, V61, P8773, DOI 10.1021/jf401240p; Faria A, 2014, FOOD CHEM, V149, P190, DOI 10.1016/j.foodchem.2013.10.095; Gammone MA, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.26762; Gorecki T, 2006, ANAL CHEM, V78, P3186, DOI 10.1021/ac060078j; Grooms KN, 2013, AM J MED, V126, P1059, DOI 10.1016/j.amjmed.2013.07.023; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P25, DOI 10.1021/jf970489o; Horszwald A, 2011, J BERRY RES, V1, P189, DOI 10.3233/BR-2011-020; Hosseinpour-Niazi S, 2012, ARCH IRAN MED, V15, P538, DOI 012159/AIM.005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23625; Kahkonen MP, 2003, J SCI FOOD AGR, V83, P1403, DOI 10.1002/jsfa.1511; Kosar M, 2005, FOOD CHEM, V91, P525, DOI 10.1016/j.foodchem.2004.06.029; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332; Krikorian R, 2010, BRIT J NUTR, V103, P730, DOI 10.1017/S0007114509992364; Kyllonen PC, 1996, HUMAN ABILITIES, P49; Li W, 2016, J ALZHEIMERS DIS, V53, P393, DOI 10.3233/JAD-160114; Lim DW, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120760; Magalhaes LM, 2008, ANAL CHIM ACTA, V613, P1, DOI 10.1016/j.aca.2008.02.047; Mane C, 2011, J AGR FOOD CHEM, V59, P3330, DOI 10.1021/jf103965b; Matthews DR., HOMEOSTASIS MODEL AS; McIntyre RS, 2012, BEHAV BRAIN RES; Mitic MN, 2011, HEM IND, V65, P611, DOI 10.2298/HEMIND110418042M; Molinett S, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/320136; Mursu J, 2014, AM J CLIN NUTR, V99, P328, DOI 10.3945/ajcn.113.069641; Nilsson A, 2009, EUR J CLIN NUTR, V63, P113, DOI 10.1038/sj.ejcn.1602900; Nilsson AC, 2015, BR J NUTR, P1; Nilsson A, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-49; Otles S, 2014, ACTA SCI POLON-TECHN, V13, P191, DOI 10.17306/J.AFS.2014.2.8; Park JH, 2015, EVID-BASED COMPL ALT, V2015; Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009; Perez-Jimenez J, EJCN S3, V64, pS112; Plaza M, 2014, J AGR FOOD CHEM, V62, P409, DOI 10.1021/jf404263k; Pounis G, 2015, THROMB HAEMOST, V115; Radeborg K, 1999, ERGONOMICS, V42, P767, DOI 10.1080/001401399185441; Raffaitin C, 2011, NEUROLOGY, V76, P518, DOI 10.1212/WNL.0b013e31820b7656; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rissanen TH, 2003, J NUTR, V133, P199, DOI 10.1093/jn/133.1.199; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sparkman NL, 2006, J NEUROSCI, V26, P10709, DOI 10.1523/JNEUROSCI.3376-06.2006; Spencer JPE, 2012, MOL ASPECTS MED, V33, P83, DOI 10.1016/j.mam.2011.10.016; Stroher DJ, 2015, INT J FOOD SCI NUTR, V66, P559, DOI 10.3109/09637486.2015.1064870; Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336; Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x; Torronen R, 2012, AM J CLIN NUTR, V96, P527, DOI 10.3945/ajcn.112.042184; Torronen R, 2010, BRIT J NUTR, V103, P1094, DOI 10.1017/S0007114509992868; Tuberoso CIG, 2013, FOOD CHEM, V140, P686, DOI 10.1016/j.foodchem.2012.09.071; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095323; Yamashita S, 2009, CLIN CHIM ACTA, V410, P31, DOI 10.1016/j.cca.2009.09.010; Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325; Yin QQ, 2014, NEUROPHARMACOLOGY, V86, P389, DOI 10.1016/j.neuropharm.2014.07.020; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	67	45	46	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188173	10.1371/journal.pone.0188173	http://dx.doi.org/10.1371/journal.pone.0188173			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141041	Green Published, gold			2022-12-27	WOS:000415260400067
J	Virgone-Carlotta, A; Lemasson, M; Mertani, HC; Diaz, JJ; Monnier, S; Dehoux, T; Delanoe-Ayari, H; Riviere, C; Rieu, JP				Virgone-Carlotta, Angelique; Lemasson, Manon; Mertani, Hichem C.; Diaz, Jean-Jacques; Monnier, Sylvain; Dehoux, Thomas; Delanoe-Ayari, Helene; Riviere, Charlotte; Rieu, Jean-Paul			In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil	PLOS ONE			English	Article							CANCER CELL-LINE; COLORECTAL-CANCER; MECHANICAL-PROPERTIES; MULTIDRUG-RESISTANCE; CULTURE MODELS; DRUG; PENETRATION; TISSUE; 3-D; PROGRESSION	MultiCellular Tumor Spheroids (MCTS), which mimic the 3-Dimensional (3D) organization of a tumor, are considered as better models than conventional cultures in 2-Dimensions (2D) to study cancer cell biology and to evaluate the response to chemotherapeutic drugs. A real time and quantitative follow-up of MCTS with simple and robust readouts to evaluate drug efficacy is still missing. Here, we evaluate the chemotherapeutic drug 5-Fluorouracil (5-FU) response on the growth and integrity of MCTS two days after treatment of MCTS and for three colorectal carcinoma cell lines with different cohesive properties (HT29, HCT116 and SW480). We found different sensitivity to 5-FU for the three CRC cell lines, ranging from high (SW480), intermediate (HCT116) and low (HT29) and the same hierarchy of CRC cell lines sensitivity is conserved in 2D. We also evidence that 5-FU has a strong impact on spheroid cohesion, with the apparition of a number of single detaching cells from the spheroid in a 5-FU dose-and cell line-dependent manner. We propose an innovative methodology for the chemosensitivity evaluation in 3D MCTS that recapitulates and regionalizes the 5-FU-induced changes within MCTS over time. These robust phenotypic read-outs could be easily scalable for high-throughput drug screening that may include different types of cancer cells to take into account tumor heterogeneity and resistance to treatment.	[Virgone-Carlotta, Angelique; Lemasson, Manon; Monnier, Sylvain; Dehoux, Thomas; Delanoe-Ayari, Helene; Riviere, Charlotte; Rieu, Jean-Paul] Univ Claude Bernard Lyon 1, CNRS, Inst Lumiere Matiere, Villeurbanne, France; [Mertani, Hichem C.; Diaz, Jean-Jacques] UMR INSERM 1052 CNRS Ctr Leon Berard, Ctr Rech Cancerol Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Rieu, JP (corresponding author), Univ Claude Bernard Lyon 1, CNRS, Inst Lumiere Matiere, Villeurbanne, France.	jean-paul.rieu@univ-lyon1.fr	DIAZ, Jean-Jacques/H-3018-2014; Delanoe-ayari, Helene/A-2085-2013; MERTANI, Hichem-Claude/AAR-6415-2020; DIAZ, Jean-Jacques/AAT-3846-2021	DIAZ, Jean-Jacques/0000-0002-7914-4319; Delanoe-ayari, Helene/0000-0002-8658-3942; DIAZ, Jean-Jacques/0000-0002-7914-4319; dehoux, thomas/0000-0003-0808-4037; Riviere, Charlotte/0000-0002-5048-5662; Monnier, Sylvain/0000-0003-1087-0459	ITMO Cancer [PC201507]	ITMO Cancer	This study was supported by the ITMO Cancer within the frame of the Programme Plan Cancer 2014-2019 (No. PC201507) and was initiated by Labexi MUST (2012-2013).	Adcock AF, 2015, J ANAL BIOANAL TECH, V6; Arul M, 2017, IN VITRO CELL DEV-AN, V53, P435, DOI 10.1007/s11626-016-0126-x; Bash-Imam Z, 2017, ONCOTARGET; CARLSSON J, 1989, EUR J CANCER CLIN ON, V25, P1127, DOI 10.1016/0277-5379(89)90404-5; Charoen KM, 2014, BIOMATERIALS, V35, P2264, DOI 10.1016/j.biomaterials.2013.11.038; Choi MS, 2011, ONCOL REP, V25, P863, DOI 10.3892/or.2011.1138; Ciasca G, 2016, WORLD J GASTROENTERO, V22, P7203, DOI 10.3748/wjg.v22.i32.7203; Daster S, 2017, ONCOTARGET, V8, P1725, DOI 10.18632/oncotarget.13857; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; Deng YC, 2001, WORLD J GASTROENTERO, V7, P93; El-Bahrawy M, 2004, INT J EXP PATHOL, V85, P65, DOI 10.1111/j.0959-9673.2004.0371.x; ERLICHMAN C, 1991, ANTICANCER RES, V11, P671; Fan XL, 2011, INT J COLORECTAL DIS, V26, P1279, DOI 10.1007/s00384-011-1248-y; Focaccetti C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115686; Foty RA, 2013, FUTURE ONCOL, V9, P1121, DOI [10.2217/FON.13.66, 10.2217/fon.13.66]; Friedrich J, 2007, INT J RADIAT BIOL, V83, P849, DOI 10.1080/09553000701727531; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; GLIMELIUS B, 1988, APMIS, V96, P433, DOI 10.1111/j.1699-0463.1988.tb05327.x; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Green SK, 2004, MOL CANCER THER, V3, P149; Hewitt RE, 2000, J PATHOL, V192, P446; Hoffmann OI, 2015, J BIOTECHNOL, V205, P14, DOI 10.1016/j.jbiotec.2015.02.029; Kalashnikova I., 2016, DRUG DELIVERY PRINCI, P131; Karlsson H, 2012, EXP CELL RES, V318, P1577, DOI 10.1016/j.yexcr.2012.03.026; Katt ME, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00012; KunzSchughart LA, 1997, IN VITRO CELL DEV-AN, V33, P73; Laurent J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-73; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Lowthers EL, 2003, IN VITRO CELL DEV-AN, V39, P340; Lu CL, 2016, TUMOR BIOL, V37, P1319, DOI 10.1007/s13277-015-3873-5; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Mhaidat NM, 2014, ONCOL LETT, V8, P699, DOI 10.3892/ol.2014.2211; NEDERMAN T, 1984, CANCER CHEMOTH PHARM, V13, P131; Pachenari M, 2014, J BIOMECH, V47, P373, DOI 10.1016/j.jbiomech.2013.11.020; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Qureshi-Baig K, 2016, PLOS ONE, V11; Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398; Sagara A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164250; Santo VE, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600505; Schmidmaier R, 2008, CURR MED CHEM, V15, P978, DOI 10.2174/092986708784049667; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Shi WB, 2014, J PHARM SCI-US, V103, P1064, DOI 10.1002/jps.23860; Spill F, 2016, CURR OPIN BIOTECHNOL, V40; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; SUTHERLAND RM, 1970, INT J RADIAT BIOL RE, V18, P491, DOI 10.1080/09553007014551401; Thakuri PS, 2016, MOL PHARMACEUT, V13, P3724, DOI 10.1021/acs.molpharmaceut.6b00527; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yue XS, 2016, J PROTEOME RES, V15, P4265, DOI 10.1021/acs.jproteome.6b00342	50	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188100	10.1371/journal.pone.0188100	http://dx.doi.org/10.1371/journal.pone.0188100			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141026	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400056
J	Hermansen, SK; Sorensen, MD; Hansen, A; Knudsen, S; Alvarado, AG; Lathia, JD; Kristensen, BW				Hermansen, Simon K.; Sorensen, Mia D.; Hansen, Anker; Knudsen, Steen; Alvarado, Alvaro G.; Lathia, Justin D.; Kristensen, Bjarne W.			A 4-miRNA signature to predict survival in glioblastomas	PLOS ONE			English	Article							MICRORNA EXPRESSION; ADJUVANT TEMOZOLOMIDE; MIR-21 EXPRESSION; PROBE LEVEL; GLIOMA; PATHWAYS; CELLS; RADIOTHERAPY; CLASSIFICATION; CONCOMITANT	Glioblastomas are among the most lethal cancers; however, recent advances in survival have increased the need for better prognostic markers. microRNAs (miRNAs) hold great prognostic potential being deregulated in glioblastomas and highly stable in stored tissue specimens. Moreover, miRNAs control multiple genes representing an additional level of gene regulation possibly more prognostically powerful than a single gene. The aim of the study was to identify a novel miRNA signature with the ability to separate patients into prognostic subgroups. Samples from 40 glioblastoma patients were included retrospectively; patients were comparable on all clinical aspects except overall survival enabling patients to be categorized as short-term or long-term survivors based on median survival. A miRNome screening was employed, and a prognostic profile was developed using leave-one-out cross-validation. We found that expression patterns of miRNAs; particularly the four miRNAs: hsa-miR-107_st, hsa-miR-548x_st, hsa-miR-3125_st and hsa-miR-331-3p_st could determine short- and long-term survival with a predicted accuracy of 78%. Heatmap dendrograms dichotomized glioblastomas into prognostic subgroups with a significant association to survival in univariate (HR 8.50; 95% CI 3.0623.62; p<0.001) and multivariate analysis (HR 9.84; 95% CI 2.9333.06; p<0.001). Similar tendency was seen in The Cancer Genome Atlas (TCGA) using a 2-miRNA signature of miR-107 and miR-331 (miR sum score), which were the only miRNAs available in TCGA. In TCGA, patients with O6-methylguanine-DNA-methyltransferase (MGMT) unmethylated tumors and low miR sum score had the shortest survival. Adjusting for age and MGMT status, low miR sum score was associated with a poorer prognosis (HR 0.66; 95% CI 0.450.97; p = 0.033). A Kyoto Encyclopedia of Genes and Genomes analysis predicted the identified miRNAs to regulate genes involved in cell cycle regulation and survival. In conclusion, the biology of miRNAs is complex, but the identified 4-miRNA expression pattern could comprise promising biomarkers in glioblastoma stratifying patients into short- and long-term survivors.	[Hermansen, Simon K.; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Hermansen, Simon K.; Sorensen, Mia D.; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Hansen, Anker; Knudsen, Steen] Med Prognosis Inst, Horsholm, Denmark; [Alvarado, Alvaro G.; Lathia, Justin D.] Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, Cleveland, OH 44106 USA; [Alvarado, Alvaro G.; Lathia, Justin D.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44106 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Sorensen, MD (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Sorensen, MD (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	Mia.Soerensen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Lathia, Justin/AHB-8296-2022; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Hermansen, Simon Kjaer/0000-0002-6420-8199; Sorensen, Mia Dahl/0000-0002-0105-2940	Region of Southern Denmark; Danish Council for Independent Research	Region of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The work was supported by the Region of Southern Denmark and The Danish Council for Independent Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areeb Z, 2015, J NEURO-ONCOL, V125, P237, DOI 10.1007/s11060-015-1912-0; Barbano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108950; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Carlsen AL, 2013, PANCREAS, V42, P1107, DOI 10.1097/MPA.0b013e318296bb34; Chen L, 2015, CELLULAR MOL NEUROBI; Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen L, 2013, J NEURO-ONCOL, V112, P59, DOI 10.1007/s11060-012-1037-7; Chen L, 2013, NEUROSCI LETT, V534, P327, DOI 10.1016/j.neulet.2012.11.047; Cheng W, 2015, ONCOTARGET, V6, P29285, DOI 10.18632/oncotarget.4978; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dahlrot RH, 2013, INT J CLIN EXP PATHO, V6, P31; Delgado-Lopez PD, 2016, SURVIVAL GLIOBLASTOM; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Epis MR, 2014, J NEURO-ONCOL, V116, P67, DOI 10.1007/s11060-013-1271-7; Fazi B, 2015, ONCOTARGET, V6, P22526, DOI 10.18632/oncotarget.4151; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giles KM, 2011, METHODS MOL BIOL, V676, P147, DOI 10.1007/978-1-60761-863-8_11; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Hayes J, 2015, MOL ONCOL, V9, P704, DOI 10.1016/j.molonc.2014.11.004; Hegi ME, 2015, NEURO-ONCOLOGY, V17, P1425, DOI 10.1093/neuonc/nov198; Hermansen SK, 2013, J NEURO-ONCOL, V114, P13, DOI 10.1007/s11060-013-1155-x; Hermansen SK, 2013, J NEURO-ONCOL, V111, P71, DOI 10.1007/s11060-012-0992-3; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jensen SS, 2013, NEUROSURGERY, V73, P868, DOI 10.1227/NEU.0000000000000118; Ji YC, 2015, TUMOR BIOL, V36, P4461, DOI 10.1007/s13277-015-3086-y; Jiang LL, 2010, AM J PATHOL, V177, P29, DOI 10.2353/ajpath.2010.090812; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kiriakidou M, 2005, METH MOL B, V309, P295; Kloosterhof NK, 2011, LANCET ONCOL, V12, P83, DOI 10.1016/S1470-2045(10)70053-X; Knudsen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115538; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Louis, 2016, WHO CLASSIFICATION G; Niyazi M, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-153; Ohgaki H, 2009, CANCER SCI, V100, P2235, DOI 10.1111/j.1349-7006.2009.01308.x; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Paravati AJ, 2011, J NEURO-ONCOL, V104, P339, DOI 10.1007/s11060-010-0499-8; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049918; Prahm KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174300; Simon JM, 2003, RADIOTHER ONCOL, V67, P45, DOI 10.1016/S0167-8140(03)00007-0; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; The WHO, 2020, CLASSIFICATION TUMOU; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8; Winther M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148070; Wolter M, 2015, BRAIN PATHOLOGY ZURI; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	57	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188090	10.1371/journal.pone.0188090	http://dx.doi.org/10.1371/journal.pone.0188090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136645	Green Published, gold			2022-12-27	WOS:000415121200062
J	Elmi, M; Sirigireddy, B; Abukar, J; Tchipeva, D; Chauhan, N; Tsitsikas, DA				Elmi, M.; Sirigireddy, B.; Abukar, J.; Tchipeva, D.; Chauhan, N.; Tsitsikas, D. A.			"Low platelet usage" haematology laboratories: To store or not to store?	PLOS ONE			English	Article								In the UK, hospitals with annual platelet use of less than 500 pools, like our institution, usually do not store platelets on-site and these are only ordered from the national blood service (NBS) when a transfusion is required. In 2016, we piloted routine on-site storage of one pool of A RhD negative PLT. Data were collected retrospectively on units of PLTs ordered from NBS, units transfused to patients, wastage, requirements for emergency deliveries from NBS and overall cost. These were compared to corresponding data from the four preceding years (2012-2015). There was a 39% reduction in the PLT ordered from NBS in 2016 compared to previous years and a 50% reduction in transfused PLT. Annual wastage for 2016 increased by 23% even though the absolute number of wasted PLT did not alter significantly. Annual cost reduced by 36% in 2016 resulting from reduction in the total amount of PLTs ordered as well as reduction in emergency deliveries.	[Elmi, M.; Sirigireddy, B.; Abukar, J.; Tchipeva, D.; Chauhan, N.; Tsitsikas, D. A.] Homerton Univ Hosp NHS Fdn Trust, Haematol & Blood Transfus Dept, London, England		Tsitsikas, DA (corresponding author), Homerton Univ Hosp NHS Fdn Trust, Haematol & Blood Transfus Dept, London, England.	dimitris.tsitsikas@nhs.net	Tsitsikas, Dimitris A./AGL-2303-2022; TSITSIKAS, DIMITRIS/GNW-3079-2022	Tsitsikas, Dimitris A./0000-0003-3468-049X; Sirigireddy, Bala/0000-0002-5017-1196				Cotton S, SURVEY PLATELET INVE; Estcourt LJ, 2017, BRIT J HAEMATOL, V176, P365, DOI 10.1111/bjh.14423; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P132, DOI 10.2450/2009.0005-09	3	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187340	10.1371/journal.pone.0187340	http://dx.doi.org/10.1371/journal.pone.0187340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131870	Green Published, Green Submitted, gold			2022-12-27	WOS:000414997800011
J	Geddes, RI; Hayashi, K; Bongers, Q; Wehber, M; Anderson, IM; Jansen, AD; Nier, C; Fares, E; Farquhar, G; Kapoor, A; Ziegler, TE; Vadakkadath, S; Bird, MIM; Atwood, CS				Geddes, Rastafa I.; Hayashi, Kentaro; Bongers, Quinn; Wehber, Marlyse; Anderson, Icelle M.; Jansen, Alex D.; Nier, Chase; Fares, Emily; Farquhar, Gabrielle; Kapoor, Amita; Ziegler, Toni E.; Vadakkadath, Sivan; Bird, Meethal Ian M.; Atwood, Craig S.			Conjugated Linoleic Acid Administration Induces Amnesia in Male Sprague Dawley Rats and Exacerbates Recovery from Functional Deficits Induced by a Controlled Cortical Impact Injury (vol 12, e0169494, 2017)	PLOS ONE			English	Correction													, Craig/AAB-3963-2022					Geddes RI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169494	1	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188611	10.1371/journal.pone.0188611	http://dx.doi.org/10.1371/journal.pone.0188611			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161323	gold, Green Published			2022-12-27	WOS:000415987000068
J	Wang, L; Li, YJ; Xiong, Y; Tan, WB; Zhang, LY; Li, X; Wang, XS; Xu, JF; Li, TT; Wang, JS; Cai, MX; Xi, BD; Wang, DH				Wang, Lei; Li, Ying-Jun; Xiong, Ying; Tan, Wen-Bing; Zhang, Lie-Yu; Li, Xiang; Wang, Xiao-Shu; Xu, Jian-Feng; Li, Tong-Tong; Wang, Jin-Sheng; Cai, Ming-Xuan; Xi, Bei-Dou; Wang, Di-Hua			Spectroscopic characterization of DOM and the nitrogen removal mechanism during wastewater reclamation plant	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; REGIONAL-INTEGRATION ANALYSIS; BIO-REFRACTORY ORGANICS; SOIL AQUIFER TREATMENT; MUNICIPAL SOLID-WASTE; RECLAIMED WATER; MEMBRANE BIOREACTOR; NUTRIENT REMOVAL; FLUORESCENCE EXCITATION; LANDFILL LEACHATE	The performance of the Sha-he wastewater reclamation plant was evaluated in this study. To remove residual nitrogen after Anaerobic-Anoxic-Oxic (A(2)O) treatment, three multistage Anoxic-Oxic (A/O) were added to investigate the nitrogen removal efficiency and its mechanism. In addition, the constituents and evolution of dissolved organic matter (DOM) during wastewater reclamation was also investigated using a method combining fluorescence spectroscopy with fluorescence regional integration (FRI). The results suggested that multistage A/O treatment can effectively improve the nitrogen removal ability under low concentrations of carbon sources. The total nitrogen (TN) exhibits significantly positive correlation with fulvic acid-like materials and humic acid-like materials. The correlation coefficient for TN and fulvic acid-like substances (R-2 = 0.810, P < 0.01) removal was greater than that of humic acid-like substances (R-2 = 0.636, P < 0.05). The results indicate that nitrogen removal may be achieved with the fulvic-like and humic-like substances, and the removal effects were higher by fulvic acid-like substances than humic-like substances, mostly due to that the latter were relatively more difficult to be utilized as carbon source during the nitrogen removal process. The effluent water quality of biological treatment reached the first grade A standard of "Cities sewage treatment plant pollutant discharge standard" (GB18918-2002). In addition, the effluent from the membrane bioreactor reached the "Standards of reclaimed water quality" (SL368-2006).	[Wang, Lei; Wang, Xiao-Shu; Xi, Bei-Dou; Wang, Di-Hua] Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Hubei, Peoples R China; [Wang, Lei; Tan, Wen-Bing; Zhang, Lie-Yu; Li, Xiang; Xu, Jian-Feng; Li, Tong-Tong; Wang, Jin-Sheng; Cai, Ming-Xuan; Xi, Bei-Dou] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Simulat & Control, Beijing, Peoples R China; [Li, Ying-Jun] Beijing Vocat Coll Agr, Beijing, Peoples R China; [Xiong, Ying] Beijing Univ Civil Engn & Architecture, Key Lab Urban Storm Water Syst & Water Environm, Minist Educ, Beijing, Peoples R China; [Li, Tong-Tong] Capital Normal Univ, Coll Resource Environm & Tourism, Beijing, Peoples R China; [Cai, Ming-Xuan] Guilin Univ Technol, Coll Environm Sci & Engn, Guilin, Peoples R China	Wuhan University; Chinese Research Academy of Environmental Sciences; Beijing University of Civil Engineering & Architecture; Capital Normal University; Guilin University of Technology	Xi, BD; Wang, DH (corresponding author), Wuhan Univ, Sch Resources & Environm Sci, Wuhan, Hubei, Peoples R China.; Xi, BD (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, State Environm Protect Key Lab Simulat & Control, Beijing, Peoples R China.	xibeidou@263.net; Dihuawang@whu.edu.cn	Wang, Dihua/G-5728-2011	Wang, Dihua/0000-0003-2364-8718	National Natural Science Foundation of China [51678549]; Fundamental Research Funds for the Central Universities (Wuhan University) [201604398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Wuhan University)	This work was kindly supported by the National Natural Science Foundation of China (51678549) and the Fundamental Research Funds for the Central Universities (Wuhan University Duke initiative project 201604398).	Akizuki S, 2015, BIOCHEM ENG J, V99, P16, DOI 10.1016/j.bej.2015.01.009; Chang J, 2016, J CLEAN PROD, V141, P728; Chen W, 2003, ENVIRON SCI TECHNOL, V37, P5701, DOI 10.1021/es034354c; Chen YZ, 2011, BIORESOURCE TECHNOL, V102, P5722, DOI 10.1016/j.biortech.2011.02.114; Dignac MF, 2000, WATER RES, V34, P4185, DOI 10.1016/S0043-1354(00)00195-0; dos Santos LM, 2010, GEODERMA, V155, P121, DOI 10.1016/j.geoderma.2009.12.006; E. P. A. Chinese, 2012, METH WAT WAST AN; Essandoh HMK, 2011, WATER RES, V45, P4211, DOI 10.1016/j.watres.2011.05.017; Falahti-Marvast H, 2015, INT BIODETER BIODEGR, V104, P363, DOI 10.1016/j.ibiod.2015.07.001; He XS, 2013, CHEMOSPHERE, V93, P2208, DOI 10.1016/j.chemosphere.2013.04.039; He XS, 2011, J HAZARD MATER, V190, P293, DOI 10.1016/j.jhazmat.2011.03.047; He XS, 2011, BIORESOURCE TECHNOL, V102, P2322, DOI 10.1016/j.biortech.2010.10.085; He XS, 2011, CHEMOSPHERE, V82, P541, DOI 10.1016/j.chemosphere.2010.10.057; Hong JM, 2016, BIORESOURCE TECHNOL, V212, P280, DOI 10.1016/j.biortech.2016.04.042; Hu HY, 2016, SCI TOTAL ENVIRON, V551, P133, DOI 10.1016/j.scitotenv.2015.12.111; Hu YS, 2013, J MEMBRANE SCI, V431, P156, DOI 10.1016/j.memsci.2013.01.001; Hu ZR, 2002, WATER RES, V36, P4927, DOI 10.1016/S0043-1354(02)00186-0; Hudson N, 2008, SCI TOTAL ENVIRON, V391, P149, DOI 10.1016/j.scitotenv.2007.10.054; Jaffe R, 2004, MAR CHEM, V84, P195, DOI 10.1016/j.marchem.2003.08.001; Levine AD, 2004, ENVIRON SCI TECHNOL, V38, p201A, DOI 10.1021/es040504n; Lyko S, 2008, J MEMBRANE SCI, V317, P78, DOI 10.1016/j.memsci.2007.07.008; Ma XYY, 2016, J HAZARD MATER, V318, P663, DOI 10.1016/j.jhazmat.2016.07.050; Mannina G, 2016, CHEM ENG J, V296, P289, DOI 10.1016/j.cej.2016.03.114; Meneses M, 2010, CHEMOSPHERE, V81, P266, DOI 10.1016/j.chemosphere.2010.05.053; Michael-Kordatou I, 2015, WATER RES, V77, P213, DOI 10.1016/j.watres.2015.03.011; Peng YZ, 2011, BIORESOURCE TECHNOL, V102, P6405, DOI 10.1016/j.biortech.2011.03.043; Pollice A, 2008, J MEMBRANE SCI, V317, P65, DOI 10.1016/j.memsci.2007.08.051; Qu FS, 2012, WATER RES, V46, P2881, DOI 10.1016/j.watres.2012.02.045; Rice J, 2015, ENVIRON SCI TECHNOL, V49, P982, DOI 10.1021/es5048057; Roccaro P, 2014, CHEM ENGINEER TRANS, V37, P817, DOI 10.3303/CET1437137; Ryu HD, 2014, SEP PURIF TECHNOL, V136, P199, DOI 10.1016/j.seppur.2014.09.003; Said-Pullicino D, 2007, CHEMOSPHERE, V66, P2166, DOI 10.1016/j.chemosphere.2006.09.010; Shao ZH, 2009, J HAZARD MATER, V164, P1191, DOI 10.1016/j.jhazmat.2008.09.035; Sun FQ, 2015, J HAZARD MATER, V286, P416, DOI 10.1016/j.jhazmat.2015.01.031; Wang YK, 2013, CHEM ENG SCI, V95, P78, DOI 10.1016/j.ces.2013.03.025; Wang ZC, 2016, BIORESOURCE TECHNOL, V205, P213, DOI 10.1016/j.biortech.2016.01.067; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x; Wu FC, 2004, BIOGEOCHEMISTRY, V71, P339, DOI 10.1007/s10533-004-0058-5; Wu LN, 2016, BIORESOURCE TECHNOL, V212, P296, DOI 10.1016/j.biortech.2016.04.041; Wu L, 2016, SEP PURIF TECHNOL, V170, P306, DOI 10.1016/j.seppur.2016.06.033; Wu LN, 2015, BIORESOURCE TECHNOL, V198, P207, DOI 10.1016/j.biortech.2015.08.072; Xia XH, 2009, ENVIRON SCI TECHNOL, V43, P3681, DOI 10.1021/es8036675; Xu JY, 2014, J ENVIRON SCI, V26, P1961, DOI 10.1016/j.jes.2014.07.008; Xu M, 2016, INT J HYDROGEN ENERG, V41, P15930, DOI 10.1016/j.ijhydene.2016.05.020; Yang L, 2016, J ENVIRON SCI, V50, P93, DOI 10.1016/j.jes.2016.05.023; Zeng W, 2010, BIORESOURCE TECHNOL, V101, P8074, DOI 10.1016/j.biortech.2010.05.098; Zhang M, 2016, BIOCHEM ENG J, V106, P26, DOI 10.1016/j.bej.2015.10.027; Zhang Zhi-yin, 2006, Fudan Xuebao Zirankexueban, V45, P755; Zhao X, 2014, J ENVIRON SCI-CHINA, V26, P2190, DOI 10.1016/j.jes.2014.09.001	49	8	8	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187355	10.1371/journal.pone.0187355	http://dx.doi.org/10.1371/journal.pone.0187355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149172	gold, Green Submitted, Green Published			2022-12-27	WOS:000415646100010
J	Beurmann, S; Ushijima, B; Videau, P; Svoboda, CM; Smith, AM; Rivers, OS; Aeby, GS; Callahan, SM				Beurmann, Silvia; Ushijima, Blake; Videau, Patrick; Svoboda, Christina Marie; Smith, Ashley Marie; Rivers, Orion Silverstar; Aeby, Greta Smith; Callahan, Sean Michael			Pseudoalteromonas piratica strain OCN003 is a coral pathogen that causes a switch from chronic to acute Montipora white syndrome in Montipora capitata	PLOS ONE			English	Article							DISEASE OUTBREAK; ELKHORN CORAL; BAND DISEASE; KANEOHE BAY; VIBRIO; VIRULENCE; DYNAMICS; BACTERIA; FLAGELLA; PROTEIN	Reports of mass coral mortality from disease have increased over the last two decades. Montipora white syndrome (MWS) is a tissue loss disease that has negatively impacted populations of the coral Montipora capitata in Kane 'ohe Bay, Hawai'i. Two types of MWS have been documented; a progressive disease termed chronic MWS (cMWS), that can be caused by Vibrio owensii strain OCN002, and a comparatively faster disease termed acute MWS (aMWS), that can be caused by Vibrio coralliilyticus strain OCN008. M. capitata colonies exhibiting cMWS can spontaneously switch to aMWS in the field. In this study, a novel Pseudoalteromonas species, P. piratica strain OCN003, fulfilled Koch's postulates of disease causation as another etiological agent of aMWS. Additionally, OCN003 induced a switch from cMWS to aMWS on M. capitata in laboratory infection trials. A comparison of OCN003 and Vibrio coralliilyticus strain OCN008, showed that OCN003 was more effective at inducing the cMWS to aMWS switch in M. capitata than OCN008. This study is the first to demonstrate that similar disease signs on one coral species (aMWS on M. capitata) can be caused by multiple pathogens, and describes the first Pseudoalteromonas species that infects coral.	[Beurmann, Silvia; Svoboda, Christina Marie; Smith, Ashley Marie; Rivers, Orion Silverstar; Callahan, Sean Michael] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA; [Beurmann, Silvia; Svoboda, Christina Marie; Smith, Ashley Marie; Aeby, Greta Smith; Callahan, Sean Michael] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Ushijima, Blake] Oregon State Univ, Coll Vet Med, Corvallis, OR 97331 USA; [Videau, Patrick] Dakota State Univ, Coll Arts & Sci, Madison, SD USA; [Beurmann, Silvia] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	University of Hawaii System; University of Hawaii Manoa; Oregon State University; Dakota State University; University System of Maryland; University of Maryland Baltimore	Beurmann, S (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.; Beurmann, S (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.; Beurmann, S (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	sbeurmann@som.umaryland.edu	Smith, Ashley/GZB-0298-2022	Ushijima, Blake/0000-0002-1053-5207; Grant, Silvia/0000-0001-5713-9212	NOAA [NA06NOS4260200, NA12NOS4820070]	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was supported by NOAA grant numbers NA06N0S4260200 and NA12N0S4820070 to GSA and SMC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NOAA grant numbers NA06NOS4260200 and NA12NOS4820070 to GSA and SMC. The authors would like to thank I. Booth and A. Unzueta Martinez for laboratory assistance and T. Carvalho for TEM sample preparation. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2016, DIS AQUAT ORGAN, V119, P189, DOI 10.3354/dao02996; ANTONIUS AA, 1973, NEW OBSERVATIONS COR; Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Beurmann S, 2016, DIS AQUAT ORGAN; Beurmann S, 2015, GENOME ANNOUNC  0115, V3; Beurmann S, 2017, INT J SYST EVOL MICR; Bigot A, 2005, INFECT IMMUN, V73, P5530, DOI 10.1128/IAI.73.9.5530-5539.2005; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Bourne DG, 2005, CORAL REEFS, V24, P304, DOI 10.1007/s00338-005-0479-1; Brandt ME, 2012, B MAR SCI, V88, P1035, DOI 10.5343/bms.2011.1104; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Cardenas A, 2012, ISME J, V6, P502, DOI 10.1038/ismej.2011.123; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; FALKOW S, 1988, REV INFECT DIS, V10, pS274; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Ghose C, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.8; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Grunenfelder B, 2003, J BACTERIOL, V185, P1624, DOI 10.1128/JB.185.5.1624-1633.2003; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kellogg CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079801; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; LEGNANIFAJARDO C, 1991, CAN J MICROBIOL, V37, P325, DOI 10.1139/m91-052; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Pollock FJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.02799-16; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; RICHARDSON K, 1991, INFECT IMMUN, V59, P2727, DOI 10.1128/IAI.59.8.2727-2736.1991; Ritchie KB, 2004, CORAL HEALTH AND DISEASE, P259; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sato Y, 2010, ISME J, V4, P203, DOI 10.1038/ismej.2009.103; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Smith Aaron P., 2008, THESIS; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; STEINMETZ M, 1985, MOL GEN GENET, V200, P220, DOI 10.1007/BF00425427; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Ushijima B, 2016, ENVIRON MICROBIOL, V18, P4055, DOI 10.1111/1462-2920.13428; Ushijima B, 2014, APPL ENVIRON MICROB, V80, P2102, DOI 10.1128/AEM.03463-13; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wolk CP, 2007, ARCH MICROBIOL, V188, P551, DOI 10.1007/s00203-007-0276-z; Woodley CM, 2016, DIS OF CORAL; Work TM, 2012, P R SOC B	57	20	22	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188319	10.1371/journal.pone.0188319	http://dx.doi.org/10.1371/journal.pone.0188319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145488	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800112
J	Kratzig, T; Mohme, M; Mende, KC; Eicker, SO; Floeth, FW				Kraetzig, Theresa; Mohme, Malte; Mende, Klaus C.; Eicker, Sven O.; Floeth, Frank W.			Impact of the surgical strategy on the incidence of C5 nerve root palsy in decompressive cervical surgery	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; OF-THE-LITERATURE; MYELOPATHY; LAMINECTOMY; ANTERIOR; FUSION; SPINE; INJURY	Objective Our aim was to identify the impact of different surgical strategies on the incidence of C5 palsy. Background Degenerative cervical spinal stenosis is a steadily increasing morbidity in the ageing population. Postoperative C5 nerve root palsy is a common complication with severe impact on the patients A quality of life. Methods We identified 1708 consecutive patients who underwent cervical decompression surgery due to degenerative changes. The incidence of C5 palsy and surgical parameters including type and level of surgery were recorded to identify predictors for C5 nerve palsy. Results The overall C5 palsy rate was 4.8%, with 18.3% of cases being bilateral. For ACDF alone the palsy rate was low (1.13%), compared to 14.0% of C5 palsy rate after corpectomy. The risk increased with extension of the procedures. Hybrid constructs with corpectomy plus ACDF at C3-6 showed significantly lower rates of C5 palsy (10.7%) than corpectomy of two vertebrae (p = 0.005). Multiple regression analysis identified corpectomy of C4 or C5 as a significant predictor. We observed a lower overall incidence for ventral (4.3%) compared to dorsal (10.9%) approaches (p<0.001). When imaging detected a postoperative shift of the spinal cord at index segment C4/5, palsy rate increased significantly (33.3% vs. 12.5%, p = 0.034). Conclusions Extended surgical strategies, such as dorsal laminectomies, multilevel corpectomies and procedures with extensive spinal cord shift were shown to display a high risk of C5 palsy. The use of extended procedures should therefore be employed cautiously. Switching to combined surgical methods like ACDF plus corpectomy can reduce the rate of C5 palsy.	[Kraetzig, Theresa; Mohme, Malte; Mende, Klaus C.; Eicker, Sven O.] Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany; [Floeth, Frank W.] Hosp Heilig Geist, Dept Spine Surg, Kempen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Kratzig, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurosurg, Hamburg, Germany.	t.kraetzig@uke.de	Mende, Klaus Christian/I-5313-2019	Mende, Klaus Christian/0000-0003-4317-1718				Alleyne CH, 1998, SURG NEUROL, V50, P213, DOI 10.1016/S0090-3019(97)00315-7; Baba S, 2016, ASIAN SPINE J, V10, P298, DOI 10.4184/asj.2016.10.2.298; Basaran R, 2016, EUR SPINE J, V25, P2050, DOI 10.1007/s00586-016-4567-4; Blizzard DJ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0297-2; Bose B, 2007, J NEUROSURG-SPINE, V6, P381, DOI 10.3171/spi.2007.6.5.381; Bydon M, 2014, NEUROSURGERY, V74, P595, DOI 10.1227/NEU.0000000000000322; Chang PY, 2013, J CHIN MED ASSOC, V76, P378, DOI 10.1016/j.jcma.2013.03.008; Chen Y, 2013, ARCH ORTHOP TRAUM SU, V133, P171, DOI 10.1007/s00402-012-1658-5; Chiba K, 2002, SPINE, V27, P2108, DOI 10.1097/00007632-200210010-00006; Choi KC, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2011.03.043; Currier BL, 2012, SPINE, V37, pE328, DOI 10.1097/BRS.0b013e3182417276; Eskander MS, 2012, J BONE JOINT SURG AM, V94A, P1605, DOI 10.2106/JBJS.K.00664; Fan DP, 2002, SPINE, V27, P2499, DOI 10.1097/00007632-200211150-00014; Guo QF, 2011, ARCH ORTHOP TRAUM SU, V131, P631, DOI 10.1007/s00402-010-1181-5; Guzman JZ, 2014, BONE JOINT J, V96B, P950, DOI 10.1302/0301-620X.96B7.33665; Hasegawa K, 2007, SPINE, V32, pE197, DOI 10.1097/01.brs.0000257576.84646.49; HIRABAYASHI K, 1988, SPINE, V13, P870, DOI 10.1097/00007632-198807000-00032; Hung LK, 2003, CLIN ORTHOP RELAT R, P131, DOI 10.1097/01.blo.0000053596.94145.57; Imagama S, 2010, J BONE JOINT SURG BR, V92B, P393, DOI 10.1302/0301-620X.92B3.22786; Jimenez JC, 2005, J NEUROSURG-SPINE, V3, P92, DOI 10.3171/spi.2005.3.2.0092; Katsumi K, 2012, SPINE, V37, P748, DOI 10.1097/BRS.0b013e3182326957; Komagata M, SPINE J, V4, P650; Lim C-H, 2016, EUR SPINE J; Liu Tielong, 2010, Orthopedics, V33, DOI 10.3928/01477447-20100625-08; Lubelski D, 2014, SPINE J, V14, P1895, DOI 10.1016/j.spinee.2013.10.038; Millstone DB, 2017, J BONE JOINT SURG AM, V99, DOI 10.2106/JBJS.16.00843; Nakashima H, 2012, J NEUROSURG-SPINE, V17, P103, DOI 10.3171/2012.4.SPINE11255; Nassr A, 2012, SPINE, V37, P174, DOI 10.1097/BRS.0b013e318219cfe9; Odate S, 2013, SPINE, V38, P2184, DOI 10.1097/BRS.0000000000000019; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Sasai K, 2003, SPINE, V28, P1972, DOI 10.1097/01.BRS.0000083237.94535.46; SHINOMIYA K, 1994, SPINE, V19, P2501, DOI 10.1097/00007632-199411001-00002; Shou FY, 2015, EUR SPINE J, V24, P2724, DOI 10.1007/s00586-015-4186-5; Su TW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001655; Yang LL, 2013, ORTHOPEDICS, V36, pE79, DOI 10.3928/01477447-20121217-23	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188338	10.1371/journal.pone.0188338	http://dx.doi.org/10.1371/journal.pone.0188338			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145512	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800115
J	Mainali, KP; Bewick, S; Thielen, P; Mehoke, T; Breitwieser, FP; Paudel, S; Adhikari, A; Wolfe, J; Slud, EV; Karig, D; Fagan, WF				Mainali, Kumar P.; Bewick, Sharon; Thielen, Peter; Mehoke, Thomas; Breitwieser, Florian P.; Paudel, Shishir; Adhikari, Arjun; Wolfe, Joshua; Slud, Eric V.; Karig, David; Fagan, William F.			Statistical analysis of co-occurrence patterns in microbial presence-absence datasets	PLOS ONE			English	Article							NULL MODELS; COMMUNITIES; DISPERSAL; HABITAT; SIMILARITY; DIVERSITY; ABUNDANCE; REGIONS; FOREST; FISH	Drawing on a long history in macroecology, correlation analysis of microbiome datasets is becoming a common practice for identifying relationships or shared ecological niches among bacterial taxa. However, many of the statistical issues that plague such analyses in macroscale communities remain unresolved for microbial communities. Here, we discuss problems in the analysis of microbial species correlations based on presence-absence data. We focus on presence-absence data because this information is more readily obtainable from sequencing studies, especially for whole-genome sequencing, where abundance estimation is still in its infancy. First, we show how Pearson's correlation coefficient (r) and Jaccard's index (J)-two of the most common metrics for correlation analysis of presence-absence data-can contradict each other when applied to a typical microbiome dataset. In our dataset, for example, 14% of species-pairs predicted to be significantly correlated by r were not predicted to be significantly correlated using J, while 37.4% of species-pairs predicted to be significantly correlated by J were not predicted to be significantly correlated using r. Mismatch was particularly common among species-pairs with at least one rare species (<10% prevalence), explaining why r and J might differ more strongly in microbiome datasets, where there are large numbers of rare taxa. Indeed 74% of all species-pairs in our study had at least one rare species. Next, we show how Pearson's correlation coefficient can result in artificial inflation of positive taxon relationships and how this is a particular problem for microbiome studies. We then illustrate how Jaccard's index of similarity (J) can yield improvements over Pearson's correlation coefficient. However, the standard null model for Jaccard's index is flawed, and thus introduces its own set of spurious conclusions. We thus identify a better null model based on a hypergeometric distribution, which appropriately corrects for species prevalence. This model is available from recent statistics literature, and can be used for evaluating the significance of any value of an empirically observed Jaccard's index. The resulting simple, yet effective method for handling correlation analysis of microbial presence-absence datasets provides a robust means of testing and finding relationships and/or shared environmental responses among microbial taxa.	[Mainali, Kumar P.; Bewick, Sharon; Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Thielen, Peter; Mehoke, Thomas; Wolfe, Joshua; Karig, David] Johns Hopkins Appl Phys Lab, Res & Exploratory Dev Dept, Laurel, MD USA; [Breitwieser, Florian P.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Ctr Computat Biol, Baltimore, MD USA; [Paudel, Shishir] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Adhikari, Arjun] Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA; [Slud, Eric V.] Univ Maryland, Dept Math, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Oklahoma State University System; Oklahoma State University - Stillwater; Montana State University System; Montana State University Bozeman; University System of Maryland; University of Maryland College Park	Mainali, KP (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	kpmainali@gmail.com	Paudel, Shishir/H-6813-2019; Paudel, Shishir/AFU-7369-2022; Mainali, Kumar/AFM-6006-2022; Karig, David/AAT-9108-2020	Paudel, Shishir/0000-0002-0794-5096; Karig, David/0000-0002-9508-6411; Breitwieser, Florian P/0000-0001-6192-0853; Mainali, Kumar/0000-0001-7470-8173; Thielen, Peter/0000-0003-1807-2785	U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-14-1-0490]	U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office	This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number #W911NF-14-1-0490.; Simulation was performed partly at Texas Advanced Computing Center (TACC), The University of Texas at Austin. We thank John Fonner at TACC for assistance with the supercomputer environment and Niti Mishra for making his cluster available for computing. This material is based upon work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office under contract/grant number #W911NF-14-1-0490.	Acevedo P, 2012, J BIOGEOGR, V39, P1383, DOI 10.1111/j.1365-2699.2012.02713.x; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Adkins JK, 2013, NAT AREA J, V33, P31, DOI 10.3375/043.033.0104; Aitchison J., 1986, THE STATISTICAL ANAL; Aryal Achyut, 2012, Diversity-Basel, V4, P301; Baba K, 2004, AUST NZ J STAT, V46, P657, DOI 10.1111/j.1467-842X.2004.00360.x; BARONIURBANI C, 1980, OECOLOGIA, V44, P287, DOI 10.1007/BF00545229; Bauer A, 2016, ECOSCIENCE, V23, P41, DOI 10.1080/11956860.2016.1213107; Beaune D, 2013, J TROP ECOL, V29, P367, DOI 10.1017/S0266467413000515; Berry D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00219; Bila K, 2013, J INSECT CONSERV, V17, P257, DOI 10.1007/s10841-012-9504-1; BIRKS HJB, 1987, ANN ZOOL FENN, V24, P165; Brooks JP, 2016, ANN EPIDEMI IN PRESS; Buckley M, 2011, RARE BIOSPHERE REPOR; Casella G., 2002, STAT INFERENCE, V2nd; CHEETHAM A H, 1969, Journal of Paleontology, V43, P1130; Chen SY, 2016, J COMPUT BIOL, V23, P229, DOI 10.1089/cmb.2015.0214; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Dalla Riva G V, 2015, OIKOS; Dapporto L, 2014, J BIOGEOGR, V41, P1639, DOI 10.1111/jbi.12315; Diamond J.M., 1975, P342; Dossou-Yovo HO, 2016, ENV ECOL RES, V4, P200; Fa JE, 2014, CONSERV BIOL, V28, P224, DOI 10.1111/cobi.12151; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Ferenti S, 2012, ARCH BIOL SCI, V64, P1029, DOI [10.2298/ABS12030291, 10.2298/ABS1203029F]; Fisher CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102451; Garcia-Abad JJ, 2010, LANDSCAPE URBAN PLAN, V95, P138, DOI 10.1016/j.landurbplan.2009.12.011; Garcia-Barros E, 2002, J BIOGEOGR, V29, P109, DOI 10.1046/j.1365-2699.2002.00653.x; Gause GF, 1934, STRUGGLE EXISTENCE; Goodman SM, 2005, ANIM CONSERV, V8, P153, DOI 10.1017/S136794300500199X; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.2307/177478; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Griffith DM, 2016, J STAT SOFTW, V69, P1; Frias-De Leon MG, 2016, AEROBIOLOGIA, V32, P187, DOI 10.1007/s10453-015-9389-z; Guilford J. P, 1942, FUNDAMENTAL STAT PSY; Hilje B, 2015, TROP CONSERV SCI, V8, P76, DOI 10.1177/194008291500800109; HUBALEK Z, 1982, BIOL REV, V57, P669, DOI 10.1111/j.1469-185X.1982.tb00376.x; Hubbell Stephen P., 2001, V32, pi; Huse S., 2012, SEQUENCING ERRORS DI; JACKSON DA, 1992, AM NAT, V139, P930, DOI 10.1086/285367; JACKSON DA, 1989, AM NAT, V133, P436, DOI 10.1086/284927; JANSON S, 1981, OECOLOGIA, V49, P371, DOI 10.1007/BF00347601; Johnston MA, 2010, J APPL MICROBIOL, V108, P965, DOI 10.1111/j.1365-2672.2009.04498.x; Kain EC, 2016, ENVIRON SCI POLLUT R, V23, P23951, DOI 10.1007/s11356-016-7613-1; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kittur S, 2010, EUR J WILDLIFE RES, V56, P195, DOI 10.1007/s10344-009-0302-3; Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002; Lashley MA, 2016, WILDLIFE RES, V43, P254, DOI 10.1071/WR15008; Lavers JL, 2016, MAR ENVIRON RES, V113, P1, DOI 10.1016/j.marenvres.2015.10.011; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Lee CL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037897, 10.1371/journal.pone.0030077]; LESCHINE SB, 1995, ANNU REV MICROBIOL, V49, P399, DOI 10.1146/annurev.mi.49.100195.002151; Li Y, 2014, SCI WORLD J, V2014; Lu J, BIORXIV; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Manjon-Cabeza M. E., 2001, Boletin Instituto Espanol de Oceanografia, V17, P263; Manjon-Cabeza ME, 1998, J NAT HIST, V32, P1619, DOI 10.1080/00222939800771151; Barbosa AM, 2015, METHODS ECOL EVOL, V6, P853, DOI 10.1111/2041-210X.12372; Barbosa AM, 2012, J BIOGEOGR, V39, P1391, DOI 10.1111/j.1365-2699.2012.02762.x; Marquez AL, 2001, ECOGRAPHY, V24, P659, DOI 10.1034/j.1600-0587.2001.240605.x; McLoughlin K., 2016, TECHNICAL REPORT BEN; Meadow JF, 2013, PEERJ, V1, DOI 10.7717/peerj.53; Misic AM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-014-0052-7; Morelli F, 2014, POL J ECOL, V62, P361, DOI 10.3161/104.062.0214; Saiz JCM, 2013, J BIOGEOGR, V40, P90, DOI 10.1111/j.1365-2699.2012.02774.x; Nakamura K, 2009, J BIOGEOGR, V36, P919, DOI 10.1111/j.1365-2699.2008.02057.x; Namgail T, 2013, CURR ZOOL, V59, P116, DOI 10.1093/czoolo/59.1.116; Neto LM, 2016, BRAZ J BOT, V39, P261, DOI 10.1007/s40415-015-0238-7; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Otuoma J., 2014, Journal of Horticulture and Forestry, V6, P38; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pueyo Y, 2008, ECOL APPL, V18, P954, DOI 10.1890/07-1770.1; Quinn LD, 2008, NAT AREA J, V28, P356, DOI 10.3375/0885-8608(2008)28[356:GOIPSA]2.0.CO;2; Real R., 1999, Miscellania Zoologica (Barcelona), V22, P29; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Reyes-Montes MR, 2009, REV ARGENT MICROBIOL, V41, P102; Rivera-Ortiz FA, 2013, REV MEX BIODIVERS, V84, P1200, DOI 10.7550/rmb.34953; Romo H, 2010, J ZOOL, V282, P180, DOI 10.1111/j.1469-7998.2010.00730.x; RYTI RT, 1987, OECOLOGIA, V73, P282, DOI 10.1007/BF00377519; Sala C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0858-8; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Trosvik P, 2015, ISME J, V9, P533, DOI 10.1038/ismej.2014.147; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van Opijnen T, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005869; Vargas JM, 1998, ECOGRAPHY, V21, P371, DOI 10.1111/j.1600-0587.1998.tb00402.x; Veech JA, 2013, GLOBAL ECOL BIOGEOGR, V22, P252, DOI 10.1111/j.1466-8238.2012.00789.x; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Vohnik M, 2009, MICROB ECOL, V57, P203, DOI 10.1007/s00248-008-9402-y; Wang Y, 1997, J BACTERIOL, V179, P3270, DOI 10.1128/jb.179.10.3270-3276.1997; Wang YP, 2010, DIVERS DISTRIB, V16, P862, DOI 10.1111/j.1472-4642.2010.00682.x; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Widder S, 2014, P NATL ACAD SCI USA, V111, P12799, DOI 10.1073/pnas.1411723111; Wilson JB, 2012, J VEG SCI, V23, P1013, DOI 10.1111/j.1654-1103.2012.01430.x; Winemiller KO, 2008, J BIOGEOGR, V35, P1551, DOI 10.1111/j.1365-2699.2008.01917.x; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zancolli G, 2014, DIVERS DISTRIB, V20, P297, DOI 10.1111/ddi.12161; Zhang ZG, 2014, ISME J, V8, P881, DOI 10.1038/ismej.2013.185; Zhou XY, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0344-6	108	20	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187132	10.1371/journal.pone.0187132	http://dx.doi.org/10.1371/journal.pone.0187132			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145425	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800011
J	Schaal, JB; Tran, DQ; Subramanian, A; Patel, R; Laragione, T; Roberts, KD; Trinh, K; Tongaonkar, P; Tran, PA; Minond, D; Fields, GB; Beringer, P; Ouellette, AJ; Gulko, PS; Selsted, ME				Schaal, Justin B.; Tran, Dat Q.; Subramanian, Akshay; Patel, Reshma; Laragione, Teresina; Roberts, Kevin D.; Trinh, Katie; Tongaonkar, Prasad; Tran, Patti A.; Minond, Dmitriy; Fields, Gregg B.; Beringer, Paul; Ouellette, Andre J.; Gulko, Percio S.; Selsted, Michael E.			Suppression and resolution of autoimmune arthritis by rhesus theta-defensin-1, an immunomodulatory macrocyclic peptide	PLOS ONE			English	Article							PRISTANE-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; HISTOCOMPATIBILITY COMPLEX; ANTIMICROBIAL ACTIVITIES; THETA-DEFENSINS; CHRONIC DISEASE; JOINT DAMAGE; SEVERITY; ALPHA	theta-defensins constitute a family of macrocyclic peptides expressed exclusively in Old World monkeys. The peptides are pleiotropic effectors of innate immunity, possessing broad spectrum antimicrobial activities and immunoregulatory properties. Here we report that rhesus theta-defensin 1 (RTD-1) is highly effective in arresting and reversing joint disease in a rodent model of rheumatoid arthritis (RA). Parenteral RTD-1 treatment of DA/OlaHsd rats with established pristane-induced arthritis (PIA) rapidly suppressed joint disease progression, restored limb mobility, and preserved normal joint architecture. RTD-1 significantly reduced joint IL-1 beta levels compared with controls. RTD-1 dose-dependently inhibited fibroblast-like synoviocyte (FLS) invasiveness and FLS IL-6 production. Consistent with the inhibition of FLS invasiveness, RTD-1 was a potent inhibitor of arthritogenic proteases including ADAMs 17 and 10 which activate TNF alpha, and inhibited matrix metalloproteases, and cathepsin K. RTD-1 was non-toxic, non-immunogenic, and effective when administered as infrequently as once every five days. Thus theta-defensins, which are absent in humans, have potential as retroevolutionary biologics for the treatment of RA.	[Schaal, Justin B.; Tran, Dat Q.; Subramanian, Akshay; Roberts, Kevin D.; Trinh, Katie; Tongaonkar, Prasad; Tran, Patti A.; Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Dept Pathol & Lab Med, Keck Sch Med, Los Angeles, CA 90007 USA; [Tran, Dat Q.] Oryn Therapeut, Vacaville, CA USA; [Patel, Reshma] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Laragione, Teresina; Gulko, Percio S.] Icahn Sch Med Mt Sinai, Div Rheumatol, Dept Med, New York, NY 10029 USA; [Minond, Dmitriy] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Fields, Gregg B.] Florida Atlantic Univ, Dept Chem & Biochem, Jupiter, FL USA; [Fields, Gregg B.] Scripps Res Inst, Jupiter, FL USA; [Beringer, Paul] Univ Southern Calif, Sch Pharm, Los Angeles, CA USA; [Ouellette, Andre J.; Selsted, Michael E.] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA	University of Southern California; Children's Hospital Los Angeles; Icahn School of Medicine at Mount Sinai; Torrey Pines Institute for Molecular Studies, Florida; State University System of Florida; Florida Atlantic University; Scripps Research Institute; University of Southern California; University of Southern California	Selsted, ME (corresponding author), Univ Southern Calif, Dept Pathol & Lab Med, Keck Sch Med, Los Angeles, CA 90007 USA.; Selsted, ME (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.	selsted@usc.edu	Beringer, Paul/AAD-7812-2022	Beringer, Paul/0000-0002-3744-3310; Schaal, Justin/0000-0002-0069-4917; Minond, Dmitriy/0000-0003-2473-5944	National Institute of Allergy and Infectious Diseases [AI22931]; Arthritis Foundation [5997]; National Institute of Dental and Craniofacial Research [DE021341]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR068833]; Wright Foundation; Southern California Clinical and Translational Science Institute [UL1TR000130]; National Cancer Institute [P30CA014089]; Seth MacFarlane Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R44AR068833] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wright Foundation; Southern California Clinical and Translational Science Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Seth MacFarlane Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funded by National Institute of Allergy and Infectious Diseases #AI22931 (MES) https://www.niaid.nih.gov/. Arthritis Foundation #5997 (MES) http://www.arthritis.org/. National Institute of Dental and Craniofacial Research #DE021341 (MES) http://www.nidcr.nih.gov. National Institute of Arthritis and Musculoskeletal and Skin Diseases #AR068833 (DQT) https://www.niams.nih.gov/. The Wright Foundation (PT) https://research.usc.edu/for-investigators/funding/usc/#wright. The Southern California Clinical and Translational Science Institute #UL1TR000130 (MES) http://www.sc-ctsi.org/. National Cancer Institute #P30CA014089 https://www.cancer.gov/. Seth MacFarlane Foundation. Oryn Therapeutics provided support in the form of salary for D.Q.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bhowmick M, 2015, CHEMBIOCHEM, V16, P1084, DOI 10.1002/cbic.201402716; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Brand DD, 2004, METH MOLEC MED, V102, P295; Brenner M, 2005, ARTHRITIS RHEUM-US, V52, P322, DOI 10.1002/art.20782; Brenner M, 2013, PHYSL GENOMICS; Brenner M, 2012, ARTHRITIS RHEUM-US, V64, P1369, DOI 10.1002/art.33468; Caporali R, 2009, AUTOIMMUN REV, V8, P274, DOI 10.1016/j.autrev.2008.11.003; CHOMARAT P, 1995, J IMMUNOL, V154, P1432; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Feldmann M, 2003, NAT MED, V9, P1245, DOI 10.1038/nm939; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Garcia AE, 2008, INFECT IMMUN, V76, P5883, DOI 10.1128/IAI.01100-08; Gulko PS, 2007, GENES IMMUN, V8, P523, DOI 10.1038/sj.gene.6364419; Hider SL, 2005, J RHEUMATOL, V32, P11; Holmberg J, 2006, J IMMUNOL, V176, P1172, DOI 10.4049/jimmunol.176.2.1172; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Hsu YH, 2010, ARTHRITIS RHEUM-US, V62, P3311, DOI 10.1002/art.27689; Jenkins E, 2012, GENES IMMUN, V13, P221, DOI 10.1038/gene.2011.73; Jiao Z., 2012, CLIN DEV IMMUNOL, V2012, P6, DOI DOI 10.1155/2012/350209; Joosten LAB, 1999, J IMMUNOL, V163, P5049; Keiserman M, 2014, EXPERT REV CLIN IMMU, V10, P1049, DOI 10.1586/1744666X.2014.926219; Laragione T, 2008, ARTHRITIS RHEUM-US, V58, P2296, DOI 10.1002/art.23610; Laragione T, 2012, MOL MED, V18, P1009, DOI 10.2119/molmed.2012.00173; Laragione T, 2012, MOL MED, V18, P194, DOI 10.2119/molmed.2011.00410; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; Laragione T, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2476; LEHRER RI, 1991, CELL, V64, P229, DOI 10.1016/0092-8674(91)90632-9; Lehrer RI, 2012, J BIOL CHEM, V287, P27014, DOI 10.1074/jbc.R112.346098; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McInnes IB, 2010, ANN RHEUM DIS, V69, P1898, DOI 10.1136/ard.2010.134684; Olofsson Peter, 2007, V136, P255; Patten C, 2004, ARTHRITIS RHEUM-US, V50, P3334, DOI 10.1002/art.20507; Rau R, 2004, CLIN EXP RHEUMATOL, V22, pS44; Schaal JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051337; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Setoguchi C, 2010, MOD RHEUMATOL, V20, P381, DOI 10.1007/s10165-010-0292-8; Shealy DJ, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar430; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Tongaonkar P, 2015, J LEUKOC BIOL; Tongaonkar P, 2011, J LEUKOCYTE BIOL, V89, P283, DOI 10.1189/jlb.0910535; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Tuncel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155936; VANDELOO AAJ, 1995, AM J PATHOL, V146, P239; Vingsbo C, 1996, AM J PATHOL, V149, P1675; Wang J, 2012, 2012 6TH ASIA-PACIFIC CONFERENCE ON ENVIRONMENTAL ELECTROMAGNETICS (CEEM' 2012), P10, DOI 10.1109/CEEM.2012.6410661; Wohlford-Lenane CL, 2009, J VIROL, V83, P11385, DOI 10.1128/JVI.01363-09; Yin GQ, 2005, LAB ANIM-UK, V39, P269, DOI 10.1258/0023677054306926; Yoshida Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698313; Zhu W, 2012, SCAND J IMMUNOL, V76, P263, DOI 10.1111/j.1365-3083.2012.02724.x	50	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187868	10.1371/journal.pone.0187868	http://dx.doi.org/10.1371/journal.pone.0187868			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145473	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800036
J	Tholking, G; Schuette-Nuetgen, K; Vogl, T; Dobrindt, U; Kahl, BC; Brand, M; Pavenstadt, H; Suwelack, B; Koch, R; Reuter, S				Thoelking, Gerold; Schuette-Nuetgen, Katharina; Vogl, Thomas; Dobrindt, Ulrich; Kahl, Barbara C.; Brand, Marcus; Pavenstaedt, Hermann; Suwelack, Barbara; Koch, Raphael; Reuter, Stefan			Male kidney allograft recipients at risk for urinary tract infection?	PLOS ONE			English	Article							ESCHERICHIA-COLI; IMMUNE-RESPONSES; RENAL-FUNCTION; H-Y; TRANSPLANTATION; SUSCEPTIBILITY; TESTOSTERONE; INTERLEUKIN-8; PREVALENCE; GENDER	Background Urinary tract infection (UTI) is the most common infection after renal transplantation (RTx). Although female sex is a well-known risk factor for the development of UTI after RTx, the role of the donor sex in this context remains unclear. Methods In this case control study 6,763 RTx cases were screened for UTI when presenting at our transplant outpatient clinics. 102 different RTx patients fulfilled the inclusion criteria and were compared to 102 controls. Data on renal function was prospectively followed for 12 months. Results were compared to a previous RTx cohort from our transplant center. Additionally, we assessed the immunological response of leukocytes from 58 kidney recipients and 16 controls to lipopolysaccharide stimulation. Result After identification by univariate analysis, multivariate logistic regression analysis indicated female sex, minor height, advanced age and male kidney allograft sex to be associated with the occurrence of UTI after RTx. Female recipients who received male grafts had the best renal function 12 months after presentation. However, leukocyte response of recipients to lipopolysaccharide was impaired irrespective of donor and recipient sex to the same extend. Conclusions We conclude from our data that male kidney allografts are associated with the occurrence of UTI after RTx but did not influence the response of leukocytes to lipopolysaccharide. Further prospective studies are needed to identify the underlying mechanisms of higher male kidney donor dependent UTI.	[Thoelking, Gerold; Schuette-Nuetgen, Katharina; Brand, Marcus; Pavenstaedt, Hermann; Suwelack, Barbara; Reuter, Stefan] Univ Hosp Munster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany; [Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, Munster, Germany; [Kahl, Barbara C.] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Koch, Raphael] Univ Munster, Inst Biostat & Clin Res, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster; University of Munster	Tholking, G (corresponding author), Univ Hosp Munster, Dept Med D, Div Gen Internal Med Nephrol & Rheumatol, Munster, Germany.	Gerold.Thoelking@ukmuenster.de	Koch, Raphael/A-7857-2013; Dobrindt, Ulrich/AEU-2378-2022	Koch, Raphael/0000-0002-5581-5122; Dobrindt, Ulrich/0000-0001-9949-1898	Deutsche Forschungsgemeinschaft [CRC 656 C7, CRC 656 A9, CRC 1009 B5, CRC 1009 B8]; University of Munster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Munster	This study was supported in part by the Deutsche Forschungsgemeinschaft (CRC 656 C7 and A9 to SR and TV, CRC 1009 B5 and B8 to TV). We acknowledge support by Open Access Publication Fund of University of Munster. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Alangaden GJ, 2006, CLIN TRANSPLANT, V20, P401, DOI 10.1111/j.1399-0012.2006.00519.x; Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; Antus B, 2002, TRANSPL INT, V15, P494, DOI 10.1111/j.1432-2277.2002.tb00205.x; Bodro M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.07.019; Dessing MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013394; Frendeus B, 2001, J INFECT DIS, V183, pS56, DOI 10.1086/318848; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Gratwohl A, 2008, LANCET, V372, P49, DOI 10.1016/S0140-6736(08)60992-7; Guo ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133270; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Ishigami J, 2016, AM J KIDNEY DIS; Kang MS, 2015, ANN REHABIL MED-ARM, V39, P686, DOI 10.5535/arm.2015.39.5.686; KASISKE BL, 1986, ARCH PATHOL LAB MED, V110, P55; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; Kwon JH, 2012, AM J CLIN PATHOL, V137, P778, DOI 10.1309/AJCP4KVGQZEG1YDM; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Liu XJ, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-70; Magliano E, 2012, SCI WORLD J, DOI 10.1100/2012/349597; Marcus N, 2005, PEDIATR INFECT DIS J, V24, P581, DOI 10.1097/01.inf.0000168743.57286.13; Oregioni O, 2005, CYTOKINE, V31, P415, DOI 10.1016/j.cyto.2005.06.009; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Pruenster M, 2016, PHARMACOL THERAPEUT, V167, P120, DOI 10.1016/j.pharmthera.2016.07.015; Robinson Dudley, 2013, Menopause Int, V19, P155, DOI 10.1177/1754045313511398; Rossaint J, 2016, J CLIN INVEST, V126, P962, DOI 10.1172/JCI83470; Sotto A, 2001, J CLIN MICROBIOL, V39, P438, DOI 10.1128/JCM.39.2.438-444.2001; Stapleton AE, 2014, INFECT DIS CLIN N AM, V28, P149, DOI 10.1016/j.idc.2013.10.006; Svanborg C, 2001, ANN MED, V33, P563, DOI 10.3109/07853890109002101; Tabibian JH, 2008, J CLIN MICROBIOL, V46, P3980, DOI 10.1128/JCM.00339-08; Tent H, 2011, AM J TRANSPLANT, V11, P2173, DOI 10.1111/j.1600-6143.2011.03687.x; Tholking G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32273; Tholking G, 2016, ANN TRANSPL, V21, P167; Tholking G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111128; Vavallo A, 2014, WORLD J UROL, V32, P709, DOI 10.1007/s00345-013-1137-9; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Wojciechowski D, 2013, TRANSPLANTATION, V96, P400, DOI 10.1097/TP.0b013e3182962cab; Wu XH, 2016, AM J INFECT CONTROL, V44, P1261, DOI 10.1016/j.ajic.2016.04.222	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188262	10.1371/journal.pone.0188262	http://dx.doi.org/10.1371/journal.pone.0188262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145515	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800103
J	Wegner, KA; Cadena, MT; Trevena, R; Turco, AE; Gottschalk, A; Halberg, RB; Guo, JJ; McMahon, JA; McMahon, AP; Vezina, CM				Wegner, Kyle A.; Cadena, Mark T.; Trevena, Ryan; Turco, Anne E.; Gottschalk, Adam; Halberg, Richard B.; Guo, Jinjin; McMahon, Jill A.; McMahon, Andrew P.; Vezina, Chad M.			An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections	PLOS ONE			English	Article							SMOOTH-MUSCLE; MOLECULAR REGULATION; ANDROGEN RECEPTOR; REACTIVE STROMA; EXPRESSION; CANCER; MODEL; MYOFIBROBLASTS; MARKERS; ORIGIN	Though many methods can be used to identify cell types contained in complex tissues, most require cell disaggregation and destroy information about where cells reside in relation to their microenvironment. Here, we describe a polytomous key for cell type identification in intact sections of adult mouse prostate and prostatic urethra. The key is organized as a decision tree and initiates with one round of immunostaining for nerve, epithelial, fibromuscular/ hematolymphoid, or vascular associated cells. Cell identities are recursively eliminated by subsequent staining events until the remaining pool of potential cell types can be distinguished by direct comparison to other cells. We validated our identification key using wild type adult mouse prostate and urethra tissue sections and it currently resolves sixteen distinct cell populations which include three nerve fiber types as well as four epithelial, five fibromuscular/ hematolymphoid, one nerve-associated, and three vascular-associated cell types. We demonstrate two uses of this novel identification methodology. We first used the identification key to characterize prostate stromal cell type changes in response to constitutive phosphatidylinositide-3-kinase activation in prostate epithelium. We then used the key to map cell lineages in a new reporter mouse strain driven by Wnt10a(em1(cre/ERT2)Amc). The identification key facilitates rigorous and reproducible cell identification in prostate tissue sections and can be expanded to resolve additional cell types as new antibodies and other resources become available.	[Wegner, Kyle A.; Cadena, Mark T.; Trevena, Ryan; Turco, Anne E.; Vezina, Chad M.] Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA; [Wegner, Kyle A.; Turco, Anne E.; Vezina, Chad M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Cadena, Mark T.] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Trevena, Ryan; Gottschalk, Adam; Vezina, Chad M.] Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA; [Halberg, Richard B.] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Madison, WI USA; [Halberg, Richard B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI USA; [Guo, Jinjin; McMahon, Jill A.; McMahon, Andrew P.] Univ Southern Calif, WM Keck Sch Med, Eli & Edythe Broad CIRM Ctr Regenerat Med & Stem C, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA; [Vezina, Chad M.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Vezina, CM (corresponding author), Univ Wisconsin, George M OBrien Benign Urol Ctr, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA.; Vezina, CM (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA.	chad.vezina@wisc.edu	McMahon, Andrew P/ABE-7520-2020; Vezina, Chad/GRO-2299-2022	Vezina, Chad/0000-0001-7058-5399; Wegner, Kyle/0000-0003-1309-0060	National Institutes of Health [R01ES001332, R01DK099328, U54 DK104310, T32 ES007015, NIH DK094526, R01CA179556, R01 CA123438]; American Motorcycle Association Ride for Research; NATIONAL CANCER INSTITUTE [R01CA179556, R01CA123438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310, U01DK110807, R01DK099328, U01DK094526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015, R01ES001332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Motorcycle Association Ride for Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by National Institutes of Health https://www.nih.gov/ grants: R01ES001332 (CMV), R01DK099328 (CMV), U54 DK104310 (CMV), T32 ES007015 (KAW), NIH DK094526 (APM) R01CA179556 (CMV), and R01 CA123438 (RBH) and the American Motorcycle Association Ride for Research http://widualsportriders.org/ content.aspx?page_id=87&club_id=411067&item_id=622955 (RBH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by National Institutes of Health grants: R01ES001332 (CMV), R01DK099328 (CMV), U54 DK104310 (CMV), T32 ES007015 (KAW), NIH DK094526 (APM) R01CA179556 (CMV), and R01 CA123438 (RBH) and the American Motorcycle Association Ride for Research (RBH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abler LL, 2011, DEV DYNAM, V240, P2364, DOI 10.1002/dvdy.22730; Abu El-Asrar AM, 2008, BRIT J OPHTHALMOL, V92, P699, DOI 10.1136/bjo.2007.134346; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bailey AL, 2006, NEUROSCIENCE, V138, P675, DOI 10.1016/j.neuroscience.2005.11.051; Barre A P, 2017, ECOLOGICAL INFORM; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Birbrair A, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt512; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; Brouns I, 2009, HISTOCHEM CELL BIOL, V131, P55, DOI 10.1007/s00418-008-0495-7; Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Cheng CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060905; Council L, 2009, MODERN PATHOL, V22, P639, DOI 10.1038/modpathol.2009.9; Cox HM, 2016, CURR OPIN PHARMACOL, V31, P50, DOI 10.1016/j.coph.2016.08.010; Creze M, 2016, MUSCLE NERVE; Cunha GR, 2004, J STEROID BIOCHEM, V92, P221, DOI 10.1016/j.jsbmb.2004.10.017; Cunha GR, 2002, DIFFERENTIATION, V70, P473, DOI 10.1046/j.1432-0436.2002.700902.x; DEERING RE, 1995, PROSTATE, V26, P111, DOI 10.1002/pros.2990260302; Domen J., 2016, BONE MARROW HEMATOPO; Foley SJ, 2000, BJU INT, V85, P70, DOI 10.1046/j.1464-410x.2000.00322.x; Fromont G, 2012, PROSTATE, V72, P542, DOI 10.1002/pros.21456; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gharaee-Kermani M, 2014, AM J PATHOL, V184, P732, DOI 10.1016/j.ajpath.2013.11.024; Gharaee-Kermani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049278; Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Habermacher GM, 2006, ANNU REV MED, V57, P195, DOI 10.1146/annurev.med.57.011205.135654; Hayward SW, 1996, ACTA ANAT, V155, P94; Hayward SW, 2000, RADIOL CLIN N AM, V38, P1, DOI 10.1016/S0033-8389(05)70146-9; Hennenberg M, 2014, INDIAN J UROL, V30, P181, DOI 10.4103/0970-1591.126903; Herum KM, 2017, MOL BIOL CELL, V28, P1871, DOI 10.1091/mbc.E17-01-0014; Hofmann PG, 2013, J ANAT, V222, P170, DOI 10.1111/joa.12002; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kojima M, 1997, ULTRASOUND MED BIOL, V23, P1305, DOI 10.1016/S0301-5629(97)00141-5; Kummer W, 2008, HISTOCHEM CELL BIOL, V130, P219, DOI 10.1007/s00418-008-0455-2; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson WE, 2005, AM J RESP CRIT CARE, V171, P899, DOI 10.1164/rccm.200311-1535OC; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee S, 2016, PROSTATE; Lehmann HC, 2012, STEM CELLS DEV, V21, P423, DOI 10.1089/scd.2010.0513; Leystra AA, 2012, CANCER RES, V72, P2931, DOI 10.1158/0008-5472.CAN-11-4097; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnussen C, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0029-y; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Marques SM, 2011, MICROVASC RES, V82, P246, DOI 10.1016/j.mvr.2011.08.011; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; McMahon A, 2010, GENITOURINARY DEV MO; McMenamin ME, 1999, CANCER RES, V59, P4291; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; Nicholson TM, 2012, ENDOCRINOLOGY, V153, P5556, DOI 10.1210/en.2012-1522; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Ohki K, 2010, INT UROL NEPHROL, V42, P113, DOI 10.1007/s11255-009-9592-3; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Ozawa MG, 2005, CANCER-AM CANCER SOC, V104, P2104, DOI 10.1002/cncr.21436; Peleshok JC, 2011, J COMP NEUROL, V519, P49, DOI 10.1002/cne.22500; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Rehg JE, 2012, TOXICOL PATHOL, V40, P345, DOI 10.1177/0192623311430695; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Rodriguez-Nieves JA, 2013, NAT REV UROL, V10, P546, DOI 10.1038/nrurol.2013.149; Rudick CN, 2008, AM J PHYSIOL-REG I, V294, pR1268, DOI 10.1152/ajpregu.00836.2007; Russo G, 2012, BJU INT, V110, pE794, DOI 10.1111/j.1464-410X.2012.11444.x; Saeed AW, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0060-z; SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944; Schwartz ES, 2016, J UROLOGY, V196, P892, DOI 10.1016/j.juro.2016.03.077; SEEMAYER TA, 1979, AM J SURG PATHOL, V3, P525, DOI 10.1097/00000478-197912000-00005; Shelukhina I, 2015, BRAIN STRUCT FUNCT, V220, P1885, DOI 10.1007/s00429-014-0762-4; Shinagawa K, 2003, AM J RESP CRIT CARE, V168, P959, DOI 10.1164/rccm.200210-1188OC; Singh M, 2014, AM J PATHOL, V184, P2598, DOI 10.1016/j.ajpath.2014.06.022; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sun Qing-Zeng, 2010, Zhonghua Nan Ke Xue, V16, P118; Taboga SR, 2008, ANAT REC, V291, P1115, DOI 10.1002/ar.20728; Thielen JL, 2007, DIFFERENTIATION, V75, P49, DOI 10.1111/j.1432-0436.2006.00115.x; Tian HY, 2017, ARTERIOSCL THROM VAS, V37, P1115, DOI 10.1161/ATVBAHA.116.308859; Torkko KC, 2015, J UROLOGY, V194, P454, DOI 10.1016/j.juro.2015.03.103; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Tuxhorn JA, 2001, J UROL, V2472-2483; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yin GN, 2015, SCI REP-UK, V5, DOI 10.1038/srep10891; Yucel S, 2004, J UROLOGY, V172, P191, DOI 10.1097/01.ju.0000128704.51870.87; Zaitouna M, 2017, NEUROUROL URODYNAM, V36, P271, DOI 10.1002/nau.22919	88	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188413	10.1371/journal.pone.0188413	http://dx.doi.org/10.1371/journal.pone.0188413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145476	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800118
J	Yang, PS; Park, YA; Kim, TH; Uhm, JS; Joung, B; Lee, MH; Pak, HN				Yang, Pil-Sung; Park, Young-Ah; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam			Which patients recur as atrial tachycardia rather than atrial fibrillation after catheter ablation of atrial fibrillation?	PLOS ONE			English	Article							CRITICAL MASS; HYPERTENSION; REDUCTION; HYPOTHESIS; MANAGEMENT; ISTHMUS; MODEL; TRIAL	Introduction The ablation gaps have been known as the main mechanism of recurrence as atrial tachycardia (AT) rather than atrial fibrillation (AF) after AF catheter ablation. However, AF organization due to reduction of critical mass or focal trigger may also be the mechanism of AT recurrence. We sought to find out the main clinical factors of recurrence as AT rather than AF after AF ablation in the absence of antiarrhythmic drug effect. Methods We analyzed 521 patients (70.8% men, 64.1% paroxysmal AF) who experienced AT or AF recurrence without antiarrhythmic drug effect during 44.7 +/- 25.4 months follow-up. Results Among 521 patients with recurrence, 42.0% (219 of 521) recurred with AT. The proportion of AT recurrence was not different between the pulmonary vein isolation only group and additional linear ablation group (45.1% vs. 38.1%, p = 0.128). The absence of hypertension (odds ratio [OR] 0.49, 95% confidence interval [CI] 0.29-0.83, p = 0.007), small left atrial (LA) volume index (OR 0.89 per 10 mL/m(2), 95% CI 0.79-1.00, p = 0.049), and high mean LA bipolar voltage (OR 2.03 per 1 mV, 95% CI 1.30-3.16, p = 0.002) were independently associated with AT recurrence, whereas additional linear ablation was not. Among 90 patients who underwent repeat ablation procedure, rates of PV reconnection (p = 0.358) and gap in prior linear ablations (p = 0.269) were not significantly different between AT recurrence group and AF recurrence group. Conclusion The degree of LA remodeling is significantly associated with recurrence as AT after AF ablation, irrespective of potential ablation gap in linear lesion.	[Yang, Pil-Sung; Kim, Tae-Hoon; Uhm, Jae-Sun; Joung, Boyoung; Lee, Moon-Hyoung; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Seoul, South Korea; [Park, Young-Ah] Inje Univ, Busan Paik Hosp, Div Cardiol, Busan, South Korea	Yonsei University; Yonsei University Health System; Inje University	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Seoul, South Korea.	hnpak@yuhs.ac	; Pak, Hui-Nam/C-4266-2015	Joung, Boyoung/0000-0001-9036-7225; Kim, Tae-Hoon/0000-0003-4200-3456; Uhm, Jae-Sun/0000-0002-1611-8172; Pak, Hui-Nam/0000-0002-3256-3620; Lee, Moon-Hyoung/0000-0002-7268-0741; Yang, Pil-sung/0000-0002-6552-1742	Ministry of Health and Welfare [A085136]; National Research Foundation of Korea - Ministry of Education [2014R1A1A2059391, NRF-2017R1A2B4003983]	Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Research Foundation of Korea - Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH and grant (NRF-2017R1A2B4003983)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anousheh R, 2010, PACE, V33, P460, DOI 10.1111/j.1540-8159.2009.02625.x; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Gerdts E, 2007, HYPERTENSION, V49, P311, DOI 10.1161/01.HYP.0000254322.96189.85; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x; Heck PM, 2011, J CARDIOVASC ELECTR, V22, P832, DOI 10.1111/j.1540-8167.2011.02090.x; Hwang ES, 2012, PACE, V35, P1428, DOI 10.1111/j.1540-8159.2012.03517.x; Hwang M, 2015, IEEE T BIO-MED ENG, V62, P673, DOI 10.1109/TBME.2014.2363669; Jais P, 2009, J CARDIOVASC ELECTR, V20, P480, DOI 10.1111/j.1540-8167.2008.01373.x; Kim TH, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003894; Kim TH, 2014, INT J CARDIOL, V176, P841, DOI 10.1016/j.ijcard.2014.08.008; Kim YH, 1997, J CLIN INVEST, V100, P2486, DOI 10.1172/JCI119791; Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lee AM, 2013, J THORAC CARDIOV SUR, V146, P593, DOI 10.1016/j.jtcvs.2012.04.021; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Okin PM, 2006, JAMA-J AM MED ASSOC, V296, P1242, DOI 10.1001/jama.296.10.1242; Park JH, 2009, J CARDIOVASC ELECTR, V20, P1349, DOI 10.1111/j.1540-8167.2009.01557.x; Park J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143853; Patel AM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P14, DOI 10.1161/CIRCEP.107.748160; Shim CY, 2011, J AM COLL CARDIOL, V57, P1226, DOI 10.1016/j.jacc.2010.09.067; Takahashi Y, 2009, J CARDIOVASC ELECTR, V20, P623, DOI 10.1111/j.1540-8167.2008.01410.x; Tzou WS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P237, DOI 10.1161/CIRCEP.109.923771; Veenhuyzen GD, 2009, PACE, V32, P393, DOI 10.1111/j.1540-8159.2008.02250.x; Won H, 2013, INT J CARDIOL, V168, P1570, DOI 10.1016/j.ijcard.2013.01.186	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188326	10.1371/journal.pone.0188326	http://dx.doi.org/10.1371/journal.pone.0188326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145517	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800113
J	Clusa, L; Miralles, L; Basanta, A; Escot, C; Garcia-Vazquez, E				Clusa, Laura; Miralles, Laura; Basanta, Ana; Escot, Carmelo; Garcia-Vazquez, Eva			eDNA for detection of five highly invasive molluscs. A case study in urban rivers from the Iberian Peninsula	PLOS ONE			English	Article							ANODONTA-WOODIANA LEA; ENVIRONMENTAL DNA; MYTILOPSIS-LEUCOPHAEATA; CORBICULA-FLUMINEA; SPECIES RICHNESS; AQUARIUM TRADE; 1834 BIVALVIA; POPULATION; MUSSEL; INVERTEBRATES	Biological invasions are an important threat to biodiversity especially in aquatic ecosystems, and their frequency is generally higher near urban areas. Potentially invasive non-indigenous molluscs were deliberately introduced into European waters for food (Corbicula fluminea) and biocontrol (Melanoides tuberculata), and unintentionally introduced by ballast water (Mytilopsis leucophaeata, Corbicula fluminea), stock contamination (Sinanodonta woodiana), accidental escapes from aquaculture (Sinanodonta woodiana), aquarium trade releases (Melanoides tuberculata) and even attached to aquatic birds (Corbicula fluminea). Three rivers from the Iberian Peninsula were monitored near the three most populated inland cities to evaluate the presence of these invasive molluscs through PCR amplification using taxon-specific primers from eDNA. New primers were designed within 16S rRNA and cytochrome oxidase subunit I genes, tested in silico from BLAST methodology and experimentally in vitro before application in the field. C. fluminea was found in Ebro River (near Zaragoza); M. leucophaeata in Guadalquivir River (near Sevilla). M. tuberculata and S. woodiana were found from enclosed areas (lake and reservoir respectively) upstream, respectively, Zaragoza and Madrid. The new tools are ready to be used in other regions where these species are also invasive.	[Clusa, Laura; Miralles, Laura; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain; [Basanta, Ana; Escot, Carmelo] Metropolitan Water Supply & Sanitat Co Sevilla, EMASESA, Seville, Spain	University of Oviedo	Clusa, L (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Asturias, Spain.	lauraclusa@gmail.com	Garcia-Vazquez, Eva/Y-7293-2019; Escot, Carmelo/ABH-8609-2020	Escot, Carmelo/0000-0002-5589-0579; Clusa, Laura/0000-0002-3503-2331; Garcia-Vazquez, Eva/0000-0002-8429-838X; Miralles, Laura/0000-0002-7146-9776	PCTI Grant from the Asturias Regional Government [BP14-145]; Ministerio de Economia y Competitividad [MINECO-13-CGL2013-42415-R]; Asturias Regional Grant [GRUPIN-2014-093]; European Commission: EU RIA [689682-AMBER]	PCTI Grant from the Asturias Regional Government; Ministerio de Economia y Competitividad(Spanish Government); Asturias Regional Grant; European Commission: EU RIA	This work was supported by PCTI Grant from the Asturias Regional Government, referenced BP14-145: LC; Ministerio de Economia y Competitividad: MINECO-13-CGL2013-42415-R; Asturias Regional Grant: GRUPIN-2014-093; and European Commission: EU RIA Contract 689682 -AMBER.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ardura A, 2017, AQUAT CONSERV, V27, P165, DOI 10.1002/aqc.2655; Ardura A, 2015, MAR ENVIRON RES, V112, P48, DOI 10.1016/j.marenvres.2015.09.013; Beasley Colin Robert, 2003, Acta Amazonica, V33, P317; Bellard C, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1241; Bodis E, 2014, LIMNOLOGICA, V49, P1, DOI 10.1016/j.limno.2014.07.002; Boltovskoy D, 2006, BIOL INVASIONS, V8, P947, DOI 10.1007/s10530-005-5107-z; Callil CT, 2002, AMAZONIANA, V17, P153; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Cianfanelli Simone, 2007, V2, P103, DOI 10.1007/978-1-4020-6029-8_5; Clusa L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162899; COHEN RRH, 1984, LIMNOL OCEANOGR, V29, P170, DOI 10.4319/lo.1984.29.1.0170; de Souza LS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165273; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Devloo-Delva F, 2016, MAR POLLUT BULL, V105, P23, DOI 10.1016/j.marpolbul.2016.03.008; Dostine PL, 2013, WILDLIFE RES, V40, P393, DOI 10.1071/WR13057; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; Duggan IC, 2002, NEW ZEAL J MAR FRESH, V36, P825, DOI 10.1080/00288330.2002.9517135; Escot C., 2003, Graellsia, V59, P91; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Florin Ann-Britt, 2013, BioInvasions Records, V2, P303, DOI 10.3391/bir.2013.2.4.07; Franch N, 2008, BIOL INVASIONS, V10, P1327, DOI 10.1007/s10530-007-9207-9; Fuller PL, 2015, 5 VECTORS INVASIONS, P88; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Graells MdlP, 1846, CATALOGO MOLUSCOS TE; Hall A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [citeulike-article-id:691774, DOI 10.1021/BK-1999-0734.CH008]; Havel JE, 2015, HYDROBIOLOGIA, V750, P147, DOI 10.1007/s10750-014-2166-0; Holopainen R, 2016, BIOL INVASIONS, V18, P3015, DOI 10.1007/s10530-016-1197-z; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kennedy VS, 2011, AQUAT ECOL, V45, P163, DOI 10.1007/s10452-010-9344-6; Kraszewski Andrzej, 2007, Folia Malacologica, V15, P65; Laamrani H, 1997, J FRESHWATER ECOL, V12, P75, DOI 10.1080/02705060.1997.9663510; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Laine Ari O., 2006, Aquatic Invasions, V1, P38; Lewis JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44152; LUDYANSKIY ML, 1993, BIOSCIENCE, V43, P533, DOI 10.2307/1311948; Maceda-Veiga A, 2013, BIOL INVASIONS, V15, P2707, DOI 10.1007/s10530-013-0485-0; MADSEN H, 1989, ACTA TROP, V46, P139, DOI 10.1016/0001-706X(89)90030-2; Martinez-Orti A, 2011, IUCN RED LIST THREAT; Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052; Nislow KH, 2011, FRESHWATER BIOL, V56, P2135, DOI 10.1111/j.1365-2427.2011.02634.x; Oliveira P, 2015, ESTUAR COAST SHELF S, V167, P191, DOI 10.1016/j.ecss.2015.06.014; Oliver PG, 1998, J CONCHOL, V36, P13; Oscoz J, 2010, AQUAT INVASIONS, V5, P263, DOI 10.3391/ai.2010.5.3.04; Pointier JP, 2000, ACTA TROP, V77, P53, DOI 10.1016/S0001-706X(00)00123-6; Pou-Rovira Q., 2009, Graellsia, V65, P67; Prie V., 2010, IUCN RED LIST THREAT, V2010, DOI DOI 10.2305/IUCN.UK.2010-4.RLTS.T12798A3381899.EN; Quinonero-Salgado S, 2010, SPIRA, V3, P141; Reyna PB, 2013, IHERINGIA SER ZOOL, V103, P77, DOI 10.1590/S0073-47212013000200001; Soler J., 2006, Graellsia, V62, P201; Sousa R, 2008, ESTUAR COAST SHELF S, V80, P289, DOI 10.1016/j.ecss.2008.08.006; Sousa R, 2014, HYDROBIOLOGIA, V735, P233, DOI 10.1007/s10750-012-1409-1; Spear D, 2013, BIOL CONSERV, V159, P137, DOI 10.1016/j.biocon.2012.11.022; Spyra A, 2012, INT REV HYDROBIOL, V97, P12, DOI 10.1002/iroh.201111425; Stoeckle BC, 2016, AQUAT CONSERV, V26, P1120, DOI 10.1002/aqc.2611; Strayer DL, 2010, FRESHWATER BIOL, V55, P152, DOI 10.1111/j.1365-2427.2009.02380.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Vaughn CC, 2001, FRESHWATER BIOL, V46, P1431, DOI 10.1046/j.1365-2427.2001.00771.x; Verween A, 2006, BIOFOULING, V22, P221, DOI 10.1080/08927010600816401; Watters GT, 1997, VELIGER, V40, P152; Zimmermann Heike, 2014, F1000Res, V3, P109, DOI 10.12688/f1000research.3740.2	66	26	27	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188126	10.1371/journal.pone.0188126	http://dx.doi.org/10.1371/journal.pone.0188126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141037	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400060
J	Ganse, B; Pishnamaz, M; Kobbe, P; Herren, C; Gradl-Dietsch, G; Bohle, F; Johannes, B; Kim, BS; Horst, K; Knobe, M				Ganse, Bergita; Pishnamaz, Miguel; Kobbe, Philipp; Herren, Christian; Gradl-Dietsch, Gertraud; Boehle, Franziska; Johannes, Bernd; Kim, Bong-Sung; Horst, Klemens; Knobe, Matthias			Microcirculation in open vs. minimally invasive dorsal stabilization of thoracolumbar fractures	PLOS ONE			English	Article								Standard open and percutaneous minimally invasive surgical procedures co-exist in the treatment of fractures of the thoracolumbar spine. Shorter skin incisions just above the pedicles are used in minimally invasive procedures. Full-length skin incisions and invasive preparations are applied in the standard open approach. While both methods show equivalent rates of intraoperative surgical complications and comparable clinical and radiological outcomes, blood loss and operation time have shown to be decreased in minimally invasive treatment. However, no study so far has investigated differences in microcirculation. This study hypothesized less impairment of microcirculation in the minimally invasive approach compared to the open approach and an improvement of microcirculation over time. A prospective cohort study was conducted using non-invasive laser-Doppler spectrophotometry (an O2C "oxygen to see" device) for measurement of cutaneous and subcutaneous blood oxygenation (SO2), haemoglobin concentration (Hb), and blood flow at depths of 2, 8, and 15 mm at six locations on the skin. Measurements were performed before surgery, 8 and 24 h after surgery, and 2, 4, 7, 12 and 20 days after surgery, however the number of patients measured decreased towards the later time points. Forty patients were included in the study, 20 with each approach (18 females and 22 males). Pair-wise comparison of the types of surgical procedure for each measurement point revealed a significantly higher flow value in the minimally invasive group at one of the measurement points located between the incisions (P = .041). The point-wise analyses of SO2 and Hb did not show significant differences between the approaches. In conclusion, significantly albeit moderately higher flow values could be found in minimally invasive procedures compared to open operations of thoracolumbar fractures in the area of skin that is spared by the incisions.	[Ganse, Bergita; Pishnamaz, Miguel; Kobbe, Philipp; Herren, Christian; Gradl-Dietsch, Gertraud; Boehle, Franziska; Horst, Klemens; Knobe, Matthias] RWTH Aachen Univ Hosp, Dept Orthopaed Trauma, Aachen, Germany; [Gradl-Dietsch, Gertraud] Univ Duisburg Essen, LVR Hosp Essen, Essen, Germany; [Johannes, Bernd] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Kim, Bong-Sung] RWTH Aachen Univ Hosp, Dept Plast & Reconstruct Surg, Hand Surg Burn Ctr, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Duisburg Essen; Helmholtz Association; German Aerospace Centre (DLR); RWTH Aachen University; RWTH Aachen University Hospital	Knobe, M (corresponding author), RWTH Aachen Univ Hosp, Dept Orthopaed Trauma, Aachen, Germany.	mknobe@ukaachen.de	Kim, Bong-Sung/AAR-3802-2021; Knobe, Matthias/Y-3537-2019; Gradl-Dietsch, Gertraud/R-1872-2018	Knobe, Matthias/0000-0002-9166-0965; Gradl-Dietsch, Gertraud/0000-0003-3577-0227; Kim, Bong-Sung/0000-0002-0493-3196; Ganse, Bergita/0000-0002-9512-2910				Beckert S, 2004, DIABETES CARE, V27, P2863, DOI 10.2337/diacare.27.12.2863; Bentov I, 2014, ANESTHESIOLOGY, V120, P760, DOI 10.1097/ALN.0000000000000036; Djurasovic Mladen, 2016, Am J Orthop (Belle Mead NJ), V45, pE77; Farouk O, 1999, J ORTHOP TRAUMA, V13, P401, DOI 10.1097/00005131-199908000-00002; Forst Thomas, 2008, J Diabetes Sci Technol, V2, P1151; Ganse B, 2017, INT ORTHOP; Gerometta A, 2012, INT ORTHOP, V36, P457, DOI 10.1007/s00264-011-1426-0; Grossbach AJ, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13176; Langer S, 2004, Handchir Mikrochir Plast Chir, V36, P197, DOI 10.1055/s-2004-821240; Lee KH, 2012, EUR SPINE J, V21, P2265, DOI 10.1007/s00586-012-2281-4; Lindenblatt N, 2008, PLAST RECONSTR SURG, V122, P1669, DOI 10.1097/PRS.0b013e31818cbeb1; Pishnamaz M, 2015, ACTA CHIR ORTHOP TR, V82, P274; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; Sedney CL, 2016, INT J SPINE SURG, V10, DOI 10.14444/3023; Sommer B, 2013, J SPORT SCI MED, V12, P414; Sun XY, 2016, EUR SPINE J; ter Gunne AFP, 2010, SPINE, V35, P1323, DOI 10.1097/BRS.0b013e3181bcde61	17	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188115	10.1371/journal.pone.0188115	http://dx.doi.org/10.1371/journal.pone.0188115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141048	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400058
J	Kim, HT; Chase, MW				Kim, Hyoung Tae; Chase, Mark W.			Independent degradation in genes of the plastid ndh gene family in species of the orchid genus Cymbidium (Orchidaceae; Epidendroideae)	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOME SEQUENCE; DEHYDROGENASE-LIKE COMPLEX; CYCLIC ELECTRON FLOW; PHOTOSYSTEM-I; EVOLUTION; REDUCTION; PLANT; DNA; ORGANIZATION	In this paper, we compare ndh genes in the plastid genome of many Cymbidium species and three closely related taxa in Orchidaceae looking for evidence of ndh gene degradation. Among the 11 ndh genes, there were frequently large deletions in directly repeated or AT-rich regions. Variation in these degraded ndh genes occurs between individual plants, apparently at population levels in these Cymbidium species. It is likely that ndh gene transfers from the plastome to mitochondrial genome (chondriome) occurred independently in Orchidaceae and that ndh genes in the chondriome were also relatively recently transferred between distantly related species in Orchidaceae. Four variants of the ycf1-rpl32 region, which normally includes the ndhF genes in the plastome, were identified, and some Cymbidium species contained at least two copies of that region in their organellar genomes. The four ycf1-rpl32 variants seem to have a clear pattern of close relationships. Patterns of ndh degradation between closely related taxa and translocation of ndh genes to the chondriome in Cymbidium suggest that there have been multiple bidirectional intracellular gene transfers between two organellar genomes, which have produced different levels of ndh gene degradation among even closely related species.	[Kim, Hyoung Tae] Kyungpook Univ, Coll Agr & Life Sci, Daegu, South Korea; [Chase, Mark W.] Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England	Kyungpook National University; Royal Botanic Gardens, Kew	Chase, MW (corresponding author), Royal Bot Gardens, Jodrell Lab, Richmond, Surrey, England.	m.chase@kew.org		Kim, Hyoung Tae/0000-0003-1823-4369; HyoungTae, Kim/0000-0002-2482-6064	National Research Foundation of Korea (NRF) - Ministry of Education [2015R1A6A3A03020621]	National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A3A03020621).; This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1A6A3A03020621).	ALDRICH J, 1988, CURR GENET, V14, P137, DOI 10.1007/BF00569337; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Barrett CF, 2012, AM J BOT, V99, P1513, DOI 10.3732/ajb.1200256; BENDALL DS, 1995, BBA-BIOENERGETICS, V1229, P23, DOI 10.1016/0005-2728(94)00195-B; Burrows PA, 1998, EMBO J, V17, P868, DOI 10.1093/emboj/17.4.868; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Blazier J, 2011, PLANT MOL BIOL, V76, P263, DOI 10.1007/s11103-011-9753-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Delannoy E, 2011, MOL BIOL EVOL, V28, P2077, DOI 10.1093/molbev/msr028; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Du Puy D., 1988, THE GENUS CYMBIDIUM; Fang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037164; Forrest LL, 2011, PLANT ECOL EVOL, V144, P29, DOI 10.5091/plecevo.2011.535; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-130; Goulding SE, 1996, MOL GEN GENET, V252, P195, DOI 10.1007/BF02173220; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; HABERHAUSEN G, 1994, PLANT MOL BIOL, V24, P217, DOI 10.1007/BF00040588; Jheng CF, 2012, PLANT SCI, V190, P62, DOI 10.1016/j.plantsci.2012.04.001; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142215; Kim HT, 2014, MOL CELLS, V37, P372, DOI 10.14348/molcells.2014.2296; Kim JS, 2015, PLANT MOL BIOL REP, V33, P1210, DOI 10.1007/s11105-014-0833-y; Kim KA, 2016, MITOCHONDRIAL DNA A, V27, P2963, DOI [10.3109/19401736.2015.1063121, 10.3109/19401736.2015.1060461]; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058747; Lin CP, 2010, GENOME BIOL EVOL, V2, P504, DOI 10.1093/gbe/evq036; Lin CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09040; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Logacheva MD, 2011, GENOME BIOL EVOL, V3, P1296, DOI 10.1093/gbe/evr102; Luo JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108185; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Mccoy SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-130; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Muller AE, 1999, J MOL BIOL, V291, P29, DOI 10.1006/jmbi.1999.2957; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Neyland R, 1996, PLANTA, V200, P273, DOI 10.1007/BF00208318; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; OGIHARA Y, 1988, P NATL ACAD SCI USA, V85, P8573, DOI 10.1073/pnas.85.22.8573; OHYAMA K, 1986, NATURE, V322, P572, DOI 10.1038/322572a0; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Pan IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034738; Park S, 2015, NEW PHYTOL, V208, P570, DOI 10.1111/nph.13467; Peredo EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068591; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruhlman TA, 2014, METHODS MOL BIOL, V1132, P3, DOI 10.1007/978-1-62703-995-6_1; Sanderson MJ, 2015, AM J BOT, V102, P1115, DOI 10.3732/ajb.1500184; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Ueda M, 2012, PLANT J, V72, P683, DOI 10.1111/j.1365-313X.2012.05115.x; van den Berg Cassio, 2002, Lindleyana, V17, P102; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wang D, 2007, MOL BIOL EVOL, V24, P2040, DOI 10.1093/molbev/msm133; Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]; Weng ML, 2014, MOL BIOL EVOL, V31, P645, DOI 10.1093/molbev/mst257; Wicke S, 2013, PLANT CELL, V25, P3711, DOI 10.1105/tpc.113.113373; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; WOLFE KH, 1992, J MOL EVOL, V35, P304, DOI 10.1007/BF00161168; Wu CS, 2011, GENOME BIOL EVOL, V3, P309, DOI 10.1093/gbe/evr026; Wu CS, 2009, MOL PHYLOGENET EVOL, V52, P115, DOI 10.1016/j.ympev.2008.12.026; Wu FH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-68; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128; Yamori W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13908; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang P, 2016, MITOCHONDRIAL DNA A, V27, P1262, DOI 10.3109/19401736.2014.945547; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Yukawa Tomohisa, 2002, Bulletin of the National Science Museum Series B (Botany), V28, P129	80	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187318	10.1371/journal.pone.0187318	http://dx.doi.org/10.1371/journal.pone.0187318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140976	Green Submitted, gold, Green Published			2022-12-27	WOS:000415260400021
J	Queen, RA; Steyn, JS; Lord, P; Elson, JL				Queen, Rachel A.; Steyn, Jannetta S.; Lord, Phillip; Elson, Joanna L.			Mitochondrial DNA sequence context in the penetrance of mitochondrial t-RNA mutations: A study across multiple lineages with diagnostic implications	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; HUMAN-DISEASE; MELAS SUBGROUP; POINT MUTATION; AFRICAN; PREVALENCE; PATHOGENICITY; GENE; EVOLUTION; ENCEPHALOMYOPATHIES	Mitochondrial DNA (mtDNA) mutations are well recognized as an important cause of inherited disease. Diseases caused by mtDNA mutations exhibit a high degree of clinical heterogeneity with a complex genotype-phenotype relationship, with many such mutations exhibiting incomplete penetrance. There is evidence that the spectrum of mutations causing mitochondrial disease might differ between different mitochondrial lineages (haplogroups) seen in different global populations. This would point to the importance of sequence context in the expression of mutations. To explore this possibility, we looked for mutations which are known to cause disease in humans, in animals of other species unaffected by mtDNA disease. The mt-tRNA genes are the location of many pathogenic mutations, with the m.3243A>G mutation on the mt-tRNA-Leu(UUR) being the most frequently seen mutation in humans. This study looked for the presence of m.3243A>G in 2784 sequences from 33 species, as well as any of the other mutations reported in association with disease located on mt-tRNA-Leu(UUR). We report a number of disease associated variations found on mt-tRNA-Leu(UUR) in other chordates, as the major population variant, with m.3243A>G being seen in 6 species. In these, we also found a number of mutations which appear compensatory and which could prevent the pathogenicity associated with this change in humans. This work has important implications for the discovery and diagnosis of mtDNA mutations in non-European populations. In addition, it might provide a partial explanation for the conflicting results in the literature that examines the role of mtDNA variants in complex traits.	[Queen, Rachel A.; Steyn, Jannetta S.; Elson, Joanna L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England; [Lord, Phillip] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Elson, Joanna L.] North West Univ, Ctr Human Metabon, Potchefstroom, South Africa	Newcastle University - UK; Newcastle University - UK; North West University - South Africa	Elson, JL (corresponding author), Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne, Tyne & Wear, England.; Elson, JL (corresponding author), North West Univ, Ctr Human Metabon, Potchefstroom, South Africa.	joanna.elson@newcastle.ac.uk		/0000-0002-3551-5624	Newcastle University internal fund	Newcastle University internal fund	Fund from a Newcastle University internal fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baranowska I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000499; Barbieri C, 2014, AM J PHYS ANTHROPOL, V153, P435, DOI 10.1002/ajpa.22441; Cai W, 2008, J GENET GENOMICS, V35, P649, DOI 10.1016/S1673-8527(08)60086-7; Chinnery PF, 1999, J MED GENET, V36, P505, DOI 10.1136/jmg.36.7.505; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; de Magalhaes JP, 2005, J MOL EVOL, V61, P491, DOI 10.1007/s00239-004-0258-6; El Meziane A, 1998, NAT GENET, V18, P350; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Houshmand M, 1996, HUM GENET, V97, P269, DOI 10.1007/BF02185750; Howell N, 2007, MOL BIOL EVOL, V24, P2213, DOI 10.1093/molbev/msm147; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Man PYW, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011247; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Martikainen MH, 2013, ACTA DIABETOL, V50, P737, DOI 10.1007/s00592-012-0393-2; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; McFarland R, 2004, AM J MED GENET A, V131A, P107, DOI 10.1002/ajmg.a.30318; Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305; Salas A, 2015, J GENET GENOMICS, V42, P169, DOI 10.1016/j.jgg.2015.03.002; Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Smith PM, 2014, HUM MOL GENET, V23, P949, DOI 10.1093/hmg/ddt490; Smuts I, 2010, J INHERIT METAB DIS, V33, pS95, DOI 10.1007/s10545-009-9031-8; SWEENEY MG, 1993, Q J MED, V86, P709; Tuppen HAL, 2010, BBA-BIOENERGETICS, V1797, P113, DOI 10.1016/j.bbabio.2009.09.005; Uusimaa J, 2007, ANN NEUROL, V62, P278, DOI 10.1002/ana.21196; van der Walt EM, 2012, EUR J HUM GENET, V20, P650, DOI 10.1038/ejhg.2011.262; van der Westhuizen FH, 2015, HUM MUTAT, V36, P569, DOI 10.1002/humu.22789; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Yakubovskaya MG, 2010, BIOCHIMIE, V92, P762, DOI 10.1016/j.biochi.2010.02.016; Yarham JW, 2012, MITOCHONDRION, V12, P533, DOI 10.1016/j.mito.2012.06.009; Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27	48	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187862	10.1371/journal.pone.0187862	http://dx.doi.org/10.1371/journal.pone.0187862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161289	gold, Green Published			2022-12-27	WOS:000415987000023
J	Park, C; Kang, MY; Kim, D; Park, J; Eom, H; Kim, EA				Park, Chulyong; Kang, Mo-Yeol; Kim, Dohyung; Park, Jaechan; Eom, Huisu; Kim, Eun-A			Prevalence of abortion and adverse pregnancy outcomes among working women in Korea: A cross-sectional study (vol 12, e0182341, 2017)	PLOS ONE			English	Correction									[Park, Chulyong] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Occupat & Environm Med, Chang Won, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Park, C (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Occupat & Environm Med, Chang Won, South Korea.		Park, Chulyong/AAN-1464-2020	Park, Chulyong/0000-0001-8584-5376				Park C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182341	1	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188673	10.1371/journal.pone.0188673	http://dx.doi.org/10.1371/journal.pone.0188673			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155889	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700067
J	Sofer, T; Baier, LJ; Browning, SR; Thornton, TA; Talavera, GA; Wassertheil-Smoller, S; Daviglus, ML; Hanson, R; Kobes, S; Cooper, RS; Cai, JW; Levy, D; Reiner, AP; Franceschini, N				Sofer, Tamar; Baier, Leslie J.; Browning, Sharon R.; Thornton, Timothy A.; Talavera, Gregory A.; Wassertheil-Smoller, Sylvia; Daviglus, Martha L.; Hanson, Robert; Kobes, Sayuko; Cooper, Richard S.; Cai, Jianwen; Levy, Daniel; Reiner, Alex P.; Franceschini, Nora			Admixture mapping in the Hispanic Community Health Study/Study of Latinos reveals regions of genetic associations with blood pressure traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INFERENCE; VARIANTS; DESIGN; COMMON	Admixture mapping can be used to detect genetic association regions in admixed populations, such as Hispanics/Latinos, by estimating associations between local ancestry allele counts and the trait of interest. We performed admixture mapping of the blood pressure traits systolic and diastolic blood pressure (SBP, DBP), mean arterial pressure (MAP), and pulse pressure (PP), in a dataset of 12,116 participants from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Hispanics/Latinos have three predominant ancestral populations (European, African, and Amerindian), for each of which we separately tested local ancestry intervals across the genome. We identified four regions that were significantly associated with a blood pressure trait at the genome-wide admixture mapping level. A 6p21.31 Amerindian ancestry association region has multiple known associations, but none explained the admixture mapping signal. We identified variants that completely explained this signal. One of these variants had p-values of 0.02 (MAP) and 0.04 (SBP) in replication testing in Pima Indians. A 11q13.4 Amerindian ancestry association region spans a variant that was previously reported (p-value = 0.001) in a targeted association study of Blood Pressure (BP) traits and variants in the vitamin D pathway. There was no replication evidence supporting an association in the identified 17q25.3 Amerindian ancestry association region. For a region on 6p12.3, associated with African ancestry, we did not identify any candidate variants driving the association. It may be driven by rare variants. Whole genome sequence data may be necessary to fine map these association signals, which may contribute to disparities in BP traits between diverse populations.	[Sofer, Tamar] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Sofer, Tamar] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Baier, Leslie J.; Hanson, Robert; Kobes, Sayuko] NIDDK, Phoenix Epidemiol & Clin Res Branch, NIH, Phoenix, AZ USA; [Browning, Sharon R.; Thornton, Timothy A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Talavera, Gregory A.] San Diego State Univ, Div Hlth Promot & Behav Sci, San Diego, CA 92182 USA; [Wassertheil-Smoller, Sylvia] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Daviglus, Martha L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Daviglus, Martha L.] Univ Illinois, Inst Minor Hlth Res, Chicago, IL USA; [Cooper, Richard S.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Chicago, IL USA; [Cai, Jianwen] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Levy, Daniel] NHLBI, Populat Sci Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Franceschini, Nora] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Washington; University of Washington Seattle; California State University System; San Diego State University; Yeshiva University; Albert Einstein College of Medicine; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Sofer, T (corresponding author), Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA.; Sofer, T (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	tsofer@bwh.harvard.edu	Browning, Sharon/B-1530-2008; Levy, Daniel/ABB-2752-2021; Levy, Daniel/ABF-6873-2021	Browning, Sharon/0000-0001-7251-9715; Levy, Daniel/0000-0003-1843-8724; Sofer, Tamar/0000-0001-8520-8860	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, N01-HC65237]; National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Neurological Disorders and Stroke; NIH Institution Office of Dietary Supplements; National Institute of Diabetes and Digestive and Kidney Diseases; NHLBI; NIDCR [HHSN268201300005C AM03, MOD03]; NHLBI [R01 HL120393-03S1, 1R35HL135818, R21HL123677-01]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R56 DK104806-01A1]; NIH Institution-Office of Dietary Supplements; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123677, R01HL065234, R35HL135818, U01HL065233, R01HL120393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK104806, ZIADK075012, ZIADK069071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Institution Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH Institution-Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Neurological Disorders and Stroke, NIH Institution Office of Dietary Supplements. This study was also supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Genetic Analysis Center at the University of Washington was supported by NHLBI and NIDCR contracts (HHSN268201300005C AM03 and MOD03). This work was supported by the NHLBI [R01 HL120393-03S1 and 1R35HL135818 supported T. S., R21HL123677-01 to N.F.]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R56 DK104806-01A1 to N.F.]. URLs of funders: NHLBI: https://www.nhibi.nih.gov/; National Institute on Minority Health and Health Disparities: https://www.nimhd.nih.gov; National Institute on Deafness and Other Communication Disorders: https://www.nidcd.nih.gov; National Institute of Dental and Craniofacial Research: https://www.nidcr.nih.gov; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): https://www.niddk.nih.gov; National Institute of Neurological Disorders and Stroke: https://www.ninds.nih.gov; NIH Institution-Office of Dietary Supplements: https://ods.od.nih.gov; The Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases: https://www.niddk.nih.gov/about-niddk/offices-divisions/division-intramural-research/Pages/default.aspx.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], GENESIS GENETIC ESTI; Brown LA, 2017, J AM SOC NEPHROL, V28, P2211, DOI 10.1681/ASN.2016091010; Browning SR, 2016, G3-GENES GENOM GENET, V6, P1525, DOI 10.1534/g3.116.028779; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conomos MP, 2016, AM J HUM GENET, V98, P165, DOI 10.1016/j.ajhg.2015.12.001; Ehret GB, 2016, NAT GENET, V48, P1171, DOI 10.1038/ng.3667; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Franceschini N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164132; Franceschini N, 2013, AM J HUM GENET, V93, P545, DOI 10.1016/j.ajhg.2013.07.010; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hanson RL, 2013, DIABETES; Hoffmann TJ, 2017, NAT GENET, V49, P54, DOI 10.1038/ng.3715; Kato N, 2015, NAT GENET, V47, P1282, DOI 10.1038/ng.3405; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liang J, 2017, PLOS GENET, V13, P1; Liu CY, 2016, NAT GENET, V48, P1162, DOI 10.1038/ng.3660; Lu X, 2015, HUMAN MOL GENETICS; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Qin HZ, 2012, GENET EPIDEMIOL, V36, P235, DOI 10.1002/gepi.21616; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Sofer T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09019-1; Sofer T, 2017, GENET EPIDEMIOL, V41, P251, DOI 10.1002/gepi.22029; Sorlie PD, 2014, AM J HYPERTENS, V27, P793, DOI 10.1093/ajh/hpu003; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Surendran P, 2016, NAT GENET, V48, P1151, DOI 10.1038/ng.3654; Wang L, 2014, AM J HYPERTENSION; Zhang QS, 2016, BIOINFORMATICS, V32, P2227, DOI 10.1093/bioinformatics/btw220	35	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188400	10.1371/journal.pone.0188400	http://dx.doi.org/10.1371/journal.pone.0188400			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155883	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700055
J	Yu, MY; Kim, YC; Koo, HS; Chin, HJ				Yu, Mi-yeon; Kim, Yong-Chul; Koo, Ho Suk; Chin, Ho Jun			Short-term anti-proteinuric effect of tacrolimus is not related to preservation of the glomerular filtration rate in IgA nephropathy: A 5-year follow-up study	PLOS ONE			English	Article							RESISTANT NEPHROTIC SYNDROME; LIVER-TRANSPLANTATION; EXPRESSION; FK506; CYCLOSPORINE; ACTIVATION; REMISSION; PODOCYTES; IMPROVES; THERAPY	Background The immunosuppressive drug tacrolimus has the short-term effect of reducing proteinuria in patients with immunoglobulin A nephropathy (IgAN). Our study investigated the effects on proteinuria and kidney function after discontinuation of tacrolimus. Methods Patients with biopsy-proven IgAN were included in the study and randomly divided into two treatment groups. There was a corresponding control group for each treatment group. The first group included patients treated with tacrolimus (Tac vs non-Tac group) and the second group included patients with a renin angiotensin system blocker (RASi vs non-RASi group). The Tac group received treatment for up to 16 weeks, with the administration of tacrolimus being ceased at the final visit (trial phase). We tracked the patients at 12, 24, 52, and 240 weeks (observational phase). The primary outcomes examined were the percentage change (from the trial phase to the observational phase) of time-averaged proteinuria (TA-proteinuria; g/g creatinine [cr]) and the estimated glomerular filtration rate (eGFR). Time-averaged proteinuria was defined as the average of urine protein to creatinine ratio (UPCR), measured every 3 months during both the trial and observational phases of the study. Results A significant reduction in UPCR was observed in the Tac group compared to non-Tac group at the 4 and 8 week visits during the trial phase (p = 0.023 and p = 0.003, respectively). However, the difference between the Tac group and non-Tac group was not evident in the other review periods, estimated by linear mixed effect model. The percentage change in TA-proteinuria was greater in the Tac group than that in the corresponding control group (116 +/- 96% vs. 63 +/- 239%, p = 0.004). Therefore, during the observational phase, TA-proteinuria was not significantly different between the Tac group and the non-Tac group (1.150 +/- 0.733 g/g cr vs. 1.455 +/- 2.017 g/g cr, p = 0.775). The levels of eGFR throughout the observational phase were not significantly different between the two groups. Furthermore, the mean rate of eGFR change throughout both phases of the study was -6.4 +/- 5.9 mL/min/1.73 m(2)/year in the non-Tac group and -5.4 +/- 7.9 mL/min/1.73 m(2)/year in the Tac group (p = 0.988). Conclusion The anti-proteinuric effect of tacrolimus was promptly reversed 3 months after discontinuing the drug. The use of tacrolimus for a short period of time for patients with IgAN temporarily reduces proteinuria, but the data showed no long-term efficacy regarding proteinuria reduction and improvement of renal function.	[Yu, Mi-yeon; Kim, Yong-Chul] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Koo, Ho Suk] Inje Univ, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seong Nam, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Chin, Ho Jun] Seoul Natl Univ, Med Res Ctr, Renal Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Inje University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seong Nam, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Chin, HJ (corresponding author), Seoul Natl Univ, Med Res Ctr, Renal Inst, Seoul, South Korea.	mednep@snubh.org	Kim, Yong Chul/L-8653-2019; Yu, Mi-Yeon/ABB-7937-2021	YU, Mi-Yeon/0000-0001-5112-6955; Kim, Yong Chul/0000-0003-3215-8681				Barratt J, 2006, KIDNEY INT, V69, P1934, DOI 10.1038/sj.ki.5000419; DAMICO G, 1988, AM J KIDNEY DIS, V12, P353, DOI 10.1016/S0272-6386(88)80023-4; Fan L, 2013, INT UROL NEPHROL, V45, P459, DOI 10.1007/s11255-012-0205-1; Kim YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071545; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li J., 2015, J CHEMOTHER, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131820; Li PKT, 2006, AM J KIDNEY DIS, V47, P751, DOI 10.1053/j.ajkd.2006.01.017; Lim SW, 2015, LAB INVEST, V95, P1174, DOI 10.1038/labinvest.2015.93; Loeffler K, 2004, PEDIATR NEPHROL, V19, P281, DOI 10.1007/s00467-003-1370-3; MARUYAMA K, 1994, NEPHRON, V66, P486, DOI 10.1159/000187876; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nolin Thomas D, 2010, Handb Exp Pharmacol, P111, DOI 10.1007/978-3-642-00663-0_5; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106164; Peng W, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004731; Qi XM, 2016, INFLAMM RES, V65, P103, DOI 10.1007/s00011-015-0893-y; Qin W, 2008, NEPHROL DIAL TRANSPL, V23, P1608, DOI 10.1093/ndt/gfm781; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Rychlik I, 1999, ANN MED INTERNE, V12, P353; Song YH, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0467-z; Staatz CE, 2004, LIVER TRANSPLANT, V10, P506, DOI 10.1002/lt.20065; TEXTOR SC, 1993, TRANSPLANTATION, V55, P1332, DOI 10.1097/00007890-199306000-00023; TEXTOR SC, 1995, KIDNEY INT, V47, P1426, DOI 10.1038/ki.1995.200; Wakamatsu A, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12679; Wang LM, 2011, MOL ENDOCRINOL, V25, P1376, DOI 10.1210/me.2011-0029; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wen YQ, 2016, RENAL FAILURE, V38, P564, DOI 10.3109/0886022X.2016.1148936; Xie LS, 2013, INT UROL NEPHROL, V45, P571, DOI 10.1007/s11255-012-0313-y; Yuzawa Y, 2016, CLIN EXP NEPHROL, V20, P511, DOI 10.1007/s10157-015-1223-y; Zhang QX, 2012, AM J NEPHROL, V35, P312, DOI 10.1159/000337175	29	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188375	10.1371/journal.pone.0188375	http://dx.doi.org/10.1371/journal.pone.0188375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155873	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700052
J	Brun, P; Scarpa, M; Marchiori, C; Sarasin, G; Caputi, V; Porzionato, A; Giron, MC; Palu, G; Castagliuolo, I				Brun, Paola; Scarpa, Melania; Marchiori, Chiara; Sarasin, Gloria; Caputi, Valentina; Porzionato, Andrea; Giron, Maria Cecilia; Palu, Giorgio; Castagliuolo, Ignazio			Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS (vol 12, e0181863, 2017)	PLOS ONE			English	Correction									[Scarpa, Melania] Veneto Inst Oncol IOV IRCCS, Padua, Italy	IRCCS Istituto Oncologico Veneto (IOV)			Giron, Maria Cecilia/AAL-4438-2021; Scarpa, Melania/M-2777-2019	Giron, Maria Cecilia/0000-0002-0825-7965; Scarpa, Melania/0000-0002-7055-635X				Brun P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181863	1	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188563	10.1371/journal.pone.0188563	http://dx.doi.org/10.1371/journal.pone.0188563			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149216	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100044
J	Erdogan, C; Kurt, Z; Diri, B				Erdogan, Cihat; Kurt, Zeyneb; Diri, Banu			Estimation of the proteomic cancer co-expression sub networks by using association estimators	PLOS ONE			English	Article							MUTUAL INFORMATION; GENE-EXPRESSION; INFERENCE; ENTROPY	In this study, the association estimators, which have significant influences on the gene network inference methods and used for determining the molecular interactions, were examined within the co-expression network inference concept. By using the proteomic data from five different cancer types, the hub genes/proteins within the disease-associated gene-gene/protein-protein interaction sub networks were identified. Proteomic data from various cancer types is collected from The Cancer Proteome Atlas (TCPA). Correlation and mutual information (MI) based nine association estimators that are commonly used in the literature, were compared in this study. As the gold standard to measure the association estimators' performance, a multi-layer data integration platform on gene-disease associations (DisGeNET) and the Molecular Signatures Database (MSigDB) was used. Fisher's exact test was used to evaluate the performance of the association estimators by comparing the created co-expression networks with the disease-associated pathways. It was observed that the MI based estimators provided more successful results than the Pearson and Spearman correlation approaches, which are used in the estimation of biological networks in the weighted correlation network analysis (WGCNA) package. In correlation-based methods, the best average success rate for five cancer types was 60%, while in MI-based methods the average success ratio was 71% for James-Stein Shrinkage (Shrink) and 64% for Schurmann-Grassberger (SG) association estimator, respectively. Moreover, the hub genes and the inferred sub networks are presented for the consideration of researchers and experimentalists.	[Erdogan, Cihat] Namik Kemal Univ, Dept Comp Engn, Tekirdag, Turkey; [Kurt, Zeyneb] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Kurt, Zeyneb; Diri, Banu] Yildiz Tech Univ, Dept Comp Engn, Istanbul, Turkey	Namik Kemal University; University of California System; University of California Los Angeles; Yildiz Technical University	Erdogan, C (corresponding author), Namik Kemal Univ, Dept Comp Engn, Tekirdag, Turkey.	cerdogan@nku.edu.tr	Erdoğan, Cihat/A-4856-2018; Erdoğan, Cihat/E-4681-2019; Diri, Banu/AAA-1020-2021	Erdoğan, Cihat/0000-0001-5495-7754; Erdoğan, Cihat/0000-0001-5495-7754; Kurt, Zeyneb/0000-0003-3186-8091; Diri, Banu/0000-0002-6652-4339				Akbani R, 2014, MOL CELL PROTEOMICS, V13, P1625, DOI 10.1074/mcp.O113.034918; Altay G, 2017, BIORXIV, P1; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; Deu-Pons J, 2015, DATABASE-OXFORD, V2015; Du J, 2016, ONCOGENE, V35, P3314, DOI 10.1038/onc.2015.393; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fisher R. A., 1938, STAT METHODS RES WOR; Fukazawa T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20113; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Fury W, 2006, 2006 EMBS 06 28 ANN, P5531; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Keehn CA, 2004, J CUTAN PATHOL, V31, P8, DOI 10.1046/j.0303-6987.2004.0158.x; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kurt Z, 2014, BIOINFORMATICS, V30, P2142, DOI 10.1093/bioinformatics/btu182; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liu NN, 2015, ONCOL LETT, V10, P1709, DOI 10.3892/ol.2015.3442; Madhamshettiwar PB, 2012, GENOME MED, V4, DOI 10.1186/gm340; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McDonald J.H., 2009, HDB BIOL STAT, P291; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller G., 1955, INFORM THEORY PSYCHO, P95; Mishima K, 2014, NEUROONCOL, V16; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Queralt-Rosinach N, 2016, NUCLEIC ACIDS RES, V45; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Senbabaoglu Y, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004765; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simone RE, 2011, PLOS ONE, V6; Song L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-328; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Q, 2016, J THORAC DIS, V8, DOI 10.21037/jtd.2016.04.13; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zhang J, 2015, INT J CLIN EXP MED, V8, P3136	51	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188016	10.1371/journal.pone.0188016	http://dx.doi.org/10.1371/journal.pone.0188016			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145449	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000415378800051
J	Provenchere, S; Chevalier, A; Ghodbane, W; Bouleti, C; Montravers, P; Longrois, D; Lung, B				Provenchere, Sophie; Chevalier, Arnaud; Ghodbane, Walid; Bouleti, Claire; Montravers, Philippe; Longrois, Dan; Lung, Bernard			Is the EuroSCORE II reliable to estimate operative mortality among octogenarians?	PLOS ONE			English	Article							AORTIC-VALVE-REPLACEMENT; HIGH-RISK PATIENTS; CARDIAC-SURGERY; EUROPEAN SYSTEM; ELDERLY-PATIENTS; METAANALYSIS; PERFORMANCE; PREDICTION; VALIDATION	Objectives Concerns have been raised about the predictive performance (PP) of the EuroSCORE I (ES I) to estimate operative mortality (OM) of patients aged >= 80. The EuroSCORE II (ES II) has been described to have better PP of OM but external validations are scarce. Furthermore, the PP of ES II has not been investigated among the octogenarians. The goal of the study was to compare the PP of ES II and ES I among the overall population and patients >= 80. Methods The ES I and ES II were computed for 7161 consecutive patients who underwent major cardiac surgery in a 7-year period. Discrimination was assessed by using the c-index and calibration with the Hosmer-Lemeshow (HL) and calibration plot by comparing predicted and observed mortality. Results From the global cohort of 7161 patients, 832 (12%) were >= 80. The mean values of ES I and ES II were 7.4 +/- 9.4 and 5.2 +/- 9.1 respectively for the whole cohort, 6.3 +/- 8.6 and 4.7 +/- 8.5 for the patients <80, 15.1 +/- 11.8 and 8.5 +/- 11.0 for the patients >= 80. The mortality was 9.38% (>= 80) versus 5.18% (<80). The discriminatory power was good for the two algorithms among the whole population and the <80 but less satisfying among the >= 80 (AUC 0.64 [0.58-0.71] for ES I and 0.67 [0.60-0.73] for the ES II without significant differences (p = 0.35) between the two scores. For the octogenarians, the ES II had a fair calibration until 10%-predicted values and over-predicted beyond. Conclusions The ES II has a better PP than the ES I among patients <80. Its discrimination and calibration are less satisfying in patients >= 80, showing an overestimation in the elderly at very high-surgical risk. Nevertheless, it shows an acceptable calibration until 10%-predicted mortality.	[Provenchere, Sophie; Chevalier, Arnaud; Montravers, Philippe; Longrois, Dan] Hop Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat, Paris, France; [Provenchere, Sophie] Hop Bichat Claude Bernard, AP HP, Ctr Invest Clin 1425, INSERM, Paris, France; [Ghodbane, Walid] Hop Bichat Claude Bernard, AP HP, Dept Chirurg Cardiaque, Paris, France; [Bouleti, Claire; Lung, Bernard] Hop Bichat Claude Bernard, AP HP, Dept Cardiol, Paris, France; [Montravers, Philippe; Longrois, Dan; Lung, Bernard] Univ Paris 7 Diderot, Paris, France; [Longrois, Dan; Lung, Bernard] INSERM 1148, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Provenchere, S (corresponding author), Hop Bichat Claude Bernard, AP HP, Dept Anesthesie Reanimat, Paris, France.; Provenchere, S (corresponding author), Hop Bichat Claude Bernard, AP HP, Ctr Invest Clin 1425, INSERM, Paris, France.	sophie.provenchere@aphp.fr	Iung, Bernard/AAQ-9004-2020	Iung, Bernard/0000-0002-9127-348X				Barili F, 2013, EUR HEART J, V34, P22, DOI 10.1093/eurheartj/ehs342; Chhor V, 2010, EUR J ANAESTH, V27, P702, DOI 10.1097/EJA.0b013e32833a45de; Curiel-Balsera E, 2013, J CRIT CARE, V28, P397, DOI 10.1016/j.jcrc.2012.12.011; Di Dedda U, 2013, EUR J CARDIO-THORAC, V43, P27, DOI 10.1093/ejcts/ezs196; Garcia-Valentin A, 2016, EUR J CARDIO-THORAC, V49, P399, DOI 10.1093/ejcts/ezv090; Ghanta RK, 2010, J THORAC CARDIOV SUR, V140, P103, DOI 10.1016/j.jtcvs.2009.10.001; Guida P, 2014, J THORAC CARDIOV SUR, V148, P3049, DOI 10.1016/j.jtcvs.2014.07.039; Holmes DR, 2013, J AM COLL CARDIOL, V61, P903, DOI 10.1016/j.jacc.2012.08.1034; Howell NJ, 2013, EUR J CARDIO-THORAC, V44, P1006, DOI 10.1093/ejcts/ezt174; Iung B, 2013, EUR HEART J, V34, P10, DOI 10.1093/eurheartj/ehs343; Krane M, 2011, ANN THORAC SURG, V91, P506, DOI 10.1016/j.athoracsur.2010.10.041; Mathers CD, 2015, LANCET, V385, P540, DOI 10.1016/S0140-6736(14)60569-9; Mitnitski A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0400-x; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Nashef SAM, 2012, EUR J CARDIO-THORAC, V41, P734, DOI 10.1093/ejcts/ezs043; Onorati F, 2014, ANN THORAC SURG, V97, P537, DOI 10.1016/j.athoracsur.2013.09.007; Pagni S, 2014, ANN THORAC SURG, V97, P569, DOI 10.1016/j.athoracsur.2013.07.083; Pasquali SK, 2001, AM HEART J, V142, P748, DOI 10.1067/mhj.2001.119134; Poullis M, 2015, INTERACT CARDIOV TH, V20, P172, DOI 10.1093/icvts/ivu345; Qato DM, 2016, JAMA INTERN MED, V176, P473, DOI 10.1001/jamainternmed.2015.8581; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Rosenhek R, 2012, EUR HEART J, V33, P822, DOI 10.1093/eurheartj/ehr061; Scrascia G, 2014, ANN THORAC SURG, V98, P869, DOI 10.1016/j.athoracsur.2014.04.124; Sepehri A, 2014, J THORAC CARDIOV SUR, V148, P3110, DOI 10.1016/j.jtcvs.2014.07.087; Swinkels BM, 2010, NETH HEART J, V18, P344, DOI 10.1007/BF03091788; Vasques F, 2012, AM HEART J, V164, P410, DOI 10.1016/j.ahj.2012.06.019; Wendt D, 2009, ANN THORAC SURG, V88, P468, DOI 10.1016/j.athoracsur.2009.04.059	27	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187056	10.1371/journal.pone.0187056	http://dx.doi.org/10.1371/journal.pone.0187056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145434	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800008
J	Van Grootel, TJ; Meeson, A; Munk, MHJ; Kourtzi, Z; Movshon, JA; Logothetis, NK; Kiorpes, L				Van Grootel, Tom J.; Meeson, Alan; Munk, Matthias H. J.; Kourtzi, Zoe; Movshon, J. Anthony; Logothetis, Nikos K.; Kiorpes, Lynne			Development of visual cortical function in infant macaques: A BOLD fMRI study	PLOS ONE			English	Article							MONKEYS MACACA-NEMESTRINA; GLASS PATTERNS; HUMAN-BRAIN; POSTNATAL-DEVELOPMENT; CONTRAST SENSITIVITY; V2 NEURONS; HIERARCHICAL DEVELOPMENT; DISPARITY SENSITIVITY; RESPONSE PROPERTIES; OPPOSITE-POLARITY	Functional brain development is not well understood. In the visual system, neurophysiological studies in nonhuman primates show quite mature neuronal properties near birth although visual function is itself quite immature and continues to develop over many months or years after birth. Our goal was to assess the relative development of two main visual processing streams, dorsal and ventral, using BOLD fMRI in an attempt to understand the global mechanisms that support the maturation of visual behavior. Seven infant macaque monkeys (Macaca mulatta) were repeatedly scanned, while anesthetized, over an age range of 102 to 1431 days. Large rotating checkerboard stimuli induced BOLD activation in visual cortices at early ages. Additionally we used static and dynamic Glass pattern stimuli to probe BOLD responses in primary visual cortex and two extrastriate areas: V4 and MTV5. The resulting activations were analyzed with standard GLM and multivoxel pattern analysis (MVPA) approaches. We analyzed three contrasts: Glass pattern present/absent, static/dynamic Glass pattern presentation, and structured/random Glass pattern form. For both GLM and MVPA approaches, robust coherent BOLD activation appeared relatively late in comparison to the maturation of known neuronal properties and the development of behavioral sensitivity to Glass patterns. Robust differential activity to Glass pattern present/ absent and dynamic/static stimulus presentation appeared first in V1, followed by V4 and MT-V5 at older ages; there was no reliable distinction between the two extrastriate areas. A similar pattern of results was obtained with the two analysis methods, although MVPA analysis showed reliable differential responses emerging at later ages than GLM. Although BOLD responses to large visual stimuli are detectable, our results with more refined stimuli indicate that global BOLD activity changes as behavioral performance matures. This reflects an hierarchical development of the visual pathways. Since fMRI BOLD reflects neural activity on a population level, our results indicate that, although individual neurons might be adult-like, a longer maturation process takes place on a population level.	[Van Grootel, Tom J.; Kourtzi, Zoe; Logothetis, Nikos K.; Kiorpes, Lynne] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Van Grootel, Tom J.; Movshon, J. Anthony; Kiorpes, Lynne] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Meeson, Alan; Kourtzi, Zoe] Univ Birmingham, Sch Psychol, Behav & Brain Sci, Birmingham, W Midlands, England; [Munk, Matthias H. J.] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Kourtzi, Zoe] Univ Cambridge, Dept Psychol, Cambridge, England	Max Planck Society; New York University; University of Birmingham; Technical University of Darmstadt; University of Cambridge	Van Grootel, TJ (corresponding author), Max Planck Inst Biol Cybernet, Tubingen, Germany.; Van Grootel, TJ (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	tvg214@nyu.edu	Logothetis, Nikos/U-9282-2019	Kourtzi, Zoe/0000-0001-9441-7832	Max Planck Society; James S. McDonnell Foundation; Biotechnology and Biological Sciences Research Council [BB/H012508/1] Funding Source: researchfish; BBSRC [BB/H012508/1] Funding Source: UKRI	Max Planck Society(Max Planck Society); James S. McDonnell Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Max Planck Society and the James S. McDonnell Foundation.	Altman NR, 2001, RADIOLOGY, V221, P56, DOI 10.1148/radiol.2211010074; [Anonymous], 2006, VISUAL BRAIN ACTION; Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Bahmani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107628; Baldwin MKL, 2012, J COMP NEUROL, V520, P544, DOI 10.1002/cne.22732; BARONE P, 1995, CEREB CORTEX, V5, P22, DOI 10.1093/cercor/5.1.22; Batardiere A, 2002, CEREB CORTEX, V12, P453, DOI 10.1093/cercor/12.5.453; Biagi L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002260; BOOTHE RG, 1985, ANNU REV NEUROSCI, V8, P495, DOI 10.1146/annurev.ne.08.030185.002431; BOOTHE RG, 1982, INVEST OPHTH VIS SCI, V22, P228; BOOTHE RG, 1988, VISION RES, V28, P387, DOI 10.1016/0042-6989(88)90181-2; Bourne JA, 2006, CEREB CORTEX, V16, P405, DOI 10.1093/cercor/bhi119; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Braddick O, 2003, NEUROPSYCHOLOGIA, V41, P1769, DOI 10.1016/S0028-3932(03)00178-7; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Burr D, 2006, VISION RES, V46, P1139, DOI 10.1016/j.visres.2005.09.018; Chino YM, 1997, J NEUROSCI, V17, P296, DOI 10.1523/JNEUROSCI.17-01-00296.1997; Chung CYL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00195; Conde F, 1996, DEV BRAIN RES, V96, P261, DOI 10.1016/S0165-3806(96)00126-5; Coogan TA, 1996, J COMP NEUROL, V372, P327, DOI 10.1002/(SICI)1096-9861(19960826)372:3<327::AID-CNE1>3.0.CO;2-4; Deen B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13995; Distler C, 1996, CEREB CORTEX, V6, P184, DOI 10.1093/cercor/6.2.184; El-Shamayleh Y, 2010, J VISION, V10, DOI 10.1167/10.11.11; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GLASS L, 1969, NATURE, V223, P578, DOI 10.1038/223578a0; GLASS L, 1973, NATURE, V246, P360, DOI 10.1038/246360a0; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Goense JBM, 2008, CURR BIOL, V18, P631, DOI 10.1016/j.cub.2008.03.054; Guillery RW, 2005, TRENDS NEUROSCI, V28, P512, DOI 10.1016/j.tins.2005.08.006; Harris JJ, 2011, DEV COGN NEUROS-NETH, V1, P199, DOI 10.1016/j.dcn.2011.04.001; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hou C, 2003, J NEUROSCI, V23, P8630; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Joachims T., 1999, MAKING LARGE SCALE S; JONES AKP, 1991, NEUROSCI LETT, V126, P25, DOI 10.1016/0304-3940(91)90362-W; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kennedy H., 2004, VISUAL NEUROSCI, V1, P146; Kiorpes L, 2004, VISUAL NEUROSCI, V21, P851, DOI 10.1017/S0952523804216054; Kiorpes L, 2003, VISUAL NEUROSCI, V20, P567, DOI 10.1017/S0952523803205101; KIORPES L, 1992, VISUAL NEUROSCI, V9, P243, DOI 10.1017/S0952523800010658; Kiorpes L, 1996, VISION RES, V36, P239, DOI 10.1016/0042-6989(95)00097-J; Kiorpes L, 2013, THE NEW VISUAL NEURO, P1423; Kiorpes L, 2004, VISUAL NEUROSCIENCES, P159; Kiorpes L, 2012, VISION RES, V63, P34, DOI 10.1016/j.visres.2012.04.018; Kiorpes L, 2008, PRIMATE MODELS OF CHILDREN'S HEALTH AND DEVELOPMENTAL DISABILITIES, P45, DOI 10.1016/B978-012373743-4.50005-9; Kourtzi Z, 2006, MAGN RESON IMAGING, V24, P359, DOI 10.1016/j.mri.2005.12.025; Krekelberg B, 2005, J NEUROPHYSIOL, V94, P4373, DOI 10.1152/jn.00690.2005; Krekelberg B, 2003, NATURE, V424, P674, DOI 10.1038/nature01852; Ku SP, 2011, NEURON, V70, P352, DOI 10.1016/j.neuron.2011.02.048; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lewkowicz D. J., 2004, HDB MULTISENSORY PRO, P655; Li DP, 2013, VISUAL NEUROSCI, V30, P263, DOI 10.1017/S0952523813000394; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Malkova L, 2006, EUR J NEUROSCI, V24, P3204, DOI 10.1111/j.1460-9568.2006.05175.x; Mannion DJ, 2009, NEUROIMAGE, V46, P511, DOI 10.1016/j.neuroimage.2009.01.052; Martin E, 1999, PEDIATR RES, V46, P135, DOI 10.1203/00006450-199908000-00001; Maruko I, 2008, J NEUROPHYSIOL, V100, P2486, DOI 10.1152/jn.90397.2008; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MAURER D, 1993, NATO ADV SCI INST SE, V69, P109; McKeefry DJ, 1997, NEUROIMAGE, V5, P1, DOI 10.1006/nimg.1996.0246; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Morita T, 2000, NEUROSCI RES, V38, P63, DOI 10.1016/S0168-0102(00)00146-2; Movshon JA, 2013, VISUAL NEUROSCI, V30, P219, DOI 10.1017/S0952523813000527; Movshon JA, 2003, NAT NEUROSCI, V6, P3, DOI 10.1038/nn0103-3a; Nankoo JF, 2012, VISION RES, V72, P55, DOI 10.1016/j.visres.2012.09.008; Or CCF, 2007, VISION RES, V47, P253, DOI 10.1016/j.visres.2006.10.010; Ostwald D, 2008, J NEUROPHYSIOL, V99, P2456, DOI 10.1152/jn.01307.2007; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Palomares M, 2010, J COGNITIVE NEUROSCI, V22, P1557, DOI 10.1162/jocn.2009.21323; Pattinson KTS, 2007, J CEREBR BLOOD F MET, V27, P414, DOI 10.1038/sj.jcbfm.9600347; PFEIFFER A, 1982, BRAIN RES, V248, P87, DOI 10.1016/0006-8993(82)91150-7; Pierre PJ, 2008, BRAIN RES, V1226, P56, DOI 10.1016/j.brainres.2008.06.001; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Rieck A, 2005, EUROPEAN J ANAESTHES, V22; RODMAN HR, 1993, J NEUROPHYSIOL, V70, P1115, DOI 10.1152/jn.1993.70.3.1115; RODMAN HR, 1994, CEREB CORTEX, V4, P484, DOI 10.1093/cercor/4.5.484; Ross J, 2000, CURR BIOL, V10, P679, DOI 10.1016/S0960-9822(00)00524-8; Saleem KS, 2012, COMBINED MRI HISTOLO; Sawada K, 2010, NEUROSCIENCE, V167, P735, DOI 10.1016/j.neuroscience.2010.02.045; Sellers KK, 2015, J NEUROPHYSIOL, V113, P3798, DOI 10.1152/jn.00923.2014; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith MA, 2002, J NEUROSCI, V22, P8334, DOI 10.1523/jneurosci.22-18-08334.2002; Smith MA, 2007, J VISION, V7, DOI 10.1167/7.3.5; Stavros KA, 2008, VISION RES, V48, P1335, DOI 10.1016/j.visres.2008.01.031; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; TELLER DY, 1979, T OPHTHAL SOC UK, V99, P333; Teller DY, 1997, INVEST OPHTH VIS SCI, V38, P2183; Tong F, 2012, ANNU REV PSYCHOL, V63, P483, DOI 10.1146/annurev-psych-120710-100412; Ungerleider L.G., 2004, VISUAL NEUROSCIENCES, P541; Watanabe H, 2010, NEUROIMAGE, V50, P1536, DOI 10.1016/j.neuroimage.2010.01.068; Wattam-Bell J, 2010, CURR BIOL, V20, P411, DOI 10.1016/j.cub.2009.12.020; Wise RG, 2002, NEUROIMAGE, V16, P999, DOI 10.1006/nimg.2002.1146; Yamada H, 1997, NEUROREPORT, V8, P3775, DOI 10.1097/00001756-199712010-00024; Yamada H, 2000, NEUROLOGY, V55, P218, DOI 10.1212/WNL.55.2.218; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080749; Zhang B, 2005, P NATL ACAD SCI USA, V102, P5862, DOI 10.1073/pnas.0501815102; Zhang B, 2008, J NEUROPHYSIOL, V100, P1476, DOI 10.1152/jn.90446.2008; Zhang B, 2013, J NEUROSCI, V33, P2639, DOI 10.1523/JNEUROSCI.4377-12.2013; Zheng J, 2007, J NEUROPHYSIOL, V97, P3905, DOI 10.1152/jn.01320.2006; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	107	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187942	10.1371/journal.pone.0187942	http://dx.doi.org/10.1371/journal.pone.0187942			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145469	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800040
J	Navarro-Quiroz, E; Pacheco-Lugo, L; Navarro-Quiroz, R; Lorenzi, H; Espana-Puccini, P; Diaz-Olmos, Y; Almendrales, L; Olave, V; Gonzalez-Torres, H; Diaz-Perez, A; Dominguez, A; Iglesias, A; Garcia, R; Aroca-Martinez, G				Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Navarro-Quiroz, Roberto; Lorenzi, Hernan; Espana-Puccini, Pierine; Diaz-Olmos, Yirys; Almendrales, Lisneth; Olave, Valeria; Gonzalez-Torres, Henry; Diaz-Perez, Anderson; Dominguez, Alex; Iglesias, Antonio; Garcia, Raul; Aroca-Martinez, Gustavo			Profiling analysis of circulating microRNA in peripheral blood of patients with class IV lupus nephritis	PLOS ONE			English	Article							T-CELLS; ERYTHEMATOSUS; EXPRESSION; DISEASE; PATHOGENESIS; DATABASE; TARGETS; CLASSIFICATION; MIGRATION; REVEALS	Renal involvement in Systemic Lupus Erythematous (SLE) patients is one of the leading causes of morbidity and a significant contributor to mortality. It's estimated that nearly 50% of SLE individuals develop kidney disease in the first year of the diagnosis. Class IV lupus nephritis (LN-IV) is the class of lupus nephritis most common in Colombian patients with SLE. Altered miRNAs expression levels have been reported in human autoimmune diseases including lupus. Variations in the expression pattern of peripheral blood circulating miRNAs specific for this class of lupus nephritis could be correlated with the pathophysiological status of this group of individuals. The aim of this study was to evaluate the relative abundance of circulating microRNAs in peripheral blood from Colombian patients with LN-IV. Circulating miRNAs in plasma of patients with diagnosis of LN-IV were compared with individuals without renal involvement (LNN group) and healthy individuals (CTL group). Total RNA was extracted from 10 ml of venous blood and subsequently sequenced using Illumina. The sequences were processed and these were analyzed using miRBase and Ensembl databases. Differential gene expression analysis was carried out with edgeR and functional analysis were done with DIANA-miRPath. Analysis was carried out using as variables of selection fold change (>= 2 o <=-2) and false discovery rate (0.05). We identified 24 circulating microRNAs with differential abundance between LN-IV and CTL groups, fourteen of these microRNAs are described for the first time to lupus nephritis (hsa-miR-589-3p, hsa-miR-1260b, hsa-miR-4511, hsa-miR485-5p, hsa-miR-584-5p, hsa-miR-543, hsa-miR-153-3p, hsa-miR-6087, hsa-miR-3942-5p, hsa-miR-7977, hsa-miR-323b-3p, hsa-miR-4732-3p and hsa-miR-6741-3p). These changes in the abundance of miRNAs could be interpreted as alterations in the miRNAs-mRNA regulatory network in the pathogenesis of LN, preceding the clinical onset of the disease. The findings thus contribute to understanding the disease process and are likely to pave the way towards identifying disease biomarkers for early diagnosis of LN.	[Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Espana-Puccini, Pierine; Diaz-Olmos, Yirys; Almendrales, Lisneth; Olave, Valeria; Gonzalez-Torres, Henry; Diaz-Perez, Anderson; Dominguez, Alex; Aroca-Martinez, Gustavo] Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia; [Navarro-Quiroz, Roberto] Univ Cooperat Colombia, Ctr Invest Salud Trop, Santa Marta, Colombia; [Lorenzi, Hernan] J Craig Venter Inst, Infect Dis Dept, Rockville, MD USA; [Iglesias, Antonio] Univ Nacl Colombia, Unidad Reumatol, Bogota, Colombia; [Garcia, Raul; Aroca-Martinez, Gustavo] Clin Costa, Barranquilla, Colombia	Universidad Cooperativa de Colombia; J. Craig Venter Institute; Universidad Nacional de Colombia	Navarro-Quiroz, E (corresponding author), Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia.	enavarro26@unisimonbolivar.edu.co	Aroca Martinez, Gustavo/N-9133-2013; Aroca, Gustavo/P-9173-2016; QUIROZ, ROBERTO CARLOS NAVARRO/P-9517-2017; Domínguez-Vargas, Alex/D-4272-2019; Quiroz, Elkin Navarro/AAB-6381-2019; Aroca-Martínez, Gustavo/AAV-7952-2021; González-Torres, Henry Joseth/AAW-4602-2020; Diaz-Perez, Anderson/Q-2320-2016	Aroca Martinez, Gustavo/0000-0002-9222-3257; Aroca, Gustavo/0000-0002-9222-3257; QUIROZ, ROBERTO CARLOS NAVARRO/0000-0002-3604-3702; Domínguez-Vargas, Alex/0000-0002-3984-8653; Quiroz, Elkin Navarro/0000-0001-7567-6409; González-Torres, Henry Joseth/0000-0001-7434-4568; Lorenzi, Hernan/0000-0003-0910-7894; Diaz-Perez, Anderson/0000-0003-2448-0953; Pacheco-Lugo, Lisandro/0000-0002-9248-4596	Colciencias [125356934453]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	Research supported by Colciencias grants 125356934453.	Ajit SK, 2012, SENSORS-BASEL, V12, P3359, DOI 10.3390/s120303359; Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Arroyo C AR, 2014, REV COLOMB NEFROL, V1, P57; Balakrishnan I, 2014, STEM CELLS, V32, P662, DOI 10.1002/stem.1531; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlsen AL, 2013, ARTHRITIS RHEUM-US, V65, P1324, DOI 10.1002/art.37890; Celhar T, 2015, P NATL ACAD SCI USA, V112, pE6195, DOI 10.1073/pnas.1507052112; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Choi EW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38237; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Contreras G, 2006, KIDNEY INT, V69, P1846, DOI 10.1038/sj.ki.5000243; Davidson A, 2016, NAT REV RHEUMATOL, V12, P143, DOI 10.1038/nrrheum.2015.159; de Souza Rocha Simonini P, 2010, CANCER RES, V70, P9175, DOI DOI 10.1158/0008-5472.CAN-10-1318; Edwards LJ, 2015, CLIN IMMUNOL, V158, P221, DOI 10.1016/j.clim.2015.04.004; Fang XY, 2014, RHEUMATOL INT, V34, P1175, DOI 10.1007/s00296-013-2873-2; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; GORDON C, 1989, CLIN IMMUNOL IMMUNOP, V52, P421, DOI 10.1016/0090-1229(89)90157-8; Haladyj Ewa, 2016, Reumatologia (Warsaw), V54, P61, DOI [10.5114/reum.2016.60214, 10.5114/reum.2016.06214]; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kutmon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082160; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Liu DM, 2016, CELL PHYSIOL BIOCHEM, V39, P303, DOI 10.1159/000445625; Liu YJ, 2014, NEPHRON CLIN PRACT, V128, P224, DOI 10.1159/000368581; Lu MC, 2013, CLIN EXP IMMUNOL, V171, P91, DOI 10.1111/j.1365-2249.2012.04676.x; Lu RJ, 2014, J CANCER RES CLIN, V140, P387, DOI 10.1007/s00432-013-1577-z; Navarro-Quiroz E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166202; Palm T, 2013, NUCLEIC ACIDS RES, V41, P3699, DOI 10.1093/nar/gkt070; Pan QJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-67; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; SAITO Y, 2012, FRONT GENET, V3; Schena FP, 2015, CLIN SCI, V128, P775, DOI 10.1042/CS20140733; Talaat RM, 2015, CYTOKINE, V72, P146, DOI 10.1016/j.cyto.2014.12.027; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13	48	43	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187973	10.1371/journal.pone.0187973	http://dx.doi.org/10.1371/journal.pone.0187973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136041	Green Published, gold			2022-12-27	WOS:000415121200052
J	Ding, WQ; Liu, TR; Liang, JG; Hu, TB; Cui, SY; Zou, GR; Cai, WW; Yang, AK				Ding, Weiquan; Liu, Tianrun; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei; Yang, Ankui			Supraglottic squamous cell carcinomas have distinctive clinical features and prognosis based on subregion	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; LARYNGEAL-CANCER; RADIOTHERAPY; SURVIVAL; NECK; HEAD	Objective To analyze the clinicopathologic characteristics and prognosis of patients with squamous cell carcinoma localized to different supraglottic subregions. Methods Clinicopathologic data were reviewed retrospectively for 111 patients with supraglottic squamous cell carcinoma who were diagnosed between January 1, 1995 and December 31, 2005 and were initially treated with surgery. DNA from human papillomavirus (HPV) 16 and (or/and) HPV 18 were detected in all the 111 supraglottic carcinoma specimens using in situ hybridization. Survival analysis was performed by Kaplan-Meier analysis, factors were compared using log-rank test, and prognostic factors were determined using Cox proportional hazards model. The relationship between subregions and clinicopathologic factors was analyzed using Chi-square tests. Results HPV prevalence differed between patients with aryepiglottic fold carcinoma and ventricle carcinoma (P < .05). The local-regional control rates, overall survival rates or cancer specific survival rates were significantly different between different subregions. Univariate analysis indicated that pTNM classification, pN spread, and subregion were associated with prognosis (P < .05). Multivariate analysis indicated that pTNM classification and subregion were associated with supraglottic carcinoma prognosis. The survival rate was better for patients with carcinoma of the epiglottis or ventricular bands compared to those with carcinoma in the aryepiglottic fold or ventricle (P =.012). Conclusions Subregion may be a new prognostic factor for supraglottic squamous cell carcinoma. Different supraglottic carcinoma subregions have distinct clinical features such as HPV expression, lymph node metastasis rate, local-regional control and prognosis. Therefore, it is necessary to subdivide supraglottic squamous cell carcinomas into several subregion groups to individualize therapy.	[Ding, Weiquan; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei] Panyu Cent Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China; [Ding, Weiquan; Liang, Jiangang; Hu, Tingbao; Cui, Shaoyun; Zou, Guorong; Cai, Weiwei] Canc Inst Panyu, Guangzhou, Guangdong, Peoples R China; [Liu, Tianrun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Otorhinolaryngol Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ankui] Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China; [Yang, Ankui] State Key Lab Southern China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Liang, JG (corresponding author), Panyu Cent Hosp, Dept Otorhinolaryngol, Guangzhou, Guangdong, Peoples R China.; Liang, JG (corresponding author), Canc Inst Panyu, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Head & Neck Surg, Guangzhou, Guangdong, Peoples R China.; Yang, AK (corresponding author), State Key Lab Southern China, Guangzhou, Guangdong, Peoples R China.	liangjiamgang111@163.com; yangak@sysucc.org.cn			National Natural Science Foundation of China [81272955, 81302368]; Guangdong Province Natural Science Foundation [2015A030313058, 2014A020212100]; Guangdong Province Science and technology Foundation [2011B031800313040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and technology Foundation	This study was supported by the National Natural Science Foundation of China (grant numbers 81272955 and 81302368) to Ankui Yang, the Guangdong Province Natural Science Foundation (grant number 2015A030313058) to Tianrun Liu and (grant number 2014A020212100) to Ankui Yang, and the Guangdong Province Science and technology Foundation (grant number 2011B031800313040) to Tianrun Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 1996, EUR J CANCER, V32A, P783, DOI 10.1016/0959-8049(95)00628-1; Boffetta P, 1997, AM J EPIDEMIOL, V145, P1100; Ganly I, 2009, HEAD NECK-J SCI SPEC, V31, P1489, DOI 10.1002/hed.21113; Jin YT, 1998, CANCER, V82, P2159, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2159::AID-CNCR10>3.3.CO;2-H; Jones TM, 2016, J LARYNGOL OTOL, V130, pS75, DOI 10.1017/S0022215116000487; Koirala Krishna, 2015, Asian Pac J Cancer Prev, V16, P6541; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Mor N, 2015, OTOLARYNG CLIN N AM, V48, P533, DOI 10.1016/j.otc.2015.04.002; Morshed K, 2010, J MED VIROL, V82, P1017, DOI 10.1002/jmv.21749; Mourad WF, 2013, ONKOLOGIE, V36, P433, DOI 10.1159/000353750; Peller M, 2016, EUR ARCH OTO-RHINO-L, V273, P1481, DOI 10.1007/s00405-016-3922-8; Peretti G, 2016, CURR OPIN OTOLARYNGO, V24, P135, DOI 10.1097/MOO.0000000000000240; Ragin CCR, 2007, INT J CANCER, V121, P1813, DOI 10.1002/ijc.22851; Raitiola H, 2000, Auris Nasus Larynx, V27, P153, DOI 10.1016/S0385-8146(99)00072-3; Santos CR, 1998, ANN OTO RHINOL LARYN, V107, P697; Smee RI, 2013, HEAD NECK-J SCI SPEC, V35, P949, DOI 10.1002/hed.23061; Subspecialty Group of Head and Neck Surgery Editorial Board of Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2014, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V49, P620; Vlachtsis K, 2005, EUR ARCH OTO-RHINO-L, V262, P890, DOI 10.1007/s00405-005-0916-3	19	3	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188322	10.1371/journal.pone.0188322	http://dx.doi.org/10.1371/journal.pone.0188322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155864	Green Published, Green Submitted, gold			2022-12-27	WOS:000415756700046
J	Subarnbhesaj, A; Miyauchi, M; Chanbora, C; Mikuriya, A; Nguyen, PT; Furusho, H; Ayuningtyas, NF; Fujita, M; Toratani, S; Takechi, M; Niida, S; Takata, T				Subarnbhesaj, Ajiravudh; Miyauchi, Mutsumi; Chanbora, Chea; Mikuriya, Aki; Phuong Thao Nguyen; Furusho, Hisako; Ayuningtyas, Nurina Febriyanti; Fujita, Minoru; Toratani, Shigeaki; Takechi, Masaaki; Niida, Shumpei; Takata, Takashi			Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; FACTOR VEGF; BONE-RESORPTION; FACTOR RECEPTOR-1; BREAST-CANCER; EXPRESSION; ANGIOGENESIS; SYSTEM; RANKL	Background Vascular endothelial growth factor (VEGF) is a highly specific signaling protein for vascular endothelial cells that plays a critical role in tumor growth and invasion through angiogenesis, and may contribute to cell migration and activation of pre-osteoclasts, osteoclasts and some tumor cells. Objectives We aimed to clarify the detailed roles of VEGF-Flt-1 signaling in bone invasion of oral squamous cell carcinoma (OSCC) cells. Results Forty-two (42) of 54 cases with gingival SCC (77.8%) strongly expressed VEGF, and had a significantly increased number of Flt-1+ osteoclasts (p<0.01) and more aggressive bone invasion (p<0.05). PlGF, a ligand of Flt-1, induced osteoclastogenesis in single culture of bone marrow cells (BMCs), and inhibition of Flt-1-signaling by VEGF tyrosine kinase inhibitor and It's down stream (Akt and ERK1/2) inhibitos reduced osteoclastogenesis in PlGF-stimulated BMCs (p<0.01). In molecular level, PlGF stimulation significantly upregulated RANKL expression in Flt-1-expressing HSC2 cells via phosphorylation of Akt and ERK1/2. In the co-culture of VEGF-producing HSC2 cells and BMCs, number of TRAP-positive osteoclasts markedly increased (p<0.01). The osteoclastogenesis was significantly inhibited by RANKL-neutralizing antibody (p<0.01) as well as by VEGF tyrosine kinase inhibitor (p<0.01) and it's downstream (Akt and ERK1/2) inhibitors (p<0.01, p<0.05, respectively). Conclusion VEGF-Flt-1 signaling induces osteoclastogenesis in OSCC through two possible ways: 1) VEGF produced from OSCC cells can directly stimulate the Flt-1 pathway in preosteoclasts to induce migration to future bone resorbing area and differentiation into osteoclasts, and 2) VEGF-Flt-1 signaling upregulates RANKL expression in OSCC cells, which indirectly leads to osteoclast differentiation. Therefore, blocking of the VEGF-Flt-1 signaling may help inhibit bone invasion of OSCC.	[Subarnbhesaj, Ajiravudh; Miyauchi, Mutsumi; Chanbora, Chea; Mikuriya, Aki; Furusho, Hisako; Ayuningtyas, Nurina Febriyanti; Takata, Takashi] Hiroshima Univ, Dept Oral & Maxillofacial Pathobiol, Sch Biomed & Hlth Sci, Hiroshima, Japan; [Phuong Thao Nguyen] Hiroshima Univ, Dept Global Dent Med & Pharm Ho Chi Minh city, Integrated Hlth Sci, Sch Biomed & Hlth Sci, Hiroshima, Japan; [Fujita, Minoru] Hiroshima Univ, Dept Oral & Maxillofacial Radiol, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Toratani, Shigeaki] Hiroshima Univ, Dept Mol Oral Med & Maxillofacial Surg, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Takechi, Masaaki] Hiroshima Univ, Dept Oral & Maxillofacial Surg, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Niida, Shumpei] Natl Ctr Geriatr & Gerontol, Biobank, Med Genome Ctr, Obu, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University; National Center for Geriatrics & Gerontology	Miyauchi, M; Takata, T (corresponding author), Hiroshima Univ, Dept Oral & Maxillofacial Pathobiol, Sch Biomed & Hlth Sci, Hiroshima, Japan.	mmiya@hiroshima-u.ac.jp; ttakata@hiroshima-u.ac.jp	Nguyen, Thao/AAH-7394-2019; Furusho, Hisako/H-2351-2019; Miyauchi, Mutsumi/G-5268-2019	Nguyen, Thao/0000-0003-4651-5168; Ayuningtyas, Nurina Febriyanti/0000-0003-4403-6542	Ministry of Education, Science and Culture [21249088]; Grants-in-Aid for Scientific Research [15K11251] Funding Source: KAKEN	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for scientific research (A) from the Ministry of Education, Science and Culture (#21249088 [T. T.]).	Aldridge SE, 2005, BRIT J CANCER, V92, P1531, DOI 10.1038/sj.bjc.6602417; [Anonymous], 2009, UICC TNM CLASSIFICAT, V7th; Attar E, 2010, ORAL ONCOL, V46, P591, DOI 10.1016/j.oraloncology.2010.05.002; Bagan J, 2010, ORAL ONCOL, V46, P414, DOI 10.1016/j.oraloncology.2010.03.009; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Brown JS, 2002, HEAD NECK-J SCI SPEC, V24, P370, DOI 10.1002/hed.10062; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Deyama Y, 2008, ONCOL REP, V20, P663, DOI 10.3892/or_00000057; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Friedrich RE, 2010, ANTICANCER RES, V30, P1765; Funk GF, 2002, HEAD NECK-J SCI SPEC, V24, P165, DOI 10.1002/hed.10004; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Guan H, 2009, ONCOL RES, V18, P117, DOI 10.3727/096504009789954627; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harry Lorraine E., 2003, Birth Defects Research, V69, P363, DOI 10.1002/bdrc.10024; Henriksen K, 2003, J BIOL CHEM, V278, P48745, DOI 10.1074/jbc.M309193200; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Jordan RC, 1997, CAN DENT ASS, V63, P517; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Margaritescu C, 2009, ROM J MORPHOL EMBRYO, V50, P527; Masood R, 2001, BLOOD, V98, P1904, DOI 10.1182/blood.V98.6.1904; MINKIN C, 1991, BONE MINER, V13, P191, DOI 10.1016/0169-6009(91)90068-B; Nakagawa M, 2000, FEBS LETT, V473, P161, DOI 10.1016/S0014-5793(00)01520-9; Nakai T, 2009, MOL MED REP, V2, P229, DOI 10.3892/mmr_00000088; Nakayama T, 2011, BONE, V49, P1331, DOI 10.1016/j.bone.2011.09.045; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Niida S, 2005, P NATL ACAD SCI USA, V102, P14016, DOI 10.1073/pnas.0503544102; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pianka A, 2015, J ORAL MAXIL SURG, V73, P897, DOI 10.1016/j.joms.2014.12.030; Salvi V, 2016, ONCOTARGET, V7, P39256, DOI 10.18632/oncotarget.9684; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shibuya M, 1999, CURR TOP MICROBIOL, V237, P59; Shibuya M, 2013, J BIOCHEM, V153, P13, DOI 10.1093/jb/mvs136; Stinga AC, 2011, ROM J MORPHOL EMBRYO, V52, P1269; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; Van der Pluijm G, 2001, J BONE MINER RES, V16, P1077, DOI 10.1359/jbmr.2001.16.6.1077; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wei SC, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-39; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Wong RJ, 2000, LARYNGOSCOPE, V110, P65, DOI 10.1097/00005537-200001000-00013; Yang QL, 2008, MATRIX BIOL, V27, P589, DOI 10.1016/j.matbio.2008.06.005	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187092	10.1371/journal.pone.0187092	http://dx.doi.org/10.1371/journal.pone.0187092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149180	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100006
J	Yindom, LM; Mendy, M; Bodimeade, C; Chambion, C; Aka, P; Whittle, HC; Rowland-Jones, SL; Walton, R				Yindom, Louis-Marie; Mendy, Maimuna; Bodimeade, Christopher; Chambion, Caroline; Aka, Peter; Whittle, Hilton C.; Rowland-Jones, Sarah L.; Walton, Robert			KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; KILLER-CELL RECEPTOR; C-VIRUS-INFECTION; HLA CLASS-I; HEPATOCELLULAR-CARCINOMA; NATURAL-KILLER; LIVER-CANCER; WEST-AFRICA; AFLATOXIN EXPOSURE; GENE-CLUSTER	Background Hepatocellular carcinoma (HCC) causes over 800,000 deaths worldwide annually, mainly in low income countries, and incidence is rising rapidly in the developed world with the spread of hepatitis B (HBV) and C (HCV) viruses. Natural Killer (NK) cells protect against viral infections and tumours by killing abnormal cells recognised by Killer-cell Immunoglobulin-like Receptors (KIR). Thus genes and haplotypes encoding these receptors may be important in determining both outcome of initial hepatitis infection and subsequent chronic liver disease and tumour formation. HBV is highly prevalent in The Gambia and the commonest cause of liver disease. The Gambia Liver Cancer Study was a matched case-control study conducted between September 1997 and January 2001 where cases with liver disease were identified in three tertiary referral hospitals and matched with out-patient controls with no clinical evidence of liver disease. Methods We typed 15 KIR genes using the polymerase chain reaction with sequence specific primers (PCR-SSP) in 279 adult Gambians, 136 with liver disease (HCC or Cirrhosis) and 143 matched controls. We investigated effects of KIR genotypes and haplotypes on HBV infection and associations with cirrhosis and HCC. Results Homozygosity for KIR group A gene-content haplotype was associated with HBsAg carriage (OR 3.7, 95% CI 1.4-10.0) whilst telomeric A genotype (t-AA) was associated with reduced risk of e antigenaemia (OR 0.2, 95% CI 0.0-0.6) and lower viral loads (mean log viral load 5.2 vs. 6.9, p(c) = 0.022). One novel telomeric B genotype (t-ABx2) containing KIR3DS1 (which is rare in West Africa) was also linked to e antigenaemia (OR 8.8, 95% CI 1.3-60.5). There were no associations with cirrhosis or HCC. Conclusion Certain KIR profiles may promote clearance of hepatitis B surface antigen whilst others predispose to e antigen carriage and high viral load. Larger studies are necessary to quantify the effects of individual KIR genes, haplotypes and KIR/HLA combinations on long-term viral carriage and risk of liver cancer. KIR status could potentially inform antiviral therapy and identify those at increased risk of complications for enhanced surveillance.	[Yindom, Louis-Marie; Rowland-Jones, Sarah L.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Yindom, Louis-Marie; Mendy, Maimuna; Bodimeade, Christopher; Chambion, Caroline; Aka, Peter; Whittle, Hilton C.; Rowland-Jones, Sarah L.] Med Res Council UK, Fajara, Gambia; [Mendy, Maimuna] Int Agcy Res Canc, Lyon, France; [Aka, Peter] ICF Int, Demog & Hlth Surveys, Rockville, MD USA; [Whittle, Hilton C.] London Sch Hyg & Trop Med, London, England; [Walton, Robert] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Walton, Robert] Queen Mary Univ, Barts & London Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of London; Queen Mary University London	Yindom, LM (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Yindom, LM (corresponding author), Med Res Council UK, Fajara, Gambia.	louis-marie.yindom@ndm.ox.ac.uk	Mendy, Maimuna/ABD-5038-2021	Bodimeade, Christopher/0000-0002-0607-3062; Walton, Robert/0000-0001-7700-1907; Yindom, Louis-Marie/0000-0001-8078-7146	Medical Research Council (UK); WHO's International Agency for Research on Cancer (IARC); National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA) [N02CP40521]; MRC [MC_U190085854, MC_U190092710, MC_U190081977] Funding Source: UKRI; Medical Research Council [MC_U190092710, MC_U190081977, MC_U190085854] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10076] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WHO's International Agency for Research on Cancer (IARC); National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Medical Research Council (UK), WHO's International Agency for Research on Cancer (IARC) and the National Cancer Institute, National Institutes of Health, Department of Health and Human Services (USA) (Contract #N02CP40521). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ICF International is currently paying PA salaries, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Faruque, 2008, Prev Chronic Dis, V5, pA74; Bah E, 2001, BRIT J CANCER, V84, P1207, DOI 10.1054/bjoc.2001.1730; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Chen YY, 2006, CELL MOL IMMUNOL, V3, P373; CHUANG WL, 1990, CANCER, V65, P926, DOI 10.1002/1097-0142(19900215)65:4<926::AID-CNCR2820650418>3.0.CO;2-U; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Di Bona D, 2017, J VIRAL HEPAT; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao XJ, 2010, CLIN IMMUNOL, V137, P139, DOI 10.1016/j.clim.2010.05.011; Gillespie GMA, 2007, AIDS RES HUM RETROV, V23, P451, DOI 10.1089/aid.2006.0165; Grebely J, 2007, CAN J GASTROENTEROL, V21, P447, DOI 10.1155/2007/796325; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jonsson AH, 2009, ADV IMMUNOL, V101, P27, DOI 10.1016/S0065-2776(08)01002-X; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Kirk GD, 2005, ONCOGENE, V24, P5858, DOI 10.1038/sj.onc.1208732; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Kovacic MB, 2005, CANCER EPIDEM BIOMAR, V14, P2673, DOI 10.1158/1055-9965.EPI-05-0229; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lemoine M, 2017, J HEPATOL, V66, P645, DOI 10.1016/j.jhep.2016.10.013; Lemoine M, 2016, LANCET GLOB HEALTH, V4, pE559, DOI 10.1016/S2214-109X(16)30130-9; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lopez-Vazquez A, 2007, TISSUE ANTIGENS, V69, P241, DOI 10.1111/j.1399-0039.2006.77341.x; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin AM, 2000, IMMUNOGENETICS, V51, P268, DOI 10.1007/s002510050620; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2005, CURR OPIN IMMUNOL, V17, P510, DOI 10.1016/j.coi.2005.07.012; Maxwell LD, 2004, HUM IMMUNOL, V65, P613, DOI 10.1016/j.humimm.2004.02.028; Mendy ME, 2010, J VIRAL HEPATITIS, V17, P115, DOI 10.1111/j.1365-2893.2009.01168.x; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; Pan N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025682; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; QIAN GS, 1994, CANCER EPIDEM BIOMAR, V3, P3; Rempel JD, 2011, EUR J HUM GENET, V19, P1276, DOI 10.1038/ejhg.2011.114; Robinson J, 2010, NUCLEIC ACIDS RES, V38, pD863, DOI 10.1093/nar/gkp879; Single RM, 2007, NAT GENET, V39, P1114, DOI 10.1038/ng2077; Taketomi A, 1998, CANCER, V83, P58, DOI 10.1002/(SICI)1097-0142(19980701)83:1<58::AID-CNCR8>3.0.CO;2-A; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Thons C, 2017, J HEPATOL; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yindom LM, 2012, TISSUE ANTIGENS, V79, P104, DOI 10.1111/j.1399-0039.2011.01818.x; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhi-Ming L, 2007, CROAT MED J, V48, P800, DOI 10.3325/cmj.2007.6.800	50	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188307	10.1371/journal.pone.0188307	http://dx.doi.org/10.1371/journal.pone.0188307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149205	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000415646100036
J	Abatayo, AL; Thorsen, BJ				Abatayo, Anna Lou; Thorsen, Bo Jellesmark			One-shot exogenous interventions increase subsequent coordination in Denmark, Spain and Ghana	PLOS ONE			English	Article							PUBLIC-GOODS; SOCIAL INFORMATION; FIELD EXPERIMENT; STRATEGIC UNCERTAINTY; ENERGY-CONSERVATION; VOLUNTARY PROVISION; GAMES; FAILURE; NORMS; COOPERATION	Everyday, we are bombarded with periodic, exogenous appeals and instructions on how to behave. How do these appeals and instructions affect subsequent coordination? Using experimental methods, we investigate how a one-time exogenous instruction affects subsequent coordination among individuals in a lab. Participants play a minimum effort game repeated 5 times under fixed matching with a one-time behavioral instruction in either the first or second round. Since coordination behavior may vary across countries, we run experiments in Denmark, Spain and Ghana, and map cross-country rankings in coordination with known national measures of fractualization, uncertainty avoidance and long-term orientation. Our results show that exogenous interventions increase subsequent coordination, with earlier interventions yielding better coordination than later interventions. We also find that cross-country rankings in coordination map with published national measures of fractualization, uncertainty avoidance, and long-term orientation.	[Abatayo, Anna Lou] Bocconi Univ, Dept Econ, Milan, Italy; [Abatayo, Anna Lou] Fdn Eni Enrico Mattei, Milan, Italy; [Thorsen, Bo Jellesmark] Univ Copenhagen, Dept Food & Resource Econ, Copenhagen, Denmark; [Thorsen, Bo Jellesmark] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark	Bocconi University; Fondazione Mattei; University of Copenhagen; University of Copenhagen	Abatayo, AL (corresponding author), Bocconi Univ, Dept Econ, Milan, Italy.; Abatayo, AL (corresponding author), Fdn Eni Enrico Mattei, Milan, Italy.	anna.abatayo@unibocconi.it	Thorsen, Bo Jellesmark J/K-8770-2014; Abatayo, Anna Lou/U-7689-2019; Abatayo, Anna Lou/Q-8010-2018	Thorsen, Bo Jellesmark J/0000-0002-3305-8343; Abatayo, Anna Lou/0000-0002-2686-5075	Danish National Research Foundation [DNRF96]; European Research Council under the European Community's Programme "Ideas" [ERC-2013-StG, 336703]	Danish National Research Foundation(Danmarks Grundforskningsfond); European Research Council under the European Community's Programme "Ideas"	A.L.A. and B.J.T. would like to acknowledge the support of the Danish National Research Foundation funding for the Center of Macroecology, Evolution and Climate (Grant No. DNRF96). A.L.A. would also like to acknowledge the support of the European Research Council under the European Community's Programme "Ideas" (Call Identifier ERC-2013-StG / Grant No. 336703, Project RISICO, "RISk and uncertainty in developing and Implementing Climate change pOlicies"). The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesina A, 2003, J ECON GROWTH, V8, P155, DOI 10.1023/A:1024471506938; Allcott H, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.1.3; Allcott H, 2011, J PUBLIC ECON, V95, P1082, DOI 10.1016/j.jpubeco.2011.03.003; Ayres I, 2013, J LAW ECON ORGAN, V29, P992, DOI 10.1093/jleo/ews020; Belot M, 2015, J ECON BEHAV ORGAN, V113, P26, DOI 10.1016/j.jebo.2015.02.007; Berninghaus SK, 2001, ECON LETT, V73, P345, DOI 10.1016/S0165-1765(01)00502-X; Brandts J, 2006, AM ECON REV, V96, P669, DOI 10.1257/aer.96.3.669; Buchan NR, 2002, AM J SOCIOL, V108, P168, DOI 10.1086/344546; Cappelen AW, 2013, J EUR ECON ASSOC, V11, P574, DOI 10.1111/jeea.12000; Cason TN, 2012, EUR ECON REV, V56, P233, DOI 10.1016/j.euroecorev.2011.09.001; Castro M. Finocchiaro, 2008, J SOCIO-ECON, V37, P2319, DOI [10.1016/j.socec.2008.04.002, DOI 10.1016/J.SOCEC.2008.04.002]; Chaudhuri A, 2006, REV ECON STUD, V73, P357, DOI 10.1111/j.1467-937X.2006.0379.x; Chaudhuri A, 2010, EXP ECON, V13, P346, DOI 10.1007/s10683-010-9245-5; Chaudhuri A, 2009, ECON J, V119, P91, DOI 10.1111/j.1468-0297.2008.02207.x; Chuah SH, 2007, J ECON BEHAV ORGAN, V64, P35, DOI 10.1016/j.jebo.2006.04.006; Cleave BL, 2013, EXP ECON, V16, P372, DOI 10.1007/s10683-012-9342-8; COOPER R, 1992, Q J ECON, V107, P739, DOI 10.2307/2118488; COOPER RW, 1990, AM ECON REV, V80, P218; Costa DL, 2013, J EUR ECON ASSOC, V11, P680, DOI 10.1111/jeea.12011; Croson R, 2008, EXP ECON, V11, P221, DOI 10.1007/s10683-007-9191-z; Croson R, 2013, ECON INQ, V51, P473, DOI 10.1111/j.1465-7295.2012.00468.x; Devetag G., 2003, Experimental Economics, V6, P53, DOI 10.1023/A:1024252725591; Devetag G, 2007, EXP ECON, V10, P331, DOI 10.1007/s10683-007-9178-9; Dolan P, 2015, NEIGHBORS KNOWLEDGE; Dufwenberg M., 2005, EXP BUSINESS RES, P253; Dugar S, 2010, J ECON BEHAV ORGAN, V73, P377, DOI 10.1016/j.jebo.2009.11.003; Eckel CC, 2007, EXP ECON, V10, P317, DOI 10.1007/s10683-007-9185-x; Engel C, 2014, CAN WE MANAGE 1 IMPR; Engelmann D, 2010, EXP ECON, V13, P249, DOI 10.1007/s10683-010-9239-3; Exadaktylos F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01213; Fehr E, 2007, GAME ECON BEHAV, V58, P246, DOI 10.1016/j.geb.2006.04.005; Fisher J, 1995, PUBLIC CHOICE, V85, P249, DOI 10.1007/BF01048198; Frey BS, 2004, AM ECON REV, V94, P1717, DOI 10.1257/0002828043052187; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Guth W, 2007, J PUBLIC ECON, V91, P1023, DOI 10.1016/j.jpubeco.2006.10.007; Hamman J, 2007, EXP ECON, V10, P285, DOI 10.1007/s10683-007-9179-8; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hofstede G., 1984, CULTURES CONSEQUENCE; Jacquemet N, 2017, EXPT EC, P1; Kamijo Y, 2015, EXPT EC, V19, P1; McCarter MW, 2010, ORGAN BEHAV HUM DEC, V111, P1, DOI 10.1016/j.obhdp.2009.06.003; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moxnes E, 2003, J CONFLICT RESOLUT, V47, P773, DOI 10.1177/0022002703258962; Offerman T, 2001, GAME ECON BEHAV, V36, P264, DOI 10.1006/game.2000.0816; Rapoport A, 2001, ORGAN BEHAV HUM DEC, V85, P135, DOI 10.1006/obhd.2000.2935; Schotter A, 2003, J POLIT ECON, V111, P498, DOI 10.1086/374187; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; Semeshenko V, 2010, THEOR DECIS, V69, P119, DOI 10.1007/s11238-009-9161-3; Shang J, 2009, ECON J, V119, P1422, DOI 10.1111/j.1468-0297.2009.02267.x; Tamir DI, 2013, J EXP PSYCHOL GEN, V142, P151, DOI 10.1037/a0028232; Thaler RH., 2021, NUDGE FINAL EDITION; VANHUYCK JB, 1990, AM ECON REV, V80, P234; VANHUYCK JB, 1991, Q J ECON, V106, P885, DOI 10.2307/2937932; Young P, 2008, THE NEW PALGRAVE DIC	56	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187840	10.1371/journal.pone.0187840	http://dx.doi.org/10.1371/journal.pone.0187840			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145411	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800033
J	Cheong, AT; Chinna, K; Khoo, EM; Liew, SM				Cheong, Ai Theng; Chinna, Karuthan; Khoo, Ee Ming; Liew, Su May			Determinants for cardiovascular disease health check questionnaire: A validation study	PLOS ONE			English	Article							PLANNED BEHAVIOR; GENERAL-PRACTICE; CONTENT VALIDITY; BELIEF MODEL; RECOMMENDATIONS; COMMUNICATION; PERSPECTIVE; INSTRUMENTS; INVITATION; ATTENDANCE	Background To improve individuals' participation in cardiovascular disease (CVD) screening, it is necessary to understand factors that influence their intention to undergo health checks. This study aimed to develop and validate an instrument that assess determinants that influence individuals' intention to undergo CVD health checks. Methods The concepts and items were developed based on findings from our prior exploratory qualitative study on factors influencing individuals' intention to undergo CVD health checks. Content validity of the questionnaire was assessed by a panel of six experts and the item-level content validity index (I-CVI) was determined. After pretesting the questionnaire was pilot tested to check reliability of the items. Exploratory factor analysis was used to test for dimensionality using a sample of 240 participants. Results The finalized questionnaire consists of 36 items, covering nine concepts. The I-CVI for all items was satisfactory with values ranging from 0.83 to 1.00. The exploratory factor analysis showed that the number of factors extracted was consistent with the theoretical concepts. Correlations values between items ranged from 0.30 to 0.85 and all the factor loadings were more than 0.40, indicating satisfactory structural validity. All concepts showed good internal consistency, Cronbach's alpha values ranged 0.66-0.85. Conclusions The determinants for CVD health check questionnaire has good content and structural validity, and its reliability was established. It can be used to assess determinants influencing individuals' intention to undergo CVD health checks.	[Cheong, Ai Theng] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia; [Chinna, Karuthan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Khoo, Ee Ming; Liew, Su May] Univ Malaya, Fac Med, UMPCRG, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Putra Malaysia; Universiti Malaya; Universiti Malaya	Cheong, AT (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia.	cheaitheng@upm.edu.my	KHOO, EE MING/B-8785-2010; LIEW, Su May/B-8852-2010; Cheong, Ai Theng/H-9884-2014	KHOO, EE MING/0000-0003-3191-1264; LIEW, Su May/0000-0003-2865-7955; Cheong, Ai Theng/0000-0002-3895-530X	University of Malaya via EMK [PG049-2014A]	University of Malaya via EMK	Financial support for this study was provided by University of Malaya Postgraduate Research Fund (PG049-2014A) via EMK. The funder had no role in study design, analysis and interpretation of this study.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Armitage CJ, 2002, BRIT J HEALTH PSYCH, V7, P299, DOI 10.1348/135910702760213698; Cheong AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159438; Collins D, 2003, QUAL LIFE RES, V12, P229, DOI 10.1023/A:1023254226592; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Ellis N, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0064-1; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Groenenberg I, 2015, PATIENT EDUC COUNS, V98, P234, DOI 10.1016/j.pec.2014.10.010; Hair J., 2010, MULTIVARIATE DATA AN, V7; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, V2; Institute of Public Health (IPH), 2008, NAT HLTH MORB SURV N; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jenkinson CE, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0244-7; Kreuter MW, 2003, AM J HEALTH BEHAV, V27, pS227; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lustria MLA, 2009, PATIENT EDUC COUNS, V74, P156, DOI 10.1016/j.pec.2008.08.023; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mokkink LB., 2012, COSMIN CHECKLIST MAN; Moran AE, 2014, GLOB HEART, V9, P91, DOI 10.1016/j.gheart.2013.12.007; NORMAN P, 1995, BRIT J CLIN PSYCHOL, V34, P461, DOI 10.1111/j.2044-8260.1995.tb01480.x; NORMAN P, 1993, SOC SCI MED, V37, P53, DOI 10.1016/0277-9536(93)90317-W; Norman P, 1996, J APPL SOC PSYCHOL, V26, P1010, DOI 10.1111/j.1559-1816.1996.tb01122.x; Norman P., 1991, COUNS PSYCHOL, V4, P143; Petter J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1379-0; PILL R, 1988, J ROY COLL GEN PRACT, V38, P57; Polit DF, 2007, RES NURS HEALTH, V30, P459, DOI 10.1002/nur.20199; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Rimer BK, 2006, J COMMUN, V56, pS184, DOI 10.1111/j.1460-2466.2006.00289.x; Shiloh S, 1997, PSYCHOL HEALTH, V12, P301, DOI 10.1080/08870449708406709; Simpson WM, 1997, SCOT MED J, V42, P178, DOI 10.1177/003693309704200606; Sinclair A, 2012, PUBLIC HEALTH, V126, P87, DOI 10.1016/j.puhe.2011.11.004; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; VassarStats, 2016, VASSARSTATS STAT COM; Wilson S, 1997, AAOHN J, V45, P254; World Health Organization, 2016, PROJ MORT CAUS DEATH	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188259	10.1371/journal.pone.0188259	http://dx.doi.org/10.1371/journal.pone.0188259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145513	gold, Green Published			2022-12-27	WOS:000415378800102
J	Hori, A; Nishida, T; Takashiba, S; Kubota, S; Takigawa, M				Hori, Ayaka; Nishida, Takashi; Takashiba, Shogo; Kubota, Satoshi; Takigawa, Masaharu			Regulatory mechanism of CCN2 production by serotonin (5-HT) via 5-HT2A and 5-HT2B receptors in chondrocytes	PLOS ONE			English	Article							TISSUE-GROWTH-FACTOR; PROTEIN-KINASE-C; GENE-PRODUCT; DIFFERENTIATION; PROLIFERATION; CTGF/HCS24; P38; CHONDROGENESIS; REGENERATION; EXPRESSION	Serotonin (5-hydroxytryptamine: 5-HT) is recognized as a neurotransmitter in the central nerve system and as a regulator of systemic blood pressure in the peripheral tissues. Recently, it was reported that 5-HT2 receptors (5-HT(2)Rs) were expressed in cartilage tissues lacking both vessels and neurons, suggesting possible novel functions of 5-HT during cartilage development and regeneration. Our previous data indicated that CCN family protein 2/connective tissue growth factor (CCN2/CTGF) plays a central role in cartilage development and regeneration. Therefore, the aim of this study was to investigate the effect of 5-HT on the production of CCN2 in chondrocytes. Firstly, we showed that the mRNAs of 5-HT2R subtypes 5-HT2AR and 5-HT2BR, were expressed in a human chondrocytic cell line, HCS-2/8; however, 5-HT2CR mRNA was not detected. In addition, exogenously added 5-HT did not affect the 5-HT2AR and 5-HT2BR expressions. Next, we demonstrated that CCN2 production was increased by treatment with a 5-HT2AR agonist and the combination of 5-HT and 5-HT2BR antagonist. In contrast, treatment with a 5-HT2BR agonist and the combination of 5-HT and 5-HT2AR antagonist decreased CCN2 production. Furthermore, we showed that phosphorylation of Akt and p38 MAPK were increased by treatment with 5-HT2AR agonist, and that phosphorylation of PKC epsilon, PKC zeta, ERK1/2 and JNK were increased by treatment with 5-HT2BR agonist. Finally, we found that 5-HT2AR was localized in the growth plate, whereas 5-HT2BR was localized in the articular cartilage. These findings suggest that 5-HT promotes CCN2 production through the 5-HT2AR in growth plates, and that it represses CCN2 production through the 5-HT2BR in articular cartilage for harmonized development of long bones.	[Hori, Ayaka; Nishida, Takashi; Kubota, Satoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan; [Hori, Ayaka; Takashiba, Shogo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathophysiol Periodontal Sci, Okayama, Japan; [Kubota, Satoshi; Takigawa, Masaharu] Okayama Univ, Dent Sch, Adv Res Ctr Oral & Craniofacial Sci, Okayama, Japan	Okayama University; Okayama University; Okayama University	Nishida, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama, Japan.	tnishida@md.okayama-u.ac.jp	Takashiba, Shogo/C-9830-2010	Takashiba, Shogo/0000-0002-4712-6829	Japan Society for the Promotion of Sciences [JP26462810, JP15H05014, JP17K19757]; Takeda Science Foundation	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants from the programs Grants-in-Aid for Scientific Research (C) to TN (#JP26462810) and (B) to MT (#JP15H05014) and Challenging Research (Exploratory) to MT (#JP17K19757) from Japan Society for the Promotion of Sciences, and by a grant from the Takeda Science Foundation to TN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondzadeh S, 2008, PROG NEURO-PSYCHOPH, V32, P1879, DOI 10.1016/j.pnpbp.2008.08.020; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bhasin N, 2004, ANAT EMBRYOL, V208, P135, DOI 10.1007/s00429-004-0380-7; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chabbi-Achengli Y, 2016, AM J PATHOL, V186, P927, DOI 10.1016/j.ajpath.2015.11.018; Chang JZC, 2013, CLIN ORAL INVEST, V17, P455, DOI 10.1007/s00784-012-0713-5; CHOI B, 1995, BIOCHEM BIOPH RES CO, V216, P1034, DOI 10.1006/bbrc.1995.2724; Di Matteo V, 1998, NEUROPHARMACOLOGY, V37, P265, DOI 10.1016/S0028-3908(98)00014-8; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Hansen M, 2014, ACS CHEM NEUROSCI, V5, P243, DOI 10.1021/cn400216u; Harmon JL, 2016, J PHARMACOL EXP THER, V357, P1, DOI 10.1124/jpet.115.228395; Itoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071156; Iwamoto-Enomoto M, 1992, BIOL REGULATION CHON, P321; Kennett GA, 1997, NEUROPHARMACOLOGY, V36, P233, DOI 10.1016/S0028-3908(96)00171-2; KILLAM AL, 1990, J PHARMACOL EXP THER, V252, P1083; Kroeze Wesley K., 2002, Current Topics in Medicinal Chemistry, V2, P507, DOI 10.2174/1568026023393796; Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maginnis MS, 2010, J VIROL, V84, P9677, DOI 10.1128/JVI.00978-10; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Nakanishi T, 2000, ENDOCRINOLOGY, V141, P264, DOI 10.1210/endo.141.1.7267; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Nishida T, 2017, OSTEOARTHR CARTILAGE, V25, P759, DOI 10.1016/j.joca.2016.10.003; Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Nishida T, 2000, J CELL PHYSIOL, V184, P197, DOI 10.1002/1097-4652(200008)184:2<197::AID-JCP7>3.0.CO;2-R; Nishida T, 2011, J BONE MINER RES, V26, P351, DOI 10.1002/jbmr.222; Oh CD, 2000, J BIOL CHEM, V275, P5613, DOI 10.1074/jbc.275.8.5613; Ozaslan D, 2003, J BIOL CHEM, V278, P43991, DOI 10.1074/jbc.M306360200; Perbal B, 2005, CCN PROTEINS: A NEW FAMILY OF CELL GROWTH AND DIFFERENTIATION REGULATORS, P1, DOI 10.1142/9781860946899; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Takigawa M, 2017, METHODS MOL BIOL, V1489, P1, DOI 10.1007/978-1-4939-6430-7; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1; Yadav VK, 2010, NAT MED, V16, P308, DOI 10.1038/nm.2098; Yosimichi G, 2006, BONE, V38, P853, DOI 10.1016/j.bone.2005.11.016	40	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188014	10.1371/journal.pone.0188014	http://dx.doi.org/10.1371/journal.pone.0188014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145495	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800049
J	Ruiz-Remolina, L; Ollauri-Ibanez, C; Perez-Roque, L; Nunez-Gomez, E; Perez-Barriocanal, F; Lopez-Novoa, JM; Pericacho, M; Rodriguez-Barbero, A				Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia			Circulating soluble endoglin modifies the inflammatory response in mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; SUPPRESSES TUMOR-GROWTH; ACUTE KIDNEY INJURY; VASCULAR-PERMEABILITY; PREECLAMPSIA; RECEPTOR; ATHEROSCLEROSIS; ANGIOGENESIS; CYTOKINES	Inflammation is associated with every health condition, and is an important component of many pathologies such as cardiovascular diseases. Circulating levels of soluble endoglin have been shown to be higher in the serum of patients with cardiovascular diseases with a significant inflammatory component. The aim of this study was to evaluate the implication of circulating soluble endoglin in the inflammatory response. For this purpose, a transgenic mouse expressing human soluble endoglin (sEng+) was employed, and three different inflammatory approaches were used to mimic inflammatory conditions in different tissues. This study shows that control sEng+ mice have a normal inflammatory state. The lung and kidney injury induced by the inflammatory agents was reduced in sEng+ mice, especially the intra-alveolar and kidney infiltrates, suggesting a possible reduction in inflammation induced by soluble endoglin. To deepen into this possible effect, the leukocyte number in the bronchoalveolar lavage and air pouch lavage was evaluated and a significant reduction of neutrophil infiltration in LPS-treated lungs and ischemic kidneys from sEng+ with respect to WT mice was observed. Additionally, the mechanisms through which soluble endoglin prevents inflammation were studied. We found that in sEng+ animals the increment of proinflammatory cytokines, TNF alpha, IL1 beta and IL6, induced by the inflammatory stimulus was reduced. Soluble endoglin also prevents the augmented adhesion molecules, ICAM, VCAM and E-selectin induced by the inflammatory stimulus. In addition, vascular permeability increased by inflammatory agents was also reduced by soluble endoglin. These results suggest that soluble endoglin modulates inflammatory-related diseases and open new perspectives leading to the development of novel and targeted approaches for the prevention and treatment of cardiovascular diseases.	[Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia] Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain; [Ruiz-Remolina, Laura; Ollauri-Ibanez, Claudia; Perez-Roque, Lucia; Nunez-Gomez, Elena; Perez-Barriocanal, Fernando; Miguel Lopez-Novoa, Jose; Pericacho, Miguel; Rodriguez-Barbero, Alicia] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain	University of Salamanca	Rodriguez-Barbero, A (corresponding author), Univ Salamanca, Dept Physiol & Pharmacol, Salamanca, Spain.; Rodriguez-Barbero, A (corresponding author), Biomed Res Inst Salamanca IBSAL, Salamanca, Spain.	barberoa@usal.es	Pericacho, Miguel/H-1786-2016; Rodriguez-Barbero, Alicia/A-7583-2017; Lopez-Novoa, Jose M/A-3672-2008; Ollauri-Ibáñez, Claudia/D-3817-2018	Pericacho, Miguel/0000-0003-0226-482X; Rodriguez-Barbero, Alicia/0000-0002-6774-7147; Ollauri-Ibáñez, Claudia/0000-0002-7319-4913	Ministerio de Economia y Competitividad of Spain [SAF2013-45784-R]; Junta de Castilla y Leon [GR-100]; Sociedad Espanola de Nefrologia (SENEFRO); Fundacion Renal Inigo Alvarez de Toledo; Kidney Research Network (REDINREN) an initiative of Institute de Salud Carlos III [RD06/0016/0013, RD12/0021/0032]; FEDER; Ministerio de Economia y Competitividad of Spain; Junta de Castilla y Leon; Fondo Social Europeo	Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Sociedad Espanola de Nefrologia (SENEFRO); Fundacion Renal Inigo Alvarez de Toledo; Kidney Research Network (REDINREN) an initiative of Institute de Salud Carlos III; FEDER(European Commission); Ministerio de Economia y Competitividad of Spain(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The studies carried out by the authors have been supported by grants from the Ministerio de Economia y Competitividad of Spain (SAF2013-45784-R to ARB), the Junta de Castilla y Leon (Grant No GR-100 to JMLN), Sociedad Espanola de Nefrologia (SENEFRO to ARB), Fundacion Renal Inigo Alvarez de Toledo to JMLN, and Kidney Research Network (REDINREN, grants RD06/0016/0013 and RD12/0021/0032 to JMLN) an initiative of Institute de Salud Carlos III, co-funded by FEDER. C Ollauri-Ibanez and E Nunez-Gomez are supported by a fellowship from the Ministerio de Economia y Competitividad of Spain. L Perez-Roque is supported by Junta de Castilla y Leon and Fondo Social Europeo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; ANDRAS S, 2010, BMC IMMUNOL, V11; Blaha M, 2008, ATHEROSCLEROSIS, V197, P264, DOI 10.1016/j.atherosclerosis.2007.04.022; Blann AD, 1996, ATHEROSCLEROSIS, V120, P221, DOI 10.1016/0021-9150(95)05713-7; Blazquez-Medela AM, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-86; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101925; Claesson-Welsh L, 2015, UPSALA J MED SCI, V120, P135, DOI 10.3109/03009734.2015.1064501; Colville-Nash Paul, 2003, Methods Mol Biol, V225, P181; Cruz-Gonzalez I, 2008, J CELL MOL MED, V12, P955, DOI 10.1111/j.1582-4934.2008.00156.x; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Djurovic S, 2002, BJOG-INT J OBSTET GY, V109, P759, DOI 10.1111/j.1471-0528.2002.01330.x; Durymanov M, 2017, J CONTROL RELEASE, V261, P10, DOI 10.1016/j.jconrel.2017.06.013; GREER IA, 1994, OBSTET GYNECOL, V84, P937; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Hawinkels LJAC, 2010, CANCER RES, V70, P4141, DOI 10.1158/0008-5472.CAN-09-4466; Hayakawa S, 2000, J REPROD IMMUNOL, V47, P121, DOI 10.1016/S0165-0378(00)00053-X; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Ikemoto T, 2012, HEART VESSELS, V27, P344, DOI 10.1007/s00380-011-0163-z; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jang Young-Saeng, 2014, Immune Netw, V14, P237, DOI 10.4110/in.2014.14.5.237; Jezkova K, 2016, J VASC RES, V53, P149, DOI 10.1159/000448996; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; Kapur NK, 2010, AM J CARDIOL, V106, P1770, DOI 10.1016/j.amjcard.2010.08.018; Lain KY, 2002, JAMA-J AM MED ASSOC, V287, P3183, DOI 10.1001/jama.287.24.3183; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; Lyall F, 2007, PRE-ECLAMPSIA: ETIOLOGY AND CLINICAL PRACTICE, P20; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Malek M, 2015, J RENAL INJ PREV, V4, P20, DOI 10.12861/jrip.2015.06; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Mihu D, 2015, TAIWAN J OBSTET GYNE, V54, P160, DOI 10.1016/j.tjog.2014.03.006; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Nachtigal P, 2012, ATHEROSCLEROSIS, V224, P4, DOI 10.1016/j.atherosclerosis.2012.03.001; Nemeckova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119665; Nonas S, 2006, AM J RESP CRIT CARE, V173, P1130, DOI 10.1164/rccm.200511-1737OC; Okusa MD, 1999, AM J PHYSIOL-RENAL, V277, pF404, DOI 10.1152/ajprenal.1999.277.3.F404; Pericacho M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054687; Pessler F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2435; Pichuantes S, 1997, TISSUE ANTIGENS, V50, P265, DOI 10.1111/j.1399-0039.1997.tb02870.x; Pollack RM, 2016, DIABETES CARE, V39, pS244, DOI 10.2337/dcS15-3015; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; Ramma W, 2011, BIOCHEM SOC T, V39, P1619, DOI 10.1042/BST20110672; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CW, 1988, LANCET LOND ENGL, P1; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Rossi E, 2013, BLOOD, P121; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Schmid-Schonbein GW, 2006, ANNU REV BIOMED ENG, V8, P93, DOI 10.1146/annurev.bioeng.8.061505.095708; Schneiders J, 2015, BRAIN BEHAV IMMUN, V48, P147, DOI 10.1016/j.bbi.2015.03.008; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Solak Y, 2016, HYPERTENS RES, V39, P567, DOI 10.1038/hr.2016.35; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; ULICH TR, 1991, AM J PATHOL, V138, P1485; Valbuena-Diez AC, 2012, CIRCULATION, V126, P2612, DOI 10.1161/CIRCULATIONAHA.112.101261; Varejckova M, 2017, LIFE SCI, V175, P52, DOI 10.1016/j.lfs.2017.03.014; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wei XC, 2016, NATURE, V539, P294, DOI 10.1038/nature20117; Yanavitski Marat, 2011, Curr Heart Fail Rep, V8, P206, DOI 10.1007/s11897-011-0065-5; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	67	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188204	10.1371/journal.pone.0188204	http://dx.doi.org/10.1371/journal.pone.0188204			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145462	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800088
J	Smith, DR; Stanley, CM; Foss, T; Boles, RG; McKernan, K				Smith, Douglas R.; Stanley, Christine M.; Foss, Theodore; Boles, Richard G.; McKernan, Kevin			Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans	PLOS ONE			English	Article							RECEPTOR 1 GENE; CANNABIS DEPENDENCE SYMPTOMS; IRRITABLE-BOWEL-SYNDROME; CLINVAR PUBLIC ARCHIVE; DNA-SEQUENCING DATA; MICROGLIAL CELLS; CB2 RECEPTOR; DISORDERS; POLYMORPHISMS; MIGRAINE	Rare genetic variants in the core endocannabinoid system genes CNR1, CNR2, DAGLA, MGLL and FAAH were identified in molecular testing data from 6,032 patients with a broad spectrum of neurological disorders. The variants were evaluated for association with phenotypes similar to those observed in the orthologous gene knockouts in mice. Heterozygous rare coding variants in CNR1, which encodes the type 1 cannabinoid receptor (CB1), were found to be significantly associated with pain sensitivity (especially migraine), sleep and memory disorders D alone or in combination with anxiety D compared to a set of controls without such CNR1 variants. Similarly, heterozygous rare variants in DAGLA, which encodes diacylglycerol lipase alpha, were found to be significantly associated with seizures and neurodevelopmental disorders, including autism and abnormalities of brain morphology, compared to controls. Rare variants in MGLL, FAAH and CNR2 were not associated with any neurological phenotypes in the patients tested. Diacylglycerol lipase alpha synthesizes the endocannabinoid 2-AG in the brain, which interacts with CB1 receptors. The phenotypes associated with rare CNR1 variants are reminiscent of those implicated in the theory of clinical endocannabinoid deficiency syndrome. The severe phenotypes associated with rare DAGLA variants underscore the critical role of rapid 2-AG synthesis and the endocannabinoid system in regulating neurological function and development. Mapping of the variants to the 3D structure of the type 1 cannabinoid receptor, or primary structure of diacylglycerol lipase alpha, reveals clustering of variants in certain structural regions and is consistent with impacts to function.	[Smith, Douglas R.; Stanley, Christine M.; Foss, Theodore; Boles, Richard G.; McKernan, Kevin] Courtagen Life Sci Inc, Woburn, MA 01801 USA; [Stanley, Christine M.; Foss, Theodore] Wuxi Nextcode, Cambridge, MA USA; [Boles, Richard G.] Mitochondrial & Mol Med, Pasadena, CA USA; [McKernan, Kevin] Med Genom Corp, Woburn, MA USA		Smith, DR (corresponding author), Courtagen Life Sci Inc, Woburn, MA 01801 USA.	drclsmith@comcast.net			Courtagen Life Sciences, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	Courtagen Life Sciences, Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Courtagen Life Sciences, Inc. We thank Josee Dupuis for advice on the statistical analysis, and Ethan Russo and Anne Conyers-Hom for helpful comments on the manuscript.	Agrawal A, 2009, AM J MED GENET B, V150B, P736, DOI 10.1002/ajmg.b.30881; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Basavarajappa BS, 2007, PROTEIN PEPTIDE LETT, V14, P237, DOI 10.2174/092986607780090829; Bilkei-Gorzo A, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.009; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Boles RG, 2015, MITOCHONDRION; Bow EW, 2016, PERSPECT MED CHEM, V8, DOI 10.4137/PMC.S32171; Cabral GA, 2015, HANDB EXP PHARMACOL, V231, P185, DOI 10.1007/978-3-319-20825-1_6; Camilleri M, 2013, AM J PHYSIOL-GASTR L, V304, pG553, DOI 10.1152/ajpgi.00376.2012; Carey CE, 2015, J ABNORM PSYCHOL, V124, P860, DOI 10.1037/abn0000079; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clarke TK, 2013, ADDICT BIOL, V18, P702, DOI 10.1111/j.1369-1600.2011.00346.x; de Miguel-Yanes JM, 2011, OBESITY, V19, P2031, DOI 10.1038/oby.2011.135; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fowler CJ, 2001, BIOCHEM PHARMACOL, V62, P517, DOI 10.1016/S0006-2952(01)00712-2; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Hartman CA, 2009, DRUG ALCOHOL DEPEN, V104, P11, DOI 10.1016/j.drugalcdep.2009.01.022; Herman AI, 2006, AM J MED GENET B, V141B, P499, DOI 10.1002/ajmg.b.30325; Hu SSJ, 2015, HANDB EXP PHARMACOL, V231, P59, DOI 10.1007/978-3-319-20825-1_3; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Ibsen MS, 2017, CANNABIS CANNABINOID, V2, P48, DOI 10.1089/can.2016.0037; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Juhasz G, 2009, NEUROSCI LETT, V461, P116, DOI 10.1016/j.neulet.2009.06.021; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Keimpema E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02093; Khajehali E, 2015, MOL PHARMACOL, V88, P368, DOI 10.1124/mol.115.099192; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee SH, 2015, J NEUROSCI, V35, P10039, DOI 10.1523/JNEUROSCI.4112-14.2015; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li  H., 2014, BIOINFORMATICS; Lieb W, 2009, OBESITY, V17, P755, DOI 10.1038/oby.2008.608; Litvin Y, 2013, GENES BRAIN BEHAV, V12, P479, DOI 10.1111/gbb.12045; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Long LE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-87; Lowin T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0743-x; Lu AT, 2008, AM J MED GENET B, V147B, P1488, DOI 10.1002/ajmg.b.30693; Maldonado R, 2016, PAIN, V157, pS23, DOI 10.1097/j.pain.0000000000000428; Maresz K, 2005, J NEUROCHEM, V95, P437, DOI 10.1111/j.1471-4159.2005.03380.x; Martella A, 2016, FASEB J, V30, P4275, DOI 10.1096/fj.201600602R; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McKernan KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096492; McKernan KJ, 2013, NAT BIOTECHNOL, V31, P884, DOI 10.1038/nbt.2703; Melroy-Greif WE, 2016, DRUG ALCOHOL DEPEN, V166, P249, DOI 10.1016/j.drugalcdep.2016.06.021; Pava MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152473; Pertwee RG, 2015, HANDB EXP PHARMACOL, V231, P1, DOI 10.1007/978-3-319-20825-1_1; Pertwee RG, 2014, P NUTR SOC, V73, P96, DOI 10.1017/S0029665113003649; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Proudnikov D, 2010, PHARMACOGENOMICS J, V10, P232, DOI 10.1038/tpj.2009.59; Pyszniak M, 2016, ONCOTARGETS THER, V9, P4323, DOI 10.2147/OTT.S106944; Ramirez-Franco J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088594; Reisenberg M, 2012, PHILOS T R SOC B, V367, P3264, DOI 10.1098/rstb.2011.0387; Rhyne DN, 2016, PHARMACOTHERAPY, V36, P505, DOI 10.1002/phar.1673; Riant F, 2010, NEUROLOGY, V75, P967, DOI 10.1212/WNL.0b013e3181f25e8f; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Rimmerman N, 2011, CELL MOL NEUROBIOL, V31, P921, DOI 10.1007/s10571-011-9692-3; Russo EB, 2008, NEUROENDOCRINOL LETT, V29, P192; Russo EB, 2016, CANNABIS CANNABINOID, V1, P154, DOI 10.1089/can.2016.0009; Russo P, 2007, J CLIN ENDOCR METAB, V92, P2382, DOI 10.1210/jc.2006-2523; Sadhasivam S, 2015, PHARMACOGENOMICS J, V15, P436, DOI 10.1038/tpj.2014.79; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Shao Z, 2016, NATURE; Silvani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089432; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Song W, 2015, GENET MED; Sugaya Y, 2016, CELL REP, V16, P1405, DOI 10.1016/j.celrep.2016.06.083; Swaminathan GJ, 2012, HUM MOL GENET, V21, pR37, DOI 10.1093/hmg/dds362; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Trubetskoy V, 2015, BIOINFORMATICS, V31, P187, DOI 10.1093/bioinformatics/btu591; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Wong BS, 2012, NEUROGASTROENT MOTIL, V24, DOI 10.1111/j.1365-2982.2011.01874.x; Yourshaw M, 2015, BRIEF BIOINFORM, V16, P255, DOI 10.1093/bib/bbu008	81	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187926	10.1371/journal.pone.0187926	http://dx.doi.org/10.1371/journal.pone.0187926			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145497	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800039
J	Vigil, JM; Stith, SS; Adams, IM; Reeve, AP				Vigil, Jacob M.; Stith, Sarah S.; Adams, Ian M.; Reeve, Anthony P.			Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study	PLOS ONE			English	Article							MARIJUANA LAWS; BACK-PAIN; PREVALENCE; SUBSTANCES; RISK	Background Current levels and dangers of opioid use in the U.S. warrant the investigation of harm-reducing treatment alternatives. Purpose A preliminary, historical, cohort study was used to examine the association between enroll-ment in the New Mexico Medical Cannabis Program (MCP) and opioid prescription use. \ Methods Thirty-seven habitual opioid using, chronic pain patients (mean age = 54 years; 54% male; 86% chronic back pain) enrolled in the MCP between 4/1/2010 and 10/3/2015 were compared to 29 non-enrolled patients (mean age = 60 years; 69% male; 100% chronic back pain). We used Prescription Monitoring Program opioid records over a 21 month period (first three months prior to enrollment for the MCP patients) to measure cessation (defined as the absence of opioid prescriptions activity during the last three months of observation) and reduction (calculated in average daily intravenous [IV] morphine dosages). MCP patient-reported benefits and side effects of using cannabis one year after enrollment were also collected. Results By the end of the 21 month observation period, MCP enrollment was associated with 17.27 higher age-and gender-adjusted odds of ceasing opioid prescriptions (CI 1.89 to 157.36, p = 0.012), 5.12 higher odds of reducing daily prescription opioid dosages (CI 1.56 to 16.88, p = 0.007), and a 47 percentage point reduction in daily opioid dosages relative to a mean change of positive 10.4 percentage points in the comparison group (CI -90.68 to -3.59, p = 0.034). The monthly trend in opioid prescriptions over time was negative among MCP patients (-0.64mg IV morphine, CI -1.10 to -0.18, p = 0.008), but not statistically different from zero in the comparison group (0.18mg IV morphine, CI -0.02 to 0.39, p = 0.081). Survey responses indicated improvements in pain reduction, quality of life, social life, activity levels, and concentration, and few side effects from using cannabis one year after enrollment in the MCP (ps<0.001). Conclusions The clinically and statistically significant evidence of an association between MCP enrollment and opioid prescription cessation and reductions and improved quality of life warrants further investigations on cannabis as a potential alternative to prescription opioids for treating chronic pain.	[Vigil, Jacob M.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Stith, Sarah S.] Univ New Mexico, Dept Econ, Albuquerque, NM 87131 USA; [Adams, Ian M.; Reeve, Anthony P.] Ind Rehabil Clin, Albuquerque, NM USA	University of New Mexico; University of New Mexico	Vigil, JM (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	vigilj@unm.edu	Adams, Ian Marshall/GQB-5002-2022		University of New Mexico Medical Cannabis Research Fund	University of New Mexico Medical Cannabis Research Fund	This research was funded in part by the University of New Mexico Medical Cannabis Research Fund.; This research was funded in part by the University of New Mexico Medical Cannabis Research Fund. All authors had access to the data in the study and take responsibility for the integrity of the data and the accuracy of the data analyses. We thank J. Alcock for comments on an earlier draft.	Abrams DI, 2016, CURR ONCOL, V23, pS8, DOI 10.3747/co.23.3099; Ashton CH, 2001, BRIT J PSYCHIAT, V178, P101, DOI 10.1192/bjp.178.2.101; Bachhuber MA, 2014, JAMA INTERN MED, V174, P1668, DOI 10.1001/jamainternmed.2014.4005; Bonn-Miller MO, 2011, PSYCHOL ADDICT BEHAV, V25, P485, DOI 10.1037/a0021945; Bradford AC, 2016, HEALTH AFFAIR, V35, P1230, DOI 10.1377/hlthaff.2015.1661; Calabria B, 2010, DRUG ALCOHOL REV, V29, P318, DOI 10.1111/j.1465-3362.2009.00149.x; CDC, 2016, WID RANG ONL DAT EP; Chey WD, 2014, NEW ENGL J MED, V370, P2387, DOI 10.1056/NEJMoa1310246; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Crane EH, EMERGENCY DEP VISITS; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; Deyo RA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g6380; Friedman D, 2015, NEW ENGL J MED, V373, P1048, DOI 10.1056/NEJMra1407304; Fuster D, J ADDICTION MED; Garcia-Portilla M. P., 2012, BRIT J CLIN PHARMACO, V77, P272; Globalrph. com, 2016, OP NARC AN CONV; Haroutounian S, 2016, CLIN J PAIN, V32, P1036, DOI 10.1097/AJP.0000000000000364; Hill KP, 2016, JAMA-J AM MED ASSOC, V315, P2338, DOI 10.1001/jama.2016.5181; Hurd YL, TRENDS IN NEUROSCIEN; Kim JH, 2016, AM J PUBLIC HEALTH, V106, P2032, DOI 10.2105/AJPH.2016.303426; Lucas P, 2017, INT J DRUG POLICY, V42, P30, DOI 10.1016/j.drugpo.2017.01.011; Lucas P, 2016, DRUG ALCOHOL REV, V35, P326, DOI 10.1111/dar.12323; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; Reiman A, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-35; Rubin R., 2017, JAMA; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Schuckit MA, 2016, NEW ENGL J MED, V375, P357, DOI 10.1056/NEJMra1604339; Shaheed CA, 2016, JAMA INTERN MED, V176, P958, DOI 10.1001/jamainternmed.2016.1251; Stith SS, 2016, SCIENCE, V352, P1182, DOI 10.1126/science.aaf7450; Tashkin Donald P, 2013, Ann Am Thorac Soc, V10, P239, DOI 10.1513/AnnalsATS.201212-127FR; Trescot A, 2008, PAIN PHYSICIAN, V11, pS181; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Wang T, 2008, CAN MED ASSOC J, V178, P1669, DOI 10.1503/cmaj.071178; Ware MA, 2015, J PAIN, V16, P1233, DOI 10.1016/j.jpain.2015.07.014; Whiting PF, 2016, JAMA-J AM MED ASSOC, V3913, P2456; Wilkie G, 2016, JAMA ONCOL, V2, P670, DOI 10.1001/jamaoncol.2016.0155	37	73	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187795	10.1371/journal.pone.0187795	http://dx.doi.org/10.1371/journal.pone.0187795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145417	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800030
J	Wen, SM; Meng, QK; Feng, C; Tang, CJ				Wen, Shameng; Meng, Qingkun; Feng, Chao; Tang, Chaojing			A model-guided symbolic execution approach for network protocol implementations and vulnerability detection	PLOS ONE			English	Article								Formal techniques have been devoted to analyzing whether network protocol specifications violate security policies; however, these methods cannot detect vulnerabilities in the implementations of the network protocols themselves. Symbolic execution can be used to analyze the paths of the network protocol implementations, but for stateful network protocols, it is difficult to reach the deep states of the protocol. This paper proposes a novel model-guided approach to detect vulnerabilities in network protocol implementations. Our method first abstracts a finite state machine (FSM) model, then utilizes the model to guide the symbolic execution. This approach achieves high coverage of both the code and the protocol states. The proposed method is implemented and applied to test numerous real-world network protocol implementations. The experimental results indicate that the proposed method is more effective than traditional fuzzing methods such as SPIKE at detecting vulnerabilities in the deep states of network protocol implementations.	[Wen, Shameng; Meng, Qingkun; Feng, Chao; Tang, Chaojing] Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Wen, SM; Feng, C (corresponding author), Natl Univ Def Technol, Coll Elect Sci & Engn, Changsha, Hunan, Peoples R China.	wenshameng@126.com; chaofeng@nudt.edu.cn	Meng, Q./GSI-6185-2022					Aitel D., 2002, ADVANTAGES BLOCK BAS, P106; ANGLUIN D, 1987, INFORM COMPUT, V75, P87, DOI 10.1016/0890-5401(87)90052-6; BARTON JH, 1990, IEEE T COMPUT, V39, P575, DOI 10.1109/12.54853; Bellard F, 2005, USENIX Association Proceedings of the FREENIX/Open Source Track, P41; Cadar C., 2008, OSDI, P209; Chipounov V, 2011, ACM SIGPLAN NOTICES, V46, P265, DOI [10.1145/1961296.1950396, 10.1145/1961295.1950396]; Chipounov Vitaly, 2009, P 5 WORKSH HOT TOP S; Cho C. Y., 2011, USENIX SEC S, V139; Fernandes JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168487; Ganesh V, 2007, LECT NOTES COMPUT SC, V4590, P519; Kaksonen R, 2001, INT FED INFO PROC, V64, P174; KING JC, 1976, COMMUN ACM, V19, P385, DOI 10.1145/360248.360252; Lattner C, 2004, INT SYM CODE GENER, P75, DOI 10.1109/CGO.2004.1281665; MEALY GH, 1955, AT&T TECH J, V34, P1045, DOI 10.1002/j.1538-7305.1955.tb03788.x; Moore Edward F., 1956, AUTOMATA STUDIES, V34, P129, DOI DOI 10.1515/9781400882618-006; Niese O, 2003, INTEGRATED APPROACH; Raffelt Harald, 2009, International Journal on Software Tools for Technology Transfer, V11, P393, DOI 10.1007/s10009-009-0111-8; Sasnauskas R., 2012, ICNP, P1; Sasnauskas R, 2010, PROCEEDINGS OF THE 9TH ACM/IEEE INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS, P186, DOI 10.1145/1791212.1791235; Sen K., 2005, P 10 EUR SOFTW ENG C, P263, DOI [10.1145/1081706.1081750, DOI 10.1145/1081706.1081750]; Song J, 2014, IEEE T SOFTWARE ENG, V40, P695, DOI 10.1109/TSE.2014.2323977; Tang SJ, 2014, IEEE T CLOUD COMPUT, V2, P333, DOI 10.1109/TCC.2014.2329299; Tang SJ, 2012, IEEE T PARALL DISTR, V23, P862, DOI 10.1109/TPDS.2011.218; Turner J., 1998, REQUEST FOR COMMENTS, DOI [10.17487/RFC2408, DOI 10.17487/RFC2408]; Zhang S., 2011, 2011 IEEE INT C COMM, P1, DOI DOI 10.1109/ICC.2011.5962528; Zhao JL, 2013, 2013 EIGHTH INTERNATIONAL CONFERENCE ON P2P, PARALLEL, GRID, CLOUD AND INTERNET COMPUTING (3PGCIC 2013), P380, DOI 10.1109/3PGCIC.2013.65	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188229	10.1371/journal.pone.0188229	http://dx.doi.org/10.1371/journal.pone.0188229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145458	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800095
J	Yuan, Q; Picco, L; Chang, S; Abdin, E; Chua, BY; Ong, S; Yow, KL; Chong, SA; Subramaniam, M				Yuan, Qi; Picco, Louisa; Chang, Sherilyn; Abdin, Edimansyah; Chua, Boon Yiang; Ong, Samantha; Yow, Kah Lai; Chong, Siow Ann; Subramaniam, Mythily			Attitudes to mental illness among mental health professionals in Singapore and comparisons with the general population	PLOS ONE			English	Article							THERAPEUTIC ALLIANCE; COMMUNITY ATTITUDES; PUBLIC-ATTITUDES; PEOPLE; STIGMA; ILL; SCHIZOPHRENIA; ATTRIBUTIONS; PSYCHIATRY; DISORDERS	Background Similar to the general public, mental health professionals sometimes also have negative attitudes towards individuals with mental illness; which could ultimately affect the quality of care received by the patients. This study aims to explore attitudes to mental illness among mental health professionals in Singapore; make comparisons with the general population; and investigate the significant correlates. Methods A cross-sectional design was used. Eligible participants were recruited from the Institute of Mental Health, Singapore. Attitudes to mental illness among the mental health professionals were measured using an adapted 26-item Attitudes to Mental Illness questionnaire (AMI). An earlier study amongst the general population in Singapore had used the same tool; however, factor analysis suggested a 20-item, 4-factor structure (AMI-SG) was the best fit. This 4-factor structure was applied among the current sample of mental health professionals to allow comparisons between the professionals and the general population. Data were collected through an online survey tool 'Questionpro' from February to April 2016, and 379 participants were included in the current analysis. Attitudes to mental illness among these professionals were compared to those of the general population, which were captured as part of a national study conducted from March 2014 to April 2015. Results The 20-item, 4-factor structure AMI-SG derived from the general population was applicable among the mental health professionals in Singapore. Compared to the general population, mental health professionals had significantly more positive attitudes to mental illness; however their scores on 'social distancing' did not differ from the general population. Indian ethnicity was negatively associated with 'social distancing' and 'social restrictiveness' among the professionals; while higher education was negatively related to 'prejudice and misconception'. Compared to nurses, doctors showed significantly more positive attitudes on 'social restrictiveness' and 'prejudice and misconception'. Having family or close friends diagnosed with mental illness was negatively associated with 'social distancing' among the professionals. Conclusion The AMI-SG is an effective tool to measure attitudes to mental illness among mental health professionals in Singapore. Although the professionals had significantly more positive attitudes to mental illness than the general public in Singapore, their attitudes on 'social distancing' resembled closely that of the general public. Professionals tended to have more negative attitudes if they were nurses, less educated, and of Chinese ethnicity. More studies are needed to explore the underlying reasons for the differences and to generalize these findings among mental health professionals elsewhere.	[Yuan, Qi; Picco, Louisa; Chang, Sherilyn; Abdin, Edimansyah; Chua, Boon Yiang; Chong, Siow Ann; Subramaniam, Mythily] Inst Mental Hlth, Res Div, Singapore, Singapore; [Ong, Samantha] Inst Mental Hlth, Nursing Adm, Singapore, Singapore; [Yow, Kah Lai] Inst Mental Hlth, Clin & Allied Hlth Profess Serv, Singapore, Singapore		Yuan, Q (corresponding author), Inst Mental Hlth, Res Div, Singapore, Singapore.	Qi_YUAN@imh.com.sg	Abdin, Edimansyah/E-6451-2011; Picco, Louisa/AAD-6236-2022	Abdin, Edimansyah/0000-0002-1016-3298; Picco, Louisa/0000-0001-7593-3209; YUAN, Qi/0000-0002-5271-6954	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme [NMRC/CG/004/2013]; SAC	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme; SAC(Department of Space (DoS), Government of India)	This study was funded by the Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme (Grant No.: NMRC/CG/004/2013). The funding recipient is SAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G., 1979, NATURE PREJUDICE, V25th; Angermeyer MC, 2011, BRIT J PSYCHIAT, V199, P367, DOI 10.1192/bjp.bp.110.085563; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Angermeyer MC, 2005, SOC PSYCH PSYCH EPID, V40, P855, DOI 10.1007/s00127-005-0958-x; Bell J, 2009, INT J SOCIAL PSYCHIA; Boelen PA, 2008, J ANXIETY DISORD, V22, P1377, DOI 10.1016/j.janxdis.2008.01.018; BROCKINGTON IF, 1993, BRIT J PSYCHIAT, V162, P93, DOI 10.1192/bjp.162.1.93; Chambers M, 2010, INT J NURS STUD, V47, P350, DOI 10.1016/j.ijnurstu.2009.08.008; Corrigan Patrick W, 2002, World Psychiatry, V1, P16; Corrigan PW, 2012, PSYCHIAT SERVICES; Delaney KR, 2012, ARCH PSYCHIAT NURS, V26, P333, DOI 10.1016/j.apnu.2012.04.006; Ebrahimi Hossein, 2012, Iran J Nurs Midwifery Res, V17, P534; ELLSWORTH R B, 1965, J Abnorm Psychol, V70, P194, DOI 10.1037/h0022132; Evans-Lacko S, 2010, CAN J PSYCHIAT, V55, P440, DOI 10.1177/070674371005500707; Forchuk C, 1998, PERSPECT PSYCHIATR C, V34, P36, DOI 10.1111/j.1744-6163.1998.tb00998.x; Forsyth A, 2007, J PSYCHIATR MENT HLT, V14, P33; Gateshill G, 2011, PSYCHIATR BULL, V35, P101, DOI 10.1192/pb.bp.110.029900; Hansson L, 2013, INT J SOC PSYCHIATR, V59, P48, DOI 10.1177/0020764011423176; Hengartner MP, 2012, REV PSIQ CLIN-BRAZIL, V39, P115; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Kopera M, 2015, COMMUNITY MENT HLT J, V51, P628, DOI 10.1007/s10597-014-9796-6; Kua EH, 2004, BRIT J PSYCHIAT, V185, P79, DOI 10.1192/bjp.185.1.79; Lauber C, 2004, EUR PSYCHIAT, V19, P423, DOI 10.1016/j.eurpsy.2004.06.019; Loch AA, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-92; Markham D, 2003, BRIT J CLIN PSYCHOL, V42, P243, DOI 10.1348/01446650360703366; Martensson G, 2014, J PSYCHIATR MENT HLT, V21, P782, DOI 10.1111/jpm.12145; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Moss S, 1998, J INTELL DISABIL RES, V42, P173, DOI 10.1046/j.1365-2788.1998.00116.x; Nakash O, 2015, PSYCHOTHER RES, V25, P214, DOI 10.1080/10503307.2014.885147; Nordt C, 2006, SCHIZOPHRENIA BULL, V32, P709, DOI 10.1093/schbul/sbj065; Parra F, 1985, Int J Soc Psychiatry, V31, P37, DOI 10.1177/002076408503100104; Picco L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178359; Rosseel, 2013, THE LAVAAN TUTORIAL; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Smith AL., 2011, PROFESSIONAL COUNSEL, V1, P13, DOI DOI 10.15241/ALS.1.1.13; Stuart H, 2001, CAN J PSYCHIAT, V46, P245, DOI 10.1177/070674370104600304; Stuber JP, 2014, PSYCHIAT SERV, V65, P490, DOI 10.1176/appi.ps.201300136; Subramaniam M, 2017, EPIDEMIOL PSYCH SCI, V26, P371, DOI 10.1017/S2045796016000159; Tay Sim-Eng Clara, 2004, J Psychosoc Nurs Ment Health Serv, V42, P40; TAYLOR SM, 1981, SCHIZOPHRENIA BULL, V7, P225, DOI 10.1093/schbul/7.2.225; Thornicroft G, 2016, LANCET, V387, P1123, DOI 10.1016/S0140-6736(15)00298-6; UK Department of Health, 2014, ATT MENT ILLN 2014 R; Verhaeghe M, 2011, ARCH PSYCHIAT NURS, V25, P294, DOI 10.1016/j.apnu.2011.02.001; Wahl O, 2010, J COMMUNITY PSYCHOL, V38, P49, DOI 10.1002/jcop.20351; Yuan Q, 2016, ATTITUDES MENTAL ILL, V11; Zisook S, 2007, ACAD PSYCHIATR, V31, P309, DOI 10.1176/appi.ap.31.4.309	47	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187593	10.1371/journal.pone.0187593	http://dx.doi.org/10.1371/journal.pone.0187593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145419	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800022
J	Zhu, HS; Liu, JT; Wen, QF; Chen, MD; Wang, B; Zhang, QR; Xue, ZZ				Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng			De novo sequencing and analysis of the transcriptome during the browning of fresh-cut Luffa cylindrica 'Fusi-3' fruits	PLOS ONE			English	Article							ACTIVE OXYGEN-METABOLISM; PHENOLIC METABOLISM; POLYPHENOL OXIDASE; LITCHI FRUIT; LOTUS ROOT; SHELF-LIFE; ACID; LETTUCE; QUALITY; GENES	Fresh-cut luffa (Luffa cylindrica) fruits commonly undergo browning. However, little is known about the molecular mechanisms regulating this process. We used the RNA-seq technique to analyze the transcriptomic changes occurring during the browning of fresh-cut fruits from luffa cultivar 'Fusi-3'. Over 90 million high-quality reads were assembled into 58,073 Unigenes, and 60.86% of these were annotated based on sequences in four public databases. We detected 35,282 Unigenes with significant hits to sequences in the NCBInr database, and 24,427 Unigenes encoded proteins with sequences that were similar to those of known proteins in the Swiss-Prot database. Additionally, 20,546 and 13,021 Unigenes were similar to existing sequences in the Eukaryotic Orthologous Groups of proteins and Kyoto Encyclopedia of Genes and Genomes databases, respectively. Furthermore, 27,301 Unigenes were differentially expressed during the browning of fresh-cut luffa fruits (i.e., after 1-6 h). Moreover, 11 genes from five gene families (i.e., PPO, PAL, POD, CAT, and SOD) identified as potentially associated with enzymatic browning as well as four WRKY transcription factors were observed to be differentially regulated in fresh-cut luffa fruits. With the assistance of rapid amplification of cDNA ends technology, we obtained the full-length sequences of the 15 Unigenes. We also confirmed these Unigenes were expressed by quantitative real-time polymerase chain reaction analysis. This study provides a comprehensive transcriptome sequence resource, and may facilitate further studies aimed at identifying genes affecting luffa fruit browning for the exploitation of the underlying mechanism.	[Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China; [Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Acad Agr Sci, Vegetable Res Ctr, Fuzhou, Fujian, Peoples R China; [Zhu, Haisheng; Liu, Jianting; Wen, Qingfang; Chen, Mindong; Wang, Bin; Zhang, Qianrong; Xue, Zhuzheng] Fujian Engn Res Ctr Vegetables, Fuzhou, Fujian, Peoples R China	Fujian Academy of Agricultural Sciences; Fujian Academy of Agricultural Sciences	Wen, QF (corresponding author), Fujian Acad Agr Sci, Crops Res Inst, Fuzhou, Fujian, Peoples R China.; Wen, QF (corresponding author), Fujian Acad Agr Sci, Vegetable Res Ctr, Fuzhou, Fujian, Peoples R China.; Wen, QF (corresponding author), Fujian Engn Res Ctr Vegetables, Fuzhou, Fujian, Peoples R China.	fjvrc@163.com		fang, wen/0000-0002-2961-3914	Natural Science fundation of Fujian Province [2015J01118]; Project of Innovative Team in Fujian Academy of Agricultural Sciences [2016PI-40]; Fujian Provincial Public Research Institute of Fundamental Research [2017R1026-6]; Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team [STIT2017-1-2]	Natural Science fundation of Fujian Province; Project of Innovative Team in Fujian Academy of Agricultural Sciences; Fujian Provincial Public Research Institute of Fundamental Research; Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team	This work was supported by Natural Science fundation of Fujian Province (2015J01118), Project of Innovative Team in Fujian Academy of Agricultural Sciences (2016PI-40), The Fujian Provincial Public Research Institute of Fundamental Research (2017R1026-6), and Fujian Academy of Agricultural Sciences Vegetable Science and Technology Innovation Team (STIT2017-1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artes-Hernandez F, 2010, POSTHARVEST BIOL TEC, V55, P114, DOI 10.1016/j.postharvbio.2009.09.002; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Cantos E, 2002, J AGR FOOD CHEM, V50, P3015, DOI 10.1021/jf0116350; Carreira A, 2002, J DAIRY RES, V69, P281, DOI 10.1017/S0022029902005393; Chen X, 2015, BIOCHEM BIOPH RES CO, V463, P1243, DOI 10.1016/j.bbrc.2015.06.093; Chi M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-62; Chisari M, 2008, J AGR FOOD CHEM, V56, P132, DOI 10.1021/jf0721491; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dan YH, 2016, PLANT CELL TISS ORG, V127, P229, DOI 10.1007/s11240-016-1045-y; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Degl'Innocenti E, 2007, FOOD CHEM, V104, P209, DOI 10.1016/j.foodchem.2006.11.026; Dewanto V, 2002, J AGR FOOD CHEM, V50, P3010, DOI 10.1021/jf0115589; Docimo T, 2016, J AGR FOOD CHEM, V64, P4675, DOI 10.1021/acs.jafc.6b00662; Dokhanieh AY, 2016, HORTIC ENVIRON BIOTE, V57, P378, DOI 10.1007/s13580-016-0087-8; Dong TT, 2015, POSTHARVEST BIOL TEC, V110, P96, DOI 10.1016/j.postharvbio.2015.07.014; DROILLARD MJ, 1987, PHYSIOL PLANTARUM, V71, P197, DOI 10.1111/j.1399-3054.1987.tb02867.x; Du YJ, 2012, FOOD CHEM, V135, P580, DOI 10.1016/j.foodchem.2012.04.131; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fan MC, 2016, LWT-FOOD SCI TECHNOL, V72, P467, DOI 10.1016/j.lwt.2016.05.015; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Fukumoto LR, 2002, J AGR FOOD CHEM, V50, P4503, DOI 10.1021/jf011415m; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076890; Hisaminato H, 2001, BIOSCI BIOTECH BIOCH, V65, P1016, DOI 10.1271/bbb.65.1016; Hong PK, 2016, FOOD CHEM, V212, P234, DOI 10.1016/j.foodchem.2016.05.170; Isutsa D. K., 2013, Journal of Agricultural and Biological Science, V8, P610; Jiang J, 2014, POSTHARVEST BIOL TEC, V92, P164, DOI 10.1016/j.postharvbio.2014.01.025; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Lamikanra O, 2001, J FOOD SCI, V66, P1283, DOI 10.1111/j.1365-2621.2001.tb15202.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lante A, 2016, INNOV FOOD SCI EMERG, V34, P141, DOI 10.1016/j.ifset.2015.12.029; Lee HS, 2002, J AGR FOOD CHEM, V50, P1400, DOI 10.1021/jf011230f; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Lin YF, 2014, POSTHARVEST BIOL TEC, V96, P42, DOI 10.1016/j.postharvbio.2014.05.001; Liu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074217; Lu XH, 2011, SCI HORTIC-AMSTERDAM, V130, P97, DOI 10.1016/j.scienta.2011.06.017; Luna MC, 2016, POSTHARVEST BIOL TEC, V119, P84, DOI 10.1016/j.postharvbio.2016.05.001; Maghoumi M, 2013, LWT-FOOD SCI TECHNOL, V54, P389, DOI 10.1016/j.lwt.2013.06.006; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Mellidou I, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0328-x; Min T, 2017, POSTHARVEST BIOL TEC, V123, P69, DOI 10.1016/j.postharvbio.2016.08.011; Nath N, 2015, INT J PURE APP BIOSC, V3, P99, DOI 10.18782/2320-7051.2140; Pen LT, 2003, LEBENSM-WISS TECHNOL, V36, P359, DOI 10.1016/S0023-6438(03)00024-0; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Pusittigul I, 2012, SCI HORTIC-AMSTERDAM, V146, P45, DOI 10.1016/j.scienta.2012.08.008; RICHARD FC, 1991, J AGR FOOD CHEM, V39, P841, DOI 10.1021/jf00005a004; Rico D, 2006, J SCI FOOD AGR, V86, P2179, DOI 10.1002/jsfa.2594; Saltveit ME, 2000, POSTHARVEST BIOL TEC, V21, P61, DOI 10.1016/S0925-5214(00)00165-4; Saltveit ME, 2004, POSTHARVEST BIOL TEC, V34, P75, DOI 10.1016/j.postharvbio.2004.05.001; Sangh Partap, 2012, Journal of Natural Product and Plant Resources, V2, P127; Sangwan RS, 2013, GENE, V525, P58, DOI 10.1016/j.gene.2013.04.057; Soliva-Fortuny RC, 2003, TRENDS FOOD SCI TECH, V14, P341, DOI 10.1016/S0924-2244(03)00054-2; Sullivan ML, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00783; Sun Y, 2015, FOOD CHEM, V177, P376, DOI 10.1016/j.foodchem.2015.01.065; Sutharshana V., 2013, J PHARM SCI RES, V5, P184; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wei WL, 2014, SCI REP-UK, V4, DOI 10.1038/srep03564; [温庆放 Wen Qingfang], 2016, [园艺学报, Acta Horticulturae Sinica], V43, P2039; Wu SJ, 2014, FOOD CHEM, V160, P8, DOI 10.1016/j.foodchem.2014.03.088; Xu Chuanjun, 2015, Horticultural Plant Journal, V1, P172, DOI 10.16420/j.issn.2095-9885.2015-0030; Xu CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123356; Yang E, 2009, PAK J BOT, V41, P2271; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi C, 2010, FOOD CHEM, V118, P42, DOI 10.1016/j.foodchem.2009.04.074; You YL, 2012, FOOD CHEM, V132, P1191, DOI 10.1016/j.foodchem.2011.11.073; Zhan LJ, 2014, POSTHARVEST BIOL TEC, V88, P17, DOI 10.1016/j.postharvbio.2013.09.006; Zhou D, 2015, FOOD CHEM, V171, P19, DOI 10.1016/j.foodchem.2014.08.115; Zhu HS, 2016, ACTA AGRIC NUCL SIN, V30; 王成, 2012, [江苏农业科学, Jiangsu Agricultural Sciences], V40, P137	74	18	26	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187117	10.1371/journal.pone.0187117	http://dx.doi.org/10.1371/journal.pone.0187117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145430	Green Submitted, gold, Green Published			2022-12-27	WOS:000415378800010
J	Siegerstetter, SC; Schmitz-Esser, S; Magowan, E; Wetzels, SU; Zebeli, Q; Lawlor, PG; O'Connell, NE; Metzler-Zebeli, BU				Siegerstetter, Sina-Catherine; Schmitz-Esser, Stephan; Magowan, Elizabeth; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Lawlor, Peadar G.; O'Connell, Niamh E.; Metzler-Zebeli, Barbara U.			Intestinal microbiota profiles associated with low and high residual feed intake in chickens across two geographical locations	PLOS ONE			English	Article							IMMUNE-RESPONSES; FECAL MICROBIOTA; CECAL MICROBIOTA; EFFICIENCY; PERFORMANCE; IDENTIFICATION; DIVERSITY; SELECTION; FCR	Intestinal microbe-host interactions can affect the feed efficiency (FE) of chickens. As inconsistent findings for FE-associated bacterial taxa were reported across studies, the present objective was to identify whether bacterial profiles and predicted metabolic functions that were associated with residual feed intake (RFI) and performance traits in female and male chickens were consistent across two different geographical locations. At six weeks of life, the microbiota in ileal, cecal and fecal samples of low (n = 34) and high (n = 35) RFI chickens were investigated by sequencing the V3-5 region of the 16S rRNA gene. Location-associated differences in alpha-diversity and relative abundances of several phyla and genera were detected. RFI-associated bacterial abundances were found at the phylum and genus level, but differed among the three intestinal sites and between males and females. Correlation analysis confirmed that, of the taxonomically classifiable bacteria, Lactobacillus (5% relative abundance) and two Lactobacillus crispatus-OTUs in feces were indicative for high RFI in females (P < 0.05). In males, Ruminococcus in cecal digesta (3.1% relative abundance) and Dorea in feces (< 0.1% relative abundance) were best indicative for low RFI, whereas Acinetobacter in feces (< 1.5% relative abundance) related to high RFI (P < 0.05). Predicted metabolic functions in feces of males confirmed compositional relationships as functions related to amino acid, fatty acid and vitamin metabolism correlated with low RFI, whereas an increasing abundance of bacterial signaling and interaction (i.e. cellular antigens) genes correlated with high RFI (P < 0.05). In conclusion, RFI-associated bacterial profiles could be identified across different geographical locations. Results indicated that consortia of low-abundance taxa in the ileum, ceca and feces may play a role for FE in chickens, whereby only bacterial FE-associations found in ileal and cecal digesta may serve as useful targets for dietary strategies.	[Siegerstetter, Sina-Catherine; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Metzler-Zebeli, Barbara U.] Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Siegerstetter, Sina-Catherine; Schmitz-Esser, Stephan; Wetzels, Stefanie Urimare; Zebeli, Qendrim; Metzler-Zebeli, Barbara U.] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria; [Schmitz-Esser, Stephan; Wetzels, Stefanie Urimare] Univ Vet Med, Inst Milk Hyg Milk Technol & Food Sci, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Magowan, Elizabeth] Agrifood & Biosci Inst, Agr Branch, Large Pk, Hillsborough, North Ireland; [Lawlor, Peadar G.] Anim & Grassland Res & Innovat Ctr, Teagasc Pig Dev Dept, Fermoy, Cork, Ireland; [O'Connell, Niamh E.] Queens Univ Belfast, Inst Global Food Secur, Univ Rd Belfast, Belfast, Antrim, North Ireland; [Schmitz-Esser, Stephan] Iowa State Univ, Coll Agr & Life Sci, Dept Anim Sci, Ames, IA USA	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Agri-Food & Biosciences Institute; Teagasc; Queens University Belfast; Iowa State University	Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Inst Anim Nutr & Funct Plant Cpds, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.; Metzler-Zebeli, BU (corresponding author), Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Res Cluster Anim Gut Hlth, Vienna, Austria.	barbara.metzler@vetmeduni.ac.at	Schmitz-Esser, Stephan/AAA-7287-2019	Schmitz-Esser, Stephan/0000-0002-1907-0709; O'Connell, Niamh/0000-0001-6831-2041	European Union's Seventh Framework Programme for research, technological development and demonstration [311794]	European Union's Seventh Framework Programme for research, technological development and demonstration	This project (ECO-FCE) has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration (grant no. 311794) to Barbara U Metzler-Zebeli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apajalahti J, 2016, ANIM FEED SCI TECH, V221, P323, DOI 10.1016/j.anifeedsci.2016.05.004; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; Berry DP, 2012, J ANIM SCI, V90, P109, DOI 10.2527/jas.2011-4245; Bottje WG, 2009, J ANIM SCI, V87, pE48, DOI 10.2527/jas.2008-1379; Brisbin Jennifer T., 2008, Animal Health Research Reviews, V9, P101, DOI 10.1017/S146625230800145X; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crisol-Martinez E, 2017, PEERJ, V5, DOI 10.7717/peerj.3071; D'Amore R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2194-9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897; Hausmann A, 2016, ENVIRON CONSERV, V43, P117, DOI 10.1017/S0376892915000314; Hwang IY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15028; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Konsak BM, 2013, ANIM PROD SCI, V53, P1269, DOI 10.1071/AN12426; Korver DR, 1997, J NUTR, V127, P2039, DOI 10.1093/jn/127.10.2039; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ludvigsen J, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00016; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McKay DM, 1999, GUT, V44, P283, DOI 10.1136/gut.44.2.283; Metzler-Zebeli BU, 2016, J ANIM SCI, V94, P2890, DOI 10.2527/jas.2016-0375; Metzler-Zebeli BU, 2016, ANIMALS-BASEL, V6, DOI 10.3390/ani6030018; Metzler-Zebeli BU, 2015, APPL ENVIRON MICROB, V81, P8489, DOI 10.1128/AEM.02756-15; Mignon-Grasteau S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135488; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Rubio LA, 2015, J ANIM PHYSIOL AN N, V99, P418, DOI 10.1111/jpn.12256; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Sekelja M, 2012, APPL ENVIRON MICROB, V78, P2941, DOI 10.1128/AEM.05391-11; Singh KM, 2014, J APPL GENET, V55, P145, DOI 10.1007/s13353-013-0179-4; Singh KM, 2012, MOL BIOL REP, V39, P10595, DOI 10.1007/s11033-012-1947-7; Stanley D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00187; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084290; Stanley D, 2013, VET MICROBIOL, V164, P85, DOI 10.1016/j.vetmic.2013.01.030; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Van Eerden E, 2004, POULTRY SCI, V83, P1602, DOI 10.1093/ps/83.9.1602; Vigors S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148145; Willems OW, 2013, WORLD POULTRY SCI J, V69, P77, DOI 10.1017/S004393391300007X; Yan W, 2017, SCI REP-UK, V7, DOI 10.1038/srep45308	45	59	60	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0187766	10.1371/journal.pone.0187766	http://dx.doi.org/10.1371/journal.pone.0187766			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141016	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000415260400028
J	Alva-Urcia, C; Aguilar-Luis, MA; Palomares-Reyes, C; Silva-Caso, W; Suarez-Ognio, L; Weilg, P; Manrique, C; Vasquez-Achaya, F; del Valle, LJ; del Valle-Mendoza, J				Alva-Urcia, Carlos; Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Suarez-Ognio, Luis; Weilg, Pablo; Manrique, Carlos; Vasquez-Achaya, Fernando; del Valle, Luis J.; del Valle-Mendoza, Juana			Emerging and reemerging arboviruses: A new threat in Eastern Peru	PLOS ONE			English	Article							MAYARO VIRUS-INFECTION; ZIKA VIRUS; AMAZON BASIN; DENGUE; PCR; EPIDEMIOLOGY; DIAGNOSIS; DISEASES; AMERICA	Background Arboviral diseases are one of the most common causes of acute febrile illness (AFI) and a significant health problem in South America. In Peru, laboratory etiologic identification of these infections occurs in less than 50% of cases, leading to underdiagnoses of important emerging arboviruses. Aim To assess the prevalence of the Dengue (DENV), Oropouche (OROV), Chikungunya (CHIKV), Mayaro (MAYV) and Zika (ZIKV) viruses in patients with acute febrile illness from Puerto Maldonado (Peru). Methodology Serum samples were obtained from patients with AFI during January 2016 to March 2016. A total of 139 specimens were analyzed for the presence of DENV, OROV, CHIKV, MAYV, and ZIKV using polymerase chain reaction (PCR). Results CHIKV in 9.4% and OROV in 8.6% were the most prevalent arboviruses, followed by DENV and ZIKV, with a prevalence of 6.5% and 5%, respectively. Among all patients, the most common symptoms accompanying fever were headaches 79.9%, muscle pain 65.5% and joint pain 63.3%. Conclusions During this short 3-month period, 4 arboviruses were detected by PCR, CHIKV and OROV being the most common arboviruses in Puerto Maldonado (Peru). Thus, it is crucial to include OROV detection in the national health surveillance. Furthermore, the etiologic clinical diagnosis of arboviral infections is not possible due to the low specificity of symptoms; therefore an increase of cases confirmed by molecular diagnostic methods will enhance arboviral surveillance in Peru.	[Alva-Urcia, Carlos; Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Suarez-Ognio, Luis; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru; [Angel Aguilar-Luis, Miguel; Palomares-Reyes, Carlos; Silva-Caso, Wilmer; Weilg, Pablo; Vasquez-Achaya, Fernando; del Valle-Mendoza, Juana] Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru; [Angel Aguilar-Luis, Miguel; Silva-Caso, Wilmer; del Valle-Mendoza, Juana] IIN, Lab Mol Biol, Lima, Peru; [Manrique, Carlos] Direcc Reg Salud Madre De Dios DIRESA Madre De D, Madre De Dios, Peru; [del Valle, Luis J.] UPC, Barcelona Res Ctr Multiscale Sci & Engn, Dept Engn Quim, EEBE,Barcelona Tech, Barcelona, Spain	Universidad Peruana de Ciencias Aplicadas (UPC); Universidad Peruana de Ciencias Aplicadas (UPC); Universitat Politecnica de Catalunya	Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Sch Med, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), Univ Peruana Ciencias Aplicadas, Fac Hlth Sci, Res & Innovat Ctr, Lima, Peru.; Aguilar-Luis, MA; del Valle-Mendoza, J (corresponding author), IIN, Lab Mol Biol, Lima, Peru.	ma23aguilar@gmail.com; jdelvall@upc.edu.pe	Palomares Reyes, Carlos Cesar/Q-1255-2018; del Valle Mendoza, Juana/C-9805-2018; Vasquez Achaya, Fernando/I-6380-2017; Aguilar-Luis, Miguel Angel/C-8686-2018; Silva, Wilmer Gianfranco/D-2699-2018; Del Valle, Luis J./I-1342-2015	Palomares Reyes, Carlos Cesar/0000-0002-7027-1952; del Valle Mendoza, Juana/0000-0002-6011-5040; Vasquez Achaya, Fernando/0000-0003-3627-7688; Aguilar-Luis, Miguel Angel/0000-0001-7023-3190; Silva, Wilmer Gianfranco/0000-0003-1086-8084; Del Valle, Luis J./0000-0001-9916-1741; Weilg Espejo, Pablo Renato/0000-0002-9711-2193; Suarez-Ognio, Luis/0000-0002-9627-799X	Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru) [116-PNICP-PIAP-2015]	Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru)	This project was supported by "Programa Nacional de Innovacion para la Competitividad y Productividad (Innovate Peru)-contract 116-PNICP-PIAP-2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315; Aguilar-Leon Pool, 2016, Infez Med, V24, P172; Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710; Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301; Chavez R, 1992, REV FARMACOL TERAP L, V2, P12; Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787; García María P, 2016, Rev. perú. med. exp. salud publica, V33, P380, DOI 10.17843/rpmesp.2016.332.2098; Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013; Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777; Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010; Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030; Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013; Lorenzi OD, 2013, AM J TROP MED HYG, V88, P472, DOI 10.4269/ajtmh.12-0373; Ministerio de Salud del Peru (MINSA), 2016, B EP 03, V03; Ministerio de Salud (MINSA), 2016, MINS EM AL EP ANT CI; Ministerio de Salud (MINSA), 2016, RES MIN; Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122; Naing C, 2012, T ROY SOC TROP MED H, V106, P331, DOI 10.1016/j.trstmh.2012.03.003; Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717; Peyrefitte CN, 2005, EMERG INFECT DIS, V11, P757, DOI 10.3201/eid1105.040959; Red Nacional de Epidemiologia (RENACE), 2016, VIG SINDR FEBR AR AL; Red Nacional de Epidemiologia (RENACE), 2016, CAS DENG DEP PER 201; Salmon-Mulanovich G, 2015, AM J TROP MED HYG, V93, P684, DOI 10.4269/ajtmh.14-0755; Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16; Tam PYI, 2016, J PEDIAT INF DIS SOC, V5, P190, DOI 10.1093/jpids/piw016; Tantalean-Yepez D, 2016, ASIAN PAC J TROP MED, V9, P819, DOI 10.1016/j.apjtm.2016.06.018; Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952; World Health Organization, 2017, DIS OUTBREAK NE 0208; Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108	32	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187897	10.1371/journal.pone.0187897	http://dx.doi.org/10.1371/journal.pone.0187897			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136650	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200043
J	Carling, CJ; Lacome, M; Flanagan, E; O'Doherty, P; Piscione, J				Carling, Christopher J.; Lacome, Mathieu; Flanagan, Eamon; O'Doherty, Pearse; Piscione, Julien			Exposure time, running and skill-related performance in international u20 rugby union players during an intensified tournament	PLOS ONE			English	Article							STATISTICS; MATCH	Purpose This study investigated exposure time, running and skill-related performance in two international u20 rugby union teams during an intensified tournament: the 2015 Junior World Rugby Championship. Method Both teams played 5 matches in 19 days. Analyses were conducted using global positioning system (GPS) tracking (Viper 2 T, Statsports Technologies Ltd) and event coding (Opta Pro (R)). Results Of the 62 players monitored, 36 (57.1%) participated in 4 matches and 23 (36.5%) in all 5 matches while player availability for selection was 88%. Analyses of team running output (all players completing > 60-min play) showed that the total and peak 5-minute high metabolic load distances covered were likely-to-very likely moderately higher in the final match compared to matches 1 and 2 in back and forward players. In individual players with the highest match-play exposure (participation in > 75% of total competition playing time and > 75-min in each of the final 3 matches), comparisons of performance in matches 4 and 5 versus match 3 (three most important matches) reported moderate-to-large decreases in total and high metabolic load distance in backs while similar magnitude reductions occurred in high-speed distance in forwards. In contrast, skill-related performance was unchanged, albeit with trivial and unclear changes, while there were no alterations in either total or high-speed running distance covered at the end of matches. Conclusions These findings suggest that despite high availability for selection, players were not overexposed to match-play during an intensified u20 international tournament. They also imply that the teams coped with the running and skill-related demands. Similarly, individual players with the highest exposure to match-play were also able to maintain skill-related performance and end-match running output (despite an overall reduction in the latter). These results support the need for player rotation and monitoring of performance, recovery and intervention strategies during intensified tournaments.	[Carling, Christopher J.] Univ Cent Lancashire, Inst Coaching & Performance, Preston, Lancs, England; [Carling, Christopher J.; Lacome, Mathieu; Piscione, Julien] French Rugby Union, Res Dept, Marcoussis, France; [Flanagan, Eamon] Irish Rugby Football Union, Fitness Dept, Dublin, Ireland; [O'Doherty, Pearse] Statsports Technol, Newry, North Ireland	University of Central Lancashire	Lacome, M (corresponding author), French Rugby Union, Res Dept, Marcoussis, France.	mathlacome@gmail.com						[Anonymous], J STRENGTH CONDITION; [Anonymous], EUROPEAN J SPORT SCI; [Anonymous], S AFRICAN J SPORTS M; Austin D, 2011, J SPORT SCI, V29, P1105, DOI 10.1080/02640414.2011.582508; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Carling C, 2012, INT J SPORTS MED, V33, P36, DOI 10.1055/s-0031-1283190; Carling C, 2015, J SPORT SCI, V33, P2116, DOI 10.1080/02640414.2015.1091492; Cunniffe B, 2010, EUR J APPL PHYSIOL, V108, P113, DOI 10.1007/s00421-009-1200-9; Cunningham D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153275; Dellal A, 2015, BRIT J SPORT MED, V49, P390, DOI 10.1136/bjsports-2012-091290; Duthie G, 2003, SPORTS MED, V33, P973, DOI 10.2165/00007256-200333130-00003; Elloumi M, 2003, EUR J APPL PHYSIOL, V90, P23, DOI 10.1007/s00421-003-0868-5; Higgins TR, 2013, J STRENGTH COND RES, V27, P954, DOI 10.1519/JSC.0b013e318260ed9b; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Johnston RD, 2015, J SCI MED SPORT, V18, P209, DOI 10.1016/j.jsams.2014.01.009; Johnston RD, 2013, J SCI MED SPORT, V16, P460, DOI 10.1016/j.jsams.2012.10.009; Jones MR, 2015, EUR J SPORT SCI, V15, P488, DOI 10.1080/17461391.2015.1010106; Jones MR, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-38; Lacome M, 2014, J SPORT SCI, V32, P290, DOI 10.1080/02640414.2013.823225; Lindsay A, 2015, EUR J SPORT SCI, V15, P480, DOI 10.1080/17461391.2015.1025858; Liu HY, 2013, INT J PERF ANAL SPOR, V13, P803, DOI 10.1080/24748668.2013.11868690; McLean BD, 2010, INT J SPORT PHYSIOL, V5, P367, DOI 10.1123/ijspp.5.3.367; Montgomery PG, 2008, J SPORT SCI, V26, P1135, DOI 10.1080/02640410802104912; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Quarrie KL, 2017, BRIT J SPORT MED, V51, P421, DOI 10.1136/bjsports-2016-096191; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Smart DJ, 2008, BRIT J SPORT MED, V42, P198, DOI 10.1136/bjsm.2007.040162; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; West DJ, 2014, J STRENGTH COND RES, V28, P194, DOI 10.1519/JSC.0b013e318291b726; Winter EM, 2014, J SPORT SCI, V32, P901, DOI 10.1080/02640414.2014.895118; Winter EM, 2009, J SPORT SCI, V27, P985, DOI 10.1080/02640410903178344	32	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186874	10.1371/journal.pone.0186874	http://dx.doi.org/10.1371/journal.pone.0186874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136039	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000415121200009
J	Komalavilas, P; Luo, WF; Guth, CM; Jolayemi, O; Bartelson, RI; Cheung-Flynn, J; Brophy, CM				Komalavilas, Padmini; Luo, Weifeng; Guth, Christy M.; Jolayemi, Olukemi; Bartelson, Rachel I.; Cheung-Flynn, Joyce; Brophy, Colleen M.			Vascular surgical stretch injury leads to activation of P2X7 receptors and impaired endothelial function	PLOS ONE			English	Article							BRILLIANT BLUE FCF; P2X(7) PURINERGIC RECEPTOR; VEIN GRAFT MARKING; EXTRACELLULAR ATP; RHEUMATOID-ARTHRITIS; CELLULAR VIABILITY; SMOOTH-MUSCLE; UP-REGULATION; L-ARGININE; ANTAGONIST	A viable vascular endothelial layer prevents vasomotor dysfunction, thrombosis, inflammation, and intimal hyperplasia. Injury to the endothelium occurs during harvest and "back table" preparation of human saphenous vein prior to implantation as an arterial bypass conduit. A subfailure overstretch model of rat aorta was used to show that subfailure stretch injury of vascular tissue leads to impaired endothelial-dependent relaxation. Stretch-induced impaired relaxation was mitigated by treatment with purinergic P2X7 receptor (P2X7R) inhibitors, brilliant blue FCF (FCF) and A740003, or apyrase, an enzyme that catalyzes the hydrolysis of ATP. Alternatively, treatment of rat aorta with exogenous ATP or 2'(3')-O-(4-Benzoyl benzoyl)-ATP (BzATP) also impaired endothelial-dependent relaxation. Treatment of human saphenous vein endothelial cells (HSVEC) with exogenous ATP led to reduced nitric oxide production which was associated with increased phosphorylation of the stress activated protein kinase, p38 MAPK. ATP-stimulated p38 MAPK phosphorylation of HSVEC was inhibited by FCF and SB203580. Moreover, ATP inhibition of nitric oxide production in HSVEC was prevented by FCF, SB203580, L-arginine supplementation and arginase inhibition. Finally, L-arginine supplementation and arginase inhibition restored endothelial dependent relaxation after stretch injury of rat aorta. These results suggest that vascular stretch injury leads to ATP release, activation of P2X7R and p38 MAPK resulting in endothelial dysfunction due to arginase activation. Endothelial function can be restored in both ATP treated HSVEC and intact stretch injured rat aorta by P2X7 receptor inhibition with FCF or L-arginine supplementation, implicating straightforward therapeutic options for treatment of surgical vascular injury.	[Komalavilas, Padmini; Luo, Weifeng; Guth, Christy M.; Jolayemi, Olukemi; Bartelson, Rachel I.; Cheung-Flynn, Joyce; Brophy, Colleen M.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Komalavilas, Padmini; Brophy, Colleen M.] VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Komalavilas, P (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA.; Komalavilas, P (corresponding author), VA Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA.	padmini.komalavilas@vanderbilt.edu	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Institute of Health grant [R01HL105731-01, R01HL70715]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105731, R01HL070715] Funding Source: NIH RePORTER	National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported in part by a National Institute of Health grant R01HL105731-01 to J Cheung-Flynn, R01HL70715 to CM Brophy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Avanzato D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32602; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Brophy C, 2015, FED REGISTER, V80, P46485; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; BUSSE R, 1985, BASIC RES CARDIOL, V80, P475, DOI 10.1007/BF01907912; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; CREAGER MA, 1992, J CLIN INVEST, V90, P1248, DOI 10.1172/JCI115987; De Ita M, 2016, LIFE SCI, V145, P85, DOI 10.1016/j.lfs.2015.12.013; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Eagle S, 2011, AM SURGEON, V77, P922; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Ferrari D, 1997, J IMMUNOL, V159, P1451; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Flynn CR, 2005, J APPL PHYSIOL, V98, P1836, DOI 10.1152/japplphysiol.01043.2004; Franke H, 2004, J NEUROPATH EXP NEUR, V63, P686, DOI 10.1093/jnen/63.7.686; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guth CM, 2017, J SURG RES, V216, P80, DOI 10.1016/j.jss.2017.03.025; Hess CN, 2014, SAPHENOUS VEIN GRAFT; Hocking KM, 2016, J VASC SURG, V64, P210, DOI 10.1016/j.jvs.2014.12.059; Hocking KM, 2011, J VASC SURG, V53, P454, DOI 10.1016/j.jvs.2010.09.010; Honore P, 2006, J PHARMACOL EXP THER, V319, P1376, DOI 10.1124/jpet.106.111559; Jacques-Silva MC, 2004, BRIT J PHARMACOL, V141, P1106, DOI 10.1038/sj.bjp.0705685; Jespersen B, 2015, JOVE-J VIS EXP, DOI 10.3791/52324; Jun DJ, 2007, J BIOL CHEM, V282, P37350, DOI 10.1074/jbc.M707915200; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Li FD, 2014, JAMA SURG, V149, P655, DOI 10.1001/jamasurg.2013.5067; Lombardi M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05137-y; Luo W, 2017, PURINERG SIGNAL; Luo WF, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00075; North RA, 2000, ANNU REV PHARMACOL, V40, P563, DOI 10.1146/annurev.pharmtox.40.1.563; Okumura H, 2008, BIOCHEM BIOPH RES CO, V372, P486, DOI 10.1016/j.bbrc.2008.05.066; Osgood MJ, 2016, J VASC SURG, V64, P471, DOI 10.1016/j.jvs.2015.02.028; Osgood MJ, 2014, J VASC SURG, V60, P202, DOI 10.1016/j.jvs.2013.06.004; Panenka W, 2001, J NEUROSCI, V21, P7135, DOI 10.1523/JNEUROSCI.21-18-07135.2001; Papp L, 2007, BIOCHEM BIOPH RES CO, V355, P568, DOI 10.1016/j.bbrc.2007.02.014; Peng WG, 2009, P NATL ACAD SCI USA, V106, P12489, DOI 10.1073/pnas.0902531106; Pernow J, 2015, BRIT J PHARMACOL, V172, P4684, DOI 10.1111/bph.13242; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sathanoori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125111; Shatanawi A, 2015, EUR J PHARMACOL, V746, P106, DOI 10.1016/j.ejphar.2014.10.042; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Steppan J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00278; Stock TC, 2012, J RHEUMATOL, V39, P720, DOI 10.3899/jrheum.110874; Tousoulis D, 2002, VASC MED, V7, P203, DOI 10.1191/1358863x02vm434ra; Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646; Volonte C, 2012, CNS NEUROL DISORD-DR, V11, P705, DOI 10.2174/187152712803581137; Voskresensky IV, 2014, JAMA SURG, V149, P1176, DOI 10.1001/jamasurg.2014.2029; Winkler B, 2016, INTERACT CARDIOV TH, V23, P300, DOI 10.1093/icvts/ivw056; Wise ES, 2016, VASC MED, V21, P413, DOI 10.1177/1358863X16649040; Wise ES, 2015, AM SURGEON, V81, pE274; Wise ES, 2015, SURGERY, V158, P537, DOI 10.1016/j.surg.2015.03.036; Yamamoto K, 2000, AM J PHYSIOL-HEART C, V279, pH285, DOI 10.1152/ajpheart.2000.279.1.H285; Yan Y, 2015, AM J PHYSL CELL PHYS; Yu Y, 2009, NEUROREPORT, V20, P393, DOI 10.1097/WNR.0b013e328324ede7; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661	59	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188069	10.1371/journal.pone.0188069	http://dx.doi.org/10.1371/journal.pone.0188069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136654	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200059
J	Ledikwe, JH; Ramabu, NM; Spees, LP; Barnhart, S; Ntsuape, C; Semo, BW; Wirth, KE				Ledikwe, Jenny H.; Ramabu, Nankie M.; Spees, Lisa P.; Barnhart, Scott; Ntsuape, Conrad; Semo, Bazghina-werq; Wirth, Kathleen E.			Early resumption of sexual activity following voluntary medical male circumcision in Botswana: A qualitative study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADULT MALE CIRCUMCISION; HIV PREVENTION; FEMALE PARTNERS; MEN; UGANDA; RAKAI; TRANSMISSION; PREVALENCE; TANZANIA	Unprotected sexual intercourse after undergoing voluntary medical male circumcision but prior to complete wound healing can lead to major adverse events including HIV acquisition. To better understand perceptions related to early resumption of sex prior to wound healing, 27 focus group discussions were conducted among 238 adult men, women, and community leaders in Botswana. Median age among all participants was 31 years of whom 60% were male and 51% were either employed and receiving salary or self-employed. Only 12% reported being currently married. Pain, not risk of HIV acquisition, was perceived as the main adverse consequence of early resumption of sex. In fact, no participant mentioned that early resumption of sex could lead to an increase in HIV risk. Demonstrating masculinity and virility, fear of losing female partners, and misperception about post-operative wound healing also played key roles in the decision to resume sex prior to complete wound healing. Findings from this study highlight a potentially widespread lack of awareness of the increased risk of HIV acquisition during the wound healing period. Strengthening post-operative counseling and identifying strategies to discourage the early resumption of sex will be increasingly important as older men and HIV-positive men seek voluntary medical male circumcision services.	[Ledikwe, Jenny H.; Barnhart, Scott; Semo, Bazghina-werq] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Ledikwe, Jenny H.; Ramabu, Nankie M.; Spees, Lisa P.; Semo, Bazghina-werq; Wirth, Kathleen E.] Botswana Int Training & Educ Ctr Hlth I TECH, Gaborone, Botswana; [Spees, Lisa P.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Ntsuape, Conrad] Botswana Minist Hlth, Dept HIV AIDS Prevent & Care, Gaborone, Botswana; [Wirth, Kathleen E.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wirth, Kathleen E.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Ledikwe, JH (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Ledikwe, JH (corresponding author), Botswana Int Training & Educ Ctr Hlth I TECH, Gaborone, Botswana.	Ledikwe@uw.edu		Wirth, Kathleen/0000-0002-7468-851X; Ledikwe, Jenny/0000-0001-8658-2993	President's Emergency Plan for AIDS Relief (PEPFAR); US Department of Health and Human Services, Health Resources and Services Administration (HRSA) Global HIV/AIDS Bureau [U91HA06801]	President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Department of Health and Human Services, Health Resources and Services Administration (HRSA) Global HIV/AIDS Bureau	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR), through funding to the University of Washington and I-TECH from the US Department of Health and Human Services, Health Resources and Services Administration (HRSA) Global HIV/AIDS Bureau under Cooperative Agreement No. U91HA06801.	Andersson KM, 2011, AIDS BEHAV, V15, P938, DOI 10.1007/s10461-010-9784-y; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Government of Botswana, 2009, BOTSW AIDS IMP SURV; Government of Botswana, 2014, BOTSW AIDS IMP SURV; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Kamath V, 2015, AIDS CARE, V27, P986, DOI 10.1080/09540121.2015.1017797; Kigozi G, 2008, PLOS MED, V5, P911, DOI 10.1371/journal.pmed.0050116; Layer EH, 2014, CULT HEALTH SEX, V16, P258, DOI 10.1080/13691058.2013.873481; Ledikwe JH, 2014, HIV AIDS-RES PALLIAT, V6, P139, DOI 10.2147/HIV.S65354; Mehta SD, 2009, AIDS, V23, P1557, DOI 10.1097/QAD.0b013e32832afe95; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Odeny TA, 2014, JAIDS-J ACQ IMM DEF, V65, pE50, DOI 10.1097/QAI.0b013e3182a0a050; Odoyo-June E, 2013, JAIDS-J ACQ IMM DEF, V62, P465, DOI [10.1097/QAI.0b013e3182800710, 10.1097/QAI.]; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Sgaier SK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001641; Shisana O, 2014, S AFRICAN NATL HIV P; Thomas AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027561; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; White RG, 2008, AIDS, V22, P1841, DOI 10.1097/QAD.0b013e32830e0137; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; World Health Organization UNAIDS, 2007, WHO UNAIDS TECHN MAL; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832; Zetola N, 2012, SEX TRANSM DIS, V39, P114, DOI 10.1097/OLQ.0b013e318242b4f3	31	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0186831	10.1371/journal.pone.0186831	http://dx.doi.org/10.1371/journal.pone.0186831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136009	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200007
J	Ramadasan-Nair, R; Hui, J; Zimin, PI; Itsara, LS; Morgan, PG; Sedensky, MM				Ramadasan-Nair, Renjini; Hui, Jessica; Zimin, Pavel I.; Itsara, Leslie S.; Morgan, Philip G.; Sedensky, Margaret M.			Regional knockdown of NDUFS4 implicates a thalamocortical circuit mediating anesthetic sensitivity	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; POSITRON-EMISSION-TOMOGRAPHY; SPINAL MOTOR-NEURONS; CEREBRAL-BLOOD-FLOW; CAENORHABDITIS-ELEGANS; VOLATILE-ANESTHETICS; PROPOFOL ANESTHESIA; FEEDFORWARD INHIBITION; LEIGH-SYNDROME; DEFAULT MODE	Knockout of the mitochondrial complex I protein, NDUFS4, profoundly increases sensitivity of mice to volatile anesthetics. In mice carrying an Ndufs4(lox/lox) gene, adeno-associated virus expressing Cre recombinase was injected into regions of the brain postulated to affect sensitivity to volatile anesthetics. These injections generated otherwise phenotypically wild type mice with region-specific, postnatal inactivation of Ndufs4, minimizing developmental effects of gene loss. Sensitivities to the volatile anesthetics isoflurane and halothane were measured using loss of righting reflex (LORR) and movement in response to tail clamp (TC) as endpoints. Knockdown (KD) of Ndufs4 in the vestibular nucleus produced resistance to both anesthetics for movement in response to TC. Ndufs4 loss in the central and dorsal medial thalami and in the parietal association cortex increased anesthetic sensitivity to both TC and LORR. Knockdown of Ndufs4 only in the parietal association cortex produced striking hypersensitivity for both endpoints, and accounted for half the total change seen in the global KO (Ndufs4(KO)). Excitatory synaptic transmission in the parietal association cortex in slices from Ndufs4(KO) animals was hypersensitive to isoflurane compared to control slices. We identified a direct neural circuit between the parietal association cortex and the central thalamus, consistent with a model in which isoflurane sensitivity is mediated by a thalamic signal relayed through excitatory synapses to the parietal association cortex. We postulate that the thalamocortical circuit is crucial for maintenance of consciousness and is disrupted by the inhibitory effects of isoflurane/halothane on mitochondria.	[Ramadasan-Nair, Renjini; Hui, Jessica; Zimin, Pavel I.; Itsara, Leslie S.; Morgan, Philip G.; Sedensky, Margaret M.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 Ninth Ave, Seattle, WA 98101 USA; [Zimin, Pavel I.; Morgan, Philip G.; Sedensky, Margaret M.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Ramadasan-Nair, R (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 Ninth Ave, Seattle, WA 98101 USA.	renjini.ramadasannair@seattlechildrens.org	Core, Vector/CAF-4832-2022	Morgan, Phil/0000-0003-4857-2756	R01 grant from National Institute of Health [NIH R01 GM105696]; NW Mitochondrial Research Guild; NIH [RO1 GM105696]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105696] Funding Source: NIH RePORTER	R01 grant from National Institute of Health; NW Mitochondrial Research Guild; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an R01 grant from National Institute of Health (https://grants.nih.gov/grants/funding/funding_program.htm#RSeries) - NIH R01 GM105696 to M.M.S. and the NW Mitochondrial Research Guild. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH RO1 GM105696 and the NW Mitochondrial Research Guild. We thank Dr. Albert Quintana for guidance with regional Ndufs4 KD techniques, Dr. Beatrice Predoi for technical support, Christian Woods and Dr. Ernst-Bernhard Kayser for meaningful discussions and critical advice.	Akeju O, 2014, ELIFE, V3, DOI 10.7554/eLife.04499; Alkire MT, 2005, PROG BRAIN RES, V150, P229, DOI 10.1016/S0079-6123(05)50017-7; Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ALKIRE MT, 1995, ANESTHESIOLOGY, V82, P393, DOI 10.1097/00000542-199502000-00010; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Baker R, 2014, J NEUROSCI, V34, P13326, DOI 10.1523/JNEUROSCI.1519-14.2014; BEITZ AJ, 1987, NEUROSCIENCE, V20, P409, DOI 10.1016/0306-4522(87)90101-1; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Bonhomme V, 2001, J NEUROPHYSIOL, V85, P1299, DOI 10.1152/jn.2001.85.3.1299; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Carriot J, 2013, J NEUROSCI, V33, P19555, DOI 10.1523/JNEUROSCI.3051-13.2013; COHEN PJ, 1973, ANESTHESIOLOGY, V39, P153, DOI 10.1097/00000542-197308000-00007; Cunningham SI, 2017, HUM BRAIN MAPP, V38, P938, DOI 10.1002/hbm.23429; Delevich K, 2015, J NEUROSCI, V35, P5743, DOI 10.1523/JNEUROSCI.4565-14.2015; Devor M, 2001, PAIN, V94, P101, DOI 10.1016/S0304-3959(01)00345-1; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Feng D, 2015, METHODS, V73, P90, DOI 10.1016/j.ymeth.2015.01.009; Fiset P, 1999, J NEUROSCI, V19, P5506; FRANK GB, 1970, BRIT J PHARMACOL, V39, P696, DOI 10.1111/j.1476-5381.1970.tb09895.x; Frias B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060797; Gupta RG, 2017, AUTON NEUROSCI-BASIC, V202, P114, DOI 10.1016/j.autneu.2016.06.007; HARRIS RA, 1971, ARCH BIOCHEM BIOPHYS, V142, P435, DOI 10.1016/0003-9861(71)90507-8; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Jinks SL, 2008, ANESTHESIOLOGY, V108, P1016, DOI 10.1097/ALN.0b013e3181730297; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Karunadharma PP, 2015, FASEB J, V29, P3582, DOI 10.1096/fj.15-272666; Kayser EB, 1999, ANESTHESIOLOGY, V90, P545, DOI 10.1097/00000542-199902000-00031; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kayser EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148219; Kayser EB, 2011, ANESTH ANALG, V112, P1321, DOI 10.1213/ANE.0b013e3182121d37; KING BS, 1994, ANESTHESIOLOGY, V81, P1484, DOI 10.1097/00000542-199412000-00024; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Lee CC, 2008, J NEUROPHYSIOL, V100, P317, DOI 10.1152/jn.90391.2008; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; MacIver MB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00203; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Morgan PG, 2002, ANESTHESIOLOGY, V96, P1268, DOI 10.1097/00000542-200205000-00036; MORGAN SE, 1994, ANESTHESIOLOGY, V80, P201, DOI 10.1097/00000542-199401000-00027; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pathak D, 2015, J BIOL CHEM, V290, P22325, DOI 10.1074/jbc.M115.656405; Porreca F, 2002, TRENDS NEUROSCI, V25, P319, DOI 10.1016/S0166-2236(02)02157-4; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Quintana A, 2010, P NATL ACAD SCI USA, V107, P10996, DOI 10.1073/pnas.1006214107; Rampil IJ, 1996, ANESTHESIOLOGY, V85, P129, DOI 10.1097/00000542-199607000-00018; Reinsel RA, 2000, INT J NEUROPSYCHOPH, V3, P117, DOI 10.1017/S1461145700001814; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; Ries CR, 1999, J NEUROPHYSIOL, V81, P1795, DOI 10.1152/jn.1999.81.4.1795; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sherrington C, 1906, INTEGRATIVE ACTION N; Shin TJ, 2016, NEUROSCI LETT, V627, P18, DOI 10.1016/j.neulet.2016.05.045; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Sobieski C, 2017, J NEUROSCI, V37, P1888, DOI 10.1523/JNEUROSCI.2712-16.2017; Song LY, 2015, BRAIN RES, V1594, P82, DOI 10.1016/j.brainres.2014.11.013; Sonner JM, 2007, ANESTHESIOLOGY, V106, P107, DOI 10.1097/00000542-200701000-00019; Spangler-Bickell MG, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0242-3; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Veselis RA, 2004, ANESTH ANALG, V99, P399, DOI 10.1213/01.ANE.0000131971.92180.DF; Wang N, 2010, NEUROSCI BULL, V26, P188, DOI 10.1007/s12264-010-0150-x; Zimin PI, 2016, CURR BIOL, V26, P2194, DOI 10.1016/j.cub.2016.06.020; Zweifel LS, 2008, NEURON, V59, P486, DOI 10.1016/j.neuron.2008.05.028	64	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188087	10.1371/journal.pone.0188087	http://dx.doi.org/10.1371/journal.pone.0188087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136012	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200060
J	Jiang, DY; Yu, L; Wang, F; Xie, XX; Yu, YS				Jiang, Dengying; Yu, Ling; Wang, Fei; Xie, Xiaoxia; Yu, Yongsheng			Design of the smart home system based on the optimal routing algorithm and ZigBee network	PLOS ONE			English	Article							HYBRID	To improve the traditional smart home system, its electric wiring, networking technology, information transmission and facility control are studied. In this paper, we study the electric wiring, networking technology, information transmission and facility control to improve the traditional smart home system. First, ZigBee is used to replace the traditional electric wiring. Second, a network is built to connect lots of wireless sensors and facilities, thanks to the capability of ZigBee self-organized network and Genetic Algorithm-Particle Swarm Optimization Algorithm (GA-PSOA) to search for the optimal route. Finally, when the smart home system is connected to the internet based on the remote server technology, home environment and facilities could be remote real-time controlled. The experiments show that the GA-PSOA reduce the system delay and decrease the energy consumption of the wireless system.	[Jiang, Dengying; Yu, Ling] Wuhan Univ Technol, Sch Sci, Wuhan, Hubei, Peoples R China; [Wang, Fei] Cent China Normal Univ, Phys Sci & Technol Dept, Wuhan, Hubei, Peoples R China; [Xie, Xiaoxia] Idaho State Univ, Dept Math & Stat, Pocatello, ID 83209 USA; [Yu, Yongsheng] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; Central China Normal University; Idaho; Idaho State University; Wuhan University of Technology	Yu, YS (corresponding author), Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan, Hubei, Peoples R China.	yongshengyu@whut.edu.cn			Fundamental Research Funds for the Central Universities [201716014]; Fundamental Research Funds for the Central Universities (WUT) [2017IB014]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for the Central Universities (WUT)	This work is supported by the Fundamental Research Funds for the Central Universities (grant number: 201716014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This article is supported by the Fundamental Research Funds for the Central Universities (WUT: 2017IB014). Thanks for the support.	Ameen SY, 2013, 2013 FIRST INTERNATIONAL SCIENTIFIC CONFERENCE ON ELECTRICAL, COMMUNICATION, COMPUTER, POWER, AND CONTROL ENGINEERING (ICECCPCE'13), P130, DOI 10.1109/ICECCPCE.2013.6998748; Anvari-Moghaddam A, 2015, IEEE T SMART GRID, V6, P324, DOI 10.1109/TSG.2014.2349352; Byun J, 2012, IEEE T CONSUM ELECTR, V58, P794, DOI 10.1109/TCE.2012.6311320; Cao Jian-zhao, 2013, Journal of Northeastern University. Natural Science, V34, P1113; De Silva LC, 2012, ENG APPL ARTIF INTEL, V25, P1313, DOI 10.1016/j.engappai.2012.05.002; Gao De-min, 2010, Application Research of Computers, V27, P4226, DOI 10.3969/j.issn.1001-3695.2010.11.061; Gao L, 2016, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-016-0091-z; Giovanni P, 2017, ENERGIES, V10; Guo P, 2012, J HUAZHONG U SCI TEC, V40, P61; Helal S. A., 2017, P 2017 IEEE 30 CANAD, P1, DOI DOI 10.1109/CCECE.2017.7946775; Khalil T. M., 2012, INT J MULTIDISCIP SC, V3, P1; Kim T, 2016, IEEE SENS J, V16, P5107, DOI 10.1109/JSEN.2016.2557344; Kuo RJ, 2010, DECIS SUPPORT SYST, V49, P451, DOI 10.1016/j.dss.2010.05.006; Lee JS, 2007, IEEE IND ELEC, P46; Liu YM, 2015, NEUROCOMPUTING, V151, P1237, DOI 10.1016/j.neucom.2014.03.081; [马超 Ma Chao], 2013, [计算机研究与发展, Journal of Computer Research and Development], V50, P2278; Mihajlov B., 2011, INT J COMPUT APPL, V29, P28, DOI DOI 10.5120/3704-5138; Muhammad RA, 2017, ENERGY EFFICIENCY; Pretty DG, 2014, FUSION ENG DES, V89, P731, DOI 10.1016/j.fusengdes.2014.03.025; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Yan X., 2014, THESIS	22	2	2	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0188026	10.1371/journal.pone.0188026	http://dx.doi.org/10.1371/journal.pone.0188026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM4OL	29131868	Green Published, gold, Green Submitted			2022-12-27	WOS:000414997800038
J	Chalmers, AD; Bursill, CA; Myerscough, MR				Chalmers, Alexander D.; Bursill, Christina A.; Myerscough, Mary R.			Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; GENE-TRANSFER; APOA-I; MATHEMATICAL-MODEL; CONTROLLED-TRIAL; DEFICIENT MICE; TNF-ALPHA	We use a computational model to explore the effect of foam cell accumulation on plaque regression following an increase in high density lipoprotein (HDL) influx into the plaque. Atherosclerotic plaque formation is the outcome of cellular and cytokine responses to low density lipoproteins (LDL) that penetrate the artery wall following an injury to the endothelium and become modified. We modelled the cells and cytokines that are most important in plaque formation using partial differential equations. The model includes monocytes and macrophages, foam cells, macrophage chemoattractants, endothelium-stimulating cytokines, modified low density lipoproteins (mod LDL) and HDL. We included interactions both at the endothelium surface and inside the artery wall. The model predicts that when HDL influx into a well-established plaque with large numbers of foam cells is increased, the plaque may not regress but may continue to grow at a slower rate. If HDL influx is increased when a model plaque is recently established and has fewer foam cells, then the plaque does regress. If modLDL influx into the plaque is lowered at the same time that HDL influx increased or the capacity of the HDL to remove cholesterol from foam cells is increased, then the plaque is more likely to regress. The predictions of the model are in qualitative agreement with experimental studies in mice and rabbits. The results suggest that the intrinsic dynamics of reverse cholesterol transport by HDL are important in determining the success of HDL raising in promoting plaque regression.	[Chalmers, Alexander D.; Myerscough, Mary R.] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Bursill, Christina A.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	University of Sydney; South Australian Health & Medical Research Institute (SAHMRI)	Myerscough, MR (corresponding author), Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia.	mary.myerscough@sydney.edu.au		Myerscough, Mary/0000-0002-4993-765X; Bursill, Christina/0000-0002-0682-8760	Australian Research Council Discovery Grant [DP160104685]; University of Sydney; Australian Postgraduate Award	Australian Research Council Discovery Grant(Australian Research Council); University of Sydney(University of Sydney); Australian Postgraduate Award(Australian Government)	MRM and CAB acknowledge an Australian Research Council Discovery Grant (DP160104685). MRM acknowledges a Thompson Fellowship from the University of Sydney. ADC acknowledges an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 2017, CARDIOVASC DIAGN THE, V7, P45, DOI 10.21037/cdt.2017.01.01; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Belalcazar LM, 2003, CIRCULATION, V107, P2726, DOI 10.1161/01.CIR.0000066913.69844.B2; Berrougui H, 2009, REJUV RES, V12, P117, DOI 10.1089/rej.2008.0840; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chalmers AD, 2015, J MATH BIOL, V71, P1451, DOI 10.1007/s00285-015-0864-5; Cilla M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0866; Cobbold CA, 2002, B MATH BIOL, V64, P65, DOI 10.1006/bulm.2001.0267; Cohen A, 2014, B MATH BIOL, V76, P1117, DOI 10.1007/s11538-014-9948-4; Colin S, 2014, IMMUNOL REV, V262, P153, DOI 10.1111/imr.12218; Dabagh M, 2009, AM J PHYSIOL-HEART C, V297, pH983, DOI 10.1152/ajpheart.00324.2009; Di Vito L, 2013, INT J CARDIOL, V168, P1917, DOI 10.1016/j.ijcard.2012.12.082; Doedel E.J., AUTO 07P CONTINUATIO; Easton R, 2014, J CLIN PHARMACOL, V54, P301, DOI 10.1002/jcph.194; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Friedman A, 2015, B MATH BIOL, V77, P758, DOI 10.1007/s11538-014-0010-3; GUCKENHEIMER J, 1993, B MATH BIOL, V55, P937, DOI 10.1007/BF02460693; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; JIMI S, 1994, ATHEROSCLEROSIS, V107, P109, DOI 10.1016/0021-9150(94)90146-5; Jovinge S, 1996, ARTERIOSCL THROM VAS, V16, P1573, DOI 10.1161/01.ATV.16.12.1573; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Khera AV, 2017, CIRCULATION, V135, P2494, DOI 10.1161/CIRCULATIONAHA.116.025678; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Kojima Y, 2017, CIRCULATION, V135, P476, DOI 10.1161/CIRCULATIONAHA.116.025684; Kootte RS, 2015, J LIPID RES, V56, P703, DOI 10.1194/jlr.M055665; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Li Rongying, 2011, J Genet Syndr Gene Ther, V2, P106; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Morton J, 2013, HEART LUNG AND CIRCU, V22, pS66; Murao K, 2000, BIOCHEM BIOPH RES CO, V276, P791, DOI 10.1006/bbrc.2000.3497; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; Ougrinovskaia A, 2010, B MATH BIOL, V72, P1534, DOI 10.1007/s11538-010-9509-4; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Peled M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00579; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Rohatgi A, 2014, NEW ENGLAND JOURNAL; Rohatgi A, 2015, PROG CARDIOVASC DIS, V58, P32, DOI 10.1016/j.pcad.2015.05.004; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Sanson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074676; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tardif JC, 2014, EUR HEART J, V35, P3277, DOI 10.1093/eurheartj/ehu171; Tardy C, 2014, ATHEROSCLEROSIS, V232, P110, DOI 10.1016/j.atherosclerosis.2013.10.018; Torii R, 2006, COMPUT METHOD APPL M, V195, P1885, DOI 10.1016/j.cma.2005.05.050; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; Wang GP, 1997, ATHEROSCLEROSIS, V133, P31, DOI 10.1016/S0021-9150(97)00109-3; Xu HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086723; Zheng KH, 2016, CURR OPIN LIPIDOL, V27, P592, DOI 10.1097/MOL.0000000000000349; Zheng KH, 2016, ATHEROSCLEROSIS, V251, P381, DOI 10.1016/j.atherosclerosis.2016.05.038	61	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187674	10.1371/journal.pone.0187674	http://dx.doi.org/10.1371/journal.pone.0187674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161303	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000015
J	Woo, CW; Kwon, JI; Kim, KW; Kim, JK; Jeon, SB; Jung, SC; Choi, CG; Kim, ST; Kim, J; Ham, SJ; Shim, WH; Sung, YS; Ha, HK; Choi, Y; Woo, DC				Woo, Chul-Woong; Kwon, Jae-Im; Kim, Kyung-Won; Kim, Jeong-Kon; Jeon, Sang-Beom; Jung, Seung-Chae; Choi, Choong-Gon; Kim, Sang-Tae; Kim, Jinil; Ham, Su Jeong; Shim, Woo-Hyun; Sung, Yu Sub; Ha, Hyun Kwon; Choi, Yoonseok; Woo, Dong-Cheol			The administration of hydrogen sulphide prior to ischemic reperfusion has neuroprotective effects in an acute stroke model	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; ISCHEMIA/REPERFUSION INJURY; BRAIN EDEMA; RATS; PROTECTS; TRANSIENT; MRI; ANGIOGENESIS; GLUTAMATE	Emerging evidence has suggested that hydrogen sulfide (H2S) may alleviate the cellular damage associated with cerebral ischemia/reperfusion (I/R) injury. In this study, we assessed using 1 H-magnetic resonance imaging/magnetic resonance spectroscopy (1 H-MRI/MRS) and histologic analysis whether H2S administration prior to reperfusion has neuroprotective effects. We also evaluated for differences in the effects of H2S treatment at 2 time points. 1 H-MRI/MRS data were obtained at baseline, and at 3, 9, and 24 h after ischemia from 4 groups: sham, control (I/R injury), sodium hydrosulfide (NaHS)-30 and NaHS-1 (NaHS delivery at 30 and 1 min before reperfusion, respectively). The total infarct volume and the midline shift at 24 h post-ischemia were lowest in the NaHS-1, followed by the NaHS-30 and control groups. Peri-infarct volume was significantly lower in the NaHS-1 compared to NaHS-30 and control animals. The relative apparent diffusion coefficient (ADC) in the peri-infarct region showed that the NaHS-1 group had significantly lower values compared to the NaHS-30 and control animals and that NaHS-1 rats showed significantly higher relative T2 values in the peri-infarct region compared to the controls. The relative ADC value, relative T2 value, levels of N-acetylL-aspartate (NAA), and the NAA, glutamate, and taurine combination score (NGT) in the ischemic core region at 24 h post-ischemia did not differ significantly between the 2 NaHS groups and the control except that the NAA and NGT values were higher in the peri-infarct region of the NaHS-1 animals at 9 h post-ischemia. In the ischemic core and peri-infarct regions, the apoptosis rate was lowest in the NaHS-1 group, followed by the NaHS-30 and control groups. Our results suggest that H2S treatment has neuroprotective effects on the peri-infarct region during the evolution of I/R injury. Furthermore, our findings indicate that the administration of H2S immediately prior to reperfusion produces the highest neuroprotective effects.	[Woo, Chul-Woong; Kwon, Jae-Im; Kim, Sang-Tae; Kim, Jinil; Ham, Su Jeong; Shim, Woo-Hyun; Woo, Dong-Cheol] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kim, Kyung-Won; Kim, Jeong-Kon; Jung, Seung-Chae; Choi, Choong-Gon; Sung, Yu Sub] Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Jeon, Sang-Beom] Asan Med Ctr, Dept Neurol, Seoul, South Korea; [Ha, Hyun Kwon; Choi, Yoonseok] Gangneung Asan Hosp, Med Res Inst, Gangneung Si, Gangwon Do, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Woo, DC (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.; Choi, Y (corresponding author), Gangneung Asan Hosp, Med Res Inst, Gangneung Si, Gangwon Do, South Korea.	yschoi21rad@gnah.co.kr; dcwoo@amc.seoul.kr	Jeon, Sang-Beom/AAD-6605-2022	Jeon, Sang-Beom/0000-0003-0735-5499	Asan Institute for Life Sciences, Asan Medical Center [2015-651]; Ministry of Science [NRF-2015R1C1A1A02036526]; Korea Health Industry Development Institute [HI14C1090]	Asan Institute for Life Sciences, Asan Medical Center; Ministry of Science(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This work was supported by Asan Institute for Life Sciences, Asan Medical Center, grant number 2015-651 to HKH (http://ails.amc.seoul.kr); Ministry of Science, grant number NRF-2015R1C1A1A02036526 to DCW (www.nrf.re.kr); and Korea Health Industry Development Institute, grant number HI14C1090 to DCW (www.khidi.or.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PA, 2005, NEUROSCI LETT, V388, P54, DOI 10.1016/j.neulet.2005.06.067; Berthet C, 2011, STROKE, V42, P799, DOI 10.1161/STROKEAHA.110.603647; Bonaventura A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121967; Cheng J, 2007, J CEREBR BLOOD F MET, V27, P1553, DOI 10.1038/sj.jcbfm.9600457; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Gheibi S, 2014, J MOL NEUROSCI, V54, P264, DOI 10.1007/s12031-014-0284-9; Ginsberg MD, 2016, PROG NEUROBIOL, V145, P46, DOI 10.1016/j.pneurobio.2016.09.002; GREGORAKOS L, 1995, ANGIOLOGY, V46, P1123, DOI 10.1177/000331979504601208; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jang H, 2014, J NEUROSCI RES, V92, P1520, DOI 10.1002/jnr.23427; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; Juenemann M, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0087-y; Khanna A, 2014, TRANSL STROKE RES, V5, P3, DOI 10.1007/s12975-013-0307-9; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Lei HX, 2009, J CEREBR BLOOD F MET, V29, P811, DOI 10.1038/jcbfm.2009.8; Li XJ, 2015, NEURAL REGEN RES, V10, P932, DOI 10.4103/1673-5374.158353; Lu M, 2008, FREE RADICAL BIO MED, V45, P1705, DOI 10.1016/j.freeradbiomed.2008.09.014; Neumann-Haefelin T, 2000, STROKE, V31, P1965, DOI 10.1161/01.STR.31.8.1965; Nour M, 2012, INTERV NEUROL, V1, P185, DOI 10.1159/000353125; O'Shea JM, 2000, MAGN RESON MED, V44, P427, DOI 10.1002/1522-2594(200009)44:3<427::AID-MRM13>3.0.CO;2-B; OH SM, 1991, STROKE, V22, P915, DOI 10.1161/01.STR.22.7.915; Palaniswami M, 2015, INTERV NEUROL, V4, P18, DOI 10.1159/000438774; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; PRICHARD JW, 1993, RES P ARNMD, V71, P153; Ren CL, 2010, BRAIN RES, V1345, P197, DOI 10.1016/j.brainres.2010.05.017; Toombs CF, 2010, BRIT J CLIN PHARMACO, V69, P626, DOI 10.1111/j.1365-2125.2010.03636.x; Walberer M, 2007, J NEUROSURG ANESTH, V19, P105, DOI 10.1097/ANA.0b013e31802c7e33; Xing BZ, 2008, J NEUROCHEM, V105, P1737, DOI 10.1111/j.1471-4159.2008.05276.x; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yin Jun, 2013, Zhonghua Yi Xue Za Zhi, V93, P868; Yin J, 2013, BRAIN RES, V1491, P188, DOI 10.1016/j.brainres.2012.10.046; Zhao HP, 2014, STROKE, V45, P2417, DOI 10.1161/STROKEAHA.114.006135	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187910	10.1371/journal.pone.0187910	http://dx.doi.org/10.1371/journal.pone.0187910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161281	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000026
J	Kasper-Sonnenberg, M; Wittsiepe, J; Wald, K; Koch, HM; Wilhelm, M				Kasper-Sonnenberg, Monika; Wittsiepe, Juergen; Wald, Katharina; Koch, Holger M.; Wilhelm, Michael			Pre-pubertal exposure with phthalates and bisphenol A and pubertal development	PLOS ONE			English	Article							ENDOCRINE DISRUPTERS; DEVELOPMENT SCALE; RISK-ASSESSMENT; METABOLITES; VARIABILITY; DIESTERS; CHILDREN; GIRLS; POPULATION; VALIDITY	Objective Epidemiological studies indicate associations between childhood exposure with phthalates and bisphenol A (BPA) and the pubertal development. We examined associations between the pre-pubertal phthalate and BPA body burden and the longitudinally assessed sexual maturation of eight-to thirteen-year-old children. Methods We started with eight-to ten-year-old children in the baseline study and quantified phthalate metabolites and BPA in 472 urine samples (250 boys; 222 girls; mean age: 8.8 years). Associations between the pubertal development, assessed in three annual follow-up studies by Puberty Development scale questionnaires (PD scales), and the chemical exposure from the baseline visit were longitudinally analyzed with generalized estimation equations. Results The number of children with both chemical measures and PD scores (calculated from the PD scales) was 408. In the third follow-up, 49% of the girls and 18% of the boys had reached mid-puberty. For girls, we observed a delayed pubertal development with the di-hexyl-ethyl phthalate (DEHP) metabolites (beta: -0.16 to -0.23; p <= 0.05 or p <= 0.1), mono-n-butyl phthalate (beta: -0.15; 95% CI: -0.31; 0.01), mono-benzyl phthalate (beta: -0.11; 95% CI: -0,24; -0,01), and mono-ethyl phthalate (MEP) (beta: -0.15; 95% CI: -0.28; -0.01). In addition, significant nonlinear associations of the DEHP metabolites and BPA with the PD scores were found, when their quadratic effects were included in the GEE models. In boys, no consistent relationships between the PD scores and the chemicals were detected except of an accelerated development with the Sigma DEHP metabolites (beta: 0.16; 95% CI: -0.02; -0.34). Conclusion We found indications that pre-pubertal exposures with phthalates and BPA were associated with pubertal timing in children, particularly in girls. For boys, associations were inconsistent, and not necessarily in line with the known anti-androgenicity of some phthalates during prenatal exposure.	[Kasper-Sonnenberg, Monika; Wittsiepe, Juergen; Wald, Katharina; Wilhelm, Michael] Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany; [Koch, Holger M.] Inst Ruhr Univ Bochum, Inst Prevent & Occupat Med German Social Accid In, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Kasper-Sonnenberg, M (corresponding author), Ruhr Univ Bochum, Dept Hyg Social & Environm Med, Bochum, Germany.	Monika.Kasper-Sonnenberg@rub.de	Kasper-Sonnenberg, Monika/AAH-2769-2021; Koch, Holger M/B-3277-2011	Kasper-Sonnenberg, Monika/0000-0002-9435-1391; Koch, Holger M/0000-0002-8328-2837	Federal Environment Agency of Germany [3708 61 201 3]; DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum	Federal Environment Agency of Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany; DFG Open Access Publication Funds of the Ruhr-University Bochum	This work was supported by the Federal Environment Agency of Germany [3708 61 201 3 (UFO Plan)] until 2011. Since then the research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The publication was supported by the DFG Open Access Publication Funds of the Ruhr-University Bochum, Bochum, Germany.; We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-University Bochum.	Apel P, 2017, INT J HYG ENVIR HEAL, V220, P152, DOI 10.1016/j.ijheh.2016.09.007; Backhaus T, 2013, INTEGR ENVIRON ASSES, V9, P547, DOI 10.1002/ieam.1475; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Biro FM, 2006, INT J ANDROL, V29, P272, DOI 10.1111/j.1365-2605.2005.00602.x; Bond L, 2006, J ADOLESCENCE, V29, P709, DOI 10.1016/j.adolescence.2005.10.001; Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139; Braun JM, 2013, CURR OPIN PEDIATR, V25, P247, DOI 10.1097/MOP.0b013e32835e1eb6; Cai W, 2008, FITTING GEN ADDITIVE; Cantonwine DE, 2014, ENVIRON INT, V62, P1, DOI 10.1016/j.envint.2013.09.014; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Christensen KLY, 2012, J EXPO SCI ENV EPID, V22, P632, DOI 10.1038/jes.2012.52; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Durmaz E, 2014, J CLIN RES PEDIATR E, V6, P16, DOI 10.4274/Jcrpe.1220; Ferguson KK, 2017, J EXPO SCI ENV EPID, V27, P326, DOI 10.1038/jes.2016.27; Ferguson KK, 2014, REPROD TOXICOL, V47, P70, DOI 10.1016/j.reprotox.2014.06.002; Fisher M, 2015, J EXPO SCI ENV EPID, V25, P231, DOI 10.1038/jes.2014.65; Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x; Frederiksen H, 2013, INT J HYG ENVIR HEAL, V216, P772, DOI 10.1016/j.ijheh.2013.02.006; Johns LE, 2015, ENVIRON INT, V85, P27, DOI 10.1016/j.envint.2015.08.005; Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2; Kasper-Sonnenberg M, 2014, INT J HYG ENVIR HEAL, V217, P830, DOI 10.1016/j.ijheh.2014.06.001; Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007; Kay VR, 2014, CRIT REV TOXICOL, V44, P467, DOI 10.3109/10408444.2013.875983; Kay VR, 2013, CRIT REV TOXICOL, V43, P200, DOI 10.3109/10408444.2013.766149; Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044; Koch HM, 2012, J EXPO SCI ENV EPID, V22, P610, DOI 10.1038/jes.2012.39; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Mantovani A, 2006, ANN NY ACAD SCI, V1076, P239, DOI 10.1196/annals.1371.063; Mantovani A, 2014, REPROD TOXICOL, V44, P15, DOI 10.1016/j.reprotox.2013.06.002; Maranghi F, 2012, REPROD TOXICOL, V33, P290, DOI 10.1016/j.reprotox.2012.01.009; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Martinez-Arguelles DB, 2013, J STEROID BIOCHEM, V137, P5, DOI 10.1016/j.jsbmb.2013.01.007; McGuinn LA, 2015, ENVIRON RES, V136, P381, DOI 10.1016/j.envres.2014.10.037; Miodovnik A, 2014, NEUROTOXICOLOGY, V41, P112, DOI 10.1016/j.neuro.2014.01.007; Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x; Mouritsen A, 2013, J CLIN ENDOCR METAB, V98, P3755, DOI 10.1210/jc.2013-1284; National Research Council (US), 2008, PHTHAL CUM RISK ASS; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048; Rasmussen AR, 2015, PEDIATRICS, V135, P86, DOI 10.1542/peds.2014-0793; Rochester JR, 2013, REPROD TOXICOL, V42, P132, DOI 10.1016/j.reprotox.2013.08.008; Schecker H., 2014, METHODEN NATURWISSEN, P439; Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007; Shirtcliff EA, 2009, CHILD DEV, V80, P327, DOI 10.1111/j.1467-8624.2009.01263.x; Su PH, 2015, ENVIRON RES, V136, P324, DOI 10.1016/j.envres.2014.10.026; Tsai YA, 2016, ENVIRON RES, V149, P197, DOI 10.1016/j.envres.2016.05.005; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Walker DM, 2011, NAT REV ENDOCRINOL, V7, P197, DOI 10.1038/nrendo.2010.215; Watkins DJ, 2016, J CLIN ENDOCR METAB, V101, P78, DOI 10.1210/jc.2015-2706; Watkins DJ, 2014, ENVIRON RES, V134, P233, DOI 10.1016/j.envres.2014.08.010; Watzlawik M, 2009, DIAGNOSTICA, V55, P55, DOI 10.1026/0012-1924.55.1.55; Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121; Wolff MS, 2014, HUM REPROD, V29, P1558, DOI 10.1093/humrep/deu081; Xie CM, 2015, MOL CELL ENDOCRINOL, V407, P67, DOI 10.1016/j.mce.2015.03.006; Zhang YH, 2015, ENVIRON INT, V83, P41, DOI 10.1016/j.envint.2015.06.005	56	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187922	10.1371/journal.pone.0187922	http://dx.doi.org/10.1371/journal.pone.0187922			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155850	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700023
J	Schaefer, B; Moriishi, K; Behrends, S				Schaefer, Bianca; Moriishi, Kohji; Behrends, Soenke			Insights into the mechanism of isoenzyme-specific signal peptide peptidase-mediated translocation of heme oxygenase	PLOS ONE			English	Article							VIRUS CORE PROTEIN; CATALYZED INTRAMEMBRANE PROTEOLYSIS; NUCLEAR TRANSLOCATION; VIRAL PROPAGATION; CELL LINE; DEGRADATION; MEMBRANE; CLEAVAGE; PRESENILIN; LOCALIZATION	It has recently been shown that signal peptide peptidase (SPP) can catalyze the intramembrane cleavage of heme oxygenase-1 (HO-1) that leads to translocation of HO-1 into the cytosol and nucleus. While there is consensus that translocated HO-1 promotes tumor progression and drug resistance, the physiological signals leading to SPP-mediated intramembrane cleavage of HO-1 and the specificity of the process remain unclear. In this study, we used co-immunoprecipitation and confocal laser scanning microscopy to investigate the translocation mechanism of HO-1 and its regulation by SPP. We show that HO-1 and the closely related HO-2 isoenzyme bind to SPP under normoxic conditions. Under hypoxic conditions SPP mediates intramembrane cleavage of HO-1, but not HO-2. In experiments with an inactive HO-1 mutant (H25A) we show that translocation is independent of the catalytic activity of HO-1. Studies with HO-1 / HO-2 chimeras indicate that the membrane anchor, the PEST-domain and the nuclear shuttle sequence of HO-1 are necessary for full cleavage and subsequent translocation under hypoxic conditions. In the presence of co-expressed exogenous SPP, the anchor and the PEST-domain are sufficient for translocation. Taken together, we identified the domains involved in HO-1 translocation and showed that SPPmediated cleavage is isoform-specific and independent of HO-activity. A closer understanding of the translocation mechanism of HO-1 is of particular importance because nuclear HO1 seems to lead to tumor progression and drug resistance.	[Schaefer, Bianca; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany; [Moriishi, Kohji] Yamanashi Univ, Fac Med, Dept Microbiol, Yamanashi, Japan	Braunschweig University of Technology; University of Yamanashi	Behrends, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Technol, Dept Pharmacol Toxicol & Clin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Moriishi, Kohji/I-4173-2019	Moriishi, Kohji/0000-0002-9542-5188; Behrends, Sonke/0000-0002-9068-0729	Deutsche Forschungsgemeinschaft [INST 188/286-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Except for funding by Deutsche Forschungsgemeinschaft INST 188/286-1 the authors did not receive other financial support for this work.	Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Allen SJ, 2014, EXP EYE RES, V123, P8, DOI 10.1016/j.exer.2014.04.004; Allen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085360; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAGGINS PE, 1986, BIOCHEM BIOPH RES CO, V141, P528, DOI 10.1016/S0006-291X(86)80205-4; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chen CY, 2014, EMBO J, V33, P2492, DOI 10.15252/embj.201488208; Dennery PA, 2014, ANTIOXID REDOX SIGN, V20, P1743, DOI 10.1089/ars.2013.5674; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Gandini NA, 2012, EXP MOL PATHOL, V93, P237, DOI 10.1016/j.yexmp.2012.05.001; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Haase N, 2010, J NEUROCHEM, V112, P542, DOI 10.1111/j.1471-4159.2009.06484.x; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; Hsu F, 2014, ONCOGENE; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; ISHIKAWA K, 1992, BIOCHEM BIOPH RES CO, V182, P981, DOI 10.1016/0006-291X(92)91828-E; ITOMAKI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P253, DOI 10.1006/abbi.1995.1160; Jo EJ, 2016, EUR J PHARMACOL, V788, P321, DOI 10.1016/j.ejphar.2016.06.052; Kemp PJ, 2005, BIOCHEM BIOPH RES CO, V338, P648, DOI 10.1016/j.bbrc.2005.08.110; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lin PH, 2013, ONCOGENE, V32, P2325, DOI 10.1038/onc.2012.244; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Linnenbaum M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035483; MAINES MD, 1986, J BIOL CHEM, V261, P411; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Okamoto K, 2008, J VIROL, V82, P8349, DOI 10.1128/JVI.00306-08; Sacca P, 2007, BRIT J CANCER, V97, P1683, DOI 10.1038/sj.bjc.6604081; Schaefer B, 2017, ONCOTARGET, V8, P67406, DOI 10.18632/oncotarget.18684; Schrul B, 2010, BIOCHEM J, V427, P523, DOI 10.1042/BJ20091005; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; Tibullo D, 2016, ONCOTARGET; Tibullo D, 2013, CURR PHARM DESIGN, V19, P2765, DOI 10.2174/1381612811319150012; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Wang J, 2006, J NEUROCHEM, V96, P218, DOI 10.1111/j.1471-4159.2005.03548.x; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Williams SEJ, 2004, SCIENCE, V306, P2093, DOI 10.1126/science.1105010	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188344	10.1371/journal.pone.0188344	http://dx.doi.org/10.1371/journal.pone.0188344			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155886	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700049
J	Vestergaard, AS; Skjoth, F; Larsen, TB; Ehlers, LH				Vestergaard, Anne Sig; Skjoth, Flemming; Larsen, Torben Bjerregaard; Ehlers, Lars Holger			The importance of mean time in therapeutic range for complication rates in warfarin therapy of patients with atrial fibrillation: A systematic review and meta-regression analysis	PLOS ONE			English	Review							NORMALIZED RATIO CONTROL; ANTICOAGULATION CONTROL; STROKE PREVENTION; ORAL ANTICOAGULATION; ELDERLY-PATIENTS; PATIENTS OLDER; RISK; EVENTS; SAFETY; OUTCOMES	Background \Anticoagulation is used for stroke prophylaxis in non-valvular atrial fibrillation, amongst other by use of the vitamin K antagonist, warfarin. Quality in warfarin therapy is often summarized by the time patients spend within the therapeutic range( percent time in therapeutic range, TTR).The correlation between TTR and the occurrence of complications during warfarin therapy has been established, but the influence of patient characteristics in that respect remains undetermined. The objective of the present papers was to examine the association between mean TTR and complication rates with adjustment for differences in relevant patient cohort characteristics. Methods A systematic literature search was conducted in MEDLINE and Embase (2005-2015) to identify eligible studies reporting on use of warfarin therapy by patients with non-valvular atrial fibrillation and the occurrence of hemorrhage and thromboembolism. Both randomized controlled trials and observational cohort studies were included. The association between the reported mean TTR and major bleeding and stroke/systemic embolism was analyzed by random-effects meta-regression with and without adjustment for relevant clinical cohort characteristics. In the adjusted meta-regressions, the impact of mean TTR on the occurrence of hemorrhage was adjusted for the mean age and the proportion of populations with prior stroke or transient ischemic attack. In the adjusted analyses on thromboembolism, the proportion of females was, furthermore, included. Results Of 2169 papers, 35 papers met pre-specified inclusion criteria, holding relevant information on 31 patient cohorts. In univariable meta-regression, increasing mean TTR was significantly associated with a decreased rate of both major bleeding and stroke/systemic embolism. However, after adjustment mean TTR was no longer significantly associated with stroke/systemic embolism. The proportion of residual variance composed by between-study heterogeneity was substantial for all analyses. Conclusions Although higher mean TTR in warfarin therapy was associated with lower complication rates in atrial fibrillation, the strength of the association was decreased when adjusting for differences in relevant clinical characteristics of the patient cohorts. This study suggests that mainly the safety of warfarin therapy increases with higher mean TTR, whereas effectiveness appears not to be substantially improved. Due to the limitations immanent in the meta-regression methods, the results of the present study should be interpreted with caution. Further research on the association between the quality of warfarin therapy and risk of complications is warranted with adjustment for clinically relevant characteristics.	[Vestergaard, Anne Sig; Ehlers, Lars Holger] Aalborg Univ, Fac Social Sci, Dept Business & Management, Danish Ctr Healthcare Improvements, Aalborg, Denmark; [Skjoth, Flemming] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Skjoth, Flemming; Larsen, Torben Bjerregaard] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Larsen, Torben Bjerregaard] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University; Aalborg University Hospital	Vestergaard, AS (corresponding author), Aalborg Univ, Fac Social Sci, Dept Business & Management, Danish Ctr Healthcare Improvements, Aalborg, Denmark.	asv@business.aau.dk	Skjøth, Flemming/AAI-9954-2020; Ehlers, Lars/P-7531-2019	Skjoth, Flemming/0000-0003-2975-647X; , Anne Sig/0000-0001-9769-1490				Abdelhafiz AH, 2008, AM J GERIATR PHARMAC, V6, P1, DOI 10.1016/j.amjopharm.2008.03.005; [Anonymous], 2016, BACKGROUND MEMORANDU, P1; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Borenstein M., 2009, INTRO METAANALYSIS; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Burton C, 2006, BRIT J GEN PRACT, V56, P697; Cancino RS, 2014, THROMB RES, V133, P652, DOI 10.1016/j.thromres.2014.01.013; Chan PH, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2015.10.029; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2013, EUR HEART J, V34, P1498, DOI 10.1093/eurheartj/eht039; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Currie CJ, 2005, CURR MED RES OPIN, V21, P1905, DOI 10.1185/030079905X75050; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; Jacobs LG, 2009, AM J GERIATR PHARMAC, V7, P159, DOI 10.1016/j.amjopharm.2009.06.002; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lane DA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005155; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lind M, 2012, THROMB RES, V129, P32, DOI 10.1016/j.thromres.2011.07.004; Lip GYH, 2015, J THROMB HAEMOST, V13, P1405, DOI 10.1111/jth.13025; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mearns ES, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-14; Menzin J, 2005, ANN PHARMACOTHER, V39, P446, DOI 10.1345/aph.1E169; Nichol MB, 2008, ANN PHARMACOTHER, V42, P62, DOI 10.1345/aph.1K157; Njaastad AM, 2006, J INTERN MED, V259, P296, DOI 10.1111/j.1365-2796.2005.01605.x; Pastori D, 2015, INT J CARDIOL, V201, P513, DOI 10.1016/j.ijcard.2015.08.054; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pengo V, 2010, THROMB HAEMOSTASIS, V103, P442, DOI 10.1160/TH09-05-0311; Piccini JP, 2014, EUR HEART J, V35, P1873, DOI 10.1093/eurheartj/ehu083; Piccini JP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000521; Poli D, 2007, THROMB RES, V121, P347, DOI 10.1016/j.thromres.2007.05.014; Poli D, 2011, CHEST, V140, P918, DOI 10.1378/chest.10-3024; Poli D, 2009, J AM COLL CARDIOL, V54, P999, DOI 10.1016/j.jacc.2009.05.046; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938; Rose AJ, 2008, J THROMB HAEMOST, V6, P1647, DOI 10.1111/j.1538-7836.2008.03075.x; Sanden P, 2015, THROMB RES, V136, P1185, DOI 10.1016/j.thromres.2015.10.031; Senoo K, 2015, STROKE, V46, P3202, DOI 10.1161/STROKEAHA.115.010614; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Sullivan RM, 2012, AM J CARDIOL, V110, P1799, DOI 10.1016/j.amjcard.2012.08.014; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tincania E, 2009, BLOOD COAGUL FIBRIN, V20, P47, DOI 10.1097/MBC.0b013e32831be9da; Turk UO, 2015, CARDIOL J, V22, P567, DOI 10.5603/CJ.a2015.0035; Van den Ham HA, 2013, J THROMB HAEMOST, V11, P107, DOI 10.1111/jth.12041; Wallentin L, 2013, CIRCULATION, V127, P2166, DOI 10.1161/CIRCULATIONAHA.112.142158; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239	53	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188482	10.1371/journal.pone.0188482	http://dx.doi.org/10.1371/journal.pone.0188482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155884	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700062
J	Jang, W; Flatley, C; Greer, RM; Kumar, S				Jang, Woonji; Flatley, Christopher; Greer, Ristan M.; Kumar, Sailesh			Comparison between public and private sectors of care and disparities in adverse neonatal outcomes following emergency intrapartum cesarean at term - A retrospective cohort study	PLOS ONE			English	Article							HEALTH-INSURANCE STATUS; MATERNITY UNIT; SECTION RATES; HOSPITALS; AUSTRALIA; DELIVERY; RISK; INTERVENTION; PHYSICIANS; MORTALITY	Background Perinatal outcomes may be influenced by a variety of factors including maternal demographics and medical condition as well as socio-economic status. The evidence for disparities in health outcomes stratified by type of care (public or private) is lacking. The aim of this study was to investigate short term neonatal outcomes following category 1 and 2 emergency cesareans at term between publicly and privately funded women at a single major tertiary centre in Australia. Category 1-immediate threat to life (maternal or fetal); Category 2-maternal or fetal compromise that is not immediately life-threatening. Methods This was a retrospective, cross sectional study of 61355 term singleton babies born at the Mater Mother's Hospital in Brisbane, Australia in 2007-2014. We collected data from the hospital's maternity database and compared maternal demographics, indications for cesarean and neonatal outcomes for publicly and privately funded women. Results Over the study period there were 32477 public and 28878 private, term singleton births. Compared to the publicly funded cohort, privately insured women were older, had lower BMI, were of Caucasian ethnicity, Australian born, nulliparous, had shorter labors and had lower rates of hypertensive disorders and diabetes. The most common indications for category 1 and category 2 cesareans in combination were non-reassuring fetal status followed by failure to progress in labor and malpresentation. For both category 1 and 2 cesareans, neonatal outcomes (Apgar score <7 at 5 minutes, abnormal cord gases, Neonatal Critical Care Unit admission rates, rates of severe respiratory distress and jaundice) were significantly worse in the publicly funded compared to the privately insured cohort Multivariate analyses controlling for maternal age, ethnicity, country of birth, parity, hypertension, diabetes mellitus, gestational age at birth and length of labour confirmed that private insurance status was highly protective for the perinatal outcomes of Apgar score <7 at 5 minutes (aOR 0.26, 95% CI 0.13-0.55), admission to NCCU (OR 0.51, 95% CI 0.30-0.92) and respiratory distress (aOR 0.60, 95% CI 0.41-0.86). Conclusion Birth in the private health sector was inversely associated with adverse neonatal outcomes following category 1 and 2 cesareans.	[Jang, Woonji; Flatley, Christopher; Greer, Ristan M.; Kumar, Sailesh] Univ Queensland, Mater Res Inst, South Brisbane, Qld, Australia; [Kumar, Sailesh] Univ Queensland, Fac Med, Brisbane, Qld, Australia	Mater Research; University of Queensland; University of Queensland	Kumar, S (corresponding author), Univ Queensland, Mater Res Inst, South Brisbane, Qld, Australia.; Kumar, S (corresponding author), Univ Queensland, Fac Med, Brisbane, Qld, Australia.	sailesh.kumar@mater.uq.edu.au	Greer, Ristan Mary/N-6948-2015; Greer, Ristan/ABB-9511-2021; Flatley, Christopher j/D-9331-2016; Kumar, Sailesh/M-3207-2014	Greer, Ristan Mary/0000-0002-1574-4729; Flatley, Christopher j/0000-0002-2225-0188; Kumar, Sailesh/0000-0003-0832-4811	Mater Foundation	Mater Foundation	The authors gratefully acknowledge the helpful suggestions by Professor David Tudehope during preparation of this manuscript and the research support by the Mater Foundation.	ACOG, 2009, OBSTET GYNECOL, P192; Al Rifai R, 2014, GLOB HEALTH-SCI PRAC, V2, P195, DOI 10.9745/GHSP-D-14-00027; Barros AJD, 2011, REV SAUDE PUBL, V45, P635, DOI 10.1590/S0034-89102011005000039; Cai WW, 1998, AM J PUBLIC HEALTH, V88, P777, DOI 10.2105/AJPH.88.5.777; Coulm B, 2012, BIRTH-ISS PERINAT C, V39, P183, DOI 10.1111/j.1523-536X.2012.00547.x; Dahlen HG, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001723; de Jongh BE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-97; DiLallo D, 1996, PREV MED, V25, P178; Einarsdottir K, 2013, BMJ OPEN, V3; Einarsdottir K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-40; Fowler RA, 2010, AM J RESP CRIT CARE, V181, P1003, DOI 10.1164/rccm.200902-0281ST; Geronimus A T, 2001, J Am Med Womens Assoc (1972), V56, P133; Geronimus Arline T., 1992, Ethnicity and Disease, V2, P207; Hindle Don, 2004, Aust Health Rev, V28, P119; Karnad DR, 2004, CRIT CARE CLIN, V20, P555, DOI 10.1016/j.ccc.2004.05.001; Lipkind HS, 2009, OBSTET GYNECOL, V113, P1239, DOI 10.1097/AOG.0b013e3181a4c3e5; Lombaard H, 2008, BEST PRACT RES CL OB, V22, P847, DOI 10.1016/j.bpobgyn.2008.06.004; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; Lutomski JE, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-13; Lyon SM, 2011, AM J RESP CRIT CARE, V184, P809, DOI 10.1164/rccm.201101-0089OC; Mazzoni A, 2011, BJOG-INT J OBSTET GY, V118, P391, DOI 10.1111/j.1471-0528.2010.02793.x; Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d; Movsas TZ, 2012, J MED ETHICS, V38, P470, DOI 10.1136/medethics-2011-100209; NICE, 2007, CG 55 INTR CAR CAR H; Olson R, 2012, AM J OBSTET GYNECOL, V207, P81, DOI 10.1016/j.ajog.2012.06.045; RANZCOG, 2014, INTR FET SURV CLIN G; Roberts CL, 2000, BRIT MED J, V321, P137, DOI 10.1136/bmj.321.7254.137; Robson SJ, 2009, BIRTH-ISS PERINAT C, V36, P208, DOI 10.1111/j.1523-536X.2009.00331.x; Robson SJ, 2009, MED J AUSTRALIA, V190, P474, DOI 10.5694/j.1326-5377.2009.tb02521.x; Stock SJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2838; Vasquez DN, 2014, J CRIT CARE, V29, P199, DOI 10.1016/j.jcrc.2013.11.010; Zhao Y, 2017, AUST NZ J OBSTET GYN, V57, P40, DOI 10.1111/ajo.12576; Zwecker P, 2011, AM J PERINAT, V28, P277, DOI 10.1055/s-0030-1271213	33	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187040	10.1371/journal.pone.0187040	http://dx.doi.org/10.1371/journal.pone.0187040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149182	Green Published, Green Submitted, gold			2022-12-27	WOS:000415646100005
J	Jonkergouw, N; Prins, MR; Buis, AWP; van der Wurff, P				Jonkergouw, Niels; Prins, Maarten R.; Buis, Arjan W. P.; van der Wurff, Peter			The Effect of Alignment Changes on Unilateral Transtibial Amputee's Gait: A Systematic Review (vol 11, e0167466, 2016)	PLOS ONE			English	Correction													; Prins, Maarten/E-7963-2018	Jonkergouw, Niels/0000-0001-6449-6656; Prins, Maarten/0000-0003-3593-202X				Jonkergouw N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167466	1	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188545	10.1371/journal.pone.0188545	http://dx.doi.org/10.1371/journal.pone.0188545			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149193	gold, Green Published			2022-12-27	WOS:000415646100043
J	Kaup, S; Naseer, A; Shivalli, S; Arunachalam, C				Kaup, Soujanya; Naseer, Ansaba; Shivalli, Siddharudha; Arunachalam, Cynthia			Occupational exposure to unburnt tobacco and potential risk of toxic optic neuropathy: A cross-sectional study among beedi rollers in selected rural areas of coastal Karnataka, India	PLOS ONE			English	Article							BIDI INDUSTRY WORKERS; CONTRAST SENSITIVITY; PROCESSORS	Background Beedi also known as poor man's cigarette is manufactured in almost all major states of India. Beedi workers are exposed to various health risks. There is an increased risk of systemic absorption of tobacco through skin and mucous membrane. The optic nerve is susceptible to damage from several toxic substances including tobacco. This group of disorders is known as toxic optic neuropathy (TON). The association of TON with occupational exposure to unburnt tobacco in beedi rollers has not been explored. Objectives Among the beedi rollers in Mangaluru and Bantwal talukas of Dakshina Kannada District, Karnataka, India: to assess the magnitude of potential TON utilizing colour vision and contrast sensitivity as screening tools and to identify the demographic, biological and occupational factors associated with potential TON. Methods A community-based cross-sectional study was conducted from April-Sept 2016 in Mangaluru and Bantwal talukas, of Dakshina Kannada district, Karnataka. Beedi rollers from twelve villages (six from each taluka) were included. In each of the selected villages, the investigators identified beedi collection centres and all the eligible beedi rollers were included in the study till the required number of beedi rollers for that village was achieved. Participants were screened at the study site for visual acuity, colour vision and contrast sensitivity and those with abnormal colour and contrast sensitivity in the presence of good visual acuity were considered to have potential TON. Results A total of 377 beedi rollers were approached; of which 365 consented to take part in the study (response rate: 96.81%). Women constituted the majority of the participants (n = 338, 92.6%). Based on the screening criteria, the prevalence of potential TON was 17.5% (n = 64, 95% CI: 13.5-21.9). On multiple logistic regression analysis, duration of beedi rolling (Adj OR: 1.061; 95% CI 1.015-1.109, p = 0.009), advancing age (Adj OR: 1.096; 95% CI 1.058-1.136, p<0.001) and presence of diabetes (Adj OR: 6.315; 95% CI 1.4572-27.376, p = 0.014) were independent correlates of potential TON. Conclusion In the present study, almost one out of six beedi rollers displayed clinical signs of potential TON. Increased duration of beedi rolling, advancing age and presence of diabetes were the independent correlates of potential TON. However, with this cross-sectional study it is not possible to conclude if these factors play a role individually or collectively or are a serendipitous association, for which large scale analytical studies are required.	[Kaup, Soujanya; Naseer, Ansaba; Arunachalam, Cynthia] Yenepoya Univ, Yenepoya Med Coll, Dept Ophthalmol, Mangalore, Karnataka, India; [Shivalli, Siddharudha] Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangalore, Karnataka, India; [Shivalli, Siddharudha] Program Task Force Global Hlth Inc, TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Kaup, S (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Ophthalmol, Mangalore, Karnataka, India.	drsoujanyak@gmail.com	Shivalli, Siddharudha/AAU-3907-2020	Kaup, Soujanya/0000-0002-5908-5921				[Anonymous], 2017, FARNSWORTH D 15 LANT; BAGWE AN, 1995, CARCINOGENESIS, V16, P1095, DOI 10.1093/carcin/16.5.1095; Bhisey RA, 1999, TOXICOL LETT, V108, P259, DOI 10.1016/S0378-4274(99)00097-1; Devi KR, 2012, NAT ENV POLL TECH, V11, P135; Gella L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129391; Grzybowski A, 2015, ACTA OPHTHALMOL, V93, P402, DOI 10.1111/aos.12515; Gupta P. C., 2008, BIDI SMOKING PUBLIC; International Labour Organization, 2003, EMPL TRENDS TOB SECT; Kerrison John B, 2004, Ophthalmol Clin North Am, V17, P481, DOI 10.1016/j.ohc.2004.05.005; MAHIMKAR MB, 1995, MUTAT RES-ENVIR MUTA, V334, P139, DOI 10.1016/0165-1161(95)90004-7; Malson JL, 2001, TOB CONTROL, V10, P181, DOI 10.1136/tc.10.2.181; Ministry of Labour, 1999, 47 ANN REP 1999 2000; Mittal S, 2008, INDIAN J OPHTHALMOL, V56, P319, DOI 10.4103/0301-4738.41415; Nandi A, 2015, TOB CONTROL, V24, P369, DOI 10.1136/tobaccocontrol-2013-051404; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Phillips PH, 2005, WALSH HOYTS CLIN NEU, P447; Ranjitsingh A, 1995, ENV EC, V13, P875; Reddy SK, 2004, REPORT TOBACCO CONTR; Riordan-Eva P, 2004, EYE, V18, P1161, DOI 10.1038/sj.eye.6701575; ROSS JE, 1985, BRIT J OPHTHALMOL, V69, P51, DOI 10.1136/bjo.69.1.51; SALMON JF, 1987, BRIT J OPHTHALMOL, V71, P192, DOI 10.1136/bjo.71.3.192; Schneck ME, 2014, OPTOMETRY VISION SCI, V91, P284, DOI 10.1097/OPX.0000000000000152; Sharma P, 2011, INDIAN J OPHTHALMOL, V59, P137, DOI 10.4103/0301-4738.77035; SILVETTE H, 1960, AM J OPHTHALMOL, V50, P71, DOI 10.1016/0002-9394(60)90842-4; Swami S, 2006, Indian J Public Health, V50, P231; Vinod V, 2007, ENV DRINKING WATER P	26	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188378	10.1371/journal.pone.0188378	http://dx.doi.org/10.1371/journal.pone.0188378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149211	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000415646100041
J	Shiao, CC; Huang, YT; Lai, TS; Huang, TM; Wang, JJ; Huang, CT; Wu, PC; Wu, CH; Tsai, IJ; Tseng, LJ; Wang, CH; Chu, TS; Wu, KD; Wu, VC				Shiao, Chih-Chung; Huang, Ya-Ting; Lai, Tai-Shuan; Huang, Tao-Min; Wang, Jian-Jhong; Huang, Chun-Te; Wu, Pei-Chen; Wu, Che-Hsiung; Tsai, I-Jung; Tseng, Li-Jung; Wang, Chih-Hsien; Chu, Tzong-Shinn; Wu, Kwan-Dun; Wu, Vin-Cent		Natl Taiwan Univ Hosp Study Grp Ac	Perioperative body weight change is associated with in-hospital mortality in cardiac surgical patients with postoperative acute kidney injury	PLOS ONE			English	Article							RENAL REPLACEMENT THERAPY; FAILURE ASSESSMENT SCORE; CRITICALLY-ILL PATIENTS; LONG-TERM SURVIVAL; HEART-FAILURE; CARDIOTHORACIC SURGERY; FLUID BALANCE; DISEASE; RECOVERY; PATHOPHYSIOLOGY	Background Postoperative acute kidney injury (AKI) is common following cardiac surgery (CS). Body weight (BW) may be an amenable variable by representing the summation of the nutritional and the fluid status. However, the predictive role of perioperative BW changes in CS patients with severe postoperative AKI is never explored. This study aimed to evaluate this association. Methods This study was conducted using a prospectively collected multicenter cohort, NSARF (National Taiwan University Hospital Study Group on Acute Renal Failure) database. The adult CS patients with postoperative AKI requiring renal replacement therapy (RRT), who had clear initial consciousness, received CS within 14 days of hospitalization, and underwent RRT within seven days after CS in intensive care units from January 2001 to January 2014 were enrolled. With the endpoint of 30-day postoperative mortality, we evaluated the association between the clinical factors denoting fluid status and patients outcomes. Results A total of 188 patients (70 female, mean age 63.7 +/- 15.2 years) were enrolled. Comparing with the survivors (n = 124), the non-survivors (n = 64) had a significantly higher perioperative BW change [3.6 +/- 6.1% versus 0.1 +/- 8.3%, p = 0.003] but not the postoperative and pre-RRT BW changes. By using multivariate Cox proportional hazards model, the independent indicators of 30-day postoperative mortality included perioperative BW change (p = 0.026) and packed red blood cells transfusion (p = 0.007), postoperative intra-aortic balloon pump (p = 0.001) and central venous pressure level (p = 0.005), as well as heart rate (p = 0.022), sequential organ failure assessment score (p < 0.001), logistic organ dysfunction score (p = 0.001), and blood total bilirubin level (p = 0.044) at RRT initiation. The generalized additive models further demonstrated, in a multivariate manner, that the mortality risk rose significantly during a perioperative BW change of 2% to 15%. Conclusions Perioperative BW change was independently associated with an increased risk for 30-day postoperative mortality in CS patients with RRT-requiring AKI.	[Shiao, Chih-Chung] St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan; [Shiao, Chih-Chung] St Marys Jr Coll Med Nursing & Management, Yilan, Taiwan; [Huang, Ya-Ting] St Marys Hosp Luodong, Dept Nursing, Yilan, Taiwan; [Huang, Ya-Ting] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Lai, Tai-Shuan; Huang, Tao-Min; Chu, Tzong-Shinn; Wu, Kwan-Dun; Wu, Vin-Cent] Natl Taiwan Univ Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Wang, Jian-Jhong] Chi Mei Med Ctr, Div Nephrol, Dept Internal Med, Tainan, Taiwan; [Huang, Chun-Te] Taichung Vet Gen Hosp, Div Internal & Crit Care Med, Dept Crit Care Med, Taichung, Taiwan; [Wu, Pei-Chen] MacKay Mem Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan; [Wu, Che-Hsiung] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Div Nephrol, Taipei, Taiwan; [Wu, Che-Hsiung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tsai, I-Jung] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan; [Tseng, Li-Jung; Wang, Chih-Hsien] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan	Chang Gung University; National Taiwan University; National Taiwan University Hospital; Chi Mei Hospital; Taichung Veterans General Hospital; Mackay Memorial Hospital; Tzu Chi University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Wang, CH (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	wchemail@gmail.com	Shiao, Chih-Chung/AAM-2716-2020	Shiao, Chih-Chung/0000-0003-2220-7574; WANG, CHIH-HSIEN/0000-0003-3214-6867; Tsai, I-Jung/0000-0003-3967-9412; Lai, Tai-Shuan/0000-0002-0552-372X; WU, VIN-CENT/0000-0001-7935-0991	Ta-Tung Kidney Foundation; Taiwan National Science Council [NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4, 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3]; NTUH [106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104S2718, 098-001177, 100-001667]; Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) [MOST 106-2321-13-182-002]	Ta-Tung Kidney Foundation; Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NTUH; Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan)	This study was financially supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4), 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3), NTUH (106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104S2718, and NTUH 098-001177, NTUH 100-001667. This study was also supported by the Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) (grant number, MOST 106-2321-13-182-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was financially supported by The Ta-Tung Kidney Foundation, Taiwan National Science Council (grant NSC 96-2314-B-002-164, NSC 96-2314-B-002-033-MY3, NSC 97-2314-B-002-155-MY2, NSC 98-2314-B-002-155-MY4), 101-2314-B-002-085-MY3, 102-2314-B-002-140-MY2, 104-2314-B-002-125-MY3), NTUH (106-FTN20, 106-P02, UN106-014, 106-S3582, 105-P05, VN105-04, 105-S3061, VN104-07, 104-S2718, and NTUH 098-001177, NTUH 100-001667. This study was also supported by the Ministry of Science and Technology (MOST) of the Re-public of China (Taiwan) (grant number, MOST 106-2321-B-182-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; BASS BH, 1969, LANCET, V2, P438; Bellomo R, 2008, INT J ARTIF ORGANS, V31, P166, DOI 10.1177/039139880803100210; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Chau Katrina, 2014, Can J Kidney Health Dis, V1, P19, DOI 10.1186/s40697-014-0019-4; Chen YS, 2001, J HEART LUNG TRANSPL, V20, P850, DOI 10.1016/S1053-2498(01)00267-4; El-Sharkawy AM, 2014, CLIN NUTR, V33, P6, DOI 10.1016/j.clnu.2013.11.010; Godin M, 2013, NEPHRON CLIN PRACT, V123, P238, DOI 10.1159/000354713; Goren O, 2015, BRIT J ANAESTH, V115, P3, DOI 10.1093/bja/aev380; Heldwein MB, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-110; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; KIM WH, 2015, MEDICINE, V94, P38408; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krupski WC, 2000, VASC MED, V5, P3, DOI 10.1177/1358836X0000500102; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lin YF, 2008, BLOOD PURIFICAT, V26, P547, DOI 10.1159/000178771; Lochs H, 2006, CLIN NUTR, V25, P180, DOI 10.1016/j.clnu.2006.02.007; Lopez-Jimenez F, 2008, AM HEART J, V155, P478, DOI 10.1016/j.ahj.2007.10.026; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Maisel AS, 2016, J CARD FAIL, V22, P283, DOI 10.1016/j.cardfail.2015.09.014; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; Olivero Juan Jose, 2012, Methodist Debakey Cardiovasc J, V8, P31; Rady MY, 1998, CRIT CARE MED, V26, P225, DOI 10.1097/00003246-199802000-00016; Reider L, 2013, J NUTR HEALTH AGING, V17, P91, DOI 10.1007/s12603-012-0073-5; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Shiao CC, 2009, CRIT CARE, V13, DOI 10.1186/cc8147; Stein A, 2012, CRIT CARE, V16, DOI 10.1186/cc11368; Thiele RH, 2015, CLIN J AM SOC NEPHRO, V10, P500, DOI 10.2215/CJN.07830814; Thongprayoon C, 2015, MAYO CLIN PROC, V90, P857, DOI 10.1016/j.mayocp.2015.03.026; van Venrooij LMW, 2008, AM J CLIN NUTR, V87, P1656, DOI 10.1093/ajcn/87.6.1656; VANDENBROECK J, 1995, J ROY SOC MED, V88, P487; Varadhan KK, 2010, P NUTR SOC, V69, P488, DOI 10.1017/S0029665110001734; Varadhan KK, 2010, CRIT CARE CLIN, V26, P527, DOI 10.1016/j.ccc.2010.04.003; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wang N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1085-4; Wu VC, 2006, CLIN INFECT DIS, V42, P66, DOI 10.1086/498509; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x; Xu JR, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001360; Zhang L, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.03.025	44	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187280	10.1371/journal.pone.0187280	http://dx.doi.org/10.1371/journal.pone.0187280			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149189	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100009
J	Yoon, SR; Kim, SH; Lee, HW; Ha, JH				Yoon, So-Ra; Kim, Sung Hyun; Lee, Hae-Won; Ha, Ji-Hyoung			A novel method to rapidly distinguish the geographical origin of traditional fermented-salted vegetables by mass fingerprinting	PLOS ONE			English	Article							MALDI-TOF-MS; SPECTROMETRY; IDENTIFICATION; KIMCHI; FOOD; DEGRADATION; PROTEINS	The geographical origin of kimchi is of interest to consumers and producers because the prices of commercial kimchi products can vary significantly according to the geographical origin. Hence, social issues related to the geographical origin of kimchi in Korea have emerged as a major problem. In this study, the geographical origin of kimchi was determined by comparing the mass fingerprints obtained for Korean and Chinese kimchi samples by MALDI-TOF MS with multivariate analysis. The results obtained herein provide an accurate, powerful tool to clearly discriminate kimchi samples based on their geographical origin within a short time and to ensure food authenticity, which is of significance in the kimchi industry. Furthermore, our MALDI-TOF MS method could be applied to determining the geographical origin of other fermented-salted vegetables at a reduced cost in shorter times.	[Yoon, So-Ra; Kim, Sung Hyun; Lee, Hae-Won; Ha, Ji-Hyoung] World Inst Kimchi, Hygien Safety & Anal Ctr, Gwangju, South Korea		Lee, HW; Ha, JH (corresponding author), World Inst Kimchi, Hygien Safety & Anal Ctr, Gwangju, South Korea.	lhw0875@wikim.re.kr; hajee@wikim.re.kr			World Institute of Kimchi [KE1601-4, KE1701-5]	World Institute of Kimchi	This work was supported by a research grant (KE1601-4 and KE1701-5) from the World Institute of Kimchi.; This study was supported by the World Institute of Kimchi (KE1601-4 and KE1701-5). We thank Dr Young-Ho Chung and Dr Jonghyun Kim (Korea Basic Science Institute, Republic of Korea) for their assistance with the MALDI-TOF MS analysis.	Albrethsen J, 2011, J PROTEOMICS, V74, P765, DOI 10.1016/j.jprot.2011.02.027; Bong YS, 2012, BIOSCI BIOTECH BIOCH, V76, P2096, DOI 10.1271/bbb.120471; Bonizzi I, 2007, J APPL MICROBIOL, V102, P667, DOI 10.1111/j.1365-2672.2006.03131.x; Caligiani A, 2016, FOOD CHEM, V211, P431, DOI 10.1016/j.foodchem.2016.05.072; D'Archivio AA, 2017, FOOD CHEM, V219, P408, DOI 10.1016/j.foodchem.2016.09.169; Dimara E, 2003, AGR ECON-BLACKWELL, V28, P187, DOI [10.1016/S0169-5150(03)00003-3, 10.1111/j.1574-0862.2003.tb00137.x]; EL SHEIKHA A F, 2010, J LIFE SCI, V4, P9; El Sheikha AF, 2011, FOOD BIOTECHNOL, V25, P115, DOI 10.1080/08905436.2011.576556; Flaudrops C, 2015, J FOOD COMPOS ANAL, V41, P104, DOI 10.1016/j.jfca.2015.02.009; Gibb S, 2012, BIOINFORMATICS, V28, P2270, DOI 10.1093/bioinformatics/bts447; Han Jae-Hwan, 2016, [Journal of Agriculture & Life Science, 농업생명과학연구], V50, P195, DOI 10.14397/jals.2016.50.2.195; Jung JY, 2014, APPL MICROBIOL BIOT, V98, P2385, DOI 10.1007/s00253-014-5513-1; Kim J, 2012, BIOSCI BIOTECH BIOCH, V76, P1752, DOI 10.1271/bbb.120356; Kim MH, 2012, FOOD SCI BIOTECHNOL, V21, P9, DOI 10.1007/s10068-012-0002-8; Lee HW, 2015, TALANTA, V132, P630, DOI 10.1016/j.talanta.2014.08.078; Lopez-Fernandez H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0752-4; Luykx DMAM, 2008, FOOD CHEM, V107, P897, DOI 10.1016/j.foodchem.2007.09.038; Park KY, 2014, J MED FOOD, V17, P6, DOI 10.1089/jmf.2013.3083; Raspor P, 2006, INT J FOOD MICROBIOL, V109, P97, DOI 10.1016/j.ijfoodmicro.2006.01.017; Risticevic S, 2008, ANAL CHIM ACTA, V617, P72, DOI 10.1016/j.aca.2008.04.009; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Salla V, 2013, ANAL CHIM ACTA, V794, P55, DOI 10.1016/j.aca.2013.07.014; Santos T, 2015, J PROTEOMICS, V127, P321, DOI 10.1016/j.jprot.2015.02.017; Sugawara R, 2016, ANAL CHIM ACTA, V934, P163, DOI 10.1016/j.aca.2016.05.056; Wang J, 2009, J AGR FOOD CHEM, V57, P10081, DOI 10.1021/jf902286p; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Xu L, 2012, ANAL CHIM ACTA, V754, P31, DOI 10.1016/j.aca.2012.10.011; Yin YL, 2015, INTERDISCIP SCI, V7, P205, DOI 10.1007/s12539-015-0262-0	28	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188217	10.1371/journal.pone.0188217	http://dx.doi.org/10.1371/journal.pone.0188217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149220	Green Submitted, Green Published, gold			2022-12-27	WOS:000415646100029
J	Pereira, LA; Munita, R; Gonzalez, MP; Andres, ME				Alberto Pereira, Luis; Munita, Roberto; Paz Gonzalez, Marcela; Estela Andres, Maria			Long 3'UTR of Nurr1 mRNAs is targeted by miRNAs in mesencephalic dopamine neurons	PLOS ONE			English	Article							IMMEDIATE-EARLY GENES; TRANSCRIPTION FACTOR NURR1; ALTERNATIVE POLYADENYLATION; SUBSTANTIA-NIGRA; EXPRESSION; MICRORNAS; NORMALIZATION; RECEPTOR; CLEAVAGE; WIDESPREAD	The development of mesencephalic dopamine neurons and their survival later in life requires the continuous presence of the transcription factor Nurr1 (NR4A2). Nurr1 belongs to the nuclear receptors superfamily. However, it is an orphan member that does not require a ligand to regulate the transcription of its target genes. Therefore, controlling the expression of Nurr1 is an important manner to control its function. Several reports have shown that microRNAs (miRNAs) regulate Nurr1 expression. However, Nurr1 has several splicing variants, posing the question what variants are subjected to miRNA regulation. In this work, we identified a long 3' UTR variant of rat Nurr1 mRNA. We used bioinformatics analysis to identify miRNAs with the potential to regulate Nurr1 expression. Reporter assays performed with the luciferase gene fused to the short (658 bp) or long (1,339 bp) 3' UTR of rat Nurr1 mRNAs, showed that miR-93, miR-204 and miR-302d selectively regulate the mRNA with the longest 3' UTR. We found that the longest variant of Nurr1 mRNA expresses in the rat mesencephalon as assessed by PCR. The transfection of rat mesencephalic neurons with mixed miR-93, miR-204 and miR-302d resulted in a significant reduction of Nurr1 protein levels. In conclusion, Nurr1 mRNA variant with the longest 3' UTR undergoes a specific regulation by miRNAs. It is discussed the importance of fine-tuning Nurr1 protein levels in mesencephalic dopamine neurons.	[Alberto Pereira, Luis; Munita, Roberto; Paz Gonzalez, Marcela; Estela Andres, Maria] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile; [Munita, Roberto] Lund Univ, Div Mol Hematol, Lund Stem Cell Ctr, BMC, Klin Gatan, Lund, Sweden	Pontificia Universidad Catolica de Chile; Lund University	Andres, ME (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile.	mandres@bio.puc.cl	Munita, Roberto/B-3143-2010	Munita, Roberto/0000-0002-6605-7160	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1150200, 1110352]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/) Grant Numbers 1150200, 1110352.	Arredondo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055035; Bai RP, 2015, INT J CANCER, V137, P2310, DOI 10.1002/ijc.29607; Bannon MJ, 2002, P NATL ACAD SCI USA, V99, P6382, DOI 10.1073/pnas.092654299; Beard JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25108; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chu YP, 2002, J COMP NEUROL, V450, P203, DOI 10.1002/cne.10261; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Duan XD, 2015, CELL SIGNAL, V27, P61, DOI 10.1016/j.cellsig.2014.10.006; Eells JB, 2002, BEHAV BRAIN RES, V136, P267, DOI 10.1016/S0166-4328(02)00185-7; Eells JB, 2006, BRAIN RES BULL, V70, P186, DOI 10.1016/j.brainresbull.2006.05.004; Elkon R, 2013, NAT REV GENET, V14, P496, DOI 10.1038/nrg3482; Enright AJ, 2004, GENOME BIOL, V5; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Honkaniemi J, 1996, J CEREBR BLOOD F MET, V16, P557, DOI 10.1097/00004647-199607000-00005; HONKANIEMI J, 1995, MOL BRAIN RES, V28, P157, DOI 10.1016/0169-328X(94)00200-X; Honkaniemi J, 1997, J CEREBR BLOOD F MET, V17, P636; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jankovic J, 2005, PROG NEUROBIOL, V77, P128, DOI 10.1016/j.pneurobio.2005.09.001; Johnson MM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00135; Kadkhodaei B, 2013, P NATL ACAD SCI USA, V110, P2360, DOI 10.1073/pnas.1221077110; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Le W, 1999, J NEUROCHEM, V73, P2218; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marques FZ, 2011, HYPERTENSION, V58, P1093, DOI 10.1161/HYPERTENSIONAHA.111.180729; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; McMorrow JP, 2011, BIOCHEM SOC T, V39, P688, DOI 10.1042/BST0390688; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Miura P, 2013, GENOME RES, V23, P812, DOI 10.1101/gr.146886.112; Nakki R, 1996, J NEUROSCI RES, V45, P13, DOI 10.1002/(SICI)1097-4547(19960701)45:1<13::AID-JNR2>3.0.CO;2-K; Ohkura N, 1999, BBA-GENE STRUCT EXPR, V1444, P69, DOI 10.1016/S0167-4781(98)00247-4; Ojeda V, 2003, J NEUROSCI RES, V73, P686, DOI 10.1002/jnr.10705; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Shi YS, 2012, RNA, V18, P2105, DOI 10.1261/rna.035899.112; Slater PG, 2016, P NATL ACAD SCI USA, V113, P4075, DOI 10.1073/pnas.1523745113; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Volakakis N, 2015, J NEUROSCI, V35, P14370, DOI 10.1523/JNEUROSCI.1155-15.2015; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xie L, 2014, ENDOCRINOLOGY, V155, P4975, DOI 10.1210/en.2014-1501; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; You LM, 2015, NUCLEIC ACIDS RES, V43, pD59, DOI 10.1093/nar/gku1076; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	70	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188177	10.1371/journal.pone.0188177	http://dx.doi.org/10.1371/journal.pone.0188177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145474	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800080
J	Aldosari, MA; Tavares, MA; Matta-Machado, ATG; Abreu, MHNG				Aldosari, Muath Abdullah; Tavares, Mary Angela; Gonzaga Matta-Machado, Antonio Thomaz; Nogueira Guimaraes Abreu, Mauro Henrique			Factors associated with patients' satisfaction in Brazilian dental primary health care	PLOS ONE			English	Article							CONTINUITY; DETERMINANTS; PREDICTORS; ISSUES; ACCESS	Objective To assess factors associated with patients' satisfaction with the treatment by dentists in primary health care (PHC) in Brazil. Materials and methods The dataset was part of a nationwide cross-sectional survey for evaluating PHC teams conducted by the Brazilian Ministry of Health. Patients from each of 16,202 oral health teams were interviewed. In addition to sociodemographic information, the questionnaire included information about patient experience domains: access and booking of dental appointments, bonding and accountability, welcoming of the patient, and their perception of dental facilities. Statistical analysis The dependent variable was the answer to the question 'From 0 to 10, how would you grade your satisfaction with treatment received from the dentist?' Negative binomial regression models were used to estimate the unadjusted and adjusted rate ratios and corresponding 95% confidence interval. Results The mean patient satisfaction was 9.4 (+/- 2.3). Higher patient satisfaction with PHC was associated with lower education and the patient's perception of the clinic conditions. Moreover, higher satisfaction was associated with positive reception and hospitality, enough time for treatment, and instructions that met patients' needs. Lower satisfaction with PHC was associated with patients who have jobs compared to those who do not work. Conclusion Patient satisfaction is increased with friendly and understanding PHC staff. Moreover, meeting patient expectations by taking time to understand the needs and giving the right instructions is associated with higher satisfaction.	[Aldosari, Muath Abdullah] Harvard Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA; [Aldosari, Muath Abdullah] King Saud Univ, Dept Periodont & Community Dent, Coll Dent, Riyadh, Saudi Arabia; [Tavares, Mary Angela] Forsyth Inst, Cambridge, MA USA; [Tavares, Mary Angela] Harvard Sch Dent Med, Dent Publ Hlth, Dept Oral Hlth Policy & Epidemiol, Boston, MA USA; [Gonzaga Matta-Machado, Antonio Thomaz] Univ Fed Minas Gerais, Dept Social & Prevent Med, Belo Horizonte, MG, Brazil; [Nogueira Guimaraes Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Community & Prevent Dent, Belo Horizonte, MG, Brazil	Harvard University; Harvard School of Dental Medicine; King Saud University; Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Aldosari, MA (corresponding author), Harvard Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA.; Aldosari, MA (corresponding author), King Saud Univ, Dept Periodont & Community Dent, Coll Dent, Riyadh, Saudi Arabia.	Muath_Aldosari@HSDM.Harvard.edu	Aldossari, Muath/AAT-7607-2021; Abreu, Mauro Henrique/G-6502-2012	Abreu, Mauro Henrique/0000-0001-8794-5725; Tavares, Mary/0000-0003-4705-1238; Aldosari, Muath/0000-0002-2200-2408				Agu KA, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-77; Al Qatari G, 1999, INT J QUAL HEALTH C, V11, P523; Al-Abri Rashid, 2014, Oman Med J, V29, P3, DOI 10.5001/omj.2014.02; Al-Hussyeen AA, 2010, SAUDI DENT J, V22, P19, DOI 10.1016/j.sdentj.2009.12.004; Andersen R M, 1997, Adv Dent Res, V11, P203; Batbaatar E, 2017, PERSPECT PUBLIC HEAL, V137, P89, DOI 10.1177/1757913916634136; Bjertnaes OA, 2012, BMJ QUAL SAF, V21, P39, DOI 10.1136/bmjqs-2011-000137; Carlin CS, 2012, HEALTH SERV RES, V47, P2250, DOI 10.1111/j.1475-6773.2012.01412.x; Carr-Hill R, 1989, Health Serv J, V99, P728; CARRHILL RA, 1992, J PUBLIC HEALTH MED, V14, P236; Chan WK, 2012, GASTROENT RES PRACT, V2012; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Martins AMEDL, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005659; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Ekback G, 2016, ACTA ODONTOL SCAND, V74, P194, DOI 10.3109/00016357.2015.1075587; Forrest CB, 1998, AM J PUBLIC HEALTH, V88, P1330, DOI 10.2105/AJPH.88.9.1330; Forrest CB, 1996, J FAM PRACTICE, V43, P40; FOX JG, 1981, SOC SCI MED-MED SOC, V15, P557, DOI 10.1016/0271-7123(81)90079-1; FRENCH K, 1981, INT J NURS STUD, V18, P7, DOI 10.1016/0020-7489(81)90004-3; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Godoi H, 2014, CAD SAUDE PUBLICA, V30, P318, DOI 10.1590/0102-311X00084513; GOLLETZ D, 1995, J PUBLIC HEALTH DENT, V55, P210, DOI 10.1111/j.1752-7325.1995.tb02372.x; Hosmer Jr DW, 2013, APPLIED LOGISTIC REG; Hsieh M O, 1991, Health Soc Work, V16, P281; International Conference on Primary Health Care, 1978, WHO Chron, V32, P428; Kikwilu Emil N, 2009, J Oral Sci, V51, P47; Protasio APL, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00184715, 10.1590/0102-311x00184715]; LOCKER D, 1978, SOC SCI MED-MED SOC, V12, P283, DOI 10.1016/0271-7123(78)90067-6; Long JS, 1997, REGRESSION MODELS CA; Mainous AG, 1998, AM J PUBLIC HEALTH, V88, P1539, DOI 10.2105/AJPH.88.10.1539; Prentice JC, 2014, AM J MED QUAL, V29, P227, DOI 10.1177/1062860613494750; Prentice JC, 2008, HEALTH SERV OUTCOME, V8, P1, DOI 10.1007/s10742-007-0024-5; Pucca GA, 2015, J DENT RES, V94, P1333, DOI 10.1177/0022034515599979; Rahmqvist M, 2010, INT J QUAL HEALTH C, V22, P86, DOI 10.1093/intqhc/mzq009; Raphael W, 1967, Int J Nurs Stud, V4, P209, DOI 10.1016/0020-7489(67)90026-0; Santos Adriano Maia dos, 2006, Ciênc. saúde coletiva, V11, P53, DOI 10.1590/S1413-81232006000100012; Shi LY, 2003, J AM BOARD FAM PRACT, V16, P412, DOI 10.3122/jabfm.16.5.412; Sitzia J, 1997, SOC SCI MED, V45, P1829, DOI 10.1016/S0277-9536(97)00128-7; Sowunmi Anthonia C, 2015, Niger J Med, V24, P246; Subramanian U, 2009, J GEN INTERN MED, V24, P327, DOI 10.1007/s11606-008-0888-2; Weinick RM, 2000, AM J PUBLIC HEALTH, V90, P1771, DOI 10.2105/AJPH.90.11.1771; Weisman CS, 2001, WOMEN HEALTH ISS, V11, P401, DOI 10.1016/S1049-3867(01)00093-7; Weiss LJ, 1996, AM J PUBLIC HEALTH, V86, P1742, DOI 10.2105/AJPH.86.12.1742; Wetmore S, 2014, CAN FAM PHYSICIAN, V60, pE230; WILLIAMS B, 1994, SOC SCI MED, V38, P509, DOI 10.1016/0277-9536(94)90247-X; Woodward CA, 2004, SOC SCI MED, V58, P177, DOI 10.1016/S0277-9536(03)00161-8; World Bank, 2015, WORLD BANK OP DAT	47	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187993	10.1371/journal.pone.0187993	http://dx.doi.org/10.1371/journal.pone.0187993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145438	gold, Green Submitted, Green Published			2022-12-27	WOS:000415378800046
J	Harper, E; Rochfort, KD; Forde, H; Davenport, C; Smith, D; Cummins, PM				Harper, Emma; Rochfort, Keith D.; Forde, Hannah; Davenport, Colin; Smith, Diarmuid; Cummins, Philip M.			TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOPTOSIS-INDUCING LIGAND; NF-KAPPA-B; ARTERIAL CALCIFICATION; RECEPTOR ACTIVATOR; OSTEOCLASTIC DIFFERENTIATION; OSTEOPROTEGERIN; MICE; PATHWAY; DISEASE	Background and objectives Vascular calcification (VC) is a major risk factor for elevated cardiovascular morbidity/mortality. Underlying this process is osteoblastic signalling within the vessel wall involving complex and interlinked roles for receptor-activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin (OPG), and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL). RANKL promotes vascular cell osteoblastic differentiation, whilst OPG acts as a neutralizing decoy receptor for RANKL (and TRAIL). With respect to TRAIL, much recent evidence points to a vasoprotective role for this ligand, albeit via unknown mechanisms. In order to shed more light on TRAILs vasoprotective role therefore, we employed in vitro cell models to test the hypothesis that TRAIL can counteract the RANKL-mediated signalling that occurs between the vascular cells that comprise the vessel wall. Methods and results Human aortic endothelial and smooth muscle cell mono-cultures (HAECs, HASMCs) were treated with RANKL (0-25 ng/mL +/- 5 ng/mL TRAIL) for 72 hr. Furthermore, to better recapitulate the paracrine signalling that exists between endothelial and smooth muscle cells within the vessel wall, non-contact transwell HAEC: HASMC co-cultures were also employed and involved RANKL treatment of HAECs (+/- TRAIL), subsequently followed by analysis of pro-calcific markers in the underlying subluminal HASMCs. RANKL elicited robust osteoblastic signalling across both mono-and co-culture models (e.g. increased BMP-2, alkaline phosphatase/ALP, Runx2, and Sox9, in conjunction with decreased OPG). Importantly, several RANKL actions (e.g. increased BMP-2 release from mono-cultured HAECs or increased ALP/Sox9 levels in co-cultured HASMCs) could be strongly blocked by co-incubation with TRAIL. In summary, this paper clearly demonstrates that RANKL can elicit pro-osteoblastic signalling in HAECs and HASMCs both directly and across paracrine signalling axes. Moreover, within these contexts we present clear evidence that TRAIL can block several key signalling actions of RANKL in vascular cells, providing further evidence of its vasoprotective potential.	[Harper, Emma; Rochfort, Keith D.; Forde, Hannah; Davenport, Colin; Cummins, Philip M.] Dublin City Univ, Sch Biotechnol, Dublin, Ireland; [Harper, Emma; Rochfort, Keith D.; Cummins, Philip M.] Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland; [Forde, Hannah; Smith, Diarmuid] Beaumont Hosp, Dept Acad Endocrinol, Dublin, Ireland	Dublin City University; Dublin City University	Cummins, PM (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin, Ireland.; Cummins, PM (corresponding author), Dublin City Univ, Natl Inst Cellular Biotechnol, Dublin, Ireland.	phil.cummins@dcu.ie	Rochfort, Keith/R-7009-2019	Rochfort, Keith/0000-0003-1198-5952; Davenport, Colin/0000-0001-6854-6147	DCU O'Hare Scholarship; Government of Ireland/Irish Research Council Postgraduate Scholarship [GOIPG/2015/3758]; Science Foundation Ireland [14/US/B3116]	DCU O'Hare Scholarship; Government of Ireland/Irish Research Council Postgraduate Scholarship; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by DCU O'Hare Scholarship (EH), Grant Number: Not applicable, URL: https://www4.dcu.ie/graduatestudies/danielohare.shtml; The Government of Ireland/Irish Research Council Postgraduate Scholarship (EH), Grant Number: GOIPG/2015/3758, URL: http://research.ie/funding-category/postgraduate/ and http://www.sfi.ie/funding/funding-calls/open-calls/us-ireland-rd-partnership-programme.html; and Science Foundation Ireland (PMC), Grant Number: 14/US/B3116, URL: http://www.sfi.ie/funding/funding-calls/open-calls/us-ireland-rd-partnership-programme.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Bernardi S, 2012, CLIN SCI, V123, P547, DOI 10.1042/CS20120176; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Callegari A, 2014, J VASC RES, V51, P118, DOI 10.1159/000358920; Cho IJ, 2015, J HYPERTENS, V33, P1633, DOI 10.1097/HJH.0000000000000607; Davenport C, 2016, INT J BIOCHEM CELL B, V77, P171, DOI 10.1016/j.biocel.2016.06.009; Davenport C, 2015, EUR J ENDOCRINOL, V173, P53, DOI 10.1530/EJE-14-1137; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Deuell KA, 2012, J VASC RES, V49, P510, DOI 10.1159/000341216; Di Bartolo BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074211; Forde H, 2016, ATHEROSCLEROSIS, V247, P87, DOI 10.1016/j.atherosclerosis.2016.02.002; Harith HH, 2013, TRENDS ENDOCRIN MET, V24, P578, DOI 10.1016/j.tem.2013.07.001; Harper E, 2016, VASC PHARMACOL, V82, P30, DOI 10.1016/j.vph.2016.02.003; Henaut L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.220; Higgins CL, 2015, PROTEIN J, V34, P315, DOI 10.1007/s10930-015-9620-3; Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296; Kaden JJ, 2004, J MOL CELL CARDIOL, V36, P57, DOI 10.1016/j.yjmcc.2003.09.015; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; Ndip A, 2011, DIABETES, V60, P2187, DOI 10.2337/db10-1220; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Olesen M, 2012, MOL CELL ENDOCRINOL, V362, P149, DOI 10.1016/j.mce.2012.06.004; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Panizo S, 2009, CIRC RES, V104, P1041, DOI 10.1161/CIRCRESAHA.108.189001; Qunibi WY, 2005, KIDNEY INT, V68, P271, DOI 10.1111/j.1523-1755.2005.00402.x; Sakaguchi M, 2016, HEART VESSELS, V31, P1915, DOI 10.1007/s00380-016-0820-3; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Shin V, 2004, J VASC RES, V41, P193, DOI 10.1159/000077394; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Tyson KL, 2003, ARTERIOSCL THROM VAS, V23, P489, DOI 10.1161/01.ATV.0000059406.92165.31; Vitovski S, 2007, J BIOL CHEM, V282, P31601, DOI 10.1074/jbc.M706078200; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Zauli G, 2004, BLOOD, V104, P2044, DOI 10.1182/blood-2004-03-1196; Zauli G, 2008, J CELL PHYSIOL, V214, P117, DOI 10.1002/jcp.21165; Zhan JK, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0153-4; Zhang J, 2014, BIOSCIENCE REP, V34, P663, DOI 10.1042/BSR20140103	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188192	10.1371/journal.pone.0188192	http://dx.doi.org/10.1371/journal.pone.0188192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145460	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800085
J	Yang, KY; Lu, C; Zhao, XD; Kawamura, R				Yang, Kaiyuan; Lu, Chen; Zhao, Xiaodan; Kawamura, Ryo			From bead to rod: Comparison of theories by measuring translational drag coefficients of micron-sized magnetic bead-chains in Stokes flow	PLOS ONE			English	Article							LOW-REYNOLDS-NUMBER; MODIFIED OSEEN TENSOR; HYDRODYNAMIC PROPERTIES; DIFFUSION-COEFFICIENTS; ROTATIONAL DIFFUSION; INTRINSIC-VISCOSITY; SHORT DNA; MACROMOLECULES; PARTICLES; TWEEZERS	Frictional drag force on an object in Stokes flow follows a linear relationship with the velocity of translation and a translational drag coefficient. This drag coefficient is related to the size, shape, and orientation of the object. For rod-like objects, analytical solutions of the drag coefficients have been proposed based on three rough approximations of the rod geometry, namely the bead model, ellipsoid model, and cylinder model. These theories all agree that translational drag coefficients of rod-like objects are functions of the rod length and aspect ratio, but differ among one another on the correction factor terms in the equations. By tracking the displacement of the particles through stationary fluids of calibrated viscosity in magnetic tweezers setup, we experimentally measured the drag coefficients of micron-sized beads and their bead-chain formations with chain length of 2 to 27. We verified our methodology with analytical solutions of dimers of two touching beads, and compared our measured drag coefficient values of rod-like objects with theoretical calculations. Our comparison reveals several analytical solutions that used more appropriate approximation and derived formulae that agree with our measurement better.	[Yang, Kaiyuan; Lu, Chen; Zhao, Xiaodan] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Yang, Kaiyuan; Lu, Chen; Zhao, Xiaodan; Kawamura, Ryo] Natl Univ Singapore, Ctr Bioimaging Sci, Dept Biol Sci, Singapore 117543, Singapore; [Kawamura, Ryo] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Yang, KY (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.; Yang, KY (corresponding author), Natl Univ Singapore, Ctr Bioimaging Sci, Dept Biol Sci, Singapore 117543, Singapore.	mbiykai@nus.edu.sg	Yang, Kaiyuan/T-7575-2017	Yang, Kaiyuan/0000-0003-0591-2079				BATCHELOR GK, 1970, J FLUID MECH, V44, P419, DOI 10.1017/S002211207000191X; BROERSMA S, 1981, J CHEM PHYS, V74, P6989, DOI 10.1063/1.441071; Brouzes E, 2015, LAB CHIP, V15, P908, DOI 10.1039/c4lc01327a; Burgers J., 1938, 2 REPORT VISCOSITY P; Carrasco B, 1999, BIOPHYS J, V76, P3044, DOI 10.1016/S0006-3495(99)77457-6; Casella G., 2002, STAT INFERENCE DUXBU; Cengel Y., 2013, FLUID MECH FUNDAMENT; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; CHWANG AT, 1975, J FLUID MECH, V67, P787, DOI 10.1017/S0022112075000614; Cox R. G., 1970, Journal of Fluid Mechanics, V44, P791, DOI 10.1017/S002211207000215X; Dai L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.168105; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; Doi M, 1988, INT SERIES MONOGRAPH; DURLOFSKY L, 1987, J FLUID MECH, V180, P21, DOI 10.1017/S002211208700171X; Elgeti J, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/5/056601; Faxen H, 1922, ANN PHYS-BERLIN, V68, P89; Fischer MWF, 2010, FUNGAL BIOL-UK, V114, P943, DOI 10.1016/j.funbio.2010.09.003; Fonnum G, 2005, J MAGN MAGN MATER, V293, P41, DOI 10.1016/j.jmmm.2005.01.041; Fu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066712; de la Torre JG, 2007, J PHYS CHEM B, V111, P955, DOI 10.1021/jp0647941; de la Torre JG, 2010, EUR BIOPHYS J BIOPHY, V39, P381, DOI 10.1007/s00249-009-0405-5; Haber C, 2000, REV SCI INSTRUM, V71, P4561, DOI 10.1063/1.1326056; Happel J., 1981, LOW REYNOLDS NUMBER; Hoffmann M, 2009, ACS NANO, V3, P3326, DOI 10.1021/nn900902b; KASPER G, 1985, J AEROSOL SCI, V16, P535, DOI 10.1016/0021-8502(85)90006-0; Kendall M., 1994, KENDALLS ADV THEORY, V1; Kenward M, 2004, EUR PHYS J E, V14, P55, DOI 10.1140/epje/i2004-10006-4; KIRKWOOD JG, 1948, J CHEM PHYS, V16, P565, DOI 10.1063/1.1746947; Lim CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00509; Lobo S, 2011, LANGMUIR, V27, P2142, DOI 10.1021/la1049452; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Milne-Thomson L.M., 1972, THEORETICAL HYDRODYN; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Oberbeck A, 1876, J REINE ANGEW MATH, V81, P62; Ortega A, 2003, J CHEM PHYS, V119, P9914, DOI 10.1063/1.1615967; Purcell EM, 1997, P NATL ACAD SCI USA, V94, P11307, DOI 10.1073/pnas.94.21.11307; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Shah S, 2011, J NANOSCI NANOTECHNO, V11, P919, DOI 10.1166/jnn.2011.3536; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Stokes G. G., 1845, T CAMBRIDGE PHILOS S, V9, P8; SWANSON E, 1978, J CHEM PHYS, V68, P5097, DOI 10.1063/1.435628; Tanase M, 2007, METHOD CELL BIOL, V83, P473, DOI 10.1016/S0091-679X(07)83020-2; TCHEN CM, 1954, J APPL PHYS, V25, P463, DOI 10.1063/1.1721663; TILLETT JPK, 1970, J FLUID MECH, V44, P401, DOI 10.1017/S0022112070001908; TIRADO MM, 1984, J CHEM PHYS, V81, P2047, DOI 10.1063/1.447827; Wise N, 2015, J MAGN MAGN MATER, V384, P328, DOI 10.1016/j.jmmm.2015.02.031; YAMAKAWA H, 1972, J CHEM PHYS, V57, P1537, DOI 10.1063/1.1678434; YAN J, 2004, PHYS REV E 1, V70; Yu ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904148; ZAHN K, 1994, J PHYS II, V4, P555, DOI 10.1051/jp2:1994146; Zhang XH, 2014, J AM CHEM SOC, V136, P16073, DOI 10.1021/ja5090805	52	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188015	10.1371/journal.pone.0188015	http://dx.doi.org/10.1371/journal.pone.0188015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145447	Green Submitted, gold, Green Published			2022-12-27	WOS:000415378800050
J	Liang, FF; Blythe, HI; Bai, XJ; Yan, GL; Li, X; Zang, CL; Liversedge, SP				Liang, Feifei; Blythe, Hazel I.; Bai, Xuejun; Yan, Guoli; Li, Xin; Zang, Chuanli; Liversedge, Simon P.			The role of character positional frequency on Chinese word learning during natural reading	PLOS ONE			English	Article							EYE-MOVEMENT CONTROL; E-Z-READER; FINNISH COMPOUND WORDS; SPACE INFORMATION; UNSPACED TEXT; MODEL; SEGMENTATION; IDENTIFICATION; 2ND-LANGUAGE; CONSTITUENTS	Readers' eye movements were recorded to examine the role of character positional frequency on Chinese lexical acquisition during reading and its possible modulation by word spacing. In Experiment 1, three types of pseudowords were constructed based on each character's positional frequency, providing congruent, incongruent, and no positional word segmentation information. Each pseudoword was embedded into two sets of sentences, for the learning and the test phases. In the learning phase, half the participants read sentences in word-spaced format, and half in unspaced format. In the test phase, all participants read sentences in unspaced format. The results showed an inhibitory effect of character positional frequency upon the efficiency of word learning when processing incongruent pseudowords both in the learning and test phase, and also showed facilitatory effect of word spacing in the learning phase, but not at test. Most importantly, these two characteristics exerted independent influences on word segmentation. In Experiment 2, three analogous types of pseudowords were created whilst controlling for orthographic neighborhood size. The results of the two experiments were consistent, except that the effect of character positional frequency was absent in the test phase in Experiment 2. We argue that the positional frequency of a word's constituent characters may influence the character-to-word assignment in a process that likely incorporates both lexical segmentation and identification.	[Liang, Feifei; Bai, Xuejun; Yan, Guoli; Li, Xin; Zang, Chuanli] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China; [Blythe, Hazel I.; Liversedge, Simon P.] Univ Southampton, Psychol, Southampton, Hants, England	Tianjin Normal University; University of Southampton	Liversedge, SP (corresponding author), Univ Southampton, Psychol, Southampton, Hants, England.	s.p.liversedge@soton.ac.uk		Zang, Chuanli/0000-0002-9573-4968	Natural Science Foundation of China [31600902, 81471629, 31571122]; Youth Talent Cultivation Program [52WX1705]; Creative Research Groups of Excellent Young Scholars in Tianjin Normal University [52WZ1702]; Special Program of Talents Development for Excellent Youth Scholars in Tianjin	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Talent Cultivation Program; Creative Research Groups of Excellent Young Scholars in Tianjin Normal University; Special Program of Talents Development for Excellent Youth Scholars in Tianjin	The study was supported by Natural Science Foundation of China Grants (31600902, 81471629, 31571122), The Youth Talent Cultivation Program (52WX1705) and Creative Research Groups of Excellent Young Scholars (52WZ1702) in Tianjin Normal University and the Special Program of Talents Development for Excellent Youth Scholars in Tianjin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, AC SIN BAL CORP VERS; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2005, CONT CHINESE DICT; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bai XJ, 2008, J EXP PSYCHOL HUMAN, V34, P1277, DOI 10.1037/0096-1523.34.5.1277; Bai XJ, 2013, J RES READ, V36, pS4, DOI 10.1111/j.1467-9817.2013.01554.x; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bertram R, 2004, J MEM LANG, V51, P325, DOI 10.1016/j.jml.2004.06.005; Bertram R, 2003, J MEM LANG, V48, P615, DOI 10.1016/S0749-596X(02)00539-9; Blythe HI, 2012, J MEM LANG, V67, P241, DOI 10.1016/j.jml.2012.05.004; Cai Q, 2011, PLOS ONE, V5; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Hanley JR, 2005, BL HBK DEV PSYCHOL, P316, DOI 10.1002/9780470757642.ch17; Huang HW, 2006, NEUROREPORT, V17, P1061, DOI 10.1097/01.wnr.0000224761.77206.1d; Hyona J, 1998, J EXP PSYCHOL HUMAN, V24, P1612, DOI 10.1037/0096-1523.24.6.1612; Hyona J, 2004, MEM COGNITION, V32, P523, DOI 10.3758/BF03195844; Inhoff AW, 2005, MEM COGNITION, V33, P1345, DOI 10.3758/BF03193367; Kasisopa B, 2013, VISION RES, V86, P71, DOI 10.1016/j.visres.2013.04.007; Li XS, 2009, COGNITIVE PSYCHOL, V58, P525, DOI 10.1016/j.cogpsych.2009.02.003; Liu PP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055440; Ma GJ, 2014, J EXP PSYCHOL HUMAN, V40, P1046, DOI 10.1037/a0035389; MALT BC, 1978, PERCEPT PSYCHOPHYS, V23, P399, DOI 10.3758/BF03204142; MORRIS RK, 1990, J EXP PSYCHOL HUMAN, V16, P268, DOI 10.1037/0096-1523.16.2.268; Perea M, 2009, VISION RES, V49, P1994, DOI 10.1016/j.visres.2009.05.009; Pollatsek A, 2000, J EXP PSYCHOL HUMAN, V26, P820, DOI 10.1037/0096-1523.26.2.820; Pollatsek A, 2006, COGNITIVE PSYCHOL, V52, P1, DOI 10.1016/j.cogpsych.2005.06.001; POLLATSEK A, 1982, J EXP PSYCHOL HUMAN, V8, P817, DOI 10.1037/0096-1523.8.6.817; RAPP BC, 1992, J MEM LANG, V31, P33, DOI 10.1016/0749-596X(92)90004-H; Rayner K, 1998, VISION RES, V38, P1129, DOI 10.1016/S0042-6989(97)00274-5; Rayner K, 1996, VISION RES, V36, P461, DOI 10.1016/0042-6989(95)00132-8; Rayner K, 2007, COGNITIVE SCI, V31, P1021, DOI 10.1080/03640210701703824; Reichle ED, 2006, COGN SYST RES, V7, P4, DOI 10.1016/j.cogsys.2005.07.002; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125; Reilly R, 2009, 15 EUR C EY MOV; Reilly RG, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P429, DOI 10.1016/B978-044451020-4/50024-4; Reilly R, 2012, READ WRIT, V25, P935, DOI 10.1007/s11145-012-9369-4; Shen DL, 2012, J EXP PSYCHOL-APPL, V18, P192, DOI 10.1037/a0027485; SPRAGINS AB, 1976, MEM COGNITION, V4, P36, DOI 10.3758/BF03213252; Tsai J-L., 2006, LANG LINGUIST-TAIWAN, V7, P659; Winskel H, 2009, J MEM LANG, V61, P339, DOI 10.1016/j.jml.2009.07.002; WU J, 2008, COGNITIVE CULTURAL I, P303; Yan M, 2010, Q J EXP PSYCHOL, V63, P705, DOI 10.1080/17470210903114858; Yen MH, 2012, READ WRIT, V25, P1007, DOI 10.1007/s11145-011-9321-z; Zang C., 2011, OXFORD HDB EYE MOVEM, P961; Zang CL, 2013, J EXP PSYCHOL HUMAN, V39, P720, DOI 10.1037/a0030097	45	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187656	10.1371/journal.pone.0187656	http://dx.doi.org/10.1371/journal.pone.0187656			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136002	Green Accepted, gold, Green Published			2022-12-27	WOS:000415121200025
J	Maggioni, E; Crespo-Facorro, B; Nenadic, I; Benedetti, F; Gaser, C; Sauer, H; Roiz-Santianez, R; Poletti, S; Marinelli, V; Bellani, M; Perlini, C; Ruggeri, M; Altamura, AC; Diwadkar, VA; Brambilla, P				Maggioni, Eleonora; Crespo-Facorro, Benedicto; Nenadic, Igor; Benedetti, Francesco; Gaser, Christian; Sauer, Heinrich; Roiz-Santianez, Roberto; Poletti, Sara; Marinelli, Veronica; Bellani, Marcella; Perlini, Cinzia; Ruggeri, Mirella; Altamura, A. Carlo; Diwadkar, Vaibhav A.; Brambilla, Paolo		ENPACT Grp	Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study	PLOS ONE			English	Article							WHITE-MATTER MICROSTRUCTURE; ANTERIOR CINGULATE CORTEX; RATING-SCALE; I DISORDER; FUNCTIONAL CONNECTIVITY; PREFRONTAL CORTEX; CORPUS-CALLOSUM; BRAIN STRUCTURE; VOLUMES; MRI	Introduction Although schizophrenia (SCZ) and bipolar disorder (BD) share elements of pathology, their neural underpinnings are still under investigation. Here, structural Magnetic Resonance Imaging (MRI) data collected from a large sample of BD and SCZ patients and healthy controls (HC) were analyzed in terms of gray matter volume (GMV) using both voxel based morphometry (VBM) and a region of interest (ROI) approach. Methods The analysis was conducted on two datasets, Dataset1 (802 subjects: 243 SCZ, 176 BD, 383 HC) and Dataset2, a homogeneous subset of Dataset1 (301 subjects: 107 HC, 85 BD and 109 SCZ). General Linear Model analyses were performed 1) at the voxel-level in the whole brain (VBM study), 2) at the regional level in the anatomical regions emerged from the VBM study (ROI study). The GMV comparison across groups was integrated with the analysis of GMV correlates of different clinical dimensions. Results The VBM results of Dataset1 showed 1) in BD compared to HC, GMV deficits in right cingulate, superior temporal and calcarine cortices, 2) in SCZ compared to HC, GMV deficits in widespread cortical and subcortical areas, 3) in SCZ compared to BD, GMV deficits in insula and thalamus (p<0.05, cluster family wise error corrected). The regions showing GMV deficits in the BD group were mostly included in the SCZ ones. The ROI analyses confirmed the VBM results at the regional level in most of the clusters from the SCZ vs. HC comparison (p<0.05, Bonferroni corrected). The VBM and ROI analyses of Dataset2 provided further evidence for the enhanced GMV deficits characterizing SCZ. Based on the clinical-neuroanatomical analyses, we cannot exclude possible confounding effects due to 1) age of onset and medication in BD patients, 2) symptoms severity in SCZ patients. Conclusion Our study reported both shared and specific neuroanatomical characteristics between the two disorders, suggesting more severe and generalized GMV deficits in SCZ, with a specific role for insula and thalamus.	[Maggioni, Eleonora; Altamura, A. Carlo] Univ Milan, Dept Neurosci & Mental Hlth, IRCCS Fdn Ca Granda Osped Maggiore Policlin, Milan, Italy; [Crespo-Facorro, Benedicto; Roiz-Santianez, Roberto] Univ Cantabria IDIVAL, Univ Hosp Marques de Valdecilla, Sch Med, Dept Psychiat, Santander, Spain; [Crespo-Facorro, Benedicto; Roiz-Santianez, Roberto] Ctr Invest Biomed Red Salud Mental, CIBERSAM, Santander, Spain; [Nenadic, Igor; Gaser, Christian; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat & Psychotherapy, Jena, Germany; [Nenadic, Igor] Philipps Univ Marburg, Marburg Univ Hosp UKGM, Dept Psychiat & Psychotherapy, Marburg, Germany; [Benedetti, Francesco; Poletti, Sara] Dept Clin Neurosci, Milan, Italy; [Benedetti, Francesco; Poletti, Sara] Ctr Eccellenza Risonanza Magnet & Alto Campo, Sci Inst, Milan, Italy; [Benedetti, Francesco; Poletti, Sara] Univ Vita Salute San Raffaele, Milan, Italy; [Gaser, Christian] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Marinelli, Veronica] Univ Udine, Dept Expt & Clin Med Sci DISM, Udine, Italy; [Bellani, Marcella] Azienda Osped Univ Integrata Verona, Sect Psychiat, Verona, Italy; [Perlini, Cinzia] Univ Verona, Sect Clin Psychol, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Ruggeri, Mirella] Univ Verona, Sect Psychiat, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Diwadkar, Vaibhav A.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI USA; [Brambilla, Paolo] IRCCS Sci Inst E Medea, Bosisio Parini, Lecco, Italy; [Marinelli, Veronica; Brambilla, Paolo] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Friedrich Schiller University of Jena; Philipps University Marburg; University Hospital of Giessen & Marburg; Vita-Salute San Raffaele University; Friedrich Schiller University of Jena; University of Udine; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Wayne State University; IRCCS Eugenio Medea; University of Milan	Brambilla, P (corresponding author), IRCCS Sci Inst E Medea, Bosisio Parini, Lecco, Italy.; Brambilla, P (corresponding author), Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy.	paolo.brambilla1@unimi.it	brambilla, paolo/B-4184-2010; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Maggioni, Eleonora/AAC-6040-2019; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Perlini, Cinzia/F-8492-2010; Bellani, Marcella/F-3929-2010; Poletti, Sara/U-3560-2017; Gaser, Christian/F-5103-2010; Benedetti, Francesco/A-4124-2015	brambilla, paolo/0000-0002-4021-8456; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Maggioni, Eleonora/0000-0003-4331-4029; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Perlini, Cinzia/0000-0002-4281-0920; Bellani, Marcella/0000-0003-1727-5396; Poletti, Sara/0000-0001-9594-0246; Gaser, Christian/0000-0002-9940-099X; Benedetti, Francesco/0000-0003-4949-856X	Ministry of Health [RF-2011-02352308]; European Unions Seventh Framework Programme for research, technological development and demonstration [602450]; Carlos III Health Institute [PI020499, PI050427, PI060507]; Plan Nacional de Drugs Research Grant [Orden sco/3246/2004]; SENY Fundacio Research Grant [CI 2005-0308007]; Fundacion Marques de Valdecilla [API07/011]; European Union [EU-FP7-HEALTH-F2-2008-222963]; Italian Ministry of Health [RF-2011-02350980]	Ministry of Health; European Unions Seventh Framework Programme for research, technological development and demonstration; Carlos III Health Institute(Instituto de Salud Carlos III); Plan Nacional de Drugs Research Grant; SENY Fundacio Research Grant; Fundacion Marques de Valdecilla(Instituto de Salud Carlos III); European Union(European Commission); Italian Ministry of Health(Ministry of Health, Italy)	PB was partially funded by grants from the Ministry of Health (RF-2011-02352308). Grant support of EM was provided by the European Unions Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602450 (IMAGEMEND Project). Part of the present study was conducted at the Hospital Universitario Marques de Valdecilla, University of Cantabria (Santander, Spain), under the following grant support: Carlos III Health Institute PI020499, PI050427, PI060507, Plan Nacional de Drugs Research Grant 2005- Orden sco/3246/2004, SENY Fundacio Research Grant CI 2005-0308007 and Fundacion Marques de Valdecilla API07/011. We wish to acknowledge IDIVAL Neuroimaging Unit for imaging acquirement and analysis. Part of the study was conducted at the Ospedale San Raffaele, Milano, supported by the European Union EU-FP7-HEALTH-F2-2008-222963 MOODINFLAME and by the Italian Ministry of Health RF-2011-02350980 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Gianluca Rambaldelli for helping in managing the dataset. PB was partially funded by grants from the Ministry of Health (RF-2011-02352308). Grant support of EM was provided by the European Unions Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602450 (IMAGEMEND Project). Part of the present study was conducted at the Hospital Universitario Marques de Valdecilla, University of Cantabria (Santander, Spain), under the following grant support: Carlos III Health Institute PI020499, PI050427, PI060507, Plan Nacional de Drugs Research Grant 2005- Orden sco/3246/2004, SENY Fundacio Research Grant CI 20050308007 and Fundacion Marques de Valdecilla API07/011. We wish to acknowledge IDIVAL Neuroimaging Unit for imaging acquirement and analysis. Part of the study was conducted at the Ospedale San Raffaele, Milano, supported by the European Union EU-FP7-HEALTH-F2-2008-222963 MOODINFLAME and by the Italian Ministry of Health RF-2011-02350980 projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2008, J PSYCHIATR NEUROSCI, V33, P440; Altamura AC, 2013, PSYCHIAT RES-NEUROIM, V214, P410, DOI 10.1016/j.pscychresns.2013.08.011; Amann BL, 2016, ACTA PSYCHIAT SCAND, V133, P23, DOI 10.1111/acps.12440; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Andreone N, 2007, BRIT J PSYCHIAT, V191, P113, DOI 10.1192/bjp.bp.105.020990; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Baiano M, 2008, SCHIZOPHR RES, V102, P171, DOI 10.1016/j.schres.2007.11.035; Bellani M, 2009, DTI STUDIES CORPUS C; Bellani M, 2010, EXP BRAIN RES, V201, P339, DOI 10.1007/s00221-009-2021-0; Bellani M, 2009, EPIDEMIOL PSICHIAT S, V18, P19, DOI 10.1017/S1121189X0000141X; Benedetti F, 2013, NEUROPSYCHOPHARMACOL, V38, P313, DOI 10.1038/npp.2012.172; Benedetti F, 2011, J AFFECT DISORDERS, V135, P139, DOI 10.1016/j.jad.2011.07.006; Benedetti F, 2011, BIOL PSYCHIAT, V69, P309, DOI 10.1016/j.biopsych.2010.07.028; Bora E, 2012, PSYCHOL MED, V42, P295, DOI 10.1017/S0033291711001450; Bouras C, 2001, ACTA NEUROPATHOL, V102, P373; Brambilla P, 2005, SCHIZOPHR RES, V79, P201, DOI 10.1016/j.schres.2005.04.012; Brambilla P, 2013, BRIT J PSYCHIAT, V202, P50, DOI 10.1192/bjp.bp.111.105700; Brambilla P, 2002, NEUROPSYCHOPHARMACOL, V27, P792, DOI 10.1016/S0893-133X(02)00352-4; Brambilla P, 2007, INT REV PSYCHIATR, V19, P459, DOI 10.1080/09540260701500975; Brambilla P, 2009, INT REV PSYCHIATR, V21, P380, DOI 10.1080/09540260902962172; Brown GG, 2011, PSYCHIAT RES-NEUROIM, V194, P149, DOI 10.1016/j.pscychresns.2011.05.005; Bruno SD, 2004, BRAIN, V127, P2433, DOI 10.1093/brain/awh274; Bruno S, 2008, BIPOLAR DISORD, V10, P460, DOI 10.1111/j.1399-5618.2007.00552.x; Caligiuri MP, 2004, BIPOLAR DISORD, V6, P183, DOI 10.1111/j.1399-5618.2004.00116.x; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Corradi-Dell'Acqua C, 2012, HUM BRAIN MAPP, V33, P740, DOI 10.1002/hbm.21246; Crespo-Facorro B, 2000, SCHIZOPHR RES, V46, P35, DOI 10.1016/S0920-9964(00)00028-1; Crossley NA, 2009, HUM BRAIN MAPP, V30, P4129, DOI 10.1002/hbm.20834; Csernansky JG, 2004, AM J PSYCHIAT, V161, P896, DOI 10.1176/appi.ajp.161.5.896; Daban C, 2006, PSYCHOTHER PSYCHOSOM, V75, P72, DOI 10.1159/000090891; Delvecchio G, 2013, PSYCHOL MED, V43, P553, DOI 10.1017/S0033291712001432; Diwadkar VA, 2004, SCHIZOPHR RES, V67, P277, DOI 10.1016/S0920-9964(03)00098-7; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Ellison-Wright I, 2010, SCHIZOPHR RES, V117, P1, DOI 10.1016/j.schres.2009.12.022; First M. B., 2004, STRUCTURED CLIN INTE; Fischer BA, 2009, NEUROPSYCHOPHARMACOL, V34, P2081, DOI 10.1038/npp.2009.32; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hao YH, 2006, NEUROREPORT, V17, P23, DOI 10.1097/01.wnr.0000195664.15090.46; Haznedar MM, 2005, BIOL PSYCHIAT, V57, P733, DOI 10.1016/j.biopsych.2005.01.002; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Houenou J, 2015, EPIDEMIOL PSYCH SCI, V24, P117, DOI 10.1017/S2045796014000766; Ivleva EI, 2016, BIOL PSYCHIAT; Ivleva EI, 2013, AM J PSYCHIAT, V170, P1285, DOI 10.1176/appi.ajp.2013.13010126; Ivleva EI, 2012, PSYCHIAT RES-NEUROIM, V204, P13, DOI 10.1016/j.pscychresns.2012.05.001; Kaur S, 2005, AM J PSYCHIAT, V162, P1637, DOI 10.1176/appi.ajp.162.9.1637; Kim MD, 2015, CLIN PSYCHOPHARM NEU, V13, P103, DOI 10.9758/cpn.2015.13.1.103; Leucht S, 2005, SCHIZOPHR RES, V79, P231, DOI 10.1016/j.schres.2005.04.008; Leucht S, 2005, BRIT J PSYCHIAT, V187, P366, DOI 10.1192/bjp.187.4.366; Leung C., 2003, HONG KONG J PSYCHIAT, V13, P31; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lui S, 2015, PSYCHOL MED, V45, P97, DOI 10.1017/S003329171400110X; Maggioni E, 2016, EPIDEMIOL PSYCH SCI, V25, P312, DOI 10.1017/S2045796016000275; Mamah D, 2013, J AFFECT DISORDERS, V150, P601, DOI 10.1016/j.jad.2013.01.051; McDonald C, 2005, BRIT J PSYCHIAT, V186, P369, DOI 10.1192/bjp.186.5.369; Michael N, 2004, J AFFECT DISORDERS, V78, P253, DOI 10.1016/S0165-0327(02)00308-7; Molina V, 2011, EUR ARCH PSY CLIN N, V261, P313, DOI 10.1007/s00406-010-0183-1; Nenadic I, 2015, SCHIZOPHR RES, V165, P212, DOI 10.1016/j.schres.2015.04.007; O'Donoghue S, 2015, EPIDEMIOL PSYCH SCI, V24, P298, DOI 10.1017/S2045796015000074; Perlini C, 2012, ACTA PSYCHIAT SCAND, V126, P235, DOI 10.1111/j.1600-0447.2012.01868.x; Peruzzo D, 2015, J NEURAL TRANSM, V122, P897, DOI 10.1007/s00702-014-1324-x; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Praharaj SK, 2009, J AFFECT DISORDERS, V117, P146, DOI 10.1016/j.jad.2008.12.020; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Sarrazin S, 2014, JAMA PSYCHIAT, V71, P388, DOI 10.1001/jamapsychiatry.2013.4513; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Squarcina L, 2015, NEUROIMAGE; Squarcina L, 2015, SCHIZOPHR RES, V165, P38, DOI 10.1016/j.schres.2015.03.017; Squarcina L, 2015, PHYS MED BIOL, V60, P1697, DOI 10.1088/0031-9155/60/4/1697; Thaker GK, 2008, SCHIZOPHRENIA BULL, V34, P760, DOI 10.1093/schbul/sbn049; Tomasino B, 2011, PSYCHOL MED, V41, P301, DOI 10.1017/S0033291710000875; Tomelleri L, 2009, EUR NEUROPSYCHOPHARM, V19, P835, DOI 10.1016/j.euroneuro.2009.07.007; Tosato S, 2012, NEUROPSYCHOBIOLOGY, V65, P119, DOI 10.1159/000330584; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wessa M, 2015, EPIDEMIOL PSYCH SCI, V24, P479, DOI 10.1017/S2045796015000098; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yoon YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135347; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189	84	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188000	10.1371/journal.pone.0188000	http://dx.doi.org/10.1371/journal.pone.0188000			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29136642	gold, Green Submitted, Green Published			2022-12-27	WOS:000415121200054
J	Swatson, WS; Katoh-Kurasawa, M; Shaulsky, G; Alexander, S				Swatson, William S.; Katoh-Kurasawa, Mariko; Shaulsky, Gad; Alexander, Stephen			Curcumin affects gene expression and reactive oxygen species via a PKA dependent mechanism in Dictyostelium discoideum	PLOS ONE			English	Article							PROTEIN-KINASE-A; ANTICANCER DRUG CISPLATIN; NF-KAPPA-B; SUPEROXIDE-DISMUTASE; TRANSCRIPTION FACTOR; CANCER CELLS; SPHINGOSINE KINASE-1; ANTIOXIDANT ENZYMES; ALZHEIMERS-DISEASE; OXIDATIVE STRESS	Botanicals are widely used as dietary supplements and for the prevention and treatment of disease. Despite a long history of use, there is generally little evidence supporting the efficacy and safety of these preparations. Curcumin has been used to treat a myriad of human diseases and is widely advertised and marketed for its ability to improve health, but there is no clear understanding how curcumin interacts with cells and affects cell physiology. D. discoideum is a simple eukaryotic lead system that allows both tractable genetic and biochemical studies. The studies reported here show novel effects of curcumin on cell proliferation and physiology, and a pleiotropic effect on gene transcription. Transcriptome analysis showed that the effect is two-phased with an early transient effect on the transcription of approximately 5% of the genome, and demonstrates that cells respond to curcumin through a variety of previously unknown molecular pathways. This is followed by later unique transcriptional changes and a protein kinase A dependent decrease in catalase A and three superoxide dismutase enzymes. Although this results in an increase in reactive oxygen species (ROS; superoxide and H2O2), the effects of curcumin on transcription do not appear to be the direct result of oxidation. This study opens the door to future explorations of the effect of curcumin on cell physiology.	[Swatson, William S.; Alexander, Stephen] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Katoh-Kurasawa, Mariko; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Missouri System; University of Missouri Columbia; Baylor College of Medicine	Alexander, S (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.; Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	gadi@bcm.edu; alexanderst@missouri.edu			National Institutes of Health [HD039691]; NIH IMSD [R25 GM 506901]; Department of Education GAANN [P200A201101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education GAANN(US Department of Education); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by grant number HD039691 from the National Institutes of Health, NIH IMSD grant number R25 GM 506901, and by Department of Education GAANN programs P200A201101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is in partial fulfillment of the requirements for the Ph.D. degree for WSS. The work was supported in part by grant number HD039691 from the National Institutes of Health. WSS thanks the University of Missouri for fellowship support from the NIH IMSD R25 GM 506901 to Mark Hannink and Department of Education GAANN programs P200A201101 to John David. We acknowledge the Dictyostelium Stock Center at Northwestern University (DictyBase.org) for supplying mutant strains and for maintaining the Dictyostelium database. We thank Dr. Aniruddha Belsare of the University of Idaho and Dr. Dan Alexander of Vanderbilt University for advice and help on preparing the figures and statistics. We particularly thank Professor Hannah Alexander for tireless advice and help performing experiments, and many reviews of this manuscript.	Able AJ, 1998, PLANT PHYSIOL, V117, P491, DOI 10.1104/pp.117.2.491; Aggeli IK, 2013, J EXP ZOOL PART A, V319A, P328, DOI 10.1002/jez.1797; Alexander S, 2006, BBA-GEN SUBJECTS, V1760, P301, DOI 10.1016/j.bbagen.2005.11.015; Alexander S, 2011, SEMIN CELL DEV BIOL, V22, P97, DOI 10.1016/j.semcdb.2010.10.005; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; [Anonymous], 2008, HERB MED US REV EFF; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Beevers C., 2011, BOT TARGETS THER, V1, P5, DOI [10.2147/btat.s17244, DOI 10.2147/BTAT.S17244]; Bloomfield G, 2003, J CELL SCI, V116, P3387, DOI 10.1242/jcs.00649; Boeckeler K, 2006, EUR J CELL BIOL, V85, P1047, DOI 10.1016/j.ejcb.2006.04.013; Chen JP, 2015, J AGR FOOD CHEM, V63, P6440, DOI 10.1021/acs.jafc.5b01773; Chiang IT, 2015, ONCOL REP, V34, P1853, DOI 10.3892/or.2015.4159; Cine N, 2013, EXP THER MED, V5, P23, DOI 10.3892/etm.2012.754; Colacino JA, 2016, BREAST CANCER RES TR, V158, P29, DOI 10.1007/s10549-016-3854-4; CONNEY AH, 1991, ADV ENZYME REGUL, V31, P385, DOI 10.1016/0065-2571(91)90025-H; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Garcia MXU, 2000, BBA-GENE STRUCT EXPR, V1492, P295, DOI 10.1016/S0167-4781(00)00063-4; Garcia MXU, 2003, BBA-MOL CELL RES, V1641, P55, DOI 10.1016/S0167-4889(03)00064-8; Garcia MXU, 2002, MICROBIOL-SGM, V148, P333, DOI 10.1099/00221287-148-1-333; Garige M, 2015, BIOCHEM BIOPH RES CO, V467, P275, DOI 10.1016/j.bbrc.2015.09.175; Guo Y, 2017, BIOCHEM PHARMACOL, V135, P22, DOI 10.1016/j.bcp.2017.02.021; Halliwell B., 1991, FREE RADICAL BIO MED, V10, P449, DOI [10.1016/0891-5849(91)90055-8, DOI 10.1016/0891-5849(91)90055-8]; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARWOOD AJ, 1992, DEV BIOL, V149, P90, DOI 10.1016/0012-1606(92)90266-J; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Herrera E, 2001, J PHYSIOL BIOCHEM, V57, P43, DOI 10.1007/BF03179812; Huang EY, 2011, DEV BIOL, V358, P137, DOI 10.1016/j.ydbio.2011.07.017; Huminiecki L, 2017, SEMIN CANCER BIOL, V46, P107, DOI 10.1016/j.semcancer.2017.04.002; Jayaprakasha GK, 2006, FOOD CHEM, V98, P720, DOI 10.1016/j.foodchem.2005.06.037; JOE B, 1994, BBA-MOL CELL RES, V1224, P255, DOI 10.1016/0167-4889(94)90198-8; Katoh-Kurasawa M, 2016, J CELL SCI, V129, P1722, DOI 10.1242/jcs.181545; Kessin RH, 2001, DICTYOSTELIUM EVOLUT, pxiv; Khan MA, 2012, MOL CANCER THER, V11, P1873, DOI 10.1158/1535-7163.MCT-12-0141; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Lal B, 1999, PHYTOTHER RES, V13, P318, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;318::AID-PTR445&gt;3.0.CO;2-7; LEICHTLING BH, 1984, J BIOL CHEM, V259, P662; Li CLF, 2016, GENOME RES, V26, P1268, DOI 10.1101/gr.205682.116; Li G., 2000, GENES PATHWAYS MEDIA; Li GC, 2000, MICROBIOL-SGM, V146, P2219, DOI 10.1099/00221287-146-9-2219; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu XJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2796260; Loomis WF, 1998, MICROBIOL MOL BIOL R, V62, P684, DOI 10.1128/MMBR.62.3.684-694.1998; Ludtmann MHR, 2011, SEMIN CELL DEV BIOL, V22, P105, DOI 10.1016/j.semcdb.2010.11.002; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mann SKO, 1997, DEV BIOL, V183, P208, DOI 10.1006/dbio.1996.8499; MANN SKO, 1991, MECH DEVELOP, V35, P89, DOI 10.1016/0925-4773(91)90060-J; MARTIN JP, 1987, ARCH BIOCHEM BIOPHYS, V255, P329, DOI 10.1016/0003-9861(87)90400-0; Mates JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MCCORD JM, 1971, P NATL ACAD SCI USA, V68, P1024, DOI 10.1073/pnas.68.5.1024; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Min JX, 2006, BIOTECHNIQUES, V41, P591, DOI 10.2144/000112260; Min JX, 2005, MOL CANCER RES, V3, P287, DOI 10.1158/1541-7786.MCR-04-0197; Min JX, 2005, EUKARYOT CELL, V4, P178, DOI 10.1128/EC.4.1.178-189.2005; Miranda ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070040; Miranda Edward Roshan, 2013, Methods Mol Biol, V983, P139, DOI 10.1007/978-1-62703-302-2_8; Mishra S, 2008, ANN INDIAN ACAD NEUR, V11, P13, DOI 10.4103/0972-2327.40220; Moussavi M, 2006, CARCINOGENESIS, V27, P1636, DOI 10.1093/carcin/bgi371; Murata H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142438; MUTZEL R, 1987, P NATL ACAD SCI USA, V84, P6, DOI 10.1073/pnas.84.1.6; Nelson K.M., 2017, J MED CHEM; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Research Markets, 2015, RES MARK GLOB MARK S; Russ M, 2006, BIOCHEM BIOPH RES CO, V345, P516, DOI 10.1016/j.bbrc.2006.04.047; Sahoo K, 2012, INVEST NEW DRUG, V30, P558, DOI 10.1007/s10637-010-9610-4; Santhanam B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8551; SEGALL JE, 1995, J CELL BIOL, V128, P405, DOI 10.1083/jcb.128.3.405; Shakor ABA, 2014, BBA-MOL CELL BIOL L, V1841, P1672, DOI 10.1016/j.bbalip.2014.09.006; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Souza GM, 1998, DEVELOPMENT, V125, P2291; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; Tc-nnesen H.H., 1992, INT J PHARMACEUT, V87, P79, DOI DOI 10.1016/0378-5173(92)90230-Y; Teo R, 2010, MOL BIOL CELL, V21, P2788, DOI 10.1091/mbc.E09-10-0891; TONNESEN HH, 1985, Z LEBENSM UNTERS FOR, V180, P402, DOI 10.1007/BF01027775; Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Waheed A, 2014, BRIT J PHARMACOL, V171, P2659, DOI 10.1111/bph.12443; Wang JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22146; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Williams RSB, 2005, PROG NEURO-PSYCHOPH, V29, P1029, DOI 10.1016/j.pnpbp.2005.03.020; Yang YL, 2012, CANCER SCI, V103, P1538, DOI 10.1111/j.1349-7006.2012.02335.x; Yoshino M, 2004, TOXICOL IN VITRO, V18, P783, DOI 10.1016/j.tiv.2004.03.009; Zhang L, 2006, J ALZHEIMERS DIS, V10, P1	92	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187562	10.1371/journal.pone.0187562	http://dx.doi.org/10.1371/journal.pone.0187562			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29135990	Green Submitted, gold, Green Published			2022-12-27	WOS:000415121200023
J	Lopez-Meseguer, M; Quezada, CA; Ramon, MA; Lazaro, M; Dos, L; Lara, A; Lopez, R; Blanco, I; Escribano, P; Roman, A				Lopez-Meseguer, Manuel; Quezada, Carlos A.; Ramon, Maria A.; Lazaro, Maria; Dos, Laura; Lara, Antonio; Lopez, Raquel; Blanco, Isabel; Escribano, Pilar; Roman, Antonio		REHAP Investigators	Lung and heart-lung transplantation in pulmonary arterial hypertension	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; PREDICTING SURVIVAL; REVEAL REGISTRY; MANAGEMENT; INSIGHTS; PROSTACYCLIN; THERAPY; FAILURE; IMPACT; SPAIN	Background Real use of lung (LT) and heart-lung (HLT) transplantation in pulmonary arterial hypertension (PAH) is unknown. The objectives were to describe the indication of these procedures on PAH treatment in a national cohort of PAH patients, and to analyze the potential improvement of its indication in severe patients. Methods Eligibility for LT/HLT was assessed for each deceased patient. Incident patients from REHAP diagnosed between January 2007 and March 2015 and considered eligible for LT/HLT were grouped as follows: those who finally underwent transplantation (LTP) and those who died (D-Non-LT). Findings Of 1391 patients included in REHAP, 36 (3%) were LTP and 375 (27%) died. Among those who died, 36 (3%) were D-Non-LT. LTP and D-Non-LT were equal in terms of age, gender, and clinical status. Ten percent of those who died were functional class I-II. Patients functional class IV were less likely to undergo LT (8.3% LTP vs. 30.6% D-Non-LT, p = 0.017). Patients with idiopathic and drug/toxin-associated PAH were more likely to undergo LT (44.4% LTP vs. 16.7% D-Non-LT, p = 0.011). Conclusions The present results show that the use of LT/HLT could double for this indication. Relevant mortality in early functional class reflects the difficulties in establishing the risk of death in PAH.	[Lopez-Meseguer, Manuel; Ramon, Maria A.; Roman, Antonio] Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain; [Lopez-Meseguer, Manuel; Ramon, Maria A.; Roman, Antonio] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain; [Lopez-Meseguer, Manuel; Ramon, Maria A.; Blanco, Isabel; Roman, Antonio] Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain; [Quezada, Carlos A.; Escribano, Pilar] Hosp Univ Doce Octubre, Cardiol Dept, Pulm Hypertens Unit, Madrid, Spain; [Lazaro, Maria] Hosp Virgen Salud, Dept Cardiol, Toledo, Spain; [Dos, Laura] Dept Cardiol, Unidad CC Adolescente & Adulto Vall dHebron St Pa, Barcelona, Spain; [Lara, Antonio] Hosp Univ Canarias, Dept Cardiol, Santa Cruz De Tenerife, Spain; [Lopez, Raquel] Hosp Univ La Fe, Dept Pneumonol, Valencia, Spain; [Blanco, Isabel] Univ Barcelona, Hosp Clin IDIBAPS, Dept Pulm Med, Barcelona, Spain; [Blanco, Isabel] Univ Barcelona, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario 12 de Octubre; Complejo Hospitalario de Toledo; Universidad de la Laguna; Hospital Universitari i Politecnic La Fe; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona	Roman, A (corresponding author), Hosp Univ Vall dHebron, Dept Pneumol, Barcelona, Spain.; Roman, A (corresponding author), Univ Autonoma Barcelona, Dept Med, Barcelona, Spain.; Roman, A (corresponding author), Biomed Res Networking Ctr Resp Dis CIBERES, Madrid, Spain.	aroman@vhebron.net	Dos Subira, Laura/AEV-6136-2022; Escribano, Pilar/R-5273-2017; Dos Subira, Laura/GRY-6349-2022; Lopez Meseguer, Manuel/D-6177-2018	Escribano, Pilar/0000-0002-6640-4839; Ramon, Maria A/0000-0002-4856-8442; DOS SUBIRA, LAURA/0000-0001-5821-4501; Lopez Meseguer, Manuel/0000-0003-2650-9238	Bayer HealthCare	Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals)	This work was supported by Bayer HealthCare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; BARST RJ, 1994, ANN INTERN MED, V121, P409, DOI 10.7326/0003-4819-121-6-199409150-00003; Benza RL, 2010, TRANSPLANTATION, V90, P298, DOI 10.1097/TP.0b013e3181e49b83; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Chen H, 2009, AM J RESP CRIT CARE, V180, P468, DOI 10.1164/rccm.200810-1603OC; Corris P, 2014, EUR RESPIR REV, V23, P488, DOI 10.1183/09059180.00007214; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; de Perrot M, 2011, J HEART LUNG TRANSPL, V30, P997, DOI 10.1016/j.healun.2011.03.002; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Escribano-Subias P, 2012, EUR RESPIR J, V40, P596, DOI 10.1183/09031936.00101211; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Farber HW, 2013, J HEART LUNG TRANSPL, V32, P1114, DOI 10.1016/j.healun.2013.08.010; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Gomberg-Maitland M, 2013, J HEART LUNG TRANSPL, V32, P1179, DOI 10.1016/j.healun.2013.08.016; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; Hoeper MM, 2011, AM J RESP CRIT CARE, V184, P1114, DOI 10.1164/rccm.201104-0662CI; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Lee WTN, 2012, EUR RESPIR J, V40, P604, DOI 10.1183/09031936.00196611; Matesanz R, 2009, TRANSPL P, V41, P3453, DOI 10.1016/j.transproceed.2009.09.011; McLaughlin VV, 2015, J AM COLL CARDIOL, V65, P1976, DOI 10.1016/j.jacc.2015.03.540; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Weill D, 2015, J HEART LUNG TRANSPL, V34, P1, DOI 10.1016/j.healun.2014.06.014; Yusen RD, 2015, J HEART LUNG TRANSPL, V34, P1264, DOI 10.1016/j.healun.2015.08.014	26	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187811	10.1371/journal.pone.0187811	http://dx.doi.org/10.1371/journal.pone.0187811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161284	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000021
J	Buchan, SA; Chung, H; Campitelli, MA; Crowcroft, NS; Gubbay, JB; Karnauchow, T; Katz, K; McGeer, AJ; McNally, JD; Richardson, D; Richardson, SE; Rosella, LC; Simor, A; Smieja, M; Tran, D; Zahariadis, G; Kwong, JC				Buchan, Sarah A.; Chung, Hannah; Campitelli, Michael A.; Crowcroft, Natasha S.; Gubbay, Jonathan B.; Karnauchow, Timothy; Katz, Kevin; McGeer, Allison J.; McNally, J. Dayre; Richardson, David; Richardson, Susan E.; Rosella, Laura C.; Simor, Andrew; Smieja, Marek; Tran, Dat; Zahariadis, George; Kwong, Jeffrey C.			Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; NEW-ZEALAND; TRIVALENT; SURVEILLANCE; SENSITIVITY; HOUSEHOLDS; INFECTION; AUCKLAND; ILLNESS; MODEL	Uncertainty remains regarding the magnitude of effectiveness of influenza vaccines for preventing serious outcomes, especially among young children. We estimated vaccine effectiveness (VE) against laboratory-confirmed influenza hospitalizations among children aged 6-59 months. We used the test-negative design in hospitalized children in Ontario, Canada during the 2010-11 to 2013-14 influenza seasons. We used logistic regression models adjusted for age, season, and time within season to calculate VE estimates by vaccination status (full vs. partial), age group, and influenza season. We also assessed VE incorporating prior history of influenza vaccination. We included specimens from 9,982 patient hospitalization episodes over four seasons, with 12.8% testing positive for influenza. We observed variation in VE by vaccination status, age group, and influenza season. For the four seasons combined, VE was 60% (95% CI, 44%-72%) for full vaccination and 39% (95% CI, 17%-56%) for partial vaccination. VE for full vaccination was 67% (95% CI, 48%-79%) for children aged 24-59 months, 48% (95% CI, 12%-69%) for children aged 6-23 months, 77% (95% CI, 47%-90%) for 2010-11, 59% (95% CI, 13%-81%) for 2011-12, 33% (95% CI, -18% to 62%) for 2012-13, and 72% (95% CI, 42%-86%) for 2013-14. VE in children aged 24-59 months appeared similar between those vaccinated in both the current and previous seasons and those vaccinated in the current season only, with the exception of 2012-13, when VE was lower for those vaccinated in the current season only. Influenza vaccination is effective in preventing pediatric laboratory-confirmed influenza hospitalizations during most seasons.	[Buchan, Sarah A.; Crowcroft, Natasha S.; McGeer, Allison J.; Rosella, Laura C.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chung, Hannah; Campitelli, Michael A.; Rosella, Laura C.; Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Crowcroft, Natasha S.; Gubbay, Jonathan B.; Rosella, Laura C.; Kwong, Jeffrey C.] Publ Hlth Ontario, Toronto, ON, Canada; [Crowcroft, Natasha S.; Gubbay, Jonathan B.; Katz, Kevin; McGeer, Allison J.; Richardson, Susan E.; Simor, Andrew] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gubbay, Jonathan B.; Richardson, Susan E.; Tran, Dat] Hosp Sick Children, Toronto, ON, Canada; [Karnauchow, Timothy; McNally, J. Dayre] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Karnauchow, Timothy] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Katz, Kevin] North York Gen Hosp, Toronto, ON, Canada; [McGeer, Allison J.] Sinai Hlth Syst, Toronto, ON, Canada; [Richardson, David] William Osler Hlth Syst, Brampton, ON, Canada; [Simor, Andrew] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Smieja, Marek] McMaster Univ, Hamilton, ON, Canada; [Tran, Dat] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Zahariadis, George] London Hlth Sci Ctr, London, ON, Canada; [Zahariadis, George] Newfoundland & Labrador Publ Hlth Lab, St John, NF, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; University of Toronto; London Health Sciences Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kwong, JC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Kwong, JC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Kwong, JC (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Kwong, JC (corresponding author), Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.; Kwong, JC (corresponding author), Univ Hlth Network, Toronto, ON, Canada.	jeff.kwong@utoronto.ca	McGeer, Allison/AAB-6885-2020; Gubbay, Jonathan/Q-8580-2019	McGeer, Allison/0000-0001-5647-6137; Gubbay, Jonathan/0000-0003-0026-3786; Buchan, Sarah/0000-0002-5286-8974	Canadian Institutes of Health Research [CIHR MOP 130568]; Canadian Immunization Research Network; Ontario Graduate Scholarship; Canadian Institutes of Health Research; University of Toronto Department of Family and Community Medicine; Canada Research Chair in Population Health Analytics; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Public Health Ontario (PHO) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Immunization Research Network; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Toronto Department of Family and Community Medicine; Canada Research Chair in Population Health Analytics; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Public Health Ontario (PHO) - Ontario Ministry of Health and Long-Term Care (MOHLTC)	This work was supported by an operating grant from the Canadian Institutes of Health Research [CIHR MOP 130568]. SAB's doctoral training is supported by a Canadian Immunization Research Network Trainee Award and an Ontario Graduate Scholarship. JCK is supported by a New Investigator Salary Award from the Canadian Institutes of Health Research and a Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine. LCR is supported by a Canada Research Chair in Population Health Analytics. This study was supported by the Institute for Clinical Evaluative Sciences (ICES) and Public Health Ontario (PHO), which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. Parts of this material are based on data and information compiled and provided by the Canadian Institute of Health Information (CIHI) and by Cancer Care Ontario (CCO).	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Blyth CC, 2016, EUROSURVEILLANCE, V21, P25, DOI 10.2807/1560-7917.ES.2016.21.30.30301; Chung JR, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3279; Cowling BJ, 2014, VACCINE, V32, P5278, DOI 10.1016/j.vaccine.2014.07.084; De Serres G, 2013, EURO SURVEILL, V18, P37; Englund H, 2013, EPIDEMIOL INFECT, V141, P1807, DOI 10.1017/S0950268812002282; Feng S, 2016, VACCINE, V34, P1672, DOI 10.1016/j.vaccine.2016.02.039; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Fox MP, 2005, INT J EPIDEMIOL, V34, P1370, DOI 10.1093/ije/dyi184; Fu C., 2013, HYDROL EARTH SYST SC, V10, P2013, DOI DOI 10.1016/J; Haber M, 2015, EPIDEMIOL INFECT, V143, P1417, DOI 10.1017/S0950268814002179; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jackson ML, 2015, VACCINE, V33, P1313, DOI 10.1016/j.vaccine.2015.01.069; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Kafatos G, 2013, INFLUENZA OTHER RESP, V7, P1175, DOI 10.1111/irv.12163; Kissling E, 2014, EURO SURVEILL, V19; Kissling E, 2013, EURO SURVEILL, V18; Lane CR, 2016, VACCINE, V34, P1070, DOI 10.1016/j.vaccine.2016.01.002; McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680; Menniti-Ippolito F, 2014, VACCINE, V32, P4466, DOI 10.1016/j.vaccine.2014.06.048; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Moran K, 2009, VACCINE, V27, P2350, DOI 10.1016/j.vaccine.2009.02.017; National Advisory Committee on Immunization, 2012, CAN COMMUN DIS REP, V38; Ohmit SE, 2016, J INFECT DIS, V213, P1229, DOI 10.1093/infdis/jiv563; Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650; Patel PA, 2011, J CLIN MICROBIOL, V49, P2266, DOI [10.1128/JCM.02431-10, 10.1128/JCM.00698-11]; Pebody R, 2013, EUROSURVEILLANCE, V18, DOI DOI 10.2807/ESE.18.05.20389-EN; Pierse N, 2016, VACCINE, V34, P503, DOI 10.1016/j.vaccine.2015.11.073; Schwartz Kevin L, 2016, CMAJ Open, V4, pE463; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Skowronski DM, 2015, J INFECT DIS, V212, P726, DOI 10.1093/infdis/jiv177; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Szilagyi PG, 2008, ARCH PEDIAT ADOL MED, V162, P943, DOI 10.1001/archpedi.162.10.943; Thompson MG, 2016, PEDIATR INFECT DIS J, V35, P299, DOI 10.1097/INF.0000000000001006; Turner N, 2014, EURO SURVEILL, V19; Turner N, 2014, VACCINE, V32, P3687, DOI 10.1016/j.vaccine.2014.04.013; Valenciano M, 2015, VACCINE, V33, P2813, DOI 10.1016/j.vaccine.2015.04.012; Wang Y, 2016, VACCINE, V34, P2460, DOI 10.1016/j.vaccine.2016.03.056	40	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187834	10.1371/journal.pone.0187834	http://dx.doi.org/10.1371/journal.pone.0187834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149183	gold, Green Published, Green Submitted			2022-12-27	WOS:000415646100013
J	Mulmi, P; Masters, WA; Ghosh, S; Namirembe, G; Rajbhandary, R; Manohar, S; Shrestha, B; West, KP; Webb, P				Mulmi, Prajula; Masters, William A.; Ghosh, Shibani; Namirembe, Grace; Rajbhandary, Ruchita; Manohar, Swetha; Shrestha, Binod; West, Keith P.; Webb, Patrick			Household food production is positively associated with dietary diversity and intake of nutrient-dense foods for older preschool children in poorer families: Results from a nationally-representative survey in Nepal	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; FEEDING PRACTICES; NUTRITIONAL-STATUS; HEALTH; CONSUMPTION; INTERVENTIONS; BANGLADESH; FREQUENCY; MOTHERS; MARKETS	Background Nutrition-sensitive interventions supporting enhanced household food production have potential to improve child dietary quality. However, heterogeneity in market access may cause systematic differences in program effectiveness depending on household wealth and child age. Identifying these effect modifiers can help development agencies specify and target their interventions. Objective This study investigates mediating effects of household wealth and child age on links between farm production and child diets, as measured by production and intake of nutrient-dense food groups. Methods Two rounds (2013 and 2014) of nationally representative survey data (n = 5,978 observations) were used to measure production and children's dietary intake, as well as a household wealth index and control variables, including breastfeeding. Novel steps used include measuring production diversity in terms of both species grown and food groups grown, as well as testing for mediating effects of family wealth and age of child. Results We find significant associations between child dietary diversity and agricultural diversity in terms of diversity of food groups and of species grown, especially for older children in poorer households, and particularly for fruits and vegetables, dairy and eggs. With each additional food group produced, log-odds of meeting minimum dietary diversity score (>= 4) increase by 0.25 (p = 0.01) for children aged 24-59 months. For younger children aged 18-23 months there is a similar effect size but only in the poorest two quintiles of household wealth, and for infants 6-18 months we find no correlation between production and intake in most models. Conclusions Child dietary intake is associated with the composition of farm production, most evident among older preschool children and in poorer households. To improve the nutrition of infants, other interventions are needed; and for relatively wealthier households, own farm production may displace market purchases, which could attenuate the impact of household production on child diets.	[Mulmi, Prajula; Masters, William A.; Ghosh, Shibani; Namirembe, Grace; Webb, Patrick] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Rajbhandary, Ruchita; Manohar, Swetha; Shrestha, Binod; West, Keith P.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD USA	Tufts University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Masters, WA (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA.	william.masters@tufts.edu	Webb, Patrick/P-3420-2017; Masters, William A./A-4796-2017	Webb, Patrick/0000-0002-9857-3354; Masters, William A./0000-0002-4546-7291	United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID] [AID-OAA-L-1-00005]; Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI] [301052.001.001.515.01.01]; Feed the Future Policy Impact Study Consortium [USDA] [TA-CA-15-008]; Logistics Management Division at the Child Health Division; UNICEF	United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID](United States Agency for International Development (USAID)); Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI]; Feed the Future Policy Impact Study Consortium [USDA](United States Agency for International Development (USAID)); Logistics Management Division at the Child Health Division; UNICEF	This project was supported by a grant to PW and subaward to KPW from the United States Agency for International Development through the Feed the Future Innovation Lab for Nutrition [USAID grant number AID-OAA-L-1-00005], online at www.nutritioninnovationlab.org. WAM was also supported by the Bill & Melinda Gates Foundation through the Advancing Research on Nutrition and Agriculture (ARENA) project [IFPRI project no. 301052.001.001.515.01.01], online at www.ifpri. org/project/advancing-research-nutrition-and-agriculture-arena, and the Feed the Future Policy Impact Study Consortium [USDA cooperative agreement TA-CA-15-008], online at http://ru-ftf.rutgers.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all contributors to the Nutrition Innovation Lab including Liz Marino-Costello of Tufts University and Gerald Shively from Purdue University; Raman Shrestha, Abhighyna Bhattarai, Hari Krishna Shah, Dev Raj Gautam and Diplav Sapkota of the PoSHAN study team in Nepal; Deepak Thapa from the Nepal Technical Assistance Group and Hari Koirala from USAID/Nepal. We are particularly grateful for the work of more than 80 interviewers and anthropometrists, field supervisors, quality control officers, data entry and management staff and research supervisors as well as Sidhartha M Tuladhar, Executive Director of New Era (P.) Ltd., and support received from the Logistics Management Division at the Child Health Division and UNICEF. We also thank the administrative leadership of Rajkumar Pokharel, Chief, Nutrition Section, at the Child Health Division of the Department of Health Services, Ministry of Health and Population in the Government of Nepal. Ethical review in Nepal was conducted by the Nepal Health Research Council (Kathmandu).	Alaofe H, 2016, FOOD NUTR BULL, V37, P164, DOI 10.1177/0379572116639710; [Anonymous], CLIMATE IMPACTS FOOD; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Bageant E, 2016, 1515 IFPRI; Bardhan P., 1999, DEV MICROECONOMICS, DOI [10.1093/0198773714.001.0001, DOI 10.1093/0198773714.001.0001]; Bellon MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162535; Bennett L., 2008, CASTE ETHNIC REGIONA; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Biehl E, 2016, FOOD NUTR BULL, V37, P247, DOI 10.1177/0379572116657267; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Block SA, 2006, OXF EC PAP, V59, P330; Byrd-Bredbenner C, 2012, WARDLAWS PERSPECTIVE; Central Bureau of Statistics, 2014, POPULATION MONOGRAPH; Darrouzet-Nardi AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168759; Darrouzet-Nardi AF, 2016, FOOD POLICY, V61, P185, DOI 10.1016/j.foodpol.2016.03.007; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; DFID and the World Bank, 2006, UN CIT GEND CAST ETH; Dorsey JL, 2017, MATERN CHILD NUTR; ESWARAN M, 1989, J DEV ECON, V31, P37, DOI 10.1016/0304-3878(89)90030-8; Gender Bennett L., 2005, NEW FRONTIERS SOCIAL; Hjelm L, 2016, FOOD NUTR BULL, V37, P275, DOI 10.1177/0379572116653509; Islam MM, 2008, AM J CLIN NUTR, V88, P84, DOI 10.1093/ajcn/88.1.84; Lamichhane DK, 2016, PAEDIATR INT CHILD H, V36, P260, DOI 10.1080/20469047.2015.1109281; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Lindsay AC, 2008, FOOD NUTR BULL, V29, P15, DOI 10.1177/156482650802900102; Malapit HJL, 2013, 1313 IFPRI; Manohar S., 2014, POSHAN COMMUNITY STU; MARTORELL R, 1984, AM J CLIN NUTR, V39, P74, DOI 10.1093/ajcn/39.1.74; Masters WA, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12421; Mendola Mariapia, 2007, ASIAN DEV REV, V24, P49, DOI DOI 10.2139/ssrn.661021; Miller LC, 2014, FOOD NUTR BULL, V35, P312, DOI 10.1177/156482651403500304; Ministry of Health and Population (MOHP), 2012, NEP DEM HLTH SURV 20; Mulmi P, 2016, ECON HUM BIOL, V23, P63, DOI 10.1016/j.ehb.2016.07.002; Nguyen PH, 2013, J NUTR, V143, P1176, DOI 10.3945/jn.112.172247; Osei A, 2017, FOOD NUTR BULL, V38, P49, DOI 10.1177/0379572116676427; Pandey J.P., 2013, MATERNAL CHILD HLTH; Pomeroy-Stevens A, 2016, FOOD NUTR BULL, V37, pS151, DOI 10.1177/0379572116674555; Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293; Rasheed S, 2011, FOOD NUTR BULL, V32, P192, DOI 10.1177/156482651103200302; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Simondon KB, 2001, INT J EPIDEMIOL, V30, P476, DOI 10.1093/ije/30.3.476; Singh Inderjit, 1986, AGR HOUSEHOLD MODELS; Singh PK, 2005, J PEDIATR GASTR NUTR, V41, P422, DOI 10.1097/01.mpg.0000178443.18041.98; Taylor J. E., 2003, REV ECON HOUSEHOLD, V1, P33, DOI DOI 10.1023/A:1021847430758; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2001, COMPL FEED REP GLOB	48	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0186765	10.1371/journal.pone.0186765	http://dx.doi.org/10.1371/journal.pone.0186765			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145391	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800004
J	O'Rourke, N; Heisel, MJ; Canham, SL; Sixsmith, A				O'Rourke, Norm; Heisel, Marnin J.; Canham, Sarah L.; Sixsmith, Andrew		BADAS Study Team	Predictors of suicide ideation among older adults with bipolar disorder	PLOS ONE			English	Article							ADAPTING INTERPERSONAL PSYCHOTHERAPY; COGNITIVE FAILURES QUESTIONNAIRE; PRIMARY-CARE PATIENTS; CLINICAL CHARACTERISTICS; PSYCHOMETRIC PROPERTIES; INTERNATIONAL SOCIETY; ALCOHOL-USE; TASK-FORCE; RISK; LIFE	Objectives Bipolar disorder (BD) carries the greatest risk of death by suicide of all psychiatric conditions as 25%-50% of those with BD will make one or more suicide attempt, and about 15% will intentionally end their lives. Among young adults with BD, substance misuse, medication non-adherence, age at onset, and comorbid psychiatric conditions each predict self-harm. It is currently unclear if these same factors or others predict suicide ideation among older adults with BD. Methods We recruited a global sample of 220 older adults with BD over 19 days using socio-demographically targeted, social media advertising and online data collection (Mean = 58.50, SD = 5.42; range 50 to 81 years). Path analyses allowed us to identify direct and indirect predictors of suicide ideation among older adults with BD. Results Cognitive failures (perception, memory, and motor function), depressive symptoms, alcohol misuse, and dissatisfaction with life as direct predictors of suicide ideation; duration of BD symptoms and medication non-adherence emerged as indirect predictors. Of note, the significant impact of sleep on suicide ideation is indirect via depressive symptoms, cognitive failures, medication non-adherence and life dissatisfaction. Conclusions As with young adults with BD, alcohol misuse and medication non-adherence emerged as significant predictors of suicide ideation. In addition, cognitive failures directly and indirectly predict suicide ideation in this sample of older adults with BD. Population aging and treatment efficacy are leading to ever growing numbers of older adults with BD. Both direct and indirect predictors of suicide ideation need to be considered in future BD research and treatment planning.	[O'Rourke, Norm] Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel; [O'Rourke, Norm] Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, Beer Sheva, Israel; [Heisel, Marnin J.] Univ Western Ontario, Dept Psychiat, London, ON, Canada; [Heisel, Marnin J.] Lawson Hlth Res Inst, London, ON, Canada; [Canham, Sarah L.] Simon Fraser Univ, Gerontol Res Ctr, Vancouver, BC, Canada; [Sixsmith, Andrew] Simon Fraser Univ, STAR Inst, Surrey, BC, Canada; [BADAS Study Team] Simon Fraser Univ, IRMACS Ctr, Burnaby, BC, Canada	Ben Gurion University; Ben Gurion University; Western University (University of Western Ontario); Western University (University of Western Ontario); Simon Fraser University; Simon Fraser University; Simon Fraser University	O'Rourke, N (corresponding author), Ben Gurion Univ Negev, Dept Publ Hlth, Beer Sheva, Israel.; O'Rourke, N (corresponding author), Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, Beer Sheva, Israel.	ORourke@bgu.ac.il	Ca, Sarah/J-2927-2019; O'Rourke, Norm/AAP-5428-2020	Ca, Sarah/0000-0002-0421-2612; O'Rourke, Norm/0000-0001-5100-427X	Age-Well Network of Centres for Excellence [CRP 2015-WP6.2]; Canadian Institutes of Health Research awarded; BADAS Study Team (CIHR) [134209 - 259022]	Age-Well Network of Centres for Excellence; Canadian Institutes of Health Research awarded; BADAS Study Team (CIHR)	This study was funded by the Age-Well Network of Centres for Excellence (O'Rourke; CRP 2015-WP6.2) and the Canadian Institutes of Health Research awarded to Drs. O'Rourke, Sixsmith (principal investigators) and the BADAS Study Team (CIHR #134209 - 259022).	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1097/00000374-199706000-00008; Almeida OP, 2002, INT PSYCHOGERIATR, V14, P311, DOI 10.1017/S1041610202008517; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Arts B, 2011, ACTA PSYCHIAT SCAND, V123, P190, DOI 10.1111/j.1600-0447.2010.01601.x; Babor T., 1989, ALCOHOL HEALTH RES W, V13, P371; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Barraco A, 2012, CNS NEUROSCI THER, V18, P110, DOI 10.1111/j.1755-5949.2010.00225.x; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Bhar SS, 2012, COGN BEHAV PRACT, V19, P116, DOI 10.1016/j.cbpra.2010.12.005; Boland EM, 2013, CLIN PSYCHOL REV, V33, P33, DOI 10.1016/j.cpr.2012.10.001; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Buysse D J, 1989, Psychiatry Res, V28, P193; Canetto SS, 1998, SUICIDE LIFE-THREAT, V28, P1; Canham Mahmood A, 2017, AGING MENT HLTH; Canham SL, 2017, AGING MENT HLTH; Carmel S, 2016, AGING MENT HLTH; Cerimele JM, 2014, PSYCHIAT SERV, V65, P1041, DOI 10.1176/appi.ps.201300374; Conigliaro J, 2000, J GERIATR PSYCH NEUR, V13, P106, DOI 10.1177/089198870001300303; Depp CA, 2004, BIPOLAR DISORD, V6, P343, DOI 10.1111/j.1399-5618.2004.00139.x; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Doty TJ, 2008, PSYCHIAT RES-NEUROIM, V163, P84, DOI 10.1016/j.pscychresns.2007.08.003; Gildengers AG, 2013, PSYCHOL MED, V43, P801, DOI 10.1017/S0033291712001614; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Heisel MJ, 2006, AM J GERIAT PSYCHIAT, V14, P742, DOI 10.1097/01.JGP.0000218699.27899.f9; Heisel MJ, 2016, AM J GERIAT PSYCHIAT, V24, P455, DOI 10.1016/j.jagp.2015.08.007; Heisel MJ, 2016, AGING MENT HEALTH, V20, P195, DOI 10.1080/13607863.2015.1078279; Heisel MJ, 2015, AM J GERIAT PSYCHIAT, V23, P87, DOI 10.1016/j.jagp.2014.03.010; Heisel MJ, 2014, MEANING IN POSITIVE AND EXISTENTIAL PSYCHOLOGY, P303, DOI 10.1007/978-1-4939-0308-5_18; Heisel MJ, 2008, CLIN GERONTOLOGIST, V31, P51, DOI 10.1080/07317110801947177; Heisel MJ, 2009, PROF PSYCHOL-RES PR, V40, P156, DOI 10.1037/a0014731; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kim HM, 2012, J CLIN PSYCHIAT, V73, P1269; King David B., 2016, Gerontechnology, V14, P105, DOI 10.4017/gt.2016.14.2.006.00; King DB, 2014, CAN PSYCHOL, V55, P240, DOI 10.1037/a0038087; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lala SV, 2012, J GERIATR PSYCH NEUR, V25, P20, DOI 10.1177/0891988712436683; Lapierre S, 2011, CRISIS, V32, P88, DOI 10.1027/0227-5910/a000076; Levy B, 2008, PSYCHIAT RES, V161, P28, DOI 10.1016/j.psychres.2007.09.009; Lopez-Castroman J, 2015, BIPOLAR DISORD, V17, P22, DOI 10.1111/bdi.12264; Montes JM, 2013, PATIENT PREFER ADHER, V7, P89, DOI 10.2147/PPA.S39290; Meyer C, 2004, SOC PSYCH PSYCH EPID, V39, P435, DOI 10.1007/s00127-004-0755-3; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; Nadorff MR, 2013, J GERONTOL B-PSYCHOL, V68, P145, DOI 10.1093/geronb/gbs061; Neufeld E, 2009, CAN J PSYCHIAT, V54, P684, DOI 10.1177/070674370905401005; O'Rourke N, 2013, A STEP BY STEP APPRO; O'Rourke N, 2017, AGING MENT HLTH; Oquendo MA, 2000, J AFFECT DISORDERS, V59, P107, DOI 10.1016/S0165-0327(99)00129-9; Robinson LJ, 2006, BIPOLAR DISORD, V8, P103, DOI 10.1111/j.1399-5618.2006.00277.x; Russo M, 2015, J AFFECT DISORDERS, V187, P156, DOI 10.1016/j.jad.2015.08.009; Sajatovic M, 2015, BIPOLAR DISORD, V17, P689, DOI 10.1111/bdi.12331; SAUNDERS EFH, 2013, INT J BIPOLAR DISORD, V1; Saunders KEA, 2015, BIPOLAR DISORD, V17, P24, DOI 10.1111/bdi.12267; Schaffer A, 2015, BIPOLAR DISORD, V17, P1, DOI 10.1111/bdi.12271; Segal DL, 2012, J GERONTOL B-PSYCHOL, V67, P159, DOI 10.1093/geronb/gbr080; Sorocco KH, 2006, J GEN PSYCHOL, V133, P453, DOI 10.3200/GENP.133.4.453-467; SPITZER RL, 1995, JAMA-J AM MED ASSOC, V274, P1511, DOI 10.1001/jama.274.19.1511; Stalman MN, 2017, INT J MENT HLTH NURS; Thomas A. J., 2010, PRACTICAL MANAGEMENT, P84; Tondo L, 2003, CNS DRUGS, V17, P491, DOI 10.2165/00023210-200317070-00003; Turvey CL, 2002, AM J GERIAT PSYCHIAT, V10, P398; van der Werf-Eldering MJ, 2011, J AFFECT DISORDERS, V130, P306, DOI 10.1016/j.jad.2010.10.005	68	13	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187632	10.1371/journal.pone.0187632	http://dx.doi.org/10.1371/journal.pone.0187632			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM8YO	29145409	Green Submitted, Green Published, gold			2022-12-27	WOS:000415378800024
J	Zaferiou, AM; Ojeda, L; Cain, SM; Vitali, RV; Davidson, SP; Stirling, L; Perkins, NC				Zaferiou, Antonia M.; Ojeda, Lauro; Cain, Stephen M.; Vitali, Rachel V.; Davidson, Steven P.; Stirling, Leia; Perkins, Noel C.			Quantifying performance on an outdoor agility drill using foot-mounted inertial measurement units	PLOS ONE			English	Article							INCREASED ROTATIONAL DEMANDS; IMPULSE GENERATION; TURNS; SENSORS; WALKING; STEP; GAIT; KINEMATICS; NAVIGATION; VELOCITY	Running agility is required for many sports and other physical tasks that demand rapid changes in body direction. Quantifying agility skill remains a challenge because measuring rapid changes of direction and quantifying agility skill from those measurements are difficult to do in ways that replicate real task/game play situations. The objectives of this study were to define and to measure agility performance for a (five-cone) agility drill used within a military obstacle course using data harvested from two foot-mounted inertial measurement units (IMUs). Thirty-two recreational athletes ran an agility drill while wearing two IMUs secured to the tops of their athletic shoes. The recorded acceleration and angular rates yield estimates of the trajectories, velocities and accelerations of both feet as well as an estimate of the horizontal velocity of the body mass center. Four agility performance metrics were proposed and studied including: 1) agility drill time, 2) horizontal body speed, 3) foot trajectory turning radius, and 4) tangential body acceleration. Additionally, the average horizontal ground reaction during each footfall was estimated. We hypothesized that shorter agility drill performance time would be observed with small turning radii and large tangential acceleration ranges and body speeds. Kruskal-Wallis and mean rank post-hoc statistical analyses revealed that shorter agility drill performance times were observed with smaller turning radii and larger tangential acceleration ranges and body speeds, as hypothesized. Moreover, measurements revealed the strategies that distinguish high versus low performers. Relative to low performers, high performers used sharper turns, larger changes in body speed (larger tangential acceleration ranges), and shorter duration footfalls that generated larger horizontal ground reactions during the turn phases. Overall, this study advances the use of foot-mounted IMUs to quantify agility performance in contextually-relevant settings (e.g., field of play, training facilities, obstacle courses, etc.).	[Zaferiou, Antonia M.; Ojeda, Lauro; Cain, Stephen M.; Vitali, Rachel V.; Davidson, Steven P.; Perkins, Noel C.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Zaferiou, Antonia M.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Stirling, Leia] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Rush University; Massachusetts Institute of Technology (MIT)	Zaferiou, AM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Zaferiou, AM (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	Antonia_Zaferiou@rush.edu			US Army Contracting Command-APG, Natick Contracting Division, Natick, MA [435, W911QY-15-C-0053]	US Army Contracting Command-APG, Natick Contracting Division, Natick, MA	This material is based upon work supported by the US Army Contracting Command-APG, 435 Natick Contracting Division, Natick, MA, under contract W911QY-15-C-0053. Contract granted to NP. The funders reviewed study design and submitted material.; The authors thank the participants of this study. This material is based upon work supported by the US Army Contracting Command-APG, 435 Natick Contracting Division, Natick, MA, under contract W911QY-15-C-0053.	Besier TF, 2001, MED SCI SPORT EXER, V33, P1168; Beyea J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040934; Cain SM, 2016, GAIT POSTURE, V43, P65, DOI 10.1016/j.gaitpost.2015.10.022; Chardonnens J, 2013, J BIOMECH, V46, P56, DOI 10.1016/j.jbiomech.2012.10.005; El-Gohary M, 2014, SENSORS-BASEL, V14, P356, DOI 10.3390/s140100356; Fino PC, 2015, SENSORS-BASEL, V15, P10676, DOI 10.3390/s150510676; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fuller JR, 2007, GAIT POSTURE, V25, P393, DOI 10.1016/j.gaitpost.2006.05.013; Havens KL, 2015, GAIT POSTURE, V42, P240, DOI 10.1016/j.gaitpost.2014.07.022; Horak FB, 2013, MOVEMENT DISORD, V28, P1544, DOI 10.1002/mds.25684; Jindrich DL, 2009, CHAOS, V19, DOI 10.1063/1.3143031; Mancini M, 2016, J GERONTOL A-BIOL, V71, P1102, DOI 10.1093/gerona/glw019; Mariani B, 2010, J BIOMECH, V43, P2999, DOI 10.1016/j.jbiomech.2010.07.003; McGinnis RS, 2017, BIOMED SIGNAL PROCES, V32, P150, DOI 10.1016/j.bspc.2016.10.013; Miranda DL, 2013, J BIOMECH, V46, P567, DOI 10.1016/j.jbiomech.2012.09.023; Novak D, 2014, SENSORS-BASEL, V14, P18800, DOI 10.3390/s141018800; Ojeda L, 2007, J NAVIGATION, V60, P391, DOI 10.1017/S0373463307004286; Orendurff MS, 2006, GAIT POSTURE, V23, P106, DOI 10.1016/j.gaitpost.2004.12.008; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Peruzzi A, 2011, J BIOMECH, V44, P1991, DOI 10.1016/j.jbiomech.2011.04.035; Pham MH, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00135; Rebula JR, 2013, GAIT POSTURE, V38, P974, DOI 10.1016/j.gaitpost.2013.05.012; Savage PG, 1998, J GUID CONTROL DYNAM, V21, P208, DOI 10.2514/2.4242; Seel T, 2012, IEEE INTL CONF CONTR, P45, DOI 10.1109/CCA.2012.6402423; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Sporri J, 2012, INT J SPORTS SCI COA, V7, P647, DOI 10.1260/1747-9541.7.4.647; Suzuki Y, 2014, SPORT BIOMECH, V13, P144, DOI 10.1080/14763141.2014.910264; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; Thigpen MT, 2000, PHYS THER, V80, P1174, DOI 10.1093/ptj/80.12.1174; Vitali RV, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17091970; Wang H, 2010, INT J SPORTS MED, V31, P742, DOI 10.1055/s-0030-1261942; Wilcox R.R., 2012, MODERN STAT SOCIAL B; Willmann RD, 2007, P ANN INT IEEE EMBS, P4015, DOI 10.1109/IEMBS.2007.4353214; Young W, 2006, STRENGTH COND J, V28, P24, DOI 10.1519/1533-4295(2006)28[24:AROAPA]2.0.CO;2; Yu G, 2016, SENSORS SWITZERLAND, V16, P1; Zaferiou AM, 2017, J BIOMECH, V52, P130, DOI 10.1016/j.jbiomech.2016.12.017; Zaferiou AM, 2016, J APPL BIOMECH, V32, P425, DOI 10.1123/jab.2015-0314; Zaferiou AM, 2016, HUM MOVEMENT SCI, V47, P220, DOI 10.1016/j.humov.2016.03.012	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188184	10.1371/journal.pone.0188184	http://dx.doi.org/10.1371/journal.pone.0188184			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145504	gold, Green Published, Green Submitted			2022-12-27	WOS:000415378800083
J	Jiang, QL; Bao, CC; Yang, YN; Liu, A; Liu, F; Huang, HY; Ye, HH				Jiang, Qingling; Bao, Chenchang; Yang, Ya'nan; Liu, An; Liu, Fang; Huang, Huiyang; Ye, Haihui			Transcriptome profiling of claw muscle of the mud crab (Scylla paramamosain) at different fattening stages	PLOS ONE			English	Article							SKELETAL-MUSCLE; DROSOPHILA; GROWTH; SARCOSPAN; CRUSTACEAN; REVEALS; QUANTIFICATION; ANNOTATION; REGULATORS; HOMOLOG	In crustaceans, muscle growth and development is complicated, and to date substantial knowledge gaps exist. In this study, the claw muscle, hepatopancreas and nervous tissue of the mud crab (Scylla paramamosain) were collected at three fattening stages for sequence by the Illumina sequencing. A total of 127.87 Gb clean data with no less than 3.94 Gb generated for each sample and the cycleQ30 percentages were more than 86.13% for all samples. De Bruijn assembly of these clean data produced 94,853 unigenes, thereinto, 50,059 unigenes were found in claw muscle. A total of 121 differentially expressed genes (DEGs) were revealed in claw muscle from the three fattening stages with a Padj value < 0.01, including 63 genes with annotation. Functional annotation and enrichment analysis showed that the DEGs clusters represented the predominant gene catalog with roles in biochemical processes (glycolysis, phosphorylation and regulation of transcription), molecular function (ATP binding, 6-phosphofructokinase activity, and sequence-specific DNA binding) and cellular component (6-phosphofructokinase complex, plasma membrane, and integral component of membrane). qRT-PCR was employed to further validate certain DEGs. Single nucleotide polymorphism (SNP) analysis obtained 159,322, 125,963 and 166,279 potential SNPs from the muscle transcriptome at stage B, stage C and stage D, respectively. In addition, there were sixteen neuropeptide transcripts being predicted in the claw muscle. The present study provides a comprehensive transcriptome of claw muscle of S. paramamosain during fattening, providing a basis for screening the functional genes that may affect muscle growth of S. paramamosain.	[Jiang, Qingling; Bao, Chenchang; Yang, Ya'nan; Liu, An; Liu, Fang; Huang, Huiyang; Ye, Haihui] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [Ye, Haihui] Collaborat Innovat Ctr Dev & Utilizat Marine Biol, Xiamen, Peoples R China	Xiamen University	Ye, HH (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China.; Ye, HH (corresponding author), Collaborat Innovat Ctr Dev & Utilizat Marine Biol, Xiamen, Peoples R China.	haihuiye@xmu.edu.cn			Important Science AMP; Technology Specific Project of Zhejiang Province for Selective Breeding [2016C02055-8]; Ningbo University; Spark Plan Project in Fujian Province [2016S0055]; Xiamen Southern Oceanographic Center [14GZY56HJ26]	Important Science AMP; Technology Specific Project of Zhejiang Province for Selective Breeding; Ningbo University; Spark Plan Project in Fujian Province; Xiamen Southern Oceanographic Center	This study was supported by the Important Science & Technology Specific Project of Zhejiang Province for Selective Breeding (2016C02055-8) and K. C. Wong Magna Fund in Ningbo University, the Spark Plan Project in Fujian Province (No. 2016S0055) and the Xiamen Southern Oceanographic Center (No. 14GZY56HJ26).	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bao CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17055; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer DC., 2011, NATURE PRECEDINGS; BITTNER GD, 1978, J COMP PHYSIOL, V124, P277, DOI 10.1007/BF00657059; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Crosbie RH, 2000, HUM MOL GENET, V9, P2019, DOI 10.1093/hmg/9.13.2019; Dreiza CM, 2010, CELL STRESS CHAPERON, V15, P1, DOI 10.1007/s12192-009-0127-8; Du HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033311; Duan H, 2001, DEVELOPMENT, V128, P4489; ELHAJ AJ, 1984, J CRUSTACEAN BIOL, V4, P536, DOI 10.2307/1548067; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Fernandes JJ, 1998, DEVELOPMENT, V125, P1769; Gao J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-585; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Ghaffari N, 2014, SCI REP-UK, V4, DOI 10.1038/srep07081; Golenhofen N, 2004, HISTOCHEM CELL BIOL, V122, P415, DOI 10.1007/s00418-004-0711-z; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grimmelikhuijzen CJP, 1996, INT REV CYTOL, V167, P37, DOI 10.1016/S0074-7696(08)61345-5; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hayashi K, 2006, MICRON, V37, P591, DOI 10.1016/j.micron.2005.11.013; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-1; Huang XS, 2014, GEN COMP ENDOCR, V204, P229, DOI 10.1016/j.ygcen.2014.06.002; Keenan C., 1999, ACAIR P; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lebakken CS, 2000, MOL CELL BIOL, V20, P1669, DOI 10.1128/MCB.20.5.1669-1677.2000; Liu SS, 2017, FISH SHELLFISH IMMUN, V60, P545, DOI 10.1016/j.fsi.2016.07.033; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152572; Marshall JL, 2012, HUM MOL GENET, V21, P4378, DOI 10.1093/hmg/dds271; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; MYKLES DL, 1980, J EXP BIOL, V84, P89; Navegantes LCC, 2001, AM J PHYSIOL-ENDOC M, V281, pE449, DOI 10.1152/ajpendo.2001.281.3.E449; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Piccirillo R, 2014, DEV DYNAM, V243, P201, DOI 10.1002/dvdy.24036; Portin P, 2002, HEREDITAS, V136, P89, DOI 10.1034/j.1601-5223.2002.1360201.x; Puppa MJ, 2015, HEALTHY AGEING LONG, V3, P107, DOI 10.1007/978-3-319-18326-8_5; Rembold CM, 2000, J PHYSIOL-LONDON, V524, P865, DOI 10.1111/j.1469-7793.2000.00865.x; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Shen Jie, 2011, Journal of Fisheries of China, V35, P1481; SKINNER DM, 1966, J EXP ZOOL, V163, P115, DOI 10.1002/jez.1401630202; Tagmount A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009327; Taylor MV, 2006, MOL B INT U, P169, DOI 10.1007/0-387-32963-3_14; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Tixier V, 2013, P NATL ACAD SCI USA, V110, P18982, DOI 10.1073/pnas.1301262110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Waiho K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171095; Watling L, 2015, NATURAL HIST CRUSTAC; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yalin S., 1994, Naga, V17, P28; Ye HH, 2011, AQUACULT INT, V19, P313, DOI 10.1007/s10499-010-9399-3; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278; Zhang FY, 2016, NEUROSCI BULL, V32, P205, DOI 10.1007/s12264-016-0032-y	61	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188067	10.1371/journal.pone.0188067	http://dx.doi.org/10.1371/journal.pone.0188067			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141033	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400052
J	Loffler, C; Bohmer, F				Loeffler, Christin; Boehmer, Femke			The effect of interventions aiming to optimise the prescription of antibiotics in dental care-A systematic review	PLOS ONE			English	Review							INFECTIVE ENDOCARDITIS; PRESCRIBING PRACTICES; CLINICAL AUDIT; PRACTITIONERS; DENTISTS; PROPHYLAXIS; GUIDELINES; KNOWLEDGE; PREVENTION; PNEUMONIA	Background Abundant evidence in dentistry suggests that antibiotics are prescribed despite the existence of guidelines aiming to reduce the development of antibiotic resistance. This review investigated (1) which type of interventions aiming to optimise prescription of antibiotics exist in dentistry, (2) the effect of these interventions and (3) the specific strengths and limitations of the studies reporting on these interventions. Method Literature search was based on Medline, Embase, Global Health, Cochrane CENTRAL, ClinicalTrials.gov and Current Controlled Trials. Studies with one of the two primary outcomes were included: (1) The number of antibiotics prescribed and/or (2) the accuracy of the prescription, commonly measured as a percentage of adherence to local clinical guidelines. Results Nine studies met these inclusion criteria. Five studies reported on the prescription of antibiotics in primary dental care and four studies focused on outpatient dental care. Interventions used in primary dental care included a combination of audit, feedback, education, local consensus, dissemination of guidelines and/or academic detailing. Trials in the outpatient setting made use of expert panel discussions, educational feedback on previous acts of prescribing, the dissemination of guidelines and the establishment of internal guidelines. All studies successfully reduced the number of antibiotics prescribed and/or increased the accuracy of the prescription. However, most studies were confounded by a high risk of selection bias, selective outcome reporting and high variance across study groups. In particular, information relating to study design and methodology was insufficient. Only three studies related the prescriptions to the number of patients treated with antibiotics. Conclusions This systematic review was able to offer conclusions which took the limitations of the investigated studies into account. Unfortunately, few studies could be included and many of these studies were confounded by a low quality of scientific reporting and lack of information regarding study methodology. High-quality research with objective and standardised outcome reporting, longer periods of follow-up, rigorous methodology and adequate standard of study reporting is urgently needed.	[Loeffler, Christin; Boehmer, Femke] Rostock Univ, Med Ctr, Inst Gen Practice, Rostock, Germany	University of Rostock	Loffler, C (corresponding author), Rostock Univ, Med Ctr, Inst Gen Practice, Rostock, Germany.	christin.loeffler@med.uni-rostock.de						Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Agnihotry A, 2016, COCHRANE DB SYST REV, V2016; Akalin Ferda Alev, 2004, J Oral Sci, V46, P25, DOI 10.2334/josnusd.46.25; Anderson R, 2000, BRIT DENT J, V188, P398, DOI 10.1038/sj.bdj.4800493a; [Anonymous], 2016, SUMM LAT DAT ANT CON; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Ataoglu H, 2008, BRIT J ORAL MAX SURG, V46, P133, DOI 10.1016/j.bjoms.2006.11.005; BUTLER CC, 2009, BRIT MED J, V338; Cahill TJ, 2017, HEART; Chate RAC, 2006, BRIT DENT J, V201, P635, DOI 10.1038/sj.bdj.4814261; Chopra Radhika, 2014, Prim Dent J, V3, P24, DOI 10.1308/205016814813877270; COOLEY N, 2008, PHARM J, V280, P476; Cope AL, 2016, BRIT J GEN PRACT, V66, pE329, DOI 10.3399/bjgp16X684757; Cope AL, 2016, COMMUNITY DENT ORAL, V44, P145, DOI 10.1111/cdoe.12199; Dailey YM, 2001, BRIT DENT J, V191, P391, DOI 10.1038/sj.bdj.4801190a; Dar-Odeh NS, 2008, CHEMOTHERAPY, V54, P17, DOI 10.1159/000112313; Dar-Odeh NS, 2010, THER CLIN RISK MANAG, V6, P301; Dayer MJ, 2015, LANCET, V385, P1219, DOI 10.1016/S0140-6736(14)62007-9; Demirbas F, 2006, ACTA ODONTOL SCAND, V64, P355, DOI 10.1080/00016350600844394; DeSimone DC, 2015, MAYO CLIN P; Doshi D, 2011, ORAL HLTH PREV DENT, V9, P347; Ellervall E, 2010, BRIT DENT J, V208, DOI 10.1038/sj.bdj.2010.107; Elouafkaoui P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002115; Embil JM, 2008, CAN J CARDIOL, V24, P673, DOI 10.1016/S0828-282X(08)70664-0; Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P101; Farbod F, 2009, INT J ORAL MAX SURG, V38, P626, DOI 10.1016/j.ijom.2009.03.717; Gulliford MC, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3410; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Iqbal A, 2015, J CLIN DIAGN RES, V9, pZC82, DOI 10.7860/JCDR/2015/13718.5964; Jaspers M T, 1984, J Dent Educ, V48, P159; Kaptan RF, 2013, THER CLIN RISK MANAG, V9, P443, DOI 10.2147/TCRM.S52009; Kenealy T, 2017, ANTIBIOTICS COMMON C; Kohler Melanie, 2013, Schweiz Monatsschr Zahnmed, V123, P748; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Loffler C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-27; Mainjot A, 2009, INT ENDOD J, V42, P1112, DOI 10.1111/j.1365-2591.2009.01642.x; Marra F, 2016, J AM DENT ASSOC, V147, P320, DOI 10.1016/j.adaj.2015.12.014; Martin MV, 2000, ADULT ANTIMICROBIAL; Mazzaglia G, 2002, J CHEMOTHERAPY, V14, P65, DOI 10.1179/joc.2002.14.1.65; Mendonca JMD, 2010, PHARM WORLD SCI, V32, P30, DOI 10.1007/s11096-009-9335-7; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Molstad S, 2008, EUROSURVEILLANCE B E, V13, P5437; Ocek Z, 2008, EUR J DENT EDUC, V12, P41, DOI 10.1111/j.1600-0579.2007.00491.x; Oliveira AS, 2015, INT J CLIN PHARM-NET, V37, P180; Palmer N, 2012, ANTIMICROBIAL PRESCR; Palmer NAO, 2002, BRIT DENT J, V193, P46, DOI 10.1038/sj.bdj.4801480a; Palmer NAO, 2001, BRIT DENT J, V191, P253, DOI 10.1038/sj.bdj.4801156a; Palmer NAO, 2000, BRIT DENT J, V189, P43, DOI 10.1038/sj.bdj.4800597a; Palmer Nickolaus O A, 2004, Prim Dent Care, V11, P77, DOI 10.1308/1355761041208476; Palmer NOA, 2001, J ANTIMICROB CHEMOTH, V47, P233, DOI 10.1093/jac/47.2.233; Palmer NOA, 2000, J ANTIMICROB CHEMOTH, V46, P1033, DOI 10.1093/jac/46.6.1033; Peric M, 2015, CENT EUR J PUBL HEAL, V23, P107; Pipalova R, 2014, INT DENT J, V64, P138, DOI 10.1111/idj.12089; Preus HR, 2017, EUR J ORAL SCI, V125, P280, DOI 10.1111/eos.12360; Price DB, 2004, RESP MED, V98, P17, DOI 10.1016/j.rmed.2003.08.011; Prior M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-50; Rauniar G P, 2012, Kathmandu Univ Med J (KUMJ), V10, P30; Richey R, 2008, BMJ-BRIT MED J, V336, P770, DOI 10.1136/bmj.39510.423148.AD; Roberts RM, 2017, J AM DENT ASSOC, V148; Roque F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1276; Roy KM, 2000, BRIT DENT J, V188, P674; SADOWSKY D, 1991, AM J PUBLIC HEALTH, V81, P923, DOI 10.2105/AJPH.81.7.923; Salako NO, 2004, J DENT, V32, P503, DOI 10.1016/j.jdent.2004.04.001; (SCDEP) SDCeP, 2011, DRUG PRESCR DENT DEN; Seager JM, 2006, BRIT DENT J, V201, P217, DOI 10.1038/sj.bdj.4813879; Steed M, 1997, Prim Dent Care, V4, P66; Thomas DW, 1997, BRIT J ORAL MAX SURG, V35, P126, DOI 10.1016/S0266-4356(97)90688-4; Thornhill Martin H, 2012, Dent Update, V39, P6; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392; van der Bijl Pieter, 2008, SADJ, V63, P240; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2015, GLOB ACT PLAN ANT RE; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; World Health Organization, 2014, ANT RES GLOB REP SUR, DOI DOI 10.1007/S13312-014-0374-3; Zahabiyoun Sana, 2015, J Dent (Tehran), V12, P171	77	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188061	10.1371/journal.pone.0188061	http://dx.doi.org/10.1371/journal.pone.0188061			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136646	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200058
J	Igarashi, K; Yamashita, K; Katoh, H; Kojima, K; Ooizumi, Y; Nishizawa, N; Nishiyama, R; Kawamata, H; Tajima, H; Kaizu, T; Kumamoto, Y; Watanabe, M				Igarashi, Kazuharu; Yamashita, Keishi; Katoh, Hiroshi; Kojima, Keita; Ooizumi, Yosuke; Nishizawa, Nobuyuki; Nishiyama, Ryo; Kawamata, Hiroshi; Tajima, Hiroshi; Kaizu, Takashi; Kumamoto, Yusuke; Watanabe, Masahiko			Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease	PLOS ONE			English	Article							XANTHOGRANULOMATOUS CHOLECYSTITIS; METHYLATION; DIAGNOSIS; SURVIVAL; BIOMARKERS; SERUM	Background Aberrant promoter DNA methylation of the cysteine dioxygenase 1 (CDO1) gene is found in various human cancers and is associated with clinical outcome. In this study, we assessed for the first time the clinicopathological significance of CDO1 methylation in primary gallbladder cancer (GBC) in comparison with non-malignant gallbladder disease. Methods CDO1 DNA methylation was quantified using quantitative TaqMan methylation specific PCR (Q-MSP) in 99 primary GBC patients together with the 78 corresponding non-tumor tissues and 26 benign gallbladder disease (including 7 patients with xanthogranulomatous cholecystitis) who underwent surgical resection between 1986 and 2014. Results The average CDO1 TaqMeth value of primary GBCs was 23.5 +/- 26. These values were significantly higher than those of corresponding non-tumor tissues (average 8 +/- 13, p < .0001) and diseased gallbladder tissues from patients with benign gallbladder diseases (average 0.98 +/- 1.6, p < .0001). CDO1 hypermethylation is also found in xanthogranulomatous cholecystitis. Using a cut-off value of 17.7, GBC cases with CDO1 hypermethylation (n = 47) showed significantly poorer prognosis than those with CDO1 hypomethylation (n = 52) (p = 0.0023). Multivariate Cox proportional hazards analysis identified that CDO1 hypermethylation was an independent prognostic factor. Notably, CDO1 hypermethylation showed prognostic relevance, especially in stage II GBC, in which it is highly anticipated to work as a predictive marker for candidates of adjuvant therapy. Conclusions Promoter NA methylation of CDO1 was demonstrated for the first time to be a cancer-associated methylation in primary GBC, and it has the potential to be a prognostic biomarker of GBC for high-risk patients with stage II GBC.	[Igarashi, Kazuharu; Yamashita, Keishi; Katoh, Hiroshi; Kojima, Keita; Ooizumi, Yosuke; Nishizawa, Nobuyuki; Nishiyama, Ryo; Kawamata, Hiroshi; Tajima, Hiroshi; Kaizu, Takashi; Kumamoto, Yusuke; Watanabe, Masahiko] Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Watanabe, M (corresponding author), Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa, Japan.	intl-aff@kitasato-u.ac.jp						Andresen K, 2015, HEPATOLOGY, V61, P1651, DOI 10.1002/hep.27707; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P811, DOI 10.1245/s10434-014-4044-4; Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; Martinelli CMD, 2017, ONCOTARGET, V8, P50608, DOI 10.18632/oncotarget.11167; Deckers IAG, 2015, CLIN CANCER RES, V21, P3492, DOI 10.1158/1078-0432.CCR-14-2049; Diaz-Lagares A, 2016, CLIN CANCER RES, V22, P3361, DOI 10.1158/1078-0432.CCR-15-2346; DIETRICH D, 2010, BMC CANCER, V10; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kayahara M, 2008, ANN SURG, V248, P807, DOI 10.1097/SLA.0b013e31818a1561; Kojima K, 2017, Dis Esophagus, V30, P1, DOI 10.1093/dote/dow001; Minatani N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144862; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sikora SS, 2006, J SURG ONCOL, V93, P670, DOI 10.1002/jso.20535; Singh VP, 2016, WORLD J RADIOL, V8, P183, DOI 10.4329/wjr.v8.i2.183; Suzuki H, 2015, WORLD J GASTROENTERO, V21, P10166, DOI 10.3748/wjg.v21.i35.10166; Ushiku H, 2017, GASTRIC CANCER, V20, P784, DOI 10.1007/s10120-017-0697-6; Ushiku Hideki, 2017, Dis Esophagus, V30, P1, DOI 10.1111/dote.12496; Vedeld HM, 2015, INT J CANCER, V136, P844, DOI 10.1002/ijc.29039; Waraya M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-397; Waraya M, 2009, ANN SURG ONCOL, V16, P1231, DOI 10.1245/s10434-009-0415-7; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113546; Yang Y, 2014, TOHOKU J EXP MED, V232, P187, DOI 10.1620/tjem.232.187	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188178	10.1371/journal.pone.0188178	http://dx.doi.org/10.1371/journal.pone.0188178			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161283	gold, Green Submitted, Green Published			2022-12-27	WOS:000415987000034
J	Petta, S; Ciresi, A; Bianco, J; Geraci, V; Boemi, R; Galvano, L; Magliozzo, F; Merlino, G; Craxi, A; Giordano, C				Petta, Salvatore; Ciresi, Alessandro; Bianco, Jessica; Geraci, Vincenzo; Boemi, Roberta; Galvano, Luigi; Magliozzo, Franco; Merlino, Giovanni; Craxi, Antonio; Giordano, Carla			Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; UNITED-STATES; WOMEN; SENSITIVITY; PREVALENCE; IMPACT; SYSTEMS	Background and aims Nonalcoholic fatty liver disease (NAFLD) and polycystic ovary syndrome (PCOS) recognize obesity and insulin resistance (IR) as common pathogenic background. We assessed 1) whether PCOS is a risk factor for steatosis, and 2) the impact, in PCOS patients, of IR and hyperandrogenism on steatosis and fibrosis. Methods We considered 202 consecutive Italian PCOS nondiabetic patients and 101 age-matched controls. PCOS was diagnosed applying the Rotterdam diagnostic criteria. Steatosis was diagnosed if hepatic steatosis index (HSI) > 36, while fibrosis by using the FIB-4 score. As surrogate estimate of insulin sensitivity we considered the insulin sensitivity index (ISI). Free androgen index (FAI) was calculated as estimate of biochemical hyperandrogenism. Results In the entire population, steatosis was observed in 68.8% of patients with PCOS, compared to 33.3 of controls (p<0.001), this association being maintained after adjusting for metabolic confounders (OR 3.73, 95% CI 1.74-8.02; P = 0.001). In PCOS patients, steatosis was independently linked to WC (OR 1.04, 95% CI 1.01-1.08; P = 0.006) and ISI Matsuda (OR 0.69, 95% CI 0.53-0.88; P = 0.004), not to free androgen index (OR 1.10, 95% CI 0.96-1.26; P = 0.14). Notably, ISI Matsuda was confirmed as independently associated with steatosis in both obese (OR 0.42, 95% CI 0.23-0.77, P = 0.005) and nonobese (OR 0.69, 95% CI 0.53-0.91, P = 0.009), patients, while FAI (OR 1.45, 95% CI 1.12-1.87; P = 0.004) emerged as an independent risk factor only in nonobese PCOS. Similarly, higher FIB-4 was independently associated with higher FAI (p = 0.02) in nonobese and with lower ISI Matsuda (p = 0.04) in obese patients. Conclusions We found that PCOS is an independent risk factor for steatosis, and that, IR and hyperandrogenism, this last especially in nonobese patients, are the key players of liver damage in PCOS.	[Petta, Salvatore; Boemi, Roberta; Craxi, Antonio] Univ Palermo, DiBiMIS, Sect Gastroenterol, Palermo, Italy; [Ciresi, Alessandro; Bianco, Jessica; Geraci, Vincenzo; Giordano, Carla] Univ Palermo, DiBiMIS, Sect Endocrinol Diabetol & Metab, Palermo, Italy; [Galvano, Luigi; Magliozzo, Franco; Merlino, Giovanni] Med Gen, Palermo, Italy	University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, DiBiMIS, Sect Gastroenterol, Palermo, Italy.	salvatore.petta@unipa.it		Merlino, Giovanni/0000-0002-4297-0035				Amato MC, 2008, CLIN ENDOCRINOL, V69, P52, DOI 10.1111/j.1365-2265.2007.03145.x; Ayonrinde OT, 2016, J GASTROEN HEPATOL, V31, P980, DOI 10.1111/jgh.13241; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Galluzzo A, 2008, NUTR METAB CARDIOVAS, V18, P511, DOI 10.1016/j.numecd.2008.05.004; Gambarin-Gelwan M, 2007, CLIN GASTROENTEROL H, V5, P496, DOI 10.1016/j.cgh.2006.10.010; Jones H, 2012, J CLIN ENDOCR METAB, V97, P3709, DOI 10.1210/jc.2012-1382; Kahl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094059; Lee JH, 2010, DIGEST LIVER DIS, V42, P503, DOI 10.1016/j.dld.2009.08.002; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Musso G, 2012, HEPATOLOGY, V56, DOI 10.1002/hep.25677; Petta S, 2016, DIGEST LIVER DIS, V48, P333, DOI 10.1016/j.dld.2015.10.027; Polyzos SA, 2014, HORM-INT J ENDOCRINO, V13, P519, DOI 10.14310/horm.2002.1493; Ramezani-Binabaj M, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.23235; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Setiawan VW, 2016, HEPATOLOGY, V64, P1969, DOI 10.1002/hep.28677; Setji TL, 2006, J CLIN ENDOCR METAB, V91, P1741, DOI 10.1210/jc.2005-2774; Tan S, 2010, J CLIN ENDOCR METAB, V95, P343, DOI 10.1210/jc.2009-1834; Targher G, 2009, J ENDOCRINOL INVEST, V32, P695, DOI [10.1007/BF03345743, 10.3275/6375]; Targher G, 2016, ENDOCRINE, V51, P211, DOI 10.1007/s12020-015-0640-8; Turola E, 2015, DIS MODEL MECH, V8, P1037, DOI 10.1242/dmm.019950; Vassilatou E, 2010, HUM REPROD, V25, P212, DOI 10.1093/humrep/dep380; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yang JD, 2014, HEPATOLOGY, V59, P1406, DOI 10.1002/hep.26761; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	31	39	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186136	10.1371/journal.pone.0186136	http://dx.doi.org/10.1371/journal.pone.0186136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161258	gold, Green Published, Green Submitted			2022-12-27	WOS:000415987000003
J	Shin, DH; Woo, KI; Kim, YD				Shin, Dong Hoon; Woo, Kyung In; Kim, Yoon-Duck			Relationship between lower eyelid epiblepharon and epicanthus in Korean children	PLOS ONE			English	Article							LASH ROTATING SUTURES; BODY-MASS INDEX; SURGICAL-CORRECTION; CONGENITAL ENTROPION; INVERTED EYELASHES; JAPANESE-CHILDREN; ASTIGMATISM; SKIN; FOLD	Purpose This study aimed to determine the relationship between lower eyelid epiblepharon and epicanthus in Korean children. Methods We performed a retrospective review of the medical records and preoperative photographs of 119 patients. These patients were aged 18 years or younger who underwent lower lid epiblepharon repair from January 2010 to December 2012. We also included 119 age-and sex-matched controls. Results The mean age of the patients was 5.7 years (range: 2-16 years) in both groups. The presence of an epicanthal fold was common in each group (98.3%). The inner intercanthal distance/interpupillary distance (IICD/IPD) ratio was significantly greater in the epiblepharon group than in the control group (mean: 0.70 vs 0.67, p<0.001), especially in those aged 5 years or older. The IICD/outer intercanthal distance ratio was also greater in the epiblepharon group than in the control group (mean: 0.48 vs 0.46, p<0.001). The IICD/IPD ratio decreased with growth in the control group, but it did not decrease with growth in the epiblepharon group. The configuration of the epicanthus, in which the upper skin fold formed a confluent fold with the lower eyelid, had a higher prevalence in the epiblepharon group than in the control group (p = 0.001), especially in those aged 5 years or older. Conclusion In early childhood (< 5 years), the relationship between epicanthus and epiblepharon cannot be established because of the high prevalence of epicanthus in children with or without epiblepharon. In children aged >= 5 years, persistent epicanthus was related to severe epiblepharon formation requiring corrective surgery.	[Shin, Dong Hoon; Woo, Kyung In; Kim, Yoon-Duck] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Woo, KI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	eyeminded@skku.edu		SHIN, Dong Hoon/0000-0003-3076-9200				Ahn HB, 2011, J PEDIAT OPHTH STRAB, V48, P57, DOI 10.3928/01913913-20100420-01; Chang M, 2011, BRIT J OPHTHALMOL, V95, P1675, DOI 10.1136/bjophthalmol-2011-300592; Duke-Elder S., 1964, SYSTEM OPHTHALMOLOGY, V3, P851; Gosain AK., 1997, GRABB SMITHS PLASTIC, V5th ed, P223; Hayasaka Y, 2005, J PEDIAT OPHTH STRAB, V42, P300; JOHNSON CC, 1968, AM J OPHTHALMOL, V66, P1172, DOI 10.1016/0002-9394(68)90830-1; JORDAN R, 1993, OPHTHALMIC SURG LAS, V24, P494; Kakizaki H, 2009, CLIN OPHTHALMOL, V3, P247; Khwarg S I, 1997, Korean J Ophthalmol, V11, P111; Khwarg SI, 2002, OPHTHALMIC SURG LAS, V33, P280; Kim MS, 2014, BRIT J OPHTHALMOL, V98, P120, DOI 10.1136/bjophthalmol-2013-303772; Lee Y, 2000, PLAST RECONSTR SURG, V105, P1872, DOI 10.1097/00006534-200004050-00040; LEVITT JM, 1957, AM J OPHTHALMOL, V44, P112, DOI 10.1016/0002-9394(57)91966-9; Liu D, 1986, Ophthalmic Plast Reconstr Surg, V2, P59, DOI 10.1097/00002341-198601050-00001; NODA S, 1989, BRIT J OPHTHALMOL, V73, P126, DOI 10.1136/bjo.73.2.126; Ohmori K., 1990, PLASTIC SURG, V3, P2415; Park J I, 2000, Arch Facial Plast Surg, V2, P43, DOI 10.1001/archfaci.2.1.43; Park SW, 2008, J PEDIAT OPHTH STRAB, V45, P31, DOI 10.3928/01913913-20080101-18; Preechawai P, 2007, AM J OPHTHALMOL, V143, P835, DOI 10.1016/j.ajo.2007.01.043; Scheie H., 1977, TXB OPHTHALMOLOGY, P79; Shih MH, 2007, CORNEA, V26, P1090, DOI 10.1097/ICO.0b013e3181451212; Sohn S. W., 2002, J KOREAN OPHTHALMOLO, V43, P1827; Sundar G, 2010, OPHTHALMOLOGY, V117, P184, DOI 10.1016/j.ophtha.2009.06.044; Tan MCJ, 2012, ORBIT, V31, P107, DOI 10.3109/01676830.2011.638095	24	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187690	10.1371/journal.pone.0187690	http://dx.doi.org/10.1371/journal.pone.0187690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161299	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000017
J	Cremers, HR; Wager, TD; Yarkoni, T				Cremers, Henk R.; Wager, Tor D.; Yarkoni, Tal			The relation between statistical power and inference in fMRI	PLOS ONE			English	Article							SAMPLE-SIZE; BRAIN; PSYCHOLOGY; METAANALYSIS; ACTIVATION; SCIENCE; EMOTION; MODELS; RULES; BACK	Statistically underpowered studies can result in experimental failure even when all other experimental considerations have been addressed impeccably. In fMRI the combination of a large number of dependent variables, a relatively small number of observations (subjects), and a need to correct for multiple comparisons can decrease statistical power dramatically. This problem has been clearly addressed yet remains controversial-especially in regards to the expected effect sizes in fMRI, and especially for between-subjects effects such as group comparisons and brain-behavior correlations. We aimed to clarify the power problem by considering and contrasting two simulated scenarios of such possible brain-behavior correlations: weak diffuse effects and strong localized effects. Sampling from these scenarios shows that, particularly in the weak diffuse scenario, common sample sizes (n = 20-30) display extremely low statistical power, poorly represent the actual effects in the full sample, and show large variation on subsequent replications. Empirical data from the Human Connectome Project resembles the weak diffuse scenario much more than the localized strong scenario, which underscores the extent of the power problem for many studies. Possible solutions to the power problem include increasing the sample size, using less stringent thresholds, or focusing on a region-of-interest. However, these approaches are not always feasible and some have major drawbacks. The most prominent solutions that may help address the power problem include model-based (multivariate) prediction methods and meta-analyses with related synthesis-oriented approaches.	[Cremers, Henk R.] Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Wager, Tor D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Yarkoni, Tal] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University of Amsterdam; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Austin	Cremers, HR (corresponding author), Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands.	h.r.cremers@uva.nl			16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; National institute of Health [R01MH096906, R01DA035484]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109682, R01MH096906, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035484] Funding Source: NIH RePORTER	16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); McDonnell Center for Systems Neuroscience at Washington University; National institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Data analyzed in section 3.2 were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was supported by National institute of Health (https://grants.nih.govigrants/ about grants.htm) award R01MH096906 to TY and R01DA035484 to T.D.W.; The Data analyzed in section 3.2 were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This work was supported by NIH award R01MH096906 to TY and R01DA035484 to T.D.W.	Bakker M, 2012, PERSPECT PSYCHOL SCI, V7, P543, DOI 10.1177/1745691612459060; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BAROUDI JJ, 1989, MIS QUART, V13, P87, DOI 10.2307/248704; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Bennett CM, 2009, SOC COGN AFFECT NEUR, V4, P417, DOI 10.1093/scan/nsp053; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Carruthers P, 2003, ROY I PH S, V53, P67, DOI 10.1017/S1358246100008274; Chambers CD, 2013, CORTEX, V49, P609, DOI 10.1016/j.cortex.2012.12.016; Chang LJ, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002180; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; CHASE LJ, 1976, J APPL PSYCHOL, V61, P234, DOI 10.1037/0021-9010.61.2.234; COHEN J, 1962, J ABNORM PSYCHOL, V65, P145, DOI 10.1037/h0045186; COHEN J, 1990, AM PSYCHOL, V45, P1304, DOI 10.1037/0003-066X.45.12.1304; COHEN J, 1994, AM PSYCHOL, V49, P997, DOI 10.1037/0003-066X.50.12.1103; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Costa P.T, 1992, REVISED NEOPERSONALI; Cremers HR, 2015, PSYCHOL MED, V45, P1521, DOI 10.1017/S0033291714002657; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Dudoit S, 2003, STAT SCI, V18, P71, DOI 10.1214/ss/1056397487; Durnez J., 2016, POWER SAMPLE SIZE CA; Durnez J, 2014, NEUROIMAGE, V84, P45, DOI 10.1016/j.neuroimage.2013.07.072; Etz A, 2016, PLOS ONE, P11; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher R. A., 1946, Statistical methods for research workers.; Fodor J. A, 1983, MODULARITY MIND; Friston K, 2012, NEUROIMAGE, V61, P1300, DOI 10.1016/j.neuroimage.2012.04.018; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Gelman A, 2014, PERSPECT PSYCHOL SCI, V9, P641, DOI 10.1177/1745691614551642; Gelman A, 2014, AM SCI, V102, P460, DOI 10.1511/2014.111.460; Gelman A, 2009, AM SCI, V97, P310, DOI 10.1511/2009.79.310; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Habeck C, 2010, CELL BIOCHEM BIOPHYS, V58, P53, DOI 10.1007/s12013-010-9093-0; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Joyce KE, 2012, NEUROINFORMATICS, V10, P351, DOI 10.1007/s12021-012-9152-3; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Krantz DH, 1999, J AM STAT ASSOC, V94, P1372, DOI 10.2307/2669949; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lindquist Martin A, 2013, Neuroimage, V81, P499, DOI 10.1016/j.neuroimage.2013.02.056; Loftus GR, 1996, CURR DIR PSYCHOL SCI, V5, P161, DOI 10.1111/1467-8721.ep11512376; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Mennes M, 2013, NEUROIMAGE, V82, P683, DOI 10.1016/j.neuroimage.2012.10.064; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Moeller JR, 2006, INT J BIOMED IMAGING, V2006, DOI 10.1155/IJBI/2006/79862; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Mumford JA, 2012, SOC COGN AFFECT NEUR, V7, P738, DOI 10.1093/scan/nss059; Murphy K, 2004, NEUROIMAGE, V22, P879, DOI 10.1016/j.neuroimage.2004.02.005; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nickerson RS, 2000, PSYCHOL METHODS, V5, P241, DOI 10.1037//1082-989X.5.2.241; Osborne JW, 2008, EDUC PSYCHOL-UK, V28, P151, DOI 10.1080/01443410701491718; Ottenbacher KJ, 1996, AM STAT, V50, P271, DOI 10.2307/2684673; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Peterman RM, 2011, CANADIAN J FISHERIES, V47, P2; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Poldrack RA, 2014, NAT NEUROSCI, V17, P1510, DOI 10.1038/nn.3818; Reddan MC, 2017, JAMA PSYCHIAT, V74, P207, DOI 10.1001/jamapsychiatry.2016.3356; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Rosa MJ, 2015, NEUROIMAGE, V105, P493, DOI 10.1016/j.neuroimage.2014.11.021; Rousselet GA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00119; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schmidt FL, 1996, PSYCHOL METHODS, V1, P115, DOI 10.1037/1082-989X.1.2.115; SEDLMEIER P, 1989, PSYCHOL BULL, V105, P309, DOI 10.1037/0033-2909.105.2.309; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Szucs D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000797; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322; van Ast VA, 2016, CEREB CORTEX, V26, P544, DOI 10.1093/cercor/bhu206; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P319, DOI 10.1111/j.1745-6924.2009.01132.x; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wager TD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004066; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wainer H, 2007, AM SCI, V95, P249, DOI 10.1511/2007.65.249; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Westfall Jacob, 2016, Wellcome Open Res, V1, P23, DOI 10.12688/wellcomeopenres.10298.2; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yarkoni T., 2015, APA HDB PERSONALITY, P61, DOI DOI 10.1037/14343-003; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yarkoni T, 2010, TRENDS COGN SCI, V14, P489, DOI 10.1016/j.tics.2010.08.004; Yarkoni T, 2009, PERSPECT PSYCHOL SCI, V4, P294, DOI 10.1111/j.1745-6924.2009.01127.x; Zhuang XW, 2017, NEUROIMAGE, V149, P63, DOI 10.1016/j.neuroimage.2016.12.081	97	178	180	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0184923	10.1371/journal.pone.0184923	http://dx.doi.org/10.1371/journal.pone.0184923			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155843	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700002
J	Singano, V; Amberbir, A; Garone, D; Kandionamaso, C; Msonko, J; van Lettow, M; Kalima, K; Mataka, Y; Kawalazira, G; Mateyu, G; Kwekwesa, A; Matengeni, A; van Oosterhout, JJ				Singano, Victor; Amberbir, Alemayehu; Garone, Daniela; Kandionamaso, Christopher; Msonko, Jack; van Lettow, Monique; Kalima, Kondwani; Mataka, Yamikani; Kawalazira, Gift; Mateyu, Gabriel; Kwekwesa, Aunex; Matengeni, Alfred; van Oosterhout, Joep J.			The burden of gynecomastia among men on antiretroviral therapy in Zomba, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; EFAVIRENZ; LIPODYSTROPHY; ALGORITHM	Background Many Africans who are on life-saving ART face challenges from a variety of toxicities. After the introduction of a standardized first-line efavirenz-containing ART regimen, reports of gynecomastia appeared in Malawian popular media, however data on the prevalence and risk factors of gynecomastia from Africa are lacking. Methods We conducted a cross-sectional study in males >= 18 years registered on ART at the HIV clinic in Zomba Central Hospital. Men who reported to have ever experienced breast or nipple enlargement received a standard questionnaire and underwent physical examination. Questions included perceptions and concerns about gynecomastia. Clinicians confirmed the presence and severity of gynecomastia. Routinely collected data on current and previous ART regimens, CD4 count, WHO clinical stage, anthropometric measurements and history of tuberculosis were extracted from the electronic database. Results We enrolled 1,027 men with median age 44 years (IQR: 38-52). The median ART duration was 57 months (IQR: 27-85); 46.7% were in WHO stage III/IV at ART initiation, 88.2% had exposure to efavirenz and 9% were overweight or obese. The prevalence of self-reported gynecomastia was 6.0% (62/1027) (95%-CI: 4.7-7.7%). Of men with gynecomastia 83.6% reported nipple enlargement and 98.4% enlarged breasts (85.5% bilateral). One-third said they had not reported gynecomastia to a health care worker. Over three-quarters mentioned that gynecomastia was an important or very important problem for them, while more than half were embarrassed by it. On examination gynecomastia was present in 90% (confirmed gynecomastia prevalence 5.5%; 95%-CI: 4.2-7.0%) and 51.8% had severity grade III or IV. History of tuberculosis treatment was independently associated with self-reported gynecomastia, adjusted OR 2.10 (95%-CI: 1.04-4.25). Conclusions The burden of gynecomastia among men on ART in Malawi was higher than previously reported, and was associated with adverse psychological consequences, calling for increased awareness, a proactive diagnostic approach and diligent clinical management.	[Singano, Victor; Amberbir, Alemayehu; Garone, Daniela; Kandionamaso, Christopher; Msonko, Jack; van Lettow, Monique; Kalima, Kondwani; Mataka, Yamikani; Mateyu, Gabriel; Kwekwesa, Aunex; Matengeni, Alfred; van Oosterhout, Joep J.] Dignitas Int, Zomba, Malawi; [van Lettow, Monique] Univ Toronto, Dala Lana Sch Publ Hlth, Toronto, ON, Canada; [Kawalazira, Gift] Malawi Minist Hlth, Zomba Dist Hlth Off, Zomba, Malawi; [van Oosterhout, Joep J.] Coll Med, Dept Med, Blantyre, Malawi	University of Toronto; University of Malawi	van Oosterhout, JJ (corresponding author), Dignitas Int, Zomba, Malawi.; van Oosterhout, JJ (corresponding author), Coll Med, Dept Med, Blantyre, Malawi.	j.vanoosterhout@dignitasinternational.org	Amberbir, Alemayehu/HGC-2647-2022	singano, victor/0000-0002-2671-7291	USAID	USAID(United States Agency for International Development (USAID))	Dignitas International's work at the Tisungane HIV clinic at Zomba Central Hospital is funded by USAID. USAID had no role in the study design, data collection, data analysis, decision to publish or preparation of the manuscript.	Abaji OO, 2011, J MED MED SCI, V2, P1221; Biglia A, 2004, CLIN INFECT DIS, V39, P1514, DOI 10.1086/425363; Birbal S, 2016, AJAR-AFR J AIDS RES, V15, P243, DOI 10.2989/16085906.2016.1191519; Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677; Caso JAA, 2001, AIDS, V15, P1447, DOI 10.1097/00002030-200107270-00018; Cordova A, 2008, J PLAST RECONSTR AES, V61, P41, DOI 10.1016/j.bjps.2007.09.033; Davison SP, 2007, PLAST RECONSTR SURG, V120, P1843, DOI 10.1097/01.prs.0000267341.14550.a7; Deepinder F, 2012, EXPERT OPIN DRUG SAF, V11, P779, DOI 10.1517/14740338.2012.712109; Deonarain J, 2008, INT J SURG PATHOL, V16, P171, DOI 10.1177/1066896907307037; Dickson G, 2012, AM FAM PHYSICIAN, V85, P716; Donovan B, 1999, INT J STD AIDS, V10, P49, DOI 10.1258/0956462991912935; Jover Francisco, 2004, Breast J, V10, P244, DOI 10.1111/j.1075-122X.2004.21392.x; Kandionamaso C., 2015, B5 OR PRES RES DISS; Khan A, 2012, LUNG INDIA, V29, P189, DOI 10.4103/0970-2113.95343; Kim MJ, 2015, INFECT CHEMOTHER, V47, P231, DOI 10.3947/ic.2015.47.4.231; Kwekwesa A, 2015, MALAWI MED J, V27, P115, DOI 10.4314/mmj.v27i3.11; Mercie P, 2001, AIDS, V15, P126, DOI 10.1097/00002030-200101050-00021; Mira JA, 2004, ANTIVIR THER, V9, P511; National Statistical Office, 2010, MAL DEM HLTH SURV; Nuttall FQ, 2015, EUR J CLIN PHARMACOL, V71, P569, DOI 10.1007/s00228-015-1835-x; Piroth L, 2001, SCAND J INFECT DIS, V33, P559, DOI 10.1080/00365540110026476; Rahim Sibtain, 2004, AIDS Read, V14, P23; Schurmann D, 1998, AIDS, V12, P2232; Shet A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091028; Tadesse WT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-32; Tapsfield J, 2011, MALAWI MED J, V23, P116; Toma E, 1998, AIDS, V12, P681; van Griensven J, 2007, T ROY SOC TROP MED H, V101, P793, DOI 10.1016/j.trstmh.2007.02.020; WHO, 2013, GLOB UPD HIV TREATM	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188379	10.1371/journal.pone.0188379	http://dx.doi.org/10.1371/journal.pone.0188379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155891	gold, Green Submitted, Green Published			2022-12-27	WOS:000415756700053
J	Lindelof, N; Lundin-Olsson, L; Skelton, DA; Lundman, B; Rosendahl, E				Lindelof, Nina; Lundin-Olsson, Lillemor; Skelton, Dawn A.; Lundman, Berit; Rosendahl, Erik			Experiences of older people with dementia participating in a high-intensity functional exercise program in nursing homes: "While it's tough, it's useful"	PLOS ONE			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; CARE FACILITIES; ADULTS; RESIDENTS; ADHERENCE; COMMUNITY; BALANCE	The objective of the study was to describe the views and experiences of participation in a high-intensity functional exercise (HIFE) program among older people with dementia in nursing homes. The study design was a qualitative interview study with 21 participants (15 women), aged 74-96, and with a Mini-Mental State Examination score of 10-23 at study start. The HIFE-program comprises exercises performed in functional weight-bearing positions and including movements used in everyday tasks. The exercise was individually designed, supervised in small groups in the nursing homes and performed during four months. Interviews were performed directly after exercise sessions and field notes about the sessions were recorded. Qualitative content analysis was used for analyses. The analysis revealed four themes: Exercise is challenging but achievable; Exercise gives pleasure and strength; Exercise evokes body memories; and Togetherness gives comfort, joy, and encouragement. The intense and tailored exercise, adapted to each participant, was perceived as challenging but achievable, and gave pleasure and improvements in mental and bodily strength. Memories of previous physical activities aroused and participants rediscovered bodily capabilities. Importance of individualized and supervised exercise in small groups was emphasized and created feelings of encouragement, safety, and coherence. The findings from the interviews reinforces the positive meaning of intense exercise to older people with moderate to severe dementia in nursing homes. The participants were able to safely adhere to and understand the necessity of the exercise. Providers of exercise should consider the aspects valued by participants, e.g. supervision, individualization, small groups, encouragement, and that exercise involved joy and rediscovery of body competencies.	[Lindelof, Nina; Lundin-Olsson, Lillemor; Rosendahl, Erik] Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden; [Lindelof, Nina; Rosendahl, Erik] Umea Univ, Dept Community Med & Rehabil, Geriatr Med, Umea, Sweden; [Skelton, Dawn A.] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland; [Lundman, Berit] Umea Univ, Dept Nursing, Umea, Sweden	Umea University; Umea University; Glasgow Caledonian University; Umea University	Lindelof, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Physiotherapy, Umea, Sweden.; Lindelof, N (corresponding author), Umea Univ, Dept Community Med & Rehabil, Geriatr Med, Umea, Sweden.	nina.lindelof@umu.se	Skelton, Dawn A/B-7552-2013	Skelton, Dawn A/0000-0001-6223-9840; Lindelof, Nina/0000-0002-4449-049X	Swedish Research Council [K2009-69P-21298-01-4, K2009-69X21299-01-1, K2009-69P-21298-04-4, K2014-99X22610-01-6]; Forte-Swedish Research Council for Health; Working Life and Welfare; Vardal Foundation; Promobilia Foundation; Swedish Society of Medicine; Swedish Dementia Association; Swedish Alzheimer Foundation; County Council of Vasterbotten; Ragnhild and Einar Lundstrom's Memorial Foundation; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Forte-Swedish Research Council for Health; Working Life and Welfare; Vardal Foundation; Promobilia Foundation; Swedish Society of Medicine; Swedish Dementia Association; Swedish Alzheimer Foundation; County Council of Vasterbotten; Ragnhild and Einar Lundstrom's Memorial Foundation; Umea University	The Swedish Research Council, https://www.vr.se/, (K2009-69P-21298-01-4, K2009-69X21299-01-1, K2009-69P-21298-04-4, K2014-99X22610-01-6), to ER, Forte-Swedish Research Council for Health, Working Life and Welfare, http://forte.se/, to ER, The Vardal Foundation, to ER, The Promobilia Foundation, to ER, The Swedish Society of Medicine, to ER, The Swedish Dementia Association, http://www.demensforbundet.se/, to NL, The Swedish Alzheimer Foundation, to ER The County Council of Vasterbotten, http://vll.se, to NL and ER, The Ragnhild and Einar Lundstrom's Memorial Foundation, to NL, and a grant provided by Umea University, http://www.umu.se/, for DS as a visiting Professor, to LLO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LM, 2005, J AM GERIATR SOC, V53, P1681, DOI 10.1111/j.1532-5415.2005.53552.x; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2014, HIFE PROGRAM HIGH IN; Atchely R., 1999, CONTINUITY ADAPTATIO; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Barreto PD, 2016, J AM MED DIR ASSOC, V17, P381, DOI 10.1016/j.jamda.2016.01.021; Beer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015621; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Brassington GS, 2002, AM J PREV MED, V23, P80, DOI 10.1016/S0749-3797(02)00477-4; Caddell LS, 2010, CLIN PSYCHOL REV, V30, P113, DOI 10.1016/j.cpr.2009.10.003; Cahill S, 2011, AGING MENT HEALTH, V15, P562, DOI 10.1080/13607863.2010.551342; Cedervall Y, 2015, AGING MENT HEALTH, V19, P679, DOI 10.1080/13607863.2014.962004; Chong TWH, 2014, ASIA-PAC PSYCHIAT, V6, P179, DOI 10.1111/appy.12015; Fjellman-Wiklundl A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166686; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Harre R., 1998, SINGULAR SELF INTRO; Hawley-Hague H, 2016, J AGING PHYS ACTIV, V24, P119, DOI 10.1123/japa.2014-0108; Hawley-Hague H, 2014, GERONTOLOGIST, V54, P599, DOI 10.1093/geront/gnt075; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kitwood T., 1995, NEW CULTURE DEMENTIA; Kontos P. C., 2005, DEMENTIA, V4, P553, DOI DOI 10.1177/1471301205058311; Krippendorff K., 2018, CONTENT ANAL INTRO I; Lindelof Nina, 2012, Physiotherapy Theory and Practice, V28, P307, DOI 10.3109/09593985.2011.611217; Littbrand H, 2006, PHYS THER, V86, P489, DOI 10.1093/ptj/86.4.489; Littbrand H, 2011, J AM GERIATR SOC, V59, P1274, DOI 10.1111/j.1532-5415.2011.03484.x; Littbrand H, 2011, AM J PHYS MED REHAB, V90, P495, DOI 10.1097/PHM.0b013e318214de26; Littbrand H, 2009, J AM GERIATR SOC, V57, P1741, DOI 10.1111/j.1532-5415.2009.02442.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Malthouse R, 2014, PHYSIOTHERAPY, V100, P169, DOI 10.1016/j.physio.2013.10.002; Mozley CG, 1999, INT J GERIATR PSYCH, V14, P776, DOI 10.1002/(SICI)1099-1166(199909)14:9<776::AID-GPS13>3.0.CO;2-C; Olsen CF, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1041-7; Pitkala KH, 2013, JAMA INTERN MED, V173, P894, DOI 10.1001/jamainternmed.2013.359; Reid N, 2013, INT J ENV RES PUB HE, V10, P6783, DOI 10.3390/ijerph10126783; Rosendahl E, 2006, AUST J PHYSIOTHER, V52, P105, DOI 10.1016/S0004-9514(06)70045-9; Scandol JP, 2013, INJURY, V44, P776, DOI 10.1016/j.injury.2012.11.023; Stathi A., 2003, J ROYAL SOC HLTH, V124, P18; Stathi A, 2007, J AGING PHYS ACTIV, V15, P272, DOI 10.1123/japa.15.3.272; Steeman E, 2006, J ADV NURS, V54, P722, DOI 10.1111/j.1365-2648.2006.03874.x; Suttanon P, 2012, INT PSYCHOGERIATR, V24, P1172, DOI 10.1017/S1041610211002729; Telenius EW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0151-8; Telenius EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126102; The National Board och Health Care and Welfare, 2010, NAT GUID CAR CAS DEM; Toots A, 2016, J AM GERIATR SOC, V64, P55, DOI 10.1111/jgs.13880; van Alphen HJM, 2016, ARCH GERONTOL GERIAT, V66, P109, DOI 10.1016/j.archger.2016.05.008; von Kutzleben M, 2012, AGING MENT HEALTH, V16, P378, DOI 10.1080/13607863.2011.614594; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Weeks LE, 2008, J GERONTOL NURS, V34, P36, DOI 10.3928/00989134-20080701-11; Westius A, 2009, DEMENTIA, V8, P481, DOI DOI 10.1177/1471301209350287; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Yu F, 2011, RES GERONTOL NURS, V4, P243, DOI 10.3928/19404921-20110303-01	52	25	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188225	10.1371/journal.pone.0188225	http://dx.doi.org/10.1371/journal.pone.0188225			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN0DI	29149198	gold, Green Submitted, Green Published			2022-12-27	WOS:000415646100030
J	de Bruyn, J; Thomson, PC; Bagnoll, B; Maulaga, W; Rukambile, E; Alders, RG				de Bruyn, Julia; Thomson, Peter C.; Bagnoll, Brigitte; Maulaga, Wende; Rukambile, Elpidius; Alders, Robyn G.			The chicken or the egg? Exploring bidirectional associations between Newcastle disease vaccination and village chicken flock size in rural Tanzania	PLOS ONE			English	Article							COMMUNITY-BASED CONSERVATION; DEVELOPING-COUNTRIES; POULTRY PRODUCTION; FAMILY POULTRY; DISTRICT; AFRICA; HEALTH; LEVEL	Newcastle disease (ND) is a viral disease of poultry with global importance, responsible for the loss of a potential source of household nutrition and economic livelihood in many low-income food-deficit countries. Periodic outbreaks of this endemic disease result in high mortality amongst free-ranging chicken flocks and may serve as a disincentive for rural households to invest time or resources in poultry-keeping. Sustainable ND control can be achieved through vaccination using a thermotolerant vaccine administered via eyedrop by trained "community vaccinators". This article evaluates the uptake and outcomes of fee-for-service ND vaccination programs in eight rural villages in the semi-arid central zone of Tanzania. It represents part of an interdisciplinary program seeking to address chronic undernutrition in children through improvements to existing poultry and crop systems. Newcastle disease vaccination uptake was found to vary substantially across communities and seasons, with a significantly higher level of vaccination amongst households participating in a longitudinal study of children's growth compared with non-participating households (p = 0.009). Two multivariable model analyses were used to explore associations between vaccination and chicken numbers, allowing for clustered data and socioeconomic and cultural variation amongst the population. Results demonstrated that both (a) households that undertook ND vaccination had a significantly larger chicken flock size in the period between that vaccination campaign and the next compared with those that did not vaccinate (p = 0.018); and (b) households with larger chicken flocks at the time of vaccination were significantly more likely to participate in vaccination programs (p < 0.001). Additionally, households vaccinating in all three vaccination campaigns held over 12 months were identified to have significantly larger chicken flocks at the end of this period (p < 0.001). Opportunities to understand causality and complexity through quantitative analyses are limited, and there is a role for qualitative approaches to explore decisions made by poultry-keeping households and the motivations, challenges and priorities of community vaccinators. Evidence of a bidirectional relationship, however, whereby vaccination leads to greater chicken numbers, and larger flocks are more likely to be vaccinated, offers useful insights into the efficacy of fee-for-service animal health programs. This article concludes that attention should be focused on ways of supporting the participation of vulnerable households in ND vaccination campaigns, and encouraging regular vaccination throughout the year, as a pathway to strengthen food security, promote resilience and contribute to improved human nutrition.	[de Bruyn, Julia; Thomson, Peter C.; Bagnoll, Brigitte; Rukambile, Elpidius; Alders, Robyn G.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [de Bruyn, Julia; Bagnoll, Brigitte; Alders, Robyn G.] Univ Sydney, Charles Perkins Ctr, Johns Hopkins Dr, Sydney, NSW, Australia; [Bagnoll, Brigitte; Alders, Robyn G.] KYEEMA Fdn, Int Rural Poultry Ctr, Brisbane, Qld, Australia; [Bagnoll, Brigitte] Univ Witwatersrand, Dept Anthropol, Johannesburg, South Africa; [Maulaga, Wende; Rukambile, Elpidius] Tanzania Vet Lab Agcy, Cent Vet Lab, Dar Es Salaam, Tanzania	University of Sydney; University of Sydney; University of Witwatersrand	de Bruyn, J (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.; de Bruyn, J (corresponding author), Univ Sydney, Charles Perkins Ctr, Johns Hopkins Dr, Sydney, NSW, Australia.	julia.debruyn@sydney.edu.au	Rukambile, Elpidius/GRF-0666-2022; Thomson, Peter/V-7290-2019	Thomson, Peter/0000-0003-4428-444X; de Bruyn, Julia/0000-0001-5222-6464	Australian Centre for International Agricultural Research [FSC/2012/023]	Australian Centre for International Agricultural Research	This work forms part of a study funded by the Australian Centre for International Agricultural Research [FSC/2012/023; http://aciar.gov.au/]: "Strengthening food and nutrition security through family poultry and crop integration in Tanzania and Zambia". RA is Principal Investigator on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlers C., 2009, IMPROVING VILLAGE CH; Akinola LAF, 2011, WORLD POULTRY SCI J, V67, P697, DOI 10.1017/S0043933911000778; Alders R, 2003, CONTROLLING NEWCASTL; Alders R, CONTROLLING NE UNPUB; Alders R, 2014, PLANET RISK, V2, P187; Alders R. G., 2001, SADC planning workshop on Newcastle disease control in village chickens. Proceedings of an International Workshop, Maputo, Mozambique, 6-9 March, 2000, P97; Alders RG, 2010, WORLD POULTRY SCI J, V66, P433, DOI 10.1017/S0043933910000516; Alders RG, 2009, WORLD POULTRY SCI J, V65, P181, DOI 10.1017/S0043933909000117; Alders RG, 2000, P INT WORKSH MAP MOZ; Alders RG, 2005, VILLAGE CHICKENS POV, P207; Alders RG, 2014, VET REC, V174, P502, DOI 10.1136/vr.g3209; Bagnol B, 2009, WORLD POULTRY SCI J, V65, P231, DOI 10.1017/S0043933909000191; Bagnol B., 2013, LIVESTOCK RES RURAL, V25; Balint PJ, 2006, ENVIRON MANAGE, V38, P137, DOI 10.1007/s00267-005-0100-y; Banks T, 2003, MT RES DEV, V23, P132, DOI 10.1659/0276-4741(2003)023[0132:CGMIWC]2.0.CO;2; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Buza J., 2001, P SADC PLANN WORKSH, V103, P38; Copland JW, 2005, WORLD POULTRY SCI J, V61, P31, DOI 10.1079/WPS200439; Curtin CG, 2002, CONSERV BIOL, V16, P880, DOI 10.1046/j.1523-1739.2002.00165.x; Dias P. T., 2001, SADC planning workshop on Newcastle disease control in village chickens. Proceedings of an International Workshop, Maputo, Mozambique, 6-9 March, 2000, P91; Dimitrov KM, 2017, VET MICROBIOL, V206, P126, DOI 10.1016/j.vetmic.2016.12.019; Gueye E H, 2000, Dev Pract, V10, P98, DOI 10.1080/09614520052565; Kitala PM, 2000, PREV VET MED, V44, P73, DOI 10.1016/S0167-5877(99)00114-2; Lema M. A., 2009, African Journal of Environmental Science and Technology, V3, P206; Mabilia M, 1996, ECOL FOOD NUTR, V35, P195, DOI 10.1080/03670244.1996.9991489; Mapiye C, 2008, ASIAN AUSTRAL J ANIM, V21, P1680, DOI 10.5713/ajas.2008.r.07; Msoffe PLM, 2010, TROP ANIM HEALTH PRO, V42, P253, DOI 10.1007/s11250-009-9414-8; Mushi E. Z., 2005, Journal of Animal and Veterinary Advances, V4, P768; Njuki J., 2011, ILRI ADD AB 2 MAY; Selemani I. S., 2012, African Journal of Agricultural Research, V7, P5537; Sonaiya EB, 2009, WORLD POULTRY SCI J, V65, P201, DOI 10.1017/S0043933909000130; van Boven M, 2008, AVIAN PATHOL, V37, P1, DOI 10.1080/03079450701772391	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188230	10.1371/journal.pone.0188230	http://dx.doi.org/10.1371/journal.pone.0188230			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145463	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000415378800096
J	Feig, JL; Mediero, A; Corciulo, C; Liu, HL; Zhang, J; Perez-Aso, M; Picard, L; Wilder, T; Cronstein, B				Feig, Jessica L.; Mediero, Aranzazu; Corciulo, Carmen; Liu, Hailing; Zhang, Jin; Perez-Aso, Miguel; Picard, Laura; Wilder, Tuere; Cronstein, Bruce			The antiviral drug tenofovir, an inhibitor of Pannexin-1-mediated ATP release, prevents liver and skin fibrosis by downregulating adenosine levels in the liver and skin	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; EXTRACELLULAR ADENOSINE; OSTEOCLAST FORMATION; DISOPROXIL FUMARATE; PRODUCTION PLAYS; COLLAGEN CONTENT; DERMAL FIBROSIS; RECEPTOR; INFLAMMATION; EXPRESSION	Background Fibrosing diseases are a leading cause of morbidity and mortality worldwide and, therefore, there is a need for safe and effective antifibrotic therapies. Adenosine, generated extracellularly by the dephosphorylation of adenine nucleotides, ligates specific receptors which play a critical role in development of hepatic and dermal fibrosis. Results of recent clinical trials indicate that tenofovir, a widely used antiviral agent, reverses hepatic fibrosis/cirrhosis in patients with chronic hepatitis B infection. Belonging to the class of acyclic nucleoside phosphonates, tenofovir is an analogue of AMP. We tested the hypothesis that tenofovir has direct antifibrotic effects in vivo by interfering with adenosine pathways of fibrosis using two distinct models of adenosine and A2AR-mediated fibrosis. Methods Thioacetamide (100mg/kg IP)-treated mice were treated with vehicle, or tenofovir (75mg/kg, SubQ) (n = 5-10). Bleomycin (0.25U, SubQ)-treated mice were treated with vehicle or tenofovir (75mg/kg, IP) (n = 5-10). Adenosine levels were determined by HPLC, and ATP release was quantitated as luciferase-dependent bioluminescence. Skin breaking strength was analysed and H&E and picrosirus red-stained slides were imaged. Pannexin-1expression was knocked down following retroviral-mediated expression of of Pannexin-1-specific or scrambled siRNA. Results Treatment of mice with tenofovir diminished adenosine release from the skin of bleomycintreated mice and the liver of thioacetamide-treated mice, models of diffuse skin fibrosis and hepatic cirrhosis, respectively. More importantly, tenofovir treatment diminished skin and liver fibrosis in these models. Tenofovir diminished extracellular adenosine concentrations by inhibiting, in a dose-dependent fashion, cellular ATP release but not in cells lacking Pannexin-1. Conclusions These studies suggest that tenofovir, a widely used antiviral agent, could be useful in the treatment of fibrosing diseases.	[Feig, Jessica L.; Mediero, Aranzazu; Corciulo, Carmen; Liu, Hailing; Zhang, Jin; Perez-Aso, Miguel; Picard, Laura; Wilder, Tuere; Cronstein, Bruce] NYU, Langone Med Ctr, Div Translat Med, Dept Med, New York, NY 10003 USA; [Mediero, Aranzazu] IIS Fdn Jimenez Diaz UAM, Bone & Joint Res Unit, Madrid, Spain; [Zhang, Jin] Ningbo Univ, Med Sch, Dept Immmunol & Rheumatol, LiHuili Hosp, Ningbo, Zhejiang, Peoples R China	New York University; NYU Langone Medical Center; Fundacion Jimenez Diaz; Ningbo University	Cronstein, B (corresponding author), NYU, Langone Med Ctr, Div Translat Med, Dept Med, New York, NY 10003 USA.	Bruce.Cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Cronstein, Bruce N/D-4678-2011	Cronstein, Bruce N/0000-0002-4295-7383; Liu, Hailing/0000-0002-4717-3086; Mediero, Aranzazu/0000-0002-5368-574X; Perez-Aso, Miguel/0000-0002-4703-4182; CORCIULO, CARMEN/0000-0002-1865-3494	National Institute of Arthritis, Musculoskeletal and Skin Diseases [R01-AR054897, R01-AR056672]; NYU-HHC Clinical and Translational Science Institute (from the National Center for Advancing Translational Sciences) [UL1-TR000038]; Gilead Pharmaceuticals; Institute de Salud Carlos III; Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445, UL1TR000038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897, R01AR056672] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NYU-HHC Clinical and Translational Science Institute (from the National Center for Advancing Translational Sciences); Gilead Pharmaceuticals(Gilead Sciences); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Institute of Arthritis, Musculoskeletal and Skin Diseases (R01-AR054897 and R01-AR056672), the NYU-HHC Clinical and Translational Science Institute (UL1-TR000038 from the National Center for Advancing Translational Sciences) and Gilead Pharmaceuticals. Dr Mediero is funded by Institute de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Server" program.; The authors thank Judith Aberg, MD for her suggestions and discussions and Doreen Tivon, BA and Timothy Cardozo, MD, PhD for their computational biology work on this project. The authors also thank the Histopathology Core of the New York University Langone Medical Center. This work was supported by grants from the National Institute of Arthritis, Musculoskeletal and Skin Diseases (RO1-AR054897 and RO1-AR056672), the NYU-HHC Clinical and Translational Science Institute (UL1-TR000038 from the National Center for Advancing Translational Sciences) and Gilead Pharmaceuticals. Dr Mediero is funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER) through the "Miguel Servet" program.	Abudara V, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00306; BALZARINI J, 1991, P NATL ACAD SCI USA, V88, P1499, DOI 10.1073/pnas.88.4.1499; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Blackburn MR, 2003, J CLIN INVEST, V112, P332, DOI 10.1172/JCI200316815; Boyd A, 2010, ANTIVIR THER, V15, P963, DOI 10.3851/IMP1649; Chan ESL, 2006, ARTHRITIS RHEUM-US, V54, P2632, DOI 10.1002/art.21974; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chan ESL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4229; Chan ESL, 2011, ARTHRITIS RHEUM-US, V63, pS907; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Cronstein BN, 2010, J HEPATOL, V53, P207, DOI 10.1016/j.jhep.2010.02.025; CUNDY KC, 1995, ANTIMICROB AGENTS CH, V39, P2401, DOI 10.1128/AAC.39.11.2401; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Evans BAJ, 2006, J BONE MINER RES, V21, P228, DOI 10.1359/JBMR.051021; FDA, 2005, GUID IND EST MAX SAF; Ferrari D, 2015, FASEB JOURNAL OFFICI; Grunig G, 2003, J CLIN INVEST, V112, P329, DOI 10.1172/JCI200319392; Inc. GS, 2001, VIR TEN PROD MON; JAMES J, 1990, LIVER, V10, P1; Kmonickova E, 2006, EUR J PHARMACOL, V530, P179, DOI 10.1016/j.ejphar.2005.11.037; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li L, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/691310; Liaw YF, 2013, JOURNAL OF HEPATOLOG; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Mary-Krause M, 2012, J CLIN DENSITOM, V15, P422, DOI 10.1016/j.jocd.2012.04.001; Mediero A, 2015, FASEB J OFFICIAL PUB; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Montesinos MC, 1997, J EXP MED, V186, P1615, DOI 10.1084/jem.186.9.1615; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Nowak M, 2010, EUR J IMMUNOL, V40, P682, DOI 10.1002/eji.200939897; Ohtsuka T, 2010, J IMMUNOL, V185, P1321, DOI 10.4049/jimmunol.0901847; Palacios RS, 2008, LAB INVEST, V88, P1192, DOI 10.1038/labinvest.2008.91; Peng ZS, 2008, NUCLEOS NUCLEOT NUCL, V27, P821, DOI 10.1080/15257770802146403; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Perez-Aso M, 2013, PURINERGIC SIGNALLIN; Perez-Aso M, 2013, PURINERG SIGNAL, V9, P573, DOI 10.1007/s11302-013-9368-1; Perez-Aso M, 2012, FASEB J, V26, P4254, DOI 10.1096/fj.12-209627; PIERARD GE, 1989, MATRIX, V9, P68, DOI 10.1016/S0934-8832(89)80021-6; Puhl SL, 2015, BRIT J PHARM; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Schafer JJ, 2013, PHARMACOTHERAPY, V33, P665, DOI 10.1002/phar.1257; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Takedachi M, 2011, J CELLULAR PHYSL; Tang J, 2015, MOL MED REP, V11, P4397, DOI 10.3892/mmr.2015.3320; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Van Rompay KKA, 2008, ANTIMICROB AGENTS CH, V52, P3144, DOI 10.1128/AAC.00350-08; Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017201; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhou Y., 2010, PLOS ONE, V5; Zidek Z, 2004, EUR J PHARMACOL, V501, P79, DOI 10.1016/j.ejphar.2004.08.031	63	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188135	10.1371/journal.pone.0188135	http://dx.doi.org/10.1371/journal.pone.0188135			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145453	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800073
J	Liu, TH; Chung, RH; Wang, SC; Fang, CP; Tsou, HH; Shih, CL; Kuo, HW; Wang, Y; Liu, YL				Liu, Tung-Hsia; Chung, Ren-Hua; Wang, Sheng-Chang; Fang, Chiu-Ping; Tsou, Hsiao-Hui; Shih, Chia-Lung; Kuo, Hsiang-Wei; Wang, Yun; Liu, Yu-Li			Missense mutation at CLDN8 associated with a high plasma interferon gamma-inducible protein 10 level in methadone-maintained patients with urine test positive for morphine	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MAINTENANCE PATIENTS; ENDOTHELIAL-CELLS; IP-10; CLAUDINS; DISEASE; GENE; CHEMOATTRACTANT; CXCL10/IP-10; INVOLVEMENT	We previously reported a high plasma chemokine interferon gamma-inducible protein 10 (IP-10) level and prolonged electrocardiography QT-interval in methadone maintenance treatment (MMT) patients with HIV or HCV infection. The purpose of this study was to evaluate the genetic association of high plasma IP-10 level in the MMT patients. The gene-based and pathway-based association analyses were conducted using a genome-wide association study dataset in 344 MMT patients for identifying genes and pathways associated with plasma IP-10 level. We found that plasma IP-10 level was significantly associated with a pathway in the tight junction (P = 1.01x10(-5)), where the claudin 8 (CLDN8) gene had the most significant association (P = 6.8x10(-5)). A functional single nucleotide polymorphism (SNP) rs686364 at exon 1 of CLDN8 showed strong association with plasma IP-10 levels, in the MMT subjects with positive urine test for morphine (dominant model, P = 0.00004). The minor allele type carriers had higher plasma IP-10 levels than the major allele type carriers. Our data support that the tight junction protein claudin 8 exon 1 is a predictor for the plasma levels of IP-10 in MMT patients with urine test positive for morphine.	[Liu, Tung-Hsia; Wang, Sheng-Chang; Fang, Chiu-Ping; Shih, Chia-Lung; Kuo, Hsiang-Wei; Wang, Yun; Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Chung, Ren-Hua; Tsou, Hsiao-Hui] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Miaoli, Taiwan; [Tsou, Hsiao-Hui] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Liu, Yu-Li] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Liu, YL (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan.; Liu, YL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	ylliou@nhri.org.tw	Chung, Ren-Hua/AAB-8364-2019	Liu, Yu-Li/0000-0001-7519-2965	National Research Program for Genomic Medicine [NSC 100-3112-B-400-015]; National Science Council [NSC 100-2314-B-400-002-MY3]; National Health Research Institutes, Taiwan [NP-105-PP-04, NP-106-PP-06, NP-105-SP-04, NP-106-SP-04]; National Heath Research Institutes and Central Government ST Grant [106-1901-01-10-02]; Ministry of Science and Technology of Taiwan [MOST 106-2320-B-400-012]; National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Heath Research Institutes and Central Government ST Grant; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology	This study was provided by the National Research Program for Genomic Medicine [NSC 100-3112-B-400-015 to YLL], National Science Council [NSC 100-2314-B-400-002-MY3 to YLL] and the National Health Research Institutes, Taiwan [NP-105-PP-04, NP-106-PP-06, NP-105-SP-04 and NP-106-SP-04 to YLL]. This study was also supported in part by the National Heath Research Institutes and Central Government S&T Grant 106-1901-01-10-02 to YW and Ministry of Science and Technology of Taiwan MOST 106-2320-B-400-012 to YLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge staff at the National Center for Genomic Medicine at Academia Sinica for their assistance in genotyping. We also thank staff in the Clinical Trial Information Management System (CTIMeS) at the National Health Research Institutes for data collection and management. This study was supported by National Health Research Institutes, and Central Government S & T grant, Taiwan; National Research Program for Genomic Medicine and Ministry of Science and Technology. All study subjects and research nurses are also appreciated.	Alinejad S, 2015, EXCLI J, V14, P577, DOI 10.17179/excli2015-553; Angelow S, 2007, J MEMBRANE BIOL, V215, P147, DOI 10.1007/s00232-007-9014-3; Balkovetz DF, 2009, BBA-BIOMEMBRANES, V1788, P858, DOI 10.1016/j.bbamem.2008.07.004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bart G, 2012, J ADDICT DIS, V31, P207, DOI 10.1080/10550887.2012.694598; Chen YH, 2009, ANN NY ACAD SCI, V1165, P126, DOI 10.1111/j.1749-6632.2009.04031.x; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Fonseca F, 2009, DRUG ALCOHOL DEPEN, V99, P327, DOI 10.1016/j.drugalcdep.2008.06.018; Fujita H, 2006, J HISTOCHEM CYTOCHEM, V54, P933, DOI 10.1369/jhc.6A6944.2006; Guan MJ, 2016, HUM GENET, V135, P1251, DOI 10.1007/s00439-016-1714-2; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Huey CL, 2004, AM J NEPHROL, V24, P483, DOI 10.1159/000080672; Iwaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42316; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Ko TM, 2015, CIRC RES, V116, P876, DOI 10.1161/CIRCRESAHA.116.305834; Kreek MJ, 2010, J ADDICT DIS, V29, P200, DOI 10.1080/10550881003684798; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Liu SW, 2015, INT J CARDIOL, V194, P36, DOI 10.1016/j.ijcard.2015.05.055; Odler B, 2017, LUPUS, V26, P572, DOI 10.1177/0961203316668418; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sajadi SMA, 2013, CLIN LAB, V59, P133, DOI 10.7754/Clin.Lab.2012.120225; Shrestha A, 2013, MBIO, V4, DOI 10.1128/mBio.00594-12; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Stumpf C, 2011, HYPERTENS RES, V34, P484, DOI 10.1038/hr.2010.258; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Wu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069310; Yang HZ, 2016, SCAND ACTUAR J, P1, DOI 10.1080/03461238.2014.884017; You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187639	10.1371/journal.pone.0187639	http://dx.doi.org/10.1371/journal.pone.0187639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145422	Green Published, Green Submitted, gold			2022-12-27	WOS:000415378800025
J	Morchang, A; Lee, RCH; Yenchitsomanus, PT; Sreekanth, GP; Noisakran, S; Chu, JJH; Limjindaporn, T				Morchang, Atthapan; Lee, Regina Ching Hua; Yenchitsomanus, Pa-thai; Sreekanth, Gopinathan Pillai; Noisakran, Sansanee; Chu, Justin Jang Hann; Limjindaporn, Thawornchai			RNAi screen reveals a role of SPHK2 in dengue virus-mediated apoptosis in hepatic cell lines	PLOS ONE			English	Article							SPHINGOSINE KINASE 2; INDUCED LIVER-INJURY; HEMORRHAGIC-FEVER; SPHINGOLIPID METABOLISM; INFECTION; DEATH; SPHINGOSINE-1-PHOSPHATE; INHIBITION; INVOLVEMENT; CANCER	Hepatic dysfunction is a feature of dengue virus (DENV) infection. Hepatic biopsy specimens obtained from fatal cases of DENV infection show apoptosis, which relates to the pathogenesis of DENV infection. However, how DENV induced liver injury is not fully understood. In this study, we aim to identify the factors that influence cell death by employing an apoptosis-related siRNA library screening. Our results show the effect of 558 gene silencing on caspase 3-mediated apoptosis in DENV-infected Huh7 cells. The majority of genes that contributed to apoptosis were the apoptosis-related kinase enzymes. Tumor necrosis factor superfamily member 12 (TNFSF12), and sphingosine kinase 2 (SPHK2), were selected as the candidate genes to further validate their influences on DENV-induced apoptosis. Transfection of siRNA targeting SPHK2 but not TNFSF12 genes reduced apoptosis determined by Annexin V/PI staining. Knockdown of SPHK2 did not reduce caspase 8 activity; however, did significantly reduce caspase 9 activity, suggesting its involvement of SPHK2 in the intrinsic pathway of apoptosis. Treatment of ABC294649, an inhibitor of SPHK2, reduced the caspase 3 activity, suggesting the involvement of its kinase activity in apoptosis. Knockdown of SPHK2 significantly reduced caspase 3 activity not only in DENV-infected Huh7 cells but also in DENV-infected HepG2 cells. Our results were consistent across all of the four sero-types of DENV infection, which supports the pro-apoptotic role of SPHK2 in DENV-infected liver cells.	[Morchang, Atthapan; Yenchitsomanus, Pa-thai; Sreekanth, Gopinathan Pillai; Limjindaporn, Thawornchai] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok, Thailand; [Morchang, Atthapan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol,Grad Program Immunol, Bangkok, Thailand; [Lee, Regina Ching Hua; Chu, Justin Jang Hann] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Singapore, Singapore; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Limjindaporn, Thawornchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok, Thailand	Mahidol University; Mahidol University; National University of Singapore; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Limjindaporn, T (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok, Thailand.; Chu, JJH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hlth Syst, Lab Mol RNA Virol & Antiviral Strategies, Singapore, Singapore.; Limjindaporn, T (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anat, Bangkok, Thailand.	miccjh@nus.edu.sg; thawornchai.lim@mahidol.ac.th	Chu, Justin Jang Hann/ABA-8297-2021; Noisakran, Sansanee/H-5186-2011; Sreekanth, Gopinathan Pillai/F-3715-2010	Noisakran, Sansanee/0000-0002-9336-3331; Sreekanth, Gopinathan Pillai/0000-0002-0278-8642; Chu, Justin Jang Hann/0000-0002-1673-6819	Mahidol University [R015810002]; Royal Golden Jubilee (RGJ) Ph.D. Scholarship [PHD/0016/2553]	Mahidol University; Royal Golden Jubilee (RGJ) Ph.D. Scholarship	This study was supported by the Mahidol University Grant (R015810002) to TL and AM was supported by the Royal Golden Jubilee (RGJ) Ph.D. Scholarship (PHD/0016/2553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Mahidol University Grant (R015810002) to TL and AM was supported by the Royal Golden Jubilee (RGJ) Ph.D. Scholarship (PHD/0016/2553).	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Antoon JW, 2011, CANCER BIOL THER, V11, P678, DOI 10.4161/cbt.11.7.14903; Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022; Barbier V, 2017, VIROLOGY, V500, P149, DOI 10.1016/j.virol.2016.10.022; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; BHAMARAPRAVATI N, 1989, REV INFECT DIS, V11, pS826; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; Carr JM, 2013, J GEN VIROL, V94, P2437, DOI 10.1099/vir.0.055616-0; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Clarke JN, 2016, J GEN VIROL, V97, P95, DOI 10.1099/jgv.0.000334; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hapuarachchi HC, 2013, J CLIN VIROL, V57, P91, DOI 10.1016/j.jcv.2012.12.021; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820; Leclercq TM, 2006, IUBMB LIFE, V58, P467, DOI 10.1080/15216540600871126; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee SY, 2015, HEPATOLOGY, V62, P135, DOI 10.1002/hep.27804; Li JL, 2012, BIOCHEM BIOPH RES CO, V418, P622, DOI 10.1016/j.bbrc.2012.01.050; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Michels M, 2015, J INFECTION, V71, P480, DOI 10.1016/j.jinf.2015.06.014; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Morchang A, 2013, BIOCHEM BIOPH RES CO, V438, P20, DOI 10.1016/j.bbrc.2013.07.009; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Navas TA, 1999, J BIOL CHEM, V274, P33684, DOI 10.1074/jbc.274.47.33684; Neubauer HA, 2013, FEBS J, V280, P5317, DOI 10.1111/febs.12314; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Panda D, 2012, CURR OPIN VIROL, V2, P784, DOI 10.1016/j.coviro.2012.10.007; Pando-Robles V, 2014, J PROTEOMICS, V111, P16, DOI 10.1016/j.jprot.2014.06.029; Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743; Santos WL, 2015, ACS CHEM BIOL, V10, P225, DOI 10.1021/cb5008426; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shi YJ, 2012, J HEPATOL, V56, P137, DOI 10.1016/j.jhep.2011.05.025; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Sreekanth GP, 2017, ANTIVIR RES, V141, P7, DOI 10.1016/j.antiviral.2017.02.003; Sreekanth GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149486; Sreekanth GP, 2014, VIRUS RES, V188, P15, DOI 10.1016/j.virusres.2014.03.025; Strub GM, 2011, FASEB J, V25, P600, DOI 10.1096/fj.10-167502; Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Tran AT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.296; Ullio C, 2012, J LIPID RES, V53, P1134, DOI 10.1194/jlr.M022384; Venkata JK, 2014, BLOOD, V124, P1915, DOI 10.1182/blood-2014-03559385; Wahid S. Fadilah S. Abdul, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P259; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhou L, 2015, J VIROL, V89, P10512, DOI 10.1128/JVI.01028-15; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	69	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0188121	10.1371/journal.pone.0188121	http://dx.doi.org/10.1371/journal.pone.0188121			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145490	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800068
J	Bupathi, M; Hays, JL; Chen, JL				Bupathi, Manojkumar; Hays, John L.; Chen, James L.			Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series	PLOS ONE			English	Article							ADVANCED SOFT-TISSUE; PHASE-II TRIAL; DOXORUBICIN; GLIOBLASTOMA; CHEMOTHERAPY; BEVACIZUMAB; GEMCITABINE; IFOSFAMIDE; DOCETAXEL; THERAPY	Background Sarcomas are rare, heterogeneous tumors for which prognosis remains dismal in patients with advanced disease. Pazopanib, a vascular endothelial growth factor receptor inhibitor, has shown modest efficacy in patients with soft tissue sarcoma who fail cytotoxic chemotherapy. The cytotoxic agent temozolomide has also demonstrated activity in patients with advanced sarcoma. Objective We performed a retrospective case series to evaluate the feasibility of adding temozolomide to pazopanib in advanced sarcoma patients following single-agent pazopanib failure. Patients and methods Patients with recurrent, metastatic sarcomas who had progressed on single-agent pazopanib and continued on pazopanib with the addition of temozolomide were included in this retrospective analysis to examine the tolerability and responses associated with the treatment combination. Results Nine patients with a range of sarcoma subtypes were identified (55% female; median age, 48 years; median number of therapies prior to pazopanib, 3). All patients received combination therapy. One patient was recently started on therapy and was excluded from the analysis (n = 8 evaluable patients). Median PFS for single-agent pazopanib was 7.5 months (range 2-19). For the eight evaluable patients (63% female), best response at 4 months with pazopanib plus temozolomide was partial response (n = 1), stable disease (n = 3) and progressive disease (n = 4), with a median PFS of 3.5 months (range 0-15). Median PFS with combination treatment in patients with stable disease or response was 8 months (range 5-15). All four patients who achieved clinical benefit remain on therapy and are tolerating the combination therapy with expected but manageable side effects. Conclusions In heavily pretreated patients with advanced sarcoma, the addition of temozolomide to pazopanib was found to be tolerable. Future prospective trials are required to deduce whether temozolomide extends the clinical benefit of pazopanib.	[Bupathi, Manojkumar; Chen, James L.] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Hays, John L.] Ohio State Univ, Dept Obstet & Gynecol, Div Gynecol Oncol, Columbus, OH 43210 USA; [Hays, John L.; Chen, James L.] Ohio State Univ, Dept Biomed Informat, Div Bioinformat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chen, JL (corresponding author), Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA.; Chen, JL (corresponding author), Ohio State Univ, Dept Biomed Informat, Div Bioinformat, Columbus, OH 43210 USA.	James.chen@osumc.edu	Chen, James/A-9964-2016	Chen, James/0000-0002-4095-5202	Novartis Pharmaceuticals; Novartis Pharmaceuticals Corporation	Novartis Pharmaceuticals(Novartis); Novartis Pharmaceuticals Corporation(Novartis)	This study was funded by Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Editorial assistance was provided by ApotheCom (Yardley, PA), supported by Novartis Pharmaceuticals Corporation.; Editorial assistance was provided by ApotheCom (Yardley, PA) supported by Novartis Pharmaceuticals Corporation.	[Anonymous], 2017, LARTR PRESCR INF; [Anonymous], 2016, AV PRESCR INF; [Anonymous], 2017, VOTR PRESCR INF; ANTMAN K, 1993, J CLIN ONCOL, V11, P1276, DOI 10.1200/JCO.1993.11.7.1276; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; de Groot JF, 2010, NEURO-ONCOLOGY, V12, P233, DOI 10.1093/neuonc/nop027; del Muro XG, 2005, CANCER, V104, P1706, DOI 10.1002/cncr.21384; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Drappatz J, 2010, INT J RADIAT ONCOL, V78, P85, DOI 10.1016/j.ijrobp.2009.07.1741; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; EDMONSON JH, 1993, J CLIN ONCOL, V11, P1269, DOI 10.1200/JCO.1993.11.7.1269; Garcia-del-Muro X, 2011, J CLIN ONCOL, V29, P2528, DOI 10.1200/JCO.2010.33.6107; Gerstner ER, 2011, J NEURO-ONCOL, V103, P325, DOI 10.1007/s11060-010-0390-7; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; Grossman R, 2014, J NEURO-ONCOL, V116, P59, DOI 10.1007/s11060-013-1268-2; Hosaka S, 2012, J ORTHOP RES, V30, P1493, DOI 10.1002/jor.22091; Italiano A, 2013, ANN ONCOL, V24, P2916, DOI 10.1093/annonc/mdt374; Kusabe Y, 2015, ONCOL LETT, V10, P2511, DOI 10.3892/ol.2015.3506; Leahy M, 2012, ANN ONCOL, V23, P2763, DOI 10.1093/annonc/mds070; Maki RG, 2007, J CLIN ONCOL, V25, P2755, DOI 10.1200/JCO.2006.10.4117; Maki RG, 2007, ONCOLOGIST, V12, P999, DOI 10.1634/theoncologist.12-8-999; National Comprehensive Cancer Network, 2021, NCCN CLIN PRACTICE G; Pang A, 2016, JAMA ONCOL, V2, P941, DOI 10.1001/jamaoncol.2016.0241; Paoluzzi L, 2016, CLIN SARCOMA RES, V6, DOI 10.1186/s13569-016-0064-0; Park MS, 2011, CANCER-AM CANCER SOC, V117, P4939, DOI 10.1002/cncr.26098; Penel N, 2008, J CLIN ONCOL, V26, P5269, DOI 10.1200/JCO.2008.17.3146; Sleijfer S, 2010, EUR J CANCER, V46, P72, DOI 10.1016/j.ejca.2009.09.022; Stacchiotti S, 2014, EUR J CANCER, V50, P1657, DOI 10.1016/j.ejca.2014.03.013; Stacchiotti S, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-16; Talbot SM, 2003, CANCER-AM CANCER SOC, V98, P1942, DOI 10.1002/cncr.11730; Tap WD, 2016, LANCET, V388, P488, DOI 10.1016/S0140-6736(16)30587-6; van der Graaf WTA, 2012, LANCET, V379, P1879, DOI 10.1016/S0140-6736(12)60651-5; Wachsberger PR, 2011, J NEURO-ONCOL, V105, P181, DOI 10.1007/s11060-011-0580-y; Woll PJ, 1999, EUR J CANCER, V35, P410, DOI 10.1016/S0959-8049(98)00403-1	34	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188116	10.1371/journal.pone.0188116	http://dx.doi.org/10.1371/journal.pone.0188116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141017	Green Submitted, gold, Green Published			2022-12-27	WOS:000415260400059
J	Lai, K; Harwood, CA; Purdie, KJ; Proby, CM; Leigh, IM; Ravi, N; Mully, TW; Brooks, L; Sandoval, PM; Rosenblum, MD; Arron, ST				Lai, Kevin; Harwood, Catherine A.; Purdie, Karin J.; Proby, Charlotte M.; Leigh, Irene M.; Ravi, Namita; Mully, Thaddeus W.; Brooks, Lionel; Sandoval, Priscilla M.; Rosenblum, Michael D.; Arron, Sarah T.			Genomic analysis of atypical fibroxanthoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-ASSOCIATED MACROPHAGES; MUTATIONAL LANDSCAPE; SOMATIC MUTATIONS; SEQUENCING DATA; CANCER; EXPRESSION; GENES; SKIN	Atypical fibroxanthoma (AFX), is a rare type of skin cancer affecting older individuals with sun damaged skin. Since there is limited genomic information about AFX, our study seeks to improve the understanding of AFX through whole-exome and RNA sequencing of 8 matched tumor-normal samples. AFX is a highly mutated malignancy with recurrent mutations in a number of genes, including COL11A1, ERBB4, CSMD3, and FAT1. The majority of mutations identified were UV signature (C>T in dipyrimidines). We observed deletion of chromosomal segments on chr9p and chr13q, including tumor suppressor genes such as KANK1 and CDKN2A, but no gene fusions were found. Gene expression profiling revealed several biological pathways that are upregulated in AFX, including tumor associated macrophage response, GPCR signaling, and epithelial to mesenchymal transition (EMT). To further investigate the presence of EMT in AFX, we conducted a gene expression meta-analysis that incorporated RNA-seq data from dermal fibroblasts and keratinocytes. Ours is the first study to employ high throughput sequencing for molecular profiling of AFX. These data provide valuable insights to inform models of carcinogenesis and additional research towards tumor-directed therapy.	[Lai, Kevin; Ravi, Namita; Mully, Thaddeus W.; Brooks, Lionel; Sandoval, Priscilla M.; Rosenblum, Michael D.; Arron, Sarah T.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Harwood, Catherine A.; Purdie, Karin J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Cutaneous Res & Cell Biol, London, England; [Proby, Charlotte M.; Leigh, Irene M.] Univ Dundee, Sch Med, Div Canc Res, Dundee, Scotland; [Arron, Sarah T.] Vet Adm Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; University of London; Queen Mary University London; University of Dundee; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Arron, ST (corresponding author), Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA.; Arron, ST (corresponding author), Vet Adm Med Ctr, San Francisco, CA 94121 USA.	Sarah.Arron@ucsf.edu		Arron, Sarah/0000-0001-5669-0627; Harwood, Catherine/0000-0002-1375-0965	Cancer Research UK programme; UCSF Department of Dermatology	Cancer Research UK programme(Cancer Research UK); UCSF Department of Dermatology	This work was funded by Cancer Research UK programme grant to Prof. Irene Leigh and UCSF Department of Dermatology funding to Dr Sarah Arron.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson HL, 2007, DERMATOL SURG, V33, P693, DOI 10.1111/j.1524-4725.2007.33145.x; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Cheng FX, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004497; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; de Gruijl FR, 2001, J PHOTOCH PHOTOBIO B, V63, P19, DOI 10.1016/S1011-1344(01)00199-3; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Goh G, 2016, ONCOTARGET, V7, P3393, DOI 10.18632/oncotarget.6494; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Griewank KG, 2014, MODERN PATHOL, V27, P502, DOI 10.1038/modpathol.2013.168; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jia WL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r12; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Kahlert UD, 2017, MOL ONCOL, V11, P860, DOI 10.1002/1878-0261.12085; Knuchel S, 2015, ONCOTARGET, V6, P14300, DOI 10.18632/oncotarget.3883; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krasinskas AM, 2010, MODERN PATHOL, V23, P531, DOI 10.1038/modpathol.2009.186; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mihic-Probst D, 2004, ANTICANCER RES, V24, P19; Mirza Basit, 2005, Australas J Dermatol, V46, P235, DOI 10.1111/j.1440-0960.2005.00190.x; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nakamura M, 2010, J EUR ACAD DERMATOL, V24, P1365, DOI 10.1111/j.1468-3083.2010.03659.x; Pacifico A, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/43418; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Polcz MM, 2017, AUSTRALAS J DERMATOL; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Sannino G, 2017, CANCER RES, V77, P4556, DOI 10.1158/0008-5472.CAN-17-0032; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schmalbach CE, 2004, ARCH OTOLARYNGOL, V130, P295, DOI 10.1001/archotol.130.3.295; Scolnick JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128916; Shyr C, 2014, BMC MED GENOMICS, V7, DOI 10.1186/s12920-014-0064-y; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talevich E, 2014, BIORXIV; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; TOS APD, 1994, AM J PATHOL, V145, P11; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang QG, 2013, GENOME MED, V5, DOI 10.1186/gm495; Wieland CN, 2011, J CUTAN PATHOL, V38, P884, DOI 10.1111/j.1600-0560.2011.01768.x; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Zhang Y, 2015, CANCER METAST REV, V34, P249, DOI 10.1007/s10555-015-9558-0; Ziemer M, 2012, J DTSCH DERMATOL GES, V10, P537, DOI 10.1111/j.1610-0387.2012.07980.x	54	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188272	10.1371/journal.pone.0188272	http://dx.doi.org/10.1371/journal.pone.0188272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141020	gold, Green Published, Green Submitted			2022-12-27	WOS:000415260400073
J	Stack, JR; Madigan, A; Helbert, L; Dunne, E; Gardiner, EE; Andrews, RK; Finan, R; Smyth, E; Kenny, D; McCarthy, GM				Stack, John R.; Madigan, Anne; Helbert, Laura; Dunne, Eimear; Gardiner, Elizabeth E.; Andrews, Robert K.; Finan, Roisin; Smyth, Elizabeth; Kenny, Dermot; McCarthy, Geraldine M.			Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis	PLOS ONE			English	Article							IMMUNE THROMBOCYTOPENIC PURPURA; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; INFLAMMATION; PATIENT; ANTIBODIES; MORTALITY; RECEPTOR; GPVI	Objectives Anti-citrullinated protein antibodies (ACPA) have been shown to cause platelet activation in vitro, through the low-affinity immunoglobulin G (IgG) receptor (Fc gamma RIIa) on platelets. Platelet activation via engagement of Fc gamma RIIa results in proteolytic cleavage and shedding of platelet specific glycoprotein VI (GPVI) which can be detected in the plasma as soluble GPVI (sGPVI). We hypothesized that plasma levels of sGPVI would be increased among patients with seropositive RA as a consequence of antibody-induced platelet activation and GPVI shedding. Methods Samples from 84 patients with RA (65 seropositive and 19 seronegative) and 67 healthy controls were collected prospectively and analysed for sGPVI using a standardised ELISA. Results Patients with seropositive RA had significantly higher levels of sGPVI compared to seronegative RA and controls. Median (IQR) sGPVI levels were 4.2 ng/ml (3.2, 8.0) in seropositve RA, 2.2 ng/ml (1.5, 3.5) in seronegative RA and 2.2 ng/ml (1.6, 3.4) in controls (p<0.0001). sGPVI levels correlated with ACPA titres (r = 0.32, p = 0.0026) and with RF titres (r = 0.48, p<0.0001). Conclusion Plasma sGPVI, a specific marker of platelet activation is increased among patients with seropositive RA.	[Stack, John R.; Madigan, Anne; Helbert, Laura; McCarthy, Geraldine M.] Mater Misericordiae Univ Hosp, Eccles St, Dublin, Ireland; [Dunne, Eimear; Finan, Roisin; Smyth, Elizabeth; Kenny, Dermot] Royal Coll Surgeons Ireland, RCSI Mol & Cellular Therapeut MCT, Dublin, Ireland; [Gardiner, Elizabeth E.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia; [Andrews, Robert K.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia	Mater Misericordiae University Hospital; University College Dublin; Royal College of Surgeons - Ireland; Australian National University; John Curtin School of Medical Research; Monash University	Stack, JR (corresponding author), Mater Misericordiae Univ Hosp, Eccles St, Dublin, Ireland.	stack.johnr@gmail.com	Kenny, Dermot/C-3898-2012; Dunne, Eimear/AGX-1949-2022; Dunne, Eimear/C-6785-2012; Smyth, Elizabeth/N-6541-2019; McCarthy, Geraldine/AFQ-5733-2022; Gardiner, Elizabeth/P-8716-2019	Kenny, Dermot/0000-0001-5548-3263; Dunne, Eimear/0000-0001-9862-1398; Dunne, Eimear/0000-0001-9862-1398; Gardiner, Elizabeth/0000-0001-9453-9688; Stack, John/0000-0003-1615-5317; Andrews, Robert Keith/0000-0001-9577-8082; McCarthy, Geraldine/0000-0003-4078-8499				Al-Tamimi M, 2012, THROMB HAEMOSTASIS, V107, P648, DOI 10.1160/TH11-10-0745; Al-Tamimi M, 2011, STROKE, V42, P498, DOI 10.1161/STROKEAHA.110.602532; Andrews RK, 2014, J BLOOD MED, V5, P59, DOI 10.2147/JBM.S39220; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Connolly-Andersen AM, 2015, J INFECT DIS, V212, P1061, DOI 10.1093/infdis/jiv161; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Dunne E, 2011, J THROMB HAEMOST S2, P1; Ertenli I, 1998, J RHEUMATOL, V25, P1054; Gardiner EE, 2008, J THROMB HAEMOST, V6, P1175, DOI 10.1111/j.1538-7836.2008.03016.x; Gardiner EE, 2008, BLOOD, V111, P165, DOI 10.1182/blood-2007-04-086983; Gardiner EE, 2010, BRIT J HAEMATOL, V149, P625, DOI 10.1111/j.1365-2141.2010.08092.x; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Goodson NJ, 2002, ARTHRITIS RHEUM-US, V46, P2010, DOI 10.1002/art.10419; Habets KLL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0665-7; Hjeltnes G, 2011, SCAND J RHEUMATOL, V40, P422, DOI 10.3109/03009742.2011.585350; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Kitas GD, 2011, ANN RHEUM DIS, V70, P8, DOI 10.1136/ard.2010.142133; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; Mason JC, 2015, EUR HEART J, V36, P482, DOI 10.1093/eurheartj/ehu403; Nurden P, 2009, J THROMB HAEMOST, V7, P1541, DOI 10.1111/j.1538-7836.2009.03537.x; O'Halloran JA, 2015, HIV MED, V16, P608, DOI 10.1111/hiv.12270; Pignatelli P, 2005, BLOOD, V106, P1992, DOI 10.1182/blood-2005-03-1247; Thomas MR, 2015, THROMB HAEMOSTASIS, V114, P449, DOI 10.1160/TH14-12-1067; Tomasson G, 2010, ANN RHEUM DIS, V69, P1649, DOI 10.1136/ard.2009.110536	24	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188027	10.1371/journal.pone.0188027	http://dx.doi.org/10.1371/journal.pone.0188027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141000	Green Published, Green Submitted, gold			2022-12-27	WOS:000415260400045
J	Venugopal, G; Mueller, M; Hartmann, S; Steinfelder, S				Venugopal, Gopinath; Mueller, Marion; Hartmann, Susanne; Steinfelder, Svenja			Differential immunomodulation in human monocytes versus macrophages by filarial cystatin	PLOS ONE			English	Article							CYSTEINE PROTEASE INHIBITOR; GROWTH-FACTOR-BETA; BRUGIA-MALAYI; HELMINTH INFECTIONS; NEMATODE; EXPRESSION; INDUCTION; RESPONSES; IMMUNITY; CELLS	Parasitic nematodes have evolved powerful immunomodulatory molecules to enable their survival in immunocompetent hosts by subverting immune responses and minimizing pathological processes. One filarial molecule known to counteract host immune responses by inducing IL-10 and regulatory macrophages in mice is filarial cystatin. During a patent filarial infection monocytes encounter microfilariae in the blood, an event that occurs in asymptomatically infected filariasis patients that are immunologically hyporeactive. The microfilarial larval stage was formerly shown to induce human regulatory monocytes and macrophages. Thus, here we aim was to determine how filarial cystatin of the human pathogenic filaria Brugia malayi (BmCPI-2) contributes to immune hyporesponsiveness in human monocytes and macrophages elicited by microfilaria. For this purpose, filarial cystatin was depleted from microfilarial lysate (Mf). Detecting the immunomodulatory potential of cystatin-depleted Mf revealed that IL-10, but not IL-8 and IL-6 induction in monocytes and macrophages is dependent on the presence of cystatin. In addition, the Mf-induced expression of the regulatory surface markers PD-L1 and PD-L2 in human monocytes, but not in macrophages, is dependent on cystatin. While Mf-treated monocytes result in decreased CD4(+) T-cell proliferation in a co-culture assay, stimulation of T-cells with human monocytes treated with cystatin-depleted Mf lead to a restoration of CD4(+) T-cell proliferation. Moreover, IL-10 induction by cystatin within Mf was dependent on p38 and ERK in macrophages, but independent of the ERK pathway in monocytes. These findings indicate that filarial nematodes differentially trigger and exploit various signaling pathways to induce immunomodulation in different myeloid cell subsets.	[Venugopal, Gopinath; Mueller, Marion; Hartmann, Susanne; Steinfelder, Svenja] Free Univ Berlin, Inst Immunol, Ctr Infect Med, Berlin, Germany	Free University of Berlin	Hartmann, S (corresponding author), Free Univ Berlin, Inst Immunol, Ctr Infect Med, Berlin, Germany.	susanne.hartmann@fu-berlin.de		Venugopal, Gopinath/0000-0001-9363-0711	German Research Foundation (DFG - International Research Training Group 1673); Sonnenfeld Foundation, Berlin, Germany	German Research Foundation (DFG - International Research Training Group 1673); Sonnenfeld Foundation, Berlin, Germany	This work was supported by the German Research Foundation (DFG - International Research Training Group 1673) and Sonnenfeld Foundation, Berlin, Germany. The funders had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; [Anonymous], 2016, DEATHS CAUS AG SEX C; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Araujo MIAS, 2004, J INFECT DIS, V190, P1797, DOI 10.1086/425017; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; Babu S, 2005, J INFECT DIS, V191, P1018, DOI 10.1086/427658; Babu S, 2014, PARASITE IMMUNOL, V36, P338, DOI 10.1111/pim.12081; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; Behrendt P, 2016, NEUROIMMUNOMODULAT, V23, P109, DOI 10.1159/000444756; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Boyd A, 2013, INFECT IMMUN, V81, P1420, DOI 10.1128/IAI.01301-12; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Coronado S, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12425; Dainichi T, 2001, INFECT IMMUN, V69, P7380, DOI 10.1128/IAI.69.12.7380-7386.2001; Fenwick A, 2012, PUBLIC HEALTH, V126, P233, DOI 10.1016/j.puhe.2011.11.015; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gomez-Escobar N, 1998, EXP PARASITOL, V88, P200, DOI 10.1006/expr.1998.4248; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Goodridge HS, 2003, IMMUNOLOGY, V109, P415, DOI 10.1046/j.1365-2567.2003.01689.x; Goodrigde HS, 2005, CELL SIGNAL, V17, P11, DOI 10.1016/j.cellsig.2004.05.014; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Gregory WF, 2008, INT J BIOCHEM CELL B, V40, P1389, DOI 10.1016/j.biocel.2007.11.012; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Harnett W, 2005, PARASITOLOGY, V130, pS63, DOI 10.1017/S0031182005008164; Hartmann S, 2003, INT J PARASITOL, V33, P1291, DOI 10.1016/S0020-7519(03)00163-2; Hartmann S, 1997, EUR J IMMUNOL, V27, P2253, DOI 10.1002/eji.1830270920; Hartmann S, 2002, CYSTATINS FILARIAL N, P253; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Johnston KL, 2014, J BIOMOL SCREEN, V19, P335, DOI 10.1177/1087057113511270; Klotz C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001248; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Manoury B, 2001, CURR BIOL, V11, P447, DOI 10.1016/S0960-9822(01)00118-X; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; O'Regan NL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003206; Pfaff AW, 2002, INT J PARASITOL, V32, P171, DOI 10.1016/S0020-7519(01)00350-2; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; Sabotic J, 2012, APPL MICROBIOL BIOT, V93, P1351, DOI 10.1007/s00253-011-3834-x; Satapathy AK, 2006, MICROBES INFECT, V8, P2414, DOI 10.1016/j.micinf.2006.05.003; Schnoeller C, 2008, J IMMUNOL, V180, P4265, DOI 10.4049/jimmunol.180.6.4265; Schonemeyer A, 2001, J IMMUNOL, V167, P3207, DOI 10.4049/jimmunol.167.6.3207; Schroeder JH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001914; Schuit M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148476; Semnani RT, 2006, INFECT IMMUN, V74, P4409, DOI 10.1128/IAI.01106-05; Semnani RT, 2004, J IMMUNOL, V172, P6229, DOI 10.4049/jimmunol.172.10.6229; Semnani RT, 2003, J IMMUNOL, V171, P1950, DOI 10.4049/jimmunol.171.4.1950; Specht S, 2012, EXP PARASITOL, V132, P90, DOI 10.1016/j.exppara.2011.09.003; Turner JD, 2008, J INFECT DIS, V197, P1204, DOI 10.1086/586717; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Weinkopff T, 2014, PLOS NEGL TROP DIS, V8; Wilcox RA, 2009, BLOOD, V114, P2149, DOI 10.1182/blood-2009-04-216671; Zang XX, 2002, J BIOL CHEM, V277, P44261, DOI 10.1074/jbc.M204655200	55	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188138	10.1371/journal.pone.0188138	http://dx.doi.org/10.1371/journal.pone.0188138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141050	Green Submitted, Green Published, gold			2022-12-27	WOS:000415260400063
J	Yuan, M; Wang, SJ; Yu, LJ; Qu, B; Xu, LM; Liu, LN; Sun, HX; Li, CX; Shi, YJ; Liu, HX				Yuan, Min; Wang, Shujun; Yu, Lijie; Qu, Bo; Xu, Liming; Liu, Lining; Sun, Huanxia; Li, Chunxian; Shi, Yanjun; Liu, Huaxiang			Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis	PLOS ONE			English	Article							CYSTIC-FIBROSIS; CELLS; IMMUNOPATHOGENESIS; IDENTIFICATION; PROTEINS; CFTR	Long noncoding RNAs (lncRNAs) have recently emerged as important biological regulators, and the aberrant expression of lncRNAs has been reported in numerous diseases. However, the expression of lncRNAs in peripheral blood mononuclear cells (PBMCs) in rheumatoid arthritis (RA) has not been well documented. We applied a microarray analysis to profile the lncRNA and mRNA expression in 3 pairs of samples. Each sample was mixed with equivalent PBMCs from 9 female RA patients and 9 corresponding healthy controls, and the data were validated via qPCR using another cohort that comprised 36 RA patients and 24 healthy controls. A bioinformatic analysis was performed to investigate the potential functions of differentially expressed genes. Overall, 2,099 lncRNAs and 2,307 mRNAs were differentially expressed between the RA patients and healthy controls. The bioinformatic analysis indicated that the differentially expressed lncRNAs regulated the abnormally expressed mRNAs, which were involved in the pathogenesis of RA through several different pathways. The qPCR results showed that the expression levels of ENST00000456270 and NR_002838 were significantly increased in the RA patients, whereas the expression levels of NR_026812 and uc001zwf. 1 were significantly decreased. Furthermore, the expression level of ENST00000456270 was strongly associated with the serum levels of IL-6 and TNF-a and the Simplified Disease Activity Index (SDAI) of the RA patients. Our data provided comprehensive evidence regarding the differential expression of lncRNAs in PBMCs of RA patients, which shed light on the understanding of the molecular mechanisms of lncRNAs in the pathogenesis of RA.	[Yuan, Min; Wang, Shujun; Yu, Lijie; Liu, Huaxiang] Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan, Shandong, Peoples R China; [Yuan, Min; Xu, Liming; Liu, Lining; Sun, Huanxia; Li, Chunxian; Shi, Yanjun] Liaocheng Peoples Hosp, Dept Rheumatol, Liaocheng, Peoples R China; [Wang, Shujun] Cent Hosp Zibo, Dept Rheumatol, Zibo, Peoples R China; [Yu, Lijie] Donge Peoples Hosp, Dept Rheumatol, Liaocheng, Peoples R China; [Qu, Bo] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai Inst Rheumatol,Dept Rheumatol, Shanghai, Peoples R China	Shandong University; Shanghai Jiao Tong University	Liu, HX (corresponding author), Shandong Univ, Qilu Hosp, Dept Rheumatol, Jinan, Shandong, Peoples R China.	huaxiangliu@hotmail.com	liu, lining/GXM-5412-2022; Qu, Bo/V-6675-2019		National Natural Science Foundation of China [81371929]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number: 81371929), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arase H, 2016, ADV IMMUNOL, V129, P1, DOI 10.1016/bs.ai.2015.09.005; Atianand MK, 2017, ANNU REV IMMUNOL, V35, P177, DOI 10.1146/annurev-immunol-041015-055459; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Brisslert M, 2013, IMMUNOLOGY, V140, P9; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hambardzumyan K, 2016, ARTHRITIS RHEUMATOL; Hambardzumyan K, 2015, ANN RHEUM DIS, V74, P1102, DOI 10.1136/annrheumdis-2013-204986; Jiang CM, 2016, INT J BIOCHEM CELL B, V72, P118, DOI 10.1016/j.biocel.2016.01.011; Kotlarz A, 2013, CELL STRESS CHAPERON, V18, P653, DOI 10.1007/s12192-013-0407-1; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Lai NS, 2017, CLIN EXP IMMUNOL, V187, P327, DOI 10.1111/cei.12903; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Li Z, 2014, PANS, V111, P6; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Lu MC, 2016, IMMUNOL RES, V64, P576, DOI 10.1007/s12026-015-8756-8; Manara M, 2015, RMD OPEN, P1; Meng X, 2017, CELL MOL LIFE SCI, V74, P23, DOI 10.1007/s00018-016-2386-8; Moskowitz SM, 2008, GENET MED, V10, P851, DOI 10.1097/GIM.0b013e31818e55a2; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Petri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138236; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Seiler J, 2017, NUCLEIC ACIDS RES, V45, P5458, DOI 10.1093/nar/gkx076; Shi H, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1005-2; Sigdel KR, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/848790; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Spurlock CF, 2014, ARTHRITIS RHEUMATOL, V66, P2947, DOI 10.1002/art.38805; Taneja V, 2000, ARTHRITIS RES THER, V2, P3; Tong WX, 2017, ONCOTARGETS THER, V10, P1227, DOI 10.2147/OTT.S125185; Tsukuda Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040136; Wang P, 2015, LUNG CANCER, V88, P147, DOI 10.1016/j.lungcan.2015.02.009; Xia F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101588; Xin JX, 2017, ONCOTARGETS THER, V10, P1, DOI 10.2147/OTT.S124201; Yang KY, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/631737; Zhang FF, 2016, J AUTOIMMUN, V75, P96, DOI 10.1016/j.jaut.2016.07.012; Zhang Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1129-4	43	42	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0186795	10.1371/journal.pone.0186795	http://dx.doi.org/10.1371/journal.pone.0186795			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29140972	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400010
J	Bakopoulos, A; Kapelouzou, A; Tsilimigras, DI; Katsimpoulas, M; Schizas, D; Aravanis, C; Balafas, E; Mavroidis, M; Pavlakis, K; Machairas, A; Liakakos, T				Bakopoulos, Anargyros; Kapelouzou, Alkistis; Tsilimigras, Diamantis I.; Katsimpoulas, Michalis; Schizas, Dimitrios; Aravanis, Chrysostomos; Balafas, Evaggelos; Mavroidis, Manolis; Pavlakis, Kitty; Machairas, Anastasios; Liakakos, Theodore			Expression of Toll-like receptors (TLRs) in the lungs of an experimental sepsis mouse model	PLOS ONE			English	Article							CECAL LIGATION; MOLECULAR-MECHANISMS; UNITED-STATES; EPIDEMIOLOGY; MORTALITY; PUNCTURE	Background Sepsis is a condition characterized by high mortality rates and often accompanied by multiple-organ dysfunction. During sepsis, respiratory system may be affected and possibly result in acute respiratory distress syndrome (ARDS). Toll-like receptors (TLRs), as a first line defense against invading pathogens, seem to be highly expressed in septic states. Therefore, expression of TLRs in the lungs of a sepsis animal model could indicate the involvement of the respiratory system and appear as a severity index of the clinical course. Materials and methods A total of 72 C57BL/6J mice, aged 12-14 weeks, were studied. The animals were divided into 3 sepsis (S) groups (24h, 48h and 72h) and 3 control (C) groups (24h, 48h and 72h), each consisting of 12 mice. The S-groups were subjected to cecal ligation and puncture (CLP) while the C-groups had a sham operation performed. Blood samples were drawn from all groups. Total blood count analysis was performed along with the measurement of certain biochemical markers. Additionally, lung tissues were harvested and the expression of TLRs, namely TLR 2, TLR 3, TLR 4 and TLR 7 were evaluated by means of immunofluorescence (IF) and qRT-PCR (quantitative-Polymerase Chain Reaction). Statistical analysis was performed by using one-way ANOVA followed by student t-test. Results were considered statistically significant when p<0.05. Results WBCs and lymphocytes were decreased in all S-groups compared to the corresponding C-groups (p<0.05), while RBCs showed a gradual decline in S-groups with the lowest levelsappearing in the S72 group. Only, monocytes were higher in S-groups, especially between S48-C48 (p<0.05) and S72-C72 (p<0.05). Creatinine, IL-10 and IL-6 levels were significantly increased in the S-groups compared to the corresponding C-groups (S24 vs C24, S48 vs C48 and S72 vs C72, p<0.05). IF showed that expression of TLRs 2, 3, 4 and 7 was increased in all S-groups compared to the time-adjusted C-groups (p<0.05). Similarly, qRT-PCR revealed that expression of all TLRs was higher in all S-groups compared to their respective C-groups in both lungs and intestine (p<0.05). Comparing lung and intestinal tissues from S-groups, TLRs 2 and 4 were found increased in the lung at 24, 48 and 72 hours (p<0.05), whereas TLR 3 was higher in the intestine at all time points examined (p<0.05). Finally, TLR 7 levels were significantly higher in the intestinal tissues at 24 hours (p<0.0001), while lungs predominated at 48 hours (p<0.0001). Conclusion TLRs seem to be highly expressed in the lungs of septic mice, therefore suggesting a potential role in the pathogenesis of ARDS during sepsis. While more studies need to be conducted in order to completely understand the underlying mechanisms, TLRs may represent a promising target for establishing novel therapeutic strategies in the treatment of sepsis.	[Bakopoulos, Anargyros; Machairas, Anastasios] Natl & Kapodistrian Univ Athens, Sch Med, Attikon Gen Hosp, Dept Surg 3, Athens, Greece; [Kapelouzou, Alkistis; Katsimpoulas, Michalis; Aravanis, Chrysostomos] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens, Greece; [Tsilimigras, Diamantis I.] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece; [Schizas, Dimitrios; Liakakos, Theodore] Natl & Kapodistrian Univ Athens, Sch Med, Laikon Gen Hosp, Dept Surg 1, Athens, Greece; [Balafas, Evaggelos] Acad Athens, Lab Anim Facil, Biomed Res Fdn, Athens, Greece; [Mavroidis, Manolis] Acad Athens, Biomed Res Fdn, Basic Res, Athens, Greece; [Pavlakis, Kitty] Univ Athens, Sch Med, Dept Pathol, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Academy of Athens; Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens	Kapelouzou, A (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens, Greece.	akapel@bioacademy.gr	Liakakos, Theodore/A-2779-2011; SCHIZAS, DIMITRIOS/Z-3323-2019; Liakakos, Theodore/AAD-7480-2019; Kapelouzou, Alkistis/AAB-5087-2021	Katsimpoulas, Michalis/0000-0001-8083-3878; Kapelouzou, Alkistis/0000-0002-7637-8152; Mavroidis, Manolis/0000-0002-3870-3954; Liakakos, Theodore/0000-0003-2289-6242; Tsilimigras, Diamantis I./0000-0002-3676-9263				[Anonymous], CRIT CARE MED; Balibrea JL, 2003, WORLD J SURG, V27, P1275, DOI 10.1007/s00268-003-7258-3; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brightbill HD, 2000, IMMUNOLOGY, V101, P1, DOI 10.1046/j.1365-2567.2000.00093.x; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2003, CRIT CARE MED, V31, P946, DOI 10.1097/01.CCM.0000057403.73299.A6; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.113, 10.1038/NMICROBIOL.2016.113]; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Foley NM, 2015, MILITARY MED RES, V2, pCP10, DOI 10.1186/s40779-014-0029-7; Goyette RE, 2004, SEMIN RESP CRIT CARE, V25, P645, DOI 10.1055/s-2004-860979; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Inger MD, 2016, METHODS MOL BIOL, V1491, P69, DOI 10.1007/978-1-4939-3581-9_6; Knapp S, 2010, WIEN MED WOCHENSCHR, V160, P107, DOI 10.1007/s10354-010-0765-6; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387; Slotwinski R, 2011, ARCH IMMUNOL THER EX, V59, P139, DOI 10.1007/s00005-011-0117-2; Turnbull IR, 2009, CRIT CARE MED, V37, P1018, DOI 10.1097/CCM.0b013e3181968f3a; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005	29	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188050	10.1371/journal.pone.0188050	http://dx.doi.org/10.1371/journal.pone.0188050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136027	Green Submitted, Green Published, gold			2022-12-27	WOS:000415121200057
J	Kaky, E; Gilbert, F				Kaky, Emad; Gilbert, Francis			Predicting the distributions of Egypt's medicinal plants and their potential shifts under future climate change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE CHANGE; PROTECTED AREAS; HABITAT SUITABILITY; RANGE SHIFTS; CONSERVATION; BIODIVERSITY; DIVERSITY; RICHNESS; EXTINCTION	Climate change is one of the most difficult of challenges to conserving biodiversity, especially for countries with few data on the distributions of their taxa. Species distribution modelling is a modern approach to the assessment of the potential effects of climate change on biodiversity, with the great advantage of being robust to small amounts of data. Taking advantage of a recently validated dataset, we use the medicinal plants of Egypt to identify hotspots of diversity now and in the future by predicting the effect of climate change on the pattern of species richness using species distribution modelling. Then we assess how Egypt's current Protected Area network is likely to perform in protecting plants under climate change. The patterns of species richness show that in most cases the A2a 'business as usual' scenario was more harmful than the B2a 'moderate mitigation' scenario. Predicted species richness inside Protected Areas was higher than outside under all scenarios, indicating that Egypt's PAs are well placed to help conserve medicinal plants.	[Kaky, Emad; Gilbert, Francis] Univ Nottingham, Sch Life Sci, Nottingham, England; [Kaky, Emad] Sulaimani Polytech Univ, Kalar Tech Inst, Sulaymaniyah, Iraq	University of Nottingham	Kaky, E (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.; Kaky, E (corresponding author), Sulaimani Polytech Univ, Kalar Tech Inst, Sulaymaniyah, Iraq.	plxedk@nottingham.ac.uk	Kaky, Emad/M-8786-2019; Kaky, Emad Dawood/A-1869-2018	Kaky, Emad/0000-0002-2354-3572; Kaky, Emad Dawood/0000-0002-2354-3572; Gilbert, Francis/0000-0002-2727-4103	Higher Committee for Education Development in Iraq (HCED); Italian Cooperation (Debt Swap)	Higher Committee for Education Development in Iraq (HCED); Italian Cooperation (Debt Swap)	We thank the Higher Committee for Education Development in Iraq (HCED) for funding this work, Italian Cooperation (Debt Swap) for funding the BioMAP Project. BioMap for sharing the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Italian Cooperation (Debt Swap) for funding the BioMAP Project; Ahmed El-Gabbas, Tim Newbold and Katie Leach for advice; and Ahmed Dhahir Athab for GIS advice. We thank two anonymous referees for their very helpful comments on earlier drafts.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson RP, 2006, SOUTHWEST NAT, V51, P471, DOI 10.1894/0038-4909(2006)51[471:VMPAVT]2.0.CO;2; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barbet-Massin M, 2014, DIVERS DISTRIB, V20, P1285, DOI 10.1111/ddi.12229; Basuony M. I., 2010, MAMMALS EGYPT ATLAS; Beaumont LJ, 2016, ECOL MODEL, V342, P135, DOI 10.1016/j.ecolmodel.2016.10.004; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Boulos L, 1999, FLORA EGYPT; Bradley BA, 2008, J BIOGEOGR, V35, P1158, DOI 10.1111/j.1365-2699.2008.01928.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Carrara R, 2010, ECOGRAPHY, V33, P942, DOI 10.1111/j.1600-0587.2009.05756.x; CBD, 2010, DEC AD C PART CONV B; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen SL, 2016, CHIN MED-UK, V11, DOI 10.1186/s13020-016-0108-7; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Coops NC, 2009, REMOTE SENS ENVIRON, V113, P668, DOI 10.1016/j.rse.2008.11.012; Crimmins SM, 2013, ECOL MODEL, V266, P126, DOI 10.1016/j.ecolmodel.2013.07.006; DeFries R, 2007, ECOL APPL, V17, P1031, DOI 10.1890/05-1111; El-Gabbas A, 2016, J ARID ENVIRON, V127, P211, DOI 10.1016/j.jaridenv.2015.12.007; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Fitzpatrick MC, 2008, GLOBAL CHANGE BIOL, V14, P1337, DOI 10.1111/j.1365-2486.2008.01559.x; Fois M, 2016, J NAT CONSERV, V33, P1, DOI 10.1016/j.jnc.2016.06.001; Franklin J., 2010, MAPPING SPECIES DIST, DOI [10.1017/CBO9780511810602, DOI 10.1017/CBO9780511810602]; Garcia-Callejas D, 2016, ECOL MODEL, V326, P4, DOI 10.1016/j.ecolmodel.2015.06.002; Gilbert F., 2008, BUTTERFLIES EGYPT AT; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Golicher DJ, 2012, BIOTROPICA, V44, P284, DOI 10.1111/j.1744-7429.2011.00815.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Hamann A, 2013, DIVERS DISTRIB, V19, P268, DOI 10.1111/j.1472-4642.2012.00945.x; Hamilton A., 2004, MED PLANTS CONSERVAT; Hannah L, 2011, CLIMATE CHANGE BIOLOGY, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huang HW, 2011, BOT J LINN SOC, V166, P282, DOI 10.1111/j.1095-8339.2011.01157.x; Ihlow F, 2012, GLOBAL CHANGE BIOL, V18, P1520, DOI 10.1111/j.1365-2486.2011.02623.x; Jarnevich CS, 2011, BIOL INVASIONS, V13, P153, DOI 10.1007/s10530-010-9798-4; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kaky E, 2016, J ARID ENVIRON, V135, P140, DOI 10.1016/j.jaridenv.2016.09.001; KERSHAW M, 1995, CONSERV BIOL, V9, P324, DOI 10.1046/j.1523-1739.1995.9020324.x; Klein JA, 2008, ECOSYSTEMS, V11, P775, DOI 10.1007/s10021-008-9160-1; Leach K, 2013, BIOL CONSERV, V159, P490, DOI 10.1016/j.biocon.2012.11.025; Lee TM, 2007, ECOL APPL, V17, P1727, DOI 10.1890/06-1256.1; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Naimi B, 2016, ECOGRAPHY, V39, P368, DOI 10.1111/ecog.01881; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Okigbo R. N., 2008, Biotechnology and Molecular Biology Reviews, V3, P127; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PRESSEY RL, 1993, TRENDS ECOL EVOL, V8, P124, DOI 10.1016/0169-5347(93)90023-I; Rafieian-Kopae M., 2013, J HERBMED PLARMACOL, V1, P1; Regos A, 2015, J ORNITHOL, V156, pS275, DOI 10.1007/s10336-015-1174-9; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Saupe EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017731; Schippmann U, 2002, IMPACT CULTIVATION G; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Soultan AA, 2011, THESIS; Ten Kate K, 1999, COMMERCIAL USE BIODI; Teodoro AC, 2013, PROC SPIE, V8887, DOI 10.1117/12.2028502; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2012, P NATL ACAD SCI USA, V109, P14063, DOI 10.1073/pnas.1210251109; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2007, NATURE, V448, P550, DOI 10.1038/448550a; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Uprety Y, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-7; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Wright AN, 2016, CLIMATIC CHANGE, V134, P579, DOI 10.1007/s10584-015-1552-6; Zhang MG, 2014, DIVERS DISTRIB, V20, P405, DOI 10.1111/ddi.12165	87	18	18	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187714	10.1371/journal.pone.0187714	http://dx.doi.org/10.1371/journal.pone.0187714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136659	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200029
J	Christensen, D; Fahey, MT; Giallo, R; Hancock, KJ				Christensen, Daniel; Fahey, Michael T.; Giallo, Rebecca; Hancock, Kirsten J.			Longitudinal trajectories of mental health in Australian children aged 4-5 to 14-15 years	PLOS ONE			English	Article							NONSPECIFIC PSYCHOLOGICAL DISTRESS; DIFFICULTIES QUESTIONNAIRE; DEPRESSIVE SYMPTOMS; RISK-FACTORS; ADOLESCENT HEALTH; CHILDHOOD; PSYCHOPATHOLOGY; POPULATION; STRENGTHS; MOTHERS	Mental health can affect young people's sense of wellbeing and life satisfaction, their ability to participate in employment and education, and their onward opportunities in life. This paper offers a rare opportunity to longitudinally examine mental health in a population-representative study of children aged 4-5 years to 14-15 years. Using data from the Longitudinal Study of Australian Children (LSAC), this study examined maternally-reported child mental health over a 10 year period, in order to understand their initial mental health status early in life and its change over time, as measured by the Strengths and Difficulties Questionnaire. Longitudinal models were fitted from ages 4-5 to 14-15 years. Results showed that child sex, maternal mental health, socio-economic status (family income, maternal education, neighbourhood disadvantage), maternal hostility, and child temperament (persistence, sociability, reactivity) are all independent contributors to child mental health at age 4. These effects largely persist over time, with the effects of maternal mental health increasing slightly over time. Persistence of these effects suggests the need for early intervention and supports. The independent contribution of these factors to child mental health suggests that multi-faceted approaches to child and maternal mental health are needed.	[Christensen, Daniel; Hancock, Kirsten J.] Telethon Kids Inst, Subiaco, WA, Australia; [Fahey, Michael T.] Swinburne Univ Technol, Dept Stat Epidemiol & Data Sci, Hawthorn, Vic, Australia; [Giallo, Rebecca] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Giallo, Rebecca] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Telethon Kids Institute; Swinburne University of Technology; Murdoch Children's Research Institute; University of Melbourne	Christensen, D (corresponding author), Telethon Kids Inst, Subiaco, WA, Australia.	daniel.christensen@telethonkids.org.au	Fahey, Michael T/E-5302-2010; Christensen, Daniel/I-2018-2019; Hancock, Kirsten/T-1836-2019; Dhungana, Raja Ram/B-3673-2016	Fahey, Michael T/0000-0002-9057-7860; Christensen, Daniel/0000-0002-9684-5782; Dhungana, Raja Ram/0000-0002-9610-6306; Giallo, Rebecca/0000-0002-1065-2921	Australian Research Council Centre of Excellence [CE140100027]; National Health and Medical Research Council	Australian Research Council Centre of Excellence(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	DC and KH were supported by the Australian Research Council Centre of Excellence for Children and Families over the Life Course (CE140100027). RG was supported by a National Health and Medical Research Council Career Development Fellowship.	AIHW, 2007, YOUNG AUSTR THEIR HL; [Australian Bureau of Statistics Statistics ABo], 2003, STAT ABO; Barlow J, 2005, CHILD CARE HLTH DEV, V31, P33, DOI 10.1111/j.1365-2214.2005.00447.x; Bayer JK, 2012, AUST NZ J PSYCHIAT, V46, P659, DOI 10.1177/0004867412450076; Bayer JK, 2011, PEDIATRICS, V128, pE865, DOI 10.1542/peds.2011-0491; Becker A, 2015, EUR CHILD ADOLES PSY, V24, P715, DOI 10.1007/s00787-014-0640-x; Begg S., 2007, BURDEN DIS INJURY AU; Blatt-Eisengart I, 2009, DEV PSYCHOL, V45, P491, DOI 10.1037/a0014942; Boe T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152202; Bosquet M, 2006, DEV PSYCHOPATHOL, V18, P517, DOI 10.1017/S0954579406060275; Bronfenbrenner U., 2007, HDB CHILD PSYCHOL TH, V1, P795, DOI [10.1002/9780470147658.chpsy0114, DOI 10.1002/9780470147658.CHPSY0114]; Bronfenbrenner U, 2005, MAKING HUMAN BEINGS, P3; Caspi A, 2000, J PERS SOC PSYCHOL, V78, P158, DOI 10.1037/0022-3514.78.1.158; Christensen D, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0172377, 10.1371/journal.pone.0168804]; Connell AM, 2002, PSYCHOL BULL, V128, P746, DOI 10.1037//0033-2909.128.5.746; Dean K, 2010, ARCH GEN PSYCHIAT, V67, P822, DOI 10.1001/archgenpsychiatry.2010.86; Edwards B, 2012, FAMILY MATTERS, P7; Evans E, 2004, CLIN PSYCHOL REV, V24, P957, DOI 10.1016/j.cpr.2004.04.005; Ford T, 2007, SOC PSYCH PSYCH EPID, V42, P953, DOI 10.1007/s00127-007-0272-2; Forrest CB, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.5.155; Ge XJ, 1996, DEV PSYCHOL, V32, P717, DOI 10.1037/0012-1649.32.4.717; GELFAND DM, 1990, CLIN PSYCHOL REV, V10, P329, DOI 10.1016/0272-7358(90)90065-I; Giallo R, 2015, EUR CHILD ADOLES PSY, V24, P1233, DOI 10.1007/s00787-014-0672-2; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R., 2015, SCORING STRENGTHS DI; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Gould MS, 2003, J AM ACAD CHILD PSY, V42, P386, DOI 10.1097/01.CHI.0000046821.95464.CF; Hancock KJ, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-299; Heckman JJ, 2012, LABOUR ECON, V19, P451, DOI 10.1016/j.labeco.2012.05.014; Hertzman C, 2010, ANNU REV PUBL HEALTH, V31, P329, DOI 10.1146/annurev.publhealth.012809.103538; Keating DP, 1999, DEV HLTH WEALTH NATI; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kim-Cohen J, 2006, MOL PSYCHIATR, V11, P903, DOI 10.1038/sj.mp.4001851; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Lanza ST, 2013, PREV SCI, V14, P157, DOI 10.1007/s11121-011-0201-1; Lawrence D., 2015, MENTAL HLTH CHILDREN; Lawrence D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-256; Low SA, 2005, J FAM PSYCHOL, V19, P394, DOI 10.1037/0893-3200.19.3.394; Marmot M, 2010, FAIR SOC HLTH LIVES; Matthews D., 2015, CASE EQUALITY OPPORT; Misson S, 2007, 5 LSAC AIOF; Norton A, 2015, 15 LSAC AUSTR I FAM; Oyserman D, 2000, AM J ORTHOPSYCHIAT, V70, P296, DOI 10.1037/h0087733; Padron A, 2012, J DEV BEHAV PEDIATR, V33, P698, DOI 10.1097/DBP.0b013e31826ba9d9; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; PATTERSON GR, 1989, AM PSYCHOL, V44, P329, DOI 10.1037/0003-066X.44.2.329; Priest N, 2012, AUST NZ J PUBL HEAL, V36, P183, DOI 10.1111/j.1753-6405.2011.00803.x; Prior M, 2000, PATHWAYS INFANCY ADO, P83; Raikkonen K, 2012, BEST PRACT RES CL EN, V26, P599, DOI 10.1016/j.beem.2012.03.001; Reiss F, 2013, SOC SCI MED, V90, P24, DOI 10.1016/j.socscimed.2013.04.026; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rushton JL, 2002, J AM ACAD CHILD PSY, V41, P199, DOI 10.1097/00004583-200202000-00014; SANSON A, 1987, INFANT BEHAV DEV, V10, P97, DOI 10.1016/0163-6383(87)90009-9; Sanson A, 2010, WILEY BLACKWELL HDB; SAS Institute Inc, 2002, SAS WIND VERS 9 4; Sawyer MG, 2000, CHILD ADOLESCENT COM; Schlotz W, 2009, BRAIN BEHAV IMMUN, V23, P905, DOI 10.1016/j.bbi.2009.02.001; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; Singer J.D., 2003, APPL LONGITUDINAL DA; Soloff C, 2005, 1 LSAC AIOF; Soloff C, 2006, 3 LSAC AIOF; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; Taylor C.L., 2016, INT J EARLY CHILD, V48, P295, DOI [10.1007/s13158-016-0172-2, DOI 10.1007/S13158-016-0172-2]; Vaz S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144039; Wilkinson R., 2010, SPIRIT LEVEL WHY EQU; World Health Organisation, 2021, MENT HLTH ACT PLAN 2; World Health Organsization, 2022, WORLD MENT HLTH REP; Zubrick S. R., 2015, AUST NZ J PSYCHIAT; Zubrick SR., 2014, LSAC TECHNICAL PAPER, V12, P1	74	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2017	12	11							e0187974	10.1371/journal.pone.0187974	http://dx.doi.org/10.1371/journal.pone.0187974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM4OL	29131873	Green Published, Green Submitted, gold			2022-12-27	WOS:000414997800033
J	Wang, B; Tran, H; Smith, MA; Kostanyan, T; Schmitt, SE; Bilonick, RA; Jan, NJ; Kagemann, L; Tyler-Kabara, EC; Ishikawa, H; Schuman, JS; Sigal, IA; Wollstein, G				Wang, Bo; Tran, Huong; Smith, Matthew A.; Kostanyan, Tigran; Schmitt, Samantha E.; Bilonick, Richard A.; Jan, Ning-Jiun; Kagemann, Larry; Tyler-Kabara, Elizabeth C.; Ishikawa, Hiroshi; Schuman, Joel S.; Sigal, Ian A.; Wollstein, Gadi			In-vivo effects of intraocular and intracranial pressures on the lamina cribrosa microstructure	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; CEREBROSPINAL-FLUID PRESSURE; NORMAL-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; MONKEY; EYES; MICROARCHITECTURE; HYPERTENSION; BIOMECHANICS	There is increasing clinical evidence that the eye is not only affected by intraocular pressure (IOP), but also by intracranial pressure (ICP). Both pressures meet at the optic nerve head of the eye, specifically the lamina cribrosa (LC). The LC is a collagenous meshwork through which all retinal ganglion cell axons pass on their way to the brain. Distortion of the LC causes a biological cascade leading to neuropathy and impaired vision in situations such as glaucoma and idiopathic intracranial hypertension. While the effect of IOP on the LC has been studied extensively, the coupled effects of IOP and ICP on the LC remain poorly understood. We investigated in-vivo the effects of IOP and ICP, controlled via cannulation of the eye and lateral ventricle in the brain, on the LC microstructure of anesthetized rhesus monkeys eyes using the Bioptigen spectral-domain optical coherence tomography (OCT) device (Research Triangle, NC). The animals were imaged with their head upright and the rest of their body lying prone on a surgical table. The LC was imaged at a variety of IOP/ICP combinations, and microstructural parameters, such as the thickness of the LC collagenous beams and diameter of the pores were analyzed. LC microstructure was confirmed by histology. We determined that LC microstructure deformed in response to both IOP and ICP changes, with significant interaction between the two. These findings emphasize the importance of considering both IOP and ICP when assessing optic nerve health.	[Wang, Bo; Tran, Huong; Smith, Matthew A.; Kostanyan, Tigran; Schmitt, Samantha E.; Bilonick, Richard A.; Jan, Ning-Jiun; Sigal, Ian A.] Univ Pittsburgh, Med Ctr, Sch Med, Dept Ophthalmol,Eye Ctr,Eye & Ear Inst,Ophthalmol, Pittsburgh, PA 15260 USA; [Wang, Bo; Tran, Huong; Jan, Ning-Jiun; Sigal, Ian A.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA; [Kagemann, Larry; Ishikawa, Hiroshi; Schuman, Joel S.; Wollstein, Gadi] NYU, Sch Med, Langone Eye Ctr, New York, NY USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sigal, IA (corresponding author), Univ Pittsburgh, Med Ctr, Sch Med, Dept Ophthalmol,Eye Ctr,Eye & Ear Inst,Ophthalmol, Pittsburgh, PA 15260 USA.; Sigal, IA (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15260 USA.	ian@OcularBiomechanics.com	Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Ishikawa, Hiroshi/ABC-6293-2020; Tyler-Kabara, Elizabeth/H-4930-2013	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Ishikawa, Hiroshi/0000-0001-6310-5748; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Wang, Bo/0000-0003-4785-3361; Smith, Matthew A/0000-0003-1192-9942; Kagemann, Larry/0000-0001-8961-0187	National Institutes of Health (Bethesda, MD) [R01-EY025011, R01-EY013178, R01-EY023966, R01-EY022928, T32-EY017271, P30-EY008098]; Glaucoma Research Foundation (San Francisco, CA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY); NATIONAL EYE INSTITUTE [R01EY023966, R01EY025011] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glaucoma Research Foundation (San Francisco, CA); Eye and Ear Foundation (Pittsburgh, PA); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health R01-EY025011, R01-EY013178, R01-EY023966, R01-EY022928, T32-EY017271, P30-EY008098 (Bethesda, MD, nei.nih.gov), Glaucoma Research Foundation (San Francisco, CA, www.glaucoma.org), Eye and Ear Foundation (Pittsburgh, PA, eyeandear.org), and Research to Prevent Blindness (New York, NY, www:rpbusa.org/). The funding organizations had no role in the design, data collection and analysis, decision to publish or preparation of the manuscript.	Agoumi Y, 2011, OPHTHALMOLOGY, V118, P52, DOI 10.1016/j.ophtha.2010.05.016; Alperin N, 2013, AM J NEURORADIOL, V34, P2354, DOI 10.3174/ajnr.A3600; Berdahl JP, 2010, CURR OPIN OPHTHALMOL, V21, P106, DOI 10.1097/ICU.0b013e32833651d8; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; CORBETT JJ, 1982, ARCH NEUROL-CHICAGO, V39, P461, DOI 10.1001/archneur.1982.00510200003001; Coudrillier B, 2016, IEEE T MED IMAGING, V35, P988, DOI 10.1109/TMI.2015.2504440; Dougherty R., 2007, MICROSC MICROANAL, V13, P1678, DOI DOI 10.1017/S1431927607074430; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; FRYCZKOWSKI AW, 1984, INT OPHTHALMOL, V7, P95, DOI 10.1007/BF00165110; GUCER G, 1979, J NEUROSURG, V51, P206, DOI 10.3171/jns.1979.51.2.0206; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Hua Y, 2016, J MED DEVICES, V10, DOI 10.1115/1.4033852; Jan NJ, 2015, BIOMED OPT EXPRESS, V6, P4705, DOI 10.1364/BOE.6.004705; Kirwan RP, 2005, MOL VIS, V11, P798; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Morgan WH, 2002, INVEST OPHTH VIS SCI, V43, P3236; Morgan WH, 2015, BR J OPHTHALMOL, P1163; Nadler Z, 2013, BIOMED OPT EXPRESS, V4, P2596, DOI 10.1364/BOE.4.002596; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ren RJ, 2010, OPHTHALMOLOGY, V117, P259, DOI 10.1016/j.ophtha.2009.06.058; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Rogers RS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012302; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sigal IA, 2014, IEEE T MED IMAGING, V33, P1381, DOI 10.1109/TMI.2014.2312133; Sigal IA, 2004, INVEST OPHTH VIS SCI, V45, P4378, DOI 10.1167/iovs.04-0133; Sigal Ian A, 2005, Technol Health Care, V13, P313; Sigal IA, 2014, BRIT J OPHTHALMOL, V98, P34, DOI 10.1136/bjophthalmol-2013-304751; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P9431, DOI 10.1167/iovs.11-7922; Strouthidis NG, 2011, INVEST OPHTH VIS SCI, V52, P1206, DOI 10.1167/iovs.10-5599; Team RDC, 2019, R LANG ENV STAT COMP; Tran H, 2017, SCIENTIFIC REPORTS A; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1458, DOI 10.1001/archopht.1977.04450080168023; Wang B, 2013, INVEST OPHTH VIS SCI, V54, P8270, DOI 10.1167/iovs.13-13109; Wostyn P, 2014, PROG RETIN EYE RES, V39, P107, DOI 10.1016/j.preteyeres.2013.12.002; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; Yang HL, 2009, INVEST OPHTH VIS SCI, V50, P224, DOI 10.1167/iovs.08-2464	39	31	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188302	10.1371/journal.pone.0188302	http://dx.doi.org/10.1371/journal.pone.0188302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161320	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000041
J	Suzuki, H; Gao, H; Bai, WJ; Evangelou, E; Glocker, B; O'Regan, DP; Elliott, P; Matthews, PM				Suzuki, Hideaki; Gao, He; Bai, Wenjia; Evangelou, Evangelos; Glocker, Ben; O'Regan, Declan P.; Elliott, Paul; Matthews, Paul M.			Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; INTEGRITY; ADULTS; DAMAGE; RAT; MR; METAANALYSIS; PROGRESSION	Objectives To characterize effects of chronically elevated blood pressure on the brain, we tested for brain white matter microstructural differences associated with normotension, pre-hypertension and hypertension in recently available brain magnetic resonance imaging data from 4659 participants without known neurological or psychiatric disease (62.3 +/- 7.4 yrs, 47.0% male) in UK Biobank. Methods For assessment of white matter microstructure, we used measures derived from neurite orientation dispersion and density imaging (NODDI) including the intracellular volume fraction (an estimate of neurite density) and isotropic volume fraction (an index of the relative extracellular water diffusion). To estimate differences associated specifically with blood pressure, we applied propensity score matching based on age, sex, educational level, body mass index, and history of smoking, diabetes mellitus and cardiovascular disease to perform separate contrasts of non-hypertensive (normotensive or pre-hypertensive, N = 2332) and hypertensive (N = 2337) individuals and of normotensive (N = 741) and pre-hypertensive (N = 1581) individuals (p<0.05 after Bonferroni correction). Results The brain white matter intracellular volume fraction was significantly lower, and isotropic volume fraction was higher in hypertensive relative to non-hypertensive individuals (N = 1559, each). The white matter isotropic volume fraction also was higher in pre-hypertensive than in normotensive individuals (N = 694, each) in the right superior longitudinal fasciculus and the right superior thalamic radiation, where the lower intracellular volume fraction was observed in the hypertensives relative to the non-hypertensive group. Significance Pathological processes associated with chronically elevated blood pressure are associated with imaging differences suggesting chronic alterations of white matter axonal structure that may affect cognitive functions even with pre-hypertension.	[Suzuki, Hideaki; Matthews, Paul M.] Imperial Coll London, Hammersmith Hosp, Dept Med, Div Brain Sci, London, England; [Gao, He; Evangelou, Evangelos; Elliott, Paul] Imperial Coll London, MRC, Sch Publ Hlth, Dept Epidemiol & Biostat,Publ Hlth England,Ctr Env, London, England; [Bai, Wenjia; Glocker, Ben] Imperial Coll London, Biomed Image Anal Grp, Dept Comp, London, England; [O'Regan, Declan P.] Imperial Coll London, Hammersmith Hosp, MRC, London Inst Med Sci, London, England	Imperial College London; Imperial College London; Public Health England; Imperial College London; Imperial College London	Suzuki, H (corresponding author), Imperial Coll London, Hammersmith Hosp, Dept Med, Div Brain Sci, London, England.	hd.suzuki.1870031@cardio.med.tohoku.ac.jp	Bai, Wenjia/ABH-6023-2020; Evangelou, Evangelos/C-3033-2013	Bai, Wenjia/0000-0003-2943-7698; Evangelou, Evangelos/0000-0002-5488-2999; O'Regan, Declan/0000-0002-0691-0270; Elliott, Paul/0000-0002-7511-5684	NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Public Health England [MR/L01341X/1]; Medical Research Council [MR/L01632X/1]; Uehara Memorial Foundation; Medical Research Council; MRC [MR/L01632X/1, MC_PC_17114, MR/L01341X/1, UKDRI-5003, G9409634, MR/M024903/1] Funding Source: UKRI; British Heart Foundation [SP/13/2/30111] Funding Source: researchfish; Medical Research Council [MR/M024903/1, UKDRI-5003, MC_qA137853, MC_PC_17114, MR/L01341X/1, G9409634] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10022] Funding Source: researchfish	NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Uehara Memorial Foundation(Uehara Memorial Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is supported by Research Fellowship from the Uehara Memorial Foundation, Medical Research Council and Public Health England (MR/L01341X/1), the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been conducted using the UK Biobank Resource under the Application 18545. We thank the UKB participants for their participation, and the UKB team for their work in collecting, processing and disseminating these data for analysis. We want to acknowledge particularly the importance to this paper of the image derived brain phenotypes generated for the benefit of the whole UK Biobank research community by Fidel Alfaro Almagro, Steve Smith, Karla Miller and their colleagues in the Oxford FMRIB Centre. This study is supported by Research Fellowship from the Uehara Memorial Foundation, Medical Research Council and Public Health England (MR/L01341X/1), the NIHR Biomedical Research Centre at Imperial College Healthcare NHS Trust and Imperial College London, and the NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (HPRU-2012-10141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work used the computing resources of the UK MEDical BlOinformatics partnership for aggregation, integration, visualisation and analysis of large, complex data (UK MED-BIO) which is supported by the Medical Research Council (MR/L01632X/1).	Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Balk LJ, 2016, J NEUROL, V263, P1323, DOI 10.1007/s00415-016-8127-y; Beauchet O, 2013, J HYPERTENS, V31, P1502, DOI 10.1097/HJH.0b013e32836184b5; Calabrese E, 2013, NEUROIMAGE, V79, P329, DOI 10.1016/j.neuroimage.2013.04.101; Cox SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13629; Gons RAR, 2012, J ALZHEIMERS DIS, V32, P623, DOI 10.3233/JAD-2012-121006; Grieve SM, 2007, AM J NEURORADIOL, V28, P226; Harrison DG, 2011, HYPERTENSION, V57, P132, DOI 10.1161/HYPERTENSIONAHA.110.163576; Iadecola C, 2016, HYPERTENSION, V68, pE67, DOI 10.1161/HYP.0000000000000053; Iadecola C, 2014, HYPERTENSION, V64, P3, DOI 10.1161/HYPERTENSIONAHA.114.03040; Jochemsen HM, 2013, JAMA NEUROL, V70, P1046, DOI 10.1001/jamaneurol.2013.217; Kennedy KM, 2009, BRAIN RES, V1297, P41, DOI 10.1016/j.brainres.2009.08.058; Leritz EC, 2010, NEUROPSYCHOLOGY, V24, P199, DOI 10.1037/a0018108; Madan Christopher R, 2015, F1000Res, V4, P466, DOI 10.12688/f1000research.6838.1; Maillard P, 2012, LANCET NEUROL, V11, P1039, DOI 10.1016/S1474-4422(12)70241-7; Makin SDJ, 2013, J NEUROL NEUROSUR PS, V84, P893, DOI 10.1136/jnnp-2012-303645; Mallik S, 2014, J NEUROL NEUROSUR PS, V85, P1396, DOI 10.1136/jnnp-2014-307650; Mancia Giuseppe, 2016, Eur Heart J, V37, P955, DOI 10.1093/eurheartj/ehv633; McEvoy LK, 2015, HYPERTENSION, V66, P317, DOI 10.1161/HYPERTENSIONAHA.115.05336; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; Miwa K, 2014, NEUROLOGY, V83, P646, DOI 10.1212/WNL.0000000000000692; Mohammadi MT, 2014, PATHOL RES PRACT, V210, P985, DOI 10.1016/j.prp.2014.05.007; MOODY DM, 1990, AM J NEURORADIOL, V11, P431; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Rosano C, 2015, AM J HYPERTENS, V28, P326, DOI 10.1093/ajh/hpu134; Rosenberg GA, 2009, STROKE, V40, pS20, DOI 10.1161/STROKEAHA.108.533133; Salat DH, 2012, NEUROIMAGE, V59, P181, DOI 10.1016/j.neuroimage.2011.07.033; Sampaio-Baptista C, 2013, J NEUROSCI, V33, P19499, DOI 10.1523/JNEUROSCI.3048-13.2013; Schneider T, 2017, FUNCT NEUROL, V32, P97; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suzuki H, 2013, NEUROIMAGE, V77, P215, DOI 10.1016/j.neuroimage.2013.03.042; Veglio F, 2009, ATHEROSCLEROSIS, V205, P331, DOI 10.1016/j.atherosclerosis.2008.10.028; Verhaaren BFJ, 2013, HYPERTENSION, V61, P1354, DOI 10.1161/HYPERTENSIONAHA.111.00430; Weber MA, 2014, J HYPERTENS, V32, P3, DOI [10.1111/jch.12237, 10.1097/HJH.0000000000000065]; Williamson JD, 2014, JAMA INTERN MED, V174, P324, DOI 10.1001/jamainternmed.2013.13656; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	37	30	30	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187600	10.1371/journal.pone.0187600	http://dx.doi.org/10.1371/journal.pone.0187600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145428	Green Published, gold, Green Submitted			2022-12-27	WOS:000415378800023
J	Abdullaev, AA; Salakhutdinov, IB; Egamberdiev, SS; Khurshut, EE; Rizaeva, SM; Ulloa, M; Abdurakhmonov, IY				Abdullaev, Alisher A.; Salakhutdinov, Ilkhom B.; Egamberdiev, Sharof S.; Khurshut, Ernest E.; Rizaeva, Sofiya M.; Ulloa, Mauricio; Abdurakhmonov, Ibrokhim Y.			Genetic diversity, linkage disequilibrium, and association mapping analyses of Gossypium barbadense L. germplasm	PLOS ONE			English	Article							FIBER QUALITY TRAITS; MARKER-ASSISTED SELECTION; UPLAND COTTON; HIRSUTUM L.; POPULATION-STRUCTURE; SSR MARKERS; P-VALUES; YIELD; QTL; LOCI	Limited polymorphism and narrow genetic base, due to genetic bottleneck through historic domestication, highlight a need for comprehensive characterization and utilization of existing genetic diversity in cotton germplasm collections. In this study, 288 worldwide Gossypium barbadense L. cotton germplasm accessions were evaluated in two diverse environments (Uzbekistan and USA). These accessions were assessed for genetic diversity, population structure, linkage disequilibrium (LD), and LD-based association mapping (AM) of fiber quality traits using 108 genome-wide simple sequence repeat (SSR) markers. Analyses revealed structured population characteristics and a high level of intra-variability (67.2%) and moderate interpopulation differentiation (32.8%). Eight percent and 4.3% of markers revealed LD in the genome of the G. barbadense at critical values of r(2) >= 0.1 and r(2) >= 0.2, respectively. The LD decay was on average 24.8 cM at the threshold of r(2) >= 0.05. LD retained on average distance of 3.36 cM at the threshold of r(2) >= 0.1. Based on the phenotypic evaluations in the two diverse environments, 100 marker loci revealed a strong association with major fiber quality traits using mixed linear model (MLM) based association mapping approach. Fourteen marker loci were found to be consistent with previously identified quantitative trait loci (QTLs), and 86 were found to be new unreported marker loci. Our results provide insights into the breeding history and genetic relationship of G. barbadense germplasm and should be helpful for the improvement of cotton cultivars using molecular breeding and omics-based technologies.	[Abdullaev, Alisher A.; Salakhutdinov, Ilkhom B.; Egamberdiev, Sharof S.; Khurshut, Ernest E.; Abdurakhmonov, Ibrokhim Y.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan; [Abdullaev, Alisher A.; Rizaeva, Sofiya M.] Acad Sci Uzbek, Inst Genet & Plant Expt Biol, Tashkent, Uzbekistan; [Ulloa, Mauricio] USDA ARS, Cropping Syst Res Lab, Lubbock, TX 79401 USA	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics; Academy of Sciences of Uzbekistan; Institute of Genetics & Experimental Biology of Plants; United States Department of Agriculture (USDA)	Abdurakhmonov, IY (corresponding author), Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Uzbekistan.	genomics@uzsci.net	Abdullaev, Alisher/ABC-7149-2021; Salakhutdinov, Ilkhom/AAA-5027-2021; Abdurakhmonov, Ibrokhim Y./F-5588-2015; Salakhutdinov, Ilkhom B/T-7215-2018; Khurshut, Ernest/AAH-3231-2020	Abdullaev, Alisher/0000-0002-8268-7699; Salakhutdinov, Ilkhom/0000-0003-1159-6500; Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Salakhutdinov, Ilkhom B/0000-0003-1159-6500; Khurshut, Ernest/0000-0003-0278-8746	Academy of Sciences of Uzbekistan; Committee for Coordination Science and Technology Development of Uzbekistan [FA-F5-T030]; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) [UZB-TA-31017]; U.S. Civilian Research and Development Foundation (CRDF) [UZB-TA-31017]; Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	Academy of Sciences of Uzbekistan; Committee for Coordination Science and Technology Development of Uzbekistan; Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS); U.S. Civilian Research and Development Foundation (CRDF); Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan	This work was supported by the Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan have provided research grant fund under the project No. FA-F5-T030 to IYA and the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) provided an international cooperative grant No. UZB-TA-31017 to IYA and MU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Academy of Sciences of Uzbekistan, and Committee for Coordination Science and Technology Development of Uzbekistan for basic science (FA-F5-T030). We greatly acknowledge the Office of International Research Programs (OIRP) of the United States Department of Agriculture (USDA)-Agricultural Research Service (ARS) and U.S. Civilian Research and Development Foundation (CRDF) for international cooperative grants UZB-TA-31017, which were devoted to study G. barbadense germplasm resources. We thank Uzbekistan Government, Ministry of Foreign Economic Relations, Trade and Investments of Uzbekistan for capacity funding of the Center of Genomics and Bioinformatics, Uzbekistan. We greatly acknowledge the Uzbek and US partner laboratories for the assistance with molecular mapping experiments described in this work. Mention of trade names or commercial products in this article is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the US Department of Agriculture. The US Department of Agriculture is an equal opportunity provider and employer.	Abdallah JM, 2003, GENET SEL EVOL, V35, P513, DOI [10.1186/1297-9686-35-6-513, 10.1051/gse:2003037]; Abdellatif K. F., 2012, Journal of Crop Science and Biotechnology, V15, P93, DOI 10.1007/s12892-011-0120-5; Abdurakhmonov IY, 2008, GENOMICS, V92, P478, DOI 10.1016/j.ygeno.2008.07.013; Abdurakhmonov I.Y., 2014, WORLD COTTON GERMPLA; Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; Abdurakhmonov IY, 2016, COTTON INDIA 2015 16, P36; Adawy S. S., 2007, Journal of Applied Sciences Research, P1581; Ademe MS, 2017, MOL GENET G IN PRESS; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Asif M, 2008, PAK J BOT, V40, P1209; BADIGANNAVAR A, 2010, THESIS; Blenda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045739; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Bolek Y, 2016, COTTON RESEARCH, P123, DOI 10.5772/64593; Boopathi N. M., 2008, Journal of Cotton Research and Development, V22, P135; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brubaker CL, 1999, GENOME, V42, P184, DOI 10.1139/gen-42-2-184; Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; Campbell BT, 2005, EUPHYTICA, V144, P69, DOI 10.1007/s10681-005-4336-7; Chakraborty R., 1981, Genetics, V96, P721; Chee Peng W., 2009, V3, P283, DOI 10.1007/978-0-387-70810-2_12; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; CULP TW, 1973, CROP SCI, V13, P686, DOI 10.2135/cropsci1973.0011183X001300060030x; D'hoop BB, 2010, THEOR APPL GENET, V121, P1151, DOI 10.1007/s00122-010-1379-5; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Fan L, 2012, BOTANY, P211; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Fang L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-838; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Goodman SN, 2005, CLIN TRIALS, V2, P282, DOI 10.1191/1740774505cn098oa; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Goodman SN, 2001, EPIDEMIOLOGY, V12, P295, DOI 10.1097/00001648-200105000-00006; Gupta PK, 2005, PLANT MOL BIOL, V57, P461, DOI 10.1007/s11103-005-0257-z; Gupta PK, 2014, ADV GENET, V85, P109, DOI 10.1016/B978-0-12-800271-1.00002-0; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hardy OJ, 2003, MOL ECOL, V12, P1577, DOI 10.1046/j.1365-294X.2003.01835.x; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; He DH, 2007, EUPHYTICA, V153, P181, DOI 10.1007/s10681-006-9254-9; Hinze LL, 2016, J HERED, V107, P274, DOI 10.1093/jhered/esw004; Holsinger KE, 2002, EEB ARTIC, V1, P1, DOI DOI 10.1046/J.1365-294X.2002.01512.X; Holsinger KE, 2007, HICKORY PACKAGE ANAL, P1; Hutchinson J., 1945, MEM COTTON RES STATI, V25, P80; Iqbal MA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00086; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Jenkins J.N., 1993, TRADITIONAL CROP BRE, P61; Jenkins JN, 2012, EUPHYTICA, V183, P49, DOI 10.1007/s10681-011-0470-6; Jia YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095882; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; Kalivas A, 2011, GENET MOL RES, V10, P208, DOI 10.4238/vol10-1gmr998; Kantartzi SK, 2008, PLANT BREEDING, V127, P173, DOI 10.1111/j.1439-0523.2008.01490.x; Karademir E, 2010, NOT BOT HORTI AGROBO, V38, P111; Katki HA, 2008, AM J EPIDEMIOL, V168, P384, DOI 10.1093/aje/kwn148; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2005, J HERED, V96, P441, DOI 10.1093/jhered/esi052; Li YC, 2007, GENETICS, V176, P1811, DOI 10.1534/genetics.106.068890; Liang QZ, 2013, CHINESE SCI BULL, V58, P3233, DOI 10.1007/s11434-013-5807-1; Lin Z, 2005, PLANT BREEDING, V124, P180, DOI 10.1111/j.1439-0523.2004.01039.x; Liu CX, 2013, J GENET, V92, P175, DOI 10.1007/s12041-013-0238-y; Liu GZ, 2015, EUPHYTICA, V205, P637, DOI 10.1007/s10681-015-1450-z; Liu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057531; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; McGowan J. A., 1960, THESIS; McRae AF, 2002, GENETICS, V160, P1113; Mei HX, 2014, EUPHYTICA, V197, P237, DOI 10.1007/s10681-014-1063-y; Mei HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082193; Meredith WR, 1994, P 7 ANN COTT INC ENG, P256; Mohlke KL, 2001, GENOME RES, V11, P1221, DOI 10.1101/gr.173201; Muhammad Saeed, 2014, Australian Journal of Crop Science, V8, P338; Murray J., 1910, REPORTS SCI EXPEDITI, P17; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Niles GA, 1984, COTTON, V24, P201, DOI DOI 10.2134/AGR0NM0N0GR24.C7; Oraguzie N. C., 2007, Association mapping in plants, P11, DOI 10.1007/978-0-387-36011-9_2; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Paterson AH., 1999, COTTON ORIGIN HIST T, P415; Paterson Andrew H., 2009, V3, P483, DOI 10.1007/978-0-387-70810-2_20; PERCY RG, 1990, THEOR APPL GENET, V79, P529, DOI 10.1007/BF00226164; Percy Richard G., 2009, V3, P53, DOI 10.1007/978-0-387-70810-2_3; Pillay M, 1999, CROP SCI, V39, P1881, DOI 10.2135/cropsci1999.3961881x; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Qin HD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118073; Reddy UK, 2017, SCI REP-UK, V7, DOI 10.1038/srep41285; REYNOLDS J, 1983, GENETICS, V105, P767; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Shappley Z. W., 1998, Journal of Cotton Science, V2, P153; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shen XL, 2006, THEOR APPL GENET, V113, P1539, DOI 10.1007/s00122-006-0401-4; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Simongulyan NG., 1987, GENETICS BREEDING SE, P18; Song XL, 2005, GENOME, V48, P378, DOI 10.1139/G04-126; Soto-Cerda BJ, 2012, GENETIC DIVERSITY IN PLANTS, P29; Steel RGD, 1980, PRINCIPLES PROCEDURE; STEPHENS SG, 1975, AM ANTIQUITY, V40, P406, DOI 10.2307/279327; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Storey JD, 2003, ANAL GENE EXPRESSION, P272; Thiyagu K, 2011, WORLD COTT RES C TEC, P104; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tuttle JR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1708-9; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Ulloa M., 2007, Technical crops, P1; Ulloa M, 2009, J COTTON SCI, V13, P246; Wang FR, 2011, EUPHYTICA, V181, P41, DOI 10.1007/s10681-011-0378-1; Wang Juan, 2007, Acta Agronomica Sinica, V33, P1915; Wang XQ, 2013, GENET MOL RES, V12, P3353, DOI 10.4238/2013.September.4.1; Wang XQ, 2011, GENET MOL RES, V10, P3620, DOI 10.4238/2011.December.8.5; Wang XiaQing, 2013, Australian Journal of Crop Science, V7, P1252; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; Whitt Sr, 2003, METH MOL B, V236, P123; Wright S., 1978, EVOLUTION GENETIC PO; Wu JX, 2009, EUPHYTICA, V165, P231, DOI 10.1007/s10681-008-9748-8; Wu ZD, 2005, J COTTON SCI, V9, P166; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Xu HM, 2006, GENET RESOUR CROP EV, V53, P515, DOI 10.1007/s10722-004-2032-4; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430; Zhang ZS, 2005, EUPHYTICA, V144, P91, DOI 10.1007/s10681-005-4629-x; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhao YL, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027370; Zhao YQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113967; Zhao YL, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4074-y	139	14	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0188125	10.1371/journal.pone.0188125	http://dx.doi.org/10.1371/journal.pone.0188125			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136656	Green Published, Green Submitted, gold			2022-12-27	WOS:000415121200068
J	Olsen, OE; Skjaervik, A; Stordal, BF; Sundan, A; Holien, T				Olsen, Oddrun Elise; Skjaervik, Anette; Stordal, Berit Fladvad; Sundan, Anders; Holien, Toril			TGF-beta contamination of purified recombinant GDF15	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; INTEGRIN ACTIVATION; MYELOMA CELLS; WEIGHT-LOSS; RECEPTOR; GDF-15; INHIBITOR; SURVIVAL; CANCER; MIC-1	Purified recombinant proteins for use in biomedical research are invaluable to investigate protein function. However, purity varies in protein batches made in mammalian expression systems, such as CHO-cells or HEK293-cells. This study points to caution while investigating effects of proteins related to the transforming growth factor (TGF)-beta superfamily. TGF-beta itself is a very potent cytokine and has effects on cells in the femtomolar range. Thus, even very small amounts of contaminating TGF-beta in purified protein batches may influence the experimental results given that receptors for TGF-beta are present. When we attempted to characterize possible receptors for the TGF-beta superfamily ligand GDF15, striking similarities between GDF15-induced activities and known TGF-beta activities were found. However, differences between batches of GDF15 were a concern and finally led us to the conclusion that the measured effects were caused by TGF-beta and not by GDF15. Our results emphasize that purified recombinant proteins must be used with caution and warrant proper controls. Notably, some conclusions made about GDF15 in already published papers may not be supported by the results shown. Awareness about this issue in the scientific community may prevent spreading of false positive results.	[Olsen, Oddrun Elise; Stordal, Berit Fladvad; Sundan, Anders; Holien, Toril] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Olsen, Oddrun Elise; Holien, Toril] St Olavs Univ Hosp, Clin Med, Trondheim, Norway; [Skjaervik, Anette] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol, Trondheim, Norway; [Sundan, Anders] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, CEMIR Ctr Mol Inflammat Res, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Holien, T (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway.; Holien, T (corresponding author), St Olavs Univ Hosp, Clin Med, Trondheim, Norway.	toril.holien@ntnu.no	Holien, Toril/M-6253-2018; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Holien, Toril/0000-0002-2051-5824; Olsen, Oddrun Elise/0000-0001-8922-5561	Kreftforeningen (NO) [5793765]	Kreftforeningen (NO)	The work was supported by a grant from Kreftforeningen (NO)(https://kreftforeningen.no), Project number: 5793765. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artz A, 2016, BLOOD, V128, P529, DOI 10.1182/blood-2016-01-696617; Baughn LB, 2009, J IMMUNOL, V182, P1810, DOI 10.4049/jimmunol.0713726; Beatson R, 2011, BIOTECHNOL BIOENG, V108, P2759, DOI 10.1002/bit.23217; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Carthy JM, 2016, J CELL BIOCHEM, V117, P938, DOI 10.1002/jcb.25378; Corre J, 2013, STEM CELL TRANSL MED, V2, P946, DOI 10.5966/sctm.2013-0055; de Jager SCA, 2011, J EXP MED, V208, P217, DOI 10.1084/jem.20100370; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Fairlie WD, 1999, J LEUKOCYTE BIOL, V65, P2, DOI 10.1002/jlb.65.1.2; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Holien T, 2014, CYTOKINE GROWTH F R, V25, P343, DOI 10.1016/j.cytogfr.2014.04.009; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JENNINGS JC, 1989, ENDOCRINOLOGY, V125, P404, DOI 10.1210/endo-125-1-404; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kaur J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043235; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Koistinen H, 2015, MOL ENDOCRINOL, V29, P1787, DOI 10.1210/me.2015-1187; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131506; Li C, 2016, ONCOTARGET, V7, P860, DOI 10.18632/oncotarget.6205; Lu JM, 2016, BIOCHEM J, V473, P1895, DOI 10.1042/BCJ20160362; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Olsen OE, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0104-z; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wang CY, 2014, BIOCHEM J, V460, P35, DOI 10.1042/BJ20140155; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Yang L, 2017, NATURE MED	29	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0187349	10.1371/journal.pone.0187349	http://dx.doi.org/10.1371/journal.pone.0187349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161287	Green Submitted, Green Published, gold			2022-12-27	WOS:000415987000008
J	Rasero, J; Amoroso, N; La Rocca, M; Tangaro, S; Bellotti, R; Stramaglia, S				Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Tangaro, Sabina; Bellotti, Roberto; Stramaglia, Sebastiano		Alzheimer's Dis Neuroimag	Multivariate regression analysis of structural MRI connectivity matrices in Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ORBITOFRONTAL CORTEX; CORTICAL NETWORKS; BRAIN NETWORKS; CONVERSION; DEMENTIA; ATROPHY; CONNECTOME; PREDICTION; PATTERNS	Alzheimer's disease (AD) is the most common form of dementia among older people and increasing longevity ensures its prevalence will rise even further. Whether AD originates by disconnecting a localized brain area and propagates to the rest of the brain across disease-severity progression is a question with an unknown answer. An important related challenge is to predict whether a given subject, with a mild cognitive impairment (MCI), will convert or not to AD. Here, our aim is to characterize the structural connectivity pattern of MCI and AD subjects using the multivariate distance matrix regression (MDMR) analysis, and to compare it to those of healthy subjects. MDMR is a technique developed in genomics that has been recently applied to functional brain network data, and here applied to identify brain nodes with different connectivity patterns, in controls and patients, because of brain atrophy. We address this issue at the macroscale by looking to differences in individual structural MRI brain networks, obtained from MR images according to a recently proposed definition of connectivity which measures the image similarity between patches at different locations in the brain. In particular, using data from ADNI, we selected four groups of subjects (all of them matched by age and sex): HC (healthy control participants), ncMCI (mild cognitive impairment not converting to AD), cMCI (mild cognitive impairment converting to AD) and AD. Next, we built structural MRI brain networks and performed group comparison for all the pairs of groups. Our results were three-fold: (i) considering the comparison of HC with the three other groups, the number of significant brain regions was 4 for ncMCI, 290 for cMCI and 74 for AD, out of a total of 549 regions; hence, in terms of the structural MRI connectivity here adopted, cMCI subjects have the maximal altered pattern w.r.t. healthy conditions. (ii) Eight and seven nodes were significant for the comparisons AD-ncMCI and AD-cMCI, respectively; six nodes, among them, were significant in both comparisons and these nodes form a connected brain region (corresponding to hippocampus, amygdala, Parahippocampal Gyrus, Planum Polare, Frontal Orbital Cortex, Temporal Pole and subcallosal cortex) showing reduced strength of connectivity in the MCI stages; (iii) The connectivity maps of cMCI and ncMCI subjects significantly differ from the connectome of healthy subjects in three regions all corresponding to Frontal Orbital Cortex.	[Rasero, Javier] Hosp Univ Cruces, Biocruces Hlth Res Inst, E-48903 Baracaldo, Spain; [Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Bellotti, Roberto; Stramaglia, Sebastiano] Univ Aldo Moro, Dipartimento Fis, Via Orabona 4, I-70126 Bari, Italy; [Rasero, Javier; Amoroso, Nicola; La Rocca, Marianna; Tangaro, Sabina; Bellotti, Roberto; Stramaglia, Sebastiano] Ist Nazl Fis Nucl, Sez Bari, Via Orabona 4, I-70126 Bari, Italy; [Bellotti, Roberto; Stramaglia, Sebastiano] Univ Aldo Moro, TIRES Ctr Innovat Technol Signal Detect & Proc, Bari, Italy	Hospital Universitario Cruces; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro	Stramaglia, S (corresponding author), Univ Aldo Moro, Dipartimento Fis, Via Orabona 4, I-70126 Bari, Italy.; Stramaglia, S (corresponding author), Ist Nazl Fis Nucl, Sez Bari, Via Orabona 4, I-70126 Bari, Italy.; Stramaglia, S (corresponding author), Univ Aldo Moro, TIRES Ctr Innovat Technol Signal Detect & Proc, Bari, Italy.	sebastiano.stramaglia@ba.infn.it	Daparte, Javier Raspero/ABC-7280-2020; Tangaro, Sabina/AAN-6617-2020; La Rocca, Marianna/ABG-1214-2021; Blanco, Leire/O-5114-2017; stramaglia, sebastiano/H-7582-2015	Daparte, Javier Raspero/0000-0003-1661-2856; Tangaro, Sabina/0000-0002-1372-3916; La Rocca, Marianna/0000-0002-2254-1583; stramaglia, sebastiano/0000-0002-5873-8564; Bellotti, Roberto/0000-0003-3198-2708	Doctoral Research Staff Improvement Programme; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Doctoral Research Staff Improvement Programme; Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); Eurolmmun; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JR's grant was funded from the Minister of Education, Language Policy and Culture (Basque Government) under Doctoral Research Staff Improvement Programme. The other authors received no specific funding for this work. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. None of these companies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (National Institutes of Health Grant U01 AG024904) and DOD ADNI(Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; Eurolmmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Amoroso N, 2015, PHYS MED BIOL, V60, P8851, DOI 10.1088/0031-9155/60/22/8851; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bellotti R, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12145-4; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Boccardi M, 2015, ALZHEIMERS DEMENT, V11, P175, DOI 10.1016/j.jalz.2014.12.002; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Cheng B, 2015, BRAIN IMAGING BEHAV, V9, P913, DOI 10.1007/s11682-015-9356-x; Ciftci K, 2011, ANN BIOMED ENG, V39, P1493, DOI 10.1007/s10439-011-0258-9; Daniel BM, 2016, MDMR MULTIVARIATE DI; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Derflinger S, 2011, J ALZHEIMERS DIS, V25, P347, DOI 10.3233/JAD-2011-110041; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012853; Dinomais M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162889; Duan HQ, 2017, BRAIN RES, V1655, P77, DOI 10.1016/j.brainres.2016.11.019; Eskildsen SF, 2013, NEUROIMAGE, V65, P511, DOI 10.1016/j.neuroimage.2012.09.058; Geslani DM, 2005, DEMENT GERIATR COGN, V19, P383, DOI 10.1159/000084709; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hardy J, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P151; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumfor F, 2013, BRAIN, V136, P2992, DOI 10.1093/brain/awt185; La Rocca M, 2017, SPRINGER PROC PHYS, V191, P189, DOI 10.1007/978-3-319-47810-4_15; Leung KK, 2013, NEUROLOGY, V80, P648, DOI 10.1212/WNL.0b013e318281ccd3; Li H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082450; Lindberg O, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00032; Liu MX, 2016, IEEE T BIO-MED ENG, V63, P1473, DOI 10.1109/TBME.2015.2496233; Liu MX, 2016, IEEE T MED IMAGING, V35, P1463, DOI 10.1109/TMI.2016.2515021; Liu MX, 2015, HUM BRAIN MAPP, V36, P1847, DOI 10.1002/hbm.22741; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055246; Lo A, 2015, P NATL ACAD SCI USA, V112, P13892, DOI 10.1073/pnas.1518285112; Mattis PJ, 2016, NEUROLOGY, V87, P1925, DOI 10.1212/WNL.0000000000003285; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Petersen RC, 2010, NEUROLOGY, V75, P889, DOI 10.1212/WNL.0b013e3181f11d85; Ritter Kerstin, 2015, Alzheimers Dement (Amst), V1, P206, DOI 10.1016/j.dadm.2015.01.006; Rozzini L, 2007, INT J GERIATR PSYCH, V22, P1217, DOI 10.1002/gps.1816; Schmidtke K, 2008, INT PSYCHOGERIATR, V20, P96, DOI 10.1017/S1041610207005509; Shehzad Z, 2014, NEUROIMAGE, V93, P74, DOI 10.1016/j.neuroimage.2014.02.024; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Suk HI, 2014, NEUROIMAGE, V101, P569, DOI 10.1016/j.neuroimage.2014.06.077; Teipel S, 2015, LANCET NEUROL, V14, P1037, DOI 10.1016/S1474-4422(15)00093-9; Tijms BM, 2015, SCHIZOPHR RES, V168, P1, DOI 10.1016/j.schres.2015.08.025; Tijms BM, 2014, BRAIN CONNECT, V4, P337, DOI 10.1089/brain.2013.0209; Tijms BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058921; Tijms BM, 2012, CEREB CORTEX, V22, P1530, DOI 10.1093/cercor/bhr221; Van Hoesen GW, 2000, CEREB CORTEX, V10, P243, DOI 10.1093/cercor/10.3.243; Wang H, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.448; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Westman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022506; Wimo A, 1997, INT J GERIATR PSYCH, V12, P841, DOI 10.1002/(SICI)1099-1166(199708)12:8<841::AID-GPS652>3.3.CO;2-I; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhang S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010386.pub2; Zhang YD, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00066	61	8	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187281	10.1371/journal.pone.0187281	http://dx.doi.org/10.1371/journal.pone.0187281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FM5YZ	29135998	gold, Green Published, Green Submitted			2022-12-27	WOS:000415121200017
J	Padovan, MG; Whitehouse, A; Gouveia, N; Habermann, M; Grigg, J				Padovan, Michele Galhardoni; Whitehouse, Abigail; Gouveia, Nelson; Habermann, Mateus; Grigg, Jonathan			Carbonaceous particulate matter on the lung surface from adults living in Sao Paulo, Brazil	PLOS ONE			English	Article							AIRWAY MACROPHAGES; PARTICLES; POLLUTION; EXPOSURE; CHILDREN; SMOKERS	Accumulation of carbonaceous particulate matter (PM) in the lung is associated with chronic disease. The amount of carbonaceous PM in airway macrophages is reported to be associated with exposure to both fossil fuel PM and cigarette smoke. However, the contribution of these exposures to carbonaceous PM at the lung surface is unclear. Objectives We therefore sought to identify the exposures associated with lung surface in long-term residents of Sao Paulo, Brazil. Methods Lung surface carbon were analyzed in 72 autopsy specimens by image analysis. Smoking history, measured PM10 nearest to the home, distance to main road, and distance-weighted traffic density were used as exposure variables. Data are summarized as median (IQR), and compared by Mann Whitney Test, with correlations done by Spearman's correlation. Results There was no association between lung surface and age or gender. There was no statistically significant association in lung surface between smokers and non-smokers 6.74 cm(2) (3.47 to 10.02) versus 5.20cm(2) (2.29 to 7.54), and there was no significant association between lung surface carbon and exposure to environmental PM and markers of traffic exposure. Conclusion We did not find a statistically significant association between lung surface and smokers and non-smokers, and no statistically significant association between lung surface carbon and environmental exposure variables. These results suggest that lung surface carbon in long-term residents of Sao Paulo may predominately be from environmental PM, but the most appropriate environmental exposure marker remains unclear.	[Padovan, Michele Galhardoni; Whitehouse, Abigail; Grigg, Jonathan] Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England; [Padovan, Michele Galhardoni] Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil; [Gouveia, Nelson; Habermann, Mateus] Univ Sao Paulo, Fac Med, Dept Prevent Med, Sao Paulo, Brazil	University of London; Queen Mary University London; Universidade de Sao Paulo; Universidade de Sao Paulo	Padovan, MG (corresponding author), Queen Mary Univ London, Blizard Inst Cell & Mol Sci, Ctr Genom & Child Hlth, London, England.; Padovan, MG (corresponding author), Univ Sao Paulo, Fac Med, Dept Pathol, Sao Paulo, Brazil.	m.padovan@qmul.ac.uk	Gouveia, Nelson C/C-4580-2013; Whitehouse, Abigail/V-3731-2019	Gouveia, Nelson C/0000-0003-0625-0265; Whitehouse, Abigail/0000-0003-1695-7141; Grigg, Jonathan/0000-0003-3109-6028	CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil [99999.010610/2014-06]	CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil	This study was supported by CAPES (Coordination for the Improvement of Higher Level -or Education- Personnel), Brazil, grant number: 99999.010610/2014-06, http://www.capes.gov.br/, to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, EVIDENCE SUBMITTED R; Arnold C., 2015, ENV HLTH PERSPECT, V124, pA13; Bai Y, 2015, ENVIRON INT, V74, P32, DOI 10.1016/j.envint.2014.09.010; Belli AJ, 2016, ENVIRON RES, V150, P398, DOI 10.1016/j.envres.2016.06.025; Bennett WD, 1996, AM J RESP CRIT CARE, V153, P1641, DOI 10.1164/ajrccm.153.5.8630615; Brauer M, 2001, ENVIRON HEALTH PERSP, V109, P1039, DOI 10.2307/3454959; Bunn HJ, 2001, THORAX, V56, P932, DOI 10.1136/thorax.56.12.932; CETESB, 2015, QUALIDADE AR ESTADO; Finch GL, 2002, INHAL TOXICOL, V14, P1017, DOI 10.1080/08958370290084764; Gerber A, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0047-8; Habermann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113900; Jacobs L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016200; Kato A, 2003, INHAL TOXICOL, V15, P799, DOI 10.1080/08958370390217855; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Nwokoro C, 2012, EUR RESPIR J, V40, P1091, DOI 10.1183/09031936.00195711; Pearson RL, 2000, J AIR WASTE MANAGE, V50, P175, DOI 10.1080/10473289.2000.10463998; PEPELKO WE, 1980, J ENVIRON PATHOL TOX, V4, P449; Pinkerton K. E., 2000, ENV HLTH PERSPECTIVE; Pratt P C, 1971, CHEST, V59, pS39; Saxena RK, 2011, J TOXICOL ENV HEAL A, V74, P706, DOI 10.1080/15287394.2011.556059; WALLACE WAH, 1992, THORAX, V47, P437, DOI 10.1136/thx.47.6.437; WHO, 2006, INDIAN J MED RES; You R, 2015, ELIFE, V4, DOI 10.7554/eLife.09623	23	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0188237	10.1371/journal.pone.0188237	http://dx.doi.org/10.1371/journal.pone.0188237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149218	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100031
J	Tang, R; Wang, YH; Cosker, D; Li, WB				Tang, Rui; Wang, Yuhan; Cosker, Darren; Li, Wenbin			Automatic structural scene digitalization	PLOS ONE			English	Article							SYMBOL RECOGNITION; FLOOR-PLANS; GENERATION	In this paper, we present an automatic system for the analysis and labeling of structural scenes, floor plan drawings in Computer-aided Design (CAD) format. The proposed system applies a fusion strategy to detect and recognize various components of CAD floor plans, such as walls, doors, windows and other ambiguous assets. Technically, a general rule-based filter parsing method is fist adopted to extract effective information from the original floor plan. Then, an image-processing based recovery method is employed to correct information extracted in the first step. Our proposed method is fully automatic and real-time. Such analysis system provides high accuracy and is also evaluated on a public website that, on average, archives more than ten thousands effective uses per day and reaches a relatively high satisfaction rate.	[Tang, Rui; Wang, Yuhan] Kujiale Com, Hangzhou, Zhejiang, Peoples R China; [Tang, Rui; Cosker, Darren] Univ Bath, Ctr Anal Mot Entertainment Res & Applicat, Bath, Somerset, England; [Li, Wenbin] Imperial Coll London, Dept Comp, London, England	University of Bath; Imperial College London	Tang, R (corresponding author), Kujiale Com, Hangzhou, Zhejiang, Peoples R China.; Tang, R (corresponding author), Univ Bath, Ctr Anal Mot Entertainment Res & Applicat, Bath, Somerset, England.; Li, WB (corresponding author), Imperial Coll London, Dept Comp, London, England.	r.tang@bath.ac.uk; wenbin.li@imperial.ac.uk		Cosker, Darren/0000-0001-5177-4741	Engineering and Physical Sciences Research Council (EPSRC) [EP/M023281/1]; Kujiale.com; EPSRC [EP/M023281/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Kujiale.com; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by a grant from the Engineering and Physical Sciences Research Council (EPSRC) to Darren Cosker (grant no. EP/M023281/1). Kujiale.com provided support in the form of salary to Rui Tang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Soon C, 2001, PATTERN RECOGN LETT, V22, P231, DOI 10.1016/S0167-8655(00)00091-X; Ahmed S, 2011, PROC INT CONF DOC, P864, DOI 10.1109/ICDAR.2011.177; Aoki Y., 1996, Proceedings of the 13th International Conference on Pattern Recognition, P747, DOI 10.1109/ICPR.1996.547268; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Dori D, 1999, IEEE T PATTERN ANAL, V21, P202, DOI 10.1109/34.754586; Dosch P., 1999, Proceedings of the Fifth International Conference on Document Analysis and Recognition. ICDAR '99 (Cat. No.PR00318), P487, DOI 10.1109/ICDAR.1999.791831; Dosch P., 2000, International Journal on Document Analysis and Recognition, V3, P102, DOI 10.1007/PL00010901; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Hilaire X, 2006, IEEE T PATTERN ANAL, V28, P890, DOI 10.1109/TPAMI.2006.127; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; Lewis R, 1998, COMPUT AIDED DESIGN, V30, P765, DOI 10.1016/S0010-4485(98)00031-1; Llados J, 1997, MACH VISION APPL, V10, P150, DOI 10.1007/s001380050068; Loria P., 2001, SYMBOL RECOGNITION C, P45; Lu T, 2007, INT J DOC ANAL RECOG, V9, P31, DOI 10.1007/s10032-006-0029-6; Mace S., 2010, P 9 IAPR DAS, P167; Or S.-h., 2005, VISION MODELING VISU, P25; Schurmann J, 1996, PATTERN CLASSIFICATI; So Clifford, 1998, P ACM S VIRT REAL SO, P17, DOI DOI 10.1145/293701.293704; Valveny E, 2003, PATTERN RECOGN LETT, V24, P2857, DOI 10.1016/S0167-8655(03)00144-2; Weber M., 2010, FRONT HANDWR REC ICF, P289; Wessel Raoul, 2008, ROOM CONNECTIVITY GR; Yan L, 2003, PROC INT CONF DOC, P190; Yang S, 2005, IEEE T PATTERN ANAL, V27, P278, DOI 10.1109/TPAMI.2005.38; Yin XT, 2009, IEEE COMPUT GRAPH, V29, P20, DOI 10.1109/MCG.2009.9	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2017	12	11							e0187513	10.1371/journal.pone.0187513	http://dx.doi.org/10.1371/journal.pone.0187513			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN0DI	29149206	Green Published, gold, Green Submitted			2022-12-27	WOS:000415646100012
J	Maghnia, FZ; Abbas, Y; Mahe, F; Kerdouh, B; Tournier, E; Ouadji, M; Tisseyre, P; Prin, Y; El Ghachtouli, N; Yakhlef, SEB; Duponnois, R; Sanguin, H				Maghnia, Fatima Zahra; Abbas, Younes; Mahe, Frederic; Kerdouh, Benaissa; Tournier, Estelle; Ouadji, Mohamed; Tisseyre, Pierre; Prin, Yves; El Ghachtouli, Naima; Yakhlef, Salah Eddine Bakkali; Duponnois, Robin; Sanguin, Herve			Habitat- and soil-related drivers of the root-associated fungal community of Quercus suber in the Northern Moroccan forest	PLOS ONE			English	Article							CENOCOCCUM-GEOPHILUM; LAND-USE; ECTOMYCORRHIZAL COMMUNITIES; PHYLOGENETIC DIVERSITY; FRUITING PATTERNS; SAPROBIC FUNGI; MYCORRHIZAL; WOODLANDS; DROUGHT; L.	Soil fungi associated with plant roots, notably ectomycorrhizal (EcM) fungi, are central in above-and below-ground interactions in Mediterranean forests. They are a key component in soil nutrient cycling and plant productivity. Yet, major disturbances of Mediterranean forests, particularly in the Southern Mediterranean basin, are observed due to the greater human pressures and climate changes. These disturbances highly impact forest cover, soil properties and consequently the root-associated fungal communities. The implementation of efficient conservation strategies of Mediterranean forests is thus closely tied to our understanding of root-associated fungal biodiversity and environmental rules driving its diversity and structure. In our study, the root-associated fungal community of Q. suber was analyzed using high-throughput sequencing across three major Moroccan cork oak habitats. Significant differences in root-associated fungal community structures of Q. suber were observed among Moroccan cork oak habitats (Maa A mora, Benslimane, Chefchaoun) subjected to different human disturbance levels (high to low disturbances, respectively). The fungal community structure changes correlated with a wide range of soil properties, notably with pH, C: N ratio (P = 0.0002), and available phosphorus levels (P = 0.0001). More than 90 belowground fungal indicators (P < 0.01)-either of a type of habitat and/or a soil property-were revealed. The results shed light on the ecological significance of ubiquitous ectomycorrhiza (Tomentella, Russula, Cenococcum), and putative sclerotia-associated/ericoid mycorrhizal fungal taxa (Cladophialophora, Oidiodendron) in the Moroccan cork oak forest, and their intraspecific variability regarding their response to land use and soil characteristics.	[Maghnia, Fatima Zahra; Kerdouh, Benaissa; Ouadji, Mohamed] Forestry Res Ctr, Rabat, Morocco; [Maghnia, Fatima Zahra; Mahe, Frederic; Tournier, Estelle; Prin, Yves; Sanguin, Herve] CIRAD, UMR LSTM, Montpellier, France; [Maghnia, Fatima Zahra; Mahe, Frederic; Tournier, Estelle; Tisseyre, Pierre; Prin, Yves; Duponnois, Robin; Sanguin, Herve] Univ Montpellier, Montpellier SupAgro, INRA, LSTM,CIRAD,IRD, Montpellier, France; [Maghnia, Fatima Zahra; Tisseyre, Pierre; Duponnois, Robin] IRD, UMR LSTM, Montpellier, France; [Abbas, Younes] Univ Sultan Moulay Slimane, Multidisciplinary Fac, Polyvalent Lab, Beni Mellal, Morocco; [El Ghachtouli, Naima] Univ Sidi Mohamed Ben Abdellah, Fac Sci & Technol, Lab Microbial Biotechnol, Fes, Morocco; [Yakhlef, Salah Eddine Bakkali] Minist Agr & Fisheries, Directorat Higher Educ Training & Res, Rabat, Morocco	CIRAD; Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Sultan Moulay Slimane University of Beni Mellal; Sidi Mohamed Ben Abdellah University of Fez	Sanguin, H (corresponding author), CIRAD, UMR LSTM, Montpellier, France.; Sanguin, H (corresponding author), Univ Montpellier, Montpellier SupAgro, INRA, LSTM,CIRAD,IRD, Montpellier, France.	herve.sanguin@cirad.fr	Mahé, Frédéric/AAR-8568-2021; MAGHNIA, Fatima Zahra/N-2549-2018	Mahé, Frédéric/0000-0002-2808-0984; MAGHNIA, Fatima Zahra/0000-0002-4378-0145; EL GHACHTOULI, naima/0000-0002-5452-5406; Abbas, Younes/0000-0003-2324-7172; Sanguin, Herve/0000-0001-7160-2840	Programme de Recherche Agronomique pour le Developpement [PRAD 04/10]; Cirad PhD program "Doctorant du Sud"	Programme de Recherche Agronomique pour le Developpement; Cirad PhD program "Doctorant du Sud"	This study was supported by the "Programme de Recherche Agronomique pour le Developpement" (PRAD 04/10, Gestion et valorisation de la strate arbustive ectotrophe pour la conservation et la productivite durable des suberaies) and the Cirad PhD program "Doctorant du Sud". We thank Morris Traduction (http:// andrewmorris.fr/) for English language editing.; This study was supported by the "Programme de Recherche Agronomique pour le Developpement" (PRAD 04/10, Gestion et valorisation de la strate arbustive ectotrophe pour la conservation et la productivite durable des suberaies) and the Cirad PhD program "Doctorant du Sud". We thank Morris Traduction (http://andrewmorris.fr/) for English language editing.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Alvarado P, 2012, MYCOLOGIA, V104, P894, DOI 10.3852/11-254; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Avis PG, 2003, NEW PHYTOL, V160, P239, DOI 10.1046/j.1469-8137.2003.00865.x; Azul AM, 2010, MYCORRHIZA, V20, P73, DOI 10.1007/s00572-009-0261-2; Azul AM, 2009, CAN J FOREST RES, V39, P2404, DOI 10.1139/X09-148; Bagella S, 2014, CR BIOL, V337, P717, DOI 10.1016/j.crvi.2014.09.005; Bahram M, 2011, FEMS MICROBIOL ECOL, V75, P313, DOI 10.1111/j.1574-6941.2010.01000.x; Baptista P, 2015, ENV MICROBIOL REP, V7, P946, DOI 10.1111/1758-2229.12336; Barrico L, 2010, EUR J SOIL BIOL, V46, P280, DOI 10.1016/j.ejsobi.2010.05.001; Bergero R, 2000, MOL ECOL, V9, P1639, DOI 10.1046/j.1365-294x.2000.01059.x; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Bonito GM, 2010, MOL ECOL, V19, P4994, DOI 10.1111/j.1365-294X.2010.04855.x; Chen H., 2016, VENNDIAGRAM GENERATE; Churchland C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00261; Clemmensen KE, 2015, NEW PHYTOL, V205, P1525, DOI 10.1111/nph.13208; Corcobado T, 2015, FORESTRY, V88, P257, DOI 10.1093/forestry/cpu056; Courty PE, 2008, APPL ENVIRON MICROB, V74, P5792, DOI 10.1128/AEM.01592-08; Courty PE, 2010, SOIL BIOL BIOCHEM, V42, P679, DOI 10.1016/j.soilbio.2009.12.006; Creamer RE, 2016, APPL SOIL ECOL, V97, P112, DOI 10.1016/j.apsoil.2015.08.006; Cudlin P, 2007, PLANT BIOSYST, V141, P406, DOI 10.1080/11263500701626028; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Egerton-Warburton L, 2001, MYCORRHIZA, V11, P283, DOI 10.1007/s005720100134; Egerton-Warburton LM, 2007, J EXP BOT, V58, P1473, DOI 10.1093/jxb/erm009; Gao C, 2015, NEW PHYTOL, V205, P771, DOI 10.1111/nph.13068; Gauquelin T., 2016, REGIONAL ENV CHANGE; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Hamilton N, 2017, GGTERN EXTENSION GGP; Heilmann-Clausen J, 2015, CONSERV BIOL, V29, P61, DOI 10.1111/cobi.12388; Herve M., 2017, RVAIDEMEMOIRE DIVERS; Jany JL, 2002, NEW PHYTOL, V154, P651, DOI 10.1046/j.1469-8137.2002.00408.x; Johnson D, 2012, NEW PHYTOL, V194, P614, DOI 10.1111/j.1469-8137.2012.04087.x; Kerner R, 2012, J PROTEOMICS, V75, P3707, DOI 10.1016/j.jprot.2012.04.039; Kohler A, 2015, NAT GENET, V47, P410, DOI 10.1038/ng.3223; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lancellotti E, 2013, MYCORRHIZA, V23, P533, DOI 10.1007/s00572-013-0493-z; Leopold DR, 2016, FUNGAL ECOL, V24, P114, DOI 10.1016/j.funeco.2016.07.004; LoBuglio KF, 1999, ECTOMYCORRHIZAL FUNGI: KEY GENERA IN PROFILE, P287; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Maghnia FZ, 2017, CR BIOL, V340, P298, DOI 10.1016/j.crvi.2017.04.001; Magri D, 2007, MOL ECOL, V16, P5259, DOI 10.1111/j.1365-294X.2007.03587.x; Mahe F, 2014, PEERJ, V2, DOI 10.7717/peerj.593; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Morris MH, 2008, NEW PHYTOL, V178, P167, DOI 10.1111/j.1469-8137.2007.02348.x; Obase K, 2016, MYCORRHIZA, V26, P529, DOI 10.1007/s00572-016-0690-7; Obase K, 2014, FEMS MICROBIOL ECOL, V90, P708, DOI 10.1111/1574-6941.12428; Oksanen J., 2022, R PACKAGE VERSION; Orgiazzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034847; Peter M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12662; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Rice AV, 2006, MICROBIAL ROOT ENDOP, P227; Richard F, 2005, NEW PHYTOL, V166, P1011, DOI 10.1111/j.1469-8137.2005.01382.x; Richard F, 2004, CAN J BOT, V82, P1711, DOI [10.1139/b04-128, 10.1139/B04-128]; Richard F, 2011, ANN FOREST SCI, V68, P57, DOI 10.1007/s13595-010-0007-5; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosling A., 2013, GENOMICS SOIL AND PL, VVolume 3, P333, DOI [10.1007/978-3-642-39339-6_14, DOI 10.1007/978-3-642-39339-6_14, 10.1007/978-3-642-39339-6, DOI 10.1007/978-3-642-39339-6]; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schaffhauser A, 2012, CR BIOL, V335, P424, DOI 10.1016/j.crvi.2012.04.006; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Smith ME, 2007, NEW PHYTOL, V174, P847, DOI 10.1111/j.1469-8137.2007.02040.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Suz LM, 2014, MOL ECOL, V23, P5628, DOI 10.1111/mec.12947; Taudiere A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00881; Tedersoo L, 2016, ISME J, V10, P346, DOI 10.1038/ismej.2015.116; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Wickham H., 2017, TIDYVERSE EASILY INS; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yakhlef S. E. B., 2011, Mycology - An International Journal on Fungal Biology, V2, P283; Yakhlef SB, 2009, BIOTECHNOL AGRON SOC, V13, P521	75	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187758	10.1371/journal.pone.0187758	http://dx.doi.org/10.1371/journal.pone.0187758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155841	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700015
J	Park, H; Cho, S; Woo, H; Park, SK; Shin, HR; Chang, SH; Yoo, KY; Shin, A				Park, Hyeree; Cho, Sooyoung; Woo, Hyeongtaek; Park, Sue K.; Shin, Hai-Rim; Chang, Soung-Hoon; Yoo, Keun-Young; Shin, Aesun			Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort	PLOS ONE			English	Article							DIABETES-MELLITUS; EPIDEMIOLOGY	Previous cohort studies have demonstrated a positive association between diabetes mellitus (DM) and colorectal cancer (CRC). However, there are few comparisons between DM groups categorized by fasting glucose level. This study examined associations between diabetes as defined by fasting glucose level and self-reported history of DM and CRC risk among Korean adults. Data from the Korean Multi-center Cancer Cohort between 1993 and 2005 were analyzed. The study population comprised 14,570 participants aged 20 years or older. Participants were followed until December 31, 2012 (median follow-up: 11.9 years). Among participants with high fasting glucose (>= 126mg/dL), the risk of developing CRC was significantly higher (HR: 1.51 [1.02-2.25]) than among participants with low fasting glucose (<126mg/dL). Risk was not significantly higher among participants with self-reported history of DM (HR: 1.34 [0.78-2.31]). When both fasting glucose and history of DM were considered together, the risk of CRC among participants with both high fasting glucose and history of DM was 54% (HR: 1.54 [0.97-2.43]), and the risk of CRC among participants with high fasting glucose and no history of DM was 50% (HR: 1.50 [0.73-3.05]). When the first 5 years of follow-up were excluded, among participants with high fasting glucose, the risk of developing CRC was significantly higher (HR: 1.61 [1.02-2.56]) than among participants with low fasting glucose. Risk of CRC was also significantly higher among participants with high fasting glucose and no history of DM (HR: 1.69 [1.01-2.84]). High fasting glucose and self-reported history of DM were associated with increased risk of CRC in this Korean population.	[Park, Hyeree] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Cho, Sooyoung; Woo, Hyeongtaek; Park, Sue K.; Yoo, Keun-Young; Shin, Aesun] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Sue K.; Shin, Aesun] Seoul Natl Univ, Coll Med, Canc Res Ctr, Seoul, South Korea; [Shin, Hai-Rim] WHO, Reg Off Western Pacific, Manila, Philippines; [Chang, Soung-Hoon] Konkuk Univ, Sch Med, Dept Prevent Med, Chungju, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); WHO Western Pacific Regional Office; World Health Organization; Konkuk University; Konkuk University Medical Center	Shin, A (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.; Shin, A (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Ctr, Seoul, South Korea.	shinaesun@snu.ac.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969; Park, Hyeree/0000-0003-1551-260X	Seoul National University Hospital	Seoul National University Hospital	This research was funded by the Seoul National University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2014, 6 KOR NAT HLTH NUTR; [Anonymous], 2007, KOR NAT HLTH NUTR EX; [Anonymous], 2015, 2014 STAT RES CAUS D; [Anonymous], 2013, ANN REP CANC INC; Caiazza F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00019; Cho Sooyoung, 2015, J Cancer Prev, V20, P147, DOI 10.15430/JCP.2015.20.2.147; Deng LY, 2012, DIGEST DIS SCI, V57, P1576, DOI 10.1007/s10620-012-2055-1; Frank EA, 2012, J CLIN LAB ANAL, V26, P317, DOI 10.1002/jcla.21524; Gallagher EJ, 2015, PHYSIOL REV, V95, P727, DOI 10.1152/physrev.00030.2014; Guraya SY, 2015, WORLD J GASTROENTERO, V21, P6026, DOI 10.3748/wjg.v21.i19.6026; Gwack Jin, 2007, J Prev Med Public Health, V40, P23; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Jenab M, 2007, INT J CANCER, V121, P368, DOI 10.1002/ijc.22697; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim DJ, 2011, DIABETES METAB J, V35, P303, DOI 10.4093/dmj.2011.35.4.303; Kim SG, 2008, J KOREAN MED ASSOC, V51, P791, DOI 10.5124/jkma.2008.51.9.791; Kiunga GA, 2004, CANCER LETT, V211, P145, DOI 10.1016/j.canlet.2004.02.015; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Luo S, 2016, CLIN RES HEPATOL GAS, V40, P110, DOI 10.1016/j.clinre.2015.05.021; Song SO, 2016, DIABETES METAB J, V40, P35, DOI 10.4093/dmj.2016.40.1.35; Tran TT, 2006, ENDOCRINOLOGY, V147, P1830, DOI 10.1210/en.2005-1012; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, DEF DIAGN DIAB MELL; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85	25	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0188465	10.1371/journal.pone.0188465	http://dx.doi.org/10.1371/journal.pone.0188465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161326	Green Published, Green Submitted, gold			2022-12-27	WOS:000415987000062
J	Dietert, K; Gutbier, B; Wienhold, SM; Reppe, K; Jiang, XH; Yao, L; Chaput, C; Naujoks, J; Brack, M; Kupke, A; Peteranderl, C; Becker, S; von Lachner, C; Baal, N; Slevogt, H; Hocke, AC; Witzenrath, M; Opitz, B; Herold, S; Hackstein, H; Sander, LE; Suttorp, N; Gruber, AD				Dietert, Kristina; Gutbier, Birgitt; Wienhold, Sandra M.; Reppe, Katrin; Jiang, Xiaohui; Yao, Ling; Chaput, Catherine; Naujoks, Jan; Brack, Markus; Kupke, Alexandra; Peteranderl, Christin; Becker, Stephan; von Lachner, Carolin; Baal, Nelli; Slevogt, Hortense; Hocke, Andreas C.; Witzenrath, Martin; Opitz, Bastian; Herold, Susanne; Hackstein, Holger; Sander, Leif E.; Suttorp, Norbert; Gruber, Achim D.			Spectrum of pathogen- and model-specific histopathologies in mouse models of acute pneumonia	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; ACUTE LUNG INJURY; PNEUMOCOCCAL PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; LEGIONELLA-PNEUMOPHILA; PULMONARY CLEARANCE; LIPOTEICHOIC ACID; MURINE MODEL; EXPRESSION; INFLUENZA	Pneumonia may be caused by a wide range of pathogens and is considered the most common infectious cause of death in humans. Murine acute lung infection models mirror human pathologies in many aspects and contribute to our understanding of the disease and the development of novel treatment strategies. Despite progress in other fields of tissue imaging, histopathology remains the most conclusive and practical read out tool for the descriptive and semiquantitative evaluation of mouse pneumonia and therapeutic interventions. Here, we systematically describe and compare the distinctive histopathological features of established models of acute pneumonia in mice induced by Streptococcus (S.) pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Legionella pneumophila, Escherichia coli, Middle East respiratory syndrome (MERS) coronavirus, influenza A virus (IAV) and superinfection of IAV-incuced pneumonia with S. pneumoniae. Systematic comparisons of the models revealed striking differences in the distribution of lesions, the characteristics of pneumonia induced, principal inflammatory cell types, lesions in adjacent tissues, and the detectability of the pathogens in histological sections. We therefore identified core criteria for each model suitable for practical semiquantitative scoring systems that take into account the pathogen-and model-specific patterns of pneumonia. Other critical factors that affect experimental pathologies are discussed, including infectious dose, time kinetics, and the genetic background of the mouse strain. The substantial differences between the model-specific pathologies underscore the necessity of pathogen-and model-adapted criteria for the comparative quantification of experimental outcomes. These criteria also allow for the standardized validation and comparison of treatment strategies in preclinical models.	[Dietert, Kristina; Gruber, Achim D.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Gutbier, Birgitt; Wienhold, Sandra M.; Reppe, Katrin; Jiang, Xiaohui; Yao, Ling; Chaput, Catherine; Naujoks, Jan; Brack, Markus; Hocke, Andreas C.; Witzenrath, Martin; Opitz, Bastian; Sander, Leif E.; Suttorp, Norbert] Charite Univ Med Berlin, Dept Infect Dis & Pulm Med, Berlin, Germany; [Kupke, Alexandra; Peteranderl, Christin; Becker, Stephan; Herold, Susanne] UGMLC, Sect Infect Dis, Dept Internal Med 2, German Ctr Lung Res DZL, Giessen, Germany; [Kupke, Alexandra; Becker, Stephan] Philipps Univ Marburg, German Ctr Infect Res DZIF, TTU Emerging Infect, Inst Virol, Marburg, Germany; [von Lachner, Carolin; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany; [Baal, Nelli; Hackstein, Holger] Justus Liebig Univ Giessen, Univ Hosp Giessen & Marburg, German Ctr Lung Res DZL, Inst Clin Immunol & Transfus Med,UGMLC, Giessen, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Center for Infection Research; Philipps University Marburg; Friedrich Schiller University of Jena; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Gruber, AD (corresponding author), Free Univ Berlin, Dept Vet Pathol, Berlin, Germany.	achim.gruber@fu-berlin.de	Gruber, Achim D./ABA-4514-2021; Sander, Leif Erik/AAI-8619-2020	Suttorp, Norbert/0000-0002-3958-1151; Dietert, Kristina/0000-0002-5667-6750; Peteranderl, Christin/0000-0003-3799-8268; Yao, Ling/0000-0002-0482-9604; Brack, Markus Christian/0000-0002-9012-3957; Opitz, Bastian/0000-0003-1276-836X	German Research Foundation (DFG) [SFB-TR 84]; DFG [KFO 309, SFB-1021, EXC147]; excellence graduate school Jena School for Microbial Communication	German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); excellence graduate school Jena School for Microbial Communication	This work was supported by the German Research Foundation (DFG) SFB-TR 84 (https://www.sfb-tr84.de/) A1, A5 (to B.O.), B2 (to S.H.), B3 (to H.H), C3, C6 (to M.W.), C8 (to L.E.S), Z1a (to A.C.H.), Z1b (to A.D.G.), DFG KFO 309 (http:// www.kfo309.de/) P2 (to S.B., S.H. and C.P.), P8 (to S.H.), DFG SFB-1021 (http://www.sfb1021.de/) C5 (to S.H.), EXC147 (http://www.eccps.de/) (to S.H.) and the excellence graduate school Jena School for Microbial Communication (JSMC, to H.S.)(http:// www.jsmc.uni-jena.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad TA, 2012, VACCINE, V30, P2411, DOI 10.1016/j.vaccine.2011.11.027; Al-Tawfiq JA, 2014, TRENDS MICROBIOL, V22, P573, DOI 10.1016/j.tim.2014.08.001; Alharbi NK, 2017, VACCINE, V35, P3780, DOI 10.1016/j.vaccine.2017.05.032; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Archer KA, 2009, CELL MICROBIOL, V11, P21, DOI 10.1111/j.1462-5822.2008.01234.x; Aulmann W, 2012, REGUL TOXICOL PHARM, V63, P286, DOI 10.1016/j.yrtph.2012.03.003; Cauvi DM, 2014, SHOCK, V42, P246, DOI 10.1097/SHK.0000000000000207; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; de Almeida SA, 2017, BIOMED PHARMACOTHER, V86, P715, DOI 10.1016/j.biopha.2016.11.146; Dietert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102606; Eveillard M, 2010, J INFECTION, V60, P154, DOI 10.1016/j.jinf.2009.09.004; Falagas ME, 2007, EUR J CLIN MICROBIOL, V26, P857, DOI 10.1007/s10096-007-0365-6; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Feldman Charles, 2014, F1000Prime Rep, V6, P82, DOI 10.12703/P6-82; Fodah RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107394; Friedman Herman, 2002, Semin Pediatr Infect Dis, V13, P273, DOI 10.1053/spid.2002.127206; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gillet Y, 2001, ARCH PEDIATRIE, V8, p742S, DOI 10.1016/S0929-693X(01)80190-1; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Gutbier B, 2015, AM J PHYSIOL-LUNG C, V309, pL250, DOI 10.1152/ajplung.00265.2014; Gutbier B, 2010, PULM PHARMACOL THER, V23, P334, DOI 10.1016/j.pupt.2010.03.007; Haagmans BL, 2014, LANCET INFECT DIS, V14, P140, DOI 10.1016/S1473-3099(13)70690-X; Hackstein H, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0288-1; Hackstein H, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-91; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Harkema JR, 2017, TOXICOL PATHOL, V45, P161, DOI 10.1177/0192623316674274; Herold S, 2015, EUR RESPIR J, V45, P1463, DOI 10.1183/09031936.00186214; Hocke AC, 2007, CYTOKINE, V38, P61, DOI 10.1016/j.cyto.2007.05.009; Hocke AC, 2013, AM J RESP CRIT CARE, V188, P882, DOI 10.1164/rccm.201305-0954LE; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; JARVIS WR, 1985, INFECT CONT HOSP EP, V6, P68, DOI 10.1017/S0195941700062639; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Joseph NM, 2009, J INFECT DEV COUNTR, V3, P771, DOI 10.3855/jidc.396; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kipar A, 2007, J VET MED EDUC, V34, P485, DOI 10.3138/jvme.34.4.485; Kipar A, 2007, J VET MED EDUC, V34, P473, DOI 10.3138/jvme.34.4.473; Klopfleisch R, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-123; Knapp S, 2006, AM J RESP CRIT CARE, V173, P122, DOI 10.1164/rccm.200505-730OC; Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354; Lammers AJJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-139; Lawrenz MB, 2014, JOVE-J VIS EXP, DOI 10.3791/52261; Leist SR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2483-y; Lippmann J, 2011, CELL MICROBIOL, V13, P1668, DOI 10.1111/j.1462-5822.2011.01646.x; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Lode HM, 2007, RESP MED, V101, P1864, DOI 10.1016/j.rmed.2007.04.008; Lorente L, 2007, EUR RESPIR J, V30, P1193, DOI 10.1183/09031936.00048507; Malczyk AH, 2015, J VIROL, V89, P11654, DOI 10.1128/JVI.01815-15; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Muller-Redetzky HC, 2015, J ANTIMICROB CHEMOTH, V70, P830, DOI 10.1093/jac/dku446; NASH TW, 1984, J CLIN INVEST, V74, P771, DOI 10.1172/JCI111493; Naujoks J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005408; Patil Harsha V, 2017, J Nat Sci Biol Med, V8, P46, DOI 10.4103/0976-9668.198360; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Petersen E, 2015, INT J INFECT DIS, V36, P54, DOI 10.1016/j.ijid.2015.06.004; Pletz M W, 2012, Pneumologie, V66, P470; Pletz MW, 2011, DEUT MED WOCHENSCHR, V136, P775, DOI 10.1055/s-0031-1275806; Rello J, 2014, LANCET RESP MED, V2, P764, DOI 10.1016/S2213-2600(14)70171-7; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Reppe K, 2015, INFECT IMMUN, V83, P4617, DOI 10.1128/IAI.00948-15; Reppe K, 2009, AM J RESP CELL MOL, V40, P474, DOI 10.1165/rcmb.2008-0071OC; Sabria Miguel, 2003, Am J Respir Med, V2, P235; Sakthivel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100970; Schauer AE, 2017, J INNATE IMMUN, V9, P403, DOI 10.1159/000469661; Schmeck B, 2004, J BIOL CHEM, V279, P53241, DOI 10.1074/jbc.M313702200; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Tateda K, 2001, J IMMUNOL, V166, P3355, DOI 10.4049/jimmunol.166.5.3355; Torres A, 2010, CLIN INFECT DIS, V51, pS48, DOI 10.1086/653049; Vergis EN, 2000, SEMIN RESP CRIT CARE, V21, P295, DOI 10.1055/s-2000-9934; Volz A, 2015, J VIROL, V89, P8651, DOI 10.1128/JVI.00614-15; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; West MA, 2017, CRIT REV ONCOL HEMAT, V112, P80, DOI 10.1016/j.critrevonc.2017.02.008; Widagdo W, 2016, J VIROL, V90, P4838, DOI 10.1128/JVI.02994-15; World Health Organization, 2014, MIDDL E RESP SYNDR C; Xiong HZ, 2015, INFECT IMMUN, V83, P3418, DOI 10.1128/IAI.00678-15; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111; Zhao JX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan5393; Zhou Tao, 2004, Zhonghua Er Ke Za Zhi, V42, P644	85	41	42	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188251	10.1371/journal.pone.0188251	http://dx.doi.org/10.1371/journal.pone.0188251			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155867	Green Submitted, Green Published, gold			2022-12-27	WOS:000415756700039
J	Stewart, D; Gibson-Smith, K; MacLure, K; Mair, A; Alonso, A; Codina, C; Cittadini, A; Fernandez-Llimos, F; Fleming, G; Gennimata, D; Gillespie, U; Harrison, C; Junius-Walker, U; Kardas, P; Kempen, T; Kinnear, M; Lewek, P; Malva, J; McIntosh, J; Scullin, C; Wiese, B				Stewart, Derek; Gibson-Smith, Kathrine; MacLure, Katie; Mair, Alpana; Alonso, Albert; Codina, Carles; Cittadini, Antonio; Fernandez-Llimos, Fernando; Fleming, Glenda; Gennimata, Dimitra; Gillespie, Ulrika; Harrison, Cathy; Junius-Walker, Ulrike; Kardas, Przemyslaw; Kempen, Thomas; Kinnear, Moira; Lewek, Pawel; Malva, Joao; McIntosh, Jennifer; Scullin, Claire; Wiese, Birgitt			A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people	PLOS ONE			English	Article							NURSING-RESEARCH; CARE; MULTIMORBIDITY; POPULATION; PREVALENCE; GUIDELINES; SAFETY; IMPACT	Background Inappropriate use of multiple medicines (inappropriate polypharmacy) is a major challenge in older people with consequences of increased prevalence and severity of adverse drug reactions and interactions, and reduced medicines adherence. The aim of this study was to determine the levels of consensus amongst key stakeholders in the European Union (EU) in relation to aspects of the management of polypharmacy in older people. Methods Forty-six statements were developed on aspects of healthcare structures, processes and desired outcomes, with consensus defined at >= 80% agreement. Panel members were strategists (e.g. directors, leading clinicians and commissioners) from each of the 28 EU member states, with a target recruitment of five per member state. Three Delphi rounds were conducted via email, with panel members being provided with summative results and collated, anonymised comments at the commencement of Rounds 2 and 3. Results Ninety panel members were recruited (64.3% of target), with high participation levels throughout the three Delphi rounds (91.1%, 83.3%, 72.2%). During Round 1, consensus was obtained for 27/46 statements (58.7%), with an additional two statements in Round 2 and none in Round 3. Consensus was obtained for statements relating to: potential gain arising from polypharmacy management (3/4 statements); strategic development (7/7); change management (5/7) indicator measures (4/6); legislation (0/3); awareness raising (5/5); polypharmacy reviews (5/7); and EU vision (0/7). Analysis of free text comments indicated that the vision statements were too ambitious and not achievable by the specified timeframe of 2025. Conclusion Consensus was obtained amongst key EU strategists around many aspects of polypharmacy management in older people. Notably, no consensus was achieved in relation to statements relating to the need to alter legislation in areas of healthcare delivery, remuneration and practitioner scope of practice. While the vision for the EU by 2025 was considered rather ambitious, there is great potential and clear opportunity to advance polypharmacy management throughout the EU and beyond.	[Stewart, Derek; Gibson-Smith, Kathrine; MacLure, Katie] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Mair, Alpana] Scottish Govt, Effect Prescribing & Therapeut Hlth & Social Care, Edinburgh, Midlothian, Scotland; [Alonso, Albert; McIntosh, Jennifer] FCRB, Directorate Res & Innovat, Barcelona, Spain; [Codina, Carles] Hosp Clin Barcelona, Pharm Dept, Barcelona, Spain; [Cittadini, Antonio] Univ Federico II, Dept Translat Med Sci, Naples, Italy; [Fernandez-Llimos, Fernando] Univ Lisbon, Fac Pharm, Dept Social Pharm, Inst Med Res iMed Ulisboa, Lisbon, Portugal; [Fleming, Glenda] Northern Hlth & Social Care Trust, Med Optimisat Innovat Ctr, Belfast, Antrim, North Ireland; [Gennimata, Dimitra] Univ Peloponnese, Dept Social & Educ Policy, Corinthos, Greece; [Gillespie, Ulrika; Kempen, Thomas] Uppsala Univ Hosp, Pharm Dept, Uppsala, Sweden; [Harrison, Cathy] Dept Hlth Social Serv & Publ Safety, Belfast, Antrim, North Ireland; [Junius-Walker, Ulrike; Wiese, Birgitt] Hannover Med Sch, Inst Gen Med, Hannover, Germany; [Kardas, Przemyslaw; Lewek, Pawel] Med Univ Lodz, Dept Family Med, Lodz, Poland; [Kinnear, Moira] Western Gen Hosp, NHS Lothian Pharm Serv, Edinburgh, Midlothian, Scotland; [Malva, Joao] Univ Coimbra, Fac Med, Coimbra, Portugal; [Scullin, Claire] Queens Univ, Sch Pharm, Belfast, Antrim, North Ireland	Robert Gordon University; University of Barcelona; Hospital Clinic de Barcelona; University of Naples Federico II; Universidade de Lisboa; Uppsala University; Uppsala University Hospital; Hannover Medical School; Medical University Lodz; University of Edinburgh; Universidade de Coimbra; Queens University Belfast	Stewart, D (corresponding author), Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland.	d.stewart@rgu.ac.uk	iMed.ULisboa, PEPSocPh/B-4101-2014; MacLure, Katie/GRJ-8912-2022; Fernandez-Llimos, Fernando/B-8931-2008; Malva, Joao/L-3557-2014	Fernandez-Llimos, Fernando/0000-0002-8529-9595; fleming, glenda/0000-0001-7321-8092; Stewart, Derek/0000-0001-7360-8592; Lewek, Pawel/0000-0003-3690-7096; Malva, Joao/0000-0002-5438-4447; Kempen, Thomas/0000-0001-5173-5005; Alonso, Albert/0000-0003-0921-8033; Kardas, Przemyslaw/0000-0002-6078-2628; MacLure, Katie/0000-0003-0686-948X	SIMPATHY project [663082]; European Commission CHAFEA Health Program; Public Health Agency [SPI/5309/16] Funding Source: researchfish	SIMPATHY project; European Commission CHAFEA Health Program; Public Health Agency	This work has been supported by the SIMPATHY project, grant agreement number 663082, co-funded by the European Commission CHAFEA Health Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beuscart JB, 2017, BRIT J CLIN PHARMACO, V83, P942, DOI 10.1111/bcp.13197; Cadogan CA, 2016, DRUG SAFETY, V39, P109, DOI 10.1007/s40264-015-0378-5; Campbell SM, 2001, J CLIN PHARM THER, V26, P5, DOI 10.1046/j.1365-2710.2001.00331.x; Clayton MJ, 1997, ED PSYCHOL, V17, P373, DOI [DOI 10.1080/0144341970170401, 10.1080/0144341970170401]; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Craig P, 2008, BMJ-BRIT MED J, V337, pa1665; Dwyer LL, 2010, AM J GERIATR PHARMAC, V8, P63, DOI 10.1016/j.amjopharm.2010.01.001; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hazen AC, 2017, RES SOCIAOL IN PRESS; Hutchings Andrew, 2006, J Health Serv Res Policy, V11, P218, DOI 10.1258/135581906778476553; Johansson T, 2016, BRIT J CLIN PHARMACO, V82, P532, DOI 10.1111/bcp.12959; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Kaufmann CP, 2014, EUR J CLIN PHARMACOL, V70, P1, DOI 10.1007/s00228-013-1575-8; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Kenz HE, 2014, HEART CHANGE, V31, P345; Kirkpatrick SA, 2016, ACAD MANAGEMENT P, P10225; Koberlein J, 2013, GRUYTER, V25, P243; Millar AN, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1915-6; Ornstein SM, 2013, J AM BOARD FAM MED, V26, P518, DOI 10.3122/jabfm.2013.05.130012; Paparella G., 2016, PERSON CTR CARE EURO; Patterson SM, 2014, COCHRANE DB SYST REV, P10, DOI DOI 10.1002/14651858.CD008165.PUB3/FULL; Payne RA, 2014, EUR J CLIN PHARMACOL, V70, P575, DOI 10.1007/s00228-013-1639-9; Payne RA, 2011, BRIT J GEN PRACT, V61, P83, DOI 10.3399/bjgp11X556146; Schien E, 1995, ORG CULTURE LEADERSH; Smith M, 2013, HEALTH AFFAIR, V32, P1963, DOI 10.1377/hlthaff.2013.0542; Stewart D, 2017, EXPERT OPIN DRUG SAF, V16, P203, DOI 10.1080/14740338.2017.1265503; Stewart D, 2012, BRIT J CLIN PHARMACO, V74, P662, DOI 10.1111/j.1365-2125.2012.04204.x; Valentijn PP, 2013, INT J INTEGR CARE, V13; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Walsh EK, 2017, PHARMACOEPIDEM DR S, V26, P481, DOI 10.1002/pds.4188; Weaver SJ, 2013, ANN INTERN MED, V158, P369, DOI 10.7326/0003-4819-158-5-201303051-00002; World Health Organization, 2015, WHO GLOB STRAT PEOPL; World Health Organization, 2018, WORLD REP AG HLTH	39	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0188348	10.1371/journal.pone.0188348	http://dx.doi.org/10.1371/journal.pone.0188348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FN1NI	29155870	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700050
J	Oliveira, RD; Mousel, MR; Pabilonia, KL; Highland, MA; Taylor, JB; Knowles, DP; White, SN				Oliveira, Ryan D.; Mousel, Michelle R.; Pabilonia, Kristy L.; Highland, Margaret A.; Taylor, J. Bret; Knowles, Donald P.; White, Stephen N.			Domestic sheep show average Coxiella burnetii seropositivity generations after a sheep-associated human Q fever outbreak and lack detectable shedding by placental, vaginal, and fecal routes	PLOS ONE			English	Article							UNITED-STATES; INFECTION; GOATS; AIR; EPIDEMIOLOGY; CALIFORNIA; RECOVERY; EPISODE; FARMS; DNA	Coxiella burnetii is a globally distributed zoonotic bacterial pathogen that causes abortions in ruminant livestock. In humans, an influenza-like illness results with the potential for hospitalization, chronic infection, abortion, and fatal endocarditis. Ruminant livestock, particularly small ruminants, are hypothesized to be the primary transmission source to humans. A recent Netherlands outbreak from 2007-2010 traced to dairy goats resulted in over 4,100 human cases with estimated costs of more than 300 million euros. Smaller human Q fever outbreaks of small ruminant origin have occurred in the United States, and characterizing shedding is important to understand the risk of future outbreaks. In this study, we assessed bacterial shedding and seroprevalence in 100 sheep from an Idaho location associated with a 1984 human Q fever outbreak. We observed 5% seropositivity, which was not significantly different from the national average of 2.7% for the U.S. (P>0.05). Furthermore, C. burnetii was not detected by quantitative PCR from placentas, vaginal swabs, or fecal samples. Specifically, a three-target quantitative PCR of placenta identified 0.0% shedding (exact 95% confidence interval: 0.0%-2.9%). While presence of seropositive individuals demonstrates some historical C. burnetii exposure, the placental sample confidence interval suggests 2016 shedding events were rare or absent. The location maintained the flock with little or no depopulation in 1984 and without C. burnetii vaccination during or since 1984. It is not clear how a zero-shedding rate was achieved in these sheep beyond natural immunity, and more work is required to discover and assess possible factors that may contribute towards achieving zero-shedding status. We provide the first U.S. sheep placental C. burnetii shedding update in over 60 years and demonstrate potential for C. burnetii shedding to reach undetectable levels after an outbreak event even in the absence of targeted interventions, such as vaccination.	[Oliveira, Ryan D.; Knowles, Donald P.; White, Stephen N.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mousel, Michelle R.; Highland, Margaret A.; Knowles, Donald P.; White, Stephen N.] USDA ARS Anim Dis Res, Pullman, WA 99164 USA; [Mousel, Michelle R.; Highland, Margaret A.; Knowles, Donald P.] Washington State Univ, Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Pabilonia, Kristy L.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Highland, Margaret A.] Washington State Univ, Washington Anim Dis Diagnost Lab, Pullman, WA 99164 USA; [Taylor, J. Bret] USDA ARS Range Sheep Prod Efficiency Res, Dubois, ID USA; [White, Stephen N.] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; Washington State University; Colorado State University; Washington State University; Washington State University	White, SN (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.; White, SN (corresponding author), USDA ARS Anim Dis Res, Pullman, WA 99164 USA.; White, SN (corresponding author), Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA.	Stephen.White@ars.usda.gov	Oliveira, Ryan D/M-9254-2019; Highland, Margaret/ABF-3396-2021	Oliveira, Ryan/0000-0002-4822-3698; White, Stephen N./0000-0001-9255-6054	National Sheep Industry Improvement Center [122337_001]; USDA-ARS [2090-32000-035-00D, 2056-31000-011-00D]; Department of Veterinary Microbiology & Pathology at Washington State University; ARCS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	National Sheep Industry Improvement Center; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Department of Veterinary Microbiology & Pathology at Washington State University; ARCS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Sheep Industry Improvement Center grant 122337_001 and by USDA-ARS 2090-32000-035-00D and USDA-ARS 2056-31000-011-00D. RDO was supported by a combined residency program fellowship from the Department of Veterinary Microbiology & Pathology at Washington State University and by an Achievement Rewards for College Scientists (ARCS) Fellowship from the ARCS Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Anderson A, 2013, DIAGNOSIS MANAGEMENT; Arricau-Bouvery N, 2005, VACCINE, V23, P4392, DOI 10.1016/j.vaccine.2005.04.010; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Berri M, 2005, VET REC, V157, P737, DOI 10.1136/vr.157.23.737; Berri M, 2002, VET MICROBIOL, V85, P55, DOI 10.1016/S0378-1135(01)00480-1; Berri M, 2001, VET REC, V148, P502, DOI 10.1136/vr.148.16.502; Brown L. D., 2001, INTERVAL ESTIMATION, P101, DOI [10.1214/ss/1009213286, DOI 10.1214/SS/1009213286]; Dahlgren FS, 2015, AM J TROP MED HYG, V92, P247, DOI 10.4269/ajtmh.14-0503; de Bruin A, 2012, APPL ENVIRON MICROB, V78, P1652, DOI 10.1128/AEM.07323-11; DELAY PD, 1950, J IMMUNOL, V65, P211; DUPONT HT, 1992, AM J MED, V93, P427, DOI 10.1016/0002-9343(92)90173-9; DUPUIS G, 1987, INT J EPIDEMIOL, V16, P282, DOI 10.1093/ije/16.2.282; Eibach R, 2012, BERLINER MUNCHENER T, V126, P3; Georgiev M, 2013, EUROSURVEILLANCE, V18, P20407; Guo HR, 1998, J OCCUP ENVIRON MED, V40, P999, DOI 10.1097/00043764-199811000-00011; Hartwell HW, 1896, PUBLIC HLTH REPORTS, V66, P1473; Hartzell JD, 2012, MIL MED, V177, P484, DOI 10.7205/MILMED-D-12-00059; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hilbert Angela, 2012, BMC Res Notes, V5, P152, DOI 10.1186/1756-0500-5-152; Jones RM, 2006, APPL BIOSAF, V11, P32; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Kersh GJ, 2010, J CLIN MICROBIOL, V48, P3428, DOI 10.1128/JCM.00758-10; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; Kim SG, 2005, EMERG INFECT DIS, V11, P619, DOI 10.3201/eid1104.041036; Lang G. H., 1990, Q FEVER, P23; Langley JM, 2003, AM J OBSTET GYNECOL, V189, P228, DOI 10.1067/mob.2003.448; LENNETTE EH, 1951, AM J HYG, V54, P44, DOI 10.1093/oxfordjournals.aje.a119469; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Lyytikainen O, 1998, EUR J EPIDEMIOL, V14, P193, DOI 10.1023/A:1007452503863; MARMION BP, 1958, BMJ-BRIT MED J, V2, P809, DOI 10.1136/bmj.2.5100.809; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Monteiro L, 1997, J CLIN MICROBIOL, V35, P995, DOI 10.1128/JCM.35.4.995-998.1997; Nielsen LN, 2011, VET J, V190, P150, DOI [10.1016/j.tvjl.2010.09.016, 10.1016/j.tvjl.2010.12.021]; Norlander L, 2000, MICROBES INFECT, V2, P417, DOI 10.1016/S1286-4579(00)00325-7; O'Neill TJ., 2012, COXIELLA BURNETII SM; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; RAUCH AM, 1987, ARCH INTERN MED, V147, P341, DOI 10.1001/archinte.147.2.341; ROBBINS FC, 1946, AM J HYG, V44, P6, DOI 10.1093/oxfordjournals.aje.a119084; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Ruppanner R, 1982, ARCH ENV HLTH, V37; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; SINGH SB, 1985, AM J VET RES, V46, P321; STOENNER HG, 1959, AM J HYG, V69, P202, DOI 10.1093/oxfordjournals.aje.a119995; Tissot-Dupont H, 1999, AM J EPIDEMIOL, V150, P67, DOI 10.1093/oxfordjournals.aje.a009920; TOPPING NH, 1947, JAMA-J AM MED ASSOC, V133, P813, DOI 10.1001/jama.1947.02880120001001; TSELENTIS Y, 1995, CLIN INFECT DIS, V20, P1311, DOI 10.1093/clinids/20.5.1311; van Asseldonk MAPM, 2015, PREV VET MED, V121, P115, DOI 10.1016/j.prevetmed.2015.06.010; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; Van Leuken JPG, 2016, ONE HEALTH, V2, P77, DOI 10.1016/j.onehlt.2016.03.004; WELSH HH, 1951, PUBLIC HEALTH REP, V66, P1473, DOI 10.2307/4587909; WELSH HH, 1958, ANN NY ACAD SCI, V70, P528, DOI 10.1111/j.1749-6632.1958.tb35409.x; Yanase T, 1998, MICROBIOL IMMUNOL, V42, P51, DOI 10.1111/j.1348-0421.1998.tb01969.x	59	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2017	12	11							e0188054	10.1371/journal.pone.0188054	http://dx.doi.org/10.1371/journal.pone.0188054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM7MC	29141023	Green Published, gold, Green Submitted			2022-12-27	WOS:000415260400048
J	Vetrivel, I; Mahajan, S; Tyagi, M; Hoffmann, L; Sanejouand, YH; Srinivasan, N; de Brevern, AG; Cadet, F; Offmann, B				Vetrivel, Iyanar; Mahajan, Swapnil; Tyagi, Manoj; Hoffmann, Lionel; Sanejouand, Yves-Henri; Srinivasan, Narayanaswamy; de Brevern, Alexandre G.; Cadet, Frederic; Offmann, Bernard			Knowledge-based prediction of protein backbone conformation using a structural alphabet	PLOS ONE			English	Article							SECONDARY STRUCTURE; TERTIARY STRUCTURES; SEQUENCE; PENTAPEPTIDES; RECOGNITION; FRAGMENTS; PROFILES; MOTIFS	Libraries of structural prototypes that abstract protein local structures are known as structural alphabets and have proven to be very useful in various aspects of protein structure analyses and predictions. One such library, Protein Blocks, is composed of 16 standard 5-residues long structural prototypes. This form of analyzing proteins involves drafting its structure as a string of Protein Blocks. Predicting the local structure of a protein in terms of protein blocks is the general objective of this work. A new approach, PB-kPRED is proposed towards this aim. It involves (i) organizing the structural knowledge in the form of a database of pentapeptide fragments extracted from all protein structures in the PDB and (ii) applying a knowledge-based algorithm that does not rely on any secondary structure predictions and/or sequence alignment profiles, to scan this database and predict most probable backbone conformations for the protein local structures. Though PB-kPRED uses the structural information from homologues in preference, if available. The predictions were evaluated rigorously on 15,544 query proteins representing a non-redundant subset of the PDB filtered at 30% sequence identity cut-off. We have shown that the kPRED method was able to achieve mean accuracies ranging from 40.8% to 66.3% depending on the availability of homologues. The impact of the different strategies for scanning the database on the prediction was evaluated and is discussed. Our results highlight the usefulness of the method in the context of proteins without any known structural homologues. A scoring function that gives a good estimate of the accuracy of prediction was further developed. This score estimates very well the accuracy of the algorithm (R-2 of 0.82). An online version of the tool is provided freely for non-commercial usage at http://www.bo-protscience.fr/kpred/.	[Vetrivel, Iyanar; Mahajan, Swapnil; Hoffmann, Lionel; Sanejouand, Yves-Henri; Offmann, Bernard] Univ Nantes, UFIP, UMR CNRS 6286, UFR Sci & Tech, 2 Chemin Houssiniere, Nantes, France; [Mahajan, Swapnil; Cadet, Frederic] Univ La Reunion, DSIMB, INSERM, UMR S 1134,Lab Excellence,GR Ex,Fac Sci & Technol, St Denis, La Reunion, France; [Tyagi, Manoj] Univ La Reunion, St Denis, La Reunion, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [de Brevern, Alexandre G.] Univ Paris Diderot, Univ Sorbonne Paris Cite, Lab Excellence, INSERM UMR S 1134,DSIMB Team,GR Ex,INTS, Rue Alexandre Cabanel, Paris, France; [Cadet, Frederic] PEACCEL SAS, Paris, France; [Tyagi, Manoj] NCI, Bethesda, MA USA	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of La Reunion; University of La Reunion; Indian Institute of Science (IISC) - Bangalore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Offmann, B (corresponding author), Univ Nantes, UFIP, UMR CNRS 6286, UFR Sci & Tech, 2 Chemin Houssiniere, Nantes, France.	bernard.offmann@univ-nantes.fr	OFFMANN, Bernard/B-5901-2011; Mahajan, Swapnil/J-4732-2019; de Brevern, Alexandre G./B-4788-2009	OFFMANN, Bernard/0000-0002-6845-5883; Mahajan, Swapnil/0000-0003-2136-1801; de Brevern, Alexandre G./0000-0001-7112-5626	Region Reunion; Fond Social Europeen [20131528]; Conseil Regional des Pays de la Loire; Ministry of Research (France); National Institute for Blood Transfusion (INTS, France); National Institute for Health and Medical Research (INSERM, France); labex GR-Ex; French National Research Agency [ANR-11-LABX-0051, ANR-11-IDEX-0005-02]; University Paris Diderot, Sorbonne, Paris Cite (France); University de La Reunion, Faculty of Sciences and Technology; Indo-French Centre for the Promotion of Advanced Research / CEFIPRA [5302-2]; Department of Biotechnology, Government of India	Region Reunion; Fond Social Europeen; Conseil Regional des Pays de la Loire(Region Pays de la Loire); Ministry of Research (France)(Ministry of Research, France); National Institute for Blood Transfusion (INTS, France); National Institute for Health and Medical Research (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); labex GR-Ex; French National Research Agency(French National Research Agency (ANR)); University Paris Diderot, Sorbonne, Paris Cite (France); University de La Reunion, Faculty of Sciences and Technology; Indo-French Centre for the Promotion of Advanced Research / CEFIPRA; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Region Reunion and the Fond Social Europeen [grant no. 20131528] to IV. This work was in part supported by Conseil Regional des Pays de la Loire in the framework of GRIOTE project. AdB and FC acknowledge grants from the Ministry of Research (France), National Institute for Blood Transfusion (INTS, France), National Institute for Health and Medical Research (INSERM, France) and labex GR-Ex. The labex GR-Ex, reference ANR-11-LABX-0051 is funded by the program "Investissements d'avenir" of the French National Research Agency, reference ANR-11-IDEX-0005-02. AdB acknowledge supports by University Paris Diderot, Sorbonne, Paris Cite (France), FC acknowledge supports by University de La Reunion, Faculty of Sciences and Technology. NS and AdB acknowledge to Indo-French Centre for the Promotion of Advanced Research / CEFIPRA for collaborative grant (number 5302-2). Research in NS laboratory is also supported by Department of Biotechnology, Government of India. NS is a J.C. Bose National Fellow.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARGOS P, 1987, J MOL BIOL, V197, P331, DOI 10.1016/0022-2836(87)90127-6; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bystroff C, 1996, CURR OPIN BIOTECH, V7, P417, DOI 10.1016/S0958-1669(96)80117-0; Cheng HT, 2007, BIOINFORMATICS, V23, P2628, DOI 10.1093/bioinformatics/btm379; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern Alexandre G, 2004, In Silico Biol, V4, P381; Dong QW, 2008, PROTEINS, V72, P163, DOI 10.1002/prot.21904; Dudev M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-106; Etchebest C, 2005, PROTEINS, V59, P810, DOI 10.1002/prot.20458; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Ghouzam Y, 2015, BIOINFORMATICS, V31, P3782, DOI 10.1093/bioinformatics/btv462; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joseph AP, 2011, BIOCHIMIE, V93, P1434, DOI 10.1016/j.biochi.2011.04.010; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2004, PROTEINS, V55, P508, DOI 10.1002/prot.20008; Karypis G, 2006, PROTEINS, V64, P575, DOI 10.1002/prot.21036; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Kolodny R, 2002, J MOL BIOL, V323, P297, DOI 10.1016/S0022-2836(02)00942-7; Luo JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00795-4; Mahajan S, 2015, PROTEIN SCI, V24, P145, DOI 10.1002/pro.2581; Nguyen L.A.T., 2014, BIOMEDICAL SCI ENG, V7, P927, DOI DOI 10.4236/JBISE.2014.711090; Offmann B, 2007, CURR BIOINFORM, V2, P165, DOI 10.2174/157489307781662105; Rangwala H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-439; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Schneider B, 2014, NUCLEIC ACIDS RES, V42, P3381, DOI 10.1093/nar/gkt1273; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Suresh V, 2015, NUCLEIC ACIDS RES, V43, P1370, DOI 10.1093/nar/gkv020; Suresh V, 2014, PROTEIN PEPTIDE LETT, V21, P736; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, PROTEINS, V65, P32, DOI 10.1002/prot.21087; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wu CY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq478; Zimmermann O, 2008, J CHEM INF MODEL, V48, P1903, DOI 10.1021/ci800178a	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2017	12	11							e0186215	10.1371/journal.pone.0186215	http://dx.doi.org/10.1371/journal.pone.0186215			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN4OQ	29161266	Green Published, gold, Green Submitted			2022-12-27	WOS:000415987000004
J	Chen, L; Hsi, RS; Yang, FF; Sherer, BA; Stoller, ML; Ho, SP				Chen, Ling; Hsi, Ryan S.; Yang, Feifei; Sherer, Benjamin A.; Stoller, Marshall L.; Ho, Sunita P.			Anatomically-specific intratubular and interstitial biominerals in the human renal medullo-papillary complex	PLOS ONE			English	Article							COLLOIDAL-GOLD IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVE BONE SIALOPROTEIN; MINERALIZED TISSUE PROTEINS; OSTEOCALCIN-DEFICIENT MICE; NEPHRON-SPARING SURGERY; RANDALLS PLAQUES; STONE FORMATION; AVIAN EGGSHELL; IN-VITRO; HYDROXYAPATITE FORMATION	Limited information exists on the anatomically-specific early stage events leading to clinically detectable mineral aggregates in the renal papilla. In this study, quantitative multiscale correlative maps of structural, elemental and biochemical properties of whole medullo-papillary complexes from human kidneys were developed. Correlative maps of properties specific to the uriniferous and vascular tubules using high-resolution X-ray computed tomography, scanning and transmission electron microscopy, energy dispersive X-ray spectroscopy, and immunolocalization of noncollagenous proteins (NCPs) along with their association with anatomy specific biominerals were obtained. Results illustrated that intratubular spherical aggregates primarily form at the proximal regions distant from the papillary tip while interstitial spherical and fibrillar aggregates are distally located near the papillary tip. Biominerals at the papillary tip were closely localized with 10 to 50 mu m diameter vasa recta immunolocalized for CD31 inside the medullo-papillary complex. Abundant NCPs known to regulate bone mineralization were localized within nanoparticles, forming early pathologic mineralized regions of the complex. Based on the physical association between vascular and urothelial tubules, results from light and electron microscopy techniques suggested that these NCPs could be delivered from vasculature to prompt calcification of the interstitial regions or they might be synthesized from local vascular smooth muscle cells after transdifferentiation into osteoblast-like phenotypes. In addition, results provided insights into the plausible temporal events that link the anatomically specific intratubular mineral aggregates with the interstitial biomineralization processes within the functional unit of the kidney.	[Chen, Ling; Yang, Feifei; Ho, Sunita P.] Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, San Francisco, CA 94143 USA; [Hsi, Ryan S.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Sherer, Benjamin A.; Stoller, Marshall L.; Ho, Sunita P.] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Vanderbilt University; University of California System; University of California San Francisco	Ho, SP (corresponding author), Univ Calif San Francisco, Sch Dent, Dept Prevent & Restorat Dent Sci, Div Biomat & Bioengn, San Francisco, CA 94143 USA.; Ho, SP (corresponding author), Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA.	sunita.ho@ucsf.edu	Ho, Sunita P/B-1084-2008	Hsi, Ryan/0000-0003-1652-694X	National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK) [R21DK109912-01]; NIDDK [P20DK100863]; National Institutes of Dental and Craniofacial Research (NIDCR) [R01DE022032]	National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Financial support was through R21DK109912-01 to Drs. Ho (contact) and Stoller (Co-PI) from National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK). Additionally, support was provided by NIDDK - P20DK100863 (to MLS) and the National Institutes of Dental and Craniofacial Research (NIDCR) - R01DE022032 (to SPH) all of which can be accessed from NIH RePORTER (https.//projectreporter.nih.gov/reporter.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2008, J BONE MINER RES, V23, P1638, DOI 10.1359/JBMR.080601; Addison WN, 2010, J BONE MINER RES, V25, P1191, DOI 10.1002/jbmr.110; Arabmotlagh M, 2006, J ORTHOP RES, V24, P1336, DOI 10.1002/jor.20162; AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E; Boskey AL, 1998, BONE, V23, P187, DOI 10.1016/S8756-3282(98)00092-1; Boskey AL, 2016, MATRIX BIOLOGY JOURN; Bouleftour W, 2016, MATRIX BIOL, V52-54, P60, DOI 10.1016/j.matbio.2015.12.011; CAMARDA AJ, 1987, CALCIFIED TISSUE INT, V40, P349, DOI 10.1007/BF02556698; Campbell S, 2017, THE JOURNAL OF UROLO; Chen L, 2015, BONE, V71, P7, DOI 10.1016/j.bone.2014.09.021; Chien YC, 2008, J STRUCT BIOL, V163, P84, DOI 10.1016/j.jsb.2008.04.008; Chien YC, 2009, CELLS TISSUES ORGANS, V189, P38, DOI 10.1159/000151374; Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Evan A, 2006, KIDNEY INT, V69, P1313, DOI 10.1038/sj.ki.5000238; Evan AP, 2006, KIDNEY INT, V69, P2227, DOI 10.1038/sj.ki.5000268; Evan AP, 2008, SEMIN NEPHROL, V28, P111, DOI 10.1016/j.semnephrol.2008.01.004; Evan AP, 2015, ANAT REC, V298, P865, DOI 10.1002/ar.23105; Evan AP, 2015, UROLITHIASIS, V43, pS19, DOI 10.1007/s00240-014-0701-0; Evan AP, 2010, PEDIATR NEPHROL, V25, P831, DOI 10.1007/s00467-009-1116-y; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Fassbender WJ, 2000, IN VIVO, V14, P619; Flade K, 2001, CHEM MATER, V13, P3596, DOI 10.1021/cm011063z; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gericke A, 2005, CALCIFIED TISSUE INT, V77, P45, DOI 10.1007/s00223-004-1288-1; GERSTENFELD LC, 1995, ANN NY ACAD SCI, V760, P67, DOI 10.1111/j.1749-6632.1995.tb44621.x; Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246; GUARNER V, 1989, DIABETES, V38, P410, DOI 10.2337/diabetes.38.4.410; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; HAUSCHKA PV, 1989, ANAT REC, V224, P180, DOI 10.1002/ar.1092240208; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; Hincke MT, 2008, J HISTOCHEM CYTOCHEM, V56, P467, DOI 10.1369/jhc.2008.950576; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; Hsi RS, 2016, BJU INT; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Hunter GK, 1996, J DENT RES, V75, P913; Khan SR, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.8; Khan SR, 2016, ANAT REC, V299, P5, DOI 10.1002/ar.23275; Khan SR, 2015, UROLITHIASIS, V43, pS109, DOI 10.1007/s00240-014-0705-9; Khan SR, 2012, J UROLOGY, V187, P1094, DOI 10.1016/j.juro.2011.10.125; Kumar V, 2006, J INVEST MED, V54, P412, DOI 10.2310/6650.2006.06021; Kumari S, 1997, J POLYM SCI POL CHEM, V35, P927, DOI 10.1002/(SICI)1099-0518(19970415)35:5<927::AID-POLA7>3.0.CO;2-H; Kuo RL, 2003, KIDNEY INT, V64, P2150, DOI 10.1046/j.1523-1755.2003.00316.x; Li JQ, 2016, J BONE MINER METAB, V34, P367, DOI 10.1007/s00774-015-0734-7; Liu Y, 2010, AM J PHYSIOL-RENAL, V299, pF469, DOI 10.1152/ajprenal.00243.2010; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294; Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0; Matlaga BR, 2006, J UROLOGY, V175, P1720, DOI 10.1016/S0022-5347(05)01017-7; Matlaga BR, 2007, J UROLOGY, V177, P31, DOI 10.1016/j.juro.2006.08.088; MCKEE MD, 1993, J BONE MINER RES, V8, P485; MCKEE MD, 1995, MICROSC RES TECHNIQ, V31, P44, DOI 10.1002/jemt.1070310105; MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x; McKee MD, 1996, J BONE MINER RES, V11, P873; MCKEE MD, 1995, J BONE MINER RES, V10, P1913; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Ogawa-Furuya N, 2013, OSTEOPOROSIS INT, V24, P2223, DOI 10.1007/s00198-013-2289-6; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Oury F, 2013, CELL, V155, P228, DOI 10.1016/j.cell.2013.08.042; Paldanius PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063036; Pallone TL, 2003, AM J PHYSIOL-REG I, V284, pR1153, DOI 10.1152/ajpregu.00657.2002; Pearle MS, 2005, J UROLOGY, V173, P848, DOI 10.1097/01.ju.0000152082.14384.d7; Raynal C, 1996, ENDOCRINOLOGY, V137, P2347, DOI 10.1210/en.137.6.2347; RITTER NM, 1992, J BONE MINER RES, V7, P877; Rowe PSN, 2006, J BONE MINER RES, V21, pS11; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Seibel MJ, 1996, J CLIN ENDOCR METAB, V81, P3289, DOI 10.1210/jc.81.9.3289; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Stoller ML, 2004, J UROLOGY, V171, P1920, DOI 10.1097/01.ju.0000120291.90839.49; Sugiyama T, 2001, J BONE MINER METAB, V19, P146, DOI 10.1007/s007740170034; Taylor ER, 2015, UROLITHIASIS, V43, pS41, DOI 10.1007/s00240-014-0718-4; Tiselius HG, 2013, UROLITHIASIS, V41, P369, DOI 10.1007/s00240-013-0602-7; Tiselius HG, 2011, UROL RES, V39, P231, DOI 10.1007/s00240-010-0349-3; Tobert CM, 2012, UROLOGY, V80, P157, DOI 10.1016/j.urology.2012.03.025; Trion A, 2004, AM HEART J, V147, P808, DOI 10.1016/j.ahj.2003.10.047; Uzzo RG, 2001, J UROLOGY, V166, P6, DOI 10.1016/S0022-5347(05)66066-1; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Wiener S, 2014, J ENDOUROL, V28, P807, DOI 10.1089/end.2013.0640; Williams JC, 2013, J NEPHROL, V26, P25, DOI 10.5301/jn.5000208; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yamauchi M, 2010, CLIN NUTR, V29, P761, DOI 10.1016/j.clnu.2010.02.010; Yao YC, 2013, CIRC RES, V113, P495, DOI 10.1161/CIRCRESAHA.113.301792	84	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2017	12	11							e0187103	10.1371/journal.pone.0187103	http://dx.doi.org/10.1371/journal.pone.0187103			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM8YO	29145401	Green Published, gold			2022-12-27	WOS:000415378800009
J	Sethumadhavan, S; Silva, M; Philbrook, P; Nguyen, T; Hatfield, SM; Ohta, A; Sitkovsky, MV				Sethumadhavan, Shalini; Silva, Murillo; Philbrook, Phaethon; Thao Nguyen; Hatfield, Stephen M.; Ohta, Akio; Sitkovsky, Michail V.			Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells	PLOS ONE			English	Article							FACTOR (HIF)-1-ALPHA; PEPTIDE TRANSPORTER; MELANOMA-CELLS; EXPRESSION; CANCER; GENE; IMMUNOTHERAPY; CARCINOMA; MICROENVIRONMENT; IMMUNOGENICITY	Human cancers are known to downregulate Major Histocompatibility Complex (MHC) class I expression thereby escaping recognition and rejection by anti-tumor T cells. Here we report that oxygen tension in the tumor microenvironment (TME) serves as an extrinsic cue that regulates antigen presentation by MHC class I molecules. In support of this view, hypoxia is shown to negatively regulate MHC expression in a HIF-dependent manner as evidenced by (i) lower MHC expression in the hypoxic TME in vivo and in hypoxic 3-dimensional (3D) but not 2-dimensional (2D) tumor cell cultures in vitro; (ii) decreased MHC in human renal cell carcinomas with constitutive expression of HIF due to genetic loss of von Hippel-Lindau (VHL) function as compared with isogenically paired cells with restored VHL function, and iii) increased MHC in tumor cells with siRNA-mediated knockdown of HIF. In addition, hypoxia downregulated antigen presenting proteins like TAP 1/2 and LMP7 that are known to have a dominant role in surface display of peptide-MHC complexes. Corroborating oxygen-dependent regulation of MHC antigen presentation, hyperoxia (60% oxygen) transcriptionally upregulated MHC expression and increased levels of TAP2, LMP2 and 7. In conclusion, this study reveals a novel mechanism by which intra-tumoral hypoxia and HIF can potentiate immune escape. It also suggests the use of hyperoxia to improve tumor cell-based cancer vaccines and for mining novel immune epitopes. Furthermore, this study highlights the advantage of 3D cell cultures in reproducing hypoxia-dependent changes observed in the TME.	[Sethumadhavan, Shalini; Silva, Murillo; Philbrook, Phaethon; Thao Nguyen; Hatfield, Stephen M.; Ohta, Akio; Sitkovsky, Michail V.] Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA; [Sitkovsky, Michail V.] Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Sitkovsky, MV (corresponding author), Northeastern Univ, New England Inflammat & Tissue Protect Inst, Boston, MA 02115 USA.; Sitkovsky, MV (corresponding author), Harvard Inst Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	m.sitkovsky@neu.edu	Silva, Murillo/I-4863-2017	Silva, Murillo/0000-0003-4668-6290	Northeastern University; NIH [R01 CA-111985, R01GM-097320, R01 CA-112561, R21AT 002788]	Northeastern University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by the following: Northeastern University and NIH grants (PI: M.S.) R01 CA-111985; R01GM-097320; R01 CA-112561; R21AT 002788.	Aptsiauri N, 2008, CANCER IMMUNOL IMMUN, V57, P1727, DOI 10.1007/s00262-008-0532-3; Barbash ZS, 2013, MOL CELL BIOL, V33, P4395, DOI 10.1128/MCB.00553-13; Barsoum IB, 2014, CANCER RES, V74, P7185, DOI 10.1158/0008-5472.CAN-14-2598; Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Carretero R, 2008, IMMUNOGENETICS, V60, P439, DOI 10.1007/s00251-008-0303-5; Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Escors D., 2014, NEW J SCI, V2014; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garrido C, 2011, CANCER IMMUNOL IMMUN, V60, P1257, DOI 10.1007/s00262-011-1027-1; Grandis JR, 2000, CLIN CANCER RES, V6, P2794; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hatfield SM, 2014, J MOL MED, V92, P1283, DOI 10.1007/s00109-014-1189-3; Howcroft TK, 2003, MOL CELL BIOL, V23, P3377, DOI 10.1128/MCB.23.10.3377-3391.2003; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivanov SV, 2007, ONCOGENE, V26, P802, DOI 10.1038/sj.onc.1209842; Jarosinski KW, 2002, J NEUROIMMUNOL, V122, P74, DOI 10.1016/S0165-5728(01)00467-2; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Leo C, 2004, SEMIN RADIAT ONCOL, V14, P207, DOI 10.1016/j.semradonc.2004.04.007; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Meissner M, 2005, CLIN CANCER RES, V11, P2552, DOI 10.1158/1078-0432.CCR-04-2146; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Montoya M, 1999, J IMMUNOL, V163, P1914; Mu J, 2014, J IMMUNOL, V192, P2892, DOI 10.4049/jimmunol.1302847; Ohta A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00027; Oliveira CC, 2011, EUR J IMMUNOL, V41, P3114, DOI 10.1002/eji.201141836; Perier A, 2011, ONCOGENE, V30, P2622, DOI 10.1038/onc.2010.638; Philip B, 2013, CARCINOGENESIS, V34, P1699, DOI 10.1093/carcin/bgt209; Pradeu T, 2006, P NATL ACAD SCI USA, V103, P17858, DOI 10.1073/pnas.0608683103; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schmitt TM, 2015, CLIN CANCER RES, V21, P5191, DOI 10.1158/1078-0432.CCR-15-0860; Seliger B, 2001, CANCER RES, V61, P1095; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shinojima T, 2007, CARCINOGENESIS, V28, P529, DOI 10.1093/carcin/bgl143; Siemens DR, 2008, CANCER RES, V68, P4746, DOI 10.1158/0008-5472.CAN-08-0054; Sijts AJAM, 2000, J IMMUNOL, V164, P4500, DOI 10.4049/jimmunol.164.9.4500; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Srivastava PK, 2013, CANCER IMMUNOL IMMUN, V62, P967, DOI 10.1007/s00262-013-1422-x; van den Elsen PJ, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00048; van den Elsen PJ, 2004, CURR OPIN IMMUNOL, V16, P67, DOI 10.1016/j.coi.2003.11.015; White CA, 1998, INT J CANCER, V75, P590	46	58	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2017	12	11							e0187314	10.1371/journal.pone.0187314	http://dx.doi.org/10.1371/journal.pone.0187314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN1NI	29155844	Green Published, gold, Green Submitted			2022-12-27	WOS:000415756700009
J	Akter, A; Biella, P; Klecka, J				Akter, Asma; Biella, Paolo; Klecka, Jan			Effects of small-scale clustering of flowers on pollinator foraging behaviour and flower visitation rate	PLOS ONE			English	Article							FLORAL DISPLAY SIZE; PROPORTIONALLY FEWER FLOWERS; PARTIAL PREY CONSUMPTION; INFLORESCENCE SIZE; SEED SET; REPRODUCTIVE SUCCESS; INSECT VISITATION; PLANT-DENSITY; PATCH SIZE; RESOURCES	Plants often grow in clusters of various sizes and have a variable number of flowers per inflorescence. This small-scale spatial clustering affects insect foraging strategies and plant reproductive success. In our study, we aimed to determine how visitation rate and foraging behaviour of pollinators depend on the number of flowers per plant and on the size of clusters of multiple plants using Dracocephalum moldavica (Lamiaceae) as a target species. We measured flower visitation rate by observations of insects visiting single plants and clusters of plants with different numbers of flowers. Detailed data on foraging behaviour within clusters of different sizes were gathered for honeybees, Apis mellifera, the most abundant visitor of Dracocephalum in the experiments. We found that the total number of flower visitors increased with the increasing number of flowers on individual plants and in larger clusters, but less then proportionally. Although individual honeybees visited more flowers in larger clusters, they visited a smaller proportion of flowers, as has been previously observed. Consequently, visitation rate per flower and unit time peaked in clusters with an intermediate number of flowers. These patterns do not conform to expectations based on optimal foraging theory and the ideal free distribution model. We attribute this discrepancy to incomplete information about the distribution of resources. Detailed observations and video recordings of individual honeybees also showed that the number of flowers had no effect on handling time of flowers by honeybees. We evaluated the implications of these patterns for insect foraging biology and plant reproduction.	[Akter, Asma; Biella, Paolo; Klecka, Jan] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic; [Akter, Asma; Biella, Paolo] Univ South Bohemia, Dept Zool, Fac Sci, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Klecka, J (corresponding author), Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic.	jan.klecka@entu.cas.cz	Klecka, Jan/H-7874-2014; Akter, Asma/AAE-2499-2021; Biella, Paolo/AAZ-5886-2020	Klecka, Jan/0000-0003-0633-3896; Akter, Asma/0000-0002-6336-2768; Biella, Paolo/0000-0003-2297-006X	Czech Science Foundation [GP14-10035P, GJ17-24795Y]; University of South Bohemia [GA JU 152/2016/P]	Czech Science Foundation(Grant Agency of the Czech Republic); University of South Bohemia	This project was supported by the Czech Science Foundation (projects GP14-10035P and GJ17-24795Y awarded to JK). AA and PB were also supported by a grant GA JU 152/2016/P provided by the University of South Bohemia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1986, BEHAV ECOL SOCIOBIOL, V19, P409, DOI 10.1007/BF00300543; ANDERSSON S, 1991, HOLARCTIC ECOL, V14, P186; Anic V, 2015, PLANT BIOLOGY, V17, P720, DOI 10.1111/plb.12293; ASTROM M, 1990, J ANIM ECOL, V59, P287, DOI 10.2307/5173; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Blaauw BR, 2014, BASIC APPL ECOL, V15, P701, DOI 10.1016/j.baae.2014.10.001; Brody AK, 1997, OECOLOGIA, V110, P86, DOI 10.1007/s004420050136; Brunet J, 2015, INT J PLANT SCI, V176, P811, DOI 10.1086/683339; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Conner JK, 1996, OECOLOGIA, V105, P509, DOI 10.1007/BF00330014; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Danderson CA, 2010, AM MIDL NAT, V163, P234, DOI 10.1674/0003-0031-163.1.234; DEJONG TJ, 1992, OECOLOGIA, V89, P310, DOI 10.1007/BF00317407; DREISIG H, 1995, OIKOS, V72, P161, DOI 10.2307/3546218; Eliassen S, 2007, OIKOS, V116, P513, DOI 10.1111/j.2006.0030-1299.15462.x; EMLEN JM, 1966, AM NAT, V100, P611, DOI 10.1086/282455; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Garbuzov M, 2015, ACTA OECOL, V62, P53, DOI 10.1016/j.actao.2014.12.002; Garcia-Meneses PM, 2012, BASIC APPL ECOL, V13, P516, DOI 10.1016/j.baae.2012.08.011; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; GILLER PS, 1980, J ANIM ECOL, V49, P699, DOI 10.2307/4222; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P61, DOI 10.1017/CBO9780511542268.005; Goulson D, 1998, OECOLOGIA, V113, P502, DOI 10.1007/s004420050402; Goulson D, 2000, OIKOS, V91, P485, DOI 10.1034/j.1600-0706.2000.910309.x; Grindeland JM, 2005, FUNCT ECOL, V19, P383, DOI 10.1111/j.1365-2435.2005.00988.x; HASSELL MP, 1976, J ANIM ECOL, V45, P135, DOI 10.2307/3772; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; Hegland SJ, 2014, FUNCT ECOL, V28, P561, DOI 10.1111/1365-2435.12223; Ishihama F, 2007, PLANT SPEC BIOL, V22, P167, DOI 10.1111/j.1442-1984.2007.00189.x; JENNERSTEN O, 1993, OIKOS, V68, P283, DOI 10.2307/3544841; Jha S, 2009, OIKOS, V118, P1174, DOI 10.1111/j.1600-0706.2009.17523.x; Krushelnycky PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088948; Kunin WE, 1997, J ECOL, V85, P225, DOI 10.2307/2960653; LUCAS JR, 1985, ANIM BEHAV, V33, P945, DOI 10.1016/S0003-3472(85)80029-4; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Milberg P, 1997, FLORA, V192, P361; Mitchell RJ, 2004, FUNCT ECOL, V18, P116, DOI 10.1111/j.1365-2435.2004.00812.x; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Ohashi K, 2002, FUNCT ECOL, V16, P492, DOI 10.1046/j.1365-2435.2002.00644.x; Ohashi K, 1998, AM J BOT, V85, P219, DOI 10.2307/2446309; Olsson O, 2006, OIKOS, V112, P260, DOI 10.1111/j.0030-1299.2006.13548.x; PATON DC, 1993, BIOSCIENCE, V43, P95, DOI 10.2307/1311970; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; R Development Core Team, 2009, R LANG ENV STAT COMP; Ruane LG, 2014, ANN BOT-LONDON, V113, P887, DOI 10.1093/aob/mcu007; Schmid B, 2016, ECOGRAPHY, V39, P619, DOI 10.1111/ecog.01621; SCHMITT J, 1983, OECOLOGIA, V60, P97, DOI 10.1007/BF00379326; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Stephens David W., 1993, P195; Stoffel MA, METHODS ECO IN PRESS; Thomson JD, 1988, EVOL ECOL, V2, P65, DOI 10.1007/BF02071589; Vaughton G, 1998, OECOLOGIA, V115, P93, DOI 10.1007/s004420050495; Wood S.N., 2017, GEN ADDITIVE MODELS, P476, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; ZIMMERMAN M, 1980, ECOLOGY, V61, P497, DOI 10.2307/1937414	56	21	21	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2017	12	11							e0187976	10.1371/journal.pone.0187976	http://dx.doi.org/10.1371/journal.pone.0187976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FM5YZ	29136042	Green Published, gold, Green Submitted			2022-12-27	WOS:000415121200053
